PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Austin, PJ; Bembrick, AL; Denyer, GS; Keay, KA				Austin, Paul J.; Bembrick, Alison L.; Denyer, Gareth S.; Keay, Kevin A.			Injury-Dependent and Disability-Specific Lumbar Spinal Gene Regulation following Sciatic Nerve Injury in the Rat	PLOS ONE			English	Article							CHRONIC CONSTRICTION INJURY; CATECHOL-O-METHYLTRANSFERASE; PERIPHERAL BENZODIAZEPINE-RECEPTOR; SUBSTANTIA-GELATINOSA NEURONS; IMAGE NEUROPATHIC PAIN; LONG-TERM CHANGES; DORSAL-HORN; CENTRAL SENSITIZATION; ANIMAL-MODEL; NOCICEPTIVE NEURONS	Allodynia, hyperalgesia and spontaneous pain are cardinal sensory signs of neuropathic pain. Clinically, many neuropathic pain patients experience affective-motivational state changes, including reduced familial and social interactions, decreased motivation, anhedonia and depression which are severely debilitating. In earlier studies we have shown that sciatic nerve chronic constriction injury (CCI) disrupts social interactions, sleep-wake-cycle and endocrine function in one third of rats, a subgroup reliably identified six days after injury. CCI consistently produces allodynia and hyperalgesia, the intensity of which was unrelated either to the altered social interactions, sleep-wake-cycle or endocrine changes. This decoupling of the sensory consequences of nerve injury from the affective-motivational changes is reported in both animal experiments and human clinical data. The sensory changes triggered by CCI are mediated primarily by functional changes in the lumbar dorsal horn, however, whether lumbar spinal changes may drive different affective-motivational states has never been considered. In these studies, we used microarrays to identify the unique transcriptomes of rats with altered social behaviours following sciatic CCI to determine whether specific patterns of lumbar spinal adaptations characterised this subgroup. Rats underwent CCI and on the basis of reductions in dominance behaviour in resident-intruder social interactions were categorised as having Pain & Disability, Pain & Transient Disability or Pain alone. We examined the lumbar spinal transcriptomes two and six days after CCI. Fifty-four 'disability-specific' genes were identified. Sixty-five percent were unique to Pain & Disability rats, two-thirds of which were associated with neurotransmission, inflammation and/or cellular stress. In contrast, 40% of genes differentially regulated in rats without disabilities were involved with more general homeostatic processes (cellular structure, transcription or translation). We suggest that these patterns of gene expression lead to either the expression of disability, or to resilience and recovery, by modifying local spinal circuitry at the origin of ascending supraspinal pathways.	[Austin, Paul J.; Bembrick, Alison L.; Keay, Kevin A.] Univ Sydney, Sch Med Sci Anat & Histol, Sydney, NSW 2006, Australia; [Denyer, Gareth S.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Keay, KA (corresponding author), Univ Sydney, Sch Med Sci Anat & Histol, Sydney, NSW 2006, Australia.	keay@anatomy.usyd.edu.au	Denyer, Gareth/M-5417-2016	Denyer, Gareth/0000-0003-1551-3936; Austin, Paul/0000-0001-5253-6876; Keay, Kevin Anthony/0000-0003-3934-4380	National Health and Medical Research Council [457490]; NWG Macintosh Memorial Research Fund	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NWG Macintosh Memorial Research Fund	Support was provided by the National Health and Medical Research Council (# 457490; KAK [https://www.nhmrc.gov.au/] NWG Macintosh Memorial Research Fund (KAK; ALB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Ahmadi S, 2001, MOL PHARMACOL, V59, P612, DOI 10.1124/mol.59.3.612; Alexander JK, 2012, EXP NEUROL, V236, P351, DOI 10.1016/j.expneurol.2012.04.018; Andersen ML, 2003, BRAIN RES, V984, P84, DOI 10.1016/S0006-8993(03)03095-6; Andersen ML, 2009, PROG NEURO-PSYCHOPH, V33, P960, DOI 10.1016/j.pnpbp.2009.04.022; Austin PJ, 2010, NEUROSCIENCE, V171, P329, DOI 10.1016/j.neuroscience.2010.08.040; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Avila-Martin G, 2015, EUR J PAIN, V19, P111, DOI 10.1002/ejp.528; Bai HP, 2014, J NEUROL SCI, V341, P68, DOI 10.1016/j.jns.2014.04.002; Baird AJ, 2013, PHYS THER, V93, P1615, DOI 10.2522/ptj.20120429; Bardin L, 2000, PAIN, V86, P11, DOI 10.1016/S0304-3959(99)00307-3; Bay-Nielsen M, 2001, ANN SURG, V233, P1, DOI 10.1097/00000658-200101000-00001; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bhangoo SK, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-48; Bond BC, 2002, MOL BRAIN RES, V106, P101, DOI 10.1016/S0169-328X(02)00417-5; Bravo L, 2012, ANESTHESIOLOGY, V117, P613, DOI 10.1097/ALN.0b013e3182657b3e; Briscini L, 2002, EUR J PHARMACOL, V447, P59, DOI 10.1016/S0014-2999(02)01833-2; Busch AK, 2002, DIABETES, V51, P977, DOI 10.2337/diabetes.51.4.977; Cafferty WBJ, 2004, J NEUROSCI, V24, P4432, DOI 10.1523/JNEUROSCI.2245-02.2004; Cardoso-Cruz H, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00043; Casellas P, 2002, NEUROCHEM INT, V40, P475, DOI 10.1016/S0197-0186(01)00118-8; Caspani O, 2014, PHARMACOL BIOCHEM BE, V124, P290, DOI 10.1016/j.pbb.2014.06.018; Catheline G, 1999, PAIN, V80, P347, DOI 10.1016/S0304-3959(98)00234-6; Chiang CY, 2007, J NEUROSCI, V27, P9068, DOI 10.1523/JNEUROSCI.2260-07.2007; Clemens S, 2004, J NEUROSCI, V24, P11337, DOI 10.1523/JNEUROSCI.3698-04.2004; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Daigo E, 2012, NEUROSCI LETT, V529, P39, DOI 10.1016/j.neulet.2012.09.007; Davis DA, 2005, CLIN J PAIN, V21, P398, DOI 10.1097/01.ajp.0000149795.08746.31; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; DeLeo JA, 1996, J INTERF CYTOK RES, V16, P695, DOI 10.1089/jir.1996.16.695; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Dominguez E, 2008, J NEUROCHEM, V107, P50, DOI 10.1111/j.1471-4159.2008.05566.x; Fishbain DA, 2014, PAIN PRACT, V14, P515, DOI 10.1111/papr.12090; Fishbain DA, 2012, PAIN MED, V13, P552, DOI 10.1111/j.1526-4637.2012.01358.x; Franek M, 2004, PHYSIOL RES, V53, P351; Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Grace PM, 2012, J NEUROCHEM, V122, P976, DOI 10.1111/j.1471-4159.2012.07833.x; GRANT E. C, 1963, BEHAVIOUR, V21, P246, DOI 10.1163/156853963X00185; Gregoire S, 2012, PAIN, V153, P1657, DOI 10.1016/j.pain.2012.04.023; Griffin RS, 2007, J NEUROSCI, V27, P8699, DOI 10.1523/JNEUROSCI.2018-07.2007; Guo W, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-35; Hama AT, 2004, NEUROSCI LETT, V358, P21, DOI 10.1016/j.neulet.2003.12.111; Hegyi Z, 2009, EUR J NEUROSCI, V30, P251, DOI 10.1111/j.1460-9568.2009.06816.x; Hu B, 2009, PAIN, V143, P206, DOI 10.1016/j.pain.2009.02.018; Hummel M, 2008, NEUROSCIENCE, V155, P492, DOI 10.1016/j.neuroscience.2008.05.041; Hummel M, 2008, PAIN, V140, P436, DOI 10.1016/j.pain.2008.09.020; Ibuki T, 1997, NEUROSCIENCE, V76, P845, DOI 10.1016/S0306-4522(96)00341-7; Jancalek R, 2011, ANN NEUROSCI, V18, P123, DOI [10.5214/ans.0972.7531.11183010, 10.5214/ans.0972-7531.11183010]; Jarvis MF, 2002, P NATL ACAD SCI USA, V99, P17179, DOI 10.1073/pnas.252537299; JASMIN L, 1994, J NEUROSCI, V14, P7252; Jergova S, 2005, EUR J PAIN, V9, P345, DOI 10.1016/j.ejpain.2004.09.002; Jiang ES, 2012, J NEUROCHEM, V121, P526, DOI 10.1111/j.1471-4159.2012.07694.x; Ju J, 2013, NEUROSCI LETT, V542, P118, DOI 10.1016/j.neulet.2013.03.026; Kambur O, 2010, BRIT J PHARMACOL, V161, P1553, DOI 10.1111/j.1476-5381.2010.00999.x; Kambur O, 2011, EUR J PAIN, V15, P732, DOI 10.1016/j.ejpain.2010.12.001; Karchewski LA, 2004, EUR J NEUROSCI, V20, P671, DOI 10.1111/j.1460-9568.2004.03530.x; Karhunen T, 1996, NEUROSCIENCE, V73, P267, DOI 10.1016/0306-4522(96)00016-4; Katano T, 2008, EUR J NEUROSCI, V27, P3161, DOI 10.1111/j.1460-9568.2008.06293.x; Keay KA, 2004, NEUROSCI LETT, V361, P188, DOI 10.1016/j.neulet.2003.12.010; Keeler BE, 2012, EXP NEUROL, V238, P273, DOI 10.1016/j.expneurol.2012.09.002; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Kennis JHH, 1997, EXP NEUROL, V147, P18, DOI 10.1006/exnr.1997.6576; Kilburn-Watt E, 2014, BRAIN RES BULL, V107, P110, DOI 10.1016/j.brainresbull.2014.07.004; Kilburn-Watt E, 2010, J NEUROENDOCRINOL, V22, P960, DOI 10.1111/j.1365-2826.2010.02038.x; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; King T, 2009, NAT NEUROSCI, V12, P1364, DOI 10.1038/nn.2407; Kondo D, 2009, J PHARMACOL SCI, V110, P55, DOI 10.1254/jphs.09028FP; Kontinen VK, 2003, PHYSIOL BEHAV, V78, P241, DOI 10.1016/S0031-9384(02)00966-6; Kontinen VK, 1999, PAIN, V80, P341, DOI 10.1016/S0304-3959(98)00230-9; Kunori S, 2009, NEUROSCIENCE, V163, P362, DOI 10.1016/j.neuroscience.2009.05.069; LaBuda CJ, 2000, EXP NEUROL, V163, P490, DOI 10.1006/exnr.2000.7395; LaBuda CJ, 2005, NEUROSCIENCE, V136, P311, DOI 10.1016/j.neuroscience.2005.07.010; LaCroix-Fralish ML, 2011, PAIN, V152, P1888, DOI 10.1016/j.pain.2011.04.014; LaCroix-Fralish ML, 2007, PAIN, V131, DOI 10.1016/j.pain.2007.04.041; LaGraize SC, 2004, EXP NEUROL, V188, P139, DOI 10.1016/j.expneurol.2004.04.003; LASCELLE.RG, 1966, BRIT J PSYCHIAT, V112, P651, DOI 10.1192/bjp.112.488.651; Lee HL, 2004, NEUROREPORT, V15, P2807; Lee KM, 2010, EUR J PAIN, V14, DOI 10.1016/j.ejpain.2009.10.017; Leite-Almeida H, 2012, PAIN, V153, P2218, DOI 10.1016/j.pain.2012.07.007; Leitner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073370; Leys LJ, 2013, PAIN, V154, P1092, DOI 10.1016/j.pain.2013.03.019; Li Q, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/158987; Li SS, 2014, NEUROSCI LETT, V560, P21, DOI 10.1016/j.neulet.2013.12.012; Lim G, 2003, PAIN, V105, P275, DOI 10.1016/S0304-3959(03)00242-2; Lim J, 2006, BRAIN RES, V1123, P80, DOI 10.1016/j.brainres.2006.09.059; Liu C, 2006, J NEUROPHYSIOL, V96, P2984, DOI 10.1152/jn.00498.2006; Matsumura S, 2010, NEUROSCIENCE, V170, P942, DOI 10.1016/j.neuroscience.2010.07.034; McCarson KE, 2005, BIOCHEM PHARMACOL, V71, P196, DOI 10.1016/j.bcp.2005.10.026; Meyer-Rosberg K, 2001, EUR J PAIN, V5, P391, DOI 10.1053/eujp.2001.0260; Mika J, 2011, NEUROPEPTIDES, V45, P247, DOI 10.1016/j.npep.2011.03.002; Milligan ED, 2003, J NEUROSCI, V23, P1026; Miyoshi K, 2008, J NEUROSCI, V28, P12775, DOI 10.1523/JNEUROSCI.3512-08.2008; Monassi CR, 2003, EUR J NEUROSCI, V17, P1907, DOI 10.1046/j.1460-9568.2003.02627.x; Moore KA, 2002, J NEUROSCI, V22, P6724, DOI 10.1523/jneurosci.22-15-06724.2002; Mor D, 2010, NEUROSCIENCE, V166, P1167, DOI 10.1016/j.neuroscience.2010.01.045; Mor D, 2013, CELL MOL NEUROBIOL, V33, P953, DOI 10.1007/s10571-013-9962-3; Mor D, 2011, J CHEM NEUROANAT, V41, P158, DOI 10.1016/j.jchemneu.2011.01.004; Murakami T, 2013, EXP THER MED, V6, P1194, DOI 10.3892/etm.2013.1296; MURPHY PG, 1995, J NEUROSCI, V15, P5130; Nackley AG, 2007, PAIN, V128, P199, DOI 10.1016/j.pain.2006.09.022; Nie FC, 2013, INT J MOL MED, V31, P1333, DOI 10.3892/ijmm.2013.1344; Nyilas R, 2009, EUR J NEUROSCI, V29, P1964, DOI 10.1111/j.1460-9568.2009.06751.x; Obata H, 2010, BRAIN RES, V1363, P72, DOI 10.1016/j.brainres.2010.09.105; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Parkitna JR, 2006, J PHYSIOL PHARMACOL, V57, P401; Pertovaara A, 2001, EXP NEUROL, V167, P425, DOI 10.1006/exnr.2000.7574; Pettersson LME, 2002, BRAIN RES, V945, P266, DOI 10.1016/S0006-8993(02)02817-2; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; PIEHL F, 1995, EUR J NEUROSCI, V7, P2101, DOI 10.1111/j.1460-9568.1995.tb00632.x; Pirildar Sebnem, 2003, Psychopharmacol Bull, V37, P127; Qu CL, 2011, PAIN, V152, P1641, DOI 10.1016/j.pain.2011.03.002; Roeska K, 2008, PAIN, V139, P349, DOI 10.1016/j.pain.2008.05.003; Roeska K, 2009, NEUROSCI LETT, V464, P160, DOI 10.1016/j.neulet.2009.08.031; SCHNITZER J, 1981, J CELL BIOL, V90, P435, DOI 10.1083/jcb.90.2.435; Schoeniger-Skinner DK, 2007, BRAIN BEHAV IMMUN, V21, P660, DOI 10.1016/j.bbi.2006.10.010; Schroder W, 2014, BRIT J PHARMACOL, V171, P3777, DOI 10.1111/bph.12744; Seminowicz DA, 2009, NEUROIMAGE, V47, P1007, DOI 10.1016/j.neuroimage.2009.05.068; Shiokawa H, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-26; Stamer UM, 2007, CURR OPIN ANESTHESIO, V20, P478, DOI 10.1097/ACO.0b013e3282ef6b2c; Sternbach R A, 1974, Clin Neurosurg, V21, P323; Streit WJ, 2000, J NEUROSCI RES, V61, P10, DOI 10.1002/1097-4547(20000701)61:1<10::AID-JNR2>3.0.CO;2-E; Sun H, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-11; Takahashi T, 2013, J PHARMACOL SCI, V122, P51, DOI 10.1254/jphs.13029SC; Tamae A, 2005, J PHYSIOL-LONDON, V568, P243, DOI 10.1113/jphysiol.2005.091843; Tammimaki A, 2012, PHARMACOGENET GENOM, V22, P673, DOI 10.1097/FPC.0b013e3283560c46; Taniguchi W, 2011, PAIN, V152, P95, DOI 10.1016/j.pain.2010.09.034; Thacker MA, 2009, EUR J PAIN, V13, P263, DOI 10.1016/j.ejpain.2008.04.017; TIMMERMANS G, 1974, SCIENCE, V184, P806, DOI 10.1126/science.184.4138.806; Toki H, 1998, J NEUROCHEM, V71, P913; Tokunaga S, 2007, BIOL PHARM BULL, V30, P2088, DOI 10.1248/bpb.30.2088; Tsuboi Y, 2011, EUR J NEUROSCI, V34, P292, DOI 10.1111/j.1460-9568.2011.07747.x; Tsuda M, 2010, BRAIN RES REV, V63, P222, DOI 10.1016/j.brainresrev.2009.11.003; Twining CM, 2004, PAIN, V110, P299, DOI 10.1016/j.pain.2004.04.008; Venneti S, 2007, EXP NEUROL, V207, P118, DOI 10.1016/j.expneurol.2007.06.003; Villarinho JG, 2013, PROG NEURO-PSYCHOPH, V44, P136, DOI 10.1016/j.pnpbp.2013.02.005; Villarinho JG, 2012, EUR J PHARMACOL, V690, P107, DOI 10.1016/j.ejphar.2012.06.042; Wang S, 2007, PAIN, V131, P96, DOI 10.1016/j.pain.2006.12.019; Wang SX, 2005, J NEUROSCI, V25, P488, DOI 10.1523/JNEUROSCI.4127-04.2005; Wang XL, 2011, NEUROSCI LETT, V490, P112, DOI 10.1016/j.neulet.2010.12.038; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Yang LA, 2004, EUR J NEUROSCI, V19, P871, DOI 10.1111/j.0953-816X.2004.03121.x; Zhang SZ, 2014, PAIN, V155, P1504, DOI 10.1016/j.pain.2014.04.026; Zhu LJ, 2005, ANAL BIOCHEM, V345, P102, DOI 10.1016/j.ab.2005.07.028; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546	147	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124755	10.1371/journal.pone.0124755	http://dx.doi.org/10.1371/journal.pone.0124755			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905723	Green Published, Green Submitted, gold			2022-12-27	WOS:000353332000087
J	Hamasur, B; Bruchfeld, J; van Helden, P; Kallenius, G; Svenson, S				Hamasur, Beston; Bruchfeld, Judith; van Helden, Paul; Kallenius, Gunilla; Svenson, Stefan			A Sensitive Urinary Lipoarabinomannan Test for Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIAL LIPOARABINOMANNAN; LAM-ELISA; DIAGNOSIS; ASSAY; FEATURES; HIV	We have previously developed a diagnostic test for tuberculosis based on detection of mycobacterial lipoarabinomannan (LAM) in urine. The method depended on a laborious concentration step. We have now developed an easy to perform test based on a magnetic immunoassay platform, utilizing high avidity monoclonal antibodies for the detection of LAM in urine. With this method the analytical sensitivity of the assay was increased 50-100-fold compared to conventional ELISA. In a pilot study of HIV-negative patients with microbiologically verified TB (n=17) and healthy controls (n=22) the sensitivity of the test was 82% and the specificity 100%. This is in stark positive contrast to a range of studies using available commercial tests with polyclonal anti-LAM Abs where the sensitivity of the tests in HIV-negative TB patients was very low.	[Hamasur, Beston; Kallenius, Gunilla; Svenson, Stefan] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Bruchfeld, Judith] Karolinska Inst Solna, Inst Med, Infect Dis Unit, Stockholm, Sweden; [Bruchfeld, Judith] Karolinska Univ Hosp, Stockholm, Sweden; [van Helden, Paul] Univ Stellenbosch, Div Mol Biol & Human Genet, DST NRF Ctr Excellence Biomed TB Res, US MRC Ctr TB Res,Fac Hlth Sci, ZA-7505 Tygerberg, South Africa	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; National Research Foundation - South Africa; Stellenbosch University	Hamasur, B (corresponding author), Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden.	beston.hamasur@ki.se	Källenius, Gunilla/AGZ-3956-2022		European Community; Swedish Medical Research Council; King Oscar II Jubilee Foundation; Swedish Heart-Lung Foundation; European Union [221948]; ICONZ (Integrated Control of Neglected Zoonoses); Foundation for Innovative New Diagnostics	European Community(European Commission); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); King Oscar II Jubilee Foundation; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); European Union(European Commission); ICONZ (Integrated Control of Neglected Zoonoses); Foundation for Innovative New Diagnostics	The study was in the early stage supported by grants from the European Community, the Swedish Medical Research Council, King Oscar II Jubilee Foundation, the Swedish Heart-Lung Foundation and funding from the European Union's Seventh Framework Program (FP7/2007-2013) under grant agreement no 221948, ICONZ (Integrated Control of Neglected Zoonoses). The production of mAbs against LAM was partially funded by Foundation for Innovative New Diagnostics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehme C, 2005, T ROY SOC TROP MED H, V99, P893, DOI 10.1016/j.trstmh.2005.04.014; CHAN J, 1991, INFECT IMMUN, V59, P1755, DOI 10.1128/IAI.59.5.1755-1761.1991; CHATTERJEE D, 1991, J BIOL CHEM, V266, P9652; Chatterjee D, 1998, GLYCOBIOLOGY, V8, P113, DOI 10.1093/glycob/8.2.113; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6228; Conesa-Botella A, 2011, JAIDS-J ACQ IMM DEF, V58, P463, DOI 10.1097/QAI.0b013e31823801de; Dheda K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009848; Hamasur B, 2004, CLIN EXP IMMUNOL, V138, P30, DOI 10.1111/j.1365-2249.2004.02593.x; Hamasur B, 2001, J MICROBIOL METH, V45, P41, DOI 10.1016/S0167-7012(01)00239-1; HUNTER SW, 1986, J BIOL CHEM, V261, P2345; Kerkhoff AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103285; Lawn SD, 2009, AIDS, V23, P1875, DOI 10.1097/QAD.0b013e32832e05c8; Mazurek J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042515; Minion J, 2011, EUR RESPIR J, V38, P1398, DOI 10.1183/09031936.00025711; Mutetwa R, 2009, INT J TUBERC LUNG D, V13, P1253; Pai NP, 2012, DISCOV MED, V13, P35; Reither K, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-141; Schmidt R, 2011, J PROTEOME RES, V10, P1316, DOI 10.1021/pr101070j; Shah M, 2010, J CLIN MICROBIOL, V48, P2972, DOI 10.1128/JCM.00363-10; Steingart KR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001062; Tessema TA, 2002, SCAND J INFECT DIS, V34, P167, DOI 10.1080/00365540110077254; Tessema TA, 2001, SCAND J INFECT DIS, V33, P279, DOI 10.1080/003655401300077306	22	34	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123457	10.1371/journal.pone.0123457	http://dx.doi.org/10.1371/journal.pone.0123457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905641	Green Published, Green Submitted, gold			2022-12-27	WOS:000353332000032
J	Pan, T; Wu, SH; Liu, YJ				Pan, Tao; Wu, Shaohong; Liu, Yujie			Relative Contributions of Land Use and Climate Change to Water Supply Variations over Yellow River Source Area in Tibetan Plateau during the Past Three Decades	PLOS ONE			English	Article							MANAGING ECOSYSTEM SERVICES; LOESS PLATEAU; IMPACTS; VARIABILITY; DEGRADATION; CATCHMENT; FUTURE; REGION; COVER	There is increasing evidence of environmental change impacts on ecosystem processes and services, yet poor understanding of the relative contributions of land use and climate change to ecosystem services variations. Based on detailed meteorological, hydrological records and satellite data over the Yellow River Source Area (YRSA) in Tibetan Plateau from 1980s to 2008, together with a water-yield module of Integrated Valuation of Ecosystem Services and Tradeoffs (InVEST) model and also a Residual Trends (RESTREND) method, we assessed the water supply variations in YRSA during the past three decades and disentangled the relative contributions of land use and climate change. Results show that water supply significantly decreased from 1980 to 2005 and then increased from 2005 to 2008. The quantity slightly decreased from 283.01mm in 1980 to 276.95mm in 1995, 270.12mm in 2000 and 267.97mm in 2005, and it then rebounded slightly to 275.26mm in 2008. The water supply variation ranged from 283.01mm to 267.97mm. Climate change contributed dominantly to water supply decrease from 1980 to 1995, which accounts for approximately 64% of the decrease. During 1995 to 2000, land use contributed more and about 58% to the water supply decrease as the intense human activities. From 2000 to 2005, climate change became a positive contribution to the water supply as the increased precipitation, but the land use still contributed negatively. From 2005 to 2008, both climate and land use have positive impacts, but land use contributed about 61% to the water supply increase. The implementation of the Three Rivers Source Area Ecological Protection Project has greatly improved the vegetation coverage conditions and the water retention ability during this period. We recommend that the implementation of ecological projects, grazing policies and artificial improvement of degraded grassland would help to conserve the water retention ability and increase water supply.	[Pan, Tao; Wu, Shaohong; Liu, Yujie] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Land Surface Pattern & Simulat, Beijing 100101, Peoples R China; [Pan, Tao; Liu, Yujie] Michigan State Univ, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48823 USA	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Michigan State University	Pan, T (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Land Surface Pattern & Simulat, Beijing 100101, Peoples R China.	T.pantao@igsnrr.ac.cn; wush@igsnrr.ac.cn			National Natural Science Foundation of China [41301092]; National Science and Technology Support Program [2012BAC19B10, 2013BAC03B04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program	This study is supported by National Natural Science Foundation of China (41301092) http://www.nsfc.gov.cn/, National Science and Technology Support Program (2012BAC19B10 & 2013BAC03B04) http://www.most.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JD, 2013, P NATL ACAD SCI USA, V110, P372, DOI 10.1073/pnas.1213841110; Allen R. G., 1998, FAO Irrigation and Drainage Paper; [Anonymous], 2005, EC HUM WELL BEING SY; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Brauman KA, 2007, ANNU REV ENV RESOUR, V32, P67, DOI 10.1146/annurev.energy.32.031306.102758; Budyko MI., 1974, CLIMATE LIFE; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Chen Long, 2011, Journal of Resources and Ecology, V2, P322; Cowling Richard, 2010, P NATL ACAD SCI USA, V105, P9483; Daily GC, 2008, P NATL ACAD SCI USA, V105, P9455, DOI 10.1073/pnas.0804960105; Ennaanay D., 2006, THESIS U MINNESOTA; Evans J, 2004, J ARID ENVIRON, V57, P535, DOI 10.1016/S0140-1963(03)00121-6; Field C.B., 2014, CLIM CHANG 2014 IMP, P1, DOI [DOI 10.1038/446727A, 10.1017/CBO9781107415379]; Fu BJ, 2011, ECOL COMPLEX, V8, P284, DOI 10.1016/j.ecocom.2011.07.003; [聂忆黄 Gong Bin], 2010, [地学前缘, Earth Science Frontiers], V17, P373; Guo ZW, 2000, ECOL APPL, V10, P925, DOI 10.1890/1051-0761(2000)010[0925:AAOESW]2.0.CO;2; Hamel P., 2014, HYDROL EARTH SYST SC, V11, P11001, DOI DOI 10.5194/hessd-11-11001-2014; Hutchinson M.F., 1991, BMRC RES REP, V27, P104; HUTCHINSON MF, 1994, GEODERMA, V62, P45, DOI 10.1016/0016-7061(94)90027-2; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Lawler JJ, 2014, P NATL ACAD SCI USA, V111, P7492, DOI 10.1073/pnas.1405557111; Li Z, 2009, J HYDROL, V377, P35, DOI 10.1016/j.jhydrol.2009.08.007; Liu JY, 2010, J GEOGRAPHICAL SCI, V18, P259; Lorencova E, 2013, LAND USE POLICY, V33, P183, DOI 10.1016/j.landusepol.2012.12.012; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031782; Minville M, 2010, J HYDROL, V358, P70; Nelson EJ, 2013, FRONT ECOL ENVIRON, V11, P483, DOI 10.1890/120312; Pielke RA, 2011, WIRES CLIM CHANGE, V2, P828, DOI 10.1002/wcc.144; Polasky S, 2011, ENVIRON RESOUR ECON, V48, P219, DOI 10.1007/s10640-010-9407-0; Salhab J, 2010, J FOOD AGRIC ENVIRON, V8, P1367; Sanchez-Canales M, 2012, SCI TOTAL ENVIRON, V440, P140, DOI 10.1016/j.scitotenv.2012.07.071; Shi Y, 2012, CHINESE SCI BULL, V57, P2120, DOI 10.1007/s11434-012-4978-5; Su CH, 2012, ACTA OECOL, V44, P46, DOI 10.1016/j.actao.2011.11.006; Su CH, 2013, GLOBAL PLANET CHANGE, V101, P119, DOI 10.1016/j.gloplacha.2012.12.014; Tallis H. T., 2013, INVEST 2 5 3 USERS G; Tallis HM, 2006, TRENDS ECOL EVOL, V21, P562, DOI 10.1016/j.tree.2006.07.009; Wang GX, 2012, AGR FOREST METEOROL, V162, P44, DOI 10.1016/j.agrformet.2012.04.006; Wang GX, 2009, GEODERMA, V149, P280, DOI 10.1016/j.geoderma.2008.12.008; Wen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058432; Wessels KJ, 2007, J ARID ENVIRON, V68, P271, DOI 10.1016/j.jaridenv.2006.05.015; World Commission on Dams, 2000, DAMS DEV NEW FRAMEWO; Yin YH, 2010, AGR WATER MANAGE, V95, P77; Zhang CanQiang, 2012, Journal of Resources and Ecology, V3, P50; Zhang L, 2001, WATER RESOUR RES, V37, P701, DOI 10.1029/2000WR900325; Zhang YY, 2012, J GEOGR SCI, V22, P781, DOI 10.1007/s11442-012-0963-9; Zhou GY, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008829; [Zhou Wenzuo 周文佐], 2005, Journal of Geographical Sciences, V15, P3, DOI 10.1007/BF02873101	47	26	29	6	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123793	10.1371/journal.pone.0123793	http://dx.doi.org/10.1371/journal.pone.0123793			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906192	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000046
J	Wilson, JL; Yu, J; Taylor, L; Polgar, P				Wilson, Jamie L.; Yu, Jun; Taylor, Linda; Polgar, Peter			Hyperplastic Growth of Pulmonary Artery Smooth Muscle Cells from Subjects with Pulmonary Arterial Hypertension Is Activated through JNK and p38 MAPK	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; PROTEIN-KINASE; PROLIFERATION; INHIBITION; RECEPTORS; THERAPY; FOXM1; TRANSDUCTION; CONTRIBUTES; PROGRESSION	Smooth muscle in the pulmonary artery of PAH subjects, both idiopathic and hereditary, is characterized by hyperplasia. Smooth muscle cells HPASMC) isolated from subjects with or without PAH retain their in vivo phenotype as illustrated by their expression of alphasmooth muscle actin and expression of H-caldesmon. Both non PAH and PAH HPASMC display a lengthy, approximately 94h, cell cycle. The HPASMC from both idiopathic and hereditary PAH display an abnormal proliferation characterized by continued growth under non-proliferative, non-growth stimulated conditions. This effector independent proliferation is JNK and p38 MAP kinase dependent. Blocking the activation of either abrogates the HPASMC growth. HPASMC from non PAH donors under quiescent conditions display negligible proliferation but divide upon exposure to growth factors such as PDGF-BB or FGF2 but not EGF. This growth does not involve the MAP kinases. Instead it routes via the tyrosine kinase receptor through mTOR and then 6SK. In the PAH cells PDGF-BB and FGF2 augment the dysregulated cell proliferation, also through mTOR/6SK. Additionally, blocking the activation of mTOR also modulates the MAP kinase promoted dysregulated growth. These results highlight key alterations in the growth of HPASMC from subjects with PAH which contribute to the etiology of the disease and can clearly be targeted at various regulatory points for future therapies.	[Wilson, Jamie L.; Yu, Jun; Taylor, Linda; Polgar, Peter] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Polgar, P (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	peterp@bu.edu	Wilson, Jamie/J-5913-2019		National Institutes of Health/National Lung, Heart, and Blood Institute [HL25776]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL025776] Funding Source: NIH RePORTER	National Institutes of Health/National Lung, Heart, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health/National Lung, Heart, and Blood Institute Grant HL25776. All of the authors were supported by this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2011, AM J RESP CELL MOL, V45, P804, DOI 10.1165/rcmb.2010-0371OC; Aldred MA, 2010, AM J RESP CRIT CARE, V182, P1153, DOI 10.1164/rccm.201003-0491OC; Bertero T, 2014, J CLIN INVEST, V124, P3514, DOI 10.1172/JCI74773; Brown RD, 2013, AM J PHYSIOL-HEART C, V304, pH269, DOI 10.1152/ajpheart.00158.2012; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Coffey ET, 2002, J NEUROSCI, V22, P4335, DOI 10.1523/JNEUROSCI.22-11-04335.2002; Comhair SAA, 2012, AM J RESP CELL MOL, V46, P723, DOI 10.1165/rcmb.2011-0416TE; Cronan MR, 2012, ONCOGENE, V31, P3889, DOI 10.1038/onc.2011.544; Dahal BK, 2010, AM J RESP CRIT CARE, V181, P158, DOI 10.1164/rccm.200811-1682OC; Davies RJ, 2012, AM J PHYSIOL-LUNG C, V302, pL604, DOI 10.1152/ajplung.00309.2011; Eddahibi S, 2006, CIRCULATION, V113, P1857, DOI 10.1161/CIRCULATIONAHA.105.591321; Francis RE, 2009, INT J ONCOL, V35, P57, DOI 10.3892/ijo_00000313; Frazier AA, 2012, SEMIN ULTRASOUND CT, V33, P535, DOI 10.1053/j.sult.2012.06.002; GABBIANI G, 1981, P NATL ACAD SCI-BIOL, V78, P298, DOI 10.1073/pnas.78.1.298; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Ghofrani HA, 2010, AM J RESP CRIT CARE, V182, P1171, DOI 10.1164/rccm.201001-0123OC; GLUKHOVA MA, 1988, P NATL ACAD SCI USA, V85, P9542, DOI 10.1073/pnas.85.24.9542; Goncharov DA, 2014, CIRCULATION, V129, P864, DOI 10.1161/CIRCULATIONAHA.113.004581; Goncharova EA, 2002, AM J PHYSIOL-LUNG C, V283, pL354, DOI 10.1152/ajplung.00010.2002; Hoeper MM, 2013, CIRCULATION, V127, P1128, DOI 10.1161/CIRCULATIONAHA.112.000765; Izikki M, 2009, J CLIN INVEST, V119, P512, DOI 10.1172/JCI35070; Jin NJ, 2000, AM J RESP CELL MOL, V23, P593, DOI 10.1165/ajrcmb.23.5.3921; Jonigk D, 2011, AM J PATHOL, V179, P167, DOI 10.1016/j.ajpath.2011.03.040; Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004; Krymskaya VP, 2011, FASEB J, V25, P1922, DOI 10.1096/fj.10-175018; Lu J, 2004, J THORAC CARDIOV SUR, V128, P850, DOI 10.1016/j.jtcvs.2004.03.003; Marcos E, 2004, CIRC RES, V94, P1263, DOI 10.1161/01.RES.0000126847.27660.69; Marcos E, 2005, CHEST, V128, p552S, DOI 10.1378/chest.128.6_suppl.552S; Mori S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088891; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Ogasawara T, 2003, INT J HEMATOL, V77, P364, DOI 10.1007/BF02982645; Perros F, 2008, AM J RESP CRIT CARE, V178, P81, DOI 10.1164/rccm.200707-1037OC; Ruan CH, 2010, TEX HEART I J, V37, P391; Savai R, 2014, NAT MED, V20, P1289, DOI 10.1038/nm.3695; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Sengupta A, 2013, CIRC RES, V112, P267, DOI 10.1161/CIRCRESAHA.112.277442; Sitbon O, 2005, CIRCULATION, V111, P3105, DOI 10.1161/CIRCULATIONAHA.104.488486; SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787; Taylor CA, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-35; Watanabe K, 2000, AM J CLIN PATHOL, V113, P663, DOI 10.1309/JNQX-F4KM-Q0Q0-7XK8; Wei L, 2010, AM J PHYSIOL-LUNG C, V298, pL863, DOI 10.1152/ajplung.00281.2009; Wilkins MR, 2008, EUR RESPIR J, V32, P198, DOI 10.1183/09031936.00124007; Wilson JL, 2012, EXP CELL RES, V318, P1125, DOI 10.1016/j.yexcr.2012.03.029; Yang XD, 2005, CIRC RES, V96, P1053, DOI 10.1161/01.RES.0000166926.54293.68; Yu J, 2015, CHEM BIOL DRUG DES, V85, P586, DOI 10.1111/cbdd.12446; Yu J, 2015, J CELL BIOCHEM, V116, P386, DOI 10.1002/jcb.24987; Yu J, 2013, J CELL PHYSIOL, V228, P322, DOI 10.1002/jcp.24132; Yuan JXJ, 1998, CIRCULATION, V98, P1400, DOI 10.1161/01.CIR.98.14.1400; Zeng Z, 2010, CARDIOVASC THER, V28, P23, DOI 10.1111/j.1755-5922.2009.00115.x; Zhang S, 2003, AM J PHYSIOL-LUNG C, V285, pL740, DOI 10.1152/ajplung.00284.2002; Zhang YM, 2014, J MANUF PROCESS, V16, P1, DOI 10.1016/j.jmapro.2013.12.004	52	27	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123662	10.1371/journal.pone.0123662	http://dx.doi.org/10.1371/journal.pone.0123662			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905460	Green Published, Green Submitted, gold			2022-12-27	WOS:000353332000040
J	Winkler, T; Melo, MFV; Degani-Costa, LH; Harris, RS; Correia, JA; Musch, G; Venegas, JG				Winkler, Tilo; Melo, Marcos F. Vidal; Degani-Costa, Luiza H.; Harris, R. Scott; Correia, John A.; Musch, Guido; Venegas, Jose G.			Estimation of Noise-Free Variance to Measure Heterogeneity	PLoS One			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PULMONARY PERFUSION; FRACTAL ANALYSIS; PET IMAGES; QUANTITATIVE-ANALYSIS; LUNG PERFUSION; BLOOD-FLOW; 3D PET; VENTILATION; STATISTICS	Variance is a statistical parameter used to characterize heterogeneity or variability in data sets. However, measurements commonly include noise, as random errors superimposed to the actual value, which may substantially increase the variance compared to a noise-free data set. Our aim was to develop and validate a method to estimate noise-free spatial heterogeneity of pulmonary perfusion using dynamic positron emission tomography (PET) scans. On theoretical grounds, we demonstrate a linear relationship between the total variance of a data set derived from averages of n multiple measurements, and the reciprocal of n. Using multiple measurements with varying n yields estimates of the linear relationship including the noise-free variance as the constant parameter. In PET images, n is proportional to the number of registered decay events, and the variance of the image is typically normalized by the square of its mean value yielding a coefficient of variation squared (CV2). The method was evaluated with a Jaszczak phantom as reference spatial heterogeneity (CVr2) for comparison with our estimate of noise-free or ' true' heterogeneity (CVt2). We found that CVt2 was only 5.4% higher than CVr2. Additional evaluations were conducted on 38 PET scans of pulmonary perfusion using (NN)-N-13-saline injection. The mean CVt2 was 0.10 (range: 0.03-0.30), while the mean CV2 including noise was 0.24 (range: 0.10-0.59). CVt2 was in average 41.5% of the CV2 measured including noise (range: 17.8-71.2%). The reproducibility of CVt(2) was evaluated using three repeated PET scans from five subjects. Individual CVt2 were within 16% of each subject's mean and paired t-tests revealed no difference among the results from the three consecutive PET scans. In conclusion, our method provides reliable noise-free estimates of CVt2 in PET scans, and may be useful for similar statistical problems in experimental data.	[Winkler, Tilo; Melo, Marcos F. Vidal; Musch, Guido; Venegas, Jose G.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Winkler, Tilo; Melo, Marcos F. Vidal; Degani-Costa, Luiza H.; Harris, R. Scott; Correia, John A.; Musch, Guido; Venegas, Jose G.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Degani-Costa, Luiza H.; Harris, R. Scott] Massachusetts Gen Hosp, Dept Med, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Correia, John A.] Massachusetts Gen Hosp, Dept Radiol, Radiol Cyclotron Lab, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Winkler, T (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA.	twinkler@mgh.harvard.edu	Melo, Marcos Vidal/AAN-7219-2020; Winkler, Tilo/B-5337-2009; Falcao, Luiza Helena Degani Costa/T-2207-2019	Winkler, Tilo/0000-0002-7276-5550; Falcao, Luiza Helena Degani Costa/0000-0001-5968-7853	National Heart, Lung, and Blood Institute of the National Institutes of Health [R01HL087281, R01HL068011, R01HL121228]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121228, R01HL068011, R01HL087281] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported by National Heart, Lung, and Blood Institute of the National Institutes of Health under award numbers R01HL087281, R01HL068011, and R01HL121228. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert N M, 1982, IEEE Trans Med Imaging, V1, P142, DOI 10.1109/TMI.1982.4307561; ALPERT NM, 1991, J CEREBR BLOOD F MET, V11, pA26, DOI 10.1038/jcbfm.1991.33; Buvat I, 2002, PHYS MED BIOL, V47, P1761, DOI 10.1088/0031-9155/47/10/311; CARSON RE, 1993, IEEE T MED IMAGING, V12, P240, DOI 10.1109/42.232252; Dahlbom M, 2002, IEEE T NUCL SCI, V49, P2062, DOI 10.1109/TNS.2002.803688; Dimitrakopoulou-Strauss A, 2001, J NUCL MED, V42, P248; Fessler JA, 1996, IEEE T IMAGE PROCESS, V5, P493, DOI 10.1109/83.491322; Fukuchi K, 2002, J NUCL MED, V43, P757; Galletti GG, 2002, J APPL PHYSIOL, V93, P1104, DOI 10.1152/japplphysiol.00910.2001; Harris RS, 2006, AM J RESP CRIT CARE, V174, P245, DOI 10.1164/rccm.200510-1634OC; Harris RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053216; Hero AO, 1996, IEEE T SIGNAL PROCES, V44, P2026, DOI 10.1109/78.533723; HUESMAN RH, 1984, PHYS MED BIOL, V29, P543, DOI 10.1088/0031-9155/29/5/007; Kalliokoski KK, 2000, EUR J APPL PHYSIOL, V83, P395, DOI 10.1007/s004210000267; Kalliokoski KK, 2001, EUR J NUCL MED, V28, P450, DOI 10.1007/s002590000458; KING RB, 1990, ANN BIOMED ENG, V18, P111, DOI 10.1007/BF02368424; Lee JS, 2004, J NEUROIMAGING, V14, P350, DOI 10.1177/1051228404268566; Li HH, 1997, IEEE T NUCL SCI, V44, P225, DOI 10.1109/23.568811; Maitra R, 1997, J COMPUT GRAPH STAT, V6, P132, DOI 10.2307/1390729; Melo MFV, 2010, J NUCL MED, V51, P57, DOI 10.2967/jnumed.109.065185; Melo MFV, 2003, J NUCL MED, V44, P1982; Mijailovich SM, 1997, J APPL PHYSIOL, V82, P1154, DOI 10.1152/jappl.1997.82.4.1154; Musch G, 2002, J APPL PHYSIOL, V93, P1841, DOI 10.1152/japplphysiol.00223.2002; O'Sullivan F, 2003, BIOSTATISTICS, V4, P433, DOI 10.1093/biostatistics/4.3.433; Oakes TR, 2000, IEEE T NUCL SCI, V47, P1233, DOI 10.1109/23.856577; Pajevic S, 1998, IEEE T MED IMAGING, V17, P9, DOI 10.1109/42.668691; PALMER MR, 1986, IEEE T NUCL SCI, V33, P439, DOI 10.1109/TNS.1986.4337138; Rose C., 2002, MATH STAT MATH; Rota KE, 1990, J COMPUT ASSIST TOMO, V14, P437; Treppo S, 1997, J APPL PHYSIOL, V82, P1163, DOI 10.1152/jappl.1997.82.4.1163; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; Venegas JG, 2000, J APPL PHYSIOL, V88, P1365, DOI 10.1152/jappl.2000.88.4.1365; Venegas JG, 1994, MED IMAGING 1994 PHY, P361; Votaw JR, 1996, IEEE T MED IMAGING, V15, P197, DOI 10.1109/42.491421; Wong Ching-yee Oliver, 2006, BMC Nucl Med, V6, P4, DOI 10.1186/1471-2385-6-4; Xu JH, 2001, EUR J NUCL MED, V28, P1795, DOI 10.1007/s002590100649	36	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123417	10.1371/journal.pone.0123417	http://dx.doi.org/10.1371/journal.pone.0123417			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906374	Green Published, Green Submitted, gold			2022-12-27	WOS:000353332000030
J	El Rahman, MA; Haase, D; Rentzsch, A; Olchvary, J; Schafers, HJ; Henn, W; Wagenpfeil, S; Abdul-Khaliq, H				El Rahman, Mohamed Abd; Haase, Denise; Rentzsch, Axel; Olchvary, Julia; Schaefers, Hans-Joachim; Henn, Wolfram; Wagenpfeil, Stefan; Abdul-Khaliq, Hashim			Left Ventricular Systolic Dysfunction in Asymptomatic Marfan Syndrome Patients Is Related to the Severity of Gene Mutation: Insights from the Novel Three Dimensional Speckle Tracking Echocardiography	PLOS ONE			English	Article							EJECTION FRACTION; STRAIN; ADULTS; HEART; IMPAIRMENT; MECHANICS; CHILDREN; VOLUMES; DISEASE; FBN1	Background In asymptomatic Marfan syndrome (MFS) patients we evaluated the relationship between the types of fibrillin-1 (FBN1) gene mutation and possible altered left ventricular (LV) function as assessed by three-dimensional speckle tracking echocardiography (3D-STE). Methods and Results Forty-five MFS patients (mean age 24 +/- 15 years) and 40 age-matched healthy controls were studied. Genetic evaluation for the FBN1 gene was carried on 32 MFS patients. Gene mutation (n = 15, 47%) was classified as mild when the mutation resulted in nearly normally functioning protein, while mutations resulting in abnormally function protein were considered to be severe (n = 17, 53%). All patients and controls underwent 3D-STE for evaluation of LV function by an echocardiographer blinded to the results of the genetic testing. Compared to controls, MFS patients had significantly lower 3D-STE derived LV ejection fraction (EF, 57.43 +/- 7.51 vs. 62.69 +/- 4.76%, p = 0.0001), global LV longitudinal strain (LS, 14.85 +/- 2.89 vs. 17.90 +/- 2.01%, p = 0.0001), global LV circumferential strain (CS, 13.93 +/- 2.81 vs. 16.82 +/- 2.17%, p = 0.0001) and global LV area strain (AS, 25.76 +/- 4.43 vs. 30.51 +/- 2.61%, p = 0.0001). Apart from the global LV LS all these parameters were significantly lower in patients with severe gene mutation than in those with mild mutation (p<0.05). In the multivariate linear regression analysis only the type of mutation had a significant influence on the 3D-STE derived LVEF (p = 0.017), global CS (p = 0.005) and global AS (p = 0.03). Conclusions In asymptomatic MFS patients latent LV dysfunction can be detected using 3D STE. The LV dysfunction is mainly related to the severity of gene mutation, suggesting possible primary cardiomyopathy in MFS patients.	[El Rahman, Mohamed Abd; Haase, Denise; Rentzsch, Axel; Olchvary, Julia; Abdul-Khaliq, Hashim] Saarland Univ Hosp, Dept Pediat Cardiol, Homburg, Germany; [El Rahman, Mohamed Abd] Cairo Univ, Dept Pediat Cardiol, Cairo, Egypt; [Schaefers, Hans-Joachim] Saarland Univ Hosp, Dept Thorac & Cardiovasc Surg, Homburg, Germany; [Henn, Wolfram] Saarland Univ Hosp, Dept Human Genet, Homburg, Germany; [Wagenpfeil, Stefan] Saarland Univ Hosp, Inst Med Biometry Epidemiol & Med Informat, Homburg, Germany	Universitatsklinikum des Saarlandes; Egyptian Knowledge Bank (EKB); Cairo University; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes	Abdul-Khaliq, H (corresponding author), Saarland Univ Hosp, Dept Pediat Cardiol, Homburg, Germany.	hashim.abdul-khaliq@uks.eu	Henn, Wolfram/AAU-1608-2020		Competence Network for Congenital Heart Defects - Federal Ministry of Education and Research (BMBF), Germany	Competence Network for Congenital Heart Defects - Federal Ministry of Education and Research (BMBF), Germany	This work was supported by the Competence Network for Congenital Heart Defects funded by the Federal Ministry of Education and Research (BMBF), Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El Rahman M, 2014, CARDIOL YOUNG, P1; Alpendurada F, 2010, EUR J HEART FAIL, V12, P1085, DOI 10.1093/eurjhf/hfq127; Aune E, 2009, EUR J ECHOCARDIOGR, V10, P738, DOI 10.1093/ejechocard/jep054; Cameli M, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-4; Cameli M, 2010, CARDIOVASC ULTRASOUN, V8, DOI 10.1186/1476-7120-8-14; Collod-Beroud G, 2003, HUM MUTAT, V22, P199, DOI 10.1002/humu.10249; Cook JR, 2014, J CLIN INVEST, V124, P1329, DOI 10.1172/JCI71059; Creemers EE, 2011, CARDIOVASC RES, V89, P265, DOI 10.1093/cvr/cvq308; Das BB, 2006, PEDIATR CARDIOL, V27, P256, DOI 10.1007/s00246-005-1139-5; De Backer JF, 2006, INT J CARDIOL, V112, P353, DOI 10.1016/j.ijcard.2005.10.010; de Witte P, 2011, HEART, V97, P2063, DOI 10.1136/heartjnl-2011-300169; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R; DIETZ HC, 1995, HUM MOL GENET, V4, P1799, DOI 10.1093/hmg/4.suppl_1.1799; DIETZ HC, 1991, GENOMICS, V9, P355, DOI 10.1016/0888-7543(91)90264-F; Hansegard J, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-18; HATLE L, 1984, HERZ, V9, P213; Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6; Kiotsekoglou A, 2011, ECHOCARDIOGR-J CARD, V28, P416, DOI 10.1111/j.1540-8175.2010.01359.x; Kiotsekoglou A, 2010, HELL J CARDIOL, V51, P501; Kleijn SA, 2012, EUR HEART J-CARD IMG, V13, P159, DOI 10.1093/ejechocard/jer174; Kleijn SA, 2011, J AM SOC ECHOCARDIOG, V24, P314, DOI 10.1016/j.echo.2011.01.014; Li RK, 1997, CIRCULATION, V96, P874; Miyoshi T, 2014, ECHOCARDIOGR-J CARD, V31, P848, DOI 10.1111/echo.12473; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; NISHIMURA RA, 1989, MAYO CLIN PROC, V64, P71, DOI 10.1016/S0025-6196(12)65305-1; Park Jae-Hyeong, 2011, J Cardiovasc Ultrasound, V19, P169, DOI 10.4250/jcu.2011.19.4.169; Pyeritz RE, 2009, HEART, V95, P173, DOI 10.1136/hrt.2008.160515; Riesenkampff E, 2010, AM J PHYSIOL-HEART C, V299, pH364, DOI 10.1152/ajpheart.00264.2010; ROMAN MJ, 1989, AM J CARDIOL, V63, P317, DOI 10.1016/0002-9149(89)90338-X; Rybczynski M, 2007, CLIN CARDIOL, V30, P19, DOI 10.1002/clc.3; SANCHEZQUINTANA D, 1995, ANAT RECORD, V243, P483, DOI 10.1002/ar.1092430411; SAVOLAINEN A, 1994, EUR HEART J, V15, P625, DOI 10.1093/oxfordjournals.eurheartj.a060558; Seguela PE, 2012, ECHOCARDIOGR-J CARD, V29, P492, DOI 10.1111/j.1540-8175.2011.01596.x; SILVERMAN DI, 1995, J AM COLL CARDIOL, V26, P1062, DOI 10.1016/0735-1097(95)00258-0; Tei C, 1995, J Cardiol, V26, P135; Urbano-Moral JA, 2013, EUR HEART J-CARD IMG, V14, P1167, DOI 10.1093/ehjci/jet065; Vahanian A, 2007, EUR HEART J, V28, P230, DOI 10.1093/eurheartj/ehl428; VRACKO R, 1990, J MOL CELL CARDIOL, V22, P749, DOI 10.1016/0022-2828(90)90087-I; Wen HL, 2011, EUR J ECHOCARDIOGR, V12, P910, DOI 10.1093/ejechocard/jer162; Xu TY, 2014, INT J CARDIOL, V176, P360, DOI 10.1016/j.ijcard.2014.07.015; Yetman AT, 2003, J AM COLL CARDIOL, V41, P329, DOI 10.1016/S0735-1097(02)02699-2; Yu HK, 2013, J AM SOC ECHOCARDIOG, V26, P846, DOI 10.1016/j.echo.2013.04.018	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124112	10.1371/journal.pone.0124112	http://dx.doi.org/10.1371/journal.pone.0124112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901601	gold, Green Submitted, Green Published			2022-12-27	WOS:000353331500077
J	Gitter, F; Gross, M; Piller, WE				Gitter, Frank; Gross, Martin; Piller, Werner E.			Sub-Decadal Resolution in Sediments of Late Miocene Lake Pannon Reveals Speciation of Cyprideis (Crustacea, Ostracoda)	PLOS ONE			English	Article							TOROSA CRUSTACEA; FLOCK CRUSTACEA; EVOLUTION; JONES; TANGANYIKA; SALINITY; EUROPE; BASIN; SHAPE	Late Miocene "Lake Pannon" (similar to 11.3 Ma) was a remnant of the Central Paratethyan Sea. Successive freshening and constantly changing environmental conditions, like oxygenation, nutrition and substrate led to a well-documented radiation in molluscs and ostracods. Among ostracods (small crustaceans), Cyprideis is one of the most common genera in "Lake Pannon", as well as in several other ancient lakes, showing numerous adaptations and speciations. Here, we present high-resolution data from an early transgression of "Lake Pannon" in the Eastern Styrian Basin (SE Austria). Mataschen clay pit is in the focus of geologic and paleontologic research since 20 years and its geologic and paleoecologic evolution is well-documented. We drilled five cores covering a similar to 2.3 m long section and completely sampled it in 5-mm thick intervals to reconstruct minute changes in the ostracod fauna over a transgression of a brackish water body. The dominant genus, Cyprideis, is represented by three species C. mataschensis, C. kapfensteinensis and C. ex gr. pannonica. Through morphometric analyses we highlight the variance of each taxon and suggest that there is no direct ecologic control on size or shape. Furthermore, we found a second, cooccurring morphotype of C. kapfensteinensis which is directly related to an elevation of salinities above 13 psu. The presence of two intermediate specimens between the two morphotypes in the sample directly below the first appearance of C. kapfensteinensis B leads us to the conclusion that we are facing a speciation event leading to four sympatric species of Cyprideis.	[Gitter, Frank; Gross, Martin] Universalmuseum Joanneum, Dept Geol & Palaeontol, A-8045 Graz, Austria; [Gitter, Frank; Piller, Werner E.] Graz Univ, Inst Earth Sci, NAWI Graz, A-8010 Graz, Austria	University of Graz	Piller, WE (corresponding author), Graz Univ, Inst Earth Sci, NAWI Graz, Heinrichstr 26, A-8010 Graz, Austria.	werner.piller@uni-graz.at		Gross, Martin/0000-0002-5113-6069; Piller, Werner E./0000-0003-2808-4720	Austrian Science Fund (FWF) [P21748-N21]; Austrian Science Fund (FWF) [P 21748] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work is financed through the Austrian Science Fund (http://www.fwf.ac.at/; FWF-project P21748-N21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello G, 2007, ACTA PALAEONTOL POL, V52, P563; ALADIN NV, 1993, OSTRACODA IN THE EARTH AND LIFE SCIENCES, P387; Aladin NV, 1996, J COMP PHYSIOL B, V166, P215, DOI 10.1007/BF00263985; Baltanas A, 1998, SEX AND PARTHENOGENESIS, P127; Baltanas A, 2000, HYDROBIOLOGIA, V419, P65, DOI 10.1023/A:1003994209369; Baltanas Angel, 2011, Joannea Geologie und Palaeontologie, V11, P235; BaltanuYs A., 2003, PALEONTOLOGICAL SOC, V9, P101, DOI DOI 10.1017/S1089332600002175; Bassiouni M.A., 1979, Geologisches Jahrbuch Reihe B, V31, P3; Bodergat AM, 1983, DOCUMENTS LAB GEOLOG, V88; Boomer I, 2011, JOANNEA GEOLOGIE PAL, V11, P26; COHEN A S, 1987, Palaios, V2, P426, DOI 10.2307/3514614; Cristescu ME, 2010, MOL ECOL, V19, P4837, DOI 10.1111/j.1365-294X.2010.04832.x; Danielopol Dan L., 2011, Joannea Geologie und Palaeontologie, V11, P273; Danielopol Dan L., 2008, Senckenbergiana Lethaea, V88, P147; Danielopol DL, 2008, CONTRIBUTION GEOMETR, P13; Decima A., 1964, Palaeontographia Italica, V57, P81; Elewa AMT, 2003, PALAEONT ELEC, V6, P11; Frenzel P, 2012, INT REV HYDROBIOL, V97, P314, DOI 10.1002/iroh.201211494; Gamenick I, 1996, MAR ECOL PROG SER, V144, P73, DOI 10.3354/meps144073; Gavrilets S, 2005, P NATL ACAD SCI USA, V102, P18040, DOI 10.1073/pnas.0506330102; Gross M., 2003, OSTERR AKAD WISS SCH, P11; Gross M, 2013, J S AM EARTH SCI, V42, P216, DOI 10.1016/j.jsames.2012.10.002; Gross M, 2011, PALAEOGEOGR PALAEOCL, V312, P181, DOI 10.1016/j.palaeo.2011.10.010; Gross Martin, 2008, Senckenbergiana Lethaea, V88, P161; Gross MD, 2004, PHARM BIOL, V42, P1, DOI 10.1080/13880200490893546; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HEIP C, 1976, OECOLOGIA, V24, P229, DOI 10.1007/BF00345475; Iepure S, 2007, HYDROBIOLOGIA, V585, P159, DOI 10.1007/s10750-007-0636-3; Jahn A, 1996, MAR ECOL PROG SER, V142, P215, DOI 10.3354/meps142215; Jones T.R., 1857, MONOGRAPH PALAEONTOG, V9, P1; Jones T.R., 1850, ANN MAGA ZINE NATURA, V6, P25; Kern AK, 2012, PALAEOGEOGR PALAEOCL, V317, P1, DOI 10.1016/j.palaeo.2011.11.021; Keyser D, 2005, HYDROBIOLOGIA, V538, P95, DOI 10.1007/s10750-004-4940-x; Keyser Dietmar, 2004, Studia Quaternaria, V21, P19; Kollmann K., 1960, Oesterreich Mitt geol Ges Wien, V51, P89; Krstic N., 1968, B MUSEUM HIST NATU A, V23, P153; Krstic N., 1968, B MUS HIST NAT BEL A, V23, P107; Ligios Silvia, 2012, Revue de Micropaleontologie, V55, P171, DOI 10.1016/j.revmic.2012.09.002; Linhart J, 2007, MORPHOMATICA VERSION; Martens K, 1997, TRENDS ECOL EVOL, V12, P177, DOI 10.1016/S0169-5347(97)01039-2; Matz H., 1970, Senckenbergiana Lethaea, V51, P1; Mehes G., 1908, FOLDTANI KOZLONY S, V38, P601; Meisch C, 2000, SUSSWASSERFAUNA MITT, V8, P522; Munoz-Torres FA, 2006, J S AM EARTH SCI, V21, P75, DOI 10.1016/j.jsames.2005.08.005; Namiotko T, 2012, INT REV HYDROBIOL, V97, P356, DOI 10.1002/iroh.201211496; Neubauer W, 2007, THESIS SALZBURG; Pint A, 2012, INT REV HYDROBIOL, V97, P330, DOI 10.1002/iroh.201111495; Reyment RA, 1997, B MATH BIOL, V59, P63; Reyment Richard A., 1993, Revista Espanola de Paleontologia, V8, P125; Rohlf FJ, 2009, TPSDIG DIGITIZE LAND; Rosenfeld A., 1976, ASPECTS ECOLOGY ZOOG, P55; Sames B, 2009, THESIS BERLIN; Sandberg P. A., 1964, Stockholm Contributions in Geology, V12, P1; Schon I, 2012, HYDROBIOLOGIA, V682, P91, DOI 10.1007/s10750-011-0935-6; SCHWEITZER PN, 1990, PALEOBIOLOGY, V16, P107, DOI 10.1017/S0094837300009830; Tanaka G, 2009, BIOL J LINN SOC, V97, P810, DOI 10.1111/j.1095-8312.2009.01222.x; van Harten D, 2000, HYDROBIOLOGIA, V419, P131, DOI 10.1023/A:1003935419364; Van Morkhoven FPCM, 1962, POSTPALAEOZOIC OSTRA, DOI [10.2108/zsj.26.846, DOI 10.2108/ZSJ.26.846]; VANHARTEN D, 1975, PALAEOGEOGR PALAEOCL, V17, P35, DOI 10.1016/0031-0182(75)90028-0; Vesper B., 1972, Mus lnst, V68, P21; Wesselingh Frank P., 2007, V29, P275; Whatley Robin, 1998, Bulletin Centre de Recherches Exploration-Production Elf-Aquitaine Memoire, V20, P231; Wouters K, 2001, HYDROBIOLOGIA, V450, P111, DOI 10.1023/A:1017547523121; Wouters Karel, 2008, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V78, P29	64	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0109360	10.1371/journal.pone.0109360	http://dx.doi.org/10.1371/journal.pone.0109360			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902063	gold, Green Submitted, Green Published			2022-12-27	WOS:000353331500001
J	Gonzalez-Rodriguez, D; Barakat, AI				Gonzalez-Rodriguez, David; Barakat, Abdul I.			Dynamics of Receptor-Mediated Nanoparticle Internalization into Endothelial Cells	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; ATOMIC-FORCE MICROSCOPY; SHEAR-STRESS; VISCOELASTIC PROPERTIES; NONSPHERICAL PARTICLES; MEMBRANE TENSION; ICAM-1; FLOW; ENDOCYTOSIS; SHAPE	Nanoparticles offer a promising medical tool for targeted drug delivery, for example to treat inflamed endothelial cells during the development of atherosclerosis. To inform the design of such therapeutic strategies, we develop a computational model of nanoparticle internalization into endothelial cells, where internalization is driven by receptor-ligand binding and limited by the deformation of the cell membrane and cytoplasm. We specifically consider the case of nanoparticles targeted against ICAM-1 receptors, of relevance for treating atherosclerosis. The model computes the kinetics of the internalization process, the dynamics of binding, and the distribution of stresses exerted between the nanoparticle and the cell membrane. The model predicts the existence of an optimal nanoparticle size for fastest internalization, consistent with experimental observations, as well as the role of bond characteristics, local cell mechanical properties, and external forces in the nanoparticle internalization process.	[Gonzalez-Rodriguez, David; Barakat, Abdul I.] Ecole Polytech, CNRS, UMR 7646, Lab Hydrodynam LadHyX, F-91128 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut Polytechnique de Paris	Gonzalez-Rodriguez, D (corresponding author), Ecole Polytech, CNRS, UMR 7646, Lab Hydrodynam LadHyX, F-91128 Palaiseau, France.	davidgr@alum.mit.edu; barakat@ladhyx.polytechnique.fr	Gonzalez-Rodriguez, David/AAY-7037-2021; Barakat, Abdul I/AAI-3117-2020	Barakat, Abdul I/0000-0002-7551-3631	Fondation pour la Recherche Medicale-France; AXA Research Fund	Fondation pour la Recherche Medicale-France(Fondation pour la Recherche Medicale); AXA Research Fund(AXA Research Fund)	The work was supported by the following: Fondation pour la Recherche Medicale-France (http://www.frm.org/); and AXA Research Fund (http://www.axa-research.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal NJ, 2007, J PHYS CHEM C, V111, P15848, DOI 10.1021/jp074514x; Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]; Bahrami AH, 2014, ADV COLLOID INTERFAC, V208, P214, DOI 10.1016/j.cis.2014.02.012; Barreiro O, 2008, J CELL BIOL, V183, P527, DOI 10.1083/jcb.200805076; BELL GI, 1984, BIOPHYS J, V45, P1051, DOI 10.1016/S0006-3495(84)84252-6; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bhowmick T, 2012, J CONTROL RELEASE, V157, P485, DOI 10.1016/j.jconrel.2011.09.067; Boulant S, 2011, NAT CELL BIOL, V13, P1124, DOI 10.1038/ncb2307; Calderon AJ, 2011, J CONTROL RELEASE, V150, P37, DOI 10.1016/j.jconrel.2010.10.025; Calderon AJ, 2009, BIORHEOLOGY, V46, P323, DOI 10.3233/BIR-2009-0544; CASASNOVAS JM, 1995, J BIOL CHEM, V270, P13216, DOI 10.1074/jbc.270.22.13216; Chang KC, 2000, P NATL ACAD SCI USA, V97, P11262, DOI 10.1073/pnas.200240897; Chaudhuri A, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/046002; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Dasgupta S, 2014, NANO LETT, V14, P687, DOI 10.1021/nl403949h; Dasgupta S, 2013, SOFT MATTER, V9, P5473, DOI 10.1039/c3sm50351h; Decuzzi P, 2008, BIOPHYS J, V94, P3790, DOI 10.1529/biophysj.107.120238; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; Evans E, 2010, BIOPHYS J, V98, P1458, DOI 10.1016/j.bpj.2009.09.067; Fery A, 2003, CR PHYS, V4, P259, DOI 10.1016/S1631-0705(03)00030-6; Gao HJ, 2005, P NATL ACAD SCI USA, V102, P9469, DOI 10.1073/pnas.0503879102; Han JY, 2012, ACS NANO, V6, P8824, DOI 10.1021/nn302687n; Jaskiewicz K, 2012, ACS NANO, V6, P7254, DOI 10.1021/nn302367m; Koay EJ, 2003, J BIOMECH ENG-T ASME, V125, P334, DOI 10.1115/1.1572517; Le Bihan O, 2009, J STRUCT BIOL, V168, P419, DOI 10.1016/j.jsb.2009.07.006; Li XL, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3502489; Liu J, 2010, P NATL ACAD SCI USA, V107, P16530, DOI 10.1073/pnas.1006611107; MacDonald C, 2012, PHARM RES-DORDR, V29, P1270, DOI 10.1007/s11095-011-0663-7; Mathur AB, 2001, J BIOMECH, V34, P1545, DOI 10.1016/S0021-9290(01)00149-X; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Mirigian S, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4813921; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Muro S, 2003, J CELL SCI, V116, P1599, DOI 10.1242/jcs.00367; Muro S, 2008, MOL THER, V16, P1450, DOI 10.1038/mt.2008.127; Muro S, 2006, J PHARMACOL EXP THER, V317, P1161, DOI 10.1124/jpet.105.098970; Muzykantov VR, 2013, ISRN VASC MED, V2013, DOI [10.1155/2013/916254, DOI 10.1155/2013/916254]; Pierres A, 2002, BIOPHYS J, V82, P3214, DOI 10.1016/S0006-3495(02)75664-6; Raatz M, 2014, SOFT MATTER, V10, P3570, DOI 10.1039/c3sm52498a; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Sato M, 1996, J BIOMECH, V29, P461, DOI 10.1016/0021-9290(95)00069-0; Sato M, 2000, J BIOMECH, V33, P127, DOI 10.1016/S0021-9290(99)00178-5; SATO M, 1990, J BIOMECH ENG-T ASME, V112, P263, DOI 10.1115/1.2891183; Schiavo VL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044070, DOI 10.1371/JOURNAL.PONE.0044070]; Seifert U, 2000, PHYS REV LETT, V84, P2750, DOI 10.1103/PhysRevLett.84.2750; Serrano D, 2012, ARTERIOSCL THROM VAS, V32, P1178, DOI 10.1161/ATVBAHA.111.244186; Verdier C, 2009, J MATH BIOL, V58, P235, DOI 10.1007/s00285-008-0164-4; Yi X, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.098101; Yue TT, 2011, SOFT MATTER, V7, P9104, DOI 10.1039/c1sm05398a; Zhou XM, 2006, MECH AGEING DEV, V127, P779, DOI 10.1016/j.mad.2006.07.003	49	13	13	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122097	10.1371/journal.pone.0122097	http://dx.doi.org/10.1371/journal.pone.0122097			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901833	gold, Green Published, Green Submitted			2022-12-27	WOS:000353331500015
J	Iacono, MI; Neufeld, E; Akinnagbe, E; Bower, K; Wolf, J; Oikonomidis, IV; Sharma, D; Lloyd, B; Wilm, BJ; Wyss, M; Pruessmann, KP; Jakab, A; Makris, N; Cohen, ED; Kuster, N; Kainz, W; Angelone, LM				Iacono, Maria Ida; Neufeld, Esra; Akinnagbe, Esther; Bower, Kelsey; Wolf, Johanna; Oikonomidis, Ioannis Vogiatzis; Sharma, Deepika; Lloyd, Bryn; Wilm, Bertram J.; Wyss, Michael; Pruessmann, Klaas P.; Jakab, Andras; Makris, Nikos; Cohen, Ethan D.; Kuster, Niels; Kainz, Wolfgang; Angelone, Leonardo M.			MIDA: A Multimodal Imaging-Based Detailed Anatomical Model of the Human Head and Neck	PLOS ONE			English	Article							INDUCED CURRENT DENSITIES; REALISTIC ANTHROPOMORPHIC PHANTOM; MONTE-CARLO CALCULATIONS; ADULT VOXEL PHANTOM; CONVERSION COEFFICIENTS; ABSORBED FRACTIONS; COLOR PHOTOGRAPHS; PREGNANT-WOMEN; RESOLUTION; FIELD	Computational modeling and simulations are increasingly being used to complement experimental testing for analysis of safety and efficacy of medical devices. Multiple voxel- and surface-based whole-and partial-body models have been proposed in the literature, typically with spatial resolution in the range of 1-2 mm and with 10-50 different tissue types resolved. We have developed a multimodal imaging-based detailed anatomical model of the human head and neck, named "MIDA". The model was obtained by integrating three different magnetic resonance imaging (MRI) modalities, the parameters of which were tailored to enhance the signals of specific tissues: i) structural T1- and T2-weighted MRIs; a specific heavily T2-weighted MRI slab with high nerve contrast optimized to enhance the structures of the ear and eye; ii) magnetic resonance angiography (MRA) data to image the vasculature, and iii) diffusion tensor imaging (DTI) to obtain information on anisotropy and fiber orientation. The unique multimodal high-resolution approach allowed resolving 153 structures, including several distinct muscles, bones and skull layers, arteries and veins, nerves, as well as salivary glands. The model offers also a detailed characterization of eyes, ears, and deep brain structures. A special automatic atlas-based segmentation procedure was adopted to include a detailed map of the nuclei of the thalamus and midbrain into the head model. The suitability of the model to simulations involving different numerical methods, discretization approaches, as well as DTI-based tensorial electrical conductivity, was examined in a case-study, in which the electric field was generated by transcranial alternating current stimulation. The voxel- and the surface-based versions of the models are freely available to the scientific community.	[Iacono, Maria Ida; Akinnagbe, Esther; Bower, Kelsey; Cohen, Ethan D.; Kainz, Wolfgang; Angelone, Leonardo M.] US FDA, Ctr Devices & Radiol Hlth, Off Sci & Engn Labs, Div Biomed Phys, Silver Spring, MD 20993 USA; [Neufeld, Esra; Wolf, Johanna; Oikonomidis, Ioannis Vogiatzis; Sharma, Deepika; Lloyd, Bryn; Kuster, Niels] ITIS Fdn Res Informat Technol Soc, Zurich, Switzerland; [Wolf, Johanna; Oikonomidis, Ioannis Vogiatzis; Sharma, Deepika; Kuster, Niels] Swiss Fed Inst Technol, CH-8092 Zurich, Switzerland; [Wilm, Bertram J.; Wyss, Michael; Pruessmann, Klaas P.] Univ Zurich, Inst Biomed Engn, Zurich, Switzerland; [Wilm, Bertram J.; Wyss, Michael; Pruessmann, Klaas P.] Swiss Fed Inst Technol, Zurich, Switzerland; [Jakab, Andras] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Computat Imaging Res Lab, Vienna, Austria; [Jakab, Andras] Swiss Fed Inst Technol, Comp Vision Lab, Zurich, Switzerland; [Makris, Nikos] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Athinoula Martinos Ctr Biomed Imaging,Dept Radiol, Charlestown, MA 02129 USA; [Makris, Nikos] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Morphometr Anal,Dept Psychiat & Neurol, Charlestown, MA 02129 USA	US Food & Drug Administration (FDA); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Medical University of Vienna; Swiss Federal Institutes of Technology Domain; ETH Zurich; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Angelone, LM (corresponding author), US FDA, Ctr Devices & Radiol Hlth, Off Sci & Engn Labs, Div Biomed Phys, Silver Spring, MD 20993 USA.	Leonardo.angelone@fda.hhs.gov	/AAB-9109-2019; Jakab, András/U-9436-2019; Pruessmann, Klaas P/H-5385-2018	Jakab, András/0000-0001-6291-9889; Pruessmann, Klaas P/0000-0003-0009-8362; COHEN, ETHAN/0000-0001-6365-2266; Kuster, Niels/0000-0002-5827-3728; Angelone, Leonardo/0000-0002-1105-021X; Sharma, Deepika/0000-0001-5445-7274	National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health [1R21EB016449-01A1]; U.S. Food and Drug Administration; CTI [14930.1 PFLS-LS]; Center for Devices and Radiological Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB016449] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); U.S. Food and Drug Administration; CTI; Center for Devices and Radiological Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was supported in part by the National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health (1R21EB016449-01A1), in part by the U.S. Food and Drug Administration's Critical Path Initiative, in part by CTI (14930.1 PFLS-LS), and in part by the Research Participation Program at the Center for Devices and Radiological Health administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the U.S. Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman MJ, 1998, P IEEE, V86, P504, DOI 10.1109/5.662875; ADAIR ER, 1983, MICROWAVES THERMOREG; Bolch WE, 1999, J NUCL MED, V40, p11S; Caon M, 2000, RADIAT PROT DOSIM, V90, P445, DOI 10.1093/oxfordjournals.rpd.a033172; CDRH, 2011, FDA SCI REP; Chen XL, 2010, IEEE INT SYMP ELEC, P702, DOI 10.1109/ISEMC.2010.5711363; Cheng S-W, 2007, ARXIV07121959; Christ A, 2010, PHYS MED BIOL, V55, pN23, DOI 10.1088/0031-9155/55/2/N01; COLEMAN GB, 1979, P IEEE, V67, P773, DOI 10.1109/PROC.1979.11327; Damsgaard M, 2006, SIMUL MODEL PRACT TH, V14, P1100, DOI 10.1016/j.simpat.2006.09.001; Deoni SCL, 2007, NEUROIMAGE, V34, P117, DOI 10.1016/j.neuroimage.2006.09.016; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dimbylow P, 2005, PHYS MED BIOL, V50, P1047, DOI 10.1088/0031-9155/50/6/002; DIMBYLOW PJ, 1994, PHYS MED BIOL, V39, P1537, DOI 10.1088/0031-9155/39/10/003; Dimbylow PJ, 1997, PHYS MED BIOL, V42, P479, DOI 10.1088/0031-9155/42/3/003; DIMBYLOW PJ, 1991, PHYS MED BIOL, V36, P1075, DOI 10.1088/0031-9155/36/8/004; Dimbylow PJ, 1998, PHYS MED BIOL, V43, P221, DOI 10.1088/0031-9155/43/2/001; DUBUISSON MP, 1994, INT C PATT RECOG, P566, DOI 10.1109/ICPR.1994.576361; ELLETT WH, 1964, BRIT J RADIOL, V37, P45, DOI 10.1259/0007-1285-37-433-45; Fill UA, 2004, HEALTH PHYS, V86, P253, DOI 10.1097/00004032-200403000-00003; Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002; Gjonaj E, 2002, IEEE T MAGN, V38, P357, DOI 10.1109/20.996096; Gosselin M, 2014, PHYS MED BI IN PRESS; Gullmar D, 2010, NEUROIMAGE, V51, P145, DOI 10.1016/j.neuroimage.2010.02.014; HARALICK RM, 1987, IEEE T PATTERN ANAL, V9, P532, DOI 10.1109/TPAMI.1987.4767941; Hart F, 1988, MODERN BIOELECTRICIT, V281, P343; HENNIG J, 1988, J MAGN RESON, V78, P397, DOI 10.1016/0022-2364(88)90128-X; Iacono MI, 2014, IEEE ENG MED BIO, P6258, DOI 10.1109/EMBC.2014.6945059; Iacono MI, 2013, COMP MATH MATH PHYS, V2013, P12; Irarrazabal P, 1996, MAGNET RESON MED, V35, P278, DOI 10.1002/mrm.1910350221; Jakab A, 2012, AM J NEURORADIOL, V33, P2110, DOI 10.3174/ajnr.A3140; Jezzard P, 1998, MAGNET RESON MED, V39, P801, DOI 10.1002/mrm.1910390518; Jones DG, 1998, RADIAT PROT DOSIM, V79, P411, DOI 10.1093/oxfordjournals.rpd.a032439; Jones DG, 1997, RADIAT PROT DOSIM, V72, P21, DOI 10.1093/oxfordjournals.rpd.a032072; Kainz W, 2003, PHYS MED BIOL, V48, P2551, DOI 10.1088/0031-9155/48/15/319; Kitware Inc, VISUALIZATION TOOLKI; Kramer R, 2004, PHYS MED BIOL, V49, P5203, DOI 10.1088/0031-9155/49/23/001; Kramer R, 2003, PHYS MED BIOL, V48, P1239, DOI 10.1088/0031-9155/48/10/301; Krauth A, 2010, NEUROIMAGE, V49, P2053, DOI 10.1016/j.neuroimage.2009.10.042; Kyriakou A, 2013, INT J HYPERTHER, P1; Laakso I, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046009; Lalys F, 2010, NEUROIMAGE, V49, P345, DOI 10.1016/j.neuroimage.2009.08.007; Lee C, 2004, MED PHYS, V31, P1017, DOI 10.1118/1.1689013; Leng J, 2012, P 20 INT MESH ROUNDT, P347, DOI DOI 10.1007/978-3-642-24734-7_19; LIN JC, 1973, IEEE T MICROW THEORY, VMT21, P791, DOI 10.1109/TMTT.1973.1128133; Makris N, 2008, MED BIOL ENG COMPUT, V46, P1239, DOI 10.1007/s11517-008-0414-z; Margulies S.S., 1987, THESIS; Mason PA, 2000, IEEE T MICROW THEORY, V48, P2050, DOI 10.1109/22.884194; Mattiello J, 1997, MAGNET RESON MED, V37, P292, DOI 10.1002/mrm.1910370226; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P589, DOI 10.1016/j.clinph.2003.10.033; Mitsuhashi N, 2009, NUCLEIC ACIDS RES, V37, pD782, DOI 10.1093/nar/gkn613; Morel A., 2007, STEREOTACTIC ATLAS H, DOI 10.3109/9781420016796; Nagaoka T, 2004, PHYS MED BIOL, V49, P1, DOI 10.1088/0031-9155/49/1/001; NEUFELD E, 2008, THESIS SWISS FEDERAL; Nikita KS, 2000, IEEE T MICROW THEORY, V48, P2003, DOI 10.1109/22.884189; Nowinski WL, 2011, NEUROIMAGE, V55, P986, DOI 10.1016/j.neuroimage.2010.12.079; Nowinski WL, 2008, ACTA NEUROCHIR, V150, P1, DOI 10.1007/s00701-007-1270-6; Nowinski WL, 2000, IEEE T MED IMAGING, V19, P62, DOI 10.1109/42.832961; Park JS, 2005, IEEE T MED IMAGING, V24, P352, DOI 10.1109/TMI.2004.842454; Paulides MM, 2013, INT J HYPERTHER, V29, P346, DOI 10.3109/02656736.2013.790092; Petoussi-Henss N, 2002, PHYS MED BIOL, V47, P89, DOI 10.1088/0031-9155/47/1/307; Petoussi-Henss N, 1998, RADIAT PROT DOSIM, V79, P415, DOI 10.1093/oxfordjournals.rpd.a032440; Pham DL, 2000, ANNU REV BIOMED ENG, V2, P315, DOI 10.1146/annurev.bioeng.2.1.315; Pluim JPW, 2003, IEEE T MED IMAGING, V22, P986, DOI 10.1109/TMI.2003.815867; Pohle R, 2001, PROC SPIE, V4322, P1337, DOI 10.1117/12.431013; Pommert A, 2001, HIGHLY REALISTIC VOL; Powell S, 2008, NEUROIMAGE, V39, P238, DOI 10.1016/j.neuroimage.2007.05.063; Rao A, 2008, MED IMAGE ANAL, V12, P55, DOI 10.1016/j.media.2007.06.006; RAYA SP, 1990, IEEE T MED IMAGING, V9, P32, DOI 10.1109/42.52980; Rineau L, 2007, COMP GEOM-THEOR APPL, V38, P100, DOI 10.1016/j.comgeo.2006.11.008; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Saito K, 2001, RADIAT ENVIRON BIOPH, V40, P69, DOI 10.1007/s004110000082; Sato K, 2007, RADIAT PROT DOSIM, V123, P337, DOI 10.1093/rpd/ncl101; Sato K, 2009, J NUCL SCI TECHNOL, V46, P907, DOI [10.3327/jnst.46.907, 10.1080/18811248.2009.9711599]; Segars WP, 2010, MED PHYS, V37, P4902, DOI 10.1118/1.3480985; Stabin MG, 2002, HEALTH PHYS, V82, P21, DOI 10.1097/00004032-200201000-00005; Staton RJ, 2003, PHYS MED BIOL, V48, P805, DOI 10.1088/0031-9155/48/7/301; Toga AW, 1997, COMPUT MED IMAG GRAP, V21, P131, DOI 10.1016/S0895-6111(96)00072-9; Tong P, 1989, 12 INT TECHN C SAF V, P617; Tuch DS, 2001, P NATL ACAD SCI USA, V98, P11697, DOI 10.1073/pnas.171473898; Tuch DS, 1997, NEUROIMAGE, V5, pS44; Viola P, 1997, INT J COMPUT VISION, V24, P137, DOI 10.1023/A:1007958904918; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354; WEIL CM, 1975, IEEE T BIO-MED ENG, V22, P468, DOI 10.1109/TBME.1975.324467; Wu DG, 2007, PHYS MED BIOL, V52, P5735, DOI 10.1088/0031-9155/52/19/001; Wu K-L, 2008, HIGH RESOLUTION ELEC; Wu TN, 2011, PHYS MED BIOL, V56, P2075, DOI 10.1088/0031-9155/56/7/011; Xu XG, 2000, HEALTH PHYS, V78, P476, DOI 10.1097/00004032-200005000-00003; Yelnik J, 2007, NEUROIMAGE, V34, P618, DOI 10.1016/j.neuroimage.2006.09.026; ZANKL M, 1988, RADIAT ENVIRON BIOPH, V27, P153, DOI 10.1007/BF01214605; Zankl M, 2003, RADIAT PROT DOSIM, V105, P539, DOI 10.1093/oxfordjournals.rpd.a006299; Zankl M, 2002, PHYS MED BIOL, V47, P2367, DOI 10.1088/0031-9155/47/14/301; Zankl M, 2001, RADIAT ENVIRON BIOPH, V40, P153, DOI 10.1007/s004110100094; Zhang BQ, 2007, RADIAT PROT DOSIM, V124, P130, DOI 10.1093/rpd/ncm184; Zhang SX, 2004, J ANAT, V204, P165, DOI 10.1111/j.0021-8782.2004.00274.x; ZUBAL IG, 1992, IMAGE VISION COMPUT, V10, P342, DOI 10.1016/0262-8856(92)90020-4; ZUBAL IG, 1994, MED PHYS, V21, P299, DOI 10.1118/1.597290	97	137	141	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124126	10.1371/journal.pone.0124126	http://dx.doi.org/10.1371/journal.pone.0124126			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901747	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000353331500078
J	Jakhetia, R; Verma, NK				Jakhetia, Richa; Verma, Naresh K.			Identification and Molecular Characterisation of a Novel Mu-Like Bacteriophage, SfMu, of Shigella flexneri	PLOS ONE			English	Article							CELL-WALL RECEPTOR; GENOME SEQUENCE; DNA INVERSION; BINDING; PROTEIN; GENES; SITE; RECOMBINATION; TRANSPOSITION; HAEMOPHILUS	S. flexneri is the leading cause of bacillary dysentery in the developing countries. Several temperate phages originating from this host have been characterised. However, all S. flexneri phages known to date are lambdoid phages, which have the ability to confer the O-antigen modification of their host. In this study, we report the isolation and characterisation of a novel Mu-like phage from a serotype 4a strain of S. flexneri. The genome of phage SfMu is composed of 37,146 bp and is predicted to contain 55 open reading frames (orfs). Comparative genome analysis of phage SfMu with Mu and other Mu-like phages revealed that SfMu is closely related to phage Mu, sharing >90% identity with majority of its proteins. Moreover, investigation of phage SfMu receptor on the surface of the host cell revealed that the O-antigen of the host serves as the receptor for the adsorption of phage SfMu. This study also demonstrates pervasiveness of SfMu phage in S. flexneri, by identifying complete SfMu prophage strains of serotype X and Y, and remnants of SfMu in strains belonging to 4 other serotypes, thereby indicating that transposable phages in S. flexneri are not uncommon. The findings of this study contribute an advance in our current knowledge of S. flexneri phages and will also play a key role in understanding the evolution of S. flexneri.	[Jakhetia, Richa; Verma, Naresh K.] Australian Natl Univ, Res Sch Biol, Div Biomed Sci & Biochem, Canberra, ACT 0200, Australia	Australian National University	Verma, NK (corresponding author), Australian Natl Univ, Res Sch Biol, Div Biomed Sci & Biochem, Canberra, ACT 0200, Australia.	naresh.verma@anu.edu.au	Verma, Naresh/C-9161-2009	Verma, Naresh/0000-0001-8109-2215				Adams MM, 2001, MICROBIOL-UK, V147, P851, DOI 10.1099/00221287-147-4-851; AKHVERDIAN VZ, 1984, GENETIKA+, V20, P1612; Allison GE, 2002, J BACTERIOL, V184, P1974, DOI 10.1128/JB.184.7.1974-1987.2002; BRADLEY DE, 1967, BACTERIOL REV, V31, P230, DOI 10.1128/MMBR.31.4.230-314.1967; BUKHARI AI, 1976, NATURE, V264, P580, DOI 10.1038/264580a0; Casjens S, 2004, J MOL BIOL, V339, P379, DOI 10.1016/j.jmb.2004.03.068; Comeau AM, 2007, VIROLOGY, V362, P384, DOI 10.1016/j.virol.2006.12.031; CRAIG NL, 1995, SCIENCE, V270, P253, DOI 10.1126/science.270.5234.253; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dupont K, 2004, APPL ENVIRON MICROB, V70, P5818, DOI 10.1128/AEM.70.10.5818-5824.2004; FAELEN M, 1976, J MOL BIOL, V104, P525, DOI 10.1016/0022-2836(76)90118-2; Fogg PCM, 2011, VIROLOGY, V421, P211, DOI 10.1016/j.virol.2011.09.028; Gautheret D, 2001, J MOL BIOL, V313, P1003, DOI 10.1006/jmbi.2001.5102; GILL GS, 1981, J VIROL, V37, P420, DOI 10.1128/JVI.37.1.420-430.1981; GIPHARTGASSLER M, 1981, J MOL BIOL, V145, P139, DOI 10.1016/0022-2836(81)90338-7; Goudie AD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-615; GRUNDY FJ, 1985, VIROLOGY, V143, P485, DOI 10.1016/0042-6822(85)90388-5; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; IIDA S, 1986, CELL, V45, P71, DOI 10.1016/0092-8674(86)90539-8; Jakhetia R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-742; Jakhetia R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-677; KAMP D, 1981, MOL GEN GENET, V184, P564, DOI 10.1007/BF00352543; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Le S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068562; LINDBERG AA, 1988, VACCINE, V6, P146, DOI 10.1016/S0264-410X(88)80018-5; Mavris M, 1997, MOL MICROBIOL, V26, P939, DOI 10.1046/j.1365-2958.1997.6301997.x; MERTENS G, 1984, EMBO J, V3, P2415, DOI 10.1002/j.1460-2075.1984.tb02148.x; MIZUUCHI K, 1992, ANNU REV BIOCHEM, V61, P1011; MONTAG D, 1987, J MOL BIOL, V196, P165, DOI 10.1016/0022-2836(87)90519-5; Morgan GJ, 2002, J MOL BIOL, V317, P337, DOI 10.1006/jmbi.2002.5437; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANDULACHE R, 1985, FEMS MICROBIOL LETT, V28, P307; SANDULACHE R, 1984, J BACTERIOL, V160, P299, DOI 10.1128/JB.160.1.299-303.1984; Santos SB, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-148; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; SCHMUCKER R, 1986, J GEN VIROL, V67, P1123, DOI 10.1099/0022-1317-67-6-1123; Summer EJ, 2004, J MOL BIOL, V340, P49, DOI 10.1016/j.jmb.2004.04.053; Sun QZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070238; Sun QZ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-39; Symonds N., 1987, PHAGE MU; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANDEPUTTE P, 1980, NATURE, V286, P218, DOI 10.1038/286218a0; VOGEL JL, 1991, J BACTERIOL, V173, P6568, DOI 10.1128/jb.173.20.6568-6577.1991; Wang J, 2000, J BACTERIOL, V182, P508, DOI 10.1128/JB.182.2.508-512.2000; WANG XH, 1994, MOL MICROBIOL, V12, P665, DOI 10.1111/j.1365-2958.1994.tb01054.x; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Zehr ES, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-331; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	49	12	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124053	10.1371/journal.pone.0124053	http://dx.doi.org/10.1371/journal.pone.0124053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902138	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500073
J	Sondermann, W; Griewank, KG; Schilling, B; Livingstone, E; Leyh, JC; Rompoti, N; Cosgarea, I; Schimming, T; Schadendorf, D; Zimmer, L; Hillen, U				Sondermann, Wiebke; Griewank, Klaus G.; Schilling, Bastian; Livingstone, Elisabeth; Leyh, Julia C.; Rompoti, Natalia; Cosgarea, Ioana; Schimming, Tobias; Schadendorf, Dirk; Zimmer, Lisa; Hillen, Uwe			Corticosteroids Augment BRAF Inhibitor Vemurafenib Induced Lymphopenia and Risk of Infection	PLOS ONE			English	Article							LYMPHOCYTE SUBPOPULATIONS; METASTATIC MELANOMA; IPILIMUMAB; SURVIVAL; DABRAFENIB; SAFETY; ANTI-PD-1; THERAPY	We have previously demonstrated an impact of the BRAF inhibitor vemurafenib on patient lymphocyte counts. In the current study, the extent to which concomitant use of corticosteroids in BRAF inhibitor treated patients affects lymphocyte counts and predisposes to infection was investigated. A cohort of 102 patients receiving either the selective BRAF inhibitor vemurafenib or dabrafenib was analyzed. The amount of patients receiving either medication with or without systemic corticosteroids (dexamethasone) was determined and lymphocyte counts before and under therapy assessed. Additionally, the number and severity of infections occurring in these groups was analyzed. Vemurafenib treatment led to a considerable decrease in lymphocyte cell counts, with 62.3% of patients having lymphopenia. Dabrafenib treated patients only rarely demonstrated lymphopenia (12.5%). Dexamethasone co-administration further diminished lymphocyte counts. Lymphopenias were observed in 84.6% of patients receiving vemurafenib and dexamethasone. In our cohort, infections were noted in 9 patients, 4 of these were severe and 2 eventually fatal. All 9 cases with infections demonstrated lymphopenia, 8 of these had received dexamethasone and 7 of these a therapy with vemurafenib. Our findings demonstrate a significant lymphopenia in patients treated with the BRAF inhibitor vemurafenib, which is further augmented by dexamethasone and predisposes to infection. If validated in other studies, risk of infection should be considered when applying corticosteroids in combination with BRAF inhibitors, in particular vemurafenib.	[Griewank, Klaus G.] Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Dept Dermatol, Essen, Germany; German Canc Consortium DKTK, Essen, Germany	University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ)	Griewank, KG (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Dept Dermatol, Essen, Germany.	klaus.griewank@uk-essen.de; uwe.hillen@uk-essen.de	Livingstone, Elisabeth/AHE-9171-2022; Griewank, Klaus G/A-9097-2017; Schilling, Bastian/AAY-8646-2020; Zimmer, Lisa/AAP-8495-2021; Schadendorf, Dirk/AAE-8206-2019	Griewank, Klaus G/0000-0003-3899-9449; Schilling, Bastian/0000-0001-8859-4103; Zimmer, Lisa/0000-0002-3680-3521; 	Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	Wiebke Sondermann has received honoraria from Roche and travel support from Bristol-Myers Squibb. Bastian Schilling has received honoraria from Roche and travel support as well research funding from Bristol-Myers Squibb. Elisabeth Livingstone has received honoraria from Roche, Bristol-Myers Squibb, Amgen, Boehringer Ingelheim, Merck Sharp & Dohme, and Merck, and travel support from Bristol-Myers Squibb. Lisa Zimmer has received honoraria from Roche, Bristol-Myers Squibb, Boehringer Ingelheim and Amgen, and travel support from Merck Sharp & Dohme and Bristol-Myers Squibb. Uwe Hillen has received honoraria from Roche. Dirk Schadendorf is on the advisory board or has received honoraria from Roche, Genentech, Novartis, Amgen, GlaxoSmithKline, Bristol-Myers Squibb, Boehringer Ingelheim, and Merck Sharp & Dohme. The remaining authors have declared no conflicts of interest. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Boni A, 2010, CANCER RES, V70, P5213, DOI 10.1158/0008-5472.CAN-10-0118; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Danielli R, 2012, CANCER IMMUNOL IMMUN, V61, P41, DOI 10.1007/s00262-011-1089-0; Deichmann M, 2000, J EXP CLIN CANC RES, V19, P301; FAUCI AS, 1975, IMMUNOLOGY, V28, P669; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Lipson EJ, 2013, CLIN CANCER RES, V19, P462, DOI 10.1158/1078-0432.CCR-12-2625; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Ribas A, 2013, NEW ENGL J MED, V368, P1365, DOI 10.1056/NEJMc1302338; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Schilling B, 2014, ANN ONCOL, V25, P747, DOI 10.1093/annonc/mdt587; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siroy AE, 2014, J INVESTIGATIVE DERM; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Wolchok JD, 2013, ANN ONCOL, V24, P2174, DOI 10.1093/annonc/mdt161; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yamane H, 2014, J CLIN ONCOL, V32, P607, DOI 10.1200/JCO.2013.53.2226; YU DTY, 1974, J CLIN INVEST, V53, P565, DOI 10.1172/JCI107591	23	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124590	10.1371/journal.pone.0124590	http://dx.doi.org/10.1371/journal.pone.0124590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897843	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600075
J	Akgun, J; Schabussova, I; Schwarzer, M; Kozakova, H; Kundi, M; Wiedermann, U				Akguen, Johnnie; Schabussova, Irma; Schwarzer, Martin; Kozakova, Hana; Kundi, Michael; Wiedermann, Ursula			The Role of Alveolar Epithelial Type II-Like Cells in Uptake of Structurally Different Antigens and in Polarisation of Local Immune Responses	PLOS ONE			English	Article							BIRCH POLLEN ALLERGEN; DENDRITIC CELLS; AIRWAY INFLAMMATION; LYMPH-NODES; EXPRESSION; LUNG; INTRANASAL; TRANSDIFFERENTIATION; SUPPRESSION; TOLERANCE	Background Our previous studies on intranasal tolerance induction demonstrated reduction of allergic responses with different allergen constructs. The underlying mechanisms varied depending on their conformation or size. Objective The aim of the present study was to compare the uptake of two structurally different allergen molecules within the respiratory tract following intranasal application. Methods The three-dimensional Bet v 1 (Bv1-Protein) and the T cell epitope peptide of Bet v 1 (Bv1-Peptide) were labelled with 5,6-Carboxyfluorescein (FAM) and their uptake was investigated in lung cells and cells of the nasal associated lymphoid tissue from naive and sensitised BALB/c mice. Phenotypic characterisation of FAM(+) lung cells after antigen incubation in vitro and after intranasal application was performed by flow cytometry. Impact of Bv1-Protein and Bv1-Peptide on cytokine profiles and gene expression in vivo or in an alveolar epithelial type II (ATII) cell line were assessed in mono-and co-cultures with monocytes using ELISA and quantitative real-time PCR. Results Both antigens were taken up preferably by ATII-like cells (ATII-LCs) in naive mice, and by macrophages in sensitised mice. After intranasal application, Bv1-Peptide was taken up faster and more efficiently than Bv1-Protein. In vivo and in vitro experiments revealed that Bv1-Protein induced the transcription of thymic stromal lymphopoietin mRNA while Bv1-Peptide induced the transcription of IL-10 and MCP1 mRNA in ATII-LCs. Conclusion and Clinical Relevance Both tested antigens were taken up by ATII-LCs under steady state conditions and induced different polarisation of the immune responses. These data may have an important impact for the generation of novel and more effective prophylactic or therapeutic tools targeting the respiratory mucosa.	[Akguen, Johnnie; Schabussova, Irma; Wiedermann, Ursula] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria; [Schwarzer, Martin; Kozakova, Hana] Acad Sci Czech Republic, Lab Gnotobiol, Inst Microbiol, Vvi, Novy Hradek, Czech Republic; [Kundi, Michael] Med Univ Vienna, Inst Environm Hlth, Vienna, Austria; [Wiedermann, Ursula] Univ Goteborg, Dept Rheumatol & Inflammat Res, Inst Med, Gothenburg, Sweden	Medical University of Vienna; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Medical University of Vienna; University of Gothenburg	Schabussova, I (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria.	irma.schabussova@meduniwien.ac.at	Kozakova, Hana/I-1153-2014; Schwarzer, Martin/P-9871-2017	Kozakova, Hana/0000-0001-7352-5922; Schwarzer, Martin/0000-0002-1401-6578; Schabussova, Irma/0000-0002-2109-2640; Wiedermann, Ursula/0000-0002-1302-3223	Austrian Science Found [SFB F46]; OEAD [WTZ CZ16]	Austrian Science Found(Austrian Science Fund (FWF)); OEAD	This work has been supported by grant SFB F46 "Towards prevention and therapy of allergy" from Austrian Science Found and by grant WTZ CZ16 of the OEAD. Furthermore the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam E, 2006, J BIOL CHEM, V281, P6910, DOI 10.1074/jbc.M507140200; Akdis CA, 1998, EUR J IMMUNOL, V28, P914, DOI 10.1002/(SICI)1521-4141(199803)28:03<914::AID-IMMU914>3.0.CO;2-C; Akkoc T, 2011, ALLERGY ASTHMA IMMUN, V3, P11, DOI 10.4168/aair.2011.3.1.11; BECKER S, 1994, AM J PHYSIOL, V266, pL278, DOI 10.1152/ajplung.1994.266.3.L278; Bozza S, 2002, J IMMUNOL, V168, P1362, DOI 10.4049/jimmunol.168.3.1362; Campbell L, 1999, BIOCHEM BIOPH RES CO, V262, P744, DOI 10.1006/bbrc.1999.1280; DANTO SI, 1995, AM J RESP CELL MOL, V12, P497, DOI 10.1165/ajrcmb.12.5.7742013; Driscoll Barbara, 2012, Methods Mol Biol, V879, P109, DOI 10.1007/978-1-61779-815-3_7; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Galligan C, 2003, CHEM IMMUNOL, V83, P24; Geha RS, 2003, CURR OPIN IMMUNOL, V15, P603, DOI 10.1016/j.coi.2003.09.017; Golias J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037156; Hammad H, 2011, ALLERGY, V66, P579, DOI 10.1111/j.1398-9995.2010.02528.x; Hufnagl K, 2008, CLIN EXP ALLERGY, V38, P1192, DOI 10.1111/j.1365-2222.2008.02992.x; Hufnagl K, 2005, J ALLERGY CLIN IMMUN, V116, P370, DOI 10.1016/j.jaci.2005.04.002; Kolesar L, 2012, IMMUNOL RES, V52, P269, DOI 10.1007/s12026-012-8338-y; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lombry C, 2002, J CONTROL RELEASE, V83, P331, DOI 10.1016/S0168-3659(02)00174-8; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; Olszewska-Pazdrak B, 1998, J VIROL, V72, P4756, DOI 10.1128/JVI.72.6.4756-4764.1998; Ozsoy Y, 2009, MOLECULES, V14, P3754, DOI 10.3390/molecules14093754; Reibman J, 2003, AM J RESP CELL MOL, V28, P648, DOI 10.1165/rcmb.2002-0095OC; Ryan GM, 2013, MOL PHARMACEUT, V10, P2986, DOI 10.1021/mp400091n; Salik E, 1999, AM J RESP CELL MOL, V21, P365, DOI 10.1165/ajrcmb.21.3.3529; Sauty A, 1999, J IMMUNOL, V162, P3549; Schabussova I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067544; Schmiedl A, 2009, INT ARCH ALLERGY IMM, V148, P118, DOI 10.1159/000155742; SINGH G, 1988, AM REV RESPIR DIS, V138, P1261, DOI 10.1164/ajrccm/138.5.1261; Striz I, 2001, INFLAMMATION, V25, P241, DOI 10.1023/A:1010975804179; STRUNK RC, 1988, J CLIN INVEST, V81, P1419, DOI 10.1172/JCI113472; Stumbles PA, 2001, J IMMUNOL, V167, P228, DOI 10.4049/jimmunol.167.1.228; Valenta R, 2011, ALLERGY, V66, P775, DOI 10.1111/j.1398-9995.2011.02565.x; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Vinhas R, 2011, ALLERGY, V66, P1088, DOI 10.1111/j.1398-9995.2011.02598.x; Wiedermann U, 1999, J ALLERGY CLIN IMMUN, V103, P1202, DOI 10.1016/S0091-6749(99)70200-9; Wills-Karp M, 2001, NAT REV IMMUNOL, V1, P69, DOI 10.1038/35095579; Winkler B, 2002, CLIN EXP ALLERGY, V32, P30, DOI 10.1046/j.0022-0477.2001.01214.x	37	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124777	10.1371/journal.pone.0124777	http://dx.doi.org/10.1371/journal.pone.0124777			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894334	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700123
J	Ghaley, BB; Sandhu, HS; Porter, JR				Ghaley, Bhim B.; Sandhu, Harpinder S.; Porter, John R.			Relationship between C:N/C:O Stoichiometry and Ecosystem Services in Managed Production Systems	PLOS ONE			English	Article							N-P STOICHIOMETRY; SOIL; AGRICULTURE; QUANTIFICATION; CARBON; AGROECOSYSTEMS; ORGANISMS; VALUATION; BIOMASS; ENERGY	Land use and management intensity can influence provision of ecosystem services (ES). We argue that forest/agroforestry production systems are characterized by relatively higher C:O/C:N and ES value compared to arable production systems. Field investigations on C:N/C:O and 15 ES were determined in three diverse production systems: wheat monoculture (C-wheat), a combined food and energy system (CFE) and a beech forest in Denmark. The C:N/C:O ratios were 194.1/1.68, 94.1/1.57 and 59.5/1.45 for beech forest, CFE and Cwheat, respectively. The economic value of the non-marketed ES was also highest in beech forest (US$ 1089 ha(-1) yr(-1)) followed by CFE (US$ 800 ha(-1) yr(-1)) and Cwheat (US$ 339 ha(-1) yr(-1)). The combined economic value was highest in the CFE (US$ 3143 ha(-1) yr(-1)) as compared to the Cwheat (US$ 2767 ha(-1) yr(-1)) and beech forest (US$ 2365 ha(-1) yr(-1)). We argue that C:N/C:O can be used as a proxy of ES, particularly for the non-marketed ES, such as regulating, supporting and cultural services. These ES play a vital role in the sustainable production of food and energy. Therefore, they should be considered in decision making and developing appropriate policy responses for land use management.	[Ghaley, Bhim B.; Porter, John R.] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, DK-2630 Taastrup, Denmark; [Ghaley, Bhim B.] Univ Copenhagen, Fac Sci, Copenhagen Plant Sci Ctr, DK-1871 Frederiksberg C, Denmark; [Sandhu, Harpinder S.] Flinders Univ S Australia, Sch Environm, Adelaide, SA 5001, Australia; [Porter, John R.] Univ Greenwich, Nat Resources Inst, Chatam, Slovakia; [Porter, John R.] Lincoln Univ, Fac Agr & Life Sci, Lincoln 7647, New Zealand	University of Copenhagen; University of Copenhagen; Flinders University South Australia; Lincoln University - New Zealand	Ghaley, BB (corresponding author), Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, Hojbakkegard Alle 30, DK-2630 Taastrup, Denmark.	bbg@plen.ku.dk	Ghaley, Bhim B/G-5232-2014; Sandhu, Harpinder S/E-9338-2010	Sandhu, Harpinder S/0000-0001-5428-094X; Ghaley, Bhim Bahadur/0000-0002-0864-7613	European Commission [289694]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by European Commission FP7 (FP7-KBBE-2011-5) programme: SmartSOIL project (Soil Management Aimed at Reducing Threats to SOILs under climate change) (Project number: 289694), smartsoil.eu. The funding is received by John R. Porter and Bhim B. Ghaley to carry out research in the University of Copenhagen, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertsens J, 2013, LAND USE POLICY, V31, P584, DOI 10.1016/j.landusepol.2012.09.003; Als C., 1989, Soil erosion protection measures in Europe, Proceedings of the European Community Workshop, Freising, Germany., P25; [Anonymous], 2000, FLASH 2000 CHNS O AN; [Anonymous], 2010, EC ECOSYSTEMS BIODIV; Bai YF, 2012, J APPL ECOL, V49, P1204, DOI 10.1111/j.1365-2664.2012.02205.x; Boyd J, 2007, ECOL ECON, V63, P616, DOI 10.1016/j.ecolecon.2007.01.002; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Costanza R, 2008, BIOL CONSERV, V141, P350, DOI 10.1016/j.biocon.2007.12.020; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; Dale VH, 2007, ECOL ECON, V64, P286, DOI 10.1016/j.ecolecon.2007.05.009; Danish Forest Association, 2012, WOOD PRIC STAT DAN F; de la Rosa D, 2000, AGR ECOSYST ENVIRON, V81, P179, DOI 10.1016/S0167-8809(00)00161-4; Dominati E, 2014, ECOL ECON, V100, P119, DOI 10.1016/j.ecolecon.2014.02.008; Drake L., 1992, European Review of Agricultural Economics, V19, P351, DOI 10.1093/erae/19.3.351; Drake L, 1999, INT J SOC ECON, V26, P1042, DOI [DOI 10.1108/03068299910245813, 10.1108/03068299910245813]; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Food and Agriculture Organization of the United Nations, 2011, SAV GROW POL GUID SU; Fountain ED, 2013, ECOSYSTEM SERVICES IN NEW ZEALAND: CONDITIONS AND TRENDS, P115; Ghaley Bhim B., 2014, International Journal of Biodiversity Science Ecosystem Services & Management, V10, P177, DOI 10.1080/21513732.2014.926990; Ghaley BB, 2014, ENVIRON SCI POLICY, V39, P139, DOI 10.1016/j.envsci.2013.08.004; Ghaley BB, 2013, ECOL INDIC, V24, P534, DOI 10.1016/j.ecolind.2012.08.009; Hansen K, 2009, FOREST ECOL MANAG, V257, P2133, DOI 10.1016/j.foreco.2009.02.021; Hogh-Jensen H, 2004, AGR SYST, V82, P181, DOI 10.1016/j.agsy.2003.12.003; Kossoy A, 2010, STATE TRENDS CARBON; Li Y, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2012GB004399; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; Millennium Ecosystem Assessment, 2005, SYNTH REP; Moller C.M.M., 1933, DANSK SKOVFORENINGS, V18, P537; Mulder C, 2011, ADV ECOL RES, V44, P277, DOI 10.1016/B978-0-12-374794-5.00005-5; Ostle NJ, 2009, LAND USE POLICY, V26, pS274, DOI 10.1016/j.landusepol.2009.08.006; Porter J, 2009, AMBIO, V38, P186, DOI 10.1579/0044-7447-38.4.186; Pretty JN, 2000, AGR SYST, V65, P113, DOI 10.1016/S0308-521X(00)00031-7; Ptacnik R, 2005, OIKOS, V109, P52, DOI 10.1111/j.0030-1299.2005.14051.x; Robinson DA, 2014, SOIL SCI SOC AM J, V78, P685, DOI 10.2136/sssaj2014.01.0017; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Sandhu H., 2013, Ecosystem services in agricultural and urban landscapes, P122; Sandhu HS, 2008, ECOL ECON, V64, P835, DOI 10.1016/j.ecolecon.2007.05.007; Sandhu HS, 2012, ECOL ECON, V74, P19, DOI 10.1016/j.ecolecon.2011.12.001; Sandhu HS, 2010, ECOL COMPLEX, V7, P302, DOI 10.1016/j.ecocom.2010.04.006; Sardans J, 2012, PERSPECT PLANT ECOL, V14, P33, DOI 10.1016/j.ppees.2011.08.002; Sistla SA, 2012, NEW PHYTOL, V196, P68, DOI 10.1111/j.1469-8137.2012.04234.x; Skovsgaard JP, 2012, EUR J FOREST RES, V131, P1035, DOI 10.1007/s10342-011-0575-4; Soegaard B., 1954, IUFRO 11 C P 1953 RO, P246; Suadicani K., 2012, SORTIMENTSFORDELINGE, P1; Tian HQ, 2010, BIOGEOCHEMISTRY, V98, P139, DOI 10.1007/s10533-009-9382-0; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Uri V, 2011, ECOL ENG, V37, P920, DOI 10.1016/j.ecoleng.2011.01.016; Vanni MJ, 2011, FRESHWATER BIOL, V56, P791, DOI 10.1111/j.1365-2427.2010.02436.x; VONTORNE E, 1990, PEDOBIOLOGIA, V34, P89; Yang Y.H., 2010, BIOGEOSCI DISCUSS, V7, P1, DOI [10.5194/bgd-7-1-2010, DOI 10.5194/BGD-7-1-2010]; Zhang W, 2007, ECOL ECON, V64, P253, DOI 10.1016/j.ecolecon.2007.02.024; Zheng SX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051750	53	4	4	4	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123869	10.1371/journal.pone.0123869	http://dx.doi.org/10.1371/journal.pone.0123869			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894553	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700061
J	Li, M; Yang, ZL; Vollmer, LL; Gao, Y; Fu, YY; Liu, C; Chen, XY; Liu, PQ; Vogt, A; Yin, XM				Li, Min; Yang, Zuolong; Vollmer, Laura L.; Gao, Ying; Fu, Yuanyuan; Liu, Cui; Chen, Xiaoyun; Liu, Peiqing; Vogt, Andreas; Yin, Xiao-Ming			AMDE-1 Is a Dual Function Chemical for Autophagy Activation and Inhibition	PLOS ONE			English	Article							MODULATORS; MTOR; DEGRADATION; INDUCTION; INDUCERS; SCREEN; ASSAYS	Autophagy is the process by which cytosolic components and organelles are delivered to the lysosome for degradation. Autophagy plays important roles in cellular homeostasis and disease pathogenesis. Small chemical molecules that can modulate autophagy activity may have pharmacological value for treating diseases. Using a GFP-LC3-based high content screening assay we identified a novel chemical that is able to modulate autophagy at both initiation and degradation levels. This molecule, termed as Autophagy Modulator with Dual Effect-1 (AMDE-1), triggered autophagy in an Atg5-dependent manner, recruiting Atg16 to the pre-autophagosomal site and causing LC3 lipidation. AMDE-1 induced autophagy through the activation of AMPK, which inactivated mTORC1 and activated ULK1. AMDE-1 did not affect MAP kinase, JNK or oxidative stress signaling for autophagy induction. Surprisingly, treatment with AMDE-1 resulted in impairment in autophagic flux and inhibition of long-lived protein degradation. This inhibition was correlated with a reduction in lysosomal degradation capacity but not with autophagosome-lysosome fusion. Further analysis indicated that AMDE-1 caused a reduction in lysosome acidity and lysosomal proteolytic activity, suggesting that it suppressed general lysosome function. AMDE-1 thus also impaired endocytosis-mediated EGF receptor degradation. The dual effects of AMDE-1 on autophagy induction and lysosomal degradation suggested that its net effect would likely lead to autophagic stress and lysosome dysfunction, and therefore cell death. Indeed, AMDE-1 triggered necroptosis and was preferentially cytotoxic to cancer cells. In conclusion, this study identified a new class of autophagy modulators with dual effects, which can be explored for potential uses in cancer therapy.	[Li, Min; Yang, Zuolong; Gao, Ying; Fu, Yuanyuan; Liu, Cui; Liu, Peiqing] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Li, Min; Chen, Xiaoyun; Yin, Xiao-Ming] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Vollmer, Laura L.; Vogt, Andreas] Univ Pittsburgh, Drug Discovery Inst, Pittsburgh, PA USA; [Vogt, Andreas] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA USA	Sun Yat Sen University; Indiana University System; Indiana University Bloomington; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Li, M (corresponding author), Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China.	limin65@mail.sysu.edu.cn; xmyin@iupui.edu		Vogt, Andreas/0000-0001-6846-9292; li, min/0000-0002-5657-8675	Natural Science Foundation of Guangdong Province, China [S2013010015876]; Specialized Research Fund for the Doctoral Program of Higher Education [20130171120049]; Opening Project of Guangdong Provincial Key Laboratory of New Drug Design and Evaluation [2011A060901014]; Key Laboratory of Regenerative Biology, Guangzhou Institute of Biomedicine and Health, CAS [KLRB201307]; National Cancer Institute; National Institute of Mental Health [R03MH083154, R01CA111456, R01CA83817]; National Cancer Institute of the National Institutes of Health [P30CA037904]; NATIONAL CANCER INSTITUTE [P30CA047904, R01CA111456, R01CA083817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH083154] Funding Source: NIH RePORTER	Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Opening Project of Guangdong Provincial Key Laboratory of New Drug Design and Evaluation; Key Laboratory of Regenerative Biology, Guangzhou Institute of Biomedicine and Health, CAS; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Natural Science Foundation of Guangdong Province, China (S2013010015876. to M. L), the Specialized Research Fund for the Doctoral Program of Higher Education (20130171120049, to M.L), the Opening Project of Guangdong Provincial Key Laboratory of New Drug Design and Evaluation (2011A060901014, to ML), Key Laboratory of Regenerative Biology, Guangzhou Institute of Biomedicine and Health, CAS (KLRB201307 to M.L), National Cancer Institute (http://www.cancer.gov/) and National Institute of Mental Health (http://www.nimh.nih.gov/index. shtml) R03MH083154, R01CA111456 and R01CA83817) (to X.-M. Y). This project used the UPCI Chemical Biology facility that is supported in part by National Cancer Institute (http://www.cancer.gov/) of the National Institutes of Health (P30CA037904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alers S, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-7; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Beau I, 2011, INT J BIOCHEM CELL B, V43, P460, DOI 10.1016/j.biocel.2011.01.006; Bischoff P, 2012, EXPERT OPIN THER PAT, V22, P1053, DOI 10.1517/13543776.2012.715148; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI 10.1056/NEJMc1303158; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Eng CH, 2011, ONCOGENE, V30, P4687, DOI 10.1038/onc.2011.220; Fleming A, 2011, NAT CHEM BIOL, V7, P9, DOI 10.1038/NCHEMBIO.500; Gonzalez P, 2012, CELL DEATH DIFFER, V19, P1337, DOI 10.1038/cdd.2012.10; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Hundeshagen P, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-38; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Iversen PW, 2004, ASSAY GUIDANCE MANUA; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kriston-Vizi J, 2010, J BIOMOL SCREEN, V15, P869, DOI 10.1177/1087057110373393; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li M, 2013, J BIOL CHEM, V288, P35769, DOI 10.1074/jbc.M113.511212; Li M, 2012, AUTOPHAGY, V8, P401, DOI 10.4161/auto.18777; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Rangwala R, 2014, AUTOPHAGY, V10, P1391, DOI 10.4161/auto.29119; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Sanghee Lee EK, 2013, CHEM SCI, V4, P6; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Shu CW, 2011, J BIOMOL SCREEN, V16, P174, DOI 10.1177/1087057110392996; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Wong CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009996; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	37	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0122083	10.1371/journal.pone.0122083	http://dx.doi.org/10.1371/journal.pone.0122083			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894744	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000353211700012
J	Saglam, O; Samayoa, E; Somasekar, S; Naccache, S; Iwasaki, A; Chiu, CY				Saglam, Ozlen; Samayoa, Erik; Somasekar, Sneha; Naccache, Samia; Iwasaki, Akiko; Chiu, Charles Y.			No Viral Association Found in a Set of Differentiated Vulvar Intraepithelial Neoplasia Cases by Human Papillomavirus and Pan-Viral Microarray Testing	PLOS ONE			English	Article							IDENTIFICATION; TERMINOLOGY	Vulvar Intraepithelial Neoplasia (VIN) is the precursor lesion of Vulvar Squamous Cell Carcinoma (VSCC), and the differentiated type (dVIN) is more frequently observed in relation to VSCC. In contrast to usual-type VIN (uVIN), which is related to infection by human papillomavirus (HPV), a germline mutation in the p53 gene is thought to be associated with similar to 90% of dVIN cases. To date, no infectious agent has been identified in association with dVIN, and studies investigating this possibility have been hindered by the difficulty in accurately diagnosing dVIN from small biopsies. Here, we used immunostaining for p16(ink4a), a biomarker for HPV infection, to study 14 uVIN high-grade VIN and 14 dVIN cases, and to select 10 dVIN cases to broadly screen for all known viruses using a pan-viral microarray platform (ViroChip). All of the uVIN tissue samples, including 8 warty and 6 basaloid cases, showed positivity with the p16(ink4a) immunostain. The staining pattern was full-thickness for all except two cases in which positive staining was localized in the lower 1/3 of the epidermis. In contrast, immunostaining for p16(ink4a) was negative in all dVIN cases. ViroChip analysis of 10 pure dVIN samples confirmed the absence of human papillomavirus subtypes or any other virus with the exception of a single sample that showed a weak microarray signature to a porcine herpesvirus. Follow-up PCR testing of the sample was negative for herpesvirus, and in-depth metagenomic next-generation sequencing revealed only sequences corresponding to non-pathogenic viral flora and bacterial contamination. In this study, we demonstrated lack of a virus association in 10 dVIN cases. Alternative pathways for carcinogenesis such as the p53 mutation should be considered for investigation of potential treatment options in dVIN.	[Saglam, Ozlen] H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, Tampa, FL 33612 USA; [Samayoa, Erik; Somasekar, Sneha; Naccache, Samia; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Samayoa, Erik; Somasekar, Sneha; Naccache, Samia; Chiu, Charles Y.] UCSF, Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA USA; [Iwasaki, Akiko] Yale Univ, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06511 USA; [Chiu, Charles Y.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA	H Lee Moffitt Cancer Center & Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Yale University; University of California System; University of California San Francisco	Saglam, O (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, Tampa, FL 33612 USA.	ozlen.saglam@moffitt.org	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856; Chiu, Charles/0000-0003-2915-2094	Howard Hughes Medical Institute; National Institutes of Health [HL105704]; Abbott Viral Discovery Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054359] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbott Viral Discovery Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by the Howard Hughes Medical Institute (AI), an R01 grant HL105704 from the National Institutes of Health (CYC), and an Abbott Viral Discovery Award (CYC). The funders had no role in the data collection, analysis, patient recruitment, or decision to publish.	Bonvicini F, 2005, J MED VIROL, V77, P102, DOI 10.1002/jmv.20420; Camargo M, 2011, J VIROL METHODS, V178, P68, DOI 10.1016/j.jviromet.2011.08.014; Chen EC, 2011, JOVE-J VIS EXP, DOI 10.3791/2536; Chen EC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002155; Chiu CY, 2008, P NATL ACAD SCI USA, V105, P14124, DOI 10.1073/pnas.0805968105; Chiu CY, 2008, J PEDIATR-US, V153, P76, DOI 10.1016/j.jpeds.2007.12.035; del Pino M, 2013, HISTOPATHOLOGY, V62, P161, DOI 10.1111/his.12034; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fancello L, 2012, VIROLOGY, V434, P162, DOI 10.1016/j.virol.2012.09.025; Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924; Greninger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013381; Hart WR, 2001, INT J GYNECOL PATHOL, V20, P16, DOI 10.1097/00004347-200101000-00003; Judson PL, 2006, OBSTET GYNECOL, V107, P1018, DOI 10.1097/01.AOG.0000210268.57527.a1; Kokka F, 2011, INT J GYNECOL CANCER, V21, P1297, DOI 10.1097/IGC.0b013e31822dbe26; Lee D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044954; Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113; Naccache SN, 2013, J VIROL, V87, P11966, DOI 10.1128/JVI.02323-13; Pinto AP, 2010, MODERN PATHOL, V23, P404, DOI 10.1038/modpathol.2009.179; Reyes MC, 2014, J CLIN PATHOL, V67, P290, DOI 10.1136/jclinpath-2013-202117; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sideri M, 2005, J REPROD MED, V50, P807; Stern PL, 2012, VACCINE, V30, pF71, DOI 10.1016/j.vaccine.2012.05.091; Terlou A, 2010, ACTA OBSTET GYN SCAN, V89, P741, DOI 10.3109/00016341003739575; Tsoumpou I, 2009, CANCER TREAT REV, V35, P210, DOI 10.1016/j.ctrv.2008.10.005; Ueda Y, 2011, J SKIN CANCER, V2011, DOI 10.1155/2011/951250; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268; Yang B, 2000, AM J SURG PATHOL, V24, P429, DOI 10.1097/00000478-200003000-00013; Yu GX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049449; Zaharia M, ARXIV201111115572; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595	32	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0125292	10.1371/journal.pone.0125292	http://dx.doi.org/10.1371/journal.pone.0125292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894343	gold, Green Published, Green Submitted			2022-12-27	WOS:000353211700137
J	Hakim, AJ; Aho, J; Semde, G; Diarrassouba, M; Ehoussou, K; Vuylsteke, B; Murrill, CS; Thiam, M; Wingate, T				Hakim, Avi J.; Aho, Josephine; Semde, Gisele; Diarrassouba, Mamadou; Ehoussou, Konan; Vuylsteke, Bea; Murrill, Christopher S.; Thiam, Marguerite; Wingate, Therese		SHARM Study Grp	The Epidemiology of HIV and Prevention Needs of Men Who Have Sex with Men in Abidjan, Cote d'Ivoire	PLOS ONE			English	Article							PREVALENCE; INFECTION; RISKS	To determine HIV prevalence and associated risk factors among men who have sex with men (MSM) in Abidjan, C (o) over cap te d'Ivoire. We conducted a cross-sectional RDS survey of MSM in Abidjan from October 2011 to February 2012. Eligibility criteria included age >= 18 years and having had oral or anal sex with another man in the last 12 months. Weighted data analysis was conducted with RDSAT and SAS. We enrolled 603 participants, of whom 601 (99.7%) completed the questionnaire and 581 (96.7%) consented to HIV testing. HIV population prevalence was estimated as 18.0% (95% CI: 13.0-23.1); 86.4%(95% CI: 75.1-94.9) of HIV-positive MSM were unaware of their serostatus. In multivariable analysis, adjusting for age, education, and income, HIV infection was associated with unprotected sex at last sex with a woman, more than two male anal sex partners in last 12 months, inconsistent condom use during anal sex with a man, self-perceived risk of HIV, history of forced sex, history of physical abuse due to MSM status, and not receiving last HIV test result prior to study. HIV prevalence among MSM in Abidjan is more than four times as high as that of general population men. MSM engage in high-risk sexual behavior and most HIV-positive MSM are unaware of their serostatus. Greater access to HIV prevention, care, and treatment services targeted to MSM is necessary.	[Hakim, Avi J.; Murrill, Christopher S.] US Ctr Dis Control & Prevent, Div Global HIV AIDS, Atlanta, GA 30333 USA; [Aho, Josephine; Vuylsteke, Bea] Inst Trop Med, B-2000 Antwerp, Belgium; [Semde, Gisele] FHI 360, Abidjan, Cote Ivoire; [Diarrassouba, Mamadou; Ehoussou, Konan; Wingate, Therese] US Ctr Dis Control & Prevent, Div Global HIV AIDS, Abidjan, Cote Ivoire; [Thiam, Marguerite] Minist Hlth & Fight HIV, Abidjan, Cote Ivoire	Centers for Disease Control & Prevention - USA; Institute of Tropical Medicine (ITM)	Hakim, AJ (corresponding author), US Ctr Dis Control & Prevent, Div Global HIV AIDS, Atlanta, GA 30333 USA.	hxv8@cdc.gov			U.S. President's Emergency Plan for AIDS Relief through U.S. Centers for Disease Control and Prevention (CDC) [FHI360]; Canadian Institutes for Health Research	U.S. President's Emergency Plan for AIDS Relief through U.S. Centers for Disease Control and Prevention (CDC); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	The survey was funded by the U.S. President's Emergency Plan for AIDS Relief through the U.S. Centers for Disease Control and Prevention (CDC), which provided funding to FHI360. JA is a recipient of a postdoctoral fellowship by the Canadian Institutes for Health Research. CDC employees were involved in the study design, analysis, decision to publish, and preparation of the manuscript.	Abdul-Quader AS, 2006, J URBAN HEALTH, V83, pI1, DOI 10.1007/s11524-006-9108-8; Altman D, 2012, LANCET, V380, P439, DOI 10.1016/S0140-6736(12)60920-9; [Anonymous], 2012, REPUBLIQUE DE COTE D; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004997; Berry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043071; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Beyrer C, 2010, SEX TRANSM INFECT, V86, P323, DOI 10.1136/sti.2009.040162; Centers for Disease Control (CDC), 1981, MMWR Morb Mortal Wkly Rep, V30, P305; Chapman J, 2011, AIDS CARE, V23, P449, DOI 10.1080/09540121.2010.507758; Dahoma M, 2011, AIDS BEHAV, V15, P186, DOI 10.1007/s10461-009-9646-7; DIOPNDIAYE H, 2009, 16 C RETR OPP INF MO; Hakim A, 2010, FORMATIVE ASSESSMENT; HECKATHORN D, 2004, SOCIAL METHODS, V34, P208; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Hladik W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038143; Lane T, 2011, AIDS BEHAV, V15, P626, DOI 10.1007/s10461-009-9598-y; Merrigan M, 2011, SEX TRANSM INFECT, V87, P65, DOI 10.1136/sti.2008.034991; Ministere de la Sante et de la Lutte contre le Sida INdlS Measure DHS ICF International, 2013, REP DE COT DIV ENQ D; Rispel LM CA, 2011, J ACQUIRED IMMUNE DE, V57; Smith A, 2009, STAND, V9, P21; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Tovanabutra S SE, 2008, 15 INT WORKSH HIV DY; Valleroy LA, 2000, JAMA-J AM MED ASSOC, V284, P198, DOI 10.1001/jama.284.2.198; Vuylsteke B, 2012, SEX TRANSM INFECT, V88, P288, DOI 10.1136/sextrans-2011-050276; Wejnert C, 2012, AIDS BEHAV, V16, P797, DOI 10.1007/s10461-012-0147-8	27	30	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125218	10.1371/journal.pone.0125218	http://dx.doi.org/10.1371/journal.pone.0125218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG6AH	25909484	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800135
J	Darak, S; Mills, M; Kulkarni, V; Kulkarni, S; Hutter, I; Janssen, F				Darak, Shrinivas; Mills, Melinda; Kulkarni, Vinay; Kulkarni, Sanjeevani; Hutter, Inge; Janssen, Fanny			Trajectories of Childbearing among HIV Infected Indian Women: A Sequence Analysis Approach	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; DISCORDANT COUPLES; ANDHRA-PRADESH; PREGNANCY; MOTHERHOOD; INTENTIONS; TRANSMISSION; FERTILITY; DESIRES; PEOPLE	Background HIV infection closely relates to and deeply affects the reproductive career of those infected. However, little is known about the reproductive career trajectories, specifically the interaction of the timing of HIV diagnosis with the timing and sequencing of reproductive events among HIV infected women. This is the first study to describe and typify this interaction. Methods Retrospective calendar data of ever married HIV infected women aged 15-45 attending a HIV clinic in Pune, Maharashtra, Western India (N=622) on reproductive events such as marriage, cohabitation with the partner, use of contraception, pregnancy, childbirth and HIV diagnosis were analyzed using sequence analysis and multinomial logistic regression. Results Optimal matching revealed three distinct trajectories: 1) HIV diagnosis concurrent with childbearing (40.7%), 2) HIV diagnosis after childbearing (32.1%), and 3) HIV diagnosis after husband's death (27.2%). Multinomial logistic regression (trajectory 1 = baseline) showed that women who got married before the age of 21 years and who had no or primary level education had a significantly higher risk of knowing their HIV status either after childbearing or close to their husband's death. The risk of HIV diagnosis after husband's death was also higher among rural women and those who were diagnosed before 2005. Conclusions Three distinct patterns of interaction of timing of HIV diagnosis with timing and sequencing of events in the reproductive career were observed that have clear implications for (i) understanding of the individual life planning process in the context of HIV, (ii) formulation of assumptions for estimating HIV infected women in need of PMTCT services, and (iii) provision of care services.	[Darak, Shrinivas; Hutter, Inge; Janssen, Fanny] Univ Groningen, Fac Spatial Sci, Populat Res Ctr, Groningen, Netherlands; [Darak, Shrinivas; Kulkarni, Vinay; Kulkarni, Sanjeevani] PRAYAS Hlth Grp, Pune, Maharashtra, India; [Mills, Melinda] Univ Oxford, Dept Sociol, Nuffield Coll, Oxford, England; [Janssen, Fanny] Netherlands Interdisciplinary Demog Inst, The Hague, Netherlands	University of Groningen; University of Oxford; Royal Netherlands Academy of Arts & Sciences; Netherlands Interdisciplinary Demographic Institute (NIDI-KNAW)	Darak, S (corresponding author), Univ Groningen, Fac Spatial Sci, Populat Res Ctr, Groningen, Netherlands.	shirishdarak@gmail.com	Darak, Shrinivas/AAB-4288-2021	Janssen, Fanny/0000-0002-3110-238X	Population Research Centre; Groningen and Eric Bluemink Foundation; University of Groningen, The Netherlands	Population Research Centre; Groningen and Eric Bluemink Foundation; University of Groningen, The Netherlands(Netherlands Government)	This study received financial support from Population Research Centre, Groningen and Eric Bluemink Foundation, University of Groningen, The Netherlands for conducting the field work.	Aassve A, 2007, EUR J POPUL, V23, P369, DOI 10.1007/s10680-007-9134-6; [Anonymous], ANN REPORT 2013 2014; [Anonymous], 2020, HIGH POSS COST COVID; Axinn WG, 1999, SOC SCI RES, V28, P243, DOI 10.1006/ssre.1998.0641; Bras H, 2010, DEMOGRAPHY, V47, P1013, DOI 10.1007/BF03213737; Brubaker SG, 2011, HIV MED, V12, P316, DOI 10.1111/j.1468-1293.2010.00884.x; Chen WJ, 2010, SEX TRANSM INFECT, V86, pI22, DOI 10.1136/sti.2010.043620; Ciaranello AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020224; Cook R, 2014, CULT HEALTH SEX, V16, P741, DOI 10.1080/13691058.2014.902103; Craft SM, 2007, AIDS BEHAV, V11, P927, DOI 10.1007/s10461-007-9219-6; Gabadinho A., 2009, MINING SEQUENCE DATA; Gabadinho A, 2011, COMM COM INF SC, V128, P94; Gangakhedkar RR, 1997, JAMA-J AM MED ASSOC, V278, P2090, DOI 10.1001/jama.278.23.2090; Giele J. Z., 1998, METHODS LIFECOURSE R; Govindasamy P, 1997, 5 NATL FAM HLTH SURV; Hutter I, 2006, CHILD SPACING REPROD; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; Kandwal R, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-18; Kanniappan S, 2008, AIDS CARE, V20, P625, DOI 10.1080/09540120701660361; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Liefbroer AC, 2012, ADV LIFE COURSE RES, V17, P1, DOI 10.1016/j.alcr.2012.01.002; Lopez M, 2012, AIDS, V26, P37, DOI 10.1097/QAD.0b013e32834db300; Marazzi MC, 2011, AIDS, V25, P1611, DOI 10.1097/QAD.0b013e3283493ed0; Mills M., 2011, INTRO SURVIVAL EVENT; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; Padmadas SS, 2004, INT FAM PLAN PERSPEC, V30, P12, DOI 10.1363/3001204; Panditrao M, 2011, AIDS CARE, V23, P593, DOI 10.1080/09540121.2010.516348; Patil S, 2011, AIDS CARE, V23, P1562, DOI 10.1080/09540121.2011.579948; Porter L, 2004, DEMOGRAPHY, V41, P465, DOI 10.1353/dem.2004.0025; Rahangdale L, 2014, JAIDS-J ACQ IMM DEF, V65, P306, DOI 10.1097/QAI.0000000000000014; Sandelowski M, 2003, RES NURS HEALTH, V26, P470, DOI 10.1002/nur.10109; Segurado AC, 2007, REPROD HEALTH MATTER, V15, P27, DOI 10.1016/S0968-8080(07)29032-9; Sharma R, 2012, INDIAN J PEDIATR, V79, P961, DOI 10.1007/s12098-011-0679-3; Tenkorang EY, 2014, INT HEALTH, V6, P46, DOI 10.1093/inthealth/ihu003; Townsend CL, 2010, BJOG-INT J OBSTET GY, V117, P1399, DOI 10.1111/j.1471-0528.2010.02689.x; UNAIDS, 2014, JC26811E UNAIDS; UNAIDS, 2014, GAP REP BEG END AIDS; UNAIDS, 2012, GLOBAL REPORT UNAIDS; UNAIDS, 2014, DOWN DET FAST TRACK; WHO, 2014, GLOB UPD HIV TREAT 2; Wilson S, 2007, SOCIOL HEALTH ILL, V29, P610, DOI 10.1111/j.1467-9566.2007.01008.x; World Health Organization, 2021, ANT DRUGS TREAT PREG	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124537	10.1371/journal.pone.0124537	http://dx.doi.org/10.1371/journal.pone.0124537			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906185	Green Published, gold			2022-12-27	WOS:000353332000073
J	Glonti, K; Gordeev, VS; Goryakin, Y; Reeves, A; Stuckler, D; McKee, M; Roberts, B				Glonti, Ketevan; Gordeev, Vladimir S.; Goryakin, Yevgeniy; Reeves, Aaron; Stuckler, David; McKee, Martin; Roberts, Bayard			A Systematic Review on Health Resilience to Economic Crises	PLOS ONE			English	Review							MENTAL-HEALTH; FINANCIAL CRISIS; RECESSION; MORTALITY; INEQUALITIES; TRENDS; SPAIN; POPULATION; SUICIDES; IMPACT	Background The health effects of recent economic crises differ markedly by population group. The objective of this systematic review is to examine evidence from longitudinal studies on factors influencing resilience for any health outcome or health behaviour among the general population living in countries exposed to financial crises. Methods We systematically reviewed studies from six electronic databases (EMBASE, Global Health, MEDLINE, PsycINFO, Scopus, Web of Science) which used quantitative longitudinal study designs and included: (i) exposure to an economic crisis; (ii) changes in health outcomes/behaviours over time; (iii) statistical tests of associations of health risk and/or protective factors with health outcomes/behaviours. The quality of the selected studies was appraised using the Quality Assessment Tool for Quantitative Studies. PRISMA reporting guidelines were followed. Results From 14,584 retrieved records, 22 studies met the eligibility criteria. These studies were conducted across 10 countries in Asia, Europe and North America over the past two decades. Ten socio-demographic factors that increased or protected against health risk were identified: gender, age, education, marital status, household size, employment/occupation, income/financial constraints, personal beliefs, health status, area of residence, and social relations. These studies addressed physical health, mortality, suicide and suicide attempts, mental health, and health behaviours. Women's mental health appeared more susceptible to crises than men's. Lower income levels were associated with greater increases in cardiovascular disease, mortality and worse mental health. Employment status was associated with changes in mental health. Associations with age, marital status, and education were less consistent, although higher education was associated with healthier behaviours. Conclusions Despite widespread rhetoric about the importance of resilience, there was a dearth of studies which operationalised resilience factors. Future conceptual and empirical research is needed to develop the epidemiology of resilience.	[Glonti, Ketevan; Gordeev, Vladimir S.; Stuckler, David; McKee, Martin; Roberts, Bayard] London Sch Hyg & Trop Med, Ctr Hlth & Social Change, ECOHOST, London WC1, England; [Goryakin, Yevgeniy] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Reeves, Aaron; Stuckler, David] Univ Oxford, Dept Sociol, Oxford, England	University of London; London School of Hygiene & Tropical Medicine; University of East Anglia; University of Oxford	Roberts, B (corresponding author), London Sch Hyg & Trop Med, Ctr Hlth & Social Change, ECOHOST, London WC1, England.	bayard.roberts@lshtm.ac.uk	Gordeev, Vladimir S/AAB-8019-2019; Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011; Goryakin, Yevgeniy/E-4658-2015	Gordeev, Vladimir S/0000-0003-3906-2316; Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X; Goryakin, Yevgeniy/0000-0002-3063-6099; Reeves, Aaron/0000-0001-9114-965X; Stuckler, David/0000-0002-1288-8401; Roberts, Bayard/0000-0003-4482-5859	Economic and Social Research Council [ES/K003496/1]; ESRC [ES/K003496/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was funded by the Economic and Social Research Council (grant ref: ES/K003496/1) (http://www.esrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo-Suarez AA, 2013, INT J PUBLIC HEALTH, V58, P627, DOI 10.1007/s00038-013-0475-0; Almedom AM, 2005, SOC SCI MED, V61, P943, DOI 10.1016/j.socscimed.2004.12.025; [Anonymous], 2014, BBC; Antonovsky A., 1979, HLTH STRESS COPING; Astell-Burt T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056674; Bambra C, 2009, J EPIDEMIOL COMMUN H, V63, P38, DOI 10.1136/jech.2007.070292; Barr B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5142; Bernal JAL, 2013, EUR J PUBLIC HEALTH, V23, P732, DOI 10.1093/eurpub/ckt083; Bor J, 2013, ALCOHOL ALCOHOLISM, V48, P343, DOI 10.1093/alcalc/agt002; Borgonovi F, 2010, SOC SCI MED, V71, P1927, DOI 10.1016/j.socscimed.2010.09.018; Castleden M, 2011, J PUBLIC HEALTH-UK, V33, P369, DOI 10.1093/pubmed/fdr027; Doherty AM, 2013, IRISH J MED SCI, V182, P113, DOI 10.1007/s11845-012-0843-4; Dregan A, 2009, SOC SCI MED, V69, P1432, DOI 10.1016/j.socscimed.2009.08.041; Economou M, 2013, J AFFECT DISORDERS, V145, P308, DOI 10.1016/j.jad.2012.08.008; Evans-Lacko S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069792; GARMEZY N, 1991, AM BEHAV SCI, V34, P416, DOI 10.1177/0002764291034004003; Gili M, 2013, EUR J PUBLIC HEALTH, V23, P103, DOI 10.1093/eurpub/cks035; Goryakin Y, 2014, HEALTH ECON POLICY L, V9, P1, DOI 10.1017/S1744133113000121; Gudmundsdottir DG, 2013, SOC INDIC RES, V110, P1083, DOI 10.1007/s11205-011-9973-8; Hajdu P., 1995, EUR J PUBLIC HEALTH, V5, P259, DOI [DOI 10.1093/EURPUB/5.4.259, 10.1093/eurpub/5.4.259]; Hauksdottir A, 2013, AM J EPIDEMIOL; Johnson R, 2007, W12825 NAT BUR EC RE; Karanikolos M, 2013, LANCET, V381, P1323, DOI 10.1016/S0140-6736(13)60102-6; Katikireddi SV, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001790; Kim Il Ho, 2011, J Prev Med Public Health, V44, P22, DOI 10.3961/jpmph.2011.44.1.22; Kondo N, 2008, J EPIDEMIOL COMMUN H, V62, P869, DOI 10.1136/jech.2007.070334; Lammintausta A, 2012, ANN EPIDEMIOL, V22, P87, DOI 10.1016/j.annepidem.2011.10.012; Lee WY, 2009, YONSEI MED J, V50, P482, DOI 10.3349/ymj.2009.50.4.482; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Luthar S, 2000, CHILD DEV, V71; Macy JT, 2013, SOC SCI MED, V89, P8, DOI 10.1016/j.socscimed.2013.04.020; Martikainen P, 2007, AM J EPIDEMIOL, V165, P1070, DOI 10.1093/aje/kwm057; McClure CB, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001386; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Montgomery S, 2013, BMJ OPEN, V3; Ostamo A, 2001, SOC PSYCH PSYCH EPID, V36, P354, DOI 10.1007/s001270170041; Pyper D, 2013, ZERO HOURS CONTRACTS; Rahmqvist M, 1998, SCAND J SOC MED, V26, P214, DOI 10.1177/14034948980260031201; Reeves A, 2014, BR J PSYCHIAT; Rutter M, 2006, ANN NY ACAD SCI, V1094, P1, DOI 10.1196/annals.1376.002; Sargent-Cox K, 2011, SOC SCI MED, V73, P1105, DOI 10.1016/j.socscimed.2011.06.063; Stuckler D, 2011, LANCET, V378, P124, DOI 10.1016/S0140-6736(11)61079-9; Stuckler David, 2009, Ulster Med J, V78, P142; Suhrcke M, 2012, SOC SCI MED, V74, P647, DOI 10.1016/j.socscimed.2011.12.011; Thomas B H, 2004, Worldviews Evid Based Nurs, V1, P176, DOI 10.1111/j.1524-475X.2004.04006.x; Viinamaki H, 2000, NORD J PSYCHIAT, V54, P177, DOI 10.1080/080394800750019079; Wada K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1191; Walsh F, 1996, FAM PROCESS, V35, P261, DOI 10.1111/j.1545-5300.1996.00261.x; World Health Organization, 2014, RISK FACT	49	67	68	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123117	10.1371/journal.pone.0123117	http://dx.doi.org/10.1371/journal.pone.0123117			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KZ	25905629	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000353332000023
J	Karam, C; Beauchet, A; Czernichow, S; de Roquefeuil, F; Bourez, A; Mansencal, N; Dubourg, O				Karam, Carma; Beauchet, Alain; Czernichow, Sebastien; de Roquefeuil, Florence; Bourez, Alain; Mansencal, Nicolas; Dubourg, Olivier			Trends in Cardiovascular Disease Risk Factor Prevalence and Estimated 10-Year Cardiovascular Risk Scores in a Large Untreated French Urban Population: The CARVAR 92 Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; PHYSICAL-ACTIVITY; SMOKING; STROKE; METAANALYSIS; PREVENTION; REDUCTION; PROMOTION	Background Surveys measuring effectiveness of public awareness campaigns in reducing cardiovascular disease (CVD) incidence have yielded equivocal findings. The aim of this study was to describe cardiovascular risk factors (CVRFs) changes over the years in an untreated population-based study. Methods Between 2007 and 2012, we conducted a screening campaign for CVRFs in men aged 40 to 65 yrs and women aged 50 to 70 yrs in the western suburbs of Paris. Data were complete for 20,324 participants of which 14,709 were untreated. Results The prevalence trend over six years was statistically significant for hypertension in men from 25.9% in 2007 to 21.1% in 2012 (p=0.002) and from 23% in 2007 to 12.7% in 2012 in women (p<0.0001). The prevalence trend of tobacco smoking decreased from 38.6% to 27.7% in men (p=0.0001) and from 22.6% to 16.8% in women (p=0.113). The Framingham 10-year risk for CVD decreased from 13.3 +/- 8.2% in 2007 to 11.7 +/- 9.0 % in 2012 in men and from 8.0 +/- 4.1 % to 5.9 +/- 3.4% in women. The 10-year risk of fatal CVD based on the European Systematic COronary Risk Evaluation (SCORE) decreased in men and in women (p<0.0001). Conclusions Over a 6-year period, several CVRFs have decreased in our screening campaign, leading to decrease in the 10-year risk for CVD and the 10-year risk of fatal CVD. Cardiologists should recognize the importance of community prevention programs and communication policies, particularly tobacco control and healthier diets to decrease the CVRFs in the general population.	[Karam, Carma; de Roquefeuil, Florence; Mansencal, Nicolas; Dubourg, Olivier] UVSQ, Hop Ambroise Pare, AP HP, Cardiol Dept,Ctr Reference Malad Cardiaques Hered, Boulogne, France; [Beauchet, Alain] UVSQ, Hop Ambroise Pare, AP HP, Dept Publ Hlth, Boulogne, France; [Czernichow, Sebastien] UVSQ, Hop Ambroise Pare, AP HP, Dept Nutr, Boulogne, France; [Czernichow, Sebastien] INSERM UMS 011, Populat Based Epidemiol Cohorts, Villejuif, France; [Bourez, Alain] Local Hlth Insurance, Nanterre, France; [Mansencal, Nicolas; Dubourg, Olivier] UVSQ, INSERM U1018, CESP, Team 5,EpReC,Renal & Cardiovasc Epidemiol, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Karam, C (corresponding author), UVSQ, Hop Ambroise Pare, AP HP, Cardiol Dept,Ctr Reference Malad Cardiaques Hered, Boulogne, France.	carma.karam@apr.aphp.fr	Mansencal, Nicolas/AAO-4549-2020					Almdal T, 2004, ARCH INTERN MED, V164, P1422, DOI 10.1001/archinte.164.13.1422; [Anonymous], 2006, ET NAT NUTR SANT ENN; Artigao-Rodenas LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073529; Barone-Adesi F, 2006, EUR HEART J, V27, P2468, DOI 10.1093/eurheartj/ehl201; Bartecchi C, 2006, CIRCULATION, V114, P1490, DOI 10.1161/CIRCULATIONAHA.106.615245; Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720; Bremner P, 2006, EVALUATION 5 DAY PRO; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Capacci S, 2012, NUTR REV, V70, P188, DOI 10.1111/j.1753-4887.2011.00442.x; Carter OBJ, 2011, PUBLIC HEALTH NUTR, V14, P982, DOI 10.1017/S1368980010003381; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Craig CL, 2010, HEALTH PROMOT INT, V25, P14, DOI 10.1093/heapro/dap048; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Dong CH, 2012, CIRCULATION, V125, P2975, DOI 10.1161/CIRCULATIONAHA.111.081083; Eckel RH, 2004, CIRCULATION, V110, P2968, DOI 10.1161/01.CIR.0000140086.88453.9A; Ford ES, 2013, J AM COLL CARDIOL, V61, P2249, DOI 10.1016/j.jacc.2013.03.023; Guignard R., 2010, TABAGISME FRANCE ANA; Guignard R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078372; Hillsdon M, 2001, J EPIDEMIOL COMMUN H, V55, P755, DOI 10.1136/jech.55.10.755; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Marques-Vidal P, 2004, EUR J EPIDEMIOL, V19, P25, DOI 10.1023/B:EJEP.0000013393.11132.e8; Pivonka E, 2011, J AM DIET ASSOC, V111, P1570, DOI 10.1016/j.jada.2011.07.001; Pollard CM, 2008, PUBLIC HEALTH NUTR, V11, P314, DOI 10.1017/S1368980007000523; Prescott E, 1998, BMJ-BRIT MED J, V316, P1043; Sargent RP, 2004, BMJ-BRIT MED J, V328, P977, DOI 10.1136/bmj.38055.715683.55; Tunstall-Pedoe H, 2006, BRIT MED J, V332, P629, DOI 10.1136/bmj.38753.779005.BE; van Dis I, 2014, EUR J PREV CARDIOL, V21, P377, DOI 10.1177/2047487312443485; Wagner A, 2011, J HYPERTENS, V29, P43, DOI 10.1097/HJH.0b013e32833f9c4d; Wanner M, 2011, BRIT J SPORT MED, V45, P1202, DOI 10.1136/bjsm.2009.070201; Webster JL, 2011, J HYPERTENS, V29, P1043, DOI 10.1097/HJH.0b013e328345ed83; World Health Organization, 2014, TOP 10 CAUS DEATH; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	34	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124817	10.1371/journal.pone.0124817	http://dx.doi.org/10.1371/journal.pone.0124817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906186	Green Submitted, Green Published, gold			2022-12-27	WOS:000353332000091
J	Wang, DN; Li, ZH; Xiao, JQ; Wang, JQ; Zhang, L; Liu, YJ; Fan, F; Xin, L; Wei, MX; Kong, ZB; Yu, H; Gu, Y; Zhang, J; Li, SW; Xia, NS				Wang, Daning; Li, Zhihai; Xiao, Jieqiong; Wang, Junqi; Zhang, Li; Liu, Yajing; Fan, Fei; Xin, Lu; Wei, Minxi; Kong, Zhibo; Yu, Hai; Gu, Ying; Zhang, Jun; Li, Shaowei; Xia, Ningshao			Identification of Broad-Genotype HPV L2 Neutralization Site for Pan-HPV Vaccine Development by a Cross-Neutralizing Antibody	PLoS One			English	Article							MINOR CAPSID PROTEIN; HUMAN-PAPILLOMAVIRUS VACCINES; VIRUS-LIKE PARTICLES; MONOCLONAL-ANTIBODIES; DIPHTHERIA-TOXIN; INFECTION; EPITOPE; IMMUNOGENICITY; L1; PROTECTION	Human Papillomavirus (HPV), a non-enveloped, double-stranded DNA virus, is responsible for 5% of human cancers. The HPV capsid consists of major and minor structural proteins, L1 and L2. L1 proteins form an icosahedral shell with building blocks of the pentameric capsomere, and one L2 molecule extends outward from the central hole of the capsid. Thus, L2 is concealed within L1 and only becomes exposed when the capsid interacts with host cells. The low antigenic variation of L2 means that this protein could offer a target for the development of a pan-HPV vaccine. Toward this goal, here we describe an anti-L2 monoclonal antibody, 14H6, which broadly neutralizes at least 11 types of HPV, covering types 6, 11, 16, 18, 31, 33, 35, 45, 52, 58 and 59, in pseudovirion-based cell neutralization assay. The mAb 14H6 recognizes a minimal linear epitope located on amino acids 21 to 30 of the L2 protein. Alanine scanning mutagenesis and sequence alignment identified several conserved residues (Cys22, Lys23, Thr27, Cys28 and Pro29) that are involved in the 14H6 binding with L2. The epitope was grafted to several scaffolding proteins, including HPV16 L1 virus-like particles, HBV 149 core antigen and CRM197. The resultant chimeric constructs were expressed in Escherichia coli and purified with high efficiency. Immunization with these pan-HPV vaccine candidates elicited high titers of the L2-specific antibody in mice and conferred robust (3-log) titers of cross-genotype neutralization, including against HPV11, 16, 18, 45, 52, 58 and 59. These findings will help in the development of an L2based, pan-HPV vaccine.	[Wang, Daning; Wang, Junqi; Xin, Lu; Kong, Zhibo; Yu, Hai; Gu, Ying; Zhang, Jun; Li, Shaowei; Xia, Ningshao] Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen 361005, Peoples R China; [Li, Zhihai; Xiao, Jieqiong; Zhang, Li; Liu, Yajing; Fan, Fei; Wei, Minxi; Gu, Ying; Li, Shaowei; Xia, Ningshao] Xiamen Univ, Sch Life Sci, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen 361005, Peoples R China	Xiamen University; Xiamen University	Li, SW (corresponding author), Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen 361005, Peoples R China.	shaowei@xmu.edu.cn; nsxia@xmu.edu.cn	Zhang, Jun/G-4598-2010	Zhang, Jun/0000-0002-6601-9180; Xia, Ningshao/0000-0003-0179-5266	Chinese government: the National Natural Science Foundation [81172885]; International Science and Technology Collaborative Program [2011DFG33050]; Key Program in New Drug RD [2012ZX09101316, 2014AA021302]; Institute Reconstruction Fund [2011FU125Z04]; Key Platform Project of Xiamen [3502Z20131001]	Chinese government: the National Natural Science Foundation; International Science and Technology Collaborative Program; Key Program in New Drug RD; Institute Reconstruction Fund; Key Platform Project of Xiamen	The authors acknowledge funding support from the Chinese government: the National Natural Science Foundation (Grants 81172885), the International Science and Technology Collaborative Program (Grant 2011DFG33050), the Key Program in New Drug R&D (Grants 2012ZX09101316, 2014AA021302), the Institute Reconstruction Fund (2011FU125Z04) and the Key Platform Project of Xiamen (3502Z20131001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buck CB, 2005, METH MOLEC MED, V119, P445; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Campos SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004463; Chen X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095448; Chen YX, 2013, VACCINE, V31, P425, DOI 10.1016/j.vaccine.2012.10.032; CLARKE BE, 1987, NATURE, V330, P381, DOI 10.1038/330381a0; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; Cubie HA, 2013, VIROLOGY, V445, P21, DOI 10.1016/j.virol.2013.06.007; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DRAZIN R, 1971, J BIOL CHEM, V246, P1504; Fay A, 2004, J VIROL, V78, P13447, DOI 10.1128/JVI.78.24.13447-13454.2004; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Gambhira R, 2007, J VIROL, V81, P13927, DOI 10.1128/JVI.00936-07; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; ISHIOKA GY, 1992, J IMMUNOL, V148, P2446; Jagu S, 2013, J VIROL, V87, P6127, DOI 10.1128/JVI.03218-12; Jagu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055538; Jagu S, 2010, VACCINE, V28, P4478, DOI 10.1016/j.vaccine.2010.04.039; Jagu S, 2009, JNCI-J NATL CANCER I, V101, P782, DOI 10.1093/jnci/djp106; Kalnin K, 2014, VACCINE, V32, P3540, DOI 10.1016/j.vaccine.2014.04.032; Kawana K, 1999, J VIROL, V73, P6188, DOI 10.1128/JVI.73.7.6188-6190.1999; Kondo K, 2007, VIROLOGY, V358, P266, DOI 10.1016/j.virol.2006.08.037; Li SW, 2005, VACCINE, V23, P2893, DOI 10.1016/j.vaccine.2004.11.064; Li SW, 2005, J BIOL CHEM, V280, P3400, DOI 10.1074/jbc.M410361200; Luo W X, 2000, Sheng Wu Gong Cheng Xue Bao, V16, P578; McClements WL, 2001, VIROLOGY, V289, P262, DOI 10.1006/viro.2001.1146; McGrath M, 2013, ARCH VIROL, V158, P2079, DOI 10.1007/s00705-013-1713-8; Mukherjee S, 2008, J MOL BIOL, V381, P229, DOI 10.1016/j.jmb.2008.05.079; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Murata Y, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-81; Nakao S, 2012, VIROLOGY, V434, P110, DOI 10.1016/j.virol.2012.09.006; Nieto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039741; Orr N, 1999, INFECT IMMUN, V67, P4290, DOI 10.1128/IAI.67.8.4290-4294.1999; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Pastrana DV, 2004, VIROLOGY, V321, P205, DOI 10.1016/j.virol.2003.12.027; Pumpens P, 1995, INTERVIROLOGY, V38, P63, DOI 10.1159/000150415; Richards KF, 2013, J VIROL, V87, P11426, DOI 10.1128/JVI.01721-13; Richards RM, 2006, P NATL ACAD SCI USA, V103, P1522, DOI 10.1073/pnas.0508815103; Rubio I, 2011, VIROLOGY, V409, P348, DOI 10.1016/j.virol.2010.10.017; Schellenbacher C, 2009, J VIROL, V83, P10085, DOI 10.1128/JVI.01088-09; Schiller J T, 2001, J Natl Cancer Inst Monogr, P50; Skamperle M, 2013, ACTA DERMATOVEN ALP, V21, P1, DOI 10.2478/v10162-012-0024-1; Slupetzky K, 2007, VACCINE, V25, P2001, DOI 10.1016/j.vaccine.2006.11.049; Snape MD, 2008, JAMA-J AM MED ASSOC, V299, P173, DOI 10.1001/jama.2007.29-c; Stanley M, 2008, GYNECOL ONCOL, V109, pS15, DOI 10.1016/j.ygyno.2008.02.003; Stern PL, 2012, VACCINE, V30, pF71, DOI 10.1016/j.vaccine.2012.05.091; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; Tumban E, 2013, VACCINE, V31, P4647, DOI 10.1016/j.vaccine.2013.07.052; Tumban E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049751; Tumban E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023310; VANNESS BG, 1980, J BIOL CHEM, V255, P710; VARECKOVA E, 1995, J IMMUNOL METHODS, V180, P107, DOI 10.1016/0022-1759(94)00307-I; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Wang JW, 2013, VIROLOGY, V445, P175, DOI 10.1016/j.virol.2013.04.017; Xiong AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh094; Xu LF, 2014, THERANOSTICS, V4, P498, DOI 10.7150/thno.7457; Yang RC, 2003, J BIOL CHEM, V278, P12546, DOI 10.1074/jbc.M208691200; Yang RC, 2003, J VIROL, V77, P3531, DOI 10.1128/JVI.77.6.3531-3541.2003	59	29	38	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123944	10.1371/journal.pone.0123944	http://dx.doi.org/10.1371/journal.pone.0123944			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905781	Green Submitted, Green Published, gold			2022-12-27	WOS:000353332000052
J	Chu, C; Zheng, GY; Hu, SG; Zhang, JS; Xie, SS; Ma, WB; Ni, MJ; Tang, CH; Zhou, L; Zhou, YC; Liu, MF; Li, YX; Zhang, YL				Chu, Chen; Zheng, Guangyong; Hu, Shuanggang; Zhang, Jinsong; Xie, Shengsong; Ma, Wubin; Ni, Minjie; Tang, Chunhua; Zhou, Lu; Zhou, Yuchuan; Liu, Mofang; Li, Yixue; Zhang, Yonglian			Epididymal Region-Specific miRNA Expression and DNA Methylation and Their Roles in Controlling Gene Expression in Rats	PLOS ONE			English	Article							MIR-200 FAMILY; MESSENGER-RNA; E-CADHERIN; MESENCHYMAL TRANSITION; MOUSE EPIDIDYMIS; REPRESSORS ZEB1; CANCER-CELLS; STEM-CELLS; MICRORNAS; DIFFERENTIATION	Region-specific gene expression is an intriguing feature of the mammalian epididymis. This unique property is essential for sperm maturation and storage, and it also implicates stringent and multi-level regulations of gene expression. Over the past decade, the androgen-driven activation of epididymal gene transcription has been extensively studied. However, it still remains largely unexplored whether and how other regulatory mechanisms, such as miRNAs and DNA methylation, are involved in controlling regional gene expression in the epididymis. Using microarray-based approaches, we studied the regional miRNA expression and DNA methylation profiles in 4 distinct epididymal regions (initial segment, caput, corpus and cauda) of rats. We found that the miR-200 family members were more expressed in caput, compared with cauda. By GSEA analysis, the differential expression of miR-200 family between caput and cauda was shown to be negatively correlated with their predicted target genes, among which 4 bona fide targets were verified by luciferase reporter assay. Predicted target genes of miR-200 family have enriched functions in anti-apoptosis, cell transportation and development, implying the regional diversity in epididymal functions. On the other hand, we revealed epididymal DNA methylation of 2002 CpG islands and 2771 gene promoters (-3.88-0.97kb), among which 1350 (67.43%) CpG islands and 2095 (75.60%) promoters contained region-specific DNA methylation. We observed significant and distinct functional enrichment in genes with specifically methylated promoters in each epididymal regions, but these DNA methylations did not show significant correlation with repressed gene transcription in the mature epididymis. Conclusively, we investigated the regional miRNA expression and DNA methylation in the rat epididymis and revealed a potential role of miR-200 family in gene expression regulation between caput and cauda. This may contribute to the distinct physiological function in sperm maturation / storage of caput / cauda epididymis.	[Chu, Chen; Hu, Shuanggang; Zhang, Jinsong; Xie, Shengsong; Ma, Wubin; Ni, Minjie; Tang, Chunhua; Zhou, Yuchuan; Liu, Mofang; Zhang, Yonglian] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol,Shanghai Key Lab Mol Andro, Shanghai 200031, Peoples R China; [Zheng, Guangyong] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai 200031, Peoples R China; [Zhou, Lu; Li, Yixue] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai 200031, Peoples R China; [Chu, Chen; Tang, Chunhua; Zhou, Lu] Chinese Acad Sci, Grad Univ, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, YX (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai 200031, Peoples R China.	yxli@sibs.ac.cn; ylzhang@sibcb.ac.cn	zhou, yuchuan/AAF-6202-2019; Chu, Chen/J-6527-2019; Ma, Wubin/P-3045-2017	Chu, Chen/0000-0001-8084-0867; 	National Basic Research Program [2014CB943103]; National Natural Science Foundation of China [31171115, 31301225]; SA-SIBS scholarship program	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); SA-SIBS scholarship program	This work was supported by the National Basic Research Program (Grant No. 2014CB943103), National Natural Science Foundation of China (Grant No. 31171115 and Grant No. 31301225). The authors gratefully acknowledge the support of SA-SIBS scholarship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Belleannee C, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110486; Belleannee C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034996; Bhardwaj A, 2012, MOL ENDOCRINOL, V26, P538, DOI 10.1210/me.2011-1059; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bjorkgren I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038457; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chabory E, 2009, J CLIN INVEST, V119, P2074, DOI 10.1172/JCI38940; Chauvin TR, 2004, BIOL REPROD, V71, P560, DOI 10.1095/biolreprod.103.026302; Corpe CP, 2010, J CLIN INVEST, V120, P1069, DOI 10.1172/JCI39191; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Feng XL, 2014, CANCER LETT, V344, P166, DOI 10.1016/j.canlet.2013.11.004; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grimm C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003250; Guerrero JA, 2014, BLOOD, V124, P3624, DOI 10.1182/blood-2014-04-566760; Hamzeh M, 2010, ENDOCRINOLOGY, V151, P4504, DOI 10.1210/en.2010-0023; Hsia N, 2004, BIOL REPROD, V70, P448, DOI 10.1095/biolreprod.103.021493; Hu SG, 2010, MOL ENDOCRINOL, V24, P2392, DOI 10.1210/me.2010-0226; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Jelinsky SA, 2007, BIOL REPROD, V76, P561, DOI 10.1095/biolreprod.106.057323; Jervis KM, 2001, BIOL REPROD, V65, P696, DOI 10.1095/biolreprod65.3.696; Khavari DA, 2010, CELL CYCLE, V9, P3880, DOI 10.4161/cc.9.19.13385; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li P, 2001, SCIENCE, V291, P1783, DOI 10.1126/science.1056545; Ma WB, 2012, J BIOL CHEM, V287, P10189, DOI 10.1074/jbc.M111.303636; Newell-Price J, 2000, TRENDS ENDOCRIN MET, V11, P142, DOI 10.1016/S1043-2760(00)00248-4; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; Robaire B, 2011, J ANDROL, V32, P592, DOI 10.2164/jandrol.111.014266; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Scacheri PC, 2006, METHOD ENZYMOL, V411, P270, DOI 10.1016/S0076-6879(06)11014-9; Simpson JC, 2004, J CELL SCI, V117, P6297, DOI 10.1242/jcs.01560; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarantino C, 2010, FASEB J, V24, P3255, DOI 10.1096/fj.09-152207; Wang JF, 2010, BIOCHEM BIOPH RES CO, V402, P222, DOI 10.1016/j.bbrc.2010.10.002; Wang JF, 2010, ACTA BIOCH BIOPH SIN, V42, P628, DOI 10.1093/abbs/gmq073; Wu XJ, 2012, ACTA BIOCH BIOPH SIN, V44, P233, DOI 10.1093/abbs/gmr122; Zhang JS, 2010, ACTA BIOCH BIOPH SIN, V42, P145, DOI 10.1093/abbs/gmp116; Zhang SP, 2014, P NATL ACAD SCI USA, V111, P17266, DOI 10.1073/pnas.1419599111; Zhao Y, 2011, CELL MOL LIFE SCI, V68, P697, DOI 10.1007/s00018-010-0478-4; Zheng GY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S6; Zhou YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004106; Zou Q, 2014, COMPUT BIOL MED, V45, P157, DOI 10.1016/j.compbiomed.2013.12.007	52	17	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124450	10.1371/journal.pone.0124450	http://dx.doi.org/10.1371/journal.pone.0124450			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901964	Green Published, gold, Green Submitted			2022-12-27	WOS:000353331500087
J	Lopez-Estepa, M; Arda, A; Savko, M; Round, A; Shepard, WE; Bruix, M; Coll, M; Fernandez, FJ; Jimenez-Barbero, J; Vega, MC				Lopez-Estepa, Miguel; Arda, Ana; Savko, Martin; Round, Adam; Shepard, William E.; Bruix, Marta; Coll, Miquel; Fernandez, Francisco J.; Jimenez-Barbero, Jesus; Cristina Vega, M.			The Crystal Structure and Small-Angle X-Ray Analysis of CsdL/TcdA Reveal a New tRNA Binding Motif in the MoeB/E1 Superfamily	PLOS ONE			English	Article							S CLUSTER BIOGENESIS; BIOLOGICAL MACROMOLECULES; CYSTEINE DESULFURASE; SOLUTION SCATTERING; BIOSYNTHESIS; TRNA(LYS); RESOLUTION; PROTEINS; MODELS; SAXS	Cyclic N-6-threonylcarbamoyladenosine ('cyclic t(6)A', ct(6)A) is a non-thiolated hypermodification found in transfer RNAs (tRNAs) in bacteria, protists, fungi and plants. In bacteria and yeast cells ct(6)A has been shown to enhance translation fidelity and efficiency of ANN codons by improving the faithful discrimination of aminoacylated tRNAs by the ribosome. To further the understanding of ct(6)A biology we have determined the high-resolution crystal structures of CsdL/TcdA in complex with AMP and ATP, an E1-like activating enzyme from Escherichia coli, which catalyzes the ATP-dependent dehydration of t(6)A to form ct(6)A. CsdL/TcdA is a dimer whose structural integrity and dimer interface depend critically on strongly bound K+ and Na+ cations. By using biochemical assays and small-angle X-ray scattering we show that CsdL/TcdA can associate with tRNA with a 1:1 stoichiometry and with the proper position and orientation for the cyclization of t(6)A. Furthermore, we show by nuclear magnetic resonance that CsdL/TcdA engages in transient interactions with CsdA and CsdE, which, in the latter case, involve catalytically important residues. These short-lived interactions may underpin the precise channeling of sulfur atoms from cysteine to CsdL/TcdA as previously characterized. In summary, the combination of structural, biophysical and biochemical methods applied to CsdL/TcdA has afforded a more thorough understanding of how the structure of this E1-like enzyme has been fine tuned to accomplish ct(6)A synthesis on tRNAs while providing support for the notion that CsdA and CsdE are able to functionally interact with CsdL/TcdA.	[Lopez-Estepa, Miguel; Arda, Ana; Fernandez, Francisco J.; Jimenez-Barbero, Jesus; Cristina Vega, M.] CSIC, CIB, Biol Res Ctr, Chem & Phys Biol, Madrid, Spain; [Arda, Ana; Jimenez-Barbero, Jesus] CIC BioGUNE, Struct Biol, Derio Bizkaia, Spain; [Savko, Martin; Shepard, William E.] Synchrotron SOLEIL, Gif Sur Yvette, France; [Round, Adam] European Mol Biol Lab, Grenoble Outstat, F-38042 Grenoble, France; [Round, Adam] Univ Grenoble Alpes, EMBL CNRS, Unit Virus Host Cell Interact, Martyrs, France; [Bruix, Marta] CSIC, IFQR, Inst Phys Chem Rocasolano, Madrid, Spain; [Coll, Miquel] IRB Barcelona, Inst Res Biomed, Barcelona, Spain; [Coll, Miquel] CSIC, IBMB, Inst Biol Mol Barcelona, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIC bioGUNE; SOLEIL Synchrotron; European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Vega, MC (corresponding author), CSIC, CIB, Biol Res Ctr, Chem & Phys Biol, Madrid, Spain.	cvega@cib.csic.es	Bruix, Marta/H-4161-2011; Coll, Miquel/L-5999-2014; JIMENEZ-BARBERO, JESUS/D-4431-2014; Vega, M. Cristina/C-3640-2011; Fernandez, Francisco J./C-3647-2011	Bruix, Marta/0000-0002-0096-3558; Coll, Miquel/0000-0003-4471-8674; JIMENEZ-BARBERO, JESUS/0000-0001-5421-8513; Vega, M. Cristina/0000-0003-0628-8378; Fernandez, Francisco J./0000-0002-5015-1849; Shepard, William/0000-0002-5724-1193	Ministerio de Economia y Competitividad [PET2008_0101, BIO2009-11184, BFU2010-22260-C02-02, BFU2008-02372/BMC, CONSOLIDER CSD 2006-23, BFU2011-22588, CTQ2012-32035]; Generalitat de Catalunya [SGR2009-1309]; European Commission [279039, 260644]	Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); European Commission(European CommissionEuropean Commission Joint Research Centre)	Ministerio de Economia y Competitividad (ES) (grants PET2008_0101, BIO2009-11184 and BFU2010-22260-C02-02 to MCV, BFU2008-02372/BMC, CONSOLIDER CSD 2006-23 and BFU2011-22588 to MC, CTQ2012-32035 to JJB), Generalitat de Catalunya (ES) (grant SGR2009-1309 to MC), the European Commission (Framework Programme 7 (FP7) projects ComplexINC No. 279039 to MCV and SILVER-GA No. 260644 to MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bolstad HM, 2010, J PROTEOME RES, V9, P5358, DOI 10.1021/pr1006087; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cole JL, 2004, METHOD ENZYMOL, V384, P212; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Grosjean H., 2000, DNA RNA MODIFICATION, P1; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Guinier A., 1955, SMALL ANGLE SCATTERI; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim S, 2014, ACTA CRYSTALLOGR F, V70, P1517, DOI 10.1107/S2053230X14020883; Kim S, 2013, J BIOL CHEM, V288, P27172, DOI 10.1074/jbc.M113.480277; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2011, ACTA CRYSTALLOGR D, V67, P376, DOI 10.1107/S0907444911007232; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lin CA, 2010, MOL CELL BIOL, V30, P354, DOI 10.1128/MCB.00754-09; Liu GH, 2005, PROTEIN SCI, V14, P1597, DOI 10.1110/ps.041322705; Loiseau L, 2005, J BIOL CHEM, V280, P26760, DOI 10.1074/jbc.M504067200; Machnicka Magdalena A, 2013, Nucleic Acids Res, V41, pD262, DOI 10.1093/nar/gks1007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miyauchi K, 2013, NAT CHEM BIOL, V9, P105, DOI [10.1038/NCHEMBIO.1137, 10.1038/nchembio.1137]; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P1186, DOI 10.1038/nsmb861; NIIMI T, 1994, NUCLEOS NUCLEOT NUCL, V13, P1231, DOI 10.1080/15257779408012147; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Phelps SS, 2004, J MOL BIOL, V338, P439, DOI 10.1016/j.jmb.2004.02.070; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Round A, 2013, ACTA CRYSTALLOGR D, V69, P2072, DOI 10.1107/S0907444913019276; Schrodinger L., 2020, PYMOL; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SCHWEIZE.MP, 1969, BIOCHEMISTRY-US, V8, P3283, DOI 10.1021/bi00836a023; Stuart JW, 2000, BIOCHEMISTRY-US, V39, P13396, DOI 10.1021/bi0013039; Sundaram M, 2000, BIOCHEMISTRY-US, V39, P15652, DOI 10.1021/bi005120y; Suzuki T, 2005, TOP CURR GENET, V12, P23, DOI 10.1007/b106361; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2000, J BIOL CHEM, V275, P14432, DOI 10.1074/jbc.275.19.14432; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Trotter V, 2009, MOL MICROBIOL, V74, P1527, DOI 10.1111/j.1365-2958.2009.06954.x; Ucci JW, 2004, BIOPHYS CHEM, V108, P127, DOI 10.1016/j.bpc.2003.10.033; van de Weert M, 2010, J FLUORESC, V20, P625, DOI 10.1007/s10895-009-0572-x; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wei FY, 2011, J CLIN INVEST, V121, P3598, DOI 10.1172/JCI58056; WEISSENBACH J, 1981, EUR J BIOCHEM, V116, P207, DOI 10.1111/j.1432-1033.1981.tb05320.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yarian C, 2002, J BIOL CHEM, V277, P16391, DOI 10.1074/jbc.M200253200	56	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0118606	10.1371/journal.pone.0118606	http://dx.doi.org/10.1371/journal.pone.0118606			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897750	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600001
J	Martinez-Cuenca, MR; Quinones, A; Primo-Millo, E; Forner-Giner, MA				Martinez-Cuenca, Mary-Rus; Quinones, Ana; Primo-Millo, Eduardo; Forner-Giner, M. Angeles			Flooding Impairs Fe Uptake and Distribution in Citrus Due to the Strong Down-Regulation of Genes Involved in Strategy I Responses to Fe Deficiency in Roots	PLOS ONE			English	Article							FERRIC-CHELATE REDUCTASE; IRON-DEFICIENCY; PHYSIOLOGICAL-RESPONSES; ANTIOXIDANT DEFENSE; REDUCING CAPACITY; PEACH ROOTSTOCKS; RT-PCR; TOLERANCE; BICARBONATE; SOIL	This work determines the ffects of long-term anoxia conditions-21 days-on Strategy I responses to iron (Fe) deficiency in Citrus and its impact on Fe uptake and distribution. The study was carried out in Citrus aurantium L. seedlings grown under flooding conditions (S) and in both the presence (+Fe) and absence of Fe (-Fe) in nutritive solution. The results revealed a strong down-regulation (more than 65%) of genes HA1 and FRO2 coding for enzymes proton-ATPase and Ferric-Chelate Reductase (FC-R), respectively, in -FeS plants when compared with -Fe ones. H+-extrusion and FC-R activity analyses confirmed the genetic results, indicating that flooding stress markedly repressed acidification and reduction responses to Fe deficiency (3.1- and 2.0-fold, respectively). Waterlogging reduced by half Fe concentration in +FeS roots, which led to 30% up-regulation of Fe transporter IRT1, although this effect was unable to improve Fe absorption. Consequently, flooding inhibited 57Fe uptake in +Fe and -Fe seedlings (29.8 and 66.2%, respectively) and 57Fe distribution to aerial part (30.6 and 72.3%, respectively). This evidences that the synergistic action of both enzymes H+-ATPase and FC-R is the preferential regulator of the Fe acquisition system under flooding conditions and, hence, their inactivation implies a limiting factor of citrus in their Fe-deficiency tolerance in waterlogged soils.	[Martinez-Cuenca, Mary-Rus; Quinones, Ana; Primo-Millo, Eduardo; Forner-Giner, M. Angeles] Valencian Inst Agrarian Res, Dept Citriculture & Vegetal Prod, Moncada, Valencia, Spain		Martinez-Cuenca, MR (corresponding author), Valencian Inst Agrarian Res, Dept Citriculture & Vegetal Prod, Moncada, Valencia, Spain.	martinez_mru@gva.es	Quinones, Ana/E-6229-2014; Forner-Giner, Angeles/D-5306-2014; Primo-Millo, Eduardo/D-8584-2014; Martinez-Cuenca, Mary-Rus/K-7710-2015	Quinones, Ana/0000-0002-6096-734X; Forner-Giner, Angeles/0000-0003-3237-0893; Primo-Millo, Eduardo/0000-0002-2146-0175; Martinez-Cuenca, Mary-Rus/0000-0002-9017-2951	National Institute of Research and Agrarian and Food Technology [RTA2011-00127]; Valencian Generalitat; FEDER funds	National Institute of Research and Agrarian and Food Technology; Valencian Generalitat; FEDER funds(European Commission)	This work was funded by the National Institute of Research and Agrarian and Food Technology (RTA2011-00127), Valencian Generalitat and FEDER funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia J, 1999, PLANT SOIL, V215, P183, DOI 10.1023/A:1004451728237; Alcantara E, 2000, J PLANT NUTR, V23, P1607, DOI 10.1080/01904160009382127; Arbona V, 2008, J PLANT GROWTH REGUL, V27, P241, DOI 10.1007/s00344-008-9051-x; Arbona V, 2008, PHYSIOL PLANTARUM, V132, P452, DOI 10.1111/j.1399-3054.2007.01029.x; Balakhnina TI, 2010, PLANT SOIL, V327, P293, DOI 10.1007/s11104-009-0054-6; Brait JF, 2002, OXIDATIVE STRESS PLA, P171; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; CHANEY RL, 1972, PLANT PHYSIOL, V50, P208, DOI 10.1104/pp.50.2.208; Chouliaras V, 2004, AGRONOMIE, V24, P1, DOI 10.1051/agro:2003055; Colmer TD, 2009, FUNCT PLANT BIOL, V36, P665, DOI 10.1071/FP09144; Colmer TD, 2003, ANN BOT-LONDON, V91, P301, DOI 10.1093/aob/mcf114; Connolly EL, 2003, PLANT PHYSIOL, V133, P1102, DOI 10.1104/pp.103.025122; Connolly EL, 2002, PLANT CELL, V14, P1347, DOI 10.1105/tpc.001263; de la Guardia MD, 2002, PLANT SOIL, V241, P49, DOI 10.1023/A:1016083512158; De Simone O, 2003, TREES-STRUCT FUNCT, V17, P535, DOI 10.1007/s00468-003-0270-2; Donnini S, 2009, J PLANT PHYSIOL, V166, P1181, DOI 10.1016/j.jplph.2009.01.007; Felle HH, 2005, ANN BOT-LONDON, V96, P519, DOI 10.1093/aob/mci207; Fox TC, 1996, PLANT PHYSIOL, V111, P93, DOI 10.1104/pp.111.1.93; Fukao T, 2003, J EXP BOT, V54, P1421, DOI 10.1093/jxb/erg140; Garcia-Sanchez F, 2007, PHYSIOL PLANTARUM, V130, P532, DOI 10.1111/j.1399-3054.2007.00925.x; Gharsalli M, 2002, J PLANT NUTR, V25, P1139, DOI 10.1081/PLN-120003945; Gimeno V, 2012, HORTSCIENCE, V47, P403, DOI 10.21273/HORTSCI.47.3.403; Gogorcena Y, 2004, J PLANT NUTR, V27, P1701, DOI [10.1081/LPLA-200026406, 10.1081/PLN-200026406]; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Hell R, 2003, PLANTA, V216, P541, DOI 10.1007/s00425-002-0920-4; Hossain Z, 2009, J PLANT PHYSIOL, V166, P1391, DOI 10.1016/j.jplph.2009.02.012; Jelali N, 2010, SCI HORTIC-AMSTERDAM, V124, P116, DOI 10.1016/j.scienta.2009.12.010; Jeong J, 2009, PLANT SCI, V176, P709, DOI 10.1016/j.plantsci.2009.02.011; Kato-Noguchi H, 2000, PHYSIOL PLANTARUM, V109, P28, DOI 10.1034/j.1399-3054.2000.100105.x; Khabaz-Saberi H, 2010, EUPHYTICA, V172, P275, DOI 10.1007/s10681-009-0069-3; Kim SA, 2007, FEBS LETT, V581, P2273, DOI 10.1016/j.febslet.2007.04.043; Kosegarten H, 2001, PHYSIOL PLANTARUM, V113, P515, DOI 10.1034/j.1399-3054.2001.1130410.x; Ksouri R, 2007, PLANT PHYSIOL BIOCH, V45, P315, DOI 10.1016/j.plaphy.2007.03.014; LAAN P, 1991, PLANT SOIL, V136, P153, DOI 10.1007/BF02150046; Ladygin VG, 2004, APPL BIOCHEM MICRO+, V40, P506, DOI 10.1023/B:ABIM.0000040676.09063.6e; LARSON KD, 1991, SOIL SCI, V152, P33, DOI 10.1097/00010694-199107000-00006; Lin KH, 2008, ANN APPL BIOL, V152, P157, DOI 10.1111/j.1744-7348.2007.00211.x; Lucena C, 2007, FUNCT PLANT BIOL, V34, P1002, DOI 10.1071/FP07136; MANTHEY JA, 1994, PLANT PHYSIOL BIOCH, V32, P211; Marschner H., 1995, MINERAL NUTR HIGHER, P651; Martinez-Alcantara B, 2012, J PLANT PHYSIOL, V169, P1150, DOI 10.1016/j.jplph.2012.03.016; Martinez-Cuenca MR, 2013, PLANT SOIL, V373, P943, DOI 10.1007/s11104-013-1861-3; Martinez-Cuenca MR, 2013, SCI HORTIC-AMSTERDAM, V153, P56, DOI 10.1016/j.scienta.2013.01.009; Martinez-Cuenca MR, 2013, ACTA PHYSIOL PLANT, V35, P2853; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Molassiotis A, 2006, J PLANT PHYSIOL, V163, P176, DOI 10.1016/j.jplph.2004.11.016; MORAN R, 1980, PLANT PHYSIOL, V65, P478, DOI 10.1104/pp.65.3.478; Msilini N, 2009, ACTA PHYSIOL PLANT, V31, P849, DOI 10.1007/s11738-009-0318-z; Pestana M, 2005, SCI HORTIC-AMSTERDAM, V104, P25, DOI 10.1016/j.scienta.2004.07.007; Pezeshki SR, 2001, ENVIRON EXP BOT, V46, P299, DOI 10.1016/S0098-8472(01)00107-1; Ponnamperuma F. N., 1984, Flooding and plant growth, P9; Rodriguez-Gamir J, 2011, PLANT PHYSIOL BIOCH, V49, P636, DOI 10.1016/j.plaphy.2011.03.003; RuizSanchez MC, 1996, PLANT SCI, V120, P119, DOI 10.1016/S0168-9452(96)04494-9; Ryser P, 2011, PLANT SOIL, V343, P247, DOI 10.1007/s11104-011-0715-0; Santi S, 2005, PLANT PHYSIOL BIOCH, V43, P287, DOI 10.1016/j.plaphy.2005.02.007; Santi S, 2009, NEW PHYTOL, V183, P1072, DOI 10.1111/j.1469-8137.2009.02908.x; Schaffer B, 2006, HORTSCIENCE, V41, P549, DOI 10.21273/HORTSCI.41.3.549; Schaffer B., 1992, Horticultural Reviews, V13, P257, DOI 10.1002/9780470650509.ch7; SCHMIDT W, 1990, J PLANT PHYSIOL, V136, P51, DOI 10.1016/S0176-1617(11)81614-7; Snowden RED, 1995, NEW PHYTOL, V131, P503, DOI 10.1111/j.1469-8137.1995.tb03087.x; SYVERTSEN JP, 1983, PLANT SOIL, V72, P3, DOI 10.1007/BF02185089; TREEBY M, 1993, Z PFLANZ BODENKUNDE, V156, P75, DOI 10.1002/jpln.19931560112; Unger IM, 2009, AGR ECOSYST ENVIRON, V131, P105, DOI 10.1016/j.agee.2008.09.013; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Vert G, 2009, PLANTA, V229, P1171, DOI 10.1007/s00425-009-0904-8; Visser EJW, 2000, PLANT CELL ENVIRON, V23, P1237, DOI 10.1046/j.1365-3040.2000.00628.x; VU JCV, 1991, PHYSIOL PLANTARUM, V81, P7, DOI 10.1111/j.1399-3054.1991.tb01705.x; Waters BM, 2002, PLANT PHYSIOL, V129, P85, DOI 10.1104/pp.010829; Wegner LH, 2004, PLANT PHYSIOL, V136, P3469, DOI 10.1104/pp.104.043844; WHITE PF, 1990, PLANT SOIL, V125, P39, DOI 10.1007/BF00010742; Yan JW, 2012, MOL BIOL REP, V39, P1831, DOI 10.1007/s11033-011-0925-9; ZOCCHI G, 1990, PLANT PHYSIOL, V92, P908, DOI 10.1104/pp.92.4.908; Zude-Sasse M., 2000, Proceedings of the Florida State Horticultural Society, V113, P1	73	12	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123644	10.1371/journal.pone.0123644	http://dx.doi.org/10.1371/journal.pone.0123644			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897804	Green Submitted, Green Published, gold			2022-12-27	WOS:000353212600038
J	Rutstein, SE; Hosseinipour, MC; Kamwendo, D; Soko, A; Mkandawire, M; Biddle, AK; Miller, WC; Weinberger, M; Wheeler, SB; Sarr, A; Gupta, S; Chimbwandira, F; Mwenda, R; Kamiza, S; Hoffman, I; Mataya, R				Rutstein, Sarah E.; Hosseinipour, Mina C.; Kamwendo, Deborah; Soko, Alice; Mkandawire, Memory; Biddle, Andrea K.; Miller, William C.; Weinberger, Morris; Wheeler, Stephanie B.; Sarr, Abdoulaye; Gupta, Sundeep; Chimbwandira, Frank; Mwenda, Reuben; Kamiza, Steve; Hoffman, Irving; Mataya, Ronald			Dried Blood Spots for Viral Load Monitoring in Malawi: Feasible and Effective	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-1 DRUG-RESISTANCE; TREATMENT FAILURE; IMMUNOLOGICAL CRITERIA; VIROLOGICAL FAILURE; INFECTED ADULTS; HIGH-FREQUENCY; VERSION 2.0; CELL COUNT; PLASMA	Objectives To evaluate the feasibility and effectiveness of dried blood spots (DBS) use for viral load (VL) monitoring, describing patient outcomes and programmatic challenges that are relevant for DBS implementation in sub-Saharan Africa. Methods We recruited adult antiretroviral therapy (ART) patients from five district hospitals in Malawi. Eligibility reflected anticipated Ministry of Health VL monitoring criteria. Testing was conducted at a central laboratory. Virological failure was defined as >5000 copies/ml. Primary outcomes were program feasibility (timely result availability and patient receipt) and effectiveness (second-line therapy initiation). Results We enrolled 1,498 participants; 5.9% were failing at baseline. Median time from enrollment to receipt of results was 42 days; 79.6% of participants received results within 3 months. Among participants with confirmed elevated VL, 92.6% initiated second-line therapy; 90.7% were switched within 365 days of VL testing. Nearly one-third (30.8%) of participants with elevated baseline VL had suppressed (<5,000 copies/ml) on confirmatory testing. Median period between enrollment and specimen testing was 23 days. Adjusting for relevant covariates, participants on ART >4 years were more likely to be failing than participants on therapy 1-4 years (RR 1.7, 95% CI 1.0-2.8); older participants were less likely to be failing (RR 0.95, 95% CI 0.92-0.98). There was no difference in likelihood of failure based on clinical symptoms (RR 1.17, 95% CI 0.65-2.11). Conclusions DBS for VL monitoring is feasible and effective in real-world clinical settings. Centralized DBS testing may increase access to VL monitoring in remote settings. Programmatic outcomes are encouraging, especially proportion of eligible participants switched to secondline therapy.	[Rutstein, Sarah E.; Biddle, Andrea K.; Weinberger, Morris; Wheeler, Stephanie B.] Univ N Carolina, Dept Hlth Policy & Management, Chapel Hill, NC 27514 USA; [Rutstein, Sarah E.; Hosseinipour, Mina C.; Miller, William C.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Hosseinipour, Mina C.; Kamwendo, Deborah; Soko, Alice] Univ North Carolina Project, Lilongwe, Malawi; [Mkandawire, Memory; Mataya, Ronald] Loma Linda Univ, Sch Publ Hlth, Loma Linda, CA 92350 USA; [Miller, William C.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Sarr, Abdoulaye; Gupta, Sundeep] Ctr Dis Control, Lilongwe, Malawi; [Chimbwandira, Frank; Mwenda, Reuben] Minist Hlth, Lilongwe, Malawi; [Kamiza, Steve] Coll Med, Blantyre, Malawi	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Loma Linda University; University of North Carolina; University of North Carolina Chapel Hill; University of Malawi	Rutstein, SE (corresponding author), Univ N Carolina, Dept Hlth Policy & Management, Chapel Hill, NC 27514 USA.	sarah_rutstein@med.unc.edu	Miller, William C/H-4800-2014	Miller, William C/0000-0002-1934-7827	Public Health Evaluation of use of Dried Blood Spots for Viral Load Monitoring [MW.10.1433];  [F30 MH098731]; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [U2GPS001965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH098731] Funding Source: NIH RePORTER	Public Health Evaluation of use of Dried Blood Spots for Viral Load Monitoring; ; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	MW.10.1433 (http://www.cdc.gov/globalhealth/countries/malawi/) Public Health Evaluation of use of Dried Blood Spots for Viral Load Monitoring received by RM. The funder assisted in the early stages of study design, and AS and SG were involved in preparation of the manuscript. Funders were not involved in data collection, analysis or decision to publish. F30 MH098731 (http://www.nimh.nih.gov/index.shtml) Fellowship support for SER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	[Anonymous], 2011, CLIN MAN HIV CHILDR; [Anonymous], 2014, HIV AIDS DIAGN TECHN; [Anonymous], 2013, INT HIV PROGR REP JU; [Anonymous], 2014, GLOB AIDS RESP PROGR; Arredondo M, 2012, J CLIN MICROBIOL, V50, P569, DOI 10.1128/JCM.00418-11; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Brambilla D, 2003, J CLIN MICROBIOL, V41, P1888, DOI 10.1128/JCM.41.5.1888-1893.2003; Chaiwarith R, 2007, INT J INFECT DIS, V11, P413, DOI 10.1016/j.ijid.2006.11.003; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; El-Khatib Z, 2011, J AIDS CLIN RES, V2; Estill J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057611; Fajardo E, 2014, J CLIN MICROBIOL, V52, P1343, DOI 10.1128/JCM.03519-13; Fiscus SA, 1998, J CLIN MICROBIOL, V36, P258, DOI 10.1128/JCM.36.1.258-260.1998; Ford N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010460; Fox MP, 2012, JAIDS-J ACQ IMM DEF, V60, P428, DOI 10.1097/QAI.0b013e3182557785; Gsponer T, 2012, AIDS, V26, P57, DOI 10.1097/QAD.0b013e32834e1b5f; Gupta RK, 2014, CLIN INFECT DIS, V58, P1023, DOI 10.1093/cid/cit933; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Johannessen A, 2009, CLIN INFECT DIS, V49, P976, DOI 10.1086/605502; Kamya MR, 2007, JAIDS-J ACQ IMM DEF, V46, P187, DOI 10.1097/QAI.0b013e31814278c0; Keiser O, 2011, AIDS, V25, P1761, DOI 10.1097/QAD.0b013e328349822f; Keiser O, 2010, TROP MED INT HEALTH, V15, P251, DOI 10.1111/j.1365-3156.2009.02445.x; Koyalta D, 2009, CLIN INFECT DIS, V49, P155, DOI 10.1086/599611; Kumarasamy N, 2009, CLIN INFECT DIS, V49, P306, DOI 10.1086/600044; Loutfy MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055747; Maldonado F, 2009, T ROY SOC TROP MED H, V103, P607, DOI 10.1016/j.trstmh.2008.07.014; Marconi VC, 2008, CLIN INFECT DIS, V46, P1589, DOI 10.1086/587109; McMahon JH, 2013, B WORLD HEALTH ORGAN, V91, P377, DOI 10.2471/BLT.12.112946; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Monleau M, 2014, J CLIN MICROBIOL, V52, P578, DOI 10.1128/JCM.02860-13; Moore DM, 2008, JAIDS-J ACQ IMM DEF, V49, P477, DOI 10.1097/QAI.0b013e318186eb18; O'Shea S, 1999, AIDS, V13, P630, DOI 10.1097/00002030-199904010-00019; Orrell C, 2007, ANTIVIR THER, V12, P83; Ouma KN, 2013, J CLIN MICROBIOL, V51, P1208, DOI 10.1128/JCM.03048-12; Pagano M., 2018, PRINCIPLES BIOSTATIS; Pannus P, 2013, JAIDS-J ACQ IMM DEF, V64, P134, DOI 10.1097/QAI.0b013e3182a61e63; Phan V, 2013, JAIDS-J ACQ IMM DEF, V62, P509, DOI 10.1097/QAI.0b013e318285d28c; Rawizza HE, 2011, CLIN INFECT DIS, V53, P1283, DOI 10.1093/cid/cir729; Reynolds SJ, 2009, ANTIVIR THER, V14, P293; Reynolds SJ, 2009, AIDS, V23, P697, DOI 10.1097/QAD.0b013e3283262a78; Rutstein SE, 2014, J CLIN VIROL; Sigaloff KCE, 2011, JAIDS-J ACQ IMM DEF, V58, P23, DOI 10.1097/QAI.0b013e318227fc34; Smit P. W., 2014, PLOS ONE, V9, P6, DOI DOI 10.1371/J0URNAL.P0NE.0086461; UNAIDS, 2013, ACC ANT THER AFR STA; van Oosterhout JJG, 2009, TROP MED INT HEALTH, V14, P856, DOI 10.1111/j.1365-3156.2009.02309.x; van Zyl GU, 2011, JAIDS-J ACQ IMM DEF, V56, P333, DOI 10.1097/QAI.0b013e31820dc0cc; WHO, 2021, HIV AIDS	53	29	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124748	10.1371/journal.pone.0124748	http://dx.doi.org/10.1371/journal.pone.0124748			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898365	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600082
J	Wagh, D; Terry-Lorenzo, R; Waites, CL; Leal-Ortiz, SA; Maas, C; Reimer, RJ; Garner, CC				Wagh, Dhananjay; Terry-Lorenzo, Ryan; Waites, Clarissa L.; Leal-Ortiz, Sergio A.; Maas, Christoph; Reimer, Richard J.; Garner, Craig C.			Piccolo Directs Activity Dependent F-Actin Assembly from Presynaptic Active Zones via Daam1	PLOS ONE			English	Article							FORMIN DAAM1; SYNAPTIC VESICLES; PROTEIN; ENDOCYTOSIS; PROFILIN; BINDING; ACTIVATION; PLASTICITY; SYNAPSIN; CDC42	The dynamic assembly of filamentous (F) actin plays essential roles in the assembly of presynaptic boutons, the fusion, mobilization and recycling of synaptic vesicles (SVs), and presynaptic forms of plasticity. However, the molecular mechanisms that regulate the temporal and spatial assembly of presynaptic F-actin remain largely unknown. Similar to other F-actin rich membrane specializations, presynaptic boutons contain a set of molecules that respond to cellular cues and trans-synaptic signals to facilitate activity-dependent assembly of F-actin. The presynaptic active zone (AZ) protein Piccolo has recently been identified as a key regulator of neurotransmitter release during SV cycling. It does so by coordinating the activity-dependent assembly of F-Actin and the dynamics of key plasticity molecules including Synapsin1, Profilin and CaMKII. The multidomain structure of Piccolo, its exquisite association with the AZ, and its ability to interact with a number of actin-associated proteins suggest that Piccolo may function as a platform to coordinate the spatial assembly of F-actin. Here we have identified Daam1, a Formin that functions with Profilin to drive F-actin assembly, as a novel Piccolo binding partner. We also found that within cells Daam1 activation promotes Piccolo binding, an interaction that can spatially direct the polymerization of F-Actin. Moreover, similar to Piccolo and Profilin, Daam1 loss of function impairs presynaptic-F-actin assembly in neurons. These data suggest a model in which Piccolo directs the assembly of presynaptic F-Actin from the AZ by scaffolding key actin regulatory proteins including Daam1.	[Wagh, Dhananjay; Terry-Lorenzo, Ryan; Leal-Ortiz, Sergio A.; Maas, Christoph; Garner, Craig C.] Stanford Univ, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Waites, Clarissa L.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Reimer, Richard J.] Stanford Univ, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA; [Reimer, Richard J.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Columbia University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Garner, CC (corresponding author), Stanford Univ, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	cgarner@stanford.edu		Garner, Craig/0000-0003-1970-5417	NIH [NS39471, NS353862]; United States/Israel Binational Science Foundation [2007425]; German Center for Neurodegenerative Diseases (DZNE); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039471] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States/Israel Binational Science Foundation(US-Israel Binational Science Foundation); German Center for Neurodegenerative Diseases (DZNE)(Helmholtz Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NS39471 and NS353862, the United States/Israel Binational Science Foundation (2007425) and German Center for Neurodegenerative Diseases (DZNE) to CCG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Aspenstrom P, 2006, EXP CELL RES, V312, P2180, DOI 10.1016/j.yexcr.2006.03.013; BANKER G, 1998, CULTURING NERVE CELL; Bloom O, 2003, J CELL BIOL, V161, P737, DOI 10.1083/jcb.200212140; Boyl PP, 2007, EMBO J, V26, P2991, DOI 10.1038/sj.emboj.7601737; Brodin L, 2006, CELL TISSUE RES, V326, P301, DOI 10.1007/s00441-006-0216-2; Bruses JL, 2006, MOL NEUROBIOL, V33, P237, DOI 10.1385/MN:33:3:237; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; CasesLanghoff C, 1996, EUR J CELL BIOL, V69, P214; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Colombo A, 2013, DEVELOPMENT, V140, P3997, DOI 10.1242/dev.091934; Darcy KJ, 2006, NAT NEUROSCI, V9, P315, DOI 10.1038/nn1640; Di Nardo A, 2000, J CELL SCI, V113, P3795; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Evergren E, 2007, J NEUROSCI RES, V85, P2648, DOI 10.1002/jnr.21176; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gareus R, 2006, J BIOL CHEM, V281, P2803, DOI 10.1074/jbc.M503528200; GREENGARD P, 1994, ADV SEC MESS PHOSPH, V29, P31; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Higashi T, 2008, J BIOL CHEM, V283, P8746, DOI 10.1074/jbc.M707839200; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; Jaiswal R, 2013, CURR BIOL, V23, P1373, DOI 10.1016/j.cub.2013.06.013; Jensen V, 2007, J PHYSIOL-LONDON, V583, P129, DOI 10.1113/jphysiol.2007.131300; Jordan R, 2005, BIOPHYS J, V89, P2091, DOI 10.1529/biophysj.105.061663; Jungling K, 2006, J NEUROSCI, V26, P6968, DOI 10.1523/JNEUROSCI.1013-06.2006; Kim S, 2003, J BIOL CHEM, V278, P6291, DOI 10.1074/jbc.M212287200; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; Leal-Ortiz S, 2008, J CELL BIOL, V181, P831, DOI 10.1083/jcb.200711167; Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105; Liu YH, 2005, J BIOL CHEM, V280, P8884, DOI 10.1074/jbc.M412200200; Maas C, 2012, J NEUROSCI, V32, P11095, DOI 10.1523/JNEUROSCI.0195-12.2012; Matusek T, 2008, J NEUROSCI, V28, P13310, DOI 10.1523/JNEUROSCI.2727-08.2008; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Moseley JB, 2006, METHOD ENZYMOL, V406, P215, DOI 10.1016/S0076-6879(06)06016-2; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Qualmann B, 2002, INT REV CYTOL, V220, P93; Rivera GM, 2004, CURR BIOL, V14, P11, DOI 10.1016/j.cub.2003.12.033; Rosenmund C, 2003, CURR OPIN NEUROBIOL, V13, P509, DOI 10.1016/j.conb.2003.09.011; Ryan TA, 1999, J NEUROSCI, V19, P1317; Salomon SN, 2008, NEUROSCI LETT, V447, P62, DOI 10.1016/j.neulet.2008.09.051; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Sato A, 2006, DEVELOPMENT, V133, P4219, DOI 10.1242/dev.02590; Schoch S, 2006, CELL TISSUE RES, V326, P379, DOI 10.1007/s00441-006-0244-y; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Shen WH, 2006, NEURON, V50, P401, DOI 10.1016/j.neuron.2006.03.017; Shupliakov O, 2002, P NATL ACAD SCI USA, V99, P14476, DOI 10.1073/pnas.212381799; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Udo H, 2005, NEURON, V45, P887, DOI 10.1016/j.neuron.2005.01.044; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Waites CL, 2011, J NEUROSCI, V31, P14250, DOI 10.1523/JNEUROSCI.1835-11.2011; Waites CL, 2009, J NEUROSCI, V29, P4332, DOI 10.1523/JNEUROSCI.4431-08.2009; Wang HG, 2005, NEURON, V45, P389, DOI 10.1016/j.neuron.2005.01.011; Wang XL, 1999, J CELL BIOL, V147, P151, DOI 10.1083/jcb.147.1.151; Watanabe S, 2013, NATURE, V504, P242, DOI 10.1038/nature12809; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Yamashita M, 2007, GENES CELLS, V12, P1255, DOI 10.1111/j.1365-2443.2007.01132.x; Yao J, 2006, J NEUROSCI, V26, P8137, DOI 10.1523/JNEUROSCI.1183-06.2006; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001	69	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0120093	10.1371/journal.pone.0120093	http://dx.doi.org/10.1371/journal.pone.0120093			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897839	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600003
J	Seuss, B; Wisshak, M; Mapes, RH; Landman, NH				Seuss, Barbara; Wisshak, Max; Mapes, Royal H.; Landman, Neil H.			Syn-Vivo Bioerosion of Nautilus by Endo- and Epilithic Foraminiferans (New Caledonia and Vanuatu)	PLOS ONE			English	Article							MUSSEL PERNA-PERNA; TAPHONOMY; SHELLS; ENDOLITHS; FUNGI	A variety of syn-vivo bioerosion traces produced by foraminiferans is recorded in shells of Nautilus sampled near New Caledonia and Vanuatu. These are two types of attachment scars of epilithic foraminiferans and two forms of previously undescribed microborings, a spiral-shaped and a dendritic one, both most likely being the work of endolithic 'naked' foraminiferans. Scanning electron microscopy of epoxy-resin casts of the latter revealed that these traces occur in clusters of up to many dozen individuals and potentially are substrate-specific. The foraminiferan traces are the sole signs of bioerosion in the studied Nautilus conchs, and neither traces of phototrophic nor other chemotrophic microendoliths were found. While the complete absence of photoautotrophic endoliths would be in good accordance with the life habit of Nautilus, which resides in aphotic deep marine environments and seeks shallower waters in the photic zone for feeding only during night-time, the absence of any microbial bioerosion may also be explained by an effective defence provided by the nautilid periostracum. Following this line of reasoning, the recorded foraminiferan bioerosion traces in turn would identify their trace makers as being specialized in their ability to penetrate the periostracum barrier and to bioerode the shell of modern Nautilus.	[Seuss, Barbara] Univ Erlangen Nurnberg, GeoZentrum Nordbayern Palaoumwelt, D-91054 Erlangen, Germany; [Wisshak, Max] Senckenberg Meer, Marine Res Dept, D-26382 Wilhelmshaven, Germany; [Mapes, Royal H.] North Carolina Museum Nat Sci, Raleigh, NC 27601 USA; [Landman, Neil H.] Amer Museum Nat Hist, New York, NY 10024 USA	University of Erlangen Nuremberg; Senckenberg Gesellschaft fur Naturforschung (SGN); American Museum of Natural History (AMNH)	Seuss, B (corresponding author), Univ Erlangen Nurnberg, GeoZentrum Nordbayern Palaoumwelt, Loewenichstr 28, D-91054 Erlangen, Germany.	barbara.seuss@fau.de	Wisshak, Max/A-3418-2011; Seuss, Barbara/G-5131-2011	Wisshak, Max/0000-0001-7531-3317; Seuss, Barbara/0000-0001-6615-8108	University of Erlangen-Nuremberg; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	University of Erlangen-Nuremberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	The project was funded by a research grant provided by the University of Erlangen-Nuremberg to the first author ("Bavarian Equal Opportunities Sponsorship - Forderung von Frauen in Forschung und Lehre (FFL) - Promoting Equal Opportunities for Women in Research and Teaching"). The authors acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing.	Beuck L, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P329, DOI 10.1007/978-3-540-77598-0_17; Bonacum J, 2011, AM MALACOL BULL, V29, P77, DOI 10.4003/006.029.0221; Bromley RG, 2004, GEOL SOC SPEC PUBL, V228, P455, DOI 10.1144/GSL.SP.2004.228.01.20; Bromley Richard G., 2007, P518, DOI 10.1016/B978-044452949-7/50158-3; Bromley Richard G., 1994, P134; CEDHAGEN T, 1994, SARSIA, V79, P65, DOI 10.1080/00364827.1994.10413549; Che LM, 1996, MAR BIOL, V126, P509; Debenay JP, 2012, GUIDE 1000 FORAMINIF; Freiwald A, 1996, MAR MICROPALEONTOL, V28, P199, DOI 10.1016/0377-8398(96)00002-3; Glaub Ingrid, 2007, P368, DOI 10.1016/B978-044452949-7/50147-9; Golubic S, 2005, TRENDS MICROBIOL, V13, P229, DOI 10.1016/j.tim.2005.03.007; GOLUBIC S, 1970, LETHAIA, V3, P203, DOI 10.1111/j.1502-3931.1970.tb01858.x; GOLUBIC S, 1983, PRAPARATOR, V29, P197; Golubic S., 1975, STUDY TRACE FOSSILS, P229; HOOK JE, 1990, PSZNI MAR ECOL, V11, P239, DOI 10.1111/j.1439-0485.1990.tb00242.x; HOOK JE, 1988, PSZNI MAR ECOL, V9, P347, DOI 10.1111/j.1439-0485.1988.tb00212.x; Kaehler S, 1999, MAR BIOL, V135, P505, DOI 10.1007/s002270050651; Kaehler S, 1999, MAR BIOL, V135, P497, DOI 10.1007/s002270050650; Klug C, 2007, CEPHALOPODS PRESENT AND PAST: NEW INSIGHTS AND FRESH PERSPECTIVES, P205, DOI 10.1007/978-1-4020-6806-5_10; Landman NH, 2010, TOP GEOBIOL, V6, P163; Maeda H, 2003, PALAIOS, V18, P421, DOI 10.1669/0883-1351(2003)018<0421:TFOALP>2.0.CO;2; MAPES R. H., 1996, AMMONOID PALEOBIOLOG, V13, P104; Mapes RH, 2003, PREDATOR PREY INTERA, P77; Mapes RH, 2010, PALAIOS, V25, P597, DOI 10.2110/palo.2009.p09-109r; Mapes RH, 2010, PALAIOS, V25, P656, DOI 10.2110/palo.2010.p10-010r; NEUMANN AC, 1966, LIMNOL OCEANOGR, V11, P92, DOI 10.4319/lo.1966.11.1.0092; Neumann Christian, 2006, Ichnos, V13, P185, DOI 10.1080/10420940600853954; Plewes C.R., 1993, Journal of Micropalaeontology, V12, P83; Ritterbush KA, 2014, J ZOOL, V292, P229, DOI 10.1111/jzo.12118; Saunders W. B., 2009, NAUTILUS BIOL PALEOB; Seuss B, PALAIOS IN PRESS; Seuss B, 2016, ICHNOS, V23, P108, DOI 10.1080/10420940.2015.1030074; TODD RUTH, 1965, DEEP SEA RES, V12, P831, DOI 10.1016/0011-7471(65)90806-5; VENECPEYRE MT, 1987, CORAL REEFS, V5, P205, DOI 10.1007/BF00300966; VenecPeyre MT, 1996, MAR MICROPALEONTOL, V28, P19, DOI 10.1016/0377-8398(95)00037-2; Waite J.H., 1983, P467; Wani R, 2004, LETHAIA, V37, P113, DOI 10.1080/00241160410006420; Wani R, 2007, ACTA PALAEONTOL POL, V52, P77; Warme JE., 1975, STUDY TRACE FOSSILS, P181, DOI DOI 10.1007/978-3-642-65923-2_11; Wilson Mark A., 2007, P356, DOI 10.1016/B978-044452949-7/50146-7; Wisshak M, 2006, FACIES, V52, P1, DOI 10.1007/s10347-005-0033-1; Wisshak M, 2011, GEOBIOLOGY, V9, P492, DOI 10.1111/j.1472-4669.2011.00299.x; Wisshak M., 2012, DEV SEDIMENTOL, V64, P213; Wisshak M, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P21, DOI 10.1007/978-3-540-77598-0_2; Zapalski MK, 2007, PALAEONTOLOGY, V50, P1375, DOI 10.1111/j.1475-4983.2007.00716.x	45	10	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0125558	10.1371/journal.pone.0125558	http://dx.doi.org/10.1371/journal.pone.0125558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894584	Green Submitted, gold, Green Published			2022-12-27	WOS:000353211700140
J	Stocklin, B; Fouzas, S; Schillinger, P; Cayir, S; Skendaj, R; Ramser, M; Weber, P; Wellmann, S				Stoecklin, Benjamin; Fouzas, Sotirios; Schillinger, Paula; Cayir, Sevgi; Skendaj, Roswitha; Ramser, Michel; Weber, Peter; Wellmann, Sven			Copeptin as a Serum Biomarker of Febrile Seizures	PLOS ONE			English	Article							ACID-INDUCED SEIZURES; RESPIRATORY ALKALOSIS; PLASMA COPEPTIN; VASOPRESSIN; CHILDREN; BRAIN; RAT; PROLACTIN; PRECURSOR; INFANTS	Background and Objectives Accurate diagnosis of febrile seizures in children presenting after paroxysmal episodes associated with fever, is hampered by the lack of objective postictal biomarkers. The aim of our study was to investigate whether FS are associated with increased levels of serum copeptin, a robust marker of arginine vasopressin secretion. Methods This was a prospective emergency-setting cross-sectional study of 161 children between six months and five years of age. Of these, 83 were diagnosed with febrile seizures, 69 had a febrile infection without seizures and nine had epileptic seizures not triggered by infection. Serum copeptin and prolactin levels were measured in addition to standard clinical, neurophysiological, and laboratory assessment. Clinical Trial Registration: NCT01884766. Results Circulating copeptin was significantly higher in children with febrile seizures (median [inter-quartile range] 18.9 pmol/L [8.5-36.6]) compared to febrile controls (5.6 pmol/L [4.1-9.4]; p < 0.001), with no differences between febrile and epileptic seizures (21.4 pmol/L [16.1-46.6]; p = 0.728). In a multivariable regression model, seizures were the major determinant of serum copeptin (beta 0.509; p < 0.001), independently of clinical and baseline laboratory indices. The area under the receiver operating curve for copeptin was 0.824 (95% CI 0.753-0.881), significantly higher compared to prolactin (0.667 [0.585-0.742]; p < 0.001). The diagnostic accuracy of copeptin increased with decreasing time elapsed since the convulsive event (at 120 min: 0.879 [0.806-0.932] and at < 60 min: 0.975 [0.913-0.997]). Conclusions Circulating copeptin has high diagnostic accuracy in febrile seizures and may be a useful adjunct for accurately diagnosing postictal states in the emergency setting.	[Stoecklin, Benjamin; Schillinger, Paula; Weber, Peter] Univ Basel Childrens Hosp UKBB, Div Pediat Neurol & Dev Med, Basel, Switzerland; [Fouzas, Sotirios] Univ Hosp Patras, Dept Pediat, Patras, Greece; [Cayir, Sevgi; Ramser, Michel] Univ Basel Childrens Hosp UKBB, Emergency Dept, Basel, Switzerland; [Skendaj, Roswitha] Univ Basel Hosp, Dept Lab Med, CH-4031 Basel, Switzerland; [Wellmann, Sven] Univ Basel Childrens Hosp UKBB, Div Neonatol, Basel, Switzerland	University of Patras; University of Basel	Wellmann, S (corresponding author), Univ Basel Childrens Hosp UKBB, Div Neonatol, Basel, Switzerland.	sven.wellmann@ukbb.ch	Fouzas, Sotirios/Q-3043-2016; Wellmann, Sven/A-2771-2017	Stoecklin, Benjamin/0000-0003-0021-0262; Fouzas, Sotirios/0000-0001-7617-9076	Swiss League Against Epilepsy, Zurich, Switzerland; Gottfried and Julia Bangerter-Rhyner-Foundation, Bern, Switzerland	Swiss League Against Epilepsy, Zurich, Switzerland; Gottfried and Julia Bangerter-Rhyner-Foundation, Bern, Switzerland	This work was supported by the Swiss League Against Epilepsy, Zurich, Switzerland (www.epi.ch) (BS) and the Gottfried and Julia Bangerter-Rhyner-Foundation, Bern, Switzerland (www.bangerter-stiftung.ch) (SW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alehan F, 2009, EPILEPSIA, V50, P755, DOI 10.1111/j.1528-1167.2008.01793.x; AMINOFF MJ, 1984, BRAIN, V107, P569, DOI 10.1093/brain/107.2.569; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Burckhardt MA, 2014, J CLIN ENDOCR METAB, V99, pE1750, DOI 10.1210/jc.2014-2244; Chen DK, 2005, NEUROLOGY, V65, P668, DOI 10.1212/01.wnl.0000178391.96957.d0; Du JM, 2013, PEPTIDES, V45, P61, DOI 10.1016/j.peptides.2013.04.015; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fein JA, 1997, ACAD EMERG MED, V4, P202, DOI 10.1111/j.1553-2712.1997.tb03741.x; Fetveit A, 2008, EUR J PEDIATR, V167, P17, DOI 10.1007/s00431-007-0577-x; Iwanaga M, 2011, BRAIN RES, V1424, P1, DOI 10.1016/j.brainres.2011.09.030; KASTING NW, 1981, BRAIN RES, V213, P327, DOI 10.1016/0006-8993(81)90238-9; KASTING NW, 1980, CAN J PHYSIOL PHARM, V58, P316, DOI 10.1139/y80-054; Katan M, 2008, NEUROENDOCRINOL LETT, V29, P341; Kiviranta T, 1996, BRAIN DEV-JPN, V18, P110, DOI 10.1016/0387-7604(95)00146-8; L'Abate P, 2013, RESP PHYSIOL NEUROBI, V185, P222, DOI 10.1016/j.resp.2012.10.011; Lagi A, 2013, INT J CLIN PRACT, V67, P512, DOI 10.1111/ijcp.12123; LANDGRAF R, 1990, AM J PHYSIOL, V259, pR1056, DOI 10.1152/ajpregu.1990.259.5.R1056; Lee JH, 2013, INTENS CARE MED, V39, P747, DOI 10.1007/s00134-013-2825-z; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Nevo I, 2011, ISR MED ASSOC J, V13, P420; Nickel CH, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-7; Ohno M, 2012, STRESS, V15, P435, DOI 10.3109/10253890.2011.637185; Pavlidou E, 2013, CHILD NERV SYST, V29, P2011, DOI 10.1007/s00381-013-2224-3; Rauchenzauner M, 2007, EPILEPSIA, V48, P101, DOI 10.1111/j.1528-1167.2006.00837.x; Schuchmann S, 2006, NAT MED, V12, P817, DOI 10.1038/nm1422; Schuchmann S, 2011, EPILEPSIA, V52, P1949, DOI 10.1111/j.1528-1167.2011.03259.x; SIESJO BK, 1985, J CEREBR BLOOD F MET, V5, P47, DOI 10.1038/jcbfm.1985.7; Stroink H, 2003, NEUROLOGY, V60, P979, DOI 10.1212/01.WNL.0000049914.25434.72; Subcommittee on Febrile Seizures, 2011, Pediatrics, V127, P389, DOI 10.1542/peds.2010-3318; Tolner EA, 2011, EPILEPSIA, V52, P104, DOI 10.1111/j.1528-1167.2010.02731.x; VEALE WL, 1984, BRAIN RES BULL, V12, P161, DOI 10.1016/0361-9230(84)90184-9	31	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124663	10.1371/journal.pone.0124663	http://dx.doi.org/10.1371/journal.pone.0124663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894585	gold, Green Published, Green Submitted			2022-12-27	WOS:000353211700115
J	Thavayogarajah, T; Gangopadhyay, P; Rahlfs, S; Becker, K; Lingelbach, K; Przyborski, JM; Holder, AA				Thavayogarajah, Thuvaraka; Gangopadhyay, Preetish; Rahlfs, Stefan; Becker, Katja; Lingelbach, Klaus; Przyborski, Jude M.; Holder, Anthony A.			Alternative Protein Secretion in the Malaria Parasite Plasmodium falciparum	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR; RED-BLOOD-CELLS; INFECTED ERYTHROCYTES; MAURERS CLEFTS; STREPTOLYSIN-O; HOST ERYTHROCYTE; GOLGI-COMPLEX; ARF PROTEINS; MEMBRANE; EXPORT	Plasmodium falciparum invades human red blood cells, residing in a parasitophorous vacuole (PV), with a parasitophorous vacuole membrane (PVM) separating the PV from the host cell cytoplasm. Here we have investigated the role of N-myristoylation and two other N-terminal motifs, a cysteine potential S-palmitoylation site and a stretch of basic residues, as the driving force for protein targeting to the parasite plasma membrane (PPM) and subsequent translocation across this membrane. Plasmodium falciparum adenylate kinase 2 (Pf AK2) contains these three motifs, and was previously proposed to be targeted beyond the parasite to the PVM, despite the absence of a signal peptide for entry into the classical secretory pathway. Biochemical and microscopy analyses of PfAK2 variants tagged with green fluorescent protein (GFP) showed that these three motifs are involved in targeting the protein to the PPM and translocation across the PPM to the PV. It was shown that the N-terminal 37 amino acids of PfAK2 alone are sufficient to target and translocate GFP across the PPM. As a control we examined the N-myristoylated Plasmodium falciparum ADP-ribosylation factor 1 (PfARF1). PfARF1 was found to co-localise with a Golgi marker. To determine whether or not the putative palmitoylation and the cluster of lysine residues from the N-terminus of PfAK2 would modulate the subcellular localization of PfARF1, a chimeric fusion protein containing the N-terminus of PfARF1 and the two additional PfAK2 motifs was analysed. This chimeric protein was targeted to the PPM, but not translocated across the membrane into the PV, indicating that other features of the N-terminus of PfAK2 also play a role in the secretion process.	[Thavayogarajah, Thuvaraka; Gangopadhyay, Preetish; Lingelbach, Klaus; Przyborski, Jude M.] Univ Marburg, Div Parasitol, Fac Biol, D-35043 Marburg, Germany; [Rahlfs, Stefan; Becker, Katja] Univ Giessen, Biochem & Mol Biol, Interdisciplinary Res Ctr, D-35392 Giessen, Germany; [Holder, Anthony A.] Francis Crick Inst, Mill Hill Lab, London NW7 1AA, England	Philipps University Marburg; Justus Liebig University Giessen; Francis Crick Institute	Przyborski, JM (corresponding author), Univ Marburg, Div Parasitol, Fac Biol, Karl von Frisch Str 8, D-35043 Marburg, Germany.	przybors@staff.uni-marburg.de; aholder@nimr.mrc.ac.uk	Holder, Anthony A/A-7554-2013; Przyborski, Jude/ABC-9498-2021	Holder, Anthony A/0000-0002-8490-6058; Przyborski, Jude/0000-0002-3494-7767	Sonder forschungs bereich [593]; MRC [U117532067]; European Community's FP7 grant (EVIMalaR) [242095]; The Francis Crick Institute [10097] Funding Source: researchfish	Sonder forschungs bereich(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community's FP7 grant (EVIMalaR); The Francis Crick Institute	This work was funded by the European Community's FP7 grant agreement 242095 (EVIMalaR; http://www.evimalar.org/) through a PhD studentship to TT, and by Sonder forschungs bereich 593 (www.dfg.de/sfb) to KL. AAH is funded through the MRC (U117532067; http://www.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge I, 1997, MOL BIOCHEM PARASIT, V84, P259, DOI 10.1016/S0166-6851(96)02806-X; Ansorge I, 1996, BIOCHEM J, V315, P307, DOI 10.1042/bj3150307; BEAUMELLE BD, 1987, J PARASITOL, V73, P743, DOI 10.2307/3282405; BHAKDI S, 1985, INFECT IMMUN, V47, P52; BOMAN AL, 1995, TRENDS BIOCHEM SCI, V20, P147, DOI 10.1016/S0968-0004(00)88991-4; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Denny PW, 2000, J BIOL CHEM, V275, P11017, DOI 10.1074/jbc.275.15.11017; Dzeja P, 2009, INT J MOL SCI, V10, P1729, DOI 10.3390/ijms10041729; Ezougou CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087695; Graewe S, 2012, FEMS MICROBIOL REV, V36, P111, DOI 10.1111/j.1574-6976.2011.00297.x; Guttery DS, 2014, CELL HOST MICROBE, V16, P128, DOI 10.1016/j.chom.2014.05.020; Haase S, 2009, MOL MICROBIOL, V71, P1003, DOI 10.1111/j.1365-2958.2008.06582.x; Heiber A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003546; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LINGELBACH KR, 1993, EXP PARASITOL, V76, P318, DOI 10.1006/expr.1993.1039; Ma J, 2012, FEBS LETT, V586, P3037, DOI 10.1016/j.febslet.2012.07.013; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Moskes C, 2004, MOL MICROBIOL, V54, P676, DOI 10.1111/j.1365-2958.2004.04313.x; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; PASVOL G, 1978, ANN TROP MED PARASIT, V72, P87, DOI 10.1080/00034983.1978.11719283; PAUL F, 1981, LANCET, V2, P70; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; Przyborski JM, 2005, EMBO J, V24, P2306, DOI 10.1038/sj.emboj.7600720; Rahlfs S, 2009, MOL BIOCHEM PARASIT, V163, P77, DOI 10.1016/j.molbiopara.2008.09.008; Rees-Channer RR, 2006, MOL BIOCHEM PARASIT, V149, P113, DOI 10.1016/j.molbiopara.2006.04.008; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Russo I, 2009, MOL MICROBIOL, V72, P229, DOI 10.1111/j.1365-2958.2009.06639.x; Saridaki T, 2009, TRAFFIC, V10, P137, DOI 10.1111/j.1600-0854.2008.00860.x; Stafford WHL, 1996, EUR J BIOCHEM, V242, P104, DOI 10.1111/j.1432-1033.1996.0104r.x; STEARNS T, 1990, P NATL ACAD SCI USA, V87, P1238, DOI 10.1073/pnas.87.3.1238; Struck NS, 2005, J CELL SCI, V118, P5603, DOI 10.1242/jcs.02673; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Wright MH, 2014, NAT CHEM, V6, P112, DOI [10.1038/NCHEM.1830, 10.1038/nchem.1830]; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973	37	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125191	10.1371/journal.pone.0125191	http://dx.doi.org/10.1371/journal.pone.0125191			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909331	Green Submitted, Green Published, gold			2022-12-27	WOS:000353376800132
J	Lin, X; Huang, CH; Shi, J; Wang, RF; Sun, X; Liu, XK; Zhao, LZ; Jin, ML				Lin, Xian; Huang, Canhui; Shi, Jian; Wang, Ruifang; Sun, Xin; Liu, Xiaokun; Zhao, Lianzhong; Jin, Meilin			Investigation of Pathogenesis of H1N1 Influenza Virus and Swine Streptococcus suis Serotype 2 Co-Infection in Pigs by Microarray Analysis	PLOS ONE			English	Article							SCAVENGER RECEPTOR CD163; EPITHELIAL-CELLS; NADPH OXIDASES; NOX FAMILY; EXPRESSION; PNEUMONIA; INFECTION; CYTOKINE; OUTBREAK; LUNG	Swine influenza virus and Streptococcus suis are two important contributors to the porcine respiratory disease complex, and both have significant economic impacts. Clinically, influenza virus and Streptococcus suis co-infections in pigs are very common, which often contribute to severe pneumonia and can increase the mortality. However, the co-infection pathogenesis in pigs is unclear. In the present study, co-infection experiments were performed using swine H1N1 influenza virus and Streptococcus suis serotype 2 (SS2). The H1N1-SS2 co-infected pigs exhibited more severe clinical symptoms, serious pathological changes, and robust apoptosis of lungs at 6 days post-infection compared with separate H1N1 and SS2 infections. A comprehensive gene expression profiling using a microarray approach was performed to investigate the global host responses of swine lungs against the swine H1N1 infection, SS2 infection, co-infection, and phosphate-buffered saline control. Results showed 457, 411, and 844 differentially expressed genes in the H1N1, SS2, and H1N1-SS2 groups, respectively, compared with the control. Noticeably, genes associated with the immune, inflammatory, and apoptosis responses were highly overexpressed in the co-infected group. Pathway analysis indicated that the cytokine-cytokine receptor interactions, MAPK, toll-like receptor, complement and coagulation cascades, antigen processing and presentation, and apoptosis pathway were significantly regulated in the co-infected group. However, the genes related to these were less regulated in the separate H1N1 and SS2 infection groups. This observation suggested that a certain level of synergy was induced by H1N1 and SS2 co-infection with significantly stronger inflammatory and apoptosis responses, which may lead to more serious respiratory disease syndrome and pulmonary pathological lesion.	[Lin, Xian; Huang, Canhui; Shi, Jian; Wang, Ruifang; Sun, Xin; Liu, Xiaokun; Zhao, Lianzhong; Jin, Meilin] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Jin, Meilin] Huazhong Agr Univ, Coll Vet Med, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Jin, ML (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.	jml8328@126.com			China National Basic Research Program (China "973" Program) [2012CB518805]	China National Basic Research Program (China "973" Program)(National Basic Research Program of China)	The study was supported by China National Basic Research Program (China "973" Program 2012CB518805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bonorino P, 2009, J HEPATOL, V51, P458, DOI 10.1016/j.jhep.2009.05.030; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; Carlson CM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001136; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Greeff A, 2010, VET MICROBIOL, V141, P59, DOI 10.1016/j.vetmic.2009.07.031; Dessing MC, 2007, AM J RESP CELL MOL, V36, P609, DOI 10.1165/rcmb.2006-0166OC; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dybing JK, 2000, J VIROL, V74, P1443, DOI 10.1128/JVI.74.3.1443-1450.2000; Fabriek BO, 2009, BLOOD, V113, P887, DOI 10.1182/blood-2008-07-167064; Fan J, 2003, J CLIN INVEST, V112, P1234, DOI 10.1172/JCI200318696; Fearon DT, 1999, QJM-MON J ASSOC PHYS, V92, P235, DOI 10.1093/qjmed/92.5.235; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Galecka Elzbieta, 2008, Pol Merkur Lekarski, V24, P446; Garcia CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064443; Gatherer D, 2009, J CLIN VIROL, V45, P174, DOI 10.1016/j.jcv.2009.06.004; Golden-Mason L, 2011, HEPATOLOGY, V54, P1559, DOI 10.1002/hep.24556; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Graham MB, 1997, J EXP MED, V186, P2063, DOI 10.1084/jem.186.12.2063; Heinen PP, 2001, J GEN VIROL, V82, P2697, DOI 10.1099/0022-1317-82-11-2697; Hofshagen M, 2009, EURO SURVEILL, V14; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Jung Y, 2005, J COMP PATHOL, V132, P179, DOI 10.1016/j.jcpa.2004.09.008; Koli K, 2008, ANTIOXID REDOX SIGN, V10, P333, DOI 10.1089/ars.2007.1914; Kudva A, 2011, J IMMUNOL, V186, P1666, DOI 10.4049/jimmunol.1002194; Lam WY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-344; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-556; Li YT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-398; Loving CL, 2010, MICROB PATHOGENESIS, V49, P237, DOI 10.1016/j.micpath.2010.06.004; Martinez-Vila E, 2001, CEREBROVASC DIS, V11, P60, DOI 10.1159/000049127; Moretta L, 2006, IMMUNOL REV, V214, P219, DOI 10.1111/j.1600-065X.2006.00450.x; Nauseef WM, 2008, J BIOL CHEM, V283, P16961, DOI 10.1074/jbc.R700045200; ODA T, 1989, SCIENCE, V244, P974, DOI 10.1126/science.2543070; Pasma T, 2010, EMERG INFECT DIS, V16, P706, DOI 10.3201/eid1604.091636; Pauligk C, 2004, IMMUNOBIOLOGY, V209, P3, DOI 10.1016/j.imbio.2004.04.002; Peiris JSM, 2009, TRENDS IMMUNOL, V30, P574, DOI 10.1016/j.it.2009.09.004; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Polfliet MMJ, 2006, IMMUNOBIOLOGY, V211, P419, DOI 10.1016/j.imbio.2006.05.015; Probst-Kepper M, 2009, J CELL MOL MED, V13, P3343, DOI 10.1111/j.1582-4934.2009.00782.x; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Seki M, 2004, EUR RESPIR J, V24, P143, DOI 10.1183/09031936.04.00126103; Selemidis S, 2008, PHARMACOL THERAPEUT, V120, P254, DOI 10.1016/j.pharmthera.2008.08.005; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Shirey KA, 2013, NATURE, V497, P498, DOI 10.1038/nature12118; Smith MW, 2007, COMPARATIVE MED, V57, P82; Starnes T, 2002, J IMMUNOL, V169, P642, DOI 10.4049/jimmunol.169.2.642; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Tenenbaum T, 2006, BRAIN RES, V1100, P1, DOI 10.1016/j.brainres.2006.05.041; Triantafilou K, 2001, J CELL SCI, V114, P2535; Van den Heuvel MM, 1999, J LEUKOCYTE BIOL, V66, P858, DOI 10.1002/jlb.66.5.858; Vlahos R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001271; Weingartl HM, 2010, J VIROL, V84, P2245, DOI 10.1128/JVI.02118-09; Williamson SM, 2012, VET REC, V171, P271, DOI 10.1136/vr.100673; Wilson SM, 2007, VET IMMUNOL IMMUNOP, V117, P116, DOI 10.1016/j.vetimm.2007.02.009; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zhang RJ, 2007, AIDS, V21, pS9, DOI 10.1097/01.aids.0000304691.32014.19; Zhou HB, 2011, EMERG INFECT DIS, V17, P1757, DOI 10.3201/eid1709.101916	62	26	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124086	10.1371/journal.pone.0124086	http://dx.doi.org/10.1371/journal.pone.0124086			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906258	Green Published, Green Submitted, gold			2022-12-27	WOS:000353332000056
J	Pinto, IC; Sabido, M; Pereira, AB; Mello, MB; Shimizu, ADX; Protti, BL; Benzaken, AS				Pinto, Ione Conceicao; Sabido, Meritxell; Pereira, Analice Barbosa; Mello, Maeve B.; Xavier Shimizu, Andrea de Melo; Protti, Bruna Lovizutto; Benzaken, Adele Schwartz			Field Evaluation of a Point-of-Care CD4 Analyzer for Monitoring HIV Patients in the Interior of the Amazon Region, Brazil	PLOS ONE			English	Article							PERFORMANCE EVALUATION; CELL ENUMERATION; INSTRUMENT; PIMA(TM); BLOOD	Objective To evaluate the accuracy of the PIMA point-of-care CD4 analyzer (PIMA) under field conditions in comparison to the current CD4 count system (FACSCalibur), and to evaluate the operational suitability and acceptability of health professionals (HP) and HIV-patients in using the PIMA in health clinics in the Amazon Region. Methods CD4 counts were measured onsite by the PIMA using fingerprick blood and in the reference laboratory by both the PIMA and FACSCalibur using venous blood. We used the Bland-Altman method to estimate the mean bias, and calculated the sensitivity and specificity at <200 and <500 cell/mu L thresholds. Patients (n = 404) and HP (n = 7) were interviewed on the acceptability and operational suitability of the PIMA. Results Using fingerprick blood (n = 337), the PIMA showed a concordance correlation coefficient (Rc) of 0.81, mean difference of -111.9 cell/mu L, 93.1%/98.5% sensitivity, and 89.2%/56.7% specificity at <200 and <500 cell/mu L thresholds, respectively. Venous blood (n = 340) showed an Rc of 0.89, mean difference of -83.4 cell/mu L, 98.3%/97.5% sensitivity, and 93.9%/66.0% specificity at <200 and <500 cell/mu L thresholds, respectively. The capillary PIMA was well accepted and found operationally appropriate by patients and HP. Conclusions The agreement between both instruments was poor and the PIMA underestimated CD4 cell counts, which was more pronounced at CD4 counts >= 500 cell/mu l. The PIMA's performance with fingerprick blood was less reliable than its performance with venous blood. In Brazil, where antiretroviral treatment is initiated regardless of CD4 counts, the PIMA's systematic bias towards CD4 underestimation may limit its role for monitoring HIV-patients.	[Pinto, Ione Conceicao; Sabido, Meritxell; Xavier Shimizu, Andrea de Melo] Fundacao Med Trop Doutor Heitor Vieira Dourado FM, Manaus, Amazonas, Brazil; [Sabido, Meritxell] Univ Girona, Dept Med Sci, TransLab, Catalunya, Spain; [Pereira, Analice Barbosa] Fac Salle, Manaus, Amazonas, Brazil; [Mello, Maeve B.] Joint United Nations Programme HIV AIDS UNAIDS, Brasilia, DF, Brazil; [Protti, Bruna Lovizutto; Benzaken, Adele Schwartz] Minist Saude, Secretaria Vigilancia Saude, Dept DST Aids & Hepatites Virais, Brasilia, DF, Brazil; [Benzaken, Adele Schwartz] Fundacao Oswaldo Cruz, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil	Universitat de Girona; Fundacao Oswaldo Cruz	Sabido, M (corresponding author), Fundacao Med Trop Doutor Heitor Vieira Dourado FM, Manaus, Amazonas, Brazil.	xellsabido@gmail.com		Schwartz Benzaken, Adele/0000-0002-5789-0695	Centers for Disease Control and Prevention [1U2GPS001204]; National Department of STD/Aids; Brazilian Ministry of Health; Foundation for Research Support of the Amazonas State (FAPEAM); National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [U2GPS001204] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Department of STD/Aids; Brazilian Ministry of Health; Foundation for Research Support of the Amazonas State (FAPEAM); National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The study was co-funded by Centers for Disease Control and Prevention through the Cooperative Agreement Award #1U2GPS001204, and by the National Department of STD/Aids and Viral Hepatitis from the Brazilian Ministry of Health. Dr. Sabido has a fellowship as a visiting researcher at the Fundacao de Medicina Tropical Dr. Heitor Vieira Dourado, funded by the Foundation for Research Support of the Amazonas State (FAPEAM) through the Strategic Programme in Science, Technology & Innovation in Health Foundations (PECTI/AM SAUDE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BD Beckton Dickinson, MULT CD3 FITC CD8 PF; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Bride M, 2005, HAM2005062; Chesher Douglas, 2008, Clin Biochem Rev, V29 Suppl 1, pS23; Department of STDs AIDS and Viral Hepatitis. Health Surveillance Secretariat. Brazilian Ministry of Health, 2013, EP B; Department of STDs AIDS and Viral Hepatitis. Ministry of Health, 2013, PROT CLIN DIR TER; Diaw PA, 2011, JAIDS-J ACQ IMM DEF, V58, pE103, DOI 10.1097/QAI.0b013e318235b378; Galiwango RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088928; Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3; Jani IV, 2011, AIDS, V25, P807, DOI 10.1097/QAD.0b013e328344f424; Larson B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035444; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Mabey DC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001233; Manabe YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034319; Mandy Francis F, 2003, MMWR Recomm Rep, V52, P1; Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071; Mwau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067612; Myer L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18649; PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709; POLLOCK MA, 1992, ANN CLIN BIOCHEM, V29, P556, DOI 10.1177/000456329202900512; Rathunde L, 2014, INT J STD AIDS, V25, P956, DOI 10.1177/0956462414526862; Rocha GM, 2011, CAD SAUDE PUBLICA, V27, pS67, DOI 10.1590/S0102-311X2011001300008; Shott JP, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/651927; Sukapirom K, 2011, JAIDS-J ACQ IMM DEF, V58, P141, DOI 10.1097/QAI.0b013e31822866a2; Van Schaik N, 2011, CROI 2011 18 C RETR; Wade D, 2014, JAIDS-J ACQ IMM DEF, V66, pE98, DOI 10.1097/QAI.0000000000000214; World Health Organisation, 2013, WHO CONS GUID US ANT; Wynberg E, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18809; Zachariah R, 2011, TROP MED INT HEALTH, V16, P37, DOI 10.1111/j.1365-3156.2010.02669.x	29	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0121400	10.1371/journal.pone.0121400	http://dx.doi.org/10.1371/journal.pone.0121400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905775	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000007
J	Johnston, C; Bootsma, HJ; Aldridge, C; Manuse, S; Gisch, N; Schwudke, D; Hermans, PWM; Grangeasse, C; Polard, P; Vollmer, W; Claverys, JP				Johnston, Calum; Bootsma, Hester J.; Aldridge, Christine; Manuse, Sylvie; Gisch, Nicolas; Schwudke, Dominik; Hermans, Peter W. M.; Grangeasse, Christophe; Polard, Patrice; Vollmer, Waldemar; Claverys, Jean-Pierre			Co-Inactivation of GlnR and CodY Regulators Impacts Pneumococcal Cell Wall Physiology	PLOS ONE			English	Article							PATHOGEN STREPTOCOCCUS-PNEUMONIAE; GRAM-POSITIVE BACTERIA; BACILLUS-SUBTILIS; LIPOTEICHOIC ACID; ESCHERICHIA-COLI; GLOBAL REGULATOR; IRON TRANSPORT; COMPETENCE; GENE; TRANSFORMATION	CodY, a nutritional regulator highly conserved in low G+C Gram-positive bacteria, is essential in Streptococcus pneumoniae (the pneumococcus). A published codY mutant possessed suppressing mutations inactivating the fatC and amiC genes, respectively belonging to iron (Fat/Fec) and oligopeptide (Ami) ABC permease operons, which are directly repressed by CodY. Here we analyzed two additional published codY mutants to further explore the essentiality of CodY. We show that one, in which the regulator of glutamine/glutamate metabolism glnR had been inactivated by design, had only a suppressor in fecE (a gene in the fat/fecoperon), while the other possessed both fecE and amiC mutations. Independent isolation of three different fat/fec suppressors thus establishes that reduction of iron import is crucial for survival without CodY. We refer to these as primary suppressors, while inactivation of ami, which is not essential for survival of codY mutants and acquired after initial fat/fec inactivation, can be regarded as a secondary suppressor. The availability of codY-ami+ cells allowed us to establish that CodY activates competence for genetic transformation indirectly, presumably by repressing ami which is known to antagonize competence. The glnR codY fecE mutant was then found to be only partially viable on solid medium and hypersensitive to peptidoglycan (PG) targeting agents such as the antibiotic cefotaxime and the muramidase lysozyme. While analysis of PG and teichoic acid composition uncovered no alteration in the glnR codY fecE mutant compared to wildtype, electron microscopy revealed altered ultrastructure of the cell wall in the mutant, establishing that co-inactivation of GlnR and CodY regulators impacts pneumococcal cell wall physiology. In light of rising levels of resistance to PG-targeting antibiotics of natural pneumococcal isolates, GlnR and CodY constitute potential alternative therapeutic targets to combat this debilitating pathogen, as co-inactivation of these regulators renders pneumococci sensitive to iron and PG-targeting agents.	[Johnston, Calum; Polard, Patrice; Claverys, Jean-Pierre] CNRS, LMGM UMR5100, F-31000 Toulouse, France; [Johnston, Calum; Polard, Patrice; Claverys, Jean-Pierre] Univ Toulouse, UPS, Lab Microbiol & Genet Mol, F-31000 Toulouse, France; [Bootsma, Hester J.; Hermans, Peter W. M.] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6500 HB Nijmegen, Netherlands; [Aldridge, Christine; Vollmer, Waldemar] Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Manuse, Sylvie; Grangeasse, Christophe] Univ Lyon 1, CNRS, IBCP, Bases Mol & Struct Syst Infect,UMR 5086, F-69007 Lyon, France; [Gisch, Nicolas; Schwudke, Dominik] Leibniz Ctr Med & Biosci, Res Ctr Borstel, D-23845 Borstel, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Radboud University Nijmegen; Newcastle University - UK; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Forschungszentrum Borstel	Johnston, C (corresponding author), CNRS, LMGM UMR5100, F-31000 Toulouse, France.	johnston@biotoul.fr; claverys@biotoul.fr	Hermans, Peter W.M./H-8042-2014; Johnston, Calum Harvey Gustave/HHZ-8472-2022; Schwudke, Dominik/B-3478-2013	Johnston, Calum Harvey Gustave/0000-0001-5942-9117; Schwudke, Dominik/0000-0002-1379-9451; Grangeasse, Christophe/0000-0002-5484-4589; Gisch, Nicolas/0000-0003-3260-5269	European Community's Seventh Framework Programme [HEALTH-F3-2009-222983]; CNRS; BBSRC [BB/G015902/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G015902/1] Funding Source: researchfish	European Community's Seventh Framework Programme(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreement number HEALTH-F3-2009-222983 (Pneumopath project) and the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloing G, 1998, MOL MICROBIOL, V29, P75, DOI 10.1046/j.1365-2958.1998.00904.x; ALLOING G, 1994, J MOL BIOL, V241, P44, DOI 10.1006/jmbi.1994.1472; Brown JS, 2002, INFECT IMMUN, V70, P4389, DOI 10.1128/IAI.70.8.4389-4398.2002; Bui NK, 2012, ANAL BIOCHEM, V421, P657, DOI 10.1016/j.ab.2011.11.026; Caymaris S, 2010, MOL MICROBIOL, V78, P344, DOI 10.1111/j.1365-2958.2010.07339.x; Chastanet A, 2001, J BACTERIOL, V183, P7295, DOI 10.1128/JB.183.24.7295-7307.2001; CHEN JD, 1987, J GEN MICROBIOL, V133, P1959; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; CLAVERYS JP, 1986, MICROBIOL REV, V50, P133, DOI 10.1128/MMBR.50.2.133-165.1986; Davis KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000241; de Jong IG, 2011, JOVE-J VIS EXP, DOI 10.3791/3145; Denapaite D, 2012, MICROB DRUG RESIST, V18, P344, DOI 10.1089/mdr.2012.0026; Draing C, 2006, J BIOL CHEM, V281, P33849, DOI 10.1074/jbc.M602676200; Figueiredo TA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002508; Filipe SR, 2002, P NATL ACAD SCI USA, V99, P1550, DOI 10.1073/pnas.032671699; FISCHER W, 1993, EUR J BIOCHEM, V215, P851, DOI 10.1111/j.1432-1033.1993.tb18102.x; GARCIA P, 1986, GENE, V43, P265, DOI 10.1016/0378-1119(86)90215-5; Garcia P, 1999, MOL MICROBIOL, V31, P1275, DOI 10.1046/j.1365-2958.1999.01238.x; GARCIABUSTOS JF, 1988, J BACTERIOL, V170, P2143, DOI 10.1128/jb.170.5.2143-2147.1988; Gisch N, 2013, J BIOL CHEM, V288, P15654, DOI 10.1074/jbc.M112.446963; Guedon E, 2001, MOL MICROBIOL, V40, P1227, DOI 10.1046/j.1365-2958.2001.02470.x; Guiral S, 2006, MICROBIOL-SGM, V152, P343, DOI 10.1099/mic.0.28433-0; Guiral S, 2005, P NATL ACAD SCI USA, V102, P8710, DOI 10.1073/pnas.0500879102; Hartel T, 2012, J BIOL CHEM, V287, P4260, DOI 10.1074/jbc.M111.304311; HAHN J, 1987, J BACTERIOL, V169, P3104, DOI 10.1128/jb.169.7.3104-3109.1987; Handke LD, 2008, J BACTERIOL, V190, P798, DOI 10.1128/JB.01115-07; Hendriksen WT, 2008, J BACTERIOL, V190, P590, DOI 10.1128/JB.00917-07; HOLTJE JV, 1976, J BIOL CHEM, V251, P4199; Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199; Johnston C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003178; Kloosterman TG, 2006, J BIOL CHEM, V281, P25097, DOI 10.1074/jbc.M601661200; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Letoffe S, 2006, P NATL ACAD SCI USA, V103, P12891, DOI 10.1073/pnas.0605440103; Molle V, 2003, J BACTERIOL, V185, P1911, DOI 10.1128/JB.185.6.1911-1922.2003; Mortier-Barriere I, 1998, MOL MICROBIOL, V27, P159, DOI 10.1046/j.1365-2958.1998.00668.x; Munch D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002509; Prudhomme M, 2007, MOL BIOL STREPTOCOCC, P519; Reith J, 2011, APPL MICROBIOL BIOT, V92, P1, DOI 10.1007/s00253-011-3486-x; SALLES C, 1992, NUCLEIC ACIDS RES, V20, P6103, DOI 10.1093/nar/20.22.6103; Serror P, 1996, J BACTERIOL, V178, P5910, DOI 10.1128/jb.178.20.5910-5915.1996; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Smith AM, 2001, ANTIMICROB AGENTS CH, V45, P2393, DOI 10.1128/AAC.45.8.2393-2396.2001; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Sonenshein AL, 2005, CURR OPIN MICROBIOL, V8, P203, DOI 10.1016/j.mib.2005.01.001; Tai SS, 2003, FEMS MICROBIOL LETT, V220, P303, DOI 10.1016/S0378-1097(03)00135-6; TOMASZ A, 1966, J BACTERIOL, V91, P1050, DOI 10.1128/JB.91.3.1050-1061.1966; Ulijasz AT, 2004, J BACTERIOL, V186, P8123, DOI 10.1128/JB.186.23.8123-8136.2004; Zapun A, 2013, ACS CHEM BIOL, V8, P2688, DOI 10.1021/cb400575t	48	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123702	10.1371/journal.pone.0123702	http://dx.doi.org/10.1371/journal.pone.0123702			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901369	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500060
J	Nandi, M; Selin, C; Brassinga, AKC; Belmonte, MF; Fernando, WGD; Loewen, PC; De Kievit, TR				Nandi, Munmun; Selin, Carrie; Brassinga, Ann Karen C.; Belmonte, Mark F.; Fernando, W. G. Dilantha; Loewen, Peter C.; De Kievit, Teresa R.			Pyrrolnitrin and Hydrogen Cyanide Production by Pseudomonas chlororaphis Strain PA23 Exhibits Nematicidal and Repellent Activity against Caenorhabditis elegans	PLOS ONE			English	Article							SCLEROTINIA-SCLEROTIORUM; STRINGENT RESPONSE; BIOFILM FORMATION; BIOCONTROL; AERUGINOSA; BACTERIA; FLUORESCENS; ANTIBIOTICS; EXPRESSION; PREDATOR	Pseudomonas chlororaphis strain PA23 is a biocontrol agent able to suppress growth of the fungal pathogen Sclerotinia sclerotiorum. This bacterium produces an arsenal of exometa-bolites including pyrrolnitrin (PRN), phenazine (PHZ), hydrogen cyanide (HCN), and degradative enzymes. Production of these compounds is controlled at both the transcriptional and posttranscriptional levels by the Gac-Rsm system, RpoS, PsrA, and the Phz quorum-sensing system. Beyond pathogen-suppression, the success of a biocontrol agent is dependent upon its ability to establish itself in the environment where predation by bacterivorous organisms, including nematodes, may threaten persistence. The focus of this study was to investigate whether PA23 is able to resist grazing by Caenorhabditis elegans and to define the role played by exoproducts in the bacterial-nematode interaction. We discovered that both PRN and HCN contribute to fast- and slow-killing of C. elegans. HCN is well-established as having lethal effects on C. elegans; however, PRN has not been reported to be nematicidal. Exposure of L4 stage nematodes to purified PRN reduced nematode viability in a dose-dependent fashion and led to reduced hatching of eggs laid by gravid adults. Because bacterial metabolites can act as chemoattractants or repellents, we analyzed whether PA23 exhibited attractant or repulsive properties towards C. elegans. Both PRN and HCN were found to be potent repellents. Next we investigated whether the presence of C. elegans would elicit changes in PA23 gene activity. Co-culturing the two organisms increased expression of a number of genes associated with biocontrol, including phzA, hcnA, phzR, phzI, rpoS and gacS. Exoproduct analysis showed that PHZ and autoinducer signals were upregulated, consistent with the gene expression profiles. Collectively, these findings indicate that PA23 is able to sense the presence of C. elegans and it is able to both repel and kill the nematodes, which should facilitate environmental persistence and ultimately biocontrol.	[Nandi, Munmun; Brassinga, Ann Karen C.; Loewen, Peter C.; De Kievit, Teresa R.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; [Selin, Carrie; Fernando, W. G. Dilantha] Univ Manitoba, Dept Plant Sci, Winnipeg, MB R3T 2N2, Canada; [Belmonte, Mark F.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba	De Kievit, TR (corresponding author), Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada.	Teresa.Dekievit@ad.umanitoba.ca			Natural Sciences and Engineering Research Council (NSERC); Canada Research Chair Program (PCL); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair Program (PCL); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Financial support was provided through grants from the Natural Sciences and Engineering Research Council (NSERC) Discovery Grants Program (TdK, AKCB, MFB, WGDF, and PCL) and the Canada Research Chair Program (PCL). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; Beale E, 2006, APPL ENVIRON MICROB, V72, P5135, DOI 10.1128/AEM.00611-06; Berry CL, 2012, CAN J MICROBIOL, V58, P1027, DOI [10.1139/w2012-079, 10.1139/W2012-079]; BRENNER S, 1974, GENETICS, V77, P71; Burlinson P, 2013, ISME J, V7, P1126, DOI 10.1038/ismej.2013.9; Cezairliyan B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003101; Darby C, 1999, P NATL ACAD SCI USA, V96, P15202, DOI 10.1073/pnas.96.26.15202; Darby C, 2002, NATURE, V417, P243, DOI 10.1038/417243a; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Girard LR, 2007, NUCLEIC ACIDS RES, V35, pD472, DOI 10.1093/nar/gkl894; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; Jousset A, 2010, APPL ENVIRON MICROB, V76, P5263, DOI 10.1128/AEM.02941-09; KING EO, 1954, J LAB CLIN MED, V44, P301; Lee JH, 2010, CURR MICROBIOL, DOI [10.1007/s00284-101-9779-y, DOI 10.1007/S00284-101-9779-Y]; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; Ling EA, 2009, PLASMID, V62, P16, DOI 10.1016/j.plasmid.2009.02.002; Manuel J, 2012, MICROBIOL-SGM, V158, P207, DOI 10.1099/mic.0.053082-0; Mazzola M, 2009, APPL ENVIRON MICROB, V75, P6804, DOI 10.1128/AEM.01272-09; Meyer SLF, 2009, J NEMATOL, V41, P274; MILLER JH, 1972, EXPT MOL GENETICS, P351; Neidig N, 2011, MICROB ECOL, V61, P853, DOI 10.1007/s00248-011-9821-z; Poritsanos N, 2006, CAN J MICROBIOL, V52, P1177, DOI 10.1139/W06-079; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Savchuk S, 2004, FEMS MICROBIOL ECOL, V49, P379, DOI 10.1016/j.femsec.2004.04.014; Selin C, 2014, BIOL CONTROL, V69, P24, DOI 10.1016/j.biocontrol.2013.10.015; Selin C, 2012, MICROBIOL-SGM, V158, P896, DOI 10.1099/mic.0.054254-0; Selin C, 2010, FEMS MICROBIOL ECOL, V71, P73, DOI 10.1111/j.1574-6941.2009.00792.x; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Zhang Y, 2006, CAN J MICROBIOL, V52, P476, DOI 10.1139/W05-152	31	52	55	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123184	10.1371/journal.pone.0123184	http://dx.doi.org/10.1371/journal.pone.0123184			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901993	Green Submitted, Green Published, gold			2022-12-27	WOS:000353331500048
J	Roi, GS; Monticone, M; Salvoni, M; Sassi, R; Alberti, G				Roi, Giulio Sergio; Monticone, Marco; Salvoni, Marco; Sassi, Roberto; Alberti, Giampietro			Self-Reported Knee Symptoms Assessed by KOOS Questionnaire in Downhill Runners (Skyrunners)	PLOS ONE			English	Article							OSTEOARTHRITIS OUTCOME SCORE; POSTTRAUMATIC OSTEOARTHRITIS; INJURY; UPHILL; LEVEL; SPORT; POPULATION; ADAPTATION; ACTIVATION; KINETICS	Background The knee is the weight-bearing joint most commonly associated with sports injuries, and therefore is most at risk of developing degenerative changes, including osteoarthritis. Skyrunners can be considered to be at risk of developing symptoms of post-traumatic osteoarthritis due to downhill running. Aim The aim of this study was to analyze the health of the knee joints of a large group of these athletes via a specific self-report questionnaire. Methods This study was carried out by asking the participants of seven official Skyraces (22.4 +/- 3.1 km length; 1596 +/- 393 m elevation) to fill out a questionnaire. Information regarding age, sex, downhill elevation (m) during training and competitions over the last month, and history of previous knee injury was also collected before the participants filled out the Knee injury and Osteoarthritis Outcome Score (KOOS), which is a reliable and validated instrument designed to assess patients' opinions about their knees and associated problems that can result in post-traumatic osteoarthritis. Athletes were divided into six age groups (from 17 to 70 years) and 12 groups based on the downhill gradient they had covered over the last month (from 1,000 to 40,000 m). Results Six hundred twenty-one questionnaires were collected from 45% of the participants in the seven races. Multivariate analysis revealed that self-reported KOOS scores were unrelated to age, sex and monthly downhill gradient. Only 74 (12%) of the participants reported previous knee injuries. Significant differences in the five subscales of the KOOS were found between skyrunners with and without previous knee injuries (P<0.01). Conclusions In the studied population, regular training for downhill running and participation in Skyraces could not be considered risk factors for subjective knee symptoms. Skyrunners with selfreported histories of knee injuries scored worse on all five subscales of the KOOS.	[Roi, Giulio Sergio; Salvoni, Marco] Isokinet Med Grp, Educ & Res Dept, Bologna, Italy; [Roi, Giulio Sergio; Salvoni, Marco] Int Skyrunning Federat, Biella, Italy; [Monticone, Marco] Salvatore Maugeri Fdn IRCCS, Sci Inst Lissone Milan, Inst Care & Res IRCCS, Phys Med & Rehabil Unit, Lissone, Italy; [Sassi, Roberto] Univ Milan, Dept Comp Sci, Milan, Italy; [Alberti, Giampietro] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy	Istituti Clinici Scientifici Maugeri IRCCS; University of Milan; University of Milan	Roi, GS (corresponding author), Isokinet Med Grp, Educ & Res Dept, Bologna, Italy.	gs.roi@isokinetic.com	Theoharides, Theoharis C/E-5596-2010; Alberti, Giampietro/M-4110-2016	Alberti, Giampietro/0000-0002-5464-9644	Isokinetic Medical Group; International Skyrunning Federation	Isokinetic Medical Group; International Skyrunning Federation	Isokinetic Medical Group and International Skyrunning Federation provided support in the form of salaries for authors GSR and MS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bremner-Smith AT, 2004, KNEE, V11, P279, DOI 10.1016/j.knee.2003.06.001; Buckwalter JA, 2003, J ORTHOP SPORT PHYS, V33, P578, DOI 10.2519/jospt.2003.33.10.578; BUCZEK FL, 1990, MED SCI SPORT EXER, V22, P669, DOI 10.1249/00005768-199010000-00019; Chakravarty EF, 2008, AM J PREV MED, V35, P133, DOI 10.1016/j.amepre.2008.03.032; Derrick TR, 1998, MED SCI SPORT EXER, V30, P128, DOI 10.1097/00005768-199801000-00018; DeVita P, 2008, J BIOMECH, V41, P3354, DOI 10.1016/j.jbiomech.2008.09.024; ESTON RG, 1995, BRIT J SPORT MED, V29, P89, DOI 10.1136/bjsm.29.2.89; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Frobell RB, 2008, KNEE SURG SPORT TR A, V16, P713, DOI 10.1007/s00167-008-0509-y; Gottschall JS, 2005, J BIOMECH, V38, P445, DOI 10.1016/j.jbiomech.2004.04.023; Hamann N, 2014, SCAND J MED SCI SPOR, V24, P179, DOI 10.1111/j.1600-0838.2012.01513.x; Hortobagyi T, 2000, J ELECTROMYOGR KINES, V10, P117, DOI 10.1016/S1050-6411(99)00026-7; Hreljac A, 2004, MED SCI SPORT EXER, V36, P845, DOI 10.1249/01.MSS.0000126803.66636.DD; Hurley MV, 1999, RHEUM DIS CLIN N AM, V25, P283, DOI 10.1016/S0889-857X(05)70068-5; Kamibayashi K, 2006, J ELECTROMYOGR KINES, V16, P432, DOI 10.1016/j.jelekin.2005.09.004; KONRADSEN L, 1990, AM J SPORT MED, V18, P379, DOI 10.1177/036354659001800408; Lahr D D, 1996, Md Med J, V45, P641; LaStayo PC, 2003, J ORTHOP SPORT PHYS, V33, P557, DOI 10.2519/jospt.2003.33.10.557; Maffulli N, 2011, BRIT MED BULL, V97, P47, DOI 10.1093/bmb/ldq026; Minetti AE, 2002, J APPL PHYSIOL, V93, P1039, DOI 10.1152/japplphysiol.01177.2001; Molloy MG, 2011, BRIT J SPORT MED, V45, P275, DOI 10.1136/bjsm.2011.083956; Monticone M, 2012, OSTEOARTHR CARTILAGE, V20, P330, DOI 10.1016/j.joca.2012.01.001; Paradowski PT, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-38; PIERRYNOWSKI MR, 1987, EUR J APPL PHYSIOL O, V56, P668, DOI 10.1007/BF00424808; Roi G. S., 1999, Medicine and Science in Sports and Exercise, V31, pS191, DOI 10.1097/00005768-199905001-00859; Roi GS, 2002, MED SPORT, V55, P51; Roos E, 2003, USERS GUIDE KNEE INJ; Roos EM, 1999, OSTEOARTHR CARTILAGE, V7, P216, DOI 10.1053/joca.1998.0153; Roos EM, 1998, J ORTHOP SPORT PHYS, V28, P88, DOI 10.2519/jospt.1998.28.2.88; Roos Ewa M, 2003, Health Qual Life Outcomes, V1, P64, DOI 10.1186/1477-7525-1-64; Shirer I, 2004, BRIT J SPORT MED, V38, P526; Snyder KL, 2012, J EXP BIOL, V215, P2283, DOI 10.1242/jeb.066332; Telhan G, 2010, J ATHL TRAINING, V45, P16, DOI 10.4085/1062-6050-45.1.16; Urquhart DM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2343; Van Ginckel A, 2010, OSTEOARTHR CARTILAGE, V18, P1564, DOI 10.1016/j.joca.2010.10.007; Willick SE, 2010, CLIN SPORT MED, V29, P417, DOI 10.1016/j.csm.2010.03.006	36	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0126382	10.1371/journal.pone.0126382	http://dx.doi.org/10.1371/journal.pone.0126382			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902316	Green Published, gold, Green Submitted			2022-12-27	WOS:000353331500123
J	Vial, F; Scharrer, S; Reist, M				Vial, Flavie; Schaerrer, Sara; Reist, Martin			Risk Factors for Whole Carcass Condemnations in the Swiss Slaughter Cattle Population	PLOS ONE			English	Article							BOVINE CYSTICERCOSIS; MEAT INSPECTION; ANIMAL HEALTH; WELFARE; MODELS	We used meat-inspection data collected over a period of three years in Switzerland to evaluate slaughterhouse-level, farm-level and animal-level factors that may be associated with whole carcass condemnation (WCC) in cattle after slaughter. The objective of this study was to identify WCC risk factors so they can be communicated to, and managed by, the slaughter industry and veterinary services. During meat inspection, there were three main important predictors of the risk of WCC; the slaughtered animal's sex, age, and the size of the slaughterhouse it was processed in. WCC for injuries and significant weight loss (visible welfare indicators) were almost exclusive to smaller slaughterhouses. Cattle exhibiting clinical syndromes that were not externally visible (e.g. pneumonia lesions) and that are associated with fattening of cattle, end up in larger slaughterhouses. For this reason, it is important for animal health surveillance to collect data from both types of slaughterhouses. Other important risk factors for WCC were on-farm mortality rate and the number of cattle on the farm of origin. This study highlights the fact that the many risk factors for WCC are as complex as the production system itself, with risk factors interacting with one another in ways which are sometimes difficult to interpret biologically. Risk-based surveillance aimed at farms with reoccurring health problems (e.g. a history of above average condemnation rates) may be more appropriate than the selection, of higher-risk animals arriving at slaughter. In Switzerland, the introduction of a benchmarking system that would provide feedback to the farmer with information on condemnation reasons, and his/her performance compared to the national/regional average could be a first step towards improving herd-management and financial returns for producers.	[Vial, Flavie; Schaerrer, Sara] Univ Bern, Vetsuisse Fac, Vet Publ Hlth Inst, Liebefeld, Switzerland; [Schaerrer, Sara; Reist, Martin] Fed Food Safety & Vet Off, Liebefeld, Switzerland	University of Bern	Vial, F (corresponding author), Univ Bern, Vetsuisse Fac, Vet Publ Hlth Inst, Liebefeld, Switzerland.	Flavie.vial@vetsuisse.unibe.ch		Vial, Flavie/0000-0003-3603-4694				Alton GD, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-42; Andreoletti O, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2351; [Anonymous], 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2481; [Anonymous], LANGUAGER DATA SETS; Bahler C, 2012, RES VET SCI, V92, P162, DOI 10.1016/j.rvsc.2010.10.009; Blanco-Penedo I, 2012, ANIMAL, V6, P1503, DOI 10.1017/S1751731112000298; Boyle L., 2012, TEAG AGR FOOD DEV AU, P48; Calvo-Artavia FF, 2013, PREV VET MED, V110, P177, DOI 10.1016/j.prevetmed.2012.11.017; Deschamps JB, 2013, PREV VET MED, V112, P428, DOI 10.1016/j.prevetmed.2013.09.008; Dupuy C, 2014, MEAT SCI, V97, P262, DOI 10.1016/j.meatsci.2014.02.008; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Faraway J., 2011, FARAWAY FUNCTIONS DA; Fleischer P, 2001, J DAIRY SCI, V84, P2025, DOI 10.3168/jds.S0022-0302(01)74646-2; Flutsch F, 2008, PARASITOLOGY, V135, P641, DOI 10.1017/S0031182008004228; Fox J., 2019, R COMPANION APPL REG, V.; Fox J, 2009, J STAT SOFTW, V32, P1; Hadorn DC, 2008, VET RES, V39, DOI 10.1051/vetres:2008033; Harrell FE, 2001, REGRESSION MODELING; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Huey R, 2012, VET REC, V170, P68, DOI 10.1136/vr.e81; Jager HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029655; Lupo C, 2010, EPIDEMIOL INFECT, V138, P364, DOI 10.1017/S0950268809990549; Lynch JA, 2013, REV SCI TECH OIE, V32, P409; Oltenacu PA, 2005, AMBIO, V34, P311, DOI 10.1639/0044-7447(2005)034[0311:SFIPAT]2.0.CO;2; R Core Team, 2014, LANG ENV STAT COMP; Scharrer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109329; Scharrer S, 2013, FLEISCHWIRTSCHAFT IN, P28; Stark KDC, 2014, FOOD CONTROL, V39, P154, DOI 10.1016/j.foodcont.2013.11.009; Vial F, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-33; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	30	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122717	10.1371/journal.pone.0122717	http://dx.doi.org/10.1371/journal.pone.0122717			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901751	Green Published, gold, Green Submitted			2022-12-27	WOS:000353331500030
J	Whitaker, JW; Boyle, DL; Bartok, B; Ball, ST; Gay, S; Wang, W; Firestein, GS				Whitaker, John W.; Boyle, David L.; Bartok, Beatrix; Ball, Scott T.; Gay, Steffen; Wang, Wei; Firestein, Gary S.			Integrative Omics Analysis of Rheumatoid Arthritis Identifies Non-Obvious Therapeutic Targets	PLOS ONE			English	Article							FIBROBLAST-LIKE SYNOVIOCYTES; GENE-EXPRESSION; ELMO1; CELLS; ASSOCIATION; RECEPTOR; ALPHA; ENGULFMENT; CYTOKINES; INVASION	Identifying novel therapeutic targets for the treatment of disease is challenging. To this end, we developed a genome-wide approach of candidate gene prioritization. We independently collocated sets of genes that were implicated in rheumatoid arthritis (RA) pathogenicity through three genome-wide assays: (i) genome-wide association studies (GWAS), (ii) differentially expression in RA fibroblast-like synoviocytes (FLS), and (iii) differentially methylation in RA FLS. Integrated analysis of these complementary data sets identified a significant enrichment of multi-evidence genes (MEGs) within pathways relating to RA pathogenicity. One MEG is Engulfment and Cell Motility Protein-1 (ELMO1), a gene not previously considered as a therapeutic target in RA FLS. We demonstrated in RA FLS that ELMO1 is: (i) expressed, (ii) promotes cell migration and invasion, and (iii) regulates Rac1 activity. Thus, we created links between ELMO1 and RA pathogenicity, which in turn validates ELMO1 as a potential RA therapeutic target. This study illustrated the power of MEG-based approaches for therapeutic target identification.	[Whitaker, John W.; Wang, Wei] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Whitaker, John W.; Wang, Wei] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Boyle, David L.; Bartok, Beatrix; Firestein, Gary S.] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA; [Ball, Scott T.] Univ Calif San Diego, Sch Med, Dept Orthopaed, La Jolla, CA 92093 USA; [Gay, Steffen] Univ Zurich Hosp, Dept Rheumatol, CH-8091 Zurich, Switzerland	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Zurich; University Zurich Hospital	Wang, W (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	wei-wang@ucsd.edu; gfirestein@ucsd.edu		Whitaker, John W./0000-0002-0585-9119	Research Foundation	Research Foundation	This project was supported by a grant from the Research Foundation (GSF).	ALVAROGRACIA JM, 1991, J IMMUNOL, V146, P3365; AREND WP, 1990, ARTHRITIS RHEUM-US, V33, P305, DOI 10.1002/art.1780330302; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bartok B, 2014, J IMMUNOL, V192, P2063, DOI 10.4049/jimmunol.1300950; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Boyle DL, 2003, ARTHRITIS RES THER, V5, pR352, DOI 10.1186/ar1004; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Burmester GR, 2011, ANN RHEUM DIS, V70, P1542, DOI 10.1136/ard.2010.146225; Castro F, 2001, ANN RHEUM DIS, V60, P791, DOI 10.1136/ard.60.8.791; Chan A, 2007, MOL MED, V13, P297, DOI 10.2119/2007-00025.Chan; Das S, 2011, P NATL ACAD SCI USA, V108, P2136, DOI 10.1073/pnas.1014775108; Del Rey MJ, 2012, ANN RHEUM DIS, V71, P275, DOI 10.1136/annrheumdis-2011-200281; Ekwall AH, 2015, ARTHRITIS RHEUMATOLO; Elliott MR, 2010, NATURE, V467, P333, DOI 10.1038/nature09356; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hanawa-Suetsugu K, 2012, P NATL ACAD SCI USA, V109, P3305, DOI 10.1073/pnas.1113512109; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Hindorff LA, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Lefevre S, 2009, NAT MED, V15, P1414, DOI 10.1038/nm.2050; Li HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2680; Nakano K, 2013, J IMMUNOL, V190, P1297, DOI 10.4049/jimmunol.1202572; Nakano K, 2013, ANN RHEUM DIS, V72, P110, DOI 10.1136/annrheumdis-2012-201526; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Rosengren Sanna, 2007, V135, P365; Simelyte E, 2004, ANN RHEUM DIS, V63, P1695, DOI 10.1136/ard.2003.017210; Sohn C, 2015, ARTHRITIS RHEUMATOL, V67, P86, DOI 10.1002/art.38871; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Stevens A, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4559; Stevenson C, 2014, J IMMUNOL, V192, P6062, DOI 10.4049/jimmunol.1303348; Tieri P, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00059; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Whitaker JW, 2015, NAT METHODS, V12, P265, DOI [10.1038/NMETH.3065, 10.1038/nmeth.3065]; Whitaker JW, 2015, METHODS, V72, P86, DOI 10.1016/j.ymeth.2014.10.008; Whitaker JW, 2013, GENOME MED, V5, DOI 10.1186/gm444; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004	47	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124254	10.1371/journal.pone.0124254	http://dx.doi.org/10.1371/journal.pone.0124254			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901943	Green Published, Green Accepted, gold			2022-12-27	WOS:000353331500079
J	Xing, LD; Zhang, JP; Lockley, MG; McCrea, RT; Klein, H; Alcala, L; Buckley, LG; Burns, ME; Kummell, SB; He, Q				Xing, Lida; Zhang, Jianping; Lockley, Martin G.; McCrea, Richard T.; Klein, Hendrik; Alcala, Luis; Buckley, Lisa G.; Burns, Michael E.; Kuemmell, Susanna B.; He, Qing			Hints of the Early Jehol Biota: Important Dinosaur Footprint Assemblages from the Jurassic-Cretaceous Boundary Tuchengzi Formation in Beijing, China	PLOS ONE			English	Article							SAUROPOD TRACKWAYS; HOUCHENG FORMATION; SHANDONG PROVINCE; NORTHERN HEBEI; THEROPOD; GANSU; BASIN; AGES; ASIA	New reports of dinosaur tracksites in the Tuchengzi Formation in the newly established Yanqing Global Geopark, Beijing, China, support previous inferences that the track assemblages from this formation are saurischian-dominated. More specifically, the assemblages appear theropod-dominated, with the majority of well-preserved tracks conforming to the Grallator type (sensus lato), thus representing relatively small trackmakers. Such ichnofaunas supplement the skeletal record from this unit that lacks theropods thus far, proving a larger diversity of dinosaur faunas in that region. Sauropods are represented by medium to large sized and narrow and wide-gauge groups, respectively. The latter correspond with earlier discoveries of titanosauriform skeletons in the same unit. Previous records of ornithischian tracks cannot be positively confirmed. Purported occurrences are re-evaluated here, the trackways and imprints, except of a single possible specimen, re-assigned to theropods. Palecologically the Tuchengzi ichnofauna is characteristic of semi-arid fluvio-lacustrine inland basins with Upper Jurassic-Lower Cretaceous deposits in northern China that all show assemblages with abundant theropod and sauropod tracks and minor components of ornithopod, pterosaur and bird tracks.	[Xing, Lida; Zhang, Jianping; He, Qing] China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; [Lockley, Martin G.] Univ Colorado Denver, Dinosaur Trackers Res Grp, Denver, CO 80217 USA; [McCrea, Richard T.; Buckley, Lisa G.] Peace Reg Palaeontol Res Ctr, Tumbler Ridge, BC V0C 2W0, Canada; [Klein, Hendrik] Saurierwelt Palaontol Museum, D-92318 Neumarkt, Germany; [Alcala, Luis] Fdn Conjunto Paleontol Teruel Dinopolis, E-44002 Teruel, Aragon, Spain; [Burns, Michael E.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Kuemmell, Susanna B.] Univ Witten Herdecke, Inst Evolutionary Biol, D-58454 Witten, Germany	China University of Geosciences; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Alberta; Witten Herdecke University	Xing, LD (corresponding author), China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China.	xinglida@gmail.com	Alcalá, Luis/A-7413-2009; Alcalá, Luis/P-5793-2014; Burns, Michael E/GPC-8311-2022	Alcalá, Luis/0000-0002-6369-6186; Burns, Michael/0000-0002-9587-563X	Yanqing Global Geopark; China University of Geosciences (Beijing), China	Yanqing Global Geopark; China University of Geosciences (Beijing), China	This research project was supported by Yanqing Global Geopark (LX, JZ), and the 2013 support fund for graduate student's science and technology innovation from China University of Geosciences (Beijing), China (LX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; Carrano MT, 2001, PALEOBIOLOGY, V27, P564, DOI 10.1666/0094-8373(2001)027<0564:TDATTT>2.0.CO;2; Castanera D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081830; Dong Zhiming, 2001, P29; DUAN S-Y, 1986, Acta Botanica Sinica, V28, P331; Farlow J.O., 1989, P371; Farlow J.O., 2013, TYRANNOSAURID PALEOB, P88; Farlow James O., 1992, Zubia, V10, P89; Fujita Masato, 2007, Memoir of the Fukui Prefectural Dinosaur Museum, V6, P17; Gaston Robert, 2003, Ichnos, V10, P153, DOI 10.1080/10420940390256258; [张建平 Zhang JianPing], 2012, [科学通报, Chinese Science Bulletin], V57, P144; Gierlinski GD, 2009, ACTA GEOL POL, V59, P221; He Q, 2014, THESIS CHINA U GEOSC; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Ji Q., 2004, MESOZOIC JEHOL BIOTA; Li J., 2011, DINOSAUR TRACKS LOWE; Li RH, 2008, NATURWISSENSCHAFTEN, V95, P185, DOI 10.1007/s00114-007-0310-7; Lim S.-K., 1989, P333; Lockley M, 2006, CRETACEOUS RES, V27, P33, DOI 10.1016/j.cretres.2005.10.007; Lockley M, 2002, CRETACEOUS RES, V23, P363, DOI 10.1006/cres.2002.1005; LOCKLEY M, 1995, DINOSAUR TRACKS OTHE; Lockley M.G., DINOSAUR TR IN PRESS; Lockley Martin, 1998, Modern Geology, V23, P317; Lockley Martin G., 1994, Gaia, V10, P135; Lockley MG, 2013, ACTA GEOL SIN-ENGL, V87, P1, DOI 10.1111/1755-6724.12026; Lockley MG, 2009, GEOL SOC SPEC PUBL, V315, P255, DOI 10.1144/SP315.18; Lockley MG, 2009, GEOL Q, V53, P415; Lull R. S., 1904, Memoirs of the Boston Society, Vv, P461; Marty D, 2008, GEOFOCUS, V21, P1; Marty D, 2010, HIST BIOL, V22, P109, DOI 10.1080/08912960903503345; Marty Daniel, 2006, Hantkeniana, V5, P38; Matsukawa M, 2006, CRETACEOUS RES, V27, P3, DOI 10.1016/j.cretres.2005.10.009; McCrea RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103613; MEYER CA, 1990, ECLOGAE GEOL HELV, V83, P389; Myers TS, 2009, PALAEOGEOGR PALAEOCL, V274, P96, DOI 10.1016/j.palaeo.2009.01.002; Oh C, 2015, ACTA PALAEONTOL POL, V60, P245, DOI 10.4202/app.2012.0132; Olsen P.E., 1980, P35; Olsen PE, 1998, J VERTEBR PALEONTOL, V18, P586, DOI 10.1080/02724634.1998.10011086; Pan YH, 2013, CRETACEOUS RES, V44, P30, DOI 10.1016/j.cretres.2013.03.007; Santos VF, 2009, ACTA PALAEONTOL POL, V54, P409, DOI 10.4202/app.2008.0049; [邵济安 Shao Jian], 2003, [地质通报, Geological Bulletin of China], V22, P751; Shikama T., 1942, CENTRAL NATURAL MUSE, V3, P21; Sullivan Corwin, 2009, Vertebrata Palasiatica, V47, P35; Swisher CC, 2002, CHINESE SCI BULL, V47, P135; Sze H.C., 1963, FOSSIL PLANTS CHINA, V2; Thulborn RA., 1990, DINOSAUR TRACKS; Tian SG, 1994, CHINESE SCI BULL, V8, P766; Wang Si-en, 2013, Dizhi Tongbao, V32, P1673; Weems R.E., 1992, P 26 FORUM GEOLOGY I, V119, P113; White D., 1929, CARNEGIE I WASHINGTO, V405, P1; Wilson JA, 1999, PALEOBIOLOGY, V25, P252, DOI 10.1017/S0094837300026543; Xing LD, CRETA RES IN PRESS; Xing LD, 2014, PALAEOWORLD, V23, P200, DOI 10.1016/j.palwor.2013.10.002; Xing Li-da, 2014, Acta Palaeontologica Sinica, V53, P381; Xing Li-Da, 2014, Vertebrata Palasiatica, V52, P233; Xing Li-da, 2012, Dizhi Tongbao, V31, P20; Xing Li-Da, 2012, Palaeoworld, V21, P50, DOI 10.1016/j.palwor.2012.02.004; Xing Li-Da, 2011, Vertebrata Palasiatica, V49, P423; Xing Li-da, 2010, Acta Palaeontologica Sinica, V49, P448; Xing Li-da, 2009, Acta Palaeontologica Sinica, V48, P662; Xing LD, 2015, CRETACEOUS RES, V52, P194, DOI 10.1016/j.cretres.2014.10.001; Xing LD, 2013, CRETACEOUS RES, V45, P114, DOI 10.1016/j.cretres.2013.07.009; Xing LD, 2013, ACTA PALAEONTOL POL, V58, P723, DOI 10.4202/app.2011.0115; [Xing Lida 邢立达], 2010, [地质通报, Geological Bulletin of China], V29, P1105; Xing X, 2006, GEOL J, V41, P419, DOI 10.1002/gj.1044; [许欢 Xu Huan], 2014, [地学前缘, Earth Science Frontiers], V21, P203; [许欢 Xu Huan], 2013, [地质通报, Geological Bulletin of China], V32, P502; [许欢 Xu Huan], 2011, [地学前缘, Earth Science Frontiers], V18, P88; Xu K, 2003, STRATIGRAPHIC REGION; Xu X, 2010, CHINESE SCI BULL, V55, P3971, DOI 10.1007/s11434-010-4150-z; Yabe H., 1940, P IMP ACAD JAPAN, V16, P560, DOI [10.2183/pjab1912.16.560, DOI 10.2183/PJAB1912.16.560]; Young C. C., 1966, VERTEBRAT PALASIATIC, V10, P68; YOUNG CHUNG-CHIEN, 1960, VERTEBR PALASIAT [CHINA], V4, P53; Zhang JP, 2006, CRETACEOUS RES, V27, P44, DOI 10.1016/j.cretres.2005.10.006; Zhang W., 2000, CHINESE B BOT, V17, P202; Zhang Yongzhong, 2004, Geological Review (Beijing), V50, P561; Zhao XJ, 2006, ACTA GEOL SIN-ENGL, V80, P467; Zhao XJ, 1999, J VERTEBR PALEONTOL, V19, P681; Zhen S., 1989, P187; Zheng S.L., 2008, FOSSIL WOOD OF CHINA; Zhou ZH, 2010, SCI CHINA EARTH SCI, V53, P1894, DOI 10.1007/s11430-010-4094-9	81	25	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122715	10.1371/journal.pone.0122715	http://dx.doi.org/10.1371/journal.pone.0122715			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901363	Green Published, gold, Green Submitted			2022-12-27	WOS:000353331500028
J	Chung, BH; Joo, YY; Lee, J; Kim, HD; Kim, JI; Moon, IS; Choi, BS; Oh, EJ; Park, CW; Kim, YS; Yang, CW				Chung, Byung Ha; Joo, Yu Young; Lee, Jaesin; Kim, Hyung Duk; Kim, Ji-Il; Moon, In Sung; Choi, Bum Soon; Oh, Eun-Jee; Park, Cheol Whee; Kim, Yong-Soo; Yang, Chul Woo			Impact of ABO Incompatibility on the Development of Acute Antibody-Mediated Rejection in Kidney Transplant Recipients Presensitized to HLA	PLOS ONE			English	Article							POSITIVE-CROSS-MATCH; SUCCESSFUL RENAL-TRANSPLANTATION; DONOR-SPECIFIC ANTIBODIES; SINGLE ANTIGEN-ASSAY; SENSITIZED PATIENTS; CLASS-I; DESENSITIZATION; RITUXIMAB; TITER; RISK	Whether the coexistence of anti-A/B antibody and donor specific anti-HLA antibody (HLA-DSA) has a synergistic impact on the development of acute antibody-mediated rejection (AAMR) in kidney transplant recipients (KTRs) is unclear. This study includes 92 KTRs who received a kidney from an ABO-incompatible (ABOi) donor or were presensitized to donor HLA (HLAs) and 292 controls (CONT). HLAs was defined as a crossmatch positivity or the presence of HLA-DSA. We compared the incidence of AAMR among ABOi (n = 58), ABOi +HLAs (n = 12), HLAs (n = 22), and CONT (n = 292) groups and evaluated the risk factors and antibody type (anti-A/B vs. HLA-DSA) responsible for AAMR. AAMR developed less frequently in ABOi and CONT than in the ABOi+HLAs or HLAs (P < 0.05 for all); however, there was no difference between the ABOi+HLAs and HLAs groups. AAMR developed more frequently with strong HLA-DSA at baseline; however, high baseline anti-A/B titer did not affect AAMR development. Strong baseline HLA-DSA was an independent predictor for AAMR, however the baseline anti-A/B titer was not. All four AAMR episodes in ABOi+HLAs were positive to HLA-DSA but not to anti-A/B. In conclusion, ABO incompatibility does not increase the risk for AAMR in HLAs KTRs.	[Chung, Byung Ha; Kim, Ji-Il; Moon, In Sung; Choi, Bum Soon; Park, Cheol Whee; Kim, Yong-Soo; Yang, Chul Woo] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Transplant Res Ctr, Seoul, South Korea; [Chung, Byung Ha; Joo, Yu Young; Lee, Jaesin; Kim, Hyung Duk; Choi, Bum Soon; Park, Cheol Whee; Kim, Yong-Soo; Yang, Chul Woo] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Nephrol, Seoul, South Korea; [Kim, Ji-Il; Moon, In Sung] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Surg, Seoul, South Korea; [Oh, Eun-Jee] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Lab Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Yang, CW (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Transplant Res Ctr, Seoul, South Korea.	yangch@catholic.ac.kr	Kim, Hyungduk/CAH-5630-2022	Oh, Eun-Jee/0000-0001-5870-915X	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2013R1A1A1009718]; Catholic Medical Center Research Foundation	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Catholic Medical Center Research Foundation	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A1009718) and the Catholic Medical Center Research Foundation made in the program year of 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung BH, 2013, TRANSPL INFECT DIS, V15, P559, DOI 10.1111/tid.12135; Chung BH, 2013, NEPHRON CLIN PRACT, V124, P79, DOI 10.1159/000355855; Chung BH, 2014, TRANSPL INT, V27, P49, DOI 10.1111/tri.12199; Chung BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042011; Chung BH, 2012, RENAL FAILURE, V34, P974, DOI 10.3109/0886022X.2012.700892; Chung BH, 2012, TRANSPL INT, V25, P687, DOI 10.1111/j.1432-2277.2012.01480.x; Chung BH, 2011, RENAL FAILURE, V33, P150, DOI 10.3109/0886022X.2011.552149; Dean PG, 2005, SURGERY, V137, P269, DOI 10.1016/j.surg.2004.08.002; Everly MJ, 2013, TRANSPLANTATION, V95, P410, DOI 10.1097/TP.0b013e31827d62e3; Gloor JM, 2003, AM J TRANSPLANT, V3, P1017, DOI 10.1034/j.1600-6143.2003.00180.x; Gloor JM, 2003, TRANSPLANTATION, V75, P971, DOI 10.1097/01.TP.0000058226.397.32; Haririan A, 2009, AM J TRANSPLANT, V9, P536, DOI 10.1111/j.1600-6143.2008.02524.x; Hidalgo LG, 2009, AM J TRANSPLANT, V9, P2532, DOI 10.1111/j.1600-6143.2009.02800.x; Huh KH, 2012, INT UROL NEPHROL, V44, P1549, DOI 10.1007/s11255-012-0169-1; Jang JY, 2012, ANN LAB MED, V32, P66, DOI 10.3343/alm.2012.32.1.66; Kim Y, 2010, ANN CLIN LAB SCI, V40, P330; Kong JM, 2013, CLIN TRANSPLANT, V27, P875, DOI 10.1111/ctr.12249; Lobo LJ, 2013, J HEART LUNG TRANSPL, V32, P70, DOI 10.1016/j.healun.2012.10.007; Caro-Oleas JL, 2012, NEPHROL DIAL TRANSPL, V27, P1231, DOI 10.1093/ndt/gfr429; Marfo K, 2011, CLIN J AM SOC NEPHRO, V6, P922, DOI 10.2215/CJN.08140910; Montgomery JR, 2012, TRANSPLANTATION, V93, P603, DOI 10.1097/TP.0b013e318245b2af; Montgomery RA, 2011, NEW ENGL J MED, V365, P318, DOI 10.1056/NEJMoa1012376; Naemi FMA, 2013, TRANSPLANTATION, V96, P258, DOI 10.1097/TP.0b013e3182985504; Padmanabhan A, 2009, TRANSPLANTATION, V87, P1889, DOI 10.1097/TP.0b013e3181a76ae1; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Stegall MD, 2006, AM J TRANSPLANT, V6, P346, DOI 10.1111/j.1600-6143.2005.01178.x; Takahashi K, 2004, AM J TRANSPLANT, V4, P1089, DOI 10.1111/j.1600-6143.2004.00464.x; Tobian AAR, 2010, AM J TRANSPLANT, V10, P1247, DOI 10.1111/j.1600-6143.2010.03103.x; Toki D, 2009, AM J TRANSPLANT, V9, P567, DOI 10.1111/j.1600-6143.2008.02538.x; Tyden G, 2007, TRANSPLANTATION, V83, P1153, DOI 10.1097/01.tp.0000262570.18117.55; Uchida J, 2010, TRANSPL P, V42, P3998, DOI 10.1016/j.transproceed.2010.09.043; Vieira CA, 2004, TRANSPLANTATION, V77, P542, DOI 10.1097/01.TP.0000112934.12622.2B; Warren DS, 2004, AM J TRANSPLANT, V4, P561, DOI 10.1111/j.1600-6143.2004.00364.x; Wiebe C, 2012, AM J TRANSPLANT, V12, P1157, DOI 10.1111/j.1600-6143.2012.04013.x; Yoon HE, 2009, J KOREAN MED SCI, V24, pS148, DOI 10.3346/jkms.2009.24.S1.S148	35	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123638	10.1371/journal.pone.0123638	http://dx.doi.org/10.1371/journal.pone.0123638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897756	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600037
J	Johnson, KR; Hindmarch, CCT; Salinas, YD; Shi, YJ; Greenwood, M; Hoe, SZ; Murphy, D; Gainer, H				Johnson, Kory R.; Hindmarch, C. C. T.; Salinas, Yasmmyn D.; Shi, YiJun; Greenwood, Michael; Hoe, See Ziau; Murphy, David; Gainer, Harold			A RNA-Seq Analysis of the Rat Supraoptic Nucleus Transcriptome: Effects of Salt Loading on Gene Expression	PLOS ONE			English	Article							HYPOTHALAMO-NEUROHYPOPHYSEAL SYSTEM; VASOPRESSIN HETERONUCLEAR RNA; DOMINANT-NEGATIVE INHIBITOR; IMMEDIATE-EARLY GENES; CELL-SIZE CHANGES; MAGNOCELLULAR NEURONS; MESSENGER-RNA; HYPOTHALAMONEUROHYPOPHYSEAL SYSTEM; C-FOS; OXYTOCIN	Magnocellular neurons (MCNs) in the hypothalamo-neurohypophysial system (HNS) are highly specialized to release large amounts of arginine vasopressin (Avp) or oxytocin (Oxt) into the blood stream and play critical roles in the regulation of body fluid homeostasis. The MCNs are osmosensory neurons and are excited by exposure to hypertonic solutions and inhibited by hypotonic solutions. The MCNs respond to systemic hypertonic and hypotonic stimulation with large changes in the expression of their Avp and Oxt genes, and microarray studies have shown that these osmotic perturbations also cause large changes in global gene expression in the HNS. In this paper, we examine gene expression in the rat supraoptic nucleus (SON) under normosmotic and chronic salt-loading SL) conditions by the first time using "new-generation", RNA sequencing (RNA-Seq) methods. We reliably detect 9,709 genes as present in the SON by RNA-Seq, and 552 of these genes were changed in expression as a result of chronic SL. These genes reflect diverse functions, and 42 of these are involved in either transcriptional or translational processes. In addition, we compare the SON transcriptomes resolved by RNA-Seq methods with the SON transcriptomes determined by Affymetrix microarray methods in rats under the same osmotic conditions, and find that there are 6,466 genes present in the SON that are represented in both data sets, although 1,040 of the expressed genes were found only in the microarray data, and 2,762 of the expressed genes are selectively found in the RNA-Seq data and not the microarray data. These data provide the research community a comprehensive view of the transcriptome in the SON under normosmotic conditions and the changes in specific gene expression evoked by salt loading.	[Johnson, Kory R.] NINDS, Bioinformat Sect, Informat Technol & Bioinformat Program, NIH, Bethesda, MD 20892 USA; [Salinas, Yasmmyn D.; Shi, YiJun; Gainer, Harold] NINDS, Neurochem Lab, NIH, Bethesda, MD 20892 USA; [Hindmarch, C. C. T.; Greenwood, Michael; Murphy, David] Univ Bristol, Sch Clin Sci, Bristol BS1 3NY, England; [Hindmarch, C. C. T.; Hoe, See Ziau; Murphy, David] Univ Malaya, Fac Med, Dept Physiol, Kuala Lumpur 50603, Malaysia	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Bristol; Universiti Malaya	Gainer, H (corresponding author), NINDS, Neurochem Lab, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	gainerh@ninds.nih.gov	Hindmarch, Charles/AAM-3385-2021; HOE, SEE ZIAU/B-8637-2010; Murphy, David/C-3967-2012	HOE, SEE ZIAU/0000-0001-6138-1271; Hindmarch, Charles/0000-0002-6036-1292; Murphy, David/0000-0003-2946-0353; Greenwood, Michael/0000-0003-0565-2748	NIH, NINDS; BHF [RG/11/28714]; BBSRC [BB/J005452/1]; High Impact Research Chancellory Grant from the University of Malaya [UM.C/625/1/HIR/MOHE/MED/22 H-20001-E000086]; Biotechnology and Biological Sciences Research Council [BB/J005452/1] Funding Source: researchfish; British Heart Foundation [RG/11/6/28714] Funding Source: researchfish	NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); BHF(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); High Impact Research Chancellory Grant from the University of Malaya; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This research was supported by the Intramural Research Program of the NIH, NINDS (KJ, HG), and by funding from the BHF (RG/11/28714, MG, DM), the BBSRC (BB/J005452/1, CH, DM) and a High Impact Research Chancellory Grant (UM.C/625/1/HIR/MOHE/MED/22 H-20001-E000086) from the University of Malaya (SZH, CH, DM).	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Antunes-Rodrigues J, 2004, PHYSIOL REV, V84, P169, DOI 10.1152/physrev.00017.2003; ARMSTRONG WE, 1977, BRAIN RES BULL, V2, P7, DOI 10.1016/0361-9230(77)90019-3; Armstrong WE, 1995, PROG NEUROBIOL, V47, P291, DOI 10.1016/0301-0082(95)00025-9; Baro DJ, 1997, J NEUROSCI, V17, P6597; BENBARAK Y, 1985, J NEUROSCI, V5, P81; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; BOURQUE CW, 1989, J PHYSIOL-LONDON, V417, P263, DOI 10.1113/jphysiol.1989.sp017800; Brown CH, 2013, J NEUROENDOCRINOL, V25, P678, DOI 10.1111/jne.12051; BROWNSTEIN MJ, 1980, SCIENCE, V207, P373, DOI 10.1126/science.6153132; Burbach JPH, 2001, PHYSIOL REV, V81, P1197, DOI 10.1152/physrev.2001.81.3.1197; CARTER DA, 1989, BRAIN RES, V487, P350, DOI 10.1016/0006-8993(89)90839-1; Chen H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00098; Chen Xiao-Ping, 2005, Methods Mol Biol, V293, P285; Fields RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032085; Glasgow E, 2000, AM J PHYSIOL-REG I, V279, pR1239, DOI 10.1152/ajpregu.2000.279.4.R1239; Greenwood M, 2015, AM J PHYSL REGUL INT; Greenwood M, 2014, J NEUROSCI, V34, P3810, DOI 10.1523/JNEUROSCI.4343-13.2014; Grunewald A, 2014, J NEUROSCI METH, V232, P143, DOI 10.1016/j.jneumeth.2014.05.026; Hashimoto H, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00213; Hatton GI, 1997, ANNU REV NEUROSCI, V20, P375, DOI 10.1146/annurev.neuro.20.1.375; HATTON GI, 1990, PROG NEUROBIOL, V34, P437, DOI 10.1016/0301-0082(90)90017-B; HATTON GI, 1973, BRAIN RES, V59, P137, DOI 10.1016/0006-8993(73)90256-4; Hindmarch C, 2006, P NATL ACAD SCI USA, V103, P1609, DOI 10.1073/pnas.0507450103; Hitzemann R, 2014, INT REV NEUROBIOL, V116, P1, DOI 10.1016/B978-0-12-801105-8.00001-1; Humerick M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069407; Iwasaki Y, 1997, ENDOCRINOLOGY, V138, P5266, DOI 10.1210/en.138.12.5266; Kawasaki M, 2005, J NEUROENDOCRINOL, V17, P227, DOI 10.1111/j.1365-2826.2005.01297.x; Kawasaki M, 2009, EXP NEUROL, V219, P212, DOI 10.1016/j.expneurol.2009.05.019; Kuwahara S, 2003, J NEUROSCI, V23, P10231; Landry CF, 1998, J NEUROSCI, V18, P7315; LIGHTMAN SL, 1987, J PHYSIOL-LONDON, V394, P23, DOI 10.1113/jphysiol.1987.sp016858; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Lubelski D, 2012, BRAIN RES, V1429, P18, DOI 10.1016/j.brainres.2011.10.033; Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806; MIYATA S, 1994, BRAIN RES BULL, V34, P169, DOI 10.1016/0361-9230(94)90057-4; MURPHY D, 1990, MOL ENDOCRINOL, V4, P1051, DOI 10.1210/mend-4-7-1051; Mutsuga N, 2004, J NEUROSCI, V24, P7174, DOI 10.1523/JNEUROSCI.2022-04.2004; Mutsuga N, 2005, ENDOCRINOLOGY, V146, P1254, DOI 10.1210/en.2004-1202; Nedungadi TP, 2012, EXP NEUROL, V237, P223, DOI 10.1016/j.expneurol.2012.06.017; Ponzio TA, 2007, J NEUROSCI METH, V164, P149, DOI 10.1016/j.jneumeth.2007.04.012; Ponzio TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048860; Qiu J, 2007, J NEUROSCI, V27, P2196, DOI 10.1523/JNEUROSCI.5420-06.2007; Qiu J, 2011, ENDOCRINOLOGY, V152, P3483, DOI 10.1210/en.2011-1044; Qiu Shenfeng, 2012, Frontiers in Genetics, V3, P124, DOI 10.3389/fgene.2012.00124; RHODES CH, 1981, J COMP NEUROL, V198, P45, DOI 10.1002/cne.901980106; Salm AK, 2004, J NEUROENDOCRINOL, V16, P661, DOI 10.1111/j.1365-2826.2004.01219.x; SHERMAN TG, 1986, NEUROENDOCRINOLOGY, V44, P222, DOI 10.1159/000124649; SHERMAN TG, 1988, J NEUROSCI, V8, P3785; Snyder SE, 1998, J COMP NEUROL, V394, P91; STEINBUSCH HWM, 1988, ACTA HISTOCHEM, P85; Stewart L, 2011, J NEUROENDOCRINOL, V23, P177, DOI 10.1111/j.1365-2826.2010.02093.x; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Toledo-Rodriguez M, 2014, METHODS MOL BIOL, V1183, P143, DOI 10.1007/978-1-4939-1096-0_8; Tosic M, 2002, GLIA, V37, P219, DOI 10.1002/glia.10028; TWEEDLE CD, 1976, BRAIN RES BULL, V1, P103, DOI 10.1016/0361-9230(76)90054-X; TWEEDLE CD, 1977, CELL TISSUE RES, V181, P59; Ueta Y, 2005, ENDOCRINOLOGY, V146, P406, DOI 10.1210/en.2004-0830; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WHITNALL MH, 1985, J NEUROSCI, V5, P98; Wichterle H, 2013, SCIENCE, V341, P726, DOI 10.1126/science.1235884; Yamashita M, 2002, ENDOCRINOLOGY, V143, P4464, DOI 10.1210/en.2002-220516; Young LJ, 1999, HORM BEHAV, V36, P212, DOI 10.1006/hbeh.1999.1548; Yue C, 2008, J NEUROENDOCRINOL, V20, P227, DOI 10.1111/j.1365-2826.2007.01640.x; Yue CM, 2006, CELL MOL NEUROBIOL, V26, P959, DOI 10.1007/s10571-006-9017-0; Zhang B, 2001, J NEUROENDOCRINOL, V13, P29, DOI 10.1046/j.1365-2826.2001.00593.x; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zwemer LM, 2014, PRENATAL DIAG, V34, P1006, DOI 10.1002/pd.4417	70	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124523	10.1371/journal.pone.0124523	http://dx.doi.org/10.1371/journal.pone.0124523			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897513	gold, Green Published, Green Submitted			2022-12-27	WOS:000353212600071
J	Lee, H; Kuk, H; Byun, SS; Lee, SE; Hong, SK				Lee, Hakmin; Kuk, Harim; Byun, Seok-Soo; Lee, Sang Eun; Hong, Sung Kyu			Preoperative Glycemic Control Status as a Significant Predictor of Biochemical Recurrence in Prostate Cancer Patients after Radical Prostatectomy	PLOS ONE			English	Article							DIABETES-MELLITUS; COLORECTAL-CANCER; MEN; MORTALITY; METFORMIN; SURVIVAL; TESTOSTERONE; OUTCOMES; GLUCOSE; HBA1C	Background The effect of diabetes mellitus (DM) on prostate cancer (PCa) outcome remains controversial. Thus, we investigated the association of DM history, glycemic control, and metformin use with oncologic outcomes after radical prostatectomy (RP). Methods We reviewed the records of 746 contemporary patients who had hemoglobin A1c (HbA1c) measured within the 6 months preceding RP. The associations between clinical variables and risk of adverse pathological features and biochemical recurrence (BCR) were tested using a multivariate logistic regression and multiple Cox-proportional hazards model, respectively. BCR was defined as prostatic specific antigen (PSA) > 0.2 ng/mL in 2 consecutive tests. Results There were no significant differences in the rates of adverse pathologic features and BCR-free survival between patients with (n = 209) and without (n = 537) a history of DM diagnosis (all p > 0.05). In multivariate analyses, high HbA1c level (>= 6.5%) was significantly related with high pathologic Gleason score (>= 4+3; odds ratio [OR] 1.704, p = 0.019) and BCR-free survival (OR 1.853, p = 0.007). Metformin use was not associated with BCR-free survival (OR 0.662, p = 0.125). Conclusions Poor glycemic control was significantly associated with BCR after RP. Meanwhile, metformin use was not associated with biochemical outcome after RP. Further investigation would be needed to identify exact mechanism underlying the impact of glycemic control on PCa treatment outcome.	[Lee, Hakmin; Kuk, Harim; Byun, Seok-Soo; Lee, Sang Eun; Hong, Sung Kyu] Seoul Natl Univ, Bundang Hosp, Dept Urol, Songnam, South Korea	Seoul National University (SNU)	Hong, SK (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Urol, Songnam, South Korea.	hsk823@chol.com						Barba M, 2012, ANN ONCOL, V23, P1838, DOI 10.1093/annonc/mdr540; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Bonovas S, 2004, DIABETOLOGIA, V47, P1071, DOI 10.1007/s00125-004-1415-6; *CDCP, 2010, NAT DIAB FACT SHEET; Chan JM, 2005, CANCER CAUSE CONTROL, V16, P789, DOI 10.1007/s10552-005-3301-z; Gapstur SM, 2001, CANCER CAUSE CONTROL, V12, P763, DOI 10.1023/A:1011279907108; Garcia-Cruz E, 2012, BJU INT, V110, pE541, DOI 10.1111/j.1464-410X.2012.11232.x; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; He XX, 2011, ANN ONCOL, V22, P2640, DOI 10.1093/annonc/mdr020; Hong SK, 2009, PROSTATE, V69, P820, DOI 10.1002/pros.20932; Isom-Batz G, 2005, J UROLOGY, V173, P1935, DOI 10.1097/01.ju.0000158040.33531.e7; Jayachandran J, 2010, CANCER EPIDEM BIOMAR, V19, P9, DOI 10.1158/1055-9965.EPI-09-0777; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kaneda K, 2012, J SURG ONCOL, V105, P606, DOI 10.1002/jso.22137; Kasper JS, 2008, CANCER CAUSE CONTROL, V19, P703, DOI 10.1007/s10552-008-9133-x; Kasper JS, 2006, CANCER EPIDEM BIOMAR, V15, P2056, DOI 10.1158/1055-9965.EPI-06-0410; Kim HS, 2010, PROSTATE, V70, P1540, DOI 10.1002/pros.21189; Krone Cheryl A, 2005, Integr Cancer Ther, V4, P25, DOI 10.1177/1534735404274167; Ma J, 2008, LANCET ONCOL, V9, P1039, DOI 10.1016/S1470-2045(08)70235-3; Merrick GS, 2007, CANCER, V110, P289, DOI 10.1002/cncr.22793; Patel T, 2010, UROLOGY, V76, P1240, DOI 10.1016/j.urology.2010.03.059; Rieken M, 2014, WORLD J UROL, V32, P999, DOI 10.1007/s00345-013-1171-7; Siddiqui AA, 2008, DIGEST DIS SCI, V53, P2486, DOI 10.1007/s10620-008-0264-4; Smith MR, 2008, J CLIN ONCOL, V26, P4333, DOI 10.1200/JCO.2008.16.5845; Spratt DE, 2013, EUR UROL, V63, P709, DOI 10.1016/j.eururo.2012.12.004; Wright JL, 2013, PROSTATE CANCER P D, V16, P204, DOI 10.1038/pcan.2013.5; Wu CW, 2013, BJU INT, V111, pE310, DOI 10.1111/j.1464-410X.2012.11687.x	27	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124761	10.1371/journal.pone.0124761	http://dx.doi.org/10.1371/journal.pone.0124761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897669	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600084
J	Moreno, M; Moreno-Navarrete, JM; Serrano, M; Ortega, F; Delgado, E; Sanchez-Ragnarsson, C; Valdes, S; Botas, P; Ricart, W; Fernandez-Real, JM				Moreno, Mara; Maria Moreno-Navarrete, Jose; Serrano, Marta; Ortega, Francisco; Delgado, Elias; Sanchez-Ragnarsson, Cecilia; Valdes, Sergio; Botas, Patricia; Ricart, Wifredo; Manuel Fernandez-Real, Jose			Circulating Irisin Levels Are Positively Associated with Metabolic Risk Factors in Sedentary Subjects	PLOS ONE			English	Article							ADIPOSE-TISSUE; EXERCISE; FAT; OBESITY; MUSCLE; SERUM; EXPRESSION; HUMANS; URBAN; FNDC5	Introduction A physically active life-style plays an independent role in the protection against type 2 diabetes and cardiovascular diseases. Irisin, a novel exercise-induced myokine, activates thermogenesis in rodents through increasing beige fat cells abundance within white fat. We aimed to investigate circulating irisin levels in association with the degree of physical activity and various metabolic parameters in humans. Methods Circulating irisin levels (ELISA) and metabolic parameters were analyzed in 428 subjects (195 men/233 women). Participants were classified according to their self-reported physical activity and to their area of residence. Results Circulating irisin levels were higher in active than in sedentary subjects (p=0.006). Rural inhabitants showed higher circulating irisin levels than urban subjects (p < 0.0001). The increase in irisin levels related to an active lifestyle was only observed in rural citizens (p = 0.014). Among sedentary participants, irisin levels were positively associated with metabolic risk factors (BMI, fasting insulin, HOMA and fasting triglycerides). The area of residence (beta = -0.592, p = < 0.0001) contributed independently to circulating irisin levels variance after controlling for age, gender, BMI, HOMA(IR), triglycerides and physical activity. Conclusions In sedentary participants, circulating irisin levels were positively associated with parameters related to an increased cardiometabolic risk. The present study confirmed that an active lifestyle increases circulating irisin levels, but only among subjects living in a rural environment. Area of residence might be a determinant of irisin levels.	[Moreno, Mara; Maria Moreno-Navarrete, Jose; Serrano, Marta; Ortega, Francisco; Ricart, Wifredo; Manuel Fernandez-Real, Jose] CIBEROBN CB06 03 010, IdIBGi, Dept Diabet Endocrinol & Nutr, Girona, Spain; [Moreno, Mara; Maria Moreno-Navarrete, Jose; Serrano, Marta; Ortega, Francisco; Ricart, Wifredo; Manuel Fernandez-Real, Jose] Inst Salud Carlos III, Girona, Spain; [Delgado, Elias; Sanchez-Ragnarsson, Cecilia] Univ Oviedo, Hosp Cent Asturias, Dept Endocrinol & Nutr, E-33080 Oviedo, Spain; [Valdes, Sergio] CIBERDEM, IBIMA, Hosp Reg Malaga, Endocrinol & Nutr, Barcelona, Spain; [Botas, Patricia] Hosp San Agustin, Dept Med, Aviles, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Instituto de Salud Carlos III; Central University Hospital Asturias; University of Oviedo; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universidad de Malaga; Hospital San Agustin	Fernandez-Real, JM (corresponding author), CIBEROBN CB06 03 010, IdIBGi, Dept Diabet Endocrinol & Nutr, Girona, Spain.	jmfreal@idibgi.org	Fernández-Real, Jose Manuel/AGH-3599-2022; Moreno-Navarrete, José María/H-9772-2015; Moreno-Navarrete, José María/ABG-5548-2021; Veiras, Oscar/GMW-9525-2022; Ortega, Francisco José J/F-3883-2016; Delgado, Elias/B-2634-2013	Fernández-Real, Jose Manuel/0000-0002-7442-9323; Moreno-Navarrete, José María/0000-0002-2883-511X; Moreno-Navarrete, José María/0000-0002-2883-511X; Ortega, Francisco José J/0000-0003-2111-769X; Delgado, Elias/0000-0001-6114-9712; Ricart, Wifredo/0000-0002-3452-9098; Sanchez Ragnarsson, Cecilia/0000-0003-3649-2636	Spanish Ministry of Health [FIS 2011-00214]; CIBERobn Fisiopatologia de la Obesidad y la Nutricion (CIBERobn)	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); CIBERobn Fisiopatologia de la Obesidad y la Nutricion (CIBERobn)	This study was supported by the Spanish Ministry of Health (FIS 2011-00214), and CIBERobn Fisiopatologia de la Obesidad y la Nutricion (CIBERobn). The CIBER de la Fisiopatologia de la Obesidad y Nutricion (CIBERobn) is an initiative from the Instituto de Salud Carlos III (ISCIII). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adediran Olufemi Sola, 2013, BMC Res Notes, V6, P123, DOI 10.1186/1756-0500-6-123; Ahmed RG, 2013, J ENDOCRINOL, V219, P205, DOI 10.1530/JOE-13-0302; Anastasilakis AD, 2014, J CLIN ENDOCR METAB, V99, P3247, DOI 10.1210/jc.2014-1367; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Broholm C, 2010, EXERC IMMUNOL REV, V16, P77; Choi YK, 2013, DIABETES RES CLIN PR, V100, P96, DOI 10.1016/j.diabres.2013.01.007; DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073; Hecksteden A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-235; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Kurdiova T, 2014, J PHYSIOL-LONDON, V592, P1091, DOI 10.1113/jphysiol.2013.264655; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Lim JE, 2015, ENDOCRINE, V48, P211, DOI 10.1007/s12020-014-0231-0; Liu JJ, 2013, J DIABETES COMPLICAT, V27, P365, DOI 10.1016/j.jdiacomp.2013.03.002; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; Moreno M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097014; Nielsen AR, 2007, APPL PHYSIOL NUTR ME, V32, P833, DOI 10.1139/H07-054; Panagiotou G, 2014, METABOLISM, V63, P1265, DOI 10.1016/j.metabol.2014.06.001; Pedersen BK, 2009, J PHYSIOL-LONDON, V587, P5559, DOI 10.1113/jphysiol.2009.179515; Pedersen Bente Klarlund, 2011, J Exp Biol, V214, P337, DOI 10.1242/jeb.048074; Polyzos SA, 2013, METABOLISM, V62, P1037, DOI 10.1016/j.metabol.2013.04.008; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Timmons JA, 2012, NATURE, V488, pE9, DOI 10.1038/nature11364; Valdes S, 2007, DIABETES CARE, V30, P2258, DOI 10.2337/dc06-2461; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yajnik CS, 2013, INT J CARDIOL, V165, P255, DOI 10.1016/j.ijcard.2011.08.053	26	53	56	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124100	10.1371/journal.pone.0124100	http://dx.doi.org/10.1371/journal.pone.0124100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897751	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600049
J	Probst, BL; Trevino, I; McCauley, L; Bumeister, R; Dulubova, I; Wigley, WC; Ferguson, DA				Probst, Brandon L.; Trevino, Isaac; McCauley, Lyndsey; Bumeister, Ron; Dulubova, Irina; Wigley, W. Christian; Ferguson, Deborah A.			RTA 408, A Novel Synthetic Triterpenoid with Broad Anticancer and Anti-Inflammatory Activity	PLOS ONE			English	Article							CDDO-METHYL ESTER; NITRIC-OXIDE PRODUCTION; DIRECT INHIBITION; DOWN-REGULATION; ACTIVATES NRF2; 2-CYANO-3,12-DIOXOOLEAN-1,9-DIEN-28-OIC ACID; OLEANANE TRITERPENOIDS; TOPICAL APPLICATION; IMMUNE-RESPONSE; GROWTH ARREST	Semi-synthetic triterpenoids are antioxidant inflammation modulator (AIM) compounds that inhibit tumor cell growth and metastasis. Compounds in the AIM class bind to Keap1 and attenuate Nrf2 degradation. In the nucleus, Nrf2 increases antioxidant gene expression and reduces pro-inflammatory gene expression. By increasing Nrf2 activity, AIMs reduce reactive oxygen species and inflammation in the tumor microenvironment, which reverses tumor-mediated immune evasion and inhibits tumor growth and metastasis. AIMs also directly inhibit tumor cell growth by modulating oncogenic signaling pathways, such as IKK beta/NF-kappa B. Here, we characterized the in vitro antioxidant, anti-inflammatory, and anticancer activities of RTA 408, a novel AIM that is currently being evaluated in patients with advanced malignancies. At low concentrations (<= 25 nM), RTA 408 activated Nrf2 and suppressed nitric oxide and pro-inflammatory cytokine levels in interferon-gamma-stimulated RAW 264.7 macrophage cells. At higher concentrations, RTA 408 inhibited tumor cell growth (GI(50) = 260 +/- 74 nM) and increased caspase activity in tumor cell lines, but not in normal primary human cells. Consistent with the direct effect of AIMs on IKK beta, RTA 408 inhibited NF-kappa B signaling and decreased cyclin D1 levels at the same concentrations that inhibited cell growth and induced apoptosis. RTA 408 also increased CDKN1A (p21) levels and JNK phosphorylation. The in vitro activity profile of RTA 408 is similar to that of bardoxolone methyl, which was well-tolerated by patients at doses that demonstrated target engagement. Taken together, these data support clinical evaluation of RTA 408 for cancer treatment.	[Probst, Brandon L.; Trevino, Isaac; McCauley, Lyndsey; Bumeister, Ron; Dulubova, Irina; Wigley, W. Christian; Ferguson, Deborah A.] Reata Pharmaceut Inc, Irving, TX 75063 USA		Wigley, WC (corresponding author), Reata Pharmaceut Inc, Irving, TX 75063 USA.	chris.wigley@reatapharma.com; deborah.ferguson@reatapharma.com			Reata Pharmaceuticals	Reata Pharmaceuticals	This work was funded by Reata Pharmaceuticals, who had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ahmad R, 2008, CANCER RES, V68, P2920, DOI 10.1158/0008-5472.CAN-07-3036; Ahmad R, 2006, J BIOL CHEM, V281, P35764, DOI 10.1074/jbc.M607160200; Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5; Carrasco RA, 2003, BIOTECHNIQUES, V34, P1064, DOI 10.2144/03345dd02; Chauhan D, 2004, BLOOD, V103, P3158, DOI 10.1182/blood-2003-08-2873; Cleasby A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098896; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hiramoto K, 2014, CANCER PREV RES, V7, P835, DOI 10.1158/1940-6207.CAPR-14-0094; Honda T, 1998, BIOORG MED CHEM LETT, V8, P2711, DOI 10.1016/S0960-894X(98)00479-X; Honda T, 1999, BIOORG MED CHEM LETT, V9, P3429, DOI 10.1016/S0960-894X(99)00623-X; Hong D.S., 2012, CLIN CANC RES; Ikeda T, 2003, CANCER RES, V63, P5551; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Kim EH, 2011, CANC PREV RES PHILA; Konopleva M, 2006, MOL CANCER THER, V5, P317, DOI 10.1158/1535-7163.MCT-05-0350; Konopleva M, 2002, BLOOD, V99, P326, DOI 10.1182/blood.V99.1.326; Lapillonne H, 2003, CANCER RES, V63, P5926; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Liby K, 2006, CLIN CANCER RES, V12, P4288, DOI 10.1158/1078-0432.CCR-06-0215; Liby KT, 2012, PHARMACOL REV, V64, P972, DOI 10.1124/pr.111.004846; Liby KT, 2010, CANCER PREV RES, V3, P1427, DOI 10.1158/1940-6207.CAPR-10-0197; Ling XY, 2007, CANCER RES, V67, P4210, DOI 10.1158/0008-5472.CAN-06-3629; Liu H, 2005, J ETHNOPHARMACOL, V100, P92, DOI 10.1016/j.jep.2005.05.024; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu TY, 2012, CLIN CANCER RES, V18, P4877, DOI 10.1158/1078-0432.CCR-11-2939; Nagaraj S, 2010, CLIN CANCER RES, V16, P1812, DOI 10.1158/1078-0432.CCR-09-3272; Niture SK, 2011, CELL DEATH DIFFER, V18, P439, DOI 10.1038/cdd.2010.114; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Rachakonda G, 2010, ONCOGENE, V29, P3703, DOI 10.1038/onc.2010.118; Reisman SA, 2014, ARCH DERMATOL RES, V306, P447, DOI 10.1007/s00403-013-1433-7; Reisman SA, 2014, RADIAT RES, V181, P512, DOI 10.1667/RR13578.1; Reisman SA, 2009, BIOCHEM PHARMACOL, V77, P1273, DOI 10.1016/j.bcp.2008.12.028; Satoh H, 2010, CARCINOGENESIS; Shishodia S, 2006, CLIN CANCER RES, V12, P1828, DOI 10.1158/1078-0432.CCR-05-2044; Singh A, 2010, ANTIOXID REDOX SIGN, V13, P1627, DOI 10.1089/ars.2010.3219; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Slocum SL, 2011, ARCH TOXICOL, V85, P273, DOI 10.1007/s00204-011-0675-4; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Suh NJ, 1999, CANCER RES, V59, P336; Thangasamy A, 2011, J BIOL CHEM, V286, P32115, DOI 10.1074/jbc.M111.245746; Thimmulappa RK, 2006, BIOCHEM BIOPH RES CO, V351, P883, DOI 10.1016/j.bbrc.2006.10.102; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Thu KL, 2011, J THORAC ONCOL, V6, P1521, DOI 10.1097/JTO.0b013e3182289479; Townson JL, 2011, CLIN EXP METASTASIS; Tran K, 2012, CANCER PREV RES, V5, P726, DOI 10.1158/1940-6207.CAPR-11-0404; Vannini N, 2007, MOL CANCER THER, V6, P3139, DOI 10.1158/1535-7163.MCT-07-0451; Wang YY, 2014, MOL CANCER, V13, DOI [10.1186/1476-4598-13-30, 10.1186/s12934-014-0151-y]; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Yates MS, 2009, CARCINOGENESIS, V30, P1024, DOI 10.1093/carcin/bgp100; Yore MM, 2006, MOL CANCER THER, V5, P3232, DOI 10.1158/1535-7163.MCT-06-0444; Zou W, 2004, CANCER RES, V64, P7570, DOI 10.1158/0008-5472.CAN-04-1238; Zou W, 2008, CANCER RES, V68, P7484, DOI 10.1158/0008-5472.CAN-08-1318; Zou W, 2007, CANCER BIOL THER, V6, P1614, DOI 10.4161/cbt.6.10.4763	55	50	53	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0122942	10.1371/journal.pone.0122942	http://dx.doi.org/10.1371/journal.pone.0122942			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897966	gold, Green Published, Green Submitted			2022-12-27	WOS:000353212600016
J	Scepanovic, S; Mishkovski, I; Hui, P; Nurminen, JK; Yla-Jaaski, A				Scepanovic, Sanja; Mishkovski, Igor; Hui, Pan; Nurminen, Jukka K.; Yla-Jaaski, Antti			Mobile Phone Call Data as a Regional Socio-Economic Proxy Indicator	PLOS ONE			English	Article							PREDICTABILITY	The advent of publishing anonymized call detail records opens the door for temporal and spatial human dynamics studies. Such studies, besides being useful for creating universal models for mobility patterns, could be also used for creating new socio-economic proxy indicators that will not rely only on the local or state institutions. In this paper, from the frequency of calls at different times of the day, in different small regional units (sub-prefectures) in Cote d'Ivoire, we infer users' home and work sub-prefectures. This division of users enables us to analyze different mobility and calling patterns for the different regions. We then compare how those patterns correlate to the data from other sources, such as: news for particular events in the given period, census data, economic activity, poverty index, power plants and energy grid data. Our results show high correlation in many of the cases revealing the diversity of socio-economic insights that can be inferred using only mobile phone call data. The methods and the results may be particularly relevant to policy-makers engaged in poverty reduction initiatives as they can provide an affordable tool in the context of resource-constrained developing economies, such as Cote d'Ivoire's.	[Scepanovic, Sanja; Nurminen, Jukka K.; Yla-Jaaski, Antti] Aalto Univ, Dept Comp Sci, Helsinki, Finland; [Mishkovski, Igor] Univ Ss Cyril & Methodius, Fac Comp Sci & Engn, Skopje, Macedonia; [Hui, Pan] Hong Kong Univ Sci & Technol, Dept Comp Sci & Engn, Hong Kong, Hong Kong, Peoples R China	Aalto University; Saints Cyril & Methodius University of Skopje; Hong Kong University of Science & Technology	Scepanovic, S (corresponding author), Aalto Univ, Dept Comp Sci, Helsinki, Finland.	sanja.scepanovic@aalto.fi	Hui, Pan/AAK-6660-2020; Ylä-Jääski, Antti S/G-2484-2013; Nurminen, Jukka K/H-7824-2012	Hui, Pan/0000-0001-6026-1083; Ylä-Jääski, Antti S/0000-0002-2069-1721; Nurminen, Jukka/0000-0001-5083-1927	CIVIS EU FP7 project (FP7-SMARTCITIES) [608774]; Aalto University Computer Science Department; Faculty of Computer Science and Engineering at University Ss. Cyril and Methodius	CIVIS EU FP7 project (FP7-SMARTCITIES); Aalto University Computer Science Department; Faculty of Computer Science and Engineering at University Ss. Cyril and Methodius	This work was partially funded by the CIVIS (http://www.civisproject.eu/) EU FP7 project (FP7-SMARTCITIES-2013, grant number: 608774), Aalto University Computer Science Department, and by the Faculty of Computer Science and Engineering at the University Ss. Cyril and Methodius.	AICD, 2011, TECHNICAL REPORT; Amini A, 2013, P 3 C AN MOB PHON DA, P331; Amini A, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds31; Anderson J. E, 2010, 16576 NAT BUR EC RES; [Anonymous], 2012, COT IV POV RED STRAT; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Bengtsson L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001083; Berlingerio Michele, 2013, Machine Learning and Knowledge Discovery in Databases. European Conference, ECML PKDD 2013. Proceedings: LNCS 8190, P663, DOI 10.1007/978-3-642-40994-3_50; Blondel VD, 2012, ARXIV E PRINTS; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bodlaj J, 2013, P 3 C AN MOB PHON DA, P481; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Candia J, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/22/224015; Carey H. C., 1867, PRINCIPLES SOCIAL SC, V3; Cho Eunjoon, 2011, KDD, P1082, DOI [10.1145/2020408.2020579, DOI 10.1145/2020408.2020579]; Eagle N, 2010, SCIENCE, V328, P1029, DOI 10.1126/science.1186605; Fajebe A, 2013, P 3 C AN MOB PHON DA, P122; Frias-Martinez V., 2012, P 5 INT C INF COMM T, P76, DOI DOI 10.1145/2160673.2160684; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Gowan M, 2013, P 3 C AN MOB PHON DA, P141; Hawelka B, 2014, CARTOGR GEOGR INF SC, V41, P260, DOI 10.1080/15230406.2014.890072; Huck J, 2013, P 3 C AN MOB PHON DA, P645; Hui P, 2010, P 2 ACM INT WORKSH H, P1; Kung KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096180; Lu X, 2012, P NATL ACAD SCI USA, V109, P11576, DOI 10.1073/pnas.1203882109; Mamei M FL, 2013, P 3 C AN MOB PHON DA, P496; Mitrovic M, 2013, P 3 C AN MOB PHON DA, P647; Morales A, 2013, P 3 C AN MOB PHON DA, P116; Nielsen TAS, 2008, J TRANSP GEOGR, V16, P90, DOI 10.1016/j.jtrangeo.2007.04.005; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Palchykov V, 2014, ARXIV E PRINTS; Ranjan G, 2012, MOB COMPUT COMMUN RE, V16, P33, DOI 10.1145/2412096.2412101; Ratti C, 2006, ENVIRON PLANN B, V33, P727, DOI 10.1068/b32047; Ratti C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014248; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Smith C, 2013, P 3 C AN MOB PHON DA, P39; Sobolevsky S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081707; Sun LJ, 2013, P NATL ACAD SCI USA, V110, P13774, DOI 10.1073/pnas.1306440110; Yan Xifeng, 2002, GSPAN GRAPH BASED SU	42	35	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124160	10.1371/journal.pone.0124160	http://dx.doi.org/10.1371/journal.pone.0124160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897957	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600052
J	Wang, F; Zhao, L; Zhang, YL; Qiao, Z				Wang, Fei; Zhao, Liang; Zhang, Yanling; Qiao, Zhi			Simplified Aeroelastic Model for Fluid Structure Interaction between Microcantilever Sensors and Fluid Surroundings	PLOS ONE			English	Article							FINITE-ELEMENT; FREQUENCY-SHIFT; FIELD	Fluid-structural coupling occurs when microcantilever sensors vibrate in a fluid. Due to the complexity of the mechanical characteristics of microcantilevers and lack of high-precision microscopic mechanical testing instruments, effective methods for studying the fluid-structural coupling of microcantilevers are lacking, especially for non-rectangular microcantilevers. Here, we report fluid-structure interactions (FSI) of the cable-membrane structure via a macroscopic study. The simplified aeroelastic model was introduced into the microscopic field to establish a fluid-structure coupling vibration model for microcantilever sensors. We used the finite element method to solve the coupled FSI system. Based on the simplified aeroelastic model, simulation analysis of the effects of the air environment on the vibration of the commonly used rectangular microcantilever was also performed. The obtained results are consistent with the literature. The proposed model can also be applied to the auxiliary design of rectangular and non-rectangular sensors used in fluid environments.	[Wang, Fei; Zhao, Liang; Zhang, Yanling; Qiao, Zhi] Harbin Inst Technol, Sch Mech & Elect Engn, Harbin 150001, Peoples R China	Harbin Institute of Technology	Wang, F (corresponding author), Harbin Inst Technol, Sch Mech & Elect Engn, Harbin 150001, Peoples R China.	wangfeivc@gmail.com			National Science Foundation of China [11372089]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Science Foundation of China through grant #11372089. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEN GY, 1994, REV SCI INSTRUM, V65, P2532, DOI 10.1063/1.1144647; Feng L, 2012, J APPL PHYS, V112, DOI 10.1063/1.4730917; Hansen KM, 2005, METHODS, V37, P57, DOI 10.1016/j.ymeth.2005.05.011; Idelsohn SR, 2003, COMPUT STRUCT, V81, P655, DOI 10.1016/S0045-7949(02)00477-7; Ilic B, 2001, J VAC SCI TECHNOL B, V19, P2825, DOI 10.1116/1.1421572; Kirstein S, 1998, J APPL PHYS, V84, P1782, DOI 10.1063/1.368335; Lavrik NV, 2003, APPL PHYS LETT, V82, P2697, DOI 10.1063/1.1569050; Lee JH, 2005, BIOSENS BIOELECTRON, V20, P2157, DOI 10.1016/j.bios.2004.09.024; Manna MC, 2005, J SOUND VIB, V281, P235, DOI 10.1016/j.jsv.2004.01.015; MORAND H, 1979, INT J NUMER METH ENG, V14, P741, DOI 10.1002/nme.1620140508; NOMURA T, 1994, COMPUT METHOD APPL M, V112, P291, DOI 10.1016/0045-7825(94)90031-0; Payam AF, 2013, ULTRAMICROSCOPY, V135, P84, DOI 10.1016/j.ultramic.2013.07.006; Sader JE, 1999, REV SCI INSTRUM, V70, P3967, DOI 10.1063/1.1150021; Sader JE, 1998, J APPL PHYS, V84, P64, DOI 10.1063/1.368002; Salort J, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4770119; Shen S.Z., 2006, J ARCHIT CIV ENG, V23, P1; Slattery AD, 2013, ULTRAMICROSCOPY, V131, P46, DOI 10.1016/j.ultramic.2013.03.009; Tenje M, 2010, ULTRAMICROSCOPY, V110, P596, DOI 10.1016/j.ultramic.2010.02.017; Zhu Q, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2921050; Zhu Q, 2009, SENSOR ACTUAT B-CHEM, V138, P1, DOI 10.1016/j.snb.2009.01.035	20	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123860	10.1371/journal.pone.0123860	http://dx.doi.org/10.1371/journal.pone.0123860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898213	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600043
J	Gradwohl, G; Berdugo-Boura, N; Segev, Y; Tarasiuk, A				Gradwohl, Gideon; Berdugo-Boura, Nilly; Segev, Yael; Tarasiuk, Ariel			Sleep/Wake Dynamics Changes during Maturation in Rats	PLOS ONE			English	Article							UPPER AIRWAY-OBSTRUCTION; SLOW-WAVE ACTIVITY; BEHAVIORAL STATES; BRAIN MATURATION; OREXIN; PATTERNS; AGE; CHILDREN; ADENOTONSILLECTOMY; HOMEOSTASIS	Objectives Conventional scoring of sleep provides little information about the process of transitioning between vigilance states. We applied the state space technique (SST) using frequency band ratios to follow normal maturation of different sleep/wake states, velocities of movements, and transitions between states of juvenile (postnatal day 34, P34) and young adult rats (P71). Design 24-h sleep recordings of eight P34 and nine P71 were analyzed using conventional scoring criteria and SST one week following implantation of telemetric transmitter. SST is a non-categorical approach that allows novel quantitative and unbiased examination of vigilance-states dynamics and state transitions. In this approach, behavioral changes are described in a 2-dimensional state space that is derived from spectral characteristics of the electroencephalography. Measurements and Results With maturation sleep intensity declines, the duration of deep slow wave sleep (DSWS) and light slow wave sleep (LSWS) decreases and increases, respectively. Vigilance state determination, as a function of frequency, is not constant; there is a substantial shift to higher ratio 1 in all vigilance states except DSWS. Deep slow wave sleep decreases in adult relative to juvenile animals at all frequencies. P71 animals have 400% more trajectories from Wake to LSWS (p = 0.005) and vice versa (p = 0.005), and 100% more micro-arousals (p = 0.021), while trajectories from LSWS to DSWS (p = 0.047) and vice versa (p = 0.033) were reduced by 60%. In both juvenile and adult animals, no significant changes were found in sleep velocity at all regions of the 2-dimensional state space plot; suggesting that maturation has a partial effect on sleep stability. Conclusions Here, we present novel and original evidence that SST enables visualization of vigilance-state intensity, transitions, and velocities that were not evident by traditional scoring methods. These observations provide new perspectives in sleep state dynamics and highlight the usefulness of this technique in exploring the development of sleep-wake activity.	[Gradwohl, Gideon; Berdugo-Boura, Nilly; Tarasiuk, Ariel] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Sleep Wake Disorders Unit, IL-84105 Beer Sheva, Israel; [Gradwohl, Gideon; Berdugo-Boura, Nilly; Tarasiuk, Ariel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, IL-84105 Beer Sheva, Israel; [Berdugo-Boura, Nilly; Segev, Yael] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel; [Gradwohl, Gideon] Jerusalem Coll Technol, Dept Phys, Unit Biomed Engn, Jerusalem, Jerusalem, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Ben Gurion University	Tarasiuk, A (corresponding author), Ben Gurion Univ Negev, Soroka Univ Med Ctr, Sleep Wake Disorders Unit, IL-84105 Beer Sheva, Israel.	tarasiuk@bgu.ac.il			Israel Science Foundation [31/14]	Israel Science Foundation(Israel Science Foundation)	This work was supported Israel Science Foundation Grant No. 31/14 to A.T. and Y.S. These funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann P, 1998, NEUROSCIENCE, V85, P1195, DOI 10.1016/S0306-4522(97)00692-1; Behn CGD, 2010, SLEEP, V33, P297, DOI 10.1093/sleep/33.3.297; Ben-Israel N, 2011, EUR RESPIR J, V37, P1144, DOI 10.1183/09031936.00106710; Campbell IG, 2009, P NATL ACAD SCI USA, V106, P5177, DOI 10.1073/pnas.0812947106; Dahl RE, 1996, DEV PSYCHOPATHOL, V8, P3, DOI 10.1017/S0954579400006945; DASILVA FL, 1991, ELECTROEN CLIN NEURO, V79, P81, DOI 10.1016/0013-4694(91)90044-5; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; de Vivo L, 2014, SLEEP, V37, P689, DOI 10.5665/sleep.3570; Dzirasa K, 2006, J NEUROSCI, V26, P10577, DOI 10.1523/JNEUROSCI.1767-06.2006; Esser SK, 2007, SLEEP, V30, P1617, DOI 10.1093/sleep/30.12.1617; FEINBERG I, 1974, J PSYCHIATR RES, V10, P283, DOI 10.1016/0022-3956(74)90011-9; Feinberg I, 2006, AM J PHYSIOL-REG I, V291, pR1724, DOI 10.1152/ajpregu.00293.2006; Feinberg I, 2010, BRAIN COGNITION, V72, P56, DOI 10.1016/j.bandc.2009.09.008; Gervasoni D, 2004, J NEUROSCI, V24, P11137, DOI 10.1523/JNEUROSCI.3524-04.2004; Gradwohl G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097111; Hagenauer MH, 2013, HORM BEHAV, V64, P270, DOI 10.1016/j.yhbeh.2013.01.013; Hagenauer MH, 2012, FRONT NEUROENDOCRIN, V33, P211, DOI 10.1016/j.yfrne.2012.04.003; Hunt NJ, 2015, NEUROBIOL AGING, V36, P292, DOI 10.1016/j.neurobiolaging.2014.08.010; Iglowstein I, 2003, PEDIATRICS, V111, P302, DOI 10.1542/peds.111.2.302; Imbach LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048660; Jenni OG, 2004, SLEEP, V27, P774; LI H, 1995, AM J PHYSIOL-REG I, V269, pR208, DOI 10.1152/ajpregu.1995.269.1.R208; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Lin SC, 2007, METHODS NEURAL ENSEM; Maret S, 2011, NAT NEUROSCI, V14, P1418, DOI 10.1038/nn.2934; Mong JA, 2011, J NEUROSCI, V31, P16107, DOI 10.1523/JNEUROSCI.4175-11.2011; Naylor E, 1998, SLEEP, V21, P687, DOI 10.1093/sleep/21.7.687; Nelson AB, 2013, BRAIN SCI, V3, P318, DOI 10.3390/brainsci3010318; OBAL F, 1991, BRAIN RES, V557, P149, DOI 10.1016/0006-8993(91)90128-I; Obal F, 2004, SLEEP MED REV, V8, P367, DOI 10.1016/j.smrv.2004.03.005; Olini N, 2014, J SLEEP RES, V23, P261, DOI 10.1111/jsr.12124; Olini N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072539; Porkka-Heiskanen T, 2013, CURR OPIN NEUROBIOL, V23, P799, DOI 10.1016/j.conb.2013.02.010; Ringli M, 2011, PROG BRAIN RES, V193, P63, DOI 10.1016/B978-0-444-53839-0.00005-3; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Segev Y, 2008, J APPL PHYSIOL, V105, P1602, DOI 10.1152/japplphysiol.90772.2008; Spruyt K, 2005, J SLEEP RES, V14, P163, DOI 10.1111/j.1365-2869.2005.00458.x; Tal A, 2003, CHEST, V124, P948, DOI 10.1378/chest.124.3.948; Tarasiuk A, 2011, EUR RESPIR J, V38, P870, DOI 10.1183/09031936.00197610; Tarasiuk A, 2014, SLEEP, V37, P987, DOI 10.5665/sleep.3676; Terao A, 2002, NEUROSCI LETT, V332, P190, DOI 10.1016/S0304-3940(02)00953-9; Thorleifsdottir B, 2002, J PSYCHOSOM RES, V53, P529, DOI 10.1016/S0022-3999(02)00444-0; Timofeeva OA, 2001, BRAIN RES, V893, P165, DOI 10.1016/S0006-8993(00)03309-6; VANGOOL WA, 1986, SLEEP, V9, P335, DOI 10.1093/sleep/9.2.335; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; WELSH DK, 1986, J GERONTOL, V41, P579, DOI 10.1093/geronj/41.5.579; Wimmer ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081880; Zamir G, 1998, J RHEUMATOL, V25, P1191	48	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0125509	10.1371/journal.pone.0125509	http://dx.doi.org/10.1371/journal.pone.0125509			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894573	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700139
J	Yoon, H; Kim, SJ; Kim, K; Lee, JE; Jhun, BW				Yoon, Hee; Kim, Se Jin; Kim, Kang; Lee, Ji Eun; Jhun, Byung Woo			The Utility of Thoracic Ultrasound in Patients with Acute Eosinophilic Pneumonia	PLOS ONE			English	Article							ALVEOLAR-INTERSTITIAL SYNDROME; COMMUNITY-ACQUIRED PNEUMONIA; LUNG ULTRASOUND; DIAGNOSTIC PERFORMANCES; CLINICAL-IMPLICATIONS; FOLLOW-UP; ULTRASONOGRAPHY; SIGN	Thoracic ultrasound (TUS) is an easy-to-use imaging modality that aids physicians in the differential diagnosis of respiratory diseases. However, no data exist on the TUS findings of acute eosinophilic pneumonia (AEP) or their clinical utility in patients with AEP. Thus, we performed an observational study on TUS findings and their clinical utility for follow-up in patients with AEP. We prospectively screened patients who visited the emergency department for acute respiratory symptoms at the Armed Forces Capital Hospital in South Korea between February 2014 and July 2014. Of them, patients suspected to have AEP underwent an etiological investigation, including flexible bronchoscopy with bronchoalveolar lavage and TUS, and we evaluated TUS findings and serial changes on TUS during the treatment course compared with those from chest radiographs. In total, 22 patients with AEP were identified. The TUS examinations reveled that all patients exhibited multiple diffuse bilateral B-lines and lung sliding, with (n = 5) or without pleural effusion, which was consistent with alveolar-interstitial syndrome. B-line numbers fell during the course of treatment, as the lines became thinner and fainter. A-lines were evident in 19 patients on day 7 of hospitalization, when B-lines had disappeared in 13 patients, and all pleural effusion had resolved. All patients exhibited complete ultrasonic resolution by day 14, along with clinicoradiological improvement. Chest radiographs of five patients taken on day 7 seemed to show complete resolution, but several abnormal B-lines were evident on TUS performed the same day. As a result, our data show common TUS findings of AEP and suggest that AEP may be included as a differential diagnosis when multiple diffuse bilateral B-lines with preserved lung sliding are identified on a TUS examination in patients with acute symptoms, and that TUS is a useful modality for evaluating the treatment response in patients with AEP.	[Yoon, Hee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Emergency Med, Seoul, South Korea; [Kim, Se Jin; Kim, Kang; Lee, Ji Eun; Jhun, Byung Woo] Armed Forces Capital Hosp, Dept Med, Div Pulm & Crit Care Med, Songnam, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Jhun, BW (corresponding author), Armed Forces Capital Hosp, Dept Med, Div Pulm & Crit Care Med, Songnam, South Korea.	byungwoo.jhun@gmail.com						Aghdashi M, 2013, INT J CLIN EXP MED, V6, P562; Fagenholz PJ, 2007, CHEST, V131, P1013, DOI 10.1378/chest.06-1864; Hasan AA, 2014, ANN THORAC MED, V9, P99, DOI 10.4103/1817-1737.128856; Jhun BW, 2014, RESP MED, V108, P1655, DOI 10.1016/j.rmed.2014.09.011; Jhun BW, 2014, RESPIROLOGY, V19, P1059, DOI 10.1111/resp.12342; Katoh S, 2004, ALLERGY, V59, P850, DOI 10.1111/j.1398-9995.2004.00492.x; Lee JE, 2012, CHEST, V141, P1267, DOI 10.1378/chest.11-1303; Lichtenstein D, 1997, AM J RESP CRIT CARE, V156, P1640, DOI 10.1164/ajrccm.156.5.96-07096; Lichtenstein D, 2004, ANESTHESIOLOGY, V100, P9, DOI 10.1097/00000542-200401000-00006; Lichtenstein DA, 2004, INTENS CARE MED, V30, P276, DOI 10.1007/s00134-003-2075-6; Lichtenstein DA, 2008, CHEST, V134, P117, DOI 10.1378/chest.07-2800; Lichtenstein DA, 2012, CURR PEDIATR REV, V8, P217, DOI 10.2174/157339612802139389; Mathis G, 2005, CHEST, V128, P1531, DOI 10.1378/chest.128.3.1531; Mato N, 2013, ALLERGOL INT, V62, P45, DOI 10.2332/allergolint.12-OA-0439; Moore CL, 2011, NEW ENGL J MED, V364, P749, DOI 10.1056/NEJMra0909487; Parlamento S, 2009, AM J EMERG MED, V27, P379, DOI 10.1016/j.ajem.2008.03.009; Philit F, 2002, AM J RESP CRIT CARE, V166, P1235, DOI 10.1164/rccm.2112056; Picano E, 2006, J AM SOC ECHOCARDIOG, V19, P356, DOI 10.1016/j.echo.2005.05.019; Reissig A, 2012, CHEST, V142, P965, DOI 10.1378/chest.12-0364; Reissig A, 2012, EUR J INTERN MED, V23, P391, DOI 10.1016/j.ejim.2012.01.003; Rhee CK, 2013, EUR RESPIR J, V41, P402, DOI 10.1183/09031936.00221811; Volpicelli G, 2006, AM J EMERG MED, V24, P689, DOI 10.1016/j.ajem.2006.02.013; Volpicelli G, 2012, INTENS CARE MED, V38, P577, DOI 10.1007/s00134-012-2513-4	23	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124370	10.1371/journal.pone.0124370	http://dx.doi.org/10.1371/journal.pone.0124370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894572	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700089
J	Poole, SG; Bell, JS; Jokanovic, N; Kirkpatrick, CM; Dooley, MJ				Poole, Susan G.; Bell, J. Simon; Jokanovic, Natali; Kirkpatrick, Carl M.; Dooley, Michael J.			A Systematic Review of Medication Exposure Assessment in Prospective Cohort Studies of Community Dwelling Older Australians	PLOS ONE			English	Review							PROFILE; HEALTH; POPULATION; DESIGN; OUTCOMES; MISCLASSIFICATION; MEDICINES; PATIENT; MEN	Introduction It is not known to what extent medication use has been comprehensively assessed in prospective cohort studies of older Australians. Understanding the varying methods to assess medication use is necessary to establish comparability and to understand the opportunities for pharmacoepidemiological analysis. The objective of this review was to compare and contrast how medication-related data have been collected in prospective cohorts of community-dwelling older Australians. Methods MEDLINE and EMBASE (1990-2014) were systematically searched to identify prospective cohorts of >= 1000 older participants that commenced recruitment after 1990. The data collection tools used to assess medication use in each cohort were independently examined by two investigators using a structured approach. Results Thirteen eligible cohorts were included. Baseline medication use was assessed in participant self-completed surveys (n = 3), by an investigator inspecting medications brought to a clinic interview (n = 7), and by interviewing participants in their home (n = 3). Five cohorts sought participant consent to access administrative claims data. Six cohorts used multiple methods to assess medication use across one or more study waves. All cohorts assessed medication use at baseline and 12 cohorts in follow-up waves. Twelve cohorts recorded prescription medications by trade or generic name; 12 cohorts recorded medication strength; and 9 recorded the daily medication dose in at least one wave of the cohort. Seven cohorts asked participants about their "current" medication use without providing a definition of "current"; and nine cohorts asked participants to report medication use over recall periods ranging from 1-week to 3-months in at least one wave of the cohort. Sixty-five original publications, that reported the prevalence or outcomes of medication use, in the 13 cohorts were identified (median = 3, range 1-21). Conclusion There has been considerable variability in the assessment of medication use within and between cohorts. This may limit the comparability of medication data collected in these cohorts.	[Poole, Susan G.; Bell, J. Simon; Jokanovic, Natali; Kirkpatrick, Carl M.; Dooley, Michael J.] Monash Univ, Fac Pharm & Pharmaceut Sci, Ctr Med Use & Safety, Melbourne, Vic 3004, Australia; [Poole, Susan G.; Jokanovic, Natali; Dooley, Michael J.] Alfred Hlth, Dept Pharm, Melbourne, Vic, Australia	Monash University	Poole, SG (corresponding author), Monash Univ, Fac Pharm & Pharmaceut Sci, Ctr Med Use & Safety, Melbourne, Vic 3004, Australia.	susan.poole@monash.edu	Kirkpatrick, Carl MJ/F-1222-2010	Kirkpatrick, Carl/0000-0002-5715-1534; Jokanovic, Natali/0000-0003-1830-9930				Abbing-Karahagopian V, 2014, CURR CLIN PHARMACOL, V9, P130, DOI 10.2174/1574884708666131111211802; Ademi Z, 2007, CLIN THER, V29, P529, DOI 10.1016/S0149-2918(07)80090-7; Andrews G, 2002, J SOC ISSUES, V58, P749, DOI 10.1111/1540-4560.00288; [Anonymous], 2005, PHARMACOEPIDEMIOLOGY; Atlantis E, 2012, AUST NZ J PSYCHIAT, V46, P445, DOI 10.1177/0004867411433218; Beer C, 2011, BRIT J CLIN PHARMACO, V71, P592, DOI 10.1111/j.1365-2125.2010.03875.x; Beiderbeck AB, 2004, J CLIN EPIDEMIOL, V57, P973, DOI 10.1016/j.jclinepi.2003.12.017; Bell JS, 2013, JAMA INTERN MED, V173, P596, DOI 10.1001/jamainternmed.2013.3280; Blaschke TF, 2012, ANNU REV PHARMACOL, V52, P275, DOI 10.1146/annurev-pharmtox-011711-113247; Brown DW, 2007, J CLIN EPIDEMIOL, V60, P525, DOI 10.1016/j.jclinepi.2006.08.007; Browning CJ, 2010, INT J EPIDEMIOL, V39, pE1, DOI 10.1093/ije/dyq137; Christensen H, 2004, AGING NEUROPSYCHOL C, V11, P169, DOI 10.1080/13825580490511053; Cumming RG, 2009, INT J EPIDEMIOL, V38, P374, DOI 10.1093/ije/dyn071; Dolja-Gore X, 2013, OPEN J EPIDEMIOL, V3, P25; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Eckert KA, 2013, PHARMACOEPIDEM DR S, V22, P271, DOI 10.1002/pds.3380; Ellis KA, 2009, INT PSYCHOGERIATR, V21, P672, DOI 10.1017/S1041610209009405; Grant JF, 2009, INT J EPIDEMIOL, V38, P1479, DOI 10.1093/ije/dyn262; Haynes RB, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub2; James A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-936; Jonikas MA, 2012, J AM MED INFORM ASSN, V19, P649, DOI 10.1136/amiajnl-2011-000416; Lau HS, 1997, J CLIN EPIDEMIOL, V50, P619, DOI 10.1016/S0895-4356(97)00040-1; Lee C, 2005, INT J EPIDEMIOL, V34, P987, DOI 10.1093/ije/dyi098; Mangoni AA, 2014, CURR CLIN PHARMACOL, V9, P91, DOI 10.2174/1574884709666140403120834; Martin S, 2007, INT J EPIDEMIOL, V36, P302, DOI 10.1093/ije/dyl279; McEvoy M, 2010, INT J EPIDEMIOL, V39, P1452, DOI 10.1093/ije/dyp343; Morgan TK, 2012, MED J AUSTRALIA, V196, P50, DOI 10.5694/mja11.10698; Norman PE, 2009, INT J EPIDEMIOL, V38, P48, DOI 10.1093/ije/dyn041; Osterberg LG, 2010, CLIN PHARMACOL THER, V88, P457, DOI 10.1038/clpt.2010.171; Panchapakesan J, 2003, BRIT J OPHTHALMOL, V87, P168, DOI 10.1136/bjo.87.2.168; Pit S, 2010, J CLIN EPIDEMIOL, V63, P428, DOI 10.1016/j.jclinepi.2009.07.008; Rauma PH, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-180; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Rikala M, 2010, DRUG AGING, V27, P337, DOI 10.2165/11315960-000000000-00000; Roughead Elizabeth E, 2009, Aust New Zealand Health Policy, V6, P18, DOI 10.1186/1743-8462-6-18; Sachdev PS, 2010, INT PSYCHOGERIATR, V22, P1248, DOI 10.1017/S1041610210001067; SIMONS LA, 1990, AUST NZ J MED, V20, P783, DOI 10.1111/j.1445-5994.1990.tb00423.x; Slade GD, 1997, COMMUNITY DENT ORAL, V25, P429, DOI 10.1111/j.1600-0528.1997.tb01734.x; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Thomson WM, 1997, DRUG AGING, V10, P290, DOI 10.2165/00002512-199710040-00005; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024; van Eijken M, 2003, DRUG AGING, V20, P229, DOI 10.2165/00002512-200320030-00006; VANSTAA TP, 1994, J CLIN EPIDEMIOL, V47, P183, DOI 10.1016/0895-4356(94)90023-X; Zulman DM, 2010, J GEN INTERN MED, V25, P408, DOI 10.1007/s11606-009-1232-1	44	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124247	10.1371/journal.pone.0124247	http://dx.doi.org/10.1371/journal.pone.0124247			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG6AH	25909191	gold, Green Submitted, Green Published			2022-12-27	WOS:000353376800071
J	Saka, HA; Thompson, JW; Chen, YS; Dubois, LG; Haas, JT; Moseley, A; Valdivia, RH				Saka, Hector Alex; Thompson, J. Will; Chen, Yi-Shan; Dubois, Laura G.; Haas, Joel T.; Moseley, Arthur; Valdivia, Raphael H.			Chlamydia trachomatis Infection Leads to Defined Alterations to the Lipid Droplet Proteome in Epithelial Cells	PLOS ONE			English	Article							OBLIGATE INTRACELLULAR PATHOGEN; PHOSPHOLIPID-COMPOSITION; PROTEINS; IDENTIFICATION; REVEALS; TRAFFICKING; ASSOCIATION; ADIPOCYTES; EXPRESSION; LOCALIZES	The obligate intracellular bacterium Chlamydia trachomatisis a major human pathogen and a main cause of genital and ocular diseases. During its intracellular cycle, C. trachomatisreplicates inside a membrane-bound vacuole termed an "inclusion". Acquisition of lipids (and other nutrients) from the host cell is a critical step in chlamydial replication. Lipid droplets (LD) are ubiquitous, ER-derived neutral lipid-rich storage organelles surrounded by a phospholipids monolayer and associated proteins. Previous studies have shown that LDs accumulate at the periphery of, and eventually translocate into, the chlamydial inclusion. These observations point out to Chlamydia-mediated manipulation of LDs in infected cells, which may impact the function and thereby the protein composition of these organelles. By means of a label-free quantitative mass spectrometry approach we found that the LD proteome is modified in the context of C. trachomatis infection. We determined that LDs isolated from C. trachomatis-infected cells were enriched in proteins related to lipid metabolism, biosynthesis and LD-specific functions. Interestingly, consistent with the observation that LDs intimately associate with the inclusion, a subset of inclusion membrane proteins co-purified with LD protein extracts. Finally, genetic ablation of LDs negatively affected generation of C. trachomatis infectious progeny, consistent with a role for LD biogenesis in optimal chlamydial growth.	[Saka, Hector Alex; Chen, Yi-Shan; Valdivia, Raphael H.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; [Saka, Hector Alex; Chen, Yi-Shan; Valdivia, Raphael H.] Duke Univ, Med Ctr, Ctr Microbial Pathogenesis, Durham, NC USA; [Thompson, J. Will; Dubois, Laura G.; Moseley, Arthur] Duke Univ, Med Ctr, Prote & Metabol Core Facil, Durham, NC USA; [Haas, Joel T.] UCSF, Dept Biochem & Biophys, San Francisco, CA USA	Duke University; Duke University; Duke University; University of California System; University of California San Francisco	Saka, HA (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, CIBICI CONICET, Dept Bioquim Clin, RA-5000 Cordoba, Argentina.	has@fcq.unc.edu.ar; raphael.valdivia@duke.edu	Saka, Hector Alex/AAQ-2424-2021; Haas, Joel/R-6379-2018; Valdivia, Raphael/R-5377-2019	Haas, Joel/0000-0002-0028-5988; Valdivia, Raphael/0000-0003-0961-073X	National Institutes of Health [AI068032]; Burroughs Wellcome Trust Program in Infectious Diseases; NCRR/NIH [UL1RR024128]; Pew Latin American Fellows Program in the Biomedical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Trust Program in Infectious Diseases; NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Pew Latin American Fellows Program in the Biomedical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (AI068032) and the Burroughs Wellcome Trust Program in Infectious Diseases. The Duke Proteomics Core Facility is supported in part by Duke University's CTSA Grant UL1RR024128 from NCRR/NIH. Hector Alex Saka was supported by a fellowship from the Pew Latin American Fellows Program in the Biomedical Sciences.	Agaisse H, 2014, INFECT IMMUN, V82, P2037, DOI 10.1128/IAI.01530-14; Andersson L, 2006, J CELL SCI, V119, P2246, DOI 10.1242/jcs.02941; Bannantine JP, 2000, CELL MICROBIOL, V2, P35; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Beatty WL, 2006, J CELL SCI, V119, P350, DOI 10.1242/jcs.02733; Beilstein F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053017; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Blouin CM, 2010, J LIPID RES, V51, P945, DOI 10.1194/jlr.M001016; Bouchoux J, 2011, BIOL CELL, V103, P499, DOI 10.1042/BC20110024; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Burton MJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000460; Capmany Anahi, 2011, Commun Integr Biol, V4, P590, DOI 10.4161/cib.4.5.16594; Capmany A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014084; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Cocchiaro JL, 2009, CELL MICROBIOL, V11, P1571, DOI 10.1111/j.1462-5822.2009.01364.x; Derre I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002092; Ding YB, 2012, ACTA BIOCH BIOPH SIN, V44, P394, DOI 10.1093/abbs/gms008; Ding YF, 2012, J LIPID RES, V53, P399, DOI 10.1194/jlr.M021899; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Gimm T, 2010, FASEB J, V24, P4443, DOI 10.1096/fj.10-159806; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Haas JT, 2012, J CLIN INVEST, V122, P4680, DOI 10.1172/JCI64873; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Hackstadt T, 2012, INTERCELLULAR PATHOGENS I: CHLAMYDIALES, P126, DOI 10.1128/9781555817329.ch6; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Harris CA, 2011, J LIPID RES, V52, P657, DOI 10.1194/jlr.M013003; Hatch GM, 1998, INFECT IMMUN, V66, P3727, DOI 10.1128/IAI.66.8.3727-3735.1998; Heid H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063061; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Jiang WY, 2013, J BIOL CHEM, V288, P589, DOI 10.1074/jbc.M112.402883; Katavic V, 2006, PROTEOMICS, V6, P4586, DOI 10.1002/pmic.200600020; Khor VK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105047; Krahmer N, 2013, MOL CELL PROTEOMICS, V12, P1115, DOI 10.1074/mcp.M112.020230; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Larsson S, 2012, J PROTEOME RES, V11, P1264, DOI 10.1021/pr200957p; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Li ZY, 2008, INFECT IMMUN, V76, P2746, DOI 10.1128/IAI.00010-08; Lipinski AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000615; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Liu T, 2004, ANAL CHEM, V76, P5345, DOI 10.1021/ac049485q; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; Moessinger C, 2011, J BIOL CHEM, V286, P21330, DOI 10.1074/jbc.M110.202424; Nguyen BD, 2012, P NATL ACAD SCI USA, V109, P1263, DOI 10.1073/pnas.1117884109; Olive AJ, 2014, CELL HOST MICROBE, V15, P113, DOI 10.1016/j.chom.2013.12.009; Owusu-Edusei K, 2013, SEX TRANSM DIS, V40, P197, DOI 10.1097/OLQ.0b013e318285c6d2; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; Robertson DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000664; Saka HA, 2011, MOL MICROBIOL, V82, P1185, DOI 10.1111/j.1365-2958.2011.07877.x; Saka HA, 2012, ANNU REV CELL DEV BI, V28, P411, DOI 10.1146/annurev-cellbio-092910-153958; Saka HA, 2010, CURR OPIN MICROBIOL, V13, P4, DOI 10.1016/j.mib.2009.11.002; Scidmore MA, 2003, INFECT IMMUN, V71, P973, DOI 10.1128/IAI.71.2.973-984.2003; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Sisko JL, 2006, MOL MICROBIOL, V60, P51, DOI 10.1111/j.1365-2958.2006.05074.x; Snavely EA, 2014, PATHOG DIS, V71, P336, DOI 10.1111/2049-632X.12179; Spaeth KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000579; Spandl J, 2011, J BIOL CHEM, V286, P5599, DOI 10.1074/jbc.M110.190785; Stamm WE, 1999, J INFECT DIS, V179, pS380, DOI 10.1086/513844; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Su H, 2004, J BIOL CHEM, V279, P9409, DOI 10.1074/jbc.M312008200; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; TEICHMAN RJ, 1972, BIOL REPROD, V7, P73, DOI 10.1093/biolreprod/7.1.73; Turro S, 2006, TRAFFIC, V7, P1254, DOI 10.1111/j.1600-0854.2006.00465.x; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; Wang CW, 2012, J CELL SCI, V125, P2930, DOI 10.1242/jcs.100230; WILLNOW TE, 1994, J CELL SCI, V107, P719; Wylie JL, 1997, J BACTERIOL, V179, P7233, DOI 10.1128/jb.179.23.7233-7242.1997; Xie XT, 2010, J PROTEOME RES, V9, P4521, DOI 10.1021/pr100268f; Zhang HN, 2011, J PROTEOME RES, V10, P4757, DOI 10.1021/pr200553c; Zhang P, 2012, MOL CELL PROTEOMICS, V11, P317, DOI 10.1074/mcp.M111.016345	79	44	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124630	10.1371/journal.pone.0124630	http://dx.doi.org/10.1371/journal.pone.0124630			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909443	Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800094
J	Hadanny, A; Fishlev, G; Bechor, Y; Bergan, J; Friedman, M; Maliar, A; Efrati, S				Hadanny, Amir; Fishlev, Gregori; Bechor, Yair; Bergan, Jacob; Friedman, Mony; Maliar, Amit; Efrati, Shai			Delayed Recompression for Decompression Sickness: Retrospective Analysis	PLoS One			English	Article							HYPERBARIC-OXYGEN; REPERFUSION INJURY; ISCHEMIA; ILLNESS; TIME; MECHANISMS; SEVERITY; EXPOSURE; THERAPY; TISSUES	Introduction Most cases of decompression sickness (DCS) occur soon after surfacing, with 98% within 24 hours. Recompression using hyperbaric chamber should be administrated as soon as feasible in order to decrease bubble size and avoid further tissue injury. Unfortunately, there may be a significant time delay from surfacing to recompression. The time beyond which hyperbaric treatment is non effective is unclear. The aims of the study were first to evaluate the effect of delayed hyperbaric treatment, initiated more than 48h after surfacing for DCS and second, to evaluate the different treatment protocols. Methods From January 2000 to February 2014, 76 divers had delayed hyperbaric treatment (>= 48h) for DCS in the Sagol center for Hyperbaric medicine and Research, Assaf-Harofeh Medical Center, Israel. Data were collected from their medical records and compared to data of 128 patients treated earlier than 48h after surfacing at the same hyperbaric institute. Results There was no significant difference, as to any of the baseline characteristics, between the delayed and early treatment groups. With respect to treatment results, at the delayed treatment divers, complete recovery was achieved in 76% of the divers, partial recovery in 17.1% and no improvement in 6.6%. Similar results were achieved when treatment started early, where 78% of the divers had complete recovery, 15.6% partial recovery and 6.2% no recovery. Delayed hyperbaric treatment using US Navy Table 6 protocol trended toward a better clinical outcome yet not statistically significant (OR=2.786, CI95%[0.896-8.66], p=0.07) compared to standard hyperbaric oxygen therapy of 90 minutes at 2 ATA, irrespective of the symptoms severity at presentation. Conclusions Late recompression for DCS, 48 hours or more after surfacing, has clinical value and when applied can achieve complete recovery in 76% of the divers. It seems that the preferred hyperbaric treatment protocol should be based on US Navy Table 6.	[Hadanny, Amir; Fishlev, Gregori; Bechor, Yair; Bergan, Jacob; Friedman, Mony; Maliar, Amit; Efrati, Shai] Assaf Harofeh Med Ctr, Sagol Ctr Hyperbar Med & Res, IL-70300 Zerifin, Israel; [Hadanny, Amir; Efrati, Shai] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Efrati, Shai] Assaf Harofeh Med Ctr, Res & Dev Unit, IL-70300 Zerifin, Israel; [Efrati, Shai] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Tel Aviv University	Hadanny, A (corresponding author), Assaf Harofeh Med Ctr, Sagol Ctr Hyperbar Med & Res, IL-70300 Zerifin, Israel.	amir.had@gmail.com						[Anonymous], 1979, P 16 ANN SCI M EUR U, V28, P1; BALL R, 1993, UNDERSEA HYPERBAR M, V20, P133; Blatteau JE, 2011, DIVING HYPERB MED, V41, P129; Bosco G, 2001, UNDERSEA HYPERBAR M, V28, P207; Boussi-Gross R, 2014, NEUROPSYCHOLOGY; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Boussuges A, 1996, UNDERSEA HYPERBAR M, V23, P151; Buras JA, 2007, NEUROL RES, V29, P127, DOI 10.1179/016164107X174147; Burls A, 2011, EMERG MED J, V28, P917, DOI 10.1136/emj.2010.103564; Desola J, 1997, P 23 ANN SCI M EUR U; Efrati S, 2014, UNDERSEA HYPERBAR M, V41, P71; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; Freiberger JJ, 2002, AVIAT SPACE ENVIR MD, V73, P980; Gempp E, 2010, J CRIT CARE, V25, P236, DOI 10.1016/j.jcrc.2009.05.011; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Hugon J, 2009, UNDERSEA HYPERBAR M, V36, P223; Jaeger K, 2002, ANASTH INTENSIV NOTF, V37, P24, DOI 10.1055/s-2001-20003; Jones SR, 2010, PLAST RECONSTR SURG, V126, P403, DOI 10.1097/PRS.0b013e3181df64a5; Kihara K, 2005, LIVER TRANSPLANT, V11, P1574, DOI 10.1002/lt.20533; KIZER KW, 1982, JAMA-J AM MED ASSOC, V247, P2555, DOI 10.1001/jama.247.18.2555; Millar I, 1996, SPUMS J, V26, P135; Nikolaev VP, 2013, AVIAT SPACE ENVIR MD, V84, P938, DOI 10.3357/ASEM.3579.2013; Nossum V, 2002, EUR J APPL PHYSIOL, V86, P209, DOI 10.1007/s00421-001-0531-y; RIVERA JC, 1964, MIL MED, V129, P314, DOI 10.1093/milmed/129.4.314; Ross JAS., 2000, CLIN AUDIT OUTCOME M; Sjoberg F, 2013, J INTERN MED, V274, P505, DOI 10.1111/joim.12139; VANLIEW HD, 1993, AVIAT SPACE ENVIR MD, V64, P859; Vann R D, 1975, Undersea Biomed Res, V2, P185; Vann RD, 2011, LANCET, V377, P153, DOI 10.1016/S0140-6736(10)61085-9; Vann RD, 2009, AVIAT SPACE ENVIR MD, V80, P466, DOI 10.3357/ASEM.2471.2009; Xu WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050079	31	28	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124919	10.1371/journal.pone.0124919	http://dx.doi.org/10.1371/journal.pone.0124919			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906396	Green Submitted, gold, Green Published			2022-12-27	WOS:000353332000093
J	Holland, CE; Papworth, E; Billong, SC; Kassegne, S; Petitbon, F; Mondoleba, V; Moukam, LV; Macauley, I; Ntsama, SPE; Yomb, YR; Eloundou, J; Mananga, F; Tamoufe, U; Baral, SD				Holland, Claire E.; Papworth, Erin; Billong, Serge C.; Kassegne, Sethson; Petitbon, Fanny; Mondoleba, Valentin; Moukam, Laure Vartan; Macauley, Isaac; Ntsama, Simon Pierre Eyene; Yomb, Yves Roger; Eloundou, Jules; Mananga, Franz; Tamoufe, Ubald; Baral, Stefan D.			Access to HIV Services at Non-Governmental and Community-Based Organizations among Men Who Have Sex with Men (MSM) in Cameroon: An Integrated Biological and Behavioral Surveillance Analysis	PLOS ONE			English	Article							PREVENTION; CARE; RISK; EPIDEMIOLOGY; POPULATIONS; RELEVANCE; INFECTION; KNOWLEDGE; WORKERS; WEST	Background Men who have sex with men (MSM) are more likely to be living with HIV than other adult men in low- and middle-income countries. MSM experience barriers to accessing HIV services including a lack of available specialized care, and community-level stigma and discrimination. This study aims to examine the uptake of HIV services at non-governmental and community- based organizations (NGOs/CBOs) to identify ways to improve coverage of HIV prevention and treatment among MSM. Methods An Integrated Biological and Behavioral Surveillance (IBBS) survey was conducted in Yaounde and Douala, Cameroon in 2011 using the respondent driven sampling (RDS) method to recruit and interview 239 MSM in Yaounde and 272 MSM in Douala. Results MSM in Yaounde were statistically significantly more likely to have accessed NGO/CBO services or been reached by an outreach worker in the past 12 months if they had any STI symptoms (aOR 2.17 CI 1.02-4.59. p=0.04), or if they had a larger MSM social network (aOR 1.02 CI 1.01-1.04. p<0.01). MSM in Douala were more likely to have accessed NGO/CBO services or been reached by an outreach worker in the past 12 months if they were living with HIV (aOR 3.60 CI 1.35-9.60. p=0.01), or if they reported higher numbers of male sexual partners (aOR 1.17 CI 1.00-1.36. p=0.046). Compared to men in Douala, MSM in Yaounde were significantly less likely to have accessed NGO/CBO services or been reached by an outreach worker in the past 12 months ( aOR 0.22 CI 0.14-0.34. p=<0.01). Conclusions With appropriate funding and resources, community-based organizations that provide care specifically for MSM can improve access to HIV prevention, treatment, and care services. Additionally, using social networks to reach MSM can connect greater numbers of the population to effective HIV interventions, which will improve health outcomes and decrease onward transmission of HIV.	[Holland, Claire E.; Papworth, Erin; Baral, Stefan D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Billong, Serge C.] Minist Publ Hlth, Natl AIDS Control Comm, Cent Tech Grp, Yaounde, Cameroon; [Kassegne, Sethson] Populat Serv Int, Cotonou, Benin; [Petitbon, Fanny; Macauley, Isaac] CARE Int Cameroon, Yaounde, Cameroon; [Mondoleba, Valentin; Ntsama, Simon Pierre Eyene] Cameroon Natl Assoc Family Welf CAMNAFAW, Yaounde, Cameroon; [Moukam, Laure Vartan] Assoc Camerounaise Mkt Sociale, Yaounde, Cameroon; [Yomb, Yves Roger; Mananga, Franz] Alternat Cameroun, Douala, Cameroon; [Eloundou, Jules] Humanity First, Yaounde, Cameroon; [Tamoufe, Ubald] Global Viral Cameroon, Yaounde, Cameroon	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Holland, CE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	cholland@jhu.edu	Baral, Stefan/AAG-4818-2020	Baral, Stefan/0000-0002-5482-2419	United States Agency for International Development (USAID); Cameroonian National AIDS Control Committee; Ministry of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Cameroonian National AIDS Control Committee; Ministry of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the United States Agency for International Development (USAID) and by the Cameroonian National AIDS Control Committee and Ministry of Health.	[Anonymous], 2012, CAMERON INVESTIGATE; [Anonymous], 2013, HUMAN RIGHTS WATCH; [Anonymous], 2013, ALT CAM GRANT HIV HU; [Anonymous], 2008, MSM HIV ROAD UN ACC; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-482; Baral SD, 2014, CURR OPIN HIV AIDS, V9, P156, DOI 10.1097/COH.0000000000000037; Baral SD, 2012, PUBLIC HEALTH REP, V127, P572, DOI 10.1177/003335491212700607; BBC, 2013, BBC; Beyrer C, 2012, LANCET, V380, P424, DOI 10.1016/S0140-6736(12)61022-8; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Beyrer C, 2011, JAIDS-J ACQ IMM DEF, V57, pS96, DOI 10.1097/QAI.0b013e31821db944; Beyrer C, 2010, CLIN INFECT DIS, V50, pS108, DOI 10.1086/651481; Clark H, 2012, MORE 70 COUNTRIES HO; Corporation S., 2011, STAT STAT SOFTW REL; Drame FM, 2013, CULT HEALTH SEX, V15, P7, DOI 10.1080/13691058.2012.748935; Duan YW, 2013, AIDS EDUC PREV, V25, P38, DOI 10.1521/aeap.2013.25.1.38; Eloundou J, 2013, MEMORANDUM; Elul B, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0549-5; Fay H, 2011, AIDS BEHAV, V15, P1088, DOI 10.1007/s10461-010-9861-2; Fox MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110252; Furtado J, 2014, SAO PAULO MED J, V132, P383, DOI 10.1590/1516-3180.20141326T2; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gurung A, 2011, BMC PUBLIC HLTH S6, DOI [10.1186/1471-2458-11-S6-S16, DOI 10.1186/1471-2458-11-S6-S16]; Kong TSK, 2008, SEX TRANSM INFECT, V84, P444, DOI 10.1136/sti.2008.030650; Kranzer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013801; Araujo MAL, 2009, AIDS PATIENT CARE ST, V23, P663, DOI 10.1089/apc.2008.0123; Lorente N, 2012, AIDS CARE, V24, P1020, DOI 10.1080/09540121.2012.668172; Ma W, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-847; Malta M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-18; Mayer KH, 2013, JAIDS-J ACQ IMM DEF, V63, pS161, DOI 10.1097/QAI.0b013e318298700e; Mayer KH, 2012, LANCET, V380, P378, DOI 10.1016/S0140-6736(12)60835-6; Mugglin C, 2012, TROP MED INT HEALTH, V17, P1509, DOI 10.1111/j.1365-3156.2012.03089.x; Muraguri N, 2012, SAHARA J-J SOC ASP H, V9, P137, DOI 10.1080/17290376.2012.744176; Ngo DA, 2009, AIDS EDUC PREV, V21, P251, DOI 10.1521/aeap.2009.21.3.251; Nordberg E, 2012, AM U INT L REV, V27, P439; Papworth E, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18751; Park JN, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1220; Park JN, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18752; Rebe K, 2012, SAHARA J-J SOC ASP H, V9, P164, DOI 10.1080/17290376.2012.744168; Schonlau M, 2012, STATA J, V12, P72, DOI 10.1177/1536867X1201200106; Semugoma P, 2012, SAHARA J-J SOC ASP H, V9, P173, DOI 10.1080/17290376.2012.744177; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Thomas B, 2009, AIDS PATIENT CARE ST, V23, P981, DOI 10.1089/apc.2009.0092; Trapence G, 2012, LANCET, V380, P400, DOI 10.1016/S0140-6736(12)60834-4; UNAIDS, 2013, UNAIDS GLOB REP; Wynberg E, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18809	48	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0122881	10.1371/journal.pone.0122881	http://dx.doi.org/10.1371/journal.pone.0122881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KZ	25906046	Green Submitted, Green Published, gold			2022-12-27	WOS:000353332000018
J	Ruschioni, S; Riolo, P; Verdolini, E; Peri, E; Guarino, S; Colazza, S; Romani, R; Isidoro, N				Ruschioni, Sara; Riolo, Paola; Verdolini, Elisa; Peri, Ezio; Guarino, Salvatore; Colazza, Stefano; Romani, Roberto; Isidoro, Nunzio			Fine Structure of Antennal Sensilla of Paysandisia archon and Electrophysiological Responses to Volatile Compounds Associated with Host Palms	PLOS ONE			English	Article							OLFACTORY RECEPTOR NEURONS; CYDIA-POMONELLA LEPIDOPTERA; MOTH MANDUCA-SEXTA; SMALL ERMINE MOTHS; CODLING MOTH; PLANT VOLATILES; SENSE-ORGANS; OVIPOSITION BEHAVIOR; FLORAL VOLATILES; PHEROMONE	Paysandisia archon (Lepidoptera: Castniidae) is a serious pest of palm trees. A comprehensive knowledge of the insect olfactory system is essential for the development of efficient semiochemical-based control methods. The olfactory sensilla are located particularly on the antennae, and these can detect plant volatiles that provide important cues for the insects in the search for their host plants. To date, the fine structure of P. archon antennal sensilla studies and their role in host-plant perception have not been investigated in great detail. Using light microscopy and scanning and transmission electron microscopy, the antennae of both sexes of P. archon are described here in detail, according to the different types, quantities and distributions of the sensilla. Six types of sensilla were identified. The most widespread are sensilla trichoidea, sensilla basiconica and sensilla auricilica, which are associated with olfactory function. These have cuticular shafts characterised by numerous pores, and they are innervated by two or three sensory neurons. Sensilla coeloconica, sensilla chaetica and sensilla ampullacea are associated with olfactory or olfactory-thermoreception, mechano-gustatory, and thermo-hygroreception functions, respectively. Moreover, the role of P. archon antennae in locating of the host palms was evaluated using electroantennograms, to monitor responses to ester and terpene compounds previously identified as volatiles of damaged/fermenting palm tissues. P. archon showed responses to all of the synthetic chemicals tested, with greater responses in the females, providing a significant sex*dose effect. Among the compounds tested, ethyl isobutyrate elicited the strongest antenna responses. The fine structure of the cuticular and cellular components of the P. archon antenna sensory equipment is described for the first time. The results of this study form an important starting point and complement physiological and behavioural studies, to provide valuable information of practical importance for the development of efficient semiochemical-based control methods.	[Ruschioni, Sara; Riolo, Paola; Verdolini, Elisa; Isidoro, Nunzio] Univ Politecn Marche, Dipartimento Sci Agr Alimentari & Ambientali, I-60131 Ancona, Italy; [Peri, Ezio; Guarino, Salvatore; Colazza, Stefano] Univ Palermo, Dipartimento Sci Agr & Forestali, I-90128 Palermo, Italy; [Romani, Roberto] Univ Perugia, Dipartimento Sci Agr Alimentari & Ambientali, I-06121 Perugia, Italy; [Guarino, Salvatore] Ist Protez Sostenibile Piante CNR, I-50019 Sesto Fiorentino, FI, Italy	Marche Polytechnic University; University of Palermo; University of Perugia; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Protezione Sostenibile delle Piante (IPSP-CNR)	Riolo, P (corresponding author), Univ Politecn Marche, Dipartimento Sci Agr Alimentari & Ambientali, I-60131 Ancona, Italy.	p.riolo@univpm.it	Romani, Roberto/O-4004-2019; Guarino, Salvatore/AAH-4217-2020; Romani, Roberto/F-4157-2014	Romani, Roberto/0000-0002-2059-4702; Romani, Roberto/0000-0002-2059-4702; colazza, stefano/0000-0001-8023-7814; Guarino, Salvatore/0000-0001-6670-3997; PERI, Ezio/0000-0002-1095-7258	European Community Seventh Framework Programme [FP7 KBBE 2011-5-289566]	European Community Seventh Framework Programme(European Commission)	European Community Seventh Framework Programme, under Grant Agreement No. FP7 KBBE 2011-5-289566 (PALM PROTECT). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagarmalai J, 2009, J CHEM ECOL, V35, P542, DOI 10.1007/s10886-009-9636-2; ALTNER H, 1977, CELL TISSUE RES, V176, P389, DOI 10.1007/BF00221796; Altner H., 1980, International Review of Cytology, V67, P69, DOI 10.1016/S0074-7696(08)62427-4; ALTNER H, 1981, CELL TISSUE RES, V215, P289; Anderson AR, 2009, INSECT BIOCHEM MOLEC, V39, P189, DOI 10.1016/j.ibmb.2008.11.002; Anderson P, 2000, ARTHROPOD STRUCT DEV, V29, P33, DOI 10.1016/S1467-8039(00)00011-6; Andersson S, 2003, J CHEM ECOL, V29, P2319, DOI 10.1023/A:1026278531806; Ansebo L, 2005, J INSECT PHYSIOL, V51, P1066, DOI 10.1016/j.jinsphys.2005.05.003; Ansebo L, 2004, J APPL ENTOMOL, V128, P488, DOI 10.1111/j.1439-0418.2004.00878.x; Bengtsson M, 2001, J AGR FOOD CHEM, V49, P3736, DOI 10.1021/jf0100548; Blight MM, 1997, J CHEM ECOL, V23, P1715, DOI 10.1023/B:JOEC.0000006446.21160.c1; Bourquin F., 1933, Revista de la Sociedad Entomologica Argentina, V5, P295; Caissard JC, 2004, AM J BOT, V91, P1190, DOI 10.3732/ajb.91.8.1190; Carlsson MA, 2013, CHEM SENSES, V38, P355, DOI 10.1093/chemse/bjt008; Gomez VRC, 2008, ANN ENTOMOL SOC AM, V101, P181, DOI 10.1603/0013-8746(2008)101[181:MCOASI]2.0.CO;2; Castrejon-Gomez VR, 1999, FLA ENTOMOL, V82, P546, DOI 10.2307/3496472; CUPERUS PL, 1985, INT J INSECT MORPHOL, V14, P179, DOI 10.1016/0020-7322(85)90004-2; Delle-Vedove R, 2012, EUR J ENTOMOL, V109, P289, DOI 10.14411/eje.2012.037; DENOTTER CJ, 1978, ENTOMOL EXP APPL, V24, P570, DOI 10.1007/BF02385110; Derksen S, 2007, ENTOMOL EXP APPL, V123, P101, DOI 10.1111/j.1570-7458.2007.00535.x; Ebbinghaus D, 1998, J INSECT PHYSIOL, V44, P49, DOI 10.1016/S0022-1910(97)00101-7; El-Sayed AM, 2005, J AGR FOOD CHEM, V53, P953, DOI 10.1021/jf048521j; EPPO, 2008, OEPP EPPO B, V3, P163; Frank DL, 2010, ANN ENTOMOL SOC AM, V103, P993, DOI 10.1603/AN09182; Fraser AM, 2003, J CHEM ECOL, V29, P1813, DOI 10.1023/A:1024898127549; Frerot B, 2013, CHEMOECOLOGY, V23, P137, DOI 10.1007/s00049-013-0128-z; Gomez VRC, 2003, ANN ENTOMOL SOC AM, V96, P672, DOI 10.1603/0013-8746(2003)096[0672:TASOZD]2.0.CO;2; GRANT AJ, 1989, J INSECT BEHAV, V2, P371, DOI 10.1007/BF01068062; Grula J.W, 1980, J KANSAS ENTOMOL SOC, P476; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; HANSSON BS, 1995, J INSECT PHYSIOL, V41, P171, DOI 10.1016/0022-1910(94)00086-V; HANSSON BS, 1995, EXPERIENTIA, V51, P1003, DOI 10.1007/BF01946910; Hern A, 2004, NATURWISSENSCHAFTEN, V91, P77, DOI 10.1007/s00114-003-0484-6; Hillier NK, 2006, J COMP PHYSIOL A, V192, P199, DOI 10.1007/s00359-005-0061-x; Honda K, 1998, J CHEM ECOL, V24, P2167, DOI 10.1023/A:1020750029362; Hunger T, 1998, TISSUE CELL, V30, P14, DOI 10.1016/S0040-8166(98)80003-7; KAFKA WA, 1987, J COMP PHYSIOL A, V161, P867, DOI 10.1007/BF00610228; Karalius V., 1994, Pheromones, V4, P93; Keil Thomas A., 1999, P5; KNUDSEN JT, 1993, PHYTOCHEMISTRY, V33, P253, DOI 10.1016/0031-9422(93)85502-I; KOH YH, 1995, ANN ENTOMOL SOC AM, V88, P519, DOI 10.1093/aesa/88.4.519; Larsson MC, 2002, J EXP BIOL, V205, P989; Li J, 2010, BIOSCI BIOTECH BIOCH, V74, P1987, DOI 10.1271/bbb.100118; Light DM, 2001, NATURWISSENSCHAFTEN, V88, P333, DOI 10.1007/s001140100243; Lopes O, 2002, ARTHROPOD STRUCT DEV, V31, P1, DOI 10.1016/S1467-8039(02)00011-7; Malo EA, 2004, ANN ENTOMOL SOC AM, V97, P1273, DOI 10.1603/0013-8746(2004)097[1273:ASAERO]2.0.CO;2; Mayhew PJ, 1997, OIKOS, V79, P417, DOI 10.2307/3546884; MOCHIZUKI F, 1992, APPL ENTOMOL ZOOL, V27, P547, DOI 10.1303/aez.27.547; MYERS J, 1968, J MORPHOL, V125, P315, DOI 10.1002/jmor.1051250305; Nardi S., 2009, IOBC/WPRS Bulletin, V45, P375; ODENDAAL FJ, 1985, J MORPHOL, V184, P3; RAMACHANDRAN R, 1990, J CHEM ECOL, V16, P2647, DOI 10.1007/BF00988076; Reboucas LMC, 1999, QUIM NOVA, V22, P645, DOI 10.1590/S0100-40421999000500003; Riolo P, 2014, J ECON ENTOMOL, V107, P1009, DOI 10.1603/EC13298; Riolo P, 2012, J CHEM ECOL, V38, P1017, DOI 10.1007/s10886-012-0154-2; ROELOFS WL, 1971, J INSECT PHYSIOL, V17, P1969, DOI 10.1016/0022-1910(71)90141-7; Rojas JC, 1999, ENVIRON ENTOMOL, V28, P588, DOI 10.1093/ee/28.4.588; Romani R, 2009, ARTHROPOD STRUCT DEV, V38, P473, DOI 10.1016/j.asd.2009.08.002; Rostelien T, 2005, CHEM SENSES, V30, P443, DOI 10.1093/chemse/bji039; Roux O, 2005, MICROSC RES TECHNIQ, V68, P36, DOI 10.1002/jemt.20220; Ruchty M, 2009, ARTHROPOD STRUCT DEV, V38, P195, DOI 10.1016/j.asd.2008.11.001; Monteys VSI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029282; Sarto i Monteys Victor, 2005, Nachrichten des Entomologischen Vereins Apollo, V26, P61; SCHNEIDER D, 1957, Z VERGL PHYSIOL, V40, P8, DOI 10.1007/BF00298148; Shields VDC, 2001, J COMP PHYSIOL A, V186, P1135, DOI 10.1007/s003590000165; Silberglied R.E., 1984, Symposia of the Royal Entomological Society of London, P207; Steinbrecht R.A., 1987, P353; STEINBRECHT RA, 1980, TISSUE CELL, V12, P73, DOI 10.1016/0040-8166(80)90053-1; Nerio LS, 2010, BIORESOURCE TECHNOL, V101, P372, DOI 10.1016/j.biortech.2009.07.048; Sun XL, 2014, J CHEM ECOL, V40, P1080, DOI 10.1007/s10886-014-0502-5; Trona F, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0267; Vacas S, 2014, J AGR FOOD CHEM, V62, P6053, DOI 10.1021/jf502663y; VANDERPERS JNC, 1980, INT J INSECT MORPHOL, V9, P15, DOI 10.1016/0020-7322(80)90032-X; VANEWRIGHT RI, 1993, PHILOS T R SOC B, V340, P197, DOI 10.1098/rstb.1993.0058; WALL C, 1978, INT J INSECT MORPHOL, V7, P237, DOI 10.1016/0020-7322(78)90006-5; War AR, 2011, PLANT SIGNAL BEHAV, V6, P1973, DOI 10.4161/psb.6.12.18053; Witzgall P, 2010, J CHEM ECOL, V36, P80, DOI 10.1007/s10886-009-9737-y; Yang ZH, 2004, J CHEM ECOL, V30, P619, DOI 10.1023/B:JOEC.0000018633.94002.af; Zacharuk R.Y., 1985, COMPREHENSIVE INSECT, P1; ZACHARUK RY, 1980, ANNU REV ENTOMOL, V25, P27, DOI 10.1146/annurev.en.25.010180.000331; Zhang SG, 2001, CHEM SENSES, V26, P885, DOI 10.1093/chemse/26.7.885	82	18	19	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124607	10.1371/journal.pone.0124607	http://dx.doi.org/10.1371/journal.pone.0124607			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905711	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000078
J	Schneider, JS; Sendek, S; Yang, CW				Schneider, Jay S.; Sendek, Stephanie; Yang, Chengwu			Relationship between Motor Symptoms, Cognition, and Demographic Characteristics in Treated Mild/Moderate Parkinson's Disease	PLoS One			English	Article							IMPAIRMENT; PERFORMANCE; DYSFUNCTION; DEFICITS; BATTERY	Background Although Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized primarily by motor symptoms, PD patients, at all stages of the disease, can experience cognitive dysfunction. However, the relationships between cognitive and motor symptoms and specific demographic characteristics are not well defined, particularly for patients who have progressed to requiring dopaminergic medication. Objective To examine relationships between motor and cognitive symptoms and various demographic factors in mild to moderate, PD patients requiring anti-PD medication. Methods Cognitive function was assessed in 94 subjects with a variety of neuropsychological tests during baseline evaluations as part of an experimental treatment study. Data were analyzed in relation to Unified Parkinson's Disease Rating Scale motor scores and demographic variables. Results Of the UPDRS subscores analyzed, posture/balance/gait was associated with the highest number of adverse cognitive outcomes followed by speech/facial expression, bradykinesia, and rigidity. No associations were detected between any of the cognitive performance measures and tremor. Motor functioning assessed in the "off" condition correlated primarily with disease duration; neuropsychological performance in general was primarily related to age. Conclusion In PD patients who have advanced to requiring anti-PD therapies, there are salient associations between axial signs and cognitive performance and in particular, with different aspects of visuospatial function suggesting involvement of similar circuits in these functions. Associations between executive functions and bradykinesia also suggest involvement similar circuits in these functions.	[Schneider, Jay S.; Sendek, Stephanie] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Yang, Chengwu] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA USA	Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Schneider, JS (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.	jay.schneider@jefferson.edu	Yang, Chengwu/X-6178-2018	Yang, Chengwu/0000-0003-0561-2340	National Institutes of Health [NS038681]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The research was supported by National Institutes of Health grant NS038681 (www.nih.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves G, 2006, MOVEMENT DISORD, V21, P1123, DOI 10.1002/mds.20897; Barone P, 2011, MOVEMENT DISORD, V26, P2483, DOI 10.1002/mds.23919; Brand M, 2004, BEHAV NEUROL, V15, P77, DOI 10.1155/2004/578354; Caviness JN, 2007, MOVEMENT DISORD, V22, P1272, DOI 10.1002/mds.21453; Domellof ME, 2011, MOVEMENT DISORD, V26, P2183, DOI 10.1002/mds.23814; Huber S. J., 1991, NEUROPSY NEUROPSY BE, V4, P147; HUBER SJ, 1988, J NEUROL NEUROSUR PS, V51, P855, DOI 10.1136/jnnp.51.6.855; IWASAKI Y, 1989, INT J NEUROSCI, V47, P295, DOI 10.3109/00207458908987442; Katzen HL, 2006, MOVEMENT DISORD, V21, P1947, DOI 10.1002/mds.21105; Kulisevsky J, 2000, DRUG AGING, V16, P365, DOI 10.2165/00002512-200016050-00006; LANGE KW, 1992, PSYCHOPHARMACOLOGY, V107, P394, DOI 10.1007/BF02245167; Litvan I, 2011, MOVEMENT DISORD, V26, P1814, DOI 10.1002/mds.23823; MORTIMER JA, 1982, NEUROLOGY, V32, P133, DOI 10.1212/WNL.32.2.133; OWEN AM, 1992, BRAIN, V115, P1727, DOI 10.1093/brain/115.6.1727; Ozonoff S, 2004, J AUTISM DEV DISORD, V34, P139, DOI 10.1023/B:JADD.0000022605.81989.cc; Poletti M, 2013, J CLIN EXP NEUROPSYC, V35, P124, DOI 10.1080/13803395.2012.751966; Portin RJ, 1989, J CLIN EXP NEUROPSYC, V11, P369; Schneider JS, 2013, J NEUROL SCI, V324, P140, DOI 10.1016/j.jns.2012.10.024; Schneider JS, 2010, PARKINSONISM RELAT D, V16, P507, DOI 10.1016/j.parkreldis.2010.06.001; Sollinger AB, 2010, PARKINSONISM RELAT D, V16, P177, DOI 10.1016/j.parkreldis.2009.11.002; Verbaan D, 2007, J NEUROL NEUROSUR PS, V78, P1182, DOI 10.1136/jnnp.2006.112367; Yang CW, 2009, MOVEMENT DISORD, V24, P1453, DOI 10.1002/mds.22552	22	27	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123231	10.1371/journal.pone.0123231	http://dx.doi.org/10.1371/journal.pone.0123231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905783	Green Published, Green Submitted, gold			2022-12-27	WOS:000353332000025
J	Wang, X; Zhu, XH; Zhang, Y; Chen, W				Wang, Xiao; Zhu, Xiao-Hong; Zhang, Yi; Chen, Wei			Simultaneous Imaging of CBF Change and BOLD with Saturation-Recovery-T-1 Method	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; LASER-DOPPLER FLOWMETRY; RAT-BRAIN; FAIR TECHNIQUE; PERFUSION; OXYGENATION; DIFFUSION; INVERSION; MODEL; MICROCIRCULATION	A neuroimaging technique based on the saturation-recovery (SR)-T-1 MRI method was applied for simultaneously imaging blood oxygenation level dependence (BOLD) contrast and cerebral blood flow change (Delta CBF), which is determined by CBF-sensitive T-1 relaxation rate change (Delta R-1(CBF)). This technique was validated by quantitatively examining the relationships among Delta R1CBF,Delta CBF, BOLD and relative CBF change (rCBF), which was simultaneously measured by laser Doppler flowmetry under global ischemia and hypercapnia conditions, respectively, in the rat brain. It was found that during ischemia, BOLD decreased 23.1 +/- 2.8% in the cortical area; Delta R-1(CBF) decreased 0.020 +/- 0.004s(-1) corresponding to a Delta CBF decrease of 1.07 +/- 0.24 ml/g/min and 89.5 +/- 1.8% CBF reduction (n=5), resulting in a baseline CBF value (=1.18 ml/g/min) consistent with the literature reports. The CBF change quantification based on temperature corrected Delta R-1 CBF had a better accuracy than apparent R-1 change (Delta R-1(app)); nevertheless, Delta R-1(app) without temperature correction still provides a good approximation for quantifying CBF change since perfusion dominates the evolution of the longitudinal relaxation rate (R-1(app)). In contrast to the excellent consistency between Delta CBF and rCBF measured during and after ischemia, the BOLD change during the post-ischemia period was temporally disassociated with Delta CBF, indicating distinct CBF and BOLD responses. Similar results were also observed for the hypercapnia study. The overall results demonstrate that the SR-T-1 MRI method is effective for noninvasive and quantitative imaging of both Delta CBF and BOLD associated with physiological and/or pathological changes.	[Wang, Xiao; Zhu, Xiao-Hong; Zhang, Yi; Chen, Wei] Univ Minnesota, Sch Med, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Chen, W (corresponding author), Univ Minnesota, Sch Med, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA.	wei@cmrr.umn.edu			NIH [NS057560, NS041262, NS070839, P41 RR08079, EB015894, P30 NS057091, NS076408]; WM Keck Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041262, R01NS070839, R01NS057560, P30NS057091, P30NS076408] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WM Keck Foundation(W.M. Keck Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially supported by NIH grants NS057560, NS041262, NS070839, P41 RR08079 & EB015894, P30 NS057091 & NS076408 and WM Keck Foundation.	ACKERMAN JJH, 1980, NATURE, V283, P167, DOI 10.1038/283167a0; Barbier EL, 2001, MAGNET RESON MED, V45, P1021, DOI 10.1002/mrm.1136; BELL BA, 1985, J NEUROSURG, V62, P31, DOI 10.3171/jns.1985.62.1.0031; Botnar R, 1998, MED RAD DIA IMG, P171; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Calamante F, 1999, MAGN RESON MED, V41, P479, DOI 10.1002/(SICI)1522-2594(199903)41:3<479::AID-MRM9>3.0.CO;2-2; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; DICKINSON RJ, 1986, J COMPUT ASSIST TOMO, V10, P468; DIRNAGL U, 1989, J CEREBR BLOOD F MET, V9, P589, DOI 10.1038/jcbfm.1989.84; EDELMAN RR, 1994, RADIOLOGY, V192, P513, DOI 10.1148/radiology.192.2.8029425; Fabricius M, 1996, J CEREBR BLOOD F MET, V16, P156, DOI 10.1097/00004647-199601000-00018; HAASE A, 1986, J MAGN RESON, V67, P258, DOI 10.1016/0022-2364(86)90433-6; Hazel RD, 2006, ISMRM P SEATTL WASH; IWAMA T, 1992, MAGN RESON MED, V25, P78, DOI 10.1002/mrm.1910250108; KIM SG, 1995, MAGNET RESON MED, V34, P293, DOI 10.1002/mrm.1910340303; Kim SG, 1997, MAGN RESON MED, V38, P59, DOI 10.1002/mrm.1910380110; Kramer MS, 1996, NEUROSURGERY, V38, P355, DOI 10.1097/00006123-199602000-00024; Kreis D, 2011, NEUROL RES, V33, P389, DOI 10.1179/1743132810Y.0000000010; KWONG KK, 1995, MAGNET RESON MED, V34, P878, DOI 10.1002/mrm.1910340613; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Linninger AA, 2007, IEEE T BIO-MED ENG, V54, P291, DOI 10.1109/TBME.2006.886853; Lythgoe MF, 2000, MAGN RESON MED, V44, P706, DOI 10.1002/1522-2594(200011)44:5<706::AID-MRM8>3.0.CO;2-1; MANSFIELD P, 1977, J PHYS C SOLID STATE, V10, pL55, DOI 10.1088/0022-3719/10/3/004; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; PARKER DL, 1983, MED PHYS, V10, P321, DOI 10.1118/1.595307; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; Quesson B, 2000, J MAGN RESON IMAGING, V12, P525, DOI 10.1002/1522-2586(200010)12:4<525::AID-JMRI3>3.0.CO;2-V; Schwarzbauer C, 1996, MAGNET RESON MED, V35, P540, DOI 10.1002/mrm.1910350413; Shen Q, 2011, J CEREBR BLOOD F MET, V31, P2076, DOI 10.1038/jcbfm.2011.64; STERN MD, 1975, NATURE, V254, P56, DOI 10.1038/254056a0; Strupp J.P., 1996, NEUROIMAGE, V3, pS607, DOI [10.1016/S1053-8119(96)80609-4, DOI 10.1016/S1053-8119(96)80609-4]; Tsekos NV, 1998, MAGNET RESON MED, V39, P564, DOI 10.1002/mrm.1910390409; vanderToorn A, 1995, NMR BIOMED, V8, P245, DOI 10.1002/nbm.1940080604; Wadhwani KC R., 1988, LASER DOPPLER BLOOD, P265; Wang X, 2012, J CEREBR BLOOD F MET, V32, P907, DOI 10.1038/jcbfm.2012.26; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Wong EC, 1997, NMR BIOMED, V10, P237, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<237::AID-NBM475>3.0.CO;2-X; YOUNG W, 1987, STROKE, V18, P751, DOI 10.1161/01.STR.18.4.751; ZHANG WG, 1992, MAGNET RESON MED, V25, P362, DOI 10.1002/mrm.1910250216	41	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0122563	10.1371/journal.pone.0122563	http://dx.doi.org/10.1371/journal.pone.0122563			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905715	gold, Green Published, Green Submitted			2022-12-27	WOS:000353332000015
J	Li, L; Ryoo, JE; Lee, KJ; Choi, BC; Baek, KH				Li, Lan; Ryoo, Ji Eun; Lee, Kyung-Ju; Choi, Bum-Chae; Baek, Kwang-Hyun			Genetic Variation in the Mcp-1 Gene Promoter Associated with the Risk of Polycystic Ovary Syndrome	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; LOW-GRADE INFLAMMATION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; ENDOCRINE ORGAN; POLYMORPHISM; EXPRESSION; OBESITY; PCOS	Monocyte chemoattractant protein-1 (MCP-1) is a pivotal chemokine in the inflammatory response, which plays an important role in recruiting monocytes to sites of injury and infection. However, the exact mechanism of Mcp-1 associated with PCOS risk was unknown. In this study, we explored whether the Mcp-1 -2518G>A polymorphism increases the risk of PCOS. We performed a comparative study of -2518G>A polymorphism of the Mcp-1 gene with PCOS. In addition, luciferase reporter assay was performed to evaluate the Mcp-1 transcriptional activity. A strong association was observed between the -2518G>A polymorphism of Mcp-1 gene and PCOS (p-value = 0.016, odd ratio (OR) = 0.693). A p-value under 0.05 is considered statistically significant. The genotype and allelic frequencies were assumed to be in Hardy-Weinberg equilibrium (HWE). The luciferase assays in 2 cell lines showed that the Mcp-1 -2518G>A substitution can increase the expression of Mcp-1. MCP-1 levels in serum for PCOS group were significantly higher than those in serum for controls (p-value = 0.02). Furthermore, the patients carrying a genotype A/A had significantly increased levels of MCP-1 in serum compared with levels of the MCP-1 of the patients with genotypes G/G and G/A (p-value = 0.031). This is the first study on the genetic variation of the Mcp-1 gene and PCOS. This finding suggests that the Mcp-1 -2518G>A polymorphism is associated with PCOS risk by affecting transcriptional activity, leading to an increased expression level of Mcp-1.	[Li, Lan; Baek, Kwang-Hyun] CHA Univ, Bundang CHA Hosp, Dept Biomed Sci, Gyeonggi Do, South Korea; [Ryoo, Ji Eun] Hankuk Acad Foreign Studies, Yongin, South Korea; [Lee, Kyung-Ju] CHA Univ, CHA Gen Hosp, Dept Gynecol & Obstet, Seoul, South Korea; [Choi, Bum-Chae] CL Womens Hosp, Dept Obstet & Gynecol, Gwangju, South Korea	Pochon Cha University; Pochon Cha University	Baek, KH (corresponding author), CHA Univ, Bundang CHA Hosp, Dept Biomed Sci, Gyeonggi Do, South Korea.	baek@cha.ac.kr		Baek, Kwang-Hyun/0000-0001-7662-7190	Ministry of Education, Republic of Korea	Ministry of Education, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of KoreaMinistry of Education (MOE), Republic of Korea)	This study was supported by a grant from BK21 program of the Ministry of Education, Republic of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Atabekoglu CS, 2011, FERTIL STERIL, V95, P295, DOI 10.1016/j.fertnstert.2010.08.030; Barthelmess Erin K, 2014, Front Biosci (Elite Ed), V6, P104; Caserta D, 2014, GYNECOL ENDOCRINOL, V30, P397, DOI 10.3109/09513590.2014.887673; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Diamanti-Kandarakis E, 2006, ANN NY ACAD SCI, V1092, P175, DOI 10.1196/annals.1365.015; Dragomir E, 2006, VASC PHARMACOL, V44, P440, DOI 10.1016/j.vph.2006.02.006; Duleba AJ, 2012, FERTIL STERIL, V97, P7, DOI 10.1016/j.fertnstert.2011.11.023; Ebejer K, 2013, GYNECOL ENDOCRINOL, V29, P536, DOI 10.3109/09513590.2012.760195; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Evian Annual Reprod EVAR Workshop, 2011, HUM REPROD UPDATE, V17, P829, DOI 10.1093/humupd/dmr033; Ewens KG, 2010, J CLIN ENDOCR METAB, V95, P2306, DOI 10.1210/jc.2009-2703; Glintborg D, 2009, CLIN ENDOCRINOL, V71, P652, DOI 10.1111/j.1365-2265.2009.03523.x; Gonzalez F, 2012, STEROIDS, V77, P300, DOI 10.1016/j.steroids.2011.12.003; Gonzalez F, 2009, METABOLISM, V58, P954, DOI 10.1016/j.metabol.2009.02.022; Guerre-Millo M, 2002, J ENDOCRINOL INVEST, V25, P855, DOI 10.1007/BF03344048; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Hu Wei-hong, 2006, Beijing Da Xue Xue Bao Yi Xue Ban, V38, P487; Hu WH, 2011, EUR J OBSTET GYN R B, V157, P53, DOI 10.1016/j.ejogrb.2011.03.015; Karadeniz M, 2010, ENDOCRINE, V37, P513, DOI 10.1007/s12020-010-9342-4; King J, 2006, J MIDWIFERY WOM HEAL, V51, P415, DOI 10.1016/j.jmwh.2006.01.008; Kolattukudy PE, 2012, CIRC RES, V110, P174, DOI 10.1161/CIRCRESAHA.111.243212; Kruger B, 2002, J AM SOC NEPHROL, V13, P2585, DOI 10.1097/01.ASN.0000031701.53792.54; Kumar PS, 2014, J OBSTET GYNAECOL RE, V40, P1361, DOI 10.1111/jog.12346; Li SX, 2013, GYNECOL ENDOCRINOL, V29, P878, DOI 10.3109/09513590.2013.819081; Moran L, 2009, HUM REPROD UPDATE, V15, P477, DOI 10.1093/humupd/dmp008; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Paneni F, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0419-z; Prins JB, 2002, BEST PRACT RES CL EN, V16, P639, DOI 10.1053/beem.2002.0222; Roberson LL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-14; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Sathyapalan T, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/758656; Shang KW, 2012, REPROD SCI, V19, P674, DOI 10.1177/1933719111430993; Shi YY, 2012, NAT GENET, V44, P1020, DOI 10.1038/ng.2384; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Simeoni E, 2004, DIABETOLOGIA, V47, P1574, DOI 10.1007/s00125-004-1494-4; Sirmans SM, 2012, ANN PHARMACOTHER, V46, P403, DOI 10.1345/aph.1Q514; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Traub ML, 2011, WORLD J DIABETES, V2, P33, DOI 10.4239/wjd.v2.i3.33; UEDA A, 1994, J IMMUNOL, V153, P2052; Xing L, 2007, ANTIOXID REDOX SIGN, V9, P1979, DOI 10.1089/ars.2007.1921	43	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123045	10.1371/journal.pone.0123045	http://dx.doi.org/10.1371/journal.pone.0123045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902044	Green Submitted, gold, Green Published			2022-12-27	WOS:000353331500040
J	Awasthi, S; Nichter, M; Verma, T; Srivastava, NM; Agarwal, M; Singh, JV				Awasthi, Shally; Nichter, Mark; Verma, Tuhina; Srivastava, Neeraj Mohan; Agarwal, Monica; Singh, Jai Vir		CAP-Lucknow Team	Revisiting Community Case Management of Childhood Pneumonia: Perceptions of Caregivers and Grass Root Health Providers in Uttar Pradesh and Bihar, Northern India	PLOS ONE			English	Article							CARE-SEEKING BEHAVIOR; ACUTE RESPIRATORY-INFECTIONS; DANGER SIGNS; URBAN-POOR; DIARRHEA; MORTALITY; ILLNESSES; CHILDREN; LUCKNOW	Background Community-acquired pneumonia (CAP) is the leading cause of under-five mortality globally with almost one-quarter of deaths occurring in India. Objectives To identify predisposing, enabling and service-related factors influencing treatment delay for CAP in rural communities of two states in India. Factors investigated included recognition of danger signs of CAP, health care decision making, self-medication, treatment and referral by local practitioners, and perceptions about quality of care. Methods Qualitative research employing case studies (CS) of care-seeking, key informant interviews (KII), semi-structured interviews (SSI) and focus group discussions (FGD) with both video presentations of CAP signs, and case scenarios. Interviews and FGDs were conducted with parents of under-five children who had suffered CAP, community health workers (CHW), and rural medical practitioners (RMP). Results From September 2013 to January 2014, 30 CS, 43 KIIs, 42 SSIs, and 42 FGDs were conducted. Recognition of danger signs of CAP among caregivers was poor. Fast breathing, an early sign of CAP, was not commonly recognized. Chest in-drawing was recognized as a sign of serious illness, but not commonly monitored by removing a child's clothing. Most cases of mild to moderate CAP were brought to RMP, and more severe cases taken to private clinics in towns. Mothers consulted local RMP directly, but decisions to visit doctors outside the village required consultation with husband or mother-in-law. By the time most cases reached a public tertiary-care hospital, children had been ill for a week and treated by 2-3 providers. Quality of care at government facilities was deemed poor by caregivers. Conclusion To reduce CAP-associated mortality, recognition of its danger signs and the consequences of treatment delay needed to be better recognized by caregivers, and confidence in government facilities increased. The involvement of RMP in community based CAP programs needs to be investigated further given their widespread popularity.	[Awasthi, Shally; Verma, Tuhina] King Georges Med Univ, Dept Pediat, Lucknow, Uttar Pradesh, India; [Nichter, Mark] Univ Arizona, Sch Anthropol, Tucson, AZ USA; [Srivastava, Neeraj Mohan] UNICEFs Off Uttar Pradesh, Lucknow, Uttar Pradesh, India; [Agarwal, Monica; Singh, Jai Vir] King Georges Med Univ, Dept Community Med, Lucknow, Uttar Pradesh, India	King George's Medical University; University of Arizona; King George's Medical University	Awasthi, S (corresponding author), King Georges Med Univ, Dept Pediat, Lucknow, Uttar Pradesh, India.	shally07@gmail.com	Rastogi, Tuhina/K-9856-2019	Rastogi, Tuhina/0000-0001-7426-0110	Bill and Melinda Gates Foundation (BMGF) [OPP1093327]	Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation)	This study is funded by Bill and Melinda Gates Foundation (BMGF) to SA through the Global Health Grant No: OPP1093327. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, J Health Popul Nutr, V19, pS111; [Anonymous], 2007, DISTRICT LEVEL HOUSE; Awasthi S, 2006, J PEDIATR GASTR NUTR, V42, P300; Awasthi S, 2008, J PERINATOL, V28, pS69, DOI 10.1038/jp.2008.169; Awasthi S, 2006, B WORLD HEALTH ORGAN, V84, P819, DOI 10.2471/BLT.05.029207; Bhattacharyya K., 1997, ANTHR INFECT DIS THE, P211; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Bojalil R, 2007, TROP MED INT HEALTH, V12, P1545, DOI 10.1111/j.1365-3156.2007.01963.x; Darmstadt GL, 2006, J HEALTH POPUL NUTR, V24, P380; Das JK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S29; Dongre AR, 2008, INDIAN J PEDIATR, V75, P325, DOI 10.1007/s12098-008-0032-7; Geldsetzer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093427; Gove S, 1994, Med Anthropol, V15, P409; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hildenwall H, 2007, ACTA TROP, V101, P217, DOI 10.1016/j.actatropica.2007.02.003; HILL Z, 2004, FAMILY COMMUNITY PRA; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hussain R, 1997, SOC SCI MED, V45, P991, DOI 10.1016/S0277-9536(97)00012-9; IGUN UA, 1979, SOC SCI MED-MED SOC, V13, P445, DOI 10.1016/0160-7979(79)90133-4; Irimu G, 2008, AFR HEALTH SCI, V8, P103; Kallander K, 2008, B WORLD HEALTH ORGAN, V86, P332, DOI 10.2471/BLT.07.049353; KROEGER A, 1983, SOC SCI MED, V17, P147, DOI 10.1016/0277-9536(83)90248-4; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Madsen HO, 2009, TROP MED INT HEALTH, V14, P1315, DOI 10.1111/j.1365-3156.2009.02374.x; May C, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-182; Mesko Natasha, 2003, BMC Int Health Hum Rights, V3, P3, DOI 10.1186/1472-698X-3-3; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Mohan P, 2008, J PERINATOL, V28, pS31, DOI 10.1038/jp.2008.167; National Health Mission. Government of Uttar Pradesh, 108 SAM SWASTH SEW U; National Health Mission. Government of Uttar Pradesh, 102 NAT AMB SERV UTT; Nichter M, 1994, Med Anthropol, V15, P353; Pillai R, 2003, SOC SCI MED, V57, P783, DOI 10.1016/S0277-9536(02)00448-3; Registrar General of India, 2011, SAMPL REG SYST SRS 2; Registrar General of India, 2012, ANN HLTH SURV UTT PR; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Ryan G.W., 2003, FIELD METHOD, V15, P85, DOI DOI 10.1177/1525822X02239569; Sreeramareddy Chandrashekhar T, 2006, BMC Int Health Hum Rights, V6, P7, DOI 10.1186/1472-698X-6-7; Srivastava NM, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-61; Srivastava NM, 2008, INDIAN PEDIATR, V45, P229; Taffa N, 2005, TROP MED INT HEALTH, V10, P240, DOI 10.1111/j.1365-3156.2004.01381.x; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Thurmond VA, 2001, J NURS SCHOLARSHIP, V33, P253, DOI 10.1111/j.1547-5069.2001.00253.x; Ukwaja KN, 2012, INT HEALTH, V4, P289, DOI 10.1016/j.inhe.2012.09.001; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Walley J, 2008, LANCET, V372, P1001, DOI 10.1016/S0140-6736(08)61409-9; WHO, 2008, INT MAN CHILDH ILLN; Winch PJ, 2005, LANCET, V366, P478, DOI 10.1016/S0140-6736(05)66836-5; Winch PJ, 2003, FINAL REPORT FORMATI	48	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123135	10.1371/journal.pone.0123135	http://dx.doi.org/10.1371/journal.pone.0123135			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XJ	25898211	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600019
J	Cheng, WP; Wang, BW; Lo, HM; Shyu, KG				Cheng, Wen-Pin; Wang, Bao-Wei; Lo, Huey-Ming; Shyu, Kou-Gi			Mechanical Stretch Induces Apoptosis Regulator TRB3 in Cultured Cardiomyocytes and Volume-Overloaded Heart	PLOS ONE			English	Article							ER STRESS; GENE; TRIBBLES; CHOP; AKT; PHOSPHORYLATION; OVEREXPRESSION; INHIBITION; EXPRESSION; INDUCTION	The expression of TRB3 (tribbles 3), an apoptosis regulated gene, increases during endoplasmic reticulum (ER) stress. How mechanical stress affects the regulation of TRB3 in cardiomyocytes during apoptosis is not fully understood. An in vivo model of aorta-caval shunt in adult rats demonstrated the increased TRB3 protein expression in the myocardium. The tumor necrosis factor-alpha (TNF-alpha) antagonist etanercept reversed the TRB3 protein expression and cardiomyocyte apoptosis induced by AV shunt. An in vitro model of cyclic stretch in neonatal rats was also used to investigate TRB3 expression. We hypothesized that cardiomyocyte apoptosis induced by cyclic stretch is TRB3 dependent. Neonatal rat cardiomyocytes grown on a flexible membrane base were stretched by vacuum to 20% of maximum elongation, at 60 cycles/min. Cyclic stretch significantly increased TRB3 protein and mRNA expression. Addition of c-jun N-terminal kinase (JNK) inhibitor SP600125, TNF-alpha antibody and etanercept 30 min before stretch reversed the induction of TRB3 protein induced by stretch. Cyclic stretch induced the DNA-binding activity of growth arrest and DNA damaged inducible gene-153 (GADD153) by electrophoretic mobility shift assay. SP600125, JNK siRNA, TNF-alpha antibody and etanercept abolished the binding activity induced by stretch. TRB3 promoter activity was enhanced by stretch and TRB3-mut plasmid, SP600125, TNF-alpha antibody and etanercept attenuated TRB3 promoter activity induced by stretch. Exogenous administration of TNF-alpha recombinant protein to the non-stretched cardiomyocytes increased TRB3 protein expression similar to that seen after stretch. Cyclic stretch induced cardiomyocyte apoptosis is inhibited by TRB3 siRNA and etanercept. The stretch-induced TRB3 is mediated by TNF-alpha. JNK and GADD153 pathway. These results indicate that TRB3 plays an important role in stretch-induced cardiomyocyte apoptosis.	[Cheng, Wen-Pin; Wang, Bao-Wei] Shin Kong Wu Ho Mem Hosp, Dept Med Educ & Res, Taipei, Taiwan; [Lo, Huey-Ming; Shyu, Kou-Gi] Shin Kong Wu Ho Mem Hosp, Div Cardiol, Taipei, Taiwan; [Lo, Huey-Ming] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Shyu, Kou-Gi] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan	Shin Kong Wu Ho Su Memorial Hospital; Shin Kong Wu Ho Su Memorial Hospital; Fu Jen Catholic University; Taipei Medical University	Shyu, KG (corresponding author), Shin Kong Wu Ho Mem Hosp, Div Cardiol, Taipei, Taiwan.	shyukg@ms12.hinet.net			National Science Council, Executive Yuan, Taiwan; Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan	National Science Council, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan); Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan	This study was sponsored in part from National Science Council, Executive Yuan, Taiwan and Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar MA, 2012, J VASC RES, V49, P463, DOI 10.1159/000339151; Avery J, 2010, CIRC RES, V106, P1516, DOI 10.1161/CIRCRESAHA.109.211920; Boltzen U, 2012, J MOL CELL CARDIOL, V52, P1056, DOI 10.1016/j.yjmcc.2012.01.015; Bromati CR, 2011, AM J PHYSIOL-REG I, V300, pR92, DOI 10.1152/ajpregu.00169.2010; Chandar S, 2010, CIRC RES, V106, P573, DOI 10.1161/CIRCRESAHA.109.204388; Chen SY, 2012, FOOD CHEM TOXICOL, V50, P3025, DOI 10.1016/j.fct.2012.06.006; Cheng WP, 2009, EUR J CLIN INVEST, V39, P960, DOI 10.1111/j.1365-2362.2009.02193.x; Cittadini A, 2012, CARDIOVASC RES, V96, P381, DOI 10.1093/cvr/cvs261; De Jong AM, 2013, J CELL MOL MED, V17, P743, DOI 10.1111/jcmm.12064; Ding WY, 2014, EXP MOL PATHOL, V96, P80, DOI 10.1016/j.yexmp.2013.12.003; Fawcett TW, 1996, J BIOL CHEM, V271, P14285, DOI 10.1074/jbc.271.24.14285; Formoso G, 2011, CARDIOVASC RES, V89, P184, DOI 10.1093/cvr/cvq255; Gutkowska J, 2011, J HYPERTENS, V29, P1203, DOI 10.1097/HJH.0b013e3283468392; Hill C, 2013, CARDIOVASC RES, V99, P121, DOI 10.1093/cvr/cvt094; Honsho S, 2009, CIRC RES, V105, P1149, DOI 10.1161/CIRCRESAHA.109.208199; Hua F, 2011, J CELL SCI, V124, P3235, DOI 10.1242/jcs.082875; Izrailit J, 2013, P NATL ACAD SCI USA, V110, P1714, DOI 10.1073/pnas.1214014110; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Koh HJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2851; Kristiansen M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-551; Lee JH, 2013, BIOCHEM BIOPH RES CO, V439, P327, DOI 10.1016/j.bbrc.2013.08.087; Logue SE, 2013, APOPTOSIS, V18, P537, DOI 10.1007/s10495-013-0818-6; Lv XX, 2013, CHIN J INTEGR MED, V19, P424, DOI 10.1007/s11655-011-0856-2; Mihailidou C, 2014, BIOCHIMIE, V99, P19, DOI 10.1016/j.biochi.2013.11.003; Moriya S, 2013, INT J ONCOL, V42, P1541, DOI 10.3892/ijo.2013.1870; Morse E, 2010, AM J PHYSIOL-RENAL, V299, pF965, DOI 10.1152/ajprenal.00236.2010; Muslin AJ, 2011, PEDIATR CARDIOL, V32, P317, DOI 10.1007/s00246-010-9879-2; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Peng W, 2010, CIRC RES, V106, P102, DOI 10.1161/CIRCRESAHA.109.210914; Prudente S, 2009, ACTA DIABETOL, V46, P79, DOI 10.1007/s00592-008-0087-y; Raaz U, 2009, MICROVASC RES, V77, P297, DOI 10.1016/j.mvr.2009.01.012; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Sun WX, 2014, FREE RADICAL BIO MED, V68, P22, DOI 10.1016/j.freeradbiomed.2013.11.015; Thaher F, 2011, INT IMMUNOPHARMACOL, V11, P1724, DOI 10.1016/j.intimp.2011.06.005; Tsoporis JN, 2010, CIRC RES, V106, P93, DOI 10.1161/CIRCRESAHA.109.195834; Wali VB, 2009, APOPTOSIS, V14, P1366, DOI 10.1007/s10495-009-0406-y; Wang ZH, 2012, DIABETES, V61, P463, DOI 10.2337/db11-0518; Wennemers M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2934; Zhang J, 2011, ORAL ONCOL, V47, P934, DOI 10.1016/j.oraloncology.2011.06.512; Zhou XP, 2011, IMMUNOPHARM IMMUNOT, V33, P594, DOI 10.3109/08923973.2010.549135	41	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123235	10.1371/journal.pone.0123235	http://dx.doi.org/10.1371/journal.pone.0123235			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898323	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600021
J	Duchesne, T; Fortin, D; Rivest, LP				Duchesne, Thierry; Fortin, Daniel; Rivest, Louis-Paul			Equivalence between Step Selection Functions and Biased Correlated Random Walks for Statistical Inference on Animal Movement	PLOS ONE			English	Article							CONDITIONAL LOGISTIC-REGRESSION; FINE-SCALE; WOODLAND CARIBOU; MODELS; BEHAVIOR; CONNECTIVITY; MECHANISMS; PATTERNS; ECOLOGY; SHAPES	Animal movement has a fundamental impact on population and community structure and dynamics. Biased correlated random walks (BCRW) and step selection functions (SSF) are commonly used to study movements. Because no studies have contrasted the parameters and the statistical properties of their estimators for models constructed under these two Lagrangian approaches, it remains unclear whether or not they allow for similar inference. First, we used the Weak Law of Large Numbers to demonstrate that the log-likelihood function for estimating the parameters of BCRW models can be approximated by the log-likelihood of SSFs. Second, we illustrated the link between the two approaches by fitting BCRW with maximum likelihood and with SSF to simulated movement data in virtual environments and to the trajectory of bison (Bison bison L.) trails in natural landscapes. Using simulated and empirical data, we found that the parameters of a BCRW estimated directly from maximum likelihood and by fitting an SSF were remarkably similar. Movement analysis is increasingly used as a tool for understanding the influence of landscape properties on animal distribution. In the rapidly developing field of movement ecology, management and conservation biologists must decide which method they should implement to accurately assess the determinants of animal movement. We showed that BCRW and SSF can provide similar insights into the environmental features influencing animal movements. Both techniques have advantages. BCRW has already been extended to allow for multi-state modeling. Unlike BCRW, however, SSF can be estimated using most statistical packages, it can simultaneously evaluate habitat selection and movement biases, and can easily integrate a large number of movement taxes at multiple scales. SSF thus offers a simple, yet effective, statistical technique to identify movement taxis.	[Duchesne, Thierry; Rivest, Louis-Paul] Univ Laval, Dept Math & Stat, Quebec City, PQ G1K 7P4, Canada; [Fortin, Daniel] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Fortin, Daniel] Univ Laval, Ctr Etud Foret, Dept Biol, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University; Laval University	Fortin, D (corresponding author), Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada.	daniel.fortin@bio.ulaval.ca	Fortin, Daniel/ABG-3554-2020; Rivest, Louis-Paul/AAU-9879-2020	Rivest, Louis-Paul/0000-0003-4351-4127; Duchesne, Thierry/0000-0001-9893-604X	Parks Canada; Natural Sciences and Engineering Research Council of Canada; Canadian Foundation for Innovation	Parks Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation)	Funding was provided by Parks Canada (www.pc.gc.ca), the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca), and the Canadian Foundation for Innovation (www.innovation.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, MATH STAT METASTATIS; Barton KA, 2009, OIKOS, V118, P309, DOI 10.1111/j.1600-0706.2008.16936.x; Benhamou S, 2014, ECOL LETT, V17, P261, DOI 10.1111/ele.12225; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Coulon A, 2008, LANDSCAPE ECOL, V23, P603, DOI 10.1007/s10980-008-9220-0; Craiu RV, 2008, BIOMETRICAL J, V50, P97, DOI 10.1002/bimj.200610379; Dancose K, 2011, ECOL APPL, V21, P1871, DOI 10.1890/10-0779.1; Duchesne T, 2010, J ANIM ECOL, V79, P548, DOI 10.1111/j.1365-2656.2010.01670.x; Fagan WF, 2013, ECOL LETT, V16, P1316, DOI 10.1111/ele.12165; Forester JD, 2007, ECOL MONOGR, V77, P285, DOI 10.1890/06-0534; Forester JD, 2009, ECOLOGY, V90, P3554, DOI 10.1890/08-0874.1; Fortin D, 2005, OECOLOGIA, V145, P335, DOI 10.1007/s00442-005-0122-4; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Fortin D, 2009, ANIM BEHAV, V78, P887, DOI 10.1016/j.anbehav.2009.06.026; Fronhofer EA, 2013, OIKOS, V122, P857, DOI 10.1111/j.1600-0706.2012.21021.x; Gillies CS, 2011, ECOL APPL, V21, P944, DOI 10.1890/09-2090.1; Hodson J, 2010, J MAMMAL, V91, P607, DOI 10.1644/09-MAMM-A-289.1; Holyoak M, 2008, P NATL ACAD SCI USA, V105, P19060, DOI 10.1073/pnas.0800483105; Langrock R, 2012, ECOLOGY, V93, P2336, DOI 10.1890/11-2241.1; Latham ADM, 2011, ECOL APPL, V21, P2854, DOI 10.1890/11-0666.1; Latombe G., 2013, THESIS U MONTREAL MO; Latombe G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099938; Latombe G, 2014, J ANIM ECOL, V83, P185, DOI 10.1111/1365-2656.12108; Manly B.F.J., 2002, RESOURCE SELECTION A; Mardia KV, 2000, DIRECTIONAL STAT; McClintock BT, 2012, ECOL MONOGR, V82, P335, DOI 10.1890/11-0326.1; Moorcroft P.R., 2006, MECHANISTIC HOME RAN; Moorcroft PR, 2008, ECOLOGY, V89, P1112, DOI 10.1890/06-1985.1; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Northrup JM, 2012, J APPL ECOL, V49, P1159, DOI 10.1111/j.1365-2664.2012.02180.x; Presnell B, 1998, J AM STAT ASSOC, V93, P1068, DOI 10.2307/2669850; Rivest LP, 1997, BIOMETRIKA, V84, P717, DOI 10.1093/biomet/84.3.717; Schultz CB, 2001, ECOLOGY, V82, P1879, DOI 10.1890/0012-9658(2001)082[1879:EMDBIA]2.0.CO;2; Severns PM, 2013, LANDSCAPE ECOL, V28, P559, DOI 10.1007/s10980-013-9860-6; Turchin Peter, 1998; Vanak AT, 2013, ECOLOGY, V94, P2619, DOI 10.1890/13-0217.1	37	41	41	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0122947	10.1371/journal.pone.0122947	http://dx.doi.org/10.1371/journal.pone.0122947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898019	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600017
J	Li, X; Wang, BZ; Liu, WW; Gui, MM; Peng, Z; Meng, SD				Li, Xin; Wang, Baozhong; Liu, Weiwei; Gui, Mingming; Peng, Zheng; Meng, Songdong			Blockage of Conformational Changes of Heat Shock Protein gp96 on Cell Membrane by a alpha-Helix Peptide Inhibits HER2 Dimerization and Signaling in Breast Cancer	PLOS ONE			English	Article							CHAPERONE GP96; THERAPEUTIC-TARGET; GRP94; HOMEOSTASIS; GP96/GRP94; DOMAIN	Cell membrane translocation of heat shock protein gp96 from the endoplasmic reticulum has been observed in multiple tumors and is associated with tumor malignancy. However, the cancer-intrinsic function and the related mechanism of cell membrane gp96 as a pro-on-cogenic chaperone remain further elucidated. In this study, we found that inhibition of gp96 intramolecular conformational changes by a single alpha-helix peptide p37 dramatically increased its binding to HER2, whereas decreased HER2 dimerization, phosphorylation and downstream signaling. Targeting cell membrane gp96 promoted HER2 ubiquitination and subsequent lysosomal degradation, which led to decreased cell growth and increased apoptosis, and inhibited tumor growth in vivo. We also demonstrate that gp96 inhibitory peptide p37 synergized with trastuzumab to suppress cell growth and induce apoptosis. Our work demonstrates that blocking gp96 conformational changes directs HER2 for cellular degradation, and represents a new therapeutic strategy for inhibiting HER2 signaling in cancer.	[Li, Xin; Liu, Weiwei; Gui, Mingming; Meng, Songdong] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Li, Xin; Liu, Weiwei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Baozhong] Anhui Univ, Sch Life Sci, Hefei 230039, Peoples R China; [Peng, Zheng] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Anhui University; Chinese People's Liberation Army General Hospital	Peng, Z (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China.	zihpeng@sina.com; mengsd@im.ac.cn			Major State Basic Research Development Program of China (973 Program) [2014CB542602]; National Natural Science Foundation of China [31230026, 81321063, 81102018, 81471960]; Key Projects in the National Science & Technology Program [2013ZX10002001-003-003]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Program	This work was supported by a grant from Major State Basic Research Development Program of China (973 Program, No.2014CB542602), grants from the National Natural Science Foundation of China (31230026, 81321063, 81102018, 81471960), and grants from Key Projects in the National Science & Technology Program (2013ZX10002001-003-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chavany C, 1996, J BIOL CHEM, V271, P4974; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Ghosh R, 2011, CANCER RES, V71, P1871, DOI 10.1158/0008-5472.CAN-10-1872; Hong F, 2013, J BIOL CHEM, V288, P18243, DOI 10.1074/jbc.M113.468850; Hong RL, 1999, CLIN CANCER RES, V5, P1884; Hua YP, 2013, CLIN CANCER RES, V19, P6242, DOI 10.1158/1078-0432.CCR-13-2083; Kliger Y, 2009, P NATL ACAD SCI USA, V106, P13797, DOI 10.1073/pnas.0906514106; Koo BH, 2010, J BIOL CHEM, V285, P197, DOI 10.1074/jbc.M109.039677; Kropp LE, 2010, J IMMUNOL, V184, P5619, DOI 10.4049/jimmunol.0902368; Li X, 2015, INT J CANCER, V137, P512, DOI 10.1002/ijc.29405; Liu B, 2013, P NATL ACAD SCI USA, V110, P6877, DOI 10.1073/pnas.1302933110; Liu Z, 2009, EUR J IMMUNOL, V39, P3110, DOI 10.1002/eji.200939593; Morales C, 2014, CANCER RES, V74, P446, DOI 10.1158/0008-5472.CAN-13-1677; Patel PD, 2013, NAT CHEM BIOL, V9, P677, DOI [10.1038/NCHEMBIO.1335, 10.1038/nchembio.1335]; Rachidi S, 2015, J HEPATOL, V62, P879, DOI 10.1016/j.jhep.2014.11.010; Rosenbaum M, 2014, GENE DEV, V28, P1165, DOI 10.1101/gad.240762.114; Staron M, 2011, BLOOD, V117, P7136, DOI 10.1182/blood-2011-01-330464; Wu B, 2015, CANCER LETT, V359, P325, DOI 10.1016/j.canlet.2015.01.034; Wu S, 2012, J BIOL CHEM, V287, P19896, DOI 10.1074/jbc.M112.343848; Wu S, 2012, J BIOL CHEM, V287, P6735, DOI 10.1074/jbc.M111.309526	21	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124647	10.1371/journal.pone.0124647	http://dx.doi.org/10.1371/journal.pone.0124647			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898135	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600078
J	Olsen, NR; Bradley, P; Espehaug, B; Nortvedt, MW; Lygren, H; Frisk, B; Bjordal, JM				Olsen, Nina Rydland; Bradley, Peter; Espehaug, Birgitte; Nortvedt, Monica Wammen; Lygren, Hildegunn; Frisk, Bente; Bjordal, Jan Magnus			Impact of a Multifaceted and Clinically Integrated Training Program in Evidence-Based Practice on Knowledge, Skills, Beliefs and Behaviour among Clinical Instructors in Physiotherapy: A Non-Randomized Controlled Study	PLOS ONE			English	Article							EVIDENCE-BASED MEDICINE; NURSING-STUDENTS; THERAPY STUDENTS; IMPLEMENTATION; EXPERIENCES; INSTRUMENTS; PLACEMENT; ATTITUDES; BARRIERS	Background and Purpose Physiotherapists practicing at clinical placement sites assigned the role as clinical instructors (CIs), are responsible for supervising physiotherapy students. For CIs to role model evidence-based practice (EBP) they need EBP competence. The aim of this study was to assess the short and long term impact of a six-month multifaceted and clinically integrated training program in EBP on the knowledge, skills, beliefs and behaviour of CIs supervising physiotherapy students. Methods We invited 37 CIs to participate in this non-randomized controlled study. Three self-administered questionnaires were used pre- and post-intervention, and at six-month follow-up: 1) The Adapted Fresno test (AFT), 2) the EBP Belief Scale and 3) the EBP Implementation Scale. The analysis approach was linear regression modeling using Generalized Estimating Equations. Results In total, 29 CIs agreed to participate in the study: 14 were invited to participate in the intervention group and 15 were invited to participate in the control group. One in the intervention group and five in the control group were lost to follow-up. At follow-up, the group difference was statistically significant for the AFT (mean difference = 37, 95% CI (15.9 -58.1), p<0.001) and the EBP Beliefs scale (mean difference = 8.1, 95% CI (3.1 -13.2), p = 0.002), but not for the EBP Implementation scale (mean difference = 1.8. 95% CI (-4.5-8.1), p = 0.574). Comparing measurements over time, we found a statistically significant increase in mean scores related to all outcome measures for the intervention group only. Conclusions A multifaceted and clinically integrated training program in EBP was successful in improving EBP knowledge, skills and beliefs among CIs. Future studies need to ensure long-term EBP behaviour change, in addition to assessing CIs' abilities to apply EBP knowledge and skills when supervising students.	[Olsen, Nina Rydland; Espehaug, Birgitte; Nortvedt, Monica Wammen; Frisk, Bente; Bjordal, Jan Magnus] Bergen Univ Coll, Fac Hlth & Social Sci, Ctr Evidence Based Practice, Bergen, Norway; [Olsen, Nina Rydland; Bjordal, Jan Magnus] Univ Bergen, Dept Global Publ Hlth & Primary Care, Physiotherapy Res Grp, Bergen, Norway; [Bradley, Peter] Publ Hlth Wales, Cardiff, S Glam, Wales; [Lygren, Hildegunn] Bergen Univ Coll, Fac Hlth & Social Sci, Dept Physiotherapy, Bergen, Norway; [Lygren, Hildegunn; Frisk, Bente] Haukeland Hosp, Dept Physiotherapy, N-5021 Bergen, Norway	Western Norway University of Applied Sciences; University of Bergen; Western Norway University of Applied Sciences; University of Bergen; Haukeland University Hospital	Olsen, NR (corresponding author), Bergen Univ Coll, Fac Hlth & Social Sci, Ctr Evidence Based Practice, Bergen, Norway.	nina.rydland.olsen@hib.no	Bjordal, Jan Magnus/T-7122-2019	Nortvedt, Monica Wammen/0000-0002-1859-6071; Olsen, Nina Rydland/0000-0002-5173-1597; Espehaug, Birgitte/0000-0002-7287-8643	Bergen University College; Haukeland University Hospital; Haraldsplass Diakonale Hospital	Bergen University College; Haukeland University Hospital; Haraldsplass Diakonale Hospital	A minor grant from a development fund made this project possible. This project was a collaboration project between Bergen University College, Haukeland University Hospital and Haraldsplass Diakonale Hospital. Funding ensured that researchers and colleagues from different institutions could take part in the process of planning and conducting this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard S., 2001, PHYSIOTHERAPY, V87, P115, DOI [DOI 10.1016/S0031-9406(05)61078-4, 10.1016/S0031-9406(05)61078-4]; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Bleakley A., 2011, MED ED FUTURE IDENTI, P43, DOI DOI 10.1007/978-90-481-9692-0_4; Bradley P, 2005, EVALUATION REV, V29, P149, DOI 10.1177/0193841X04269085; Bradley P, 2005, THESIS U OSLO NORWAY; Bradley P. M. A., 2001, EUROPEAN J PUBLIC HL, V11, P238; Cole B, 2008, ADV HEALTH SCI EDUC, V13, P163, DOI 10.1007/s10459-006-9030-6; Dannapfel P, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-31; Dawes Martin, 2005, BMC Med Educ, V5, P1; Eccles MP, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-1; Frost JS, 2013, HDB TEACHING LEARNIN, P124; Glasziou P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1253; Hagler D, 2012, J CONTIN EDUC NURS, V43, P502, DOI 10.3928/00220124-20120815-27; Hankemeier DA, 2013, J ATHL TRAINING, V48, P382, DOI 10.4085/1062-6050-48.1.18; Ilic D, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-58; Jonsen E, 2013, NURS EDUC TODAY, V33, P297, DOI 10.1016/j.nedt.2012.06.012; Kljakovic Marjan, 2006, Aust Fam Physician, V35, P999; Kljakovic Marjan, 2004, Aust Fam Physician, V33, P376; Kongerud Ingrid Charlotte, 2013, Tidsskr Nor Laegeforen, V133, P1587, DOI 10.4045/tidsskr.12.1441; Kouhpayehzadeh J, 2006, J CONTIN EDUC HEALTH, V26, P210, DOI 10.1002/chp.72; Lave J., 1991, SITUATED LEARNING LE; Maben J, 2006, J ADV NURS, V55, P465, DOI 10.1111/j.1365-2648.2006.03939.x; McCluskey Annie, 2005, BMC Med Educ, V5, P40, DOI 10.1186/1472-6920-5-40; McCluskey A, 2009, J CONTIN EDUC HEALTH, V29, P119, DOI 10.1002/chp.20021; Melnyk BM, 2008, WORLDV EVID-BASED NU, V5, P208, DOI 10.1111/j.1741-6787.2008.00126.x; Meyer Kyle P, 2007, J Allied Health, V36, pe293; Mohide E Ann, 2007, Evid Based Nurs, V10, P36, DOI 10.1136/ebn.10.2.36; Mota da Silva T, 2014, MAN THER; Olsen NR, 2014, PHYSIOTHER RES INT, V19, P238, DOI 10.1002/pri.1590; Olsen NR, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-52; Oude Rengerink Katrien, 2013, Evid Based Med, V18, P129, DOI 10.1136/eb-2012-100969; Plack M, 2008, J PHYS THER ED, P7, DOI [10.1097/00001416-200810000-00002, DOI 10.1097/00001416-200810000-00002]; Plack M.M., 2006, J PHYS THER ED, V20, P37, DOI [10.1097/00001416-200601000-00005, DOI 10.1097/00001416-200601000-00005]; Scurlock-Evans L, 2014, PHYSIOTHERAPY, V100, P208, DOI 10.1016/j.physio.2014.03.001; Shaneyfelt T, 2006, JAMA-J AM MED ASSOC, V296, P1116, DOI 10.1001/jama.296.9.1116; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Skoien Anne Kari, 2009, Physiotherapy Theory and Practice, V25, P268, DOI 10.1080/09593980902782298; Spouse F, 1996, Nurs Times, V92, P32; Spouse J, 2001, J ADV NURS, V33, P512, DOI 10.1046/j.1365-2648.2001.01683.x; Stronge M, 2012, OCCUP THER INT, V19, P7, DOI 10.1002/oti.328; Taylor Rod S, 2004, BMC Med Educ, V4, P30, DOI 10.1186/1472-6920-4-30; Tilburt JC, 2008, J EVAL CLIN PRACT, V14, P780, DOI 10.1111/j.1365-2753.2008.00966.x; Tilburt JC, 2007, J EVAL CLIN PRACT, V13, P772, DOI 10.1111/j.1365-2753.2006.00752.x; Tilson JK, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-78; Twisk JW, 2013, APPL LONGITUDINAL DA; Utdannings-og forskningsdepartementet, 2005, RAMM FYS; Walczak J, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-64; Weberschock Tobias, 2013, Evid Based Med, V18, P170, DOI 10.1136/eb-2012-100801; Wenger E., 1998, COMMUNITIES PRACTICE; World Confederation of Physical Therapy, WCPT GUID CLIN ED CO; World Health Organization, PROC TRANSL AD INSTR; Yardley S, 2012, MED TEACH, V34, P161, DOI 10.3109/0142159X.2012.643264; Young T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086706	53	11	11	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124332	10.1371/journal.pone.0124332	http://dx.doi.org/10.1371/journal.pone.0124332			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XA	25894559	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700088
J	Tan, YD; Chandler, AM; Chaudhury, A; Neilson, JR				Tan, Yuan-De; Chandler, Anita M.; Chaudhury, Arindam; Neilson, Joel R.			A Powerful Statistical Approach for Large-Scale Differential Transcription Analysis	PLOS ONE			English	Article							RNA-SEQ; EXPRESSION ANALYSIS; SAGE; DISPERSION; PROFILES; PACKAGE; GENES; TESTS	Next generation sequencing (NGS) is increasingly being used for transcriptome-wide analysis of differential gene expression. The NGS data are multidimensional count data. Therefore, most of the statistical methods developed well for microarray data analysis are not applicable to transcriptomic data. For this reason, a variety of new statistical methods based on count data of transcript reads have been correspondingly proposed. But due to high cost and limitation of biological resources, current NGS data are still generated from a few replicate libraries. Some of these existing methods do not always have desirable performances on count data. We here developed a very powerful and robust statistical method based on beta and binomial distributions. Our method (mBeta t-test) is specifically applicable to sequence count data from small samples. Both simulated and real transcriptomic data showed mBeta t-test significantly outperformed the existing top statistical methods chosen in all 12 given scenarios and performed with high efficiency and high stability. The differentially expressed genes found by our method from real transcriptomic data were validated by qPCR experiments. Our method shows high power in finding truly differential expression, conservatively estimating FDR and high stability in RNA sequence count data derived from small samples. Our method can also be extended to genome-wide detection of differential splicing events.	[Neilson, Joel R.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Neilson, JR (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.	neilson@bcm.edu		Neilson, Joel R./0000-0002-3408-608X; Chaudhury, Arindam/0000-0001-5916-4534	Cancer Prevention and Research Institute of Texas [HIRP100475]; National Cancer Institute [CA126752, CA131474]; NATIONAL CANCER INSTITUTE [P50CA126752, R00CA131474] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by The Cancer Prevention and Research Institute of Texas (HIRP100475) and the National Cancer Institute (CA126752, CA131474). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baggerly KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-144; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-234; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r50; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Man MZ, 2000, BIOINFORMATICS, V16, P953, DOI 10.1093/bioinformatics/16.11.953; Mathews J, 1964, MATH METHODS PHYS; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Michiels EMC, 1999, PHYSIOL GENOMICS, V1, P83, DOI 10.1152/physiolgenomics.1999.1.2.83; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NIKOLAYEVA O, 2009, NOVYI MIR APR, P3, DOI DOI 10.1007/978-1-4939-0512-6_; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tan YD, 2011, AM J MOL BIOL, V1, P87; Tan YD, 2006, GENOMICS, V88, P846, DOI 10.1016/j.ygeno.2006.08.003; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu ZJ, 2010, GENOME RES, V20, P1730, DOI 10.1101/gr.108217.110; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	37	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123658	10.1371/journal.pone.0123658	http://dx.doi.org/10.1371/journal.pone.0123658			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894390	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700047
J	Wang, YK; Ning, ZY; Hu, Y; Chen, JD; Zhao, R; Chen, H; Ai, NJ; Guo, WZ; Zhang, TZ				Wang, Yangkun; Ning, Zhiyuan; Hu, Yan; Chen, Jiedan; Zhao, Rui; Chen, Hong; Ai, Nijiang; Guo, Wangzhen; Zhang, Tianzhen			Molecular Mapping of Restriction-Site Associated DNA Markers in Allotetraploid Upland Cotton	PLOS ONE			English	Article							VERTICILLIUM WILT; FIBER QUALITY; GENOME; DISCOVERY; RESISTANCE; QTLS	Upland cotton (Gossypium hirsutum L., 2n = 52, AADD) is an allotetraploid, therefore the discovery of single nucleotide polymorphism (SNP) markers is difficult. The recent emergence of genome complexity reduction technologies based on the next-generation sequencing (NGS) platform has greatly expedited SNP discovery in crops with highly repetitive and complex genomes. Here we applied restriction-site associated DNA (RAD) sequencing technology for de novo SNP discovery in allotetraploid cotton. We identified 21,109 SNPs between the two parents and used these for genotyping of 161 recombinant inbred lines (RILs). Finally, a high dense linkage map comprising 4,153 loci over 3500-cM was developed based on the previous result. Using this map quantitative trait locus (QTLs) conferring fiber strength and Verticillium Wilt (VW) resistance were mapped to a more accurate region in comparison to the 1576-cM interval determined using the simple sequence repeat (SSR) genetic map. This suggests that the newly constructed map has more power and resolution than the previous SSR map. It will pave the way for the rapid identification of the marker-assisted selection in cotton breeding and cloning of QTL of interest traits.	[Wang, Yangkun; Ning, Zhiyuan; Hu, Yan; Chen, Jiedan; Zhao, Rui; Guo, Wangzhen; Zhang, Tianzhen] Nanjing Agr Univ, Minist Educ, Natl Key Lab Crop Genet & Germplasm Enhancement, Cotton Hybrid R&D Engn Ctr, Nanjing 210095, Jiangsu, Peoples R China; [Chen, Hong] Xinjiang Acad Agr & Reclamat Sci, Cotton Res Inst, Shihezi 832000, Xinjiang, Peoples R China; [Ai, Nijiang] Shihezi Agr Sci & Tec Res Ctr, Shihezi 832000, Xinjiang, Peoples R China	Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Zhang, TZ (corresponding author), Nanjing Agr Univ, Minist Educ, Natl Key Lab Crop Genet & Germplasm Enhancement, Cotton Hybrid R&D Engn Ctr, Nanjing 210095, Jiangsu, Peoples R China.	cotton@njau.edu.cn			Major State Basic Research Development Program of China (973 Program) [2011CB109300]; National High Technology Research and Development Program of China (863 Program) [2011AA10A102]; Jiangsu province [BE2012329]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Jiangsu province	This work was supported by the Major State Basic Research Development Program of China (973 Program) (2011CB109300), the National High Technology Research and Development Program of China (863 Program) (2011AA10A102), and Jiangsu province (BE2012329). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An CF, 2007, MOL GENET GENOMICS, V278, P539, DOI 10.1007/s00438-007-0270-9; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Brubaker CL, 1999, GENOME, V42, P184, DOI 10.1139/gen-42-2-184; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Byers RL, 2012, THEOR APPL GENET, V124, P1201, DOI 10.1007/s00122-011-1780-8; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Chen AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096417; Chen H, 2009, THEOR APPL GENET, V119, P605, DOI 10.1007/s00122-009-1070-x; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Flagel LE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-302; Guo WZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-314; Hansey CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033071; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Jiang F, 2009, SCI CHINA SER C, V52, P872, DOI 10.1007/s11427-009-0110-8; Lacape JM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-132; Lacape JM, 2003, GENOME, V46, P612, DOI [10.1139/G03-050, 10.1139/g03-050]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071067; Mammadov J, 2012, INT J PANT PROD; Matsumura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087138; Ning ZY, 2013, CROP SCI, V53, P2304, DOI 10.2135/cropsci2012.12.0694; Ning ZY, 2014, EUPHYTICA, V195, P143, DOI 10.1007/s10681-013-0990-3; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Pfender WF, 2011, THEOR APPL GENET, V122, P1467, DOI 10.1007/s00122-011-1546-3; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Talukder ZI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098628; Ulloa M., 2000, Journal of Cotton Science, V4, P161; Van Deynze A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-125; van Poecke RMP, 2013, PLANT BIOTECHNOL J, V11, P809, DOI 10.1111/pbi.12072; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; WANG GL, 1995, THEOR APPL GENET, V91, P1153, DOI 10.1007/BF00223934; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang S., WINDOWS QTL CARTOGRA; Wang S, 2012, NAT METHODS, V9, P808, DOI [10.1038/nmeth.2023, 10.1038/NMETH.2023]; Xie SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068510; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang K, 2012, MOL BREEDING, V29, P335, DOI 10.1007/s11032-011-9549-y	40	36	38	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124781	10.1371/journal.pone.0124781	http://dx.doi.org/10.1371/journal.pone.0124781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894395	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700124
J	Naville, D; Labaronne, E; Vega, N; Pinteur, C; Canet-Soulas, E; Vidal, H; Le Magueresse-Battistoni, B				Naville, Danielle; Labaronne, Emmanuel; Vega, Nathalie; Pinteur, Claudie; Canet-Soulas, Emmanuelle; Vidal, Hubert; Le Magueresse-Battistoni, Brigitte			Metabolic Outcome of Female Mice Exposed to a Mixture of Low-Dose Pollutants in a Diet-Induced Obesity Model	PLOS ONE			English	Article							BISPHENOL-A; POLYCHLORINATED-BIPHENYLS; ENDOCRINE DISRUPTORS; PERINATAL EXPOSURE; INSULIN-RESISTANCE; FATTY LIVER; BODY-FAT; ADIPOSE; EXPRESSION; HEALTH	Pollutants are suspected to contribute to the etiology of obesity and related metabolic disorders. Apart from occupational exposure which concerns a subset of chemicals, humans are mostly exposed to a large variety of chemicals, all life-long and at low doses. Food ingestion is a major route of exposure and it is suggested that pollutants have a worsened impact when combined with a high-fat diet. In the experimental studies described herein, we aimed to add further evidence on the metabolic impact of food pollutants using a recently set up model in which mice are life-long fed a high-fat/high-sucrose diet (HFSD) with/without common food pollutants shown to exhibit metabolic disrupting activities. Specifically, this mixture comprised bisphenol A, dioxin, polychlorobiphenyl PCB153, and phthalate and was added in HFSD at doses resulting in mice exposure at the Tolerable Daily Intake dose range for each pollutant. We herein focused on the 7-week-old females which exhibited early signs of obesity upon HFSD feeding. We observed no signs of toxicity and no additional weight gain following exposure to the mixture but alleviated HFSD-induced glucose intolerance in the absence of alteration of gluconeogenesis and steatosis. It suggested that the observed metabolic improvement was more likely due to effects on muscle and/or adipose tissues rather than on the liver. Consistently, female mice exhibited enhanced lean/fat mass ratio and skeletal muscle insulin sensitivity. Moreover, expression levels of inflammatory markers were reduced in adipose tissue at 7 but enhanced at 12 weeks of age in agreement with the inverse alterations of glucose tolerance observed at these ages upon pollutant exposure in the HFSD-fed females. Collectively, these data suggest apparent biphasic effects of pollutants upon HFSD feeding along with obesity development. These effects were not observed in males and may depend on interactions between diet and pollutants.	[Naville, Danielle; Labaronne, Emmanuel; Vega, Nathalie; Pinteur, Claudie; Canet-Soulas, Emmanuelle; Vidal, Hubert; Le Magueresse-Battistoni, Brigitte] Univ Lyon 1, INSA Lyon, INSERM, INRA,UMR1397,CarMeN Lab,U1060, Oullins, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Le Magueresse-Battistoni, B (corresponding author), Univ Lyon 1, INSA Lyon, INSERM, INRA,UMR1397,CarMeN Lab,U1060, Oullins, France.	brigitte.lemagueresse@inserm.fr	Carmen, Team1/Y-7382-2019; Carmen, Team3/Y-7384-2019; Vidal, Hubert/M-6674-2017; Naville, Danielle/N-1200-2017; Le Magueresse-Battistoni, Brigitte/AAZ-5601-2021; Le Magueresse-Battistoni, Brigitte/M-6927-2017	Carmen, Team1/0000-0003-4234-1746; Carmen, Team3/0000-0002-3614-0924; Vidal, Hubert/0000-0002-9467-0317; Naville, Danielle/0000-0003-2615-6161; Le Magueresse-Battistoni, Brigitte/0000-0002-7247-4403; Le Magueresse-Battistoni, Brigitte/0000-0002-7247-4403; Lab, Carmen/0000-0002-5935-3236; Labaronne, Emmanuel/0000-0001-6314-7809	European Foundation of the Study of Diabetes (EFSD/Novo Nordisk, program); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement et du Travail (ANSES; Programme National Environnement-Sante-Travail) [EST-2010/2/2007]; "Region Rhone-Alpes", France	European Foundation of the Study of Diabetes (EFSD/Novo Nordisk, program); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement et du Travail (ANSES; Programme National Environnement-Sante-Travail)(French National Research Agency (ANR)); "Region Rhone-Alpes", France(Region Auvergne-Rhone-Alpes)	The authors declare that this research project was supported by grants from the European Foundation of the Study of Diabetes (EFSD/Novo Nordisk, program 2011) and the Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement et du Travail (ANSES; Programme National Environnement-Sante-Travail, EST-2010/2/2007). Emmanuel Labaronne is a recipient of "Region Rhone-Alpes", France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alligier M, 2013, J CLIN ENDOCR METAB, V98, P802, DOI 10.1210/jc.2012-3289; Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Alonso-Magdalena P, 2011, NAT REV ENDOCRINOL, V7, P346, DOI 10.1038/nrendo.2011.56; [Anonymous], 2005, EFSA J, V243, P1; [Anonymous], 2006, EFSA J, P1; Baillie-Hamilton PF, 2002, J ALTERN COMPLEM MED, V8, P185, DOI 10.1089/107555302317371479; Barouki R, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-42; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Braniste V, 2010, P NATL ACAD SCI USA, V107, P448, DOI 10.1073/pnas.0907697107; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Carpenter David O., 2008, Reviews on Environmental Health, V23, P59; Casals-Casas C, 2011, ANNU REV PHYSIOL, V73, P135, DOI 10.1146/annurev-physiol-012110-142200; Choi YJ, 2010, ENVIRON HEALTH PERSP, V118, P976, DOI 10.1289/ehp.0901751; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Di Gregorio GB, 2005, DIABETES, V54, P2305, DOI 10.2337/diabetes.54.8.2305; Dorne JLCM, 2010, TOXICOLOGY, V268, P156, DOI 10.1016/j.tox.2009.11.004; Emond C, 2006, ENVIRON HEALTH PERSP, V114, P1394, DOI 10.1289/ehp.8805; Faulds MH, 2012, J ENDOCRINOL, V212, P3, DOI 10.1530/JOE-11-0044; Gao H, 2008, MOL ENDOCRINOL, V22, P10, DOI 10.1210/me.2007-0121; Gout J, 2010, MOL CELL ENDOCRINOL, V319, P99, DOI 10.1016/j.mce.2010.01.021; Grun F, 2007, REV ENDOCR METAB DIS, V8, P161, DOI 10.1007/s11154-007-9049-x; Guyot E, 2013, DRUG DISCOV TODAY, V18, P479, DOI 10.1016/j.drudis.2012.11.014; Heindel JJ, 2009, MOL CELL ENDOCRINOL, V304, P90, DOI 10.1016/j.mce.2009.02.025; Ibrahim MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025170; Janesick A, 2012, INT J ANDROL, V35, P437, DOI 10.1111/j.1365-2605.2012.01247.x; Kerr C. A., 2014, CRITICAL REV MICROBI; Kim MJ, 2012, ENVIRON HEALTH PERSP, V120, P508, DOI 10.1289/ehp.1104282; La Merrill M, 2013, ENVIRON HEALTH PERSP, V121, P162, DOI 10.1289/ehp.1205485; Lai KD, 2003, J BIOL CHEM, V278, P36418, DOI 10.1074/jbc.M303913200; Lee DH, 2014, ENDOCR REV; List EO, 2011, ENDOCR REV, V32, P356, DOI 10.1210/er.2010-0009; Magre S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040306; Marmugi A, 2012, HEPATOLOGY, V55, P395, DOI 10.1002/hep.24685; Matthews Jason, 2006, Nucl Recept Signal, V4, pe016; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; Milbrath MO, 2009, ENVIRON HEALTH PERSP, V117, P417, DOI 10.1289/ehp.11781; Miyawaki J, 2007, J ATHEROSCLER THROMB, V14, P245, DOI 10.5551/jat.E486; Naville D, 2013, FASEB J, V27, P3860, DOI 10.1096/fj.13-231670; Naville D, 2011, TOXICOL LETT, V207, P251, DOI 10.1016/j.toxlet.2011.09.019; Nieuwdorp M, 2014, BRIT J SURG, V101, P887, DOI 10.1002/bjs.9549; Norstrom K, 2010, ENVIRON INT, V36, P855, DOI 10.1016/j.envint.2009.03.005; Rebourcet D, 2010, INT J ANDROL, V33, P413, DOI 10.1111/j.1365-2605.2009.01020.x; Riant E, 2009, ENDOCRINOLOGY, V150, P2109, DOI 10.1210/en.2008-0971; Ruzzin J, 2010, ENVIRON HEALTH PERSP, V118, P465, DOI 10.1289/ehp.0901321; Silins I, 2011, INT J ENV RES PUB HE, V8, P629, DOI 10.3390/ijerph8030629; Sun Q, 2014, ENVIRON HEALTH PERSP, V122, P616, DOI 10.1289/ehp.1307201; Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597; Tubbs E, 2014, DIABETES, V63, P3279, DOI 10.2337/db13-1751; Turner N, 2014, J ENDOCRINOL, V220, pT61, DOI 10.1530/JOE-13-0397; van Leeuwen FXR, 2000, CHEMOSPHERE, V40, P1095, DOI 10.1016/S0045-6535(99)00358-6; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Vandormael-Pournin S, 2014, CELL DEATH DIFFERENT; Wahlang B, 2013, J NUTR BIOCHEM, V24, P1587, DOI 10.1016/j.jnutbio.2013.01.009; Wei J, 2011, ENDOCRINOLOGY, V152, P3049, DOI 10.1210/en.2011-0045; *WHO, 2003, 55 WHO; Yoon M, 2010, PPAR RES, V2010, DOI 10.1155/2010/584296; Zhu L, 2013, DIABETES, V62, P424, DOI 10.2337/db11-1718; Zota AR, 2014, ENVIRON HEALTH PERSP, V122, P235, DOI 10.1289/ehp.1306681	59	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124015	10.1371/journal.pone.0124015	http://dx.doi.org/10.1371/journal.pone.0124015			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909471	Green Submitted, Green Published, gold			2022-12-27	WOS:000353376800055
J	Wu, SY; Liu, SY; Liu, ZM; Huang, JF; Pu, XY; Li, J; Yang, DH; Deng, HJ; Yang, N; Xu, JS				Wu, Shiyang; Liu, Suyan; Liu, Zhiming; Huang, Jiefeng; Pu, Xiaoyu; Li, Jing; Yang, Dinghua; Deng, Haijun; Yang, Ning; Xu, Jiasen			Classification of Circulating Tumor Cells by Epithelial-Mesenchymal Transition Markers	PLOS ONE			English	Article							BREAST-CANCER; METASTASIS; VIMENTIN; TWIST; MIGRATION; EPCAM	In cancer, epithelial-mesenchymal transition (EMT) is associated with metastasis. Characterizing EMT phenotypes in circulating tumor cells (CTCs) has been challenging because epithelial marker-based methods have typically been used for the isolation and detection of CTCs from blood samples. The aim of this study was to use the optimized CanPatrol CTC enrichment technique to classify CTCs using EMT markers in different types of cancers. The first step of this technique was to isolate CTCs via a filter-based method; then, an RNA in situ hybridization (RNA-ISH) method based on the branched DNA signal amplification technology was used to classify the CTCs according to EMT markers. Our results indicated that the efficiency of tumor cell recovery with this technique was at least 80%. When compared with the non-optimized method, the new method was more sensitive and more CTCs were detected in the 5-ml blood samples. To further validate the new method, 164 blood samples from patients with liver, nasopharyngeal, breast, colon, gastric cancer, or nonsmall-cell lung cancer (NSCLC) were collected for CTC isolation and characterization. CTCs were detected in 107(65%) of 164 blood samples, and three CTC subpopulations were identified using EMT markers, including epithelial CTCs, biophenotypic epithelial/mesenchymal CTCs, and mesenchymal CTCs. Compared with the earlier stages of cancer, mesenchymal CTCs were more commonly found in patients in the metastatic stages of the disease in different types of cancers. Circulating tumor microemboli (CTM) with a mesenchymal phenotype were also detected in the metastatic stages of cancer. Classifying CTCs by EMT markers helps to identify the more aggressive CTC subpopulation and provides useful evidence for determining an appropriate clinical approach. This method is suitable for a broad range of carcinomas.	[Wu, Shiyang; Liu, Suyan; Liu, Zhiming; Huang, Jiefeng; Pu, Xiaoyu; Xu, Jiasen] SurExam Biotech, Guangzhou Technol Innovat Base, Guangzhou, Guangdong, Peoples R China; [Li, Jing] Guangzhou Mil Command, Guangzhou Gen Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China; [Yang, Dinghua] Guangzhou Nanfang Hosp, Dept Hepatobiliary Surg, Guangzhou, Guangdong, Peoples R China; [Deng, Haijun] Guangzhou Nanfang Hosp, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China; [Yang, Ning] Guangdong Coll Pharm, Hosp 1, Dept Pathol, Guangzhou, Guangdong, Peoples R China	Southern Theater Command General Hospital; Guangdong Pharmaceutical University	Xu, JS (corresponding author), SurExam Biotech, Guangzhou Technol Innovat Base, 80 Lan Yue Rd, Guangzhou, Guangdong, Peoples R China.	jsx_surexam@sina.cn	Liu, Zhiming/GXG-6785-2022; Liu, Zhiming/AGO-6824-2022		SurExam BioTech	SurExam BioTech	This study was funded by SurExam BioTech. The funder provided support in the form of salaries for authors SW, SL, ZL, JH, XP and JX, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; DOMAGALA W, 1990, AM J PATHOL, V136, P219; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Giuliano M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2907; Gorges TM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-178; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Hou JM, 2011, AM J PATHOL, V178, P989, DOI 10.1016/j.ajpath.2010.12.003; Kallergi G, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2896; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Konigsberg R, 2011, ACTA ONCOL, V50, P700, DOI 10.3109/0284186X.2010.549151; Ksiazkiewicz M, 2012, PATHOBIOLOGY, V79, P195, DOI 10.1159/000337106; Larsson A, 2004, NEUROCHEM RES, V29, P2069, DOI 10.1007/s11064-004-6880-2; Li YM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.347; McInroy L, 2007, BIOCHEM BIOPH RES CO, V360, P109, DOI 10.1016/j.bbrc.2007.06.036; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tsongalis GJ, 2006, AM J CLIN PATHOL, V126, P448, DOI 10.1039/90BU6KDXANFLN4RJ; Wu SY, 2014, CLIN CHEM LAB MED, V52, P243, DOI 10.1515/cclm-2013-0558; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Yu WL, 2008, DEV DYNAM, V237, P2716, DOI 10.1002/dvdy.21627; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhao Y, 2008, CELL BIOCHEM FUNCT, V26, P571, DOI 10.1002/cbf.1478	26	183	202	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123976	10.1371/journal.pone.0123976	http://dx.doi.org/10.1371/journal.pone.0123976			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909322	Green Published, Green Submitted, gold			2022-12-27	WOS:000353376800052
J	Chen, J; Lin, MY; Hrabovsky, A; Pedrosa, E; Dean, J; Jain, S; Zheng, DY; Lachman, HM				Chen, Jian; Lin, Mingyan; Hrabovsky, Anastasia; Pedrosa, Erika; Dean, Jason; Jain, Swati; Zheng, Deyou; Lachman, Herbert M.			ZNF804A Transcriptional Networks in Differentiating Neurons Derived from Induced Pluripotent Stem Cells of Human Origin	PLOS ONE			English	Article							MATERNAL IMMUNE ACTIVATION; GENOME-WIDE ASSOCIATION; AUTISM SPECTRUM DISORDERS; BIPOLAR DISORDER; PRENATAL INFECTION; CANDIDATE GENES; NEURODEVELOPMENTAL PATHWAYS; INFLAMMATORY CYTOKINES; INCREASED EXPRESSION; PREFRONTAL CORTEX	ZNF804A (Zinc Finger Protein 804A) has been identified as a candidate gene for schizophrenia (SZ), autism spectrum disorders (ASD), and bipolar disorder (BD) in replicated genome wide association studies (GWAS) and by copy number variation (CNV) analysis. Although its function has not been well-characterized, ZNF804A contains a C2H2-type zinc-finger domain, suggesting that it has DNA binding properties, and consequently, a role in regulating gene expression. To further explore the role of ZNF804A on gene expression and its downstream targets, we used a gene knockdown (KD) approach to reduce its expression in neural progenitor cells (NPCs) derived from induced pluripotent stem cells (iPSCs). KD was accomplished by RNA interference (RNAi) using lentiviral particles containing shRNAs that target ZNF804A mRNA. Stable transduced NPC lines were generated after puromycin selection. A control cell line expressing a random (scrambled) shRNA was also generated. Neuronal differentiation was induced, RNA was harvested after 14 days and transcriptome analysis was carried out using RNA-seq. 1815 genes were found to be differentially expressed at a nominally significant level (p<0.05); 809 decreased in expression in the KD samples, while 1106 increased. Of these, 370 achieved genome wide significance (FDR<0.05); 125 were lower in the KD samples, 245 were higher. Pathway analysis showed that genes involved in interferon-signaling were enriched among those that were down-regulated in the KD samples. Correspondingly, ZNF804A KD was found to affect interferon-alpha 2 (IFNA2)-mediated gene expression. The findings suggest that ZNF804A may affect a differentiating neuron's response to inflammatory cytokines, which is consistent with models of SZ and ASD that support a role for infectious disease, and/or autoimmunity in a subgroup of patients.	[Chen, Jian; Hrabovsky, Anastasia; Pedrosa, Erika; Dean, Jason; Jain, Swati; Lachman, Herbert M.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA; [Lin, Mingyan; Zheng, Deyou; Lachman, Herbert M.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Zheng, Deyou; Lachman, Herbert M.] Albert Einstein Coll Med, Dominick Purpura Dept Neurosci, Bronx, NY 10467 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Lachman, Herbert M.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Zheng, DY (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.	Deyou.Zheng@einstein.yu.edu; Herb.Lachman@einstein.yu.edu	lin, mingyan/HDL-9420-2022	Zheng, Deyou/0000-0003-4354-5337	National Institute of Mental Health [MH073164, MH097893, MH099427, MH087840]; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087840, R21MH087840, R01MH073164, R01MH099427, R21MH097893] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health (MH073164, MH097893, MH099427, and MH087840). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abazyan B, 2014, SCHIZOPHRENIA BULL, V40, P575, DOI 10.1093/schbul/sbt071; Abdallah MW, 2012, BRAIN BEHAV IMMUN, V26, P170, DOI 10.1016/j.bbi.2011.09.003; AL-Ayadhi LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-158; Almeida-Suhett CP, 2014, J NEUROTRAUM, V31, P683, DOI 10.1089/neu.2013.3029; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arion D, 2007, BIOL PSYCHIAT, V62, P711, DOI 10.1016/j.biopsych.2006.12.021; Arrode-Bruses G, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-83; Atladottir HO, 2012, PEDIATRICS, V130, pE1447, DOI 10.1542/peds.2012-1107; Bachus SE, 1997, J PSYCHIATR RES, V31, P233, DOI 10.1016/S0022-3956(96)00041-6; Barry G, 2014, MOL PSYCHIATR, V19, P486, DOI 10.1038/mp.2013.45; Bek MJ, 2003, J IMMUNOL, V170, P931, DOI 10.4049/jimmunol.170.2.931; Beumer W, 2012, PSYCHONEUROENDOCRINO, V37, P1901, DOI 10.1016/j.psyneuen.2012.04.001; Blake J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090894; Borovcanin M, 2012, J PSYCHIATR RES, V46, P1421, DOI 10.1016/j.jpsychires.2012.08.016; Boulanger LM, 2004, NEURON GLIA BIOL, V1, P283, DOI 10.1017/S1740925X05000128; Brimberg L, 2013, MOL PSYCHIATR, V18, P1171, DOI 10.1038/mp.2013.101; Brown AS, 2012, DEV NEUROBIOL, V72, P1272, DOI 10.1002/dneu.22024; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774; Canetta SE, 2012, TRANSL NEUROSCI, V3, P320, DOI 10.2478/s13380-012-0045-6; Carter CJ, 2009, SCHIZOPHRENIA BULL, V35, P1163, DOI 10.1093/schbul/sbn054; Chen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075682; Chen XX, 2011, BIOCHEM BIOPH RES CO, V404, P1029, DOI 10.1016/j.bbrc.2010.12.104; Chiang SSW, 2013, PSYCHIAT CLIN NEUROS, V67, P228, DOI 10.1111/pcn.12040; Chintawar S, 2009, STEM CELLS, V27, P838, DOI 10.1002/stem.25; Connor CM, 2012, SCHIZOPHR RES, V140, P175, DOI 10.1016/j.schres.2012.06.037; Corvin A, 2014, BIOL PSYCHIAT, V75, P276, DOI 10.1016/j.biopsych.2013.09.018; Davis LK, 2012, AM J MED GENET A, V158A, P1654, DOI 10.1002/ajmg.a.35396; Debnath M, 2014, SCHIZOPHRENIA BULL, V40, P1412, DOI 10.1093/schbul/sbu049; Declercq J, 2013, STEM CELLS DEV, V22, P2017, DOI 10.1089/scd.2012.0651; Del Boca C, 2012, NEUROSCIENCE, V218, P185, DOI 10.1016/j.neuroscience.2012.05.022; Desbonnet L, 2012, BRAIN BEHAV IMMUN, V26, P660, DOI 10.1016/j.bbi.2012.02.010; Di Schiavi E, 2013, CURR GENOMICS, V14, P2, DOI 10.2174/138920213804999174; Dimitrov DH, 2013, SCHIZOPHR RES, V151, P29, DOI 10.1016/j.schres.2013.10.019; Ding ML, 2014, PROG NEURO-PSYCHOPH, V51, P78, DOI 10.1016/j.pnpbp.2014.01.001; Djurovic S, 2010, J AFFECT DISORDERS, V126, P312, DOI 10.1016/j.jad.2010.04.007; Drexhage RC, 2008, SCHIZOPHR RES, V102, P352, DOI 10.1016/j.schres.2008.03.018; Drummond DL, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-31; Eizirik DL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002552; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Fatjo-Vilas M, 2012, BIOL PSYCHIAT, V72, P758, DOI 10.1016/j.biopsych.2012.04.035; Garbett KA, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.24; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Gesundheit B, 2013, J AUTOIMMUN, V44, P1, DOI 10.1016/j.jaut.2013.05.005; Ghanizadeh A, 2011, INT J HYPERTHER, V27, P737, DOI 10.3109/02656736.2011.604665; Girgenti MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032404; Gordon RJ, 2009, MOL CELL NEUROSCI, V41, P219, DOI 10.1016/j.mcn.2009.03.001; Goshen I, 2009, FRONT NEUROENDOCRIN, V30, P30, DOI 10.1016/j.yfrne.2008.10.001; Griswold AJ, 2012, HUM MOL GENET, V21, P3513, DOI 10.1093/hmg/dds164; Guyon A, 2009, NEUROSCIENCE, V162, P1072, DOI 10.1016/j.neuroscience.2009.05.048; Hammer C, 2014, MOL PSYCHIATR, V19, P1143, DOI 10.1038/mp.2013.110; Hamshere ML, 2013, MOL PSYCHIATR, V18, P708, DOI 10.1038/mp.2012.67; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hicks DJ, 2013, J COMP PATHOL, V149, P446, DOI 10.1016/j.jcpa.2013.04.001; Hill MJ, 2012, HUM MOL GENET, V21, P1018, DOI 10.1093/hmg/ddr532; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hornberg M, 2009, J NEUROCHEM, V110, P1263, DOI 10.1111/j.1471-4159.2009.06216.x; Horvath S, 2014, BIOL PSYCHIAT, V75, P316, DOI 10.1016/j.biopsych.2013.06.010; Hovey D, 2014, SOC NEUROSCI-UK, V9, P378, DOI 10.1080/17470919.2014.897995; Hsiao EY, 2012, P NATL ACAD SCI USA, V109, P12776, DOI 10.1073/pnas.1202556109; Hsiao EY, 2011, BRAIN BEHAV IMMUN, V25, P604, DOI 10.1016/j.bbi.2010.12.017; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Hwang Y, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.94; Inoue T, 2008, J NEUROSCI, V28, P4712, DOI 10.1523/JNEUROSCI.5735-07.2008; Jyonouchi H, 2011, J NEUROIMMUNOL, V238, P73, DOI 10.1016/j.jneuroim.2011.07.001; Kalman S, 2014, EXP CELL RES, V320, P343, DOI 10.1016/j.yexcr.2013.10.019; Kamnasaran D, 2003, J MED GENET, V40, P325, DOI 10.1136/jmg.40.5.325; Kato T, 2007, PSYCHIAT CLIN NEUROS, V61, P3, DOI 10.1111/j.1440-1819.2007.01604.x; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Khorooshi R, 2008, J IMMUNOL, V181, P7284, DOI 10.4049/jimmunol.181.10.7284; Kim DS, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00109; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koga M, 2009, HUM MOL GENET, V18, P2483, DOI 10.1093/hmg/ddp166; Koo JW, 2009, NEUROSCI LETT, V456, P39, DOI 10.1016/j.neulet.2009.03.068; Krumm N, 2014, TRENDS NEUROSCI, V37, P95, DOI 10.1016/j.tins.2013.11.005; Kuo YL, 2012, J CLIN NEUROSCI, V19, P896, DOI 10.1016/j.jocn.2011.10.006; Kutzleb C, 2007, HISTOCHEM CELL BIOL, V127, P13, DOI 10.1007/s00418-006-0209-y; Kwon E, 2013, MOL PSYCHIATR, V18, P11, DOI 10.1038/mp.2011.170; Lacerda HR, 2014, J INTERF CYTOK RES, V34, P385, DOI 10.1089/jir.2013.0029; Landreau F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051068; Lawson-Yuen A, 2008, EUR J HUM GENET, V16, P614, DOI 10.1038/sj.ejhg.5202006; Lee SY, 2011, DEV NEUROBIOL, V71, P83, DOI 10.1002/dneu.20815; Lee Y, 2012, PSYCHIAT GENET, V22, P206, DOI 10.1097/YPG.0b013e328353ae3d; Lee YH, 2013, GENE, V525, P107, DOI 10.1016/j.gene.2013.04.014; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Lin MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094968; Lin MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044017; Listwak SJ, 2013, NEUROSCIENCE, V250, P282, DOI 10.1016/j.neuroscience.2013.07.013; Loe-Mie Y, 2010, HUM MOL GENET, V19, P2841, DOI 10.1093/hmg/ddq184; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Marchetto MC, 2011, HUM MOL GENET, V20, pR109, DOI 10.1093/hmg/ddr336; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Martin CL, 2007, AM J MED GENET B, V144B, P869, DOI 10.1002/ajmg.b.30530; Matsumoto K, 2012, NEUROSCI RES, V73, P257, DOI 10.1016/j.neures.2012.04.004; McAllister AK, 2014, BIOL PSYCHIAT, V75, P262, DOI 10.1016/j.biopsych.2013.10.003; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Miller BJ, 2011, BIOL PSYCHIAT, V70, P663, DOI 10.1016/j.biopsych.2011.04.013; Miya K, 2013, BRAIN DEV; Miya K, 2014, BRAIN DEV-JPN, V36, P645, DOI 10.1016/j.braindev.2013.10.005; Modinos G, 2013, SCHIZOPHR RES, V150, P356, DOI 10.1016/j.schres.2013.09.010; Na KS, 2014, PROG NEURO-PSYCHOPH, V48, P277, DOI 10.1016/j.pnpbp.2012.10.022; Nilsberth C, 2009, ENDOCRINOLOGY, V150, P1850, DOI 10.1210/en.2008-0806; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; O'Leary C, 2014, NEUROSCIENCE, V277, P294, DOI 10.1016/j.neuroscience.2014.06.028; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Olechnowicz SWZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044564; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Oxenkrug GF, 2011, J NEURAL TRANSM, V118, P75, DOI 10.1007/s00702-010-0475-7; Parker-Athill EC, 2010, NEUROSIGNALS, V18, P113, DOI 10.1159/000319828; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Pedrosa E, 2011, J NEUROGENET, V25, P88, DOI 10.3109/01677063.2011.597908; Pickard BS, 2009, MOL PSYCHIATR, V14, P874, DOI 10.1038/mp.2008.24; Pinciroli P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-508; Pirnik Z, 2010, PEPTIDES, V31, P139, DOI 10.1016/j.peptides.2009.09.035; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P96, DOI 10.1093/schbul/sbn155; Ramos PS, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-4; Rao JS, 2013, SCHIZOPHR RES, V147, P24, DOI 10.1016/j.schres.2013.02.017; Reaux-Le Goazigo A, 2013, PROG NEUROBIOL, V104, P67, DOI 10.1016/j.pneurobio.2013.02.001; Redies C, 2012, BRAIN RES, V1470, P130, DOI 10.1016/j.brainres.2012.06.020; Riley B, 2010, MOL PSYCHIATR, V15, P29, DOI 10.1038/mp.2009.109; Riordan JD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003441; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rosito M, 2012, J NEUROSCI, V32, P3154, DOI 10.1523/JNEUROSCI.4046-11.2012; Ross HE, 2013, BRAIN BEHAV IMMUN, V31, P76, DOI 10.1016/j.bbi.2012.12.021; Rostene W, 2011, J NEUROCHEM, V118, P680, DOI 10.1111/j.1471-4159.2011.07371.x; Roumier A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002595; Saben J, 2013, AM J PHYSIOL-ENDOC M, V305, pE1, DOI 10.1152/ajpendo.00076.2013; Saetre P, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-46; Seibt J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048675; Shao W, 2013, NATURE, V494, P90, DOI 10.1038/nature11748; Siegel BI, 2014, BIOL PSYCHIAT, V76, P160, DOI 10.1016/j.biopsych.2013.09.019; Soronen P, 2010, MOL PSYCHIATR, V15, P4, DOI 10.1038/mp.2009.86; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Steinberg S, 2011, MOL PSYCHIATR, V16, P59, DOI 10.1038/mp.2009.149; Steinecke A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00190; Steiner J, 2014, PROG NEURO-PSYCHOPH, V48, P287, DOI 10.1016/j.pnpbp.2012.09.016; Strange A, 2012, BIOL PSYCHIAT, V72, P620, DOI 10.1016/j.biopsych.2012.05.035; Stuart MJ, 2014, NEUROSCI BIOBEHAV R, V42, P93, DOI 10.1016/j.neubiorev.2014.02.001; Sugathan A, 2014, P NATL ACAD SCI USA, V111, pE4468, DOI 10.1073/pnas.1405266111; Suzuki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020470; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Talebizadeh Z, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036897; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Torrey EF, 1997, SCHIZOPHR RES, V28, P1, DOI 10.1016/S0920-9964(97)00092-3; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vaccarino FM, 2011, NEUROPHARMACOLOGY, V60, P1355, DOI 10.1016/j.neuropharm.2011.02.021; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Wakim LM, 2013, NAT IMMUNOL, V14, P238, DOI 10.1038/ni.2525; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang G, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/825364; Wei H, 2013, NEUROSCIENCE, V252, P320, DOI 10.1016/j.neuroscience.2013.08.025; Wei HG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-52; Widera D, 2004, EUR J CELL BIOL, V83, P381, DOI 10.1078/0171-9335-00403; Williams HJ, 2011, HUM MOL GENET, V20, P387, DOI 10.1093/hmg/ddq471; Wojkowska DW, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/590409; Zerbo O, 2013, J AUTISM DEV DISORD, V43, P25, DOI 10.1007/s10803-012-1540-x; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhang YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2433; Zhang YB, 2013, J NEUROIMMUNOL, V258, P51, DOI 10.1016/j.jneuroim.2013.02.019; Zwanzger P, 2012, DEPRESS ANXIETY, V29, P762, DOI 10.1002/da.21919	165	26	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124597	10.1371/journal.pone.0124597	http://dx.doi.org/10.1371/journal.pone.0124597			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905630	gold, Green Published, Green Submitted			2022-12-27	WOS:000353332000077
J	Kabakov, AY; Lisman, JE				Kabakov, Anatoli Y.; Lisman, John E.			Catalytically Dead aCaMKII K42M Mutant Acts as a Dominant Negative in the Control of Synaptic Strength	PLoS One			English	Article							LONG-TERM POTENTIATION; KINASE-II; PROTEIN-KINASE; AUTONOMOUS CAMKII; PHOSPHORYLATION; LTP; AUTOPHOSPHORYLATION; CONDUCTANCE; INHIBITION; PLASTICITY	During long-term potentiation (LTP) of excitatory synapses, Ca2+/calmodulin-dependent protein kinase II (CaMKII) is activated by Ca2+ influx through NMDA receptors that potentiate AMPA receptor currents by insertion of additional GluR1-containing receptors at the synapse and by increasing AMPA channel conductance, as well as by stimulating structural changes. CaMKII is also involved in the maintenance of LTP and contributes to maintenance of behavioral sensitization by cocaine or amphetamine. Recent studies show that transient expression of catalytically dead alpha CaMKII K42M mutant after exposure to amphetamine persistently reverses the behavioral effects of the addiction. A suggested interpretation is that this mutant acts as a dominant negative in the control of synaptic strength, but this interpretation has not been physiologically tested. Here we investigate the effect of alpha CaMKII K42M mutant expressed in single CA1 pyramidal neurons on basal excitatory neurotransmission in cultured rat hippocampal organotypic slices. The mutant caused nearly 50% reduction in the basal CA3-CA1 transmission, while overexpression of the wild-type alpha CaMKII had no effect. This result is consistent with the dominant negative hypothesis, but there are complexities. We found that the decrease in basal transmission did not occur when activity in the slices was suppressed after transfection by TTX or when NMDA receptors were blocked by APV. Thus, the dominant negative effect requires neural activity for its expression.	[Lisman, John E.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02254 USA	Brandeis University; Brandeis University	Lisman, JE (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.	lisman@brandeis.edu			National Institute on Drug Abuse (NIDA) Collaborative Research in Computational Neuroscience (CRCNS) [R01DA027807];  [NIH-U01NS090583]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027807] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA) Collaborative Research in Computational Neuroscience (CRCNS); ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institute on Drug Abuse (NIDA) Collaborative Research in Computational Neuroscience (CRCNS) Grant R01DA027807 and by NIH-U01NS090583. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asrican B, 2007, J NEUROSCI, V27, P14007, DOI 10.1523/JNEUROSCI.3587-07.2007; Barcomb K, 2014, FASEB J, V28, P3810, DOI 10.1096/fj.14-250407; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Lemieux M, 2012, J CELL BIOL, V198, P1055, DOI 10.1083/jcb.201202058; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Loweth JA, 2013, J NEUROSCI, V33, P1411, DOI 10.1523/JNEUROSCI.4386-13.2013; Lucchesi W, 2011, BRAIN RES BULL, V85, P2, DOI 10.1016/j.brainresbull.2010.10.009; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; O'Leary H, 2011, J BIOL CHEM, V286, P31272, DOI 10.1074/jbc.M111.233668; Pi HJ, 2010, P NATL ACAD SCI USA, V107, P14437, DOI 10.1073/pnas.1009268107; Pi HJ, 2010, J NEUROSCI, V30, P8704, DOI 10.1523/JNEUROSCI.0133-10.2010; Rathenberg J, 2003, J NEUROSCI METH, V126, P91, DOI 10.1016/S0165-0270(03)00069-4; Sanhueza M, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-10; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; Stratton M, 2014, ELIFE, V3, DOI 10.7554/eLife.01610; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134	25	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123718	10.1371/journal.pone.0123718	http://dx.doi.org/10.1371/journal.pone.0123718			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905720	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000042
J	Kaddumukasa, M; Lwanira, C; Lugaajju, A; Katabira, E; Persson, KEM; Wahlgren, M; Kironde, F				Kaddumukasa, Mark; Lwanira, Catherine; Lugaajju, Allan; Katabira, Elly; Persson, Kristina E. M.; Wahlgren, Mats; Kironde, Fred			Parasite Specific Antibody Increase Induced by an Episode of Acute P-falciparum Uncomplicated Malaria	PLOS ONE			English	Article							GLUTAMATE-RICH PROTEIN; MEROZOITE SURFACE PROTEIN-1; VACCINE CANDIDATE GMZ2; BLOOD-STAGE ANTIGENS; NEW-GUINEAN CHILDREN; CLINICAL MALARIA; IMMUNE-RESPONSES; ACQUIRED-IMMUNITY; SEASONAL MALARIA; IMMUNOGLOBULIN-G	Introduction There is no approved vaccine for malaria, and precisely how human antibody responses to malaria parasite components and potential vaccine molecules are developed and maintained remains poorly defined. In this study, antibody anamnestic or memory response elicited by a single episode of P. falciparum infection was investigated. Methods This study involved 362 malaria patients aged between 6 months to 60 years, of whom 19% were early-diagnosed people living with HIV/AIDS (PLWHA). On the day malaria was diagnosed and 42 days later, blood specimens were collected. Parasite density, CD4(+) cells, and antibodies specific to synthetic peptides representing antigenic regions of the P. falciparum proteins GLURP, MSP3 and HRPII were measured. Results On the day of malaria diagnosis, Immunoglobulin (IgG) antibodies against GLURP, MSP3 and HRP II peptides were present in the blood of 75%, 41% and 60% of patients, respectively. 42 days later, the majority of patients had boosted their serum IgG antibody more than 1.2 fold. The increase in level of IgG antibody against the peptides was not affected by parasite density at diagnosis. The median CD4(+) cell counts of PLWHAs and HIV negative individuals were not statistically different, and median post-infection increases in anti-peptide IgG were similar in both groups of patients. Conclusion In the majority (70%) of individuals, an infection of P. falciparum elicits at least 20% increase in level of anti-parasite IgG. This boost in anti-P. falciparum IgG is not affected by parasite density on the day of malaria diagnosis, or by HIV status.	[Kaddumukasa, Mark; Katabira, Elly] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Lwanira, Catherine; Lugaajju, Allan; Kironde, Fred] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Persson, Kristina E. M.; Wahlgren, Mats] Karolinska Inst, Dept Microbiol Tumour & Cell Biol, Stockholm, Sweden; [Persson, Kristina E. M.] Lund Univ, Dept Lab Med, Stockholm, Sweden; [Kironde, Fred] IUIU, Habib Med Sch, Kampala, Uganda	Makerere University; Makerere University; Karolinska Institutet; Lund University	Kaddumukasa, M (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda.	kaddumark@yahoo.co.uk		Kironde, Fred/0000-0003-4981-6417; Lugaajju, Allan/0000-0003-4841-0538; Nassozi Lwanira, Catherine/0000-0003-1767-6851; Persson, Kristina E M/0000-0003-2661-3115	European & Developing Countries Clinical Trials Partnership (EDCTP) grant [IP.2007.31100.001]; Makerere Sida-SAREC collaborative grant for research and training; European Community's Seventh Framework Programme (FP7) [242095]	European & Developing Countries Clinical Trials Partnership (EDCTP) grant; Makerere Sida-SAREC collaborative grant for research and training; European Community's Seventh Framework Programme (FP7)	This research was conducted with funding from the European & Developing Countries Clinical Trials Partnership (EDCTP) grant (number IP.2007.31100.001) and from Makerere Sida-SAREC collaborative grant for research and training. The research leading to these results has also received funding (to FK and MW) from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement N<SUP>o</SUP> 242095 (www.evimalar.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpogheneta OJ, 2008, INFECT IMMUN, V76, P1748, DOI 10.1128/IAI.01333-07; AlYaman F, 1996, AM J TROP MED HYG, V54, P443, DOI 10.4269/ajtmh.1996.54.443; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; [Anonymous], 2003, ASS MON ANT DRUG EFF; Avila Sandra L. M., 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P309, DOI 10.1590/S0036-46651998000500008; Baumann A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-46; BORRE MB, 1991, MOL BIOCHEM PARASIT, V49, P119, DOI 10.1016/0166-6851(91)90135-S; Boutlis CS, 2003, J INFECT DIS, V187, P862, DOI 10.1086/367897; BROWN H, 1987, MOL BIOL MED, V4, P365; Bull PC, 2002, TRENDS MICROBIOL, V10, P55, DOI 10.1016/S0966-842X(01)02278-8; BUTCHER GA, 1992, PARASITOL TODAY, V8, P307, DOI 10.1016/0169-4758(92)90104-A; Cavanagh DR, 1998, J IMMUNOL, V161, P347; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; de Souza W, 2008, CURR PHARM DESIGN, V14, P822, DOI 10.2174/138161208784041123; Dodoo D, 2000, J INFECT DIS, V181, P1202, DOI 10.1086/315341; GARNHAM PCC, 1949, ANN TROP MED PARASIT, V43, P47, DOI 10.1080/00034983.1949.11685394; GREENWOOD BM, 1991, T ROY SOC TROP MED H, V85, P186, DOI 10.1016/0035-9203(91)90015-Q; Hochman S, 2012, J NEUROPARASITOLOGY, P3; Jepsen MPG, 2013, J INFECT DIS, V208, P479, DOI 10.1093/infdis/jit185; Kats LM, 2008, TRAFFIC, V9, P176, DOI 10.1111/j.1600-0854.2007.00681.x; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Kinyanjui SM, 2003, J INFECT DIS, V187, P667, DOI 10.1086/373994; KIRONDE FAS, 1991, INFECT IMMUN, V59, P3909, DOI 10.1128/IAI.59.11.3909-3916.1991; Laman M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-145; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lousada-Dietrich S, 2011, VACCINE, V29, P3284, DOI 10.1016/j.vaccine.2011.02.022; Mamo H, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-51; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; MCBRIDE JS, 1982, SCIENCE, V217, P254, DOI 10.1126/science.6178159; Metzger WG, 2003, PARASITE IMMUNOL, V25, P307, DOI 10.1046/j.1365-3024.2003.00636.x; Migot F, 1996, PARASITE IMMUNOL, V18, P333, DOI 10.1046/j.1365-3024.1996.d01-116.x; Mordmuller B, 2010, VACCINE, V28, P6698, DOI 10.1016/j.vaccine.2010.07.085; Mulumba JGT, 2012, J COMMUN HEALTH, V37, P1234, DOI 10.1007/s10900-012-9559-7; Ndungu FM, 2013, EUR J IMMUNOL, V43, P2919, DOI 10.1002/eji.201343630; Ndungu FM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000690; Nebie I, 2008, INFECT IMMUN, V76, P759, DOI 10.1128/IAI.01147-07; O'Meara WP, 2006, PARASITOL RES, V99, P500, DOI 10.1007/s00436-006-0135-x; Oeuvray C, 2000, INFECT IMMUN, V68, P2617, DOI 10.1128/IAI.68.5.2617-2620.2000; Ofori MF, 2002, INFECT IMMUN, V70, P2982, DOI 10.1128/IAI.70.6.2982-2988.2002; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Perraut R, 2005, J INFECT DIS, V191, P264, DOI 10.1086/426398; Perraut R, 2002, MICROBES INFECT, V4, P31, DOI 10.1016/S1286-4579(01)01506-4; Pinder M, 2010, VACCINE, V28, P4695, DOI 10.1016/j.vaccine.2010.04.091; RAY P, 1994, INFECT IMMUN, V62, P2354, DOI 10.1128/IAI.62.6.2354-2361.1994; RILEY EM, 1992, PARASITE IMMUNOL, V14, P321, DOI 10.1111/j.1365-3024.1992.tb00471.x; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Soe S, 2004, INFECT IMMUN, V72, P247, DOI 10.1128/IAI.72.1.247-252.2004; Tall A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-161; Tang HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096098; Theisen M, 1998, INFECT IMMUN, V66, P11, DOI 10.1128/IAI.66.1.11-17.1998; Wanyenze RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021794; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; WHO, 2006, WHO GUID TREATM MAL; Wykes MN, 2005, J IMMUNOL, V175, P2510, DOI 10.4049/jimmunol.175.4.2510; Xu HJ, 2002, J EXP MED, V195, P881, DOI 10.1084/jem.20011174; Zerpa NC, 2006, EXP PARASITOL, V113, P227, DOI 10.1016/j.exppara.2006.01.007	58	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124297	10.1371/journal.pone.0124297	http://dx.doi.org/10.1371/journal.pone.0124297			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906165	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000064
J	Dunning, A; Ghoreyshi, A; Bertucco, M; Sanger, TD				Dunning, Amber; Ghoreyshi, Atiyeh; Bertucco, Matteo; Sanger, Terence D.			The Tuning of Human Motor Response to Risk in a Dynamic Environment Task	PLOS ONE			English	Article							STATISTICAL DECISION-THEORY; UNCERTAINTY; PERCEPTION	The role of motor uncertainty in discrete or static space tasks, such as pointing tasks, has been investigated in many experiments. These studies have shown that humans hold an internal representation of intrinsic and extrinsic motor uncertainty and compensate for this variability when planning movement. The aim of this study was to investigate how humans respond to uncertainties during movement execution in a dynamic environment despite indeterminate knowledge of the outcome of actions. Additionally, the role of errors, or lack thereof, in predicting risk was examined. In the experiment, subjects completed a driving simulation game on a two-lane road. The road contained random curves so that subjects were forced to use sensory feedback to complete the task and could not rely only on motor planning. Risk was manipulated by using horizontal perturbations to create the illusion of driving on a bumpy road, thereby imposing motor uncertainty, and altering the cost function of the road. Results suggest continual responsiveness to cost and uncertainty in a dynamic task and provide evidence that subjects avoid risk even in the absence of errors. The results suggest that humans tune their statistical motor behavior based on cost, taking into account probabilities of possible outcomes in response to environmental uncertainty.	[Dunning, Amber; Ghoreyshi, Atiyeh; Bertucco, Matteo; Sanger, Terence D.] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Sanger, Terence D.] Univ So Calif, Dept Neurol, Los Angeles, CA USA; [Sanger, Terence D.] Univ So Calif, Dept Biokinesiol, Los Angeles, CA USA; [Sanger, Terence D.] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA	University of Southern California; University of Southern California; University of Southern California; Children's Hospital Los Angeles	Dunning, A (corresponding author), Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA.	dunning@usc.edu			University of Southern California Provost Fellowship; James McDonnell Foundation; National Institutes of Neurological Disorders and Stroke [NS069214]; University of Southern California Department of Biomedical Engineering; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069214] Funding Source: NIH RePORTER	University of Southern California Provost Fellowship; James McDonnell Foundation; National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Southern California Department of Biomedical Engineering; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support for this project was provided by the University of Southern California Provost Fellowship, the James McDonnell Foundation, the National Institutes of Neurological Disorders and Stroke (NS069214), and the University of Southern California Department of Biomedical Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braun DA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00001; Faisal AA, 2009, J NEUROPHYSIOL, V101, P1901, DOI 10.1152/jn.90974.2008; Farin G, 1997, CURVES SURFACES CAGD, P33; KEELE SW, 1968, J EXP PSYCHOL, V77, P155, DOI 10.1037/h0025754; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Maloney L.T., 2007, INTEGRATED MODELS CO, P297, DOI [10.1093/acprof:oso/9780195189193.003.0021, DOI 10.1093/ACPROF:OSO/9780195189193.003.0021, https://doi.org/10.1093/acprof:oso/9780195189193.003.0021]; Maloney LT, 2010, VISION RES, V50, P2362, DOI 10.1016/j.visres.2010.09.031; Sanger TD, 2014, NEURAL COMPUT, V26, P2669, DOI 10.1162/NECO_a_00662; Tassinari H, 2006, J NEUROSCI, V26, P10154, DOI 10.1523/JNEUROSCI.2779-06.2006; Trommershauser J, 2005, J NEUROSCI, V25, P7169, DOI 10.1523/JNEUROSCI.1906-05.2005; Trommershauser J, 2003, SPATIAL VISION, V16, P255, DOI 10.1163/156856803322467527; Trommershauser J, 2003, J OPT SOC AM A, V20, P1419, DOI 10.1364/JOSAA.20.001419; VANGALEN GP, 1995, HUM MOVEMENT SCI, V14, P539, DOI 10.1016/0167-9457(95)00027-3; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; Wolpert D, 2012, CURR OPIN NEUROBIOL, V22, P1, DOI [10.1016/j.conb.2012.01.004, DOI 10.1016/J.CONB.2012.01.004]; Zhang H, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00214	18	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0125461	10.1371/journal.pone.0125461	http://dx.doi.org/10.1371/journal.pone.0125461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KV	25901604	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500117
J	Kang, W; Lee, DS; Jang, JH				Kang, Wonmo; Lee, Dong-Sung; Jang, Jun-Hyeog			Evaluation of Sustained BMP-2 Release Profiles Using a Novel Fluorescence-Based Retention Assay	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; GROWTH-FACTORS; VASCULARIZATION; SCAFFOLDS; DELIVERY	The purpose of this study was to develop and characterize a novel fluorescence-based retention assay for the evaluation of the release profile of bone morphogenetic protein-2 (BMP-2) released from bone graft carrier. In this study, we evaluated the binding, release kinetics, and delivery efficacies of BMP-2 incorporated into hydroxyapatite (HA) bone grafts. The evaluation of the release profile of BMP-2 from HA bone grafts using a fluorescence-based retention assay revealed initial burst releases from the HA bone grafts followed by long sustained releases up to 14 weeks. The sustained biological activity of the released BMP-2 from HA bone grafts over the full 14-week period supports a long sustained mechanism via fluorescence-based retention assay. Thus, the results from this study show that BMP-2 could be incorporated into HA bone grafts for sustained release over a prolonged period of time with retention of bioactivity and our fluorescence-based retention assay, which is principally detecting the retention profile of BMP-2 in HA bone grafts, is more accurate than conventionally collecting the released BMP-2 for evaluation of BMP-2 release profiles.	[Kang, Wonmo; Jang, Jun-Hyeog] Inha Univ, Sch Med, Dept Biochem, Inchon, South Korea; [Lee, Dong-Sung] Konkuk Univ, Dept Biomed Chem, Chungju, South Korea	Inha University; Konkuk University	Jang, JH (corresponding author), Inha Univ, Sch Med, Dept Biochem, Inchon, South Korea.	juhjang@inha.ac.kr			Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) [HI14C0522]; Ministry of Health & Welfare, Republic of Korea	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by a grant of the Korea Health Technology R&D Project (HI14C0522) through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessho K, 2000, BRIT J ORAL MAX SURG, V38, P645, DOI 10.1054/bjom.2000.0533; BOTHWELL MA, 1977, J BIOL CHEM, V252, P8532; Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Draenert FG, 2013, CLIN ORAL IMPLAN RES, V24, P750, DOI 10.1111/j.1600-0501.2012.02481.x; Du P, 2014, J CONTROL RELEASE, V194, P122, DOI 10.1016/j.jconrel.2014.08.026; Fu YC, 2008, BIOTECHNOL BIOENG, V99, P996, DOI 10.1002/bit.21648; Garcia P, 2012, J BONE JOINT SURG AM, V94A, P49, DOI 10.2106/JBJS.J.00795; Hanseler P, 2014, J BIOMED MATER RES A, V2014, P35211; Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24; Jeon O, 2008, BIOCHEM BIOPH RES CO, V369, P774, DOI 10.1016/j.bbrc.2008.02.099; Jones AL, 2006, J BONE JOINT SURG AM, V88A, P1431, DOI 10.2106/JBJS.E.00381; Kim JE, 2012, J BIOMED MATER RES A, V100A, P1488, DOI 10.1002/jbm.a.34089; Knaack S, 2014, J BIOMED MATER RES A, V102, P3500, DOI 10.1002/jbm.a.35020; Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022; Matsumoto T, 2004, BIOMATERIALS, V25, P3807, DOI 10.1016/j.biomaterials.2003.10.081; Poldervaart MT, 2014, J CONTROL RELEASE, V184, P58, DOI 10.1016/j.jconrel.2014.04.007; Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001; SMITH JC, 1982, NATURE, V296, P154, DOI 10.1038/296154a0; Tampieri A, 2005, ANAL BIOANAL CHEM, V381, P568, DOI 10.1007/s00216-004-2943-0	20	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123402	10.1371/journal.pone.0123402	http://dx.doi.org/10.1371/journal.pone.0123402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901352	Green Submitted, Green Published, gold			2022-12-27	WOS:000353331500052
J	Liu, YF; Sowell, SM; Luo, Y; Chaubey, A; Cameron, RS; Kim, HG; Srivastava, AK				Liu, Ying F.; Sowell, Sarah M.; Luo, Yue; Chaubey, Alka; Cameron, Richard S.; Kim, Hyung-Goo; Srivastava, Anand K.			Autism and Intellectual Disability-Associated KIRREL3 Interacts with Neuronal Proteins MAP1B and MYO16 with Potential Roles in Neurodevelopment	PLOS ONE			English	Article							CELL-ADHESION; SPECTRUM DISORDERS; GENES; BRAIN; CASK; PHENOTYPE; DELETION; MICE; SYNAPTOGENESIS; EXPRESSION	Cell-adhesion molecules of the immunoglobulin superfamily play critical roles in brain development, as well as in maintaining synaptic plasticity, the dysfunction of which is known to cause cognitive impairment. Recently dysfunction of KIRREL3, a synaptic molecule of the immunoglobulin superfamily, has been implicated in several neurodevelopmental conditions including intellectual disability, autism spectrum disorder, and in the neurocognitive delay associated with Jacobsen syndrome. However, the molecular mechanisms of its physiological actions remain largely unknown. Using a yeast two-hybrid screen, we found that the KIRREL3 extracellular domain interacts with brain expressed proteins MAP1B and MYO16 and its intracellular domain can potentially interact with ATP1B1, UFC1, and SHMT2. The interactions were confirmed by co-immunoprecipitation and colocalization analyses of proteins expressed in human embryonic kidney cells, mouse neuronal cells, and rat primary neuronal cells. Furthermore, we show KIRREL3 colocalization with the marker for the Golgi apparatus and synaptic vesicles. Previously, we have shown that KIRREL3 interacts with the X-linked intellectual disability associated synaptic scaffolding protein CASK through its cytoplasmic domain. In addition, we found a genomic deletion encompassing MAP1B in one patient with intellectual disability, microcephaly and seizures and deletions encompassing MYO16 in two unrelated patients with intellectual disability, autism and microcephaly. MAP1B has been previously implicated in synaptogenesis and is involved in the development of the actin-based membrane skeleton. MYO16 is expressed in hippocampal neurons and also indirectly affects actin cytoskeleton through its interaction with WAVE1 complex. We speculate KIRREL3 interacting proteins are potential candidates for intellectual disability and autism spectrum disorder. Moreover, our findings provide further insight into understanding the molecular mechanisms underlying the physiological action of KIRREL3 and its role in neurodevelopment.	[Liu, Ying F.; Sowell, Sarah M.; Luo, Yue; Chaubey, Alka; Srivastava, Anand K.] Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA; [Srivastava, Anand K.] Clemson Univ, Dept Genet & Biochem, Clemson, SC USA; [Cameron, Richard S.] Georgia Regents Univ, Dept Med, Augusta, GA USA; [Kim, Hyung-Goo] Georgia Regents Univ, Dept OB GYN, Inst Mol Med & Genet, Augusta, GA USA	Greenwood Genetic Center; Clemson University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Srivastava, AK (corresponding author), Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA.	anand@ggc.org			Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01-HD039331]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD039331] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01-HD039331 to A.K.S.).	Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Betancur C, 2009, TRENDS NEUROSCI, V32, P402, DOI 10.1016/j.tins.2009.04.003; Bhalla K, 2008, AM J HUM GENET, V83, P703, DOI 10.1016/j.ajhg.2008.10.020; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Chao DL, 2008, MOL CELL NEUROSCI, V39, P248, DOI 10.1016/j.mcn.2008.07.001; Chattopadhyaya B, 2013, J NEUROSCI, V33, P5957, DOI 10.1523/JNEUROSCI.1306-12.2013; Cheng Y, 2013, HUM MOL GENET, V22, P2960, DOI 10.1093/hmg/ddt150; Chia PH, 2014, CELL, V156, P208, DOI 10.1016/j.cell.2013.12.009; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; Cordelieres FP, 2014, METHOD CELL BIOL, V123, P395, DOI [10.1016/B978-0-12.420138-5.00021-S, 10.1016/B978-0-12-420138-5.00021-5]; Ding JQ, 2002, J CELL BIOL, V158, P427, DOI 10.1083/jcb.200202055; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Friedman JM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-526; Froyen G, 2007, HUM MUTAT, V28, P1034, DOI 10.1002/humu.20564; Gerke P, 2006, J COMP NEUROL, V498, P466, DOI 10.1002/cne.21064; Guerin A, 2012, AM J MED GENET A, V158A, P2551, DOI 10.1002/ajmg.a.35621; Henriquez DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053123; Homrich M, 2014, EXP CELL RES, V324, P192, DOI 10.1016/j.yexcr.2014.04.003; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Johar K, 2014, EUR J NEUROSCI, V39, P566, DOI 10.1111/ejn.12415; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Lee GY, 2014, CANCER RES, V74, P3114, DOI 10.1158/0008-5472.CAN-13-2683; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Najm J, 2008, NAT GENET, V40, P1065, DOI 10.1038/ng.194; Nakayama M, 2002, GENOME RES, V12, P1773, DOI 10.1101/gr.406902; Opal P, 2003, J BIOL CHEM, V278, P34691, DOI 10.1074/jbc.M302785200; Pangratz-Fuehrer S, 2005, BEHAV BRAIN RES, V164, P188, DOI 10.1016/j.bbr.2005.06.018; Patel KG, 2001, J NEUROSCI, V21, P7954; Piluso G, 2009, AM J HUM GENET, V84, P162, DOI 10.1016/j.ajhg.2008.12.018; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Srivastava AK, 2014, NEUROSCI BIOBEHAV R, V46, P161, DOI 10.1016/j.neubiorev.2014.02.015; Sun JY, 2014, J ALZHEIMERS DIS, V41, P1039, DOI 10.3233/JAD-140054; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Tamura S, 2005, NEUROSCIENCE, V133, P615, DOI 10.1016/j.neuroscience.2005.03.030; Tucker T, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-25; Vieira GH, 2012, EUR J HUM GENET, V20, P148, DOI 10.1038/ejhg.2011.167; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Yao AY, 2011, HUM MOL GENET, V20, P51, DOI 10.1093/hmg/ddq431; Yokoyama K, 2011, EMBO J, V30, P4739, DOI 10.1038/emboj.2011.348; Zervas M, 2005, J NEUROSCI RES, V82, P83, DOI 10.1002/jnr.20624	40	23	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123106	10.1371/journal.pone.0123106	http://dx.doi.org/10.1371/journal.pone.0123106			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902260	Green Submitted, gold, Green Published			2022-12-27	WOS:000353331500042
J	Zhang, M; Fu, GZ; Lei, T				Zhang, Man; Fu, Guangzhen; Lei, Ting			Two Urinary Peptides Associated Closely With Type 2 Diabetes Mellitus	PLOS ONE			English	Article							MASS-SPECTROMETRY; OXIDANT STRESS; RISK FACTOR; BIOMARKERS; ACTIVATION; FIBRINOGEN; ELECTROPHORESIS; IDENTIFICATION; NEPHROPATHY; PROGRESSION	Objective To monitor of type 2 diabetes more simply, conveniently and noninvasively, we are trying to identify the potential urinary peptides that associated with different stages of glucose control in type 2 diabetes mellitus. Methods Firstly, we collected urine samples from type 2 diabetic patients and normal controls. These type 2 diabetic patients were divided into two groups according to fasting plasma glucose (FPG) and hemoglobin A1c% (HbA1c), respectively. Magnetic beads based weak cation exchange chromatography (MB-WCX) was used to condense urinary peptides. The eluates were then analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). Subsequently, ClinProt was used to profile and screen the polypeptide patterns based on different methods of grouping in diabetic patients and normal controls. Finally, the amino acid sequences of differentially expressed peptides were identified by nano-liquid chromatography-tandem mass spectrometry and the protein sources of the corresponding peptide were matched in IPI Human database. Results Proteomics analysis found two up-regulated peptide (m/z 2756.1 and m/z 3223.2) representations in diabetic subjects, and the two peptides increased with increases in the amount of glycosylated hemoglobin. Further, the parallelism between m/z 3223.2 and glycosylated hemoglobin was better than the parallelism between m/z 2756.1 and glycosylated hemoglobin. Area under the receiver operating characteristic of the two peptides was 0.722 and 0.661, respectively. The above-mentioned peptide m/z 2756.1 was further identified as fragment of fibrinogen alpha chain precursor and m/z 3223.2 was fragment of prothrombin precusor. Conclusion These results suggested the two urinary biomarkers enable monitor of type 2 diabetes patients with different stages of glucose control.	[Zhang, Man; Fu, Guangzhen; Lei, Ting] Peking Univ, Dept Clin Lab, Sch Clin Med 9, Beijing Shijitan Hosp, Beijing 100871, Peoples R China; [Zhang, Man; Lei, Ting] Capital Med Univ, Beijing Shijitan Hosp, Dept Clin Lab, Beijing, Peoples R China	Peking University; Capital Medical University	Zhang, M (corresponding author), Peking Univ, Dept Clin Lab, Sch Clin Med 9, Beijing Shijitan Hosp, Beijing 100871, Peoples R China.	mzhang99@aliyun.com			Capital Health Research and Development of Special [2011-2008-02]; National Key Technology RD Program [2013BAI12B01-4]	Capital Health Research and Development of Special; National Key Technology RD Program(National Key Technology R&D Program)	The authors' sources of funding that supported the work were Capital Health Research and Development of Special (2011-2008-02) and National Key Technology R&D Program (No. 2013BAI12B01-4). Man Zhang received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carr ME, 2001, J DIABETES COMPLICAT, V15, P44, DOI 10.1016/S1056-8727(00)00132-X; CERIELLO A, 1994, THROMB HAEMOSTASIS, V71, P593; Chu L, 2013, DIABETES RES CLIN PR, V101, P187, DOI 10.1016/j.diabres.2013.05.004; Decramer S, 2008, MOL CELL PROTEOMICS, V7, P1850, DOI 10.1074/mcp.R800001-MCP200; Forsblom CM, 1998, DIABETES CARE, V21, P1932, DOI 10.2337/diacare.21.11.1932; Goodwill AG, 2012, VASC PHARMACOL, V57, P150, DOI 10.1016/j.vph.2012.07.002; IDF. Task Force, 2005, GLOB GUID TYP 2 DIAB, P1; Khechai F, 1997, ARTERIOSCL THROM VAS, V17, P2885, DOI 10.1161/01.ATV.17.11.2885; Kolch W, 2005, MASS SPECTROM REV, V24, P959, DOI 10.1002/mas.20051; Lapolla A, 2005, CLIN CHIM ACTA, V357, P236, DOI 10.1016/j.cccn.2005.03.032; Lei T, 2013, CLIN GENITOURIN CANC, V11, P56, DOI 10.1016/j.clgc.2012.06.003; Matheson A, 2010, DIABETES-METAB RES, V26, P150, DOI 10.1002/dmrr.1068; Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358; Overgaard AJ, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-4; Padrao AI, 2012, PROTEOM CLIN APPL, V6, P447, DOI 10.1002/prca.201200044; Rao AK, 1999, DIABETES, V48, P1156, DOI 10.2337/diabetes.48.5.1156; Rao PV, 2007, DIABETES CARE, V30, P629, DOI 10.2337/dc06-2056; Rossing K, 2004, KIDNEY INT, V66, P1596, DOI 10.1111/j.1523-1755.2004.00925.x; SCHAFER AI, 1985, ANN INTERN MED, V102, P814, DOI 10.7326/0003-4819-102-6-814; Schaffer SW, 2012, VASC PHARMACOL, V57, P139, DOI 10.1016/j.vph.2012.03.005; Shechter M, 2000, J AM COLL CARDIOL, V35, P300, DOI 10.1016/S0735-1097(99)00545-8; Tilton RG, 2007, PROTEOMICS, V7, P1729, DOI 10.1002/pmic.200700017; Waugh N, 2007, HEALTH TECHNOL ASSES, V11, P1; WILHELMSEN L, 1984, NEW ENGL J MED, V311, P501, DOI 10.1056/NEJM198408233110804; YARNELL JWG, 1991, CIRCULATION, V83, P836, DOI 10.1161/01.CIR.83.3.836	25	14	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122950	10.1371/journal.pone.0122950	http://dx.doi.org/10.1371/journal.pone.0122950			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902048	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500032
J	Villalobos-Sambucaro, MJ; Lorenzo-Figueiras, AN; Riccillo, FL; Diambra, LA; Noriega, FG; Ronderos, JR				Jose Villalobos-Sambucaro, Maria; Nieves Lorenzo-Figueiras, Alicia; Luis Riccillo, Fernando; Anibal Diambra, Luis; Gabriel Noriega, Fernando; Rafael Ronderos, Jorge			Allatotropin Modulates Myostimulatory and Cardioacceleratory Activities in Rhodnius prolixus (Stal)	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; HOST IMMUNOGLOBULIN; MALPIGHIAN TUBULES; DORSAL VESSEL; HEART-RATE; HEMOLYMPH; PEPTIDE; INSECT; SEROTONIN; RECEPTOR	Haematophagous insects can ingest large quantities of blood in a single meal and eliminate high volumes of urine in the next few hours. This rise in diuresis is possible because the excretory activity of the Malpighian tubules is facilitated by an increase in haemolymph circulation as a result of intensification of aorta contractions combined with an increase of the anterior midgut peristaltic waves. It has been previously described that haemolymph circulation during post-prandial diuresis is stimulated by the synergistic activity of allatotropin (AT) and serotonin in the kissing bug Triatoma infestans; resulting in an increase in aorta contractions. In the same species, AT stimulates anterior midgut and rectum muscle contractions to mix urine and feces and facilitate the voiding of the rectum. Furthermore, levels of AT in midgut and Malpighian tubules increased in the afternoon when insects are getting ready for nocturnal feeding. In the present study we describe the synergistic effect of AT and serotonin increasing the frequency of contractions of the aorta in Rhodnius prolixus. The basal frequency of contractions of the aorta in the afternoon is higher that the observed during the morning, suggesting the existence of a daily rhythmic activity. The AT receptor is expressed in the rectum, midgut and dorsal vessel, three critical organs involved in postprandial diuresis. All together these findings provide evidence that AT plays a role as a myoregulatory and cardioacceleratory peptide in Rhodnius prolixus.	[Jose Villalobos-Sambucaro, Maria; Luis Riccillo, Fernando; Rafael Ronderos, Jorge] FCNyM UNLP, Catedra Histol & Embriol Anim, La Plata, Buenos Aires, Argentina; [Jose Villalobos-Sambucaro, Maria; Luis Riccillo, Fernando; Anibal Diambra, Luis; Rafael Ronderos, Jorge] Ctr Reg Estudios Genom CREG UNLP, La Plata, Buenos Aires, Argentina; [Gabriel Noriega, Fernando] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Nieves Lorenzo-Figueiras, Alicia] FCEyN UBA, IBBEA, Dept Biodiversidad & Biol Expt, Buenos Aires, DF, Argentina	National University of La Plata; State University System of Florida; Florida International University; University of Buenos Aires	Ronderos, JR (corresponding author), FCNyM UNLP, Catedra Histol & Embriol Anim, La Plata, Buenos Aires, Argentina.	jrondero@museo.fcnym.unlp.edu.ar	L, Diambra/F-6319-2015	L, Diambra/0000-0001-8052-4880; Villalobos-Sambucaro, Maria Jose/0000-0001-9815-7185	Universidad Nacional de La Plata [N559, N673]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045545] Funding Source: NIH RePORTER	Universidad Nacional de La Plata(National University of La Plata); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Universidad Nacional de La Plata N559 and N673 to JRR.	ALLINGHAM PG, 1992, J INSECT PHYSIOL, V38, P9, DOI 10.1016/0022-1910(92)90017-8; BENYAKIR D, 1989, J MED ENTOMOL, V26, P243, DOI 10.1093/jmedent/26.4.243; BUXTON P. A., 1930, TRANS ENT SOC LONDON, V78, P227; CHIANG RG, 1990, J MORPHOL, V204, P9, DOI 10.1002/jmor.1052040103; CHIANG RG, 1992, EXPERIENTIA, V48, P1122, DOI 10.1007/BF01948003; Dasari S, 2006, J COMP PHYSIOL B, V176, P349, DOI 10.1007/s00360-005-0058-3; Duve H, 1999, J COMP NEUROL, V413, P405, DOI 10.1002/(SICI)1096-9861(19991025)413:3&lt;405::AID-CNE4&gt;3.0.CO;2-R; Duve H, 2000, CELL TISSUE RES, V300, P153, DOI 10.1007/s004410050056; Alzugaray ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077520; Gerould JH, 1933, BIOL BULL-US, V64, P424, DOI 10.2307/1537208; Glenn JD, 2010, J EXP BIOL, V213, P541, DOI 10.1242/jeb.035014; Hernandez-Martinez S, 2005, CELL TISSUE RES, V321, P105, DOI 10.1007/s00441-005-1133-5; Horodyski FM, 2011, INSECT BIOCHEM MOLEC, V41, P804, DOI 10.1016/j.ibmb.2011.06.002; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; KATAOKA H, 1989, SCIENCE, V243, P1481, DOI 10.1126/science.243.4897.1481; Koladich PM, 2002, PEPTIDES, V23, P645, DOI 10.1016/S0196-9781(01)00658-1; Kumari A, 2009, J VECTOR DIS, V46, P255; League GP, 2015, J EXP BIOL, V218, P370, DOI 10.1242/jeb.114942; MADDRELL SH, 1964, J EXP BIOL, V41, P163; MADDRELL SHP, 1978, J EXP BIOL, V75, P133; MADDRELL SHP, 1991, J EXP BIOL, V156, P557; MADDRELL SHP, 1975, J EXP BIOL, V62, P671; Masood M, 2014, PEPTIDES, V53, P159, DOI 10.1016/j.peptides.2013.10.017; Matsushita T, 2002, COMP BIOCHEM PHYS A, V133, P625, DOI 10.1016/S1095-6433(02)00154-X; Nichols R, 2006, PEPTIDES, V27, P1130, DOI 10.1016/j.peptides.2005.07.032; Nouzova M, 2012, PEPTIDES, V34, P201, DOI 10.1016/j.peptides.2011.07.025; NUNEZ JA, 1990, J APPL ENTOMOL, V109, P87, DOI 10.1111/j.1439-0418.1990.tb00023.x; O'Donnell MJ, 2003, BBA-BIOMEMBRANES, V1618, P194, DOI 10.1016/j.bbamem.2003.07.003; Orchard I, 2006, COMP BIOCHEM PHYS A, V144, P316, DOI 10.1016/j.cbpa.2005.11.010; RAMSAY JA, 1952, J EXP BIOL, V29, P110; Riccillo FL, 2010, TISSUE CELL, V42, P355, DOI 10.1016/j.tice.2010.07.011; Rudwall AJ, 2000, J COMP NEUROL, V428, P159, DOI 10.1002/1096-9861(20001204)428:1<159::AID-CNE11>3.0.CO;2-Y; Santini MS, 2007, J EXP BIOL, V210, P1986, DOI 10.1242/jeb.004291; Santini MS, 2009, GEN COMP ENDOCR, V160, P243, DOI 10.1016/j.ygcen.2008.12.002; Santini MS, 2009, BIOL RHYTHM RES, V40, P299, DOI 10.1080/09291010802214583; Steel CGH, 2006, COMP BIOCHEM PHYS A, V144, P351, DOI 10.1016/j.cbpa.2006.02.018; Sterkel M, 2010, COMP BIOCHEM PHYS A, V155, P371, DOI 10.1016/j.cbpa.2009.12.002; Vafopoulou X, 2010, J COMP NEUROL, V518, P1264, DOI 10.1002/cne.22274; VEENSTRA JA, 1994, J EXP BIOL, V188, P347; Voisin T, 2003, CELL MOL LIFE SCI, V60, P72, DOI 10.1007/s000180300005; Vuerinckx K, 2011, INSECT BIOCHEM MOLEC, V41, P815, DOI 10.1016/j.ibmb.2011.06.003; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	42	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124131	10.1371/journal.pone.0124131	http://dx.doi.org/10.1371/journal.pone.0124131			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897783	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600050
J	Zhu, XY; He, XY; Wang, W; Zhou, QY; Yu, Z; Dai, Y; Zhu, XF; Yan, QF				Zhu, Xiaoyu; He, Xiangyu; Wang, Wei; Zhou, Qiyin; Yu, Zhe; Dai, Yu; Zhu, Xufen; Yan, Qingfeng			MTO1 Worked as a Modifier in the Aminoglycosides Sensitivity of Yeast Carrying a Mitochondrial 15S rRNA C1477G Mutation	PLOS ONE			English	Article							A1555G MUTATION; PROTEINS MNME; DEAFNESS; GENE; EXPRESSION; PATHOGENESIS; GIDA	MTO1, together with MSS1 and MTO2, is a gene involved in the pathway of encoding a mitochondria- specific RNA-modifying enzyme related to the post-transcriptional modification of mitochondrial tRNAs. We have previously shown that a mutation of the MTO2 or MSS1 gene can suppress the neomycin-sensitive phenotype of yeast carrying a mitochondrial 15S rRNA C1477G mutation. Here we report that a null mutation of MTO1 also can inhibit the aminoglycoside-sensitivity of yeast carrying mitochondrial 15S rRNA C1477G mutation. The C1477G mutation corresponds to the human 12S rRNA A1555G mutation. Yeast with an mtDNA C1477G mutation exhibits hypersensitivity to neomycin and displays mitochondrial function impairment beyond neomycin treatment. When the mto1 null mutation and mitochondrial C1477G mutation coexist, the yeast strain shows growth recovery. The deletion of the nuclear gene MTO1 regulates neomycin sensitivity in yeast carrying the mitochondrial 15S rRNA C1477G mutation. MTO1 deletion causes the expression levels of the key glycolytic genes HXK2, PFK1 and PYK1 to become significantly up-regulated. The energy deficit due to impaired mitochondrial function was partially compensated by the energy generated by glycolysis. Being in the same pathway, the regulation of MTO1, MSS1 and MTO2 to the neomycin-sensitivity of yeast showed difference in the growth activity of strains, mitochondrial function and the expression level of glycolytic genes.	[Zhu, Xiaoyu; He, Xiangyu; Wang, Wei; Zhou, Qiyin; Yu, Zhe; Dai, Yu; Zhu, Xufen; Yan, Qingfeng] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Zhu, XF (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	xufenzhu@zju.edu.cn; qfyan@zju.edu.cn	yan, qing/GZN-2287-2022	Yu, Zhe/0000-0002-6908-6135	National Basic Research Program of China [2014CB943001, 2012CB966804]; National Natural Science Foundation of China [30971599]; Natural Science Foundation of Zhejiang Province [LY14C060004]; Program for New Century Excellent Talents in University [NCET-06-0526]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Basic Research Program of China (2014CB943001, 2012CB966804), National Natural Science Foundation of China (30971599), Natural Science Foundation of Zhejiang Province (LY14C060004), Program for New Century Excellent Talents in University (NCET-06-0526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bykhovskaya Y, 2004, MOL GENET METAB, V83, P199, DOI 10.1016/j.ymgme.2004.07.009; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Colby G, 1998, J BIOL CHEM, V273, P27945, DOI 10.1074/jbc.273.43.27945; DECOSTER E, 1993, J MOL BIOL, V232, P79, DOI 10.1006/jmbi.1993.1371; Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676; Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011; Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006; He XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081490; Kim TW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-502; Li RH, 2003, BBA-GENE STRUCT EXPR, V1629, P53, DOI 10.1016/S0167-4781(03)00160-X; Li XM, 2002, MOL CELL BIOL, V22, P7701, DOI 10.1128/MCB.22.21.7701-7711.2002; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; Meyer S, 2009, J MOL BIOL, V392, P910, DOI 10.1016/j.jmb.2009.07.004; Moukadiri I, 2009, NUCLEIC ACIDS RES, V37, P7177, DOI 10.1093/nar/gkp762; Qian YP, 2009, ANTIMICROB AGENTS CH, V53, P4612, DOI 10.1128/AAC.00965-08; Ryu DH, 2001, BIOORGAN MED CHEM, V9, P2601; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Vicens Q, 2001, STRUCTURE, V9, P647, DOI 10.1016/S0969-2126(01)00629-3; Wang XJ, 2007, FEBS LETT, V581, P4228, DOI 10.1016/j.febslet.2007.07.067; Wang XJ, 2010, J MOL BIOL, V395, P1038, DOI 10.1016/j.jmb.2009.12.002; Wang XJ, 2009, MITOCHONDRION, V9, P180, DOI 10.1016/j.mito.2009.01.010; Yan QF, 2005, J BIOL CHEM, V280, P29151, DOI 10.1074/jbc.M504247200; Yim L, 2006, NUCLEIC ACIDS RES, V34, P5892, DOI 10.1093/nar/gkl752; Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133; Zhou QY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090336	26	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124200	10.1371/journal.pone.0124200	http://dx.doi.org/10.1371/journal.pone.0124200			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898254	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600056
J	Kim, HR; Kim, KW; Kim, BM; Cho, ML; Lee, SH				Kim, Hae-Rim; Kim, Kyoung-Woon; Kim, Bo-Mi; Cho, Mi-La; Lee, Sang-Heon			The Effect of Vascular Endothelial Growth Factor on Osteoclastogenesis in Rheumatoid Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; COLONY-STIMULATING FACTOR; SYNOVIAL FIBROBLASTS; INHIBITORY FACTOR; BONE-RESORPTION; KEY REGULATOR; T-LYMPHOCYTES; UP-REGULATION; EXPRESSION; VEGF	Vascular endothelial growth factor (VEGF) has angiogenic, inflammatory, and bone-destructive roles in rheumatoid arthritis (RA). We aimed to determine the unique role of VEGF in osteoclastogenesis in RA. VEGF-induced receptor activator of nuclear factor kappa B ligand (RANKL) expression was determined in RA synovial fibroblasts by real-time PCR, luciferase assays, and ELISA. Osteoclastogenesis in peripheral blood monocytes cultured with VEGF was assessed by determining the numbers of tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cells. Synovial fluid RANKL was correlated with VEGF concentration in the RA patients. VEGF stimulated the expression of RANKL in RA synovial fibroblasts. The RANKL promoter activity was upregulated by VEGF in the synovial fibroblasts transfected with RANKL-reporter plasmids. The VEGF-induced RANKL expression was decreased by the inhibition of both VEGF receptors (VEGFR) 1 and 2, Src, protein kinase C (PKC) and p38 MAPK. VEGF induced osteoclast differentiation from monocytes in the absence of RANKL and this was decreased by the inhibition of VEGFR1 and 2, Src, PKC and p38 MAPK. On coculturing with VEGF-prestimulated RA synovial fibroblasts, the monocytes differentiated into osteoclasts, and the osteoclastogenesis decreased by inhibition of Src and PKC pathways. VEGF plays dual roles on osteoclastogenesis in RA: direct induction of osteoclastogenesis from the precursors and stimulation of RANKL production in synovial fibroblasts, which is mediated by Src and PKC pathways. The axis of VEGF and RANKL could be a potential therapeutic target for RA-associated bone destruction.	[Kim, Hae-Rim; Lee, Sang-Heon] Konkuk Univ, Sch Med, Dept Rheumatol, Res Inst Med Sci, Seoul, South Korea; [Kim, Kyoung-Woon; Kim, Bo-Mi; Cho, Mi-La] Catholic Univ Korea, Conversant Res Consortium Immunol Dis, Seoul St Marys Hosp, Coll Med, Seoul, South Korea; [Kim, Kyoung-Woon; Kim, Bo-Mi; Cho, Mi-La] Catholic Univ Korea, Rheumatism Res Ctr, Catholic Res Inst Med Sci, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Cho, ML (corresponding author), Catholic Univ Korea, Conversant Res Consortium Immunol Dis, Seoul St Marys Hosp, Coll Med, Seoul, South Korea.	iammila@catholic.ac.kr; shlee@kuh.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [NRF-2010-0024198, NRF-2013R1A1A1008171]	National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (NRF-2010-0024198 and NRF-2013R1A1A1008171). http://www.nrf.re.kr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge SE, 2005, BRIT J CANCER, V92, P1531, DOI 10.1038/sj.bjc.6602417; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Cho CS, 2000, J IMMUNOL, V164, P5055, DOI 10.4049/jimmunol.164.10.5055; Cho ML, 2006, IMMUNOL LETT, V103, P159, DOI 10.1016/j.imlet.2005.10.020; Choi ST, 2009, CLIN RHEUMATOL, V28, P333, DOI 10.1007/s10067-008-1075-x; De Bandt M, 2003, J IMMUNOL, V171, P4853, DOI 10.4049/jimmunol.171.9.4853; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FREEMAN MR, 1995, CANCER RES, V55, P4140; Fujikawa Y, 1996, ANN RHEUM DIS, V55, P816, DOI 10.1136/ard.55.11.816; Fujikawa Y, 2001, BONE, V28, P261, DOI 10.1016/S8756-3282(00)00453-1; Garcia-Gomez A, 2013, INVEST NEW DRUG, V31, P200, DOI 10.1007/s10637-012-9845-3; Gronthos S, 2007, TRENDS ENDOCRIN MET, V18, P108, DOI 10.1016/j.tem.2007.02.002; Harada M, 1998, SCAND J RHEUMATOL, V27, P377; HARRIS ED, 1990, NEW ENGL J MED, V322, P1277, DOI 10.1056/nejm199005033221805; Ikeda M, 2000, J PATHOL, V191, P426; Kasama T, 2000, CLIN EXP IMMUNOL, V121, P533, DOI 10.1046/j.1365-2249.2000.01272.x; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kikuchi K, 1998, BRIT J DERMATOL, V139, P1049; Kim HR, 2007, J RHEUMATOL, V34, P927; Kim HR, 2014, ARTHRITIS RHEUMATOL, V66, P538, DOI 10.1002/art.38286; Kim KW, 2007, ARTHRITIS RHEUM-US, V56, P1076, DOI 10.1002/art.22439; Kim KW, 2012, ARTHRITIS RHEUM-US, V64, P1015, DOI 10.1002/art.33446; Kim W, 2006, NY TIMES BK REV, P1; Koch AE, 1998, ARTHRITIS RHEUM-US, V41, P951, DOI 10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D; KOCH AE, 1994, J IMMUNOL, V152, P4149; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Konisti S, 2012, NAT REV RHEUMATOL, V8, P153, DOI 10.1038/nrrheum.2011.205; Lee SS, 2001, CLIN EXP RHEUMATOL, V19, P321; Lee TH, 2002, J BIOL CHEM, V277, P10445, DOI 10.1074/jbc.M107348200; Marumo T, 1999, DIABETES, V48, P1131, DOI 10.2337/diabetes.48.5.1131; McLaren J, 1996, J CLIN INVEST, V98, P482, DOI 10.1172/JCI118815; Mould AW, 2003, ARTHRITIS RHEUM-US, V48, P2660, DOI 10.1002/art.11232; Namiki A, 1995, J BIOL CHEM, V270, P31189, DOI 10.1074/jbc.270.52.31189; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Niida S, 1999, J EXP MED, V190, P293, DOI 10.1084/jem.190.2.293; Oura H, 2003, BLOOD, V101, P560, DOI 10.1182/blood-2002-05-1516; PERTOVAARA L, 1994, J BIOL CHEM, V269, P6271; Ryu S, 2006, CLIN RHEUMATOL, V25, P16, DOI 10.1007/s10067-005-1081-1; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; Szekanecz Zoltan, 2005, Current Drug Targets - Inflammation and Allergy, V4, P319, DOI 10.2174/1568010054022187; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Tunyogi-Csapo M, 2008, ARTHRITIS RHEUM-US, V58, P2397, DOI 10.1002/art.23653; Wu YL, 2005, ARTHRITIS RHEUM-US, V52, P3257, DOI 10.1002/art.21354; Yang QL, 2008, MATRIX BIOL, V27, P589, DOI 10.1016/j.matbio.2008.06.005; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yoo SA, 2005, J IMMUNOL, V174, P5846, DOI 10.4049/jimmunol.174.9.5846; Yoo SA, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/129873; Zhou JL, 2009, J ORTHOP SCI, V14, P313, DOI 10.1007/s00776-009-1329-8	50	43	47	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124909	10.1371/journal.pone.0124909	http://dx.doi.org/10.1371/journal.pone.0124909			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894998	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700129
J	Qiu, YX; Sun, SH; Charkraborty, T; Wu, LM; Sun, LN; Wei, J; Nagahama, Y; Wang, DS; Zhou, LY				Qiu, Yongxiu; Sun, Shaohua; Charkraborty, Tapas; Wu, Limin; Sun, Lina; Wei, Jing; Nagahama, Yoshitaka; Wang, Deshou; Zhou, Linyan			Figla Favors Ovarian Differentiation by Antagonizing Spermatogenesis in a Teleosts, Nile Tilapia (Oreochromis niloticus)	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; SEX DETERMINATION; GENE-EXPRESSION; GERM-CELLS; GONADAL DIFFERENTIATION; MAMMALIAN GONAD; ALPHA; FISH; AROMATASE; FEMALE	Figla (factor in the germ line, alpha), a female germ cell-specific transcription factor, had been shown to activate genetic hierarchies in oocytes. The ectopic expression of Figla was known to repress spermatogenesis-associated genes in male mice. However, the potential role of Figla in other vertebrates remains elusive. The present work was aimed to identify and characterize the functional relevance of Figla in the ovarian development of Nile tilapia (Oreochromis niloticus). Tissue distribution and ontogeny analysis revealed that tilapia Figla gene was dominantly expressed in the ovary from 30 days after hatching. Immunohistochemistry analysis also demonstrated that Figla was expressed in the cytoplasm of early primary oocytes. Intriguingly, over-expression of Figla in XY fish resulted in the disruption of spermatogenesis along with the depletion of meiotic spermatocytes and spermatids in testis. Dramatic decline of sycp3 (synaptonemal complex protein 3) and prm (protamine) expression indicates that meiotic spermatocytes and mature sperm production are impaired. Even though Sertoli cell (dmrt1) and Leydig cell (star and cyp17a1) marker genes remained unaffected, hsd3b1 expression and 11-KT production were enhanced in Figla-transgene testis. Taken together, our data suggest that fish Figla might play an essential role in the ovarian development by antagonizing spermatogenesis.	[Qiu, Yongxiu; Sun, Shaohua; Wu, Limin; Sun, Lina; Wei, Jing; Wang, Deshou; Zhou, Linyan] Southwest Univ, Sch Life Sci, Minist Educ, Key Lab Freshwater Fish Reprod & Dev, Chongqing, Peoples R China; [Charkraborty, Tapas; Nagahama, Yoshitaka] Ehime Univ, South Ehime Fisheries Res Ctr, Ainan, Ehime, Japan	Southwest University - China; Ehime University	Wang, DS (corresponding author), Southwest Univ, Sch Life Sci, Minist Educ, Key Lab Freshwater Fish Reprod & Dev, Chongqing, Peoples R China.	wdeshou@swu.edu.cn; yanlinzhou916@126.com	wei, jing/GXA-1455-2022; Wang, Deshou/ABD-6014-2021; Chakraborty, Tapas/M-5865-2018	Wang, Deshou/0000-0002-4967-524X; Chakraborty, Tapas/0000-0003-1984-234X	National Natural Science Foundation of China [31201986, 91331119, 31201979, 31030063]; Research Foundation of Talent Introduction of Southwest University, China [SWU111003]; Specialized Research Fund for the Doctoral Program of Higher Education of China; Ministry of Education [20110182120003, 20130182130003]; special fund of Chongqing key laboratory (CSTC), Natural Science Foundation Project of Chongqing, China [cstc2012jjA80005, cstc2012jjA80041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation of Talent Introduction of Southwest University, China; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Ministry of Education; special fund of Chongqing key laboratory (CSTC), Natural Science Foundation Project of Chongqing, China	This work was supported in part by Grants for Scientific Research from the National Natural Science Foundation of China (31201986, 91331119, 31201979, and 31030063). This work was also supported in part by Research Foundation of Talent Introduction of Southwest University, China (SWU111003). The project was supported by the Specialized Research Fund for the Doctoral Program of Higher Education of China, Ministry of Education (20110182120003 and 20130182130003) and the special fund of Chongqing key laboratory (CSTC), Natural Science Foundation Project of Chongqing, China (cstc2012jjA80005 and cstc2012jjA80041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayne RAL, 2004, MOL HUM REPROD, V10, P373, DOI 10.1093/molehr/gah056; Brennan J, 2004, NAT REV GENET, V5, P509, DOI 10.1038/nrg1381; Capel B, 2000, MECH DEVELOP, V92, P89, DOI 10.1016/S0925-4773(99)00327-5; Chassot AA, 2014, REPRODUCTION, V148, pR97, DOI 10.1530/REP-14-0177; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Dohle GR, 2003, WORLD J UROL, V21, P341, DOI 10.1007/s00345-003-0365-9; Eggers S, 2014, NAT REV ENDOCRINOL, V10, P673, DOI 10.1038/nrendo.2014.163; Fujimoto T, 2010, P NATL ACAD SCI USA, V107, P17211, DOI 10.1073/pnas.1007032107; GRECO TL, 1994, ENDOCRINOLOGY, V135, P262, DOI 10.1210/en.135.1.262; Guigon CJ, 2006, BIOL REPROD, V74, P450, DOI 10.1095/biolreprod.105.047134; Guigon CJ, 2005, ENDOCRINOLOGY, V146, P2992, DOI 10.1210/en.2005-0045; Hu W, 2010, MOL CELL BIOL, V30, P3661, DOI 10.1128/MCB.00201-10; Huntriss J, 2002, MOL HUM REPROD, V8, P1087, DOI 10.1093/molehr/8.12.1087; Jorgensen A, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-25; Joshi S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-67; Kanamori A, 2000, Tanpakushitsu Kakusan Koso, V45, P2949; Kanamori A, 2008, GENE, V423, P180, DOI 10.1016/j.gene.2008.07.007; Kobayashi T, 2009, SEX DEV, V3, P108, DOI 10.1159/000223076; Kobayashi T, 2008, DEV DYNAM, V237, P297, DOI 10.1002/dvdy.21409; Kurokawa H, 2007, P NATL ACAD SCI USA, V104, P16958, DOI 10.1073/pnas.0609932104; Li MH, 2013, ENDOCRINOLOGY, V154, P4814, DOI 10.1210/en.2013-1451; Li MH, 2014, GENETICS, V197, P591, DOI 10.1534/genetics.114.163667; Liang LF, 1997, DEVELOPMENT, V124, P4939; Liu G, 2014, J MOL ENDOCRINOL, V53, P57, DOI 10.1530/JME-13-0300; Maatouk DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047238; MCLAREN A, 1991, BIOESSAYS, V13, P151, DOI 10.1002/bies.950130402; McLaren A, 2000, MOL CELL ENDOCRINOL, V163, P3, DOI 10.1016/S0303-7207(99)00234-8; Nishimura T, 2014, SEX DEV, V8, P252, DOI 10.1159/000364924; Onichtchouk D, 2003, DEV DYNAM, V228, P393, DOI 10.1002/dvdy.10392; Rodriguez-Mari A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001034; Siegfried KR, 2008, DEV BIOL, V324, P277, DOI 10.1016/j.ydbio.2008.09.025; Slanchev K, 2005, P NATL ACAD SCI USA, V102, P4074, DOI 10.1073/pnas.0407475102; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Swain A, 1999, GENE DEV, V13, P755, DOI 10.1101/gad.13.7.755; Tao WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063604; Thompson WE, 1997, J REPROD FERTIL, V109, P337, DOI 10.1530/jrf.0.1090337; Wang DS, 2007, MOL ENDOCRINOL, V21, P712, DOI 10.1210/me.2006-0248; Wang DS, 2010, ENDOCRINOLOGY, V151, P1331, DOI 10.1210/en.2009-0999; Wu GC, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104398; Yokoi H, 2002, MOL REPROD DEV, V63, P5, DOI 10.1002/mrd.10169; Yu XG, 2014, MOL CELL ENDOCRINOL, V392, P152, DOI 10.1016/j.mce.2014.05.013; ZAMBONI L, 1983, J EXP ZOOL, V228, P173, DOI 10.1002/jez.1402280204	42	25	29	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123900	10.1371/journal.pone.0123900	http://dx.doi.org/10.1371/journal.pone.0123900			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894586	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700063
J	Singh, P; Wadhwa, N; Lodha, R; Sommerfelt, H; Aneja, S; Natchu, UCM; Chandra, J; Rath, B; Sharma, VK; Kumari, M; Saini, S; Kabra, SK; Bhatnagar, S; Strand, TA				Singh, Prashant; Wadhwa, Nitya; Lodha, Rakesh; Sommerfelt, Halvor; Aneja, Satinder; Natchu, Uma Chandra Mouli; Chandra, Jagdish; Rath, Bimbadhar; Sharma, Vinod Kumar; Kumari, Mohini; Saini, Savita; Kabra, Sushil Kumar; Bhatnagar, Shinjini; Strand, Tor A.			Predictors of Time to Recovery in Infants with Probable Serious Bacterial Infection	PLOS ONE			English	Article							C-REACTIVE PROTEIN; NEONATAL SEPSIS; MORTALITY; MALNUTRITION; CHILDREN; GROWTH; LENGTH; ZINC	Introduction Serious bacterial infections continue to be an important cause of death and illness among infants in developing countries. Time to recovery could be considered a surrogate marker of severity of the infection. We therefore aimed to identify clinical and laboratory predictors of time to recovery in infants with probable serious bacterial infection (PSBI). Methods We used the dataset of 700 infants (7-120 days) enrolled in a randomised controlled trial in India in which 10mg of oral zinc or placebo was given to infants with PSBI. PSBI was defined as signs/symptoms of possible serious bacterial infection along with baseline C-reactive protein(CRP) level >12mg/L. Time to recovery was defined as time from enrolment to the end of a 2-day period with no symptoms/signs of PSBI and daily weight gain of at least 10g over 2 succesive days on exclusive oral feeding. Cox proportional hazard regression was used to measure the associations between relevant variables and time to recovery. Results Infants who were formula fed prior to illness episode had 33% longer time to recovery (HR-0.67, 95% CI-0.52, 0.87) than those who were not. Being underweight (HR-0.84, 95% CI-0.70, 0.99), lethargic (HR-0.77, 95% CI-0.62, 0.96) and irritable (HR-0.81, 95% CI-0.66, 0.99) were independent predictors of time to recovery. Baseline CRP was significantly associated with time to recovery (P<0.001), higher CRP was associated with longer time to recovery and this association was nearly linear. Conclusion Simple clinical and laboratory parameters such as formula feeding prior to the illness, being underweight, lethargic, irritable and having elevated CRP levels could be used for early identification of infants with PSBI at risk for protracted illness and could guide prompt referral to higher centers in resource limited settings. This also provides prognostic information to clinicians and family as longer recovery time has economic and social implications on the family in our setting.	[Singh, Prashant; Wadhwa, Nitya; Natchu, Uma Chandra Mouli; Bhatnagar, Shinjini] Translat Hlth Sci & Technol Inst, Gurgaon, India; [Singh, Prashant; Wadhwa, Nitya; Lodha, Rakesh; Saini, Savita; Kabra, Sushil Kumar; Bhatnagar, Shinjini] All India Inst Med Sci, Dept Pediat, New Delhi, India; [Sommerfelt, Halvor; Strand, Tor A.] Univ Bergen, Ctr Int Hlth, Ctr Intervent Sci Maternal & Child Hlth CISMAC, Bergen, Norway; [Sommerfelt, Halvor] Norwegian Inst Publ Hlth, Dept Int Publ Hlth, Oslo, Norway; [Aneja, Satinder; Chandra, Jagdish; Rath, Bimbadhar] Lady Hardinge Med Coll & Hosp, Dept Pediat, New Delhi, India; [Aneja, Satinder; Chandra, Jagdish; Rath, Bimbadhar] Kalawati Saran Childrens Hosp, New Delhi, India; [Sharma, Vinod Kumar; Kumari, Mohini] Deen Dayal Upadhyay Hosp, Dept Pediat, New Delhi, India; [Strand, Tor A.] Innlandet Hosp Trust, Div Med Serv, Lillehammer, Norway	Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); All India Institute of Medical Sciences (AIIMS) New Delhi; University of Bergen; Norwegian Institute of Public Health (NIPH); Lady Hardinge Medical College & Hospital; Innlandet Hospital Trust	Bhatnagar, S (corresponding author), Translat Hlth Sci & Technol Inst, Gurgaon, India.	shinjini.bhatnagar@gmail.com	singh, prashant/AAQ-4412-2020; Sommerfelt, Halvor/ABD-3552-2020; Strand, Tor/D-9836-2016	Sommerfelt, Halvor/0000-0002-5670-9786; Strand, Tor/0000-0002-4038-151X; bhatnagar, shinjini/0000-0003-1703-5296	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR5238/MED/14/610/2004]; European Commission [INCO-FP6-003740]; Research Council of Norway [172226]; Meltzer foundation (Bergen, Norway); South-Eastern Norway Regional Health Authority [2012090]; Research Council of Norway's Centre of Excellence Scheme [223269]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); European Commission(European CommissionEuropean Commission Joint Research Centre); Research Council of Norway(Research Council of Norway); Meltzer foundation (Bergen, Norway); South-Eastern Norway Regional Health Authority; Research Council of Norway's Centre of Excellence Scheme(Research Council of Norway)	Department of Biotechnology, Ministry of Science and Technology, Government of India (BT/PR5238/MED/14/610/2004); the European Commission (EU-INCO-DC contract number INCO-FP6-003740); the Research Council of Norway (Project No. 172226); and the Meltzer foundation (Bergen, Norway); TAS and HS were funded through grants from the South-Eastern Norway Regional Health Authority (Grant No. 2012090) and The Research Council of Norway's Centre of Excellence Scheme (Grant No. 223269), respectively.	Andreola B, 2007, PEDIATR INFECT DIS J, V26, P672, DOI 10.1097/INF.0b013e31806215e3; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Bhandari N, 2003, LANCET, V361, P1418, DOI 10.1016/S0140-6736(03)13134-0; Bhatnagar S, 2012, LANCET, V379, P2072, DOI 10.1016/S0140-6736(12)60477-2; Bilavsky E, 2009, ACTA PAEDIATR, V98, P1776, DOI 10.1111/j.1651-2227.2009.01469.x; Chandra RK, 1997, AM J CLIN NUTR, V66, P460; Child Trends, 2013, FAM LIF DIFF CENTR S; Coles CL, 2007, AM J CLIN NUTR, V86, P397, DOI 10.1093/ajcn/86.2.397; Devran O, 2012, MULTIDISCIP RESP MED, V7, DOI 10.1186/2049-6958-7-47; Gradel KO, 2011, CLIN MICROBIOL INFEC, V17, P627, DOI 10.1111/j.1469-0691.2010.03284.x; Hengstermann S, 2010, J HUM LACT, V26, P19, DOI 10.1177/0890334409344078; Hofer N, 2012, NEONATOLOGY, V102, P25, DOI 10.1159/000336629; Kaur S, 2011, INDIAN PEDIATR, V48, P955, DOI 10.1007/s13312-011-0155-1; KORPPI M, 1993, SCAND J INFECT DIS, V25, P207, DOI 10.3109/00365549309008486; Kyle UG, 2010, CAN MED ASSOC J, V182, P1831, DOI 10.1503/cmaj.101256; Lim SL, 2012, CLIN NUTR, V31, P345, DOI 10.1016/j.clnu.2011.11.001; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Lobo SMA, 2003, CHEST, V123, P2043, DOI 10.1378/chest.123.6.2043; Ministry of Health and Family Welfare Government of India, 2003, INT MAN NEON CHILDH; National Center for Health Statistics, 2000, IND GROWTH CHARTS; SIRISINHA S, 1975, PEDIATRICS, V55, P166; SURI M, 1991, Indian Pediatrics, V28, P1159; UNICEF, 2003, GLOB STRAT INF YOUNG; Venkataseshan S, 2007, PEDIATR INFECT DIS J, V26, P684, DOI 10.1097/INF.0b013e3180f616f0; Vesel L, 2010, B WORLD HEALTH ORGAN, V88, P39, DOI 10.2471/BLT.08.057901; Weber MW, 2003, PEDIATR INFECT DIS J, V22, P711, DOI 10.1097/01.inf.0000078163.80807.88	26	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124594	10.1371/journal.pone.0124594	http://dx.doi.org/10.1371/journal.pone.0124594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909192	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800091
J	Ahn, JH; Kim, JS; Kim, S; Soh, HY; Shin, H; Jang, H; Ryu, JH; Kim, A; Yun, KY; Kim, S; Kim, KS; Choi, D; Huh, JH				Ahn, Jong Hwa; Kim, June-Sik; Kim, Seungill; Soh, Hye Yeon; Shin, Hosub; Jang, Hosung; Ryu, Ju Hyun; Kim, Ahyeong; Yun, Kil-Young; Kim, Shinje; Kim, Ki Sun; Choi, Doil; Huh, Jin Hoe			De Novo Transcriptome Analysis to Identify Anthocyanin Biosynthesis Genes Responsible for Tissue-Specific Pigmentation in Zoysiagrass (Zoysia japonica Steud.)	PLOS ONE			English	Article							MOLECULAR-CLONING; TRANSPOSABLE ELEMENTS; EXPRESSION; PATHWAY; TOOL; DNA; ANNOTATION; BLAST2GO; MUTANTS; CLONES	Zoysiagrass (Zoysia japonica Steud.) is commonly found in temperate climate regions and widely used for lawns, in part, owing to its uniform green color. However, some zoysiagrass cultivars accumulate red to purple pigments in their spike and stolon tissues, thereby decreasing the aesthetic value. Here we analyzed the anthocyanin contents of two zoysiagrass cultivars 'Anyang-jungji' (AJ) and 'Greenzoa' (GZ) that produce spikes and stolons with purple and green colors, respectively, and revealed that cyanidin and petunidin were primarily accumulated in the pigmented tissues. In parallel, we performed a de novo transcriptome assembly and identified differentially expressed genes between the two cultivars. We found that two anthocyanin biosynthesis genes encoding anthocyanidin synthase (ANS) and dihydroflavonol 4-reductase (DFR) were preferentially upregulated in the purple AJ spike upon pigmentation. Both ANS and DFR genes were also highly expressed in other zoysiagrass cultivars with purple spikes and stolons, but their expression levels were significantly low in the cultivars with green tissues. We observed that recombinant ZjDFR1 and ZjANS1 proteins successfully catalyze the conversions of dihydroflavonols into leucoanthocyanidins and leucoanthocyanidins into anthocyanidins, respectively. These findings strongly suggest that upregulation of ANS and DFR is responsible for tissue-specific anthocyanin biosynthesis and differential pigmentation in zoysiagrass. The present study also demonstrates the feasibility of a de novo transcriptome analysis to identify the key genes associated with specific traits, even in the absence of reference genome information.	[Ahn, Jong Hwa; Shin, Hosub; Jang, Hosung; Ryu, Ju Hyun; Kim, Ki Sun; Choi, Doil; Huh, Jin Hoe] Seoul Natl Univ, Dept Plant Sci, Seoul 151921, South Korea; [Kim, June-Sik; Kim, Ki Sun; Choi, Doil; Huh, Jin Hoe] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea; [Kim, Seungill; Soh, Hye Yeon; Choi, Doil; Huh, Jin Hoe] Seoul Natl Univ, Interdisciplinary Program Agr Genom, Seoul 151921, South Korea; [Kim, Ahyeong; Yun, Kil-Young; Kim, Shinje] FnP Co Ltd, Jeungpyeong 368811, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Huh, JH (corresponding author), Seoul Natl Univ, Dept Plant Sci, Seoul 151921, South Korea.	huhjh@snu.ac.kr	Kim, Seungill/AAR-1099-2021; Kim, June-Sik/R-6474-2017; Choi, Doil/F-5002-2011	Kim, Seungill/0000-0001-6287-8693; Kim, June-Sik/0000-0002-4703-609X; Shin, Hosub/0000-0001-6488-8430	Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries, Korea [110005-05-4-HD110]; FnP Co. Ltd.	Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries, Korea; FnP Co. Ltd.	The work was supported by a Grant from the Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (No. 110005-05-4-HD110), Korea to JHH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. FnP Co. Ltd. provided support in the form of salaries for authors AK, KYY and SK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	Arumuganathan K, 1999, CROP SCI, V39, P1518; Awika JM, 2005, FOOD CHEM, V90, P293, DOI 10.1016/j.foodchem.2004.03.058; Cai H, 2004, PLANT BREEDING, V123, P543, DOI 10.1111/j.1439-0523.2004.01022.x; Cai HW, 2005, THEOR APPL GENET, V112, P158, DOI 10.1007/s00122-005-0118-9; Chen Z., 2009, FLORICULTURE ORNAMEN, V1, P20; Choi JS, 2006, WEED TURF SCI, V20, P1; Choi JS, 2004, WEED TURF SCI, V18, P1; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Des Marais DL, 2008, NATURE, V454, P762, DOI 10.1038/nature07092; Dixon RA, 2013, CURR OPIN BIOTECH, V24, P329, DOI 10.1016/j.copbio.2012.07.004; Doyle J. J., 1987, PHYTOCHEM B, P11; Emmons RD, 1995, TURFGRASS SCI MANAGE, P40; Engelke M.C., 2003, TURFGRASS BIOL GENET, P271; FORBES I, 1952, AGRON J, V44, P194, DOI 10.2134/agronj1952.00021962004400040008x; GOIFFON JP, 1991, J CHROMATOGR, V537, P101, DOI 10.1016/S0021-9673(01)88890-7; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hetzl J, 2007, PLANT J, V51, P526, DOI 10.1111/j.1365-313X.2007.03152.x; Inokuma C, 1996, PLANT CELL REP, V15, P737, DOI 10.1007/BF00232218; Jaakola L, 2013, TRENDS PLANT SCI, V18, P477, DOI 10.1016/j.tplants.2013.06.003; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee J, 2014, NUCLEIC ACIDS RES, V42, P11408, DOI 10.1093/nar/gku834; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li ML, 2009, EUPHYTICA, V170, P327, DOI 10.1007/s10681-009-9990-8; Li ST, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27522; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Lu YQ, 2003, MOL BIOL EVOL, V20, P1844, DOI 10.1093/molbev/msg197; Mazza G., 1993, Anthocyanins in fruits, vegetables, and grains.; MENSSEN A, 1990, EMBO J, V9, P3051, DOI 10.1002/j.1460-2075.1990.tb07501.x; Neill SO, 2003, FUNCT PLANT BIOL, V30, P865, DOI 10.1071/FP03118; OREILLY C, 1985, EMBO J, V4, P877, DOI 10.1002/j.1460-2075.1985.tb03713.x; Prior RL, 1998, J AGR FOOD CHEM, V46, P2686, DOI 10.1021/jf980145d; REDDY AR, 1987, PLANT SCI, V52, P7, DOI 10.1016/0168-9452(87)90098-7; Ruemmele BA, 1990, GROUNDS MAINTENANCE, V25, P92; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; SCHWARZSOMMER Z, 1987, EMBO J, V6, P287, DOI 10.1002/j.1460-2075.1987.tb04752.x; Shang YJ, 2011, NEW PHYTOL, V189, P602, DOI 10.1111/j.1469-8137.2010.03498.x; Shikazono N, 2003, GENETICS, V163, P1449; SHIRLEY BW, 1995, PLANT J, V8, P659, DOI 10.1046/j.1365-313X.1995.08050659.x; Singh K, 2008, TREE PHYSIOL, V28, P1349, DOI 10.1093/treephys/28.9.1349; Sleper DA, 1989, CSSA SPECIAL PUBLICA, V15, P56; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TANAKA Y, 1995, PLANT CELL PHYSIOL, V36, P1023, DOI 10.1093/oxfordjournals.pcp.a078844; Tsuruta Shin-Ichi, 2005, Grassland Science, V51, P249, DOI 10.1111/j.1744-697X.2005.00033.x; Tulio AZ, 2008, J AGR FOOD CHEM, V56, P1880, DOI 10.1021/jf072313k; Xie DY, 2004, PLANT PHYSIOL, V134, P979, DOI 10.1104/pp.103.030221; Yaneshita M, 1999, THEOR APPL GENET, V98, P751, DOI 10.1007/s001220051131; Yang YN, 2013, TREE GENET GENOMES, V9, P1351, DOI 10.1007/s11295-013-0644-6; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang Z, 2004, J AGR FOOD CHEM, V52, P688, DOI 10.1021/jf034596w; Zhou B, 2013, AM J BOT, V100, P2458, DOI 10.3732/ajb.1300305; Zifkin M, 2012, PLANT PHYSIOL, V158, P200, DOI 10.1104/pp.111.180950	53	89	97	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124497	10.1371/journal.pone.0124497	http://dx.doi.org/10.1371/journal.pone.0124497			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905914	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000071
J	Galvao, LCC; Miller, JH; Kajfasz, JK; Scott-Anne, K; Freires, IA; Franco, GCN; Abranches, J; Rosalen, PL; Lemos, JA				Galvao, Lvia C. C.; Miller, James H.; Kajfasz, Jessica K.; Scott-Anne, Kathy; Freires, Irlan A.; Franco, Gilson C. N.; Abranches, Jacqueline; Rosalen, Pedro L.; Lemos, Jose A.			Transcriptional and Phenotypic Characterization of Novel Spx-Regulated Genes in Streptococcus mutans	PLOS ONE			English	Article							IRON-BINDING PROTEIN; OXIDATIVE STRESS; RNA-POLYMERASE; ENERGY-METABOLISM; OXYGEN TOLERANCE; ASSEMBLY SYSTEM; NADH OXIDASE; FERROUS IRON; VIRULENCE; CARIES	In oral biofilms, two of the major environmental challenges encountered by the dental pathogen Streptococcus mutans are acid and oxidative stresses. Previously, we showed that the S. mutans transcriptional regulators SpxA1 and SpxA2 (formerly SpxA and SpxB, respectively) are involved in stress survival by activating the expression of classic oxidative stress genes such as dpr, nox, sodA and tpx. We reasoned that some of the uncharacterized genes under SpxA1/A2 control are potentially involved in oxidative stress management. Therefore, the goal of this study was to use Spx-regulated genes as a tool to identify novel oxidative stress genes in S. mutans. Quantitative real-time PCR was used to evaluate the responses of ten Spx-regulated genes during H2O2 stress in the parent and Delta spx strains. Transcription activation of the H2O2-induced genes (8 out of 10) was strongly dependent on SpxA1 and, to a lesser extent, SpxA2. In vitro transcription assays revealed that one or both Spx proteins directly regulate three of these genes. The gene encoding the FeoB ferrous permease was slightly repressed by H2O2 but constitutively induced in strains lacking SpxA1. Nine genes were selected for downstream mutational analysis but inactivation of smu127, encoding a subunit of the acetoin dehydrogenase was apparently lethal. In vitro and in vivo characterization of the viable mutants indicated that, in addition to the transcriptional activation of reducing and antioxidant pathways, Spx performs an important role in iron homeostasis by regulating the intracellular availability of free iron. In particular, inactivation of the genes encoding the Fe-S biogenesis SUF system and the previously characterized iron-binding protein Dpr resulted in impaired growth under different oxidative stress conditions, increased sensitivity to iron and lower infectivity in rats. These results serve as an entryway into the characterization of novel genes and pathways that allow S. mutans to cope with oxidative stress.	[Galvao, Lvia C. C.; Miller, James H.; Kajfasz, Jessica K.; Scott-Anne, Kathy; Freires, Irlan A.; Abranches, Jacqueline; Lemos, Jose A.] Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA; [Galvao, Lvia C. C.; Abranches, Jacqueline; Lemos, Jose A.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Freires, Irlan A.; Rosalen, Pedro L.] Univ Estadual Campinas, Dent Sch Piracicaba, Dept Physiol Sci, Piracicaba, SP, Brazil; [Franco, Gilson C. N.] Univ Estadual Ponta Grossa, Lab Physiol & Pathophysiol, Dept Gen Biol, Ponta Grossa, PR, Brazil	University of Rochester; University of Rochester; Universidade Estadual de Campinas; Universidade Estadual de Ponta Grossa	Lemos, JA (corresponding author), Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA.	jose_lemos@urmc.rochester.edu	Freires, Irlan/M-9214-2014; de Carvalho Galvao, Livia Camara/AAU-1109-2020; Rosalen, Pedro Luiz/I-3718-2012	Freires, Irlan/0000-0002-1079-6941; de Carvalho Galvao, Livia Camara/0000-0001-9540-649X; Rosalen, Pedro Luiz/0000-0003-0812-4027; Lemos, Jose/0000-0003-0791-5863	National Institute of Dental and Craniofacial Research [DE019783]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [6849-12-1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/032278-3, 2014/03816-4]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019783] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institute of Dental and Craniofacial Research DE019783 (JAL), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - 6849-12-1 (LCCG), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - 2012/032278-3 (LCCG), and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - 2014/03816-4 (LCCG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches J, 2006, J BACTERIOL, V188, P3748, DOI 10.1128/JB.00169-06; Aranda J, 2009, INT MICROBIOL, V12, P137, DOI 10.2436/20.1501.01.91; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barendt S, 2013, MICROBIOLOGYOPEN, V2, P695, DOI 10.1002/mbo3.109; Becker MR, 2002, J CLIN MICROBIOL, V40, P1001, DOI 10.1128/JCM.40.3.1001-1009.2002; Biswas S, 2011, ANTIMICROB AGENTS CH, V55, P1460, DOI 10.1128/AAC.01094-10; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; BOWEN WH, 1988, J DENT RES, V67, P1316, DOI 10.1177/00220345880670101401; Cartron ML, 2006, BIOMETALS, V19, P143, DOI 10.1007/s10534-006-0003-2; Caufield PW, 2000, INFECT IMMUN, V68, P4018, DOI 10.1128/IAI.68.7.4018-4023.2000; Chen LH, 2012, J NANOMATER, V2012, DOI 10.1155/2012/491051; Decourty L, 2008, P NATL ACAD SCI USA, V105, P5821, DOI 10.1073/pnas.0710533105; Derr AM, 2012, APPL ENVIRON MICROB, V78, P1215, DOI 10.1128/AEM.06890-11; Fujishima K, 2013, APPL ENVIRON MICROB, V79, P1436, DOI 10.1128/AEM.03306-12; Higuchi M, 1999, J BACTERIOL, V181, P5940, DOI 10.1128/JB.181.19.5940-5947.1999; Jain R, 2005, CURR MED CHEM, V12, P1607, DOI 10.2174/0929867054367194; Jang SJ, 2010, MOL MICROBIOL, V78, P1448, DOI 10.1111/j.1365-2958.2010.07418.x; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kajfasz JK, 2012, INFECT IMMUN, V80, P2265, DOI 10.1128/IAI.00026-12; Kajfasz JK, 2010, J BACTERIOL, V192, P2546, DOI 10.1128/JB.00028-10; Kajfasz JK, 2009, J BACTERIOL, V191, P2060, DOI 10.1128/JB.01609-08; Kremer BHA, 2001, J BACTERIOL, V183, P2543, DOI 10.1128/JB.183.8.2543-2552.2001; Kreth J, 2008, J BACTERIOL, V190, P4632, DOI 10.1128/JB.00276-08; Lee KC, 2008, J BACTERIOL, V190, P8244, DOI 10.1128/JB.01161-08; Lemos JA, 2008, MICROBIOL-SGM, V154, P3247, DOI 10.1099/mic.0.2008/023770-0; Lin AA, 2012, J BACTERIOL, V194, P1697, DOI 10.1128/JB.06660-11; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; Marcenes W, 2013, J DENT RES, V92, P592, DOI 10.1177/0022034513490168; Marco S, 2013, BIOCHIMIE, V95, P2145, DOI 10.1016/j.biochi.2013.08.008; MARQUIS RE, 1995, J IND MICROBIOL, V15, P198, DOI 10.1007/BF01569826; MIKX FHM, 1972, CARIES RES, V6, P211, DOI 10.1159/000259801; Naikare H, 2006, INFECT IMMUN, V74, P5433, DOI 10.1128/IAI.00052-06; Nakano S, 2005, MOL MICROBIOL, V55, P498, DOI 10.1111/j.1365-2958.2004.04395.x; Nakano S, 2003, P NATL ACAD SCI USA, V100, P13603, DOI 10.1073/pnas.2235180100; Poole LB, 2000, FREE RADICAL BIO MED, V28, P108, DOI 10.1016/S0891-5849(99)00218-X; Riboldi GP, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-3; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Seepersaud R, 2006, J BACTERIOL, V188, P2096, DOI 10.1128/JB.188.6.2096-2105.2006; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong HC, 2007, MOL MICROBIOL, V63, P872, DOI 10.1111/j.1365-2958.2006.05546.x; Tsou CC, 2008, INFECT IMMUN, V76, P4038, DOI 10.1128/IAI.00477-08; Turlan C, 2009, MOL MICROBIOL, V73, P492, DOI 10.1111/j.1365-2958.2009.06789.x; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; Vergauwen B, 2013, MOL MICROBIOL, V89, P288, DOI 10.1111/mmi.12274; Wolf C, 2008, PROTEOMICS, V8, P3139, DOI 10.1002/pmic.200701062; Yamamoto Y, 2000, J BACTERIOL, V182, P3740, DOI 10.1128/JB.182.13.3740-3747.2000; Yamamoto Y, 2000, BIOSCI BIOTECH BIOCH, V64, P1106, DOI 10.1271/bbb.64.1106; Yamamoto Y, 2002, J BACTERIOL, V184, P2931, DOI 10.1128/JB.184.11.2931-2939.2002; YEOWELL HN, 1982, ANTIMICROB AGENTS CH, V22, P961, DOI 10.1128/AAC.22.6.961; Zhang JQ, 2009, J BACTERIOL, V191, P4330, DOI 10.1128/JB.00184-09; Zheng CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108197; Zuber P, 2004, J BACTERIOL, V186, P1911, DOI 10.1128/JB.186.7.1911-1918.2004; Zuber P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025066	55	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124969	10.1371/journal.pone.0124969	http://dx.doi.org/10.1371/journal.pone.0124969			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905865	gold, Green Published, Green Submitted			2022-12-27	WOS:000353332000098
J	Ernst, CM; Buddle, CM				Ernst, Crystal M.; Buddle, Christopher M.			Drivers and Patterns of Ground-Dwelling Beetle Biodiversity across Northern Canada	PLOS ONE			English	Article							LATITUDINAL GRADIENTS; SPECIES-RICHNESS; FUNCTIONAL DIVERSITY; DIFFERENT RESPONSES; GLOBAL PATTERNS; ASSEMBLAGES; PHENOLOGY; INSECTS; SCALE; PERMAFROST	Many macroecological patterns of biodiversity, including the relationship between latitude and species richness, are well-described. Data collected in a repeatable, standardized manner can advance the discipline beyond the description of patterns and be used to elucidate underlying mechanisms. Using standardized field methods and a hyper-diverse focal taxon, viz. Coleoptera, we aim to (1) describe large-scale latitudinal patterns of taxonomic diversity, functional diversity, and assemblage structure across northern Canada, and (2) determine which climatic, spatial, and habitat variables best explain these patterns. We collected terrestrial beetles at twelve locations in the three northernmost ecoclimatic zones in North America: north boreal, subarctic, and high arctic (51-81 degrees N, 60-138 degrees W). After identifying beetles and assigning them to a functional group, we assessed latitudinal trends for multiple diversity indices using linear regression and visualized spatial patterns of assemblage structure with multivariate ordinations. We used path analysis to test causal hypotheses for species and functional group richness, and we used a permutational approach to assess relationships between assemblage structure and 20 possible climatic and environmental mechanisms. More than 9,000 beetles were collected, representing 464 species and 18 functional groups. Species and functional diversity have significant negative relationships with latitude, which are likely explained by the mediating effects of temperature, precipitation, and plant height. Assemblages within the same ecoclimatic zone are similar, and there is a significant relationship between assemblage structure and latitude. Species and functional assemblage structure are significantly correlated with many of the same climatic factors, particularly temperature maxima and minima. At a large spatial extent, the diversity and assemblage structure of northern beetles show strong latitudinal gradients due to the mediating effects of climate, particularly temperature. Northern arthropod assemblages present significant opportunities for biodiversity research and conservation efforts, and their sensitivity to climate make them ideal targets for long-term terrestrial diversity monitoring.	[Ernst, Crystal M.; Buddle, Christopher M.] McGill Univ, Dept Nat Resource Sci, Ste Anne De Bellevue, PQ, Canada	McGill University	Ernst, CM (corresponding author), McGill Univ, Dept Nat Resource Sci, Ste Anne De Bellevue, PQ, Canada.	crystal.ernst@mail.mcgill.ca	Ernst, Christopher M./O-8317-2018	Ernst, Christopher M./0000-0002-0257-6252; Buddle, Christopher/0000-0002-7494-9732	National Science and Engineering Research Council of Canada (NCERC); NSERC CGS-D Alexander Graham Bell Canada	National Science and Engineering Research Council of Canada (NCERC); NSERC CGS-D Alexander Graham Bell Canada	This work was supported by a National Science and Engineering Research Council of Canada (NCERC) Strategic Project Grant (Ecological Structure of Northern Arthropods: Adaptation to a Changing Environment) awarded to C. Buddle, T. Wheeler, and D. Currie (University of Toronto), its supporting partners and collaborators, and a NSERC CGS-D Alexander Graham Bell Canada Graduate Scholarship awarded to C. Ernst. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beche LA, 2009, BIODIVERS CONSERV, V18, P3909, DOI 10.1007/s10531-009-9688-1; Beck J, 2012, ECOGRAPHY, V35, P673, DOI 10.1111/j.1600-0587.2012.07364.x; Bolduc E, 2013, CAN ENTOMOL, V145, P155, DOI 10.4039/tce.2013.4; Bowden JJ, 2010, ECOSCIENCE, V17, P287, DOI 10.2980/17-3-3308; Boyero L, 2011, ECOLOGY, V92, P1839, DOI 10.1890/10-2244.1; Braun-Blanquet J., 1964, PFLANZENSOZIOLOGIE G; Buschke FT, 2011, AFR INVERTEBR, V52, P217, DOI 10.5733/afin.052.0112; Cardoso P, 2014, METHODS ECOL EVOL, V5, P452, DOI 10.1111/2041-210X.12173; CHAO A, 1984, SCAND J STAT, V11, P265; Chernov Y.I., 2014, ENTOMOL REV, V94, P438, DOI [10.1134/S0013873814040022, DOI 10.1134/S0013873814040022]; Christensen T, 2013, CAFF MONITORING SERI; Condamine FL, 2012, ECOL LETT, V15, P267, DOI 10.1111/j.1461-0248.2011.01737.x; Danks H. V., 1981, ARCTIC ARTHROPODS RE; DANKS HV, 1992, ARCTIC, V45, P159; Danks HV, 2004, INTEGR COMP BIOL, V44, P85, DOI 10.1093/icb/44.2.85; DANKS HV, 1993, MEM ENTOMOL SOC CAN, P51; Ernst CM, 2013, CAN ENTOMOL, V145, P171, DOI 10.4039/tce.2012.111; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Frouz J, 2004, ENVIRON ENTOMOL, V33, P1282, DOI 10.1603/0046-225X-33.5.1282; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; GASTON KJ, 1992, OECOLOGIA, V90, P417, DOI 10.1007/BF00317700; Hawkins BA, 2004, BASIC APPL ECOL, V5, P1, DOI 10.1078/1439-1791-00214; Heiberger RM, 2014, HH STAT ANAL DATA DI, DOI [10.1186/1687-4153-2014-7, DOI 10.1186/1687-4153-2014-7]; Hilty J, 2000, BIOL CONSERV, V92, P185, DOI 10.1016/S0006-3207(99)00052-X; Hinkel KM, 2000, ADV SOIL S, P197; Hodar JA, 1996, ACTA OECOL, V17, P421; Hooper DU, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P195; Hoye TT, 2008, ADV ECOL RES, V40, P299, DOI 10.1016/S0065-2504(07)00013-X; Hoye Toke T., 2008, BMC Ecology, V8, P8, DOI 10.1186/1472-6785-8-8; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; JAROSIK V, 1989, PEDOBIOLOGIA, V33, P87; KANE DL, 1991, COLD REG SCI TECHNOL, V19, P111, DOI 10.1016/0165-232X(91)90002-X; Keil P, 2008, ECOL ENTOMOL, V33, P748, DOI 10.1111/j.1365-2311.2008.01032.x; Keith SA, 2012, BIOL LETT; Kevan P.G., 1986, P72; Lamanna C, 2014, P NATL ACAD SCI USA, V111, P13745, DOI 10.1073/pnas.1317722111; Lemieux JP, 1999, PEDOBIOLOGIA, V43, P245; Ma M, 2005, OIKOS, V111, P192, DOI 10.1111/j.0030-1299.2005.13049.x; Magurran A.E, 2003, MEASURING BIOL DIVER; Marchetti G. M., 2014, GGM PACKAGE GRAPHICA; McGeoch MA, 1998, BIOL REV, V73, P181, DOI 10.1017/S000632319700515X; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McGill BJ, 2010, OIKOS, V119, P591, DOI 10.1111/j.1600-0706.2009.17771.x; Missa O, 2009, J INSECT CONSERV, V13, P103, DOI 10.1007/s10841-007-9130-5; Mjaaseth RR, 2005, OECOLOGIA, V145, P53, DOI 10.1007/s00442-005-0089-1; Oksanen J, 2010, VEGEN COMMUNITY ECOL; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Poyry J, 2006, OIKOS, V115, P401, DOI 10.1111/j.2006.0030-1299.15126.x; QUINN JF, 1983, AM NAT, V122, P602, DOI 10.1086/284161; Rainio J, 2003, BIODIVERS CONSERV, V12, P487, DOI 10.1023/A:1022412617568; Rich ME, 2013, ECOGRAPHY, V36, P994, DOI 10.1111/j.1600-0587.2012.00078.x; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Rossi J, 2011, RICH SPECIES RICHNES; Safi K, 2011, PHILOS T R SOC B, V366, P2536, DOI 10.1098/rstb.2011.0024; SERVICE MW, 1980, INT J BIOMETEOROL, V24, P347, DOI 10.1007/BF02250577; Shipley B, 2000, STRUCT EQU MODELING, V7, P206, DOI 10.1207/S15328007SEM0702_4; Shipley B, 2009, ECOLOGY, V90, P363, DOI 10.1890/08-1034.1; Smith SL, 2010, PERMAFROST PERIGLAC, V21, P117, DOI 10.1002/ppp.690; SPENCE JR, 1994, CAN ENTOMOL, V126, P881, DOI 10.4039/Ent126881-3; Stevens RD, 2003, ECOL LETT, V6, P1099, DOI 10.1046/j.1461-0248.2003.00541.x; Stirling G, 2001, AM NAT, V158, P286, DOI 10.1086/321317; Strong W., 1989, ECOCLIMATIC REGIONS; Timms LL, 2013, ECOGRAPHY, V36, P1227, DOI 10.1111/j.1600-0587.2012.00278.x; Timms LL, 2013, INSECT CONSERV DIVER, V6, P453, DOI 10.1111/icad.12004; Voigt W, 2007, GLOBAL CHANGE BIOL, V13, P1710, DOI 10.1111/j.1365-2486.2007.01398.x; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	69	16	16	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122163	10.1371/journal.pone.0122163	http://dx.doi.org/10.1371/journal.pone.0122163			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901996	Green Submitted, Green Published, gold			2022-12-27	WOS:000353331500016
J	Jager, S; Jacobs, S; Kroger, J; Stefan, N; Fritsche, A; Weikert, C; Boeing, H; Schulze, MB				Jaeger, Susanne; Jacobs, Simone; Kroeger, Janine; Stefan, Norbert; Fritsche, Andreas; Weikert, Cornelia; Boeing, Heiner; Schulze, Matthias B.			Association between the Fatty Liver Index and Risk of Type 2 Diabetes in the EPIC-Potsdam Study	PLOS ONE			English	Article							BODY-MASS INDEX; INSULIN-RESISTANCE; HEPATIC STEATOSIS; METABOLICALLY BENIGN; EXTERNAL VALIDATION; NATURAL DIRECT; DISEASE; MELLITUS; CANCER; COHORT	The fatty liver index (FLI) predicts fatty liver by using BMI, waist circumference, gamma-glutamyl-transferase and triglycerides. We investigated the association between the FLI and the risk of type 2 diabetes and evaluated to what extent single FLI components contribute to the diabetes risk. We analysed a case-cohort study (random sub-cohort: 1922; incident cases: 563) nested within the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. The proportion of exposure effect (PEE) explained by single FLI components was evaluated and effect decomposition using inverse probability weighting (IPW) was applied. Women and men with a FLI >= 60 compared to those with a FLI <30 had a multivariable-adjusted Hazard Ratio (HR) of 17.6; 95% confidence interval (CI) 11.1-28.0 and HR: 10.9; 95% CI 6.22-19.2, respectively. Adjustment for BMI or waist circumference attenuated this association in men [PEEBMI(95% CI) = 53.8% (43.9%-65.8%); PEEwaist(95% CI) = 54.8% (44.2%-68.8%)]. In women, adjustment for waist circumference attenuated the association to a lesser degree than in men [PEEwaist(95% CI) = 31.1%; (21.9%-43.1%)] while BMI had no appreciable effect [PEEBMI(95% CI) = 11.0% (2.68%-21.0%)] gamma-glutamyl-transferase and triglycerides showed only a small attenuation in women [PEEGGT(95% CI) = 3.11% (-0.72%-4.48%); PEETG(95% CI) = 6.36% (3.81%-9.92%)] and in men [PEEGGT = 0%; PEETG(95% CI) = 6.23% (2.03%-11.8%)]. In women, the total effect was decomposed into a direct effect and 4 indirect effects (HRBMI= 1.10; HRwaist = 1.28; HRGGT = 0.97 and HRTG= 1.03). In men, the 4 indirect effects were HRBMI= 1.25; HRwaist = 1.29; HRGGT = 0.97 and HRTG= 0.99. These data suggest that the FLI, as a proxy for fatty liver, is associated with risk of type 2 diabetes. This association is only partly explained by standard estimates of overall and abdominal body fatness, particularly among women.	[Jaeger, Susanne; Jacobs, Simone; Kroeger, Janine; Schulze, Matthias B.] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Nuthetal, Germany; [Jaeger, Susanne; Jacobs, Simone; Kroeger, Janine; Stefan, Norbert; Fritsche, Andreas; Schulze, Matthias B.] German Ctr Diabet Res DZD, Neuherberg, Germany; [Stefan, Norbert; Fritsche, Andreas] Univ Tubingen Hosp, Dept Internal Med, Div Endocrinol Diabetol Nephrol Vasc Dis & Clin C, Tubingen, Germany; [Weikert, Cornelia] German Inst Human Nutr Potsdam Rehbrucke, Res Grp Cardiovasc Epidemiol, Nuthetal, Germany; [Weikert, Cornelia] Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany; [Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Schulze, MB (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Nuthetal, Germany.	mschulze@dife.de	Schulze, Matthias B/AAH-6906-2021	Schulze, Matthias B/0000-0002-0830-5277; Kroger, Janine/0000-0002-7496-3665; Stefan, Norbert/0000-0002-2186-9595; Jager, Susanne/0000-0001-6619-0861	Federal Ministry of Science, Germany [01 EA 9401]; European Union [SOC 95201408 05 F02]; German Cancer Aid [70-2488-Ha I]; European Community [SOC 98200769 05 F02]; German Federal Ministry of Education and Research (BMBF)	Federal Ministry of Science, Germany; European Union(European Commission); German Cancer Aid(Deutsche Krebshilfe); European Community(European Commission); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The recruitment phase of the EPIC-Potsdam Study was supported by the Federal Ministry of Science, Germany (grant 01 EA 9401) and the European Union (grant SOC 95201408 05 F02). The follow-up of the EPIC-Potsdam Study is supported by the German Cancer Aid (grant 70-2488-Ha I) and the European Community (grant SOC 98200769 05 F02). This study was supported in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkau B, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-56; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bergmann MM, 2013, INT J EPIDEMIOL, V42, P1772, DOI 10.1093/ije/dyt154; Bergmann MM, 2004, EUR J EPIDEMIOL, V19, P411, DOI 10.1023/B:EJEP.0000027350.85974.47; Boeing H, 1999, ANN NUTR METAB, V43, P205, DOI 10.1159/000012787; Boeing H, 1999, ANN NUTR METAB, V43, P195, DOI 10.1159/000012786; Borman MA, 2013, HEPATOL INT, V7, P592, DOI 10.1007/s12072-012-9401-4; Brandstetter BR, 1999, ANN NUTR METAB, V43, P246, DOI 10.1159/000012791; Chang Y, 2013, AM J GASTROENTEROL, V108, P1861, DOI 10.1038/ajg.2013.349; Choi JH, 2013, ARCH MED RES, V44, P115, DOI 10.1016/j.arcmed.2013.01.007; Enzenbach C, 2011, EUR J NUTR, V50, P625, DOI 10.1007/s00394-011-0169-4; Feller S, 2010, DTSCH ARZTEBL INT, V107, P470, DOI 10.3238/arztebl.2010.0470; Ford ES, 2008, DIABETES CARE, V31, P1138, DOI [10.2337/dc07-2159, 10.2337/dc08-1138]; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gastaldelli A, 2009, HEPATOLOGY, V49, P1537, DOI 10.1002/hep.22845; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Hoffmann K, 2008, AM J EPIDEMIOL, V167, P517, DOI 10.1093/aje/kwm357; Jacobs S, 2014, AM J CLIN NUTR, V100, P891, DOI 10.3945/ajcn.113.080317; Jung CH, 2013, DIABETIC MED, V30, P428, DOI 10.1111/dme.12104; Kahl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094059; Kantartzis K, 2010, DIABETOLOGIA, V53, P882, DOI 10.1007/s00125-010-1663-6; Kasturiratne A, 2013, J GASTROEN HEPATOL, V28, P142, DOI 10.1111/j.1440-1746.2012.07264.x; Kim CH, 2008, DIABETIC MED, V25, P476, DOI 10.1111/j.1464-5491.2008.02410.x; Kim JH, 2011, LIVER INT, V31, P1600, DOI 10.1111/j.1478-3231.2011.02580.x; KlipsteinGrobusch K, 1997, INT J EPIDEMIOL, V26, pS174, DOI 10.1093/ije/26.suppl_1.S174; Koehler EM, 2013, CLIN GASTROENTEROL H, V11, P1201, DOI 10.1016/j.cgh.2012.12.031; Kotronen A, 2008, DIABETES CARE, V31, P165, DOI 10.2337/dc07-1463; Kroke A, 1999, ANN NUTR METAB, V43, P216, DOI 10.1159/000012788; LaBrecque DR, 2014, J CLIN GASTROENTEROL, V48, P467, DOI 10.1097/MCG.0000000000000116; Lange T, 2014, AM J EPIDEMIOL, V179, P513, DOI 10.1093/aje/kwt270; Lange T, 2012, AM J EPIDEMIOL, V176, P190, DOI 10.1093/aje/kwr525; Langsted A, 2008, CIRCULATION, V118, P2047, DOI 10.1161/CIRCULATIONAHA.108.804146; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448; Lin DY, 1997, STAT MED, V16, P1515, DOI 10.1002/(SICI)1097-0258(19970715)16:13<1515::AID-SIM572>3.3.CO;2-T; Meffert PJ, 2014, AM J GASTROENTEROL, V109, P1404, DOI 10.1038/ajg.2014.155; Myers RP, 2012, LIVER INT, V32, P902, DOI 10.1111/j.1478-3231.2012.02781.x; Okamoto M, 2003, J EPIDEMIOL, V13, P15, DOI 10.2188/jea.13.15; Park SK, 2013, HEPATOLOGY, V57, P1378, DOI 10.1002/hep.26183; Pearl J, 2001, P 17 C UNC ART INT S, P411; PICCININO F, 1986, J HEPATOL, V2, P165, DOI 10.1016/S0168-8278(86)80075-7; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Sahani DV, 2004, ONCOLOGIST, V9, P385, DOI 10.1634/theoncologist.9-4-385; Schienkiewitz A, 2006, AM J CLIN NUTR, V84, P427; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Schwenzer NF, 2009, J HEPATOL, V51, P433, DOI 10.1016/j.jhep.2009.05.023; Shibata M, 2007, DIABETES CARE, V30, P2940, DOI 10.2337/dc07-0792; Siegert S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076813; Stefan N, 2008, DIABETES, V57, P2762, DOI 10.2337/db08-0538; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Stefan N, 2011, DIABETES, V60, P2011, DOI 10.2337/db11-0231; Strauss S, 2007, AM J ROENTGENOL, V189, pW320, DOI 10.2214/AJR.07.2123; Sung KC, 2013, J CLIN ENDOCR METAB, V98, P3637, DOI 10.1210/jc.2013-1519; Sung KC, 2012, DIABETES CARE, V35, P717, DOI 10.2337/dc11-1853; Sung KC, 2011, J CLIN ENDOCR METAB, V96, P1093, DOI 10.1210/jc.2010-2190; WACHOLDER S, 1989, BIOMETRIKA, V76, P117, DOI 10.1093/biomet/76.1.117; Wieckowska A, 2008, SEMIN LIVER DIS, V28, P386, DOI 10.1055/s-0028-1091983; Yamada T, 2010, J GASTROEN HEPATOL, V25, P352, DOI 10.1111/j.1440-1746.2009.05998.x; Yki-Jarvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4; Zelber-Sagi S, 2013, LIVER INT, V33, P1406, DOI 10.1111/liv.12200	60	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124749	10.1371/journal.pone.0124749	http://dx.doi.org/10.1371/journal.pone.0124749			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902304	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500099
J	Lange, BA; Michel, C; Beckers, JF; Casey, JA; Flores, H; Hatam, I; Meisterhans, G; Niemi, A; Haas, C				Lange, Benjamin A.; Michel, Christine; Beckers, Justin F.; Casey, J. Alec; Flores, Hauke; Hatam, Ido; Meisterhans, Guillaume; Niemi, Andrea; Haas, Christian			Comparing Springtime Ice-Algal Chlorophyll a and Physical Properties of Multi-Year and First-Year Sea Ice from the Lincoln Sea	PLOS ONE			English	Article							SNOW COVER; ARCTIC-OCEAN; GREENLAND SEA; PACK-ICE; BIOMASS; MICROALGAE; MEIOFAUNA; ABUNDANCE; GROWTH; PHYTOPLANKTON	With near-complete replacement of Arctic multi-year ice (MYI) by first-year ice (FYI) predicted to occur within this century, it remains uncertain how the loss of MYI will impact the abundance and distribution of sea ice associated algae. In this study we compare the chlorophyll a (chl a) concentrations and physical properties of MYI and FYI from the Lincoln Sea during 3 spring seasons (2010-2012). Cores were analysed for texture, salinity, and chl a. We identified annual growth layers for 7 of 11 MYI cores and found no significant differences in chl a concentration between the bottom first-year-ice portions of MYI, upper old-ice portions of MYI, and FYI cores. Overall, the maximum chl a concentrations were observed at the bottom of young FYI. However, there were no significant differences in chl a concentrations between MYI and FYI. This suggests little or no change in algal biomass with a shift from MYI to FYI and that the spatial extent and regional variability of refrozen leads and younger FYI will likely be key factors governing future changes in Arctic sea ice algal biomass. Bottom-integrated chl a concentrations showed negative logistic relationships with snow depth and bulk (snow plus ice) integrated extinction coefficients; indicating a strong influence of snow cover in controlling bottom ice algal biomass. The maximum bottom MYI chl a concentration was observed in a hummock, representing the thickest ice with lowest snow depth of this study. Hence, in this and other studies MYI chl a biomass may be under-estimated due to an under-representation of thick MYI (e.g., hummocks), which typically have a relatively thin snowpack allowing for increased light transmission. Therefore, we suggest the on-going loss of MYI in the Arctic Ocean may have a larger impact on ice-associated production than generally assumed.	[Lange, Benjamin A.; Flores, Hauke] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Polar Biol Oceanog, Bremerhaven, Germany; [Lange, Benjamin A.; Flores, Hauke] Univ Hamburg, Ctr Nat Hist CeNak, Zool Museum, Bioctr Grindel, Hamburg, Germany; [Lange, Benjamin A.; Beckers, Justin F.; Casey, J. Alec; Haas, Christian] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB, Canada; [Michel, Christine; Meisterhans, Guillaume; Niemi, Andrea] Fisheries & Oceans Canada, Inst Freshwater, Winnipeg, MB R3T 2N6, Canada; [Hatam, Ido] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Haas, Christian] York Univ, Dept Earth & Space Sci & Engn, Toronto, ON M3J 2R7, Canada	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Hamburg; University of Alberta; Fisheries & Oceans Canada; University of Alberta; York University - Canada	Lange, BA (corresponding author), Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Polar Biol Oceanog, Bremerhaven, Germany.	benjamin.lange@awi.de	Flores, Hauke/ABD-1888-2020; Beckers, Justin/I-2806-2014; Haas, Christian/L-5279-2016; Lange, Benjamin/H-4733-2017	Flores, Hauke/0000-0003-1617-5449; Beckers, Justin/0000-0003-0751-3995; Haas, Christian/0000-0002-7674-3500; Casey, Alec/0000-0001-6011-4112; Lange, Benjamin Allen/0000-0003-4534-8978	Alberta Ingenuity Scholarship program [RN:200700172]; NSERC [356589-08]; Canadian Federal Programme on Energy Research and Development; Polar Continental Shelf Project; Northern Scientific Training Program (NSTP); Circumpolar-Boreal Arctic Research (C-BAR) program; Helmholtz Young Investigators Group "Iceflux" [VH-NG-800]	Alberta Ingenuity Scholarship program; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Federal Programme on Energy Research and Development; Polar Continental Shelf Project(Natural Resources Canada); Northern Scientific Training Program (NSTP); Circumpolar-Boreal Arctic Research (C-BAR) program; Helmholtz Young Investigators Group "Iceflux"	This study was supported by the Alberta Ingenuity Scholarship program (RN:200700172) to CH, NSERC Discovery Grants to CH (356589-08) and CM (http://www.nserc-crsng.gc.ca/index_eng.asp), and the Canadian Federal Programme on Energy Research and Development to CM (http://www.nrcan.gc.ca/energy/funding/current-funding-programs/perd/4993). Some in-kind support was provided by the Polar Continental Shelf Project (PCSP; http://www.nrcan.gc.ca/the-north/polarcontinental-shelf-program). BAL, JB, JAC, and IH were supported by the Northern Scientific Training Program (NSTP) and Circumpolar-Boreal Arctic Research (C-BAR) program. Additional funding was provided to HF and BAL as part of the Helmholtz Young Investigators Group "Iceflux" (VH-NG-800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alou-Font E, 2013, MAR ECOL PROG SER, V474, P89, DOI 10.3354/meps10107; [Anonymous], 2011, SNOW WATER ICE PERMA; Arrigo KR, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007151; Arrigo KR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035028; ARRIGO KR, 1991, J GEOPHYS RES-OCEANS, V96, P10581, DOI 10.1029/91JC00455; Arrigo KR, 2004, ANTARCT SCI, V16, P471, DOI 10.1017/S0954102004002263; Arrigo KR., 2010, SEA ICE, P283, DOI DOI 10.1002/9781444317145.CH8; BARLOW RG, 1988, MAR ECOL PROG SER, V45, P145, DOI 10.3354/meps045145; Boetius A, 2013, SCIENCE, V339, P1430, DOI 10.1126/science.1231346; Bowman JS, 2011, ISME J, P1, DOI [10.1038/ismej.2011.71, DOI 10.1038/ISMEJ.2011.71]; Budge SM, 2008, OECOLOGIA, V157, P117, DOI 10.1007/s00442-008-1053-7; Campbell K, 2014, J MARINE SY IN PRESS; Cota GF., 1991, J MARINE SYST, V2, P257, DOI [10.1016/0924-7963(91)90036-T, DOI 10.1016/0924-7963(91)90036-T]; COTA GF, 1991, J MARINE SYST, V2, P297, DOI DOI 10.1016/0924-7963(91)90038-V; COX GFN, 1983, J GLACIOL, V29, P306, DOI 10.3189/S0022143000008364; EICKEN H, 1989, J GEOPHYS RES-OCEANS, V94, P8193, DOI 10.1029/JC094iC06p08193; EICKEN H, 1995, J GEOPHYS RES-OCEANS, V100, P22697, DOI 10.1029/95JC02188; GOSSELIN M, 1985, CAN J FISH AQUAT SCI, V42, P999, DOI 10.1139/f85-125; Gosselin M, 1997, DEEP-SEA RES PT II, V44, P1623, DOI 10.1016/S0967-0645(97)00054-4; GOSSELIN M, 1990, J PHYCOL, V26, P220, DOI 10.1111/j.0022-3646.1990.00220.x; GOSSELIN M, 1986, MAR ECOL PROG SER, V29, P289, DOI 10.3354/meps029289; Gradinger R, 1997, POLAR BIOL, V17, P448, DOI 10.1007/s003000050139; Gradinger R, 1999, MAR BIOL, V133, P745, DOI 10.1007/s002270050516; Gradinger R, 2005, POLAR BIOL, V28, P171, DOI 10.1007/s00300-004-0674-5; Gradinger R, 1999, DEEP-SEA RES PT II, V46, P1457, DOI 10.1016/S0967-0645(99)00030-2; Gradinger R, 2010, DEEP-SEA RES PT II, V57, P86, DOI 10.1016/j.dsr2.2009.08.008; Grenfell TC, 1977, J GLACIOL, V18, P445, DOI [DOI 10.3189/S0022143000021122, 10.3189/S0022143000021122]; Haas C, 2006, ANN GLACIOL-SER, V44, P247, DOI 10.3189/172756406781811781; Haas C, 2011, CRYOVEX 2011 ALERT S, P1; Haas C, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042652; Hamre B, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001926; Hatam I, 2014, FEMS MICROBIOLOGY EC, P1; HORNER R, 1982, ARCTIC, V35, P485; Howell SEL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037681; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jarvinen O, 2011, J GLACIOL, V57, P861; Jeffries MO, 1988, ANN GLACIOL, V10, P63, DOI DOI 10.3198/1988A0G10-63-67; Kovacs Kit M., 2011, Marine Biodiversity, V41, P181, DOI 10.1007/s12526-010-0061-0; Kwok R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039035; Kwok R, 2005, GEOPHYS RES LETT; Kwok R, 2010, GEOPHYS RES LETT; Lalande C, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040570; Lange M.A., 1988, ANN GLACIOL, V10, P95; LANGE MA, 1989, ANN GLACIOL, V12, P92, DOI DOI 10.3189/S0260305500007023; Lavoie D, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2005JC002922; Legendre L., 1991, J MARINE SYST, V2, P347, DOI DOI 10.1016/0924-7963(91)90041-R; Leu E, 2011, PROG OCEANOGR, V90, P18, DOI 10.1016/j.pocean.2011.02.004; Light B, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2006JC003977; Lund-Hansen LC, 2014, POLAR BIOL, V37, P471, DOI 10.1007/s00300-013-1444-z; Markus T, 2009, J GEOPHYS RES; Maslanik JA, 2011, GEOPHYS RES LETT; MASSONNET F, 2012, CRYOSPHERE, V6, P1383, DOI [10.5194/tc-6-1383-2012, DOI 10.5194/tc-6-1383-2012]; MAYKUT GA, 1975, LIMNOL OCEANOGR, V20, P554, DOI 10.4319/lo.1975.20.4.0554; MAYKUT GA, 1971, J GEOPHYS RES, V76, P1550, DOI 10.1029/JC076i006p01550; MCROY CP, 1974, OCEANOGRAPHY BERING, P403; Melnikov IA, 2002, DEEP-SEA RES PT I, V49, P1623, DOI 10.1016/S0967-0637(02)00042-0; Michel C, 1996, J GEOPHYS RES-OCEANS, V101, P18345, DOI 10.1029/96JC00045; MICHEL C, 1988, MAR ECOL PROG SER, V50, P177, DOI 10.3354/meps050177; Michel C., 2013, ARCTIC BIODIVERSITY, P486, DOI 10.1201/9780203757222-17.; Mundy CJ, 2011, POLAR BIOL, V34, P1869, DOI 10.1007/s00300-011-0998-x; Mundy CJ, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003683; Newton JL, 1997, J GEOPHYS RES-OCEANS, V102, P3393, DOI 10.1029/96JC03441; Nicolaus M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053738; Nicolaus M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC006074; Nozais C, 2001, MAR ECOL PROG SER, V217, P235, DOI 10.3354/meps217235; Overland JE, 2013, GEOPHYS RES LETT, V40, P2097, DOI 10.1002/grl.50316; Parkinson CL, 2013, GEOPHYS RES LETT, V40, DOI 10.1002/grl.50349; Parsons T.R., 1989, MANUAL CHEM BIOL MET; Perovich DK, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001079; Perovich DK, 1996, COLD REGIONS RES ENG, P96; R Development Core Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Rampal P, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007110; Riedel A, 2006, AQUAT MICROB ECOL, V45, P195, DOI 10.3354/ame045195; Rigor IG, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019492; Rigor IG, 2002, J CLIMATE, V15, P2648, DOI 10.1175/1520-0442(2002)015<2648:ROSITT>2.0.CO;2; Riihela A, 2013, NAT CLIM CHANGE, V3, P895, DOI [10.1038/NCLIMATE1963, 10.1038/nclimate1963]; Rintala JM, 2014, POLAR BIOL, V37, P1811, DOI 10.1007/s00300-014-1563-1; Rysgaard S, 2008, POLAR BIOL, V31, P527, DOI 10.1007/s00300-007-0384-x; Schunemann H, 2005, MAR BIOL, V146, P1091, DOI 10.1007/s00227-004-1511-7; SCHWARZACHER W, 1959, J GEOPHYS RES, V64, P2357, DOI 10.1029/JZ064i012p02357; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051; SMITH REH, 1990, MAR BIOL, V107, P255, DOI 10.1007/BF01319824; Soreide JE, 2006, PROG OCEANOGR, V71, P59, DOI 10.1016/j.pocean.2006.06.001; Soreide JE, 2013, MAR BIOL RES, V9, P831, DOI 10.1080/17451000.2013.775457; Soreide JE, 2010, GLOBAL CHANGE BIOL, V16, P3154, DOI 10.1111/j.1365-2486.2010.02175.x; Stammerjohn S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL050874; Stroeve JC, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021810; Stroeve JC, 2012, CLIMATIC CHANGE, V110, P1005, DOI 10.1007/s10584-011-0101-1; Stroeve JC, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052676; Sturm M, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000400; THOMAS DN, 1995, POLAR BIOL, V15, P477; Tremblay JE, 2012, CLIMATIC CHANGE, V115, P161, DOI 10.1007/s10584-012-0496-3; Vancoppenolle M, 2013, QUATERNARY SCI REV, V79, P207, DOI 10.1016/j.quascirev.2013.04.011; Werner I, 2002, MAR BIOL, V140, P317, DOI 10.1007/s00227-001-0709-1	95	24	26	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122418	10.1371/journal.pone.0122418	http://dx.doi.org/10.1371/journal.pone.0122418			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901605	Green Submitted, gold, Green Published			2022-12-27	WOS:000353331500021
J	Stayte, S; Rentsch, P; Li, KM; Vissel, B				Stayte, Sandy; Rentsch, Peggy; Li, Kong M.; Vissel, Bryce			Activin A Protects Midbrain Neurons in the 6-Hydroxydopamine Mouse Model of Parkinson's Disease	PLOS ONE			English	Article							NIGRAL DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; 6-OHDA LESION; NIGROSTRIATAL PATHWAY; FUNCTIONAL RECOVERY; NEUROTROPHIC FACTOR; TIME-COURSE; RAT MODEL; GDNF; DELIVERY	Parkinson's disease (PD) is a chronic neurodegenerative disease characterized by a significant loss of dopaminergic neurons within the substantia nigra pars compacta (SNpc) and a subsequent loss of dopamine (DA) within the striatum. Despite advances in the development of pharmacological therapies that are effective at alleviating the symptoms of PD, the search for therapeutic treatments that halt or slow the underlying nigral degeneration remains a particular challenge. Activin A, a member of the transforming growth factor beta superfamily, has been shown to play a role in the neuroprotection of midbrain neurons against 6-hydroxydopamine (6-OHDA) in vitro, suggesting that activin A may offer similar neuroprotective effects in in vivo models of PD. Using robust stereological methods, we found that intrastriatal injections of 6-OHDA results in a significant loss of both TH positive and NeuN positive populations in the SNpc at 1, 2, and 3 weeks post-lesioning in drug naive mice. Exogenous application of activin A for 7 days, beginning the day prior to 6-OHDA administration, resulted in a significant survival of both dopaminergic and total neuron numbers in the SNpc against 6-OHDA-induced toxicity. However, we found no corresponding protection of striatal DA or dopamine transporter (DAT) expression levels in animals receiving activin A compared to vehicle controls. These results provide the first evidence that activin A exerts potent neuroprotection in a mouse model of PD, however this neuroprotection may be localized to the midbrain.	[Stayte, Sandy; Rentsch, Peggy; Vissel, Bryce] Garvan Inst Med Res, Neurosci Dept, Sydney, NSW, Australia; [Stayte, Sandy] UNSW Australia, Fac Med, Sydney, NSW, Australia; [Rentsch, Peggy] UNSW Australia, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Li, Kong M.] Univ Sydney, Dept Pharmacol, Bosch Inst, Sydney Med Sch, Sydney, NSW 2006, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney	Vissel, B (corresponding author), Garvan Inst Med Res, Neurosci Dept, Sydney, NSW, Australia.	brycevissel@gmail.com	Stayte, Sandy/AAC-5457-2019; Li, Kong M./R-4655-2019	Stayte, Sandy/0000-0002-6518-1979; Li, Kong/0000-0003-2709-0344; Rentsch, Peggy/0000-0002-2108-3568; Vissel, Bryce/0000-0001-8860-8050	Parkinson's NSW; Bill Gruy; Boyarsky family; Stanley and John Roth; David Baffsky; Patricia A. Quick Foundation; David King; Doug Battersby; Iain S. Gray Foundation in memory of Kylie; FIVEX in memory of Marko Berger; Tony and Vivian Howland-Rose; Walter and Edith Sheldon in memory of Walter Sheldon; Gleneagle Securities; Geoffrey Towner; Amadeus Energy Ltd.; Nick and Melanie Kell, J. O. and J. R.; Wicking Trust; Mason Foundation and SpinalCure Australia	Parkinson's NSW; Bill Gruy; Boyarsky family; Stanley and John Roth; David Baffsky; Patricia A. Quick Foundation; David King; Doug Battersby; Iain S. Gray Foundation in memory of Kylie; FIVEX in memory of Marko Berger; Tony and Vivian Howland-Rose; Walter and Edith Sheldon in memory of Walter Sheldon; Gleneagle Securities; Geoffrey Towner; Amadeus Energy Ltd.; Nick and Melanie Kell, J. O. and J. R.; Wicking Trust; Mason Foundation and SpinalCure Australia	Funding provided by Parkinson's NSW, Bill Gruy, The Boyarsky family, Stanley and John Roth, David Baffsky, Patricia A. Quick Foundation, David King, Doug Battersby, Iain S. Gray Foundation in memory of Kylie, FIVEX in memory of Marko Berger, Tony and Vivian Howland-Rose, Walter and Edith Sheldon in memory of Walter Sheldon, Gleneagle Securities, Geoffrey Towner, Amadeus Energy Ltd., Nick and Melanie Kell, J. O. and J. R. Wicking Trust and the Mason Foundation and SpinalCure Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdipranoto-Cowley A, 2009, STEM CELLS, V27, P1330, DOI 10.1002/stem.80; Bartus RT, 2013, NEUROLOGY, V80, P1698, DOI 10.1212/WNL.0b013e3182904faa; Bartus RT, 2011, MOVEMENT DISORD, V26, P27, DOI 10.1002/mds.23442; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bezard E, 2001, J NEUROSCI, V21, P6853, DOI 10.1523/JNEUROSCI.21-17-06853.2001; Cenci MA, 2007, CURR PROTOC NEUROSCI; Eberling JL, 2009, HUM GENE THER, V20, P511, DOI 10.1089/hum.2008.201; Eslamboli A, 2003, EXP NEUROL, V184, P536, DOI 10.1016/j.expneurol.2003.08.007; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Herzog CD, 2013, NEUROBIOL DIS, V58, P38, DOI 10.1016/j.nbd.2013.04.011; Jaber M, 1999, EUR J NEUROSCI, V11, P3499, DOI 10.1046/j.1460-9568.1999.00764.x; JEON BS, 1995, NEURODEGENERATION, V4, P131, DOI 10.1006/neur.1995.0016; Johnston LC, 2009, HUM GENE THER, V20, P497, DOI 10.1089/hum.2008.137; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Kirik D, 2000, EUR J NEUROSCI, V12, P3871, DOI 10.1046/j.1460-9568.2000.00274.x; Kordower JH, 2013, MOVEMENT DISORD, V28, P96, DOI 10.1002/mds.25344; Kordower JH, 1999, ANN NEUROL, V46, P419, DOI 10.1002/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q; KRIEGLSTEIN K, 1995, EMBO J, V14, P736, DOI 10.1002/j.1460-2075.1995.tb07052.x; Kupershmidt L, 2007, J NEUROCHEM, V103, P962, DOI 10.1111/j.1471-4159.2007.04785.x; Lai M, 1996, NEUROSCIENCE, V70, P1013, DOI 10.1016/0306-4522(95)00413-0; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Rosenblad C, 2000, EXP NEUROL, V161, P503, DOI 10.1006/exnr.1999.7296; Rosenblad C, 1999, EUR J NEUROSCI, V11, P1554, DOI 10.1046/j.1460-9568.1999.00566.x; SAUER H, 1994, NEUROSCIENCE, V59, P401, DOI 10.1016/0306-4522(94)90605-X; SAUER H, 1995, P NATL ACAD SCI USA, V92, P8935, DOI 10.1073/pnas.92.19.8935; Stayte S, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00113; Stott SRW, 2014, EUR J NEUROSCI, V39, P1042, DOI 10.1111/ejn.12459; Tretter YP, 2000, NAT MED, V6, P812, DOI 10.1038/77548; Tretter YP, 1996, NEUROREPORT, V7, P1819, DOI 10.1097/00001756-199607290-00026; Vaughan RA, 2013, TRENDS PHARMACOL SCI, V34, P489, DOI 10.1016/j.tips.2013.07.005; Wang L, 2002, GENE THER, V9, P381, DOI 10.1038/sj.gt.3301682; Winkler C, 1996, J NEUROSCI, V16, P7206	32	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124325	10.1371/journal.pone.0124325	http://dx.doi.org/10.1371/journal.pone.0124325			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902062	Green Submitted, gold, Green Published			2022-12-27	WOS:000353331500081
J	Clarke, AM; Friedrich, J; Tartaglia, EM; Marchesotti, S; Senn, W; Herzog, MH				Clarke, Aaron Michael; Friedrich, Johannes; Tartaglia, Elisa M.; Marchesotti, Silvia; Senn, Walter; Herzog, Michael H.			Human and Machine Learning in Non-Markovian Decision Making	PLOS ONE			English	Article							REWARD VALUE; NEURAL BASIS; RISK; UNCERTAINTY; ACTIVATION; FEEDBACK; NEURONS; CORTEX	Humans can learn under a wide variety of feedback conditions. Reinforcement learning (RL), where a series of rewarded decisions must be made, is a particularly important type of learning. Computational and behavioral studies of RL have focused mainly on Markovian decision processes, where the next state depends on only the current state and action. Little is known about non-Markovian decision making, where the next state depends on more than the current state and action. Learning is non-Markovian, for example, when there is no unique mapping between actions and feedback. We have produced a model based on spiking neurons that can handle these non-Markovian conditions by performing policy gradient descent [1]. Here, we examine the model's performance and compare it with human learning and a Bayes optimal reference, which provides an upper-bound on performance. We find that in all cases, our population of spiking neurons model well-describes human performance.	[Clarke, Aaron Michael; Marchesotti, Silvia; Herzog, Michael H.] Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Friedrich, Johannes; Senn, Walter] Univ Bern, Dept Physiol, CH-3012 Bern, Switzerland; [Friedrich, Johannes] Columbia Univ, Dept Stat, New York, NY USA; [Tartaglia, Elisa M.] CNRS, Paris, France; [Tartaglia, Elisa M.] Univ Paris 05, Ctr Neurophys, Paris, France; [Tartaglia, Elisa M.] Physiol & Pathol, Paris, France; [Tartaglia, Elisa M.] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Tartaglia, Elisa M.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Bern; Columbia University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Chicago; University of Chicago	Clarke, AM (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland.	aaron.clarke@utoronto.ca	Marchesotti, Silvia/AAM-1522-2020; Friedrich, Johannes/GXH-9356-2022; Senn, Walter/D-6308-2014	Friedrich, Johannes/0000-0002-1321-5866; Senn, Walter/0000-0003-3622-0497; Tartaglia, Elisa/0000-0002-0078-8163	Swiss National Science Foundation (SNSF) [PBBEP3-146112, PBELP3-135838]; Human Brain Project (HBP); SystemsX.ch; ProDoc project "Top-down and bottom-up processes in perceptual learning" [PDFM11-114404]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Human Brain Project (HBP); SystemsX.ch; ProDoc project "Top-down and bottom-up processes in perceptual learning"	The authors would like to thank Marc Repnow for excellent technical support. The project was supported by the Sinergia project "Learning from delayed and sparse feedback" of the Swiss National Science Foundation (SNSF) and by the Human Brain Project (HBP). Johannes Friedrich received additional funding from SystemsX.ch (Neurochoice, evaluated by the SNSF) and from the "Perspective Researcher fellowship" (project number PBBEP3-146112) of the SNSF. Elisa Tartaglia received additional funding from the ProDoc project "Top-down and bottom-up processes in perceptual learning" (project number: PDFM11-114404), and is currently funded by the "Perspective Researcher fellowship" (project number: PBELP3-135838) of the SNSF.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Badre D, 2010, NEURON, V66, P315, DOI 10.1016/j.neuron.2010.03.025; Baxter J, 2001, J ARTIF INTELL RES, V15, P319, DOI 10.1613/jair.806; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Elliott R, 1999, NEUROPSYCHOLOGIA, V37, P403, DOI 10.1016/S0028-3932(98)00107-9; Farrell MJ, 2003, J EXP PSYCHOL-APPL, V9, P219, DOI 10.1037/1076-898X.9.4.219; FERGUSON TS, 1973, ANN STAT, V1, P209, DOI 10.1214/aos/1176342360; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; FitzGerald THB, 2010, CURR BIOL, V20, P1823, DOI 10.1016/j.cub.2010.08.048; Friedrich J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002092; Friedrich J, 2010, NEURAL COMPUT, V22, P1698, DOI 10.1162/neco.2010.05-09-1010; Gerstner W, 2002, SPIKING NEURON MODEL; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Heft H., 1979, J NONVERBAL BEHAV, V3, P172, DOI [10.1007/BF01142591, DOI 10.1007/BF01142591]; Hertwig R, 2004, PSYCHOL SCI, V15, P534, DOI 10.1111/j.0956-7976.2004.00715.x; Hertwig R, 2009, TRENDS COGN SCI, V13, P517, DOI 10.1016/j.tics.2009.09.004; Herzog MH, 1997, VISION RES, V37, P2133, DOI 10.1016/S0042-6989(97)00043-6; Hjort N.L., 2010, BAYESIAN NONPARAMETR, V28, DOI 10.1017/CBO9780511802478; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Hsu M, 2009, J NEUROSCI, V29, P2231, DOI 10.1523/JNEUROSCI.5296-08.2009; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Janzen G, 2001, J ENVIRON PSYCHOL, V21, P149, DOI 10.1006/jevp.2000.0195; Jessup RK, 2008, PSYCHOL SCI, V19, P1015, DOI 10.1111/j.1467-9280.2008.02193.x; Jolivet R, 2006, J COMPUT NEUROSCI, V21, P35, DOI 10.1007/s10827-006-7074-5; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pfister JP, 2006, NEURAL COMPUT, V18, P1318, DOI 10.1162/neco.2006.18.6.1318; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Ribas-Fernandes JJF, 2011, NEURON, V71, P370, DOI 10.1016/j.neuron.2011.05.042; Ruddle RA, 2005, P IEEE VIRT REAL ANN, P115; Santamaria JC, 1997, ADAPT BEHAV, V6, P163, DOI 10.1177/105971239700600201; SCHMAJUK NA, 1992, BIOL CYBERN, V67, P165, DOI 10.1007/BF00201023; SETHURAMAN J, 1994, STAT SINICA, V4, P639; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Teh Y.W., 2010, ENCY MACHINE LEARNIN, P280, DOI [10.1007/978-0-387-30164-8_219, DOI 10.1007/978-0-387-30164-8_219]; TESAURO G, 1995, COMMUN ACM, V38, P58, DOI 10.1145/203330.203343; TLAUKA M, 1994, J ENVIRON PSYCHOL, V14, P305, DOI 10.1016/S0272-4944(05)80221-X; Tobler PN, 2007, J NEUROPHYSIOL, V97, P1621, DOI 10.1152/jn.00745.2006; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Urbanczik R, 2009, NAT NEUROSCI, V12, P250, DOI 10.1038/nn.2264; Wiering M, 1996, REINFORCEMENT LEARNI; WILLIAMS RJ, 1992, MACH LEARN, V8, P229, DOI 10.1007/BF00992696; Witmer BG, 1994, INT IND TRAIN SIM ED	49	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123105	10.1371/journal.pone.0123105	http://dx.doi.org/10.1371/journal.pone.0123105			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XJ	25898139	Green Submitted, Green Published, gold			2022-12-27	WOS:000353212600018
J	Osypuk, TL; Kehm, R; Misra, DP				Osypuk, Theresa L.; Kehm, Rebecca; Misra, Dawn P.			Where We Used to Live: Validating Retrospective Measures of Childhood Neighborhood Context for Life Course Epidemiologic Studies	PLOS ONE			English	Article							SOCIOECONOMIC CIRCUMSTANCES; MULTILEVEL; DISEASE; POVERTY; RECALL; DIRECTIONS; DISORDER; HEALTH; ADULTS; PROXY	Early life exposures influence numerous social determinants of health, as distal causes or confounders of later health outcomes. Although a growing literature is documenting how early life socioeconomic position affects later life health, few epidemiologic studies have tested measures for operationalizing early life neighborhood context, or examined their effects on later life health. In the Life-course Influences on Fetal Environments (LIFE) Study, a retrospective cohort study among Black women in Southfield, Michigan (71% response rate), we tested the validity and reliability of retrospectively-reported survey-based subjective measures of early life neighborhood context(N=693). We compared 3 subjective childhood neighborhood measures (disorder, informal social control, victimization), with 3 objective childhood neighborhood measures derived from 4 decades of historical census tract data 1970-2000, linked through geocoded residential histories (tract % poverty, tract % black, tract deprivation score derived from principal components analysis), as well as with 2 subjective neighborhood measures in adulthood. Our results documented that internal consistency reliability was high for the subjective childhood neighborhood scales (Cronbach's alpha = 0.89, 0.93). Comparison of subjective with objective childhood neighborhood measures found moderate associations in hypothesized directions. Associations with objective variables were strongest for neighborhood disorder (rhos = .40), as opposed to with social control or victimization. Associations between subjective neighborhood context in childhood versus adulthood were moderate and stronger for residentially-stable populations. We lastly formally tested for, but found little evidence of, recall bias of the retrospective subjective reports of childhood context. These results provide evidence that retrospective reports of subjective neighborhood context may be a cost-effective, valid, and reliable method to operationalize early life context for health studies.	[Osypuk, Theresa L.; Kehm, Rebecca] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Misra, Dawn P.] Wayne State Univ, Sch Med, Dept Family Med & Publ Hlth Sci, Detroit, MI USA	University of Minnesota System; University of Minnesota Twin Cities; Wayne State University	Osypuk, TL (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	tosypuk@umn.edu		Osypuk, Theresa/0000-0001-5770-3346	National Institutes of Health (NIH); National Institute of Child Health and Development (NICHD) [R01HD058510]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058510, R24HD041023] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding provided by National Institutes of Health (NIH), National Institute of Child Health and Development (NICHD) grant R01HD058510. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Garcia D, 2008, HEALTH AFFAIR, V27, P321, DOI 10.1377/hlthaff.27.2.321; Acevedo-Garcia D, 2013, AM J PUBLIC HEALTH, V103, P1754, DOI 10.2105/AJPH.2012.300986; [Anonymous], 2004, LIFE COURSE APPROACH; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Batty GD, 2005, J EPIDEMIOL COMMUN H, V59, P898, DOI 10.1136/jech.2004.030932; Campbell F, 2014, SCIENCE, V343, P1478, DOI 10.1126/science.1248429; Carson AP, 2007, ANN EPIDEMIOL, V17, P296, DOI 10.1016/j.annepidem.2006.07.009; Cerda M, 2010, EPIDEMIOLOGY, V21, P482, DOI 10.1097/EDE.0b013e3181e13539; Chaix B, 2009, ANNU REV PUBL HEALTH, V30, P81, DOI 10.1146/annurev.publhealth.031308.100158; Cook T.D., 2002, EXPT QUASIEXPERIMENT; Cutler DM, 1997, Q J ECON, V112, P827, DOI 10.1162/003355397555361; DeVellis RF, 2016, SCALE DEV THEORY APP; Dunn J.R., 2002, POPULATION HLTH APPR; Earls FJ, 1994, 2766 ICPSR U MICH; Echeverria SE, 2004, J URBAN HEALTH, V81, P682, DOI 10.1093/jurban/jth151; Farver JAM, 2000, J APPL DEV PSYCHOL, V21, P139, DOI 10.1016/S0193-3973(99)00032-5; Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053; Galobardes B, 2004, EPIDEMIOL REV, V26, P7, DOI 10.1093/epirev/mxh008; Geolytics, 2003, NEIGHB CHANG DAT LON; Glymour MM, 2007, STROKE, V38, P2415, DOI 10.1161/STROKEAHA.107.482059; Hatcher L, 1994, PRINCIPAL COMPONENT; Hertzman C, 2010, ANNU REV PUBL HEALTH, V31, P329, DOI 10.1146/annurev.publhealth.012809.103538; Kawachi I., 2003, NEIGHBORHOODS HLTH; Kuh D, 2003, J EPIDEMIOL COMMUN H, V57, P778, DOI 10.1136/jech.57.10.778; Kutty Nandinee, 2008, SEGREGATION RISING C, P197; Lucas PJ, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-56; Lynch J, 2005, ANNU REV PUBL HEALTH, V26, P1, DOI 10.1146/annurev.publhealth.26.021304.144505; Mair C, 2008, J EPIDEMIOL COMMUN H, V62, P940, DOI 10.1136/jech.2007.066605; Merolla DM, 2011, SOCIOL PERSPECT, V54, P205, DOI 10.1525/sop.2011.54.2.205; Messer LC, 2006, J URBAN HEALTH, V83, P1041, DOI 10.1007/s11524-006-9094-x; Nandi A, 2010, AM J EPIDEMIOL, V171, P391, DOI 10.1093/aje/kwp416; O'Campo P, 2003, AM J EPIDEMIOL, V157, P9, DOI 10.1093/aje/kwf171; Osypuk TL, 2013, REV EPIDEMIOL SANTE, V61, pS61, DOI 10.1016/j.respe.2013.03.040; Osypuk TL, 2015, SOC PSYCH PSYCH EPID, V50, P215, DOI 10.1007/s00127-014-0998-6; Pollitt RA, 2008, J EPIDEMIOL COMMUN H, V62, P484, DOI 10.1136/jech.2006.054106; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Rutter M, 2012, DEV PSYCHOPATHOL, V24, P335, DOI 10.1017/S0954579412000028; Sampson RJ, 1999, AM J SOCIOL, V105, P603, DOI 10.1086/210356; Sampson RJ, 1999, AM SOCIOL REV, V64, P633, DOI 10.2307/2657367; Sampson RJ, 2004, SOC PSYCHOL QUART, V67, P319, DOI 10.1177/019027250406700401; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Scheurer ME, 2010, AM J EPIDEMIOL, V172, P1099, DOI [10.1093/aje/kwq044, 10.1093/aje/kwq261]; Schneider A, 2012, GPS VIS; Straughen JK, 2013, PAEDIATR PERINAT EP, V27, P294, DOI 10.1111/ppe.12045; SZKLO M., 2014, EPIDEMIOLOGY BASICS, V3; US Census Bureau Annual Social and Economic Supplement (ASEC) to the Current Population Survey (CPS), 2010, ANN SOC EC S ASEC CU; Walton KA, 2000, EUR J EPIDEMIOL, V16, P793, DOI 10.1023/A:1007625030509; Yen IH, 2009, AM J PREV MED, V37, P455, DOI 10.1016/j.amepre.2009.06.022	48	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124635	10.1371/journal.pone.0124635	http://dx.doi.org/10.1371/journal.pone.0124635			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XJ	25898015	Green Submitted, Green Published, gold			2022-12-27	WOS:000353212600077
J	Paz-Ferreiro, J; Liang, CF; Fu, SL; Mendez, A; Gasco, G				Paz-Ferreiro, Jorge; Liang, Chenfei; Fu, Shenglei; Mendez, Ana; Gasco, Gabriel			The Effect of Biochar and Its Interaction with the Earthworm Pontoscolex corethrurus on Soil Microbial Community Structure in Tropical Soils	PLOS ONE			English	Article							RICE STRAW; BIOMASS; CARBON; EMISSIONS; BACTERIAL; PROFILES; IMPACTS; N2O; CO2	Biochar effects on soil microbial abundance and community structure are keys for understanding the biogeochemical cycling of nutrients and organic matter turnover, but are poorly understood, in particular in tropical areas. We conducted a greenhouse experiment in which we added biochars produced from four different feedstocks [sewage sludge (B1), deinking sewage sludge (B2), Miscanthus (B3) and pine wood (B4)] at a rate of 3% (w/w) to two tropical soils (an Acrisol and a Ferralsol) planted with proso millet (Panicum milliaceum L.). The interactive effect of the addition of earthworms was also addressed. For this purpose we utilized soil samples from pots with or without the earthworm Pontoscolex corethrurus, which is a ubiquitous earthworm in tropical soils. Phospholipid fatty acid (PLFA) measurements showed that biochar type, soil type and the presence of earthworms significantly affected soil microbial community size and structure. In general, biochar addition affected fungal but not bacterial populations. Overall, biochars rich in ash (B1 and B2) resulted in a marked increase in the fungi to bacteria ratio, while this ratio was unaltered after addition of biochars with a high fixed carbon content (B3 and B4). Our study remarked the contrasting effect that both, biochar prepared from different materials and macrofauna, can have on soil microbial community. Such changes might end up with ecosystem-level effects.	[Paz-Ferreiro, Jorge] RMIT Univ, Sch Civil Environm & Chem Engn, Melbourne, Vic, Australia; [Liang, Chenfei; Fu, Shenglei] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Liang, Chenfei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Mendez, Ana] Univ Politecn Madrid, ETSI Minas, Dept Ingn Geol & Minera, Madrid, Spain; [Gasco, Gabriel] Univ Politecn Madrid, ETSI Agron, Dept Prod Agr, Madrid, Spain	Royal Melbourne Institute of Technology (RMIT); Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Universidad Politecnica de Madrid; Universidad Politecnica de Madrid	Paz-Ferreiro, J (corresponding author), RMIT Univ, Sch Civil Environm & Chem Engn, Melbourne, Vic, Australia.	jorge.paz-ferreiro@rmit.edu.au	Fu, Shenglei/B-2729-2012; Méndez, Ana María/L-5946-2014; Paz-Ferreiro, Jorge/H-6297-2011	Méndez, Ana María/0000-0001-9642-0875; Paz-Ferreiro, Jorge/0000-0001-8169-4099	Chinese Academy of Sciences (fellowship for Young International Scientists) [2012Y1SA0002]	Chinese Academy of Sciences (fellowship for Young International Scientists)	J. Paz-Ferreiro was sponsored by the Chinese Academy of Sciences (fellowship for Young International Scientists number 2012Y1SA0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aira M, 2014, J SOIL SEDIMENT, V14, P1335, DOI 10.1007/s11368-014-0889-1; Ameloot N, 2015, GCB BIOENERGY, V7, P135, DOI 10.1111/gcbb.12119; Ameloot N, 2013, SOIL BIOL BIOCHEM, V57, P401, DOI 10.1016/j.soilbio.2012.10.025; Augustenborg CA, 2012, J ENVIRON QUAL, V41, P1203, DOI 10.2134/jeq2011.0119; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Bougnom BP, 2010, APPL SOIL ECOL, V45, P319, DOI 10.1016/j.apsoil.2010.05.009; BROWN GG, 1995, PLANT SOIL, V170, P209, DOI 10.1007/BF02183068; Case SDC, 2012, SOIL BIOL BIOCHEM, V51, P125, DOI 10.1016/j.soilbio.2012.03.017; Curry JP, 2007, PEDOBIOLOGIA, V50, P463, DOI 10.1016/j.pedobi.2006.09.001; de Vries FT, 2012, NAT CLIM CHANGE, V2, P276, DOI [10.1038/NCLIMATE1368, 10.1038/nclimate1368]; Dominguez J, 2004, EARTHWORM ECOLOGY, P401; Enami Y, 2001, EUR J SOIL BIOL, V37, P269, DOI 10.1016/S1164-5563(01)01096-2; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Gomez JD, 2014, EUR J SOIL SCI, V65, P28, DOI 10.1111/ejss.12097; Gormsen D, 2004, APPL SOIL ECOL, V27, P211, DOI 10.1016/j.apsoil.2004.06.001; Kim JS, 2007, SOIL BIOL BIOCHEM, V39, P684, DOI 10.1016/j.soilbio.2006.08.010; Kramer C, 2008, SOIL BIOL BIOCHEM, V40, P425, DOI 10.1016/j.soilbio.2007.09.016; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; Liu L, 2012, SOIL BIOL BIOCHEM, V44, P31, DOI 10.1016/j.soilbio.2011.08.017; Liu XY, 2013, PLANT SOIL, V373, P583, DOI 10.1007/s11104-013-1806-x; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; McCormack SA, 2013, GCB BIOENERGY, V5, P81, DOI 10.1111/gcbb.12046; Mendez A, 2012, CHEMOSPHERE, V89, P1354, DOI 10.1016/j.chemosphere.2012.05.092; Muhammad N, 2014, GEODERMA, V226, P270, DOI 10.1016/j.geoderma.2014.01.023; Noguera D, 2012, SOIL BIOL BIOCHEM, V52, P13, DOI 10.1016/j.soilbio.2012.04.004; Noguera D, 2010, SOIL BIOL BIOCHEM, V42, P1017, DOI 10.1016/j.soilbio.2010.03.001; Olsson PA, 1999, FEMS MICROBIOL ECOL, V29, P303, DOI 10.1111/j.1574-6941.1999.tb00621.x; Paz-Ferreiro J, 2012, BIOL FERT SOILS, V48, P511, DOI 10.1007/s00374-011-0644-3; Paz-Ferreiro J, 2014, J SOIL SEDIMENT, V14, P483, DOI 10.1007/s11368-013-0806-z; Peng X, 2011, SOIL TILL RES, V112, P159, DOI 10.1016/j.still.2011.01.002; Ponge JF, 2006, SOIL BIOL BIOCHEM, V38, P2008, DOI 10.1016/j.soilbio.2005.12.024; Prayogo C, 2014, BIOL FERT SOILS, V50, P695, DOI 10.1007/s00374-013-0884-5; Rousk J, 2010, SOIL BIOL BIOCHEM, V42, P516, DOI 10.1016/j.soilbio.2009.11.026; Sanchez PA, 1992, MYTHS SCI SOILS TROP, P17; Steinbeiss S, 2009, SOIL BIOL BIOCHEM, V41, P1301, DOI 10.1016/j.soilbio.2009.03.016; Van Zwieten L, 2010, PLANT SOIL, V327, P235, DOI 10.1007/s11104-009-0050-x; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Yin YF, 2014, J INTEGR AGR, V13, P491, DOI 10.1016/S2095-3119(13)60704-2	38	39	39	3	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124891	10.1371/journal.pone.0124891	http://dx.doi.org/10.1371/journal.pone.0124891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898344	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600093
J	Sonestedt, E; Hellstrand, S; Schulz, CA; Wallstrom, P; Drake, I; Ericson, U; Gullberg, B; Hedblad, B; Orho-Melander, M				Sonestedt, Emily; Hellstrand, Sophie; Schulz, Christina-Alexandra; Wallstrom, Peter; Drake, Isabel; Ericson, Ulrika; Gullberg, Bo; Hedblad, Bo; Orho-Melander, Marju			The Association between Carbohydrate-Rich Foods and Risk of Cardiovascular Disease Is Not Modified by Genetic Susceptibility to Dyslipidemia as Determined by 80 Validated Variants	PLOS ONE			English	Article							WHOLE-GRAIN INTAKE; SWEETENED BEVERAGE CONSUMPTION; CORONARY-HEART-DISEASE; DIET HISTORY METHOD; MALMO DIET; HABIT CHANGE; CANCER; OBESITY; STROKE; CEREAL	Background It is still unclear whether carbohydrate consumption is associated with cardiovascular disease (CVD) risk. Genetic susceptibility might modify the associations between dietary intakes and disease risk. Objectives The aim was to examine the association between the consumption of carbohydrate-rich foods (vegetables, fruits and berries, juice, potatoes, whole grains, refined grains, cookies and cakes, sugar and sweets, and sugar-sweetened beverages) and the risk of incident ischemic CVD (iCVD; coronary events and ischemic stroke), and whether these associations differ depending on genetic susceptibility to dyslipidemia. Methods Among 26,445 individuals (44-74 years; 62% females) from the Malmo Diet and Cancer Study cohort, 2,921 experienced an iCVD event during a mean follow-up time of 14 years. At baseline, dietary data were collected using a modified diet history method, and clinical risk factors were measured in 4,535 subjects. We combined 80 validated genetic variants associated with triglycerides and HDL-C or LDL-C, into genetic risk scores and examined the interactions between dietary intakes and genetic risk scores on the incidence of iCVD. Results Subjects in the highest intake quintile for whole grains had a 13% (95% CI: 3-23%; p-trend: 0.002) lower risk for iCVD compared to the lowest quintile. A higher consumption of foods rich in added sugar (sugar and sweets, and sugar-sweetened beverages) had a significant cross-sectional association with higher triglyceride concentrations and lower HDL-C concentrations. A stronger positive association between a high consumption of sugar and sweets on iCVD risk was observed among those with low genetic risk score for triglycerides (p-interaction=0.05). Conclusion In this prospective cohort study that examined food sources of carbohydrates, individuals with a high consumption of whole grains had a decreased risk of iCVD. No convincing evidence of an interaction between genetic susceptibility for dyslipidemia, measured as genetic risk scores of dyslipidemia-associated variants, and the consumption of carbohydrate-rich foods on iCVD risk was observed.	[Sonestedt, Emily; Hellstrand, Sophie; Schulz, Christina-Alexandra; Ericson, Ulrika; Orho-Melander, Marju] Lund Univ, Dept Clin Sci Malmo, Diabet & Cardiovasc Dis Genet Epidemiol, Malmo, Sweden; [Wallstrom, Peter; Drake, Isabel; Gullberg, Bo] Lund Univ, Dept Clin Sci Malmo, Nutr Epidemiol, Malmo, Sweden; [Hedblad, Bo] Lund Univ, Dept Clin Sci Malmo, Cardiovasc Dis Epidemiol, Malmo, Sweden	Lund University; Lund University; Lund University	Sonestedt, E (corresponding author), Lund Univ, Dept Clin Sci Malmo, Diabet & Cardiovasc Dis Genet Epidemiol, Malmo, Sweden.	Emily.Sonestedt@med.lu.se	Sonestedt, Emily/I-3814-2016	Sonestedt, Emily/0000-0002-0747-4562; Drake, Isabel/0000-0002-6500-6310	Swedish Medical Research Council; Swedish Heart and Lung Foundation; Skane University Hospital; Albert Pahlsson Research Foundation; Crafoord Foundation; Swedish Society for Medical Research; Novo Nordisk Fonden [NNF14OC0011049] Funding Source: researchfish	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Skane University Hospital; Albert Pahlsson Research Foundation; Crafoord Foundation; Swedish Society for Medical Research; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by the Swedish Medical Research Council, Swedish Society for Medical Research, the Swedish Heart and Lung Foundation, the Skane University Hospital, the Albert Pahlsson Research Foundation, and the Crafoord Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KE, 2012, MOL NUTR FOOD RES, V56, P1003, DOI 10.1002/mnfr.201100706; [Anonymous], 2000, VARD DIAGN AK HJART; Becker W, 2002, RIKSMATEN 1997 98 KO, DOI [10.1007/s00394-008-0701-3, DOI 10.1007/S00394-008-0701-3]; Bernstein AM, 2012, AM J CLIN NUTR, V95, P1190, DOI 10.3945/ajcn.111.030205; CALLMER E, 1993, J INTERN MED, V233, P53, DOI 10.1111/j.1365-2796.1993.tb00648.x; Costabile A, 2008, BRIT J NUTR, V99, P110, DOI 10.1017/S0007114507793923; de Koning L, 2012, CIRCULATION, V125, P1735, DOI 10.1161/CIRCULATIONAHA.111.067017; Elmstahl S, 1996, EUR J CLIN NUTR, V50, P143; Elmstahl S, 1996, EUR J CLIN NUTR, V50, P134; Eshak ES, 2012, AM J CLIN NUTR, V96, P1390, DOI 10.3945/ajcn.112.037903; Fung TT, 2009, AM J CLIN NUTR, V89, P1037, DOI 10.3945/ajcn.2008.27140; Hellstrand S, 2012, J LIPID RES, V53, P1183, DOI 10.1194/jlr.P023721; Hlebowicz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071095; Kyro C, 2013, CANCER CAUSE CONTROL, V24, P1363, DOI 10.1007/s10552-013-0215-z; Maersk M, 2012, AM J CLIN NUTR, V95, P283, DOI 10.3945/ajcn.111.022533; Manjer J, 2001, EUR J CANCER PREV, V10, P489, DOI 10.1097/00008469-200112000-00003; Manjer J, 2002, SCAND J PUBLIC HEALT, V30, P103, DOI 10.1080/14034940210133771; Mellen PB, 2008, NUTR METAB CARDIOVAS, V18, P283, DOI 10.1016/j.numecd.2006.12.008; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Nettleton JA, 2010, DIABETES CARE, V33, P2684, DOI 10.2337/dc10-1150; Pollin TI, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002895; Pollin TI, 2011, J CLIN ENDOCR METAB, V96, pE1142, DOI 10.1210/jc.2010-2324; Riboli E, 1997, INT J EPIDEMIOL, V26, pS161, DOI 10.1093/ije/26.suppl_1.S161; Sharma S, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-65; Silbernagel G, 2012, EXP DIABETES RES, DOI 10.1155/2012/361863; Sonestedt E, 2005, PUBLIC HEALTH NUTR, V8, P876, DOI 10.1079/PHN2005736; SONESTEDT E, 2012, HIGH DISACCHARIDE IN, V107, P1062, DOI DOI 10.1017/S0007114511003783; Sonestedt E, 2007, PUBLIC HEALTH NUTR, V10, P769, DOI 10.1017/S1368980007246646; Sonestedt E, 2011, EUR J EPIDEMIOL, V26, P609, DOI 10.1007/s10654-011-9589-y; TESLOVICH TM, 2010, BIOLOGICAL CLIN POPU, V466, P707, DOI DOI 10.1038/NATURE09270; Wallstrom P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031637; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wirfalt E, 2002, NUTR J, V1, DOI 10.1186/1475-2891-1-3; Ye EQ, 2012, J NUTR, V142, P1304, DOI 10.3945/jn.111.155325; Zia E, 2006, CEREBROVASC DIS, V21, P18, DOI 10.1159/000089589	35	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0126104	10.1371/journal.pone.0126104	http://dx.doi.org/10.1371/journal.pone.0126104			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898210	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600103
J	Verdejo-Garcia, A; Moreno-Padilla, M; Garcia-Rios, MC; Lopez-Torrecillas, F; Delgado-Rico, E; Schmidt-Rio-Valle, J; Fernandez-Serrano, MJ				Verdejo-Garcia, Antonio; Moreno-Padilla, Maria; Carmen Garcia-Rios, M.; Lopez-Torrecillas, Francisca; Delgado-Rico, Elena; Schmidt-Rio-Valle, Jacqueline; Fernandez-Serrano, Maria J.			Social Stress Increases Cortisol and Hampers Attention in Adolescents with Excess Weight	PLOS ONE			English	Article							REDUCED OBESE INDIVIDUALS; DECISION-MAKING; PSYCHOSOCIAL STRESS; ANTERIOR CINGULATE; PREFRONTAL CORTEX; PEER REJECTION; GAMBLING TASK; RISK-TAKING; REACTIVITY; RESPONSES	Objective To experimentally examine if adolescents with excess weight are more sensitive to social stress and hence more sensitive to harmful effects of stress in cognition. Design and Methods We conducted an experimental study in 84 adolescents aged 12 to 18 years old classified in two groups based on age adjusted Body Mass Index percentile: Normal weight (n=42) and Excess weight (n=42). Both groups were exposed to social stress as induced by the virtual reality version of the Trier Social Stress Task -participants were requested to give a public speech about positive and negative aspects of their personalities in front of a virtual audience. The outcome measures were salivary cortisol levels and performance in cognitive tests before and after the social stressor. Cognitive tests included the CANTAB Rapid Visual Processing Test (measuring attention response latency and discriminability) and the Iowa Gambling Task (measuring decision-making). Results Adolescents with excess weight compared to healthy weight controls displayed increased cortisol response and less improvement of attentional performance after the social stressor. Decision-making performance decreased after the social stressor in both groups. Conclusion Adolescents who are overweight or obese have increased sensitivity to social stress, which detrimentally impacts attentional skills.	[Verdejo-Garcia, Antonio; Moreno-Padilla, Maria; Lopez-Torrecillas, Francisca; Delgado-Rico, Elena] Univ Granada, Dept Clin Psychol, Granada, Spain; [Verdejo-Garcia, Antonio; Moreno-Padilla, Maria; Lopez-Torrecillas, Francisca; Delgado-Rico, Elena] Univ Granada, Inst Neurosci F Oloriz, Granada, Spain; [Verdejo-Garcia, Antonio] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia; [Carmen Garcia-Rios, M.; Schmidt-Rio-Valle, Jacqueline] Univ Granada, Sch Hlth Sci, Granada, Spain; [Fernandez-Serrano, Maria J.] Univ Jaen, Dept Psychol, Jaen, Spain	University of Granada; University of Granada; Monash University; University of Granada; Universidad de Jaen	Verdejo-Garcia, A (corresponding author), Univ Granada, Dept Clin Psychol, Granada, Spain.	antonio.verdejo@monash.edu	Lopez-Torrecillas, Francisca/C-8267-2018; Fernandez-Serrano, Maria Jose/AGA-6711-2022; Serrano, M Josefa Fernández/V-3124-2019; PADILLA, MARÍA M/Z-1050-2018; García-Ríos, María del Carmen/I-3603-2015; del Carmen García-Ríos, María/L-9683-2019; Verdejo-Garcia, Antonio/AAV-1147-2021; Rueda, Maria del Mar/F-9571-2015	Serrano, M Josefa Fernández/0000-0002-6158-237X; García-Ríos, María del Carmen/0000-0003-2913-1410; del Carmen García-Ríos, María/0000-0003-2913-1410; Verdejo-Garcia, Antonio/0000-0001-8874-9339; lopez-torrecillas, francisca/0000-0002-4541-5184; MORENO PADILLA, MARIA/0000-0002-4751-8283; Bauldry, Shawn/0000-0002-6679-3125; Rueda, Maria del Mar/0000-0002-2903-8745; Delgado Rico, Elena/0000-0001-9424-8928	Ministry of Innovation and Science (MICINN) [PSI2010-17290, P-10-HUM-6635]	Ministry of Innovation and Science (MICINN)	This study has been funded by grants PSI2010-17290 (INTEROBE) from the Ministry of Innovation and Science (MICINN), and P-10-HUM-6635 (NEUROECOBE).	Baeken C, 2011, PSYCHONEUROENDOCRINO, V36, P60, DOI 10.1016/j.psyneuen.2010.06.006; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Bechara A, 2007, IOWA GAMBLING TASK; Butler TR, 2014, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00102; Chein J, 2011, DEVELOPMENTAL SCI, V14, pF1, DOI 10.1111/j.1467-7687.2010.01035.x; Chudasama Y, 2003, BEHAV BRAIN RES, V146, P105, DOI 10.1016/j.bbr.2003.09.020; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Davidson RJ, 2012, NAT NEUROSCI, V15, P689, DOI 10.1038/nn.3093; DeSantis AS, 2012, PSYCHONEUROENDOCRINO, V37, P1009, DOI 10.1016/j.psyneuen.2011.11.009; Frazier-Wood AC, OBESITY IN PRESS; Gardner M, 2005, DEV PSYCHOL, V41, P625, DOI 10.1037/0012-1649.41.4.625; Garner DM, 1994, EDI 2 INVENTARIO TRA; Gunnarsdottir T, 2012, J EVAL CLIN PRACT, V18, P465, DOI 10.1111/j.1365-2753.2010.01603.x; Hanson JL, 2012, J NEUROSCI, V32, P7917, DOI 10.1523/JNEUROSCI.0307-12.2012; He Q, 2013, BRAIN STRUCT FUNCT; Jahn AL, 2010, BIOL PSYCHIAT, V67, P175, DOI 10.1016/j.biopsych.2009.07.039; Kelly O, 2007, CYBERPSYCHOL BEHAV, V10, P655, DOI 10.1089/cpb.2007.9973; Kiem SA, 2013, PSYCHONEUROENDOCRINO, V38, P1338, DOI 10.1016/j.psyneuen.2012.11.021; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kubzansky LD, 2014, JAMA PSYCHIAT, V71, P44, DOI 10.1001/jamapsychiatry.2013.2798; Liang J, 2014, INT J OBESITY, V38, P494, DOI 10.1038/ijo.2013.142; Liu J, 2012, J AM ACAD CHILD PSY, V51, P304, DOI 10.1016/j.jaac.2011.12.014; Lowe C, 1998, NEUROPSYCHOLOGIA, V36, P915, DOI 10.1016/S0028-3932(98)00036-0; Lu QY, 2014, APPETITE, V72, P13, DOI 10.1016/j.appet.2013.09.019; Ludwig DS, 2007, NEW ENGL J MED, V357, P2325, DOI 10.1056/NEJMp0706538; Masten CL, 2013, DEVELOPMENTAL SCI, V16, P743, DOI 10.1111/desc.12056; Masten CL, 2011, DEV PSYCHOPATHOL, V23, P283, DOI 10.1017/S0954579410000799; Moreno-Lopez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049185; Preston SD, 2007, BEHAV NEUROSCI, V121, P257, DOI 10.1037/0735-7044.121.2.257; Rao U, 2008, BIOL PSYCHIAT, V64, P521, DOI 10.1016/j.biopsych.2008.05.012; Robbins TW, 1998, J INT NEUROPSYCH SOC, V4, P474, DOI 10.1017/s1355617798455073; Root JC, 2009, NEUROREPORT, V20, P429, DOI 10.1097/WNR.0b013e328326a031; Rouach V, 2007, PSYCHONEUROENDOCRINO, V32, P693, DOI 10.1016/j.psyneuen.2007.04.010; Seeyave DM, 2009, ARCH PEDIAT ADOL MED, V163, P303, DOI 10.1001/archpediatrics.2009.12; Slavich GM, 2010, P NATL ACAD SCI USA, V107, P14817, DOI 10.1073/pnas.1009164107; Strauss RS, 2003, ARCH PEDIAT ADOL MED, V157, P746, DOI 10.1001/archpedi.157.8.746; Therrien F, 2007, OBESITY, V15, P377, DOI 10.1038/oby.2007.509; Therrien F, 2010, BIOL PSYCHOL, V84, P325, DOI 10.1016/j.biopsycho.2010.03.013; Thomason ME, 2011, J CHILD PSYCHOL PSYC, V52, P1026, DOI 10.1111/j.1469-7610.2011.02422.x; Tsai SF, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00027; van den Bos R, 2009, PSYCHONEUROENDOCRINO, V34, P1449, DOI 10.1016/j.psyneuen.2009.04.016; van Strien T, 2013, PSYCHONEUROENDOCRINO, V38, P677, DOI 10.1016/j.psyneuen.2012.08.008; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Verdejo-Garcia A, 2006, PSYCHOL BELG, V46, P55, DOI 10.5334/pb-46-1-2-55; Verdejo-Garcia A, 2015, HUM BRAIN MAPP, V36, P226, DOI 10.1002/hbm.22625	45	26	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123565	10.1371/journal.pone.0123565	http://dx.doi.org/10.1371/journal.pone.0123565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XJ	25898204	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600031
J	Wang, TY; Jao, CW; Soong, BW; Wu, HM; Shyu, KK; Wang, PS; Wu, YT				Wang, Tzu-Yun; Jao, Chii-Wen; Soong, Bing-Wen; Wu, Hsiu-Mei; Shyu, Kuo-Kai; Wang, Po-Shan; Wu, Yu-Te			Change in the Cortical Complexity of Spinocerebellar Ataxia Type 3 Appears Earlier than Clinical Symptoms	PLOS ONE			English	Article							MACHADO-JOSEPH-DISEASE; FRACTAL DIMENSION ANALYSIS; POSITRON-EMISSION-TOMOGRAPHY; COGNITIVE DYSFUNCTION; WHITE-MATTER; EEG PATTERNS; STRUCTURAL COMPLEXITY; VARIABLE TOPOGRAPHIES; CEREBRAL-CORTEX; BASAL GANGLIA	Patients with spinocerebellar ataxia type 3 (SCA3) have exhibited cerebral cortical involvement and various mental deficits in previous studies. Clinically, conventional measurements, such as the Mini-Mental State Examination (MMSE) and electroencephalography (EEG), are insensitive to cerebral cortical involvement and mental deficits associated with SCA3, particularly at the early stage of the disease. We applied a three-dimensional fractal dimension (3D-FD) method, which can be used to quantify the shape complexity of cortical folding, in assessing cortical degeneration. We evaluated 48 genetically confirmed SCA3 patients by employing clinical scales and magnetic resonance imaging and using 50 healthy participants as a control group. According to the Scale for the Assessment and Rating of Ataxia (SARA), the SCA3 patients were diagnosed with cortical dysfunction in the cerebellar cortex; however, no significant difference in the cerebral cortex was observed according to the patients' MMSE ratings. Using the 3D-FD method, we determined that cortical involvement was more extensive than involvement of traditional olivopontocerebellar regions and the corticocerebellar system. Moreover, the significant correlation between decreased 3D-FD values and disease duration may indicate atrophy of the cerebellar cortex and cerebral cortex in SCA3 patients. The change of the cerebral complexity in the SCA3 patients can be detected throughout the disease duration, especially it becomes substantial at the late stage of the disease. Furthermore, we determined that atrophy of the cerebral cortex may occur earlier than changes in MMSE scores and EEG signals.	[Wang, Tzu-Yun; Jao, Chii-Wen; Wu, Yu-Te] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Jao, Chii-Wen] Asia Pacific Inst Creat, Dept Recreat Sports & Hlth Promot, Tao Fen, Taiwan; [Soong, Bing-Wen; Wang, Po-Shan] Taipei Vet Gen Hosp, Neurol Inst, Taipei, Taiwan; [Soong, Bing-Wen; Wang, Po-Shan] Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei 112, Taiwan; [Wu, Hsiu-Mei] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Shyu, Kuo-Kai] Natl Cent Univ, Dept Elect Engn, Chungli 32054, Taiwan; [Wang, Po-Shan] Taipei Municipal Gan Dau Hosp, Neurol Inst, Taipei, Taiwan; [Wang, Po-Shan; Wu, Yu-Te] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Central University; National Yang Ming Chiao Tung University	Wang, PS (corresponding author), Taipei Vet Gen Hosp, Neurol Inst, Taipei, Taiwan.	b8001071@gmail.com; ytwu@ym.edu.tw			National Science Council [103-2221-E-010-003-MY3, 101-2314-B-733-001-MY2, NSC 102-2911-I-008-001]; Ministry of Education, Aim for the Top University Plan; Brain Research Center, National Yang-Ming University	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan); Brain Research Center, National Yang-Ming University	This work was supported by the National Science Council supported for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC 102-2911-I-008-001), Brain Research Center, National Yang-Ming University and a grant from Ministry of Education, Aim for the Top University Plan, and National Science Council (103-2221-E-010-003-MY3 and 101-2314-B-733-001-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS R, 1979, ARCH GEN PSYCHIAT, V36, P1355; ANDREASEN NC, 1995, P NATL ACAD SCI USA, V92, P5111, DOI 10.1073/pnas.92.11.5111; BARBAS H, 1995, NEUROSCI BIOBEHAV R, V19, P499, DOI 10.1016/0149-7634(94)00053-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boutros NN, 2008, SCHIZOPHR RES, V99, P225, DOI 10.1016/j.schres.2007.11.020; Braga-Neto P, 2011, PARKINSONISM RELAT D, V17, P353, DOI 10.1016/j.parkreldis.2011.02.004; Braga-Neto P, 2014, MOVEMENT DISORD, V29, P156, DOI 10.1002/mds.25756; Burk K, 1996, BRAIN, V119, P1497, DOI 10.1093/brain/119.5.1497; D'Abreu A, 2012, J NEUROIMAGING, V22, P285, DOI 10.1111/j.1552-6569.2011.00614.x; Di Ieva A, 2015, NEUROSCIENTIST, V21, P30, DOI 10.1177/1073858413513928; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Esteban FJ, 2007, NEUROIMAGE, V36, P543, DOI 10.1016/j.neuroimage.2007.03.057; Esteban FJ, 2009, J NEUROL SCI, V282, P67, DOI 10.1016/j.jns.2008.12.023; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FUKUTANI Y, 1993, J NEUROL NEUROSUR PS, V56, P1207, DOI 10.1136/jnnp.56.11.1207; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; Ghisolfi ES, 2004, CLIN NEUROPHYSIOL, V115, P2231, DOI 10.1016/j.clinph.2004.04.025; Goel G, 2011, PARKINSONISM RELAT D, V17, P521, DOI 10.1016/j.parkreldis.2011.04.008; Ha TH, 2005, NEUROSCI LETT, V384, P172, DOI 10.1016/j.neulet.2005.04.078; Hoehn MM, 1998, NEUROLOGY, V50, P318, DOI 10.1212/WNL.50.2.318; Hoffman R E, 1991, J Neuropsychiatry Clin Neurosci, V3, P169; Hu HH, 2013, BRAIN STRUCT FUNCT, V218, P1451, DOI 10.1007/s00429-012-0469-3; Im K, 2006, HUM BRAIN MAPP, V27, P994, DOI 10.1002/hbm.20238; Ishikawa A, 2002, ARCH NEUROL-CHICAGO, V59, P1804, DOI 10.1001/archneur.59.11.1804; Jacobi H, 2011, NEUROLOGY, V77, P1035, DOI 10.1212/WNL.0b013e31822e7ca0; Jacobi H, 2012, CEREBELLUM, V11, P155, DOI 10.1007/s12311-011-0292-z; JARQUE CM, 1980, ECON LETT, V6, P255, DOI 10.1016/0165-1765(80)90024-5; Kaplan PW, 2011, J CLIN NEUROPHYSIOL, V28, P233, DOI 10.1097/WNP.0b013e31821c33a0; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kawai Y, 2004, ARCH NEUROL-CHICAGO, V61, P1757, DOI 10.1001/archneur.61.11.1757; King RD, 2010, NEUROIMAGE, V53, P471, DOI 10.1016/j.neuroimage.2010.06.050; King RD, 2009, BRAIN IMAGING BEHAV, V3, P154, DOI 10.1007/s11682-008-9057-9; Klinke I, 2010, CEREBELLUM, V9, P433, DOI 10.1007/s12311-010-0183-8; Klockgether T, 1998, BRAIN, V121, P1687, DOI 10.1093/brain/121.9.1687; Li XB, 2007, BRAIN DEV-JPN, V29, P649, DOI 10.1016/j.braindev.2007.04.008; Li YJ, 2008, CLIN NEUROPHYSIOL, V119, P1232, DOI 10.1016/j.clinph.2008.01.104; Lopes TM, 2013, J NEUROL, V260, P2370, DOI 10.1007/s00415-013-6998-8; Mandelbrot B.B, 1977, FRACTALS FORM CHANCE; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Murata Y, 1998, ARCH NEUROL-CHICAGO, V55, P33, DOI 10.1001/archneur.55.1.33; Mustafa N, 2012, NEUROIMAGE, V61, P694, DOI 10.1016/j.neuroimage.2012.03.088; Pendlebury ST, 2010, STROKE, V41, P1290, DOI 10.1161/STROKEAHA.110.579888; Pereira JB, 2012, HUM BRAIN MAPP, V33, P2521, DOI 10.1002/hbm.21378; Radvany J, 1993, Arq Neuropsiquiatr, V51, P21; Reetz K, 2013, BRAIN, V136, P905, DOI 10.1093/brain/aws369; Riess O, 2008, CEREBELLUM, V7, P125, DOI 10.1007/s12311-008-0013-4; Roeske S, 2014, MOVEMENT DISORD, V29, P157, DOI 10.1002/mds.25755; Roeske S, 2013, MOVEMENT DISORD, V28, P1435, DOI 10.1002/mds.25512; Rub U, 2007, BRAIN RES REV, V53, P235, DOI 10.1016/j.brainresrev.2006.08.003; Rub U, 2006, BRAIN PATHOL, V16, P218, DOI 10.1111/j.1750-3639.2006.00022.x; Sandu AL, 2014, ACTA PSYCHIAT SCAND, V130, P227, DOI 10.1111/acps.12243; Sandu AL, 2008, COMPUT MED IMAG GRAP, V32, P150, DOI 10.1016/j.compmedimag.2007.10.005; Scherzed W, 2012, CEREBELLUM, V11, P749, DOI 10.1007/s12311-011-0340-8; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Schmitz-Hubsch T, 2006, MOVEMENT DISORD, V21, P699, DOI 10.1002/mds.20781; Schulz JB, 2010, NEUROIMAGE, V49, P158, DOI 10.1016/j.neuroimage.2009.07.027; Seidel K, 2010, ACTA NEUROPATHOL, V120, P449, DOI 10.1007/s00401-010-0717-7; Socal MP, 2009, PARKINSONISM RELAT D, V15, P374, DOI 10.1016/j.parkreldis.2008.09.005; Soong BW, 1998, J NEUROL NEUROSUR PS, V64, P499, DOI 10.1136/jnnp.64.4.499; Sutter R, 2013, J NEUROL, V260, P1087, DOI 10.1007/s00415-012-6766-1; TAKIYAMA Y, 1994, NEUROLOGY, V44, P1302, DOI 10.1212/WNL.44.7.1302; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Wu YH, 2012, DERMATOL SIN, V30, P1, DOI 10.1016/j.dsi.2012.02.004; Wu YT, 2010, NEUROIMAGE, V49, P539, DOI 10.1016/j.neuroimage.2009.07.042; Wu YT, 2009, NONLINEAR DYNAM, V58, P745, DOI 10.1007/s11071-009-9515-y; Wullner U, 2005, ARCH NEUROL-CHICAGO, V62, P1280, DOI 10.1001/archneur.62.8.1280; Yamada M, 2004, NEUROPATH APPL NEURO, V30, P665, DOI 10.1111/j.1365-2990.2004.00583.x; Yamada M, 2001, ACTA NEUROPATHOL, V101, P140; Yamada M, 2008, ACTA NEUROPATHOL, V115, P71, DOI 10.1007/s00401-007-0287-5; Yang JJ, 2013, NEUROSCIENCE, V246, P351, DOI 10.1016/j.neuroscience.2013.04.051; Zawacki TM, 2002, MOVEMENT DISORD, V17, P1004, DOI 10.1002/mds.10033; Zhang LD, 2006, J NEUROSCI METH, V150, P242, DOI 10.1016/j.jneumeth.2005.06.021; Zhang LD, 2008, BRAIN RES, V1228, P229, DOI 10.1016/j.brainres.2008.06.008; Zhang L, 2007, NEUROBIOL AGING, V28, P1543, DOI 10.1016/j.neurobiolaging.2006.06.020; ZILLES K, 1988, ANAT EMBRYOL, V179, P173, DOI 10.1007/BF00304699	80	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0118828	10.1371/journal.pone.0118828	http://dx.doi.org/10.1371/journal.pone.0118828			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897782	gold, Green Published, Green Submitted			2022-12-27	WOS:000353212600002
J	Achana, FA; Sutton, AJ; Kendrick, D; Wynn, P; Young, B; Jones, DR; Hubbard, SJ; Cooper, NJ				Achana, Felix A.; Sutton, Alex J.; Kendrick, Denise; Wynn, Persephone; Young, Ben; Jones, David R.; Hubbard, Stephanie J.; Cooper, Nicola J.			The Effectiveness of Different Interventions to Promote Poison Prevention Behaviours in Households with Children: A Network Meta-Analysis	PLOS ONE			English	Article							CARE	Background There is evidence from 2 previous meta-analyses that interventions to promote poison prevention behaviours are effective in increasing a range of poison prevention practices in households with children. The published meta-analyses compared any intervention against a "usual care or no intervention" which potentially limits the usefulness of the analysis to decision makers. We aim to use network meta-analysis to simultaneously evaluate the effectiveness of different interventions to increase prevalence of safe storage of i) Medicines only, ii) Other household products only, iii) Poisons (both medicines and non-medicines), iv) Poisonous plants; and v) Possession of poison control centre (PCC) telephone number in households with children. Methods Data on the effectiveness of poison prevention interventions was extracted from primary studies identified in 2 newly-undertaken systematic reviews. Effect estimates were pooled across studies using a random effects network meta-analysis model. Results 28 of the 47 primary studies identified were included in the analysis. Compared to usual care intervention, the intervention with education and low cost/free equipment elements was most effective in promoting safe storage of medicines (odds ratio 2.51, 95% credible interval 1.01 to 6.00) while interventions with education, low cost/free equipment, home safety inspection and fitting components were most effective in promoting safe storage of other household products (2.52, 1.12 to 7.13), safe storage of poisons (11.10, 1.60 to 141.50) and possession of PCC number (38.82, 2.19 to 687.10). No one intervention package was more effective than the others in promoting safe storage of poisonous plants. Conclusion The most effective interventions varied by poison prevention practice, but education alone was not the most effective intervention for any poison prevention practice. Commissioners and providers of poison prevention interventions should tailor the interventions they commission or provide to the poison prevention practices they wish to promote.	[Achana, Felix A.] Univ Warwick, Warwick Med Sch, Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; [Sutton, Alex J.; Jones, David R.; Hubbard, Stephanie J.; Cooper, Nicola J.] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Kendrick, Denise; Wynn, Persephone; Young, Ben] Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England	University of Warwick; University of Leicester; University of Nottingham	Kendrick, D (corresponding author), Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England.	denise.kendrick@nottingham.ac.uk		Sutton, Alexander/0000-0002-8934-9940; Kendrick, Denise/0000-0003-3603-6542	National Institute for Health Research (NIHR) [RP-PG-0407-10231]; National Institute for Health Research [RP-PG-0407-10231] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This study presents independent research by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0407-10231). The views expressed are those of the author(s) and are not necessarily those of the National Health Service (NHS), the NIHR, or the Department of Health.	American Academy of Pediatrics Committee on Injury Violence and Poison Prevention, 2003, Pediatrics, V112, P1182; Babul S, 2007, Int J Inj Contr Saf Promot, V14, P109, DOI 10.1080/17457300701272474; Bafeta A, 2014, BRIT MED J, V348; Benson BE, 2013, CLIN TOXICOL, V51, P140, DOI 10.3109/15563650.2013.770154; Borenstein M., 2009, INTRO METAANALYSIS; Bronstein AC, 2011, CLIN TOXICOL, V49, P910, DOI 10.3109/15563650.2011.635149; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; CAPT, CHILD ACC PREV TRUST; Congdon P., 2014, APPL BAYESIAN MODELL; Cooper NJ, 2011, VALUE HEALTH, V14, P371, DOI 10.1016/j.jval.2010.09.001; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; DiGuiseppi C, 2000, ARCH DIS CHILD, V82, P341, DOI 10.1136/adc.82.5.341; DiGuiseppi C, 2001, COCHRANE DB SYST REV, P1; KELLY B, 1987, PEDIATRICS, V79, P818; Kendrick D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005014.pub2; Kendrick D., 2012, COCHRANE DB SYST REV, V12; Kendrick D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005014.pub3; King WJ, 2001, PEDIATRICS, V108, P382, DOI 10.1542/peds.108.2.382; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Minkovitz CS, 2003, JAMA-J AM MED ASSOC, V290, P3081, DOI 10.1001/jama.290.23.3081; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Phelan KJ, 2011, ARCH PEDIAT ADOL MED, V165, P339, DOI 10.1001/archpediatrics.2011.29; Saramago P, 2012, STAT MED, V31, P3516, DOI 10.1002/sim.5442; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Spiegelhalter DJ., 2004, BAYESIAN APPROACHES; Spiller HA, 2009, PUBLIC HEALTH REP, V124, P359, DOI 10.1177/003335490912400303; Tan SH, 2014, J CLIN EPIDEMIOLOGY; The Royal Society for the prevention of accidents, 2002, HOM LEIS ACC SURV SY; Towner E, 2001, WHAT WORKS UNINTENTI; Wells G., 2013, OTTAWA HOSP RES I; World Health Organization, 2008, WORLD REPORT CHILD I; Wynn P, 2014, INT J INJURY CONTROL; Xiang YX, 2012, AM J EMERG MED, V30, P293, DOI 10.1016/j.ajem.2010.11.031	37	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0121122	10.1371/journal.pone.0121122	http://dx.doi.org/10.1371/journal.pone.0121122			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894385	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000353211700008
J	Heroux, ME; Law, TCY; Fitzpatrick, RC; Blouin, JS				Heroux, Martin E.; Law, Tammy C. Y.; Fitzpatrick, Richard C.; Blouin, Jean-Sebastien			Cross-Modal Calibration of Vestibular Afference for Human Balance	PLOS ONE			English	Article							INNERVATING SEMICIRCULAR CANALS; SQUIRREL-MONKEY; HEAD ROTATION; STIMULATION; RESPONSES; REFLEXES; NEURONS; OTOLITH; MOTION; REAFFERENCE	To determine how the vestibular sense controls balance, we used instantaneous head angular velocity to drive a galvanic vestibular stimulus so that afference would signal that head movement was faster or slower than actual. In effect, this changed vestibular afferent gain. This increased sway 4-fold when subjects (N = 8) stood without vision. However, after a 240 s conditioning period with stable balance achieved through reliable visual or somatosensory cues, sway returned to normal. An equivalent galvanic stimulus unrelated to sway (not driven by head motion) was equally destabilising but in this situation the conditioning period of stable balance did not reduce sway. Reflex muscle responses evoked by an independent, higher bandwidth vestibular stimulus were initially reduced in amplitude by the galvanic stimulus but returned to normal levels after the conditioning period, contrary to predictions that they would decrease after adaptation to increased sensory gain and increase after adaptation to decreased sensory gain. We conclude that an erroneous vestibular signal of head motion during standing has profound effects on balance control. If it is unrelated to current head motion, the CNS has no immediate mechanism of ignoring the vestibular signal to reduce its influence on destabilising balance. This result is inconsistent with sensory reweighting based on disturbances. The increase in sway with increased sensory gain is also inconsistent with a simple feedback model of vestibular reflex action. Thus, we propose that recalibration of a forward sensory model best explains the reinterpretation of an altered reafferent signal of head motion during stable balance.	[Heroux, Martin E.; Law, Tammy C. Y.; Blouin, Jean-Sebastien] Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada; [Fitzpatrick, Richard C.] Univ New S Wales, Neurosci Res Australia, Sydney, NSW, Australia; [Fitzpatrick, Richard C.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Blouin, Jean-Sebastien] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC V5Z 1M9, Canada; [Blouin, Jean-Sebastien] Univ British Columbia, Inst Comp Informat & Cognit Syst, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; Neuroscience Research Australia; University of New South Wales Sydney; University of New South Wales Sydney; University of British Columbia; University of British Columbia	Fitzpatrick, RC (corresponding author), Univ New S Wales, Neurosci Res Australia, Sydney, NSW, Australia.	r.fitzpatrick@neura.edu.au	Heroux, Martin/AAD-7694-2021	Heroux, Martin/0000-0002-3354-7104	Natural Sciences and Engineering Research Council of Canada; Canadian Chiropractic Research Foundation; Michael Smith Foundation for Health Research; National Health and Medical Research Council of Australia; Canadian Institute for Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Chiropractic Research Foundation; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by a grant to JSB from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca). JSB received support from the Canadian Chiropractic Research Foundation (www.chiropractic.ca/research-foundation) and the Michael Smith Foundation for Health Research (www.msfhr.org). RCF received support from the National Health and Medical Research Council of Australia (www.nhmrc.gov.au). MEH received a post-doctoral fellowship from the Michael Smith Foundation for Health Research and the Canadian Institute for Health Research (www.cihr-irsc.gc.ca) and support from a Natural Sciences and Engineering Research Council of Canada Discovery Accelerator Supplement awarded to J. Timothy Inglis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allum JHJ, 2001, GAIT POSTURE, V14, P227, DOI 10.1016/S0966-6362(01)00132-1; Bacsi AM, 2005, EXP BRAIN RES, V160, P22, DOI 10.1007/s00221-004-1982-2; Basta D, 2005, HUM MOVEMENT SCI, V24, P268, DOI 10.1016/j.humov.2005.04.002; Brooks JX, 2014, J NEUROPHYSIOL, V111, P2465, DOI 10.1152/jn.00600.2013; Brooks JX, 2013, CURR BIOL, V23, P947, DOI 10.1016/j.cub.2013.04.029; Cathers I, 2005, J PHYSIOL-LONDON, V563, P229, DOI 10.1113/jphysiol.2004.079525; Cenciarini M, 2006, J NEUROPHYSIOL, V95, P2733, DOI 10.1152/jn.00856.2004; Curthoys I S, 1995, J Vestib Res, V5, P67, DOI 10.1016/0957-4271(94)00026-X; Dakin CJ, 2007, J PHYSIOL-LONDON, V583, P1117, DOI 10.1113/jphysiol.2007.133264; Dakin CJ, 2010, J NEUROPHYSIOL, V103, P1048, DOI 10.1152/jn.00881.2009; Day BL, 2005, J PHYSIOL-LONDON, V567, P591, DOI 10.1113/jphysiol.2005.092544; Day BL, 2005, CURR BIOL, V15, P1390, DOI 10.1016/j.cub.2005.06.036; Day BL, 2002, BRAIN, V125, P2081, DOI 10.1093/brain/awf212; Dilda V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112131; FERNANDEZ C, 1971, J NEUROPHYSIOL, V34, P661, DOI 10.1152/jn.1971.34.4.661; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Fitzpatrick R, 1996, J NEUROPHYSIOL, V76, P3994, DOI 10.1152/jn.1996.76.6.3994; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V478, P363, DOI 10.1113/jphysiol.1994.sp020257; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V480, P395, DOI 10.1113/jphysiol.1994.sp020369; Fitzpatrick RC, 2004, J APPL PHYSIOL, V96, P2301, DOI 10.1152/japplphysiol.00008.2004; Fitzpatrick RC, 2002, NEUROREPORT, V13, P2379, DOI 10.1097/00001756-200212200-00001; Fitzpatrick RC, 2006, CURR BIOL, V16, P1509, DOI 10.1016/j.cub.2006.05.063; GOLDBERG JM, 1971, J NEUROPHYSIOL, V34, P635, DOI 10.1152/jn.1971.34.4.635; GOLDBERG JM, 1982, BRAIN RES, V252, P156, DOI 10.1016/0006-8993(82)90990-8; Guerraz M, 2005, J COGNITIVE NEUROSCI, V17, P463, DOI 10.1162/0898929053279540; Iwasaki S, 2014, NEUROLOGY, V82, P969, DOI 10.1212/WNL.0000000000000215; JOYCE GC, 1974, J PHYSIOL-LONDON, V240, P351, DOI 10.1113/jphysiol.1974.sp010614; Kim J, 2004, BRAIN RES BULL, V64, P265, DOI 10.1016/j.brainresbull.2004.07.008; Kitazaki M, 2010, PRESENCE-TELEOP VIRT, V19, P544, DOI 10.1162/pres_a_00017; Mian OS, 2010, J PHYSIOL-LONDON, V588, P4441, DOI 10.1113/jphysiol.2010.195222; Oie KS, 2002, COGNITIVE BRAIN RES, V14, P164, DOI 10.1016/S0926-6410(02)00071-X; Pasma JH, 2012, J NEUROPHYSIOL, V108, P1138, DOI 10.1152/jn.01008.2011; Rabbitt RD, 2005, J NEUROPHYSIOL, V93, P424, DOI 10.1152/jn.00426.2004; Reynolds Raymond Francis, 2012, Front Neurol, V3, P104; ROSENBERG JR, 1989, PROG BIOPHYS MOL BIO, V53, P1, DOI 10.1016/0079-6107(89)90004-7; Roy JE, 2004, J NEUROSCI, V24, P2102, DOI 10.1523/JNEUROSCI.3988-03.2004; Roy JE, 2001, J NEUROSCI, V21, P2131, DOI 10.1523/JNEUROSCI.21-06-02131.2001; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; Schneider E, 2002, J NEUROPHYSIOL, V87, P2064, DOI 10.1152/jn.00558.2001; von Holst E, 1959, NATURWISSENSCHAFTEN, V7, P1109; Wardman DL, 2003, J PHYSIOL-LONDON, V547, P293, DOI 10.1113/jphysiol.2002.030767; Wardman DL, 2003, J PHYSIOL-LONDON, V551, P1033, DOI 10.1113/jphysiol.2003.045971; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2	44	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124532	10.1371/journal.pone.0124532	http://dx.doi.org/10.1371/journal.pone.0124532			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894558	gold, Green Published			2022-12-27	WOS:000353211700101
J	Kirschner, MMJ; Schemionek, M; Schubert, C; Chatain, N; Sontag, S; Isfort, S; Ortiz-Bruchle, N; Schmitt, K; Kruger, L; Zerres, K; Zenke, M; Brummendorf, TH; Koschmieder, S				Kirschner, Martin M. J.; Schemionek, Mirle; Schubert, Claudia; Chatain, Nicolas; Sontag, Stephanie; Isfort, Susanne; Ortiz-Bruechle, Nadina; Schmitt, Karla; Krueger, Luisa; Zerres, Klaus; Zenke, Martin; Bruemmendorf, Tim H.; Koschmieder, Steffen			Dissecting Genomic Aberrations in Myeloproliferative Neoplasms by Multiplex-PCR and Next Generation Sequencing	PLOS ONE			English	Article							JAK2V617F ALLELE BURDEN; ACUTE MYELOID-LEUKEMIA; 1ST-LINE TREATMENT; SOMATIC MUTATIONS; DNA-BINDING; JAK2; KINASE; CANCER; FLUOROURACIL; LEUCOVORIN	In order to assess the feasibility of amplicon-based parallel next generation sequencing (NGS) for the diagnosis of myeloproliferative neoplasms (MPN), we investigated multiplex-PCR of 212 amplicons covering genomic mutational hotspots in 48 cancer-related genes. Samples from 64 patients with MPN and five controls as well as seven (myeloid) cell lines were analyzed. Healthy donor and reactive erythrocytosis samples showed several frequent single-nucleotide polymorphisms (SNPs) but no known pathogenic mutation. Sequencing of the cell lines confirmed the presence of the known mutations. In the patient samples, JAK2 V617F was present in all PV, 4 of 10 ET, and 16 of 19 MF patients. The JAK2 V617F allele burden was different in the three groups (ET, 33+/-22%; PV 48+/-28% and MF 68+/-29%). Further analysis detected both previously described and undescribed mutations (i.e., G12V NRAS, IDH1 R132H, E255G ABL, and V125G IDH1 mutations). One patient with lymphoid BC/Ph+ALL who harbored a T315I ABL mutation and was treated with ponatinib was found to have developed a newly acquired V216M TP53 mutation (12% of transcripts) when becoming resistant to ponatinib. Ponatinib led to a decrease of ABL T315I positive transcripts from 47% before ponatinib treatment to 16% at the time of ponatinib resistance in this patient, suggesting that both TP53 and ABL mutations were present in the same clone and that the newly acquired TP53 mutation might have caused ponatinib resistance in this patient. In conclusion, amplicon-sequencing-based NGS allows simultaneous analysis of multiple MPN associated genes for diagnosis and during treatment and measurement of the mutant allele burden.	[Kirschner, Martin M. J.; Schemionek, Mirle; Schubert, Claudia; Chatain, Nicolas; Isfort, Susanne; Schmitt, Karla; Krueger, Luisa; Bruemmendorf, Tim H.; Koschmieder, Steffen] Rhein Westfal TH Aachen, Dept Hematol Oncol Hemostaseol & Stem Cell Transp, Fac Med, Aachen, Germany; [Sontag, Stephanie; Zenke, Martin] Rhein Westfal TH Aachen, Inst Biomed Engn Cell Biol, Aachen, Germany; [Ortiz-Bruechle, Nadina; Zerres, Klaus] Rhein Westfal TH Aachen, Fac Med, Inst Human Genet, Aachen, Germany	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University	Koschmieder, S (corresponding author), Rhein Westfal TH Aachen, Dept Hematol Oncol Hemostaseol & Stem Cell Transp, Fac Med, Aachen, Germany.	skoschmieder@ukaachen.de		Koschmieder, Steffen/0000-0002-1011-8171	BILD hilft e.V. "Ein Herz fur Kinder" foundation	BILD hilft e.V. "Ein Herz fur Kinder" foundation	This work was in part supported by a research grant from the BILD hilft e.V. "Ein Herz fur Kinder" foundation (to SK).	Antonioli E, 2007, HAEMATOLOGICA, V93, P41, DOI 10.3324/haematol.11653; Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bokemeyer C, 2011, ANN ONCOL, V22, P1535, DOI 10.1093/annonc/mdq632; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Buzek J, 2002, NUCLEIC ACIDS RES, V30, P2340, DOI 10.1093/nar/30.11.2340; Cammenga J, 2005, BLOOD, V106, P3958, DOI 10.1182/blood-2005-02-0583; Chanock SJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1637; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; GARDNER AM, 1993, J BIOL CHEM, V268, P17896; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Guglielmelli P, 2014, BLOOD, V123, P2157, DOI 10.1182/blood-2013-11-536557; Hussein K, 2009, EXP HEMATOL, V37, P1186, DOI 10.1016/j.exphem.2009.07.005; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Janin M, 2014, J CLIN ONCOL, V32, P297, DOI 10.1200/JCO.2013.50.2047; Kittur J, 2007, CANCER-AM CANCER SOC, V109, P2279, DOI 10.1002/cncr.22663; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Kurtz Jean-Emmanuel, 2010, Sarcoma, V2010, P458156, DOI 10.1155/2010/458156; Larsen TS, 2008, LEUKEMIA, V22, P194, DOI 10.1038/sj.leu.2404861; Latini A, 2003, EUR J NEUROSCI, V17, P2017, DOI 10.1046/j.1460-9568.2003.02639.x; Lippert E, 2009, HAEMATOL-HEMATOL J, V94, P38, DOI 10.3324/haematol.13486; Lundberg P, 2014, BLOOD, V123, P2220, DOI 10.1182/blood-2013-11-537167; MACDONALD SG, 1993, MOL CELL BIOL, V13, P6615, DOI 10.1128/MCB.13.11.6615; Martinez-Aviles L, 2012, ANN HEMATOL, V91, P533, DOI 10.1007/s00277-011-1330-0; Maxson JE, 2013, NEW ENGL J MED, V368, P1781, DOI 10.1056/NEJMoa1214514; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Oh ST, 2010, BLOOD, V116, P988, DOI 10.1182/blood-2010-02-270108; Orouji A, 2014, BR J DERMATOL; PARK SJ, 2013, ASIAN WOMEN, V29, P1, DOI DOI 10.5045/BR.2013.48.2.128; Peeters M, 2010, J CLIN ONCOL, V28, P4706, DOI 10.1200/JCO.2009.27.6055; Piazza R, 2013, NAT GENET, V45, P18, DOI 10.1038/ng.2495; Pietsch EC, 2008, J BIOL CHEM, V283, P21294, DOI 10.1074/jbc.M710539200; Qin Wei, 2013, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V21, P1507, DOI 10.7534/j.issn.1009-2137.2013.06.026; Ross CW, 2007, CLIN CANCER RES, V13, P4777, DOI 10.1158/1078-0432.CCR-07-0456; Schwaab J, 2013, BLOOD, V122, P2460, DOI 10.1182/blood-2013-04-496448; Soverini S, 2013, BLOOD, V122, P1634, DOI 10.1182/blood-2013-03-487728; Tefferi A, 2007, LEUKEMIA, V21, P2074, DOI 10.1038/sj.leu.2404724; Tefferi A, 2010, LEUKEMIA, V24, P1302, DOI 10.1038/leu.2010.113; Tenedini E, 2014, LEUKEMIA, V28, P1052, DOI 10.1038/leu.2013.302; Theocharides A, 2008, HAEMATOL-HEMATOL J, V93, P1890, DOI 10.3324/haematol.13074; Thol F, 2012, GENE CHROMOSOME CANC, V51, P689, DOI 10.1002/gcc.21955; Thornton PD, 2003, ANN HEMATOL, V82, P759, DOI 10.1007/s00277-003-0710-5; Tyner JW, 2009, BLOOD, V113, P1749, DOI 10.1182/blood-2008-04-152157; Vainchenker W, 2011, BLOOD, V118, P1723, DOI 10.1182/blood-2011-02-292102; Vannucchi AM, 2008, LEUKEMIA, V22, pCP5, DOI 10.1038/leu.2008.113; Wang JY, 2013, BLOOD, V121, P5203, DOI 10.1182/blood-2012-12-475863; Wang JY, 2011, CELL CYCLE, V10, P2836, DOI 10.4161/cc.10.17.17195; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Zhao WK, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-15	50	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123476	10.1371/journal.pone.0123476	http://dx.doi.org/10.1371/journal.pone.0123476			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894969	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700037
J	Nishimatsu, H; Suzuki, E; Saito, Y; Niimi, A; Nomiya, A; Fukuhara, H; Kume, H; Homma, Y				Nishimatsu, Hiroaki; Suzuki, Etsu; Saito, Yasuho; Niimi, Aya; Nomiya, Akira; Fukuhara, Hiroshi; Kume, Haruki; Homma, Yukio			Senescent Cells Impair Erectile Function through Induction of Endothelial Dysfunction and Nerve Injury in Mice	PLOS ONE			English	Article							ADIPOSE-TISSUE; GROWTH-FACTOR; NITRIC-OXIDE; DNA-DAMAGE; STEM-CELLS; TNF-ALPHA; ATHEROSCLEROSIS; ADRENOMEDULLIN; ANGIOPOIETIN-1; INFLAMMATION	Erectile dysfunction (ED) is a major health problem, particularly in the elderly population, which is rapidly increasing. It is necessary to elucidate the mechanism by which ED occurs in the elderly. Cellular senescence is commonly detected in old tissues, and it is well known that senescent cells not only withdraw from the cell cycle but also remain viable and actively produce a variety of cytokines. We examined the effect of senescent cells on erectile function after injection of senescent cells into the penises of mice. Human umbilical vein endothelial cells were infected with an adenovirus expressing a constitutively active mutant of Ras to induce senescence, and were injected into the penises of nude mice. These senescent cells expressed proinflammatory cytokines such as interleukin-1 beta (IL-1 beta). Injection of senescent cells impaired erectile function, as assessed by the measurement of intracavernous pressure. Although the structure of the cavernous body did not remarkably change, expression of the catalytically active form of endothelial nitric oxide synthase and that of total neural nitric oxide synthase significantly decreased after injection. The penises injected with the senescent cells expressed human IL-1 beta and subsequently endogenous proinflammatory cytokines such as mouse IL-1 beta and tumor necrosis factor-alpha. These results suggested that senescent cells impaired erectile function through induction of endothelial dysfunction and nerve injury. These effects may be mediated by proinflammatory cytokines produced by senescent cells.	[Nishimatsu, Hiroaki; Saito, Yasuho; Niimi, Aya; Nomiya, Akira; Fukuhara, Hiroshi; Kume, Haruki; Homma, Yukio] Univ Tokyo, Fac Med, Dept Urol, Bunkyo Ku, Tokyo 113, Japan; [Suzuki, Etsu] St Marianna Univ, Sch Med, Inst Med Sci, Miyamae Ku, Kawasaki, Kanagawa, Japan	University of Tokyo; Saint Marianna University	Suzuki, E (corresponding author), St Marianna Univ, Sch Med, Inst Med Sci, Miyamae Ku, Kawasaki, Kanagawa, Japan.	esuzuki-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24592422, 24592423]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan to AN 24592422 [http://www.jsps.go.jp]; and to HN 24592423 from Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan; [http://www.jsps.go.jp]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson D, 2008, ADV CARDIOL, V45, P1, DOI 10.1159/000115118; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Batten P, 1996, IMMUNOLOGY, V87, P127; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; BURNETT AL, 1992, SCIENCE, V257, P401, DOI 10.1126/science.1378650; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Du XL, 1999, FREE RADICAL BIO MED, V27, P752, DOI 10.1016/S0891-5849(99)00079-9; Fantuzzi G, 2007, ARTERIOSCL THROM VAS, V27, P996, DOI 10.1161/ATVBAHA.106.131755; Ferrini MG, 2007, BIOL REPROD, V76, P915, DOI 10.1095/biolreprod.106.059642; FLANAGAN SP, 1966, GENET RES, V8, P295, DOI 10.1017/S0016672300010168; Fraga-Silva RA, 2013, J SEX MED, V10, P2430, DOI 10.1111/jsm.12262; GALIS ZS, 1995, ANN NY ACAD SCI, V748, P501; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Hedlund P, 1999, BRIT J PHARMACOL, V127, P349, DOI 10.1038/sj.bjp.0702556; Huang YC, 2010, J SEX MED, V7, P1391, DOI 10.1111/j.1743-6109.2009.01697.x; Khera M, 2011, J SEX MED, V8, P3204, DOI 10.1111/j.1743-6109.2011.02436.x; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Labazi H, 2013, J SEX MED, V10, P2154, DOI 10.1111/jsm.12245; Luttrell IP, 2008, AM J PHYSIOL-HEART C, V294, pH2204, DOI 10.1152/ajpheart.00027.2008; Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc; Minamino T, 2003, CIRCULATION, V108, P2264, DOI 10.1161/01.CIR.0000093274.82929.22; MULLARKEY CJ, 1990, BIOCHEM BIOPH RES CO, V173, P932, DOI 10.1016/S0006-291X(05)80875-7; Nishimatsu H, 2013, J SEX MED, V10, P1707, DOI 10.1111/jsm.12177; Nishimatsu H, 2012, J SEX MED, V9, P482, DOI 10.1111/j.1743-6109.2011.02469.x; Orasanu G, 2009, J AM COLL CARDIOL, V53, pS35, DOI 10.1016/j.jacc.2008.09.055; Orimo M, 2009, ARTERIOSCL THROM VAS, V29, P889, DOI 10.1161/ATVBAHA.109.185694; Pelleitier M, 1975, Methods Achiev Exp Pathol, V7, P149; Qiu XF, 2011, J SEX MED, V8, P427, DOI 10.1111/j.1743-6109.2010.02118.x; Ryu JK, 2006, MOL THER, V13, P705, DOI 10.1016/j.ymthe.2005.10.016; Seftel AD, 2004, J ANDROL, V25, P963; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shirai M, 2002, NIHON RINSHO, V60, P91; Suzuki E, 2002, HYPERTENS RES, V25, P773; Suzuki E, 2000, J BIOL CHEM, V275, P3637, DOI 10.1074/jbc.275.5.3637; Suzuki E, 2013, SCI WORLD J, DOI 10.1155/2013/754735; Taube A, 2012, AM J PHYSIOL-HEART C, V302, pH2148, DOI 10.1152/ajpheart.00907.2011; Yokoi T, 2006, DIABETES, V55, P1660, DOI 10.2337/db05-1607; Zhang HR, 2009, CLIN SCI, V116, P219, DOI 10.1042/CS20080196	42	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124129	10.1371/journal.pone.0124129	http://dx.doi.org/10.1371/journal.pone.0124129			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894557	gold, Green Submitted, Green Published			2022-12-27	WOS:000353211700075
J	De Marco, P; Batista, JD; Cabette, HSR				De Marco Junior, Paulo; Batista, Joana Darc; Ramos Cabette, Helena Soares			Community Assembly of Adult Odonates in Tropical Streams: An Ecophysiological Hypothesis	PLOS ONE			English	Article							RIVER CONTINUUM CONCEPT; DRAGONFLIES ODONATA; SPECIES RICHNESS; NEOTROPICAL STREAMS; MICROHABITAT USE; HABITAT SPLIT; FOOD WEBS; THERMOREGULATION; PATTERNS; ANISOPTERA	Community assembly theory is founded on the premise that the relative importance of local environmental processes and dispersal shapes the compositional structure of metacommunities. The species sorting model predicts that assemblages are dominated by the environmental filtering of species that are readily able to disperse to suitable sites. We propose an ecophysiological hypothesis (EH) for the mechanism underlying the organization of species-sorting odonate metacommunities based on the interplay of thermoregulation, body size and the degree of sunlight availability in small-to-medium tropical streams. Due to thermoregulatory restrictions, the EH predicts (i) that larger species are disfavored in small streams and (ii) that streams exhibit a nested compositional pattern characterized by species' size distribution. To test the EH, we evaluate the longitudinal distribution of adult Odonata at 19 sites in 1(st)- to 6(th)-order streams in the Tropical Cerrado of Brazil. With increasing channel width, the total abundance and species richness of Anisoptera increased, while the abundance of Zygoptera decreased. The first axis of an ordination analysis of the species abundance data was directly related to channel width. Mean and maximum thorax size are positively correlated to channel width, but no relationship was found for the minimum thorax size, suggesting that there is no lower size constraint on the occurrence of these species. Additionally, a nested compositional pattern related to body size was observed. Our results support the EH and its use as an ecological assembly rule based on abiotic factors. Forest cover functions as a filter to determine which species successfully colonize a given site within a metacommunity. As a consequence, the EH also indicates higher treats for small-bodied zygopterans in relation to the loss of riparian forests in tropical streams.	[De Marco Junior, Paulo] Univ Fed Goias, ICB, Dept Ecol, Lab Teoria Metacomunidades & Ecol Paisa, Goiania, Go, Brazil; [Batista, Joana Darc] Univ Estado Mato Grosso UNEMAT, Entomol Lab, Nova Xavantina, MT, Brazil; [Ramos Cabette, Helena Soares] Univ Estado Mato Grosso UNEMAT, Dept Biol, Nova Xavantina, MT, Brazil	Universidade Federal de Goias; Universidade do Estado de Mato Grosso; Universidade do Estado de Mato Grosso	De Marco, P (corresponding author), Univ Fed Goias, ICB, Dept Ecol, Lab Teoria Metacomunidades & Ecol Paisa, Goiania, Go, Brazil.	pdemarco@pq.cnpq.br	De Marco, Paulo/B-2209-2009	De Marco, Paulo/0000-0002-3628-6405	UNEMAT/FAPEMAT/FIDPEX; CAPES; CNPq [305542/2010-9]	UNEMAT/FAPEMAT/FIDPEX; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by UNEMAT/FAPEMAT/FIDPEX. J.D. Batista was funded by CAPES and P. De Marco by continuous productivity CNPq grants (305542/2010-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Agarwal DK, 2005, ECOL MODEL, V185, P105, DOI 10.1016/j.ecolmodel.2004.11.023; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Azeria ET, 2008, OIKOS, V117, P1006, DOI [10.1111/j.0030-1299.2008.16529.x, 10.1111/j.2008.0030-1299.16529.x]; Bartholomew GA, 1981, INSECT THERMOREGULAT, P46; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Becker CG, 2010, CONSERV BIOL, V24, P287, DOI 10.1111/j.1523-1739.2009.01324.x; Becker CG, 2007, SCIENCE, V318, P1775, DOI 10.1126/science.1149374; Biggs TW, 2008, ECOL APPL, V18, P31, DOI 10.1890/06-1689.1; Bojsen BH, 2003, ARCH HYDROBIOL, V158, P317, DOI 10.1127/0003-9136/2003/0158-0317; Borror Donald J., 1945, ANN ENT SOC AMERICA, V38, P168; Brown BL, 2011, J N AM BENTHOL SOC, V30, P310, DOI 10.1899/10-129.1; Carvalho A. L., 2000, MUSEU ZOOLOGIA U SAO, V41, P223; Carvalho FMV, 2009, BIOL CONSERV, V142, P1392, DOI 10.1016/j.biocon.2009.01.031; Clausnitzer V, 2003, BIODIVERS CONSERV, V12, P333, DOI 10.1023/A:1021920402913; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Conneil J.H., 1975, P460; CONNERS ME, 1984, CAN J FISH AQUAT SCI, V41, P1473, DOI 10.1139/f84-181; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Corbet PS, 2008, INT J ODONATOL, V11, P155, DOI 10.1080/13887890.2008.9748320; COVICH AP, 1988, J N AM BENTHOL SOC, V7, P361, DOI 10.2307/1467297; Craig CN, 2008, WETLANDS, V28, P995, DOI 10.1672/07-214.1; CROWLEY PH, 1982, ECOLOGY, V63, P1064, DOI 10.2307/1937245; CUMMINS KW, 1979, ANNU REV ECOL SYST, V10, P147, DOI 10.1146/annurev.es.10.110179.001051; Damm S, 2010, MOL PHYLOGENET EVOL, V54, P870, DOI 10.1016/j.ympev.2009.12.006; De Marco P, 2005, NEOTROP ENTOMOL, V34, P155, DOI 10.1590/S1519-566X2005000200002; De Marco P, 2004, ODONATOLOGICA, V33, P73; De Marco P, 1998, ODONATOLOGICA, V27, P239; De Marco P, 2002, ODONATOLOGICA, V31, P129; De Marco P, 2008, ODONATOLOGICA, V37, P1; Diamond J.M., 1975, P342; Ferreira-Peruquetti Patrícia Santos, 2002, Rev. Bras. Zool., V19, P317, DOI 10.1590/S0101-81752002000200002; FISHER SG, 1973, ECOL MONOGR, V43, P421, DOI 10.2307/1942301; Franken RJM, 2005, FRESHWATER BIOL, V50, P459, DOI 10.1111/j.1365-2427.2005.01333.x; GLEASON H. A., 1939, AMER MIDLAND NAT, V21, P92, DOI 10.2307/2420377; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Gotelli NJ, 1999, SCIENCE, V286, P1684; Grubaugh JW, 1996, CAN J FISH AQUAT SCI, V53, P896, DOI 10.1139/cjfas-53-4-896; Heino J, 2005, HYDROBIOLOGIA, V539, P121, DOI 10.1007/s10750-004-3914-3; HEINRICH B, 1978, J EXP BIOL, V74, P17; Hellmann JJ, 1999, ECOL APPL, V9, P824, DOI 10.1890/1051-0761(1999)009[0824:BPAAOF]2.0.CO;2; Helson JE, 2006, HYDROBIOLOGIA, V559, P413, DOI 10.1007/s10750-005-0977-8; HELTSHE JF, 1983, BIOMETRICS, V39, P1, DOI 10.2307/2530802; Henriques-Silva R, 2013, ECOLOGY, V94, P627, DOI 10.1890/12-0683.1; HILL MO, 1980, VEGETATIO, V42, P47, DOI 10.1007/BF00048870; Holdaway RJ, 2006, J ECOL, V94, P1092, DOI 10.1111/j.1365-2745.2006.01170.x; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hubbell Stephen P., 2001, V32, pi; Ishizawa Naoya, 1994, Gekkan-Mushi, V281, P13; Juen L, 2011, INSECT CONSERV DIVER, V4, P265, DOI 10.1111/j.1752-4598.2010.00130.x; Kadoya T, 2008, LANDSCAPE ECOL, V23, P149, DOI 10.1007/s10980-007-9151-1; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; KLOPFER PH, 1961, AM NAT, V95, P223, DOI 10.1086/282179; Layer K, 2013, OECOLOGIA, V171, P459, DOI 10.1007/s00442-012-2421-x; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lencioni F. A. A., 2006, BIOTA NEOTROP, V1, DOI DOI 10.1590/1676-0611-BN-2018-0609; Lencioni FAA, 2005, DAMSELFLIES BRAZIL I, V1; MAC ARTHUR ROBERT H., 1967; MATLACK GR, 1993, BIOL CONSERV, V66, P185, DOI 10.1016/0006-3207(93)90004-K; May M.L., 1991, Advances in Odonatology, V5, P71; MAY ML, 1979, J EXP BIOL, V83, P79; MAY ML, 1977, ECOLOGY, V58, P787, DOI 10.2307/1936214; MAY ML, 1979, ANNU REV ENTOMOL, V24, P313, DOI 10.1146/annurev.en.24.010179.001525; MAY ML, 1976, ECOL MONOGR, V46, P1, DOI 10.2307/1942392; Mckay T, 2008, ODONATOLOGICA, V37, P29; Melo AS, 2001, J N AM BENTHOL SOC, V20, P1, DOI 10.2307/1468184; Morton DC, 2006, P NATL ACAD SCI USA, V103, P14637, DOI 10.1073/pnas.0606377103; Mouillot D, 2007, J APPL ECOL, V44, P760, DOI 10.1111/j.1365-2664.2007.01330.x; NAIMAN RJ, 1987, ECOLOGY, V68, P1139, DOI 10.2307/1939199; POLCYN DM, 1994, FUNCT ECOL, V8, P441, DOI 10.2307/2390067; Remsburg AJ, 2008, J INSECT BEHAV, V21, P460, DOI 10.1007/s10905-008-9138-z; Rith-Najarian JC, 1998, ODONATOLOGICA, V27, P335; Ruhi A, 2013, OECOLOGIA, V171, P545, DOI 10.1007/s00442-012-2440-7; Sformo T, 2006, FUNCT ECOL, V20, P114, DOI 10.1111/j.1365-2435.2006.01064.x; Shurin JB, 2004, J THEOR BIOL, V227, P359, DOI 10.1016/j.jtbi.2003.11.013; Silva DD, 2010, ECOL INDIC, V10, P744, DOI 10.1016/j.ecolind.2009.12.004; STATZNER B, 1985, CAN J FISH AQUAT SCI, V42, P1038, DOI 10.1139/f85-129; Strahler A.N., 1957, EOS T AM GEOPHYS UNI, V38, P912, DOI [10.1029/TR038i006p00913, DOI 10.1029/TR038I006P00913]; Swenson NG, 2011, AM J BOT, V98, P472, DOI 10.3732/ajb.1000289; Tilman D, 1998, AM NAT, V151, P277, DOI 10.1086/286118; TRACY CR, 1979, PHYSIOL ZOOL, V52, P565, DOI 10.1086/physzool.52.4.30155947; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; WATANABE M, 1991, ZOOL SCI, V8, P983; Winemiller KO, 2010, J N AM BENTHOL SOC, V29, P84, DOI 10.1899/08-048.1; Yang J, 2011, LANDSCAPE ECOL, V26, P381, DOI 10.1007/s10980-010-9565-z; Zar JH, 1999, BIOSTATISTICAL ANAL	89	40	44	5	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123023	10.1371/journal.pone.0123023	http://dx.doi.org/10.1371/journal.pone.0123023			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906243	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000020
J	Kooiman, J; van Hagen, N; del Sol, AI; Planken, EV; Lip, GYH; van der Meer, FJM; Cannegieter, SC; Klok, FA; Huisman, MV				Kooiman, Judith; van Hagen, Nadja; del Sol, Antonio Iglesias; Planken, Erwin V.; Lip, Gregory Y. H.; van der Meer, Felix J. M.; Cannegieter, Suzanne C.; Klok, Frederikus A.; Huisman, Menno V.			The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; PREDICTION SCORES; ANTITHROMBOTIC THERAPY; VALIDATION; WARFARIN; PERFORMANCE; HEMORRHAGE; EVENTS; HEMORR(2)HAGES; POPULATION	Objective The HAS-BLED score enables a risk estimate of major bleeds in patients with atrial fibrillation on vitamin K-antagonists (VKA) treatment, but has not been validated for patients with venous thromboembolism (VTE). We analyzed whether the HAS-BLED score accurately identifies patients at high risk of major bleeds during VKA treatment for acute VTE. Methods Medical records of 537 patients with acute VTE (primary diagnosis pulmonary embolism in 223, deep vein thrombosis in 314) starting VKA treatment between 2006-2007 were searched for items on the HAS-BLED score and the occurrence of major bleeds during the first 180 days of follow-up. The hazard ratio (HR) for the occurrence of major bleeds comparing non-high with high-risk patients as defined by a HAS-BLED score >= 3 points was calculated using Cox-regression analysis. Results Major bleeds occurred in 11/537 patients (2.0%, 5.2/100 person years, 95% CI 2.8-9.2). Cumulative incidences of major bleeds were 1.3% (95% CI 0.1-2.5) in the non-high (HASBLED <3) and 9.6% (95% CI 2.2-17.0) in the high-risk group (HAS-BLED > 3), (p < 0.0001 by Log-Rank test), with a HR of 8.7 (95% CI 2.7-28.4). Of the items in the HAS-BLED score, abnormal renal function (HR 10.8, 95% CI 1.9-61.7) and a history of bleeding events (HR 10.4, 95% CI 2.5-42.5) were independent predictors of major bleeds during follow-up. Conclusion Acute VTE patients with a HAS-BLED score >= 3 points are at increased risk of major bleeding. These results warrant for correction of the potentially reversible risk factors for major bleeding and careful International Normalized Ratio monitoring in acute VTE patients with a high HAS-BLED score.	[Kooiman, Judith; van Hagen, Nadja; van der Meer, Felix J. M.; Cannegieter, Suzanne C.; Klok, Frederikus A.; Huisman, Menno V.] Leiden Univ, Med Ctr, Dept Thrombosis & Haemostasis, Leiden, Netherlands; [del Sol, Antonio Iglesias] Rijnland Hosp, Dept Internal Med, Leiderdorp, Netherlands; [Planken, Erwin V.] Diaconessenhuis, Dept Internal Med, Leiden, Netherlands; [Lip, Gregory Y. H.] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England; [Cannegieter, Suzanne C.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Rijnland Hospital; University of Birmingham; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kooiman, J (corresponding author), Leiden Univ, Med Ctr, Dept Thrombosis & Haemostasis, Leiden, Netherlands.	j.kooiman@lumc.nl	Klok, Erik/U-4870-2019; Cannegieter, Suzanne/W-3696-2019; del Sol, Antonio/M-7431-2017	Klok, Erik/0000-0001-9961-0754; Cannegieter, Suzanne/0000-0003-4707-2303; del Sol, Antonio/0000-0002-9926-617X				Nieto JA, 2008, THROMB HAEMOSTASIS, V100, P789, DOI 10.1160/TH08-06-0390; Apostolakis S, 2013, J AM COLL CARDIOL, V61, P386, DOI 10.1016/j.jacc.2012.10.010; Apostolakis S, 2012, J AM COLL CARDIOL, V60, P861, DOI 10.1016/j.jacc.2012.06.019; Aujesky D, 2005, AM J RESP CRIT CARE, V172, P1041, DOI 10.1164/rccm.200506-862OC; Beyth RJ, 1998, AM J MED, V105, P91, DOI 10.1016/S0002-9343(98)00198-3; Beyth RJ, 2000, ANN INTERN MED, V133, P687, DOI 10.7326/0003-4819-133-9-200011070-00010; Burgess S, 2013, J THROMB HAEMOST, V11, P1647, DOI 10.1111/jth.12352; Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/europace/eus305, 10.1093/eurheartj/ehs253]; Donze J, 2012, AM J MED, V125, P1095, DOI 10.1016/j.amjmed.2012.04.005; Fang MC, 2011, J AM COLL CARDIOL, V58, P395, DOI 10.1016/j.jacc.2011.03.031; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Gage BF, 2006, AM HEART J, V151, P713, DOI 10.1016/j.ahj.2005.04.017; Gallego P, 2012, CIRC-ARRHYTHMIA ELEC, V5, P312, DOI 10.1161/CIRCEP.111.967000; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Kuijer PMM, 1999, ARCH INTERN MED, V159, P457, DOI 10.1001/archinte.159.5.457; Linkins LA, 2003, ANN INTERN MED, V139, P893, DOI 10.7326/0003-4819-139-11-200312020-00007; Lip GYH, 2013, INT J CARDIOL, V168, P1832, DOI 10.1016/j.ijcard.2012.12.076; Lip GYH, 2011, J AM COLL CARDIOL, V57, P173, DOI 10.1016/j.jacc.2010.09.024; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Omran H, 2012, THROMB HAEMOSTASIS, V108, P65, DOI 10.1160/TH11-12-0827; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Poli D, 2013, J THROMB HAEMOST, V11, P1053, DOI 10.1111/jth.12239; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Ruiz-Gimenez N, 2008, THROMB HAEMOSTASIS, V100, P26, DOI 10.1160/TH08-03-0193; Scherz N, 2013, J THROMB HAEMOST, V11, P435, DOI 10.1111/jth.12111; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Schulman S, 1997, NEW ENGL J MED, V336, P393, DOI 10.1056/NEJM199702063360601; Schulman S, 2008, CHEST, V133, p257S, DOI 10.1378/chest.08-0674; Seet RCS, 2013, J STROKE CEREBROVASC, V22, P561, DOI 10.1016/j.jstrokecerebrovasdis.2013.01.019; Shireman TI, 2006, CHEST, V130, P1390, DOI 10.1378/chest.130.5.1390; Smith JG, 2012, EUROINTERVENTION, V8, P672, DOI 10.4244/EIJV8I6A105; Wells PS, 2003, ARCH INTERN MED, V163, P917, DOI 10.1001/archinte.163.8.917; White RH, 1999, AM J MED, V107, P414, DOI 10.1016/S0002-9343(99)00267-3; Wong PYH, 2013, J THROMB HAEMOST, V11, P491, DOI 10.1111/jth.12107	36	55	56	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0122520	10.1371/journal.pone.0122520	http://dx.doi.org/10.1371/journal.pone.0122520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905638	gold, Green Submitted, Green Published			2022-12-27	WOS:000353332000014
J	Marwick, JA; Tudor, C; Khorasani, N; Michaeloudes, C; Bhavsar, PK; Chung, KF				Marwick, John A.; Tudor, Corina; Khorasani, Nadia; Michaeloudes, Charalambos; Bhavsar, Pankaj K.; Chung, Kian F.			Oxidants Induce a Corticosteroid-Insensitive Phosphorylation of Histone 3 at Serine 10 in Monocytes	PLOS ONE			English	Article							STRESS-INDUCED PHOSPHORYLATION; KAPPA-B ACTIVATION; OXIDATIVE STRESS; CYTOKINE RELEASE; P38 MAPK; ASTHMA; INHIBITOR; GENES; H3; PHOSPHATASES	Oxidative stress enhances inflammation and reduces the effectiveness of corticosteroids, but the inflammatory signalling pathways induced by oxidants remain III-defined. Phosphorylation of histone 3 at serine 10 (H3-Pser10) marks out a subset of inflammatory genes for transcription, several of which are induced in oxidant-associated inflammation. However, the influence of oxidants or of corticosteroids on this modification remains unknown. We assessed the regulation of H3-Pser10 by oxidants and lipopolysaccharide (LPS) in human blood monocytes and lung macrophages and the effectiveness of its abolition in controlling inflammatory gene expression in cells from asthmatic subjects compared to corticosteroids alone. Both oxidants and LPS promoted the induction of H3-Pser10 which was unaffected by corticosteroids. The induction of H3-Pser10 was mediated through p38 alpha mitogen-activated protein kinase (MAPK) and I kappa B kinase 2 (IKK-2) signalling. Consequently, inhibitors of p38 alpha MAPK or IKK-2 used in combination with dexamethasone were more effective at controlling inflammatory gene expression from monocytes and lung macrophages from asthmatic patients than the corticosteroid alone. Therefore, reduction of H3-Pser10 by inhibition of p38 alpha MAPK or of IKK-2 may provide greater anti-inflammatory control than corticosteroids alone in oxidant-associated inflammation such as severe asthma.	[Marwick, John A.; Tudor, Corina; Khorasani, Nadia; Michaeloudes, Charalambos; Bhavsar, Pankaj K.; Chung, Kian F.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Sect Airways Dis, London, England; [Marwick, John A.] Univ Edinburgh, Sch Med, Queens Med Res Inst, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Chung, Kian F.] Royal Brompton Hosp, NIHR Biomed Res Unit, London SW3 6LY, England	Imperial College London; University of Edinburgh; Royal Brompton Hospital	Marwick, JA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Sect Airways Dis, London, England.	John.Marwick@eda.c.uk	Chung, Kian Fan/B-1872-2012	Chung, Kian Fan/0000-0001-7101-1426; Michaeloudes, Charalambos/0000-0002-4107-4028	UK Medical Research Council [G0700900]; Medical Research Council [G0700900] Funding Source: researchfish; MRC [G0700900] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the UK Medical Research Council (Grant G0700900 to KFC). http://www.mrc.ac.uk/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Adcock IM, 2008, LANCET, V372, P1073, DOI 10.1016/S0140-6736(08)61449-X; American Thoracic Society, 2000, AM J RESP CRIT CARE, V162, P2341; Barrett DM, 2005, J BIOL CHEM, V280, P14453, DOI 10.1074/jbc.M411523200; Bhavsar P, 2008, THORAX, V63, P784, DOI 10.1136/thx.2007.090027; Bhavsar P, 2010, EUR RESPIR J, V35, P750, DOI 10.1183/09031936.00071309; Birrell MA, 2005, AM J RESP CRIT CARE, V172, P962, DOI 10.1164/rccm.200412-1647OC; Choi JK, 2009, BIOCHEM CELL BIOL, V87, P139, DOI 10.1139/O08-112; Chung KF, 2010, ANN NY ACAD SCI, V1203, P85, DOI 10.1111/j.1749-6632.2010.05600.x; Chung KF, 1999, EUR RESPIR J, V13, P1198; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; Evans DJ, 1997, NEW ENGL J MED, V337, P1412, DOI 10.1056/NEJM199711133372002; Gagliardo R, 2011, J ALLERGY CLIN IMMUN, V128, P635, DOI 10.1016/j.jaci.2011.03.045; Hew M, 2006, AM J RESP CRIT CARE, V174, P134, DOI 10.1164/rccm.200512-1930OC; Irusen E, 2002, J ALLERGY CLIN IMMUN, V109, P649, DOI 10.1067/mai.2002.122465; Ito K., 2001, FASEB Journal, V15, P1110; LaHair MM, 2006, ANTIOXID REDOX SIGN, V8, P1749, DOI 10.1089/ars.2006.8.1749; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Marwick JA, 2004, AM J RESP CELL MOL, V31, P633, DOI 10.1165/rcmb.2004-0006OC; Marwick JA, 2010, J ALLERGY CLIN IMMUN, V125, P1146, DOI 10.1016/j.jaci.2010.02.003; Medicherla S, 2008, J PHARMACOL EXP THER, V324, P921, DOI 10.1124/jpet.107.127092; Moodie FM, 2004, FASEB J, V18, P1897, DOI 10.1096/fj.04-1506fje; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Rahman I, 2002, MOL CELL BIOCHEM, V234, P239, DOI 10.1023/A:1015905010086; Rajendrasozhan S, 2010, PULM PHARMACOL THER, V23, P172, DOI 10.1016/j.pupt.2010.01.002; Rastrick JMD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054128; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Smith SJ, 2006, BRIT J PHARMACOL, V149, P393, DOI 10.1038/sj.bjp.0706885; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Sugiura H, 2008, ANTIOXID REDOX SIGN, V10, P785, DOI 10.1089/ars.2007.1937; Tomlinson JEM, 2005, THORAX, V60, P282, DOI 10.1136/thx.2004.033688; Yamada T, 2012, FREE RADICAL BIO MED, V52, P1285, DOI 10.1016/j.freeradbiomed.2012.02.003; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576	33	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124961	10.1371/journal.pone.0124961	http://dx.doi.org/10.1371/journal.pone.0124961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905622	Green Published, Green Submitted, gold			2022-12-27	WOS:000353332000095
J	Baban, B; Liu, JY; Qin, X; Weintraub, NL; Mozaffari, MS				Baban, Babak; Liu, Jun Yao; Qin, Xu; Weintraub, Neal L.; Mozaffari, Mahmood S.			Upregulation of Programmed Death-1 and Its Ligand in Cardiac Injury Models: Interaction with GADD153	PLOS ONE			English	Article							GRAFT ARTERIAL-DISEASE; PD-L1; INFLAMMATION; PATHWAY; B7-H1; EXPRESSION; OVEREXPRESSION; MYOCARDITIS; PROGNOSIS; CARCINOMA	Purpose Programmed Death-1 (PD-1) and its ligand, PD-L1, are regulators of immune/inflammatory mechanisms. We explored the potential involvement of PD-1/PD-L1 pathway in the inflammatory response and tissue damage in cardiac injury models. Experimental Design Ischemic-reperfused and cryoinjured hearts were processed for flow cytometry and immunohistochemical studies for determination of cardiac PD-1 and PD-L1 in the context of assessment of the growth arrest-and DNA damage-inducible protein 153 (GADD153) which regulates both inflammation and cell death. Further, we explored the potential ability of injured cardiac cells to influence proliferation of T lymphocytes. Results The isolated ischemic-reperfused hearts displayed marked increases in expression of PD-1 and PD-L1 in cardiomyocytes; however, immunofluorescent studies indicate that PD-1 and PD-L1 are not primarily co-expressed on the same cardiomyocytes. Upregulation of PD-1/PD-L1 was associated with a) marked increases in GADD153 and interleukin (IL)-17 but a mild increase in IL-10 and b) disruption of mitochondrial membrane potential (psi(m)) as well as apoptotic and necrotic cell death. Importantly, while isotype matching treatment did not affect the aforementioned changes, treatment with the PD-L1 blocking antibody reversed those effects in association with marked cardioprotection. Further, ischemic-reperfused cardiac cells reduced proliferation of T lymphocytes, an effect partially reversed by PD-L1 antibody. Subsequent studies using the cryoinjury model of myocardial infarction revealed significant increases in PD-1, PD-L1, GADD153 and IL-17 positive cells in association with significant apoptosis/necrosis. Conclusions The data suggest that upregulation of PD-1/PD-L1 pathway in cardiac injury models mediates tissue damage likely through a paracrine mechanism. Importantly, inhibition of T cell proliferation by ischemic-reperfused cardiac cells is consistent with the negative immunoregulatory role of PD-1/PD-L1 pathway, likely reflecting an endogenous cardiac mechanism to curtail the deleterious impact of infiltrating immune cells to the damaged myocardium. The balance of these countervailing effects determines the extent of cardiac injury.	[Baban, Babak; Liu, Jun Yao; Qin, Xu; Mozaffari, Mahmood S.] Georgia Regents Univ, Coll Dent Med, Dept Oral Biol, Augusta, GA 30912 USA; [Weintraub, Neal L.] Georgia Regents Univ, Dept Med, Cardiol Sect, Augusta, GA 30912 USA; [Weintraub, Neal L.] Georgia Regents Univ, Vasc Biol Ctr, Med Coll Georgia, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Baban, B (corresponding author), Georgia Regents Univ, Coll Dent Med, Dept Oral Biol, Augusta, GA 30912 USA.	bbaban@gru.edu		Weintraub, Neal/0000-0002-5138-3705	Georgia Regents University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112640] Funding Source: NIH RePORTER	Georgia Regents University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Source of funding for supporting all studies in this article is the institutional seed money, Georgia Regents University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baban B, 2014, J EXPT CLIN CARDIOLO, V5, P286; Baban B, 2014, AM J HYPERTENS, V27, P846, DOI 10.1093/ajh/hpt269; Baban B, 2013, HYPERTENSION, V61, P95, DOI 10.1161/HYPERTENSIONAHA.111.00028; Baban B, 2011, J IMMUNOL, V187, P2329, DOI 10.4049/jimmunol.1100276; Baban B, 2009, J IMMUNOL, V183, P2475, DOI 10.4049/jimmunol.0900986; Becher UM, 2011, J MOL CELL CARDIOL, V50, P570, DOI 10.1016/j.yjmcc.2010.11.013; Blackburn SD, 2010, J VIROL, V84, P2078, DOI 10.1128/JVI.01579-09; Bodhankar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-111; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Bu DX, 2011, ARTERIOSCL THROM VAS, V31, P1100, DOI 10.1161/ATVBAHA.111.224709; Carter LL, 2007, J NEUROIMMUNOL, V182, P124, DOI 10.1016/j.jneuroim.2006.10.006; Chiodi F, 2010, J CLIN INVEST, V120, P3810, DOI 10.1172/JCI44872; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Furukawa Y, 2000, AM J PATHOL, V157, P473, DOI 10.1016/S0002-9440(10)64559-2; Ghebeh H, 2006, NEOPLASIA, V8, P190, DOI 10.1593/neo.05733; Grabie N, 2007, CIRCULATION, V116, P2062, DOI 10.1161/CIRCULATIONAHA.107.709360; Kim KS, 2001, AM J PATHOL, V158, P977, DOI 10.1016/S0002-9440(10)64044-8; Koga N, 2004, ARTERIOSCL THROM VAS, V24, P2057, DOI 10.1161/01.ATV.0000145015.23656.e4; Lucas JA, 2008, J IMMUNOL, V181, P2513, DOI 10.4049/jimmunol.181.4.2513; Miyazaki Y, 2011, ARTERIOSCL THROM VAS, V31, P1124, DOI 10.1161/ATVBAHA.111.224519; Mozaffari MS, 2013, AM J CARDIOVASC DIS, V3, P180; Nakanishi J, 2007, CANCER IMMUNOL IMMUN, V56, P1173, DOI 10.1007/s00262-006-0266-z; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Ozkaynak E, 2002, J IMMUNOL, V169, P6546, DOI 10.4049/jimmunol.169.11.6546; Ren XF, 2011, STROKE, V42, P2578, DOI 10.1161/STROKEAHA.111.613182; ROSE ML, 1986, TRANSPLANTATION, V41, P776, DOI 10.1097/00007890-198606000-00021; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Seko Y, 2007, CARDIOVASC RES, V75, P158, DOI 10.1016/j.cardiores.2007.03.012; Tarrio ML, 2012, J IMMUNOL, V188, P4876, DOI 10.4049/jimmunol.1200389; Thompson RH, 2006, CLIN GENITOURIN CANC, V5, P206, DOI 10.3816/CGC.2006.n.038; Thompson RH, 2006, CANCER RES, V66, P3381, DOI 10.1158/0008-5472.CAN-05-4303; Topalian SL, 2011, J CLIN ONCOL, V29, P4828, DOI 10.1200/JCO.2011.38.0899; van den Bos EJ, 2005, AM J PHYSIOL-HEART C, V289, pH1291, DOI 10.1152/ajpheart.00111.2005; Wang LQ, 2007, EUR J IMMUNOL, V37, P2983, DOI 10.1002/eji.200737583; Wang WG, 2008, TRANSPLANTATION, V86, P836, DOI 10.1097/TP.0b013e3181861932; Zhang Y, 2010, CRIT CARE, V14, DOI 10.1186/cc9354	36	56	61	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124059	10.1371/journal.pone.0124059	http://dx.doi.org/10.1371/journal.pone.0124059			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902191	Green Published, gold, Green Submitted			2022-12-27	WOS:000353331500074
J	Huang, L; Counter, CM				Huang, Lu; Counter, Christopher M.			Reduced HRAS(G12V)-Driven Tumorigenesis of Cell Lines Expressing KRAS(C118S)	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; GUANINE-NUCLEOTIDE EXCHANGE; P21(RAS) S-NITROSYLATION; WILD-TYPE RAS; MUTANT K-RAS; ENDOTHELIAL-CELLS; ACTIVATION; ONCOGENES; PROTEIN; AKT	In many different human cancers, one of the HRAS, NRAS, or KRAS genes in the RAS family of small GTPases acquires an oncogenic mutation that renders the encoded protein constitutively GTP-bound and thereby active, which is well established to promote tumorigenesis. In addition to oncogenic mutations, accumulating evidence suggests that the wild-type isoforms may also be activated and contribute to oncogenic RAS-driven tumorigenesis. In this regard, redox-dependent reactions with cysteine 118 (C118) have been found to promote activation of wild-type HRAS and NRAS. We sought to determine if this residue is also important for the activation of wild-type KRAS and promotion of tumorigenesis. Thus, we mutated C118 to serine (C118S) in wild-type KRAS to block redox-dependent reactions at this site. We now report that this mutation reduced the level of GTP-bound KRAS and impaired RAS signaling stimulated by the growth factor EGF. With regards to tumorigenesis, we also report that oncogenic HRAS-transformed human cells in which endogenous KRAS was knocked down and replaced with KRAS(C118S) exhibited reduced xenograft tumor growth, as did oncogenic HRAS-transformed Kras(C118S/C118S) murine cells in which the C118S mutation was knocked into the endogenous Kras gene. Taken together, these data suggest a role for redox-dependent activation of wild-type KRAS through C118 in oncogenic HRAS-driven tumorigenesis.	[Huang, Lu; Counter, Christopher M.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Counter, Christopher M.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA	Duke University; Duke University	Counter, CM (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.	count004@mc.duke.edu	Huang, Lu/I-4148-2018	Counter, Christopher M/0000-0003-0748-3079	National Cancer Institute [R01CA123031]; NATIONAL CANCER INSTITUTE [R01CA123031] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant R01CA123031 to CMC from the National Cancer Institute (http://www.cancer.gov/researchandfunding) supported this research. The funding agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2004, J BIOL CHEM, V279, P29857, DOI 10.1074/jbc.M313320200; An HJ, 2006, J BIOL CHEM, V281, P33939, DOI 10.1074/jbc.M605819200; Batista WL, 2013, ANTIOXID REDOX SIGN, V18, P221, DOI 10.1089/ars.2011.4455; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Brady DC, 2014, NATURE, V509, P492, DOI 10.1038/nature13180; Clavreul N, 2006, FASEB J, V20, P518, DOI 10.1096/fj.05-4875fje; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Grabocka E, 2014, CANCER CELL, V25, P243, DOI 10.1016/j.ccr.2014.01.005; Heo JY, 2004, BIOCHEMISTRY-US, V43, P2314, DOI 10.1021/bi035275g; Hobbs GA, 2013, FREE RADICAL BIO MED, V57, P221, DOI 10.1016/j.freeradbiomed.2012.10.531; Jeng HH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2173; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kashatus DF, 2011, NAT CELL BIOL, V13, P1108, DOI 10.1038/ncb2310; Lampson BL, 2013, CURR BIOL, V23, P70, DOI 10.1016/j.cub.2012.11.031; Lander HM, 1996, NATURE, V381, P380, DOI 10.1038/381380a0; Lander HM, 1997, J BIOL CHEM, V272, P4323, DOI 10.1074/jbc.272.7.4323; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Matallanas D, 2011, MOL CELL, V44, P893, DOI 10.1016/j.molcel.2011.10.016; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Mott HR, 1997, BIOCHEMISTRY-US, V36, P3640, DOI 10.1021/bi962790o; O'Hayer KM, 2006, METHOD ENZYMOL, V407, P637, DOI 10.1016/S0076-6879(05)07050-3; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Raines KW, 2007, CARDIOVASC RES, V75, P229, DOI 10.1016/j.cardiores.2007.04.013; Raines KW, 2006, BIOCHEM J, V397, P329, DOI 10.1042/BJ20052002; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Teng KK, 1999, J BIOL CHEM, V274, P37315, DOI 10.1074/jbc.274.52.37315; To MD, 2013, ONCOGENE, V32, P4028, DOI 10.1038/onc.2012.404; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Williams JG, 2003, P NATL ACAD SCI USA, V100, P6376, DOI 10.1073/pnas.1037299100; Wittinghofer A, 1996, TRENDS BIOCHEM SCI, V21, P488, DOI 10.1016/S0968-0004(96)10064-5; Xu JX, 2014, INT J ADAPT CONTROL, V28, P1, DOI 10.1002/acs.2380; Young A, 2013, CANCER DISCOV, V3, P112, DOI 10.1158/2159-8290.CD-12-0231; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721	36	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123918	10.1371/journal.pone.0123918	http://dx.doi.org/10.1371/journal.pone.0123918			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902334	Green Submitted, Green Published, gold			2022-12-27	WOS:000353331500067
J	Seredin, P; Goloshchapov, D; Prutskij, T; Ippolitov, Y				Seredin, Pavel; Goloshchapov, Dmitry; Prutskij, Tatiana; Ippolitov, Yury			Phase Transformations in a Human Tooth Tissue at the Initial Stage of Caries	PLOS ONE			English	Article							EARLY DENTAL-CARIES; MICRO-RAMAN SPECTROSCOPY; X-RAY-DIFFRACTION; HUMAN ENAMEL; HYDROXYAPATITE; SOLUBILITY	The aim of the paper is to study phase transformations in solid tissues of the human teeth during the development of fissure caries by Raman and fluorescence microspectroscopy. The study of the areas with fissure caries confirmed the assumption of the formation of a weak interaction between phosphate apatite enamel and organic acids (products of microorganisms). The experimental results obtained with by Raman microspectroscopy showed the formation of dicalcium phosphate dihydrate - CaHPO4-2H(2)O in the area of mural demineralization of carious fissure. A comparative analysis of structural and spectroscopic data for the intact and carious enamel shows that emergence of a more soluble phase - carbonate-substituted hydroxyapatite - is typical for the initial stage of caries. It is shown that microareas of dental hard tissues in the carious fissure due to an emerging misorientation of apatite crystals have a higher fluorescence yield than the area of the intact enamel. These areas can be easily detected even prior to a deep demineralization (white spot stage) for the case of irreversibly changed organomineral complex and intensive removal of the mineral component.	[Seredin, Pavel; Goloshchapov, Dmitry] Voronezh State Univ, Dept Solid State Phys & Nanostruct, Voronezh 394693, Russia; [Prutskij, Tatiana] Benemerita Univ Autonoma Puebla, Inst Ciencias, Puebla, Mexico; [Ippolitov, Yury] Voronezh State Univ, Dept Prevent Dent, Voronezh 394693, Russia	Voronezh State University; Benemerita Universidad Autonoma de Puebla; Voronezh State University	Seredin, P (corresponding author), Voronezh State Univ, Dept Solid State Phys & Nanostruct, Voronezh 394693, Russia.	paul@phys.vsu.ru	Seredin, Pavel/M-3682-2014; Goloshchapov, Dmitry/M-5149-2016	Seredin, Pavel/0000-0002-6724-0063; Goloshchapov, Dmitry/0000-0002-1400-2870; Ippolitov, Yury/0000-0001-9922-137X	Russian Foundation for Basic Research (RFBR) [13-02-97500]	Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR))	The work was supported by Russian Foundation for Basic Research (RFBR), project number 13-02-97500. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoba T, 2004, ORAL DIS, V10, P249, DOI 10.1111/j.1601-0825.2004.01030.x; Farlay D, 2010, J BONE MINER METAB, V28, P433, DOI 10.1007/s00774-009-0146-7; Gimenez T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060421; Gross EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047722; Ippolitov Y, 2014, INDIAN J DENT S, V5, P135; Kapolos J, 1999, LANGMUIR, V15, P6557, DOI 10.1021/la981285k; Kashkarov VM, 2011, J SURF INVESTIG, V5, P1162, DOI 10.1134/S1027451011120068; Ko ACT, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1915488; Ko ACT, 2006, OPT EXPRESS, V14, P203, DOI 10.1364/OPEX.14.000203; Ko ACT, 2008, OPT EXPRESS, V16, P6274, DOI 10.1364/OE.16.006274; Kon M, 2002, DENT MATER J, V21, P170, DOI 10.4012/dmj.21.170; Lieber CA, 2003, APPL SPECTROSC, V57, P1363, DOI 10.1366/000370203322554518; Mann S., 2001, BIOMINERALIZATION PR; Margolis HC, 1999, J DENT RES, V78, P1326, DOI 10.1177/00220345990780070701; Markovic M, 2004, J RES NATL INST STAN, V109, P553, DOI 10.6028/jres.109.042; MORENO EC, 1990, J BIOL BUCCALE, V18, P195; Pan HB, 2010, CRYST GROWTH DES, V10, P845, DOI 10.1021/cg901199h; Rey C, 2007, MAT SCI ENG C-BIO S, V27, P198, DOI 10.1016/j.msec.2006.05.015; Reyes-Gasga J, 2013, MAT SCI ENG C-MATER, V33, P4568, DOI 10.1016/j.msec.2013.07.014; Robinson C, 2000, CRIT REV ORAL BIOL M, V11, P481, DOI 10.1177/10454411000110040601; Robinson C., 1995, DENT ENAMEL FORMATIO, P223; Schulze KA, 2004, J BIOMED MATER RES A, V69A, P286, DOI 10.1002/jbm.a.20130; Seredin P, 2013, J SYNCHROTRON RADIAT, V20, P705, DOI 10.1107/S0909049513019444; TSUDA H, 1994, J DENT RES, V73, P1703, DOI 10.1177/00220345940730110501; Tsuda H, 1997, Adv Dent Res, V11, P539; Veresov A.G., 2004, ROSS KHIM ZH, V48, P52; Xue J, 2008, J SYNCHROTRON RADIAT, V15, P235, DOI 10.1107/S0909049508003397; Zavala-Alonso V, 2012, J ORAL SCI, V54, P93, DOI 10.2334/josnusd.54.93	28	37	46	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124008	10.1371/journal.pone.0124008	http://dx.doi.org/10.1371/journal.pone.0124008			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901743	Green Published, gold, Green Submitted			2022-12-27	WOS:000353331500070
J	Tessier, L; Bienzle, D; Williams, LB; Koch, TG				Tessier, Laurence; Bienzle, Dorothee; Williams, Lynn B.; Koch, Thomas G.			Phenotypic and Immunomodulatory Properties of Equine Cord Blood-Derived Mesenchymal Stromal Cells	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; TOLL-LIKE RECEPTORS; STEM-CELLS; BONE-MARROW; ADIPOSE-TISSUE; MARKERS; CULTURE; DIFFERENTIATION; IMMUNOPHENOTYPE; THERAPY	Multipotent mesenchymal stromal cells (MSC) have attracted interest for their cytotherapeutic potential, partly due to their immunomodulatory abilities. The aim of this study was to test the robustness of our equine cord blood (CB) MSC isolation protocol, to characterize the CB-MSC before and after cryopreservation, and to evaluate their immunosuppressive phenotype. We hypothesized that MSC can be consistently isolated from equine CB, have unique and reproducible marker expression and in vitro suppress lymphoproliferation. Preliminary investigation of constitutive cytoplasmic Toll-like receptor (TLR) 3 and 4 expression was also preformed due to their possible association with anti-or pro-inflammatory MSC phenotypes, respectively. Surface markers were assessed for antigen and mRNA expression by flow cytometry and quantitative polymerase chain reaction (qPCR). Immunomodulatory properties were evaluated in mixed lymphocyte reaction assays, and TLR3 and TLR4 expression were measured by qPCR and immunocytochemistry (ICC). CB-MSC were isolated from each off nine cord blood samples. CB-MSC highly expressed CD29, CD44, CD90, and lacked or had low expression of major histocompatibility complex (MHC) class I, MHC-II, CD4, CD8, CD11a/18 and CD73 before and after cryopreservation. CB-MSC suppressed in vitro lymphoproliferation and constitutively expressed TLR4. Our findings confirmed CB as a reliable MSC source, provides an association of surface marker phenotype and mRNA expression and suggest anti-inflammatory properties of CB-MSC. The relationship between TLRs and lymphocyte function warrants further investigation.	[Tessier, Laurence; Koch, Thomas G.] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; [Bienzle, Dorothee] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Williams, Lynn B.] Univ Guelph, Ontario Vet Coll, Dept Clin Studies, Guelph, ON N1G 2W1, Canada; [Koch, Thomas G.] Aarhus Univ, Orthopaed Res Lab, Aarhus, Denmark	University of Guelph; University of Guelph; University of Guelph; Aarhus University	Koch, TG (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada.	tkoch@uoguelph.ca	Bienzle, Dorothee/AAY-5009-2020	Bienzle, Dorothee/0000-0002-2301-2931	Danish Agency for Technology, Production and Innovation; Equine Guelph; Department of Biomedical Sciences at the University of Guelph	Danish Agency for Technology, Production and Innovation; Equine Guelph; Department of Biomedical Sciences at the University of Guelph	This project was supported by the Danish Agency for Technology, Production and Innovation, Equine Guelph and the Department of Biomedical Sciences at the University of Guelph. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnhold SJ, 2007, AM J VET RES, V68, P1095, DOI 10.2460/ajvr.68.10.1095; Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; Braun J, 2010, AM J VET RES, V71, P1228, DOI 10.2460/ajvr.71.10.1228; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calloni R, 2013, STEM CELLS DEV, V22, P1455, DOI 10.1089/scd.2012.0637; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Carrade DD, 2012, CELL MED, V4, P1, DOI 10.3727/215517912X647217; Carvalho AD, 2009, VET IMMUNOL IMMUNOP, V132, P303, DOI 10.1016/j.vetimm.2009.06.014; Chagastelles PC, 2011, KIDNEY INT SUPPL, V1, P63, DOI 10.1038/kisup.2011.15; Cyranoski D, 2013, NATURE, V496, P148, DOI 10.1038/496148a; De Schauwer C, 2013, EQUINE VET J, V45, P518, DOI 10.1111/evj.12003; De Schauwer C, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt395; De Schauwer C, 2012, CYTOM PART A, V81A, P312, DOI 10.1002/cyto.a.22026; De Schauwer C, 2011, TISSUE ENG PART C-ME, V17, P1061, DOI 10.1089/ten.tec.2011.0052; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Ferwerda B, 2008, MOL MED, V14, P346, DOI 10.2119/2007-00135.Ferwerda; Figueiredo MD, 2009, VET IMMUNOL IMMUNOP, V131, P65, DOI 10.1016/j.vetimm.2009.03.013; Fortier LA, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt50; Frisbie DD, 2009, J ORTHOP RES, V27, P1675, DOI 10.1002/jor.20933; Frisbie DD, 2005, VET CLIN N AM-EQUINE, V21, P713, DOI 10.1016/j.cveq.2005.07.001; Galipeau J, 2013, CYTOTHERAPY, V15, P2, DOI 10.1016/j.jcyt.2012.10.002; Geng SM, 2013, ARCH DERMATOL RES, V305, P35, DOI 10.1007/s00403-012-1260-2; Guest DJ, 2008, EQUINE VET J, V40, P178, DOI 10.2746/042516408X276942; Haeryfar SMM, 2004, J IMMUNOL, V173, P3581, DOI 10.4049/jimmunol.173.6.3581; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Iacono E, 2012, REPRODUCTION, V143, P455, DOI 10.1530/REP-10-0408; Kang JG, 2013, J VET SCI, V14, P367, DOI 10.4142/jvs.2013.14.3.367; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Koch TG, 2008, CAN VET J, V49, P1009; Koch TG, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-26; Koch TG, 2009, CAN VET J, V50, P155; Koch TG, 2009, CYTOTHERAPY, V11, P443, DOI 10.1080/14653240902887259; Kogler G, 2006, EXP HEMATOL, V34, P1589, DOI 10.1016/j.exphem.2006.07.011; Lange-Consiglio A, 2013, EQUINE VET J, V45, P737, DOI 10.1111/evj.12052; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Li Q, 2013, J MOL HISTOL, V44, P411, DOI 10.1007/s10735-013-9492-9; Liotta F, 2008, STEM CELLS, V26, P279, DOI 10.1634/stemcells.2007-0454; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovati AB, 2011, VET RES COMMUN, V35, P103, DOI 10.1007/s11259-010-9457-3; Lundberg AM, 2007, BLOOD, V110, P3245, DOI 10.1182/blood-2007-02-072934; Maia L, 2013, MICROSC RES TECHNIQ, V76, P618, DOI 10.1002/jemt.22208; Mohanty N, 2014, IN VITRO CELL DEV-AN, V50, P538, DOI 10.1007/s11626-013-9729-7; Nailis H, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-25; Paebst F, 2014, CYTOM PART A, V85A, P678, DOI 10.1002/cyto.a.22491; Pascucci L, 2011, VET IMMUNOL IMMUNOP, V144, P499, DOI 10.1016/j.vetimm.2011.07.017; Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704; Pigott JH, 2013, VET IMMUNOL IMMUNOP, V156, P99, DOI 10.1016/j.vetimm.2013.09.003; Raabe O, 2011, VET RES COMMUN, V35, P355, DOI 10.1007/s11259-011-9480-z; Radcliffe CH, 2010, STEM CELLS DEV, V19, P269, DOI 10.1089/scd.2009.0091; Radtke CL, 2013, AM J VET RES, V74, P790, DOI 10.2460/ajvr.74.5.790; Raicevic G, 2011, CELL IMMUNOL, V270, P207, DOI 10.1016/j.cellimm.2011.05.010; Ranera B, 2012, EQUINE VET J, V44, P33, DOI 10.1111/j.2042-3306.2010.00353.x; Ranera B, 2011, VET IMMUNOL IMMUNOP, V144, P147, DOI 10.1016/j.vetimm.2011.06.033; Schnabel LV, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt402; Schuh EM, 2009, AM J VET RES, V70, P1526, DOI 10.2460/ajvr.70.12.1526; Singh A, 2014, BONE JOINT RES, V3, P32, DOI 10.1302/2046-3758.32.2000187; Tomchuck SL, 2008, STEM CELLS, V26, P99, DOI 10.1634/stemcells.2007-0563; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Violini S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-29; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Zhang X, 2011, J CELL BIOCHEM, V112, P1206, DOI 10.1002/jcb.23042	63	33	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122954	10.1371/journal.pone.0122954	http://dx.doi.org/10.1371/journal.pone.0122954			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902064	Green Submitted, Green Published, gold			2022-12-27	WOS:000353331500033
J	Vaillant, C; Valdivieso, P; Nuciforo, S; Kool, M; Schwarzentruber-Schauerte, A; Mereau, H; Cabuy, E; Lobrinus, JA; Pfister, S; Zuniga, A; Frank, S; Zeller, R				Vaillant, Catherine; Valdivieso, Paola; Nuciforo, Sandro; Kool, Marcel; Schwarzentruber-Schauerte, Alexandra; Mereau, Helene; Cabuy, Erik; Lobrinus, Johannes A.; Pfister, Stefan; Zuniga, Aimee; Frank, Stephan; Zeller, Rolf			Serpine2/PN-1 Is Required for Proliferative Expansion of Pre-Neoplastic Lesions and Malignant Progression to Medulloblastoma	PLOS ONE			English	Article							SONIC HEDGEHOG; PROTEASE NEXIN-1; MOUSE MODEL; GENETIC PROFILES; MESSENGER-RNA; EXPRESSION; MUTATIONS; SUBGROUPS; TARGET; GROWTH	Background Medulloblastomas are malignant childhood brain tumors that arise due to the aberrant activity of developmental pathways during postnatal cerebellar development and in adult humans. Transcriptome analysis has identified four major medulloblastoma subgroups. One of them, the Sonic hedgehog (SHH) subgroup, is caused by aberrant Hedgehog signal transduction due to mutations in the Patched1 (PTCH1) receptor or downstream effectors. Mice carrying a Patched-1 null allele (Ptch1(Delta/+)) are a good model to study the alterations underlying medulloblastoma development as a consequence of aberrant Hedgehog pathway activity. Results Transcriptome analysis of human medulloblastomas shows that SERPINE2, also called Protease Nexin-1 (PN-1) is overexpressed in most medulloblastomas, in particular in the SHH and WNT subgroups. As siRNA-mediated lowering of SERPINE2/PN-1 in human medulloblastoma DAOY cells reduces cell proliferation, we analyzed its potential involvement in medulloblastoma development using the Ptch1(Delta/+) mouse model. In Ptch1(Delta/+) mice, medulloblastomas arise as a consequence of aberrant Hedgehog pathway activity. Genetic reduction of Serpine2/Pn-1 interferes with medulloblastoma development in Ptch1(Delta/+) mice, as similar to 60% of the pre-neoplastic lesions (PNLs) fail to develop into medulloblastomas and remain as small cerebellar nodules. In particular the transcription factor Atoh1, whose expression is essential for development of SHH subgroup medulloblastomas is lost. Comparative molecular analysis reveals the distinct nature of the PNLs in young Ptch1(Delta/+)Pn-1(Delta/+) mice. The remaining wild-type Ptch1 allele escapes transcriptional silencing in most cases and the aberrant Hedgehog pathway activity is normalized. Furthermore, cell proliferation and the expression of the cell-cycle regulators Mycn and Cdk6 are significantly reduced in PNLs of Ptch1(Delta/+)Pn-1(Delta/+) mice. Conclusions Our analysis provides genetic evidence that aberrant Serpine2/Pn-1 is required for proliferation of human and mouse medulloblastoma cells. In summary, our analysis shows that Serpine2/PN-1 boosts malignant progression of PNLs to medulloblastomas, in which the Hedgehog pathway is activated in a SHH ligand-independent manner.	[Vaillant, Catherine; Valdivieso, Paola; Nuciforo, Sandro; Schwarzentruber-Schauerte, Alexandra; Mereau, Helene; Zuniga, Aimee; Zeller, Rolf] Univ Basel, Dept Biomed, Dev Genet, Basel, Switzerland; [Kool, Marcel; Pfister, Stefan] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany; [Cabuy, Erik] Friedrich Miescher Inst, Single Cell Genom, CH-4002 Basel, Switzerland; [Lobrinus, Johannes A.] Univ Hosp Geneva, Dept Clin Pathol, Neuropathol Unit, Geneva, Switzerland; [Frank, Stephan] Univ Basel, Inst Pathol, Div Neuropathol, Basel, Switzerland	University of Basel; Helmholtz Association; German Cancer Research Center (DKFZ); Friedrich Miescher Institute for Biomedical Research; University of Geneva; University of Basel	Zeller, R (corresponding author), Univ Basel, Dept Biomed, Dev Genet, Basel, Switzerland.	rolf.zeller@unibas.ch	Zeller, Rolf/C-2610-2013; Zuniga, Aimée/Q-2692-2018; Zuniga, Aimée/AAG-7335-2020; Pfister, Stefan M/F-6860-2013	Zeller, Rolf/0000-0002-3186-7403; Zuniga, Aimée/0000-0002-9953-3637; Zuniga, Aimée/0000-0002-9953-3637; Pfister, Stefan M/0000-0002-5447-5322; Nuciforo, Sandro/0000-0002-1863-1869; Valdivieso, Paola/0000-0001-9322-4510	Swiss National Science Foundation Marie-Heim Vogtlin fellowship; OncoSuisse research grant; Krebsforschung Schweiz grant; cantons of Basel	Swiss National Science Foundation Marie-Heim Vogtlin fellowship; OncoSuisse research grant; Krebsforschung Schweiz grant; cantons of Basel	This research was supported by a Swiss National Science Foundation Marie-Heim Vogtlin fellowship (to C.V.), an OncoSuisse research grant (to R.Z and S.F), a Krebsforschung Schweiz grant (to R.Z) and the cantons of Basel (to A.Z. and R.Z).	Asuthkar S, 2014, ONCOGENE, V33, P1922, DOI 10.1038/onc.2013.151; Beliveau A, 2010, GENE DEV, V24, P2800, DOI 10.1101/gad.1990410; Benazet JD, 2009, SCIENCE, V323, P1050, DOI 10.1126/science.1168755; Bergeron S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-271; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Buchholz M, 2003, CANCER RES, V63, P4945; Fattet S, 2009, J PATHOL, V218, P86, DOI 10.1002/path.2514; Fayard B, 2009, CANCER RES, V69, P5690, DOI 10.1158/0008-5472.CAN-08-4573; FLOOR E, 1988, J NEUROCHEM, V50, P1597, DOI 10.1111/j.1471-4159.1988.tb03049.x; Flora A, 2009, SCIENCE, V326, P1424, DOI 10.1126/science.1181453; Gao S, 2008, ORAL ONCOL, V44, P309, DOI 10.1016/j.oraloncology.2007.02.009; Garcia-Lopez R, 2013, J CANCER RES THER, V1, P11; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Gotschel F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065403; Goodrich LV, 1999, DEV BIOL, V211, P323, DOI 10.1006/dbio.1999.9311; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Hatten ME, 1997, CURR OPIN NEUROBIOL, V7, P40, DOI 10.1016/S0959-4388(97)80118-3; Heit C, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-22; Hoffman LM, 2014, ACTA NEUROPATHOL, V127, P731, DOI 10.1007/s00401-013-1212-8; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kessler JD, 2009, GENE DEV, V23, P157, DOI 10.1101/gad.1759909; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Lee EY, 2010, P NATL ACAD SCI USA, V107, P9736, DOI 10.1073/pnas.1004602107; Lee J, 1997, DEVELOPMENT, V124, P2537; Lopez-Rios J, 2012, DEV CELL, V22, P837, DOI 10.1016/j.devcel.2012.01.006; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Matsuo S, 2013, EXP TOXICOL PATHOL, V65, P863, DOI 10.1016/j.etp.2012.12.005; Mckee CM, 2012, J CLIN INVEST, V122, P4025, DOI 10.1172/JCI59348; Mendrzyk F, 2005, J CLIN ONCOL, V23, P8853, DOI 10.1200/JCO.2005.02.8589; Monje M, 2011, J CLIN ONCOL, V29, P1395, DOI 10.1200/JCO.2010.34.0547; Nagahara A, 2010, BIOCHEM BIOPH RES CO, V391, P1641, DOI 10.1016/j.bbrc.2009.12.105; Northcott PA, 2012, NAT REV NEUROL, V8, P340, DOI 10.1038/nrneurol.2012.78; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pfister S, 2009, J CHILD NEUROL, V24, P1375, DOI 10.1177/0883073809339213; Pierson J, 2008, J NEURO-ONCOL, V90, P1, DOI 10.1007/s11060-008-9624-3; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Salsano E, 2004, NEUROSCI LETT, V370, P180, DOI 10.1016/j.neulet.2004.08.053; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Swartling FJ, 2010, GENE DEV, V24, P1059, DOI 10.1101/gad.1907510; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Vaillant C, 2007, DEVELOPMENT, V134, P1745, DOI 10.1242/dev.02840; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wang K, 2015, J CANCER RES CLIN, V141, P805, DOI 10.1007/s00432-014-1858-1; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Xu DM, 2010, CANCER RES, V70, P6988, DOI 10.1158/0008-5472.CAN-10-0242; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; ZHENG T, 1993, DEV BRAIN RES, V75, P91, DOI 10.1016/0165-3806(93)90068-L	65	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124870	10.1371/journal.pone.0124870	http://dx.doi.org/10.1371/journal.pone.0124870			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901736	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500102
J	Wang, J; Caccamise, SAL; Woodward, LA; Li, QX				Wang, Jun; Caccamise, Sarah A. L.; Woodward, Lee Ann; Li, Qing X.			Polychlorinated Biphenyls in the Plasma and Preen Oil of Black-Footed Albatross (Diomedea nigripes) Chicks and Adults on Midway Atoll, North Pacific Ocean	PLOS ONE			English	Article							EATING SEA BIRDS; ORGANOCHLORINE PESTICIDES; PHALACROCORAX-CARBO; TISSUE DISTRIBUTION; MOLECULAR-FEATURES; METABOLIC-RATE; PCB ISOMERS; CONGENERS; TOXICITY; EGGS	Polychlorinated biphenyls (PCBs) are ubiquitous in the environment. Midway Atoll, located in the North Pacific Ocean, was occupied by the military during and after World War II. However, Midway Atoll has become a national wildlife refuge and home to many different sea-birds today, including the black-footed albatross (Diomedea nigripes) (BFAL). The profiles and toxic equivalents (TEQ) of PCB congeners in the plasma and preen oil of BFAL chicks and adults were determined in this study. The concentrations of the total PCBs in the plasma samples of chicks and adults collected in Midway Atoll ranged from 2.3 to 223.8 (mean 80.1) and 22.8 to 504.5 (mean 158.6) ng g(-1) (wet weight, ww), respectively. The TEQs ranged from 0.2 to 0.6 (mean 0.4) and 0.4 to 1.6 (mean 0.9) pg g(-1) ww, respectively, in the plasma samples of chicks and adults from Midway Atoll. The major congeners in the plasma samples of chicks and adults included PCBs 31, 87, 97, 99, 118, 138, 153, and 180, accounting for 70% of the total PCBs. The concentrations of the total PCBs in the adult preen oil samples ranged from 1693 to 39404 (mean 10122) ng g(-1) (ww), of which 97% were PCBs 105, 118, 128, 138, 153, 161, 172, and 183.	[Wang, Jun; Caccamise, Sarah A. L.; Li, Qing X.] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; [Woodward, Lee Ann] US Fish & Wildlife Serv, Pacific Reefs NWRC, Honolulu, HI 96850 USA	University of Hawaii System; University of Hawaii Manoa; United States Department of the Interior; US Fish & Wildlife Service	Caccamise, SAL (corresponding author), Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA.	qingl@hawaii.edu	Wang, Jun/H-5837-2015; Wang, Jun/AAN-4446-2021; Li, Qing/AAO-3938-2020	Wang, Jun/0000-0002-7574-9468; Caccamise, Sarah/0000-0002-2710-1683				[Anonymous], 1997, ANAL CHEM PCBS; Auman HJ, 1997, ENVIRON TOXICOL CHEM, V16, P498, DOI [10.1897/1551-5028(1997)016&lt;0498:PDDATE&gt;2.3.CO;2, 10.1002/etc.5620160315]; BARRON MG, 1995, COMP BIOCHEM PHYS C, V112, P1, DOI 10.1016/0742-8413(95)00074-7; BORLAKOGLU JT, 1990, COMP BIOCHEM PHYS C, V97, P173, DOI 10.1016/0742-8413(90)90188-F; BORLAKOGLU JT, 1990, COMP BIOCHEM PHYS C, V97, P161, DOI 10.1016/0742-8413(90)90187-E; BRAUNE BM, 1989, ENVIRON TOXICOL CHEM, V8, P957, DOI 10.1002/etc.5620081015; Caccamise SAL, 2012, ECOL INDIC, V20, P75, DOI 10.1016/j.ecolind.2012.01.023; Castello G, 1997, J CHROMATOGR A, V787, P215, DOI 10.1016/S0021-9673(97)00662-6; Cifuentes JM, 2003, ENVIRON POLLUT, V126, P123, DOI 10.1016/S0269-7491(02)00400-1; FALANDYSZ J, 1994, ARCH ENVIRON CON TOX, V26, P13, DOI 10.1007/BF00212788; Ge J, 2013, SCI TOTAL ENVIRON, V452, P421, DOI 10.1016/j.scitotenv.2013.03.015; Geyer H. J., 2000, HDB ENV CHEM; Giesy JP, 1994, DIOXINS HLTH; GONZALEZ MJ, 1991, ARCH ENVIRON CON TOX, V20, P343, DOI 10.1007/BF01064400; Guruge KS, 2001, ENVIRON POLLUT, V114, P389, DOI 10.1016/S0269-7491(00)00234-7; Guruge KS, 2001, MAR ENVIRON RES, V52, P271, DOI 10.1016/S0141-1136(01)00099-X; Guruge KS, 2000, ARCH ENVIRON CON TOX, V38, P509, DOI 10.1007/s002449910067; Hario M, 2004, ENVIRON POLLUT, V127, P411, DOI 10.1016/j.envpol.2003.08.008; Hope B, 1997, MAR POLLUT BULL, V34, P548, DOI 10.1016/S0025-326X(96)00180-4; Jones PD, 1996, ENVIRON TOXICOL CHEM, V15, P1793, DOI 10.1002/etc.5620151021; Kannan K, 2000, HUM ECOL RISK ASSESS, V6, P181, DOI 10.1080/10807030091124491; LEMMETYINEN R, 1982, CHEMOSPHERE, V11, P1059, DOI 10.1016/0045-6535(82)90080-7; Miao XS, 2000, SCI TOTAL ENVIRON, V257, P17, DOI 10.1016/S0048-9697(00)00484-8; Mora MA, 1996, ENVIRON TOXICOL CHEM, V15, P1003, DOI 10.1002/etc.5620150624; Parham FM, 1998, TOXICOL APPL PHARM, V151, P110, DOI 10.1006/taap.1998.8441; Phillips RA, 2003, COMP BIOCHEM PHYS A, V135, P185, DOI 10.1016/S1095-6433(03)00073-4; RICKETTS C, 1984, AUK, V101, P790, DOI 10.2307/4086905; Van den Berg M, 1998, ENVIRON HEALTH PERSP, V106, P775, DOI 10.1289/ehp.98106775; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Wang DL, 2010, ARCH ENVIRON CON TOX, V58, P478, DOI 10.1007/s00244-009-9396-6; WARHAM J, 1990, PETRELS THEIR ECOLOG; Yang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086441; Yu LH, 2014, ENVIRON POLLUT, V188, P118, DOI 10.1016/j.envpol.2014.01.023	33	4	4	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123041	10.1371/journal.pone.0123041	http://dx.doi.org/10.1371/journal.pone.0123041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901941	Green Submitted, gold, Green Published			2022-12-27	WOS:000353331500039
J	Brieno-Enriquez, MA; Garcia-Lopez, J; Cardenas, DB; Guibert, S; Cleroux, E; Ded, L; Hourcade, JD; Peknicova, J; Weber, M; del Mazo, J				Brieno-Enriquez, Miguel A.; Garcia-Lopez, Jesus; Cardenas, David B.; Guibert, Sylvain; Cleroux, Elouan; Ded, Lukas; de Dios Hourcade, Juan; Peknicova, Jana; Weber, Michael; del Mazo, Jesus			Exposure to Endocrine Disruptor Induces Transgenerational Epigenetic Deregulation of MicroRNAs in Primordial Germ Cells	PLOS ONE			English	Article							BINDING PROTEIN LIN28; DNA METHYLATION; IMPRINTED GENES; PRE-MICRORNA; VINCLOZOLIN; EXPRESSION; DYNAMICS; SPECIFICATION; BIOGENESIS; LINEAGE	In mammals, germ cell differentiation is initiated in the Primordial Germ Cells (PGCs) during fetal development. Prenatal exposure to environmental toxicants such as endocrine disruptors may alter PGC differentiation, development of the male germline and induce transgenerational epigenetic disorders. The anti-androgenic compound vinclozolin represents a paradigmatic example of molecule causing transgenerational effects on germ cells. We performed prenatal exposure to vinclozolin in mice and analyzed the phenotypic and molecular changes in three successive generations. A reduction in the number of embryonic PGCs and increased rate of apoptotic cells along with decrease of fertility rate in adult males were observed in F1 to F3 generations. Blimp1 is a crucial regulator of PGC differentiation. We show that prenatal exposure to vinclozolin deregulates specific microRNAs in PGCs, such as miR-23b and miR-21, inducing disequilibrium in the Lin28/let-7/Blimp1 pathway in three successive generations of males. As determined by global maps of cytosine methylation, we found no evidence for prominent changes in DNA methylation in PGCs or mature sperm. Our data suggest that embryonic exposure to environmental endocrine disruptors induces transgenerational epigenetic deregulation of expression of microRNAs affecting key regulatory pathways of germ cells differentiation.	[Brieno-Enriquez, Miguel A.; Garcia-Lopez, Jesus; Cardenas, David B.; de Dios Hourcade, Juan; del Mazo, Jesus] CSIC, Dept Cellular & Mol Biol, Ctr Invest Biol, Madrid, Spain; [Guibert, Sylvain; Cleroux, Elouan; Weber, Michael] Univ Strasbourg, CNRS UMR7242, Biotechnol & Cell Signaling, Strasbourg, France; [Ded, Lukas; Peknicova, Jana] Inst Biotechnol AS CR, Vvi, Prague, Czech Republic	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences	del Mazo, J (corresponding author), CSIC, Dept Cellular & Mol Biol, Ctr Invest Biol, Madrid, Spain.	jdelmazo@cib.csic.es	Weber, Michael/P-1914-2016; Ded, Lukas/G-9543-2014; del Mazo, Jesus/L-3156-2015; Lopez, Jesus Garcia/N-7952-2019	Weber, Michael/0000-0003-3484-5821; Ded, Lukas/0000-0003-1053-4025; del Mazo, Jesus/0000-0003-3269-3895; Lopez, Jesus Garcia/0000-0002-1877-3402; Cardenas Sanjur, David Bolivar/0000-0001-6952-7140; Brieno-Enriquez, Miguel Angel/0000-0002-8806-0918	CONACYT Mexico [165418]; CEFIC-LRi; MEDDTL, France [11-MRES-PNRPE-9-CVS-072]; CSIC [PIE-201020E016]; MINECO, Spain [BFU2013-42164-R]; Grant Agency of the Czech Republic [P503/12/1834]; BIOCEV project from the ERDF [CZ.1.05 / 1.1.00/02.0109]	CONACYT Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CEFIC-LRi; MEDDTL, France; CSIC; MINECO, Spain; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); BIOCEV project from the ERDF	M. A. Brieno-Enriquez was supported by Postdoctoral Grant from CONACYT Mexico (165418). This work was supported by grants from The CEFIC-LRi; MEDDTL, France (11-MRES-PNRPE-9-CVS-072): CSIC, (PIE-201020E016) and MINECO (BFU2013-42164-R), Spain; Grant Agency of the Czech Republic (No. P503/12/1834) and BIOCEV project (CZ.1.05 / 1.1.00/02.0109) from the ERDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034158, 10.1371/journal.pone.0049576]; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Auclair G, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0545-5; Avissar-Whiting M, 2010, REPROD TOXICOL, V29, P401, DOI 10.1016/j.reprotox.2010.04.004; Barnes NA, 2012, J IMMUNOL, V189, P253, DOI 10.4049/jimmunol.1101563; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Buckley Jill, 2006, Environ Health, V5, P4, DOI 10.1186/1476-069X-5-4; Cao DF, 2011, HUM PATHOL, V42, P710, DOI 10.1016/j.humpath.2010.09.007; Cowin PA, 2010, ENDOCRINOLOGY, V151, P783, DOI 10.1210/en.2009-0982; Del Mazo J, 2013, INT J DEV BIOL, V57, P225, DOI 10.1387/ijdb.130042jd; Elzeinova F, 2008, REPROD TOXICOL, V26, P231, DOI 10.1016/j.reprotox.2008.09.007; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Guerrero-Bosagna C, 2012, REPROD TOXICOL, V34, P694, DOI 10.1016/j.reprotox.2012.09.005; Guibert S, 2012, GENOME RES, V22, P633, DOI 10.1101/gr.130997.111; Heo I, 2012, CELL, V151, P521, DOI 10.1016/j.cell.2012.09.022; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hou LF, 2011, MUTAT RES-FUND MOL M, V714, P105, DOI 10.1016/j.mrfmmm.2011.05.004; Ivanova E, 2012, EPIGENETICS-US, V7, P1200, DOI 10.4161/epi.22141; Kelce WR, 1997, TOXICOL APPL PHARM, V142, P192, DOI 10.1006/taap.1996.7966; Kiani J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003498; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Liu XL, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-96; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majid S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067686; Matsuura Ikuo, 2005, Journal of Toxicological Sciences, V30, P163; Matzuk MM, 2009, DEV CELL, V17, P160, DOI 10.1016/j.devcel.2009.07.020; Merlet J, 2007, P NATL ACAD SCI USA, V104, P3615, DOI 10.1073/pnas.0611421104; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Niu ZY, 2011, P NATL ACAD SCI USA, V108, P12740, DOI 10.1073/pnas.1109987108; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ohinata Y, 2009, CELL, V137, P571, DOI 10.1016/j.cell.2009.03.014; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; PESCE M, 1995, DEV BIOL, V170, P722, DOI 10.1006/dbio.1995.1250; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Radford EJ, 2014, SCIENCE, V345, P785, DOI 10.1126/science.1255903; Radford EJ, 2012, PLOS GENET, V8, P41, DOI 10.1371/journal.pgen.1002605; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Rodgers AB, 2013, J NEUROSCI, V33, P9003, DOI 10.1523/JNEUROSCI.0914-13.2013; Romanuik TL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-476; Saitou M, 2012, COLD SPRING HARB PER, V4; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Shinoda G, 2013, STEM CELLS, V31, P1001, DOI 10.1002/stem.1343; Skinner MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066318; Skinner MK, 2011, REPROD TOXICOL, V31, P337, DOI 10.1016/j.reprotox.2010.10.012; Skogen JC., 2012, JRSM SHORT REP, V3, P59, DOI [10.1258/shorts.2012.012048, DOI 10.1258/SHORTS.2012.012048]; Stouder C, 2010, REPRODUCTION, V139, P373, DOI 10.1530/REP-09-0340; Teng Y, 2013, TOXICOL SCI, V131, P71, DOI 10.1093/toxsci/kfs290; van den Bergen JA, 2009, BIOL REPROD, V81, P362, DOI 10.1095/biolreprod.109.076224; Vincent JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028960; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Wang KC, 2010, P NATL ACAD SCI USA, V107, P3234, DOI 10.1073/pnas.0914825107; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Xu Z., 2013, ADV DIFFER EQU-NY, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0053146; Xue DB, 2011, HISTOPATHOLOGY, V59, P452, DOI 10.1111/j.1365-2559.2011.03949.x; Zhang HS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1555; Zinchuk V, 2013, SCI REP-UK, V3, DOI 10.1038/srep01365	63	67	74	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124296	10.1371/journal.pone.0124296	http://dx.doi.org/10.1371/journal.pone.0124296			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897752	gold, Green Published, Green Submitted			2022-12-27	WOS:000353212600061
J	Cox, JA; Lukande, RL; Kalungi, S; Van Marck, E; Van de Vijver, K; Kambugu, A; Nelson, AM; Colebunders, R; Manabe, YC				Cox, Janneke A.; Lukande, Robert L.; Kalungi, Sam; Van Marck, Eric; Van de Vijver, Koen; Kambugu, Andrew; Nelson, Ann M.; Colebunders, Robert; Manabe, Yukari C.			Is Urinary Lipoarabinomannan the Result of Renal Tuberculosis? Assessment of the Renal Histology in an Autopsy Cohort of Ugandan HIV-Infected Adults	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; DIAGNOSTIC-ACCURACY; MYCOBACTERIAL LIPOARABINOMANNAN; ANTIRETROVIRAL THERAPY; HOSPITALIZED-PATIENTS; LAM-ELISA; ASSAY; DEATH; ASSOCIATION; MICROSCOPY	Objective The detection of urinary lipoarabinomannan (LAM), a mycobacterial cell wall component, is used to diagnose tuberculosis (TB). How LAM enters the urine is not known. To investigate if urinary LAM-positivity is the result of renal TB infection we correlated the outcomes of urinary LAM-antigen testing to renal histology in an autopsy cohort of hospitalized, Ugandan, HIV-infected adults. Methods We performed a complete autopsy, including renal sampling, in HIV-infected adults that died during hospitalization after written informed consent was obtained from the next of kin. Urine was collected postmortem through post-mortem catheterisation or by bladder puncture and tested for LAM with both a lateral flow assay (LFA) and an ELISA assay. Two pathologists assessed the kidney histology. We correlated the LAM-assay results and the histology findings. Results Of the 13/36 (36%) patients with a positive urinary LAM ELISA and/or LFA, 8/13 (62%) had renal TB. The remaining 5 LAM-positive patients had disseminated TB without renal involvement. Of the 23 LAM-negative patients, 3 had disseminated TB without renal involvement. The remaining LAM-negative patients had no TB infection and died mostly of fungal and bacterial infections. LAM LFA had a sensitivity of 81% and specificity of 100% to diagnose TB at any location, and the LAM ELISA a sensitivity of 63% and a specificity of 100%. 54% (7/13) LAM LFA-positive patients were not on anti-TB treatment at the time of death. Conclusion Renal TB infection explained LAM-positivity in the majority of patients. Patients with disseminated TB without renal involvement can also be diagnosed with LAM. This suggests that other mechanisms that lead to urinary LAM-positivity exist in a minority of patients.	[Cox, Janneke A.; Colebunders, Robert] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Cox, Janneke A.; Kambugu, Andrew; Manabe, Yukari C.] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Lukande, Robert L.; Kalungi, Sam] Makerere Univ, Coll Hlth Sci, Dept Pathol, Kampala, Uganda; [Kalungi, Sam] Mulago Hosp Complex, Dept Pathol, Kampala, Uganda; [Van Marck, Eric] Univ Antwerp, Univ Antwerp Hosp, Dept Pathol, B-2020 Antwerp, Belgium; [Van de Vijver, Koen] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Diagnost Oncol & Mol Pathol, Amsterdam, Netherlands; [Nelson, Ann M.] Joint Pathol Ctr, Silver Spring, MD USA; [Colebunders, Robert] Univ Antwerp, Dept Epidemiol & Social Med, B-2020 Antwerp, Belgium; [Manabe, Yukari C.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Dept Med, Baltimore, MD 21205 USA	Institute of Tropical Medicine (ITM); Makerere University; Makerere University; Mulago National Referral Hospital; University of Antwerp; Netherlands Cancer Institute; University of Antwerp; Johns Hopkins University	Cox, JA (corresponding author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	jannekecox@xs4all.nl	Van de Vijver, Koen/N-7895-2019	Van de Vijver, Koen/0000-0002-2026-9790; Colebunders, Robert/0000-0002-1919-1340	Belgium government through the "Fonds Wetenschappelijk Onderzoek" Flanders; Division of Microbiology and Infectious Diseases [HHSN272200900050C]; Division of AIDS, National Institute of Allergy and Infectious Diseases [1P30AI094189]; Fogarty International Center at the National Institutes of Health [1D43TW009771]; FOGARTY INTERNATIONAL CENTER [D43TW009771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	Belgium government through the "Fonds Wetenschappelijk Onderzoek" Flanders; Division of Microbiology and Infectious Diseases; Division of AIDS, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JAC received a travel grant from the Belgium government through the "Fonds Wetenschappelijk Onderzoek" Flanders. YCM receives funding support from HHSN272200900050C grant from the Division of Microbiology and Infectious Diseases, 1P30AI094189 grant to the Johns Hopkins University Center for AIDS Research from the Division of AIDS, National Institute of Allergy and Infectious Diseases, and 1D43TW009771 grant from the Fogarty International Center at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The remaining authors received no specific funding for this work.	Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; Boehme C, 2005, T ROY SOC TROP MED H, V99, P893, DOI 10.1016/j.trstmh.2005.04.014; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; Cox JA, 2014, JAIDS-J ACQ IMM DEF, V67, P169, DOI 10.1097/QAI.0000000000000290; DACOSTA CTKA, 1993, CLIN EXP IMMUNOL, V91, P25; Dheda K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009848; Fenner L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077697; Gounder CR, 2011, JAIDS-J ACQ IMM DEF, V58, P219, DOI 10.1097/QAI.0b013e31822b75d4; Gupta RK, 2013, INT J TUBERC LUNG D, V17, P1014, DOI 10.5588/ijtld.13.0032; HUNTER SW, 1986, J BIOL CHEM, V261, P2345; Kivihya-Ndugga LEA, 2003, INT J TUBERC LUNG D, V7, P1163; Kroidl I, 2013, SCAND J INFECT DIS, DOI 10.3109/00365548.2013.853133; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Lawn SD, 2009, AIDS, V23, P1875, DOI 10.1097/QAD.0b013e32832e05c8; Martinson NA, 2007, AIDS, V21, P2043, DOI 10.1097/QAD.0b013e3282eea47f; Mishra AK, 2011, FEMS MICROBIOL REV, V35, P1126, DOI 10.1111/j.1574-6976.2011.00276.x; MYERS BD, 1993, AM J NEPHROL, V13, P311, DOI 10.1159/000168645; Nakiyingi L, 2014, JAIDS-J ACQ IMM DEF, V66, P270, DOI 10.1097/QAI.0000000000000151; Patel VB, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-13; Peter JG, 2012, EUR RESPIR J, V40, P1211, DOI 10.1183/09031936.00201711; Rana FS, 2000, J ACQ IMMUN DEF SYND, V24, P23; Reither K, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-141; SADA E, 1992, J CLIN MICROBIOL, V30, P2415, DOI 10.1128/JCM.30.9.2415-2418.1992; SCHUBERT GE, 1992, EUR UROL, V21, P216; Shah M, 2010, J CLIN MICROBIOL, V48, P2972, DOI 10.1128/JCM.00363-10; Shah M, 2009, JAIDS-J ACQ IMM DEF, V52, P145, DOI 10.1097/QAI.0b013e3181b98430; Symes J M, 1973, Br J Urol, V45, P432, DOI 10.1111/j.1464-410X.1973.tb12184.x; Tessema TA, 2002, SCAND J INFECT DIS, V34, P97, DOI 10.1080/00365540110077263; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; Trebucq A, 2011, INT J TUBERC LUNG D, V15, P1567, DOI 10.5588/ijtld.11.0392; UNAIDS, 2013, AIDS BY THE NUMB; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2011, POL STAT AUT REAL TI; Wood R, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-47; World Health Organisation, 2015, EST TB MDR TB BURD U	35	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123323	10.1371/journal.pone.0123323	http://dx.doi.org/10.1371/journal.pone.0123323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897661	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600024
J	Sawada, I; Tanuma, J; Cuong, DD; Tra, TD; Quynh, PL; Lan, ATN; Tuong, VTV; Tuan, QN; Tsuchiya, N; Shiino, T; Yoshida, LM; Thanh, TTP; Ariyoshi, K; Oka, S				Sawada, Ikumi; Tanuma, Junko; Cuong Duy Do; Tra Thu Doan; Quynh Phuong Luu; Lan Anh Thi Nguyen; Tuong Van Thi Vu; Tuan Quang Nguyen; Tsuchiya, Naho; Shiino, Teiichiro; Yoshida, Lay-Myint; Thanh Thuy Thi Pham; Ariyoshi, Koya; Oka, Shinichi			High Proportion of HIV Serodiscordance among HIV-Affected Married Couples in Northern Vietnam	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HETEROSEXUAL TRANSMISSION; HEPATITIS-B; DISCORDANT COUPLES; SEXUAL PARTNERS; CELL ACTIVATION; DRUG-USERS; VIRAL LOAD; PREVENTION; INFECTION	Introduction Little is known about the state of HIV transmission among married couples in Vietnam. This study aims to clarify HIV serostatus in this group and elucidate risk factors for intra-marital HIV transmission. Methods In 2012, we enrolled a group of HIV-positive married men registered at the HIV outpatient clinic of a referral hospital in northern Vietnam, along with their wives. Sociodemographic, behavioural and clinical data were collected from men and wives. HIV serodiscordant couples were followed until March 2014 to determine seroconversion rate. A phylogenetic analysis was performed based on env V3 sequence to detail cluster formation among men. Results Of the 163 HIV-positive men enrolled in the study, 101 (62.0%) had wives testing HIV-negative. Half of men reported injecting drug use (IDU) as a likely transmission route. Couples reported a high incidence of unprotected sexual intercourse prior to diagnosis; the median (inter quartile range) was 4 (4-8) times per month. Only 17 couples (10.4%) reported using condoms during at least half these instances. Multivariable analysis revealed IDU history among men was independently associated with HIV-negative wives (adjusted OR 0.31; 95% CI 0.10-0.95, p=0.041). Phylogenetic analysis of 80 samples indicated CRF01_AE. Of these, 69 (86.3%) clustered with IDU-associated viruses from Vietnam. No HIV seroconversion was identified during a follow-up of 61 serodiscordant couples, with 126.5 person-years of observation during which HIV-infectedmen were on antiretroviral drug therapy (ART). Conclusion High HIV serodiscordance was observed among HIV-affected married couples in northern Vietnam. A large number of at-risk wives therefore remain HIV-negative and can be protected with measures including proper use of ART if couples are made aware of the serodiscordance through screening.	[Sawada, Ikumi; Tsuchiya, Naho; Ariyoshi, Koya] Nagasaki Univ, Grad Sch Biomed Sci, Inst Trop Med, Dept Clin Trop Med, Nagasaki 852, Japan; [Sawada, Ikumi; Tanuma, Junko; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Cuong Duy Do; Tra Thu Doan; Tuan Quang Nguyen; Thanh Thuy Thi Pham] Bach Mai Hosp, Dept Infect Dis, Hanoi, Vietnam; [Quynh Phuong Luu; Lan Anh Thi Nguyen] Natl Inst Hyg & Epidemiol, Dept Immunol & Mol Biol, Lab Mol Diagnost, Hanoi, Vietnam; [Tuong Van Thi Vu] BachMai Hosp, Dept Microbiol, Hanoi, Vietnam; [Shiino, Teiichiro] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan; [Yoshida, Lay-Myint] Nagasaki Univ, Inst Trop Med, Dept Pediat Infect Dis, Nagasaki 852, Japan	Nagasaki University; National Center for Global Health & Medicine - Japan; National Institute of Hygiene & Epidemiology (NIHE); National Institute of Infectious Diseases (NIID); Nagasaki University	Ariyoshi, K (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Inst Trop Med, Dept Clin Trop Med, Nagasaki 852, Japan.	kari@nagasaki-u.ac.jp	lan, A/HHZ-6588-2022; Tanuma, Junko/AAE-5395-2020	YOSHIDA, LAYMYINT/0000-0002-7567-3248	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) of Japanese Initiative for Global Research Network on Infectious Diseases (J-GRID)	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) of Japanese Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Financial support from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) as a project of the Japanese Initiative for Global Research Network on Infectious Diseases (J-GRID, http://www.crnid.riken.jp/jgrid/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Capoulade-Metay C, 2004, AIDS, V18, P2243, DOI 10.1097/00002030-200411190-00004; Chun HM, 2012, J INFECT DIS, V205, P185, DOI 10.1093/infdis/jir720; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Deschamps MM, 1996, ANN INTERN MED, V125, P324, DOI 10.7326/0003-4819-125-4-199608150-00011; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Go VF, 2006, DRUG ALCOHOL DEPEN, V84, P69, DOI 10.1016/j.drugalcdep.2005.12.006; Gomez-Gonzalo M, 2001, J BIOL CHEM, V276, P35435, DOI 10.1074/jbc.M103020200; Gonzalez Adam, 2011, Curr HIV/AIDS Rep, V8, P223, DOI 10.1007/s11904-011-0093-5; Hammett TM, 2010, AIDS CARE, V22, P1466, DOI 10.1080/09540121003758580; Hien NT, 2004, AIDS EDUC PREV, V16, P137, DOI 10.1521/aeap.16.3.5.137.35527; Hisada M, 2000, J INFECT DIS, V181, P1475, DOI 10.1086/315396; Kaur G, 2009, TISSUE ANTIGENS, V73, P289, DOI 10.1111/j.1399-0039.2009.01220.x; KUNANUSONT C, 1995, LANCET, V345, P1078, DOI 10.1016/S0140-6736(95)90818-8; Liao HA, 2009, VIROLOGY, V391, P51, DOI 10.1016/j.virol.2009.05.023; McGovern RA, 2010, AIDS, V24, P2512, DOI 10.1097/QAD.0b013e32833e6cfb; Ministry of Health, 2009, GUID HIV AIDS DIAGN; MUSICCO M, 1994, ARCH INTERN MED, V154, P1971, DOI 10.1001/archinte.154.17.1971; Nguyen TA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-37; Punpanich W, 2004, AIDS EDUC PREV, V16, P119, DOI 10.1521/aeap.16.3.5.119.35520; Quan VM, 2000, J ACQ IMMUN DEF SYND, V25, P360, DOI 10.1097/00126334-200012010-00011; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Luu QP, 2012, AIDS RES HUM RETROV, V28, P1344, DOI 10.1089/aid.2011.0396; Ravet S, 2007, BLOOD, V109, P4296, DOI 10.1182/blood-2006-08-040238; Raymond S, 2013, J CLIN MICROBIOL, V51, P564, DOI 10.1128/JCM.02328-12; Rojanawiwat A, 2009, JPN J INFECT DIS, V62, P32; Ruxrungtham K, 2004, LANCET, V364, P69, DOI 10.1016/S0140-6736(04)16593-8; Saez-Cirion A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-81; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsuchiya N, 2013, EPIDEMIOL INFECT, V141, P1840, DOI 10.1017/S0950268812002397; UNAIDS, 2010, HIV TRANSM MEN WOM I; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Venkatesh KK, 2011, AIDS CARE, V23, P722, DOI 10.1080/09540121.2010.525616; Vietnam administratoin of HIV/ AIDS control ( Ministry of Health) & Family Health International, 2009, AIDS ED PREV; Vietnam administratoin of HIV/AIDS control (Ministry of Health) & Family Health International & National Institute for Hygiene and Epidemiology, 2011, RESULTS HIV STI; Wang L, 2012, AIDS CARE, V24, P1059, DOI 10.1080/09540121.2012.661837	38	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0125299	10.1371/journal.pone.0125299	http://dx.doi.org/10.1371/journal.pone.0125299			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898138	gold, Green Published, Green Submitted			2022-12-27	WOS:000353212600102
J	Thomas, JM; Allison, AB; Holmes, EC; Phillips, JE; Bunting, EM; Yabsley, MJ; Brown, JD				Thomas, Jesse M.; Allison, Andrew B.; Holmes, Edward C.; Phillips, Jamie E.; Bunting, Elizabeth M.; Yabsley, Michael J.; Brown, Justin D.			Molecular Surveillance for Lymphoproliferative Disease Virus in Wild Turkeys (Meleagris gallopavo) from the Eastern United States	PLOS ONE			English	Article							MAREKS-DISEASE; AVIAN-LEUKOSIS; RETICULOENDOTHELIOSIS	Lymphoproliferative disease virus (LPDV) is a poorly understood, oncogenic avian retrovirus of domestic turkeys that has historically been restricted to Europe and Israel. However, a recent study reported LPDV in multiple wild turkey diagnostic cases from throughout the eastern United States of America (USA). To better understand the distribution of LPDV in the eastern USA, we surveyed 1,164 reportedly asymptomatic hunter-harvested wild turkeys from 17 states for the presence of LPDV proviral DNA by PCR. In total, 564/1,164 (47%) turkeys were positive for LPDV. Wild turkeys from each state had a relatively high prevalence of LPDV, although statewide prevalence varied from 26 to 83%. Phylogenetic analysis revealed two major clades of LPDV in the USA, although one was at a low frequency suggesting restricted transmission, as well as significant clustering by state of isolation. To determine the best tissue to target for diagnostic purposes, liver, spleen, and bone marrow were tested from a subset of 15 hunter-harvested wild turkeys and 20 wild turkey diagnostic cases. Overall, bone marrow provided the highest level of detection for both hunterharvested turkeys and diagnostic cases. The sensitivity of LPDV detection between tissues was not significantly different for diagnostic cases, but was for hunter-harvested birds. These results indicate that LPDV infection is common and widespread in wild turkey populations throughout the eastern USA, even without overt signs of disease.	[Thomas, Jesse M.; Phillips, Jamie E.; Yabsley, Michael J.; Brown, Justin D.] Univ Georgia, Coll Vet Med, Dept Populat Hlth, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA; [Thomas, Jesse M.; Yabsley, Michael J.] Univ Georgia, Daniel B Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Allison, Andrew B.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Holmes, Edward C.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Charles Perkins Ctr, Sch Biol Sci, Sydney, NSW 2006, Australia; [Holmes, Edward C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Bunting, Elizabeth M.] Cornell Univ, Coll Vet Med, Anim Hlth Diagnost Ctr, Ithaca, NY 14853 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Cornell University; University of Sydney; University of Sydney; Cornell University	Brown, JD (corresponding author), Univ Georgia, Coll Vet Med, Dept Populat Hlth, Southeastern Cooperat Wildlife Dis Study, 589 D-W Brooks Dr,Wildlife Hlth Bldg, Athens, GA 30602 USA.	judbrow@pa.gov	Holmes, Edward/Y-2789-2019; Holmes, Edward/GVR-9499-2022	Holmes, Edward/0000-0001-9596-3552; Yabsley, Michael/0000-0003-2452-5015; Allison, Andrew B./0000-0003-0971-1215	Southeastern Cooperative Wildlife Disease; Arcadia Wildlife Preserve, Inc.; National Health and Medical Research Council Australia Fellowship [AF30]	Southeastern Cooperative Wildlife Disease; Arcadia Wildlife Preserve, Inc.; National Health and Medical Research Council Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This research was funded through the continued sponsorship of the Southeastern Cooperative Wildlife Disease Study by member states and federal agencies as well as the Arcadia Wildlife Preserve, Inc. Dr. Edward Holmes was funded by a National Health and Medical Research Council Australia Fellowship (AF30).	Allison AB, 2013, VIROLOGY, V450-451, P2, DOI [10.1016/j.virol.2013.12.013, DOI 10.1016/J.VIROL.2013.12.013]; Biggs PM, 1997, DIS POULTRY, P485; BUSCH RH, 1970, AVIAN DIS, V14, P550, DOI 10.2307/1588617; Carlson H C, 1974, Avian Pathol, V3, P169, DOI 10.1080/03079457409353829; CHEN PY, 1987, ARCH VIROL, V93, P233, DOI 10.1007/BF01310977; COTTRAL GE, 1954, POULTRY SCI, V33, P1174, DOI 10.3382/ps.0331174; DAVIDSON WR, 1985, J WILDLIFE DIS, V21, P386, DOI 10.7589/0090-3558-21.4.386; DREN CN, 1983, AVIAN PATHOL, V12, P55, DOI 10.1080/03079458308436149; Drew Mark L., 2007, P216, DOI 10.1002/9780470344668.ch11; Drew ML, 1998, J WILDLIFE DIS, V34, P783, DOI 10.7589/0090-3558-34.4.783; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fadly A, 2008, DIS POULTRY, p[514, 34]; Fadly AM, 2008, DIS POULTRY, P449; Fadly AM, 2008, DIS POULTRY, P568; GAZIT A, 1982, INT J CANCER, V29, P599, DOI 10.1002/ijc.2910290518; Gazit A, 1999, ENCY VIROLOGY, V2nd, P911; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HAYES LE, 1992, J WILDLIFE DIS, V28, P154, DOI 10.7589/0090-3558-28.1.154; IANCONESCU M, 1981, AVIAN PATHOL, V10, P131, DOI 10.1080/03079458108418467; LEY DH, 1989, J WILDLIFE DIS, V25, P262, DOI 10.7589/0090-3558-25.2.262; MCDOUGALL JS, 1978, AVIAN PATHOL, V7, P141, DOI 10.1080/03079457808418266; Miller PE, 1998, J AM VET MED ASSOC, V213, P377; National Wild Turkey Federation, 2009, NAT WILD TURK FED SU; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Payne LN, 2000, REV SCI TECH OIE, V19, P544, DOI 10.20506/rst.19.2.1226; Payne LN, 1998, POULTRY SCI, V77, P1204, DOI 10.1093/ps/77.8.1204; RUBIN H, 1962, VIROLOGY, V17, P143, DOI 10.1016/0042-6822(62)90091-0; SCHAT KA, 1976, AVIAN DIS, V20, P153, DOI 10.2307/1589484; Schat KA, 2008, DIS POULTRY, P453; SIEGFRIED LM, 1983, AVIAN DIS, V27, P86, DOI 10.2307/1590375; Tapley J.L., 2005, P NATL WILD TURKEY S, V9, P21; Wakeling BF, 1997, WILDLIFE SOC B, V25, P706	33	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0122644	10.1371/journal.pone.0122644	http://dx.doi.org/10.1371/journal.pone.0122644			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897755	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600013
J	Vaquero, ME; de Eugenio, LI; Martinez, MJ; Barriuso, J				Vaquero, Maria E.; de Eugenio, Laura I.; Martinez, Maria J.; Barriuso, Jorge			A Novel CalB-Type Lipase Discovered by Fungal Genomes Mining	PLOS ONE			English	Article							CANDIDA-ANTARCTICA; INTERFACIAL ACTIVATION; ESTERASES; REDESIGN; SEQUENCE; USTILAGO; SITE	The fungus Pseudozyma antarctica produces a lipase (CalB) with broad substrate specificity, stability, high regio-and enantio-selectivity. It is active in non-aqueous organic solvents and at elevated temperatures. Hence, CalB is a robust biocatalyst for chemical conversions on an industrial scale. Here we report the in silico mining of public metagenomes and fungal genomes to discover novel lipases with high homology to CalB. The candidates were selected taking into account homology and conserved motifs criteria, as well as, phylogeny and 3D model analyses. The most promising candidate (PlicB) presented interesting structural properties. PlicB was expressed in a heterologous host, purified and partially characterized. Further experiments will allow finding novel catalytic properties with biotechnological interest.	[Vaquero, Maria E.; de Eugenio, Laura I.; Martinez, Maria J.; Barriuso, Jorge] CSIC, Ctr Invest Biol, Madrid 28040, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Martinez, MJ (corresponding author), CSIC, Ctr Invest Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	mjmartinez@cib.csic.es; jbarriuso@cib.csic.es	Martinez, Maria Jesus/F-9147-2015; Vaquero Morales, Maria Eugenia/Y-6304-2018; Barriuso, Jorge/AAF-6118-2020	Martinez, Maria Jesus/0000-0003-2166-1097; Vaquero Morales, Maria Eugenia/0000-0003-3277-5532; Barriuso, Jorge/0000-0003-0916-6560	JAE-DOC CSIC program;  [BIO2012-36372];  [RTC-2014-1777-3];  [S2013/MAE-2907]	JAE-DOC CSIC program; ; ; 	This work was supported by the Spanish projects BIO2012-36372, RTC-2014-1777-3 and S2013/MAE-2907. J. Barriuso thanks the financial support from the JAE-DOC CSIC program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, HDB HYDROCARBON LIPI, DOI [DOI 10.1007/978-3-540-77587-4_247, 10.1007/978-3-540-77587-4_247]; Barriuso J, 2014, J MICROBIOL BIOTECHN, DOI [10.4014/jmb1406.06049, DOI 10.4014/JMB1406.06049]; Barriuso J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-712; Ben Ali Y, 2012, METHODS MOL BIOL, V861, P31, DOI 10.1007/978-1-61779-600-5_2; Besenmatter W, 2013, Patent, Patent No. [WO2013010783 A1, 2013010783]; Brundiek H, 2012, APPL MICROBIOL BIOT, V94, P141, DOI 10.1007/s00253-012-3903-9; Buerth C, 2014, APPL MICROBIOL BIOT, V98, P4963, DOI 10.1007/s00253-013-5493-6; Casas-Godoy L, 2012, METHODS MOL BIOL, V861, P3, DOI 10.1007/978-1-61779-600-5_1; Choi SJ, 2003, J BIOCHEM MOL BIOL, V36, P417; Farias RN, 1997, ANAL BIOCHEM, V252, P186, DOI 10.1006/abio.1997.2240; Ganjalikhany MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040327; Gasser B, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-11; Gordon S, 2014, BIORXIV, DOI [10.1101/012542, DOI 10.1101/012542]; Gutierrez-Fernandez J, 2014, J STRUCT BIOL, V187, P215, DOI 10.1016/j.jsb.2014.07.007; Hibbett D, 2014, SYSTEMATICS EVOLUTIO, P373, DOI DOI 10.1007/978-3-642-55318-9_14; Idris A, 2012, BIOTECHNOL ADV, V30, P550, DOI 10.1016/j.biotechadv.2011.10.002; Magnusson AO, 2005, CHEMBIOCHEM, V6, P1051, DOI 10.1002/cbic.200400410; MARTINELLE M, 1995, BBA-LIPID LIPID MET, V1258, P272, DOI 10.1016/0005-2760(95)00131-U; Naik S, 2010, J MOL CATAL B-ENZYM, V65, P18, DOI 10.1016/j.molcatb.2010.01.002; Pleiss J, 2000, J MOL CATAL B-ENZYM, V10, P491, DOI 10.1016/S1381-1177(00)00092-8; Pleiss J, 1998, CHEM PHYS LIPIDS, V93, P67, DOI 10.1016/S0009-3084(98)00030-9; Qian Z, 2009, J MOL BIOL, V393, P191, DOI 10.1016/j.jmb.2009.08.008; Shivaji S., 2009, YEAST BIOTECHNOLOGY, P3, DOI DOI 10.1007/978-1-4020-8292-4_1; Skjot M, 2009, CHEMBIOCHEM, V10, P520, DOI 10.1002/cbic.200800668; Stoll M, 2003, CAN J BOT, V81, P976, DOI [10.1139/b03-094, 10.1139/B03-094]; UPPENBERG J, 1994, STRUCTURE, V2, P293, DOI 10.1016/S0969-2126(00)00031-9; Valero F, 2012, METHODS MOL BIOL, V861, P161, DOI 10.1007/978-1-61779-600-5_11; Verger R, 1997, TRENDS BIOTECHNOL, V15, P32, DOI 10.1016/S0167-7799(96)10064-0; Wang QM, 2006, INT J SYST EVOL MICR, V56, P289, DOI 10.1099/ijs.0.63827-0; Xie Y, 2014, J BIOL CHEM, V289, P7994, DOI 10.1074/jbc.M113.536045	30	9	12	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124882	10.1371/journal.pone.0124882	http://dx.doi.org/10.1371/journal.pone.0124882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898146	Green Submitted, Green Published, gold			2022-12-27	WOS:000353212600090
J	Khuperkar, D; Helen, M; Magre, I; Joseph, J				Khuperkar, Deepak; Helen, Mary; Magre, Indrasen; Joseph, Jomon			Inter-Cellular Transport of Ran GTPase	PLOS ONE			English	Article							NUCLEAR EXPORT; INTERCELLULAR TRANSFER; PROTEOMIC ANALYSIS; BINDING PROTEIN; RCC1 PROTEIN; CHROMOSOME; REGULATOR; RECEPTOR; RANGAP1; RNA	Ran, a member of the Ras-GTPase superfamily, has a well-established role in regulating the transport of macromolecules across the nuclear envelope (NE). Ran has also been implicated in mitosis, cell cycle progression, and NE formation. Over-expression of Ran is associated with various cancers, although the molecular mechanism underlying this phenomenon is unclear. Serendipitously, we found that Ran possesses the ability to move from cell-to-cell when transiently expressed in mammalian cells. Moreover, we show that the inter-cellular transport of Ran is GTP-dependent. Importantly, Ran displays a similar distribution pattern in the recipient cells as that in the donor cell and co-localizes with the Ran binding protein Nup358 (also called RanBP2). Interestingly, leptomycin B, an inhibitor of CRM1-mediated export, or siRNA mediated depletion of CRM1, significantly impaired the inter-cellular transport of Ran, suggesting a function for CRM1 in this process. These novel findings indicate a possible role for Ran beyond nucleo-cytoplasmic transport, with potential implications in inter-cellular communication and cancers.	[Khuperkar, Deepak; Helen, Mary; Magre, Indrasen; Joseph, Jomon] Natl Ctr Cell Sci, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Joseph, J (corresponding author), Natl Ctr Cell Sci, Pune, Maharashtra, India.	josephj@nccs.res.in	Joseph, Jomon/C-1397-2009	Joseph, Jomon/0000-0002-3042-6286	NCCS	NCCS	This work was supported by the Intramural funding from NCCS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2008, INT J CANCER, V122, P2391, DOI 10.1002/ijc.23400; Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Arts GJ, 1998, EMBO J, V17, P7430, DOI 10.1093/emboj/17.24.7430; Azuma K, 2004, CLIN CANCER RES, V10, P6695, DOI 10.1158/1078-0432.CCR-04-0818; Barres V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-272; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Choi DS, 2007, J PROTEOME RES, V6, P4646, DOI 10.1021/pr070192y; Clarke PR, 2001, TRENDS CELL BIOL, V11, P366, DOI 10.1016/S0962-8924(01)02071-2; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Cullen BR, 2003, J CELL SCI, V116, P587, DOI 10.1242/jcs.00268; DASSO M, 1994, EMBO J, V13, P5732, DOI 10.1002/j.1460-2075.1994.tb06911.x; Dasso M, 2002, CURR BIOL, V12, pR502, DOI 10.1016/S0960-9822(02)00970-3; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gerdes HH, 2008, CURR OPIN CELL BIOL, V20, P470, DOI 10.1016/j.ceb.2008.03.005; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Grosshans H, 2000, GENE DEV, V14, P830; Guescini M, 2010, EXP CELL RES, V316, P1977, DOI 10.1016/j.yexcr.2010.04.006; Hetzer M, 2002, NAT CELL BIOL, V4, pE177, DOI 10.1038/ncb0702-e177; Huber J, 1998, EMBO J, V17, P4114, DOI 10.1093/emboj/17.14.4114; Hung KE, 2009, CANCER PREV RES, V2, P224, DOI 10.1158/1940-6207.CAPR-08-0153; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Janowska-Wieczorek A, 2005, INT J CANCER, V113, P752, DOI 10.1002/ijc.20657; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Joseph J, 2008, FEBS LETT, V582, P190, DOI 10.1016/j.febslet.2007.11.087; Joseph J, 2006, J CELL SCI, V119, P3481, DOI 10.1242/jcs.03071; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Koppen T, 2011, PROTEOMICS, V11, P4397, DOI 10.1002/pmic.201000774; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kurisetty VV, 2008, ONCOGENE, V27, P7139, DOI 10.1038/onc.2008.325; Lounsbury KM, 1996, J BIOL CHEM, V271, P32834, DOI 10.1074/jbc.271.51.32834; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Mears R, 2004, PROTEOMICS, V4, P4019, DOI 10.1002/pmic.200400876; Miguet L, 2006, PROTEOMICS, V6, P153, DOI 10.1002/pmic.200500133; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; MOSER FG, 1975, J CELL BIOL, V66, P676, DOI 10.1083/jcb.66.3.676; Moy TI, 2002, J CELL SCI, V115, P2985; Moy TI, 1999, GENE DEV, V13, P2118, DOI 10.1101/gad.13.16.2118; Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386; OHTSUBO M, 1989, J CELL BIOL, V109, P1389, DOI 10.1083/jcb.109.4.1389; Pires-daSilva A, 2003, NAT REV GENET, V4, P39, DOI 10.1038/nrg977; Prochiantz A, 2013, CURR GENOMICS, V14, P361, DOI 10.2174/1389202911314060009; Prochiantz A, 2011, METHODS MOL BIOL, V683, P249, DOI 10.1007/978-1-60761-919-2_18; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Sahoo PK, 2012, BIOL OPEN, V1, P109, DOI 10.1242/bio.2011023; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strom AC, 2001, GENOME BIOL, V2; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Xia F, 2008, CANCER RES, V68, P1826, DOI 10.1158/0008-5472.CAN-07-5279; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0	62	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0125506	10.1371/journal.pone.0125506	http://dx.doi.org/10.1371/journal.pone.0125506			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894517	Green Submitted, Green Published, gold			2022-12-27	WOS:000353211700138
J	Liao-Chan, S; Daine-Matsuoka, B; Heald, N; Wong, T; Lin, T; Cai, AG; Lai, M; D'Alessio, JA; Theunissen, JW				Liao-Chan, Sindy; Daine-Matsuoka, Barbara; Heald, Nathan; Wong, Tiffany; Lin, Tracey; Cai, Allen G.; Lai, Michelle; D'Alessio, Joseph A.; Theunissen, Jan-Willem			Quantitative Assessment of Antibody Internalization with Novel Monoclonal Antibodies against Alexa Fluorophores	PLOS ONE			English	Article							DRUG CONJUGATE; CANCER THERAPEUTICS; IMAGE-ANALYSIS; IN-VIVO; TRASTUZUMAB; CELLS; SENSITIVITY; ENDOCYTOSIS; EXPRESSION; SURVIVAL	Antibodies against cell surface antigens may be internalized through their specific interactions with these proteins and in some cases may induce or perturb antigen internalization. The anti-cancer efficacy of antibody-drug conjugates is thought to rely on their uptake by cancer cells expressing the surface antigen. Numerous techniques, including microscopy and flow cytometry, have been used to identify antibodies with desired cellular uptake rates. To enable quantitative measurements of internalization of labeled antibodies, an assay based on internalized and quenched fluorescence was developed. For this approach, we generated novel anti-Alexa Fluor monoclonal antibodies (mAbs) that effectively and specifically quench cell surface-bound Alexa Fluor 488 or Alexa Fluor 594 fluorescence. Utilizing Alexa Fluor-labeled mAbs against the EphA2 receptor tyrosine kinase, we showed that the anti-Alexa Fluor reagents could be used to monitor internalization quantitatively over time. The anti-Alexa Fluor mAbs were also validated in a proof of concept dual-label internalization assay with simultaneous exposure of cells to two different mAbs. Importantly, the unique anti-Alexa Fluor mAbs described here may also enable other single-and dual-label experiments, including label detection and signal enhancement in macromolecules, trafficking of proteins and microorganisms, and cell migration and morphology.	[Liao-Chan, Sindy; Daine-Matsuoka, Barbara; Heald, Nathan; Wong, Tiffany; Lin, Tracey; Cai, Allen G.; Lai, Michelle; D'Alessio, Joseph A.; Theunissen, Jan-Willem] Igen Biotherapeut, Dept Discovery Res, Burlingame, CA 94010 USA		Theunissen, JW (corresponding author), Igen Biotherapeut, Dept Discovery Res, Burlingame, CA 94010 USA.	jtheunissen@igenica.com			Igenica Biotherapeutics	Igenica Biotherapeutics	Igenica Biotherapeutics provided support in the form of salaries for authors SLC, BDM, NH, TW, TL, AGC, ML, JAD'A and JWT but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Austin CD, 2004, MOL BIOL CELL, V15, P5268, DOI 10.1091/mbc.E04-07-0591; Blot V, 2006, EMBO J, V25, P5648, DOI 10.1038/sj.emboj.7601462; Chen AK, 2008, ANAL CHEM, V80, P7437, DOI 10.1021/ac8011347; Chen HM, 2010, J AM CHEM SOC, V132, P7244, DOI 10.1021/ja100500k; Coleman RA, 2006, J HISTOCHEM CYTOCHEM, V54, P817, DOI 10.1369/jhc.6A6929.2006; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; de Groot DM, 2009, J IMMUNOL, V183, P4127, DOI 10.4049/jimmunol.0901253; Demichelis VT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055304; FitzGerald DJ, 2011, CANCER RES, V71, P6300, DOI 10.1158/0008-5472.CAN-11-1374; Ford CHJ, 1996, CYTOMETRY, V23, P228; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Ingle GS, 2008, BRIT J HAEMATOL, V140, P46, DOI 10.1111/j.1365-2141.2007.06883.x; Jackson D, 2008, CANCER RES, V68, P9367, DOI 10.1158/0008-5472.CAN-08-1933; Jones SL, 2014, J CELL BIOL, V205, P67, DOI 10.1083/jcb.201401045; Kilpatrick KE, 1997, HYBRIDOMA, V16, P381, DOI 10.1089/hyb.1997.16.381; Kudo T, 2012, J NEUROSCI, V32, P18035, DOI 10.1523/JNEUROSCI.4057-12.2012; Leal M, 2014, ANN NY ACAD SCI, V1321, P41, DOI 10.1111/nyas.12499; Liao-Chan S, 2014, J IMMUNOL METHODS, V405, P1, DOI 10.1016/j.jim.2013.12.007; MAIER LA, 1991, CANCER RES, V51, P5361; McDonagh CF, 2008, MOL CANCER THER, V7, P2913, DOI 10.1158/1535-7163.MCT-08-0295; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Miksa M, 2009, J IMMUNOL METHODS, V342, P71, DOI 10.1016/j.jim.2008.11.019; Nahta R, 2004, CANCER RES, V64, P2343, DOI 10.1158/0008-5472.CAN-03-3856; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; Ogata K, 2002, NEUROSCIENCE, V113, P221, DOI 10.1016/S0306-4522(02)00041-6; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Peng L, 2011, J MOL BIOL, V413, P390, DOI 10.1016/j.jmb.2011.08.018; Phillips GDL, 2014, CLIN CANCER RES, V20, P456, DOI 10.1158/1078-0432.CCR-13-0358; Rudnick SI, 2011, CANCER RES, V71, P2250, DOI 10.1158/0008-5472.CAN-10-2277; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrama D, 2006, NAT REV DRUG DISCOV, V5, P147, DOI 10.1038/nrd1957; Sutherland MSK, 2013, BLOOD, V122, P1455, DOI 10.1182/blood-2013-03-491506; van der Horst E, 2009, NEOPLASIA, V11, P355, DOI 10.1593/neo.81536; Wade JB, 2006, P NATL ACAD SCI USA, V103, P8558, DOI 10.1073/pnas.0603109103; Wang IH, 2013, CELL HOST MICROBE, V14, P468, DOI 10.1016/j.chom.2013.09.004	35	20	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124708	10.1371/journal.pone.0124708	http://dx.doi.org/10.1371/journal.pone.0124708			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894652	Green Submitted, Green Published, gold			2022-12-27	WOS:000353211700116
J	Chen, W; He, Z; Ji, XL; Tang, ST; Hu, HY				Chen, Wei; He, Zhang; Ji, Xiao-Li; Tang, Si-Ting; Hu, Hao-Yuan			Hyperparasitism in a Generalist Ectoparasitic Pupal Parasitoid, Pachycrepoideus vindemmiae (Hymenoptera: Pteromalidae), on Its Own Conspecifics: When the Lack of Resource Lead to Cannibalism	PLOS ONE			English	Article							SEX-RATIO; HOST SELECTION; BODY-SIZE; VINDEMIAE HYMENOPTERA; NATURAL-POPULATIONS; BIOLOGICAL-CONTROL; FRUIT-FLY; DROSOPHILA; EVOLUTION; QUALITY	Hyperparasitism is a normal behavior of parasitoids, which often happens among species. Conspecific hyperparasitism, such as some kinds of heteronomous hyperparasitic behaviors, has been only reported in some species belonging to Aphelinidae. In this article, the conspecific hyperparasitism of Pachycrepoideus vindemmiae (Pteromalidae) is reported, with Drosophila puparia as hosts. Hosts were exposed to Pachycrepoideus vindemmiae females twice to parasitism with nine, twelve, and fifteen day intervals between the two exposures. None of the infested hosts emerged more than one offspring, and emergence of parasitoid offspring occurred in two obvious events, synchronously with the exposure time intervals, which suggested that offspring emerging during the first and second events would come from the primary and secondary parasitoids, respectively, and the inference with the developmental duration of offspring also indicated this. With two Pachycrepoideus vindemmiae strains that could be identified by a simple sequence repeat marker, the above speculation of the origin of those offspring emerging during the two events was confirmed. Dissection of hosts exposed twice revealed a cannibalism behavior of larvae from the secondary foundresses on the primary conspecific pupae. Our results suggested a conspecific hyperparasitism behavior of the secondary parasitoids on the primary conspecifics. Measures showed a reduced body size for the adults from the conspecific hyperparasitism. Foundresses from the conspecific hyperparasitism had less fitness variables than those from primary parasitism, with shorter longevity, less life time fecundity, lower values of infestation degree, and lower success rate of parasitism. However, when the parasitoids from the conspecific hyperparasitism met healthy Drosophila puparia, their offspring would recover to normal size. Frequency of the conspecific hyperparasitism behavior enhanced with the decreasing of proportion of healthy hosts in the oviposition patch. The conspecific hyperparasitism of Pachycrepoideus vindemmiae on the primary conspecifics would be helpful to last the population when healthy hosts are absent in the oviposition patch.	[Chen, Wei; He, Zhang; Ji, Xiao-Li; Tang, Si-Ting; Hu, Hao-Yuan] Anhui Normal Univ, Coll Life Sci, Key Lab Biot Environm & Ecol Safety Anhui Prov, Wuhu, Anhui, Peoples R China	Anhui Normal University	Hu, HY (corresponding author), Anhui Normal Univ, Coll Life Sci, Key Lab Biot Environm & Ecol Safety Anhui Prov, Wuhu, Anhui, Peoples R China.	haoyuanhu@126.com			National Natural Science Foundation of China [31172145]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20113424120005]; Natural Science Foundation of Anhui Province [1408085MKL24]; Provincial Key Laboratory of Conservation and Utilization for Important Biological Resource in Anhui Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); Provincial Key Laboratory of Conservation and Utilization for Important Biological Resource in Anhui Province	This work was supported by the National Natural Science Foundation of China (31172145), the Specialized Research Fund for the Doctoral Program of Higher Education of China (20113424120005), the Natural Science Foundation of Anhui Province (1408085MKL24), and the Provincial Key Laboratory of Conservation and Utilization for Important Biological Resource in Anhui Province.	Brown PH, 2011, ESA 59 ANN M REN NV; Burton-Chellew MN, 2008, AM NAT, V172, P393, DOI 10.1086/589895; Chabert S, 2012, BIOL CONTROL, V63, P40, DOI 10.1016/j.biocontrol.2012.05.005; CHARNOV E L, 1982; CHARNOV EL, 1981, NATURE, V289, P27, DOI 10.1038/289027a0; Crawley M.J., 2007, R BOOK; Cusumano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064768; DAVID JEAN, 1965, BULL BIOL FRANCE BELG, V99, P369; Duron O, 2010, ECOL LETT, V13, P1139, DOI 10.1111/j.1461-0248.2010.01502.x; Ellers J, 2003, OIKOS, V102, P164, DOI 10.1034/j.1600-0706.2003.12285.x; Fellowes MDE, 1998, ECOL ENTOMOL, V23, P281, DOI 10.1046/j.1365-2311.1998.00137.x; Gibert P, 2010, EVOL ECOL RES, V12, P873; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Goubault M, 2005, BEHAV ECOL, V16, P693, DOI 10.1093/beheco/ari043; Goubault M, 2003, ENTOMOL EXP APPL, V109, P123, DOI 10.1046/j.1570-7458.2003.00101.x; Goubault M, 2007, ETHOLOGY, V113, P334, DOI 10.1111/j.1439-0310.2006.01325.x; Grandgirard J, 2002, ENTOMOL EXP APPL, V103, P239, DOI 10.1023/A:1021193329749; Grillenberger BK, 2008, MOL ECOL, V17, P2854, DOI 10.1111/j.1365-294X.2008.03800.x; He Zhang, 2013, Yingyong Shengtai Xuebao, V24, P795; HOCHBERG ME, 1992, SCIENCE, V255, P973, DOI 10.1126/science.255.5047.973; Hunter MS, 2001, ANNU REV ENTOMOL, V46, P251, DOI 10.1146/annurev.ento.46.1.251; Kageyama D, 2006, APPL ENVIRON MICROB, V72, P6667, DOI 10.1128/AEM.00803-06; MESSING RH, 1993, BIOL CONTROL, V3, P140, DOI 10.1006/bcon.1993.1021; Mills NJ, 1996, J APPL ECOL, V33, P1379, DOI 10.2307/2404778; Morris RJ, 2002, BEHAV ECOL SOCIOBIOL, V51, P386, DOI 10.1007/s00265-001-0439-x; Moynihan AM, 2011, J EVOLUTION BIOL, V24, P2002, DOI 10.1111/j.1420-9101.2011.02343.x; NADEL H, 1985, ANN ENTOMOL SOC AM, V78, P410, DOI 10.1093/aesa/78.3.410; Noyes J.S., 2002, INTERACTIVE CATALOGU; Perez-Lachaud G, 2004, BIOL CONTROL, V30, P149, DOI 10.1016/j.biocontrol.2004.03.003; Petersen JJ, 1992, BIOL CONTROL, V2, P44, DOI 10.1016/1049-9644(92)90074-N; PHILLIPS DS, 1993, ENTOMOL EXP APPL, V69, P75, DOI 10.1007/BF02380676; Quicke D. L. J., 1997, PARASITIC WASPS; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rojas-Rousse D, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.10101; ROTH JP, 1991, J ECON ENTOMOL, V84, P94, DOI 10.1093/jee/84.1.94; Sagarra LA, 2001, B ENTOMOL RES, V91, P363, DOI 10.1079/BER2001121; SULLIVAN DJ, 1987, ANNU REV ENTOMOL, V32, P49, DOI 10.1146/annurev.en.32.010187.000405; Sullivan DJ, 1999, ANNU REV ENTOMOL, V44, P291, DOI 10.1146/annurev.ento.44.1.291; Tormos J, 2009, MICROSC MICROANAL, V15, P422, DOI 10.1017/S1431927609090801; VANALPHEN JJM, 1983, NETH J ZOOL, V33, P497, DOI 10.1163/002829683X00228; Wang XG, 2004, BEHAV ECOL SOCIOBIOL, V56, P513, DOI 10.1007/s00265-004-0829-y; Wang XG, 2004, BIOL CONTROL, V31, P227, DOI 10.1016/j.biocontrol.2004.04.019; Williams T, 1996, BIOL J LINN SOC, V57, P35, DOI 10.1111/j.1095-8312.1996.tb01694.x; WILLIAMS T, 1991, ECOL ENTOMOL, V16, P377, DOI 10.1111/j.1365-2311.1991.tb00230.x; Wyckhuys KAG, 2011, BIOCONTROL SCI TECHN, V21, P953, DOI 10.1080/09583157.2011.591923; Zang LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020324; Zhang YB, 2014, INSECT SCI, DOI 101111/1744-791712152	47	11	12	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124305	10.1371/journal.pone.0124305	http://dx.doi.org/10.1371/journal.pone.0124305			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909476	Green Published, Green Submitted, gold			2022-12-27	WOS:000353376800075
J	Gonzalez, Y; Herrera, MT; Juarez, E; Salazar-Lezama, MA; Bobadilla, K; Torres, M				Gonzalez, Yolanda; Teresa Herrera, Mara; Juarez, Esmeralda; Angel Salazar-Lezama, Miguel; Bobadilla, Karen; Torres, Martha			CD161 Expression Defines a Th1/Th17 Polyfunctional Subset of Resident Memory T Lymphocytes in Bronchoalveolar Cells	PLOS ONE			English	Article							HUMAN TH17 CELLS; NKRP1A MOLECULE; IFN-GAMMA; MIGRATION; LUNG; NK; TUBERCULOSIS; MAINTENANCE; SARCOIDOSIS; ACCUMULATE	Alveolar resident memory T cells (TRM) comprise a currently uncharacterized mixture of cell subpopulations. The CD3(+)CD161(+) T cell subpopulation resides in the liver, intestine and skin, but it has the capacity for tissue migration; however, the presence of resident CD3(+)CD161(+) T cells in the bronchoalveolar space under normal conditions has not been reported. Bronchoalveolar cells (BACs) from healthy volunteers were evaluated and found that 8.6% (range 2.5%-21%) of these cells were CD3(+) T lymphocytes. Within the CD3(+) population, 4.6% of the cells (2.1-11.3) expressed CD161 on the cell surface, and 74.2% of the CD161(+)CD3(+) T cells expressed CD45RO. The number of CD3(+)CD161(+) T cells was significantly lower in the bronchoalveolar space than in the blood (4.6% of BACs vs 8.4% of peripheral blood mononuclear cells (PBMCs); P<0.05). We also found that 2.17% of CD4(+) T lymphocytes and 1.52% of CD8(+) T lymphocytes expressed CD161. Twenty-two percent of the alveolar CD3(+)CD161(+) T lymphocytes produced cytokines upon stimulation by PMA plus ionomycin, and significantly more interferon gamma (IFN-gamma) was produced compared with other cytokines (P = 0.05). Most alveolar CD3(+)CD161(+) T cells produced interleukin-17 (IL-17) and IFN-gamma simultaneously, and the percentage of these cells was significantly higher than the percentage of CD3(+)CD161(-) T cells. Moreover, the percentage of alveolar CD3(+)CD161(+) T lymphocytes that produced IFN-gamma/IL-17 was significantly higher than those in the peripheral blood (p<0.05). In conclusion, Th1/Th17-CD3(+)CD161(+) T-RM could contribute to compartment-specific immune responses in the lung.	[Gonzalez, Yolanda; Teresa Herrera, Mara; Juarez, Esmeralda; Bobadilla, Karen; Torres, Martha] Natl Inst Resp Dis INER, Dept Microbiol Res, Mexico City, DF, Mexico; [Angel Salazar-Lezama, Miguel] Natl Inst Resp Dis INER, TB Clin, Mexico City, DF, Mexico		Torres, M (corresponding author), Natl Inst Resp Dis INER, Dept Microbiol Res, Mexico City, DF, Mexico.	marthatorres98@yahoo.com	Juárez, Esmeralda/GQP-7703-2022; González, Yolanda/AAC-3329-2021	González, Yolanda/0000-0002-7066-6188; Juarez, Esmeralda/0000-0001-9036-004X; Torres, Martha/0000-0003-3217-9407				Agostini C, 2005, AM J RESP CRIT CARE, V172, P1290, DOI 10.1164/rccm.200501-142OC; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Campbell JJ, 2001, J IMMUNOL, V166, P2842, DOI 10.4049/jimmunol.166.4.2842; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Cosmi L, 2011, ARTHRITIS RHEUM-US, V63, P2504, DOI 10.1002/art.30332; Day CE, 2010, IMMUNOLOGY, V130, P564, DOI 10.1111/j.1365-2567.2010.03257.x; Gonzalez-Hernandez Y, 2007, SCAND J IMMUNOL, V65, P368, DOI 10.1111/j.1365-3083.2006.01885.x; Harris NL, 2002, J EXP MED, V195, P317, DOI 10.1084/jem.20011558; HIRSCH CS, 1994, J IMMUNOL, V152, P743; Hogan RJ, 2002, J IMMUNOL, V169, P4976, DOI 10.4049/jimmunol.169.9.4976; Iiai T, 2002, CLIN EXP IMMUNOL, V129, P92, DOI 10.1046/j.1365-2249.2002.01886.x; Iliopoulou EG, 2006, CLIN CANCER RES, V12, P6901, DOI 10.1158/1078-0432.CCR-06-0977; Ishihara S, 1999, EUR J IMMUNOL, V29, P2406, DOI 10.1002/(SICI)1521-4141(199908)29:08<2406::AID-IMMU2406>3.3.CO;2-6; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Kolopp-Sarda MN, 2000, LAB INVEST, V80, P1065, DOI 10.1038/labinvest.3780111; Korosec P, 2007, CHEST, V132, P1291, DOI 10.1378/chest.07-0128; LANIER LL, 1994, J IMMUNOL, V153, P2417; Loza MJ, 2002, EUR J IMMUNOL, V32, P3453, DOI 10.1002/1521-4141(200212)32:12<3453::AID-IMMU3453>3.0.CO;2-D; Maggi L, 2010, EUR J IMMUNOL, V40, P2174, DOI 10.1002/eji.200940257; Northfield JW, 2008, HEPATOLOGY, V47, P396, DOI 10.1002/hep.22040; O'Keeffe J, 2004, EUR J IMMUNOL, V34, P2110, DOI 10.1002/eji.200424958; Poggi A, 1997, IMMUNOL LETT, V57, P121, DOI 10.1016/S0165-2478(97)00050-3; Poggi A, 1997, EUR J IMMUNOL, V27, P2965, DOI 10.1002/eji.1830271132; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; Shen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057746; Takahashi T, 2006, J IMMUNOL, V176, P211, DOI 10.4049/jimmunol.176.1.211; Herrera MT, 2009, TUBERCULOSIS, V89, P38, DOI 10.1016/j.tube.2008.08.002; Woodland David L, 2005, Proc Am Thorac Soc, V2, P126; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; Zhao Z, 2011, ATHEROSCLEROSIS, V217, P518, DOI 10.1016/j.atherosclerosis.2011.03.043	31	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123591	10.1371/journal.pone.0123591	http://dx.doi.org/10.1371/journal.pone.0123591			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906076	gold, Green Published, Green Submitted			2022-12-27	WOS:000353332000036
J	Na, X; Martin, AJ; Sethi, S; Kyne, L; Garey, KW; Flores, SW; Hu, M; Shah, DN; Shields, K; Leffler, DA; Kelly, CP				Na, Xi; Martin, Alan J.; Sethi, Saurabh; Kyne, Lorraine; Garey, Kevin W.; Flores, Sarah W.; Hu, Mary; Shah, Dhara N.; Shields, Kelsey; Leffler, Daniel A.; Kelly, Ciaran P.			A Multi-Center Prospective Derivation and Validation of a Clinical Prediction Tool for Severe Clostridium difficile Infection	PLOS ONE			English	Article							DISEASE; MORTALITY; DIARRHEA; METRONIDAZOLE; VANCOMYCIN; SURVEILLANCE; MORBIDITY; HOSPITALS; OUTCOMES; SOCIETY	Background and Aims Prediction of severe clinical outcomes in Clostridium difficile infection (CDI) is important to inform management decisions for optimum patient care. Currently, treatment recommendations for CDI vary based on disease severity but validated methods to predict severe disease are lacking. The aim of the study was to derive and validate a clinical prediction tool for severe outcomes in CDI. Methods A cohort totaling 638 patients with CDI was prospectively studied at three tertiary care clinical sites (Boston, Dublin and Houston). The clinical prediction rule (CPR) was developed by multivariate logistic regression analysis using the Boston cohort and the performance of this model was then evaluated in the combined Houston and Dublin cohorts. Results The CPR included the following three binary variables: age >= 65 years, peak serum creatinine >= 2 mg/dL and peak peripheral blood leukocyte count of >= 20,000 cells/mu L. The Clostridium difficile severity score (CDSS) correctly classified 76.5% (95% CI: 70.87-81.31) and 72.5% (95% CI: 67.52-76.91) of patients in the derivation and validation cohorts, respectively. In the validation cohort, CDSS scores of 0, 1, 2 or 3 were associated with severe clinical outcomes of CDI in 4.7%, 13.8%, 33.3% and 40.0% of cases respectively. Conclusions We prospectively derived and validated a clinical prediction rule for severe CDI that is simple, reliable and accurate and can be used to identify high-risk patients most likely to benefit from measures to prevent complications of CDI.	[Na, Xi; Sethi, Saurabh; Flores, Sarah W.; Hu, Mary; Shields, Kelsey; Leffler, Daniel A.; Kelly, Ciaran P.] Beth Israel Deaconess Med Ctr, Dept Med, Div Gastroenterol, Boston, MA 02215 USA; [Na, Xi; Sethi, Saurabh; Flores, Sarah W.; Hu, Mary; Shields, Kelsey; Leffler, Daniel A.; Kelly, Ciaran P.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Martin, Alan J.; Kyne, Lorraine] Mater Misericordiae Univ Hosp, Dept Med Older Person, Dublin, Ireland; [Martin, Alan J.; Kyne, Lorraine] Univ Coll Dublin, Dublin 2, Ireland; [Garey, Kevin W.; Shah, Dhara N.] Univ Houston, Coll Pharm, Houston, TX 77030 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Mater Misericordiae University Hospital; University College Dublin; University College Dublin; University of Houston System; University of Houston	Kelly, CP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Gastroenterol, Boston, MA 02215 USA.	ckelly2@bidmc.harvard.edu	Garey, Kevin/AAH-5540-2019	Garey, Kevin/0000-0003-2063-7503	NIH [DK-07760, AI95256]; Merck Investigator Studies Program; Health Research Board Ireland [CSA 2007/4]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI095256, R01AI095256] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Investigator Studies Program; Health Research Board Ireland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by the following grants: NIH Awards DK-07760 (XN) and AI95256 (CPK), Merck Investigator Studies Program (CPK and KWG), and Health Research Board Ireland CSA 2007/4 (LK and AJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Chakra CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030258; Arora V, 2011, J HOSP INFECT, V79, P23, DOI 10.1016/j.jhin.2011.04.027; Bauer MP, 2009, CLIN MICROBIOL INFEC, V15, P1067, DOI 10.1111/j.1469-0691.2009.03099.x; Bhangu S, 2010, COLORECTAL DIS, V12, P241, DOI 10.1111/j.1463-1318.2009.01832.x; Burns K, 2010, INFECT CONT HOSP EP, V31, P1085, DOI 10.1086/656376; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cloud J, 2009, CLIN GASTROENTEROL H; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Cornely OA, 2012, LANCET INFECT DIS, V12, P281, DOI 10.1016/S1473-3099(11)70374-7; Dubberke ER, 2008, CLIN INFECT DIS, V46, P497, DOI 10.1086/526530; Dubberke ER, 2010, INFECT CONT HOSP EP, V31, P1030, DOI 10.1086/656245; HORN SD, 1983, MED CARE, V21, P14, DOI 10.1097/00005650-198301000-00002; Hu MY, 2008, CLIN GASTROENTEROL H, V6, P1354, DOI 10.1016/j.cgh.2008.06.024; Hu MY, 2009, GASTROENTEROLOGY, V136, P1206, DOI 10.1053/j.gastro.2008.12.038; Kelly CP, 2011, J MED MICROBIOL, V60, P1070, DOI 10.1099/jmm.0.030015-0; Kelly CP, 2009, JAMA-J AM MED ASSOC, V301, P954, DOI 10.1001/jama.2009.171; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kyne L, 2002, CLIN INFECT DIS, V34, P346, DOI 10.1086/338260; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Lungulescu OA, 2011, J HOSP INFECT, V79, P151, DOI 10.1016/j.jhin.2011.04.017; May S, 2009, J MAN MANIP THER, V17, P36, DOI 10.1179/106698109790818214; McDonald LC, 2007, INFECT CONT HOSP EP, V28, P140, DOI 10.1086/511798; McDonald LC, 2006, EMERG INFECT DIS, V12, P409, DOI 10.3201/eid1203.051064; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; O'Brien JA, 2007, INFECT CONT HOSP EP, V28, P1219, DOI 10.1086/522676; Pepin J, 2007, AM J GASTROENTEROL, V102, P2781, DOI 10.1111/j.1572-0241.2007.01539.x; Redelings MD, 2007, EMERG INFECT DIS, V13, P1417, DOI 10.3201/eid1309.061116; Wilson V, 2010, CLIN INFECT DIS, V50, pE77, DOI 10.1086/653012; Zar FA, 2007, CLIN INFECT DIS, V45, P302, DOI 10.1086/519265; Zilberberg MD, 2009, CRIT CARE MED, V37, P2583, DOI 10.1097/CCM.0b013e3181ab8388	33	35	36	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123405	10.1371/journal.pone.0123405	http://dx.doi.org/10.1371/journal.pone.0123405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906284	Green Published, gold			2022-12-27	WOS:000353332000029
J	Semlitsch, RD; Peterman, WE; Anderson, TL; Drake, DL; Ousterhout, BH				Semlitsch, Raymond D.; Peterman, William E.; Anderson, Thomas L.; Drake, Dana L.; Ousterhout, Brittany H.			Intermediate Pond Sizes Contain the Highest Density, Richness, and Diversity of Pond-Breeding Amphibians	PLoS One			English	Article							COMPLEX LIFE-CYCLES; COMMUNITY STRUCTURE; SPECIES-DIVERSITY; HYLA-CHRYSOSCELIS; TEMPORARY PONDS; DISTURBANCE; PREDATORS; WETLANDS; FORESTS; SYSTEMS	We present data on amphibian density, species richness, and diversity from a 7140-ha area consisting of 200 ponds in the Midwestern U.S. that represents most of the possible lentic aquatic breeding habitats common in this region. Our study includes all possible breeding sites with natural and anthropogenic disturbance processes that can be missing from studies where sampling intensity is low, sample area is small, or partial disturbance gradients are sampled. We tested whether pond area was a significant predictor of density, species richness, and diversity of amphibians and if values peaked at intermediate pond areas. We found that in all cases a quadratic model fit our data significantly better than a linear model. Because small ponds have a high probability of pond drying and large ponds have a high probability of fish colonization and accumulation of invertebrate predators, drying and predation may be two mechanisms driving the peak of density and diversity towards intermediate values of pond size. We also found that not all intermediate sized ponds produced many larvae; in fact, some had low amphibian density, richness, and diversity. Further analyses of the subset of ponds represented in the peak of the area distribution showed that fish, hydro-period, invertebrate density, and canopy are additional factors that drive density, richness and diversity of ponds up or down, when extremely small or large ponds are eliminated. Our results indicate that fishless ponds at intermediate sizes are more diverse, produce more larvae, and have greater potential to recruit juveniles into adult populations of most species sampled. Further, hylid and chorus frogs are found predictably more often in ephemeral ponds whereas bullfrogs, green frogs, and cricket frogs are found most often in permanent ponds with fish. Our data increase understanding of what factors structure and maintain amphibian diversity across large landscapes.	[Semlitsch, Raymond D.; Peterman, William E.; Anderson, Thomas L.; Drake, Dana L.; Ousterhout, Brittany H.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Semlitsch, RD (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	SemlitschR@missouri.edu	Peterman, William/H-7809-2013	Peterman, William/0000-0001-5229-9268; Ousterhout, Brittany/0000-0001-5303-515X	U.S. Department of Defense, Strategic Environmental Research and Development Program [RC-2155]	U.S. Department of Defense, Strategic Environmental Research and Development Program(United States Department of Defense)	Funding was provided by the U.S. Department of Defense, Strategic Environmental Research and Development Program, RC-2155, PI RDS, and co-PI WEP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2003, ECOL LETT, V6, P343, DOI 10.1046/j.1461-0248.2003.00435.x; ALLEN DM, 1974, TECHNOMETRICS, V16, P125, DOI 10.2307/1267500; Anderson T.L., 2015, ECOLOGICAL IN PRESS, DOI [10.1890/14-2096.1, DOI 10.1890/14-2096.1]; Biek R, 2002, CONSERV BIOL, V16, P728, DOI 10.1046/j.1523-1739.2002.00433.x; BRADFORD DF, 1989, COPEIA, P775, DOI 10.2307/1445515; Brooks RT, 2009, CLIMATIC CHANGE, V95, P469, DOI 10.1007/s10584-008-9531-9; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Dahl TE, 2011, STATUS TRENDS WETLAN; Drake DL, 2015, AM MIDLAND IN PRESS; Fox JW, 2013, TRENDS ECOL EVOL, V28, P86, DOI 10.1016/j.tree.2012.08.014; Haddad NM, 2008, ECOL LETT, V11, P348, DOI 10.1111/j.1461-0248.2007.01149.x; HEYER W R, 1975, Biotropica, V7, P100, DOI 10.2307/2989753; Heyer W.R., 1994, MEASURING MONITORING; Hocking DJ, 2008, AM MIDL NAT, V160, P41, DOI 10.1674/0003-0031(2008)160[41:BARPOA]2.0.CO;2; Huston MA, 2014, ECOLOGY, V95, P2382, DOI 10.1890/13-1397.1; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Lawler SP, 1999, CONSERV BIOL, V13, P613, DOI 10.1046/j.1523-1739.1999.98075.x; LEVIN SA, 1974, P NATL ACAD SCI USA, V71, P2744, DOI 10.1073/pnas.71.7.2744; Mackey RL, 2001, ECOLOGY, V82, P3479, DOI 10.1890/0012-9658(2001)082[3479:TDDRII]2.0.CO;2; Miller AD, 2011, P NATL ACAD SCI USA, V108, P5643, DOI 10.1073/pnas.1018594108; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Pechmann J.H.K., 1989, Wetlands Ecology and Management, V1, P3; Peterman WE, 2013, ANIMAL CONSERVATION, V17, P275; Pickett S. T. A., 1985, ECOLOGY NATURAL DIST; Pilliod DS, 2010, DIVERS DISTRIB, V16, P959, DOI 10.1111/j.1472-4642.2010.00699.x; RESETARITS WJ, 1989, ECOLOGY, V70, P220, DOI 10.2307/1938428; RESETARITS WJ, 1991, ECOLOGY, V72, P778, DOI 10.2307/1940580; Ricklefs RE., 1990, ECOLOGY; Schneider DW, 1996, J N AM BENTHOL SOC, V15, P64, DOI 10.2307/1467433; Schriever TA, 2013, FRESHW SCI, V32, P964, DOI 10.1899/13-008.1; Semlitsch Raymond D., 1996, P217, DOI 10.1016/B978-012178075-3/50010-6; Semlitsch RD, 1998, CONSERV BIOL, V12, P1129, DOI 10.1046/j.1523-1739.1998.98166.x; Shulse CD, 2013, J APPL ECOL, V50, P1244, DOI 10.1111/1365-2664.12126; Shulse CD, 2012, ECOL APPL, V22, P1675, DOI 10.1890/11-0212.1; Shulse CD, 2010, WETLANDS, V30, P915, DOI 10.1007/s13157-010-0069-z; Skelly DK, 1999, ECOLOGY, V80, P2326, DOI 10.1890/0012-9658(1999)080[2326:LTDDOA]2.0.CO;2; Skelly DK, 1996, COPEIA, P599; SKELLY DK, 1995, ECOLOGY, V76, P150, DOI 10.2307/1940638; Smith GR, 1999, FRESHWATER BIOL, V41, P829, DOI 10.1046/j.1365-2427.1999.00445.x; Snodgrass JW, 2000, ECOL APPL, V10, P1219, DOI 10.1890/1051-0761(2000)010[1219:DOEOLA]2.0.CO;2; Snodgrass JW, 2000, CONSERV BIOL, V14, P414, DOI 10.1046/j.1523-1739.2000.99161.x; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Van Buskirk J, 2003, DIVERS DISTRIB, V9, P399; VANBUSKIRK J, 1988, ECOLOGY, V69, P857, DOI 10.2307/1941035; Vonesh JR, 2002, OECOLOGIA, V133, P325, DOI 10.1007/s00442-002-1039-9; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; Werner EE, 2007, OIKOS, V116, P1713, DOI 10.1111/j.2007.0030-1299.16039.x; Werner EE, 2007, OIKOS, V116, P1697, DOI 10.1111/j.2007.0030-1299.15935.x; Werner EE, 2009, ECOL MONOGR, V79, P503, DOI 10.1890/08-1047.1; WERNER EE, 1994, ECOLOGY, V75, P1368, DOI 10.2307/1937461; WILBUR HM, 1990, TRENDS ECOL EVOL, V5, P37, DOI 10.1016/0169-5347(90)90043-D; WILBUR HM, 1980, ANNU REV ECOL SYST, V11, P67, DOI 10.1146/annurev.es.11.110180.000435; WILBUR HM, 1987, ECOLOGY, V68, P1437, DOI 10.2307/1939227; Wilbur HM, 1997, ECOLOGY, V78, P2279, DOI 10.1890/0012-9658(1997)078[2279:EEOFWC]2.0.CO;2; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830	55	57	59	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123055	10.1371/journal.pone.0123055	http://dx.doi.org/10.1371/journal.pone.0123055			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906355	Green Submitted, gold, Green Published			2022-12-27	WOS:000353332000021
J	Thakarar, K; Morgan, JR; Gaeta, JM; Hohl, C; Drainoni, ML				Thakarar, Kinna; Morgan, Jake R.; Gaeta, Jessie M.; Hohl, Carole; Drainoni, Mari-Lynn			Predictors of Frequent Emergency Room Visits among a Homeless Population	PLOS ONE			English	Article							CLINICAL CASE-MANAGEMENT; HEALTH-CARE UTILIZATION; INJECTION-DRUG USERS; DEPARTMENT VISITS; RANDOMIZED-TRIAL; HEPATITIS-C; SERVICE USE; RISK; MORTALITY; OVERDOSE	Background Homelessness, HIV, and substance use are interwoven problems. Furthermore, homeless individuals are frequent users of emergency services. The main purpose of this study was to identify risk factors for frequent emergency room (ER) visits and to examine the effects of housing status and HIV serostatus on ER utilization. The second purpose was to identify risk factors for frequent ER visits in patients with a history of illicit drug use. Methods A retrospective analysis was performed on 412 patients enrolled in a Boston-based health care for the homeless program (HCH). This study population was selected as a 2: 1 HIV seronegative versus HIV seropositive match based on age, sex, and housing status. A subgroup analysis was performed on 287 patients with history of illicit drug use. Chart data were analyzed to compare demographics, health characteristics, and health service utilization. Results were stratified by housing status. Logistic models using generalized estimating equations were used to predict frequent ER visits. Results In homeless patients, hepatitis C was the only predictor of frequent ER visits (OR 4.49, p<0.01). HIV seropositivity was not predictive of frequent ER visits. In patients with history of illicit drug use, mental health (OR 2.53, 95% CI 1.07-5.95) and hepatitis C (OR 2.85, 95% CI 1.37-5.93) were predictors of frequent ER use. HIV seropositivity did not predict ER use (OR 0.45, 95% CI 0.21 -0.97). Conclusions In a HCH population, hepatitis C predicted frequent ER visits in homeless patients. HIV seropositivity did not predict frequent ER visits, likely because HIV seropositive HCH patients are engaged in care. In patients with history of illicit drug use, hepatitis C and mental health disorders predicted frequent ER visits. Supportive housing for patients with mental health disorders and hepatitis C may help prevent unnecessary ER visits in this population.	[Thakarar, Kinna; Drainoni, Mari-Lynn] Boston Med Ctr, Infect Dis Sect, Boston, MA 02118 USA; [Morgan, Jake R.; Drainoni, Mari-Lynn] Boston Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Gaeta, Jessie M.; Hohl, Carole] Boston Hlth Care Homeless Program, Boston, MA USA; [Gaeta, Jessie M.; Hohl, Carole] Boston Med Ctr, Gen Internal Med Sect, Boston, MA USA; [Drainoni, Mari-Lynn] ENRM Mem VA Hosp, Ctr Healthcare Org & Implementat Res, Bedford, MA USA	Boston Medical Center; Boston University; Boston Medical Center	Thakarar, K (corresponding author), Boston Med Ctr, Infect Dis Sect, Boston, MA 02118 USA.	kinna.thakarar@bmc.org	Morgan, Jake R/H-3487-2019	Morgan, Jake R/0000-0002-1559-3983; Drainoni, Mari-Lynn/0000-0001-7214-8037	National Institute of Health/National Institute of Allergy and Infectious Diseases [T32 A1052074-10]; Fellow Immersion Training (FIT) Program under the CARE grant [R25DA013582]; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA013582] Funding Source: NIH RePORTER	National Institute of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fellow Immersion Training (FIT) Program under the CARE grant; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Dr. Thakarar was primarily supported by T32 A1052074-10 from the National Institute of Health/National Institute of Allergy and Infectious Diseases. The project was also supported by the Fellow Immersion Training (FIT) Program under the CARE grant, R25DA013582. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abello A, 2012, AM J EMERG MED, V30, P1061, DOI 10.1016/j.ajem.2011.07.002; Suarez MA, 2011, EPIDEMIOL PSYCH SCI, V20, P65, DOI 10.1017/S2045796011000138; Baggett TP, 2013, JAMA INTERN MED, V173, P189, DOI 10.1001/jamainternmed.2013.1604; Bharel M, 2013, AM J PUBLIC HEALTH, V103, pS311, DOI 10.2105/AJPH.2013.301421; Binswanger IA, 2008, J STUD ALCOHOL DRUGS, V69, P924, DOI 10.15288/jsad.2008.69.924; Bodenmann P, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-264; BOND GR, 1995, J MENT HEALTH ADMIN, V22, P4, DOI 10.1007/BF02519193; Booth BM, 2011, J BEHAV HEALTH SER R, V38, P358, DOI 10.1007/s11414-010-9227-6; Cederbaum JA, 2014, SUBST ABUSE TREAT PR, V9, DOI 10.1186/1747-597X-9-16; Chambers C, 2013, AM J PUBLIC HEALTH, V103, pS302, DOI 10.2105/AJPH.2013.301397; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Culhane Dennis P, 2002, LDI Issue Brief, V7, P1; Dipetro BY, 2012, SCI WORLD J, DOI [10.1100/2012/726568, DOI 10.1100/2012/726568]; Fairbairn N, 2012, J EMERG MED, V43, P236, DOI 10.1016/j.jemermed.2011.05.020; Hammig B, 2013, ACAD EMERG MED, V21, P450; Hasegawa K, 2014, MAYO CLIN PROC, V89, P462, DOI 10.1016/j.mayocp.2013.12.008; Hunt KA, 2006, ANN EMERG MED, V48, P1, DOI 10.1016/j.annemergmed.2005.12.030; Jarlais DCD, 2007, AIDS BEHAV, V11, pS78, DOI 10.1007/s10461-007-9227-6; Ku BS, 2010, PUBLIC HEALTH REP, V125, P398, DOI 10.1177/003335491012500308; Kushel MB, 2002, AM J PUBLIC HEALTH, V92, P778, DOI 10.2105/AJPH.92.5.778; Larimer ME, 2009, JAMA-J AM MED ASSOC, V301, P1349, DOI 10.1001/jama.2009.414; Liu SW, 2013, AM J EMERG MED, V31, P1512, DOI 10.1016/j.ajem.2013.08.006; MCGREW JH, 1995, PSYCHIAT SERV, V46, P696; Minassian A, 2013, J EMERG MED, V45, P520, DOI 10.1016/j.jemermed.2013.05.007; O'Connell JJ, 2005, J PUBLIC HEALTH MAN, V11, P311; Ochoa KC, 2005, DRUG ALCOHOL DEPEN, V80, P297, DOI 10.1016/j.drugalcdep.2005.04.012; Okin RL, 2000, AM J EMERG MED, V18, P603, DOI 10.1053/ajem.2000.9292; Palepu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075133; Pines JM, 2011, ACAD EMERG MED, V18, P655, DOI 10.1111/j.1553-2712.2011.01085.x; Riley ED, 2013, JAMA INTERN MED, V173, P1264, DOI 10.1001/jamainternmed.2013.6838; Romanowski B, 2013, HEPATITIS C SEROPREV, V30, P33; Sadowski LS, 2009, JAMA-J AM MED ASSOC, V301, P1771, DOI 10.1001/jama.2009.561; Schwarz R, 2012, J SUBST ABUSE TREAT, V43, P451, DOI 10.1016/j.jsat.2012.03.008; Shapatava E, 2006, DRUG ALCOHOL DEPEN, V82, pS35, DOI 10.1016/S0376-8716(06)80006-2; Shumway M, 2008, AM J EMERG MED, V26, P155, DOI 10.1016/j.ajem.2007.04.021; Strehlow AJ, 2012, J HEALTH CARE POOR U, V23, P811, DOI 10.1353/hpu.2012.0047; Sullivan B., 2010, 2010 ANN HOMELESS AS; Thakarar K, 2013, IDWEEK 2013 OCT 4 20; Thompson RG, 2013, AM J PUBLIC HEALTH, V103, pS282, DOI 10.2105/AJPH.2013.301302; Thornquist L, 2002, ACAD EMERG MED, V9, P300, DOI 10.1111/j.1553-2712.2002.tb01323.x; Tsai J, 2013, AM J EMERG MED, V31, P855, DOI 10.1016/j.ajem.2013.02.046; YINGLING KW, 1993, J GEN INTERN MED, V8, P231	42	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124552	10.1371/journal.pone.0124552	http://dx.doi.org/10.1371/journal.pone.0124552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906394	Green Published, gold			2022-12-27	WOS:000353332000075
J	Abujiya, MR; Riaz, M; Lee, MH				Abujiya, Mu'azu Ramat; Riaz, Muhammad; Lee, Muhammad Hisyam			Enhanced Cumulative Sum Charts for Monitoring Process Dispersion	PLOS ONE			English	Article							CUSUM	The cumulative sum (CUSUM) control chart is widely used in industry for the detection of small and moderate shifts in process location and dispersion. For efficient monitoring of process variability, we present several CUSUM control charts for monitoring changes in standard deviation of a normal process. The newly developed control charts based on well-structured sampling techniques - extreme ranked set sampling, extreme double ranked set sampling and double extreme ranked set sampling, have significantly enhanced CUSUM chart ability to detect a wide range of shifts in process variability. The relative performances of the proposed CUSUM scale charts are evaluated in terms of the average run length (ARL) and standard deviation of run length, for point shift in variability. Moreover, for overall performance, we implore the use of the average ratio ARL and average extra quadratic loss. A comparison of the proposed CUSUM control charts with the classical CUSUM R chart, the classical CUSUM S chart, the fast initial response (FIR) CUSUM R chart, the FIR CUSUM S chart, the ranked set sampling (RSS) based CUSUM R chart and the RSS based CUSUM S chart, among others, are presented. An illustrative example using real dataset is given to demonstrate the practicability of the application of the proposed schemes.	[Abujiya, Mu'azu Ramat; Lee, Muhammad Hisyam] Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Utm Skudai 81310, Johor, Malaysia; [Riaz, Muhammad] King Fahd Univ Petr & Minerals, Dept Math & Stat, Dhahran 31261, Saudi Arabia; [Abujiya, Mu'azu Ramat] King Fahd Univ Petr & Minerals, Preparatory Year Math Program, Dhahran 31261, Saudi Arabia	Universiti Teknologi Malaysia; King Fahd University of Petroleum & Minerals; King Fahd University of Petroleum & Minerals	Lee, MH (corresponding author), Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Utm Skudai 81310, Johor, Malaysia.	mhl@utm.my	Abujiya, Muazu Ramat/A-8532-2013; RIAZ, MUHAMMAD/I-8259-2015; Riaz, Muhammad/L-1634-2019; Lee, Muhammad Hisyam/C-9063-2011; Lee, Muhammad Hisyam/G-1914-2017	Abujiya, Muazu Ramat/0000-0003-1795-8875; RIAZ, MUHAMMAD/0000-0002-7599-6928; Riaz, Muhammad/0000-0002-7599-6928; Lee, Muhammad Hisyam/0000-0002-3700-2363; Lee, Muhammad Hisyam/0000-0002-3700-2363				Abbasi SA, 2012, COMPUT IND ENG, V63, P400, DOI 10.1016/j.cie.2012.03.013; Abujiya MR, 2004, J APPL STAT, V31, P1185, DOI 10.1080/0266476042000285549; Abujiya MR, 2014, QUALITY RELIABILITY, DOI [10.1002/qre.661, DOI 10.1002/QRE.661]; Abujiya MR, 2014, QUALITY RELIABILITY, DOI [10.1002/qre.725, DOI 10.1002/QRE.725]; Acosta-Mejia CA, 1999, IIE TRANS, V31, P569, DOI 10.1080/07408179908969859; Al-Nasser AD, 2009, J STAT COMPUT SIM, V79, P859, DOI 10.1080/00949650701683084; Al-Omari AI, 2011, J STAT COMPUT SIM, V81, P1055, DOI 10.1080/00949651003649161; Al-Sabah WS, 2010, PAK J STAT, V26, P365; Bhoj DS, 1997, COMMUN STAT-THEOR M, V26, P653, DOI 10.1080/03610929708831940; BROOK D, 1972, BIOMETRIKA, V59, P539; CHANG TC, 1995, J QUAL TECHNOL, V27, P109, DOI 10.1080/00224065.1995.11979574; Haq A, 2013, QUALITY RELIABILITY, DOI [10.1002/qre.586, DOI 10.1002/QRE.586]; Haq A, 2015, QUAL QUANT, V49, P1185, DOI 10.1007/s11135-014-0042-7; Hawkins D. M., 2003, Quality Engineering, V16, P143, DOI 10.1081/QEN-120020780; HAWKINS DM, 1981, J QUAL TECHNOL, V13, P228, DOI 10.1080/00224065.1981.11978762; Jozani MJ, 2011, J STAT PLAN INFER, V141, P2386, DOI 10.1016/j.jspi.2011.01.024; Knoth S, 2006, COMPUT STAT DATA AN, V51, P499, DOI 10.1016/j.csda.2005.09.015; LUCAS JM, 1982, TECHNOMETRICS, V24, P199, DOI 10.2307/1268679; MCINTYRE GA, 1952, AUST J AGR RES, V3, P385, DOI 10.1071/AR9520385; Mehmood R, 2014, QUAL ENG, V26, P370, DOI 10.1080/08982112.2014.903971; Mehmood R, 2013, J APPL STAT, V40, P483, DOI 10.1080/02664763.2012.740624; Montgomery D.C., 2011, INTRO STAT QUALITY C, V6th; Muttlak HA, 2004, APPL MATH COMPUT, V151, P645, DOI 10.1016/S0096-3003(03)00367-9; Muttlak HA, 2003, J APPL STAT, V30, P1055, DOI 10.1080/0266476032000076173; Ou YJ, 2012, INT J PROD ECON, V135, P479, DOI 10.1016/j.ijpe.2011.08.026; PAGE ES, 1963, TECHNOMETRICS, V5, P307, DOI 10.2307/1266335; PAGE ES, 1954, BIOMETRIKA, V41, P100, DOI 10.1093/biomet/41.1-2.100; Poetroojojo S., 2002, INT J MATH MATH SCI, V32, P1; Purkayastha S., 1996, STAT DECISIONS, V14, P223, DOI DOI 10.1524/STRM.1996.14.3.223; Reynolds MR, 2006, TECHNOMETRICS, V48, P550, DOI 10.1198/004017006000000255; Samawi H. M., 2002, METRON, V60, P50; Samawi HM, 1996, BIOMETRICAL J, V38, P577, DOI 10.1002/bimj.4710380506; Shaibu AB, 2004, STATISTICA, V64; STOKES SL, 1980, BIOMETRICS, V36, P35, DOI 10.2307/2530493; STOKES SL, 1977, COMMUN STAT A-THEOR, V6, P1207, DOI 10.1080/03610927708827563; TAKAHASI K, 1968, ANN I STAT MATH, V20, P1, DOI 10.1007/BF02911622; Tuprah K., 1987, SEQUENTIAL ANAL, V6, P155, DOI [10.1080/07474948708836122, DOI 10.1080/]; Wu Z, 2009, IIE TRANS, V41, P642, DOI 10.1080/07408170802712582; Wu Z, 2008, COMPUT STAT DATA AN, V53, P496, DOI 10.1016/j.csda.2008.08.032; Yu PLH, 1999, ENVIRON ECOL STAT, V6, P23, DOI 10.1023/A:1009687332668	40	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124520	10.1371/journal.pone.0124520	http://dx.doi.org/10.1371/journal.pone.0124520			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901356	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500092
J	He, J; Lu, YQ; Xia, H; Liang, YJ; Wang, X; Bao, WDN; Yun, SF; Ye, YT; Zheng, CX; Liu, ZH; Shi, SL				He, Jing; Lu, Yuqiu; Xia, Hong; Liang, Yaojun; Wang, Xiao; Bao, Wenduona; Yun, Shifeng; Ye, Yuting; Zheng, Chunxia; Liu, Zhihong; Shi, Shaolin			Circulating Mitochondrial DAMPs Are Not Effective Inducers of Proteinuria and Kidney Injury in Rodents	PLOS ONE			English	Article							INFLAMMATORY RESPONSES; TRANSCRIPTION FACTOR; CELL ACTIVATION; NECROTIC CELLS; DNA LEVELS; IN-VIVO; TRAUMA; PODOCYTE; DISEASE; GLOMERULOSCLEROSIS	Mitochondria in eukaryotic cells are derived from bacteria in evolution. Like bacteria, mitochondria contain DNA with unmethylated CpG motifs and formyl peptides, both of which have recently been shown to be damage associated molecular patterns (DAMPs) and induce immune response and cell injury. Based on the facts that circulating mitochondrial DAMPs (mtDAMPs) are increased in the patients of trauma or burn injury who also have proteinuria, that mtDAMPs can activate immune cells which in turn secrete glomerular permeability factors, that renal intrinsic cells express a variety of DAMP receptors, and that mtDAMPs can directly increase endothelial cell permeability in vitro, we hypothesized that mtDAMPs may be novel circulating factors inducing proteinuria and kidney injury. We tested this hypothesis by directly injecting mtDAMPs into rodents and examining urinary protein and kidney histology. We prepared mtDAMP samples, including mitochondrial DNA (mtDNA) and mitochondrial debris (MTD), from rodent liver. In mice, injection of mtDNA for 20 mu g/ml initial concentration in circulation (much higher than the clinical range), did not cause any renal manifestations. However, an increased dose leading to 45 mu g/ml initial concentration in circulation resulted in a transient, slight increase in urinary albumin. In rats, MTD injection resulting in 450 mu g/ml initial concentration of MTD protein in circulation, which was much higher than the clinical range, caused mild, transient proteinuria and lung lesions. Multiple injections of such large amount of either mtDNA or MTD into rodents on 3 consecutive days also failed in inducing proteinuria and kidney injury. In summary, clinical levels of circulating mtDAMPs do not induce proteinuria and clinically irrelevant high levels of mtDAMPs cause only a transient and slight increase in urinary protein in rodents, suggesting that circulating mtDAMPs may not be responsible for the proteinuria and kidney injury in patients with trauma, burn injury, and other diseases.	[He, Jing; Lu, Yuqiu; Xia, Hong; Liang, Yaojun; Wang, Xiao; Bao, Wenduona; Ye, Yuting; Zheng, Chunxia; Liu, Zhihong; Shi, Shaolin] Nanjing Univ, Sch Med, Jinling Hosp, Natl Clin Res Ctr Kidney Dis, Nanjing 210008, Jiangsu, Peoples R China; [Yun, Shifeng] Nanjing Univ, Sch Med, Jinling Hosp, Dept Comparat Med, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Liu, ZH (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Natl Clin Res Ctr Kidney Dis, Nanjing 210008, Jiangsu, Peoples R China.	liuzhihong@nju.edu.cn; shaolinshi1001@yahoo.com		Shi, Shaolin/0000-0003-2297-6496; Liu, Zhi-Hong/0000-0001-6093-0726	National Natural Science Foundation of China [81370827, 30900686, 81100508]; National Basic Research Program of China 973 Program [2012CB517600/2012CB517606]; Natural Science Foundation of Jiangsu Province [BK20131324]; Jiangsu Innovation Talent Program [2011-32]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Innovation Talent Program	This work was supported by the grants funded by National Natural Science Foundation of China - No. 81370827 (http://www.nsfc.gov.cn/) to SS, National Basic Research Program of China 973 Program - No. 2012CB517600/2012CB517606 (www.most.gov.cn) to ZL and SS, Natural Science Foundation of Jiangsu Province - BK20131324 (www.jstd.gov.cn) to SS, Jiangsu Innovation Talent Program - No. 2011-32) (http://www.jsrcgz.gov.cn/) to SS, National Natural Science Foundation of China - No. 30900686 (http://www.nsfc.gov.cn/) to CZ (Chunxia Zheng), and National Natural Science Foundation of China - No. 81100508 (http://www.nsfc.gov.cn/) to YL (Yaojun Liang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2007, KIDNEY INT, V72, P1051, DOI 10.1038/sj.ki.5002436; Anders HJ, 2011, J AM SOC NEPHROL, V22, P1007, DOI 10.1681/ASN.2010080798; Axelsson J, 2009, AM J PHYSIOL-RENAL, V297, pF577, DOI 10.1152/ajprenal.00246.2009; BORST P, 1967, BIOCHIM BIOPHYS ACTA, V149, P140, DOI 10.1016/0005-2787(67)90697-1; CARDON LR, 1994, P NATL ACAD SCI USA, V91, P3799, DOI 10.1073/pnas.91.9.3799; Chaung WW, 2012, INT J MOL MED, V30, P199, DOI 10.3892/ijmm.2012.959; Chou CC, 2008, DIGEST SURG, V25, P300, DOI 10.1159/000152846; Collins LV, 2004, J LEUKOCYTE BIOL, V75, P995, DOI 10.1189/jlb.0703328; Crouser ED, 2009, CRIT CARE MED, V37, P2000, DOI 10.1097/CCM.0b013e3181a001ae; De Gaudio AR, 1999, CRIT CARE MED, V27, P2105, DOI 10.1097/00003246-199910000-00004; Futrakul N, 2009, RENAL FAILURE, V31, P140, DOI 10.1080/08860220802595948; Goncalves GM, 2010, SHOCK, V34, P22, DOI 10.1097/SHK.0b013e3181e7e69e; GOSLING P, 1986, ANN CLIN BIOCHEM, V23, P681, DOI 10.1177/000456328602300610; Goulopoulou S, 2012, CLIN SCI, V123, P429, DOI 10.1042/CS20120130; Gu XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072834; Guo JC, 2008, J AM SOC NEPHROL, V19, P961, DOI 10.1681/ASN.2007101109; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Lam NYL, 2004, CLIN CHEM, V50, P213, DOI 10.1373/clinchem.2003.025783; Lang A, 2005, J AM SOC NEPHROL, V16, P383, DOI 10.1681/ASN.2004040276; Little JP, 2014, MOL CELL NEUROSCI, V60, P88, DOI 10.1016/j.mcn.2014.04.003; Mathieson PW, 2003, CLIN EXP IMMUNOL, V134, P1, DOI 10.1046/j.1365-2249.2003.02236.x; Miranda ML, 2013, AM J HYPERTENS, V26, P1377, DOI 10.1093/ajh/hpt187; Nagata T, 2010, ANAL BIOCHEM, V398, P178, DOI 10.1016/j.ab.2009.11.017; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Ries M, 2013, J LEUKOCYTE BIOL, V94, P123, DOI 10.1189/jlb.0612278; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schaefer L, 2010, CURR OPIN PHARMACOL, V10, P185, DOI 10.1016/j.coph.2009.11.007; Schlondorff DO, 2008, KIDNEY INT, V74, P860, DOI 10.1038/ki.2008.351; SHAKESPEARE PG, 1981, ANN CLIN BIOCHEM, V18, P353, DOI 10.1177/000456328101800606; Shi SL, 2008, J AM SOC NEPHROL, V19, P2159, DOI 10.1681/ASN.2008030312; Shi SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075572; Shimada M, 2009, NEPHROL DIAL TRANSPL, V24, P2960, DOI 10.1093/ndt/gfp330; Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108; Simmons JD, 2013, ANN SURG, V258, P591, DOI 10.1097/SLA.0b013e3182a4ea46; Sun SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059989; TAMURA K, 1988, BIOCHEM GENET, V26, P815, DOI 10.1007/BF02395525; Wu HL, 2010, J AM SOC NEPHROL, V21, P1878, DOI 10.1681/ASN.2009101048; Yamanouchi S, 2013, J CRIT CARE, V28, P1027, DOI 10.1016/j.jcrc.2013.05.006; Zhang Q, 2010, SHOCK, V34, P55, DOI 10.1097/SHK.0b013e3181cd8c08; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	42	17	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124469	10.1371/journal.pone.0124469	http://dx.doi.org/10.1371/journal.pone.0124469			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902071	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500089
J	Hu, GH; Chen, B; Fu, WG; Xu, X; Guo, DQ; Jiang, JH; Yang, J; Wang, YQ				Hu, Guohua; Chen, Bin; Fu, Weiguo; Xu, Xin; Guo, Daqiao; Jiang, Junhao; Yang, Jue; Wang, Yuqi			Predictors and Treatments of Proglide-Related Complications in Percutaneous Endovascular Aortic Repair	PLOS ONE			English	Article							ANEURYSM REPAIR; PRECLOSE TECHNIQUE; CLOSURE DEVICES; ACCESS; OUTCOMES; IMPLANTATION; METAANALYSIS; MULTICENTER; EXPERIENCE; SUCCESS	Purpose To investigate the predictors and treatment of the 6-Fr Perclose Proglide-related complications ( PRC) in percutaneous endovascular aortic repair (pEVAR). Methods We retrospectively analyzed the PRC after pEVAR for the treatment of aortic aneurysm or dissection in our center from December 2012 to November 2013. Procedure success was defined as effective functioning of the two devices and local hemostasis. Access-related adverse events included vascular complications and device failures. Operative data and angiographic and computed tomography images were collected to assess the complications and treatment strategy. Results A total of 198 patients with 275 puncture sites underwent pEVAR with the 6-Fr Perclose Proglide. The procedure was successful in 178 patients (89.9%), whereas PRC occurred in 20 cases (10.1%), including 10 device failures and 10 vascular complications. An extra manual ancillary compression was conducted in 7 patients, one more device was used in 8 patients, and surgical repair of the femoral artery was performed in 5 patients. PRC had a tendency to occur in patients with body mass index (BMI)>30 kg/m(2) (p = 0.021), thoracic stent grafts (p = 0.038), common femoral artery (CFA) calcification (p = 0.001), CFA depth>4 cm(p = 0.001), and sheath size>20Fr (p = 0.005). Device failure-related mortality was zero. None of the access sites had complications during the midterm follow-up. Conclusions The pre-close technique with 6-Fr Perclose Proglide devices for pEVAR appears to be safe and effective with low technical failure and complication rates. Careful patient selection and proficiency in device manipulation might reduce the device related complications.	[Hu, Guohua; Chen, Bin; Fu, Weiguo; Xu, Xin; Guo, Daqiao; Jiang, Junhao; Yang, Jue; Wang, Yuqi] Fudan Univ, Zhongshan Hosp, Dept Vasc Surg, Shanghai 200433, Peoples R China	Fudan University	Fu, WG (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Vasc Surg, Shanghai 200433, Peoples R China.	fu.weiguo@zs-hospital.sh.cn						Al-Khatib WK, 2012, ANN VASC SURG, V26, P476, DOI 10.1016/j.avsg.2011.11.026; [Anonymous], 2007, VASC ENDOVASC SURG; Applegate RJ, 2012, JACC-CARDIOVASC INTE, V5, P845, DOI 10.1016/j.jcin.2012.06.006; Bechara CF, 2013, J VASC SURG, V57, P72, DOI 10.1016/j.jvs.2012.07.050; Bensley RP, 2012, J VASC SURG, V55, P1554, DOI 10.1016/j.jvs.2011.12.042; Dosluogiu HH, 2007, J ENDOVASC THER, V14, P184, DOI 10.1583/1545-1550(2007)14[184:TPEROA]2.0.CO;2; Dosluoglu HH, 2014, J VASC SURG, V59, P58, DOI 10.1016/j.jvs.2013.06.076; Eisenack M, 2009, J ENDOVASC THER, V16, P708, DOI 10.1583/08-2622.1; Georgiadis GS, 2011, J ENDOVASC THER, V18, P445, DOI 10.1583/11-342.1; Grenon SM, 2009, CAN J SURG, V52, pE156; Griese DP, 2013, CATHETER CARDIO INTE, V82, pE734, DOI 10.1002/ccd.25053; Haas PC, 1999, J ENDOVASC SURG, V6, P168, DOI 10.1583/1074-6218(1999)006<0168:COLPAS>2.0.CO;2; Harkin DW, 2007, EUR J VASC ENDOVASC, V34, P673, DOI 10.1016/j.ejvs.2007.06.004; Howell M, 2001, J ENDOVASC THER, V8, P68, DOI 10.1583/1545-1550(2001)008<0068:PAACOF>2.0.CO;2; Jabori S, 2013, ANN VASC SURG, V27, P1049, DOI 10.1016/j.avsg.2013.04.008; Jean-Baptiste E, 2008, EUR J VASC ENDOVASC, V35, P422, DOI 10.1016/j.ejvs.2007.10.021; Jonker FHW, 2010, J VASC SURG, V51, P1026, DOI 10.1016/j.jvs.2009.10.103; Kahlert P, 2008, CATHETER CARDIO INTE, V72, P877, DOI 10.1002/ccd.21711; Kim WH, 2013, J ENDOVASC THER, V20, P350, DOI 10.1583/12-4103MR2.1; Krajcer Z, 2011, J CARDIOVASC SURG, V52, P651; Krajcer Z, 2010, J CARDIOVASC SURG, V51, P493; Lee WA, 2008, J VASC SURG, V47, P919, DOI 10.1016/j.jvs.2007.12.029; Lee WA, 2007, J VASC SURG, V45, P1095, DOI 10.1016/j.jvs.2007.01.050; Malkawi AH, 2010, EUR J VASC ENDOVASC, V39, P676, DOI 10.1016/j.ejvs.2010.02.001; Manunga JM, 2013, J VASC SURG, V58, P1208, DOI 10.1016/j.jvs.2013.05.028; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Morasch MD, 2004, J VASC SURG, V40, P12, DOI 10.1016/j.jvs.2004.03.019; Nelson PR, 2014, J VASC SURG, V59, P1181, DOI 10.1016/j.jvs.2013.10.101; Ni ZH, 2011, CHINESE MED J-PEKING, V124, P851, DOI 10.3760/cma.j.issn.0366-6999.2011.06.009; Smith ST, 2009, ANN VASC SURG, V23, P621, DOI 10.1016/j.avsg.2008.09.002; Starnes BW, 2006, J VASC SURG, V43, P270, DOI 10.1016/j.jvs.2005.11.004; Steuer J, 2011, EUR J VASC ENDOVASC, V41, P318, DOI 10.1016/j.ejvs.2010.11.024; Wei Ren, 2012, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V26, P968; Ye Peng, 2014, Nan Fang Yi Ke Da Xue Xue Bao, V34, P747; Zakko J, 2014, J VASC SURG, V60, P921, DOI 10.1016/j.jvs.2014.04.051; Zhang Hong-peng, 2010, Zhonghua Wai Ke Za Zhi, V48, P1855	36	42	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123739	10.1371/journal.pone.0123739	http://dx.doi.org/10.1371/journal.pone.0123739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901610	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500061
J	Nakagawa, F; Miners, A; Smith, CJ; Simmons, R; Lodwick, RK; Cambiano, V; Lundgren, JD; Delpech, V; Phillips, AN				Nakagawa, Fumiyo; Miners, Alec; Smith, Colette J.; Simmons, Ruth; Lodwick, Rebecca K.; Cambiano, Valentina; Lundgren, Jens D.; Delpech, Valerie; Phillips, Andrew N.			Projected Lifetime Healthcare Costs Associated with HIV Infection	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT; UK; MORTALITY; THERAPY; FAILURE; SUCCESS; PEOPLE; TRENDS; TIME	Objective Estimates of healthcare costs associated with HIV infection would provide valuable insight for evaluating the cost-effectiveness of possible prevention interventions. We evaluate the additional lifetime healthcare cost incurred due to living with HIV. Methods We used a stochastic computer simulation model to project the distribution of lifetime outcomes and costs of men-who-have-sex-with-men (MSM) infected with HIV in 2013 aged 30, over 10,000 simulations. We assumed a resource-rich setting with no loss to follow-up, and that standards and costs of healthcare management remain as now. Results Based on a median (interquartile range) life expectancy of 71.5 (45.0-81.5) years for MSM in such a setting, the estimated mean lifetime cost of treating one person was (sic)360,800 ($567,000 or (sic)480,000). With 3.5% discounting, it was (sic)185,200 ($291,000 or (sic)246,000). The largest proportion (68%) of these costs was attributed to antiretroviral drugs. If patented drugs are replaced by generic versions (at 20% cost of patented prices), estimated mean lifetime costs reduced to (sic)179,000 ($281,000 or (sic)238,000) and (sic)101,200 ($158,900 or (sic)134,600) discounted. Conclusions If 3,000 MSM had been infected in 2013, then future lifetime costs relating to HIV care is likely to be in excess of (sic)1 billion. It is imperative for investment into prevention programmes to be continued or scaled-up in settings with good access to HIV care services. Costs would be reduced considerably with use of generic antiretroviral drugs.	[Nakagawa, Fumiyo; Smith, Colette J.; Cambiano, Valentina; Phillips, Andrew N.] UCL, Res Dept Infect & Populat Hlth, London, England; [Miners, Alec] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England; [Simmons, Ruth; Delpech, Valerie] Publ Hlth England, HIV & STI Dept, London, England; [Lodwick, Rebecca K.] UCL, Res Dept Primary Care & Populat Hlth, London, England; [Lundgren, Jens D.] Univ Copenhagen, Rigshosp, Copenhagen HIV Programme CHIP, Dept Infect Dis 8632, DK-2100 Copenhagen, Denmark	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Public Health England; University of London; University College London; Rigshospitalet; University of Copenhagen	Nakagawa, F (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	f.nakagawa@ucl.ac.uk	Phillips, Andrew N/B-4427-2008; Lodwick, Rebecca/B-7578-2015; Lundgren, Jens/AAE-6876-2019	Phillips, Andrew N/0000-0003-2384-4807; Lodwick, Rebecca/0000-0003-2558-4762; Lundgren, Jens/0000-0001-8901-7850; Smith, Colette/0000-0003-2847-3355; delpech, valerie/0000-0002-9952-8109; Nakagawa, Fumiyo/0000-0002-6646-8744				Arribas JR, 2012, HIV MED, V13, P398, DOI 10.1111/j.1468-1293.2012.00989.x; Bansi L, 2010, HIV MED, V11, P432, DOI 10.1111/j.1468-1293.2009.00809.x; Beck EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027830; Daskalopoulou M, 2014, LANCET HIV, V1, pE22, DOI 10.1016/S2352-3018(14)70001-3; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Department of Health, 15869 DEP HLTH; Gazzard B, 2012, CLINICOECONOMIC OUTC, V4, P193, DOI 10.2147/CEOR.S12496; Hagger-Johnson G, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002810; Harding R, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-43; Health Protection Agency, 2012, HIV UK 2012 REP; Kanavos P, 2007, CURR MED RES OPIN, V23, P105, DOI 10.1185/030079907X159506; Katlama C, 2010, AIDS, V24, P2365, DOI 10.1097/QAD.0b013e32833dec20; KULLER LH, 1991, PREV MED, V20, P638, DOI 10.1016/0091-7435(91)90060-H; Lampe FC, 2006, ARCH INTERN MED, V166, P521, DOI 10.1001/archinte.166.5.521; Lampe FC, 2007, ARCH INTERN MED, V167, P692, DOI 10.1001/archinte.167.7.692; May M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6016; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; O'Connor J, 2014, J INT AIDS SOC, V17, P25, DOI 10.7448/IAS.17.4.19527; Office for National Statistics, 2011, DEATHS REG ENGL W DR; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Phillips AN, 2007, HIV MED, V8, P536, DOI 10.1111/j.1468-1293.2007.00507.x; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Rao G, 2013, 53 INT C ANT AG CHEM; Sax PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031591; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Sloan CE, 2012, AIDS, V26, P45, DOI 10.1097/QAD.0b013e32834dce6e; Turner J, 2010, J VIRAL HEPATITIS, V17, P569, DOI 10.1111/j.1365-2893.2009.01215.x; Walensky RP, 2013, ANN INTERN MED, V158, P84, DOI 10.7326/0003-4819-158-2-201301150-00002; Yazdanpanah Y, 2002, ANTIVIR THER, V7, P257; Yin Z, 2014, HIV UK 2014 REPORT D	32	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0125018	10.1371/journal.pone.0125018	http://dx.doi.org/10.1371/journal.pone.0125018			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901355	Green Accepted, Green Published, gold			2022-12-27	WOS:000353331500108
J	Swift, BJF; Baneyx, F				Swift, Brian J. F.; Baneyx, Franois			Microbial Uptake, Toxicity, and Fate of Biofabricated ZnS:Mn Nanocrystals	PLOS ONE			English	Article							SEMICONDUCTOR QUANTUM DOTS; ESCHERICHIA-COLI; MEMBRANE; CDSE; CYTOTOXICITY; PROTEINS; CDTE	Despite their importance in nano-environmental health and safety, interactions between engineered nanomaterials and microbial life remain poorly characterized. Here, we used the model organism E. coli to study the penetration requirements, subcellular localization, induction of stress responses, and long-term fate of luminescent Mn-doped ZnS nanocrystals fabricated under "green" processing conditions with a minimized ZnS-binding protein. We find that such protein-coated quantum dots (QDs) are unable to penetrate the envelope of unmodified E. coli but readily translocate to the cytoplasm of cells that have been made competent by chemical treatment. The process is dose-dependent and reminiscent of bacterial transformation. Cells that have internalized up to 0.5 mu g/mL of nanocrystals do not experience a significant activation of the unfolded protein or SOS responses but undergo oxidative stress when exposed to high QD doses (2.5 mu g/mL). Finally, although they are stable in quiescent cells over temperatures ranging from 4 to 42 degrees C, internalized QDs are rapidly diluted by cell division in a process that does not involve TolC-dependent efflux. Taken together, our results suggest that biomimetic QDs based on low toxicity inorganic cores capped by a protein shell are unlikely to cause significant damage to the microbial ecosystem.	[Swift, Brian J. F.; Baneyx, Franois] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Baneyx, F (corresponding author), Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.	baneyx@uw.edu			National Insitute of Environmental Health Sciences [1U19ES019545-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U19ES019545] Funding Source: NIH RePORTER	National Insitute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Insitute of Environmental Health Sciences 1U19ES019545-01 (subcontract to FB - PI Kavanagh) (http://www.niehs.nih.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anas A, 2008, J PHYS CHEM B, V112, P10005, DOI 10.1021/jp8018606; BAYER ME, 1968, J GEN MICROBIOL, V53, P395, DOI 10.1099/00221287-53-3-395; Bianchi AA, 1999, APPL ENVIRON MICROB, V65, P5023; Biju V, 2008, ANAL BIOANAL CHEM, V391, P2469, DOI 10.1007/s00216-008-2185-7; Bottrill M, 2011, CHEM COMMUN, V47, P7039, DOI 10.1039/c1cc10692a; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; Dumas EM, 2009, IEEE T NANOBIOSCI, V8, P58, DOI 10.1109/TNB.2009.2017313; Dwarakanath S, 2007, FOLIA MICROBIOL, V52, P31, DOI 10.1007/BF02932134; Frigerio C, 2012, ANAL CHIM ACTA, V735, P9, DOI 10.1016/j.aca.2012.04.042; Gomes SAO, 2011, SENSORS-BASEL, V11, P11664, DOI 10.3390/s111211664; He Y, 2008, ANAL CHEM, V80, P3832, DOI 10.1021/ac800100y; Hoshino A, 2011, ARCH TOXICOL, V85, P707, DOI 10.1007/s00204-011-0695-0; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jamieson T, 2007, BIOMATERIALS, V28, P4717, DOI 10.1016/j.biomaterials.2007.07.014; Kloepfer JA, 2005, APPL ENVIRON MICROB, V71, P2548, DOI 10.1128/AEM.71.5.2548-2557.2005; Kloepfer JA, 2003, APPL ENVIRON MICROB, V69, P4205, DOI 10.1128/AEM.69.7.4205-4213.2003; Koronakis V, 2004, ANNU REV BIOCHEM, V73, P467, DOI 10.1146/annurev.biochem.73.011303.074104; Li WH, 2004, J BIOCHEM BIOPH METH, V58, P59, DOI 10.1016/S0165-022X(03)00154-4; Lu ZS, 2008, LANGMUIR, V24, P5445, DOI 10.1021/la704075r; Mahendra S, 2008, ENVIRON SCI TECHNOL, V42, P9424, DOI 10.1021/es8023385; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; MINSKY A, 1986, P NATL ACAD SCI USA, V83, P4180, DOI 10.1073/pnas.83.12.4180; Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nozik AJ, 2010, CHEM REV, V110, P6873, DOI 10.1021/cr900289f; Ostermeier M, 2005, PROTEIN ENG DES SEL, V18, P359, DOI 10.1093/protein/gzi048; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Schneider R, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/22/225101; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shapiro E, 2002, ANTIMICROB AGENTS CH, V46, P2490, DOI 10.1128/AAC.46.8.2490-2497.2002; Shirasaki Y, 2013, NAT PHOTONICS, V7, P13, DOI 10.1038/nphoton.2012.328; Silhavy T.J., 1984, EXPT GENE FUSIONS; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Smith WE, 2012, ACS NANO, V6, P9475, DOI 10.1021/nn302288r; Sun Q, 2007, NAT PHOTONICS, V1, P717, DOI 10.1038/nphoton.2007.226; Winnik FM, 2013, ACCOUNTS CHEM RES, V46, P672, DOI 10.1021/ar3000585; Yong KT, 2013, CHEM SOC REV, V42, P1236, DOI 10.1039/c2cs35392j; Zhou W, 2015, CHEM COMMUN UNPUB; Zhou WB, 2011, ACS NANO, V5, P8013, DOI 10.1021/nn2024896; Zhou W, 2010, J AM CHEM SOC, V132, P4731, DOI 10.1021/ja909406n; Zrazhevskiy P, 2010, CHEM SOC REV, V39, P4326, DOI 10.1039/b915139g	41	8	8	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124916	10.1371/journal.pone.0124916	http://dx.doi.org/10.1371/journal.pone.0124916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902065	Green Submitted, Green Published, gold			2022-12-27	WOS:000353331500105
J	Klaver, EJ; Kuijk, LM; Lindhorst, TK; Cummings, RD; van Die, I				Klaver, Elsenoor J.; Kuijk, Loes M.; Lindhorst, Thisbe K.; Cummings, Richard D.; van Die, Irma			Schistosoma mansoni Soluble Egg Antigens Induce Expression of the Negative Regulators SOCS1 and SHP1 in Human Dendritic Cells via Interaction with the Mannose Receptor	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; C-TYPE LECTINS; DC-SIGN; IMMUNE-RESPONSES; TH2 RESPONSES; INFLAMMATORY PHENOTYPE; LEWIS-X; HELMINTH; INFECTION; RECOGNITION	Schistosomiasis is a common debilitating human parasitic disease in (sub) tropical areas, however, schistosome infections can also protect against a variety of inflammatory diseases. This has raised broad interest in the mechanisms by which Schistosoma modulate the immune system into an anti-inflammatory and regulatory state. Human dendritic cells (DCs) show many phenotypic changes upon contact with Schistosoma mansoni soluble egg antigens (SEA). We here show that oxidation of SEA glycans, but not heat-denaturation, abrogates the capacity of SEA to suppress both LPS-induced cytokine secretion and DC proliferation, indicating an important role of SEA glycans in these processes. Remarkably, interaction of SEA glycans with DCs results in a strongly increased expression of Suppressor Of Cytokine Signalling1 (SOCS1) and SH2-containing protein tyrosine Phosphatase-1 (SHP1), important negative regulators of TLR4 signalling. In addition, SEA induces the secretion of transforming growth factor beta (TGF-beta), and the surface expression of the costimulatory molecules Programmed Death Ligand-1 (PD-L1) and OX40 ligand (OX40L), which are known phenotypic markers for the capacity of DCs to polarize naive T cells into Th2/Treg cell subsets. Inhibition of mannose receptor (MR)-mediated internalization of SEA into DCs by blocking with allyl alpha-D-mannoside or anti-MR antibodies, significantly reduced SOCS1 and SHP1 expression. In conclusion, we demonstrate that SEA glycans are essential for induction of enhanced SOCS1 and SHP1 levels in DCs via the MR. Our data provide novel mechanistic evidence for the potential of Schistosoma mansoni SEA glycans to modulate human DCs, which may contribute to the capacity of SEA to down-regulate inflammatory responses.	[Klaver, Elsenoor J.; Kuijk, Loes M.; van Die, Irma] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [Lindhorst, Thisbe K.] Univ Kiel, Otto Diels Inst Organ Chem, Kiel, Germany; [Cummings, Richard D.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Kiel; Emory University	van Die, I (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands.	im.vandie@vumc.nl		Klaver, Elsenoor/0000-0001-7956-1449	Broad Medical Research Program of The Broad Foundation [IBD-0234R]; National Institute of Health [AI101982]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101982] Funding Source: NIH RePORTER	Broad Medical Research Program of The Broad Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Broad Medical Research Program of The Broad Foundation (http://www.broadmedical.org/), Grant IBD-0234R to IVD, and The National Institute of Health (http://www.nih.gov/), Grant AI101982 to RDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Chen XP, 2002, P NATL ACAD SCI USA, V99, P2175, DOI 10.1073/pnas.042035699; Chieppa M, 2003, J IMMUNOL, V171, P4552, DOI 10.4049/jimmunol.171.9.4552; Christophi GP, 2009, LAB INVEST, V89, P742, DOI 10.1038/labinvest.2009.32; Correale J, 2013, J IMMUNOL, V191, P3827, DOI 10.4049/jimmunol.1301110; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; de Jong EC, 2002, J IMMUNOL, V168, P1704, DOI 10.4049/jimmunol.168.4.1704; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Faveeuw C, 2002, J IMMUNOL, V169, P906, DOI 10.4049/jimmunol.169.2.906; Gadina M, 2001, CURR OPIN IMMUNOL, V13, P363, DOI 10.1016/S0952-7915(00)00228-4; Garcia-Vallejo Juan J., 2006, V347, P187; Garcia-Vallejo JJ, 2008, MOL IMMUNOL, V45, P2359, DOI 10.1016/j.molimm.2007.11.001; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Geijtenbeek TBH, 2002, J BIOL CHEM, V277, P11314, DOI 10.1074/jbc.M111532200; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Gregorieff A, 2000, J BIOL CHEM, V275, P21596, DOI 10.1074/jbc.M910087199; Gringhuis SI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4898; Hamilton CM, 2009, INFECT IMMUN, V77, P2488, DOI 10.1128/IAI.00919-08; HAY G. W., 1965, METHOD CARBOHYD CHEM, V5, P357; Hokke CH, 2007, EXP PARASITOL, V117, P275, DOI 10.1016/j.exppara.2007.06.003; Jang-Lee J, 2007, MOL CELL PROTEOMICS, V6, P1485, DOI 10.1074/mcp.M700004-MCP200; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Kapsenberg ML, 1999, IMMUNOL LETT, V69, P5, DOI 10.1016/S0165-2478(99)00096-6; Klaver EJ, 2013, INT J PARASITOL, V43, P191, DOI 10.1016/j.ijpara.2012.10.021; Kuijk LM, 2012, MOL IMMUNOL, V51, P210, DOI 10.1016/j.molimm.2012.03.020; Kuijk LM, 2010, IUBMB LIFE, V62, P303, DOI 10.1002/iub.304; La Flamme AC, 2003, INFECT IMMUN, V71, P4996, DOI 10.1128/IAI.71.9.4996-5004.2003; Mckay DM, 2009, TRENDS PARASITOL, V25, P109, DOI 10.1016/j.pt.2008.11.008; Meevissen MHJ, 2012, INT J PARASITOL, V42, P269, DOI 10.1016/j.ijpara.2012.01.004; Meevissen MHJ, 2010, J PROTEOME RES, V9, P2630, DOI 10.1021/pr100081c; Minoo P, 2004, BLOOD, V103, P1398, DOI 10.1182/blood-2003-07-2617; Moreels TG, 2004, GUT, V53, P99, DOI 10.1136/gut.53.1.99; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nyame AK, 2003, EXP PARASITOL, V104, P1, DOI 10.1016/S0014-4894(03)00110-3; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Okano M, 1999, J IMMUNOL, V163, P6712; Osada Y, 2009, INT J PARASITOL, V39, P457, DOI 10.1016/j.ijpara.2008.08.007; Paveley RA, 2011, INT J PARASITOL, V41, P1335, DOI 10.1016/j.ijpara.2011.08.005; Pearce EJ, 2004, IMMUNOL REV, V201, P117, DOI 10.1111/j.0105-2896.2004.00187.x; PEREZ JFA, 1982, IMMUNOLOGY, V47, P695; Riella LV, 2012, AM J TRANSPLANT, V12, P2575, DOI 10.1111/j.1600-6143.2012.04224.x; Rutella S, 2006, BLOOD, V108, P1435, DOI 10.1182/blood-2006-03-006403; Schramm G, 2003, J BIOL CHEM, V278, P18384, DOI 10.1074/jbc.M300497200; Schramm G, 2009, MOL BIOCHEM PARASIT, V166, P4, DOI 10.1016/j.molbiopara.2009.02.003; Smith P, 2007, J IMMUNOL, V178, P4557, DOI 10.4049/jimmunol.178.7.4557; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; van Die I, 2003, GLYCOBIOLOGY, V13, P471, DOI 10.1093/glycob/cwg052; van Liempt E, 2007, MOL IMMUNOL, V44, P2605, DOI 10.1016/j.molimm.2006.12.012; van Liempt E, 2006, FEBS LETT, V580, P6123, DOI 10.1016/j.febslet.2006.10.009; van Stijn CMW, 2010, MOL IMMUNOL, V47, P1544, DOI 10.1016/j.molimm.2010.01.014; van Stijn CMW, 2009, MOL IMMUNOL, V46, P3292, DOI 10.1016/j.molimm.2009.07.026; van Vliet SJ, 2005, INT IMMUNOL, V17, P661, DOI 10.1093/intimm/dxh246; Vazquez N, 2006, J LEUKOCYTE BIOL, V80, P1136, DOI 10.1189/jlb.0306206; Weinstock JV, 2009, INFLAMM BOWEL DIS, V15, P128, DOI 10.1002/ibd.20633; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; WINNIK FM, 1982, CARBOHYD RES, V103, P15, DOI 10.1016/S0008-6215(82)80004-9; Wuhrer M, 2006, FEBS J, V273, P2276, DOI 10.1111/j.1742-4658.2006.05242.x; Yadav A, 2009, VIROLOGY, V385, P126, DOI 10.1016/j.virol.2008.11.039	64	25	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124089	10.1371/journal.pone.0124089	http://dx.doi.org/10.1371/journal.pone.0124089			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897665	Green Submitted, Green Published, gold			2022-12-27	WOS:000353212600048
J	Stupnisek, M; Kokot, A; Drmic, D; Patrlj, MH; Sever, AZ; Kolenc, D; Radic, B; Suran, J; Bojic, D; Vcev, A; Seiwerth, S; Sikiric, P				Stupnisek, Mirjana; Kokot, Antonio; Drmic, Domagoj; Patrlj, Masa Hrelec; Sever, Anita Zenko; Kolenc, Danijela; Radic, Bozo; Suran, Jelena; Bojic, Davor; Vcev, Aleksandar; Seiwerth, Sven; Sikiric, Predrag			Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine	PLOS ONE			English	Article							NITRIC-OXIDE; PLASMINOGEN-ACTIVATOR; PLATELET ACTIVATION; METHYL-ESTER; INHIBITION; RELEASE; EGR-1; ENDOTHELIN-1; ENHANCEMENT; ANASTOMOSIS	Background BPC 157 is a stable gastric pentadecapeptide recently implicated with a role in hemostasis. While NO is largely implicated in hemostatic mechanisms, in tail-amputation-models under heparin-and warfarin-administration, both the NO-synthase (NOS)-blocker, L-NAME (prothrombotic) and the NOS-substrate L-arginine (antithrombotic), were little investigated. Objective. To investigate the effect of L-NAME and L-arginine on hemostatic parameters, and to reveal the effects of BPC 157 on the L-NAME-and L-arginine-induced hemostatic actions under different pathological condition: tail amputation without or with anticoagulants, heparin or warfarin. Methods Tail amputation, and/or i.v.-heparin (10 mg/kg), i.g.-warfarin (1.5 mu g/kg/day for 3 days) were used in rats. Treatment includes BPC 157, L-NAME, L-arginine, per se and their combination. Results After (tail) amputation, with or without i.v.-heparin or i.g.-warfarin, BPC 157 (10 mu g/kg, 10 ng/kg, i.p., i.v. (heparin), 10 g/kg i.g. (warfarin)) always reduced bleeding time and/or haemorrhage and counteracted thrombocytopenia. As for L-NAME and/or L-arginine, we noted: L-arginine (100 mg/kg i.p.)-rats: more bleeding, less/no thrombocytopenia; L-NAME (5 mg/kg i.p.)-rats: less bleeding (amputation only), but present thrombocytopenia; L-NAME+ L-argininerats also exhibited thrombocytopenia: L-NAME counteracted L-arginine-increased bleeding, L-arginine did not counteract L-NAME-thrombocytopenia. All animals receiving BPC 157 in addition (BPC 157 mu g+ L-NAME; BPC 157 mu g+ L-arginine, BPC 157 mu g+ L-NAME+ L-arginine), exhibited decreased haemorrhage and markedly counteracted thrombocytopenia. Conclusions L-NAME (thrombocytopenia), L-arginine (increased haemorrhage) counteraction and BPC 157 (decreased haemorrhage, counteracted thrombocytopenia) with rescue against two different anticoagulants, implicate a BPC 157 modulatory and balancing role with rescued NO-hemostatic mechanisms.	[Stupnisek, Mirjana; Kokot, Antonio; Vcev, Aleksandar] JJ Strossmayer Univ Osijek, Fac Med, Osijek, Croatia; [Drmic, Domagoj; Patrlj, Masa Hrelec; Radic, Bozo; Suran, Jelena; Bojic, Davor; Sikiric, Predrag] Univ Zagreb, Sch Med, Dept Pharmacol, Zagreb 41001, Croatia; [Sever, Anita Zenko; Kolenc, Danijela; Seiwerth, Sven] Univ Zagreb, Sch Med, Dept Pathol, Zagreb 41001, Croatia	University of JJ Strossmayer Osijek; University of Zagreb; University of Zagreb	Sikiric, P (corresponding author), Univ Zagreb, Sch Med, Dept Pharmacol, Zagreb 41001, Croatia.	sikiric@mef.hr	Stupnisek, Mirjana/A-9884-2015; Kokot, Antonio/O-3111-2019; Suran, Jelena/AAU-8102-2020; Kokot, Antonio/HGB-2080-2022; Kokot, Antonio/B-3276-2017	Stupnisek, Mirjana/0000-0003-2109-2787; Kokot, Antonio/0000-0002-4836-7536; 	Ministry of Science, Education and Sports, Republic of Croatia [108-1083570-3635]	Ministry of Science, Education and Sports, Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia)	The research described in this manuscript was supported by grant 108-1083570-3635, Ministry of Science, Education and Sports, Republic of Croatia.	Ashour M, 2004, EUR J CARDIO-THORAC, V25, P839, DOI 10.1016/j.ejcts.2003.12.010; Balenovic D, 2012, J CLIN EXP CARDIOLOG, V3, P201, DOI [10.4172/2155-9880.1000201, DOI 10.4172/2155-9880.1000201]; Balenovic D, 2009, REGUL PEPTIDES, V156, P83, DOI 10.1016/j.regpep.2009.05.008; Barisic I, 2013, REGUL PEPTIDES, V181, P50, DOI 10.1016/j.regpep.2012.12.007; Boban-Blagaic A, 2006, MED SCI MONITOR, V12, pBR36; Cesarec V, 2013, EUR J PHARMACOL, V701, P203, DOI 10.1016/j.ejphar.2012.11.055; Dambisya YM, 1996, BLOOD COAGUL FIBRIN, V7, P678, DOI 10.1097/00001721-199610000-00003; Diodati JG, 1998, CIRCULATION, V98, P17, DOI 10.1161/01.CIR.98.1.17; Dran GI, 2002, KIDNEY INT, V62, P1338, DOI 10.1046/j.1523-1755.2002.00554.x; Duplancic B, 2014, EUR J PHARMACOL, V727, P75, DOI 10.1016/j.ejphar.2014.01.046; Freedman JE, 1997, J CLIN INVEST, V100, P350, DOI 10.1172/JCI119540; Gozdzikiewicz J, 2014, HEMODIAL INT, V18, P819, DOI 10.1111/hdi.12177; Grabarevic Z, 1997, J PHYSIOLOGY-PARIS, V91, P139, DOI 10.1016/S0928-4257(97)89478-8; HIEBERT LM, 1993, Q J MED, V86, P341; Hrelec M, 2009, J PHYSIOL PHARMACOL, V60, P161; HUNEIDI AHS, 1991, J CARDIOVASC PHARM, V17, pS492; Kalogjera L, 1997, EUR ARCH OTO-RHINO-L, V254, pS9, DOI 10.1007/BF02439711; KESTIN AS, 1993, BLOOD, V82, P107, DOI 10.1182/blood.V82.1.107.bloodjournal821107; Kim SS, 2003, J KOREAN MED SCI, V18, P637, DOI 10.3346/jkms.2003.18.5.637; Kitashoji A, 2013, STROKE, V44, P2862, DOI 10.1161/STROKEAHA.113.001183; Klicek R, 2013, J PHYSIOL PHARMACOL, V64, P597; Klicek R, 2008, J PHARMACOL SCI, V108, P7, DOI 10.1254/jphs.FP0072161; KORBUT R, 1990, LANCET, V335, P669, DOI 10.1016/0140-6736(90)90462-E; KORBUT R, 1995, J PHYSIOL PHARMACOL, V46, P37; LIDBURY PS, 1990, BRIT J PHARMACOL, V101, P527, DOI 10.1111/j.1476-5381.1990.tb14115.x; Lombardini Cristina, 2009, Am J Emerg Med, V27, DOI 10.1016/j.ajem.2009.02.005; Lovric-Bencic M, 2004, J PHARMACOL SCI, V95, P19, DOI 10.1254/jphs.95.19; Lucerna M, 2003, J BIOL CHEM, V278, P11433, DOI 10.1074/jbc.M204937200; Marietta M, 1997, THROMB RES, V88, P229, DOI 10.1016/S0049-3848(97)00233-8; McMahon GS, 2013, THROMB HAEMOSTASIS, V109, P1099, DOI 10.1160/TH12-11-0793; MOLNAR M, 1994, AM J OBSTET GYNECOL, V170, P1458; Noguchi K, 1996, BRIT J PHARMACOL, V118, P941, DOI 10.1111/j.1476-5381.1996.tb15490.x; Sakawi Y, 2000, ANESTHESIOLOGY, V93, P1446, DOI 10.1097/00000542-200012000-00017; Seiwerth S, 2014, CURR PHARM DESIGN, V20, P1121, DOI 10.2174/13816128113199990421; Sikiric P, 2012, CURR MED CHEM, V19, P126, DOI 10.2174/092986712803414015; Sikiric P, 1997, EUR J PHARMACOL, V332, P23, DOI 10.1016/S0014-2999(97)01033-9; Sikiric P, 2014, CURR PHARM DESIGN, V20, P1126, DOI 10.2174/13816128113190990411; Sikiric P, 2013, CURR PHARM DESIGN, V19, P76; Sikiric P, 2011, CURR PHARM DESIGN, V17, P1612, DOI 10.2174/138161211796196954; Sikiric P, 2010, CURR PHARM DESIGN, V16, P1224, DOI 10.2174/138161210790945977; Stupnisek M, 2012, THROMB RES, V129, P652, DOI 10.1016/j.thromres.2011.07.035; Thom SR, 1999, AM J PHYSIOL-HEART C, V276, pH984, DOI 10.1152/ajpheart.1999.276.3.H984; Tkalcevic VI, 2007, EUR J PHARMACOL, V570, P212, DOI 10.1016/j.ejphar.2007.05.072; Upchurch GR, 1997, CIRCULATION, V95, P2115, DOI 10.1161/01.CIR.95.8.2115; VELJACA M, 1995, J PHARMACOL EXP THER, V272, P417; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168	47	42	42	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123454	10.1371/journal.pone.0123454	http://dx.doi.org/10.1371/journal.pone.0123454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897838	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000353212600027
J	Ozeki, N; Hase, N; Hiyama, T; Yamaguchi, H; Kawai, R; Kondo, A; Matsumoto, T; Nakata, K; Mogi, M				Ozeki, Nobuaki; Hase, Naoko; Hiyama, Taiki; Yamaguchi, Hideyuki; Kawai, Rie; Kondo, Ayami; Matsumoto, Toru; Nakata, Kazuhiko; Mogi, Makio			Interleukin-1 beta-Induced Autophagy-Related Gene 5 Regulates Proliferation of Embryonic Stem Cell-Derived Odontoblastic Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; DIFFERENTIATION; LIPOPOLYSACCHARIDE; EXPRESSION; INDUCTION; IMMUNITY; SYSTEM; DEATH; LINE	We previously established a method for the differentiation of induced pluripotent stem cells and embryonic stem cells into alpha 2 integrin-positive odontoblast-like cells. We also reported that Wnt5 in response to interleukin (IL)-1 beta induces matrix metalloproteinase (MMP)-3-regulated cell proliferation in these cells. Our findings suggest that MMP-3 plays a potentially unique physiological role in the generation of odontoblast-like cells under an inflammatory state. Here, we examined whether up-regulation of autophagy-related gene (Atg) 5 by IL-1 beta was mediated by Wnt5 signaling, thus leading to increased proliferation of odontoblast-like cells. IL-1 beta increased the mRNA and protein levels of Atg5, microtubule-associated protein 1 light chain (LC3, a mammalian homolog of yeast Atg8) and Atg12. Treatment with siRNAs against Atg5, but not LC3 and Atg12, suppressed the IL-1 beta-induced increase in MMP-3 expression and cell proliferation. Our siRNA analyses combined with western blot analysis revealed a unique sequential cascade involving Atg5, Wnt5a and MMP-3, which resulted in the potent increase in odontoblastic cell proliferation. These results demonstrate the unique involvement of Atg5 in IL-1 beta-induced proliferation of embryonic stem cell-derived odontoblast-like cells.	[Ozeki, Nobuaki; Hase, Naoko; Hiyama, Taiki; Yamaguchi, Hideyuki; Kawai, Rie; Matsumoto, Toru; Nakata, Kazuhiko] Aichi Gakuin Univ, Sch Pharm, Dept Endodont, Chikusa Ku, Nagoya, Aichi 4648651, Japan; [Kondo, Ayami; Mogi, Makio] Aichi Gakuin Univ, Sch Pharm, Dept Med Biochem, Chikusa Ku, Nagoya, Aichi 4648650, Japan	Aichi Gakuin University; Aichi Gakuin University	Mogi, M (corresponding author), Aichi Gakuin Univ, Sch Pharm, Dept Med Biochem, Chikusa Ku, 1-100 Kusumoto, Nagoya, Aichi 4648650, Japan.	makio@dpc.agu.ac.jp			Japan Society for the Promotion of Science [26462903, 26462904]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science KAKENHI (grant numbers: 26462903 and 26462904).	Ainle FN, 2011, J BIOL CHEM, V286, P1323, DOI 10.1074/jbc.M110.159475; Almonte-Becerril M, 2010, APOPTOSIS, V15, P631, DOI 10.1007/s10495-010-0458-z; Bullon P, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-122; Candelario-Jalil E, 2007, J PHARMACOL EXP THER, V323, P488, DOI 10.1124/jpet.107.127035; Choi Alexander J S, 2011, Int J Cell Biol, V2011, P732798, DOI 10.1155/2011/732798; Couve E, 2013, J DENT RES, V92, P765, DOI 10.1177/0022034513495874; Durand SH, 2006, J IMMUNOL, V176, P2880, DOI 10.4049/jimmunol.176.5.2880; Eba H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052523; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Farges JC, 2009, J EXP ZOOL PART B, V312B, P425, DOI 10.1002/jez.b.21259; Gordy C, 2012, PROTEIN CELL, V3, P17, DOI 10.1007/s13238-011-1127-x; Ha SW, 2014, ACS NANO, V8, P5898, DOI 10.1021/nn5009879; Hayami T, 2008, MATRIX BIOL, V27, P682, DOI 10.1016/j.matbio.2008.07.005; Hiyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083563; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Huang CYC, 2009, REGEN MED, V4, P809, DOI [10.2217/rme.09.55, 10.2217/RME.09.55]; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019; Kawai R, 2014, ORAL DIS, V20, P395, DOI 10.1111/odi.12134; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Mogi M, 2003, J BIOL CHEM, V278, P47477, DOI 10.1074/jbc.M307055200; Noguchi F, 2009, J ENDODONT, V35, P668, DOI 10.1016/j.joen.2009.01.016; Nomiyama K, 2007, J ENDODONT, V33, P1187, DOI 10.1016/j.joen.2007.05.015; Okamoto M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04493; Ozeki N, 2014, ORAL DIS, V20, P505, DOI 10.1111/odi.12165; Ozeki N, 2002, ARCH ORAL BIOL, V47, P511, DOI 10.1016/S0003-9969(02)00035-3; Ozeki N, 2014, EXP CELL RES, V328, P69, DOI 10.1016/j.yexcr.2014.05.006; Ozeki N, 2014, J BIOL CHEM, V289, P14380, DOI 10.1074/jbc.M113.526772; Ozeki N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080026; Rosello A, 2012, CLIN EXP IMMUNOL, V168, P52, DOI 10.1111/j.1365-2249.2011.04544.x; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Shimizukawa R, 2005, GENESIS, V42, P47, DOI 10.1002/gene.20122; Simon S R J, 2011, Adv Dent Res, V23, P340, DOI 10.1177/0022034511405327; Smith Anthony J, 2003, J Dent Educ, V67, P678; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Wang RC, 2010, FEBS LETT, V584, P1417, DOI 10.1016/j.febslet.2010.01.009; Wisithphrom K, 2006, J ENDODONT, V32, P853, DOI 10.1016/j.joen.2006.03.017; Xu JP, 2009, STEM CELLS DEV, V18, P487, DOI 10.1089/scd.2008.0113; Xu K, 2013, INFLAMM RES, V62, P229, DOI 10.1007/s00011-012-0572-1; Zheng L, 2009, AM J PATHOL, V175, P1905, DOI 10.2353/ajpath.2009.080705; Zhu LX, 2013, J ENDODONT, V39, P1379, DOI 10.1016/j.joen.2013.07.013	44	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124542	10.1371/journal.pone.0124542	http://dx.doi.org/10.1371/journal.pone.0124542			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894570	gold, Green Published			2022-12-27	WOS:000353211700102
J	Zimmermann, M; Kugler, SJ; Schulz, A; Nagel, AC				Zimmermann, Mirjam; Kugler, Sabrina J.; Schulz, Adriana; Nagel, Anja C.			Loss of putzig Activity Results in Apoptosis during Wing Imaginal Development in Drosophila	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; COMPENSATORY PROLIFERATION; TRANSCRIPTIONAL REGULATION; DISTINCT MECHANISMS; NOTCH ACTIVITY; TELOMERE LOSS; GENE; DREF; JNK; GROWTH	The Drosophila gene putzig (pzg) encodes a nuclear protein that is an integral component of the Trf2/Dref complex involved in the transcription of proliferation-related genes. Moreover, Pzg is found in a complex together with the nucleosome remodeling factor NURF, where it promotes Notch target gene activation. Here we show that downregulation of pzg activity in the developing wing imaginal discs induces an apoptotic response, accompanied by the induction of the pro-apoptotic gene reaper, repression of Drosophila inhibitor of apoptosis protein accumulation and the activation of the caspases Drice, Caspase3 and Dcp1. As a further consequence 'Apoptosis induced Proliferation' (AiP) and 'Apoptosis induced Apoptosis' (AiA) are triggered. As expected, the activity of the stress kinase Jun N-terminal kinase (JNK), proposed to mediate both processes, is ectopically induced in response to pzg loss. In addition, the expression of the mitogen wingless (wg) but not of decapentaplegic (dpp) is observed. We present evidence that downregulation of Notch activates Dcp1 caspase and JNK signaling, however, neither induces ectopic wg nor dpp expression. In contrast, the consequences of Dref-RNAi were largely indistinguishable from pzg-RNAi with regard to apoptosis induction. Moreover, overexpression of Dref ameliorated the downregulation of pzg compatible with the notion that the two are required together to maintain cell and tissue homeostasis in Drosophila.	[Zimmermann, Mirjam; Kugler, Sabrina J.; Schulz, Adriana; Nagel, Anja C.] Univ Hohenheim, Inst Genet, D-70599 Stuttgart, Germany	University Hohenheim	Nagel, AC (corresponding author), Univ Hohenheim, Inst Genet, D-70599 Stuttgart, Germany.	anja.nagel@uni-hohenheim.de	Nagel, Anja/AAA-4254-2022	Nagel, Anja/0000-0002-2733-3249				Abrams JM, 1999, TRENDS CELL BIOL, V9, P435, DOI 10.1016/S0962-8924(99)01646-3; Ahmad K, 1999, GENETICS, V151, P1041; Andreyeva EN, 2005, J CELL SCI, V118, P5465, DOI 10.1242/jcs.02654; Bergantinos C, 2010, DEVELOPMENT, V137, P1169, DOI 10.1242/dev.045559; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Bergmann A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145re8; Berthelet Jean, 2013, Cells, V2, P163, DOI 10.3390/cells2010163; BLACKMAN RK, 1991, DEVELOPMENT, V111, P657; Bosch M, 2005, DEV BIOL, V280, P73, DOI 10.1016/j.ydbio.2005.01.002; Brancolini C, 1997, J CELL BIOL, V139, P759, DOI 10.1083/jcb.139.3.759; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; Colombani J, 2012, SCIENCE, V336, P582, DOI 10.1126/science.1216689; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Djiane A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106211; Djiane A, 2013, EMBO J, V32, P60, DOI 10.1038/emboj.2012.326; Dominguez M, 2014, SEMIN CELL DEV BIOL, V28, P78, DOI 10.1016/j.semcdb.2014.04.012; Fan Y, 2008, TRENDS CELL BIOL, V18, P467, DOI 10.1016/j.tcb.2008.08.001; Fan Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004131; Fujiwara S, 2012, AM J CANCER RES, V2, P36; Garelli A, 2012, SCIENCE, V336, P579, DOI 10.1126/science.1216735; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hay BA, 1997, P NATL ACAD SCI USA, V94, P5195, DOI 10.1073/pnas.94.10.5195; HAY BA, 1994, DEVELOPMENT, V120, P2121; Herrera SC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003446; Hirose F, 2001, MOL CELL BIOL, V21, P7231, DOI 10.1128/MCB.21.21.7231-7242.2001; Hochheimer A, 2002, NATURE, V420, P439, DOI 10.1038/nature01167; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Hyun JY, 2005, MOL CELL BIOL, V25, P5590, DOI 10.1128/MCB.25.13.5590-5598.2005; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Igaki T, 2009, APOPTOSIS, V14, P1021, DOI 10.1007/s10495-009-0361-7; Iyer EPR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072434; Jacobson MD, 1997, CURR BIOL, V7, pR277, DOI 10.1016/S0960-9822(06)00136-9; Kashio S, 2014, DEV GROWTH DIFFER, V56, P368, DOI 10.1111/dgd.12139; Kessler T, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-15; Kondo S, 2006, MOL CELL BIOL, V26, P7258, DOI 10.1128/MCB.00183-06; Kugler SJ, 2007, MOL BIOL CELL, V18, P3733, DOI 10.1091/mbc.E07-03-0263; Kugler SJ, 2011, GENETICS, V188, P127, DOI 10.1534/genetics.111.127795; Kugler SJ, 2010, MOL BIOL CELL, V21, P3443, DOI 10.1091/mbc.E10-03-0212; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Maier D, 2002, P NATL ACAD SCI USA, V99, P15480, DOI 10.1073/pnas.242596699; Martin FA, 2009, INT J DEV BIOL, V53, P1341, DOI 10.1387/ijdb.072447fm; Martin SJ, 2002, CELL, V109, P793, DOI 10.1016/S0092-8674(02)00802-4; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Mason JM, 2008, BIOESSAYS, V30, P25, DOI 10.1002/bies.20688; Matsukage A, 2008, BBA-GENE REGUL MECH, V1779, P81, DOI 10.1016/j.bbagrm.2007.11.011; Mattila J, 2005, INT J DEV BIOL, V49, P391, DOI 10.1387/ijdb.052006jm; McCall K, 1997, TRENDS GENET, V13, P222, DOI 10.1016/S0168-9525(97)01126-8; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Milan M, 1997, P NATL ACAD SCI USA, V94, P5691, DOI 10.1073/pnas.94.11.5691; Mollereau B, 2013, CELL DEATH DIFFER, V20, P181, DOI 10.1038/cdd.2012.82; Morata G, 2013, ELIFE, V2, DOI 10.7554/eLife.01388; Morata G, 2011, DEV GROWTH DIFFER, V53, P168, DOI 10.1111/j.1440-169X.2010.01225.x; Muller D, 2005, GENETICS, V171, P1137, DOI 10.1534/genetics.105.044453; Nagel AC, 2005, MOL CELL BIOL, V25, P10433, DOI 10.1128/MCB.25.23.10433-10441.2005; Neufeld TP, 1998, CURR OPIN CELL BIOL, V10, P784, DOI 10.1016/S0955-0674(98)80122-1; Nigg EA, 2005, ADV EXPT MED BIOL; Ohler U, 2002, GENOME BIOL, V3, P87, DOI DOI 10.1186/GB-2002-3-12-RESEARCH0087; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Perez-Garijo A, 2013, ELIFE, V2, DOI 10.7554/eLife.01004; Perez-Garijo A, 2009, DEVELOPMENT, V136, P1169, DOI 10.1242/dev.034017; Protzer CE, 2008, J CELL SCI, V121, P3167, DOI 10.1242/jcs.035014; Richardson H, 2002, J IMMUNOL METHODS, V265, P21, DOI 10.1016/S0022-1759(02)00068-6; RING JM, 1993, DEVELOPMENT, P251; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Ryoo HD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008797; Ryu JR, 1997, NUCLEIC ACIDS RES, V25, P794, DOI 10.1093/nar/25.4.794; Silva-Sousa R, 2013, MOBILE DNA-UK, V4, DOI 10.1186/1759-8753-4-18; Silva-Sousa R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003153; Smith-Bolton RK, 2009, DEV CELL, V16, P797, DOI 10.1016/j.devcel.2009.04.015; Sogame N, 2003, P NATL ACAD SCI USA, V100, P4696, DOI 10.1073/pnas.0736384100; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Titen SWA, 2008, GENETICS, V180, P1821, DOI 10.1534/genetics.108.093625; Trong-Tue N, 2010, ONCOGENE, V29, P2060, DOI 10.1038/onc.2009.483; Vidal M, 2006, CURR OPIN GENET DEV, V16, P10, DOI 10.1016/j.gde.2005.12.004; Vo N, 2014, SCI REP-UK, V4, DOI 10.1038/srep07196; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Worley MI, 2012, ANNU REV GENET, V46, P289, DOI 10.1146/annurev-genet-110711-155637; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793; Yoshida H, 2004, GENES CELLS, V9, P935, DOI 10.1111/j.1365-2443.2004.00775.x; You H, 2013, J CELL SCI, V126, P2718, DOI 10.1242/jcs.122903	92	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124652	10.1371/journal.pone.0124652	http://dx.doi.org/10.1371/journal.pone.0124652			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894556	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700113
J	Chatzidaki, A; Fouillet, A; Li, JL; Dage, J; Millar, NS; Sher, E; Ursu, D				Chatzidaki, Anna; Fouillet, Antoine; Li, Jingling; Dage, Jeffrey; Millar, Neil S.; Sher, Emanuele; Ursu, Daniel			Pharmacological Characterisation of Nicotinic Acetylcholine Receptors Expressed in Human iPSC-Derived Neurons	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; ALLOSTERIC TRANSMEMBRANE SITE; PARTIAL DUPLICATION; ALZHEIMERS-DISEASE; SINGLE-CHANNEL; GENE CHRFAM7A; ION CHANNELS; ALPHA-7; SCHIZOPHRENIA; CHRNA7	Neurons derived from human induced pluripotent stem cells (iPSCs) represent a potentially valuable tool for the characterisation of neuronal receptors and ion channels. Previous studies on iPSC-derived neuronal cells have reported the functional characterisation of a variety of receptors and ion channels, including glutamate receptors, gamma-aminobutyric acid (GABA) receptors and several voltage-gated ion channels. In the present study we have examined the expression and functional properties of nicotinic acetylcholine receptors (nAChRs) in human iPSC-derived neurons. Gene expression analysis indicated the presence of transcripts encoding several nAChR subunits, with highest levels detected for alpha 3-alpha 7, beta 1, beta 2 and beta 4 subunits (encoded by CHRNA3-CHRNA7, CHRNB1, CHRNB2 and CHRNB4 genes). In addition, similarly high transcript levels were detected for the truncated dupa7 subunit transcript, encoded by the partially duplicated gene CHRFAM7A, which has been associated with psychiatric disorders such as schizophrenia. The functional properties of these nAChRs have been examined by calcium fluorescence and by patch-clamp recordings. The data obtained suggest that the majority of functional nAChRs expressed in these cells have pharmacological properties typical of alpha 7 receptors. Large responses were induced by a selective alpha 7 agonist (compound B), in the presence of the alpha 7-selective positive allosteric modulator (PAM) PNU-120596, which were blocked by the alpha 7-selective antagonist methyllycaconitine (MLA). In addition, a small proportion of the neurons express nAChRs with properties typical of heteromeric (non-alpha 7 containing) nAChR subtypes. These cells therefore represent a great tool to advance our understanding of the properties of native human nAChRs, alpha 7 in particular.	[Chatzidaki, Anna; Millar, Neil S.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Fouillet, Antoine; Sher, Emanuele; Ursu, Daniel] Eli Lilly & Co, Lilly Res Ctr, Windlesham, Surrey, England; [Li, Jingling; Dage, Jeffrey] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	University of London; University College London; Eli Lilly; Eli Lilly	Ursu, D (corresponding author), Eli Lilly & Co, Lilly Res Ctr, Windlesham, Surrey, England.	Ursu_Daniel@lilly.com			Industrial CASE Studentship; Medical Research Council (MRC) [G1001602]; Medical Research Council [1069300] Funding Source: researchfish	Industrial CASE Studentship; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by an Industrial CASE Studentship awarded by the Medical Research Council (MRC; G1001602). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araud T, 2011, BIOCHEM PHARMACOL, V82, P904, DOI 10.1016/j.bcp.2011.06.018; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Collins T, 2011, NEUROPHARMACOLOGY, V61, P1306, DOI 10.1016/j.neuropharm.2011.07.035; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; daCosta CJB, 2011, J NEUROSCI, V31, P13870, DOI 10.1523/JNEUROSCI.2652-11.2011; Dage JL, 2014, PSYCHOPHARMACOLOGY, V231, P1105, DOI 10.1007/s00213-013-3384-2; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Dolmetsch R, 2011, CELL, V145, P831, DOI 10.1016/j.cell.2011.05.034; Flomen RH, 2006, AM J MED GENET B, V141B, P571, DOI 10.1002/ajmg.b.30306; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; Gault J, 1998, GENOMICS, V52, P173, DOI 10.1006/geno.1998.5363; Gill JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055047; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073/pnas.1017975108; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Gundisch D, 2011, EXPERT OPIN THER PAT, V21, P1867, DOI 10.1517/13543776.2011.637919; Haydar SN, 2010, CURR TOP MED CHEM, V10, P144, DOI 10.2174/156802610790410983; Haythornthwaite A, 2012, J BIOMOL SCREEN, V17, P1264, DOI 10.1177/1087057112457821; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Jindrichova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032073; Leonard S, 2002, ARCH GEN PSYCHIAT, V59, P1085, DOI 10.1001/archpsyc.59.12.1085; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Millar NS, 2003, BIOCHEM SOC T, V31, P869, DOI 10.1042/BST0310869; Miller DT, 2009, J MED GENET, V46, P242, DOI 10.1136/jmg.2008.059907; Palczynska MM, 2012, MOL PHARMACOL, V82, P910, DOI 10.1124/mol.112.080259; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Parri HR, 2011, BIOCHEM PHARMACOL, V82, P931, DOI 10.1016/j.bcp.2011.06.039; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; PHILLIPS E, Patent No. 0160821; Riley B, 2002, GENOMICS, V79, P197, DOI 10.1006/geno.2002.6694; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618; Sinkus ML, 2009, BRAIN RES, V1291, P1, DOI 10.1016/j.brainres.2009.07.041; Sitzia F, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00081; Steinlein OK, 2008, BIOCHEM PHARMACOL, V76, P1175, DOI 10.1016/j.bcp.2008.07.012; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wang Y, 2014, J BIOL CHEM, V289, P26451, DOI 10.1074/jbc.M114.582858; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Wilens TE, 2007, BIOCHEM PHARMACOL, V74, P1212, DOI 10.1016/j.bcp.2007.07.002; Williams DK, 2012, MOL PHARMACOL, V82, P746, DOI 10.1124/mol.112.080317; Williams DK, 2011, MOL PHARMACOL, V80, P1013, DOI 10.1124/mol.111.074302; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105	42	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125116	10.1371/journal.pone.0125116	http://dx.doi.org/10.1371/journal.pone.0125116			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906356	Green Published, Green Submitted, gold			2022-12-27	WOS:000353332000102
J	Chiappori, F; Fumian, M; Milanesi, L; Merelli, I				Chiappori, Federica; Fumian, Marco; Milanesi, Luciano; Merelli, Ivan			DnaK as Antibiotic Target: Hot Spot Residues Analysis for Differential Inhibition of the Bacterial Protein in Comparison with the Human HSP70	PLOS ONE			English	Article							ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; MOLECULAR CHAPERONES; BOUND PEPTIDE; BINDING; DOMAIN; HEAT-SHOCK-PROTEIN-70; MODEL	DnaK, the bacterial homolog of human Hsp70, plays an important role in pathogens survival under stress conditions, like antibiotic therapies. This chaperone sequesters protein aggregates accumulated in bacteria during antibiotic treatment reducing the effect of the cure. Although different classes of DnaK inhibitors have been already designed, they present low specificity. DnaK is highly conserved in prokaryotes (identity 50-70%), which encourages the development of a unique inhibitor for many different bacterial strains. We used the DnaK of Acinetobacter baumannii as representative for our analysis, since it is one of the most important opportunistic human pathogens, exhibits a significant drug resistance and it has the ability to survive in hospital environments. The E. coli DnaK was also included in the analysis as reference structure due to its wide diffusion. Unfortunately, bacterial DnaK and human Hsp70 have an elevated sequence similarity. Therefore, we performed a differential analysis of DnaK and Hsp70 residues to identify hot spots in bacterial proteins that are not present in the human homolog, with the aim of characterizing the key pharmacological features necessary to design selective inhibitors for DnaK. Different conformations of DnaK and Hsp70 bound to known inhibitor-peptides for DnaK, and ineffective for Hsp70, have been analysed by molecular dynamics simulations to identify residues displaying stable and selective interactions with these peptides. Results achieved in this work show that there are some residues that can be used to build selective inhibitors for DnaK, which should be ineffective for the human Hsp70.	[Chiappori, Federica; Fumian, Marco; Milanesi, Luciano; Merelli, Ivan] Natl Res Council CNR, Inst Biomed Technol, Segrate, MI, Italy; [Fumian, Marco] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Milano-Bicocca	Chiappori, F (corresponding author), Natl Res Council CNR, Inst Biomed Technol, Segrate, MI, Italy.	federica.chiappori@itb.cnr.it	Merelli, Ivan/O-2543-2015; Chiappori, Federica/S-5689-2019; Merelli, Ivan/AAX-6171-2020; Milanesi, Luciano/AAE-7230-2019	Merelli, Ivan/0000-0003-3587-3680; Chiappori, Federica/0000-0001-8099-4348; Merelli, Ivan/0000-0003-3587-3680; Milanesi, Luciano/0000-0002-1201-3939	Italian Ministry of Education and Research (MIUR) [PB05]; HIRMA [RBAP11YS7 K]; European MIMOMICS projects	Italian Ministry of Education and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); HIRMA; European MIMOMICS projects	This paper has been supported by the Italian Ministry of Education and Research (MIUR) through the Flagship (PB05) InterOmics, HIRMA (RBAP11YS7 K), and the European MIMOMICS projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Azoulay I, 2013, INT J MOL SCI, V14, P12675, DOI 10.3390/ijms140612675; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Chiappori F, 2013, EUR J MED CHEM, V63, P423, DOI 10.1016/j.ejmech.2013.02.021; Chiappori F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002844; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Czihal P, 2012, ACS CHEM BIOL, V7, P1281, DOI 10.1021/cb300063v; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Gao XC, 2012, J BIOL CHEM, V287, P6044, DOI 10.1074/jbc.M111.294728; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Hansen A, 2012, ANTIMICROB AGENTS CH, V56, P5194, DOI 10.1128/AAC.00585-12; Henderson B, 2006, INFECT IMMUN, V74, P3693, DOI 10.1128/IAI.01882-05; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hesterkamp T, 1998, EMBO J, V17, P4818, DOI 10.1093/emboj/17.16.4818; Humphrey W, 1996, J MOL GRAPHICS, V14; Knappe D, 2011, CHEMBIOCHEM, V12, P874, DOI 10.1002/cbic.201000792; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; MILNER CM, 1990, IMMUNOGENETICS, V32, P242; Montgomery DL, 1999, J MOL BIOL, V286, P915, DOI 10.1006/jmbi.1998.2514; Patury S, 2009, CURR TOP MED CHEM, V9, P1337, DOI 10.2174/156802609789895674; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Rudiger S, 2000, J MOL BIOL, V304, P245, DOI 10.1006/jmbi.2000.4193; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Shan YB, 2011, J AM CHEM SOC, V133, P9181, DOI 10.1021/ja202726y; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh VK, 2007, MICROBIOL-SGM, V153, P3162, DOI 10.1099/mic.0.2007/009506-0; Srinivasan SR, 2012, MOL BIOSYST, V8, P2323, DOI 10.1039/c2mb25145k; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Tomoyasu T, 2012, CELL STRESS CHAPERON, V17, P41, DOI 10.1007/s12192-011-0284-4; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Yamaguchi Y, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-16; Zahn M, 2013, J MOL BIOL, V425, P2463, DOI 10.1016/j.jmb.2013.03.041	40	30	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124563	10.1371/journal.pone.0124563	http://dx.doi.org/10.1371/journal.pone.0124563			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905464	gold, Green Published, Green Submitted			2022-12-27	WOS:000353332000076
J	Lin, J; Karlsson, M; Olofson, AS; Belak, S; Malmsten, J; Dalin, AM; Widen, F; Norder, H				Lin, Jay; Karlsson, Marie; Olofson, Ann-Sophie; Belak, Sandor; Malmsten, Jonas; Dalin, Anne-Marie; Widen, Frederik; Norder, Helene			High Prevalence of Hepatitis E Virus in Swedish Moose - A Phylogenetic Characterization and Comparison of the Virus from Different Regions	PLOS ONE			English	Article							GENOTYPE 4; MOLECULAR CHARACTERIZATION; INFECTION; HEV; FAMILY; TRANSMISSION; GENOME; HEPEVIRIDAE; DEER; PIGS	Background Hepatitis E virus (HEV) infects a range of species, including humans, pigs, wild boars and deer. Zoonotic transmission may contribute to the high HEV seroprevalence in the human population of many countries. A novel divergent HEV from moose (Alces alces) in Sweden was recently identified by partial genome sequencing. Since only one strain was found, its classification within the HEV family, prevalence in moose and zoonotic potential was unclear. We therefore investigated samples from 231 moose in seven Swedish counties for HEV, and sequenced a near complete moose HEV genome. Phylogenetic analysis to classify this virus within the family Hepeviridae and to explore potential host specific determinants was performed. Methods and Findings The HEV prevalence of moose was determined by PCR (marker for active infection) and serological assays (marker of past infection) of sera and 51 fecal samples from 231 Swedish moose. Markers of active and past infection were found in 67 (29%) animals, while 34 (15%) were positive for HEV RNA, 43 (19%) were seropositive for anti-HEV antibodies, and 10 (4%) had both markers. The number of young individuals positive for HEV RNA was larger than for older individuals, and the number of anti-HEV antibody positive individuals increased with age. The high throughput sequenced moose HEV genome was 35-60% identical to existing HEVs. Partial ORF1 sequences from 13 moose strains showed high similarity among them, forming a distinct monophyletic clade with a common ancestor to HEV genotype 1-6 group, which includes members known for zoonotic transmission. Conclusions This study demonstrates a high frequency of HEV in moose in Sweden, with markers of current and past infection demonstrated in 30% of the animals. Moose is thus an important animal reservoir of HEV. The phylogenetic relationship demonstrated that the moose HEV belonged to the genotype 1-6 group, which includes strains that also infect humans, and therefore may signify a potential for zoonotic transmission of this HEV.	[Lin, Jay; Olofson, Ann-Sophie; Belak, Sandor; Widen, Frederik] Natl Vet Inst SVA, Dept Virol Immunobiol & Parasitol VIP, Uppsala, Sweden; [Lin, Jay; Belak, Sandor; Widen, Frederik] Swedish Univ Agr Sci SLU, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Karlsson, Marie; Norder, Helene] Univ Gothenburg, Inst Biomed, Dept Infect Dis, Sect Clin Virol, Gothenburg, Sweden; [Malmsten, Jonas] Natl Vet Inst SVA, Dept Pathol andWildlife Dis, Uppsala, Sweden; [Malmsten, Jonas; Dalin, Anne-Marie] Swedish Univ Agr Sci SLU, Dept Clin Sci, Div Reprod, Uppsala, Sweden	National Veterinary Institute SVA; Swedish University of Agricultural Sciences; University of Gothenburg; National Veterinary Institute SVA; Swedish University of Agricultural Sciences	Lin, J (corresponding author), Natl Vet Inst SVA, Dept Virol Immunobiol & Parasitol VIP, Uppsala, Sweden.	jay.lin@sva.se	Norder, Helene/GSD-5853-2022; Belak, Sandor/AAP-4759-2021	Norder, Helene/0000-0002-7528-3872; Malmsten, Jonas/0000-0003-1868-3746; widen, frederik/0000-0002-6484-3408	Swedish Research Council FORMAS [2009747]; 'PREDEMICS' [278433]; Wildtech Project of the EU Seventh Framework Program [222633]	Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); 'PREDEMICS'; Wildtech Project of the EU Seventh Framework Program	This study was supported by a grant 2009747 from the Swedish Research Council FORMAS (FW), and part of this study was supported under the project 'PREDEMICS', (7th Framework Program, grant agreement no. 278433) (HN) and the Wildtech Project of the EU Seventh Framework Program, (FP7/2007-2013) grant agreement no. 222633. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2011, VIRUS RES, V161, P15, DOI 10.1016/j.virusres.2011.03.017; Batts W, 2011, VIRUS RES, V158, P116, DOI 10.1016/j.virusres.2011.03.019; Baylis SA, 2012, VOX SANG, V103, P89, DOI 10.1111/j.1423-0410.2011.01583.x; Choi JY, 2013, CLIN MOL HEPATOL, V19, P309, DOI 10.3350/cmh.2013.19.3.309; Colson P, 2012, EMERG INFECT DIS, V18, P1361, DOI 10.3201/eid1808.111827; de Deus N, 2008, VET MICROBIOL, V129, P163, DOI 10.1016/j.vetmic.2007.11.002; Dremsek P, 2012, MED MICROBIOL IMMUN, V201, P189, DOI 10.1007/s00430-011-0221-2; Drexler JF, 2012, J VIROL, V86, P9134, DOI 10.1128/JVI.00800-12; Feagins AR, 2007, J GEN VIROL, V88, P912, DOI 10.1099/vir.0.82613-0; Garbuglia AR, 2013, EMERG INFECT DIS, V19, P110, DOI 10.3201/eid1901.120983; Guo QS, 2010, J CLIN MICROBIOL, V48, P317, DOI 10.1128/JCM.01466-09; Halbur PG, 2001, J CLIN MICROBIOL, V39, P918, DOI 10.1128/JCM.39.3.918-923.2001; Haqshenas G, 2001, J GEN VIROL, V82, P2449, DOI 10.1099/0022-1317-82-10-2449; Holla RP, 2013, SEMIN LIVER DIS, V33, P3, DOI 10.1055/s-0033-1338110; Holmes K, 2011, CERVIDAE; Jagarforbundet, 2012, ALGAVSKJUTNING SHOOT; Johne R, 2014, INFECT GENET EVOL, V27, P212, DOI 10.1016/j.meegid.2014.06.024; Johne R, 2010, EMERG INFECT DIS, V16, P1452, DOI 10.3201/eid1609.100444; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Khuroo MS, 2009, J VIRAL HEPATITIS, V16, P519, DOI 10.1111/j.1365-2893.2009.01101.x; KOONIN EV, 1992, P NATL ACAD SCI USA, V89, P8259, DOI 10.1073/pnas.89.17.8259; Krawczynski K, 2011, VIRUS RES, V161, P78, DOI 10.1016/j.virusres.2011.03.007; Kukielka D, 2016, TRANSBOUND EMERG DIS, V63, pE360, DOI 10.1111/tbed.12311; Kumar RM, 2001, EUR J OBSTET GYN R B, V100, P9, DOI 10.1016/S0301-2115(01)00448-1; La Rosa G, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-72; Lin J, 2014, J GEN VIROL, V95, P557, DOI 10.1099/vir.0.059238-0; Liu P, 2012, INFECT GENET EVOL, V12, P428, DOI 10.1016/j.meegid.2012.01.017; Malmsten J, 2014, EPIDEMIOL INFECT, V142, P1205, DOI 10.1017/S0950268813002094; Mansuy JM, 2011, EMERG INFECT DIS, V17, P2309, DOI 10.3201/eid1712.110371; Meng XJ, 1998, ARCH VIROL, V143, P1405, DOI 10.1007/s007050050384; Midgley S, 2014, EMERG INFECT DIS, V20, P156, DOI 10.3201/eid2001.130600; Miyashita K, 2012, HEPATOL RES, V42, P870, DOI 10.1111/j.1872-034X.2012.01006.x; National Center for Biotechnology Information (NCBI), 2014, OP READ FRAM FIND OR; Norder H, 2009, EUROSURVEILLANCE, V14, P20; Raj VS, 2012, EMERG INFECT DIS, V18, P1369, DOI 10.3201/eid1808.111659; Reuter G, 2009, J CLIN VIROL, V44, P277, DOI 10.1016/j.jcv.2009.01.008; Rikihisa Y, 2011, CLIN MICROBIOL REV, V24, P469, DOI 10.1128/CMR.00064-10; Smith DB, 2014, J GEN VIROL, V95, P2223, DOI 10.1099/vir.0.068429-0; Takahashi K, 2004, VIROLOGY, V330, P501, DOI 10.1016/j.virol.2004.10.006; Takahashi M, 2007, J CLIN MICROBIOL, V45, P3671, DOI 10.1128/JCM.01086-07; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tei S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1; Widen F, 2011, EPIDEMIOL INFECT, V139, P361, DOI 10.1017/S0950268810001342; World Health Organization (WHO), 2014, ZOONOSES; Xia HY, 2008, VIRUS GENES, V37, P39, DOI 10.1007/s11262-008-0246-9; Yugo DM, 2013, INT J ENV RES PUB HE, V10, P4507, DOI 10.3390/ijerph10104507; Zhai LJ, 2006, VIRUS RES, V120, P57, DOI 10.1016/j.virusres.2006.01.013	47	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0122102	10.1371/journal.pone.0122102	http://dx.doi.org/10.1371/journal.pone.0122102			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906163	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000353332000010
J	Netten, AP; Rieffe, C; Theunissen, SCPM; Soede, W; Dirks, E; Briaire, JJ; Frijns, JHM				Netten, Anouk P.; Rieffe, Carolien; Theunissen, Stephanie C. P. M.; Soede, Wim; Dirks, Evelien; Briaire, Jeroen J.; Frijns, Johan H. M.			Low Empathy in Deaf and Hard of Hearing (Pre)Adolescents Compared to Normal Hearing Controls	PLOS ONE			English	Article							MENTAL-HEALTH PROBLEMS; SOCIAL NEUROSCIENCE; FRIENDSHIP QUALITY; IMPAIRED CHILDREN; ADOLESCENTS; BEHAVIOR; VALIDATION; AWARENESS; RESPONSES; EMOTIONS	Objective The purpose of this study was to examine the level of empathy in deaf and hard of hearing (pre)adolescents compared to normal hearing controls and to define the influence of language and various hearing loss characteristics on the development of empathy. Methods The study group (mean age 11.9 years) consisted of 122 deaf and hard of hearing children (52 children with cochlear implants and 70 children with conventional hearing aids) and 162 normal hearing children. The two groups were compared using self-reports, a parent-report and observation tasks to rate the children's level of empathy, their attendance to others' emotions, emotion recognition, and supportive behavior. Results Deaf and hard of hearing children reported lower levels of cognitive empathy and prosocial motivation than normal hearing children, regardless of their type of hearing device. The level of emotion recognition was equal in both groups. During observations, deaf and hard of hearing children showed more attention to the emotion evoking events but less supportive behavior compared to their normal hearing peers. Deaf and hard of hearing children attending mainstream education or using oral language show higher levels of cognitive empathy and prosocial motivation than deaf and hard of hearing children who use sign (supported) language or attend special education. However, they are still outperformed by normal hearing children. Conclusions Deaf and hard of hearing children, especially those in special education, show lower levels of empathy than normal hearing children, which can have consequences for initiating and maintaining relationships.	[Netten, Anouk P.; Theunissen, Stephanie C. P. M.; Soede, Wim; Briaire, Jeroen J.; Frijns, Johan H. M.] Leiden Univ, Med Ctr, Dept Otorhinolaryngol & Head & Neck Surg, Leiden, Netherlands; [Rieffe, Carolien] Leiden Univ, Dept Dev Psychol, Leiden, Netherlands; [Rieffe, Carolien; Dirks, Evelien] Dutch Fdn Deaf & Hard Hearing Child, Amsterdam, Netherlands; [Frijns, Johan H. M.] Leiden Inst Brain & Cognit, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC)	Netten, AP (corresponding author), Leiden Univ, Med Ctr, Dept Otorhinolaryngol & Head & Neck Surg, Leiden, Netherlands.	a.p.netten@lumc.nl	Briaire, Jeroen/A-7972-2008; dirks, evelien/M-9914-2017; Frijns, Johan H.M./H-6249-2011	Briaire, Jeroen/0000-0003-4302-817X; Frijns, Johan H.M./0000-0002-1180-3314; Rieffe, Carolien/0000-0002-7584-6698	Netherlands Organisation for Scientific Research (NWO) [452-07-004]; Stichting Het Heinsius-Houbolt Fonds, the Netherlands	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Stichting Het Heinsius-Houbolt Fonds, the Netherlands(Netherlands Government)	This research was supported by the Innovational Research Incentives Scheme (a VIDI grant) by The Netherlands Organisation for Scientific Research (NWO), no. 452-07-004 to CR. AN is supported by the Stichting Het Heinsius-Houbolt Fonds, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHARA GH, 1980, AM ANN DEAF, V125, P38, DOI 10.1353/aad.2012.1175; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Batson CD, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P3; Berndt TJ, 2002, CURR DIR PSYCHOL SCI, V11, P7, DOI 10.1111/1467-8721.00157; Bernhardt BC, 2012, ANNU REV NEUROSCI, V35, P1, DOI 10.1146/annurev-neuro-062111-150536; Blair RJR, 2005, CONSCIOUS COGN, V14, P698, DOI 10.1016/j.concog.2005.06.004; Brownell CA, 2002, BEHAV BRAIN SCI, V25, P28, DOI 10.1017/S0140525X02300013; Calderson Rosemary, 2003, OXFORD HDB DEAF STUD; Chow CM, 2013, J ADOLESCENCE, V36, P191, DOI 10.1016/j.adolescence.2012.10.004; Decety J, 2006, THESCIENTIFICWORLDJO, V6, P1146, DOI 10.1100/tsw.2006.221; Decety J, 2014, PERSPECT PSYCHOL SCI, V9, P525, DOI 10.1177/1745691614545130; Dyck MJ, 2004, J CHILD PSYCHOL PSYC, V45, P789, DOI 10.1111/j.1469-7610.2004.00272.x; EISENBERG N, 1987, PSYCHOL BULL, V101, P91, DOI 10.1037/0033-2909.101.1.91; Engen HG, 2013, CURR OPIN NEUROBIOL, V23, P275, DOI 10.1016/j.conb.2012.11.003; Hall JA, 2009, J NONVERBAL BEHAV, V33, P149, DOI 10.1007/s10919-009-0070-5; Harris P.L., 1989, CHILDREN EMOTION DEV; Hein G, 2010, NEURON, V68, P149, DOI 10.1016/j.neuron.2010.09.003; Hermans D, 2010, J DEAF STUD DEAF EDU, V15, P107, DOI 10.1093/deafed/enp030; Hoffman M. L., 1987, EMPATHY ITS DEV, P47; Jolliffe D, 2006, AGGRESSIVE BEHAV, V32, P540, DOI 10.1002/ab.20154; Ketelaar L, 2012, J PEDIATR PSYCHOL, V37, P1041, DOI 10.1093/jpepsy/jss086; Kort W., 2008, CELF4NL PEARS ASS IN; Kouwenberg M, DEAF HARD HEAR UNPUB; Lamm C, 2015, NEUROSCI RES, V90, P15, DOI 10.1016/j.neures.2014.10.008; Lovett BJ, 2007, CLIN PSYCHOL REV, V27, P1, DOI 10.1016/j.cpr.2006.03.003; Moeller MP, 2007, EAR HEARING, V28, P729, DOI 10.1097/AUD.0b013e318157f033; Overgaauw S, VALIDATION EMP UNPUB; Pfeifer JH, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P183; Pouw LBC, 2013, RES DEV DISABIL, V34, P1256, DOI 10.1016/j.ridd.2012.12.022; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Rieffe C, TEACHING DEAF LEARNE; Rieffe C, 2008, PERS INDIV DIFFER, V45, P756, DOI 10.1016/j.paid.2008.08.001; Rieffe C, 2012, BRIT J DEV PSYCHOL, V30, P477, DOI 10.1111/j.2044-835X.2011.02057.x; Rieffe C, 2010, PERS INDIV DIFFER, V49, P362, DOI 10.1016/j.paid.2010.03.046; Semel E., 2003, CLIN EVALUATION LANG, V4th Edn; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Smith RL, 2011, DEV PSYCHOL, V47, P1792, DOI 10.1037/a0025309; Spinella M, 2005, BIOL PSYCHOL, V70, P175, DOI 10.1016/j.biopsycho.2004.01.005; Stevenson J, 2010, J CHILD PSYCHOL PSYC, V51, P77, DOI 10.1111/j.1469-7610.2009.02124.x; Tellegen P., 1993, EUROPEAN J PSYCHOL A, V9, P147, DOI DOI 10.1016/J.AJHG.2016.01.016; Theunissen SC, 2013, EUR CHILD ADOLESC PS; Theunissen SCPM, 2011, INT J PEDIATR OTORHI, V75, P1313, DOI 10.1016/j.ijporl.2011.07.023; Van Eldik T, 2005, AM ANN DEAF, V150, P11, DOI 10.1353/aad.2005.0024; Van Eldik T, 2004, AM ANN DEAF, V148, P390, DOI 10.1353/aad.2004.0002; van Gent T, 2007, J CHILD PSYCHOL PSYC, V48, P950, DOI 10.1111/j.1469-7610.2007.01775.x; Wechsler D., 1991, WISC 3 WECHSLER INTE; Whitt A, 2013, PSYCHOL REP, V112, P325, DOI 10.2466/16.08.20.PR0.112.1.325-339; Wiefferink CH, 2013, J DEAF STUD DEAF EDU, V18, P175, DOI 10.1093/deafed/ens042; Yoshinaga-Itano C, 2003, MENT RETARD DEV D R, V9, P252, DOI 10.1002/mrdd.10088; Zaki J, 2012, NAT NEUROSCI, V15, P675, DOI 10.1038/nn.3085	50	51	54	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124102	10.1371/journal.pone.0124102	http://dx.doi.org/10.1371/journal.pone.0124102			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KZ	25906365	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000057
J	Savage, CR; Arnold, WK; Gjevre-Nail, A; Koestler, BJ; Bruger, EL; Barker, JR; Waters, CM; Stevenson, B				Savage, Christina R.; Arnold, William K.; Gjevre-Nail, Alexandra; Koestler, Benjamin J.; Bruger, Eric L.; Barker, Jeffrey R.; Waters, Christopher M.; Stevenson, Brian			Intracellular Concentrations of Borrelia burgdorferi Cyclic Di-AMP Are Not Changed by Altered Expression of the CdaA Synthase	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; AFFECT BACTERIAL-GROWTH; GENE-EXPRESSION; BACILLUS-SUBTILIS; STREPTOCOCCUS-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; BINDING PROTEINS; GENOME SEQUENCE; YDAO RIBOSWITCH; I IFN	The second messenger nucleotide cyclic diadenylate monophosphate (c-di-AMP) has been identified in several species of Gram positive bacteria and Chlamydia trachomatis. This molecule has been associated with bacterial cell division, cell wall biosynthesis and phosphate metabolism, and with induction of type I interferon responses by host cells. We demonstrate that B. burgdorferi produces a c-di-AMP synthase, which we designated CdaA. Both CdaA and c-di-AMP levels are very low in cultured B. burgdorferi, and no conditions were identified under which cdaA mRNA was differentially expressed. A mutant B. burgdorferi was produced that expresses high levels of CdaA, yet steady state borrelial cdi-AMP levels did not change, apparently due to degradation by the native DhhP phosphodiesterase. The function(s) of c-di-AMP in the Lyme disease spirochete remains enigmatic.	[Savage, Christina R.; Arnold, William K.; Gjevre-Nail, Alexandra; Stevenson, Brian] Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40506 USA; [Koestler, Benjamin J.; Bruger, Eric L.; Waters, Christopher M.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Barker, Jeffrey R.] Duke Univ, Dept Mol Genet & Microbiol, Ctr Microbial Pathogenesis, Durham, NC USA	University of Kentucky; Michigan State University; Duke University	Stevenson, B (corresponding author), Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40506 USA.	brian.stevenson@uky.edu		Arnold, Will/0000-0003-2447-3489; Koestler, Benjamin/0000-0001-7213-0953; Nail, Alexandra/0000-0002-8008-3891	University of Kentucky College of Medicine; National Science Foundation [MCB1253684]	University of Kentucky College of Medicine; National Science Foundation(National Science Foundation (NSF))	Funded by an exploratory grant from the University of Kentucky College of Medicine to B. Stevenson, and National Science Foundation grant MCB1253684 to CMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2013, EMBO REP, V14, P900, DOI 10.1038/embor.2013.132; Bai YL, 2014, J BACTERIOL, V196, P614, DOI 10.1128/JB.01041-13; Bai YL, 2013, J BACTERIOL, V195, P5123, DOI 10.1128/JB.00769-13; Bai YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035206; BARBOUR AG, 1986, INFECT IMMUN, V52, P549, DOI 10.1128/IAI.52.2.549-554.1986; Barker JR, 2013, MBIO, V4, DOI 10.1128/mBio.00018-13; Bian J, 2011, J BACTERIOL, V193, P3912, DOI 10.1128/JB.00386-11; Bono JL, 2000, J BACTERIOL, V182, P2445, DOI 10.1128/JB.182.9.2445-2452.2000; Bono JL, 1998, MICROBIOL-UK, V144, P1033, DOI 10.1099/00221287-144-4-1033; Calmano MJ, 2007, MOL MICROBIOL, V65, P1193, DOI 10.1111/j.1365-2958.2007.05860.x; Campeotto I, J BIOL CHEM, V2-15, P2888; Casjens S, 1997, J BACTERIOL, V179, P217, DOI 10.1128/jb.179.1.217-227.1997; Choi PH, 2015, MICROBIOLOG IN PRESS, DOI [10.1002/mbo1003.1243, DOI 10.1002/MBO1003.1243]; Corrigan RM, 2015, J BIOL CHEM, V290, P5826, DOI 10.1074/jbc.M114.598300; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Dengler V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073512; Dey B, 2015, NAT MED, V21, P401, DOI 10.1038/nm.3813; Fang M, 2009, NUCLEIC ACIDS RES, V37, P5114, DOI 10.1093/nar/gkp527; Fisher MA, 2005, P NATL ACAD SCI USA, V102, P5162, DOI 10.1073/pnas.0408536102; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Gandara C, 2015, DNA REPAIR, V27, P1, DOI 10.1016/j.dnarep.2014.12.007; Gao A, 2014, NAT CHEM BIOL, V10, P787, DOI [10.1038/NCHEMBIO.1607, 10.1038/nchembio.1607]; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hastey CJ, 2014, INFECT IMMUN, V82, P1548, DOI 10.1128/IAI.00969-13; Huynh TN, 2015, P NATL ACAD SCI USA, V112, pE747, DOI 10.1073/pnas.1416485112; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Jones CP, 2014, EMBO J, V33, P2692, DOI 10.15252/embj.201489209; Jutras BL, 2012, J BACTERIOL, V194, P3395, DOI 10.1128/JB.00252-12; Jutras BL, 2012, J BACTERIOL, V194, P778, DOI 10.1128/JB.06394-11; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Kamegaya T, 2011, NAGOYA J MED SCI, V73, P49; Liu MF, 2012, MICROBIOL-SGM, V158, P886, DOI 10.1099/mic.0.054619-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Massie JP, 2012, P NATL ACAD SCI USA, V109, P12746, DOI 10.1073/pnas.1115663109; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Miller JC, 2003, INFECT IMMUN, V71, P6943, DOI 10.1128/IAI.71.12.6943-6952.2003; Miller Jennifer C, 2005, Curr Protoc Microbiol, VChapter 1D, DOI 10.1002/9780471729259.mc01d03s00; Miller JC, 2010, INFECT IMMUN, V78, P3144, DOI 10.1128/IAI.01070-09; Miller JC, 2008, J IMMUNOL, V181, P8492, DOI 10.4049/jimmunol.181.12.8492; Muller M, 2015, FEBS LETT, V589, P45, DOI 10.1016/j.febslet.2014.11.022; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Nelson JW, 2013, NAT CHEM BIOL, V9, P834, DOI [10.1038/NCHEMBIO.1363, 10.1038/nchembio.1363]; Nickels BE, 2012, TRANSCR-AUSTIN, V3, P300, DOI 10.4161/trns.21903; Nickels BE, 2011, J MOL BIOL, V412, P772, DOI 10.1016/j.jmb.2011.06.015; Ojaimi C, 2003, INFECT IMMUN, V71, P1689, DOI 10.1128/IAI.71.4.1689-1705.2003; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Ren AM, 2014, NAT CHEM BIOL, V10, P780, DOI [10.1038/NCHEMBIO.1606, 10.1038/nchembio.1606]; Revel AT, 2002, P NATL ACAD SCI USA, V99, P1562, DOI 10.1073/pnas.032667699; Rogers EA, 2009, MOL MICROBIOL, V71, P1551, DOI 10.1111/j.1365-2958.2009.06621.x; Rosenberg J, 2015, J BIOL CHEM; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Srivastav R, 2014, NUCLEIC ACIDS RES, V42, P7894, DOI 10.1093/nar/gku425; Stevenson B, 1998, INFECT IMMUN, V66, P2648, DOI 10.1128/IAI.66.6.2648-2654.1998; Sureka K, 2014, CELL, V158, P1389, DOI 10.1016/j.cell.2014.07.046; SUZUKI H, 1978, P NATL ACAD SCI USA, V75, P664, DOI 10.1073/pnas.75.2.664; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tilly K, 1997, MOL MICROBIOL, V25, P361, DOI 10.1046/j.1365-2958.1997.4711838.x; Tokarz R, 2004, INFECT IMMUN, V72, P5419, DOI 10.1128/IAI.72.9.5419-5432.2004; Vvedenskaya IO, 2012, GENE DEV, V26, P1498, DOI 10.1101/gad.192732.112; Whetstine CR, 2009, APPL ENVIRON MICROB, V75, P6553, DOI 10.1128/AEM.02825-08; Witte CE, 2013, MBIO, V4, DOI 10.1128/mBio.00282-13; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Yamamoto T, 2012, INFECT IMMUN, V80, P2323, DOI 10.1128/IAI.06162-11; Yang J, 2014, MOL MICROBIOL, V93, P65, DOI 10.1111/mmi.12641; Ye MP, 2014, INFECT IMMUN, V82, P1840, DOI 10.1128/IAI.00030-14; Zhang L, 2013, J BIOL CHEM, V288, P3085, DOI 10.1074/jbc.M112.428110; Zuckert Wolfram R, 2007, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12c01s4	74	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125440	10.1371/journal.pone.0125440	http://dx.doi.org/10.1371/journal.pone.0125440			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906393	gold, Green Published, Green Submitted			2022-12-27	WOS:000353332000111
J	Aldaz, G; Shluzas, LA; Pickham, D; Eris, O; Sadler, J; Joshi, S; Leifer, L				Aldaz, Gabriel; Shluzas, Lauren Aquino; Pickham, David; Eris, Ozgur; Sadler, Joel; Joshi, Shantanu; Leifer, Larry			Hands-Free Image Capture, Data Tagging and Transfer Using Google Glass: A Pilot Study for Improved Wound Care Management	PLOS ONE			English	Article							SPEECH RECOGNITION; PRESSURE ULCERS; NAVIGATION; WORDS; ERROR	Chronic wounds, including pressure ulcers, compromise the health of 6.5 million Americans and pose an annual estimated burden of $25 billion to the U.S. health care system. When treating chronic wounds, clinicians must use meticulous documentation to determine wound severity and to monitor healing progress over time. Yet, current wound documentation practices using digital photography are often cumbersome and labor intensive. The process of transferring photos into Electronic Medical Records (EMRs) requires many steps and can take several days. Newer smartphone and tablet-based solutions, such as Epic Haiku, have reduced EMR upload time. However, issues still exist involving patient positioning, image-capture technique, and patient identification. In this paper, we present the development and assessment of the SnapCap System for chronic wound photography. Through leveraging the sensor capabilities of Google Glass, SnapCap enables hands-free digital image capture, and the tagging and transfer of images to a patient's EMR. In a pilot study with wound care nurses at Stanford Hospital (n=16), we (i) examined feature preferences for hands-free digital image capture and documentation, and (ii) compared SnapCap to the state of the art in digital wound care photography, the Epic Haiku application. We used the Wilcoxon Signed-ranks test to evaluate differences in mean ranks between preference options. Preferred hands-free navigation features include barcode scanning for patient identification, Z(15) = -3.873, p < 0.001, r = 0.71, and double-blinking to take photographs, Z(13) = -3.606, p < 0.001, r = 0.71. In the comparison between SnapCap and Epic Haiku, the SnapCap System was preferred for sterile image-capture technique, Z(16) = -3.873, p < 0.001, r = 0.68. Responses were divided with respect to image quality and overall ease of use. The study's results have contributed to the future implementation of new features aimed at enhancing mobile hands-free digital photography for chronic wound care.	[Aldaz, Gabriel; Shluzas, Lauren Aquino; Sadler, Joel; Joshi, Shantanu; Leifer, Larry] Stanford Univ, Ctr Design Res, Stanford, CA 94305 USA; [Pickham, David] Stanford Hlth Care, Stanford, CA USA; [Eris, Ozgur] Delft Univ Technol, Delft, Netherlands	Stanford University; Stanford University; Delft University of Technology	Shluzas, LA (corresponding author), Stanford Univ, Ctr Design Res, Stanford, CA 94305 USA.	lauren.aquino@stanford.edu	Joshi, Sudhanshu/L-2284-2019; Pickham, David/AAD-8301-2021	Joshi, Sudhanshu/0000-0003-4748-5001; 	Hasso Plattner Design Thinking Research Program	Hasso Plattner Design Thinking Research Program	This work was supported by Hasso Plattner Design Thinking Research Program, http://www.hpi.uni-potsdam.de/. Authors who received funding: LAS GA SSJ LJL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Chulhyun, 2008, Adv Skin Wound Care, V21, P85, DOI 10.1097/01.ASW.0000305411.58350.7d; Albrecht UV, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3225; Beard HR, 2014, HEALTHCARE, V2, P22, DOI 10.1016/j.hjdsi.2013.09.009; Bigham J. P., 2010, P 23 ANN ACM S US IN, P333, DOI [DOI 10.1145/1866029.1866080, 10.1145/1866029.1866080?casa_token=eqdciLsaAKsAAAAA:v_iSvCJKVqaa-xY5ls_4fwveOme0IVWxS0hy40kPYpp]; Bizzotto N, 2014, SURG INNOV, V21, P338, DOI 10.1177/1553350613513514; Craig A.B., 2013, UNDERSTANDING AUGMEN, P209; Dixon BJ, 2013, SURG ENDOSC, V27, P454, DOI 10.1007/s00464-012-2457-3; Doherty A, 2013, SENSECAM 13, P60; Glauser W, 2013, CAN MED ASSOC J, V185, P1385, DOI 10.1503/cmaj.109-4607; Goldwater S, 2010, SPEECH COMMUN, V52, P181, DOI 10.1016/j.specom.2009.10.001; Gonzales D, 2011, STANFORD NURSE, V31, P12; Google, GLASS UPD; Google, GOOGL GL; Graves N, 2005, INFECT CONT HOSP EP, V26, P293, DOI 10.1086/502542; Hayes S, 2003, NURSING TIMES, V99, P1; Ishimaru S, 2014, AH 14, P150; Jacob R. J. K., 1990, SIGCHI Bulletin, P11; Jurafsky Dan, 2014, SPEECH LANGUAGE PROC, V3; Krouskop TA, 2002, J REHABIL RES DEV, V39, P337; Lutz BJ, 2013, CHICAGO SURG USE GOO; Lyder CH, 2012, J AM GERIATR SOC, V60, P1603, DOI 10.1111/j.1532-5415.2012.04106.x; Medical Xpress, 2013, 1 US SURG TRANSM LIV; Muensterer OJ, 2014, INT J SURG, V12, P281, DOI 10.1016/j.ijsu.2014.02.003; National Pressure Ulcer Advisory Council, FAQ PHOT PRESS ULC D; NPUAP, PRESS ULC STAG CAT; Perry Baromedical, MAVIS 3; Sears A, 2003, HUM-COMPUT INTERACT, V18, P229, DOI 10.1207/S15327051HCI1803_2; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Shluzas LA, 2014, US Provisional Patent, Patent No. 61968857; Wagner P, 2006, ETRA 2006, P117; Zafar A, 2004, INT J MED INFORM, V73, P719, DOI 10.1016/j.ijmedinf.2004.05.008; ZBar, BARC READ	32	28	28	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0121179	10.1371/journal.pone.0121179	http://dx.doi.org/10.1371/journal.pone.0121179			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902061	Green Submitted, gold, Green Published			2022-12-27	WOS:000353331500009
J	Beissner, F; Brunner, F; Fink, M; Meissner, K; Kaptchuk, TJ; Napadow, V				Beissner, Florian; Bruenner, Franziska; Fink, Maria; Meissner, Karin; Kaptchuk, Ted J.; Napadow, Vitaly			Placebo-Induced Somatic Sensations: A Multi-Modal Study of Three Different Placebo Interventions	PLOS ONE			English	Article							MCGILL PAIN QUESTIONNAIRE; PERSONALITY-TRAIT; NOVELTY SEEKING; MUSCLE PAIN; ACUPUNCTURE; BRAIN; PERCEPTION; MICROSTIMULATION; SYNAESTHESIA; MIGRAINE	Somatic sensations induced by placebos are a frequent phenomenon whose etiology and clinical relevance remains unknown. In this study, we have evaluated the quantitative, qualitative, spatial, and temporal characteristics of placebo-induced somatic sensations in response to three different placebo interventions: (1) placebo irritant solution, (2) placebo laser stimulation, and (3) imagined laser stimulation. The quality and intensity of evoked sensations were assessed using the McGill pain questionnaire and visual analogue scales (VAS), while subjects' sensation drawings processed by a geographic information system (GIS) were used to measure their spatial characteristics. We found that all three interventions are capable of producing robust sensations most frequently described as "tingling" and "warm" that can reach consider-able spatial extent (<= 205mm(2)) and intensity (<= 80/100 VAS). Sensations from placebo stimulation were often referred to areas remote from the stimulation site and exhibit considerable similarity with referred pain. Interestingly, there was considerable similarity of qualitative features as well as spatial patterns across subjects and placebos. However, placebo laser stimulation elicited significantly stronger and more widespread sensations than placebo irritant solution. Finally, novelty seeking, a character trait assessed by the Temperament and Character Inventory and associated with basal dopaminergic activity, was less pronounced in subjects susceptible to report placebo-induced sensations. Our study has shown that placebo-induced sensations are frequent and can reach considerable intensity and extent. As multiple somatosensory subsystems are involved despite the lack of peripheral stimulus, we propose a central etiology for this phenomenon.	[Beissner, Florian] Hannover Med Sch, Somatosensory & Auton Therapy Res, Inst Neuroradiol, D-30625 Hannover, Germany; [Beissner, Florian; Napadow, Vitaly] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Boston, MA 02129 USA; [Bruenner, Franziska; Fink, Maria] Jena Univ Hosp, Pain & Auton Integrat Res PAIR, Dept Psychiat & Psychotherapy, D-07743 Jena, Germany; [Meissner, Karin] Univ Munich, Inst Med Psychol, D-80336 Munich, Germany; [Kaptchuk, Ted J.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Program Placebo Studies, Boston, MA 02215 USA; [Napadow, Vitaly] Kyung Hee Univ, Dept Biomed Engn, Yongin, South Korea	Hannover Medical School; Harvard University; Massachusetts General Hospital; Friedrich Schiller University of Jena; University of Munich; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Kyung Hee University	Beissner, F (corresponding author), Hannover Med Sch, Somatosensory & Auton Therapy Res, Inst Neuroradiol, D-30625 Hannover, Germany.	beissner.florian@mh-hannover.de	MEISSNER, Karin/AAS-2483-2021; Beissner, Florian/I-3474-2019	Beissner, Florian/0000-0003-0513-7551; Napadow, Vitaly/0000-0003-1941-1750	Horst Gortz Foundation; German Research Foundation [BE4677/1-1]; Schweizer-Arau Foundation; Theophrastus Foundation; NIH [K24-AT004095, P01-AT006663, R01-AT007550, R01-AR064367]; National Center for Complementary & Integrative Health [K24AT004095, R01AT007550, P01AT006663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064367] Funding Source: NIH RePORTER	Horst Gortz Foundation; German Research Foundation(German Research Foundation (DFG)); Schweizer-Arau Foundation; Theophrastus Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by Horst Gortz Foundation (FBe, FBr), German Research Foundation BE4677/1-1 (FB), Schweizer-Arau Foundation (KM), Theophrastus Foundation (KM) and NIH grants K24-AT004095 (TJK), P01-AT006663 (VN, TJK), R01-AT007550 (VN), and R01-AR064367 (VN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banissy MJ, 2009, EXP BRAIN RES, V198, P261, DOI 10.1007/s00221-009-1810-9; Beissner F, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/591304; Benedetti F, 2011, NEUROPSYCHOPHARMACOL, V36, P339, DOI 10.1038/npp.2010.81; Bryant BP, 1999, BRAIN RES, V842, P452, DOI 10.1016/S0006-8993(99)01878-8; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; Colloca L, 2009, PAIN, V144, P28, DOI 10.1016/j.pain.2009.01.033; Darragh M, 2014, J PSYCHOSOM RES, V76, P414, DOI 10.1016/j.jpsychores.2014.02.011; De Pascalis V, 2002, PAIN, V96, P393, DOI 10.1016/S0304-3959(01)00485-7; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Enck P, 2013, NAT REV DRUG DISCOV, V12, P191, DOI 10.1038/nrd3923; FEINSTEIN B, 1954, J BONE JOINT SURG AM, V36-A, P981, DOI 10.2106/00004623-195436050-00007; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Fiorio M, 2012, NEUROSCIENCE, V217, P96, DOI 10.1016/j.neuroscience.2012.04.066; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; GravenNielsen T, 1997, BRAIN RES, V744, P121, DOI 10.1016/S0006-8993(96)01077-3; GravenNielsen T, 1997, J MUSCULOSKELET PAIN, V5, P49, DOI 10.1300/J094v05n01_04; Harrison J, 1997, SYNAESTHESIA INTRO, P281; Head H, 1893, BRAIN, V16, P1, DOI DOI 10.1093/BRAIN/16.1-2.1; Hrobjartsson A, 2011, J CLIN EPIDEMIOL, V64, P1223, DOI 10.1016/j.jclinepi.2011.01.008; Hui Kathleen K S, 2007, BMC Complement Altern Med, V7, P33, DOI 10.1186/1472-6882-7-33; Irnich D, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq009; JOHNSON AG, 1994, LANCET, V344, P1140, DOI 10.1016/S0140-6736(94)90637-8; Kaptchuk TJ, 2006, BMJ-BRIT MED J, V332, P391, DOI 10.1136/bmj.38726.603310.55; Kaptchuk TJ, 2000, J CLIN EPIDEMIOL, V53, P786, DOI 10.1016/S0895-4356(00)00206-7; Kerr CE, 2011, CONSCIOUS COGN, V20, P784, DOI 10.1016/j.concog.2010.12.009; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Kong J, 2007, J ALTERN COMPLEM MED, V13, P1059, DOI 10.1089/acm.2007.0524; Lennertz RC, 2010, J NEUROSCI, V30, P4353, DOI 10.1523/JNEUROSCI.4666-09.2010; LENZ FA, 1993, J NEUROPHYSIOL, V70, P200, DOI 10.1152/jn.1993.70.1.200; Liang ZH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/620671; Linde K, 2010, FORSCH KOMPLEMENTMED, V17, P259, DOI 10.1159/000320374; Longley P.A., 2005, GEOGRAPHIC INFORM SY, V2nd, P536; Lucas MV, 2015, CEREB CORTEX, V25, P2623, DOI 10.1093/cercor/bhu061; Mackenzie J, 1893, BRAIN, V16, P321; MARCHAND S, 1993, PAIN, V54, P99, DOI 10.1016/0304-3959(93)90104-W; MAUGUIERE F, 1978, BRAIN, V101, P307, DOI 10.1093/brain/101.2.307; Meissner K, 2013, JAMA INTERN MED, V173, P1941, DOI 10.1001/jamainternmed.2013.10391; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Michael GA, 2011, CONSCIOUS COGN, V20, P603, DOI 10.1016/j.concog.2010.11.013; Napadow V, 2009, NEUROIMAGE, V47, P1055, DOI 10.1016/j.neuroimage.2009.05.079; NORDIN M, 1984, PAIN, V20, P231, DOI 10.1016/0304-3959(84)90013-7; OCHOA J, 1983, J PHYSIOL-LONDON, V342, P633, DOI 10.1113/jphysiol.1983.sp014873; Park H, 2002, AM J CHINESE MED, V30, P45, DOI 10.1142/S0192415X02000053; Penfield W, 1933, ARCH NEURO PSYCHIATR, V30, P709, DOI 10.1001/archneurpsyc.1933.02240160009001; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; Ro T, 2007, ANN NEUROL, V62, P433, DOI 10.1002/ana.21219; ROBERTS AH, 1993, CLIN PSYCHOL REV, V13, P375, DOI 10.1016/0272-7358(93)90010-J; Salih N, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-81; Schmidt TT, 2014, NEUROIMAGE, V98, P216, DOI 10.1016/j.neuroimage.2014.05.014; Schweinhardt P, 2009, J NEUROSCI, V29, P4882, DOI 10.1523/JNEUROSCI.5634-08.2009; SHAPIRO AK, 1968, PSYCHIAT QUART, V42, P653, DOI 10.1007/BF01564309; Sihvonen R, 2013, NEW ENGL J MED, V369, P2515, DOI 10.1056/NEJMoa1305189; STEIN C, 1988, PAIN, V32, P251, DOI 10.1016/0304-3959(88)90074-7; Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8; Suhara T, 2001, NEUROIMAGE, V13, P891, DOI 10.1006/nimg.2001.0761; TANSEY MJB, 1993, J NEUROL SCI, V114, P109, DOI 10.1016/0022-510X(93)90057-6; Tracey I, 2010, NAT MED, V16, P1277, DOI 10.1038/nm.2229; Vecchiet, 1999, Curr Rev Pain, V3, P489; Ward J, 2013, ANNU REV PSYCHOL, V64, P49, DOI 10.1146/annurev-psych-113011-143840; Wartolowska K, 2014, BMJ IN PRESS, P348	61	21	21	15	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124808	10.1371/journal.pone.0124808	http://dx.doi.org/10.1371/journal.pone.0124808			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KV	25901350	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500100
J	Bizjak, DA; Brinkmann, C; Bloch, W; Grau, M				Bizjak, Daniel Alexander; Brinkmann, Christian; Bloch, Wilhelm; Grau, Marijke			Increase in Red Blood Cell-Nitric Oxide Synthase Dependent Nitric Oxide Production during Red Blood Cell Aging in Health and Disease: A Study on Age Dependent Changes of Rheologic and Enzymatic Properties in Red Blood Cells	PLOS ONE			English	Article							IN-VIVO; S-NITROSOHEMOGLOBIN; ANALYZER LORCA; PLASMA NITRITE; ARGINASE; HEMOGLOBIN; NO; ERYTHROCYTES; CHEMILUMINESCENCE; DEFORMABILITY	Aim To investigate RBC-NOS dependent NO signaling during in vivo RBC aging in health and disease. Method RBC from fifteen healthy volunteers (HC) and four patients with type 2 diabetes mellitus (DM) were separated in seven subpopulations by Percoll density gradient centrifugation. Results The proportion of old RBC was significantly higher in DM compared to HC. In both groups, in vivo aging was marked by changes in RBC shape and decreased cell volume. RBC nitrite, as marker for NO, was higher in DM and increased in both HC and DM during aging. RBC deformability was lower in DM and significantly decreased in old compared to young RBC in both HC and DM. RBC-NOS Serine(1177) phosphorylation, indicating enzyme activation, increased during aging in both HC and DM. Arginase I activity remained unchanged during aging in HC. In DM, arginase I activity was significantly higher in young RBC compared to HC but decreased during aging. In HC, concentration of L-arginine, the substrate of RBC-NOS and arginase I, significantly dropped from young to old RBC. In DM, L-arginine concentration was significantly higher in young RBC compared to HC and significantly decreased during aging. In blood from healthy subjects, RBC-NOS activation was additionally inhibited by N-5-(1-iminoethyl)-L-Ornithine dihydrochloride which decreased RBC nitrite, and impaired RBC deformability of all but the oldest RBC subpopulation. Conclusion This study first-time showed highest RBC-NOS activation and NO production in old RBC, possibly to counteract the negative impact of cell shrinkage on RBC deformability. This was even more pronounced in DM. It is further suggested that highly produced NO only insufficiently affects cell function of old RBC maybe because of isolated RBC-NOS in old RBC thus decreasing NO bioavailability. Thus, increasing NO availability may improve RBC function and may extend cell life span in old RBC.	[Bizjak, Daniel Alexander; Brinkmann, Christian; Bloch, Wilhelm; Grau, Marijke] German Sport Univ Cologne, Dept Mol & Cellular Sport Med, Cologne, Germany	German Sport University Cologne	Grau, M (corresponding author), German Sport Univ Cologne, Dept Mol & Cellular Sport Med, Cologne, Germany.	m.grau@dshs-koeln.de	Grau, Marijke/AAM-7025-2020	Grau, Dr. Marijke/0000-0003-1980-9195; Bizjak, Daniel/0000-0003-4075-0204; , Christian Brinkmann/0000-0001-8419-7565				Alaarg A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00365; Antonelou MH, 2010, BLOOD TRANSFUS-ITALY, V8, pS39, DOI 10.2450/2010.007S; Bivalacqua TJ, 2001, BIOCHEM BIOPH RES CO, V283, P923, DOI 10.1006/bbrc.2001.4874; Bonnefont-Rousselot D, 2002, CURR OPIN CLIN NUTR, V5, P561, DOI 10.1097/00075197-200209000-00016; Bor-Kucukatay M, 2003, AM J PHYSIOL-HEART C, V284, pH1577, DOI 10.1152/ajpheart.00665.2002; BOSCH FH, 1992, BLOOD, V79, P254; Bosman GJCGM, 2010, J PROTEOMICS, V73, P396, DOI 10.1016/j.jprot.2009.07.010; Bosman GJCGM, 2008, TRANSFUSION MED, V18, P335, DOI 10.1111/j.1365-3148.2008.00892.x; Bruckdorfer Richard, 2005, Molecular Aspects of Medicine, V26, P3, DOI 10.1016/j.mam.2004.09.002; CHANDRAMOULI V, 1975, DIABETES, V24, P257, DOI 10.2337/diabetes.24.3.257; CLARK MR, 1983, BLOOD, V61, P899, DOI 10.1182/blood.V61.5.899.899; CONNOR J, 1994, J BIOL CHEM, V269, P2399; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Franco RS, 2009, AM J HEMATOL, V84, P109, DOI 10.1002/ajh.21298; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gifford SC, 2006, BRIT J HAEMATOL, V135, P395, DOI 10.1111/j.1365-2141.2006.06279.x; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; Grau M, 2007, J CHROMATOGR B, V851, P106, DOI 10.1016/j.jchromb.2007.02.002; Grau M, 2015, BRIT J HAEMATOL, V168, P728, DOI 10.1111/bjh.13185; Grau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056759; Green DJ, 2004, J PHYSIOL-LONDON, V561, P1, DOI 10.1113/jphysiol.2004.068197; Gronros J, 2011, AM J PHYSIOL-HEART C, V300, pH1174, DOI 10.1152/ajpheart.00560.2010; Gupta BL, 2004, J BIOSCIENCES, V29, P73, DOI 10.1007/BF02702564; Handelman GJ, 2010, J RENAL NUTR, V20, pS84, DOI 10.1053/j.jrn.2010.06.007; HARDEMAN MR, 1994, CLIN HEMORHEOL, V14, P605; Hardeman MR, 2001, CLIN HEMORHEOL MICRO, V25, P1; Hayashino Y, 2014, METABOLISM, V63, P431, DOI 10.1016/j.metabol.2013.08.018; Hendgen-Cotta U, 2008, METHOD ENZYMOL, V441, P295, DOI 10.1016/S0076-6879(08)01216-0; Hobbs AJ, 2002, TRENDS PHARMACOL SCI, V23, P406, DOI 10.1016/S0165-6147(02)02067-9; Horn P, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.003764; Huang KT, 2005, J BIOL CHEM, V280, P31126, DOI 10.1074/jbc.M501496200; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; IGNARRO LJ, 1993, P NATL ACAD SCI USA, V90, P8103, DOI 10.1073/pnas.90.17.8103; IKEMOTO M, 1990, BIOCHEM J, V270, P697, DOI 10.1042/bj2700697; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Joshi MS, 2002, P NATL ACAD SCI USA, V99, P10341, DOI 10.1073/pnas.152149699; Kelm M, 1999, CARDIOVASC RES, V41, P765, DOI 10.1016/S0008-6363(98)00259-4; Kim-Shapiro DB, 2006, ARTERIOSCL THROM VAS, V26, P697, DOI 10.1161/01.ATV.0000204350.44226.9a; Kleinbongard P, 2006, BLOOD, V107, P2943, DOI 10.1182/blood-2005-10-3992; Kleinbongard P, 2007, THROMB HAEMOSTASIS, V98, P970, DOI 10.1160/TH07-04-0305; KOLLURU GK, 2012, INT J VASC MED, DOI DOI 10.1155/2012/918267; Lauer T, 2001, P NATL ACAD SCI USA, V98, P12814, DOI 10.1073/pnas.221381098; LEDEVEHAT C, 1994, DIABETES METAB, V20, P401; LINDERKAMP O, 1982, BLOOD, V59, P1121; Liu X, J BIOL CHEM, V277, P26194; Liu XP, 1998, J BIOL CHEM, V273, P18709, DOI 10.1074/jbc.273.30.18709; MAZZANTI L, 1992, CLIN BIOCHEM, V25, P41, DOI 10.1016/0009-9120(92)80044-H; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; MOORE EG, 1976, J BIOL CHEM, V251, P2788; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; NASH GB, 1980, BIORHEOLOGY, V17, P479; NASH GB, 1983, BIOPHYS J, V43, P63, DOI 10.1016/S0006-3495(83)84324-0; Owusu BY, 2013, ANTIOXID REDOX SIGN, V19, P1198, DOI 10.1089/ars.2012.4884; Palis J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00003; Pelletier MM, 2006, FREE RADICAL BIO MED, V41, P541, DOI 10.1016/j.freeradbiomed.2006.05.001; Quinones Manuel J, 2005, Curr Diab Rep, V5, P246, DOI 10.1007/s11892-005-0018-z; Ramirez-Zamora S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066823; Rassaf T, 2007, CIRC RES, V100, P1749, DOI 10.1161/CIRCRESAHA.107.152488; Rifkind JM, 2013, ANTIOXID REDOX SIGN, V18, P2274, DOI 10.1089/ars.2012.4867; Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028; Sakai H, 2008, J BIOL CHEM, V283, P1508, DOI 10.1074/jbc.M707660200; Savu O, 2015, ANN CLIN BIOCHEM, V52, P135, DOI 10.1177/0004563214531739; SCHWARTZ RS, 1991, DIABETES, V40, P701, DOI 10.2337/diabetes.40.6.701; SHARMA VS, 1978, J BIOL CHEM, V253, P6467; Shemyakin A, 2012, CIRCULATION, V126, P2943, DOI 10.1161/CIRCULATIONAHA.112.140335; Shiva S, 2013, REDOX BIOL, V1, P40, DOI 10.1016/j.redox.2012.11.005; Simmonds MJ, 2014, BIORHEOLOGY, V51, P121, DOI 10.3233/BIR-140653; Smith JA, 1999, AM J PHYSIOL-HEART C, V276, pH2188, DOI 10.1152/ajpheart.1999.276.6.H2188; Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034; Subasinghe W, 2008, ANAL CHIM ACTA, V618, P227, DOI 10.1016/j.aca.2008.04.061; Suhr F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045982; Tessari P, 2010, DIABETES, V59, P2152, DOI 10.2337/db09-1772; Totzeck M, 2012, CIRCULATION, V126, P325, DOI 10.1161/CIRCULATIONAHA.111.087155; Vaughn MW, 2001, NITRIC OXIDE-BIOL CH, V5, P18, DOI 10.1006/niox.2000.0328; Virtue MA, 2004, DIABETES CARE, V27, P931, DOI 10.2337/diacare.27.4.931; Witte MB, 2002, METABOLISM, V51, P1269, DOI 10.1053/meta.2002.35185; Yang JN, 2013, P NATL ACAD SCI USA, V110, P15049, DOI 10.1073/pnas.1307058110; Yang ZH, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00149; Zimny S, 2001, DIABETES CARE, V24, P1810, DOI 10.2337/diacare.24.10.1810	80	43	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0125206	10.1371/journal.pone.0125206	http://dx.doi.org/10.1371/journal.pone.0125206			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902315	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500115
J	Broadway, KJ; Pyron, M; Gammon, JR; Murry, BA				Broadway, Kyle J.; Pyron, Mark; Gammon, James R.; Murry, Brent A.			Shift in a Large River Fish Assemblage: Body-Size and Trophic Structure Dynamics	PLOS ONE			English	Article							REGIME SHIFTS; WABASH RIVER; ECOLOGICAL-SYSTEMS; BERING-SEA; COMMUNITY; RESILIENCE; ABUNDANCE; SPECTRA; THRESHOLDS; ECOSYSTEMS	As the intensity and speed of environmental change increase at both local and global scales it is imperative that we gain a better understanding of the ecological implications of community shifts. While there has been substantial progress toward understanding the drivers and subsequent responses of community change (e.g. lake trophic state), the ecological impacts of food web changes are far less understood. We analyzed Wabash River fish assemblage data collected from 1974-2008, to evaluate temporal variation in body-size structure and functional group composition. Two parameters derived from annual community size-spectra were our major response variables: (1) the regression slope is an index of ecological efficiency and predator-prey biomass ratios, and (2) spectral elevation (regression midpoint height) is a proxy for food web capacity. We detected a large assemblage shift, over at least a seven year period, defined by dramatic changes in abundance (measured as catchper- unit-effort) of the dominant functional feeding groups among two time periods; from an assemblage dominated by planktivore-omnivores to benthic invertivores. There was a concurrent increase in ecological efficiency (slopes increased over time) following the shift associated with an increase in large-bodied low trophic level fish. Food web capacity remained relatively stable with no clear temporal trends. Thus, increased ecological efficiency occurred simultaneous to a compensatory response that shifted biomass among functional feeding groups.	[Broadway, Kyle J.; Murry, Brent A.] Cent Michigan Univ, Dept Biol, Inst Great Lakes Res, Mt Pleasant, MI 48858 USA; [Pyron, Mark] Ball State Univ, Dept Biol, Muncie, IN 47306 USA; [Gammon, James R.] Depauw Univ, Dept Biol, Greencastle, IN 46135 USA	Central Michigan University; Ball State University; DePauw University	Pyron, M (corresponding author), Ball State Univ, Dept Biol, Muncie, IN 47306 USA.	mpyron@bsu.edu	Pyron, Mark/D-4572-2011	Pyron, Mark/0000-0003-0451-7827	Duke Power; Eli Lilly, Inc.	Duke Power; Eli Lilly, Inc.(Eli Lilly)	Pyron field collections were funded by Duke Power and Eli Lilly, Inc. no grant numbers available. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; Arim M, 2010, OIKOS, V119, P147, DOI 10.1111/j.1600-0706.2009.17768.x; Benson AJ, 2002, FISH FISH, V3, P95, DOI 10.1046/j.1467-2979.2002.00078.x; Blanchard JL, 2009, J ANIM ECOL, V78, P270, DOI 10.1111/j.1365-2656.2008.01466.x; Boldt JL, 2012, T AM FISH SOC, V141, P327, DOI 10.1080/00028487.2012.662205; Brose U, 2006, ECOLOGY, V87, P2411, DOI 10.1890/0012-9658(2006)87[2411:CBRINF]2.0.CO;2; Brown JL, 2004, J RAPTOR RES, V38, P148; Buishand TA, 1984, J HYDROL, V73, P51069; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; CARPENTER SR, 1989, ECOLOGY, V70, P1142, DOI 10.2307/1941382; Castrale JS, 1983, P INDIANA ACAD SCI, V93, P173; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Coulter AA, 2013, FRESHWATER BIOL, V58, P1029, DOI 10.1111/fwb.12106; Daan N, 2005, ICES J MAR SCI, V62, P177, DOI 10.1016/j.icesjms.2004.08.020; Deyoung B, 2008, TRENDS ECOL EVOL, V23, P402, DOI 10.1016/j.tree.2008.03.008; Dossena M, 2012, P ROY SOC B-BIOL SCI, V279, P3011, DOI 10.1098/rspb.2012.0394; DUARTE CM, 1987, OECOLOGIA, V74, P272, DOI 10.1007/BF00379370; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Folke C, 2010, ECOL SOC, V15, DOI 10.5751/es-03610-150420; Frimpong EA, 2009, FISHERIES, V34, P487, DOI 10.1577/1548-8446-34.10.487; GAEDKE U, 1993, LIMNOL OCEANOGR, V38, P112, DOI 10.4319/lo.1993.38.1.0112; Gammon J. R., 1998, WABASH RIVER ECOSYST; Gammon JR, 2000, HYDROBIOLOGIA, V422, P291, DOI 10.1023/A:1017060520873; Gammon JR, 1976, IWRRC TECHNICAL REPO; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Hastings A, 2010, ECOL LETT, V13, P464, DOI 10.1111/j.1461-0248.2010.01439.x; HAYES DB, 1994, T AM FISH SOC, V123, P204, DOI 10.1577/1548-8659(1994)123<0204:CITCOS>2.3.CO;2; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jennings S, 2003, ECOL LETT, V6, P971, DOI 10.1046/j.1461-0248.2003.00529.x; Jennings S, 2002, MAR ECOL PROG SER, V240, P11, DOI 10.3354/meps240011; Jennings S, 2010, J MARINE SYST, V79, P418, DOI 10.1016/j.jmarsys.2008.12.016; Jung S, 2005, ESTUARIES, V28, P226, DOI 10.1007/BF02732857; Karns Daryl R., 2006, Proceedings of the Indiana Academy of Science, V115, P79; Karr J. R., 1986, SPECIAL PUBLICATION, V5; Kerr S. R., 2001, COM ECO SYS; Kinzig AP, 2006, ECOL SOC, V11; Maxwell TAD, 2006, OECOLOGIA, V150, P282, DOI 10.1007/s00442-006-0520-2; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; Mueller R, 2010, COPEIA, P47, DOI 10.1643/CE-08-154; Murry BA, 2014, FRESHWATER BIOL, V59, P155, DOI 10.1111/fwb.12255; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Paul MJ, 2001, ANNU REV ECOL SYST, V32, P333, DOI 10.1146/annurev.ecolsys.32.081501.114040; Persson L, 2007, SCIENCE, V316, P1743, DOI 10.1126/science.1141412; PETERS RH, 1983, OECOLOGIA, V60, P89, DOI 10.1007/BF00379325; Post DM, 2002, TRENDS ECOL EVOL, V17, P269, DOI 10.1016/S0169-5347(02)02455-2; Pritchett J, 2012, RIVER RES APPL, V28, P1501, DOI 10.1002/rra.1528; Pyron M, 2004, HYDROBIOLOGIA, V525, P203, DOI 10.1023/B:HYDR.0000038867.28271.45; Pyron M, 2008, RIVER RES APPL, V24, P1175, DOI 10.1002/rra.1155; Pyron M, 2008, HYDROBIOLOGIA, V600, P205, DOI 10.1007/s10750-007-9232-9; Pyron M, 2006, FRESHWATER BIOL, V51, P1789, DOI 10.1111/j.1365-2427.2006.01609.x; Pyron Mark, 2011, River Systems, V19, P239, DOI 10.1127/1868-5749/2011/019-0028; Pyron M, 2011, FRESHWATER BIOL, V56, P1579, DOI 10.1111/j.1365-2427.2011.02596.x; Robinson CT, 2008, ECOL APPL, V18, P511, DOI 10.1890/07-0886.1; Rochet MJ, 2012, P ROY SOC B-BIOL SCI, V279, P284, DOI 10.1098/rspb.2011.0893; RODRIGUEZ J, 1990, J PLANKTON RES, V12, P593, DOI 10.1093/plankt/12.3.593; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; SHELDON RW, 1972, LIMNOL OCEANOGR, V17, P327, DOI 10.4319/lo.1972.17.3.0327; Small GE, 2011, ECOLOGY, V92, P386, DOI 10.1890/10-0081.1; SPRULES WG, 1986, CAN J FISH AQUAT SCI, V43, P1789, DOI 10.1139/f86-222; Suding KN, 2009, TRENDS ECOL EVOL, V24, P271, DOI 10.1016/j.tree.2008.11.012; Sweeting CJ, 2009, ICES J MAR SCI, V66, P195, DOI 10.1093/icesjms/fsn203; Tockner K, 2010, FRESHWATER BIOL, V55, P135, DOI 10.1111/j.1365-2427.2009.02371.x; Trebilco R, 2013, TRENDS ECOL EVOL, V28, P423, DOI 10.1016/j.tree.2013.03.008; Vanni MJ, 1997, ECOLOGY, V78, P1; Walker B, 2004, ECOL SOC, V9; Walker B, 2004, ECOL SOC, V9; White EP, 2007, TRENDS ECOL EVOL, V22, P323, DOI 10.1016/j.tree.2007.03.007; Yvon-Durocher G, 2011, OIKOS, V120, P550, DOI 10.1111/j.1600-0706.2010.18863.x	70	18	19	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124954	10.1371/journal.pone.0124954	http://dx.doi.org/10.1371/journal.pone.0124954			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902144	Green Published, gold, Green Submitted			2022-12-27	WOS:000353331500106
J	Sangi, M; Win, KT; Shirvani, F; Namazi-Rad, MR; Shukla, N				Sangi, Mohsen; Win, Khin Than; Shirvani, Farid; Namazi-Rad, Mohammad-Reza; Shukla, Nagesh			Applying a Novel Combination of Techniques to Develop a Predictive Model for Diabetes Complications	PLOS ONE			English	Article							NEURAL-NETWORKS; MANAGEMENT; CLASSIFICATION; CARE; PHYSICIANS	Among the many related issues of diabetes management, its complications constitute the main part of the heavy burden of this disease. The aim of this paper is to develop a risk advisor model to predict the chances of diabetes complications according to the changes in risk factors. As the starting point, an inclusive list of (k) diabetes complications and (n) their correlated predisposing factors are derived from the existing endocrinology text books. A type of data meta-analysis has been done to extract and combine the numeric value of the relationships between these two. The whole n (risk factors) - k (complications) model was broken down into k different (n-1) relationships and these (n-1) dependencies were broken into n (1-1) models. Applying regression analysis (seven patterns) and artificial neural networks (ANN), we created models to show the (1-1) correspondence between factors and complications. Then all 1-1 models related to an individual complication were integrated using the naive Bayes theorem. Finally, a Bayesian belief network was developed to show the influence of all risk factors and complications on each other. We assessed the predictive power of the 1-1 models by R-2, F-ratio and adjusted R-2 equations; sensitivity, specificity and positive predictive value were calculated to evaluate the final model using real patient data. The results suggest that the best fitted regression models outperform the predictive ability of an ANN model, as well as six other regression patterns for all 1-1 models.	[Sangi, Mohsen; Shirvani, Farid; Namazi-Rad, Mohammad-Reza; Shukla, Nagesh] Univ Wollongong, SMART Infrastruct Facil, Wollongong, NSW 2522, Australia; [Sangi, Mohsen; Win, Khin Than] Univ Wollongong, Sch Informat Syst & Technol, Wollongong, NSW 2522, Australia	University of Wollongong; University of Wollongong	Sangi, M (corresponding author), Univ Wollongong, SMART Infrastruct Facil, Wollongong, NSW 2522, Australia.	m64473s@yahoo.com	Win, Khin Than/F-7491-2018; Shukla, Nagesh/X-6556-2019	Win, Khin Than/0000-0002-7810-6388; NAMAZI-RAD, Mohammad-Reza/0000-0003-1941-9445; Shirvani, Fariba/0000-0003-1161-8650; Shukla, Nagesh/0000-0002-8421-3972				[Anonymous], 1996, DIABETES, V45, P1289; [Anonymous], 2010, IBM SPSS STAT; [Anonymous], 2007, PRACTICE NURSE, V33, P6, DOI DOI 10.1578/AM.33.1.2007.6; Balas EA, 1998, J AM MED INFORM ASSN, P295; Balas EA, 2004, MED CARE, V42, P610, DOI 10.1097/01.mlr.0000128008.12117.f8; Boulton A J, 2000, J Fam Pract, V49, pS3; Brierley P, 2011, TIBERIUS DATA MINING; BROWN DE, 1993, PATTERN RECOGN, V26, P953, DOI 10.1016/0031-3203(93)90060-A; Brownlee M, 2011, COMPLICATIONS DIABET; Celler BG, 2003, MED J AUSTRALIA, V179, P242, DOI 10.5694/j.1326-5377.2003.tb05529.x; CURRAM SP, 1994, J OPER RES SOC, V45, P440, DOI 10.2307/2584215; DEUTSCH T, 1989, COMPUT METH PROG BIO, V29, P75, DOI 10.1016/0169-2607(89)90076-X; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Everett J, 2004, PRACTICAL DIABETES I, V21, P173; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Griffith J, 2000, MED DECIS MAKING, V20, P243, DOI 10.1177/0272989X0002000210; Habacher W, 2007, J EVAL CLIN PRACT, V13, P906, DOI 10.1111/j.1365-2753.2006.00770.x; Han J., 2006, DATA MINING CONCEPTS, DOI 10.1016/C2009-0-61819-5; HARRIS MI, 1990, DIABETES CARE, V13, P419, DOI 10.2337/diacare.13.4.419; Hernando ME, 2000, COMPUT METH PROG BIO, V62, P235, DOI 10.1016/S0169-2607(00)00070-5; Hutcheson G. D., 1999, MULTIVARIATE SOCIAL; International Diabetes Federation, 2011, MODULE 2 2B NUTR THE; JACQUES CHM, 1991, DIABETES CARE, V14, P712, DOI 10.2337/diacare.14.8.712; Kapur A, 2007, INDIAN J MED RES, V125, P473; Koleszynska J, 2008, KNOWLEDGE BASED INTE, P789; Koumakis L., 2012, WIRELESS MOBILE COMM, P46; Lagani V, 2013, J DIABETES COMPLICAT, V27, P407, DOI 10.1016/j.jdiacomp.2012.11.003; Lawrence J., 1994, INTRO NEURAL NETWORK; Lim TS, 2000, MACH LEARN, V40, P203, DOI 10.1023/A:1007608224229; Longo DL, 2012, HARRISONS PRINCIPLES; Masharani U, 2013, CURRENT MED DIAGNOSI; Montani S, 2001, Diabetes Technol Ther, V3, P347, DOI 10.1089/15209150152607123; Murphy K, 2002, SOFTWARE PACKAGES GR; PEARL J, 1998, PROBABILISTIC REASON; Pickup John C, 2012, Int J Clin Pract Suppl, P15, DOI 10.1111/j.1742-1241.2011.02849.x; Quinlan J R, 1988, EMPIRICAL COMP GENET, P135; Razi MA, 2005, EXPERT SYST APPL, V29, P65, DOI 10.1016/j.eswa.2005.01.006; RODBARD D, 1988, DIABETES CARE, V11, P54; Sangi M, 2010, KNOWLEDGE BASED RISK, P1798; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; SHAVLIK JW, 1991, MACH LEARN, V6, P111, DOI 10.1007/BF00114160; Smith A. E., 1997, Engineering Economist, V42, P137, DOI 10.1080/00137919708903174; Stevens J.P., 2009, APPL MULTIVARIATE ST, V5th ed.; Zikmund W.G., 2010, EXPLORING MARKETING	44	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0121569	10.1371/journal.pone.0121569	http://dx.doi.org/10.1371/journal.pone.0121569			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902317	Green Published, gold, Green Submitted			2022-12-27	WOS:000353331500011
J	Zhang, XM; Li, FP; Guo, L; Hei, HY; Tian, LL; Peng, W; Cai, H				Zhang, Xuemei; Li, Fangping; Guo, Lin; Hei, Hongya; Tian, Lulu; Peng, Wen; Cai, Hui			Forskolin Regulates L-Type Calcium Channel through Interaction between Actinin 4 and beta(3) Subunit in Osteoblasts	PLOS ONE			English	Article							INDUCED BONE-FORMATION; CA2+ CHANNELS; ALPHA-ACTININ; PARATHYROID-HORMONE; KINASE; CYTOSKELETON; MODULATION; REQUIRES; COMPLEX; CELLS	Voltage-dependent L-type calcium channels that permit cellular calcium influx are essential in calcium-mediated modulation of cellular signaling. Although the regulation of voltage-dependent L-type calcium channels is linked to many factors including cAMP-dependent protein kinase A (PKA) activity and actin cytoskeleton, little is known about the detailed mechanisms underlying the regulation in osteoblasts. Our present study investigated the modulation of L-type calcium channel activities through the effects of forskolin on actin reorganization and on its functional interaction with actin binding protein actinin 4. The results showed that forskolin did not significantly affect the trafficking of pore forming alpha(1c) subunit and its interaction with actin binding protein actinin 4, whereas it significantly increased the expression of beta(3) subunit and its interaction with actinin 4 in osteoblast cells as assessed by co-immunoprecipitation, pull-down assay, and immunostaining. Further mapping showed that the ABD and EF domains of actinin 4 were interaction sites. This interaction is independent of PKA phosphorylation. Knockdown of actinin 4 significantly decreased the activities of L-type calcium channels. Our study revealed a new aspect of the mechanisms by which the forskolin activation of adenylyl cyclase - cAMP cascade regulates the L-type calcium channel in osteoblast cells, besides the PKA mediated phosphorylation of the channel subunits. These data provide insight into the important role of interconnection among adenylyl cyclase, cAMP, PKA, the actin cytoskeleton, and the channel proteins in the regulation of voltage-dependent L-type calcium channels in osteoblast cells.	[Zhang, Xuemei; Guo, Lin; Hei, Hongya; Tian, Lulu] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 201203, Peoples R China; [Li, Fangping] Fudan Univ, Huashan Hosp, Jingan Dist Ctr Hosp Shanghai, Dept Pharm,Jingan Branch, Shanghai 200040, Peoples R China; [Peng, Wen] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Nephrol, Shanghai 200062, Peoples R China; [Cai, Hui] Emory Univ, Sch Med, Dept Med, Div Renal, Atlanta, GA 30322 USA; [Cai, Hui] Atlanta Veteran Adm Med Ctr, Renal Sect, Decatur, GA 30033 USA	Fudan University; Fudan University; Shanghai University of Traditional Chinese Medicine; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Zhang, XM (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, 826 Zhangheng Rd, Shanghai 201203, Peoples R China.	xuemzhang@fudan.edu.cn; wenpeng@shutcm.edu.cn			National Science Foundation of China [81370979]; Shanghai science and technology innovation [14140903202, 14431905102]; Department of Veteran Affairs [5I01BX000994]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai science and technology innovation; Department of Veteran Affairs(US Department of Veterans Affairs)	This work is supported by the National Science Foundation of China No. 81370979 (X. Zhang), Shanghai science and technology innovation grants 14140903202 and 14431905102 (X. Zhang), and Department of Veteran Affairs MERIT Award 5I01BX000994 (H. Cai).	Ayling LJ, 2012, J CELL SCI, V125, P869, DOI 10.1242/jcs.091090; Bergh JJ, 2003, CALCIFIED TISSUE INT, V73, P502, DOI 10.1007/s00223-002-0016-y; Betanzos A, 2004, EXP CELL RES, V292, P51, DOI 10.1016/j.yexcr.2003.08.007; BLANCHARD A, 1989, J MUSCLE RES CELL M, V10, P280, DOI 10.1007/BF01758424; Broderick MJF, 2005, ADV PROTEIN CHEM, V70, P203, DOI 10.1016/S0065-3233(04)70007-8; Bunemann M, 1999, J BIOL CHEM, V274, P33851, DOI 10.1074/jbc.274.48.33851; Chan YM, 1998, J CELL BIOL, V143, P2033, DOI 10.1083/jcb.143.7.2033; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Gerits N, 2007, J BIOL CHEM, V282, P37232, DOI 10.1074/jbc.M704873200; GUGGINO SE, 1989, P NATL ACAD SCI USA, V86, P2957, DOI 10.1073/pnas.86.8.2957; Haase H, 1999, FASEB J, V13, P2161, DOI 10.1096/fasebj.13.15.2161; Hall DD, 2013, NEURON, V78, P483, DOI 10.1016/j.neuron.2013.02.032; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Johnson BD, 2005, P NATL ACAD SCI USA, V102, P4191, DOI 10.1073/pnas.0409695102; Johnson BD, 1999, ADV SEC MESS PHOSPH, V33, P203; Kim JH, 2002, J BIOL CHEM, V277, P23714, DOI 10.1074/jbc.M200835200; Leach RN, 2005, CELL CALCIUM, V38, P515, DOI 10.1016/j.ceca.2005.07.006; Li FP, 2011, J BONE MINER METAB, V29, P515, DOI 10.1007/s00774-010-0252-6; Li J, 2003, ENDOCRINOLOGY, V144, P1226, DOI 10.1210/en.2002-220821; Li JL, 2002, J BONE MINER RES, V17, P1795, DOI 10.1359/jbmr.2002.17.10.1795; Liu RT, 2000, J BIOL CHEM, V275, P8711, DOI 10.1074/jbc.275.12.8711; Lu L, 2007, CIRC RES, V100, P112, DOI 10.1161/01.RES.0000253095.44186.72; Meszaros JG, 1996, J BIOL CHEM, V271, P32981, DOI 10.1074/jbc.271.51.32981; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Radermacher AN, 2008, IMMUNITY, V28, P13, DOI 10.1016/j.immuni.2007.12.009; Rey A, 2007, BONE, V41, P59, DOI 10.1016/j.bone.2007.02.031; RITCHIE CK, 1994, ENDOCRINOLOGY, V135, P996, DOI 10.1210/en.135.3.996; Sadeghi A, 2002, AM J PHYSIOL-CELL PH, V282, pC1502, DOI 10.1152/ajpcell.00435.2001; Scott JD, 2003, BIOCHEM SOC T, V31, P87, DOI 10.1042/bst0310087; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Takahashi SX, 2004, P NATL ACAD SCI USA, V101, P7193, DOI 10.1073/pnas.0306665101; TETI A, 1989, Bollettino Societa Italiana Biologia Sperimentale, V65, P1115; VADIAKAS GP, 1992, MATRIX, V12, P439, DOI 10.1016/S0934-8832(11)80088-0; Wang Y, 2010, VIRULENCE, V1, P202, DOI 10.4161/viru.1.3.11836; Yamaguchi H, 1998, J BIOL CHEM, V273, P19348, DOI 10.1074/jbc.273.30.19348; Zanello LP, STEROIDS; Zhao PL, 2002, KIDNEY INT, V61, P1393, DOI 10.1046/j.1523-1755.2002.00267.x	42	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124274	10.1371/journal.pone.0124274	http://dx.doi.org/10.1371/journal.pone.0124274			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902045	Green Published, gold, Green Submitted			2022-12-27	WOS:000353331500080
J	Jackson, B; Compton, J; Whiddett, R; Anthony, DR; Dimmock, JA				Jackson, Ben; Compton, Josh; Whiddett, Ryan; Anthony, David R.; Dimmock, James A.			Preempting Performance Challenges: The Effects of Inoculation Messaging on Attacks to Task Self-Efficacy	PLOS ONE			English	Article							PSYCHOMETRIC PROPERTIES; ATTITUDE ACCESSIBILITY; RESISTANCE; FEEDBACK; IMPACT; PERSUASION; SCALE; METAANALYSIS; EXPLANATION; ADOLESCENTS	Although inoculation messages have been shown to be effective for inducing resistance to counter-attitudinal attacks, researchers have devoted relatively little attention toward studying the way in which inoculation theory principles might support challenges to psychological phenomena other than attitudes (e.g., self-efficacy). Prior to completing a physical (i.e., balance) task, undergraduates (N = 127, M-age = 19.20, SD = 2.16) were randomly assigned to receive either a control or inoculation message, and reported their confidence in their ability regarding the upcoming task. During the task, a confederate provided standardized negative feedback to all participants regarding their performance, and following the completion of the task, participants again reported their self-efficacy along with measures assessing in-task processes. Findings supported the viability of efficacy inoculation; controlling for pre-task self-efficacy, task performance, and relevant psycho-social variables (e.g., resilience, self-confidence robustness), participants in the inoculation condition reported greater confidence in their ability (i.e., task self-efficacy) than those in the control condition at post-task. Relative to those in the inoculation condition, participants in the control condition also experienced greater concentration disruption and self-presentation concerns during the task.	[Jackson, Ben; Whiddett, Ryan; Anthony, David R.; Dimmock, James A.] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Perth, WA 6009, Australia; [Compton, Josh] Dartmouth Coll, Inst Writing & Rhetor, Hanover, NH 03755 USA	University of Western Australia; Dartmouth College	Jackson, B (corresponding author), Univ Western Australia, Sch Sport Sci Exercise & Hlth, Perth, WA 6009, Australia.	ben.jackson@uwa.edu.au	Compton, Josh/I-6729-2019; Jackson, Ben/H-5117-2014	Compton, Josh/0000-0003-4625-3823; Jackson, Ben/0000-0003-0351-8377; Dimmock, James/0000-0002-4475-8169				An C, 2004, J COMMUN, V54, P421, DOI 10.1111/j.1460-2466.2004.tb02637.x; Audia P.G., 2003, HUM RESOUR MANAGE R, V13, P631, DOI [10.1016/j.hrmr.2003.11.006, DOI 10.1016/J.HRMR.2003.11.006]; Banas JA, 2010, COMMUN MONOGR, V77, P281, DOI 10.1080/03637751003758193; BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122; Bandura A., 2006, SELF EFFICACY BELIEF, P307, DOI DOI 10.1017/CBO9781107415324.004; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bandura A, 1997, SELF EFFICACY EXERCI, DOI [10.1080/08870440802254597, DOI 10.1080/08870440802254597]; Bandura A., 1977, COGNITIVE THERAPY RE, V1, P287, DOI [10.1007/BF01663995, DOI 10.1007/BF01663995]; BARON RA, 1988, J APPL PSYCHOL, V73, P199, DOI 10.1037/0021-9010.73.2.199; Beachamp M. R., 2012, OXFORD HDB SPORT PER, P273, DOI DOI 10.1093/OXFORDHB/9780199731763.013.0014; Beattie S, 2011, PSYCHOL SPORT EXERC, V12, P184, DOI 10.1016/j.psychsport.2010.09.008; Bohner G, 2011, ANNU REV PSYCHOL, V62, P391, DOI 10.1146/annurev.psych.121208.131609; Carmona C, 2008, EUR PSYCHOL, V13, P188, DOI 10.1027/1016-9040.13.3.188; Compton J, 2012, SAGE HDB PERSUASION, V2nd, P220, DOI [10.4135/9781452218410, DOI 10.4135/9781452218410]; Compton JA, 2004, J APPL COMMUN RES, V32, P343, DOI 10.1080/0090988042000276014; Compton JA, 2005, COMM YEARB, P97; Compton J, 2008, J APPL COMMUN RES, V36, P98, DOI 10.1080/00909880701799329; DeMarree KG, 2007, SOC PERSONAL PSYCHOL, V1, P441, DOI 10.1111/j.1751-9004.2007.00012.x; Dillard J.P., 2012, SAGE HDB PERSUASION; Dimmock JA, 2013, SPORT EXERC PERFORM, V2, P102, DOI 10.1037/a0030191; FELTZ DL, 1990, J SPORT EXERCISE PSY, V12, P132, DOI 10.1123/jsep.12.2.132; Godbold LC, 2000, COMMUN RES, V27, P411, DOI 10.1177/009365000027004001; Grossbard JR, 2009, ANXIETY STRESS COPIN, V22, P153, DOI 10.1080/10615800802020643; Howle TC, 2013, ANXIETY STRESS COPIN, V26, P700, DOI 10.1080/10615806.2013.763934; Insko CH.A., 1967, THEORIES ATTITUDE CH; Ivanov B., 2012, HLTH COMMUNICATION M, P73; Jones LW, 2003, J APPL SOC PSYCHOL, V33, P179, DOI 10.1111/j.1559-1816.2003.tb02078.x; Judge TA, 2001, J APPL PSYCHOL, V86, P80, DOI 10.1037/0021-9010.86.1.80; Kashdan TB, 2004, COGNITIVE THER RES, V28, P119, DOI 10.1023/B:COTR.0000016934.20981.68; Kluger AN, 1996, PSYCHOL BULL, V119, P254, DOI 10.1037/0033-2909.119.2.254; Leary M. R, 2019, SELF PRESENTATION IM; Lumsdaine AA, 1953, PUBLIC OPIN QUART, V17, P311, DOI 10.1086/266464; Martin KA, 2001, J APPL SOC PSYCHOL, V31, P1000, DOI 10.1111/j.1559-1816.2001.tb02659.x; MCAULEY E, 1989, RES Q EXERCISE SPORT, V60, P48, DOI 10.1080/02701367.1989.10607413; McCormick J., 2003, PSYCHOL MUSIC, V31, P37, DOI [10.1177/0305735603031001322, DOI 10.1177/0305735603031001322]; MCGUIRE WJ, 1961, J ABNORM SOC PSYCH, V63, P326, DOI 10.1037/h0048344; MCGUIRE WJ, 1961, J ABNORM SOC PSYCH, V62, P327, DOI 10.1037/h0042026; MCGUIRE WJ, 1961, SOCIOMETRY, V24, P184, DOI 10.2307/2786067; MCGUIRE WJ, 1964, ADV EXP SOC PSYCHOL, V1, P191, DOI 10.1016/S0065-2601(08)60052-0; MCGUIRE WJ, 1962, PUBLIC OPIN QUART, V26, P24, DOI 10.1086/267068; Myers ND, 2008, RES Q EXERCISE SPORT, V79, P300, DOI 10.5641/193250308X13086832905752; Myers ND, 2005, MEAS PHYS EDUC EXERC, V9, P135, DOI 10.1207/s15327841mpee0903_1; Nease AJA, 1999, J APPL PSYCHOL, V84, P806, DOI 10.1037/0021-9010.84.5.806; Nideffer R.M., 2006, APPL SPORT PSYCHOL P, P382; Pfau M, 2004, HUM COMMUN RES, V30, P329, DOI 10.1111/j.1468-2958.2004.tb00735.x; Pfau M, 2003, COMMUN MONOGR, V70, P39, DOI 10.1080/0363775032000104577; Pfau M, 2001, HUM COMMUN RES, V27, P216, DOI 10.1093/hcr/27.2.216; PFAU M, 1992, COMMUN MONOGR, V59, P213, DOI 10.1080/03637759209376266; Pfau M, 2009, COMMUN MONOGR, V76, P73, DOI 10.1080/03637750802378807; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; RYAN RM, 1982, J PERS SOC PSYCHOL, V43, P450, DOI 10.1037/0022-3514.43.3.450; SCHUNK DH, 1982, J EDUC PSYCHOL, V74, P548, DOI 10.1037/0022-0663.74.4.548; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; Terry PC, 1999, J SPORT SCI, V17, P861, DOI 10.1080/026404199365425; Terry PC, 2003, PSYCHOL SPORT EXERC, V4, P125, DOI 10.1016/S1469-0292(01)00035-8; Tormala ZL, 2002, J PERS SOC PSYCHOL, V83, P1298, DOI 10.1037//0022-3514.83.6.1298; Vrugt A, 2002, APPL PSYCHOL-INT REV, V51, P593, DOI 10.1111/1464-0597.00110; Wigley S, 2010, COMMUN RES REP, V27, P217, DOI 10.1080/08824091003737901	58	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124886	10.1371/journal.pone.0124886	http://dx.doi.org/10.1371/journal.pone.0124886			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XJ	25898287	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000353212600092
J	Kim, HJ; Kim, WH; Lim, HW; Kim, JA; Kim, DK; Shin, BS; Sim, WS; Hahm, TS; Kim, CS; Lee, SM				Kim, Hyo-Jin; Kim, Won Ho; Lim, Hyung Woo; Kim, Jie Ae; Kim, Duk-Kyung; Shin, Byung Seop; Sim, Woo Seog; Hahm, Tae Soo; Kim, Chung Su; Lee, Sangmin M.			Obesity Is Independently Associated with Spinal Anesthesia Outcomes: A Prospective Observational Study	PLOS ONE			English	Article							BODY-MASS INDEX; ISOBARIC 0.5-PERCENT BUPIVACAINE; CEREBROSPINAL-FLUID VOLUME; SPREAD; INTERSPACE; ANALGESIA; BLOCKADE	The influence of body-mass index (BMI) on spinal anesthesia is still controversial, with discrepant results reported in previous studies. To compare spinal anesthesia in obese and non-obese subjects, the anesthesia profiles in patients who underwent spinal anesthesia using intrathecal hyperbaric bupivacaine were compared. A total of 209 patients undergoing elective total knee replacement arthroplasty (TKRA) surgery under spinal anesthesia were divided into an NO (non-obese) group (BMI < 30 kg/m(2), n = 141) and an O (obese) group (BMI >= 30 kg/m(2), n = 68). Anesthesia was deemed successful if a bilateral T12 sensory block occurred within 15 minutes of intrathecal drug administration, and if the level of sensory block was higher than T12 when the surgery ended. Logistic regression analysis with multiple variables known to influence spinal anesthesia was performed to identify which parameters independently determined the spinal anesthesia outcome. Similar doses of bupivacaine were administered to the NO and O groups. The incidence of anesthesia failure was significantly lower in the O group [n = 43 (30.5%) in the NO group vs. n = 10 (18.9%) in the O group, p = 0.014]. The independent predictors for successful anesthesia in all patients were dose of hyperbaric bupivacaine [odds ratio (OR) 2.12, 95% CI: 1.64-2.73] and obese status (BMI >= 30 kg/m(2), OR 2.86, 95% CI: 1.25-6.52). Time to first report of postoperative pain and time to first self-void were significantly longer in the O group. These results suggest that the duration of block with hyperbaric bupivacaine is prolonged in obese patients and obesity is independently associated with spinal anesthesia outcomes, as is bupivacaine dosage. A further study enrolling patients with morbid obesity and using a fixed bupivacaine dosage is required to confirm the effect of obesity on spinal anesthesia.	[Kim, Hyo-Jin; Kim, Won Ho; Kim, Jie Ae] Sungkyunkwan Univ, Samsung Changwon Hosp, Sch Med, Dept Anesthesiol & Pain Med, Chang Won, South Korea; [Lim, Hyung Woo; Kim, Duk-Kyung; Shin, Byung Seop; Sim, Woo Seog; Hahm, Tae Soo; Kim, Chung Su; Lee, Sangmin M.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, WH (corresponding author), Sungkyunkwan Univ, Samsung Changwon Hosp, Sch Med, Dept Anesthesiol & Pain Med, Chang Won, South Korea.	wonhokim.ane@gmail.com	Lim, HW/GRY-3517-2022; Kim, Won Ho/S-8671-2019	Kim, Won Ho/0000-0003-1748-1296				Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; BARCLAY DL, 1968, AM J OBSTET GYNECOL, V101, P792, DOI 10.1016/0002-9378(68)90035-5; BLOMBERG R, 1986, ANESTH ANALG, V65, P747; Broadbent CR, 2000, ANAESTHESIA, V55, P1122, DOI 10.1046/j.1365-2044.2000.01547-4.x; BROMAGE PR, 1964, BRIT J ANAESTH, V36, P342, DOI 10.1093/bja/36.6.342; CAPOGNA G, 1995, REGION ANESTH, V20, P369; Carpenter RL, 1998, ANESTHESIOLOGY, V89, P24, DOI 10.1097/00000542-199807000-00007; Carvalho B, 2011, ANESTHESIOLOGY, V114, P529, DOI 10.1097/ALN.0b013e318209a92d; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; Dalton WT, 2014, SOUTH MED J, V107, P348, DOI 10.14423/01.SMJ.0000450708.52011.7c; Demidenko E, 2007, STAT MED, V26, P3385, DOI 10.1002/sim.2771; Ginosar Y, 2004, ANESTHESIOLOGY, V100, P676, DOI 10.1097/00000542-200403000-00031; HARTWELL BL, 1991, REGION ANESTH, V16, P17; Hocking G, 2004, BRIT J ANAESTH, V93, P568, DOI 10.1093/bja/aeh204; Hogan QH, 1996, ANESTHESIOLOGY, V84, P1341, DOI 10.1097/00000542-199606000-00010; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; Kim WH, 2012, ANAESTH INTENS CARE, V40, P410, DOI 10.1177/0310057X1204000305; Leino KA, 2011, J ANESTH, V25, P213, DOI 10.1007/s00540-010-1082-3; LOGAN MR, 1986, BRIT J ANAESTH, V58, P292, DOI 10.1093/bja/58.3.292; Lundstrom LH, 2009, ANESTHESIOLOGY, V110, P266, DOI 10.1097/ALN.0b013e318194cac8; MCCULLOCH WJD, 1986, BRIT J ANAESTH, V58, P610, DOI 10.1093/bja/58.6.610; Nie JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107548; Pan PH, 2004, SOUTH MED J, V97, P359, DOI 10.1097/01.SMJ.0000078681.07409.F7; Patel AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109153; PITKANEN M, 1984, BRIT J ANAESTH, V56, P279, DOI 10.1093/bja/56.3.279; PITKANEN MT, 1987, ANESTH ANALG, V66, P127, DOI 10.1213/00000539-198702000-00005; ROBINSON LS, 1949, SURGERY, V25, P329; Schnider TW, 1996, ANESTHESIOLOGY, V85, P502, DOI 10.1097/00000542-199609000-00009; TAIVAINEN T, 1990, BRIT J ANAESTH, V64, P542, DOI 10.1093/bja/64.5.542	29	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124264	10.1371/journal.pone.0124264	http://dx.doi.org/10.1371/journal.pone.0124264			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898360	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600058
J	Paganin, P; Fiscarelli, EV; Tuccio, V; Chiancianesi, M; Bacci, G; Morelli, P; Dolce, D; Dalmastri, C; De Alessandri, A; Lucidi, V; Taccetti, G; Mengoni, A; Bevivino, A				Paganin, Patrizia; Fiscarelli, Ersilia Vita; Tuccio, Vanessa; Chiancianesi, Manuela; Bacci, Giovanni; Morelli, Patrizia; Dolce, Daniela; Dalmastri, Claudia; De Alessandri, Alessandra; Lucidi, Vincenzina; Taccetti, Giovanni; Mengoni, Alessio; Bevivino, Annamaria			Changes in Cystic Fibrosis Airway Microbial Community Associated with a Severe Decline in Lung Function	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISMS; T-RFLP ANALYSIS; BACTERIAL DIVERSITY; PULMONARY-FUNCTION; SPUTUM SAMPLES; FEV1 DECLINE; INFECTION; 16S; INSIGHTS; IDENTIFICATION	Cystic fibrosis (CF) is a genetic disease resulting in chronic polymicrobial infections of the airways and progressive decline in lung function. To gain insight into the underlying causes of severe lung diseases, we aimed at comparing the airway microbiota detected in sputum of CF patients with stable lung function (S) versus those with a substantial decline in lung function (SD). Microbiota composition was investigated by using culture-based and culture-independent methods, and by performing multivariate and statistical analyses. Culture-based methods identified some microbial species associated with a worse lung function, i.e. Pseudomonas aeruginosa, Rothia mucilaginosa, Streptococcus pneumoniae and Candida albicans, but only the presence of S. pneumoniae and R. mucilaginosa was found to be associated with increased severe decline in forced expiratory volume in 1 second (FEV1). Terminal-Restriction Fragment Length Polymorphism (T-RFLP) analysis revealed a higher bacterial diversity than that detected by culture-based methods. Molecular signatures with a statistically significant odds ratio for SD status were detected, and classified as Pseudomonas, Burkholderia and Shewanella, while for other Terminal Restriction Fragments (T-RFs) no species assignation was achieved. The analysis of T-RFLP data using ecological biodiversity indices showed reduced Evenness in SD patients compared to S ones, suggesting an impaired ecology of the bacterial community in SD patients. Statistically significant differences of the ecological biodiversity indices among the three sub-groups of FEV1 (normal/mild vs moderate vs severe) were also found, suggesting that the patients with moderate lung disease experienced changes in the airway assembly of taxa. Overall, changes in CF airway microbial community associated with a severe lung function decline were detected, allowing us to define some discriminatory species as well as some discriminatory T-RFs that represent good candidates for the development of predictive biomarkers of substantial decline in lung function.	[Paganin, Patrizia; Dalmastri, Claudia; Bevivino, Annamaria] Casaccia Res Ctr, ENEA Italian Natl Agcy New Technol Energy & Susta, Tech Unit Sustainable Dev & Innovat Agroind Syst, Rome, Italy; [Fiscarelli, Ersilia Vita; Tuccio, Vanessa; Lucidi, Vincenzina] Childrens Hosp, Cyst Fibrosis Microbiol & Cyst Fibrosis Ctr, Rome, Italy; [Fiscarelli, Ersilia Vita; Tuccio, Vanessa; Lucidi, Vincenzina] Inst Bambino Gesu, Rome, Italy; [Chiancianesi, Manuela; Bacci, Giovanni; Mengoni, Alessio] Univ Florence, Dept Evolutionary Biol, Florence, Italy; [Morelli, Patrizia; De Alessandri, Alessandra] G Gaslini Inst Children, Cyst Fibrosis Ctr, Dept Pediat, Genoa, Italy; [Dolce, Daniela; Taccetti, Giovanni] Meyer Hosp, Cyst Fibrosis Ctr, Dept Pediat, Florence, Italy	Italian National Agency New Technical Energy & Sustainable Economics Development; University of Florence; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER	Bevivino, A (corresponding author), Casaccia Res Ctr, ENEA Italian Natl Agcy New Technol Energy & Susta, Tech Unit Sustainable Dev & Innovat Agroind Syst, Rome, Italy.	annamaria.bevivino@enea.it	Bevivino, Annamaria/F-4060-2015; Fiscarelli, Ersilia Vita/K-3035-2016; Dalmastri, Claudia/AAD-1627-2021; Mengoni, Alessio/G-5336-2013; Paganin, Patrizia/AAB-9735-2022; Taccetti, Giovanni/K-9519-2016	Fiscarelli, Ersilia Vita/0000-0003-4156-1835; Mengoni, Alessio/0000-0002-1265-8251; Paganin, Patrizia/0000-0002-8993-6651; Dolce, Daniela/0000-0002-8317-9928; Taccetti, Giovanni/0000-0002-9448-5381; Bacci, Giovanni/0000-0003-4406-7816; Lucidi, Vincenzina/0000-0003-3661-607X; Bevivino, Annamaria/0000-0003-4277-7048	Italian Cystic Fibrosis Research Foundation (FCC) [8/2012, 10/2014]; Italian Cystic Fibrosis Research Foundation	Italian Cystic Fibrosis Research Foundation (FCC); Italian Cystic Fibrosis Research Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation)	This research was supported by grants from the Italian Cystic Fibrosis Research Foundation (FCC) (http://www.fibrosicisticaricerca.it/) to AB [Project FFC #8/2012 (with the contribution of "Delegazione FFC di Latina", "Delegazione FFC di Imola", "Delegazione FFC di Cecina", Associazione Trentina FC onlus in ricordo di Vanessa Weber, and "Associazione Davide e Guido - Insieme - Fibrosi Cistica Trust Online) and Project FFC #10/2014 (with the contribution of "Delegazione FFC di Villa D'Alme - Bergamo", "Gruppo di Sostegno FFC di Reggello Firenze", Gruppo di Sostegno FFC di Lainate", and "Delegazione FFC di Verbania e V.C.O")]. PP, VT, and MC were supported by grants awarded by the Italian Cystic Fibrosis Research Foundation. The funders had no role in study design, data collection, analysis and interpretation of the data, decision to publish, or preparation of the manuscript.	Bevivino A, 2013, CML CYSTIC FIBROSIS, V3, P93; Bittar F, 2010, CLIN MICROBIOL INFEC, V16, P809, DOI 10.1111/j.1469-0691.2010.03236.x; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Blackwood CB, 2007, APPL ENVIRON MICROB, V73, P5276, DOI 10.1128/AEM.00514-07; Burns JL, 1998, CLIN INFECT DIS, V27, P158, DOI 10.1086/514631; Cai L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053649; Camarinha-Silva A, 2012, FEMS MICROBIOL ECOL, V79, P98, DOI 10.1111/j.1574-6941.2011.01197.x; Carmody Lisa A, 2013, Ann Am Thorac Soc, V10, P179, DOI 10.1513/AnnalsATS.201211-107OC; Cazzola M, 2008, EUR RESPIR J, V31, P416, DOI 10.1183/09031936.00099306; Chotirmall SH, 2010, CHEST, V138, P1186, DOI 10.1378/chest.09-2996; Del Chierico F, 2012, J PROTEOMICS, V75, P3314, DOI 10.1016/j.jprot.2012.03.048; Ding T, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-1; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; Filkins LM, 2012, J BACTERIOL, V194, P4709, DOI 10.1128/JB.00566-12; Flume PA, 2009, AM J RESP CRIT CARE, V180, P802, DOI 10.1164/rccm.200812-1845PP; Foweraker J, 2009, BRIT MED BULL, V89, P93, DOI 10.1093/bmb/ldn050; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Huang YJ, 2011, EXPERT REV RESP MED, V5, P809, DOI [10.1586/ERS.11.76, 10.1586/ers.11.76]; Joo S, 2010, J MICROBIOL METH, V81, P61, DOI 10.1016/j.mimet.2010.01.025; Kerem Eitan, 2005, J Cyst Fibros, V4, P7, DOI 10.1016/j.jcf.2004.12.002; Kerem E, 2014, EUR RESPIR J, V43, P125, DOI 10.1183/09031936.00166412; Konstan MW, 2007, J PEDIATR-US, V151, P134, DOI 10.1016/j.jpeds.2007.03.006; Lim YW, 2014, J CLIN MICROBIOL, V52, P425, DOI 10.1128/JCM.02204-13; Lim YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064285; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Lynch SV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009738; Maeda Y, 2011, J CYST FIBROS, V10, P133, DOI 10.1016/j.jcf.2010.11.003; Mahenthiralingam E, 2014, PAEDIATR RESPIR REV, V15, P13, DOI 10.1016/j.prrv.2014.04.006; Marsh TL, 2005, METHOD ENZYMOL, V397, P308, DOI 10.1016/S0076-6879(05)97018-3; Maughan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045791; McCafferty J, 2012, ENV MICROBIOL REP, V4, P556, DOI 10.1111/j.1758-2229.2012.00368.x; Milla CE, 1998, CHEST, V113, P1230, DOI 10.1378/chest.113.5.1230; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nakano Y, 2010, MICROB ECOL, V60, P364, DOI 10.1007/s00248-010-9703-9; Osborn AM, 2000, ENVIRON MICROBIOL, V2, P39, DOI 10.1046/j.1462-2920.2000.00081.x; R Development Core Team, R LANG ENV STAT COMP; Ramsey BW, 1999, NEW ENGL J MED, V340, P23, DOI 10.1056/NEJM199901073400104; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2003, J CLIN MICROBIOL, V41, P3548, DOI 10.1128/JCM.41.8.3548-3558.2003; Rogers GB, 2015, THORAX, V70, P74, DOI 10.1136/thoraxjnl-2014-205826; Rogers GB, 2010, J CLIN MICROBIOL, V48, P78, DOI 10.1128/JCM.01324-09; Rosenbluth DB, 2004, CHEST, V126, P412, DOI 10.1378/chest.126.2.412; Saiman L, 2014, INFECT CONT HOSP EP, V35, pS1, DOI 10.1086/676882; Sanders DB, 2010, AM J RESP CRIT CARE, V182, P627, DOI 10.1164/rccm.200909-1421OC; Seng P, 2013, J CLIN MICROBIOL, V51, P2182, DOI 10.1128/JCM.00492-13; Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0; Sibley CD, 2009, CURR OPIN INVEST DR, V10, P787; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Stressmann FA, 2011, J CLIN MICROBIOL, V49, P281, DOI 10.1128/JCM.01650-10; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Taylor-Robinson D, 2012, THORAX, V67, P860, DOI 10.1136/thoraxjnl-2011-200953; Tiquia SM, 2010, METHODS MOL BIOL, V599, P89, DOI 10.1007/978-1-60761-439-5_6; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; VandenBranden SL, 2012, PEDIATR PULM, V47, P135, DOI 10.1002/ppul.21526; Zhao JC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04345; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	59	47	48	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124348	10.1371/journal.pone.0124348	http://dx.doi.org/10.1371/journal.pone.0124348			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898134	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600066
J	Afanasyev, V; Buldyrev, SV; Dunn, MJ; Robst, J; Preston, M; Bremner, SF; Briggs, DR; Brown, R; Adlard, S; Peat, HJ				Afanasyev, Vsevolod; Buldyrev, Sergey V.; Dunn, Michael J.; Robst, Jeremy; Preston, Mark; Bremner, Steve F.; Briggs, Dirk R.; Brown, Ruth; Adlard, Stacey; Peat, Helen J.			Increasing Accuracy: A New Design and Algorithm for Automatically Measuring Weights, Travel Direction and Radio Frequency Identification (RFID) of Penguins	PLOS ONE			English	Article							FORAGING-TRIP DURATION; ADELIE PENGUINS; FLIPPER BANDS; CHINSTRAP PENGUINS; BECHERVAISE-ISLAND; SIGNY ISLAND; SUCCESS; ANTARCTICA; SURVIVAL; CHICKS	A fully automated weighbridge using a new algorithm and mechanics integrated with a Radio Frequency Identification System is described. It is currently in use collecting data on Macaroni penguins (Eudyptes chrysolophus) at Bird Island, South Georgia. The technology allows researchers to collect very large, highly accurate datasets of both penguin weight and direction of their travel into or out of a breeding colony, providing important contributory information to help understand penguin breeding success, reproductive output and availability of prey. Reliable discrimination between single and multiple penguin crossings is demonstrated. Passive radio frequency tags implanted into penguins allow researchers to match weight and trip direction to individual birds. Low unit and operation costs, low maintenance needs, simple operator requirements and accurate time stamping of every record are all important features of this type of weighbridge, as is its proven ability to operate 24 hours a day throughout a breeding season, regardless of temperature or weather conditions. Users are able to define required levels of accuracy by adjusting filters and raw data are automatically recorded and stored allowing for a range of processing options. This paper presents the underlying principles, design specification and system description, provides evidence of the weighbridge's accurate performance and demonstrates how its design is a significant improvement on existing systems.	[Afanasyev, Vsevolod; Dunn, Michael J.; Robst, Jeremy; Preston, Mark; Bremner, Steve F.; Briggs, Dirk R.; Brown, Ruth; Adlard, Stacey; Peat, Helen J.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England; [Buldyrev, Sergey V.] Yeshiva Univ, Dept Phys, New York, NY 10033 USA	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Yeshiva University	Afanasyev, V (corresponding author), British Antarctic Survey, NERC, High Cross,Madingley Rd, Cambridge CB3 0ET, England.	hjpe@bas.ac.uk	Peat, Helen J/E-9666-2015; Buldyrev, Sergey V/I-3933-2015	Buldyrev, Sergey/0000-0002-3008-1070; Dunn, Michael/0000-0003-4633-5466; Peat, Helen/0000-0003-2017-8597	Bernard W. Gamson Computational Science Center at Yeshiva College; Natural Environment Research Council (NERC) British Antarctic Survey core budget; Natural Environment Research Council [bas0100025, bas010011, bas0100035] Funding Source: researchfish; NERC [bas0100025, bas0100035, bas010011] Funding Source: UKRI	Bernard W. Gamson Computational Science Center at Yeshiva College; Natural Environment Research Council (NERC) British Antarctic Survey core budget; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	SVB acknowledges partial support of this research through Bernard W. Gamson Computational Science Center at Yeshiva College. This project is also funded by Natural Environment Research Council (NERC) British Antarctic Survey core budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballard G, 2001, CONDOR, V103, P481, DOI 10.1650/0010-5422(2001)103[0481:EOIAAO]2.0.CO;2; Ballard G, 2010, MAR ECOL PROG SER, V405, P287, DOI 10.3354/meps08514; Boersma PD, 2009, J FIELD ORNITHOL, V80, P408, DOI 10.1111/j.1557-9263.2009.00248.x; Bonter DN, 2011, J FIELD ORNITHOL, V82, P1, DOI 10.1111/j.1557-9263.2010.00302.x; Clarke J, 2002, POLAR BIOL, V25, P21, DOI 10.1007/s003000100307; Clarke JR, 2001, POLAR BIOL, V24, P16, DOI 10.1007/s003000000168; Clarke J, 2006, MAR ECOL PROG SER, V310, P247, DOI 10.3354/meps310247; Dehnhard N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079487; Dugger KM, 2006, AUK, V123, P858, DOI 10.1642/0004-8038(2006)123[858:EOFBOF]2.0.CO;2; Gauthier-Clerc M, 2004, P ROY SOC B-BIOL SCI, V271, pS423, DOI 10.1098/rsbl.2004.0201; Green CJ, 2006, POLAR BIOL, V29, P1003, DOI 10.1007/s00300-006-0143-4; Harding AMA, 2011, OECOLOGIA, V167, P49, DOI 10.1007/s00442-011-1971-7; Kerry Knowles, 1993, Proceedings of the NIPR Symposium on Polar Biology, V6, P62; LISHMAN GS, 1985, J ZOOL, V205, P245, DOI 10.1111/j.1469-7998.1985.tb03532.x; Newton I., 1687, MATH PRINCIPLES NATU; Renner Martin, 2000, Notornis, V47, P163; Robinson S, 2005, IBIS, V147, P483, DOI 10.1111/j.1474-919x.2005.00431.x; Takahashi A, 2003, MAR ECOL PROG SER, V250, P279, DOI 10.3354/meps250279; Vertigan C, 2012, ANIM WELFARE, V21, P101, DOI 10.7120/096272812799129493; Waluda CM, 2012, MAR ECOL PROG SER, V466, P261, DOI 10.3354/meps09930; Watanuki Y, 2002, POLAR BIOL, V25, P672, DOI 10.1007/s00300-002-0399-2; Williams T.D., 1995, PENGUINS	22	0	0	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0126292	10.1371/journal.pone.0126292	http://dx.doi.org/10.1371/journal.pone.0126292			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894763	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000353211700142
J	Tagwireyi, P; Sullivan, SMP				Tagwireyi, Paradzayi; Sullivan, S. Mazeika P.			Riverine Landscape Patch Heterogeneity Drives Riparian Ant Assemblages in the Scioto River Basin, USA	PLOS ONE			English	Article							HYMENOPTERA-FORMICIDAE; HABITAT; COMMUNITIES; ECOLOGY; FLOODPLAIN; DIVERSITY; URBANIZATION; FOREST; INVERTEBRATES; BIODIVERSITY	Although the principles of landscape ecology are increasingly extended to include riverine landscapes, explicit applications are few. We investigated associations between patch heterogeneity and riparian ant assemblages at 12 riverine landscapes of the Scioto River, Ohio, USA, that represent urban/developed, agricultural, and mixed (primarily forested, but also wetland, grassland/fallow, and exurban) land-use settings. Using remotely-sensed and ground-collected data, we delineated riverine landscape patch types (crop, grass/herbaceous, gravel, lawn, mudflat, open water, shrub, swamp, and woody vegetation), computed patch metrics (area, density, edge, richness, and shape), and conducted coordinated sampling of surface-active Formicidae assemblages. Ant density and species richness was lower in agricultural riverine landscapes than at mixed or developed reaches (measured using S [total number of species], but not using Menhinick's Index [D-M]), whereas ant diversity (using the Berger-Park Index [D-BP]) was highest in agricultural reaches. We found no differences in ant density, richness, or diversity among internal riverine landscape patches. However, certain characteristics of patches influenced ant communities. Patch shape and density were significant predictors of richness (S: R-2 = 0.72; D-M: R-2 = 0.57). Patch area, edge, and shape emerged as important predictors of D-BP (R-2 = 0.62) whereas patch area, edge, and density were strongly related to ant density (R-2 = 0.65). Non-metric multidimensional scaling and analysis of similarities distinguished ant assemblage composition in grass and swamp patches from crop, gravel, lawn, and shrub as well as ant assemblages in woody vegetation patches from crop, lawn, and gravel (stress = 0.18, R-2 = 0.64). These findings lend insight into the utility of landscape ecology to river science by providing evidence that spatial habitat patterns within riverine landscapes can influence assemblage characteristics of riparian arthropods.	[Tagwireyi, Paradzayi; Sullivan, S. Mazeika P.] Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Tagwireyi, P (corresponding author), Univ Zimbabwe, Dept Geog & Environm Sci, Geoinformat & Earth Observat Ctr, POB MP 167, Harare, Zimbabwe.	tagwireyi.1@buckeyemail.osu.edu	Sulliván, Mažeika Patricio/C-8261-2012	Sulliván, Mažeika Patricio/0000-0003-2341-5316	Ohio Agricultural Research and Development Center	Ohio Agricultural Research and Development Center	Support for this research was provided by state and federal funds appropriated to The Ohio State University, and The Ohio Agricultural Research and Development Center (SMPS).	Alberts JM, 2013, SCI TOTAL ENVIRON, V463, P42, DOI 10.1016/j.scitotenv.2013.05.065; Andersen A. N., 1997, CONSERV ECOL, V1, P8, DOI DOI 10.5751/ES-00014-010108; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2005, B OHIO BIOL SURV; Ballinger A, 2007, OECOLOGIA, V152, P227, DOI 10.1007/s00442-006-0648-0; BAXTER MJ, 1995, J R STAT SOC C-APPL, V44, P513, DOI 10.2307/2986142; BAYLEY PB, 1995, BIOSCIENCE, V45, P153, DOI 10.2307/1312554; BERGER WH, 1970, SCIENCE, V168, P1345, DOI 10.1126/science.168.3937.1345; BRUDER KW, 1972, ANN ENTOMOL SOC AM, V65, P358, DOI 10.1093/aesa/65.2.358; Buczkowski G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041729; Burt TP, 2005, PROG PHYS GEOG, V29, P297, DOI 10.1191/0309133305pp450ra; Carbonneau P, 2012, GEOMORPHOLOGY, V137, P74, DOI 10.1016/j.geomorph.2010.09.030; Church M, 2002, GEOMORPHOLOGY, V45, P1; Church M, 2002, FRESHWATER BIOL, V47, P541, DOI 10.1046/j.1365-2427.2002.00919.x; Dix NJ, 1995, MOSAIC LANDSCAPES EC, DOI [10.1007/978-94-011-0693-1, DOI 10.1007/978-94-011-0717-4_1]; Elkie P, 1999, PATCH ANAL USERS MAN; Fisher B. L., 2007, ANTS N AM GUIDE GENE; Fletcher RJ, 2007, CAN J ZOOL, V85, P1017, DOI 10.1139/Z07-100; Framenau VW, 2002, AUST J ZOOL, V50, P103, DOI 10.1071/ZO01039; Goebel PC, 2012, WETLANDS, V32, P679, DOI 10.1007/s13157-012-0300-1; Gollan JR, 2011, ECOL INDIC, V11, P1517, DOI 10.1016/j.ecolind.2009.09.007; Gomez C, 2013, ECOGRAPHY, V36, P1193, DOI 10.1111/j.1600-0587.2013.00289.x; Hammond PM, 1998, RIPARIAN FLOODPLAIN, P237; Hering D, 2004, RIVER RES APPL, V20, P445, DOI 10.1002/rra.759; Hering D, 1997, OECOLOGIA, V111, P261, DOI 10.1007/s004420050234; Holmes KL, 2011, J FOREST, V109, P233; Holway DA, 2006, BIOL CONSERV, V127, P319, DOI 10.1016/j.biocon.2005.05.016; Hufkens K, 2009, ECOL RES, V24, P977, DOI 10.1007/s11284-009-0584-7; Ivanov K, 2011, BIOL INVASIONS, V13, P1945, DOI 10.1007/s10530-011-0021-z; Ives CD, 2013, LANDSCAPE URBAN PLAN, V110, P155, DOI 10.1016/j.landurbplan.2012.11.005; Jarolimek I, 1999, BIOLOGIA, V54, P405; Johansen K, 2010, REMOTE SENS ENVIRON, V114, P2679, DOI 10.1016/j.rse.2010.06.004; Johnston CA, 2001, SOIL SCI SOC AM J, V65, P557, DOI 10.2136/sssaj2001.652557x; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Karl T. R., 1984, HIST CLIMATOLOGY SER, V4-3; Kaspari M, 2000, P ROY SOC B-BIOL SCI, V267, P485, DOI 10.1098/rspb.2000.1026; Kawula R., 2009, FLORIDA LAND COVER C; KIM HH, 1992, INT J REMOTE SENS, V13, P2319, DOI 10.1080/01431169208904271; King JR, 2006, J ANIM ECOL, V75, P1370, DOI 10.1111/j.1365-2656.2006.01161.x; Lambeets K, 2008, J ANIM ECOL, V77, P1162, DOI 10.1111/j.1365-2656.2008.01443.x; Latterell JJ, 2006, FRESHWATER BIOL, V51, P523, DOI 10.1111/j.1365-2427.2006.01513.x; Lessard JP, 2005, CAN ENTOMOL, V137, P215, DOI 10.4039/N04-055; Lude A, 1999, ENTOMOL GEN, V24, P75; MAC ARTHUR ROBERT H., 1967; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; McGarigal K., 2012, TECH REP; McGlynn TP, 1999, J BIOGEOGR, V26, P535, DOI 10.1046/j.1365-2699.1999.00310.x; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Menke SB, 2011, URBAN ECOSYST, V14, P135, DOI 10.1007/s11252-010-0150-7; Menke SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009194; Mitchell CE, 2002, ECOL APPL, V12, P1364, DOI 10.2307/3099977; Muller J, 2009, J APPL ECOL, V46, P897, DOI 10.1111/j.1365-2664.2009.01677.x; NLCD, 2006, NATL LAND COVER DATA; Ohio Division of Geological Survey, 1998, PHYS REG OH; Orrock JL, 2011, LANDSCAPE ECOL, V26, P1361, DOI 10.1007/s10980-011-9656-5; Paetzold A, 2008, J APPL ECOL, V45, P894, DOI 10.1111/j.1365-2664.2008.01463.x; Pecarevic M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013222; Petal J.M., 1976, Polish ecol Stud, V2, P209; Poole GC, 2002, FRESHWATER BIOL, V47, P641, DOI 10.1046/j.1365-2427.2002.00922.x; Rencher A.C., 1995, METHODS MULTIVARIATE; Retana J, 2000, OECOLOGIA, V123, P436, DOI 10.1007/s004420051031; Richards K, 2002, FRESHWATER BIOL, V47, P559, DOI 10.1046/j.1365-2427.2002.00920.x; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; ROGERS JC, 1993, OHIO J SCI, V93, P51; Sadler JP, 2004, BIOL CONSERV, V118, P41, DOI 10.1016/j.biocon.2003.07.007; Sanders NJ, 2003, P NATL ACAD SCI USA, V100, P2474, DOI 10.1073/pnas.0437913100; Scheifer MC, 2002, OHIO B, V47; STAMPS JA, 1987, AM NAT, V129, P533, DOI 10.1086/284656; Steiner FM, 2008, DIVERS DISTRIB, V14, P538, DOI 10.1111/j.1472-4642.2008.00472.x; Sullivan SMP, 2007, LANDSCAPE ECOL, V22, P1169, DOI 10.1007/s10980-007-9097-3; Sullivan SMP, 2008, CAN J FISH AQUAT SCI, V65, P2667, DOI 10.1139/F08-165; Thompson Bill, 2007, Urban Ecosystems, V10, P43, DOI 10.1007/s11252-006-0013-4; Thorp JH, 2014, FRESHWATER BIOL, V59, P200, DOI 10.1111/fwb.12237; Thorp JH, 2006, RIVER RES APPL, V22, P123, DOI 10.1002/rra.901; Underwood EC, 2006, BIOL CONSERV, V132, P166, DOI 10.1016/j.biocon.2006.03.022; US Census Bureau, 2011, GUID STAT LOC CENS G; Vierling KT, 2011, ECOL APPL, V21, P577, DOI 10.1890/09-2155.1; Ward D, 2008, PAC SCI, V62, P473, DOI 10.2984/1534-6188(2008)62[473:EPAIAH]2.0.CO;2; Ward JV, 2001, FRESHWATER BIOL, V46, P807, DOI 10.1046/j.1365-2427.2001.00713.x; Ward JV, 2002, LANDSCAPE ECOL, V17, P35, DOI 10.1023/A:1015277626224; Ward JV, 2002, FRESHWATER BIOL, V47, P517, DOI 10.1046/j.1365-2427.2002.00893.x; Ward JV, 1999, REGUL RIVER, V15, P125, DOI 10.1002/(SICI)1099-1646(199901/06)15:1/3&lt;125::AID-RRR523&gt;3.0.CO;2-E; White D., 2005, RIVERS N AM, P375; Wiens JA, 2002, FRESHWATER BIOL, V47, P501, DOI 10.1046/j.1365-2427.2002.00887.x; Yasuda M, 2009, LANDSCAPE URBAN PLAN, V92, P276, DOI 10.1016/j.landurbplan.2009.05.008	86	15	17	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124807	10.1371/journal.pone.0124807	http://dx.doi.org/10.1371/journal.pone.0124807			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894540	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700125
J	Gutierrez, A; Bento, L; Bautista-Gili, AM; Garcia, F; Martinez-Serra, J; Sanchez, B; Martorell, C; Gines, J; Garcia, L; Gimeno, E; Ferraro, M; Del Campo, R; Bargay, J; Perez, A; Vercher, J; Scaff, M; Pacheco, A; Ballester, C; Garcia, F; Ramos, R; Salar, A; Besalduch, J				Gutierrez, Antonio; Bento, Leyre; Maria Bautista-Gili, Antonia; Garcia, Francesc; Martinez-Serra, Jordi; Sanchez, Blanca; Martorell, Clara; Gines, Jordi; Garcia, Lucia; Gimeno, Eva; Ferraro, Mariana; Del Campo, Raquel; Bargay, Joan; Perez, Albert; Vercher, Javier; Scaff, Miguel; Pacheco, Ana; Ballester, Carmen; Garcia, Florencia; Ramos, Rafael; Salar, Antonio; Besalduch, Joan			Differential Impact of Relative Dose-Intensity Reductions in Diffuse Large B-Cell Lymphoma Treated with R-CHOP21 or R-CHOP14	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; ELDERLY-PATIENTS; CHOP CHEMOTHERAPY; PROGNOSTIC-SIGNIFICANCE; PREDICTIVE MODEL; RITUXIMAB-CHOP; DOXORUBICIN; TRIAL; SURVIVAL; DISEASE	DLBCL is an aggressive lymphoma treated with R-CHOP. Recently, attempts have been made to improve the outcome by increasing both dose-density and intensity but there have been no benefits in terms of survival. When treating malignancies RDI is important to consider but there is little published information on DLBCL. The purpose of this study was to analyze the differential prognostic impact of RDI in two cohorts of DLBCL patients treated with R-CHOP21 or R-CHOP14. From January 2001 to August 2013 we included DLBCL patients homogenously treated with R-CHOP21 or R-CHOP14, with or without radiotherapy, at University Hospital Son Espases, Hospital Son Llatzer of Palma and Hospital del Mar of Barcelona (N = 157). In order to avoid selection bias the patients were retrospectively identified from the Pathology Department and Pharmacy registries. Median follow-up was 68 months. There was no difference in the response or survival between the two cohorts. In the R-CHOP21 group, both a reduction higher than 15% in RDI (RR 7.41) and R-IPI (RR 2.99) were independently associated with OS. However, a reduction higher than 15% in RDI (RR 4.41) was only noted for PFS. In the R-CHOP14 group, NCCN-IPI (RR 7.09) and B-symptoms (RR 5.37) for OS; AA stage III-IV (RR 6.26) and bulky disease (RR 4.05) for PFS. There was a trend towards a higher rate of RDI reduction observed in the R-CHOP14 group but it only made an impact in the R-CHOP21 group. We conclude that R-CHOP21 and R-CHOP14 are equivalent regimens in terms of response and survival, but only if RDI reductions are avoided. For patients receiving R-CHOP21 we recommend using clinical and support measures in order to avoid RDI reductions.	[Gutierrez, Antonio; Bento, Leyre; Maria Bautista-Gili, Antonia; Martinez-Serra, Jordi; Garcia, Lucia; Ferraro, Mariana; Perez, Albert; Ballester, Carmen; Besalduch, Joan] Son Espases Univ Hosp, Dept Hematol, Palma De Mallorca, Spain; [Garcia, Francesc; Sanchez, Blanca; Gimeno, Eva; Salar, Antonio] Hosp del Mar, Dept Hematol, Barcelona, Spain; [Martorell, Clara; Gines, Jordi] Son Espases Univ Hosp, Dept Pharm, Palma De Mallorca, Spain; [Del Campo, Raquel; Bargay, Joan] Son Llatzer Hosp, Dept Hematol, Palma De Mallorca, Spain; [Vercher, Javier] Can Misses Hosp, Dept Hematol, Ibiza, Spain; [Scaff, Miguel] Hosp Manacor, Dept Hematol, Manacor, Spain; [Pacheco, Ana] Mateu Orfila Hosp, Dept Hematol, Mahon, Spain; [Garcia, Florencia] Univ Hosp Son Espases, Dept Oncol, Palma De Mallorca, Spain; [Ramos, Rafael] Univ Hosp Son Espases, Dept Pathol, Palma De Mallorca, Spain	Hospital Universitari Son Espases; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital Universitari Son Espases; Hospital Universitari Son Llatzer; Hospital Can Misses; Hospital de Manacor; Hospital Mateu Orfila; Hospital Universitari Son Espases; Hospital Universitari Son Espases	Gutierrez, A (corresponding author), Son Espases Univ Hosp, Dept Hematol, Palma De Mallorca, Spain.	antoniom.gutierrez@ssib.es	Gutiérrez, Antonio/AAL-9381-2021; Llàtzer, Son/ABG-1829-2020; garcia, lucia/GXV-8296-2022	Llàtzer, Son/0000-0002-6739-3916; Salar, Antonio/0000-0002-4652-4825				Aapro MS, 2011, EUR J CANCER, V47, P8, DOI 10.1016/j.ejca.2010.10.013; Bosly A, 2008, ANN HEMATOL, V87, P277, DOI 10.1007/s00277-007-0399-y; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; COX DR, 1972, J R STAT SOC B, V34, P187; Cunningham D, 2013, LANCET, V381, P1817, DOI 10.1016/S0140-6736(13)60313-X; Delarue R, 2013, LANCET ONCOL, V14, P525, DOI 10.1016/S1470-2045(13)70122-0; Doorduijn JK, 2003, J CLIN ONCOL, V21, P3041, DOI 10.1200/JCO.2003.01.076; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; GREEN JA, 1980, BRIT J CLIN PHARMACO, V9, P511, DOI 10.1111/j.1365-2125.1980.tb05847.x; Habermann TM, 2006, J CLIN ONCOL, V24, P3121, DOI 10.1200/JCO.2005.05.1003; Hershman DL, 2008, J CLIN ONCOL, V26, P3159, DOI 10.1200/JCO.2007.14.1242; HRYNIUK W, 1984, J CLIN ONCOL, V2, P1281, DOI 10.1200/JCO.1984.2.11.1281; Hryniuk W M, 1988, Important Adv Oncol, P121; HRYNIUK WM, 1990, J CLIN ONCOL, V8, P1935, DOI 10.1200/JCO.1990.8.12.1935; Intragumtornchai T, 2000, LEUKEMIA LYMPHOMA, V37, P351, DOI 10.3109/10428190009089435; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KWAK LW, 1990, J CLIN ONCOL, V8, P963, DOI 10.1200/JCO.1990.8.6.963; Landgren O, 2003, HAEMATOLOGICA, V88, P438; LEPAGE E, 1993, ANN ONCOL, V4, P651, DOI 10.1093/oxfordjournals.annonc.a058619; Linch DC, 2010, BRIT J HAEMATOL, V149, P237, DOI 10.1111/j.1365-2141.2010.08081.x; Luminari S, 2010, ANN ONCOL, V21, P1492, DOI 10.1093/annonc/mdp544; Lyman GH, 2004, J CLIN ONCOL, V22, P4302, DOI 10.1200/JCO.2004.03.213; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Pfreundschuh M, 2004, BLOOD, V104, P634, DOI 10.1182/blood-2003-06-2095; ROBERT J, 1983, CANCER RES, V43, P4467; Sehn LH, 2007, BLOOD, V109, P1857, DOI 10.1182/blood-2006-08-038257; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Swerdlow SH, 2008, WHO CLASSIFICATION T; VANRIJSWIJK REN, 1989, J CLIN ONCOL, V7, P1776, DOI 10.1200/JCO.1989.7.12.1776; Yamaguchi H, 2011, J CLIN EXP HEMATOP, V51, P1, DOI 10.3960/jslrt.51.1; Zelenetz Andrew D, 2003, Oncology (Williston Park), V17, P21; Zhou Z, 2014, BLOOD, V123, P837, DOI 10.1182/blood-2013-09-524108	34	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123978	10.1371/journal.pone.0123978	http://dx.doi.org/10.1371/journal.pone.0123978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909361	Green Submitted, Green Published, gold			2022-12-27	WOS:000353376800053
J	Gunaratna, NS; Masanja, H; Mrema, S; Levira, F; Spiegelman, D; Hertzmark, E; Saronga, N; Irema, K; Shuma, M; Elisaria, E; Fawzi, W				Gunaratna, Nilupa S.; Masanja, Honorati; Mrema, Sigilbert; Levira, Francis; Spiegelman, Donna; Hertzmark, Ellen; Saronga, Naomi; Irema, Kahema; Shuma, Mary; Elisaria, Ester; Fawzi, Wafaie			Multivitamin and Iron Supplementation to Prevent Periconceptional Anemia in Rural Tanzanian Women: A Randomized, Controlled Trial	PLOS ONE			English	Article							FOLIC-ACID SUPPLEMENTATION; REPRODUCTIVE AGE; PROSPECTIVE COHORT; PREGNANT-WOMEN; FETAL-GROWTH; HEALTH; RISK; HEMOGLOBIN; DEFICIENCY; IMPACT	Objective Women's nutritional status during conception and early pregnancy can influence maternal and infant outcomes. This study examined the efficacy of pre-pregnancy supplementation with iron and multivitamins to reduce the prevalence of anemia during the periconceptional period among rural Tanzanian women and adolescent girls. Design A double-blind, randomized controlled trial was conducted in which participants were individually randomized to receive daily oral supplements of folic acid alone, folic acid and iron, or folic acid, iron, and vitamins A, B-complex, C, and E at approximately single recommended dietary allowance (RDA) doses for six months. Setting Rural Rufiji District, Tanzania. Subjects Non-pregnant women and adolescent girls aged 15-29 years (n = 802). Results The study arms were comparable in demographic and socioeconomic characteristics, food security, nutritional status, pregnancy history, and compliance with the regimen (p>0.05). In total, 561 participants (70%) completed the study and were included in the intention-to-treat analysis. Hemoglobin levels were not different across treatments (median: 11.1 g/dL, Q1-Q3: 10.0-12.4 g/dL, p = 0.65). However, compared with the folic acid arm (28%), there was a significant reduction in the risk of hypochromic microcytic anemia in the folic acid and iron arm (17%, RR: 0.61, 95% CI: 0.42-0.90, p = 0.01) and the folic acid, iron, and multivitamin arm (19%, RR: 0.66, 95% CI: 0.45-0.96, p = 0.03). Inverse probability of treatment weighting (IPTW) to adjust for potential selection bias due to loss to follow-up did not materially change these results. The effect of the regimens was not modified by frequency of household meat consumption, baseline underweight status, parity, breastfeeding status, or level of compliance (in all cases, p for interaction>0.2). Conclusions Daily oral supplementation with iron and folic acid among women and adolescents prior to pregnancy reduces risk of anemia. The potential benefits of supplementation on the risk of periconceptional anemia and adverse pregnancy outcomes warrant investigation in larger studies.	[Gunaratna, Nilupa S.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Masanja, Honorati; Mrema, Sigilbert; Levira, Francis; Irema, Kahema; Shuma, Mary; Elisaria, Ester] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Spiegelman, Donna; Hertzmark, Ellen; Fawzi, Wafaie] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Spiegelman, Donna] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Spiegelman, Donna; Fawzi, Wafaie] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Saronga, Naomi] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Fawzi, Wafaie] Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Ifakara Health Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Muhimbili University of Health & Allied Sciences; Harvard University; Harvard T.H. Chan School of Public Health	Gunaratna, NS (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.	ngunarat@hsph.harvard.edu		Levira, Francis/0000-0002-7063-2447; Gunaratna, Nilupa/0000-0003-2504-4694				Agnarson AM, 2010, TROP MED INT HEALTH, V15, P1000, DOI 10.1111/j.1365-3156.2010.02587.x; Agresti A, 2007, INTRO CATEGORICAL DA; Allen LH, 2001, J NUTR, V131, p581S, DOI 10.1093/jn/131.2.581S; Angeles-Agdeppa I, 2005, NUTR REV, V63, pS116, DOI 10.1301/nr.2005.dec.S116-S125; Bain BJ, 2006, HAEMOGLOBINOPATHY DIAGNOSIS, 2ND EDITION, P1, DOI 10.1002/9780470988787; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; BEATON GH, 1999, EFFICACY INTERMITTEN; Berger J, 2005, NUTR REV, V63, pS95, DOI 10.1301/nr.2005.dec.S95-S108; Berry RJ, 2010, FOOD NUTR BULL, V31, pS22, DOI 10.1177/15648265100311S103; Bodnar LM, 2005, BIOL PSYCHIAT, V58, P679, DOI 10.1016/j.biopsych.2005.05.009; Bothwell TH, 2000, AM J CLIN NUTR, V72, p257S, DOI 10.1093/ajcn/72.1.257S; Casey GJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002146; Casey GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015691; Cavalli-Sforza T, 2005, NUTR REV, V63, pS77, DOI 10.1301/nr.2005.dec.S77-S80; Cetin I, 2010, HUM REPROD UPDATE, V16, P80, DOI 10.1093/humupd/dmp025; Corwin EJ, 2003, J NUTR, V133, P4139, DOI 10.1093/jn/133.12.4139; Crape BL, 2005, NUTR REV, V63, pS134, DOI 10.1301/nr.2005.dec.S134-S138; de Benoist B, 2008, WHO GLOBAL DATABASE; De-Regil LM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007950.pub2; Fernandez-Gaxiola AC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009218.pub2; Gambling L, 2002, BIOL REPROD, V66, P516, DOI 10.1095/biolreprod66.2.516; Haas JD, 2001, J NUTR, V131, p676S, DOI 10.1093/jn/131.2.676S; Haider BA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3443; Hindmarsh PC, 2000, LANCET, V356, P719, DOI 10.1016/S0140-6736(00)02630-1; Horton S, 2003, FOOD POLICY, V28, P51, DOI 10.1016/S0306-9192(02)00070-2; Institute of Medicine, 2001, DIET REF INT VIT A V; Institute of Medicine, 1998, DIET REF INT THIAM R; Institute of Medicine (US) Panel on Dietary Antioxidants and Related Compounds, 2000, DIET REF INT VIT C V; Iolascon A, 2009, HAEMATOL-HEMATOL J, V94, P395, DOI 10.3324/haematol.13619; Ip H, 2009, EUR J CLIN NUTR, V63, P165, DOI 10.1038/sj.ejcn.1602917; Iron and Malaria Technical Working Group, 2009, CONS SAF EFF US IR I; Kaushansky K, 2010, WILLIAMS HEMATOLOGY; Khambalia A, 2009, J NUTR, V139, P1179, DOI 10.3945/jn.108.101022; Khan FA, 2007, INT J INFECT DIS, V11, P482, DOI 10.1016/j.ijid.2007.04.007; Martorell R, 2012, PAEDIATR PERINAT EP, V26, P302, DOI 10.1111/j.1365-3016.2012.01298.x; Mason John, 2005, Food and Nutrition Bulletin, V26, P59; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; Mpembeni Rose Nm, 2007, BMC Pregnancy Childbirth, V7, P29, DOI 10.1186/1471-2393-7-29; National Bureau of Statistics & MACRO, 2010, TANZ DEM HLTH SURV 2; Ogundipe O, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-481; Patterson AJ, 2001, J AM COLL NUTR, V20, P337, DOI 10.1080/07315724.2001.10719054; Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332; Ramakrishnan U, 2012, PAEDIATR PERINAT EP, V26, P285, DOI 10.1111/j.1365-3016.2012.01281.x; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Ronnenberg AG, 2004, J NUTR, V134, P2586, DOI 10.1093/jn/134.10.2586; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Scholl TO, 2011, NUTR REV, V69, pS23, DOI 10.1111/j.1753-4887.2011.00429.x; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Stoltzfus RJ., 2004, COMP QUANTIFICATION, pp. 163; Temin M., 2009, START GIRL NEW AGEND; Viteri FE, 2005, NUTR REV, V63, pS65, DOI 10.1301/nr.2005.dec.S65-S76; Volberding PA, 2004, CLIN INFECT DIS, V38, P1459, DOI 10.1086/383031; Weinberg ED, 1999, EMERG INFECT DIS, V5, P346, DOI 10.3201/eid0503.990305; WHO, 2001, IRON DEFICIENCY ANAE; Zhang QY, 2009, PAEDIATR PERINAT EP, V23, P282, DOI 10.1111/j.1365-3016.2009.01031.x	55	13	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0121552	10.1371/journal.pone.0121552	http://dx.doi.org/10.1371/journal.pone.0121552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905863	Green Submitted, gold, Green Published			2022-12-27	WOS:000353332000008
J	Pan, XF; Gu, JQ; Shan, ZY				Pan, Xi-Feng; Gu, Jian-Qiu; Shan, Zhong-Yan			Patients with Systemic Lupus Erythematosus Have Higher Prevalence of Thyroid Autoantibodies: A Systematic Review and Meta-Analysis	PLoS One			English	Article							GENETIC SUSCEPTIBILITY; AUTOIMMUNE-THYROIDITIS; SLE; ASSOCIATION; DISEASE	Background Thyroid autoimmunity is considered the most common type of organ-specific autoimmune disorder and can be associated with other autoimmune endocrine disorders or non-endocrine diseases. Systemic lupus erythematosus is a prototypical autoimmune disorder with multifactorial etiology. The pathogenesis and development of the disease may result from a loss of immune tolerance and the resulting synthesis of autoantibodies against nuclear antigens. Autoimmune factors may be common features of both thyroid autoimmunity and systemic lupus erythematosus, making it likely that both conditions may coexist within some patients. Methods and Findings A number of studies have investigated whether an association between thyroid autoimmunity and systemic lupus erythematosus exists. However, the results of these studies have been inconsistent. Furthermore, most of these studies have had relatively small sample sizes, which have rendered them insufficiently powerful to determine whether there is an association between systemic lupus erythematosus and thyroid autoimmunity. The main objective of this meta-analysis is to provide reliable estimates of the extent of any association between thyroid autoimmunity and systemic lupus erythematosus by combining the primary data from all relevant studies. Literature databases were searched, including the Medline, Embase, Web of Science, Chinese Wanfang and CBM databases, from January 1970 to May 2014. A total of 1076 systemic lupus erythematosus cases and 1661 healthy controls were included in this study. From these data, the odds ratio (OR) and the corresponding 95% confidence interval (95% CI) were calculated. The meta-analysis results showed that the prevalence of thyroid autoantibody positivity in patients with systemic lupuserythematosus was higher than in healthy controls (TgAb: OR = 2.99, 95% CI = 1.83- 4.89; TPOAb: OR = 2.20, 95% CI = 1.27- 3.82, respectively). Conclusion The results of this meta- analysis suggest that thyroid autoimmunity is more prevalent in patients with systemic lupus erythematosus than in a control group.	[Pan, Xi-Feng; Gu, Jian-Qiu; Shan, Zhong-Yan] China Med Univ, Affiliated Hosp 1, Inst Endocrinol, Dept Endocrinol & Metab,Liaoning Prov Key Lab End, Shenyang 110001, Liaoning, Peoples R China	China Medical University	Shan, ZY (corresponding author), China Med Univ, Affiliated Hosp 1, Inst Endocrinol, Dept Endocrinol & Metab,Liaoning Prov Key Lab End, Shenyang 110001, Liaoning, Peoples R China.	shanzhongyan@medmail.com.cn						Al-Awadhi AM, 2008, MED PRIN PRACT, V17, P61, DOI 10.1159/000109592; Al-Motwee S, 2013, ANN SAUDI MED, V33, P229, DOI 10.5144/0256-4947.2013.229; Antonelli A, 2010, METABOLISM, V59, P896, DOI 10.1016/j.metabol.2009.10.010; Assal HS, 2009, MACEDONIAN J MED SCI, V2, P223; Cui Y, 2013, J AUTOIMMUN, V41, P25, DOI 10.1016/j.jaut.2013.01.008; Devaraju P, 2014, TISSUE ANTIGENS, V83, P418, DOI 10.1111/tan.12363; El-Saadany H, 2014, EGYPT RHEUMATOL, V36, P71, DOI 10.1016/j.ejr.2013.12.003; El-Sherif Wafaa T, 2004, Egypt J Immunol, V11, P81; Ganesh BB, 2011, J INTERF CYTOK RES, V31, P721, DOI 10.1089/jir.2011.0049; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Hrycek Antoni, 2010, Pol Merkur Lekarski, V29, P231; Huber A, 2008, ENDOCR REV, V29, P697, DOI 10.1210/er.2008-0015; Kawashima A, 2011, J CLIN ENDOCR METAB, V96, P3661, DOI 10.1210/jc.2011-1568; Kostic I., 2006, MEDICUS, V7, P61; Kramer CK, 2005, ARCH MED RES, V36, P54, DOI 10.1016/j.arcmed.2004.11.007; Laurberg P, 2013, HORM-INT J ENDOCRINO, V12, P30, DOI 10.1007/BF03401284; Mader R, 2007, CLIN RHEUMATOL, V26, P1891, DOI 10.1007/s10067-007-0602-5; Mousa AA., 2012, TRENDS MED RES, V7, P25, DOI [10.3923/tmr.2012.25.33, DOI 10.3923/TMR.2012.25.33]; Viggiano DPPO, 2008, ARQ BRAS ENDOCRINOL, V52, P531, DOI 10.1590/S0004-27302008000300014; Parameswaran A, 2015, BRIT J DERMATOL, V172, P729, DOI 10.1111/bjd.13433; RIVERO I, 1974, MEDICINA-BUENOS AIRE, V34, P307; Soukup T, 2004, RHEUMATOLOGIA, V18, P167; WEETMAN AP, 1987, BRIT J RHEUMATOL, V26, P359; Wells G.A., NEWCASTLE OTTAWA SCA; Wemeau JL, 2013, HORM-INT J ENDOCRINO, V12, P39, DOI 10.1007/BF03401285; Xu R. J., 1995, IMMUNOLOGICAL J, V11, P262; Zhang M, 2014, INT J CLIN EXP PATHO, V7, P6270	27	21	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123291	10.1371/journal.pone.0123291	http://dx.doi.org/10.1371/journal.pone.0123291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905898	gold, Green Published, Green Submitted			2022-12-27	WOS:000353332000026
J	Xu, LY; Qi, JN; Liu, X; Ma, HX; Yuan, W; Zhao, PQ; Liang, XH; Xu, Y; Wang, HX; Xu, XY; Wang, W; Ma, CH; Gao, LF				Xu, Li-yun; Qi, Jian-ni; Liu, Xiao; Ma, Hong-xin; Yuan, Wei; Zhao, Pei-qing; Liang, Xiao-hong; Xu, Yong; Wang, Hong-xing; Xu, Xiao-yan; Wang, Wei; Ma, Chun-hong; Gao, Li-fen			Tim-4 Inhibits NO Generation by Murine Macrophages	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; T-CELL IMMUNOGLOBULIN; DOMAIN-CONTAINING MOLECULE-4; NF-KAPPA-B; PHOSPHATIDYLSERINE; EXPRESSION; ACTIVATION; LIPOPOLYSACCHARIDE	Objective T cell immunoglobulin-and mucin-domain-containing molecule-4 (Tim-4) receives much attention as a potentially negative regulator of immune responses. However, its modulation on macrophages has not been fully elucidated so far. This study aimed to identify the role of Tim-4 in nitric oxide (NO) modulation. Methods Macrophages were stimulated with 100 ng/ml LPS or 100 U/ml IFN-gamma. RT-PCR was performed to detect TIM-4 mRNA expression. Tim-4 blocking antibody and NF-kappa B inhibitory ligand were involved in the study. NO levels were assayed by Griess reaction. Phosphorylation of NF-kappa B, Jak2 or Stat1 was verified by western blot. Results Tim-4 was up-regulated in murine macrophages after interferon-gamma (IFN-gamma) stimulation. Tim-4 over-expression decreased NO production and inducible nitric oxide synthase (iNOS) expression in lipopolysaccharide (LPS) or IFN-gamma-stimulated macrophages. Consistently, Tim-4 blockade promoted LPS or IFN-gamma-induced NO secretion and iNOS expression. Tim-4 over-expression decreased LPS-induced nuclear factor kappa B (NF-kappa B) p65 phosphorylation in macrophages, which was abrogated by NF-kappa B inhibitory ligand. On the contrary, Tim-4 blocking increased LPS-induced NF-kappa B signaling, which was also abrogated by NF-kappa B inhibition. In addition, Tim-4 blockade promoted Jak2 and Stat1 phosphorylation in IFN-gamma stimulated macrophages. Conclusion These results indicate that Tim-4 is involved in negative regulation of NO production in macrophages, suggesting the critical role of Tim-4 in immune related diseases.	[Xu, Li-yun; Qi, Jian-ni; Liu, Xiao; Ma, Hong-xin; Zhao, Pei-qing; Liang, Xiao-hong; Xu, Yong; Wang, Hong-xing; Xu, Xiao-yan; Wang, Wei; Ma, Chun-hong; Gao, Li-fen] Shandong Univ, Key Lab Expt Teratol, Shandong Prov Key Lab Infect & Immunol, Dept Immunol,Minist Educ,Sch Med, Jinan 250012, Shandong, Peoples R China; [Xu, Li-yun] Zhoushan Hosp, Cell & Mol Biol Lab, Zhoushan 316000, Zhejiang, Peoples R China; [Yuan, Wei] Zhangqiu Hosp, Dept Bone Surg, Jinan 250200, Shandong, Peoples R China	Shandong University	Gao, LF (corresponding author), Shandong Univ, Key Lab Expt Teratol, Shandong Prov Key Lab Infect & Immunol, Dept Immunol,Minist Educ,Sch Med, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	glfflg@sdu.edu.cn	zhao, peiqing/E-6602-2014; ma, chunhong/C-6043-2008	ma, chunhong/0000-0002-8121-4718; Zhao, Peiqing/0000-0002-9311-1927	National Nature Science Foundation of China [30872298, 81172862]; Research Fund for the Doctoral Program of Higher Education of China (RFDP) [20110131110034]; Shandong Provincial Natural Science Foundation [ZR2010HM025]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China (RFDP)(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province)	This work was supported in part by grants from the National Nature Science Foundation of China (No. 30872298, 81172862), Research Fund for the Doctoral Program of Higher Education of China (RFDP) (20110131110034) and the Shandong Provincial Natural Science Foundation (No. ZR2010HM025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baghdadi M, 2013, IMMUNITY, V39, P1070, DOI 10.1016/j.immuni.2013.09.014; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; Cam A, 2012, MOL NUTR FOOD RES, V56, P1569, DOI 10.1002/mnfr.201200301; Czuczman MA, 2014, NATURE, V509, P230, DOI 10.1038/nature13168; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Elliott JI, 2005, NAT CELL BIOL, V7, P808, DOI 10.1038/ncb1279; Flannagan RS, 2014, MOL BIOL CELL, V25, P1511, DOI 10.1091/mbc.E13-04-0212; Hein RM, 2007, IMMUNOL LETT, V108, P103, DOI 10.1016/j.imlet.2006.11.004; Hou YC, 1999, CURR PHARM DESIGN, V5, P417; Ji HF, 2014, HEPATOLOGY, V60, P2052, DOI 10.1002/hep.27334; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Khan BV, 1996, P NATL ACAD SCI USA, V93, P9114, DOI 10.1073/pnas.93.17.9114; Kim HS, 2010, J IMMUNOL, V184, P4095, DOI 10.4049/jimmunol.0901991; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; KOLB JP, 1994, J BIOL CHEM, V269, P9811; Lee SH, 2004, BIOCHEM BIOPH RES CO, V323, P125, DOI 10.1016/j.bbrc.2004.08.063; Lei J, 2013, NITRIC OXIDE-BIOL CH, V35, P175, DOI 10.1016/j.niox.2013.09.004; MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003; Mazaheri F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5046; Meyers JH, 2005, NAT IMMUNOL, V6, P455, DOI 10.1038/ni1185; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Mizui M, 2008, INT IMMUNOL, V20, P695, DOI 10.1093/intimm/dxn029; MONCADA S, 1991, PHARMACOL REV, V43, P109; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Niedbala W, 2011, P NATL ACAD SCI USA, V108, P9220, DOI 10.1073/pnas.1100667108; PONS F, 1993, EUR J PHARMACOL, V239, P23, DOI 10.1016/0014-2999(93)90971-J; Raso GM, 2001, LIFE SCI, V68, P921, DOI 10.1016/S0024-3205(00)00999-1; Rawlingson A, 2003, BURNS, V29, P631, DOI 10.1016/S0305-4179(03)00079-2; Rodriguez-Manzanet R, 2008, J IMMUNOL, V180, P4706, DOI 10.4049/jimmunol.180.7.4706; Saika S, 2005, AM J PATHOL, V166, P1393, DOI 10.1016/S0002-9440(10)62357-7; Singh S, 2011, CANCER CHEMOTH PHARM, V67, P1211, DOI 10.1007/s00280-011-1654-4; dos Santos TAT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027867; Thornley TB, 2014, J CLIN INVEST, V124, P3443, DOI 10.1172/JCI73527; Wong K, 2010, P NATL ACAD SCI USA, V107, P8712, DOI 10.1073/pnas.0910929107; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; Xu LY, 2010, J LEUKOCYTE BIOL, V88, P329, DOI 10.1189/jlb.1209797; Zhao PQ, 2010, CELL MOL IMMUNOL, V7, P152, DOI 10.1038/cmi.2009.118	39	14	16	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124771	10.1371/journal.pone.0124771	http://dx.doi.org/10.1371/journal.pone.0124771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905790	gold, Green Submitted, Green Published			2022-12-27	WOS:000353332000088
J	Arya, M; Thrasivoulou, C; Henrique, R; Millar, M; Hamblin, R; Davda, R; Aare, K; Masters, JR; Thomson, C; Muneer, A; Patel, HRH; Ahmed, A				Arya, Manit; Thrasivoulou, Christopher; Henrique, Rui; Millar, Michael; Hamblin, Ruth; Davda, Reena; Aare, Kristina; Masters, John R.; Thomson, Calum; Muneer, Asif; Patel, Hitendra R. H.; Ahmed, Aamir			Targets of Wnt/beta-Catenin Transcription in Penile Carcinoma	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; BETA-CATENIN; CYCLIN D1; MATRIX METALLOPROTEINASE-7; C-MYC; EXPRESSION; WNT; CANCER; OVEREXPRESSION; PROTEIN	Penile squamous cell carcinoma (PeCa) is a rare malignancy and little is known regarding the molecular mechanisms involved in carcinogenesis of PeCa. The Wnt signaling pathway, with the transcription activator beta-catenin as a major transducer, is a key cellular pathway during development and in disease, particularly cancer. We have used PeCa tissue arrays and multi-fluorophore labelled, quantitative, immunohistochemistry to interrogate the expression of WNT4, a Wnt ligand, and three targets of Wnt-beta-catenin transcription activation, namely, MMP7, cyclinD1 (CD1) and c-MYC in 141 penile tissue cores from 101 unique samples. The expression of all Wnt signaling proteins tested was increased by 1.6 to 3 fold in PeCa samples compared to control tissue (normal or cancer adjacent) samples (p<0.01). Expression of all proteins, except CD1, showed a significant decrease in grade II compared to grade I tumors. High magnification, deconvolved confocal images were used to measure differences in co-localization between the four proteins. Significant (p<0.04-0.0001) differences were observed for various permutations of the combinations of proteins and state of the tissue (control, tumor grades I and II). Wnt signaling may play an important role in PeCa and proteins of the Wnt signaling network could be useful targets for diagnosis and prognostic stratification of disease.	[Arya, Manit] Univ Coll London Hosp, Div Surg, London, England; [Arya, Manit] Queen Mary Univ London, Barts Canc Inst, London, England; [Thrasivoulou, Christopher] UCL, Res Dept Cell & Dev Biol, Ctr Cell & Mol Dynam, London, England; [Henrique, Rui] Univ Porto, Dept Pathol, Portuguese Oncol Inst, P-4100 Porto, Portugal; [Henrique, Rui] Univ Porto, Dept Pathol & Mol Immunol, Abel Salazar Inst Biomed Sci, P-4100 Porto, Portugal; [Millar, Michael; Hamblin, Ruth] Univ Edinburgh, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Davda, Reena; Aare, Kristina; Masters, John R.; Ahmed, Aamir] UCL, Prostate Canc Res Ctr, Div Surg, London, England; [Thomson, Calum] Univ Dundee, Dundee Imaging Facil, Coll Life Sci, Dundee, Scotland; [Muneer, Asif] Univ Coll London Hosp, Dept Urol, London, England; [Patel, Hitendra R. H.] Univ Hosp Northern Norway, Div Surg Oncol Urol & Womens Hlth, Tromso, Norway	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; Queen Mary University London; University of London; University College London; Portuguese Institute of Oncology; Universidade do Porto; Universidade do Porto; University of Edinburgh; University of London; University College London; University of Dundee; University College London Hospitals NHS Foundation Trust; University of London; University College London; UiT The Arctic University of Tromso; University Hospital of North Norway	Ahmed, A (corresponding author), Kings Coll London, Ctr Stem Cells & Regenerat Med, London WC2R 2LS, England.	aamir.ahmed@kcl.ac.uk	Henrique, Rui Manuel Ferreira/I-2757-2013; Thrasivoulou, Christopher/F-7087-2010	Henrique, Rui Manuel Ferreira/0000-0003-3171-4666; Thrasivoulou, Christopher/0000-0001-9425-8624; Ahmed, Aamir/0000-0001-7405-5336	Prostate Cancer Research Centre [1156027]	Prostate Cancer Research Centre	This research was funded by the Prostate Cancer Research Centre charity (registered UK charity no. 1156027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya M, 2013, CANCER CAUSE CONTROL, V24, P2169, DOI 10.1007/s10552-013-0293-y; Arya M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1149; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Brabletz T, 2000, VERH DEUT G, V84, P175; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Campos RSM, 2006, UROLOGY, V67, P797, DOI 10.1016/j.urology.2005.10.026; Clevers H, 2004, CANCER CELL, V5, P5, DOI 10.1016/S1535-6108(03)00339-8; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cui J, 2001, J CANCER RES CLIN, V127, P577, DOI 10.1007/s004320100259; DAKSIS JI, 1994, ONCOGENE, V9, P3635; de Vicente JC, 2007, J ORAL PATHOL MED, V36, P415, DOI 10.1111/j.1600-0714.2007.00546.x; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Golijanin D, 2004, CLIN CANCER RES, V10, P1024, DOI 10.1158/1078-0432.CCR-1032-3; GOSNEY JR, 1990, ANTICANCER RES, V10, P623; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hofmann BM, 2006, AM J SURG PATHOL, V30, P1595, DOI 10.1097/01.pas.0000213328.64121.12; HUGUET EL, 1994, CANCER RES, V54, P2615; Hung MC, 2011, J CELL SCI, V124, P3381, DOI 10.1242/jcs.089110; KANDA Y, 1994, INT J CANCER, V58, P291, DOI 10.1002/ijc.2910580224; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Leis PF, 1998, CANCER-AM CANCER SOC, V83, P122, DOI 10.1002/(SICI)1097-0142(19980701)83:1<122::AID-CNCR16>3.0.CO;2-Z; LEW DJ, 1991, CELL, V66, P1197, DOI 10.1016/0092-8674(91)90042-W; Li WP, 2014, J CLIN NEUROSCI, V21, P137, DOI 10.1016/j.jocn.2013.04.034; Liu D, 2007, LUNG CANCER, V58, P384, DOI 10.1016/j.lungcan.2007.07.005; Martins ACP, 2002, J UROLOGY, V167, P89, DOI 10.1016/S0022-5347(05)65389-X; Masferrer E, 2012, J UROLOGY, V188, P1965, DOI 10.1016/j.juro.2012.07.003; Mentrikoski MJ, 2014, AM J SURG PATHOL, V38, P1340, DOI 10.1097/PAS.0000000000000124; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Ohashi K, 2000, CANCER-AM CANCER SOC, V88, P2201, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2201::AID-CNCR2>3.3.CO;2-E; Papadopoulos O, 2007, ANTICANCER RES, V27, P2167; Pizzocaro G, 2010, EUR UROL, V57, P1002, DOI 10.1016/j.eururo.2010.01.039; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Polakis P, 2012, EMBO J, V31, P2737, DOI 10.1038/emboj.2012.126; Rauch GJ, 1997, COLD SPRING HARB SYM, V62, P227, DOI 10.1101/SQB.1997.062.01.028; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Symes AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084295; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thrasivoulou C, 2013, J BIOL CHEM, V288, P35651, DOI 10.1074/jbc.M112.437913; Ting WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056196; Toth ZE, 2007, J HISTOCHEM CYTOCHEM, V55, P545, DOI 10.1369/jhc.6A7134.2007; Vaid M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023000; Veeck J, 2006, ONCOGENE, V25, P3479, DOI 10.1038/sj.onc.1209386; Velazquez EF, 2008, AM J SURG PATHOL, V32, P974, DOI 10.1097/PAS.0b013e3181641365; Wang Q, 2007, ONCOGENE, V26, P6560, DOI 10.1038/sj.onc.1210472; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010456; YAMAMOTO H, 2010, ONCOGENE; Zeng G, 2006, NEOPLASIA, V8, P279, DOI 10.1593/neo.05607	49	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124395	10.1371/journal.pone.0124395	http://dx.doi.org/10.1371/journal.pone.0124395			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901368	Green Published, gold			2022-12-27	WOS:000353331500084
J	Beller, CJ; Farag, M; Wannaku, S; Seppelt, P; Arif, R; Ruhparwar, A; Karck, M; Weymann, A; Kallenbach, K				Beller, Carsten J.; Farag, Mina; Wannaku, Sepali; Seppelt, Philipp; Arif, Rawa; Ruhparwar, Arjang; Karck, Matthias; Weymann, Alexander; Kallenbach, Klaus			Gender-Specific Differences in Outcome of Ascending Aortic Aneurysm Surgery	PLOS ONE			English	Article							HEART-DISEASE; GUIDELINES; EXPERIENCE; MANAGEMENT; DISSECTION; MORTALITY; STROKE; VALVE; WOMEN; ROOT	Objectives Gender specific differences receive increasing attention and are known to affect the outcome of cardiovascular diseases. We investigated possible risk-factors for gender-specific differences in ascending aortic aneurysm surgery. Methods 548 consecutive patients (male: n = 390, age: 58.3 +/- 14.4 years; female: n = 158, age: 65.3 +/- 12.9 years) with aneurysms of the ascending aorta eligible for cardiac surgery were retrospectively analyzed. Results Women were significantly older when operation was indicated (p<0.001) and presented with significantly more hypertension (p=0.04) and chronic obstructive pulmonary disease (COPD; p = 0.017), whereas men had significantly more previous cardiac operations (p = 0.016). Normalized aortic diameters (diameter / body surface area) were significantly larger in women (3.10 +/- 0.6 cm) vs. (2.75 +/- 0,5 cm, p <= 0.001) in men, without differences in absolute values (5.74 +/- 1.04 cm vs. 5.86 +/- 1.34 cm). The aortic arch was significantly more involved in aneurysm formation in women (p = 0.04). Follow-up was available in 93% of the patients with a mean follow-up time of 3.9 +/- 3.9 (0-17.8) years. 30-day mortality was 3.5% in men (n=12) and 7.9% in women (n=11; p = 0.058). Univariate regression analysis shows gender specific risk factors for 30-day mortality in men to be age: p = 0.028; myocardial infarction: p = 0.0.24 and in women diameter of the ascending aorta: p=0.014; renal insufficiency: p=0.007. Long-term survival was significantly reduced in women (log-rank p = 0.0052). Conclusions The outcome after surgery for ascending aortic aneurysm is less favourable in women with significantly reduced long-term survival and a trend to increased 30-day mortality in this cohort. Larger normalized aortic diameters, higher incidence of involvement of the aortic arch and differences in comorbidities may contribute to gender differences. Women undergo surgery at higher age and more progressed state of aortic disease. Therefore, gender-specific guidelines for ascending replacement may be useful to improve outcome in women.	[Beller, Carsten J.; Farag, Mina; Wannaku, Sepali; Seppelt, Philipp; Arif, Rawa; Ruhparwar, Arjang; Karck, Matthias; Weymann, Alexander; Kallenbach, Klaus] Heidelberg Univ, Heart Ctr Heidelberg, Clin Cardiac Surg, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Beller, CJ (corresponding author), Heidelberg Univ, Heart Ctr Heidelberg, Clin Cardiac Surg, Heidelberg, Germany.	carsten.beller@urz.uni-heidelberg.de	Weymann, Alexander/AAQ-5115-2021		German Research Foundation (DFG) [SFB-TRR 125]; German Heart Foundation	German Research Foundation (DFG)(German Research Foundation (DFG)); German Heart Foundation	This study was supported by the German Research Foundation (DFG), SFB-TRR 125 "Cognition-Guided Surgery" Project R03, and the German Heart Foundation "Dr. Rusche-Forderprojekt 2012". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Etz CD, 2007, J THORAC CARDIOV SUR, V133, P1455, DOI 10.1016/j.jtcvs.2007.01.058; Grubb KJ, 2011, SEMIN THORAC CARDIOV, V23, P124, DOI 10.1053/j.semtcvs.2011.08.009; Guethoff S GL, 2013, THORAC CARDIOVASC SU, V2013; Hannawa KK, 2009, VASCULAR, V17, pS30, DOI 10.2310/6670.2008.00092; Hiratzka LF, 2010, CIRCULATION, V121, pE266, DOI 10.1161/CIR.0b013e3181d4739e; Huynh TTT, 2013, J VASC SURG, V57, p11S, DOI 10.1016/j.jvs.2012.08.126; Kaczmarek I, 2013, THORAC CARDIOV SURG, V61, P29, DOI 10.1055/s-0032-1331467; Kallenbach K, 2013, JACC-CARDIOVASC IMAG, V6, P1321, DOI 10.1016/j.jcmg.2013.08.009; Kallenbach K, 2013, EUR J CARDIO-THORAC, V44, P337, DOI 10.1093/ejcts/ezs661; Katz DJ, 1997, J VASC SURG, V25, P561, DOI 10.1016/S0741-5214(97)70268-4; Laser A, 2014, J SURG RES, V186, P467, DOI 10.1016/j.jss.2013.07.050; Matura LA, 2007, CIRCULATION, V116, P1663, DOI 10.1161/CIRCULATIONAHA.106.685487; McPhee JT, 2007, J VASC SURG, V45, P891, DOI 10.1016/j.jvs.2007.01.043; Nienaber CA, 2004, CIRCULATION, V109, P3014, DOI 10.1161/01.CIR.0000130644.78677.2C; Okita Y, 1998, J THORAC CARDIOV SUR, V115, P129, DOI 10.1016/S0022-5223(98)70451-9; Rylski B, 2014, EUR J CARDIO-THORAC, V45, P805, DOI 10.1093/ejcts/ezt597; Seeburger J, 2013, THORAC CARDIOV SURG, V61, P42, DOI 10.1055/s-0032-1331583; Solimene MC, 2010, CLINICS, V65, P99, DOI 10.1590/S1807-59322010000100015; Vahanian A, 2012, EUR J CARDIO-THORAC, V42, pS1, DOI 10.1093/ejcts/ezs455; Zehr KJ, 2004, CIRCULATION, V110, P1364, DOI 10.1161/01.CIR.0000141593.05085.87	20	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124461	10.1371/journal.pone.0124461	http://dx.doi.org/10.1371/journal.pone.0124461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902057	Green Published, gold, Green Submitted			2022-12-27	WOS:000353331500088
J	Iida, Y; van't Hof, P; Beenen, H; Mesarich, C; Kubota, M; Stergiopoulos, I; Mehrabi, R; Notsu, A; Fujiwara, K; Bahkali, A; Abd-Elsalam, K; Collemare, J; de Wit, PJGM				Iida, Yuichiro; van't Hof, Pieter; Beenen, Henriek; Mesarich, Carl; Kubota, Masaharu; Stergiopoulos, Ioannis; Mehrabi, Rahim; Notsu, Ayumi; Fujiwara, Kazuki; Bahkali, Ali; Abd-Elsalam, Kamel; Collemare, Jerome; de Wit, Pierre J. G. M.			Novel Mutations Detected in Avirulence Genes Overcoming Tomato Cf Resistance Genes in Isolates of a Japanese Population of Cladosporium fulvum	PLOS ONE			English	Article							LEAF MOLD; CF-4-MEDIATED RESISTANCE; ALLELIC VARIATION; VIRULENCE FACTOR; PASSALORA-FULVA; PLANT-PATHOGEN; EFFECTOR ECP6; BINDING-SITE; AVR4; RECOGNITION	Leaf mold of tomato is caused by the biotrophic fungus Cladosporium fulvum which complies with the gene-for-gene system. The disease was first reported in Japan in the 1920s and has since been frequently observed. Initially only race 0 isolates were reported, but since the consecutive introduction of resistance genes Cf-2, Cf-4, Cf-5 and Cf-9 new races have evolved. Here we first determined the virulence spectrum of 133 C. fulvum isolates collected from 22 prefectures in Japan, and subsequently sequenced the avirulence (Avr) genes Avr2, Avr4, Avr4E, Avr5 and Avr9 to determine the molecular basis of overcoming Cfgenes. Twelve races of C. fulvum with a different virulence spectrum were identified, of which races 9, 2.9, 4.9, 4.5.9 and 4.9.11 occur only in Japan. The Avr genes in many of these races contain unique mutations not observed in races identified elsewhere in the world including (i) frameshift mutations and (ii) transposon insertions in Avr2, (iii) point mutations in Avr4and Avr4E, and (iv) deletions of Avr4E, Avr5 and Avr9. New races have developed by selection pressure imposed by consecutive introductions of Cf-2, Cf-4, Cf-5and Cf-9 genes in commercially grown tomato cultivars. Our study shows that molecular variations to adapt to different Cf genes in an isolated C. fulvum population in Japan are novel but overall follow similar patterns as those observed in populations from other parts of the world. Implications for breeding of more durable C. fulvum resistant varieties are discussed.	[Iida, Yuichiro; Kubota, Masaharu; Fujiwara, Kazuki] Natl Agr & Food Res Org, Tsu, Mie, Japan; [Iida, Yuichiro; van't Hof, Pieter; Beenen, Henriek; Mesarich, Carl; Stergiopoulos, Ioannis; Mehrabi, Rahim; Collemare, Jerome; de Wit, Pierre J. G. M.] Wageningen Univ, Lab Phytopathol, NL-6700 AP Wageningen, Netherlands; [Mehrabi, Rahim] Seed & Plant Improvement Inst, Karaj, Iran; [Notsu, Ayumi] Hokkaido Res Org, Ornamental Plants & Vegetables Res Ctr, Sapporo, Hokkaido, Japan; [Bahkali, Ali; Abd-Elsalam, Kamel] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia; [Abd-Elsalam, Kamel] Agr Res Ctr, Plant Pathol Res Inst, Giza, Egypt; [de Wit, Pierre J. G. M.] Ctr Biosyst Genom, Wageningen, Netherlands	National Agriculture & Food Research Organization - Japan; Wageningen University & Research; King Saud University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Centre for BioSystems Genomics	de Wit, PJGM (corresponding author), Wageningen Univ, Lab Phytopathol, NL-6700 AP Wageningen, Netherlands.	pierre.dewit@wur.nl	Mehrabi, Rahim/S-1800-2016; Mesarich, Carl H/E-4304-2015; Abd-Elsalam, Kamel Ahmed/AAU-4696-2020; Bahkali, Ali/E-3720-2014; Stergiopoulos, Ioannis/N-5430-2014	Mehrabi, Rahim/0000-0002-5098-9123; Mesarich, Carl H/0000-0002-5207-4074; Bahkali, Ali/0000-0003-3936-0436; Stergiopoulos, Ioannis/0000-0002-2368-6119; Collemare, Jerome/0000-0001-8152-6642; Abd-Elsalam, Kamel/0000-0002-4042-4022	Dutch Organization for Advanced Science (NWO) [23780046]; Dutch Organization for Advanced Science (ERA-NET); Royal Netherlands Academy of Sciences; King Saud University, Riyadh, SaudiArabia	Dutch Organization for Advanced Science (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Organization for Advanced Science (ERA-NET); Royal Netherlands Academy of Sciences; King Saud University, Riyadh, SaudiArabia	This work was supported in part by Grant-in-Aid for Young Scientists (23780046 to YI) (http://www.jsps.go.jp/english/e-grants/), grants from the Dutch Organization for Advanced Science (NWO; ERA-NET to IS, RM and JC) (http://www.nwo.nl/en/), grants from the Royal Netherlands Academy of Sciences (to PJGMW)(https://www.knaw.nl/en) and a grant from the King Saud University, Riyadh, SaudiArabia (to PVH)(http://ksu.edu.sa/en/) for study design, data collection, and data analysis. The funders had no role in the decision to publish or in the preparation of the manuscript.	Bolton MD, 2008, MOL MICROBIOL, V69, P119, DOI 10.1111/j.1365-2958.2008.06270.x; Cooke MC, 1883, GREVILLEA, VXII, P32; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; de Wit PJGM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003088; de Wit PJGM, 2009, MOL PLANT PATHOL, V10, P735, DOI 10.1111/j.1364-3703.2009.00591.x; De Wit PJGM., 2009, PLANT RELATIONSHIPS, P135, DOI DOI 10.1007/978-3-540-87407-2_7; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Dixon MS, 1998, PLANT CELL, V10, P1915, DOI 10.1105/tpc.10.11.1915; Dixon MS, 1996, CELL, V84, P451, DOI 10.1016/S0092-8674(00)81290-8; Enya J, 2009, J GEN PLANT PATHOL, V75, P76, DOI 10.1007/s10327-008-0134-0; Fujimori M, 1980, J JAPAN SOC HORT SCI, V49, P208; HOLIDAY P, 1976, CMI DESCRIPTIONS PAT; Iida Y, 2010, J GEN PLANT PATHOL, V76, P84, DOI 10.1007/s10327-009-0207-8; JONES DA, 1994, SCIENCE, V266, P789, DOI 10.1126/science.7973631; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; JOOSTEN MHAJ, 1994, NATURE, V367, P384, DOI 10.1038/367384a0; Joosten MHAJ, 1997, PLANT CELL, V9, P367; Joosten MHAJ, 1999, ANNU REV PHYTOPATHOL, V37, P335, DOI 10.1146/annurev.phyto.37.1.335; KISHI K., 1962, Annals of the Phytopathological Society of Japan, V27, P189; Kishi K, 1976, JAPANEASE J PHYTOPAT, V42, P497; KOOISTRA E, 1964, EUPHYTICA, V13, P103; Kooman-Gersmann M, 1998, PLANT PHYSIOL, V117, P609, DOI 10.1104/pp.117.2.609; KoomanGersmann M, 1996, PLANT CELL, V8, P929, DOI 10.1105/tpc.8.5.929; Kubota M, 2015, J GEN PLANT PATHOL; Langford AN, 1937, CAN J RES C, V15, P109; Lauge R, 2000, PLANT J, V23, P735, DOI 10.1046/j.1365-313x.2000.00843.x; Lauge R, 1998, P NATL ACAD SCI USA, V95, P9014, DOI 10.1073/pnas.95.15.9014; Lauge R, 1998, FUNGAL GENET BIOL, V24, P285, DOI 10.1006/fgbi.1998.1076; LAZAROVITS G, 1976, CAN J BOT, V54, P235, DOI 10.1139/b76-023; LAZAROVITS G, 1976, CAN J BOT, V54, P224, DOI 10.1139/b76-022; LINDHOUT P, 1989, NETH J PLANT PATHOL, V95, P143, DOI 10.1007/BF01999969; Mesarich CH, 2014, MOL PLANT MICROBE IN, V27, P846, DOI 10.1094/MPMI-02-14-0050-R; Rivas S, 2005, ANNU REV PHYTOPATHOL, V43, P395, DOI 10.1146/annurev.phyto.43.040204.140224; Rooney HCE, 2005, SCIENCE, V308, P1783, DOI 10.1126/science.1111404; Satou Mamoru, 2005, Journal of General Plant Pathology, V71, P436, DOI 10.1007/s10327-005-0223-2; Stergiopoulos I, 2007, MOL PLANT MICROBE IN, V20, P1271, DOI 10.1094/MPMI-20-10-1271; Stergiopoulos I, 2007, FUNGAL GENET BIOL, V44, P415, DOI 10.1016/j.fgb.2006.11.004; Stergiopoulos I, 2010, P NATL ACAD SCI USA, V107, P7610, DOI 10.1073/pnas.1002910107; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Sugahara Y, 1965, B HORTICULTURAL RE B, V4, P17; Takken FLW, 1999, PLANT J, V20, P279, DOI 10.1046/j.1365-313X.1999.t01-1-00601.x; Thomas CM, 1997, PLANT CELL, V9, P2209, DOI 10.1105/tpc.9.12.2209; Thomma BPHJ, 2005, MOL PLANT PATHOL, V6, P379, DOI 10.1111/J.1364-3703.2005.00292.X; van den Burg HA, 2004, J BIOL CHEM, V279, P16786, DOI 10.1074/jbc.M312594200; van den Burg HA, 2003, J BIOL CHEM, V278, P27340, DOI 10.1074/jbc.M212196200; van den Burg HA, 2006, MOL PLANT MICROBE IN, V19, P1420, DOI 10.1094/MPMI-19-1420; Van der Hoorn RAL, 2000, MOL PLANT MICROBE IN, V13, P439, DOI 10.1094/MPMI.2000.13.4.439; van Esse HP, 2008, PLANT CELL, V20, P1948, DOI 10.1105/tpc.108.059394; van Esse HP, 2007, MOL PLANT MICROBE IN, V20, P1092, DOI 10.1094/MPMI-20-9-1092; van't Klooster JW, 2011, MOL PLANT PATHOL, V12, P21, DOI 10.1111/j.1364-3703.2010.00647.x; VANDENACKERVEKEN GFJM, 1992, PLANT J, V2, P359, DOI 10.1111/j.1365-313X.1992.00359.x; VANKAN JAL, 1991, MOL PLANT MICROBE IN, V4, P52, DOI 10.1094/MPMI-4-052; Westerink N, 2004, FUNGAL DISEASE RESISTANCE IN PLANTS: BIOCHEMISTRY, MOLECULAR BIOLOGY, AND GENETIC ENGINEERING, P93; Westerink N, 2004, MOL MICROBIOL, V54, P533, DOI 10.1111/j.1365-2958.2004.04288.x; Wit P. J. G. M. de, 1977, Netherlands Journal of Plant Pathology, V83, P109, DOI 10.1007/BF01981556; Yamada K, 2002, JAPANESE J PHYTOPATH, V68, P36	56	26	26	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123271	10.1371/journal.pone.0123271	http://dx.doi.org/10.1371/journal.pone.0123271			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902074	gold, Green Published			2022-12-27	WOS:000353331500050
J	Maetzler, W; Ellerbrock, M; Heger, T; Sass, C; Berg, D; Reilmann, R				Maetzler, Walter; Ellerbrock, Maren; Heger, Tanja; Sass, Christian; Berg, Daniela; Reilmann, Ralf			Digitomotography in Parkinson's Disease: A Cross-Sectional and Longitudinal Study	PLOS ONE			English	Article							SOCIETY-SPONSORED REVISION; SCALE MDS-UPDRS; PROGRESSION; MOVEMENT; ONSET; RELIABILITY; PREMANIFEST; IMPAIRMENT	Motor symptoms in Parkinson's disease (PD) are usually assessed with semi-quantitative tests such as the Unified PD Rating Scale (UPDRS) which are limited by subjectivity, categorical design, and low sensitivity. Particularly bradykinesia as assessed e.g. with speeded index finger tapping exhibits low validity measures. This exploratory study set out to (i) assess whether force transducer-based objective and quantitative analysis of motor coordination in index finger tapping is able to distinguish between PD patients and controls, and (ii) assess longitudinal changes. Sixteen early-stage and 17 mid-stage PD patients as well as 18 controls were included in the cross-sectional part of the study; thirteen, 16 and 16 individuals of the respective groups agreed in a reassessment 12 months later. Frequency, force, rhythmicity, regularity and laterality of speeded and metronome paced tapping were recorded by digitomotography using a quantitative motor system ("Q-Motor"). Analysis of cross-sectional data revealed most consistent differences between PD patients and controls in variability of tap performance across modalities assessed. Among PD patients, variability of taps and the ability to keep a given rhythm were associated with UPDRS motor and finger tapping scores. After 12 months, laterality parameters were reduced but no other parameters changed significantly. This data suggests that digitomotography provides quantitative and objective measures capable to differentiate PD from non-PD in a small cohort, however, the value of the assessment to track PD progression has to be further evaluated in larger cohorts of patients.	[Maetzler, Walter; Ellerbrock, Maren; Heger, Tanja; Berg, Daniela; Reilmann, Ralf] Univ Tubingen, Ctr Neurol, Dept Neurodegenerat, Hertie Inst Clin Brain Res, Tubingen, Germany; [Maetzler, Walter; Heger, Tanja; Berg, Daniela] German Ctr Neurodegenerat Dis, DZNE, Tubingen, Germany; [Ellerbrock, Maren] Clin Ctr Lunenburg, Neurol Clin, Lunenburg, Germany; [Berg, Daniela; Reilmann, Ralf] George Huntington Inst, Munster, Germany; [Berg, Daniela; Reilmann, Ralf] Univ Munster, Dept Radiol, Munster, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munster	Maetzler, W (corresponding author), Univ Tubingen, Ctr Neurol, Dept Neurodegenerat, Hertie Inst Clin Brain Res, Tubingen, Germany.	Walter.maetzler@uni-tuebingen.de; ralf.reilmann@ghi-muenster.de	Maetzler, Walter/A-6796-2011; Maetzler, Walter/AAE-5831-2020; Berg, Daniela/A-8728-2019	Maetzler, Walter/0000-0002-5945-4694; Maetzler, Walter/0000-0002-5945-4694; Berg, Daniela/0000-0001-5796-5442; Reilmann, Ralf/0000-0002-5904-9517	European Union project SENSE-PARK, under Seventh Framework Programme, Cooperation-ICT [288557]; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Tuebingen University	European Union project SENSE-PARK, under Seventh Framework Programme, Cooperation-ICT; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen University	WM was partly supported by the European Union project SENSE-PARK, funded under the Seventh Framework Programme, Cooperation-ICT (grant agreement no. 288557). The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University. No other external funding was obtained for this study.	Baltadjieva R, 2006, EUR J NEUROSCI, V24, P1815, DOI 10.1111/j.1460-9568.2006.05033.x; Bechtel N, 2010, NEUROLOGY, V75, P2150, DOI 10.1212/WNL.0b013e3182020123; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Costa J, 2010, MOVEMENT DISORD, V25, P2577, DOI 10.1002/mds.23334; Espay AJ, 2009, MOVEMENT DISORD, V24, P1001, DOI 10.1002/mds.22480; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GIBB WRG, 1988, NEUROLOGY, V38, P1402, DOI 10.1212/WNL.38.9.1402; Goetz CG, 2004, MOVEMENT DISORD, V19, P1453, DOI 10.1002/mds.20220; Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Heldman DA, 2011, MOVEMENT DISORD, V26, P1859, DOI 10.1002/mds.23740; HENDERSON L, 1991, J NEUROL NEUROSUR PS, V54, P18, DOI 10.1136/jnnp.54.1.18; Hobert MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027831; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Kim JW, 2011, MED BIOL ENG COMPUT, V49, P365, DOI 10.1007/s11517-010-0697-8; Louie S, 2009, MOVEMENT DISORD, V24, P1991, DOI 10.1002/mds.22741; Maetzler W, 2013, MOVEMENT DISORD, V28, P1576, DOI 10.1002/mds.25682; Maetzler W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032240; Maetzler W, 2009, LANCET NEUROL, V8, P1158, DOI 10.1016/S1474-4422(09)70291-1; Rascol O, 2009, NEUROLOGY, V72, pS51, DOI 10.1212/WNL.0b013e318199049e; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Uitti RJ, 2005, NEUROLOGY, V64, P1925, DOI 10.1212/01.WNL.0000163993.82388.C8; Yahalom G, 2004, PARKINSONISM RELAT D, V10, P143, DOI 10.1016/j.parkreldis.2003.10.001	24	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123914	10.1371/journal.pone.0123914	http://dx.doi.org/10.1371/journal.pone.0123914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902182	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500066
J	Malli, C; Pandit, L; D'Cunha, A; Mustafa, S				Malli, Chaithra; Pandit, Lekha; D'Cunha, Anita; Mustafa, Sharik			Environmental Factors Related to Multiple Sclerosis in Indian Population	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; VITAMIN-D; RISK-FACTORS; ASSOCIATION; DISEASES; SUSCEPTIBILITY; EPIDEMIOLOGY; AUTOIMMUNE; MS	Background Multiple sclerosis (MS) is less prevalent among Indians when compared to white populations. Genetic susceptibility remaining the same it is possible that environmental associations may have a role in determining disease prevalence. Aims To determine whether childhood infections, vaccination status, past infection with Helicobacter pylori (H.pylori), diet, socioeconomic and educational status were associated with MS. Material and Methods 139 patients and 278 matched control subjects were selected. A validated environmental exposure questionnaire was administered. Estimation of serum H.pylori IgG antibody was done by ELISA. Patients and controls were genotyped for HLA-DRB1*15:01. Results In our cohort a significant association was seen with measles (p < 0.007), vegetarian diet (p < 0.001, higher educational status (p < 0.0001) and urban living (p < 0.0001). An inverse relationship was seen with H.Pylori infection and MS (p < 0.001). Measles infection (OR 6.479, CI 1.21-34.668, p < 0.029) and high educational status (OR 3.088, CI 1.212-7.872, p < 0.018) were significant risk factors associated with MS. H. pylori infection was inversely related to MS (OR 0.319, CI 0.144-0.706, p < 0.005). Conclusions Environmental influences may be important in determining MS prevalence.	[Malli, Chaithra; Pandit, Lekha; D'Cunha, Anita; Mustafa, Sharik] Nitte Univ, KS Hegde Med Acad, Ctr Adv Neurol Res, Mangalore, India	NITTE (Deemed to be University); K.S. Hegde Medical Academy	Pandit, L (corresponding author), Nitte Univ, KS Hegde Med Acad, Ctr Adv Neurol Res, Mangalore, India.	panditmng@gmail.com	Malli, Chaithra/AAO-3778-2021; Pandit, Lekha/AAO-3791-2021	malli, Chaithra/0000-0003-1969-034X; Pandit, Lekha/0000-0002-2269-5312	Department of Science and Technology, Government of India [SR/SO/HS/127/2010]	Department of Science and Technology, Government of India(Department of Science & Technology (India))	L.P. received funding from Department of Science and Technology, Government of India (SR/SO/HS/127/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A N, 2006, Indian J Chest Dis Allied Sci, V48, P13; Amezcua L, 2012, J NEUROL, V259, P2565, DOI 10.1007/s00415-012-6537-z; [Anonymous], 1985, ANN ACAD MED SINGAP; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bager P, 2004, BRAIN, V127, P2491, DOI 10.1093/brain/awh283; Cisneros E, 2010, J NEUROIMMUNOL, V225, P143, DOI 10.1016/j.jneuroim.2010.03.019; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; Gale CR, 1995, PROG NEUROBIOL, V47, P425, DOI 10.1016/0301-0082(95)00033-X; Gelfand JM, 2011, NEUROLOGY, V76, P1824, DOI 10.1212/WNL.0b013e31821cccf5; Ghosal Samit, 2013, J Indian Med Assoc, V111, P751; GRAHAM DY, 1991, J GASTROEN HEPATOL, V6, P105, DOI 10.1111/j.1440-1746.1991.tb01448.x; Harinarayan C V, 2009, J Assoc Physicians India, V57, P40; Hunter SF, 2000, NEUROLOGY, V55, P164, DOI 10.1212/WNL.55.2.164; Kankonkar S, 2003, HUM IMMUNOL, V64, P478, DOI 10.1016/S0198-8859(03)00014-4; Kurtzke JF, 1997, NEUROLOGY, V48, P204, DOI 10.1212/WNL.48.1.204; LEIBOWITZ U, 1966, J NEUROL NEUROSUR PS, V29, P60, DOI 10.1136/jnnp.29.1.60; Li W, 2007, J NEUROIMMUNOL, V184, P227, DOI 10.1016/j.jneuroim.2006.12.010; Long YM, 2013, NEUROIMMUNOMODULAT, V20, P107, DOI 10.1159/000345838; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Mohebi N, 2013, NEUROL INT, V5, P31, DOI 10.4081/ni.2013.e10; Norrby E, 1973, ARCH NEUROL-CHICAGO, V127, P467; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Pandit L, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/937586; Pandit L, 2014, MULT SCLER J, V20, P1651, DOI 10.1177/1352458514521503; Pandit L, 2013, MULT SCLER J, V19, P1592, DOI 10.1177/1352458513482375; Pandit L, 2013, J NEUROL SCI, V325, P86, DOI 10.1016/j.jns.2012.12.004; Pandit L, 2012, NEUROL INDIA, V60, P470, DOI 10.4103/0028-3886.103186; Pandit L, 2011, MULT SCLER J, V17, P139, DOI 10.1177/1352458510384011; Prabhu, 2014, INT J RES HLTH SCI, V2, P875; Rosche B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028094; RUSSELL WR, 1971, LANCET, V2, P832; Schmidt H, 2007, AM J EPIDEMIOL, V165, P1097, DOI 10.1093/aje/kwk118; Thirumurthi S, 2012, INDIAN J MED RES, V136, P549; VENKITARAMAN AR, 1986, INT J EPIDEMIOL, V15, P561, DOI 10.1093/ije/15.4.561; Vieira SM, 2014, LUPUS, V23, P518, DOI 10.1177/0961203313501401; Weinstock JV, 2014, J IMMUNOL, V193, P3239, DOI 10.4049/jimmunol.1400927	37	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124064	10.1371/journal.pone.0124064	http://dx.doi.org/10.1371/journal.pone.0124064			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902359	Green Published, gold, Green Submitted			2022-12-27	WOS:000353331500075
J	Qi, DF; Hu, Y; Li, JH; Peng, T; Su, JL; He, Y; Ji, WD				Qi, Defeng; Hu, Yuan; Li, Jinhui; Peng, Tao; Su, Jialin; He, Yun; Ji, Weidong			Hyperthermia Induces Apoptosis of 786-O Cells through Suppressing Ku80 Expression	PLOS ONE			English	Article							DOUBLE-STRAND BREAK; DEPENDENT PROTEIN-KINASE; IONIZING-RADIATION; CATALYTIC SUBUNIT; ANTICANCER DRUGS; GAMMA-H2AX FOCI; DEFICIENT CELLS; DNA-REPAIR; HEAT-SHOCK; CARCINOMA	Hyperthermia as an anticancer method has been paid increasing attention in recent years. Several studies have shown that hyperthermia can kill tumor cells by inducing apoptosis. However, the underlying molecular mechanisms of hyperthermia-induced apoptosis are largely unknown. To investigate the effects and molecular mechanism of hyperthermia on the apoptosis in renal carcinoma 786-O cells, we firstly examined apoptosis and Ku expression in 786-O cell line treated with heat exposure (42 degrees C for 0-4 h). The results showed that hyperthermia induced apoptosis of 786-O cells, and suppressed significantly Ku80 expression, but not Ku70 expression. Next, we knock-down Ku80 in 786-O cells, generating stable cell line 786-O-shKu80, and detected apoptosis, cell survival and cell cycle distribution. Our data showed higher apoptotic rate and lower surviving fraction in the stable cell line 786-O-shKu80 compared with those in control cells, exposed to the same heat stress (42 degrees C for 0-4 h). Moreover, the results also showed suppression of Ku80 led to G2/M phase arrest in the stable cell line 786-O-shKu80 following heat treatment. Together, these findings indicate that Ku80 may play an important role in hyperthermia-induced apoptosis and heat-sensitivity of renal carcinoma cells through influencing the cell cycle distribution.	[Qi, Defeng; Hu, Yuan; Li, Jinhui; Peng, Tao; Su, Jialin] Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Dept Urol,Guangdong Prov Key Lab Urol, Guangzhou, Guangdong, Peoples R China; [He, Yun] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Ji, Weidong] Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Translat Med, Guangzhou 510275, Guangdong, Peoples R China	Guangzhou Medical University; Sun Yat Sen University; Sun Yat Sen University	Qi, DF (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Dept Urol,Guangdong Prov Key Lab Urol, Guangzhou, Guangdong, Peoples R China.	qdf70818@tom.com; heyun_jane@163.com; wdji2008@163.com	ji, weidong/AAX-7397-2020	Peng, Tao/0000-0001-5260-7128	National Natural Science Foundation of China [30872142, 81272350, 81472999]; Natural Science Foundation of Guangdong [S2012010008908, 8151012003000011]; University Talent Program of Guangzhou [12A015G]; Science and Technology Program of Guangdong [2010B060900096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); University Talent Program of Guangzhou; Science and Technology Program of Guangdong	This work was supported by grants from National Natural Science Foundation of China (No. 30872142, No. 81272350, No. 81472999 to WJ), Natural Science Foundation of Guangdong (No. S2012010008908 to WJ, No. 8151012003000011 to DQ), University Talent Program of Guangzhou (No. 12A015G to WJ) and Science and Technology Program of Guangdong (No. 2010B060900096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRY MA, 1990, BIOCHEM PHARMACOL, V40, P2353, DOI 10.1016/0006-2952(90)90733-2; Basile A, 2008, J CELL BIOCHEM, V103, P212, DOI 10.1002/jcb.21401; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Campbell SC, 2009, J UROLOGY, V182, P1271, DOI 10.1016/j.juro.2009.07.004; Coffey DS, 2006, JAMA-J AM MED ASSOC, V296, P445, DOI 10.1001/jama.296.4.445; Davis AJ, 2013, J BIOL CHEM, V288, P7037, DOI 10.1074/jbc.M112.434498; DIKOMEY E, 1992, INT J RADIAT BIOL, V61, P221, DOI 10.1080/09553009214550851; DYSON JED, 1986, CELL TISSUE KINET, V19, P311, DOI 10.1111/j.1365-2184.1986.tb00683.x; GABAI VL, 1995, FEBS LETT, V375, P21, DOI 10.1016/0014-5793(95)01152-5; Gabai VL, 1998, FEBS LETT, V438, P1, DOI 10.1016/S0014-5793(98)01242-3; HARMON BV, 1991, INT J RADIAT BIOL, V59, P489, DOI 10.1080/09553009114550441; Hildebrandt B, 2002, CRIT REV ONCOL HEMAT, V43, P33, DOI 10.1016/S1040-8428(01)00179-2; Ihara M, 2014, INT J HYPERTHER, V30, P102, DOI 10.3109/02656736.2014.887793; Iliakis G, 2004, CYTOGENET GENOME RES, V104, P14, DOI 10.1159/000077461; Ismail-Zade RS, 2005, PEDIATR BLOOD CANCER, V44, P679, DOI 10.1002/pbc.20299; Jones EL, 2005, J CLIN ONCOL, V23, P3079, DOI 10.1200/JCO.2005.05.520; Kajihara A, 2008, INT J HYPERTHER, V24, P605, DOI 10.1080/02656730802348339; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim SH, 1999, CANCER RES, V59, P4012; Kim SH, 2000, LEUKEMIA RES, V24, P917, DOI 10.1016/S0145-2126(00)00061-8; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; Kurimasa A, 1999, P NATL ACAD SCI USA, V96, P1403, DOI 10.1073/pnas.96.4.1403; Li G, 2002, P NATL ACAD SCI USA, V99, P832, DOI 10.1073/pnas.022649699; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; MIKKELSEN RB, 1991, CANCER RES, V51, P359; Moriyama-Gonda N, 2002, BJU INT, V90, P317, DOI 10.1046/j.1464-410X.2002.02810.x; Motzer RJ, 1997, CURR PROB CANCER, V21, P191, DOI 10.1016/S0147-0272(97)80007-4; Munoz P, 1998, MOL CELL BIOL, V18, P5797, DOI 10.1128/MCB.18.10.5797; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Nussenzweig A, 1997, P NATL ACAD SCI USA, V94, P13588, DOI 10.1073/pnas.94.25.13588; Okamoto N, 2011, INT J HYPERTHER, V27, P297, DOI 10.3109/02656736.2010.545365; Omori S, 2002, DNA REPAIR, V1, P299, DOI 10.1016/S1568-7864(02)00006-X; Ouyang H, 1997, J EXP MED, V186, P921, DOI 10.1084/jem.186.6.921; Ponnala S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026191; RADFORD IR, 1983, INT J RADIAT BIOL, V43, P551, DOI 10.1080/09553008314550641; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Takahashi A, 2004, CANCER RES, V64, P8839, DOI 10.1158/0008-5472.CAN-04-1876; Takahashi A, 2008, MUTAT RES-GEN TOX EN, V656, P88, DOI 10.1016/j.mrgentox.2008.07.012; Takahashi A, 2010, J RADIAT RES, V51, P91, DOI [10.1269/jrr.09111, 10.1269/jrr.0911]; VIDAIR CA, 1995, J CELL PHYSIOL, V163, P194, DOI 10.1002/jcp.1041630122; Wang C, 2013, INT J RADIAT ONCOL, V86, P440, DOI 10.1016/j.ijrobp.2013.01.011; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Zhuang L, 2011, INT J ONCOL, V39, P443, DOI 10.3892/ijo.2011.1041; Zuo L, 2000, AM J PHYSIOL-CELL PH, V279, pC1058, DOI 10.1152/ajpcell.2000.279.4.C1058	44	16	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122977	10.1371/journal.pone.0122977	http://dx.doi.org/10.1371/journal.pone.0122977			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902193	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500035
J	Singh, M; Evans, D; Tan, BS; Nin, CS				Singh, Minerva; Evans, Damian; Tan, Boun Suy; Nin, Chan Samean			Mapping and Characterizing Selected Canopy Tree Species at the Angkor World Heritage Site in Cambodia Using Aerial Data	PLOS ONE			English	Article							FOREST BIOMASS; CROWN DELINEATION; LAND-USE; WATERSHED SEGMENTATION; MULTISCALE TEXTURE; INDIVIDUAL TREES; LIDAR DATA; CLASSIFICATION; IMAGERY; QUICKBIRD	At present, there is very limited information on the ecology, distribution, and structure of Cambodia's tree species to warrant suitable conservation measures. The aim of this study was to assess various methods of analysis of aerial imagery for characterization of the forest mensuration variables (i.e., tree height and crown width) of selected tree species found in the forested region around the temples of Angkor Thom, Cambodia. Object-based image analysis (OBIA) was used (using multiresolution segmentation) to delineate individual tree crowns from very-high-resolution (VHR) aerial imagery and light detection and ranging (LiDAR) data. Crown width and tree height values that were extracted using multiresolution segmentation showed a high level of congruence with field-measured values of the trees (Spearman's rho 0.782 and 0.589, respectively). Individual tree crowns that were delineated from aerial imagery using multiresolution segmentation had a high level of segmentation accuracy (69.22%), whereas tree crowns delineated using watershed segmentation underestimated the field-measured tree crown widths. Both spectral angle mapper (SAM) and maximum likelihood (ML) classifications were applied to the aerial imagery for mapping of selected tree species. The latter was found to be more suitable for tree species classification. Individual tree species were identified with high accuracy. Inclusion of textural information further improved species identification, albeit marginally. Our findings suggest that VHR aerial imagery, in conjunction with OBIA-based segmentation methods (such as multiresolution segmentation) and supervised classification techniques are useful for tree species mapping and for studies of the forest mensuration variables.	[Singh, Minerva] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Evans, Damian] Univ Sydney, Dept Asian Studies, Sydney, NSW 2006, Australia; [Evans, Damian] Univ Sydney, Dept Archaeol, Sydney, NSW 2006, Australia; [Tan, Boun Suy] Angkor Int Res & Documentat Ctr, Siem Reap, Cambodia; [Nin, Chan Samean] APSARA Natl Author, Dept Forestry Management Cultural Landscape & Env, Siem Reap, Cambodia	University of Cambridge; University of Sydney; University of Sydney	Singh, M (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge, England.	ms2127@cam.ac.uk		Singh, Minerva/0000-0002-7148-0078	APSARA Authority; University of Sydney; Ecole Francaise d'Extreme Orient; Hungarian Southeast Asian Research Institute; Japan-APSARA Safeguarding Angkor; Archaeology and Development Foundation; World Monuments Fund; Societe Concessionaire d'Aeroport	APSARA Authority; University of Sydney(University of Sydney); Ecole Francaise d'Extreme Orient; Hungarian Southeast Asian Research Institute; Japan-APSARA Safeguarding Angkor; Archaeology and Development Foundation; World Monuments Fund; Societe Concessionaire d'Aeroport	We are grateful to the APSARA National Authority for permission to undertake field research in the Angkor Thom area, including Bun Chamrouen and Ley Kimsy for their assistance in the field. So Malay, Martin Polkinghorne, Son Rothaphum, and the Robert Christie Foundation made essential contributions to the logistical and administrative components of the field program. We thank PT McElhanney Indonesia for their contribution to the LiDAR acquisition and acknowledge support and funding from eight institutions of the Khmer Archaeology LiDAR Consortium: the APSARA Authority, the University of Sydney, the Ecole Francaise d'Extreme Orient, Societe Concessionaire d'Aeroport, the Hungarian Southeast Asian Research Institute, Japan-APSARA Safeguarding Angkor, the Archaeology and Development Foundation, and the World Monuments Fund.	Abd Latif Zulkiflee, 2011, 2011 Proceedings of IEEE 7th International Colloquium on Signal Processing & its Applications (CSPA 2011), P354, DOI 10.1109/CSPA.2011.5759902; Anthony G, 2007, 10 INT S PHYS MEAS S; Arasato LS, 2011, AN 15 S BRAS SENS RE, P7628; Benz UC, 2004, ISPRS J PHOTOGRAMM, V58, P239, DOI 10.1016/j.isprsjprs.2003.10.002; Blaschke T, 2010, ISPRS J PHOTOGRAMM, V65, P2, DOI 10.1016/j.isprsjprs.2009.06.004; Campbell MO, 2005, SINGAPORE J TROP GEO, V26, P151, DOI 10.1111/j.0129-7619.2005.00211.x; Carleer AP, 2005, PHOTOGRAMM ENG REM S, V71, P1285, DOI 10.14358/PERS.71.11.1285; Cho M., 2011, P 34 INT S REM SENS, P10; Cho MA, 2012, REMOTE SENS ENVIRON, V125, P214, DOI 10.1016/j.rse.2012.07.010; Clark ML, 2012, REMOTE SENS-BASEL, V4, P1820, DOI 10.3390/rs4061820; Clark ML, 2004, REMOTE SENS ENVIRON, V91, P68, DOI 10.1016/j.rse.2004.02.008; Clinton N., 2008, INT ARCH PHOTOGRAMM, V37, P1189; Coburn CA, 2004, INT J REMOTE SENS, V25, P4287, DOI 10.1080/0143116042000192367; Corlett RT, 2000, SEED DISPERSAL FRUGI, P451; d'Oliveira MVN, 2012, REMOTE SENS ENVIRON, V124, P479, DOI 10.1016/j.rse.2012.05.014; Dey V, 2010, INT ARCH PHOTOGRAMM, V38, P31; Diamond J, 2009, NATURE, V461, P479, DOI 10.1038/461479a; Dupuy S, 2012, 4 INT C GEOGR OBJ B; Eckert S, 2012, REMOTE SENS-BASEL, V4, P810, DOI 10.3390/rs4040810; Edson C, 2011, REMOTE SENS-BASEL, V3, P2494, DOI 10.3390/rs3112494; Englhart S, 2013, REMOTE SENS-BASEL, V5, P2368, DOI 10.3390/rs5052368; Erikson M, 2005, MACH VISION APPL, V16, P258, DOI 10.1007/s00138-005-0180-y; Evans D, 2007, P NATL ACAD SCI USA, V104, P14277, DOI 10.1073/pnas.0702525104; Evans DH, 2013, P NATL ACAD SCI USA, V110, P12595, DOI 10.1073/pnas.1306539110; Fletcher R, 2007, WORLD ARCHAEOL, V39, P385, DOI 10.1080/00438240701465001; Fowler P. J., 2003, WORLD HERITAGE 2002, V7, P16; Franklin SE, 2001, PHOTOGRAMM ENG REM S, V67, P849; Galletti CS, 2014, REMOTE SENS-BASEL, V6, P6089, DOI 10.3390/rs6076089; Gao J, 2009, MULTITEMPORAL IMAGE, P645; Gao Y, 2006, INT J REMOTE SENS, V27, P4039, DOI 10.1080/01431160600702632; Garzon-Lopez CX, 2013, BIOTROPICA, V45, P308, DOI 10.1111/btp.12009; Gaucher J, 2002, MUSEUM INT, V54, P28, DOI 10.1111/1468-0033.00361; Gaucher J, 2003, FISHBONES GLITTERING, P233; Gaughan AE, 2009, APPL GEOGR, V29, P212, DOI 10.1016/j.apgeog.2008.09.007; Gillespie J, 2009, INT J HERIT STUD, V15, P338, DOI 10.1080/13527250902933900; Gomes MF, 2013, SPIE REMOTE SENSING; Gonzalez-Orozco CE, 2010, APPL VEG SCI, V13, P510, DOI 10.1111/j.1654-109X.2010.01090.x; Gougeon FA, 2006, PHOTOGRAMM ENG REM S, V72, P1287, DOI 10.14358/PERS.72.11.1287; Guo QH, 2007, GISCI REMOTE SENS, V44, P24, DOI 10.2747/1548-1603.44.1.24; Hall O, 2004, LANDSCAPE ECOL, V19, P59, DOI 10.1023/B:LAND.0000018371.43447.1f; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hatami F, 2012, CARBON ESTIMATION IN; Heenkenda MK, 2014, REMOTE SENS-BASEL, V6, P6064, DOI 10.3390/rs6076064; Heinzel JN, 2008, P SILVILASER ED UK; Hodgson ME, 2004, PHOTOGRAMM ENG REM S, V70, P331, DOI 10.14358/PERS.70.3.331; Huang HB, 2009, SENSORS-BASEL, V9, P1541, DOI 10.3390/s90301541; Hunter MO, 2013, BIOGEOSCIENCES, V10, P8385, DOI 10.5194/bg-10-8385-2013; Imai Y, 2004, INT SOC PHOTOGRAMMET, V4; Jakubowski MK, 2013, REMOTE SENS-BASEL, V5, P4163, DOI 10.3390/rs5094163; Jansen PA, 2008, ECOGRAPHY, V31, P33, DOI 10.1111/j.2007.0906-7590.05151.x; Jing LH, 2012, ISPRS J PHOTOGRAMM, V70, P88, DOI 10.1016/j.isprsjprs.2012.04.003; Jones H.G., 2010, REMOTE SENSING VEGET; Kakunda CB, 2013, THESIS U TWENTE ENSC; Kanda F, 2004, INT GEOSCI REMOTE SE, P3822; Karegowda AG, 2010, INT J INFORM TECHNOL, V2, P271; Ke YH, 2010, REMOTE SENS ENVIRON, V114, P1141, DOI 10.1016/j.rse.2010.01.002; Kim M, 2009, PHOTOGRAMM ENG REM S, V75, P819, DOI 10.14358/PERS.75.7.819; Koedsin W, 2013, REMOTE SENS-BASEL, V5, P3562, DOI 10.3390/rs5073562; Koh LP, 2012, TROP CONSERV SCI, V5, P121, DOI 10.1177/194008291200500202; Korom A, 2004, IOP C SER EARTH ENV, V18; Kraus K, 1998, ISPRS J PHOTOGRAMM, V53, P193, DOI 10.1016/S0924-2716(98)00009-4; Kulikova M, 2007, EUSIPCO POZN POL, p[2007, 1]; Kumar M, 2012, OSGEO INDIA, P1; Kux HJ, 2012, ISPRS ANN PHOTOGRAMM, V1-4, P95, DOI DOI 10.5194/ISPRSANNALS-I-4-95-2012; Larjavaara M, 2013, METHODS ECOL EVOL, V4, P793, DOI 10.1111/2041-210X.12071; Lemaistre A, 2002, MUSEUM INT, V54, P117, DOI 10.1111/1468-0033.00375; Li Z, 2010, DIGITAL TERRAIN MODE; Liu X, 2007, MODSIM 2007: INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION, P1363; Lizarazo I, 2008, PIXELS GRIXELS UNIFI; Malhi Y, 2012, J ECOL, V100, P65, DOI 10.1111/j.1365-2745.2011.01916.x; Marthews T., 2012, MEASURING TROPICAL F; Martinez-Uso A, 2007, IEEE T GEOSCI REMOTE, V45, P4158, DOI 10.1109/TGRS.2007.904951; Maxwell J. F., 1995, Natural History Bulletin of the Siam Society, V43, P131; Mbaabu PR, 2012, AGB CARBON MAPPING U; McGaughey R. J., 2010, FUSION LDV SOFTWARE; McKay JE, 2014, ORYX, V48, P23, DOI 10.1017/S0030605313001087; Mei C., 2004, INT ARCH PHOTOGRAMME, V36, P218; Michael Spencer and the FREELAND Foundation, 2013, AS MOST PREC WOOD SO; Mikusinski G, 2014, ORYX, V48, P17, DOI 10.1017/S0030605312000993; Miura K., 2005, CONSERV MANAGE ARCHA, V7, P3, DOI [DOI 10.1179/135050305793137602, 10.1179/135050305793137602]; Palace M, 2008, BIOTROPICA, V40, P141, DOI 10.1111/J.1744-7429.2007.00353.x; Phua MH, 2003, CAN J REMOTE SENS, V29, P429, DOI 10.5589/m03-005; Popescu SC, 2003, CAN J REMOTE SENS, V29, P564, DOI 10.5589/m03-027; Primack R., 1998, TIMBER TOURISTS TEMP; Chen Q, 2006, PHOTOGRAMM ENG REM S, V72, P923, DOI 10.14358/PERS.72.8.923; Shafri Helmi Zulhaidi Mohd, 2007, Journal of Computer Sciences, V3, P419, DOI 10.3844/jcssp.2007.419.423; Shendryk I, 2013, THESIS DEP PHYS GEOG; Simard M, 2000, IEEE T GEOSCI REMOTE, V38, P2310, DOI 10.1109/36.868888; Singh M, 2014, J APPL REMOTE SENS, V8, DOI 10.1117/1.JRS.8.083695; Smits I., 2012, BIOSYST INF TECHNOL, V1, P19, DOI [10.11592/bit.121103, DOI 10.11592/BIT.121103, DOI 10.11592/bit.121103]; Steinmetz RG., 2009, THESIS U MINNEAPOLIS; Tan BS, 2012, DETERIORATION STONE, P108; Tinkham WT, 2012, CAN J FOREST RES, V42, P413, DOI [10.1139/X11-193, 10.1139/x11-193]; Tochon G, 2012, INT GEOSCI REMOTE SE, P6368, DOI 10.1109/IGARSS.2012.6352716; Tokola T, 2008, ISPRS C GEORG; Tsendbazar NE, 2011, THESIS U TWENTE ENSC; Turner BL, 2012, P NATL ACAD SCI USA, V109, P13908, DOI 10.1073/pnas.1210106109; Turner BL, 2001, FOREST ECOL MANAG, V154, P353, DOI 10.1016/S0378-1127(01)00508-4; UN-REDD, 2010, CAMB NAT UN REDD NAT; Vadakkenveettil B., 2012, INT J COMPUT SCI ENG, V2, P151, DOI [10.5121/ijcseit.2012.2213, DOI 10.5121/IJCSEIT.2012.2213]; Wales N, 2012, COMBINING REMOTE SEN; Walsh SJ, 2008, REMOTE SENS ENVIRON, V112, P1927, DOI 10.1016/j.rse.2007.06.028; Wang L, 2004, PHOTOGRAMM ENG REM S, V70, P351, DOI 10.14358/PERS.70.3.351; Wang L, 2013, GEOINFORMATICA, V17, P35, DOI 10.1007/s10707-011-0148-1; Whiteside T, 2011, THESIS C DARWIN U ME; Wijaya A, 2007, 5 ISPRS INT S SPAT D; World Agroforestry Centre, 2013, AGR DAT; Yang J, 2014, INT GEOSCI REMOTE SE, P1588, DOI 10.1109/IGARSS.2014.6945949; Zhou JJ, 2013, J APPL REMOTE SENS, V7, DOI 10.1117/1.JRS.7.073484	110	37	37	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0121558	10.1371/journal.pone.0121558	http://dx.doi.org/10.1371/journal.pone.0121558			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902148	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500010
J	Vieira, MF; de Avelar, IS; Silva, MS; Soares, V; da Costa, PHL				Vieira, Marcus Fraga; de Avelar, Ivan Silveira; Silva, Maria Sebastiana; Soares, Viviane; Lobo da Costa, Paula Hentschel			Effects of Four Days Hiking on Postural Control	PLOS ONE			English	Article							STRENUOUS TREADMILL EXERCISE; TRICEPS SURAE MUSCLES; MUSCULAR FATIGUE; VISUAL CONTRIBUTION; UPRIGHT STANCE; POSITION SENSE; LOCAL FATIGUE; SWAY-DENSITY; QUIET STANCE; BODY SWAY	Hiking is a demanding form of exercise that may cause delayed responses of the postural muscles and a loss of somatosensory information, particularly when repeatedly performed for several days. These effects may negatively influence the postural control of hikers. Therefore, the aim of this study was to investigate the effects of a four-day hike on postural control. Twenty-six adults of both sexes travelled 262 kilometers, stopping for lunch and resting in the early evening each day. Force platforms were used to collect center of pressure (COP) data at 100 Hz for 70 seconds before hiking started and immediately after arriving at the rest station each day. The COP time course data were analyzed according to global stabilometric descriptors, spectral analysis and structural descriptors using sway density curve (SDC) and stabilometric diffusion analysis (SDA). Significant increases were found for global variables in both the anterior-posterior and medial-lateral directions (COP sway area, COP total sway path, COP mean velocity, COP root mean square value and COP range). In the spectral analysis, only the 80% power frequency (F80) in the anterior-posterior direction showed a significant increase, reflecting the increase of the sway frequencies. The SDC revealed a significant increase in the mean distance between peaks (MD) and a significant decrease in the mean peak amplitudes (MP), suggesting that a larger torque amplitude is required for stabilization and that the postural stability is reduced. The SDA revealed a decrease in the long-term slope (Hl) and increases in the short-term (Ks) and the long-term (Kl) intercepts. We considered the likelihood that the presence of local and general fatigue, pain and related neuromuscular adaptations and somatosensory deficits may have contributed to these postural responses. Together, these results demonstrated that four days of hiking increased sway frequencies and deteriorated postural control in the standing position.	[Vieira, Marcus Fraga; de Avelar, Ivan Silveira; Silva, Maria Sebastiana; Soares, Viviane] Univ Fed Goias, Bioengn & Biomech Lab, Goiania, Go, Brazil; [Lobo da Costa, Paula Hentschel] Univ Fed Sao Carlos, Dept Phys Educ, Sao Paulo, Brazil	Universidade Federal de Goias; Universidade Federal de Sao Carlos	Vieira, MF (corresponding author), Univ Fed Goias, Bioengn & Biomech Lab, Goiania, Go, Brazil.	marcus@ufg.br	da Costa, Paula Hentschel Lobo/AAQ-3498-2021; Soares, Viviane/AAE-9771-2020; Vieira, Marcus Fraga/G-4840-2012	da Costa, Paula Hentschel Lobo/0000-0003-2117-0423; Soares, Viviane/0000-0002-1570-6626; Vieira, Marcus Fraga/0000-0001-9096-1603	Capes Foundation, Brazil	Capes Foundation, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Ivan Silveira de Avelar and Viviane Soares were supported by a scholarship provided by Capes Foundation, Brazil.	Amoud H, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-12; Asseman F, 2005, INT J SPORTS MED, V26, P116, DOI 10.1055/s-2004-830529; Baratto L, 2002, MOTOR CONTROL, V6, P246, DOI 10.1123/mcj.6.3.246; BONNARD M, 1994, NEUROSCI LETT, V166, P101, DOI 10.1016/0304-3940(94)90850-8; Bove M, 2007, NEUROSCI LETT, V418, P276, DOI 10.1016/j.neulet.2007.03.036; Burdet C, 2004, SCI SPORT, V19, P308, DOI 10.1016/j.scispo.2004.02.003; Caron O, 2004, NEUROSCI LETT, V363, P18, DOI 10.1016/j.neulet.2004.03.038; Chiari L, 2000, GAIT POSTURE, V12, P225, DOI 10.1016/S0966-6362(00)00086-2; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; Corbeil P, 2003, GAIT POSTURE, V18, P92, DOI 10.1016/S0966-6362(02)00198-4; Cote JN, 2002, EXP BRAIN RES, V146, P394, DOI 10.1007/s00221-002-1186-6; Degache F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084554; Derave W, 2002, INT J SPORTS MED, V23, P44, DOI 10.1055/s-2002-19374; Enoka RM, 2008, J PHYSIOL-LONDON, V586, P11, DOI 10.1113/jphysiol.2007.139477; Forestier N, 1998, NEUROSCI LETT, V252, P187, DOI 10.1016/S0304-3940(98)00584-9; Forestier N, 2002, MED SCI SPORT EXER, V34, P117, DOI 10.1097/00005768-200201000-00018; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Garland SJ, 1995, ADV EXP MED BIOL, V384, P271; Gauchard GC, 2002, INT J NEUROSCI, V112, P1191, DOI 10.1080/00207450290026157; Gimmon Y, 2011, J ELECTROMYOGR KINES, V21, P922, DOI 10.1016/j.jelekin.2011.08.005; Golomer E, 1999, NEUROSCI LETT, V267, P189, DOI 10.1016/S0304-3940(99)00356-0; Gribble PA, 2004, ARCH PHYS MED REHAB, V85, P589, DOI 10.1016/j.apmr.2003.06.031; Guidetti L, 2011, J SPORT SCI MED, V10, P515; Hayes K C, 1982, Exerc Sport Sci Rev, V10, P363, DOI 10.1249/00003677-198201000-00011; Henriksen M, 2007, J APPL PHYSIOL, V103, P132, DOI 10.1152/japplphysiol.01105.2006; Hodges PW, 2011, PAIN, V152, pS90, DOI 10.1016/j.pain.2010.10.020; Hosseini S, 2012, MIDDLE E J SCI RES, V11, P230; Jacono M, 2004, MOTOR CONTROL, V8, P292, DOI 10.1123/mcj.8.3.292; Lafond D, 2004, ARCH PHYS MED REHAB, V85, P896, DOI 10.1016/j.apmr.2003.08.089; Laughton CA, 2003, GAIT POSTURE, V18, P101, DOI 10.1016/S0966-6362(02)00200-X; Ledin T, 2004, GAIT POSTURE, V19, P184, DOI 10.1016/S0966-6362(03)00061-4; Lepers R, 1997, EUR J APPL PHYSIOL, V76, P55, DOI 10.1007/s004210050212; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; Loram ID, 2001, J PHYSIOL-LONDON, V532, P879, DOI 10.1111/j.1469-7793.2001.0879e.x; Vieira TDM, 2009, J ELECTROMYOGR KINES, V19, pE513, DOI 10.1016/j.jelekin.2008.10.007; McLean L, 2004, EUR J APPL PHYSIOL, V91, P204, DOI 10.1007/s00421-003-0967-3; Mello RG, 2009, ENG MED BIOL SOC 200; Mezzarane RA, 2007, EXP BRAIN RES, V180, P377, DOI 10.1007/s00221-007-0865-8; Nagy E, 2004, EUR J APPL PHYSIOL, V92, P407, DOI 10.1007/s00421-004-1157-7; Nardone A, 1997, ELECTROMYOGR MOTOR C, V105, P309, DOI 10.1016/S0924-980X(97)00040-4; Nardone A, 1998, ARCH PHYS MED REHAB, V79, P920, DOI 10.1016/S0003-9993(98)90088-0; NELSON DL, 1985, MED SCI SPORT EXER, V17, P445, DOI 10.1249/00005768-198508000-00007; Oliveira LF, 1996, PHYSIOL MEAS, V17, P305, DOI 10.1088/0967-3334/17/4/008; Oppenheim U, 1999, DIABETES CARE, V22, P328, DOI 10.2337/diacare.22.2.328; Paillard T, 2012, NEUROSCI BIOBEHAV R, V36, P162, DOI 10.1016/j.neubiorev.2011.05.009; Patel M, 2011, EXP BRAIN RES, V208, P519, DOI 10.1007/s00221-010-2498-6; Pedersen J, 1998, NEUROSCIENCE, V84, P953, DOI 10.1016/S0306-4522(97)00403-X; Pollak KA, 2014, EXP PHYSIOL, V99, P368, DOI 10.1113/expphysiol.2013.075812; Rival C, 2005, NEUROSCI LETT, V376, P133, DOI 10.1016/j.neulet.2004.11.042; Saffer M, 2008, EXP BRAIN RES, V185, P215, DOI 10.1007/s00221-007-1145-3; Schilling R. J., 2011, FUNDAMENTALS DIGITAL; Simoneau G., 1995, GAIT POSTURE, V3, P115, DOI [DOI 10.1016/0966-6362(95)99061-O, 10.1016/0966-6362(95)99061-O]; SKINNER HB, 1986, J ORTHOP RES, V4, P112, DOI 10.1002/jor.1100040115; SOAMES RW, 1982, EUR J APPL PHYSIOL O, V49, P169, DOI 10.1007/BF02334065; Sparto PJ, 1997, SPINE, V22, P2647, DOI 10.1097/00007632-199711150-00013; Springer BK, 2009, GAIT POSTURE, V30, P50, DOI 10.1016/j.gaitpost.2009.02.014; Stolwijk NM, 2010, MED SCI SPORT EXER, V42, P2264, DOI 10.1249/MSS.0b013e3181e305f4; Mello RGT, 2010, GAIT POSTURE, V32, P220, DOI 10.1016/j.gaitpost.2010.04.016; Vieira MF, 2013, P 24 C INT SOC BIOM; Vuillerme N, 2003, ARCH PHYS MED REHAB, V84, P1560, DOI 10.1016/S0003-9993(03)00235-1; Vuillerme N, 2007, EUR J APPL PHYSIOL, V100, P169, DOI 10.1007/s00421-007-0419-6; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334; Wojcik LA, 2011, HUM MOVEMENT SCI, V30, P574, DOI 10.1016/j.humov.2010.03.008; Yoshino K, 2004, J BIOMECH, V37, P1271, DOI 10.1016/j.jbiomech.2003.11.031	64	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123214	10.1371/journal.pone.0123214	http://dx.doi.org/10.1371/journal.pone.0123214			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902060	gold, Green Published, Green Submitted			2022-12-27	WOS:000353331500049
J	Arner, P; Henjes, F; Schwenk, JM; Darmanis, S; Dahlman, I; Iresjo, BM; Naredi, P; Agustsson, T; Lundholm, K; Nilsson, P; Ryden, M				Arner, Peter; Henjes, Frauke; Schwenk, Jochen M.; Darmanis, Spyros; Dahlman, Ingrid; Iresjo, Britt-Marie; Naredi, Peter; Agustsson, Thorhallur; Lundholm, Kent; Nilsson, Peter; Ryden, Mikael			Circulating Carnosine Dipeptidase 1 Associates with Weight Loss and Poor Prognosis in Gastrointestinal Cancer	PLOS ONE			English	Article							DIABETIC-NEPHROPATHY; PALLIATIVE CARE; CACHEXIA; METABOLISM; TISSUE; SERUM; FAT; ERYTHROPOIETIN; DEFINITION; MECHANISMS	Background Cancer cachexia (CC) is linked to poor prognosis. Although the mechanisms promoting this condition are not known, several circulating proteins have been proposed to contribute. We analyzed the plasma proteome in cancer subjects in order to identify factors associated with cachexia. Design/Subjects Plasma was obtained from a screening cohort of 59 patients, newly diagnosed with suspected gastrointestinal cancer, with (n = 32) or without (n = 27) cachexia. Samples were subjected to proteomic profiling using 760 antibodies (targeting 698 individual proteins) from the Human Protein Atlas project. The main findings were validated in a cohort of 93 patients with verified and advanced pancreas cancer. Results Only six proteins displayed differential plasma levels in the screening cohort. Among these, Carnosine Dipeptidase 1 (CNDP1) was confirmed by sandwich immunoassay to be lower in CC (p = 0.008). In both cohorts, low CNDP1 levels were associated with markers of poor prognosis including weight loss, malnutrition, lipid breakdown, low circulating albumin/IGF1 levels and poor quality of life. Eleven of the subjects in the discovery cohort were finally diagnosed with non-malignant disease but omitting these subjects from the analyses did not have any major influence on the results. Conclusions In gastrointestinal cancer, reduced plasma levels of CNDP1 associate with signs of catabolism and poor outcome. These results, together with recently published data demonstrating lower circulating CNDP1 in subjects with glioblastoma and metastatic prostate cancer, suggest that CNDP1 may constitute a marker of aggressive cancer and CC.	[Arner, Peter; Dahlman, Ingrid; Ryden, Mikael] Karolinska Univ Hosp, Karolinska Inst, Dept Med H7, S-14186 Stockholm, Sweden; [Henjes, Frauke; Schwenk, Jochen M.; Darmanis, Spyros; Nilsson, Peter] Royal Inst Technol, Sch Biotechnol, Affin Prote Sci Life Lab, Solna, Sweden; [Iresjo, Britt-Marie; Naredi, Peter; Lundholm, Kent] Univ Gothenburg, Sahlgrenska Acad, Dept Surg, S-41345 Gothenburg, Sweden; [Agustsson, Thorhallur] CLINTEC, Dept Clin Sci Intervent & Technol, Div Surg, S-11883 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Royal Institute of Technology; University of Gothenburg	Ryden, M (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Med H7, S-14186 Stockholm, Sweden.	mikael.ryden@ki.se	Schwenk, Jochen/AAS-4164-2021; Schwenk, Jochen M/F-1730-2010; Nilsson, Peter/E-4547-2010; Naredi, Peter/AAG-1504-2019; Darmanis, Spyros/ABG-4670-2020	Schwenk, Jochen/0000-0001-8141-8449; Schwenk, Jochen M/0000-0001-8141-8449; Nilsson, Peter/0000-0002-4657-8532; Darmanis, Spyros/0000-0003-4002-8158; Iresjo, Britt-Marie/0000-0002-7724-0243; Lundholm, Kent/0000-0002-8727-6266; Arner, Peter/0000-0002-6208-6220; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Naredi, Peter/0000-0002-5652-0422; Dahlman, Ingrid/0000-0003-3819-5977	Swedish Heart and Lung Foundation; Swedish Diabetes Association; Novo Nordisk Foundation; Swedish Cancer Foundation; DiabetesWellness; Swedish Medical Association; Swedish Research Council; Strategic Research Programme in Diabetes at the Karolinska Institute; Knut and Alice Wallenberg Foundation; SciLifeLab Stockholm; Novo Nordisk Fonden [NNF14OC0010187, NNF12OC1016371] Funding Source: researchfish	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Diabetes Association; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Cancer Foundation; DiabetesWellness; Swedish Medical Association; Swedish Research Council(Swedish Research CouncilEuropean Commission); Strategic Research Programme in Diabetes at the Karolinska Institute; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); SciLifeLab Stockholm; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Swedish Heart and Lung Foundation, the Swedish Diabetes Association, the Novo Nordisk Foundation, the Swedish Cancer Foundation, DiabetesWellness, the Swedish Medical Association, the Swedish Research Council, the Strategic Research Programme in Diabetes at the Karolinska Institute, the Knut and Alice Wallenberg Foundation and SciLifeLab Stockholm. None of the funding sources have taken part in planning, performing, analyzing the data or writing the manuscript.	Adelmann K, 2012, AMINO ACIDS, V43, P143, DOI 10.1007/s00726-012-1244-8; Agustsson T, 2007, CANCER RES, V67, P5531, DOI 10.1158/0008-5472.CAN-06-4585; Ahluwalia TS, 2011, DIABETOLOGIA, V54, P2295, DOI 10.1007/s00125-011-2178-5; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Arner P, 2011, SCIENCE, V333, P163, DOI 10.1126/science.1209418; Barski OA, 2013, ARTERIOSCL THROM VAS, V33, P1162, DOI 10.1161/ATVBAHA.112.300572; Bosaeus I, 2001, INT J CANCER, V93, P380, DOI 10.1002/ijc.1332; Braoudaki M, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-52; Dahlman I, 2010, BRIT J CANCER, V102, P1541, DOI 10.1038/sj.bjc.6605665; Dieplinger H, 2009, CANCER EPIDEM BIOMAR, V18, P1127, DOI 10.1158/1055-9965.EPI-08-0653; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Fouladiun M, 2005, CANCER-AM CANCER SOC, V103, P2189, DOI 10.1002/cncr.21013; Gaunitz F, 2012, AMINO ACIDS, V43, P135, DOI 10.1007/s00726-012-1271-5; Gautam P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046153; HELLMER J, 1992, J CLIN ENDOCR METAB, V75, P15, DOI 10.1210/jc.75.1.15; Iovine B, 2012, CANCER LETT, V315, P122, DOI 10.1016/j.canlet.2011.07.021; Janssen B, 2005, DIABETES, V54, P2320, DOI 10.2337/diabetes.54.8.2320; Lainscak M, 2008, AM J CARDIOL, V101, p8E, DOI 10.1016/j.amjcard.2008.02.065; Laurencikiene J, 2008, CANCER RES, V68, P9247, DOI 10.1158/0008-5472.CAN-08-1343; LENNEY JF, 1982, CLIN CHIM ACTA, V123, P221, DOI 10.1016/0009-8981(82)90166-8; Li L, 2012, ASIAN PAC J CANCER P, V13, P3265, DOI 10.7314/APJCP.2012.13.7.3265; Lindholm E, 2004, CLIN CANCER RES, V10, P6855, DOI 10.1158/1078-0432.CCR-04-0373; Ljungman D, 2013, WORLD J SURG, V37, P1883, DOI 10.1007/s00268-013-2003-z; Lundholm K, 2004, CANCER-AM CANCER SOC, V100, P1967, DOI 10.1002/cncr.20160; Lundholm K, 2007, CLIN CANCER RES, V13, P2699, DOI 10.1158/1078-0432.CCR-06-2720; Lundholm K, 2010, CANCER-AM CANCER SOC, V116, P2044, DOI 10.1002/cncr.24917; Mong MC, 2011, EUR J PHARMACOL, V653, P82, DOI 10.1016/j.ejphar.2010.12.001; Mooyaart AL, 2010, DIABETES, V59, P1555, DOI 10.2337/db09-1377; Nagai K, 1986, Nihon Seirigaku Zasshi, V48, P741; Ottery FD, 1996, NUTRITION, V12, pS15, DOI 10.1016/0899-9007(95)00067-4; Qundos U, 2014, TRANSL PROTEOMICS, V2, P14; Renner C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-2; Ryden M, 2011, J INTERN MED; Ryden M, 2007, CLIN NUTR, V26, P1, DOI 10.1016/j.clnu.2006.09.009; Schwenk JM, 2010, MOL CELL PROTEOMICS, V9, P2497, DOI 10.1074/mcp.M110.001560; Schwenk JM, 2010, PROTEOMICS, V10, P532, DOI 10.1002/pmic.200900657; Stoevesandt O, 2012, EXPERT REV PROTEOMIC, V9, P401, DOI [10.1586/EPR.12.34, 10.1586/epr.12.34]; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tisdale MJ, 2003, SUPPORT CARE CANCER, V11, P73, DOI 10.1007/s00520-002-0408-6; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wallengren O, 2013, SUPPORT CARE CANCER, V21, P1569, DOI 10.1007/s00520-012-1697-z; Zhu JM, 2013, GENET TEST MOL BIOMA, V17, P289, DOI 10.1089/gtmb.2012.0341	44	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123566	10.1371/journal.pone.0123566	http://dx.doi.org/10.1371/journal.pone.0123566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898255	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600032
J	Hsu, JC; Hsieh, CY; Yang, YHK; Lu, CY				Hsu, Jason C.; Hsieh, Cheng-Yang; Yang, Yea-Huei Kao; Lu, Christine Y.			Net Clinical Benefit of Oral Anticoagulants: A Multiple Criteria Decision Analysis	PLOS ONE			English	Article							MEDICINES-PART 1; ATRIAL-FIBRILLATION; QUANTITATIVE APPROACH; STROKE PREVENTION; RISK ASSESSMENT; NEW-MODEL; COST-EFFECTIVENESS; ISCHEMIC-STROKE; TASK-FORCE; EFFICACY	Background This study quantitatively evaluated the comparative efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, and apizaban) and warfarin for treatment of nonvalvular atrial fibrillation. We also compared these agents under different scenarios, including population with high risk of stroke and for primary vs. secondary stroke prevention. Methods We used multiple criteria decision analysis (MCDA) to assess the benefit-risk of these medications. Our MCDA models contained criteria for benefits (prevention of ischemic stroke and systemic embolism) and risks (intracranial and extracranial bleeding). We calculated a performance score for each drug accounting for benefits and risks in comparison to treatment alternatives. Results Overall, new agents had higher performance scores than warfarin; in order of performance scores: dabigatran 150 mg (0.529), rivaroxaban (0.462), apixaban (0.426), and warfarin (0.191). For patients at a higher risk of stroke (CHADS(2) score >= 3), apixaban had the highest performance score (0.686); performance scores for other drugs were 0.462 for dabigatran 150 mg, 0.392 for dabigatran 110 mg, 0.271 for rivaroxaban, and 0.116 for warfarin. Dabigatran 150 mg had the highest performance score for primary stroke prevention, while dabigatran 110 mg had the highest performance score for secondary prevention. Conclusions Our results suggest that new oral anticoagulants might be preferred over warfarin. Selecting appropriate medicines according to the patient's condition based on information from an integrated benefit-risk assessment of treatment options is crucial to achieve optimal clinical outcomes.	[Hsu, Jason C.; Hsieh, Cheng-Yang; Yang, Yea-Huei Kao] Natl Cheng Kung Univ, Sch Pharm, Tainan 70101, Taiwan; [Hsu, Jason C.; Hsieh, Cheng-Yang; Yang, Yea-Huei Kao] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Tainan 70101, Taiwan; [Hsieh, Cheng-Yang] Tainan Sin Lau Hosp, Stroke Ctr, Tainan, Taiwan; [Hsieh, Cheng-Yang] Tainan Sin Lau Hosp, Dept Neurol, Tainan, Taiwan; [Lu, Christine Y.] Harvard Univ, Sch Med, Dept Populat Med, Cambridge, MA 02138 USA; [Lu, Christine Y.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA	National Cheng Kung University; National Cheng Kung University; Harvard University; Harvard Pilgrim Health Care	Hsu, JC (corresponding author), Natl Cheng Kung Univ, Sch Pharm, Tainan 70101, Taiwan.	jasonhsu@mail.ncku.edu.tw	Hsieh, Cheng-Yang/W-4841-2019	Hsieh, Cheng-Yang/0000-0002-8772-4073	Taiwan National Science Council Fellowship [102-2917-I-564-013]	Taiwan National Science Council Fellowship	Dr. Hsu was supported by the Taiwan National Science Council Fellowship (Fellowship ID 102-2917-I-564-013). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker WL, 2012, CIRC-CARDIOVASC QUAL, V5, P711, DOI 10.1161/CIRCOUTCOMES.112.966572; Cairns JA, 2011, CAN J CARDIOL, V27, P74, DOI 10.1016/j.cjca.2010.11.007; Canestaro WJ, 2013, CIRC-CARDIOVASC QUAL, V6, P724, DOI 10.1161/CIRCOUTCOMES.113.000661; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Connolly SJ, 2010, NEW ENGL J MED, V363, P1875, DOI 10.1056/NEJMc1007378; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Feeny D, 2002, MED CARE, V40, P113, DOI 10.1097/00005650-200202000-00006; Gage BF, 2004, CIRCULATION, V110, P2287, DOI 10.1161/01.CIR.0000145172.55640.93; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Guo JJ, 2010, VALUE HEALTH, V13, P657, DOI 10.1111/j.1524-4733.2010.00725.x; Hsu JC, 2014, INT J CLIN PRACTICE; Karasakal E, 2009, OPER RES, V57, P187, DOI 10.1287/opre.1080.0581; Keeney R.L., 1996, VALUE FOCUSED THINKI; Koksalan M.M., 2011, MULTIPLE CRITERIA DE; Lee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047473; Lip GYH, 2012, J AM COLL CARDIOL, V60, P738, DOI 10.1016/j.jacc.2012.03.019; Marini C, 2005, STROKE, V36, P1115, DOI 10.1161/01.STR.0000166053.83476.4a; Medi C, 2010, STROKE, V41, P2705, DOI 10.1161/STROKEAHA.110.589218; Meenan RT, 2007, MED DECIS MAKING, V27, P161, DOI 10.1177/0272989X06297388; Miller CS, 2012, AM J CARDIOL, V110, P453, DOI 10.1016/j.amjcard.2012.03.049; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Mussen F, 2007, PHARMACOEPIDEM DR S, V16, pS2, DOI 10.1002/pds.1435; Mussen F, 2007, PHARMACOEPIDEM DR S, V16, pS42, DOI 10.1002/pds.1436; Mussen F, 2007, PHARMACOEPIDEM DR S, V16, pS16, DOI 10.1002/pds.1434; O'Brien CL, 2005, JAMA-J AM MED ASSOC, V293, P699, DOI 10.1001/jama.293.6.699; Paciaroni M, 2011, J THROMB HAEMOST, V9, P893, DOI 10.1111/j.1538-7836.2011.04241.x; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Rasmussen LH, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7097; Saaty T.L., 2008, GROUP DECISION MAKIN; SAATY TL, 1990, EUR J OPER RES, V48, P9, DOI 10.1016/0377-2217(90)90057-I; Saaty TL, 2003, EUR J OPER RES, V145, P85, DOI 10.1016/S0377-2217(02)00227-8; Schneeweiss S, 2012, CIRC-CARDIOVASC QUAL, V5, P480, DOI 10.1161/CIRCOUTCOMES.112.965988; Stevens K, 2007, J HEALTH ECON, V26, P992, DOI 10.1016/j.jhealeco.2006.12.007; Turpie AGG, 2008, EUR HEART J, V29, P155, DOI 10.1093/eurheartj/ehm575; Wann LS, 2011, J AM COLL CARDIOL, V57, P1330, DOI 10.1016/j.jacc.2011.01.010; Weinstein MC, 2003, VALUE HEALTH, V6, P9, DOI 10.1046/j.1524-4733.2003.00234.x; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yip PK, 1997, STROKE, V28, P2507, DOI 10.1161/01.STR.28.12.2507	40	18	19	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124806	10.1371/journal.pone.0124806	http://dx.doi.org/10.1371/journal.pone.0124806			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897861	Green Submitted, Green Published, gold			2022-12-27	WOS:000353212600087
J	Kramer, M; Quickert, S; Sponholz, C; Menzel, U; Huse, K; Platzer, M; Bauer, M; Claus, RA				Kramer, Marcel; Quickert, Stefanie; Sponholz, Christoph; Menzel, Uwe; Huse, Klaus; Platzer, Matthias; Bauer, Michael; Claus, Ralf A.			Alternative Splicing of SMPD1 in Human Sepsis	PLOS ONE			English	Article							HUMAN ACID SPHINGOMYELINASE; ORGAN FAILURE; CERAMIDE	Acid sphingomyelinase (ASM or sphingomyelin phosphodiesterase, SMPD) activity engages a critical role for regulation of immune response and development of organ failure in critically ill patients. Beside genetic variation in the human gene encoding ASM (SMPD1), alternative splicing of the mRNA is involved in regulation of enzymatic activity. Here we show that the patterns of alternatively spliced SMPD1 transcripts are significantly different in patients with systemic inflammatory response syndrome and severe sepsis/septic shock compared to control subjects allowing discrimination of respective disease entity. The different splicing patterns might contribute to the better understanding of the pathophysiology of human sepsis.	[Kramer, Marcel; Quickert, Stefanie; Bauer, Michael; Claus, Ralf A.] Jena Univ Hosp, CSCC, Integrated Res & Treatment Ctr, Jena, Germany; [Kramer, Marcel; Huse, Klaus; Platzer, Matthias] Fritz Lipmann Inst, Leibniz Inst Age Res, Genome Anal, Jena, Germany; [Sponholz, Christoph; Bauer, Michael; Claus, Ralf A.] Jena Univ Hosp, Dept Anesthesiol & Intens Care Therapy, Jena, Germany; [Menzel, Uwe] Leibniz Inst, Hans Knoll Inst Nat Prod Res & Infect Biol, Jena, Germany	Friedrich Schiller University of Jena; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Friedrich Schiller University of Jena; Hans Knoll Institute (HKI)	Claus, RA (corresponding author), Jena Univ Hosp, CSCC, Integrated Res & Treatment Ctr, Jena, Germany.	ralf.claus@med.uni-jena.de	Sponholz, Christoph/I-3585-2019; Quickert, Stefanie/AAD-1412-2020; Claus, Ralf A./Q-4035-2016	Sponholz, Christoph/0000-0002-1746-7024; Bauer, Michael/0000-0002-1521-3514; Huse, Klaus/0000-0003-3854-1884; Claus, Ralf A./0000-0001-7232-4088	Federal Ministry of Education and Research (BMBF, Germany) [FKZ: 01EO1002]; Deutsche Forschungsgemeinschaft (DFG, Germany) [CL173/4-2]	Federal Ministry of Education and Research (BMBF, Germany)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG, Germany)(German Research Foundation (DFG))	This work was supported by the Federal Ministry of Education and Research (BMBF, Germany, FKZ: 01EO1002 to MB) and the Deutsche Forschungsgemeinschaft (DFG, Germany, CL173/4-2 to RAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker Katrin Anne, 2008, V49, P523, DOI 10.1007/978-1-4020-8831-5_20; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bota DP, 2002, INTENS CARE MED, V28, P1619, DOI 10.1007/s00134-002-1491-3; BRADY RO, 1966, P NATL ACAD SCI USA, V55, P366, DOI 10.1073/pnas.55.2.366; Claus RA, 2005, FASEB J, V19, P1719, DOI 10.1096/fj.04-2842fje; Fried E, 2011, CURR OPIN CRIT CARE, V17, P396, DOI 10.1097/MCC.0b013e328348bee2; Jbeily N, 2013, J LIPID RES, V54, P410, DOI 10.1194/jlr.M031625; Jenkins RW, 2010, J BIOL CHEM, V285, P35706, DOI 10.1074/jbc.M110.125609; Jenkins RW, 2009, CELL SIGNAL, V21, P836, DOI 10.1016/j.cellsig.2009.01.026; Kramer M, 2011, GENETICS, V187, P761, DOI 10.1534/genetics.110.125096; Lareau LF, 2007, ADV EXP MED BIOL, V623, P190, DOI 10.1007/978-0-387-77374-2_12; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Martin GS, 2012, EXPERT REV ANTI-INFE, V10, P701, DOI [10.1586/ERI.12.50, 10.1586/eri.12.50]; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nikolova-Karakashian MN, 2010, ADV EXP MED BIOL, V688, P86; Peters JH, 2011, BIOMARK INSIGHTS, V6, P59, DOI 10.4137/BMI.S7204; QUINTERN LE, 1989, EMBO J, V8, P2469, DOI 10.1002/j.1460-2075.1989.tb08382.x; Rhein C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035467; SCHUCHMAN EH, 1991, J BIOL CHEM, V266, P8531; Simonaro CM, 2002, AM J HUM GENET, V71, P1413, DOI 10.1086/345074; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043	21	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124503	10.1371/journal.pone.0124503	http://dx.doi.org/10.1371/journal.pone.0124503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898364	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600070
J	Lan, KC; Chiu, CY; Kao, CW; Huang, KH; Wang, CC; Huang, KT; Tsai, KS; Sheu, ML; Liu, SH				Lan, Kuo-Cheng; Chiu, Chen-Yuan; Kao, Chia-Wei; Huang, Kuo-How; Wang, Ching-Chia; Huang, Kuo-Tong; Tsai, Keh-Sung; Sheu, Meei-Ling; Liu, Shing Hwa			Advanced Glycation End-Products Induce Apoptosis in Pancreatic Islet Endothelial Cells via NF-kappa B-Activated Cyclooxygenase-2/Prostaglandin E-2 Up-Regulation	PLOS ONE			English	Article							HIGH GLUCOSE; PHENOTYPIC HETEROGENEITY; BETA-CELLS; RECEPTOR; ATHEROSCLEROSIS; DYSFUNCTION; STRESS; AGES; COMPLICATIONS; INHIBITION	Microvascular complications eventually affect nearly all patients with diabetes. Advanced glycation end-products (AGEs) resulting from hyperglycemia are a complex and heterogeneous group of compounds that accumulate in the plasma and tissues in diabetic patients. They are responsible for both endothelial dysfunction and diabetic vasculopathy. The aim of this study was to investigate the cytotoxicity of AGEs on pancreatic islet microvascular endothelial cells. The mechanism underlying the apoptotic effect of AGEs in pancreatic islet endothelial cell line MS1 was explored. The results showed that AGEs significantly decreased MS1 cell viability and induced MS1 cell apoptosis in a dose-dependent manner. AGEs dose-dependently increased the expressions of cleaved caspase-3, and cleaved poly (ADP-ribose) polymerase in MS1 cells. Treatment of MS1 cells with AGEs also resulted in increased nuclear factor (NF)-kappa B-p65 phosphorylation and cyclooxygenase (COX)-2 expression. However, AGEs did not affect the expressions of endoplasmic reticulum (ER) stress-related molecules in MS1 cells. Pretreatment with NS398 (a COX-2 inhibitor) to inhibit prostaglandin E-2 (PGE(2)) production reversed the induction of cleaved caspase-3, cleaved PARP, and MS1 cell viability. Moreover, AGEs significantly increased the receptor for AGEs (RAGE) protein expression in MS1 cells, which could be reversed by RAGE neutralizing antibody. RAGE Neutralizing antibody could also reverse the induction of cleaved caspase-3 and cleaved PARP and decreased cell viability induced by AGEs. These results implicate the involvement of NF-kappa B-activated COX-2/PGE(2) up-regulation in AGEs/RAGE-induced islet endothelial cell apoptosis and cytotoxicity. These findings may provide insight into the pathological processes within the pancreatic islet microvasculature induced by AGEs accumulation.	[Lan, Kuo-Cheng] Triserv Gen Hosp, Natl Def Med Ctr, Dept Emergency Med, Taipei, Taiwan; [Chiu, Chen-Yuan; Kao, Chia-Wei; Huang, Kuo-Tong; Liu, Shing Hwa] Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei 10764, Taiwan; [Huang, Kuo-How] Natl Taiwan Univ, Coll Med & Hosp, Dept Urol, Taipei 10764, Taiwan; [Wang, Ching-Chia; Liu, Shing Hwa] Natl Taiwan Univ, Coll Med & Hosp, Dept Pediat, Taipei 10764, Taiwan; [Tsai, Keh-Sung] Natl Taiwan Univ, Coll Med & Hosp, Dept Lab Med, Taipei 10764, Taiwan; [Sheu, Meei-Ling] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Liu, Shing Hwa] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Chung Hsing University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Liu, SH (corresponding author), Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei 10764, Taiwan.	shinghwaliu@ntu.edu.tw	Sheu, Meei-Ling/AAT-3401-2020	Sheu, Meei-Ling/0000-0002-0431-1282; Chiu, Chen-Yuan/0000-0003-4378-993X; WANG, CHING-CHIA/0000-0002-5954-5684; TSAI, KEH-SUNG/0000-0001-8528-1566; LIU, SHING-HWA/0000-0002-9976-1197	National Science Council of Taiwan [NSC100-2314-B-002-084]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the grant from the National Science Council of Taiwan (NSC100-2314-B-002-084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulos C, 2014, CLIN CHEM LAB MED, V52, P151, DOI 10.1515/cclm-2012-0826; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Basta G, 2004, CARDIOVASC RES, V63, P582, DOI 10.1016/j.cardiores.2004.05.001; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Bucciarelli LG, 2002, CELL MOL LIFE SCI, V59, P1117, DOI 10.1007/s00018-002-8491-x; Chawla D, 2014, MICROVASC RES, V95, P1, DOI 10.1016/j.mvr.2014.06.010; Chen YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066611; Chistiakov DA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/610140; Favaro E, 2008, AM J PATHOL, V173, P442, DOI 10.2353/ajpath.2008.080238; Figarola JL, 2014, APOPTOSIS, V19, P776, DOI 10.1007/s10495-014-0974-3; Gastaldelli A, 2011, DIABETES RES CLIN PR, V93, pS60, DOI 10.1016/S0168-8227(11)70015-8; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Hadi HAR, 2007, VASC HEALTH RISK MAN, V3, P853; Hernandez-Fonseca JP, 2009, EXP DIABETES RES, DOI 10.1155/2009/329632; Ho FM, 2000, CIRCULATION, V101, P2618, DOI 10.1161/01.CIR.101.22.2618; Ido Y, 2002, DIABETES, V51, P159, DOI 10.2337/diabetes.51.1.159; Jakus V, 2004, PHYSIOL RES, V53, P131; Kang YH, 2008, J CELL PHYSIOL, V217, P23, DOI 10.1002/jcp.21470; Konstantinova I, 2004, BIOESSAYS, V26, P1069, DOI 10.1002/bies.20105; Lim M, 2008, ANN NY ACAD SCI, V1150, P311, DOI 10.1196/annals.1447.011; McElroy SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038373; Orasanu G, 2009, J AM COLL CARDIOL, V53, pS35, DOI 10.1016/j.jacc.2008.09.055; Pal PB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107220; Robertson RP, 1998, DIABETES, V47, P1379, DOI 10.2337/diabetes.47.9.1379; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Schmidt AM, 1999, CIRC RES, V84, P489, DOI 10.1161/01.RES.84.5.489; Shanmugam N, 2006, DIABETOLOGIA, V49, P100, DOI 10.1007/s00125-005-0065-7; Shen C, 2010, BIOMED PHARMACOTHER, V64, P35, DOI 10.1016/j.biopha.2009.03.002; Sheu ML, 2005, ARTERIOSCL THROM VAS, V25, P539, DOI 10.1161/01.ATV.0000155462.24263.e4; Shi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066781; Thomas Merlin C, 2005, Am J Ther, V12, P562, DOI 10.1097/01.mjt.0000178769.52610.69; Tran POT, 1999, J BIOL CHEM, V274, P31245, DOI 10.1074/jbc.274.44.31245; van den Oever IA, 2010, MEDIAT INFLAMM, V2010, DOI [10.1155/2010/792393, DOI 10.1155/2010/792393]; Wada R, 2005, ANN NY ACAD SCI, V1043, P598, DOI 10.1196/annals.1338.067; Xiang Y, 2011, CELL BIOCHEM FUNCT, V29, P149, DOI 10.1002/cbf.1736; Yamagishi S, 2005, CURR DIABETES REV, V1, P93, DOI 10.2174/1573399052952631; Yamagishi S, 2011, EXP GERONTOL, V46, P217, DOI 10.1016/j.exger.2010.11.007; Zanone MM, 2008, CURR DIABETES REV, V4, P1, DOI 10.2174/157339908783502415	42	39	42	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124418	10.1371/journal.pone.0124418	http://dx.doi.org/10.1371/journal.pone.0124418			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898207	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600067
J	Spitschan, M; Aguirre, GK; Brainard, DH				Spitschan, Manuel; Aguirre, Geoffrey K.; Brainard, David H.			Selective Stimulation of Penumbral Cones Reveals Perception in the Shadow of Retinal Blood Vessels	PLOS ONE			English	Article							ILLUMINATION PUPIL RESPONSE; GANGLION-CELLS; SUBJECTIVE PATTERNS; ENTOPTIC TEST; VISUAL-FIELD; MELANOPSIN; LIGHT; ROD; REPRESENTATION; VASCULATURE	In 1819, Johann Purkinje described how a moving light source that displaces the shadow of the retinal blood vessels to adjacent cones can produce the entopic percept of a branching tree. Here, we describe a novel method for producing a similar percept. We used a device that mixes 56 narrowband primaries under computer control, in conjunction with the method of silent substitution, to present observers with a spectral modulation that selectively targeted penumbral cones in the shadow of the retinal blood vessels. Such a modulation elicits a clear Purkinje-tree percept. We show that the percept is specific to penumbral L and M cone stimulation and is not produced by selective penumbral S cone stimulation. The Purkinje-tree percept was strongest at 16 Hz and fell off at lower (8 Hz) and higher (32 Hz) temporal frequencies. Selective stimulation of open-field cones that are not in shadow, with penumbral cones silenced, also produced the percept, but it was not seen when penumbral and open-field cones were modulated together. This indicates the need for spatial contrast between penumbral and open-field cones to create the Purkinje-tree percept. Our observation provides a new means for studying the response of retinally stabilized images and demonstrates that penumbral cones can support spatial vision. Further, the result illustrates a way in which silent substitution techniques can fail to be silent. We show that inadvertent penumbral cone stimulation can accompany melanopsin-directed modulations that are designed only to silence open-field cones. This in turn can result in visual responses that might be mistaken as melanopsin-driven.	[Spitschan, Manuel; Brainard, David H.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; [Aguirre, Geoffrey K.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Aguirre, GK (corresponding author), Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA.	aguirreg@mail.med.upenn.edu; brainard@psych.upenn.edu		Spitschan, Manuel/0000-0002-8572-9268	National Institutes of Health [1 R01 EY020516, R01 EY10016, P30 EY001583]; Deutscher Akademischer Austauschdienst; NATIONAL EYE INSTITUTE [P30EY001583, R01EY020516, R01EY010016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grant 1 R01 EY020516 (GKA), R01 EY10016 (DHB), P30 EY001583 (Core Grant for Vision Research) and Deutscher Akademischer Austauschdienst (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DL, 2003, J NEUROSCI, V23, P5984, DOI 10.1523/JNEUROSCI.23-14-05984.2003; Adams DL, 2002, SCIENCE, V298, P572, DOI 10.1126/science.1074887; Adams DL, 2003, J NEUROSCI, V23, P3771; al Enezi J, 2011, J BIOL RHYTHM, V26, P314, DOI 10.1177/0748730411409719; Allefeld C, 2011, CONSCIOUS COGN, V20, P1344, DOI 10.1016/j.concog.2010.10.026; Allen AE, 2014, CURR BIOL, V24, P2481, DOI 10.1016/j.cub.2014.09.015; Applegate RA, 1997, INVEST OPHTH VIS SCI, V38, P783; APPLEGATE RA, 1990, INVEST OPHTH VIS SCI, V31, P2088; ASHTON N, 1957, AM J OPHTHALMOL, V44, P7, DOI 10.1016/0002-9394(57)90426-9; Atchison DA, 1997, CLIN EXPT OPTOMETRY, V80, P49, DOI [10.1111/j.1444-0938.1997.tb04850.x, DOI 10.1111/J.1444-0938.1997.TB04850.X]; Aubert H, 1865, PHYSIOLOGIE NETZHAUT; Bailes HJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2987; Barrionuevo PA, 2014, INVEST OPHTH VIS SCI, V55, P719, DOI 10.1167/iovs.13-13252; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; BIRD AC, 1974, EXP EYE RES, V19, P409, DOI 10.1016/0014-4835(74)90050-5; BOWEN SF, 1963, ARCH OPHTHALMOL-CHIC, V69, P551, DOI 10.1001/archopht.1963.00960040557003; Bradley A, 1998, VISION RES, V38, P2685, DOI 10.1016/S0042-6989(97)00345-3; Brainard D. H, 2010, OPTICAL SOC AM HDB O, VIII; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRODIE SE, 1987, INT OPHTHALMOL CLIN, V27, P153, DOI 10.1097/00004397-198702730-00004; BROWN CR, 1948, J EXP PSYCHOL, V38, P188, DOI 10.1037/h0054433; Brown TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053583; Brown TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000558; CIE, 2006, 1701 CIE CENTR BUR; COMBERG D, 1971, OPHTHALMOLOGICA, V162, P140, DOI 10.1159/000306255; Coppola D, 1996, P NATL ACAD SCI USA, V93, P8001, DOI 10.1073/pnas.93.15.8001; Cornsweet T., 1970, VISUAL PERCEPTION; Cornsweet TN, 1966, RECENT DEV VISION RE; Deeley RM, 1913, NATURE, V90, P594, DOI 10.1038/090594e0; Ditchburn RW, 1936, NATURE, V137, P661, DOI [10.1038/137661a0, DOI 10.1038/137661A0]; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; DONNER KO, 1959, J PHYSIOL-LONDON, V149, P288, DOI 10.1113/jphysiol.1959.sp006340; Drews LC, 1943, AM J OPHTHALMOL, V26, P1143, DOI [10.1016/s0002-9394(43)90490-8, DOI 10.1016/S0002-9394(43)90490-8]; Drews LC, 1941, AM J OPHTHALMOL, V24, P1403, DOI [10.1016/s0002-9394(14)77452-5, DOI 10.1016/S0002-9394(14)77452-5]; DRYSDALE AE, 1975, VISION RES, V15, P813, DOI 10.1016/0042-6989(75)90259-X; Eber SI, 1922, AM J OPHTHALMOL, V5, P973, DOI [10.1016/s0002-9394(22)90950-x, DOI 10.1016/S0002-9394(22)90950-X]; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; EHRICH W, 1958, Klin Monbl Augenheilkd Augenarztl Fortbild, V133, P396; EHRICH W, 1961, Doc Ophthalmol, V15, P371, DOI 10.1007/BF00234354; Ehrich W, 1961, MED KLIN, V54, P31; ESTEVEZ O, 1982, VISION RES, V22, P681, DOI 10.1016/0042-6989(82)90104-3; Exner S, 1868, ARCH PHYSL, V1, P375, DOI [10.1007/bf01640325, DOI 10.1007/BF01640325]; Exner S, 1884, SITZUNGSBERICHTE MN, V88, P103; Feigl B, 2014, OPTOMETRY VISION SCI, V91, P894, DOI 10.1097/OPX.0000000000000284; Feigl B, 2012, ACTA OPHTHALMOL, V90, pe230, DOI 10.1111/j.1755-3768.2011.02226.x; Friedman B, 1931, ARCH OPHTHALMOL-CHIC, V5, P636, DOI [10.1001/archopht.1931.00820040132010, DOI 10.1001/ARCHOPHT.1931.00820040132010]; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Goebel K, 1922, ARCH AUGENHEILKD, V90, P245, DOI [10.1055/s-0033-1360260, DOI 10.1055/S-0033-1360260]; GOLDMANN H, 1972, AM J OPHTHALMOL, V73, P309; Gooley JJ, 2012, J NEUROSCI, V32, P14242, DOI 10.1523/JNEUROSCI.1321-12.2012; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Gudden B, 1849, ARCH ANAT PHYSL WISS, P522; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Hilmantel G, 1999, OPTOMETRY VISION SCI, V76, P826, DOI 10.1097/00006324-199912000-00017; Horiguchi H, 2013, P NATL ACAD SCI USA, V110, pE260, DOI 10.1073/pnas.1214240110; Ishihara S., 1977, TESTS COLOUR BLINDNE; ISO, 2007, 150042 ISO, DOI [10.1097/HP.0b013e3181f4993d.Retinal, DOI 10.1097/HP.0B013E3181F4993D.RETINAL]; Kahn RH, 1908, FARBIGE SCHATTEN NET, V56, P1; Kaiser P.K, 1996, HUMAN COLOR VISION; Kankipati L, 2010, INVEST OPHTH VIS SCI, V51, P2764, DOI 10.1167/iovs.09-4717; Kardon R, 2009, OPHTHALMOLOGY, V116, P1564, DOI 10.1016/j.ophtha.2009.02.007; KELLY D H, 1964, Doc Ophthalmol, V18, P16, DOI 10.1007/BF00160561; KELLY DH, 1979, J OPT SOC AM, V69, P1340, DOI 10.1364/JOSA.69.001340; KLUXEN G, 1987, DIABETES CARE, V10, P800, DOI 10.2337/diacare.10.6.800; Kolb H., 1995, WEBVISION ORG RETINA; KRAUPA E, 1949, OPHTHALMOLOGICA, V118, P318, DOI 10.1159/000300734; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 2014, TRENDS NEUROSCI, V37, P1, DOI 10.1016/j.tins.2013.10.004; M_uller H., 1854, VERHANDLUNGEN PHYSIK, V4, P96; Martin PR, 2014, VISUAL NEUROSCI, V31, P177, DOI 10.1017/S0952523813000631; McDougal DH, 2010, VISION RES, V50, P72, DOI 10.1016/j.visres.2009.10.012; Muller H., 1855, VERHANDLUNGEN PHYSIK, V5, P411; Murillo-Lopez F, 2000, J CATARACT REFR SURG, V26, P260, DOI 10.1016/S0886-3350(99)00341-7; Noseda R, 2011, CURR OPIN NEUROL, V24, P197, DOI 10.1097/WCO.0b013e3283466c8e; Pagenstecher AH, 1903, Z AUGENHEILD, V10, P206, DOI [10.1107/S0108767309007235, DOI 10.1107/S0108767309007235]; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Prahl  S., 1999, OPTICAL ABSORPTION H; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Purkinje J., 1825, NEUE BEITRAGE KENNTN, V2; Purkinje JE, 1819, BEOBACHTUNGEN VERSUC; REMOLE A, 1971, J OPT SOC AM, V61, P1164, DOI 10.1364/JOSA.61.001164; Roecklein K, 2013, PSYCHIAT RES, V210, P150, DOI 10.1016/j.psychres.2013.05.023; Rood ON, 1860, AM J SCI ARTS, V30, P264; RUSHTON WAH, 1968, VISION RES, V8, P617, DOI 10.1016/0042-6989(68)90040-0; Scheerer R, 1924, KLIN MONATSBL AUGENH, V73, P67; SHARPE CR, 1972, J PHYSIOL-LONDON, V222, P113, DOI 10.1113/jphysiol.1972.sp009790; Smithson HE, 2014, VISUAL NEUROSCI, V31, P211, DOI 10.1017/S0952523814000030; SMYTHIES JR, 1957, NATURE, V179, P523, DOI 10.1038/179523a0; SNODDERLY DM, 1992, J NEUROSCI, V12, P1169; Spitschan M, 2014, P NATL ACAD SCI USA, V111, P15568, DOI 10.1073/pnas.1400942111; Steinbuch W, 1813, JB TSCH MD CHIR, V3, P270; Stigler R, 1905, Z PSYCHOL PHYSIOL SI, V39, P332; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; Suzuki R, 1941, NIPPON GANKA GAKKAI, V45, P590; TALBOT EM, 1992, EYE, V6, P322, DOI 10.1038/eye.1992.64; Tsujimura S, 2011, OPHTHAL PHYSL OPT, V31, P469, DOI 10.1111/j.1475-1313.2011.00846.x; Tsujimura S, 2010, P ROY SOC B-BIOL SCI, V277, P2485, DOI 10.1098/rspb.2010.0330; Vienot F, 2014, J OPT SOC AM A, V31, pA38, DOI 10.1364/JOSAA.31.000A38; Vienot F, 2012, J OPT SOC AM A, V29, pA366, DOI 10.1364/JOSAA.29.00A366; Vienot F, 2010, OPHTHAL PHYSL OPT, V30, P484, DOI 10.1111/j.1475-1313.2010.00754.x; Vierodt K, 1856, ARCH PHYSL HEILK, V15, P255, DOI [10.1055/s-0033-1360260, DOI 10.1055/S-0033-1360260]; von Helmholtz H., 1867, HDB PHYSL OPTIK, VVol. 9, DOI 10.1007/BF01708548; von Thomsen E, 1919, SKANDINAVISCHES ARCH, V37, P1, DOI [10.1111/j.1748-1716.1919.tb00120.x, DOI 10.1111/J.1748-1716.1919.TB00120.X]; von Zehender W, 1895, KLIN MONATSBL AUGENH, V33, P112; Wade N. J., 2001, PURKINJES VISION DAW; Walker CB, 1940, AM J OPHTHALMOL, V23, P803, DOI [10.1016/S0002-9394(40)92383-2, DOI 10.1016/S0002-9394(40)92383-2]; Watson AB, 2012, J VISION, V12, DOI 10.1167/12.10.12; WEBSTER MA, 1988, J OPT SOC AM A, V5, P1722, DOI 10.1364/JOSAA.5.001722; WYATT HJ, 1978, VISION RES, V18, P875, DOI 10.1016/0042-6989(78)90133-5; Xu J, 1997, J OPT SOC AM A, V14, P953, DOI 10.1364/JOSAA.14.000953; YOUNG RSL, 1975, VISION RES, V15, P1291, DOI 10.1016/0042-6989(75)90177-7	115	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124328	10.1371/journal.pone.0124328	http://dx.doi.org/10.1371/journal.pone.0124328			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897842	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600063
J	Lindova, J; Spinka, M; Novakova, L				Lindova, Jitka; Spinka, Marek; Novakova, Lenka			Decoding of Baby Calls: Can Adult Humans Identify the Eliciting Situation from Emotional Vocalizations of Preverbal Infants?	PLOS ONE			English	Article							MOTIVATION-STRUCTURAL RULES; DISTRESS VOCALIZATIONS; MAMMAL SOUNDS; PERCEPTION; MOTHERS; CRIES; CRY; RESPONSIVENESS; EXPRESSION; EXPERIENCE	Preverbal infants often vocalize in emotionally loaded situations, yet the communicative potential of these vocalizations is not well understood. The aim of our study was to assess how accurately adult listeners extract information about the eliciting situation from infant preverbal vocalizations. Vocalizations of 19 infants aged 5-10 months were recorded in 3 negative (Pain, Isolation, Demand for Food) and 3 positive (Play, Reunion, After Feeding) situations. The recordings were later rated by 333 adult listeners on the scales of emotional valence and intensity. Subsequently, the listeners assigned the eliciting situations in a forced choice task. Listeners were almost perfectly able to discriminate whether a recording came from a negative or a positive situation. Their discrimination may have been based on perceived valence as they consistently assigned higher valence when listening to positive, and lower valence when listening to negative, recordings. Ability to identify the particular situation within the negative or positive realm was substantially weaker, with only three of the six situations being discriminated above chance. The best discriminated situation, Play, was associated with high perceived intensity. The weak qualitative discrimination of negative situations seemed to be based on graded perception of negative recordings, from the most intense and unpleasant (assigned to Pain) to the least intense and least unpleasant (assigned to Demand for Food). Parenthood and younger age, but not gender of listeners, had weak positive effects on the accuracy of judgments. Our results indicate that adults almost flawlessly distinguish positive and negative infant sounds, but are rather inaccurate regarding identification of the specific needs of the infant and may normally employ other sensory channels to gain this information.	[Lindova, Jitka; Novakova, Lenka] Charles Univ Prague, Fac Humanities, Prague, Czech Republic; [Lindova, Jitka; Novakova, Lenka] Natl Inst Mental Hlth, Klecany, Czech Republic; [Spinka, Marek] Inst Anim Sci, Dept Ethol, Prague, Czech Republic	Charles University Prague; National Institute of Mental Health - Czech Republic; Czech Research Institute of Animal Science	Lindova, J (corresponding author), Charles Univ Prague, Fac Humanities, Prague, Czech Republic.	jitka.lindova@seznam.cz	Lindová, Jitka/T-3756-2017; Lindová, Jitka/AAL-6658-2021; Martinec Nováková, Lenka/F-6474-2015; Spinka, Marek/E-2395-2011	Lindová, Jitka/0000-0001-8846-4552; Lindová, Jitka/0000-0001-8846-4552; Martinec Nováková, Lenka/0000-0002-5695-2903; Spinka, Marek/0000-0002-2506-9552	Charles University in Prague, Faculty of Humanities [UNCE204004]; Ministry of Education, Youth and Sports - Institutional Support for Longterm Development of Research Organizations Charles University, Faculty of Humanities; Czech Grant Agency [14-27925S]; Czech Ministry of Agriculture [MZERO0714]	Charles University in Prague, Faculty of Humanities; Ministry of Education, Youth and Sports - Institutional Support for Longterm Development of Research Organizations Charles University, Faculty of Humanities; Czech Grant Agency(Grant Agency of the Czech Republic); Czech Ministry of Agriculture(Ministry of Agriculture, Czech Republic)	This publication is the outcome of the project UNCE204004 realized at the Charles University in Prague, Faculty of Humanities (JL, LMN). It was also supported by the Ministry of Education, Youth and Sports - Institutional Support for Longterm Development of Research Organizations Charles University, Faculty of Humanities (JL, LMN). MS was supported by the grant 14-27925S from the Czech Grant Agency and MZERO0714 from the Czech Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUGUST PV, 1987, J MAMMAL, V68, P1, DOI 10.2307/1381039; Belin P, 2008, P ROY SOC B-BIOL SCI, V275, P473, DOI 10.1098/rspb.2007.1460; Briefer EF, 2012, J ZOOL, V288, P1, DOI 10.1111/j.1469-7998.2012.00920.x; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Dessureau BK, 1998, INFANT BEHAV DEV, V21, P367, DOI 10.1016/S0163-6383(98)90013-3; Farago T, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0926; Farago T, 2010, ANIM BEHAV, V79, P917, DOI 10.1016/j.anbehav.2010.01.005; Gogoleva SS, 2010, BEHAVIOUR, V147, P1713, DOI 10.1163/000579510X528242; Gros-Louis J, 2006, INT J BEHAV DEV, V30, P509, DOI 10.1177/0165025406071914; Gros-Louis J, 2014, INFANCY, V19, P385, DOI 10.1111/infa.12054; GUSTAFSON GE, 1989, CHILD DEV, V60, P772, DOI 10.1111/j.1467-8624.1989.tb03508.x; GUSTAFSON GE, 1990, DEV PSYCHOL, V26, P144, DOI 10.1037/0012-1649.26.1.144; Gustafsson E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2713; HOLDEN GW, 1988, CHILD DEV, V59, P1623; Hollen LI, 2007, AM NAT, V169, P758, DOI 10.1086/516719; KELLER H, 1987, DEV PSYCHOL, V23, P62, DOI 10.1037/0012-1649.23.1.62; Leger DW, 1996, CHILD DEV, V67, P3238, DOI 10.1111/j.1467-8624.1996.tb01911.x; Lingle S, 2014, AM NAT, V184, P510, DOI 10.1086/677677; Lingle S, 2012, CURR ZOOL, V58, P698, DOI 10.1093/czoolo/58.5.698; Maruscakova IL, 2015, J COMP PSYCHOL; McCathren RB, 1999, J SPEECH LANG HEAR R, V42, P915, DOI 10.1044/jslhr.4204.915; Mendl M, 2010, P ROY SOC B-BIOL SCI, V277, P2895, DOI 10.1098/rspb.2010.0303; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; Muller E, 1973, J CHILD LANG, V1, P89; MURRAY AD, 1979, PSYCHOL BULL, V86, P191, DOI 10.1037/0033-2909.86.1.191; PAPOUSEK M, 1989, INFANT BEHAV DEV, V12, P507, DOI 10.1016/0163-6383(89)90030-1; Papousek M., 1992, STUDIES EMOTION SOCI, P230; Parsons CE, 2012, ACTA PAEDIATR, V101, pE189, DOI 10.1111/j.1651-2227.2011.02554.x; Reilly S, 2006, J PAEDIATR CHILD H, V42, P764, DOI 10.1111/j.1440-1754.2006.00974.x; Ricks DM, 1979, SPEECH BEGINNING INT, P245; Sanchez SM, 2014, ANIM BEHAV, V97, P95, DOI 10.1016/j.anbehav.2014.09.002; Scheiner E, 2002, J VOICE, V16, P509, DOI 10.1016/S0892-1997(02)00127-3; Scheiner E, 2011, INTERDISCIPLINARY AN, P105; Stark R. E., 1980, CHILD PHONOLOGY, V1, P73, DOI DOI 10.1016/B978-0-12-770601-6.50010-3; Tallet C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071841; Tallet C, 2010, J COMP PSYCHOL, V124, P81, DOI 10.1037/a0017354; Wasz- Hockert O, 1964, DEV MED CHILD NEUROL, V6, P397; WIESENFELD AR, 1981, INFANT BEHAV DEV, V4, P281, DOI 10.1016/S0163-6383(81)80030-6; Wolff PH., 1969, DETERMINATS INFANT B, V1, P81; Zeifman DM, 2001, DEV PSYCHOBIOL, V39, P265, DOI 10.1002/dev.1005; ZESKIND PS, 1988, CHILD DEV, V59, P193	41	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124317	10.1371/journal.pone.0124317	http://dx.doi.org/10.1371/journal.pone.0124317			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XA	25894513	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700086
J	Konrad, FM; Bury, A; Schick, MA; Ngamsri, KC; Reutershan, J				Konrad, Franziska M.; Bury, Annette; Schick, Martin A.; Ngamsri, Kristian-Christos; Reutershan, Joerg			The Unrecognized Effects of Phosphodiesterase 4 on Epithelial Cells in Pulmonary Inflammation	PLOS ONE			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; PDE4 INHIBITOR ROFLUMILAST; GRO-ALPHA; MICE; EXPRESSION; ROLIPRAM; DISEASE; 4D; INFILTRATION	Acute pulmonary inflammation is characterized by migration of polymorphonuclear neutrophils (PMNs) into the different compartments of the lung, passing an endothelial and epithelial barrier. Recent studies showed evidence that phosphodiesterase (PDE) 4-inhibitors stabilized endothelial cells. PDE4B and PDE4D subtypes play a pivotal role in inflammation, whereas blocking PDE4D is suspected to cause gastrointestinal side effects. We thought to investigate the particular role of the PDE4-inhibitors roflumilast and rolipram on lung epithelium. Acute pulmonary inflammation was induced by inhalation of LPS. PDE4-inhibitors were administered i.p. or nebulized after inflammation. The impact of PDE4-inhibitors on PMN migration was evaluated in vivo and in vitro. Microvascular permeability, cytokine levels, and PDE4B and PDE4D expression were analyzed. In vivo, both PDE4-inhibitors decreased transendothelial and transepithelial migration even when administered after inflammation, whereas roflumilast showed a superior effect compared to rolipram on the epithelium. Both inhibitors decreased TNF beta, IL6, and CXCL2/3. CXCL1, the strong PMN chemoattractant secreted by the epithelium, was significantly more reduced by roflumilast. In vitro assays with human epithelium also emphasized the pivotal role of roflumilast on the epithelium. Additionally, LPS-induced stress fibers, an essential requirement for a direct migration of PMNs into the alveolar space, were predominantly reduced by roflumilast. Expression of PDE4B and PDE4D were both increased in the lungs by LPS, PDE4-inhibitors decreased mainly PDE4B. The topical administration of PDE4-inhibitors was also effective in curbing down PMN migration, further highlighting the clinical potential of these compounds. In pulmonary epithelial cells, both subtypes were found coexistent around the nucleus and the cytoplasm. In these epithelial cells, LPS increased PDE4B and, to a lesser extend, PDE4D, whereas the effect of the inhibitors was prominent on the PDE4B subtype. In conclusion, we determined the pivotal role of the PDE4-inhibitor roflumilast on lung epithelium and emphasized its main effect on PDE4B in hyperinflammation.	[Konrad, Franziska M.; Bury, Annette; Ngamsri, Kristian-Christos; Reutershan, Joerg] Univ Tubingen Hosp, Dept Anesthesiol & Intens Care Med, Tubingen, Germany; [Schick, Martin A.] Univ Hosp Wurzburg, Dept Anesthesiol & Intens Care Med, Wurzburg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Wurzburg	Reutershan, J (corresponding author), Univ Tubingen Hosp, Dept Anesthesiol & Intens Care Med, Tubingen, Germany.	joerg.reutershan@uni-tuebingen.de	Schick, Martin/ABH-6971-2020		German Research Foundation [RE 1683/4-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by German Research Foundation Grant RE 1683/4-1 (to J. Reutershan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariga M, 2004, J IMMUNOL, V173, P7531, DOI 10.4049/jimmunol.173.12.7531; Atkins CM, 2013, NEUROSCI LETT, V532, P1, DOI 10.1016/j.neulet.2012.10.019; BECKER S, 1994, AM J PHYSIOL, V266, pL278, DOI 10.1152/ajplung.1994.266.3.L278; Giembycz MA, 2010, DRUG DES DEV THER, V4, P147; Gobejishvili L, 2013, J PHARMACOL EXP THER, V347, P80, DOI 10.1124/jpet.113.204933; Hatzelmann A, 2001, J PHARMACOL EXP THER, V297, P267; Houslay MD, 1998, ADV PHARMACOL, V44, P225, DOI 10.1016/S1054-3589(08)60128-3; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Jin S-L Catherine, 2012, Chang Gung Med J, V35, P197; Jin SLC, 2005, J IMMUNOL, V175, P1523, DOI 10.4049/jimmunol.175.3.1523; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; Komatsu K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2674; Konrad FM, 2013, FASEB J, V27, P3524, DOI 10.1096/fj.13-228122; Konrad FM, 2012, AM J PHYSIOL-LUNG C, V303, pL425, DOI 10.1152/ajplung.00387.2011; Kranz M, 2009, BIOORGAN MED CHEM, V17, P5336, DOI 10.1016/j.bmc.2009.03.061; Lipworth BJ, 2005, LANCET, V365, P167, DOI 10.1016/S0140-6736(05)17708-3; Mamiya T, 2001, BRIT J PHARMACOL, V132, P1111, DOI 10.1038/sj.bjp.0703912; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Michalski JM, 2012, CLIN PHARMACOL THER, V91, P134, DOI 10.1038/clpt.2011.266; Moodley T, 2013, MOL PHARMACOL, V83, P894, DOI 10.1124/mol.112.083493; MORGAN AJ, 1993, BIOCHEM PHARMACOL, V45, P2373, DOI 10.1016/0006-2952(93)90216-J; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Page CP, 2012, CURR OPIN PHARMACOL, V12, P275, DOI 10.1016/j.coph.2012.02.016; Razavi HM, 2004, AM J RESP CRIT CARE, V170, P227, DOI 10.1164/rccm.200306-846OC; Rennard SI, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-18; Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004; Reutershan J, 2006, J CLIN INVEST, V116, P695, DOI 10.1172/JCI27009; Reutershan J, 2007, AM J RESP CRIT CARE, V175, P1027, DOI 10.1164/rccm.200612-1822OC; Robichaud A, 2002, J CLIN INVEST, V110, P1045, DOI 10.1172/JCI200215506; Sanz MJ, 2007, BRIT J PHARMACOL, V152, P481, DOI 10.1038/sj.bjp.0707428; Schick MA, 2012, J PHYSIOL-LONDON, V590, P2693, DOI 10.1113/jphysiol.2012.232116; Schmal H, 1996, J IMMUNOL, V156, P1963; SCHUMACHER C, 1992, P NATL ACAD SCI USA, V89, P10542, DOI 10.1073/pnas.89.21.10542; Suzuki O, 2013, J PHARMACOL SCI, V123, P219, DOI 10.1254/jphs.13103FP; Tang HF, 2010, INT IMMUNOPHARMACOL, V10, P406, DOI 10.1016/j.intimp.2010.01.003; Williams AE, 2014, AM J PHYSIOL-LUNG C, V306, pL217, DOI 10.1152/ajplung.00311.2013; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014525; Zimmerman NP, 2012, INFLAMM BOWEL DIS, V18, P1081, DOI 10.1002/ibd.21898	39	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0121725	10.1371/journal.pone.0121725	http://dx.doi.org/10.1371/journal.pone.0121725			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909327	Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800012
J	Negassa, WC; Guber, AK; Kravchenko, AN; Marsh, TL; Hildebrandt, B; Rivers, ML				Negassa, Wakene C.; Guber, Andrey K.; Kravchenko, Alexandra N.; Marsh, Terence L.; Hildebrandt, Britton; Rivers, Mark L.			Properties of Soil Pore Space Regulate Pathways of Plant Residue Decomposition and Community Structure of Associated Bacteria	PLOS ONE			English	Article							RAY COMPUTED-TOMOGRAPHY; ORGANIC-MATTER; NITROGEN MINERALIZATION; MICROBIAL COMMUNITIES; SPATIAL-DISTRIBUTION; CARBON MINERALIZATION; IMAGE-ANALYSIS; AGGREGATE; DYNAMICS; MECHANISMS	Physical protection of soil carbon (C) is one of the important components of C storage. However, its exact mechanisms are still not sufficiently lucid. The goal of this study was to explore the influence of soil structure, that is, soil pore spatial arrangements, with and without presence of plant residue on (i) decomposition of added plant residue, (ii) CO2 emission from soil, and (iii) structure of soil bacterial communities. The study consisted of several soil incubation experiments with samples of contrasting pore characteristics with/without plant residue, accompanied by X-ray micro-tomographic analyses of soil pores and by microbial community analysis of amplified 16S-18S rRNA genes via pyrosequencing. We observed that in the samples with substantial presence of air-filled well-connected large (>30 mu m) pores, 75-80% of the added plant residue was decomposed, cumulative CO2 emission constituted 1,200 mu m C g(-1) soil, and movement of C from decomposing plant residue into adjacent soil was insignificant. In the samples with greater abundance of water-filled small pores, 60% of the added plant residue was decomposed, cumulative CO2 emission constituted 2,000 mu m C g(-1) soil, and the movement of residue C into adjacent soil was substantial. In the absence of plant residue the influence of pore characteristics on CO2 emission, that is on decomposition of the native soil organic C, was negligible. The microbial communities on the plant residue in the samples with large pores had more microbial groups known to be cellulose decomposers, that is, Bacteroidetes, Proteobacteria, Actinobacteria, and Firmicutes, while a number of oligotrophic Acidobacteria groups were more abundant on the plant residue from the samples with small pores. This study provides the first experimental evidence that characteristics of soil pores and their air/water flow status determine the phylogenetic composition of the local microbial community and directions and magnitudes of soil C decomposition processes.	[Negassa, Wakene C.] Inst Adv Sustainabil Studies, IASS Global Soil Forum, Potsdam, Germany; [Guber, Andrey K.; Kravchenko, Alexandra N.] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Marsh, Terence L.; Hildebrandt, Britton] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI USA; [Rivers, Mark L.] Univ Chicago, Argonne Natl Lab, Ctr Adv Radiat Sources, Argonne, IL USA	Michigan State University; Michigan State University; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago	Kravchenko, AN (corresponding author), Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA.	kravche1@msu.edu	Negassa, Wakene/J-9445-2019; Guber, Andrey/AAP-3576-2021	Negassa, Wakene/0000-0001-8629-8239; Marsh, Terence/0000-0002-7015-975X	United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) award [2011-68002-301907]; U.S. National Science Foundation Long-Term Ecological Research (LTER) Program at the Kellogg Biological Station [DEB 1027253]; Kellogg Biological Station; Michigan State University's "Project GREEEN" Program; Michigan State University's "Discretionary Fund Initiative" Program; Division Of Environmental Biology [1027253] Funding Source: National Science Foundation	United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) award; U.S. National Science Foundation Long-Term Ecological Research (LTER) Program at the Kellogg Biological Station(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Kellogg Biological Station; Michigan State University's "Project GREEEN" Program; Michigan State University's "Discretionary Fund Initiative" Program; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support for this research was provided in parts by the United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) award No. 2011-68002-301907 cropping systems Coordinated Agricultural Project (CAP); by the U.S. National Science Foundation Long-Term Ecological Research (LTER) Program at the Kellogg Biological Station (DEB 1027253); by Kellogg Biological Station; by Michigan State University's "Project GREEEN" Program; and by Michigan State University's "Discretionary Fund Initiative" Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADU JK, 1978, SOIL BIOL BIOCHEM, V10, P109, DOI 10.1016/0038-0717(78)90080-9; Ananyeva K, 2013, SOIL BIOL BIOCHEM, V57, P868, DOI 10.1016/j.soilbio.2012.10.019; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Baldock Jeffrey A., 2007, V10, P1; Bastian F, 2009, SOIL BIOL BIOCHEM, V41, P262, DOI 10.1016/j.soilbio.2008.10.024; Bertrand I, 2007, SOIL BIOL BIOCHEM, V39, P276, DOI 10.1016/j.soilbio.2006.07.016; Blagodatskaya EV, 2009, EUR J SOIL SCI, V60, P186, DOI 10.1111/j.1365-2389.2008.01103.x; CAMBARDELLA CA, 1992, SOIL SCI SOC AM J, V56, P777, DOI 10.2136/sssaj1992.03615995005600030017x; Chenu C, 2001, BIOL FERT SOILS, V34, P349, DOI 10.1007/s003740100419; Christensen BT, 2001, EUR J SOIL SCI, V52, P345, DOI 10.1046/j.1365-2389.2001.00417.x; Conant RT, 2007, SOIL TILL RES, V95, P1, DOI 10.1016/j.still.2006.12.006; Crum JR, 1995, KELLOGG BIOL STATION; CURRIE JA, 1984, J SOIL SCI, V35, P1, DOI 10.1111/j.1365-2389.1984.tb00253.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; De Gryze S, 2006, GEODERMA, V134, P82, DOI 10.1016/j.geoderma.2005.09.002; De Neve S, 2000, BIOL FERT SOILS, V30, P544, DOI 10.1007/s003740050034; De Troyer I, 2011, SOIL BIOL BIOCHEM, V43, P513, DOI 10.1016/j.soilbio.2010.11.016; Dechesne A, 2003, SOIL BIOL BIOCHEM, V35, P1537, DOI 10.1016/S0038-0717(03)00243-8; Dechesne A, 2008, FEMS MICROBIOL ECOL, V64, P1, DOI 10.1111/j.1574-6941.2008.00446.x; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Dungait JAJ, 2012, GLOBAL CHANGE BIOL, V18, P1781, DOI 10.1111/j.1365-2486.2012.02665.x; Espana M, 2011, PEDOBIOLOGIA, V54, P187, DOI 10.1016/j.pedobi.2011.03.001; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Fan FL, 2014, SOIL BIOL BIOCHEM, V70, P12, DOI 10.1016/j.soilbio.2013.12.002; Feeney DS, 2006, MICROB ECOL, V52, P151, DOI 10.1007/s00248-006-9062-8; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Flavel RJ, 2012, J EXP BOT, V63, P2503, DOI 10.1093/jxb/err421; Fontaine S, 2003, SOIL BIOL BIOCHEM, V35, P837, DOI 10.1016/S0038-0717(03)00123-8; Gaillard V, 2003, SOIL BIOL BIOCHEM, V35, P93, DOI 10.1016/S0038-0717(02)00241-9; Gaillard V, 1999, EUR J SOIL SCI, V50, P567, DOI 10.1046/j.1365-2389.1999.00266.x; Guenet B, 2010, ECOLOGY, V91, P2850, DOI 10.1890/09-1968.1; Haling RE, 2013, PLANT SOIL, V372, P619, DOI 10.1007/s11104-013-1777-y; HASSINK J, 1992, BIOL FERT SOILS, V14, P126, DOI 10.1007/BF00336262; Helliwell JR, 2014, SOIL BIOL BIOCHEM, V74, P138, DOI 10.1016/j.soilbio.2014.03.009; Jastrow JD, 1996, SOIL SCI SOC AM J, V60, P801, DOI 10.2136/sssaj1996.03615995006000030017x; Jastrow JD, 2007, CLIMATIC CHANGE, V80, P5, DOI 10.1007/s10584-006-9178-3; Juarez S, 2013, EUR J SOIL BIOL, V58, P81, DOI 10.1016/j.ejsobi.2013.06.005; Juarez S, 2013, BIOL FERT SOILS, V49, P939, DOI 10.1007/s00374-013-0784-8; Kravchenko AN, 2014, SOIL SCI SOC AM J, V78, P1177, DOI 10.2136/sssaj2014.01.0039; Kravchenko AN, 2011, SOIL SCI SOC AM J, V75, P1658, DOI 10.2136/sssaj2011.0096; Kravchenko A, 2011, ECOL APPL, V21, P1202, DOI 10.1890/10-0525.1; Kravchenko AN, 2014, SOIL SCI SOC AM J, V78, P1924, DOI 10.2136/sssaj2014.07.0308; Krull ES, 2003, FUNCT PLANT BIOL, V30, P207, DOI 10.1071/FP02085; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; LADD JN, 1993, GEODERMA, V56, P401, DOI 10.1016/0016-7061(93)90124-4; Lal R, 2008, PHILOS T R SOC B, V363, P815, DOI 10.1098/rstb.2007.2185; Lindquist WB, 2000, J GEOPHYS RES-SOL EA, V105, P21509, DOI 10.1029/2000JB900208; McMahon SK, 2005, SOIL SCI SOC AM J, V69, P1238, DOI 10.2136/sssaj2004.0289; Moldrup P, 2001, SOIL SCI SOC AM J, V65, P613, DOI 10.2136/sssaj2001.653613x; Mooney SJ, 2012, PLANT SOIL, V352, P1, DOI 10.1007/s11104-011-1039-9; Mooney SJ, 2008, CATENA, V73, P204, DOI 10.1016/j.catena.2007.09.003; Moyano FE, 2013, SOIL BIOL BIOCHEM, V59, P72, DOI 10.1016/j.soilbio.2013.01.002; Nunan N, 2003, FEMS MICROBIOL ECOL, V44, P203, DOI 10.1016/S0168-6496(03)00027-8; Oh W, 1999, IEEE T PATTERN ANAL, V21, P590, DOI 10.1109/34.777370; Or D, 2007, ADV WATER RESOUR, V30, P1505, DOI 10.1016/j.advwatres.2006.05.025; Pascault N, 2013, ECOSYSTEMS, V16, P810, DOI 10.1007/s10021-013-9650-7; Peth S., 2010, DEV SOIL SCI, V34, P73, DOI [10.1016/S0166-2481(10)34003-7, DOI 10.1016/S0166-2481(10)34003-7]; Potthoff M, 2005, SOIL BIOL BIOCHEM, V37, P1259, DOI 10.1016/j.soilbio.2004.11.022; POWLSON DS, 1980, J SOIL SCI, V31, P77, DOI 10.1111/j.1365-2389.1980.tb02066.x; Quinn GP, 2001, EXPT DESIGN DATA ANA; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Rasband W.S., 1997, IMAGEJ; Resurreccion AC, 2010, SOIL SCI SOC AM J, V74, P481, DOI 10.2136/sssaj2009.0055; Rivers ML, 2006, SPIE, VJ3180, DOI [10.1007/s00259-013-2614-5, DOI 10.1007/S00259-013-2614-5]; Rivers ML, 2012, P SOC PHOTO-OPT INS, V8505; Ruamps LS, 2013, FEMS MICROBIOL ECOL, V86, P26, DOI 10.1111/1574-6941.12078; Ruamps LS, 2011, SOIL BIOL BIOCHEM, V43, P280, DOI 10.1016/j.soilbio.2010.10.010; Salome C, 2010, GLOBAL CHANGE BIOL, V16, P416, DOI 10.1111/j.1365-2486.2009.01884.x; SAS Institute, 2009, SAS US GUID VERS 9 2; Schimel JP, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00348; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt B., 2007, IMAGEJ 3D VIEWER; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Semenov AV, 2012, SOIL BIOL BIOCHEM, V49, P88, DOI 10.1016/j.soilbio.2012.02.016; SEXSTONE AJ, 1985, SOIL SCI SOC AM J, V49, P645, DOI 10.2136/sssaj1985.03615995004900030024x; Six J, 2000, SOIL BIOL BIOCHEM, V32, P2099, DOI 10.1016/S0038-0717(00)00179-6; Six J, 1999, SOIL SCI SOC AM J, V63, P1350, DOI 10.2136/sssaj1999.6351350x; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; Sleutel S, 2008, COMPUT GEOSCI-UK, V34, P931, DOI 10.1016/j.cageo.2007.10.006; Stenger R, 2002, AUST J SOIL RES, V40, P149, DOI 10.1071/SR01003; Stoyan H, 2000, PLANT SOIL, V222, P203, DOI 10.1023/A:1004757405147; Strong DT, 2004, EUR J SOIL SCI, V55, P739, DOI 10.1111/j.1365-2389.2004.00639.x; Taina IA, 2008, CAN J SOIL SCI, V88, P1, DOI 10.4141/CJSS06027; Thomas G. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P475; Thomson BC, 2010, J MICROBIOL METH, V83, P69, DOI 10.1016/j.mimet.2010.07.021; TISDALL JM, 1982, J SOIL SCI, V33, P141, DOI 10.1111/j.1365-2389.1982.tb01755.x; Trumbore S, 2006, GLOBAL CHANGE BIOL, V12, P141, DOI 10.1111/j.1365-2486.2006.01067.x; von Lutzow M, 2006, EUR J SOIL SCI, V57, P426, DOI 10.1111/j.1365-2389.2006.00809.x; von Lutzow M, 2007, SOIL BIOL BIOCHEM, V39, P2183, DOI 10.1016/j.soilbio.2007.03.007; Wang W, 2012, SOIL SCI SOC AM J, V76, P1159, DOI 10.2136/sssaj2011.0281; Wang W, 2011, GEODERMA, V162, P231, DOI 10.1016/j.geoderma.2011.01.006	92	73	78	2	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123999	10.1371/journal.pone.0123999	http://dx.doi.org/10.1371/journal.pone.0123999			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909444	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800054
J	Stemmer, M; Thumberger, T; Keyer, MD; Wittbrodt, J; Mateo, JL				Stemmer, Manuel; Thumberger, Thomas; Keyer, Maria del Sol; Wittbrodt, Joachim; Mateo, Juan L.			CCTop: An Intuitive, Flexible and Reliable CRISPR/Cas9 Target Prediction Tool	PLOS ONE			English	Article							GENOME; ZEBRAFISH; MEDAKA; SYSTEM; ENDONUCLEASE; BACTERIA; GENE	Engineering of the CRISPR/Cas9 system has opened a plethora of new opportunities for site-directed mutagenesis and targeted genome modification. Fundamental to this is a stretch of twenty nucleotides at the 5' end of a guide RNA that provides specificity to the bound Cas9 endonuclease. Since a sequence of twenty nucleotides can occur multiple times in a given genome and some mismatches seem to be accepted by the CRISPR/Cas9 complex, an efficient and reliable in silico selection and evaluation of the targeting site is key prerequisite for the experimental success. Here we present the CRISPR/Cas9 target online predictor (CCTop, http://crispr.cos.uni-heidelberg.de) to overcome limitations of already available tools. CCTop provides an intuitive user interface with reasonable default parameters that can easily be tuned by the user. From a given query sequence, CCTop identifies and ranks all candidate sgRNA target sites according to their off-target quality and displays full documentation. CCTop was experimentally validated for gene inactivation, non-homologous end-joining as well as homology directed repair. Thus, CCTop provides the bench biologist with a tool for the rapid and efficient identification of high quality target sites.	[Stemmer, Manuel; Thumberger, Thomas; Keyer, Maria del Sol; Wittbrodt, Joachim; Mateo, Juan L.] Heidelberg Univ, COS, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Thumberger, T (corresponding author), Heidelberg Univ, COS, Heidelberg, Germany.	thomas.thumberger@cos.uni-heidelberg.de; jochen.wittbrodt@cos.uni-heidelberg.de; juan.mateo@cos.uni-heidelberg.de	Cerdan, Juan Luis Mateo/N-2550-2015; Thumberger, Thomas/P-7772-2019; Thumberger, Thomas/E-3823-2014; Wittbrodt, Joachim/D-4735-2014	Cerdan, Juan Luis Mateo/0000-0001-9902-6048; Thumberger, Thomas/0000-0001-8485-457X; Thumberger, Thomas/0000-0001-8485-457X; Wittbrodt, Joachim/0000-0001-8550-7377; Stemmer, Manuel/0000-0003-1607-3573	European Research Council; German Research Foundation (DFG) [SFB873]; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg; cluster of excellence CellNetworks	European Research Council(European Research Council (ERC)European Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg; cluster of excellence CellNetworks	TT received a Postdoctoral Fellowship of the cluster of excellence CellNetworks. The project was supported by the European Research Council (JW: ManISteC) and the German Research Foundation (DFG: SFB873, JW). The authors acknowledge the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansai S, 2014, BIOL OPEN, V3, P362, DOI 10.1242/bio.20148177; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Baena-Lopez L a., 2013, DEVELOPMENT; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Centanin L, 2011, CELL STEM CELL, V9, P553, DOI 10.1016/j.stem.2011.11.004; Chen CC, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt805; Cong L, 2013, MULTIPLEX GENOME ENG; Farboud B, 2015, DRAMATIC ENHANCEMENT; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kirchner SM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071030, 10.1371/journal.pone.0076117]; Koster R, 1997, DEVELOPMENT, V124, P3147; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Loosli F, 2001, DEVELOPMENT, V128, P4035; Mali P, 2013, SCIENCE; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Ota S, 2014, GENES CELLS, V19, P555, DOI 10.1111/gtc.12154; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Rembold M, 2006, SCIENCE, V313, P1130, DOI 10.1126/science.1127144; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shin J, 2014, DEVELOPMENT, V141, P3807, DOI 10.1242/dev.108019; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Vopalensky P, 2010, BIOTECHNIQUES, V48, P235, DOI 10.2144/000113368; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Yoshinari N, 2012, DEV GROWTH DIFFER, V54, P818, DOI 10.1111/dgd.12013; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200	36	484	502	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124633	10.1371/journal.pone.0124633	http://dx.doi.org/10.1371/journal.pone.0124633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909470	Green Published, gold			2022-12-27	WOS:000353376800095
J	Duarte, A; Queiroz, ATL; Tosta, R; Carvalho, AM; Barbosa, CH; Bellio, M; de Oliveira, CI; Barral-Netto, M				Duarte, Angelo; Queiroz, Artur T. L.; Tosta, Rafael; Carvalho, Augusto M.; Barbosa, Carlos Henrique; Bellio, Maria; de Oliveira, Camila I.; Barral-Netto, Manoel			Prediction of CD8(+) Epitopes in Leishmania braziliensis Proteins Using EPIBOT: In Silico Search and In Vivo Validation	PLOS ONE			English	Article							HUMAN CUTANEOUS LEISHMANIASIS; T-CELL RESPONSE; VACCINE CANDIDATES; BINDING PEPTIDES; INFECTION; NETWORKS; ANTIGENS; IMMUNITY; DATABASE; VIANNIA	Background Leishmaniasis is caused by intracellular Leishmania parasites that induce a T-cell mediated response associated with recognition of CD4(+) and CD8(+) T cell Line 1Lineepitopes. Identification of CD8(+) antigenic determinants is crucial for vaccine and therapy development. Herein, we developed an open-source software dedicated to search and compile data obtained from currently available on line prediction algorithms. Methodology/Principal Findings We developed a two-phase algorithm and implemented in an open source software called EPIBOT, that consolidates the results obtained with single prediction algorithms, generating a final output in which epitopes are ranked. EPIBOT was initially trained using a set of 831 known epitopes from 397 proteins from IEDB. We then screened 63 Leishmania braziliensis vaccine candidates with the EPIBOT trained tool to search for CD8(+) T cell epitopes. A proof-of-concept experiment was conducted with the top eight CD8(+) epitopes, elected by EPIBOT. To do this, the elected peptides were synthesized and validated for their in vivo cytotoxicity. Among the tested epitopes, three were able to induce lysis of pulsed-target cells. Conclusion Our results show that EPIBOT can successfully search across existing prediction tools, generating a compiled list of candidate CD8(+) epitopes. This software is fast and a simple search engine that can be customized to search over different MHC alleles or HLA haplotypes.	[Duarte, Angelo; Tosta, Rafael] Univ Estadual Feira de Santana, Dept Tecnol, BR-44036900 Feira De Santana, BA, Brazil; [Queiroz, Artur T. L.; Carvalho, Augusto M.; de Oliveira, Camila I.; Barral-Netto, Manoel] CPqGM FIOCRUZ, BR-40296710 Salvador, BA, Brazil; [Barbosa, Carlos Henrique; Bellio, Maria] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Microbiol Paulo de Goes, BR-21941902 Rio de Janeiro, RJ, Brazil; [de Oliveira, Camila I.; Barral-Netto, Manoel] Inst Invest Imunol, Sao Paulo, Brazil	Universidade Estadual de Feira de Santana; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	de Oliveira, CI (corresponding author), CPqGM FIOCRUZ, R Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.	camila@bahia.fiocruz.br; mbarral@bahia.fiocruz.br	Bellio, Maria/N-8525-2018; Barral-Netto, Manoel/B-3904-2009; Queiroz, Artur/AAT-9330-2021; de Oliveira, Camila I/B-4358-2009	Bellio, Maria/0000-0002-3360-2740; Barral-Netto, Manoel/0000-0002-5823-7903; de Oliveira, Camila I/0000-0002-7868-5164	FAPESB (Fundacao de Amparo a Pesquisa da Bahia) [SUS0003/2009]	FAPESB (Fundacao de Amparo a Pesquisa da Bahia)	This work was supported with a grant from FAPESB (Fundacao de Amparo a Pesquisa da Bahia) (SUS0003/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agallou M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00268; Alvar J, 2013, VACCINE, V31, pB244, DOI 10.1016/j.vaccine.2012.11.080; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Brodskyn CI, 1997, J IMMUNOL, V159, P4467; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; CUENTAS EAL, 1984, T ROY SOC TROP MED H, V78, P845, DOI 10.1016/0035-9203(84)90043-9; Davies MN, 2007, DRUG DISCOV TODAY, V12, P389, DOI 10.1016/j.drudis.2007.03.010; de Moura TR, 2005, INFECT IMMUN, V73, P5827, DOI 10.1128/IAI.73.9.5827-5834.2005; Donnes P, 2006, NUCLEIC ACIDS RES, V34, pW194, DOI 10.1093/nar/gkl284; Guerfali FZ, 2009, INFECT GENET EVOL, V9, P344, DOI 10.1016/j.meegid.2008.02.011; Gurunathan S, 1997, J EXP MED, V186, P1137, DOI 10.1084/jem.186.7.1137; Harty JT, 2002, CURR OPIN IMMUNOL, V14, P360, DOI 10.1016/S0952-7915(02)00333-3; Herrera-Najera C, 2009, PROTEOMICS, V9, P1293, DOI 10.1002/pmic.200800533; Hughey R, 1996, COMPUT APPL BIOSCI, V12, P95; Jayakumar A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001204; Kronenberg K, 2010, J INVEST DERMATOL, V130, P2602, DOI 10.1038/jid.2010.171; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Maroof A, 2012, J INFECT DIS, V205, P853, DOI 10.1093/infdis/jir842; Costa CHN, 2011, PLOS NEGLECT TROP D, V5, DOI [10.1371/journal.pntd.0000965, 10.1371/journal.pntd.0000943]; Noben-Trauth N, 2003, J IMMUNOL, V170, P5152, DOI 10.4049/jimmunol.170.10.5152; Novais FO, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003504; Okwor I, 2009, HUM VACCINES, V5, P291, DOI 10.4161/hv.5.5.7607; PARKER KC, 1994, J IMMUNOL, V152, P163; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; PRESNELL SR, 1993, ANNU REV BIOPH BIOM, V22, P283, DOI 10.1146/annurev.bb.22.060193.001435; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Resende DM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-309; Salay G, 2007, CLIN VACCINE IMMUNOL, V14, P1173, DOI 10.1128/CVI.00060-07; Santos CDS, 2013, J INVEST DERMATOL, V133, P1533, DOI 10.1038/jid.2013.4; Seyed N, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001295; Tzelepis F, 2008, J IMMUNOL, V180, P1737, DOI 10.4049/jimmunol.180.3.1737; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004	33	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124786	10.1371/journal.pone.0124786	http://dx.doi.org/10.1371/journal.pone.0124786			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905908	Green Published, Green Submitted, gold			2022-12-27	WOS:000353332000089
J	Putranto, RA; Duan, CF; Kuswanhadi; Chaidamsari, T; Rio, M; Piyatrakul, P; Herlinawati, E; Pirrello, J; Dessailly, F; Leclercq, J; Bonnot, F; Tang, CR; Hu, SN; Montoro, P				Putranto, Riza-Arief; Duan, Cuifang; Kuswanhadi; Chaidamsari, Tetty; Rio, Maryannick; Piyatrakul, Piyanuch; Herlinawati, Eva; Pirrello, Julien; Dessailly, Florence; Leclercq, Julie; Bonnot, Francois; Tang, Chaorong; Hu, Songnian; Montoro, Pascal			Ethylene Response Factors Are Controlled by Multiple Harvesting Stresses in Hevea brasiliensis	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; RUBBER TREE; GENE-EXPRESSION; SOMATIC EMBRYOGENESIS; METHYL JASMONATE; LATEX YIELD; ARABIDOPSIS; FAMILY; COLD; IDENTIFICATION	Tolerance of recurrent mechanical wounding and exogenous ethylene is a feature of the rubber tree. Latex harvesting involves tapping of the tree bark and ethephon is applied to increase latex flow. Ethylene is an essential element in controlling latex production. The ethylene signalling pathway leads to the activation of Ethylene Response Factor (ERF) transcription factors. This family has been identified in Hevea brasiliensis. This study set out to understand the regulation of ERF genes during latex harvesting in relation to abiotic stress and hormonal treatments. Analyses of the relative transcript abundance were carried out for 35 HbERF genes in latex, in bark from mature trees and in leaves from juvenile plants under multiple abiotic stresses. Twenty-one HbERF genes were regulated by harvesting stress in laticifers, revealing an overrepresentation of genes in group IX. Transcripts of three HbERF-IX genes from HbERF-IXc4, HbERF-IXc5 and HbERF-IXc6 were dramatically accumulated by combining wounding, methyl jasmonate and ethylene treatments. When an ethylene inhibitor was used, the transcript accumulation for these three genes was halted, showing ethylene-dependent induction. Subcellular localization and transactivation experiments confirmed that several members of HbERF-IX are activator-type transcription factors. This study suggested that latex harvesting induces mechanisms developed for the response to abiotic stress. These mechanisms probably depend on various hormonal signalling pathways. Severalmembers of HbERF-IX could be essential integrators of complex hormonal signalling pathways in Hevea.	[Putranto, Riza-Arief; Duan, Cuifang; Rio, Maryannick; Piyatrakul, Piyanuch; Pirrello, Julien; Dessailly, Florence; Leclercq, Julie; Montoro, Pascal] CIRAD, UMR DAP, Montpellier, France; [Putranto, Riza-Arief; Chaidamsari, Tetty] IBRIEC, Bogor, Indonesia; [Duan, Cuifang; Tang, Chaorong] CATAS, RRI, Danzhou, Hainan, Peoples R China; [Kuswanhadi; Herlinawati, Eva] IRRI, Sembawa, Palembang, Indonesia; [Piyatrakul, Piyanuch] Rubber Res Inst, Bangkok, Thailand; [Bonnot, Francois] CIRAD, UMR BGPI, Montpellier, France; [Hu, Songnian] BIG CAS, Beijing, Peoples R China	CIRAD; Chinese Academy of Tropical Agricultural Sciences; Riset Perkebunan Nusantara; Indonesian Rubber Research Institute (IRRI); CIRAD	Montoro, P (corresponding author), CIRAD, UMR DAP, Montpellier, France.	pascal.montoro@cirad.fr	Putranto, Riza-Arief/X-3130-2019; Tang, Chaorong/V-1483-2019; Pirrello, Julien/AAI-1692-2020	Putranto, Riza-Arief/0000-0002-1327-1200; Pirrello, Julien/0000-0002-5725-885X; Leclercq, Julie/0000-0001-8110-3762; RIO, Maryannick/0000-0002-4573-1371	French Government; Chinese Scholarship Council; Institut Francais du Caoutchouc (IFC); Michelin; Socfinco; Societe Internationale de PLantations d'Heveas (SIPH)	French Government; Chinese Scholarship Council(China Scholarship Council); Institut Francais du Caoutchouc (IFC); Michelin; Socfinco; Societe Internationale de PLantations d'Heveas (SIPH)	The French Government (BGF scholarship) provided a 18-month scholarship to Mr. Riza-Arief Putranto. The Chinese Scholarship Council provided a 3-year scholarship to Mrs. Cuifang Duan. The Institut Francais du Caoutchouc (IFC), and the Michelin, Socfinco and Societe Internationale de PLantations d'Heveas (SIPH) companies provided a 18-month scholarship to Mr. Riza-Arief Putranto, and funded all bench fees for experiments related to this paper. CATAS and the Beijing Institute of Genomics provided access to the Hevea genome sequence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The IFC agreed to publish this manuscript.	Akhtar M, 2012, J GENET, V91, P385, DOI 10.1007/s12041-012-0201-3; Cai HB, 2008, TROPICAL AGR SCI TEC, V31, P424; Chaabouni S, 2009, J EXP BOT, V60, P1349, DOI 10.1093/jxb/erp009; Champion A, 2009, MOL PLANT PATHOL, V10, P471, DOI [10.1111/J.1364-3703.2009.00549.X, 10.1111/j.1364-3703.2009.00549.x]; Chen YC, 2011, BREAKING FEM WAVES, P1, DOI 10.1057/9780230119185; Chen YF, 2005, ANN BOT-LONDON, V95, P901, DOI 10.1093/aob/mci100; Chen YY, 2011, AFR J BIOTECHNOL, V10, P9751; Cheng M-C, 2013, PLANT PHYSL; d'Auzac J, 1992, CELLULAR MOL ASPECTS, P205; d'Auzac J, 1989, PHYSL RUBBER TREE LA, P58; De Fay E, 1989, PHYSL RUBBER TREE LA, P4; Duan CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-30; Duan C, 2010, TREE PHYSIOL, V30, P1349, DOI 10.1093/treephys/tpq066; Dusotoit-Coucaud A, 2010, TREE PHYSIOL, V30, P1586, DOI 10.1093/treephys/tpq088; Etheridge Naomi, 2005, Briefings in Functional Genomics & Proteomics, V3, P372, DOI 10.1093/bfgp/3.4.372; GIDROL X, 1994, J BIOL CHEM, V269, P9278; Hao BingZhong, 2004, Journal of Rubber Research, V7, P281; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Jeffares DC, 2008, TRENDS GENET, V24, P375, DOI 10.1016/j.tig.2008.05.006; Kadow D, 2012, ANN BOT-LONDON, V109, P1253, DOI 10.1093/aob/mcs057; Khandelwal A, 2008, PLANT PHYSIOL, V148, P2050, DOI 10.1104/pp.108.128488; Kuswanhadi, 2010, J RUBBER RES, V13, P185; Lardet L, 2009, TREE PHYSIOL, V29, P291, DOI 10.1093/treephys/tpn027; Licausi F, 2013, NEW PHYTOL, V199, P639, DOI 10.1111/nph.12291; Licausi F, 2013, J INTEGR PLANT BIOL, V55, P31, DOI 10.1111/jipb.12011; Lim CJ, 2007, BIOCHEM BIOPH RES CO, V362, P431, DOI 10.1016/j.bbrc.2007.08.007; Medina J, 2011, PLANT SCI, V180, P3, DOI 10.1016/j.plantsci.2010.06.019; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Okoma K. M., 2011, Agriculture and Biology Journal of North America, V2, P559, DOI 10.5251/abjna.2011.2.3.559.569; Pauwels L, 2008, P NATL ACAD SCI USA, V105, P1380, DOI 10.1073/pnas.0711203105; Pauwels L, 2008, PLANT SIGNAL BEHAV, V3, P846, DOI 10.4161/psb.3.10.5993; Pirrello J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-190; Piyatrakul P, DNA RES IN PRESS; Piyatrakul P, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-244; Pollier J, 2013, NATURE, V504, P148, DOI 10.1038/nature12685; Pre M, 2008, PLANT PHYSIOL, V147, P1347, DOI 10.1104/pp.108.117523; Riechmann JL, 1998, BIOL CHEM, V379, P633; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schippers JHM, 2012, CELL MOL LIFE SCI, V69, P3245, DOI 10.1007/s00018-012-1092-4; Sewelam N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070289; Shoji T, 2013, PLANT PHYSIOL, V162, P977, DOI 10.1104/pp.113.217455; SIVAKUMARAN S, 1984, J RUBBER RES I MALAY, V32, P155; Tsai K-J, 2014, PLANT CELL ENVIRON; Tungngoen K, 2009, PLANT PHYSIOL, V151, P843, DOI 10.1104/pp.109.140228; van der Fits L, 2001, PLANT J, V25, P43, DOI 10.1046/j.1365-313x.2001.00932.x; Vogel MO, 2012, INT J MOL SCI, V13, P5933, DOI 10.3390/ijms13055933; Wu H., 2010, CHINESE AGR SCI B, V5; Xiao XH, 2014, FEBS J, V281, P291, DOI 10.1111/febs.12595; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yang Z, 2005, PLANT MOL BIOL, V58, P585, DOI 10.1007/s11103-005-7294-5; Zhu D, 2013, MOL PLANT	54	17	20	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123618	10.1371/journal.pone.0123618	http://dx.doi.org/10.1371/journal.pone.0123618			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906196	Green Published, gold			2022-12-27	WOS:000353332000037
J	Stokol, T; Yeo, WM; Burnett, D; DeAngelis, N; Huang, T; Osterrieder, N; Catalfamo, J				Stokol, Tracy; Yeo, Wee Ming; Burnett, Deborah; DeAngelis, Nicole; Huang, Teng; Osterrieder, Nikolaus; Catalfamo, James			Equid Herpesvirus Type 1 Activates Platelets	PLOS ONE			English	Article							COMPLEX CLASS-I; GLYCOPROTEIN-C; TISSUE FACTOR; P-SELECTIN; ENVELOPED VIRUS; DENGUE VIRUS; INFECTION; SIMPLEX; COAGULATION; ENDOTHELIUM	Equid herpesvirus type 1 (EHV-1) causes outbreaks of abortion and neurological disease in horses. One of the main causes of these clinical syndromes is thrombosis in placental and spinal cord vessels, however the mechanism for thrombus formation is unknown. Platelets form part of the thrombus and amplify and propagate thrombin generation. Here, we tested the hypothesis that EHV-1 activates platelets. We found that two EHV-1 strains, RacL11 and Ab4 at 0.5 or higher plaque forming unit/cell, activate platelets within 10 minutes, causing alpha-granule secretion (surface P-selectin expression) and platelet microvesiculation (increased small events double positive for CD41 and Annexin V). Microvesiculation was more pronounced with the RacL11 strain. Virus-induced P-selectin expression required plasma and 1.0 mM exogenous calcium. P-selectin expression was abolished and microvesiculation was significantly reduced in factor VII- or X-deficient human plasma. Both Pselectin expression and microvesiculation were re-established in factor VII-deficient human plasma with added purified human factor VIIa (1 nM). A glycoprotein C-deficient mutant of the Ab4 strain activated platelets as effectively as non-mutated Ab4. P-selectin expression was abolished and microvesiculation was significantly reduced by preincubation of virus with a goat polyclonal anti-rabbit tissue factor antibody. Infectious virus could be retrieved from washed EHV-1-exposed platelets, suggesting a direct platelet-virus interaction. Our results indicate that EHV-1 activates equine platelets and that alpha-granule secretion is a consequence of virus-associated tissue factor triggering factor X activation and thrombin generation. Microvesiculation was only partly tissue factor and thrombin-dependent, suggesting the virus causes microvesiculation through other mechanisms, potentially through direct binding. These findings suggest that EHV-1-induced platelet activation could contribute to the thrombosis that occurs in clinically infected horses and provides a new mechanism by which viruses activate hemostasis.	[Stokol, Tracy; Yeo, Wee Ming; Burnett, Deborah; DeAngelis, Nicole; Catalfamo, James] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Huang, Teng; Osterrieder, Nikolaus] Free Univ Berlin, Inst Virol, Berlin, Germany	Cornell University; Free University of Berlin	Stokol, T (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	tracy.stokol@cornell.edu		Osterrieder, Nikolaus/0000-0002-5313-2176	Harold M. Zweig Memorial Fund for Research, College of Veterinary Medicine, Cornell University	Harold M. Zweig Memorial Fund for Research, College of Veterinary Medicine, Cornell University	This work was supported by Harold M. Zweig Memorial Fund for Research, College of Veterinary Medicine, Cornell University (TS), (http://www.vet.cornell.edu/zweig/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGBANYO FR, 1994, J INFECT DIS, V170, P1120, DOI 10.1093/infdis/170.5.1120; Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x; Alonzo MTG, 2012, J INFECT DIS, V205, P1321, DOI 10.1093/infdis/jis180; Brooks MB, 2013, AM J VET RES, V74, P1212, DOI 10.2460/ajvr.74.9.1212; Bunce PE, 2011, CLIN INFECT DIS, V52, pE14, DOI 10.1093/cid/ciq125; Choi W, 2010, PLATELETS, V21, P167, DOI 10.3109/09537101003611385; de Witt SM, 2014, THROMB RES, V133, pS139, DOI 10.1016/S0049-3848(14)50024-2; EDINGTON N, 1986, ARCH VIROL, V90, P111, DOI 10.1007/BF01314149; Geisbert TW, 2003, J INFECT DIS, V188, P1618, DOI 10.1086/379724; Gershom ES, 2010, J THROMB HAEMOST, V8, P1037, DOI 10.1111/j.1538-7836.2010.03789.x; HIRNI H, 1988, ANIM GENET, V19, P391, DOI 10.1111/j.1365-2052.1988.tb00830.x; Hottz ED, 2013, J THROMB HAEMOST, V11, P951, DOI 10.1111/jth.12178; Hottz ED, 2013, BLOOD, V122, P3405, DOI 10.1182/blood-2013-05-504449; Kim SK, 2003, J VIROL, V77, P2675, DOI 10.1128/JVI.77.4.2675-2685.2003; Koupenova M, 2014, BLOOD, V124, P791, DOI 10.1182/blood-2013-11-536003; Kurtz BM, 2010, J VIROL, V84, P9027, DOI 10.1128/JVI.00287-10; Lunn DP, 2009, J VET INTERN MED, V23, P450, DOI 10.1111/j.1939-1676.2009.0304.x; Ma GG, 2012, J VIROL, V86, P3554, DOI 10.1128/JVI.06994-11; Mayne E, 2012, JAIDS-J ACQ IMM DEF, V59, P340, DOI 10.1097/QAI.0b013e3182439355; MCSORLEY J, 1974, INT J DERMATOL, V13, P69, DOI 10.1111/j.1365-4362.1974.tb01769.x; Morizono K, 2014, J VIROL, V88, P4275, DOI 10.1128/JVI.03287-13; Noisakran S, 2009, SE ASIAN J TROP MED, V40, P253; Oostingh GJ, 2007, HAEMATOLOGICA, V92, P502, DOI 10.3324/haematol.10741; Osterrieder N, 1999, VIRUS RES, V59, P165, DOI 10.1016/S0168-1702(98)00134-8; Othman M, 2007, BLOOD, V109, P2832, DOI 10.1182/blood-2006-06-032524; Passacquale G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025595; PRYZDIAL ELG, 1994, BLOOD, V84, P3749, DOI 10.1182/blood.V84.11.3749.bloodjournal84113749; Pugliese A, 2004, CELL BIOCHEM FUNCT, V22, P353, DOI 10.1002/cbf.1113; Reczko E, ARCH GES VIRUSFORSCH, V13, P591; Segura D, 2005, VET J, V170, P108, DOI 10.1016/j.tvjl.2004.05.013; Shah MD, 2008, PLATELETS, V19, P365, DOI 10.1080/09537100802054107; Sinauridze EI, 2007, THROMB HAEMOSTASIS, V97, P425, DOI 10.1160/TH06-06-0313; Slotta JE, 2009, PLATELETS, V20, P505, DOI 10.3109/09537100903215417; Smith KC, 1996, J COMP PATHOL, V114, P231, DOI 10.1016/S0021-9975(96)80045-4; SMITH KC, 1993, EQUINE VET J, V25, P36, DOI 10.1111/j.2042-3306.1993.tb02898.x; Sutherland MR, 2012, BLOOD, V119, P3638, DOI 10.1182/blood-2011-08-376814; Sutherland MR, 1997, P NATL ACAD SCI USA, V94, P13510, DOI 10.1073/pnas.94.25.13510; Sutherland MR, 2004, THROMB HAEMOSTASIS, V92, P947, DOI 10.1160/TH04-04-0242; Szeredi L, 2003, J COMP PATHOL, V129, P147, DOI 10.1016/S0021-9975(03)00022-7; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; VERCELLOTTI GM, 1990, BLOOD CELLS, V16, P209; Wang J, 2011, J THROMB HAEMOST, V9, P562, DOI 10.1111/j.1538-7836.2010.04168.x; Yang J, 1999, THROMB HAEMOSTASIS, V81, P1; Yeo WM, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-16; Youssefian T, 2002, BLOOD, V99, P4021, DOI 10.1182/blood-2001-12-0191	45	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0122640	10.1371/journal.pone.0122640	http://dx.doi.org/10.1371/journal.pone.0122640			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905776	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000016
J	Tian, MM; Wang, H; Tong, XT; Zhu, K; Zhang, XJ; Chen, X				Tian, Miaomiao; Wang, Heng; Tong, Xuetao; Zhu, Kun; Zhang, Xiaojuan; Chen, Xi			Essential Public Health Services' Accessibility and its Determinants among Adults with Chronic Diseases in China	PLOS ONE			English	Article							CARE	Background Along with three years implementation of health reform in China, this study aimed at providing the up-to-date evidence about the accessibility of essential public health services (EPHS) among adults with chronic diseases (CDs) in both urban and rural areas, as well as determinants in access to EPHS. Methods The data were collected from a cross-sectional survey conducted in 2013, which used a multistage stratified random sampling method to select 54 urban communities and 54 rural villages. Hypertension patients and diabetes patients were the target population who are the main beneficiaries of EPHS. Single factor analysis of influencing factors on difference access to EPHS was performed by Chi-Square analysis. Logistic regression analysis was used to determine the predictors of effective management and effective control. Results Patients with hypertension or diabetes were predominantly middle-aged or older persons and had a mean age of 65.26 year. People with CDs in China have a higher basic accessibility rate in EPHS with more than 90% of them having experience in receiving EPHS. And those who are willing to receive services from doctors have the most positive influence on effective management and control in blood pressure or blood glucose. But unsatisfied quality and equity of EPHS still exist in primary health system. 90% of participants could receive EPHS, but just 44% of them could control their diseases effectively. And participants from cities had the higher rates in effective management (urban: rural = 57%: 50.6%) and effective control (urban: rural = 39.5%: 27.8%). Conclusion People with CDs have a high level in geography and economic accessibility to EPHS, but the effectiveness of health management also needs to be improved, especially for those living in rural areas. Our study highlights the continuing need for improving ability to provide EPHS and the equality among regions. Meanwhile, strengthen health education and promotion for patients with CDs to improve their willingness to receive EPHS is also highlighted.	[Tian, Miaomiao; Zhu, Kun; Zhang, Xiaojuan] Chinese Acad Med Sci, Ctr Hlth Policy & Management, Inst Med Informat, Beijing 100020, Peoples R China; [Wang, Heng] Anhui Med Univ, Affiliated Hosp 1, Hefei 230022, Anhui, Peoples R China; [Tong, Xuetao] Guiyang Med Univ, Guiyang 550004, Guizhou, Peoples R China; [Chen, Xi] Jiangsu Univ, Sch Management, Zhanjiang 212013, Jiangsu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Information - CAMS; Anhui Medical University; Guizhou Medical University; Jiangsu University	Wang, H (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Hefei 230022, Anhui, Peoples R China.	857203662@qq.com						Anthony F, 2005, HARRISONS PRINCIPLES, P1463; Beaglehole R, 2004, LANCET, V363, P2084, DOI 10.1016/S0140-6736(04)16461-1; Bergsten U, 2011, INT J QUAL STUD HEAL, V6, DOI 10.3402/qhw.v6i4.8473; Carretero OA, 2000, CIRCULATION, V101, P329, DOI 10.1161/01.CIR.101.3.329; Center for Health Statistics and Information, 2004, REP NAT HLTH SERV SU; Center for Health Statistics and Information National Health and Family Planning Commission, 2009, AN REP NAT HLTH SERV; Communist Party of China Central Committee, 2013, STT COUNC IMPL PLAN; Communist Party of China Central Committee, 2009, IMPL PLAN REC PRIOR, V2009, P38; Diderichsen F, 2004, RESOURCE ALLOCATION, P20; Haggerty Jeannie L, 2011, Healthc Policy, V7, P94; Liu Q, 2011, LANCET, V377, P2064, DOI 10.1016/S0140-6736(11)60167-0; Liu ZR, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-394; Lu Z, 2012, BMC HEALTH SERV RES, V24, P212; MacGregor JCD, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-726; Ministry of Health PRC, 2009, OP PROM ESS PUBL HLH; Ministry of Health PRC, 2013, CHIN HLTH STAT YB 20; Ministry of Health PRC, 2014, CHIN HLTH STAT DIG 2; *NAT BUR STAT CHIN, 2009, CHIN STAT YB 2009; National bureau of statistics of China, 2013, CHIN HLTH STAT YB 20; National Bureau of Statistics of China, 2014, CHIN STAT YB 2013; National Bureau of Statistics of China, 2014, CHIN HLTH STAT YB 20; National health and family planning commission of the People's Republic of China, 2011, NAT ESS PUBL HLTH SE; Niu HL, 2014, CHINESE MED J-PEKING, V127, P1626, DOI 10.3760/cma.j.issn.0366-6999.20132786; Qian G, 2011, CHINESE J PUBLIC HLT, V28, P986; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; Teng L, 2011, CHINESE J NEW CLIN M, V4, P909; The Central People's Government of PRC, 2012, 12 5 YEAR PER DEEP H; Tian MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083822; Tian MM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-948; UNDP, 2010, CHIN HUM DEV REP 200; World Health Organization, 2014, DIABETES MELLITUS; World Health Organization, 1999, DEF DIAGN CLASS DIAB, P52; Yang J, 2008, ANN FAM MED, V6, P421, DOI 10.1370/afm.888	33	24	24	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125262	10.1371/journal.pone.0125262	http://dx.doi.org/10.1371/journal.pone.0125262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906073	Green Submitted, gold, Green Published			2022-12-27	WOS:000353332000108
J	Zhou, SM; Kong, XZ; Kang, HH; Sun, XD; Wang, W				Zhou, Shu-Mei; Kong, Xiang-Zhu; Kang, Han-Han; Sun, Xiu-Dong; Wang, Wei			The Involvement of Wheat F-Box Protein Gene TaFBA1 in the Oxidative Stress Tolerance of Plants	PLOS ONE			English	Article							TRANSGENIC TOBACCO PLANTS; LIPID-PEROXIDATION; UBIQUITIN LIGASE; DROUGHT STRESS; ARABIDOPSIS; ENHANCEMENT; SENSITIVITY; RESISTANCE; ELEMENTS; DATABASE	As one of the largest gene families, F-box domain proteins have been found to play important roles in abiotic stress responses via the ubiquitin pathway. TaFBA1 encodes a homologous F-box protein contained in E3 ubiquitin ligases. In our previous study, we found that the overexpression of TaFBA1 enhanced drought tolerance in transgenic plants. To investigate the mechanisms involved, in this study, we investigated the tolerance of the transgenic plants to oxidative stress. Methyl viologen was used to induce oxidative stress conditions. Real-time PCR and western blot analysis revealed that TaFBA1 expression was up-regulated by oxidative stress treatments. Under oxidative stress conditions, the transgenic tobacco plants showed a higher germination rate, higher root length and less growth inhibition than wild type (WT). The enhanced oxidative stress tolerance of the transgenic plants was also indicated by lower reactive oxygen species (ROS) accumulation, malondialdehyde (MDA) content and cell membrane damage under oxidative stress compared with WT. Higher activities of antioxidant enzymes, including superoxide dismutase (SOD), catalase (CAT), ascorbate peroxidase (APX) and peroxidase (POD), were observed in the transgenic plants than those in WT, which may be related to the upregulated expression of some antioxidant genes via the overexpression of TaFBA1. In others, some stress responsive elements were found in the promoter region of TaFBA1, and TaFBA1 was located in the nucleus, cytoplasm and plasma membrane. These results suggest that TaFBA1 plays an important role in the oxidative stress tolerance of plants. This is important for understanding the functions of F-box proteins in plants' tolerance to multiple stress conditions.	[Zhou, Shu-Mei; Kong, Xiang-Zhu; Kang, Han-Han; Wang, Wei] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Sun, Xiu-Dong] Shandong Agr Univ, Coll Hort Sci & Engn, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Wang, W (corresponding author), Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	wangw@sdau.edu.cn			National Natural Science Foundation of China [31370304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the National Natural Science Foundation of China (Grant number: 31370304), and the URL is http://www.nsfc.gov.cn/. W.W. received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AONO M, 1995, PLANT PHYSIOL, V107, P645, DOI 10.1104/pp.107.2.645; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calderon-Villalobos LIA, 2007, GENE, V392, P106, DOI 10.1016/j.gene.2006.11.016; Dalle-Donne I, 2002, FREE RADICAL BIO MED, V32, P927, DOI 10.1016/S0891-5849(02)00799-2; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; DODGE AD, 1994, CAUSES PHOTOOXIDATIV, P219; Iannone MF, 2012, BIOL TRACE ELEM RES, V146, P246, DOI 10.1007/s12011-011-9244-1; Fonseca S, 2009, CURR OPIN PLANT BIOL, V12, P539, DOI 10.1016/j.pbi.2009.07.013; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Griffiths J.W.R., 1983, ABSTR APPL ANAL, V130, P3, DOI DOI 10.1371/J0URNAL.P0NE.0054002; Guerra D, 2012, PLANT PHYSIOL, V158, P777, DOI 10.1104/pp.111.183988; Hemavathi, 2010, BIOTECHNOL LETT, V32, P321, DOI 10.1007/s10529-009-0140-0; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jia YY, 2012, MOL BIOL REP, V39, P2337, DOI 10.1007/s11033-011-0984-y; Lee DG, 2007, CR BIOL, V330, P215, DOI 10.1016/j.crvi.2007.01.001; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Lopez MA, 2011, PLANT J, V67, P447, DOI 10.1111/j.1365-313X.2011.04608.x; Lyzenga WJ, 2012, J EXP BOT, V63, P599, DOI 10.1093/jxb/err310; Mito T, 2011, PLANT BIOTECHNOL J, V9, P736, DOI 10.1111/j.1467-7652.2010.00578.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Moore K, 1998, FREE RADICAL RES, V28, P659, DOI 10.3109/10715769809065821; Morel J, 2004, PLANT J, V37, P282, DOI 10.1046/j.1365-313X.2003.01957.x; Neto ADD, 2006, ENVIRON EXP BOT, V56, P87, DOI 10.1016/j.envexpbot.2005.01.008; Pasqualini S, 2007, PLANT CELL ENVIRON, V30, P1545, DOI 10.1111/j.1365-3040.2007.01730.x; Qiu QS, 2008, PHOTOSYNTH RES, V97, P155, DOI 10.1007/s11120-008-9310-5; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Slaymaker DH, 2002, P NATL ACAD SCI USA, V99, P11640, DOI 10.1073/pnas.182427699; SLOOTEN L, 1995, PLANT PHYSIOL, V107, P737, DOI 10.1104/pp.107.3.737; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Terauchi R, 2000, MOL GEN GENET, V263, P554, DOI 10.1007/s004380051201; Maldonado-Calderon MT, 2012, PLANT SCI, V185, P208, DOI 10.1016/j.plantsci.2011.10.013; Tian FX, 2013, J EXP BOT, V64, P1509, DOI 10.1093/jxb/ert004; Yan JQ, 2003, PLANT PHYSIOL, V132, P861, DOI 10.1104/pp.103.020800; Yan YS, 2011, MOL PLANT, V4, P190, DOI 10.1093/mp/ssq066; Yoshimura K, 2004, PLANT J, V37, P21, DOI 10.1046/j.1365-313X.2003.01930.x; Yun BW, 2000, J PLANT PHYSIOL, V156, P504, DOI 10.1016/S0176-1617(00)80165-0; Zhang CJ, 2011, PLANT CELL REP, V30, P389, DOI 10.1007/s00299-010-0939-0; Zhang J, 2012, PLANT BIOLOGY, V14, P315, DOI 10.1111/j.1438-8677.2011.00512.x; Zhang Y, 2008, PLANT PHYSIOL, V148, P2121, DOI 10.1104/pp.108.126912; Zhou SM, 2014, PLANT PHYSIOL BIOCH, V84, P213, DOI 10.1016/j.plaphy.2014.09.017	43	41	52	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0122117	10.1371/journal.pone.0122117	http://dx.doi.org/10.1371/journal.pone.0122117			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906259	Green Submitted, gold, Green Published			2022-12-27	WOS:000353332000011
J	Saitta, ET				Saitta, Evan Thomas			Evidence for Sexual Dimorphism in the Plated Dinosaur Stegosaurus mjosi (Ornithischia, Stegosauria) from the Morrison Formation (Upper Jurassic) of Western USA	PLOS ONE			English	Article							RELATIVE GROWTH; SELECTION; EVOLUTION; PTEROSAURS; HISTOLOGY	Conclusive evidence for sexual dimorphism in non-avian dinosaurs has been elusive. Here it is shown that dimorphism in the shape of the dermal plates of Stegosaurus mjosi (Upper Jurassic, western USA) does not result from non-sex-related individual, interspecific, or ontogenetic variation and is most likely a sexually dimorphic feature. One morph possessed wide, oval plates 45% larger in surface area than the tall, narrow plates of the other morph. Intermediate morphologies are lacking as principal component analysis supports marked size-and shape-based dimorphism. In contrast, many non-sex-related individual variations are expected to show intermediate morphologies. Taphonomy of a new quarry in Montana (JRDI 5ES Quarry) shows that at least five individuals were buried in a single horizon and were not brought together by water or scavenger transportation. This new site demonstrates co-existence, and possibly suggests sociality, between two morphs that only show dimorphism in their plates. Without evidence for niche partitioning, it is unlikely that the two morphs represent different species. Histology of the new specimens in combination with studies on previous specimens indicates that both morphs occur in fully-grown individuals. Therefore, the dimorphism is not a result of ontogenetic change. Furthermore, the two morphs of plates do not simply come from different positions on the back of a single individual. Plates from all positions on the body can be classified as one of the two morphs, and previously discovered, isolated specimens possess only one morph of plates. Based on the seemingly display-oriented morphology of plates, female mate choice was likely the driving evolutionary mechanism rather than male-male competition. Dinosaur ornamentation possibly served similar functions to the ornamentation of modern species. Comparisons to ornamentation involved in sexual selection of extant species, such as the horns of bovids, may be appropriate in predicting the function of some dinosaur ornamentation.	Univ Bristol, Sch Earth Sci, Bristol, Avon, England	University of Bristol	Saitta, ET (corresponding author), Univ Bristol, Sch Earth Sci, Bristol, Avon, England.	evansaitta@gmail.com	Saitta, Evan Thomas/H-6884-2019	Saitta, Evan Thomas/0000-0002-9306-9060	Princeton University's Office of the Dean of the College; Princeton University's Mountlake Field Research Fund; Princeton University's Fred Fox Class	Princeton University's Office of the Dean of the College; Princeton University's Mountlake Field Research Fund; Princeton University's Fred Fox Class	This work was supported by Princeton University's Office of the Dean of the College, Princeton University's Mountlake Field Research Fund, and Princeton University's Fred Fox Class of 1939 Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayer JV., 2000, HOWE RANCH DINOSAURS, P95; Barden HE, 2011, J VERTEBR PALEONTOL, V31, P641, DOI 10.1080/02724634.2011.557112; Bro-Jorgensen J, 2007, EVOLUTION, V61, P1316, DOI 10.1111/j.1558-5646.2007.00111.x; Brusatte S. L., 2012, DINOSAUR PALEOBIOLOG, V2; Carpenter K, 2001, LIFE O PAST, P55; Carpenter K., 1990, P141, DOI 10.1017/CBO9780511608377.013; Carpenter K, 2005, LIFE O PAST, P325; Carpenter Kenneth, 2007, Journal of Paleontological Sciences, VC.07.0001, P1; Carpenter K, 2010, SWISS J GEOSCI, V103, P155, DOI 10.1007/s00015-010-0020-6; Carpenter Kenneth, 1998, Modern Geology, V23, P127; Chapman R.E., 1990, P21, DOI 10.1017/CBO9780511608377.005; Chapman Ralph E., 1997, P83; CHAPMAN RE, 1981, J PALEONTOL, V55, P608; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Colbert EH., 1989, MUS NORTH ARIZ BULL, V57, P160; Currie, 1990, DINOSAUR SYSTEMATICS, P91; Czerkas S.A., 1987, P82; DEBUFFRENIL V, 1986, PALEOBIOLOGY, V12, P459, DOI 10.1017/S0094837300003171; DODSON P, 1975, SYST ZOOL, V24, P37, DOI 10.2307/2412696; DODSON P, 1976, J PALEONTOL, V50, P929; Escaso F, 2007, NATURWISSENSCHAFTEN, V94, P367, DOI 10.1007/s00114-006-0209-8; Galton P.M., 1982, Geologica et Palaeontologica, V15, P139; Galton P.M., 1991, Geologica et Palaeontologica, V25, P299; GALTON P.M., 2012, COMPLETE DINOSAUR, P482; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P343; Galton Peter M., 2012, P225; Galton PM, 1999, NEUES JAHRB GEOL P-A, V213, P19, DOI 10.1127/njgpa/213/1999/19; Galton PM., 1974, B BRIT MUS NAT HIS A, V25, P1; Gilmore CW, 1914, B US NATN MUS, V89, P1; Hayashi S, 2012, PALAEONTOLOGY, V55, P145, DOI 10.1111/j.1475-4983.2011.01122.x; Hayashi S, 2009, J VERTEBR PALEONTOL, V29, P123, DOI 10.1080/02724634.2009.10010366; Hennig, 1925, PALAEONTOGRAPHICA S, V7, P101; Hone DWE, 2012, LETHAIA, V45, P139, DOI 10.1111/j.1502-3931.2011.00300.x; Horner JR, 2006, P ROY SOC B-BIOL SCI, V273, P2757, DOI 10.1098/rspb.2006.3643; Hunt Rebecca K., 2010, P447; Knell RJ, 2013, TRENDS ECOL EVOL, V28, P38, DOI 10.1016/j.tree.2012.07.015; Lehman T.M., 1990, P211, DOI 10.1017/CBO9780511608377.019; Lu JC, 2011, SCIENCE, V331, P321, DOI 10.1126/science.1197323; Maidment SCR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036904; Maidment SCR, 2008, J SYST PALAEONTOL, V6, P367, DOI 10.1017/S1477201908002459; Main RP, 2005, PALEOBIOLOGY, V31, P291, DOI 10.1666/0094-8373(2005)031[0291:TEAFOT]2.0.CO;2; Main Russell P., 2000, Journal of Vertebrate Paleontology, V20, p56A; Mallison H, 2011, PALAEONTOL ELECTRON, V14; Marsh O.C., 1877, AM J SCI, V3, P513, DOI [10.2475/ajs.s3-14.84.513, DOI 10.2475/AJS.S3-14.84.513]; PACKER C, 1983, SCIENCE, V221, P1191, DOI 10.1126/science.221.4616.1191; Padian K, 2011, J ZOOL, V283, P23, DOI 10.1111/j.1469-7998.2010.00761.x; Padian K, 2011, J ZOOL, V283, P3, DOI 10.1111/j.1469-7998.2010.00719.x; Padian K, 2013, TRENDS ECOL EVOL, V28, P249, DOI 10.1016/j.tree.2013.01.011; Paul GS, 1987, DINOSAURS PAST PRESE, V2, P4; Paul GS, 1992, GARDEN PARK PALEONTO, V3, P1; Prieto-Marquez A, 2007, J VERTEBR PALEONTOL, V27, P603, DOI 10.1671/0272-4634(2007)27[603:NEOPSA]2.0.CO;2; Redelstorff R, 2009, J VERTEBR PALEONTOL, V29, P1087, DOI 10.1671/039.029.0420; Richmond Dean R., 1996, Museum of Northern Arizona Bulletin, V60, P533; Schmude David E., 1996, Museum of Northern Arizona Bulletin, V60, P547; Siber H.-J., 2009, STEGOSAURS SAURIERMU; Stankowich T, 2009, P ROY SOC B-BIOL SCI, V276, P4329, DOI 10.1098/rspb.2009.1256; VOORHIES M R, 1969, Contributions to Geology Special Paper, P1; Wang XL, 2014, CURR BIOL, V24, P1323, DOI 10.1016/j.cub.2014.04.054	58	19	21	113	146	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123503	10.1371/journal.pone.0123503	http://dx.doi.org/10.1371/journal.pone.0123503			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901727	gold, Green Published, Green Submitted			2022-12-27	WOS:000353331500054
J	Shim, H; Chasman, DI; Smith, JD; Mora, S; Ridker, PM; Nickerson, DA; Krauss, RM; Stephens, M				Shim, Heejung; Chasman, Daniel I.; Smith, Joshua D.; Mora, Samia; Ridker, Paul M.; Nickerson, Deborah A.; Krauss, Ronald M.; Stephens, Matthew			A Multivariate Genome-Wide Association Analysis of 10 LDL Subfractions, and Their Response to Statin Treatment, in 1868 Caucasians	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; GENETIC-DETERMINANTS; THERAPY; PLASMA; LOCI; ROSUVASTATIN; TRIAL; MEN	We conducted a genome-wide association analysis of 7 subfractions of low density lipoproteins (LDLs) and 3 subfractions of intermediate density lipoproteins (IDLs) measured by gradient gel electrophoresis, and their response to statin treatment, in 1868 individuals of European ancestry from the Pharmacogenomics and Risk of Cardiovascular Disease study. Our analyses identified four previously-implicated loci (SORT1, APOE, LPA, and CETP) as containing variants that are very strongly associated with lipoprotein subfractions (log(10)Bayes Factor > 15). Subsequent conditional analyses suggest that three of these (APOE, LPA and CETP) likely harbor multiple independently associated SNPs. Further, while different variants typically showed different characteristic patterns of association with combinations of subfractions, the two SNPs in CETP show strikingly similar patterns - both in our original data and in a replication cohort - consistent with a common underlying molecular mechanism. Notably, the CETP variants are very strongly associated with LDL subfractions, despite showing no association with total LDLs in our study, illustrating the potential value of the more detailed phenotypic measurements. In contrast with these strong subfraction associations, genetic association analysis of subfraction response to statins showed much weaker signals (none exceeding log(10)Bayes Factor of 6). However, two SNPs (in APOE and LPA) previously-reported to be associated with LDL statin response do show some modest evidence for association in our data, and the subfraction response proles at the LPA SNP are consistent with the LPA association, with response likely being due primarily to resistance of Lp(a) particles to statin therapy. An additional important feature of our analysis is that, unlike most previous analyses of multiple related phenotypes, we analyzed the subfractions jointly, rather than one at a time. Comparisons of our multivariate analyses with standard univariate analyses demonstrate that multivariate analyses can substantially increase power to detect associations. Software implementing our multivariate analysis methods is available at http://stephenslab.uchicago.edu/software.html.	[Shim, Heejung; Stephens, Matthew] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Chasman, Daniel I.; Mora, Samia; Ridker, Paul M.] Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA; [Chasman, Daniel I.; Mora, Samia; Ridker, Paul M.] Harvard Univ, Sch Med, Boston, MA USA; [Smith, Joshua D.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Krauss, Ronald M.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of Chicago	Krauss, RM (corresponding author), Childrens Hosp, Oakland Res Inst, 747 52nd St, Oakland, CA 94609 USA.	RKrauss@chori.org; stephens@galton.uchicago.edu		Mora, Samia/0000-0001-6283-0980; Shim, Heejung/0000-0002-1375-9310; Venkatasubramanian, Siddharth/0000-0002-5860-0768	National Institutes of Health [U19HL069757]; National Heart, Lung, and Blood Institute [HL117861]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117861, U19HL069757] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Institutes of Health grant U19HL069757 to RMK and MS. The replication data from JUPITER was supported by National Heart, Lung, and Blood Institute grant HL117861 to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baker Allison R, 2009, BMC Proc, V3 Suppl 7, pS42; Banerjee S, 2008, GENETICS, V179, P2275, DOI 10.1534/genetics.108.088427; Barber MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009763; Berneis KK, 2002, J LIPID RES, V43, P1363, DOI 10.1194/jlr.R200004-JLR200; Campos H, 1996, ARTERIOSCL THROM VAS, V16, P794, DOI 10.1161/01.ATV.16.6.794; Caulfield MP, 2008, CLIN CHEM, V54, P1307, DOI 10.1373/clinchem.2007.100586; Chasman DI, 2012, CIRC-CARDIOVASC GENE, V5, P257, DOI 10.1161/CIRCGENETICS.111.961144; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Deshmukh HA, 2012, J LIPID RES, V53, P1000, DOI 10.1194/jlr.P021113; Dreon DM, 1997, ARTERIOSCL THROM VAS, V17, P707, DOI 10.1161/01.ATV.17.4.707; Ferreira MAR, 2009, BIOINFORMATICS, V25, P132, DOI 10.1093/bioinformatics/btn563; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Hindorff LA, CATALOG PUBLISHED GE; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kettunen J, 2012, NAT GENET, V44, P269, DOI 10.1038/ng.1073; Kim S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000587; Kim S, 2009, BIOINFORMATICS, V25, pI204, DOI 10.1093/bioinformatics/btp218; Krauss RM, 2012, J LIPID RES, V53, P540, DOI 10.1194/jlr.M018010; Mangravite LM, 2013, NATURE, V502, P377, DOI 10.1038/nature12508; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Musunuru K, 2009, ARTERIOSCL THROM VAS, V29, P1975, DOI 10.1161/ATVBAHA.109.190405; O'Reilly PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034861; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Qi QB, 2012, EUR HEART J, V33, P325, DOI 10.1093/eurheartj/ehr350; Rader DJ, 2014, ANNU REV MED, V65, P385, DOI 10.1146/annurev-med-050311-163305; Rainwater DL, 1999, INT J OBESITY, V23, DOI [10.1038/sj.ijo.0800813, DOI 10.1038/SJ.IJ0.0800813]; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; SAKAI N, 1991, ARTERIOSCLER THROMB, V11, P71, DOI 10.1161/01.ATV.11.1.71; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Simon JA, 2006, AM J CARDIOL, V97, P843, DOI 10.1016/j.amjcard.2005.09.134; Stephens M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065245; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thompson JF, 2009, CIRC-CARDIOVASC GENE, V2, P173, DOI 10.1161/CIRCGENETICS.108.818062; Verzilli CJ, 2005, GENET EPIDEMIOL, V28, P313, DOI 10.1002/gepi.20072; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Williams PT, 2014, ATHEROSCLEROSIS, V233, P713, DOI 10.1016/j.atherosclerosis.2014.01.034; WILLIAMS PT, 1992, J LIPID RES, V33, P765; Zhang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006502	43	146	146	8	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0120758	10.1371/journal.pone.0120758	http://dx.doi.org/10.1371/journal.pone.0120758			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898129	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600006
J	Webster, FJ; Babcock, RC; Van Keulen, M; Loneragan, NR				Webster, Fiona J.; Babcock, Russell C.; Van Keulen, Mike; Loneragan, Neil R.			Macroalgae Inhibits Larval Settlement and Increases Recruit Mortality at Ningaloo Reef, Western Australia	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CORAL-REEFS; PHASE-SHIFTS; CLIMATE-CHANGE; SCLERACTINIAN CORALS; COMMUNITY STRUCTURE; JUVENILE CORALS; ALGAL TURFS; MARINE PARK; RESILIENCE	Globally, many coral reefs are degraded and demonstrate reduced coral cover and increased macroalgal abundance. While negative correlations between macroalgae and coral recruitment have commonly been documented, the mechanisms by which macroalgae affects recruitment have received little attention. Here we examined the effect of macroalgae on larval settlement and the growth and survival of coral recruits, in a field experiment over nine months. Exclusion treatments were used to manipulate herbivory and macroalgal biomass, while settlement tiles measured coral settlement and survival. After nine months the volume of macroalgae was up to 40 times greater in the caged treatments than in controls and the settlement of coral larvae on the undersides of tiles within caged plots was 93% lower than in the uncaged treatments. The growth and survival of coral recruits was also severely reduced in the presence of macroalgae: survival was 79% lower in caged treatments and corals were up to 58% smaller with 75% fewer polyps. These data indicate that macroalgae has an additive effect on coral recruitment by reducing larval settlement and increasing recruit mortality. This research demonstrates that macroalgae can not only inhibit coral recruitment, but also potentially maintain dominance through a positive feedback system.	[Webster, Fiona J.; Van Keulen, Mike] Murdoch Univ, Sch Biol Sci & Biotechnol, Perth, WA 6849, Australia; [Babcock, Russell C.] CSIRO, Marine & Atmospher Res, Cleveland Marine Labs, Cleveland, Qld 4163, Australia; [Loneragan, Neil R.] Murdoch Univ, Ctr Fish Fisheries & Aquat Ecosyst Res, Perth, WA 6849, Australia	Murdoch University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Murdoch University	Webster, FJ (corresponding author), Murdoch Univ, Sch Biol Sci & Biotechnol, GPO Box S1400, Perth, WA 6849, Australia.	fiwebster001@hotmail.com	Loneragan, Neil/A-3386-2008; van Keulen, Mike/Q-9856-2019; Babcock, Russell C/A-3794-2012	Loneragan, Neil/0000-0003-2536-8656; van Keulen, Mike/0000-0001-6235-5788; Babcock, Russell C/0000-0002-7756-1290	Department of Environment and Conservation (Exmouth branch); North West Research Association; Australian Federation of University Women (Western Australian Branch)	Department of Environment and Conservation (Exmouth branch); North West Research Association; Australian Federation of University Women (Western Australian Branch)	We are deeply grateful to the Department of Environment and Conservation (Exmouth branch) and the North West Research Association for providing financial support and facilities. We also acknowledge the Australian Federation of University Women (Western Australian Branch) for funding. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, GUIDE SOFTWARE STAT; Arnold SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028681; Arnold SN, 2010, MAR ECOL PROG SER, V414, P91, DOI 10.3354/meps08724; ATKINSON MJ, 1992, LIMNOL OCEANOGR, V37, P273, DOI 10.4319/lo.1992.37.2.0273; BABCOCK RC, 1986, CORAL REEFS, V5, P111, DOI 10.1007/BF00298178; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Burkepile DE, 2013, SCI REP-UK, V3, DOI 10.1038/srep01493; Clarke K.R, 2006, PRIMER 6; Connell JH, 2004, ECOL MONOGR, V74, P179, DOI 10.1890/02-4043; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Diaz-Pulido G, 2002, MAR ECOL PROG SER, V232, P115, DOI 10.3354/meps232115; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Doropoulos C, 2013, MAR ECOL PROG SER, V486, P153, DOI 10.3354/meps10325; Doropoulos C, 2012, ECOLOGY, V93, P2131, DOI 10.1890/12-0495.1; Edmunds PJ, 2001, P NATL ACAD SCI USA, V98, P5067, DOI 10.1073/pnas.071524598; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Finelli CM, 2006, CORAL REEFS, V25, P47, DOI 10.1007/s00338-005-0055-8; Foster NL, 2008, MAR ECOL PROG SER, V367, P143, DOI 10.3354/meps07594; Freeman LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082404; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoey AS, 2011, ECOL LETT, V14, P267, DOI 10.1111/j.1461-0248.2010.01581.x; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1989, ECOLOGY, V70, P275, DOI 10.2307/1938434; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; HUNTER CL, 1995, B MAR SCI, V57, P501; Johansson CL, 2010, MAR ECOL PROG SER, V414, P65, DOI 10.3354/meps08730; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; Ledlie MH, 2007, CORAL REEFS, V26, P641, DOI 10.1007/s00338-007-0230-1; McClanahan TR, 2001, CORAL REEFS, V19, P380, DOI 10.1007/s003380000133; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Miller K, 2003, CORAL REEFS, V22, P99, DOI 10.1007/s00338-003-0290-9; Mumby PJ, 2013, CORAL REEFS, V32, P213, DOI 10.1007/s00338-012-0966-0; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Muscatine, 1990, CORAL REEFS, V25, P1; Paul VJ, 2011, MAR ECOL PROG SER, V426, P161, DOI 10.3354/meps09032; Penin L, 2010, MAR ECOL PROG SER, V408, P55, DOI 10.3354/meps08554; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Ritson-Williams R, 2014, CORAL REEFS, V33, P59, DOI 10.1007/s00338-013-1113-2; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; SAMMARCO PW, 1980, J EXP MAR BIOL ECOL, V45, P245, DOI 10.1016/0022-0981(80)90061-1; Sebens KP, 1997, P 8 INT COR REEF S, P1053; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Smallwood CB, 2012, FISH RES, V125, P40, DOI 10.1016/j.fishres.2012.01.019; Smallwood CB, 2011, OCEAN COAST MANAGE, V54, P330, DOI 10.1016/j.ocecoaman.2010.11.007; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Steneck RS, 2014, MAR ECOL PROG SER, V506, P115, DOI 10.3354/meps10764; TANNER JE, 1995, J EXP MAR BIOL ECOL, V190, P151, DOI 10.1016/0022-0981(95)00027-O; Trapon ML, 2013, CORAL REEFS, V32, P1051, DOI 10.1007/s00338-013-1059-4; Venera-Ponton DE, 2011, MAR ECOL PROG SER, V421, P109, DOI 10.3354/meps08869; Verges A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017115; Vermeij MJA, 2009, OECOLOGIA, V159, P325, DOI 10.1007/s00442-008-1223-7; Vermeij MJA, 2008, ECOLOGY, V89, P1994, DOI 10.1890/07-1296.1; Vermeij MJA, 2006, CORAL REEFS, V25, P59, DOI 10.1007/s00338-005-0056-7; Vroom PS, 2006, AM SCI, V94, P430, DOI 10.1511/2006.61.1004; Webster FW, 2008, THESIS MURDOCH U; Westera M, 2003, J EXP MAR BIOL ECOL, V294, P145, DOI 10.1016/S0022-0981(03)00268-5; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790	66	43	43	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124162	10.1371/journal.pone.0124162	http://dx.doi.org/10.1371/journal.pone.0124162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898011	gold, Green Published, Green Submitted			2022-12-27	WOS:000353212600053
J	Nanthavong, N; Black, AP; Nouanthong, P; Souvannaso, C; Vilivong, K; Muller, CP; Goossens, S; Quet, F; Buisson, Y				Nanthavong, Naphavanh; Black, Antony P.; Nouanthong, Phonethipsavanh; Souvannaso, Chanthasone; Vilivong, Keooudomphone; Muller, Claude P.; Goossens, Sylvie; Quet, Fabrice; Buisson, Yves			Diphtheria in Lao PDR: Insufficient Coverage or Ineffective Vaccine?	PLOS ONE			English	Article							CHILD IMMUNIZATION; MATERNAL ANTIBODIES; DETERMINANTS; HEALTH; ERADICATION; BANGLADESH; RESPONSES; EDUCATION; INFANTS; PROGRAM	Background During late 2012 and early 2013 several outbreaks of diphthe-ria were notified in the North of the Lao People's Democratic Republic. The aim of this study was to determine whether the re-emergence of this vaccine-preventable disease was due to insufficient vaccination coverage or reduction of vaccine effectiveness within the affected regions. Methods A serosurvey was conducted in the Huaphan Province on a cluster sampling of 132 children aged 12-59 months. Serum samples, socio-demographic data, nutri-tional status and vaccination history were collected when available. Anti-diphtheria and anti-tetanus IgG antibody levels were measured by ELISA. Results Overall, 63.6% of participants had detectable diphtheria antibodies and 71.2% tetanus antibodies. Factors independently associated with non-vaccination against diphtheria were the distance from the health centre (OR: 6.35 [95% CI: 1.4-28.8], p = 0.01), the Lao Theung ethnicity (OR: 12.2 [95% CI: 1,74-85, 4], p = 0.01) and the lack of advice on vac-cination given at birth (OR: 9.8 [95% CI: 1.5-63.8], (p = 0.01) while the level of maternal edu-cation was a protective factor (OR: 0.08 [95% CI: 0.008-0.81], p = 0.03). Most respondents claimed financial difficulties as the main reason for non-vaccination. Out of 55 children whose vaccination certificates stated that they were given all 3 doses of diphtheria-containing vaccine, 83.6% had diphtheria antibodies and 92.7% had tetanus antibodies. Furthermore, despite a high prevalence of stunted and underweight children (53% and 25.8%, respectively), the low levels of anti-diphtheria antibodies were not correlated to the nutritional status. Conclusions Our data highlight a significant deficit in both the vaccination coverage and diphtheria vaccine effectiveness within the Huaphan Province. Technical defi-ciencies in the methods of storage and distribution of vaccines as well as unreliability of vac-cination cards are discussed. Several hypotheses are advanced to explain such a decline in immunity against diphtheria and recommendations are provided to prevent future outbreaks.	[Nanthavong, Naphavanh; Quet, Fabrice; Buisson, Yves] Inst Francophonie Med Trop, Viangchan, Laos; [Black, Antony P.; Nouanthong, Phonethipsavanh; Souvannaso, Chanthasone; Vilivong, Keooudomphone; Muller, Claude P.] Inst Pasteur Laos, Lao Lux Lab, Viangchan, Laos; [Black, Antony P.; Muller, Claude P.] Ctr Rech Publ Sante, Inst Immunol, Lab Natl Sante, Dudelange, Luxembourg	Luxembourg Institute of Health	Buisson, Y (corresponding author), Inst Francophonie Med Trop, Viangchan, Laos.	yvesbuisson@hotmail.com	QUET, Fabrice/AAT-5871-2021	QUET, Fabrice/0000-0003-4777-5527	Agence Universitaire de la Francophonie; Ministry of Cooperation in Luxembourg, Institut Pasteur du Laos	Agence Universitaire de la Francophonie; Ministry of Cooperation in Luxembourg, Institut Pasteur du Laos	The field Survey was funded by the Agence Universitaire de la Francophonie. The lab analyses were funded by Ministry of Cooperation in Luxembourg, Institut Pasteur du Laos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu G, 2011, INTERNET JOURNAL OF, V9; Barennes H, 2009, EUR J CLIN NUTR, V63, P323, DOI 10.1038/sj.ejcn.1602928; BHUIYA A, 1995, HEALTH POLICY PLANN, V10, P304, DOI 10.1093/heapol/10.3.304; Chan J, 2011, VACCINE, V29, P1242, DOI 10.1016/j.vaccine.2010.11.087; Chowdhury AMR, 2003, J HEALTH POPUL NUTR, V21, P193; Cutts FT, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001404; Department of Planning and International Cooperation M Lao PDR, 2011, NATIONAL HEALTH STAT; Galazka A, 1998, THERMOSTABILITY OF V; Gans HA, 2013, J INFECT DIS, V208, P1, DOI 10.1093/infdis/jit144; Kamiya Y, 2011, J HEALTH POPUL NUTR, V29, P339, DOI 10.3329/jhpn.v29i4.8449; Kanra G, 2006, HUM VACCINES, V2, P155, DOI 10.4161/hv.2.4.2942; Kaufman DR, 2011, J IMMUNOL, V187, P1877, DOI 10.4049/jimmunol.1101248; Khor Geok Lin, 2003, Nepal Med Coll J, V5, P113; Kitamura T, 2013, BIOSCI TRENDS, V7, P178, DOI 10.5582/bst.2013.v7.4.178; Kristensen D, 2011, VACCINE, V29, P7122, DOI 10.1016/j.vaccine.2011.05.070; LaBeaud AD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000442; Lalor MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016709; Maekawa M, 2007, BIOSCI TRENDS, V1, P43; Messerli P., 2008, SOCIOECONOMIC ATLAS; National Statistics Centre of the Lao PDR, 2005, POPULATION CENSUS; Okwo-Bele JM, 2011, VACCINE, V29, pD74, DOI 10.1016/j.vaccine.2012.01.080; Parashar S, 2005, SOC SCI MED, V61, P989, DOI 10.1016/j.socscimed.2004.12.023; Phimmasane M, 2010, VACCINE, V28, P6723, DOI 10.1016/j.vaccine.2010.07.077; Rey-Cuille MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038153; Rogers B, 2010, AAOHN J, V58, P391, DOI 10.3928/08910162-20100816-02; Scheppers E, 2006, FAM PRACT, V23, P325, DOI 10.1093/fampra/cmi113; Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6; STREATFIELD K, 1990, DEMOGRAPHY, V27, P447, DOI 10.2307/2061378; Sullivan KM, 2009, PUBLIC HEALTH REP, V124, P471, DOI 10.1177/003335490912400320; Sychareun V, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-255; WHO, 2012, INTERNATIONAL REVIEW; Xie JP, 2005, SOC SCI MED, V61, P601, DOI 10.1016/j.socscimed.2004.12.016; Zasada AA, 2013, EUR J CLIN MICROBIOL, V32, P891, DOI 10.1007/s10096-013-1823-y	33	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0121749	10.1371/journal.pone.0121749	http://dx.doi.org/10.1371/journal.pone.0121749			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909365	Green Published, Green Submitted, gold			2022-12-27	WOS:000353376800013
J	Vysniauskaite, M; Hertfelder, HJ; Oldenburg, J; Dressen, P; Brettner, S; Homann, J; Molderings, GJ				Vysniauskaite, Milda; Hertfelder, Hans-Joerg; Oldenburg, Johannes; Dressen, Peter; Brettner, Stefan; Homann, Juergen; Molderings, Gerhard J.			Determination of Plasma Heparin Level Improves Identification of Systemic Mast Cell Activation Disease	PLOS ONE			English	Article							SERUM TRYPTASE LEVELS; DIFFERENTIAL RELEASE; SEROTONIN LEVELS; MASTOCYTOSIS; HISTAMINE; MARKERS; URINE; DIAGNOSIS; CRITERIA; CLASSIFICATION	Diagnosis of mast cell activation disease (MCAD), i.e. systemic mastocytosis (SM) and idiopathic systemic mast cell activation syndrome (MCAS), usually requires demonstration of increased mast cell (MC) mediator release. Since only a few MC mediators are currently established as biomarkers of MCAD, the sensitivity of plasma heparin level (pHL) as an indicator of increased MC activation was compared with that of serum tryptase, chromogranin A and urinary N-methylhistamine levels in 257 MCAD patients. Basal pHL had a sensitivity of 41% in MCAS patients and 27% in SM patients. Non-pharmacologic stimulation of MC degranulation by obstruction of venous flow for 10 minutes increased the sensitivity of pHL in MCAS patients to 59% and in SM patients to 47%. In MCAS patients tryptase, chromogranin A, and N-methylhistamine levels exhibited low sensitivities (10%, 12%, and 22%, respectively), whereas sensitivities for SM were higher (73%, 63%, and 43%, respectively). Taken together, these data suggest pHL appears more sensitive than the other mediators for detecting systemic MC activity in patients with MCAS. The simple, brief venous occlusion test appears to be a useful indicator of the presence of pathologically irritable MCs, at least in the obstructed compartment of the body.	[Vysniauskaite, Milda; Hertfelder, Hans-Joerg; Oldenburg, Johannes] Univ Hosp Bonn, Inst Exp Haematol & Transfus Med, Bonn, Germany; [Dressen, Peter] St Franziskus Hosp, Dept Internal Med, Eitorf, Germany; [Brettner, Stefan] Cty Hosp, Dept Oncol Hematol & Palliat Care, Waldbrol, Germany; [Homann, Juergen] Community Hosp St Elisabeth, Bonn, Germany; [Molderings, Gerhard J.] Univ Hosp Bonn, Inst Human Genet, Bonn, Germany	University of Bonn; University of Bonn	Molderings, GJ (corresponding author), Univ Hosp Bonn, Inst Human Genet, Bonn, Germany.	molderings@uni-bonn.de	Oldenburg, Johannes/ABB-7817-2020	Oldenburg, Johannes/0000-0002-1585-4100				Afrin LB, 2011, AM J MED SCI, V342, P44, DOI 10.1097/MAJ.0b013e31821d41dd; Afrin LB, 2014, WORLD J HEMATOL, V3, P1, DOI [10.5315/wjh.v3.i1.1, DOI 10.5315/WJH.V3.I1.1]; Akhavein A, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/950582; Akin C, 2002, INT ARCH ALLERGY IMM, V127, P133, DOI 10.1159/000048184; Alfter K, 2009, LIVER INT, V29, P181, DOI 10.1111/j.1478-3231.2008.01839.x; Alvarez-Twose I, 2010, J ALLERGY CLIN IMMUN, V125, P1269, DOI 10.1016/j.jaci.2010.02.019; Bochenek G, 2004, THORAX, V59, P459, DOI 10.1136/thx.2003.013573; Butterfield J, 2011, J ALLERGY CLIN IMMUN, V127, pAB132, DOI 10.1016/j.jaci.2010.12.528; Butterfield JH, 2008, INT ARCH ALLERGY IMM, V147, P338, DOI 10.1159/000144042; Butterfield JH, 2010, PROSTAG OTH LIPID M, V92, P73, DOI 10.1016/j.prostaglandins.2010.03.003; Butterfield JH, 2009, PROSTAG OTH LIPID M, V88, P122, DOI 10.1016/j.prostaglandins.2009.01.001; Cohen SS, 2014, BRIT J HAEMATOL, V166, P521, DOI 10.1111/bjh.12916; CRAIG SS, 1993, LAB INVEST, V69, P552; Dahlen SE, 2004, THORAX, V59, P453, DOI 10.1136/thx.2004.026641; Di Lorenzo G, 2002, ALLERGY, V57, P1180, DOI 10.1034/j.1398-9995.2002.23767.x; Sirvent AE, 2010, J NEPHROL, V23, P282; Fowlkes V, 2013, J BIOMECH, V46, P788, DOI 10.1016/j.jbiomech.2012.11.014; Frieling T, 2011, Z GASTROENTEROL, V49, P191, DOI 10.1055/s-0029-1245707; Haenisch B, 2012, IMMUNOLOGY, V137, P197, DOI 10.1111/j.1365-2567.2012.03627.x; Hamilton MJ, 2011, J ALLERGY CLIN IMMUN, V128, P147, DOI 10.1016/j.jaci.2011.04.037; Hogan AD, 1997, METHODS, V13, P43, DOI 10.1006/meth.1997.0494; Ibelgaufts H, COPE CYTOKINES CELLS; JAQUES LB, 1978, SEMIN THROMB HEMOST, V4, P326; Kassab D, 2008, J ALLERGY CLIN IMMUN, V121, pS67, DOI 10.1016/j.jaci.2007.12.268; Kushnir-Sukhov NM, 2008, EUR J CLIN INVEST, V38, P953, DOI 10.1111/j.1365-2362.2008.02047.x; Luna-Gomes T, 2011, J IMMUNOL, V187, P6518, DOI 10.4049/jimmunol.1101806; METCALFE DD, 1979, J CLIN INVEST, V64, P1537, DOI 10.1172/JCI109613; Molderings GJ, 2012, ARZNEIMITTELFORSCH, V62, P157, DOI 10.1055/s-0032-1306321; Molderings GJ, 2015, CRIT REV ONCOL HEMAT, V93, P75, DOI 10.1016/j.critrevonc.2014.09.001; Molderings GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076241; Molderings GJ, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-10; MORROW JD, 1995, J INVEST DERMATOL, V104, P937, DOI 10.1111/1523-1747.ep12606209; O'Sullivan S, 1999, ACTA PHYSIOL SCAND, V166, P1; Pardanani A, 2013, LEUKEMIA, V27, P2091, DOI 10.1038/leu.2013.227; Prasad P, 2008, J IMMUNOL, V181, P5024, DOI 10.4049/jimmunol.181.7.5024; Quintas-Cardama A, 2013, LEUKEMIA LYMPHOMA, V54, P1959, DOI 10.3109/10428194.2012.763121; Raithel M, 2011, J PHYSIOL PHARMACOL, V62, P469; Ravi A, 2014, J ALLER CL IMM-PRACT, V2, P775, DOI 10.1016/j.jaip.2014.06.011; Ravi A, 2013, J ALLERGY CLIN IMMUN, V131, pAB117, DOI 10.1016/j.jaci.2012.12.1088; Ronnberg E, 2012, J HISTOCHEM CYTOCHEM, V60, P950, DOI 10.1369/0022155412458927; Sargur R, 2011, CLIN EXP IMMUNOL, V163, P339, DOI 10.1111/j.1365-2249.2010.04287.x; Schafer D, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0213-2; Schwartz LB, 2006, IMMUNOL ALLERGY CLIN, V26, P451, DOI 10.1016/j.iac.2006.05.010; Seidel H, 2011, THROMB HAEMOSTASIS, V106, P987, DOI 10.1160/TH11-05-0351; Sperr WR, 2002, INT ARCH ALLERGY IMM, V128, P136, DOI 10.1159/000059404; Stefanov S, 2013, REV MED VET, V164, P453, DOI [10.1016/j.bulcan.2015.01.010, DOI 10.1016/J.BULCAN.2015.01.010]; STUDER A, 1954, EXPERIENTIA, V10, P148, DOI 10.1007/BF02158526; THEOHARIDES TC, 1982, NATURE, V297, P229, DOI 10.1038/297229a0; Theoharides TC, 2007, IMMUNOL REV, V217, P65, DOI 10.1111/j.1600-065X.2007.00519.x; Valent P, 2007, EUR J CLIN INVEST, V37, P435, DOI 10.1111/j.1365-2362.2007.01807.x; Valent P, 2001, LEUKEMIA RES, V25, P603, DOI 10.1016/S0145-2126(01)00038-8; Valent P, 2012, INT ARCH ALLERGY IMM, V157, P215, DOI 10.1159/000328760; van Doormaal JJ, 2012, ALLERGY, V67, P683, DOI 10.1111/j.1398-9995.2012.02809.x; van Doormaal JJ, 2013, J ALLERGY CLIN IMMUN, V131, P1429, DOI 10.1016/j.jaci.2012.10.015; van Toorenenbergen AW, 2005, CLIN CHIM ACTA, V359, P72, DOI 10.1016/j.cccn.2005.03.041; Wladyslaw S, 2002, CORONARY ARTERY DIS, V13, P423, DOI 10.1097/00019501-200212000-00007; Yang WZ, 2009, J ENVIRON PATHOL TOX, V28, P223, DOI 10.1615/JEnvironPatholToxicolOncol.v28.i3.30	57	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124912	10.1371/journal.pone.0124912	http://dx.doi.org/10.1371/journal.pone.0124912			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909362	Green Submitted, gold, Green Published			2022-12-27	WOS:000353376800113
J	Zhu, XM; Wu, LJ; Yao, J; Jiang, H; Wang, QF; Yang, ZJ; Wu, FS				Zhu, Xiuming; Wu, Lingjiao; Yao, Jian; Jiang, Han; Wang, Qiangfeng; Yang, Zhijian; Wu, Fusheng			MicroRNA let-7c Inhibits Cell Proliferation and Induces Cell Cycle Arrest by Targeting CDC25A in Human Hepatocellular Carcinoma	PLOS ONE			English	Article							EXPRESSION; CANCER; APOPTOSIS; INVASION; FAMILY; SIGNATURES; MIGRATION; PATHWAY; GROWTH	Down-regulation of the microRNA let-7c plays an important role in the pathogenesis of human hepatocellular carcinoma (HCC). The aim of the present study was to determine whether the cell cycle regulator CDC25A is involved in the antitumor effect of let-7c in HCC. The expression levels of let-7c in HCC cell lines were examined by quantitative real-time PCR, and a let-7c agomir was transfected into HCC cells to overexpress let-7c. The effects of let-7c on HCC proliferation, apoptosis and cell cycle were analyzed. The in vivo tumor-inhibitory efficacy of let-7c was evaluated in a xenograft mouse model of HCC. Luciferase reporter assays and western blotting were conducted to identify the targets of let-7c and to determine the effects of let-7c on CDC25A, CyclinD1, CDK6, pRb and E2F2 expression. The results showed that the expression levels of let-7c were significantly decreased in HCC cell lines. Overexpression of let-7c repressed cell growth, induced cell apoptosis, led to G1 cell cycle arrest in vitro, and suppressed tumor growth in a HepG2 xenograft model in vivo. The luciferase reporter assay showed that CDC25A was a direct target of let-7c, and that let-7c inhibited the expression of CDC25A protein by directly targeting its 3' UTR. Restoration of CDC25A induced a let-7c-mediated G1-to-S phase transition. Western blot analysis demonstrated that overexpression of let-7c decreased CyclinD1, CDK6, pRb and E2F2 protein levels. In conclusion, this study indicates that let-7c suppresses HCC progression, possibly by directly targeting the cell cycle regulator CDC25A and indirectly affecting its downstream target molecules. Let-7c may therefore be an effective therapeutic target for HCC.	[Zhu, Xiuming; Jiang, Han; Wang, Qiangfeng; Wu, Fusheng] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Xiuming] Zhejiang Prov Peoples Hosp, Dept Oncol, Hangzhou, Zhejiang, Peoples R China; [Wu, Lingjiao; Yao, Jian] Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou, Zhejiang, Peoples R China; [Yang, Zhijian] Origin Biosci Inc, Nanjing, Jiangsu, Peoples R China	Zhejiang University; Zhejiang Provincial People's Hospital; Zhejiang University	Wu, FS (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China.	wufusheng@zju.edu.cn	zhu, xm/K-5002-2019; Jian, YAO/AAT-4231-2021	Jian, YAO/0000-0002-3746-1279	National 863 Program of China [2008AA02Z109]; National Natural Science Foundation of China [81272354]; Medicine Foundation of Zhejiang Province [2013RCA006]	National 863 Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medicine Foundation of Zhejiang Province	The work was supported by the National 863 Program of China (FSW, Grant No. 2008AA02Z109), and National Natural Science Foundation of China (FSW, Grant No. 81272354), as well as in part by Medicine Foundation of Zhejiang Province (XMZ, Grant No. 2013RCA006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bae HJ, 2014, ONCOGENE, V33, P2557, DOI 10.1038/onc.2013.216; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carleton M, 2007, CELL CYCLE, V6, P2127, DOI 10.4161/cc.6.17.4641; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Emmrich S, 2010, CELL CYCLE, V9, P2555, DOI 10.4161/cc.9.13.12061; Gong Fang-xiao, 2011, Zhonghua Gan Zang Bing Za Zhi, V19, P853, DOI 10.3760/cma.j.issn.1007-3418.2011.11.014; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji JF, 2010, J HEPATOL, V52, P690, DOI 10.1016/j.jhep.2009.12.025; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Landrieu I, 2004, P NATL ACAD SCI USA, V101, P13380, DOI 10.1073/pnas.0405248101; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Nadiminty N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032832; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Peghini PL, 2002, CLIN CANCER RES, V8, P2273; Pickering MT, 2009, ONCOGENE, V28, P140, DOI 10.1038/onc.2008.372; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Shen T, 2012, ANTI-CANCER AGENT ME, V12, P631, DOI 10.2174/187152012800617678; Shimizu S, 2010, J HEPATOL, V52, P698, DOI 10.1016/j.jhep.2009.12.024; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Tian J, 1999, BRIT J CANCER, V81, P814, DOI 10.1038/sj.bjc.6690769; Wong JV, 2011, CELL CYCLE, V10; Xu J, 2012, LIVER INT, V32, P752, DOI 10.1111/j.1478-3231.2011.02750.x; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Xui XD, 2008, INT J MOL MED, V21, P145; Yang X, 2014, HEPATOLOGY, V59, P1874, DOI 10.1002/hep.26941; Yao J, 2010, HEPATOLOGY, V51, P846, DOI 10.1002/hep.23443; Yu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091661; Zhang J, 2010, BRIT J CANCER, V103, P1215, DOI 10.1038/sj.bjc.6605895; Zhao BT, 2014, CANCER LETT, V342, P43, DOI 10.1016/j.canlet.2013.08.030; Zhu XM, 2011, J INT MED RES, V39, P2323, DOI 10.1177/147323001103900631	46	47	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124266	10.1371/journal.pone.0124266	http://dx.doi.org/10.1371/journal.pone.0124266			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909324	gold, Green Submitted, Green Published			2022-12-27	WOS:000353376800072
J	Corona, G; Giuliani, C; Verbalis, JG; Forti, G; Maggi, M; Peri, A				Corona, Giovanni; Giuliani, Corinna; Verbalis, Joseph G.; Forti, Gianni; Maggi, Mario; Peri, Alessandro			Hyponatremia Improvement Is Associated with a Reduced Risk of Mortality: Evidence from a Meta-Analysis	PLOS ONE			English	Article							WORSENING HEART-FAILURE; HOSPITALIZED-PATIENTS; SERUM SODIUM; OUTCOMES; IMPACT; MANAGEMENT	Background Hyponatremia is the most common electrolyte disorder and it is associated with increased morbidity and mortality. However, there is no clear demonstration that the improvement of serum sodium concentration ([Na+]) counteracts the increased risk of mortality associated with hyponatremia. Thus, we performed a meta-analysis that included the published studies that addressed the effect of hyponatremia improvement on mortality. Methods and Findings A Medline, Embase and Cochrane search was performed to retrieve all English-language studies of human subjects published up to June 30th 2014, using the following words: "hyponatremia", "hyponatraemia", "mortality", "morbidity" and "sodium". Fifteen studies satisfied inclusion criteria encompassing a total of 13,816 patients. The identification of relevant abstracts, the selection of studies and the subsequent data extraction were performed independently by two of the authors, and conflicts resolved by a third investigator. Across all fifteen studies, any improvement of hyponatremia was associated with a reduced risk of overall mortality (OR=0.57[0.40-0.81]). The association was even stronger when only those studies (n=8) reporting a threshold for serum [Na+] improvement to >130 mmol/L were considered (OR=0.51[0.31-0.86]). The reduced mortality rate persisted at follow-up (OR=0.55[0.36-0.84] at 12 months). Meta-regression analyses showed that the reduced mortality associated with hyponatremia improvement was more evident in older subjects and in those with lower serum [Na+] at enrollment. Conclusions This meta-analysis documents for the first time that improvement in serum [Na+] in hyponatremic patients is associated with a reduction of overall mortality.	[Corona, Giovanni] Maggiore Bellaria Hosp, Endocrinol Unit, Bologna, Italy; [Giuliani, Corinna; Forti, Gianni; Peri, Alessandro] Univ Florence, Endocrine Unit,Careggi Hosp, Ctr Res Transfer & High Educ Chron Inflammatory D, Dept Expt & Clin Biomed Sci Mario Serio, I-50139 Florence, Italy; [Verbalis, Joseph G.] Georgetown Univ, Div Endocrinol & Metab, Washington, DC 20007 USA; [Maggi, Mario] Univ Florence, Androl Unit,Careggi Hosp, Ctr Res Transfer & High Educ Chron Inflammatory D, Dept Expt & Clin Biomed Sci Mario Serio, I-50139 Florence, Italy	AUSL di Bologna; University of Florence; Azienda Ospedaliero Universitaria Careggi; Georgetown University; University of Florence; Azienda Ospedaliero Universitaria Careggi	Peri, A (corresponding author), Univ Florence, Endocrine Unit,Careggi Hosp, Ctr Res Transfer & High Educ Chron Inflammatory D, Dept Expt & Clin Biomed Sci Mario Serio, I-50139 Florence, Italy.	alessandro.peri@unifi.it	Peri, Alessandro/AAR-9664-2021; Maggi, Mario/AAB-8284-2019	MAGGI, Mario/0000-0003-3267-4221	Otsuka	Otsuka(Otsuka Pharmaceutical)	Joseph G. Verbalis has served as a consultant and member of advisory boards and Speakers' Bureau for Otsuka and has received research grants from Otsuka; Alessandro Peri has served as a consultant and member of advisory boards for Otsuka. Giovanni Corona, Corinna Giuliani, Gianni Forti and Mario Maggi have nothing to disclose. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Ng ACC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061966; Barsony J, 2012, AGE DORDR, V35, P271; Barsony J, 2011, J BIOL CHEM, V286, P10864, DOI 10.1074/jbc.M110.155002; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Benvenuti S, 2013, NEUROMOL MED, V15, P493, DOI 10.1007/s12017-013-8235-0; Corona G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080451; Darmon M, 2014, SHOCK, V41, P394, DOI 10.1097/SHK.0000000000000135; Doshi SM, 2012, AM J KIDNEY DIS, V59, P222, DOI 10.1053/j.ajkd.2011.08.029; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gheorghiade M, 2007, ARCH INTERN MED, V167, P1998, DOI 10.1001/archinte.167.18.1998; Gill G, 2006, CLIN ENDOCRINOL, V65, P246, DOI 10.1111/j.1365-2265.2006.02583.x; Giuliani C, 2013, J ENDOCRINOL INVEST, V36, P693, DOI 10.3275/8925; Hackworth WA, 2009, LIVER INT, V29, P1071, DOI 10.1111/j.1478-3231.2009.01982.x; Hansen O, 2010, LUNG CANCER, V68, P111, DOI 10.1016/j.lungcan.2009.05.015; Hauptman PJ, 2013, J CARD FAIL, V19, P390, DOI 10.1016/j.cardfail.2013.04.001; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hoorn EJ, 2006, NEPHROL DIAL TRANSPL, V21, P70, DOI 10.1093/ndt/gfi082; Huda MSB, 2006, POSTGRAD MED J, V82, P216, DOI 10.1136/pmj.2005.036947; Kengne FG, 2008, QJM-INT J MED, V101, P583, DOI 10.1093/qjmed/hcn061; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Kinsella S, 2010, CLIN J AM SOC NEPHRO, V5, P275, DOI 10.2215/CJN.06120809; Klein L, 2005, CIRCULATION, V111, P2454, DOI 10.1161/01.CIR.0000165065.82609.3D; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Konstam MA, 2011, EUR J HEART FAIL, V13, P242, DOI 10.1093/eurjhf/hfq236; Lee J, 2013, TOHOKU J EXP MED, V229, P97, DOI 10.1620/tjem.229.97; Lee SE, 2012, HEART, V98, P1798, DOI 10.1136/heartjnl-2012-302334; Licata G, 2003, AM HEART J, V145, P459, DOI 10.1067/mhj.2003.166; Madan VD, 2011, CIRC-HEART FAIL, V4, P637, DOI 10.1161/CIRCHEARTFAILURE.111.961011; Nzerue CM, 2003, J NATL MED ASSOC, V95, P335; Peri A, 2010, J ENDOCRINOL INVEST, V33, P671, DOI 10.1007/BF03346668; Peri A, 2013, J CLIN ENDOCR METAB, V98, P1321, DOI 10.1210/jc.2012-4082; Qureshi W, 2013, CLIN RES CARDIOL, V102, P637, DOI 10.1007/s00392-013-0576-z; Renneboog B, 2006, AM J MED, V119, DOI [DOI 10.1016/J.AMJMED.2005.09.026, 10.1016/j.amjmed.2005.09.026]; Rossi Joseph, 2007, Acute Card Care, V9, P82, DOI 10.1080/17482940701210179; Rusinaru D, 2009, AM J CARDIOL, V103, P405, DOI 10.1016/j.amjcard.2008.09.091; TERZIAN C, 1994, J GEN INTERN MED, V9, P89, DOI 10.1007/BF02600208; Upadhyay A, 2006, AM J MED, V119, pS30, DOI 10.1016/j.amjmed.2006.05.005; Vaishya Richa, 2012, J Indian Med Assoc, V110, P94; Verbalis JG, 2013, AM J MED, V126, pS5, DOI 10.1016/j.amjmed.2013.07.006; Verbalis JG, 2010, J BONE MINER RES, V25, P554, DOI 10.1359/jbmr.090827; Waikar SS, 2009, AM J MED, V122, P857, DOI 10.1016/j.amjmed.2009.01.027; Wald R, 2010, ARCH INTERN MED, V170, P294, DOI 10.1001/archinternmed.2009.513; Zilberberg Marya D, 2008, BMC Pulm Med, V8, P16, DOI 10.1186/1471-2466-8-16	43	69	69	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124105	10.1371/journal.pone.0124105	http://dx.doi.org/10.1371/journal.pone.0124105			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905459	gold, Green Submitted, Green Published			2022-12-27	WOS:000353332000058
J	McEvoy, J; While, GM; Jones, SM; Wapstra, E				McEvoy, Jo; While, Geoffrey M.; Jones, Susan M.; Wapstra, Erik			Examining the Role of Testosterone in Mediating Short-Term Aggressive Responses to Social Stimuli in a Lizard	PLOS ONE			English	Article							TERRITORIAL AGGRESSION; INDIVIDUAL VARIATION; PLASMA TESTOSTERONE; BEHAVIORAL SYNDROMES; ANIMAL PERSONALITY; FEMALE AGGRESSION; STEROID-HORMONES; TREE LIZARDS; EVOLUTIONARY; SEX	Hormones have been suggested as a key proximate mechanism that organize and maintain consistent individual differences in behavioural traits such as aggression. The steroid hormone testosterone in particular has an important activational role in mediating short-term aggressive responses to social and environmental stimuli within many vertebrate systems. We conducted two complementary experiments designed to investigate the activational relationship between testosterone and aggression in male Egernia whitii, a social lizard species. First, we investigated whether a conspecific aggressive challenge induced a testosterone response and second, we artificially manipulated testosterone concentrations to examine whether this changed aggression levels. We found that at the mean level, plasma T concentration did not appear to be influenced by an aggression challenge. However, there was a slight indication that receiving a challenge may influence intra-individual consistency of plasma T concentrations, with individuals not receiving an aggression challenge maintaining consistency in their circulating testosterone concentrations, while those individuals that received a challenge did not. Manipulating circulating testosterone concentrations had no influence on either mean-level or individual-level aggression. Combined with our previous work, our study adds increasing evidence that the relationship between testosterone and aggression is not straightforward, and promotes the investigation of alternative hormonal pathways and differences in neuro-synthesis and neuroendocrine pathways to account for species variable testosterone - aggression links.	[McEvoy, Jo; While, Geoffrey M.; Jones, Susan M.; Wapstra, Erik] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia; [While, Geoffrey M.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford, England	University of Tasmania; University of Oxford	McEvoy, J (corresponding author), Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia.	jmcevoy@utas.edu.au	McEvoy, Jo/M-7204-2015; While, Geoffrey M/O-6306-2017; Wapstra, Erik/J-7482-2014	McEvoy, Jo/0000-0001-9591-1824; While, Geoffrey M/0000-0001-8122-9322; Wapstra, Erik/0000-0002-2050-8026	Holsworth Wildlife Research Endowment; Winifred Violet Scott Estate; Ecological Society of Australia; Bookend Trust; Australian Research Council	Holsworth Wildlife Research Endowment; Winifred Violet Scott Estate; Ecological Society of Australia; Bookend Trust; Australian Research Council(Australian Research Council)	This work was funded in part by the Holsworth Wildlife Research Endowment, the Winifred Violet Scott Estate, the Ecological Society of Australia, the Bookend Trust (JM), and the Australian Research Council (EW, GMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E., 2005, HORMONES ANIMAL SOCI; Apfelbeck B, 2011, P ROY SOC B-BIOL SCI, V278, P3233, DOI 10.1098/rspb.2011.0098; Ball GF, 2008, PHILOS T R SOC B, V363, P1699, DOI 10.1098/rstb.2007.0010; Baugh AT, 2012, GEN COMP ENDOCR, V175, P488, DOI 10.1016/j.ygcen.2011.12.012; Bell AM, 2007, NATURE, V447, P539, DOI 10.1038/447539a; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; Canoine V, 2007, DEV NEUROBIOL, V67, P57, DOI 10.1002/dneu.20296; Chapple DG, 2003, HERPETOL MONOGR, V17, P145, DOI 10.1655/0733-1347(2003)017[0145:ELABIT]2.0.CO;2; CLEMENS LG, 1982, J COMP PHYSIOL PSYCH, V96, P114, DOI 10.1037/h0077859; Cramer ERA, 2012, ETHOLOGY, V118, P975, DOI 10.1111/j.1439-0310.2012.02091.x; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Davis ES, 2003, HORM BEHAV, V44, P185, DOI 10.1016/S0018-506X(03)00128-4; DENARDO DF, 1994, HORM BEHAV, V28, P273, DOI 10.1006/hbeh.1994.1023; DeVries MS, 2012, HORM BEHAV, V62, P99, DOI 10.1016/j.yhbeh.2012.05.008; Dingemanse NJ, 2013, ANIM BEHAV, V85, P1031, DOI 10.1016/j.anbehav.2012.12.032; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Duckworth RA, 2006, P ROY SOC B-BIOL SCI, V273, P1789, DOI 10.1098/rspb.2006.3517; Duckworth RA, 2012, FUNCT ECOL, V26, P559, DOI 10.1111/j.1365-2435.2012.01966.x; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; Groothuis TGG, 2011, DEV PSYCHOBIOL, V53, P641, DOI 10.1002/dev.20574; Hau M, 2000, GEN COMP ENDOCR, V117, P20, DOI 10.1006/gcen.1999.7390; Isaksson C, 2011, BEHAVIOUR, V148, P713, DOI 10.1163/000579511X574204; JOHNSON F, 1993, J NEUROBIOL, V24, P400, DOI 10.1002/neu.480240311; Jones SM, 2004, COMP BIOCHEM PHYS A, V137, P105, DOI 10.1016/S1095-6433(03)00267-8; Kempenaers B, 2008, PHILOS T R SOC B, V363, P1711, DOI 10.1098/rstb.2007.0001; Knapp R, 1997, GEN COMP ENDOCR, V107, P273, DOI 10.1006/gcen.1997.6923; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Landys MM, 2007, PHYSIOL BIOCHEM ZOOL, V80, P228, DOI 10.1086/510564; Langkilde T, 2005, ECOLOGY, V86, P1650, DOI 10.1890/04-1331; Langkilde T, 2007, AUSTRAL ECOL, V32, P869, DOI 10.1111/j.1442-9993.2007.01771.x; Le Galliard JF, 2005, P NATL ACAD SCI USA, V102, P18231, DOI 10.1073/pnas.0505172102; LINCOLN GA, 1972, HORM BEHAV, V3, P375, DOI 10.1016/0018-506X(72)90027-X; Magnhagen C, 2012, J ANIM ECOL, V81, P1311, DOI 10.1111/j.1365-2656.2012.02007.x; MARLER CA, 1988, BEHAV ECOL SOCIOBIOL, V23, P21, DOI 10.1007/BF00303053; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; McEvoy J, 2015, J ZOOL, V296, P58, DOI 10.1111/jzo.12217; McEvoy J, 2013, BEHAV ECOL SOCIOBIOL, V67, P79, DOI 10.1007/s00265-012-1427-z; McGlothlin JW, 2008, PHILOS T R SOC B, V363, P1611, DOI 10.1098/rstb.2007.0002; McGlothlin JW, 2007, AM NAT, V170, P864, DOI 10.1086/522838; Mikics E, 2004, PSYCHONEUROENDOCRINO, V29, P618, DOI 10.1016/S0306-4530(03)00090-8; MOORE MC, 1987, GEN COMP ENDOCR, V65, P225, DOI 10.1016/0016-6480(87)90170-5; Mougeot F, 2003, NATURE, V421, P737, DOI 10.1038/nature01395; Nicol S, 2005, GEN COMP ENDOCR, V144, P204, DOI 10.1016/j.ygcen.2005.05.013; Oliveira RF, 1996, HORM BEHAV, V30, P2, DOI 10.1006/hbeh.1996.0002; Oliveira RF, 2002, COMP BIOCHEM PHYS B, V132, P203, DOI 10.1016/S1096-4959(01)00523-1; Oyegbile TO, 2005, HORM BEHAV, V48, P259, DOI 10.1016/j.yhbeh.2005.04.007; Pinheiro J, 2020, R PACKAGE VERSION 31; R Core Development Team, 2008, R LANG ENV STAT COMP; Remage-Healey L, 2005, HORM BEHAV, V47, P297, DOI 10.1016/j.yhbeh.2004.11.017; Rubenstein DR, 2005, HORM BEHAV, V48, P329, DOI 10.1016/j.yhbeh.2005.04.006; SCHLINGER BA, 1990, COMP BIOCHEM PHYS A, V97, P307, DOI 10.1016/0300-9629(90)90616-Z; Scriba MF, 2010, J ORNITHOL, V151, P607, DOI 10.1007/s10336-010-0493-0; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Simpson K., 2001, MCGILL J MED, V6; Sinn DL, 2008, ANIM BEHAV, V76, P1249, DOI 10.1016/j.anbehav.2008.06.009; Soma KK, 2006, J NEUROENDOCRINOL, V18, P543, DOI 10.1111/j.1365-2826.2006.01440.x; Soma KK, 2000, P ROY SOC B-BIOL SCI, V267, P1089, DOI 10.1098/rspb.2000.1113; Soma KK, 1999, GEN COMP ENDOCR, V115, P442, DOI 10.1006/gcen.1999.7334; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Stamps JA, 2010, PHILOS T R SOC B, V365, P4029, DOI 10.1098/rstb.2010.0218; Stapley J, 2006, J THERM BIOL, V31, P362, DOI 10.1016/j.jtherbio.2006.01.008; Thaker M, 2009, ANIM BEHAV, V77, P395, DOI 10.1016/j.anbehav.2008.10.014; Ubuka T, 2014, GEN COMP ENDOCR, V205, P49, DOI 10.1016/j.ygcen.2014.03.014; Weiss SL, 2004, GEN COMP ENDOCR, V136, P282, DOI 10.1016/j.ygcen.2004.01.001; While GM, 2011, MOL ECOL, V20, P844, DOI 10.1111/j.1365-294X.2010.04976.x; While GM, 2010, HORM BEHAV, V58, P208, DOI 10.1016/j.yhbeh.2010.03.016; While GM, 2009, AUSTRAL ECOL, V34, P938, DOI 10.1111/j.1442-9993.2009.02002.x; While GM, 2009, FUNCT ECOL, V23, P818, DOI 10.1111/j.1365-2435.2009.01544.x; While GM, 2009, P ROY SOC B-BIOL SCI, V276, P2021, DOI 10.1098/rspb.2008.1926; While GM, 2009, BEHAV ECOL, V20, P245, DOI 10.1093/beheco/arp015; Wikelski M, 1999, P ROY SOC B-BIOL SCI, V266, P551, DOI 10.1098/rspb.1999.0671; Wikelski M, 2005, BEHAV ECOL, V16, P260, DOI 10.1093/beheco/arh160; Wingfield J.C., 2006, BIOL AGGRESSION, P179, DOI DOI 10.1093/ACPRO6OSO/9780195168261.0030008; WINGFIELD JC, 1985, HORM BEHAV, V19, P174, DOI 10.1016/0018-506X(85)90017-0; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; WINGFIELD JC, 1987, AM SCI, V75, P602; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001; Yang EJ, 2002, HORM BEHAV, V42, P192, DOI 10.1006/hbeh.2002.1811	80	1	1	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125015	10.1371/journal.pone.0125015	http://dx.doi.org/10.1371/journal.pone.0125015			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906149	Green Submitted, Green Published, gold			2022-12-27	WOS:000353332000100
J	Mahling, M; Fuchs, K; Thaiss, WM; Maier, FC; Feger, M; Bukala, D; Harant, M; Eichner, M; Reutershan, J; Lang, F; Reischl, G; Pichler, BJ; Kneilling, M				Mahling, Moritz; Fuchs, Kerstin; Thaiss, Wolfgang M.; Maier, Florian C.; Feger, Martina; Bukala, Daniel; Harant, Maren; Eichner, Martin; Reutershan, Joerg; Lang, Florian; Reischl, Gerald; Pichler, Bernd J.; Kneilling, Manfred			A Comparative pO(2) Probe and [F-18]-Fluoro-Azomycinarabino-Furanoside ([F-18]FAZA) PET Study Reveals Anesthesia-Induced Impairment of Oxygenation and Perfusion in Tumor and Muscle	PLOS ONE			English	Article							KETAMINE-XYLAZINE; HYPOXIA; CANCER; MICE; ARABINOSIDE; IMPACT; VIVO; FLOW; MRI	Tumor hypoxia can be identified by [F-18]FAZA positron emission tomography, or invasively using oxygen probes. The impact of anesthetics on tumor hypoxia remains controversial. The aim of this comprehensive study was to investigate the impact of isoflurane and ketamine/xylazine anesthesia on [F-18]FAZA uptake and partial oxygen pressure (pO(2)) in carcinoma and muscle tissue of air-and oxygen-breathing mice. Methods CT26 colon carcinoma-bearing mice were anesthetized with isoflurane (IF) or ketamine/xylazine (KX) while breathing air or oxygen (O-2). We performed 10 min static PET scans 1 h, 2 h and 3 h after [F-18]FAZA injection and calculated the [F-18]FAZA-uptake and tumor-to-muscle ratios (T/M). In another experimental group, we placed a pO(2) probe in the tumor as well as in the gastrocnemius muscle to measure the pO(2) and perfusion. Results Ketamine/xylazine-anesthetized mice yielded up to 3.5-fold higher T/M-ratios compared to their isoflurane-anesthetized littermates 1 h, 2 h and 3 h after [F-18]FAZA injection regardless of whether the mice breathed air or oxygen (3 h, KX-air: 7.1 vs. IF-air: 1.8, p = 0.0001, KX-O-2: 4.4 vs. IF-O-2: 1.4, p < 0.0001). The enhanced T/M-ratios in ketamine/xylazine-anesthetized mice were mainly caused by an increased [F-18]FAZA uptake in the carcinomas. Invasive pO(2) probe measurements yielded enhanced intra-tumoral pO(2) values in air-and oxygen-breathing ketamine/xylazine-anesthetized mice compared to isoflurane-anesthetized mice (KX-air: 1.01 mmHg, IF-air: 0.45 mmHg; KX-O-2 9.73 mmHg, IF-O-2: 6.25 mmHg). Muscle oxygenation was significantly higher in air-breathing isoflurane-anesthetized (56.9 mmHg) than in ketamine/xylazine-anesthetized mice (33.8 mmHg, p = 0.0003). Conclusion [F-18]FAZA tumor uptake was highest in ketamine/xylazine-anesthetized mice regardless of whether the mice breathed air or oxygen. The generally lower [F-18]FAZA whole-body uptake in isoflurane-anesthetized mice could be due to the higher muscle pO(2)-values in these mice compared to ketamine/xylazine-anesthetized mice. When performing preclinical in vivo hypoxia PET studies, oxygen should be avoided, and ketamine/xylazine-anesthesia might alleviate the identification of tumor hypoxia areals.	[Mahling, Moritz; Fuchs, Kerstin; Thaiss, Wolfgang M.; Maier, Florian C.; Bukala, Daniel; Harant, Maren; Reischl, Gerald; Pichler, Bernd J.; Kneilling, Manfred] Univ Tubingen, Werner Siemens Imaging Ctr, Dept Preclin Imaging & Radiopharm, D-72076 Tubingen, Germany; [Fuchs, Kerstin; Kneilling, Manfred] Univ Tubingen, Dept Dermatol, D-72076 Tubingen, Germany; [Thaiss, Wolfgang M.] Univ Tubingen, Dept Radiol, D-72076 Tubingen, Germany; [Feger, Martina; Lang, Florian] Univ Tubingen, Dept Physiol, D-72076 Tubingen, Germany; [Eichner, Martin] Univ Tubingen, Inst Clin Epidemiol & Appl Biometry, D-72076 Tubingen, Germany; [Reutershan, Joerg] Univ Tubingen, Dept Anesthesiol & Intens Care Med, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Siemens AG; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Mahling, M (corresponding author), Univ Tubingen, Werner Siemens Imaging Ctr, Dept Preclin Imaging & Radiopharm, Rontgenweg 13, D-72076 Tubingen, Germany.	moritz.mahling@med.uni-tuebingen.de; bernd.pichler@med.uni-tuebingen.de	Thaiss, Wolfgang/ABH-9299-2020	/0000-0001-7960-4015	ERC Advanced Grant IMAGELINK; Medical Faculty Tuebingen; Deutsche Forschungsgemeinschaft [SFB 773]; Bundesministerium fur Bildung und Forschung (BMBF) [FKZ 0314103]; Werner Siemens-Foundation; Interdisciplinary Center for Clinical Research of the University of Tubingen (IZKF)	ERC Advanced Grant IMAGELINK; Medical Faculty Tuebingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Werner Siemens-Foundation; Interdisciplinary Center for Clinical Research of the University of Tubingen (IZKF)	The work was funded by the ERC Advanced Grant IMAGELINK, institutional funding of the Medical Faculty Tuebingen, Deutsche Forschungsgemeinschaft (SFB 773), Bundesministerium fur Bildung und Forschung (BMBF, FKZ 0314103), Werner Siemens-Foundation and the Interdisciplinary Center for Clinical Research of the University of Tubingen (IZKF).	Abramovic Z, 2007, SKIN PHARMACOL PHYS, V20, P77, DOI 10.1159/000097654; Bao Q, 2009, J NUCL MED, V50, P401, DOI 10.2967/jnumed.108.056374; Baudelet C, 2004, MAGN RESON IMAGING, V22, P905, DOI 10.1016/j.mri.2004.02.005; Bergman S A, 1999, Anesth Prog, V46, P10; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; BRATTAIN MG, 1980, CANCER RES, V40, P2142; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; ELMOTAL SMA, 1985, ENDOCRINOLOGY, V116, P2337, DOI 10.1210/endo-116-6-2337; ERHARDT W, 1984, RES EXP MED, V184, P159, DOI 10.1007/BF01852390; Flecknell P., 2009, LAB ANIMAL ANAESTHES; Fuchs K, 2013, MOL IMAGING, V12, P1, DOI 10.2310/7290.2012.00042; Fuchs K, 2012, J NUCL MED, V53, P823, DOI 10.2967/jnumed.111.101808; Gargiulo S, 2012, ILAR J, V53, pE70, DOI 10.1093/ilar.53.1.70; Griffiths JR, 1999, BRIT J RADIOL, V72, P627, DOI 10.1259/bjr.72.859.10624317; HOLM S, 1979, SCAND J STAT, V6, P65; Jaffray DA, 2012, NAT REV CLIN ONCOL, V9, P688, DOI 10.1038/nrclinonc.2012.194; Judenhofer MS, 2008, NAT MED, V14, P459, DOI 10.1038/nm1700; Kersemans V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025911; Krohn KA, 2008, J NUCL MED, V49, p129S, DOI 10.2967/jnumed.107.045914; Kumar P, 1999, J LABELLED COMPD RAD, V42, P3, DOI 10.1002/(SICI)1099-1344(199901)42:1<3::AID-JLCR160>3.0.CO;2-H; Lei H, 2001, BRAIN RES, V913, P174, DOI 10.1016/S0006-8993(01)02786-X; Maier FC, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-165; Matsumura A, 2003, NEUROIMAGE, V20, P2040, DOI 10.1016/j.neuroimage.2003.08.020; Piert M, 2005, J NUCL MED, V46, P106; Pomplun D, 2004, HORM METAB RES, V36, P67, DOI 10.1055/s-2004-814104; Reischl G, 2005, APPL RADIAT ISOTOPES, V62, P897, DOI 10.1016/j.apradiso.2004.12.004; Reischl G, 2007, J PHARM PHARM SCI, V10, P203; Schramm U, 1990, CLIN OXYGEN PRESSURE, VII; Sinclair MD, 2003, CAN VET J, V44, P885; Sumitra M, 2004, LIFE SCI, V75, P1887, DOI 10.1016/j.lfs.2004.05.009; Tavare AN, 2012, INT J CANCER, V130, P1237, DOI 10.1002/ijc.26448; The Jackson Laboratory, 2013, MULT AN PHYS 7 INBR; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Xu Q, 2007, CLIN EXP PHARMACOL P, V34, P499, DOI 10.1111/j.1440-1681.2007.04601.x	34	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124665	10.1371/journal.pone.0124665	http://dx.doi.org/10.1371/journal.pone.0124665			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902054	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500097
J	Chun, YH; Han, K; Park, YG; Yoon, JS; Kim, HH; Kim, JT; Jeong, DC				Chun, Yoon Hong; Han, Kyungdo; Park, Yong-Gyu; Yoon, Jong-Seo; Kim, Hyun Hee; Kim, Jin Tack; Jeong, Dae Chul			Examining Impacts of Allergic Diseases on Psychological Problems and Tobacco Use in Korean Adolescents: The 2008-2011 Korean National Health and Nutrition Examination Survey	PLOS ONE			English	Article							QUALITY-OF-LIFE; ASTHMA OUTCOMES; DEPRESSION; ANXIETY; RISK; ASSOCIATION; PREVALENCE; DISORDERS; SYMPTOMS; GIRLS	Purpose Asthma during adolescence can induce social, psychological, and behavioral problems. We examined the impact of asthma and other allergic diseases on psychological symptoms and health risk behaviors among South Korean adolescents. Methods In this population-based cross-sectional study, 3192 adolescents (10-18 years of age) participating in the 2008-2011 Korean National Health and Nutrition Examination Survey were enrolled. Psychological problems associated with clinically diagnosed asthma, allergic rhinitis, and atopic dermatitis were assessed using questionnaires and surveys. Data was analyzed using logistic regression to determine the association of depression with allergic disease while controlling for age, sex, body mass index, smoking experience, and alcohol use. Results Asthma and atopic dermatitis were associated with a higher prevalence of depression (17.2% and 13%, respectively). After adjusting for the covariates, asthma patients were approximately two times as likely to have depression as non-allergic participants (odds ratio, 1.81; 95% confidence interval, 1.22-2.68). Psychosocial stress significantly increased in the following order: no allergy, any allergy without asthma, asthma only, and asthma with any allergy (p for linear trend = 0.01). The asthma without other allergies group showed the highest prevalence of cigarette smoking (p = 0.007). Conclusions In this study, asthma with or without other allergies was significantly related to increases in depression, psychosocial stress, and smoking experience. Thus, care should be taken to adjust treatment to account for the psychological symptoms and health risk behaviors common among asthmatic adolescents.	[Chun, Yoon Hong] Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Dept Pediat, Seoul, South Korea; [Han, Kyungdo; Park, Yong-Gyu] Catholic Univ Korea, Dept Biostat, Seoul, South Korea; [Yoon, Jong-Seo; Jeong, Dae Chul] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Pediat, Seoul, South Korea; [Kim, Hyun Hee] Catholic Univ Korea, Bucheon St Marys Hosp, Coll Med, Dept Pediat, Seoul, South Korea; [Kim, Jin Tack] Catholic Univ Korea, Uijeongbu St Marys Hosp, Coll Med, Dept Pediat, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea	Jeong, DC (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Pediat, Seoul, South Korea.	dcjeong@catholic.ac.kr		Chun, Yoon Hong/0000-0002-9871-5244; Park, Yong Gyu/0000-0002-8721-3230				[Anonymous], KOR NAT HLTH NUTR EX; Bahreinian S, 2011, CHEST, V140, P1138, DOI 10.1378/chest.11-0219; Chen MH, 2013, J AFFECT DISORDERS, V145, P49, DOI 10.1016/j.jad.2012.07.011; Covaciu C, 2013, J ASTHMA, V50, P522, DOI 10.3109/02770903.2013.789057; Dowdell EB, 2011, NURS RES PRACT, V2011, DOI 10.1155/2011/503201; Feldman JM, 2005, PSYCHOSOM MED, V67, P989, DOI 10.1097/01.psy.0000188556.97979.13; Fonken LK, 2011, MOL PSYCHIATR, V16, P987, DOI 10.1038/mp.2011.76; Hurwitz EL, 1999, AM J EPIDEMIOL, V150, P1107, DOI 10.1093/oxfordjournals.aje.a009936; JUNIPER EF, 1994, J ALLERGY CLIN IMMUN, V93, P413, DOI 10.1016/0091-6749(94)90349-2; Katon W, 2007, J ADOLESCENT HEALTH, V41, P455, DOI 10.1016/j.jadohealth.2007.05.023; Katon W, 2010, AM J PSYCHIAT, V167, P1020, DOI 10.1176/appi.ajp.2010.10050657; Kelsay K, 2005, J PEDIATR PSYCHOL, V30, P522, DOI 10.1093/jpepsy/jsi077; Krauskopf KA, 2013, J ASTHMA, V50, P260, DOI 10.3109/02770903.2012.757779; Lewis-Jones S, 2006, INT J CLIN PRACT, V60, P984, DOI 10.1111/j.1742-1241.2006.01047.x; Liu LY, 2002, AM J RESP CRIT CARE, V165, P1062, DOI 10.1164/ajrccm.165.8.2109065; McCauley E, 2007, GEN HOSP PSYCHIAT, V29, P214, DOI 10.1016/j.genhosppsych.2007.02.003; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Richardson LP, 2006, PEDIATRICS, V118, P1042, DOI 10.1542/peds.2006-0249; Thapar A, 2012, LANCET, V379, P1056, DOI 10.1016/S0140-6736(11)60871-4; Thompson PJ, 2013, RESPIROLOGY, V18, P957, DOI 10.1111/resp.12137; Timonen M, 2003, MOL PSYCHIATR, V8, P738, DOI 10.1038/sj.mp.4001274; Timonen M, 2002, BIOL PSYCHIAT, V52, P349, DOI 10.1016/S0006-3223(01)01364-6; Van Lieshout RJ, 2009, PSYCHOSOM MED, V71, P187, DOI 10.1097/PSY.0b013e3181907012; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Whooley MA, 2000, NEW ENGL J MED, V343, P1942, DOI 10.1056/NEJM200012283432607; Yaghmaie P, 2013, J ALLERGY CLIN IMMUN, V131, P428, DOI 10.1016/j.jaci.2012.10.041	26	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0125172	10.1371/journal.pone.0125172	http://dx.doi.org/10.1371/journal.pone.0125172			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XJ	25897790	Green Submitted, Green Published, gold			2022-12-27	WOS:000353212600098
J	Conway, DP; Guy, R; Davies, SC; Couldwell, DL; McNulty, A; Smith, DE; Keen, P; Cunningham, P; Holt, M				Conway, Damian P.; Guy, Rebecca; Davies, Stephen C.; Couldwell, Deborah L.; McNulty, Anna; Smith, Don E.; Keen, Phillip; Cunningham, Philip; Holt, Martin		Sydney Rapid HIV Test Study	Rapid HIV Testing Is Highly Acceptable and Preferred among High-Risk Gay And Bisexual Men after Implementation in Sydney Sexual Health Clinics	PLOS ONE			English	Article							INFECTION; PREFERENCES; FREQUENCY; EPIDEMIOLOGY; GUIDELINES; BARRIERS; PROGRAM; PILOT	Background Rapid HIV testing (RHT) is well established in many countries, but it is new in Australia. We assessed the acceptability of RHT and its associations among gay, bisexual and other men who have sex with men (GBM) after implementation of RHT in Sydney sexual health clinics. Methods GBM were invited to complete an acceptability questionnaire before and after provision of the result of finger-prick blood RHT, comparing their experience of RHT with conventional HIV testing (CHT) involving venipuncture. Logistic regression was used to assess associations between patient characteristics and the preference for RHT over CHT next time they tested for HIV. Results Of 1061 GBM who received non-reactive RHT results, 59% found RHT less stressful than CHT and 34% reported no difference, and 61% found RHT more comfortable than CHT and 26% reported no difference. Nearly all men were satisfied with RHT result delivery (99%) and the RHT process overall (99%). Most men (79%) preferred RHT for their next HIV test and this preference was stronger in men who were aged 35-44 years (adjusted odds ratio [AOR] 2.49, p<0.01), reported they would test more often if RHT was available (AOR 1.66, p=0.01), found returning for results annoying (AOR 1.67, p=0.01), and found RHT less stressful (AOR 2.37, p<0.01) and more comfortable (AOR 1.62, p=0.02) than CHT. Men concerned about the reliability of RHT were less than half as likely to prefer RHT for their next HIV test (AOR 0.44, p<0.01). Conclusions Most GBM preferred RHT to CHT next time and this preference was associated with finding RHT more convenient, more comfortable and less stressful than CHT. These findings suggest that in a clinic setting RHT should be considered to improve the patient experience and may potentially increase uptake and frequency of HIV testing.	[Conway, Damian P.; Guy, Rebecca; Keen, Phillip] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Conway, Damian P.] St George Hosp, Short St Sexual Hlth Ctr, Kogarah, NSW, Australia; [Davies, Stephen C.] Royal N Shore Hosp, North Shore Sexual Hlth Serv, St Leonards, NSW 2065, Australia; [Davies, Stephen C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Couldwell, Deborah L.] Western Sydney Local Hlth Dist, Western Sydney Sexual Hlth Ctr, Sydney, NSW, Australia; [Couldwell, Deborah L.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [McNulty, Anna] Sydney Hosp, Sydney Sexual Hlth Ctr, Sydney, NSW, Australia; [McNulty, Anna; Smith, Don E.] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Smith, Don E.] Albion Ctr, Surry Hills, NSW, Australia; [Cunningham, Philip] Univ New S Wales, St Vincents Ctr Appl Med Res, Sydney, NSW, Australia; [Cunningham, Philip] St Vincents Hosp, NSW State Reference Lab HIV, Darlinghurst, NSW 2010, Australia; [Holt, Martin] Univ New S Wales, Ctr Social Res Hlth, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute; St George Hospital; Royal North Shore Hospital; University of Sydney; University of Sydney; University of New South Wales Sydney; University of New South Wales Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney	Conway, DP (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	dconway@kirby.unsw.edu.au	Cunningham, Philip/GZH-1820-2022; Conway, Damian Patrick/F-2789-2012; Holt, Martin/X-6482-2019	Conway, Damian Patrick/0000-0003-3316-2199; Holt, Martin/0000-0002-2586-8274; O'Sullivan, Matthew/0000-0001-8783-5323; Rawlinson, William/0000-0003-0988-7827; Keen, Phillip/0000-0002-2678-0645; Cunningham, Philip/0000-0003-2613-6910; Guy, Rebecca/0000-0002-2929-4634	National Health & Medical Research Council STI Program Grant [568971]; Australian Rotary Health & Sydney CBD Rotary Club	National Health & Medical Research Council STI Program Grant; Australian Rotary Health & Sydney CBD Rotary Club	The Sydney Rapid HIV Test Study was supported by funding from the National Health & Medical Research Council STI Program Grant Application ID 568971 (https://www.nhmrc.gov.au). Australian Rotary Health & Sydney CBD Rotary Club supported a scholarship for DPC (http://www.australianrotaryhealth.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alere Medical Co. Ltd, 2011, DET HIV 1 2 AG AB CO; Bavinton BR, 2013, AIDS BEHAV, V17, P2084, DOI 10.1007/s10461-013-0450-z; Beelaert G, 2010, J VIROL METHODS, V168, P218, DOI 10.1016/j.jviromet.2010.06.002; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Bilardi JE, 2013, AIDS BEHAV, V17, P2093, DOI 10.1007/s10461-012-0395-7; Birrell F, 2010, SEX HEALTH, V7, P11, DOI 10.1071/SH09029; Centers for Diease Control and Prevention, 2011, HIV SURV REP, V23; Champenois K, 2012, BMJ OPEN, V2, DOI [10.1136/bmjopen-2011-000693, DOI 10.1136/bmjopen-2011-000693]; Chen MY, 2010, INT J STD AIDS, V21, P428, DOI 10.1258/ijsa.2010.009552; Cohen MS, 2010, CLIN INFECT DIS, V50, pS85, DOI 10.1086/651478; Conway DP, 2015, HIV MED, V16, P280, DOI 10.1111/hiv.12209; Conway DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094062; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; de Wit J, 2014, HIV AIDS HEPATITIS S; Debattista J, 2007, SEX HEALTH, V4, P105, DOI 10.1071/SH07014; European Centre for Disease Prevention and Control/ WHO Regional Office for Europe, 2013, HIV AIDS SURV EUR 20; Fidler S, 2013, NEW ENGL J MED, V368, P207, DOI 10.1056/NEJMoa1110039; Gray RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055449; Guenter D, 2008, AIDS PATIENT CARE ST, V22, P195, DOI 10.1089/apc.2007.0137; Guy R, 2010, SEX TRANSM INFECT, V86, P371, DOI 10.1136/sti.2009.040972; Hull P, 2011, SYDNEY GAY COMMUNITY; Hutchinson AB, 2004, AIDS EDUC PREV, V16, P101, DOI 10.1521/aeap.16.2.101.29394; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1; MacKellar DA, 2011, SEX TRANSM DIS, V38, P419, DOI 10.1097/OLQ.0b013e31820369dd; Mallitt KA, 2012, SEX HEALTH, V9, P138, DOI 10.1071/SH10141; Masciotra S, 2013, J CLIN VIROL, V58, pE54, DOI 10.1016/j.jcv.2013.07.002; Merchant RC, 2009, AIDS CARE, V21, P490, DOI 10.1080/09540120802270284; New South Wales Centre for Population Health, 2013, HIV NSW DAT PERF MON, P12; Paz-Bailey G, 2013, MMWR-MORBID MORTAL W, V62, P958; Poynten IM, 2010, HIV MED, V11, P635, DOI 10.1111/j.1468-1293.2010.00833.x; Prestage G, 2012, SEX HEALTH, V9, P453, DOI 10.1071/SH12033; Read TRH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5086; Rosenberg NE, 2012, J INFECT DIS, V205, P528, DOI 10.1093/infdis/jir789; San Antonio-Gaddy M, 2006, JAIDS-J ACQ IMM DEF, V43, P446; Sharma A, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-109; Smith LV, 2006, AIDS PATIENT CARE ST, V20, P693, DOI 10.1089/apc.2006.20.693; Spielberg F, 2003, JAIDS-J ACQ IMM DEF, V32, P318, DOI 10.1097/00126334-200303010-00012; Templeton DJ, 2014, SEX HEALTH, V11, P217, DOI 10.1071/SH14003; The Kirby Institute, 2014, HIV VIR HEP SEX TRAN; Therapeutic Goods Administration, 2014, HIV SELF TESTS AUSTR; Wilson DP, 2009, SEX HEALTH, V6, P19, DOI 10.1071/SH08081; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	43	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123814	10.1371/journal.pone.0123814	http://dx.doi.org/10.1371/journal.pone.0123814			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XJ	25898140	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600042
J	Liu, JC; Li, MH; Lu, H; Qiao, WG; Xi, D; Luo, TT; Xiong, HW; Guo, ZG				Liu, Jichen; Li, Menghao; Lu, Hao; Qiao, Weiguang; Xi, Dan; Luo, Tian Tian; Xiong, Haowei; Guo, Zhigang			Effects of Probucol on Restenosis after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							BALLOON ANGIOPLASTY; ANTIOXIDANT PROBUCOL; ENDOTHELIAL FUNCTION; STENT IMPLANTATION; OXIDATIVE STRESS; ARTERY-DISEASE; ATHEROSCLEROSIS; AGI-1067; PREVENTION; INHIBITION	Background Restenosis after percutaneous coronary intervention (PCI) is a remained clinical problem which limits long-term success of PCI. Although there was recognition that probucol in treating restenosis after percutaneous transluminal coronary angioplasty, the efficacy of probucol on restenosis after stent-implantation is controversial. So this meta-analysis was conducted to investigate the association between probucol and late restenosis. Methods Articles were assessed by four trained investigators, with divergences resolved by consensus. PubMed, EMBASE, ScienceDirect and the Cochrane Central Register of clinical trials were searched for pertinent studies. Inclusion criteria were random allocated to treatment and a comparison of probucol-treated patients and control patients (not treated with lipid-lowering drug) undergoing PCI. Results Fifteen studies with 859 subjects were analyzed. Major outcome, binary angiographic restenosis defined as >50% stenosis upon follow-up angiography, was significantly decreased with probucol treatment (RR = 0.59 [0.43, 0.80] among vessels, P = 0.0007; and RR = 0.52 [0.40, 0.68] among patients, P<0.00001). Probucol also increased the minimal luminal diameter (SMD = 0.45 [0.30, 0.61], P<0.00001) and decreased late loss upon follow-up after 6 months (SMD = -0.41 [-0.60, -0.22], P<0.0001). Moreover, there was a significantly lower incidence of major adverse cardiac events (MACE) in the probucol group than control group (RR = 0.69 [0.51, 0.93], P = 0.01). Conclusion Probucol is more than a lipid-lowering drug. It is also effective in reducing the risk of restenosis and incidence of MACE after PCI.	[Liu, Jichen; Li, Menghao; Lu, Hao; Xi, Dan; Luo, Tian Tian; Xiong, Haowei; Guo, Zhigang] Southern Med Univ, Nanfang Hosp, Div Cardiol, Guangzhou 510515, Guangdong, Peoples R China; [Qiao, Weiguang] Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Guo, ZG (corresponding author), Southern Med Univ, Nanfang Hosp, Div Cardiol, Guangzhou 510515, Guangdong, Peoples R China.	guozhigang126@126.com			National Natural Science Foundation of China [81370380]; Natural Science Foundation of Guangdong Province of China [S2013010014739]; Science and Technology Foundation of Guangdong Province of China [2012B091100155]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); Science and Technology Foundation of Guangdong Province of China	This project was supported by the National Natural Science Foundation of China (81370380), the Natural Science Foundation of Guangdong Province of China (S2013010014739), and the Science and Technology Foundation of Guangdong Province of China (2012B091100155). The funders had no role in study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Byrne RA, 2009, EUR HEART J, V30, P923, DOI 10.1093/eurheartj/ehp044; CALIFF RM, 1991, J AM COLL CARDIOL, V17, pB2; Daida H, 2000, AM J CARDIOL, V86, P550, DOI 10.1016/S0002-9149(00)01013-4; Deng YM, 2004, CIRCULATION, V110, P1855, DOI 10.1161/01.CIR.0000142610.10530.25; DRASH AL, 1988, AM J CARDIOL, V62, pB27, DOI 10.1016/S0002-9149(88)80047-X; DUSSAILLANT GR, 1995, J AM COLL CARDIOL, V26, P720, DOI 10.1016/0735-1097(95)00249-4; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FANELLI C, 1990, AM HEART J, V119, P357, DOI 10.1016/S0002-8703(05)80028-6; FERNS GAA, 1993, ATHEROSCLEROSIS, V100, P171, DOI 10.1016/0021-9150(93)90203-7; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; FRANCESCHINI G, 1989, ARTERIOSCLEROSIS, V9, P462, DOI 10.1161/01.ATV.9.4.462; Gorogawa S, 2002, DIABETES RES CLIN PR, V57, P1, DOI 10.1016/S0168-8227(02)00005-0; Grewe PH, 2000, J AM COLL CARDIOL, V35, P157, DOI 10.1016/S0735-1097(99)00486-6; Guo ZG, 2012, CHEM PHYS LIPIDS, V165, P32, DOI 10.1016/j.chemphyslip.2011.10.005; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoffmann R, 1996, CIRCULATION, V94, P1247, DOI 10.1161/01.CIR.94.6.1247; Kaminnyi AI, 2005, B EXP BIOL MED+, V139, P183, DOI 10.1007/s10517-005-0242-1; Kasai T, 2012, ATHEROSCLEROSIS, V220, P463, DOI 10.1016/j.atherosclerosis.2011.09.051; KEANEY JF, 1995, J CLIN INVEST, V95, P2520, DOI 10.1172/JCI117953; Kim MH, 2002, CATHETER CARDIO INTE, V57, P424, DOI 10.1002/ccd.10346; Kunsch C, 2004, J PHARMACOL EXP THER, V308, P820, DOI 10.1124/jpet.103.059733; KUNTZ RE, 1993, CIRCULATION, V88, P1310, DOI 10.1161/01.CIR.88.3.1310; Lau AK, 2003, CIRCULATION, V107, P2031, DOI 10.1161/01.CIR.0000062682.40051.43; Li JF, 2014, EXP MOL PATHOL, V96, P250, DOI 10.1016/j.yexmp.2014.02.010; Li S, 2014, J ATHEROSCLER THROMB, V21, P648, DOI 10.5551/jat.21600; Mak KH, 1996, J AM COLL CARDIOL, V27, P494, DOI 10.1016/0735-1097(95)00466-1; Massberg S, 2011, CIRCULATION, V124, P624, DOI 10.1161/CIRCULATIONAHA.111.026732; Mintz GS, 1996, CIRCULATION, V94, P35, DOI 10.1161/01.CIR.94.1.35; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Moreno R, 2004, J AM COLL CARDIOL, V43, P1964, DOI 10.1016/j.jacc.2004.01.039; Nunes GL, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.05.005; Pratt RE, 1996, CIRCULATION, V93, P848, DOI 10.1161/01.CIR.93.5.848; Reinoehl J, 1996, AM HEART J, V131, P1184, DOI 10.1016/S0002-8703(96)90095-2; Rodes J, 1998, CIRCULATION, V97, P429; Sawayama Y, 2002, J AM COLL CARDIOL, V39, P610, DOI 10.1016/S0735-1097(01)01783-1; SCHNEIDER JE, 1993, CIRCULATION, V88, P628, DOI 10.1161/01.CIR.88.2.628; Sekiya M, 1998, AM J CARDIOL, V82, P144, DOI 10.1016/S0002-9149(98)00323-3; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; SETSUDA M, 1993, CLIN THER, V15, P374; Sundell CL, 2003, J PHARMACOL EXP THER, V305, P1116, DOI 10.1124/jpet.102.048132; Tagawa T, 2004, HYPERTENS RES, V27, P311, DOI 10.1291/hypres.27.311; Tan YW, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0105192, 10.1371/journal.pone.0094264]; Tardif JC, 2003, CIRCULATION, V107, P552, DOI 10.1161/01.CIR.0000047525.58618.3C; Tardif JC, 1997, NEW ENGL J MED, V337, P365, DOI 10.1056/NEJM199708073370601; Tardif JC, 2008, LANCET, V371, P1761, DOI 10.1016/S0140-6736(08)60763-1; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Wakeyama T, 2003, CIRC J, V67, P519; Watanabe K, 1996, AM HEART J, V132, P23, DOI 10.1016/S0002-8703(96)90386-5; Wu BJ, 2006, J EXP MED, V203, P1117, DOI 10.1084/jem.20052321; Yamamoto S, 2011, CIRCULATION, V124, P1382, DOI 10.1161/CIRCULATIONAHA.110.009704; Yokoi H, 1997, J AM COLL CARDIOL, V30, P855, DOI 10.1016/S0735-1097(97)00270-2; Zhong JK, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-210	53	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124021	10.1371/journal.pone.0124021	http://dx.doi.org/10.1371/journal.pone.0124021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898372	Green Submitted, Green Published, gold			2022-12-27	WOS:000353212600046
J	Nakao, S; Wakabayashi, S; Nakamura, TY				Nakao, Shu; Wakabayashi, Shigeo; Nakamura, Tomoe Y.			Stimulus-Dependent Regulation of Nuclear Ca2+ Signaling in Cardiomyocytes: A Role of Neuronal Calcium Sensor-1	PLOS ONE			English	Article							CARDIAC MYOCYTES; ATRIAL MYOCYTES; RELEASE; MEMORY; MICRODOMAINS; MODULATION; PLASTICITY; RETICULUM; ENVELOPE; RECEPTOR	In cardiomyocytes, intracellular calcium (Ca2+) transients are elicited by electrical and receptor stimulations, leading to muscle contraction and gene expression, respectively. Although such elevations of Ca2+ levels ([Ca2+]) also occur in the nucleus, the precise mechanism of nuclear [Ca2+] regulation during different kinds of stimuli, and its relationship with cytoplasmic [Ca2+] regulation are not fully understood. To address these issues, we used a new region-specific fluorescent protein-based Ca2+ indicator, GECO, together with the conventional probe Fluo-4 AM. We confirmed that nuclear Ca2+ transients were elicited by both electrical and receptor stimulations in neonatal mouse ventricular myocytes. Kinetic analysis revealed that electrical stimulation-elicited nuclear Ca2+ transients are slower than cytoplasmic Ca2+ transients, and chelating cytoplasmic Ca2+ abolished nuclear Ca2+ transients, suggesting that nuclear Ca2+ are mainly derived from the cytoplasm during electrical stimulation. On the other hand, receptor stimulation such as with insulin-like growth factor-1 (IGF-1) preferentially increased nuclear [Ca2+] compared to cytoplasmic [Ca2+]. Experiments using inhibitors revealed that electrical and receptor stimulation-elicited Ca2+ transients were mainly mediated by ryanodine receptors and inositol 1,4,5-trisphosphate receptors (IP3Rs), respectively, suggesting different mechanisms for the two signals. Furthermore, IGF-1-elicited nuclear Ca2+ transient amplitude was significantly lower in myocytes lacking neuronal Ca2+ sensor-1 (NCS-1), a Ca2+ binding protein implicated in IP3R-mediated pathway in the heart. Moreover, IGF-1 strengthened the interaction between NCS-1 and IP3R. These results suggest a novel mechanism for receptor stimulation-induced nuclear [Ca2+] regulation mediated by IP3R and NCS-1 that may further fine-tune cardiac Ca2+ signal regulation.	[Nakao, Shu; Wakabayashi, Shigeo; Nakamura, Tomoe Y.] Natl Cerebral & Cardiovasc Ctr, Dept Mol Physiol, Suita, Osaka, Japan; [Wakabayashi, Shigeo] Natl Cerebral & Cardiovasc Ctr, Dept Cardiac Physiol, Suita, Osaka, Japan	National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan	Nakamura, TY (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Mol Physiol, Suita, Osaka, Japan.	tomoen@ri.ncvc.go.jp	Nakao, Shu/L-1796-2019	Nakao, Shu/0000-0001-8990-1179	JSPS KAKENHI [25860174, 24590293]; Naito Science & Engineering Foundation [J004]; Intramural Research Fund for Cardiovascular Disease of the National Cerebral and Cardiovascular Center [22-2-3]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Naito Science & Engineering Foundation; Intramural Research Fund for Cardiovascular Disease of the National Cerebral and Cardiovascular Center	This work was supported by JSPS KAKENHI, Grant-in-Aid for Young Scientists (B) #25860174 (http://www.jsps.go.jp/j-grantsinaid/03_keikaku/download.html) that SN received, Grant-in-Aid for Scientific Research (C) #24590293 (http://www.jsps.go.jp/j-grantsinaid/03_keikaku/download.html) that TYN received, The Naito Science & Engineering Foundation #J004 (https://www.naito-f.or.jp/jp/joseikn/jo_index.php?data = detail&grant_id=KEN) that TYN received, and by Intramural Research Fund for Cardiovascular Disease of the National Cerebral and Cardiovascular Center #22-2-3 that SW received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bare DJ, 2005, J BIOL CHEM, V280, P15912, DOI 10.1074/jbc.M414212200; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Drumond LE, 2012, BRAIN RES BULL, V88, P385, DOI 10.1016/j.brainresbull.2012.04.005; Escobar M, 2011, J MOL CELL CARDIOL, V50, P451, DOI 10.1016/j.yjmcc.2010.11.021; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; Fox JL, 1997, BIOCHEM J, V326, P491, DOI 10.1042/bj3260491; Gomez M, 2001, NEURON, V30, P241, DOI 10.1016/S0896-6273(01)00276-8; Guatimosim S, 2008, CELL CALCIUM, V44, P230, DOI 10.1016/j.ceca.2007.11.016; Higazi DR, 2009, MOL CELL, V33, P472, DOI 10.1016/j.molcel.2009.02.005; Hui K, 2007, DEVELOPMENT, V134, P4479, DOI 10.1242/dev.008979; Ibarra C, 2013, CIRC RES, V112, P236, DOI 10.1161/CIRCRESAHA.112.273839; Kim JC, 2010, MOL CELLS, V29, P387, DOI 10.1007/s10059-010-0039-6; Kockskamper J, 2008, J CELL SCI, V121, P186, DOI 10.1242/jcs.021386; Koizumi S, 2002, J BIOL CHEM, V277, P30315, DOI 10.1074/jbc.M201132200; Ledeen R, 2007, J NEUROCHEM, V103, P126, DOI 10.1111/j.1471-4159.2007.04722.x; Ljubojevic S, 2011, BIOPHYS J, V100, P2356, DOI 10.1016/j.bpj.2011.03.060; Nakamura TY, 2011, CIRC RES, V109, P512, DOI 10.1161/CIRCRESAHA.111.248864; Nakamura TY, 2006, J CELL BIOL, V172, P1081, DOI 10.1083/jcb.200508156; NAKAMURA TY, 1993, CIRC RES, V73, P758, DOI 10.1161/01.RES.73.4.758; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Saab BJ, 2009, NEURON, V63, P643, DOI 10.1016/j.neuron.2009.08.014; Sippy T, 2003, NAT NEUROSCI, V6, P1031, DOI 10.1038/nn1117; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Wu X, 2006, CIRC RES, V99, P283, DOI 10.1161/01.RES.0000233386.02708.72; Zhang K, 2010, J MOL CELL CARDIOL, V49, P829, DOI 10.1016/j.yjmcc.2010.08.018; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592; Zima AV, 2007, J PHYSIOL-LONDON, V584, P601, DOI 10.1113/jphysiol.2007.140731	30	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0125050	10.1371/journal.pone.0125050	http://dx.doi.org/10.1371/journal.pone.0125050			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897502	gold, Green Published, Green Submitted			2022-12-27	WOS:000353212600095
J	De Souza, DA; Wang, Y; Kaftanoglu, O; De Jong, D; Amdam, GV; Goncalves, LS; Francoy, TM				De Souza, Daiana A.; Wang, Ying; Kaftanoglu, Osman; De Jong, David; Amdam, Gro V.; Goncalves, Lionel S.; Francoy, Tiago M.			Morphometric Identification of Queens, Workers and Intermediates in In Vitro Reared Honey Bees (Apis mellifera)	PLOS ONE			English	Article							JUVENILE-HORMONE; EVOLUTION; LARVAL; NUMBER; BROOD	In vitro rearing is an important and useful tool for honey bee (Apis mellifera L.) studies. However, it often results in intercastes between queens and workers, which are normally are not seen in hive-reared bees, except when larvae older than three days are grafted for queen rearing. Morphological classification (queen versus worker or intercastes) of bees produced by this method can be subjective and generally depends on size differences. Here, we propose an alternative method for caste classification of female honey bees reared in vitro, based on weight at emergence, ovariole number, spermatheca size and size and shape, and features of the head, mandible and basitarsus. Morphological measurements were made with both traditional morphometric and geometric morphometrics techniques. The classifications were performed by principal component analysis, using naturally developed queens and workers as controls. First, the analysis included all the characters. Subsequently, a new analysis was made without the information about ovariole number and spermatheca size. Geometric morphometrics was less dependent on ovariole number and spermatheca information for caste and intercaste identification. This is useful, since acquiring information concerning these reproductive structures requires time-consuming dissection and they are not accessible when abdomens have been removed for molecular assays or in dried specimens. Additionally, geometric morphometrics divided intercastes into more discrete phenotype subsets. We conclude that morphometric geometrics are superior to traditional morphometrics techniques for identification and classification of honey bee castes and intermediates.	[De Souza, Daiana A.; De Jong, David; Francoy, Tiago M.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, BR-14049 Ribeirao Preto, SP, Brazil; [Wang, Ying; Kaftanoglu, Osman; Amdam, Gro V.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Amdam, Gro V.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Goncalves, Lionel S.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, BR-14049 Ribeirao Preto, SP, Brazil; [Goncalves, Lionel S.] Univ Fed Semiarido, Mossoro, RN, Brazil; [Francoy, Tiago M.] Univ Sao Paulo, Escola Artes Ciencias Humanidades, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Arizona State University; Arizona State University-Tempe; Norwegian University of Life Sciences; Universidade de Sao Paulo; Universidade de Sao Paulo	De Souza, DA (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, BR-14049 Ribeirao Preto, SP, Brazil.	daianasouz@usp.br	De Jong, David/H-4668-2012; Francoy, TIago/AFW-5399-2022	De Jong, David/0000-0003-2131-9988; Francoy, Tiago Mauricio/0000-0002-2413-966X	National Counsel of Technological and Scientific Development [141512/2010-5]; CAPES foundation [9813/11-0]; Sao Paulo Research Foundation [2011/07857-9]	National Counsel of Technological and Scientific Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by 141512/2010-5 to DADS, National Counsel of Technological and Scientific Development, http://www.cnpq.br/; 9813/11-0 to DADS, CAPES foundation, http://sacexterior.capes.gov.br/sacexterior/; 2011/07857-9 to TMF, Sao Paulo Research Foundation, http://www.fapesp.br/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Adams DC, 2013, HYSTRIX, V24, P7, DOI 10.4404/hystrix-24.1-6283; [Anonymous], 2008, TPSDIG VERSION 2 12, DOI DOI 10.1111/ecog.00762; [Anonymous], 1974, SOCIAL BEHAV BEES; ASENCOT M, 1976, LIFE SCI, V18, P693, DOI 10.1016/0024-3205(76)90180-6; Aupinel Merrick, 2007, Redia, V90, P91; BECKER R, 2009, JULIUS KUHN ARCH, V423, P43; Bookstein FL, 1998, ACTA ZOOL ACAD SCI H, V44, P7; Bookstein FL, 1996, B MATH BIOL, V58, P313, DOI 10.1016/0092-8240(95)00329-0; Bridges C.B., 1923, 3 CHROMOSOME GROUP M; Brodschneider R, 2009, APIDOLOGIE, V40, P441, DOI 10.1051/apido/2009006; Crailsheim K, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.05; Dedej S, 1998, J APICULT RES, V37, P183, DOI 10.1080/00218839.1998.11100970; DeGrandi-Hoffman G, 2004, ANN ENTOMOL SOC AM, V97, P1299, DOI 10.1603/0013-8746(2004)097[1299:DOAIBA]2.0.CO;2; Dietrich MR, 2000, AM ZOOL, V40, P738, DOI 10.1668/0003-1569(2000)040[0738:FHMTHE]2.0.CO;2; Eckert JE, 1934, J ECON ENTOMOL, V27, P629, DOI 10.1093/jee/27.3.629; Francoy TM, 2008, APIDOLOGIE, V39, P488, DOI 10.1051/apido:2008028; Francoy TM, 2012, APIDOLOGIE, V43, P609, DOI 10.1007/s13592-012-0132-2; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; JAY SC, 1965, CAN J ZOOLOG, V43, P541, DOI 10.1139/z65-053; Kaftanoglu O, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.9601; Laidlaw Jr H. H., 1979, CONT QUEEN REARING; Leimar O, 2012, ECOL EVOL, V2, P3098, DOI 10.1002/ece3.414; Linksvayer TA, 2011, J EVOLUTION BIOL, V24, P1939, DOI 10.1111/j.1420-9101.2011.02331.x; Luna L.G., 1992, HISTOPATHOLOGICAL ME; Maeda RK, 2009, CURR TOP DEV BIOL, V88, P1, DOI 10.1016/S0070-2153(09)88001-0; MICHAEL AS, 1955, J ECON ENTOMOL, V48, P43, DOI 10.1093/jee/48.1.43; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; MORSE RA, 1979, REARING QUEEN HONEY; Mutti NS, 2011, J EXP BIOL, V214, P3977, DOI 10.1242/jeb.061499; Oomen P. A., 1992, Bulletin OEPP, V22, P613, DOI 10.1111/j.1365-2338.1992.tb00546.x; Page RE, 2001, EXP GERONTOL, V36, P695, DOI 10.1016/S0531-5565(00)00236-9; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; PENG YSC, 1992, J INVERTEBR PATHOL, V60, P127, DOI 10.1016/0022-2011(92)90085-I; REMBOLD H, 1974, J INSECT PHYSIOL, V20, P307, DOI 10.1016/0022-1910(74)90063-8; Rembold H., 1983, QUEEN REARING BIOL B; REMBOLD HEINZ, 1965, VITAMINS HORMONES, V23, P359; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; ROHLF FJ, 2007, TPSRELW VERSION 1 45; Schur Andrea, 2003, Bulletin of Insectology, V56, P91; SHUEL RW, 1978, J APICULT RES, V17, P57, DOI 10.1080/00218839.1978.11099904; Snodgrass RE, 1992, HIVE HONEY BEE, P103; STATSOFT INC, 2004, PROGR COMP STAT 7 0; Tarpy DR, 2011, INSECT SOC, V58, P569, DOI 10.1007/s00040-011-0180-z; Von Rhein Werner, 1933, Wilhelm Roux Arch Entwickl Mech Org, V129, P601, DOI 10.1007/BF00656581; Winston M.L., 1991, BIOL HONEY BEE; WITTMANN D, 1981, Z ANGEW ENTOMOL, V92, P165; Wolschin F, 2011, BIOL LETTERS, V7, P112, DOI 10.1098/rsbl.2010.0463	48	23	23	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123663	10.1371/journal.pone.0123663	http://dx.doi.org/10.1371/journal.pone.0123663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894528	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000353211700048
J	Grier, MD; Carson, RP; Lagrange, AH				Grier, Mark D.; Carson, Robert P.; Lagrange, Andre Hollis			Toward a Broader View of Ube3a in a Mouse Model of Angelman Syndrome: Expression in Brain, Spinal Cord, Sciatic Nerve and Glial Cells	PLOS ONE			English	Article							UBIQUITIN LIGASE; WHITE-MATTER; REVEALS; GENE	Angelman Syndrome (AS) is a devastating neurodevelopmental disorder characterized by developmental delay, speech impairment, movement disorder, sleep disorders and refractory epilepsy. AS is caused by loss of the Ube3a protein encoded for by the imprinted Ube3a gene. Ube3a is expressed nearly exclusively from the maternal chromosome in mature neurons. While imprinting in neurons of the brain has been well described, the imprinting and expression of Ube3a in other neural tissues remains relatively unexplored. Moreover, given the overwhelming deficits in brain function in AS patients, the possibility of disrupted Ube3a expression in the infratentorial nervous system and its consequent disability have been largely ignored. We evaluated the imprinting status of Ube3a in the spinal cord and sciatic nerve and show that it is also imprinted in these neural tissues. Furthermore, a growing body of clinical and radiological evidence has suggested that myelin dysfunction may contribute to morbidity in many neurodevelopmental syndromes. However, findings regarding Ube3a expression in non-neuronal cells of the brain have varied. Utilizing enriched primary cultures of oligodendrocytes and astrocytes, we show that Ube3a is expressed, but not imprinted in these cell types. Unlike many other neurodevelopmental disorders, AS symptoms do not become apparent until roughly 6 to 12 months of age. To determine the temporal expression pattern and silencing, we analyzed Ube3a expression in AS mice at several time points. We confirm relaxed imprinting of Ube3a in neurons of the postnatal developing cortex, but not in structures in which neurogenesis and migration are more complete. This furthers the hypothesis that the apparently normal window of development in AS patients is supported by an incompletely silenced paternal allele in developing neurons, resulting in a relative preservation of Ube3a expression during this crucial epoch of early development.	[Grier, Mark D.; Carson, Robert P.; Lagrange, Andre Hollis] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37232 USA; [Carson, Robert P.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Lagrange, Andre Hollis] Tennessee Valley Vet Adm, Dept Neurol, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University	Lagrange, AH (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37232 USA.	Andre.H.Lagrange@vanderbilt.edu	Lagrange, Andre/B-1227-2008	Lagrange, Andre/0000-0003-0147-7778	Vanderbilt Kennedy Center [VA 1I01BX001189]; National Institute of Neurological Disorders and Stroke; NIH [5K08NS050484]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS050484, K08NS083710] Funding Source: NIH RePORTER	Vanderbilt Kennedy Center; National Institute of Neurological Disorders and Stroke; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by a Hobbs Discovery Grant from the Vanderbilt Kennedy Center and VA 1I01BX001189 to AHL and the National Institute of Neurological Disorders and Stroke; NIH (5K08NS050484) to RPC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Castro-Gago M, 2010, EUR J PAEDIATR NEURO, V14, P292, DOI 10.1016/j.ejpn.2009.07.007; Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107; Corty Megan M, 2013, J Cell Biol, V203, P395, DOI 10.1083/jcb.201306099; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Egawa K, 2008, NEUROIMAGE, V39, P593, DOI 10.1016/j.neuroimage.2007.09.006; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gustin RM, 2010, NEUROBIOL DIS; Harting I, 2009, EUR J PAEDIATR NEURO, V13, P271, DOI 10.1016/j.ejpn.2008.04.005; Heck DH, 2008, HUM MOL GENET, V17, P2181, DOI 10.1093/hmg/ddn117; Huang HS, 2012, NATURE, V481, P185, DOI 10.1038/nature10726; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Judson MC, 2014, J COMP NEUROL, V522, P1874, DOI 10.1002/cne.23507; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Lossie AC, 2001, J MED GENET, V38, P834, DOI 10.1136/jmg.38.12.834; Lu YB, 2009, HUM MOL GENET, V18, P454, DOI 10.1093/hmg/ddn373; Meng LY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004039; Meng LY, 2012, HUM MOL GENET, V21, P3001, DOI 10.1093/hmg/dds130; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; O'Meara RW, 2011, JOVE-J VIS EXP, DOI 10.3791/3324; Peters SU, 2011, DEV MED CHILD NEUROL, V53, P361, DOI 10.1111/j.1469-8749.2010.03838.x; Sato M, 2010, P NATL ACAD SCI USA, V107, P5611, DOI 10.1073/pnas.1001281107; Simao G, 2010, AM J NEURORADIOL, V31, P1273, DOI 10.3174/ajnr.A2033; Smith A, 1997, J MED GENET, V34, P426, DOI 10.1136/jmg.34.5.426; Smith SEP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002627; Walz NC, 2006, AM J OCCUP THER, V60, P472, DOI 10.5014/ajot.60.4.472; Williams CA, 2006, AM J MED GENET A, V140A, P413, DOI 10.1002/ajmg.a.31074; Williams CA, 2010, GENET MED, V12, P385, DOI 10.1097/GIM.0b013e3181def138; Wolff JJ, 2012, AM J PSYCHIAT, V169, P589, DOI 10.1176/appi.ajp.2011.11091447; Yarnasaki K, 2003, HUM MOL GENET, V12, P837, DOI 10.1093/hmg/ddg106	31	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124649	10.1371/journal.pone.0124649	http://dx.doi.org/10.1371/journal.pone.0124649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894543	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700112
J	Hubble, RP; Naughton, GA; Silburn, PA; Cole, MH				Hubble, Ryan P.; Naughton, Geraldine A.; Silburn, Peter A.; Cole, Michael H.			Wearable Sensor Use for Assessing Standing Balance and Walking Stability in People with Parkinson's Disease: A Systematic Review	PLOS ONE			English	Review							EXERCISE PROGRAM; INERTIAL SENSORS; CONTROLLED-TRIAL; HARMONIC RATIOS; BODY MOTION; FALL RISK; GO TEST; GAIT; HEAD; STRATEGIES	Background Postural instability and gait disability threaten the independence and well-being of people with Parkinson's disease and increase the risk of falls and fall-related injuries. Prospective research has shown that commonly-used clinical assessments of balance and walking lack the sensitivity to accurately and consistently identify those people with Parkinson's disease who are at a higher risk of falling. Wearable sensors provide a portable and affordable alternative for researchers and clinicians who are seeking to objectively assess movements and falls risk in the clinical setting. However, no consensus currently exists on the optimal placements for sensors and the best outcome measures to use for assessing standing balance and walking stability in Parkinson's disease patients. Hence, this systematic review aimed to examine the available literature to establish the best sensor types, locations and outcomes to assess standing balance and walking stability in this population. Methods Papers listed in three electronic databases were searched by title and abstract to identify articles measuring standing balance or walking stability with any kind of wearable sensor among adults diagnosed with PD. To be eligible for inclusion, papers were required to be full-text articles published in English between January 1994 and December 2014 that assessed measures of standing balance or walking stability with wearable sensors in people with PD. Articles were excluded if they; i) did not use any form of wearable sensor to measure variables associated with standing balance or walking stability; ii) did not include a control group or control condition; iii) were an abstract and/or included in the proceedings of a conference; or iv) were a review article or case study. The targeted search of the three electronic databases identified 340 articles that were potentially eligible for inclusion, but following title, abstract and full-text review only 26 articles were deemed to meet the inclusion criteria. Included articles were assessed for methodological quality and relevant data from the papers were extracted and synthesized. Results Quality assessment of these included articles indicated that 31% were of low methodological quality, while 58% were of moderate methodological quality and 11% were of high methodological quality. All studies adopted a cross-sectional design and used a variety of sensor types and outcome measures to assess standing balance or walking stability in people with Parkinson's disease. Despite the typically low to moderate methodological quality, 81% of the studies reported differences in sensor-based measures of standing balance or walking stability between different groups of Parkinson's disease patients and/or healthy controls. Conclusion These data support the use of wearable sensors for detecting differences in standing balance and walking stability between people with PD and controls. Further high-quality research is needed to better understand the utility of wearable sensors for the early identification of Parkinson's disease symptoms and for assessing falls risk in this population. PROSPERO Registration CRD42014010838	[Hubble, Ryan P.; Cole, Michael H.] Australian Catholic Univ, Sch Exercise Sci, Brisbane, Qld, Australia; [Naughton, Geraldine A.] Australian Catholic Univ, Sch Exercise Sci, Melbourne, Vic, Australia; [Silburn, Peter A.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia	Australian Catholic University; Australian Catholic University; University of Queensland	Hubble, RP (corresponding author), Australian Catholic Univ, Sch Exercise Sci, Brisbane, Qld, Australia.	ryan.hubble@acu.edu.au; michael.cole@acu.edu.au	Cole, Michael H/O-6816-2018; Naughton, Geraldine/M-4094-2017	Naughton, Geraldine/0000-0002-0534-1627; Cole, Michael/0000-0003-1817-7528	Australian Catholic University [2013000584]; Australian National Health and Medical Research Council Early Career Researcher Fellowship [GNT1016481]	Australian Catholic University; Australian National Health and Medical Research Council Early Career Researcher Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This project was supported by research funding provided by the Australian Catholic University (Research Grant #2013000584), which funded a 3-year International PhD scholarship for Mr Ryan P. Hubble. Dr Michael H. Cole was also supported by an Australian National Health and Medical Research Council Early Career Researcher Fellowship (Project #GNT1016481). The funding body played no role in the design of this study and did not contribute to the data collection, analysis, decision to publish or the preparation of this manuscript.	Alexander NB, 1996, J AM GERIATR SOC, V44, P434, DOI 10.1111/j.1532-5415.1996.tb06417.x; Allen NE, 2010, MOVEMENT DISORD, V25, P1217, DOI 10.1002/mds.23082; Ashburn A, 2008, DISABIL REHABIL, V30, P1205, DOI 10.1080/09638280701828930; Ashburn A, 2007, J NEUROL NEUROSUR PS, V78, P678, DOI 10.1136/jnnp.2006.099333; Baston C, 2014, GAIT POSTURE, V40, P70, DOI 10.1016/j.gaitpost.2014.02.012; Berg WP, 1997, AGE AGEING, V26, P261, DOI 10.1093/ageing/26.4.261; Cole MH, 2011, PARKINSONISM RELAT D, V17, P610, DOI 10.1016/j.parkreldis.2011.05.019; Cole MH, 2010, MOVEMENT DISORD, V25, P2369, DOI 10.1002/mds.23292; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; ELBLE RJ, 1991, J NEUROL, V238, P1, DOI 10.1007/BF00319700; Fazio P, 2013, NEUROL SCI, V34, P435, DOI 10.1007/s10072-012-1017-x; Gago MF, 2014, GAIT POSTURE; Gill J, 2001, J GERONTOL A-BIOL, V56, pM438, DOI 10.1093/gerona/56.7.M438; Goodwin VA, 2011, J NEUROL NEUROSUR PS, V82, P1232, DOI 10.1136/jnnp-2011-300919; HAGEMAN PA, 1995, ARCH PHYS MED REHAB, V76, P961, DOI 10.1016/S0003-9993(95)80075-1; Hasmann SE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00286; Helbostad JL, 2003, GAIT POSTURE, V18, P27, DOI 10.1016/S0966-6362(02)00197-2; Herman T, 2014, J NEUROL, V261, P2401, DOI 10.1007/s00415-014-7513-6; Hirasaki E, 1999, EXP BRAIN RES, V127, P117, DOI 10.1007/s002210050781; Kerr GK, 2010, NEUROLOGY, V75, P116, DOI 10.1212/WNL.0b013e3181e7b688; Landers Merrill R, 2008, J Neurol Phys Ther, V32, P56, DOI 10.1097/NPT.0b013e3181761330; Latt MD, 2008, EXP BRAIN RES, V184, P201, DOI 10.1007/s00221-007-1094-x; Latt MD, 2009, J GERONTOL A-BIOL, V64, P700, DOI 10.1093/gerona/glp009; Lin MR, 2007, J AM GERIATR SOC, V55, P499, DOI 10.1111/j.1532-5415.2007.01146.x; Lowry KA, 2010, ARCH PHYS MED REHAB, V91, P632, DOI 10.1016/j.apmr.2009.12.016; Lowry KA, 2009, MOVEMENT DISORD, V24, P261, DOI 10.1002/mds.22352; Lun V, 2005, MOVEMENT DISORD, V20, P971, DOI 10.1002/mds.20475; Maetzler W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032240; Mak MKY, 2009, J NEUROL, V256, P742, DOI 10.1007/s00415-009-5007-8; Mancini M, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-59; Mancini M, 2012, GAIT POSTURE, V36, P471, DOI 10.1016/j.gaitpost.2012.04.010; Mancini M, 2011, PARKINSONISM RELAT D, V17, P557, DOI 10.1016/j.parkreldis.2011.05.010; Mirelman A, 2013, MOVEMENT DISORD, V28, P1683, DOI 10.1002/mds.25587; Nayak BK, 2010, INDIAN J OPHTHALMOL, V58, P469, DOI 10.4103/0301-4738.71673; Nova IC, 2004, PARKINSONISM RELAT D, V10, P411, DOI 10.1016/j.parkreldis.2004.04.004; O'Sullivan JD, 1998, MOVEMENT DISORD, V13, P900, DOI 10.1002/mds.870130607; Palmerini L, 2013, IEEE T NEUR SYS REH, V21, P664, DOI 10.1109/TNSRE.2012.2236577; Palmerini L, 2011, IEEE T INF TECHNOL B, V15, P481, DOI 10.1109/TITB.2011.2107916; Rocchi L, 2014, IEEE T NEUR SYS REH, V22, P1064, DOI 10.1109/TNSRE.2013.2292496; Salarian A, 2010, IEEE T NEUR SYS REH, V18, P303, DOI 10.1109/TNSRE.2010.2047606; Sant'Anna A, 2011, IEEE T BIO-MED ENG, V58, P2127, DOI 10.1109/TBME.2011.2149521; Schaafsma JD, 2003, J NEUROL SCI, V212, P47, DOI 10.1016/S0022-510X(03)00104-7; Sejdic E, 2014, IEEE T NEUR SYS REH, V22, P603, DOI 10.1109/TNSRE.2013.2265887; Sekine M, 2004, MED BIOL ENG COMPUT, V42, P30, DOI 10.1007/BF02351008; Sekine M, 2004, J NEURAL ENG, V1, DOI 10.1088/1741-2560/1/1/002; Shulman LM, 2008, MOVEMENT DISORD, V23, P790, DOI 10.1002/mds.21879; Skelly Andrea C, 2012, Evid Based Spine Care J, V3, P9, DOI 10.1055/s-0031-1298595; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Van Emmerik REA, 1999, ARCH PHYS MED REHAB, V80, P186, DOI 10.1016/S0003-9993(99)90119-3; Weiss A, 2015, J NEURAL TRANSM, V122, P403, DOI 10.1007/s00702-014-1279-y; Weiss A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096675; Weiss A, 2011, NEUROREHAB NEURAL RE, V25, P810, DOI 10.1177/1545968311424869; Weiss A, 2010, MED ENG PHYS, V32, P119, DOI 10.1016/j.medengphy.2009.10.015; Wilcox RA, 2011, J NEUROL NEUROSUR PS, V82, P1256, DOI 10.1136/jnnp.2010.213462; Wood BH, 2002, J NEUROL NEUROSUR PS, V72, P721, DOI 10.1136/jnnp.72.6.721; Yang CC, 2011, SENSORS-BASEL, V11, P7314, DOI 10.3390/s110807314; Zampieri C, 2010, J NEUROL NEUROSUR PS, V81, P171, DOI 10.1136/jnnp.2009.173740	57	107	109	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123705	10.1371/journal.pone.0123705	http://dx.doi.org/10.1371/journal.pone.0123705			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894561	gold, Green Published, Green Submitted			2022-12-27	WOS:000353211700050
J	Lin, CY; Li, PZ; Cheng, HG; Ouyang, W				Lin, Chunye; Li, Peizhong; Cheng, Hongguang; Ouyang, Wei			Vertical Distribution of Lead and Mercury in the Wetland Argialbolls of the Sanjiang Plain in Northeastern China	PLOS ONE			English	Article							SOIL PROFILES; DEPTH PROFILE; UPLAND FOREST; HEAVY-METALS; PEAT BOG; CONTAMINATION; DEPOSITION; SPECIATION; FRACTIONS; DOWNWASH	The wetland Argialbolls pedon was chosen to investigate the effects of pedogenic processes and anthropogenic activities on the vertical distribution of lead and mercury concentration and to assess the potential use of soil as an archive of atmospheric Pb and Hg pollution. The soil was sampled from 5 cm from the surface to a depth of 90 cm at two locations in the Sanjiang Plain in northeastern China. The soil was analyzed for pH, soil organic matter (SOM), Fe, Mn, and Al. The results indicate that the SOM concentration gradually decreased with depth, while Fe and Mn were reductively leached from the upper horizons and accumulated significantly in the lower argillic horizons. Atmospheric Pb and Hg deposition and their redistribution during the pedogenic process led to a unique vertical distribution in the wetland Argialbolls. Overall, Pb was leached from the upper horizons and then accumulated in the lower argillic horizons. However, the Hg concentration decreased with depth, following the SOM distribution. The Pb concentration was significantly correlated to the Fe and Mn concentrations in the Argialbolls profiles, while the Hg concentration was significantly correlated with SOM. Post-depositional mobility along the wetland Argialbolls profile is higher for Pb and low for Hg. Therefore, the Argialbolls profile does not provide an accurate reconstruction of atmospheric Pb deposition, but might provide an accurate reconstruction of net atmospheric Hg deposition.	[Lin, Chunye; Li, Peizhong; Cheng, Hongguang; Ouyang, Wei] Beijing Normal Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100875, Peoples R China	Beijing Normal University	Lin, CY (corresponding author), Beijing Normal Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100875, Peoples R China.	c.lin@bnu.edu.cn		wei, ouyang/0000-0002-5851-056X	National Natural Science Foundation of China [41171359]; National Science and Technology Infrastructure Program [2012BAD15B05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Infrastructure Program	This study was supported by the National Natural Science Foundation of China (41171359) (http://www.nsfc.gov.cn/) and National Science and Technology Infrastructure Program (2012BAD15B05) (http://program.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDOR E, 1989, COMMUN SOIL SCI PLAN, V20, P1675, DOI 10.1080/00103628909368175; Bowen H. J. M, 1979, ENV CHEM ELEMENTS; Burns DA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086855, 10.1371/journal.pone.0090913]; Chi GY, 2010, J SOIL SEDIMENT, V10, P787, DOI 10.1007/s11368-009-0140-7; do Valle CM, 2005, CHEMOSPHERE, V58, P779, DOI 10.1016/j.chemosphere.2004.09.005; Donisa C, 2005, APPL GEOCHEM, V20, P1258, DOI 10.1016/j.apgeochem.2005.03.006; Fu XW, 2010, ENVIRON POLLUT, V158, P2324, DOI 10.1016/j.envpol.2010.01.032; Gong P, 2014, ENVIRON POLLUT, V188, P94, DOI 10.1016/j.envpol.2014.01.020; Gong Z.T., 2007, CHINA SOIL GENETIC T; Grimaldi C, 2008, SCI TOTAL ENVIRON, V401, P121, DOI 10.1016/j.scitotenv.2008.04.001; Grybos M, 2007, J COLLOID INTERF SCI, V314, P490, DOI 10.1016/j.jcis.2007.04.062; Han F.X., 2007, BIOGEOCHEMISTRY TRAC; Han FXX, 2002, NATURWISSENSCHAFTEN, V89, P497, DOI 10.1007/s00114-002-0373-4; Han FXX, 2003, NATURWISSENSCHAFTEN, V90, P395, DOI 10.1007/s00114-003-0451-2; Hansson SV, 2015, SCI TOTAL ENVIRON, V506, P95, DOI 10.1016/j.scitotenv.2014.10.083; Hansson SV, 2014, SCI TOTAL ENVIRON, V493, P170, DOI 10.1016/j.scitotenv.2014.05.088; Hansson SV, 2014, BIOGEOCHEMISTRY, V119, P329, DOI 10.1007/s10533-014-9969-y; Johnson CE, 1998, SOIL SCI SOC AM J, V62, P782, DOI 10.2136/sssaj1998.03615995006200030035x; Karczewska A, 1996, APPL GEOCHEM, V11, P35, DOI 10.1016/0883-2927(95)00063-1; Kaste JM, 2011, GEOCHIM COSMOCHIM AC, V75, P1642, DOI 10.1016/j.gca.2011.01.011; Kylander ME, 2008, ENVIRON SCI TECHNOL, V42, P3177, DOI 10.1021/es702358e; Li ZG, 2011, APPL GEOCHEM, V26, P160, DOI 10.1016/j.apgeochem.2010.11.014; Lin CY, 2008, ENVIRON MONIT ASSESS, V137, P329, DOI 10.1007/s10661-007-9768-1; Liu RH, 2003, ENVIRON POLLUT, V124, P39, DOI 10.1016/S0269-7491(02)00432-3; Liu Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0106787, 10.1371/journal.pone.0098157, 10.1371/journal.pone.0085323]; Martinez-Cortizas A, 1999, SCIENCE, V284, P939, DOI 10.1126/science.284.5416.939; Pingitore NE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005019; Prapaipong P, 2008, APPL GEOCHEM, V23, P2156, DOI 10.1016/j.apgeochem.2008.05.002; Prohaska T, 2005, INT J MASS SPECTROM, V242, P243, DOI 10.1016/j.ijms.2004.11.028; Prohaska T, 2000, J ANAL ATOM SPECTROM, V15, P365, DOI 10.1039/a907203i; Qi YB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097327; Richardson JB, 2013, ENVIRON POLLUT, V182, P127, DOI 10.1016/j.envpol.2013.07.011; Seybold CA, 2002, WETLANDS, V22, P149, DOI 10.1672/0277-5212(2002)022[0149:SRPTAW]2.0.CO;2; Shotyk W., 1998, HIST ATMOSPHERIC LEA, V12, P370; Sipos P, 2005, ENVIRON GEOCHEM HLTH, V27, P1, DOI 10.1007/s10653-004-1581-y; Stumm W., 2012, AQUATIC CHEM CHEM EQ; Wei F.S., 1990, BACKGROUND CONTENTS; Xie P. R., 2010, CHEM MINERAL PROPERT; Yang WJ, 2012, GEODERMA, V189, P207, DOI 10.1016/j.geoderma.2012.06.025; Zheng SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049664	40	3	3	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124294	10.1371/journal.pone.0124294	http://dx.doi.org/10.1371/journal.pone.0124294			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894341	gold, Green Published, Green Submitted			2022-12-27	WOS:000353211700085
J	Ravichandran, A; Ramachandran, M; Suriyanarayanan, T; Wong, CC; Swarup, S				Ravichandran, Ayshwarya; Ramachandran, Malarmathy; Suriyanarayanan, Tanujaa; Wong, Chui Ching; Swarup, Sanjay			Global Regulator MorA Affects Virulence-Associated Protease Secretion in Pseudomonas aeruginosa PAO1	PLOS ONE			English	Article							C-DI-GMP; QUORUM-SENSING SYSTEMS; II SECRETION; EXTRACELLULAR SECRETION; CYCLIC DIGUANYLATE; BIOFILM FORMATION; OLIGOMERIC RINGS; EPITHELIAL-CELLS; DOMAIN PROTEINS; OUTER-MEMBRANE	Bacterial invasion plays a critical role in the establishment of Pseudomonas aeruginosainfection and is aided by two major virulence factors - surface appendages and secreted proteases. The second messenger cyclic diguanylate (c-di-GMP) is known to affect bacterial attachment to surfaces, biofilm formation and related virulence phenomena. Here we report that MorA, a global regulator with GGDEF and EAL domains that was previously reported to affect virulence factors, negatively regulates protease secretion via the type II secretion system (T2SS) in P. aeruginosa PAO1. Infection assays with mutant strains carrying gene deletion and domain mutants show that host cell invasion is dependent on the active domain function of MorA. Further investigations suggest that the MorA-mediated c-di-GMP signaling affects protease secretion largely at a post-translational level. We thus report c-di-GMP second messenger system as a novel regulator of T2SS function in P. aeruginosa. Given that T2SS is a central and constitutive pump, and the secreted proteases are involved in interactions with the microbial surroundings, our data broadens the significance of c-di-GMP signaling in P. aeruginosa pathogenesis and ecological fitness.	[Ravichandran, Ayshwarya; Ramachandran, Malarmathy; Suriyanarayanan, Tanujaa; Wong, Chui Ching; Swarup, Sanjay] Natl Univ Singapore, Dept Biol Sci, Metabolites Biol Lab, Singapore 117543, Singapore; [Ravichandran, Ayshwarya; Wong, Chui Ching; Swarup, Sanjay] Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore; [Swarup, Sanjay] Natl Univ Singapore, NUS Environm Res Inst NERI, Singapore 117411, Singapore; [Suriyanarayanan, Tanujaa; Swarup, Sanjay] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 637551, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Swarup, S (corresponding author), Natl Univ Singapore, Dept Biol Sci, Metabolites Biol Lab, Singapore 117543, Singapore.	sanjay@nus.edu.sg	Swarup, Sanjay/I-1592-2012	Swarup, Sanjay/0000-0001-6391-0624; Wong, Judith Chui Ching/0000-0002-2061-4486	Mechanobiology Institute [R714-010-006-271]	Mechanobiology Institute	This work was supported by the Mechanobiology Institute (www.mbi.nus.edu.sg) grant no: R714-010-006-271. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2011, MOL CELL, V43, P550, DOI 10.1016/j.molcel.2011.07.018; Albus AM, 1997, J BACTERIOL, V179, P3928, DOI 10.1128/jb.179.12.3928-3935.1997; Ball G, 2002, MOL MICROBIOL, V43, P475, DOI 10.1046/j.1365-2958.2002.02759.x; Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; Bitter W, 1998, MOL MICROBIOL, V27, P209, DOI 10.1046/j.1365-2958.1998.00677.x; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Borlee BR, 2010, MOL MICROBIOL, V75, P827, DOI 10.1111/j.1365-2958.2009.06991.x; Braun P, 1998, J BACTERIOL, V180, P3467, DOI 10.1128/JB.180.13.3467-3469.1998; Brok R, 1999, J MOL BIOL, V294, P1169, DOI 10.1006/jmbi.1999.3340; Cahan R, 2001, J BIOL CHEM, V276, P43645, DOI 10.1074/jbc.M106950200; ChaponHerve V, 1997, MOL MICROBIOL, V24, P1169, DOI 10.1046/j.1365-2958.1997.4271794.x; Choy W, 2006, SERIES ADV BIOINFORM, V8, P123; Choy WK, 2004, J BACTERIOL, V186, P7221, DOI 10.1128/JB.186.21.7221-7228.2004; Christen M, 2010, SCIENCE, V328, P1295, DOI 10.1126/science.1188658; Cianciotto NP, 2014, CURR TOP MICROBIOL, V376, P81, DOI 10.1007/82_2013_339; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; Cowell BA, 2003, MICROBIOL-SGM, V149, P2291, DOI 10.1099/mic.0.26280-0; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Douzi B, 2012, PHILOS T R SOC B, V367, P1059, DOI 10.1098/rstb.2011.0204; Engel LS, 1998, J BIOL CHEM, V273, P16792, DOI 10.1074/jbc.273.27.16792; Erickson DL, 2002, INFECT IMMUN, V70, P1783, DOI 10.1128/IAI.70.4.1783-1790.2002; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Filloux A, 1998, FEMS MICROBIOL REV, V22, P177, DOI 10.1016/S0168-6445(98)00013-8; Fleiszig SMJ, 2001, INFECT IMMUN, V69, P4931, DOI 10.1128/IAI.69.8.4931-4937.2001; FLEISZIG SMJ, 1995, INFECT IMMUN, V63, P4072, DOI 10.1128/IAI.63.10.4072-4077.1995; Fleiszig SMJ, 1997, INFECT IMMUN, V65, P579, DOI 10.1128/IAI.65.2.579-586.1997; Fleiszig SMJ, 1996, ARVO ABSTR INVESTIG; Folders J, 2000, J BACTERIOL, V182, P1257, DOI 10.1128/JB.182.5.1257-1263.2000; Grande KK, 2007, J BACTERIOL, V189, P3960, DOI 10.1128/JB.01828-06; Guvener ZT, 2007, MOL MICROBIOL, V66, P1459, DOI 10.1111/j.1365-2958.2007.06008.x; Ha UH, 2004, MOL MICROBIOL, V54, P307, DOI 10.1111/j.1365-2958.2004.04282.x; HE SY, 1991, J BACTERIOL, V173, P4310, DOI 10.1128/JB.173.14.4310-4317.1991; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Johnson TL, 2014, J BACTERIOL, V196, P4245, DOI 10.1128/JB.01944-14; Kader A, 2006, MOL MICROBIOL, V60, P602, DOI 10.1111/j.1365-2958.2006.05123.x; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x; Levi A, 2006, J BACTERIOL, V188, P5315, DOI 10.1128/JB.01725-05; Lindenberg S, 2013, EMBO J, V32, P2001, DOI 10.1038/emboj.2013.120; Lu HM, 1996, EMBO J, V15, P429, DOI 10.1002/j.1460-2075.1996.tb00373.x; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Martinez A, 1998, MOL MICROBIOL, V28, P1235, DOI 10.1046/j.1365-2958.1998.00888.x; Massengale ARD, 2000, EXP LUNG RES, V26, P163; Matsumoto K, 2004, BIOL CHEM, V385, P1007, DOI 10.1515/BC.2004.131; McIver KS, 1995, MOL MICROBIOL, V18, P877, DOI 10.1111/j.1365-2958.1995.18050877.x; Meissner A, 2007, ENVIRON MICROBIOL, V9, P2475, DOI 10.1111/j.1462-2920.2007.01366.x; Merritt JH, 2010, MBIO, V1, DOI 10.1128/mBio.00183-10; Michel GPF, 2007, J BACTERIOL, V189, P3776, DOI 10.1128/JB.00205-07; Michel Gerard P. F., 2009, P67; MORIHARA K, 1965, J BIOL CHEM, V240, P3295; Moscoso JA, 2011, ENVIRON MICROBIOL, V13, P3128, DOI 10.1111/j.1462-2920.2011.02595.x; Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588; Newell PD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000587; Nivaskumar M, 2014, BBA-MOL CELL RES, V1843, P1568, DOI 10.1016/j.bbamcr.2013.12.020; Nouwens AS, 2003, MICROBIOL-SGM, V149, P1311, DOI 10.1099/mic.0.25967-0; Palomaki T, 2002, MOL MICROBIOL, V43, P585, DOI 10.1046/j.1365-2958.2002.02793.x; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Perez-Mendoza D, 2011, MOL MICROBIOL, V82, P719, DOI 10.1111/j.1365-2958.2011.07849.x; Phippen CW, 2014, FEBS LETT, V588, P4631, DOI 10.1016/j.febslet.2014.11.002; Pollack M., 2000, PRINCIPLES PRACTICE; Pratt JT, 2007, J BIOL CHEM, V282, P12860, DOI 10.1074/jbc.M611593200; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Robert V, 2005, FEMS MICROBIOL LETT, V252, P43, DOI 10.1016/j.femsle.2005.08.029; Robert V, 2005, RES MICROBIOL, V156, P880, DOI 10.1016/j.resmic.2005.04.002; Romling U, 2009, CONTRIB MICROBIOL, V16, P161, DOI 10.1159/000219379; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Saier MH, 2006, J MEMBRANE BIOL, V214, P75, DOI 10.1007/s00232-006-0049-7; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Senf F, 2008, MICROBIOL-SGM, V154, P3025, DOI 10.1099/mic.0.2008/018069-0; Sheng LL, 2013, VET MICROBIOL, V162, P652, DOI 10.1016/j.vetmic.2012.09.009; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Tao F, 2010, J BACTERIOL, V192, P1020, DOI 10.1128/JB.01253-09; Traidej M, 2003, INVEST OPHTH VIS SCI, V44, P190, DOI 10.1167/iovs.02-0458; Tuckerman JR, 2011, J MOL BIOL, V407, P633, DOI 10.1016/j.jmb.2011.02.019; Ueda A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000483; von Tils D, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00160; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x; Whiteley M, 1999, P NATL ACAD SCI USA, V96, P13904, DOI 10.1073/pnas.96.24.13904; Wilderman PJ, 2001, INFECT IMMUN, V69, P5385, DOI 10.1128/IAI.69.9.5385-5394.2001	91	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123805	10.1371/journal.pone.0123805	http://dx.doi.org/10.1371/journal.pone.0123805			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894344	Green Submitted, Green Published, gold			2022-12-27	WOS:000353211700059
J	Paudyal, P; Llewellyn, C; Lau, J; Mahmud, M; Smith, H				Paudyal, Priyamvada; Llewellyn, Carrie; Lau, Jason; Mahmud, Mohammad; Smith, Helen			Obtaining Self-Samples to Diagnose Curable Sexually Transmitted Infections: A Systematic Review of Patients' Experiences	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS INFECTIONS; ADMINISTERED VAGINAL SWABS; NEISSERIA-GONORRHOEAE; HUMAN-PAPILLOMAVIRUS; ACCEPTABILITY; HOME; WOMEN; SEX; MEN; COLLECTION	Background Routine screening is key to sexually transmitted infection (STI) prevention and control. Previous studies suggest that clinic-based screening programmes capture only a small proportion of people with STIs. Self-sampling using non- or minimally invasive techniques may be beneficial for those reluctant to actively engage with conventional sampling methods. We systematically reviewed studies of patients' experiences of obtaining self-samples to diagnose curable STIs. Methods We conducted an electronic search of MEDLINE, EMBASE, CINAHL, PsychINFO, BNI, and Cochrane Database of Systematic Reviews to identify relevant articles published in English between January 1980 and March 2014. Studies were included if participants self-sampled for the diagnosis of a curable STI and had specifically sought participants' opinions of their experience, acceptability, preferences, or willingness to self-sample. Results The initial search yielded 558 references. Of these, 45 studies met the inclusion criteria. Thirty-six studies assessed patients' acceptability and experiences of self-sampling. Pooled results from these studies shows that self-sampling is a highly acceptable method with 85% of patients reporting the method to be well received and acceptable. Twenty-eight studies reported on ease of self-sampling; the majority of patients (88%) in these studies found self-sampling an "easy" procedure. Self-sampling was favoured compared to clinician sampling, and home sampling was preferred to clinic-based sampling. Females and older participants were more accepting of self-sampling. Only a small minority of participants (13%) reported pain during self-sampling. Participants were willing to undergo self-sampling and recommend others. Privacy and safety were the most common concerns. Conclusion Self-sampling for diagnostic testing is well accepted with the majority having a positive experience and willingness to use again. Standardization of self-sampling procedures and rigorous validation of outcome measurement will lead to better comparability across studies. Future studies need to conduct rigorous economic evaluations of self-sampling to inform policy development for the management of STI.	[Paudyal, Priyamvada; Llewellyn, Carrie; Lau, Jason; Smith, Helen] Brighton & Sussex Med Sch, Div Primary Care & Publ Hlth, Brighton, E Sussex, England; [Mahmud, Mohammad] North West Thames London Deanery, London, England	University of Brighton; University of Sussex	Paudyal, P (corresponding author), Brighton & Sussex Med Sch, Div Primary Care & Publ Hlth, Brighton, E Sussex, England.	p.paudyal@bsms.ac.uk	Smith, Helen E/M-2449-2016	Smith, Helen E/0000-0003-1883-6124; Llewellyn, Carrie/0000-0002-9107-8473; Paudyal, Priyamvada/0000-0002-6209-575X				Adams EJ, 2007, SEX TRANSM INFECT, V83, DOI 10.1136/sti.2006.024364; [Anonymous], 2012, GLOB INC PREV SEL CU; Basta MST, 2009, INT J HEALTH PROMOT, V47, P40, DOI 10.1080/14635240.2009.10708157; Berwald N, 2009, ACAD EMERG MED, V16, P360, DOI 10.1111/j.1553-2712.2009.00359.x; Bloomfield PJ, 2003, SEX TRANSM INFECT, V79, P28, DOI 10.1136/sti.79.1.28; Bloomfield PJ, 2002, SEX TRANSM DIS, V29, P294, DOI 10.1097/00007435-200205000-00008; Brown L, 2010, SEX TRANSM INFECT, V86, P525, DOI 10.1136/sti.2009.039479; Chai SJ, 2010, SEX TRANSM DIS, V37, P756, DOI 10.1097/OLQ.0b013e3181e3d771; Chandeying V, 2004, Sex Health, V1, P51, DOI 10.1071/SH03009; Chernesky MA, 2005, SEX TRANSM DIS, V32, P729, DOI 10.1097/01.olq.0000190057.61633.8d; Development Economics, 2013, FIN EC IMP RESTR CON; Dodge B, 2010, INT J STD AIDS, V21, P260, DOI 10.1258/ijsa.2009.009056; Fenton KA, 2001, SEX TRANSM INFECT, V77, P194, DOI 10.1136/sti.77.3.194; Fielder RL, 2013, J AM COLL HEALTH, V61, P46, DOI 10.1080/07448481.2012.750610; Forrest S, 2004, J MED SCREEN, V11, P85, DOI 10.1258/096914104774061065; Freeman AH, 2011, SEX TRANSM DIS, V38, P1036, DOI [10.1097/OLQ.0b013e3182275499, 10.1097/OLQ.0b013e318227713e]; Garland Suzanne M, 2004, Sex Health, V1, P121, DOI 10.1071/SH03014; Gaydos CA, 2013, INT J STD AIDS, V24, P736, DOI 10.1177/0956462413483252; Gaydos CA, 2006, SEX TRANSM DIS, V33, P451, DOI 10.1097/01.olq.0000200497.14326.fb; Gotz HM, 2005, SEX TRANSM DIS, V32, P557, DOI 10.1097/01.olq.0000175416.15905.db; Graseck AS, 2010, OBSTET GYNECOL, V116, P1311, DOI 10.1097/AOG.0b013e3181fae60d; Graseck AS, 2010, OBSTET GYNECOL, V115, P745, DOI 10.1097/AOG.0b013e3181d4450d; Greenland KE, 2011, SEX TRANSM DIS, V38, P467, DOI 10.1097/OLQ.0b013e318204546e; Gudka S, 2013, J PHARM PRACTICE RES, V43; Gudka S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003338; Hoebe CJPA, 2006, SEX TRANSM DIS, V33, P491, DOI 10.1097/01.olq.0000204619.87066.28; Holland-Hall C M, 2002, J Pediatr Adolesc Gynecol, V15, P307, DOI 10.1016/S1083-3188(02)00197-3; Howard M, 2009, CAN J PUBLIC HEALTH, V100, P365, DOI 10.1007/BF03405272; Hsieh YH, 2003, SEX TRANSM DIS, V30, P769, DOI 10.1097/01.OLQ.0000079048.11771.46; Huppert JS, 2012, J ADOLESCENT HEALTH, V51, P400, DOI 10.1016/j.jadohealth.2012.01.017; Huppert JS, 2011, SEX TRANSM INFECT, V87, P494, DOI 10.1136/sextrans-2011-050037; Huynh J, 2010, J LOW GENIT TRACT DI, V14, P356, DOI 10.1097/LGT.0b013e3181dc115b; Jones HE, 2007, SEX TRANSM INFECT, V83, P552, DOI 10.1136/sti.2007.027060; Kimmitt PT, 2010, INT J STD AIDS, V21, P279, DOI 10.1258/ijsa.2009.009277; Kohli Ruchika, 2013, BMC Res Notes, V6, P44, DOI 10.1186/1756-0500-6-44; Kwan KSH, 2012, MED J AUSTRALIA, V197, P287, DOI 10.5694/mja11.11517; LaMontagne DS, 2004, SEX TRANSM INFECT, V80, P335, DOI 10.1136/sti.2004.012856; Lippman SA, 2007, SEX TRANSM DIS, V34, P421, DOI 10.1097/01.olq.0000245958.34961.27; Low N, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11080; Macmillan S, 2000, BRIT J FAM PLAN, V26, P202; Mahilum-Tapay L, 2007, BMJ-BRIT MED J, V335, P1190, DOI 10.1136/bmj.39402.463854.AE; MARKOS AR, 1994, INT J STD AIDS, V5, P284, DOI 10.1177/095646249400500411; Mavedzenge S, 2011, HIV SELF TESTING HLT; Mavedzenge SN, 2013, CLIN INFECT DIS, V57, P126, DOI 10.1093/cid/cit156; Mayaud P, 2004, SEX TRANSM INFECT, V80, P174, DOI 10.1136/sti.2002.004101; Newman SB, 2003, SEX TRANSM DIS, V30, P306, DOI 10.1097/00007435-200304000-00006; Odesanmi TY, 2013, SEX HEALTH, V10, P559, DOI 10.1071/SH13029; Papp JR, 2007, DIAGN MICR INFEC DIS, V59, P259, DOI 10.1016/j.diagmicrobio.2007.05.010; Pimenta JM, 2003, SEX TRANSM INFECT, V79, P16, DOI 10.1136/sti.79.1.16; Reagan MM, 2012, SEX TRANSM DIS, V39, P842, DOI 10.1097/OLQ.0b013e3182649165; Richardson E, 2003, SEX TRANSM DIS, V30, P880, DOI 10.1097/01.OLQ.0000091142.68884.2A; Rosenberger JG, 2011, ARCH SEX BEHAV, V40, P281, DOI 10.1007/s10508-009-9569-4; Roth AM, 2013, INT J STD AIDS, V24, P323, DOI 10.1177/0956462412472791; Serlin M, 2002, ARCH PEDIAT ADOL MED, V156, P588, DOI 10.1001/archpedi.156.6.588; Shih SL, 2011, CURR OPIN INFECT DIS, V24, P78, DOI 10.1097/QCO.0b013e32834204a8; Stephenson J, 2000, SEX TRANSM INFECT, V76, P25, DOI 10.1136/sti.76.1.25; Stewart DE, 2007, J OBSTET GYNAECOL CA, V29, P817, DOI 10.1016/S1701-2163(16)32636-6; Tanksale VS, 2003, SEX TRANSM INFECT, V79, P251, DOI 10.1136/sti.79.3.251; Tebb KP, 2004, J ADOLESCENT HEALTH, V35, P462, DOI 10.1016/j.jadohealth.2004.01.006; Van De Wijgert J, 2006, SEX TRANSM DIS, V33, P516, DOI 10.1097/01.olq.0000204671.62529.1f; van der Helm JJ, 2009, SEX TRANSM DIS, V36, P493, DOI 10.1097/OLQ.0b013e3181a44b8c; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012; Wayal S, 2009, SEX TRANSM INFECT, V85, P60, DOI 10.1136/sti.2008.032193; Wayal S, 2011, CULT HEALTH SEX, V13, P343, DOI 10.1080/13691058.2010.535018; Wiesenfeld HC, 2001, SEX TRANSM DIS, V28, P321, DOI 10.1097/00007435-200106000-00003; World Health Organization, 2013, SEXUALLY TRANSMITTED	66	55	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124310	10.1371/journal.pone.0124310	http://dx.doi.org/10.1371/journal.pone.0124310			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909508	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800076
J	Santana, CD; Silva, DDT; Deana, AM; Prates, RA; Souza, AP; Gomes, MT; Sampaio, BPD; Shibuya, JF; Bussadori, SK; Mesquita-Ferrari, RA; Fernandes, KPS; Franca, CM				Santana, Cristiano de Loura; Teixeira Silva, Daniela de Fatima; Deana, Alessandro Melo; Prates, Renato Araujo; Souza, Amanda Pires; Gomes, Mariana Teixeira; de Azevedo Sampaio, Brunna Pileggi; Shibuya, Josiane Ferraretto; Bussadori, Sandra Kalil; Mesquita-Ferrari, Raquel Agnelli; Santos Fernandes, Kristianne Porta; Franca, Cristiane Miranda			Tissue Responses to Postoperative Laser Therapy in Diabetic Rats Submitted to Excisional Wounds	PLOS ONE			English	Article							LEVEL DIODE-LASER; COLLAGEN; CELLS; IRRADIATION; REPAIR; MICE; RED; ANGIOGENESIS; INFLAMMATION; RADIATION	In a previous study about low-level laser therapy biomodulation on a full-thickness burn model we showed that single and fractionated dose regimens increased wound healing and leukocyte influx similarly when compared with untreated control. In order to verify if this finding would be similar in an impaired wound model, we investigated the effect of single and multiple irradiations on wound closure rate, type of inflammatory infiltrate, myofibroblasts, collagen deposition, and optical retardation of collagen in diabetic rats. Female Wistar rats in the same estrous cycle had diabetes induced with streptozotocin and an 8-mm excisional wound performed with a punch. The experimental groups were: control group - untreated ulcer; single-dose group - ulcer submitted to single dose of diode laser therapy (lambda = 660 +/- 2 nm; P = 30 mW; energy density: 4 J/cm(2)) and fractionated-dose group - ulcer submitted to 1 J/cm(2) laser therapy on Days 1, 3, 8, and 10. The ulcers were photographed on the experimental days and after euthanasia tissue samples were routinely processed for histological and immunohistochemistry analyses. Independently of the energy density, laser therapy accelerated wound closure by approximately 40% in the first three days in comparison to the control group. Laser therapy increased acute inflammatory infiltrate until Day 3. Both laser groups exhibited more myofibroblasts and better collagen organization than the control group. The findings demonstrate that low-level laser therapy in the immediate postoperative period can enhance the tissue repair process in a diabetes model. Similar effects were achieved with laser therapy applied a single time with an energy density of 4 J/cm(2) and applied four times with an energy density of 1 J/cm(2). The application of laser therapy in the inflammatory phase was the most important factor to the enhancement of the tissue repair process.	[Santana, Cristiano de Loura; Teixeira Silva, Daniela de Fatima; Deana, Alessandro Melo; Prates, Renato Araujo; Souza, Amanda Pires; Gomes, Mariana Teixeira; de Azevedo Sampaio, Brunna Pileggi; Shibuya, Josiane Ferraretto; Bussadori, Sandra Kalil; Mesquita-Ferrari, Raquel Agnelli; Santos Fernandes, Kristianne Porta; Franca, Cristiane Miranda] Univ Nove de Julho UNINOVE, Postgrad Program Biophoton Appl Hlth Sci, Sao Paulo, SP, Brazil	Universidade Nove de Julho	Franca, CM (corresponding author), Univ Nove de Julho UNINOVE, Postgrad Program Biophoton Appl Hlth Sci, Sao Paulo, SP, Brazil.	cristiane321@gmail.com	Ferrari, Raquel/I-4419-2016; Deana, Alessandro M/K-4787-2012; Franca, Cristiane/B-2563-2014; Fernandes, Kristianne Porta Santos/I-4417-2016; Prates, Renato A/F-8235-2014; Bussadori, Sandra/J-5458-2014; da Silva, Daniela de Fátima Teixeira/K-3071-2012	Ferrari, Raquel/0000-0001-5142-9526; Franca, Cristiane/0000-0002-9285-4622; Fernandes, Kristianne Porta Santos/0000-0001-7156-9286; Prates, Renato A/0000-0002-8115-9237; Bussadori, Sandra/0000-0002-9853-1138; da Silva, Daniela de Fátima Teixeira/0000-0002-7228-6146; Deana, Alessandro Melo/0000-0002-0014-6953	State of Sao Paulo Research Foundation (FAPESP), Brazil [2012/01944-0, 2012/02801-8, 2012/03334-4]	State of Sao Paulo Research Foundation (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Research Grants # 2012/01944-0 (CMF), 2012/02801-8 (BPAS) and 2012/03334-4 (JAFS) from the State of Sao Paulo Research Foundation (FAPESP), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, DIAB STAT DAT 2011 N; Alves ACA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4296; Chen J, 2005, DIABETES, V54, P2143, DOI 10.2337/diabetes.54.7.2143; Cury V, 2013, J PHOTOCH PHOTOBIO B, V125, P164, DOI 10.1016/j.jphotobiol.2013.06.004; Deana AM, 2013, WOUND REPAIR REGEN, V21, P755, DOI 10.1111/wrr.12085; Dixit Snehil, 2012, Adv Biomed Res, V1, P38, DOI 10.4103/2277-9175.100132; Ferraro F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002191; Firat ET, 2013, PHOTOMED LASER SURG, V31, P315, DOI 10.1089/pho.2012.3406; Franca CM, 2013, LASER MED SCI, V28, P1331, DOI 10.1007/s10103-012-1249-2; Fukuda TY, 2013, LASER MED SCI, V28, P1305, DOI 10.1007/s10103-012-1231-z; Fukuda TY, 2010, LASER SURG MED, V42, P584, DOI 10.1002/lsm.20949; Giannopoulou C, 2012, J PERIODONTOL, V83, P1018, DOI 10.1902/jop.2011.110281; Ribeiro MAG, 2009, PHOTOMED LASER SURG, V27, P49, DOI 10.1089/pho.2007.2215; Houreld NN, 2014, SCI WORLD J, DOI 10.1155/2014/398412; Junker JPE, 2014, WOUND REPAIR REGEN, V22, P2, DOI 10.1111/wrr.12162; Kajagar BM, 2012, INDIAN J SURG, V74, P359, DOI 10.1007/s12262-011-0393-4; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Kataoka M, 2013, BIOCHEM BIOPH RES CO, V430, P1103, DOI 10.1016/j.bbrc.2012.12.030; Kaviani A, 2011, PHOTOMED LASER SURG, V29, P109, DOI 10.1089/pho.2009.2680; Kim BM, 2000, LASER SURG MED, V27, P329, DOI 10.1002/1096-9101(2000)27:4<329::AID-LSM5>3.0.CO;2-C; Leal EC, 2011, LASER MED SCI, V26, P493, DOI 10.1007/s10103-010-0866-x; Buchleitner AM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007315.pub2; Nunez SC, 2013, LASER MED SCI, V28, P633, DOI 10.1007/s10103-012-1105-4; Oberoi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107418; Oviedo-Socarras T, 2014, MICROVASC RES, V93, P23, DOI 10.1016/j.mvr.2014.02.011; Peppa M, 2009, WOUND REPAIR REGEN, V17, P461, DOI 10.1111/j.1524-475X.2009.00518.x; Pereira AN, 2002, LASER SURG MED, V31, P263, DOI 10.1002/lsm.10107; Pinto FC, 2010, PEDIATR NEUROSURG, V46, P249, DOI 10.1159/000319363; Ribeiro MS, 2002, J CLIN LASER MED SUR, V20, P37, DOI 10.1089/104454702753474995; Rosado P, 2014, HEAD NECK; Silva DFT, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2187418; Silveira PCL, 2009, J PHOTOCH PHOTOBIO B, V95, P89, DOI 10.1016/j.jphotobiol.2009.01.004; Szymanska J, 2013, J PHYSIOL PHARMACOL, V64, P387; TANAKA S, 1988, J MOL BIOL, V203, P495, DOI 10.1016/0022-2836(88)90015-0; Silva DFT, 2013, ANN BIOMED ENG, V41, P752, DOI 10.1007/s10439-012-0720-3; VIDAL BD, 1982, HISTOCHEM J, V14, P857, DOI 10.1007/BF01005229; Wang CZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103348; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	38	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0122042	10.1371/journal.pone.0122042	http://dx.doi.org/10.1371/journal.pone.0122042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909480	Green Submitted, Green Published, gold			2022-12-27	WOS:000353376800015
J	Fiser, C; Lustrik, R; Sarbu, S; Flot, JF; Trontelj, P				Fiser, Cene; Lustrik, Roman; Sarbu, Serban; Flot, Jean-Francois; Trontelj, Peter			Morphological Evolution of Coexisting Amphipod Species Pairs from Sulfidic Caves Suggests Competitive Interactions and Character Displacement, but No Environmental Filtering and Convergence	PLOS ONE			English	Article							NIPHARGUS CRUSTACEA; LIMITING SIMILARITY; PARALLEL EVOLUTION; FRASASSI CAVES; BODY-SIZE; DIVERSITY; FISH; IMPROVEMENT; HABITAT; TRAITS	Phenotypically similar species coexisting in extreme environments like sulfidic water are subject to two opposing eco-evolutionary processes: those favoring similarity of environmentspecific traits, and those promoting differences of traits related to resource use. The former group of processes includes ecological filtering and convergent or parallel evolution, the latter competitive exclusion, character displacement and divergent evolution. We used a unique eco-evolutionary study system composed of two independent pairs of coexisting amphipod species (genus Niphargus) from the sulfidic caves Movile in Romania and Frasassi in Italy to study the relative contribution and interaction of both processes. We looked at the shape of the multifunctional ventral channel as a trait ostensibly related to oxygenation and sulfide detoxification, and at body size as a resource-related trait. Phylogenetic analysis suggests that the sulfidic caves were colonized separately by ancestors of each species. Species within pairs were more dissimilar in their morphology than expected according to a null model based on regional species pool. This might indicate competitive interactions shaping the morphology of these amphipod species. Moreover, our results suggest that the shape of the ventral channel is not subject to long-term convergent selection or to the process of environmental filtering, and as such probably does not play a role in sulfide tolerance. Nevertheless, the ancestral conditions reconstructed using the comparative method tended to be more similar than null-model expectations. This shift in patterns may reflect a temporal hierarchy of ecoevolutionary processes, in which initial environmental filtering became later on superseded by character displacement or other competition-driven divergent evolutionary processes.	[Fiser, Cene; Lustrik, Roman; Trontelj, Peter] Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana 1000, Slovenia; [Sarbu, Serban] Grp Explorari Subacvatice & Speol, Bucharest, Romania; [Flot, Jean-Francois] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Trontelj, Peter] Humboldt Univ, Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, D-10115 Berlin, Germany	University of Ljubljana; University of London; University College London; Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung	Fiser, C (corresponding author), Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana 1000, Slovenia.	cene.fiser@bf.uni-lj.si		Flot, Jean-Francois/0000-0003-4091-7916; sarbu, serban m/0000-0001-8126-7193	Slovenian Research Agency Program [P1-0184]; European Research Council [ERC-2012-AdG 322790]	Slovenian Research Agency Program(Slovenian Research Agency - Slovenia); European Research Council(European Research Council (ERC)European Commission)	The research was partially funded by the Slovenian Research Agency Program P1-0184 (CF and PT); JFF is supported by the European Research Council (ERC-2012-AdG 322790). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauermeister J, 2013, INT J SPELEOL, V42, P141, DOI 10.5038/1827-806X.42.2.6; Best RJ, 2013, ECOL LETT, V16, P72, DOI 10.1111/ele.12016; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Cothran RD, 2013, OIKOS, V122, P1429, DOI 10.1111/j.1600-0706.2013.00294.x; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; DAHL E, 1977, ZOOL SCR, V6, P221; Dattagupta S, 2009, ISME J, V3, P935, DOI 10.1038/ismej.2009.34; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Fargione J, 2003, P NATL ACAD SCI USA, V100, P8916, DOI 10.1073/pnas.1033107100; Fiser C, 2008, ZOOL SCR, V37, P665, DOI 10.1111/j.1463-6409.2008.00347.x; Fiser C, 2008, ORG DIVERS EVOL, V8, P146, DOI 10.1016/j.ode.2007.06.002; Fiser C, 2013, OIKOS, V122, P770, DOI 10.1111/j.1600-0706.2012.20644.x; Fiser C, 2009, ZOOTAXA, P1; Flot JF, 2014, MOL ECOL, V23, P1405, DOI 10.1111/mec.12461; Flot JF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-171; Gotelli N.J., 1996, NULL MODELS ECOLOGY; Hervant F, 1998, J CRUSTACEAN BIOL, V18, P717, DOI 10.2307/1549148; Ingram T, 2009, ECOLOGY, V90, P2444, DOI 10.1890/08-1841.1; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Latella Leonardo, 1999, Memoires de Biospeologie, V26, P131; Lawniczak M, 2013, COMP BIOCHEM PHYS A, V165, P299, DOI 10.1016/j.cbpa.2013.03.028; LOSOS JB, 1995, PHILOS T ROY SOC B, V349, P69, DOI 10.1098/rstb.1995.0092; Malard F, 2012, ENCY CAVES, P651; Martin RA, 2009, AM NAT, V174, P268, DOI 10.1086/600090; Martins E. P., 2004, COMPARE VERSION 4 6B; Moen DS, 2009, EVOLUTION, V63, P3228, DOI 10.1111/j.1558-5646.2009.00810.x; Mouchet MA, 2013, OIKOS, V122, P247, DOI 10.1111/j.1600-0706.2012.20411.x; NICHOLLS P, 1975, BIOCHIM BIOPHYS ACTA, V396, P24, DOI 10.1016/0005-2728(75)90186-3; Niphargus Fiser C., 2012, ENCY CAVES, P555; Olson SL, 2010, BIOL LETTERS, V6, P807, DOI 10.1098/rsbl.2010.0423; Pfenninger M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4873; Plath M, 2007, NATURWISSENSCHAFTEN, V94, P991, DOI 10.1007/s00114-007-0279-2; R Development Core Team, 2014, R LANG ENV STAT COMP; Rabosky DL, 2007, OECOLOGIA, V154, P561, DOI 10.1007/s00442-007-0849-1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruffo S, 2005, MEMOIRE MUSEO CIVICO; Sarbu SM, 2000, ECOSY WORLD, V30, P319; Sarbu SM, 2000, ECOSY WORLD, V30, P359; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SKET B, 1981, Bioloski Vestnik, V29, P87; Stuart YE, 2013, TRENDS ECOL EVOL, V28, P402, DOI 10.1016/j.tree.2013.02.014; Stubbs WJ, 2004, J ECOL, V92, P557, DOI 10.1111/j.0022-0477.2004.00898.x; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tobler M, 2008, EVOLUTION, V62, P2643, DOI 10.1111/j.1558-5646.2008.00466.x; Tobler M, 2006, EXTREMOPHILES, V10, P577, DOI 10.1007/s00792-006-0531-2; Tobler M, 2014, COMP BIOCHEM PHYS A, V175, P7, DOI 10.1016/j.cbpa.2014.04.012; Tobler M, 2011, EVOLUTION, V65, P2213, DOI 10.1111/j.1558-5646.2011.01298.x; Trontelj P, 2012, EVOLUTION, V66, P3852, DOI 10.1111/j.1558-5646.2012.01734.x; Trontelj P, 2009, FRESHWATER BIOL, V54, P727, DOI 10.1111/j.1365-2427.2007.01877.x; Vergnon R, 2013, AM NAT, V182, P67, DOI 10.1086/670589; Weiher E, 2011, PHIL T R SOC B, V366; Wiens JJ, 2008, ECOL LETT, V11, P1004, DOI 10.1111/j.1461-0248.2008.01238.x; Wilson JB, 2012, J ECOL, V100, P210, DOI 10.1111/j.1365-2745.2011.01891.x; Zagmajster M, 2014, GLOBAL ECOL BIOGEOGR, V23, P1135, DOI 10.1111/geb.12200	61	23	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123535	10.1371/journal.pone.0123535	http://dx.doi.org/10.1371/journal.pone.0123535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905793	gold, Green Published, Green Submitted			2022-12-27	WOS:000353332000034
J	Liu, DL; Jin, JX; Tian, JH; Yang, KH				Liu, Danlu; Jin, Jiaxin; Tian, Jinhui; Yang, Kehu			Quality Assessment and Factor Analysis of Systematic Reviews and Meta-Analyses of Endoscopic Ultrasound Diagnosis	PLOS ONE			English	Review							METHODOLOGICAL QUALITY; MEASUREMENT TOOL; COCHRANE REVIEWS; AMSTAR	Background Comprehensive monitoring of the quality of systematic reviews (SRs) and meta-analyses (MAs) of endoscopic ultrasound (EUS) requires complete and accurate reporting and methodology. Objective To assess the reporting and methodological quality of SRs/MAs on EUS diagnosis and to explore the potential factors influencing articles' quality. Methods The quality of the reporting and methodology was evaluated in relation to the adherence of papers to the PRISMA checklist and the AMSTAR quality scale. The total scores for every criterion and for every article on the two standards were calculated. Data were evaluated and analyzed using SPSS17.0 and RevMan 5.1 in terms of publication time, category of reviews, category of journals, and funding resource. Results A total of 72 SRs/MAs was included, but no Cochrane Systematic Reviews (CSRs) were obtained. The number of SRs/MAs ranged from 1 in 1998 to 15 in 2013; 88.1% used the QUA-DAS tool; the average overall scores by PRISMA statement and AMSTAR tool were 19.9 and 5.4, respectively. Scores on some items showed substantial improvement after publication of PRISMA and AMSTAR. However, no reviews followed the criterion of protocol and registration, and only 11.1% of articles fulfilled the criterion of literature search. SRs/MAs from the Science Citation Index (SCI) were of better quality than non-SCI studies. Funding resource made no difference to quality. Regression analysis showed that time of publication and inclusion in the SCI were significantly correlated with total scores on the two standards. Conclusion The reporting and methodological quality of SRs/MAs on EUS diagnosis has improved measurably since PRISMA and AMSTAR checklists released. It is hoped that CSR in this field will be produced. Literature searching and protocol criteria, as well as QUADAS-2 tool need to be addressed more in the future. Time of publication and SCI relate more to the overall quality of SRs/MAs than does funding resource.	[Liu, Danlu; Yang, Kehu] Lanzhou Univ, Clin Med Coll 1, Lanzhou 730000, Gansu, Peoples R China; [Liu, Danlu; Jin, Jiaxin; Tian, Jinhui; Yang, Kehu] Lanzhou Univ, Sch Basic Med Sci, Evidence Based Med Ctr, Lanzhou 730000, Gansu, Peoples R China; [Liu, Danlu; Jin, Jiaxin; Tian, Jinhui; Yang, Kehu] Key Lab Evidence Based Med & Knowledge Translat G, Lanzhou, Gansu, Peoples R China; [Jin, Jiaxin] Lanzhou Univ, Clin Med Coll 2, Lanzhou 730000, Gansu, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University	Yang, KH (corresponding author), Lanzhou Univ, Clin Med Coll 1, Lanzhou 730000, Gansu, Peoples R China.	kehuyangebm2006@126.com						Al Faleh K, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-38; Bero LA, 1997, ANN INTERN MED, V127, P37, DOI 10.7326/0003-4819-127-1-199707010-00007; Biondi-Zoccai GGL, 2006, BMJ-BRIT MED J, V332, P202, DOI 10.1136/bmj.38693.516782.7C; Booth A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5870; Booth A, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-2; Deville Walter L, 2002, BMC Med Res Methodol, V2, P9, DOI 10.1186/1471-2288-2-9; Faggion CM, 2013, J CLIN PERIODONTOL, V40, P883, DOI 10.1111/jcpe.12132; Jadad AR, 2000, BRIT MED J, V320, P537, DOI 10.1136/bmj.320.7234.537; Jadad AR, 1998, JAMA-J AM MED ASSOC, V280, P278, DOI 10.1001/jama.280.3.278; Johanson JF, 2002, GASTROINTEST ENDOSC, V55, P798, DOI 10.1016/S0016-5107(02)70406-9; Kinney T, 2010, SURG CLIN N AM, V90, P235, DOI 10.1016/j.suc.2009.12.003; Kirkham JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009810; Kung Jason, 2010, Open Dent J, V4, P84, DOI 10.2174/1874210601004020084; Law JK, 2014, SURG ENDOSC, V28, P2592, DOI 10.1007/s00464-014-3508-8; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Ma B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020185; Macaskill P, 2010, COCHRANE HDB SYSTEMA, P46, DOI [10.1002/14651858.MR000022.pub3, DOI 10.1002/14651858.MR000022.PUB3]; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Manchikanti L, 2009, PAIN PHYSICIAN, V12, P517; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Panic N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083138; Popovich I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050403; Sequeira-Byron P, 2011, J APPL ORAL SCI, V19, P440, DOI 10.1590/S1678-77572011000500002; Shea B, 2002, EVAL HEALTH PROF, V25, P116, DOI 10.1177/0163278702025001008; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Shea BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001350; Silagy CA, 2002, JAMA-J AM MED ASSOC, V287, P2831, DOI 10.1001/jama.287.21.2831; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Willis BH, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-163	31	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0120911	10.1371/journal.pone.0120911	http://dx.doi.org/10.1371/journal.pone.0120911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905713	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000006
J	Salmon, R; Garbey, M; Moore, LW; Bass, BL				Salmon, Remi; Garbey, Marc; Moore, Linda W.; Bass, Barbara L.			Interrogating a Multifactorial Model of Breast Conserving Therapy with Clinical Data	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; CANCER; SURGERY; SKIN; LUMPECTOMY	Most women with early stage breast cancer do not require removal of the entire breast to treat their cancer; instead, up to 70% of women can be effectively and safely treated by breast conserving therapy (BCT) with surgical removal of the tumor only (lumpectomy) followed by radiation treatment of the remaining breast tissue. Unfortunately, the final contour and cosmesis of the treated breast is suboptimal in approximately 30% of patients. The ability to accurately predict breast contour after BCT for breast cancer could significantly improve patient decision-making regarding the choice of surgery for breast cancer. Our overall hypothesis is that the complex interplay among mechanical forces due to gravity, breast tissue constitutive law distribution, inflammation induced by radiotherapy and internal stress generated by the healing process play a dominant role in determining the success or failure of lumpectomy in preserving the breast contour and cosmesis. We have shown here from a first patient study that even in the idealistic situation of excellent cosmetic outcome this problem requires multiscale modeling. We propose a method to decide which component of the model works best for each phase of healing and what parameters should be considered dominant and patient specific. This patient study is part of a clinical trial registered on ClinicalTrial.gov, identifier NCT02310711.	[Salmon, Remi] Univ Houston, Dept Comp Sci, Houston, TX 77204 USA; [Garbey, Marc] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA; [Garbey, Marc; Bass, Barbara L.] Methodist Inst Technol Innovat & Educ, Houston, TX USA; [Moore, Linda W.; Bass, Barbara L.] Houston Methodist, Dept Surg, Houston, TX USA	University of Houston System; University of Houston; University of Houston System; University of Houston; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute; The Methodist Hospital System; The Methodist Hospital - Houston	Garbey, M (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA.	mgarbey@central.uh.edu	Moore, Linda W/HHN-1307-2022	Moore, Linda W/0000-0003-2519-5150				Abe O, 2005, LANCET, V366, P2087; Al-Ghazal SK, 1999, EUR J SURG ONCOL, V25, P566, DOI 10.1053/ejso.1999.0707; Al-Ghazal SK, 1999, EUR J SURG ONCOL, V25, P571, DOI 10.1053/ejso.1999.0708; Azar F, 1999, P INT SOC MAGN RESON, V7, P1084; Bass BL, 2010, COMPUTATIONAL SURGERY AND DUAL TRAINING, P3, DOI 10.1007/978-1-4419-1123-0_1; Benson JR, 2009, LANCET, V373, P1463, DOI 10.1016/S0140-6736(09)60316-0; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; Bower JE, 2009, CLIN CANCER RES, V15, P5534, DOI 10.1158/1078-0432.CCR-08-2584; Breast Cancer Risk in American Women, 2012, BREAST CANC RISK AM; Chapellier BM, 2012, SHEARWAVE ELASTOGRAP; Clough KB, 1998, ANN PLAS SURG, V41, P471, DOI 10.1097/00000637-199811000-00004; COLLINS AJ, 1976, CLIN RADIOL, V27, P237, DOI 10.1016/S0009-9260(76)80153-5; Delalleau A, 2006, J BIOMECH, V39, P1603, DOI 10.1016/j.jbiomech.2005.05.001; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Diridollou S, 2000, SKIN RES TECHNOL, V6, P214, DOI 10.1034/j.1600-0846.2000.006004214.x; Dormand Emma-Louise, 2005, Int Wound J, V2, P112, DOI 10.1111/j.1742-4801.2005.00079.x; ERMENTROUT GB, 1993, J THEOR BIOL, V160, P97, DOI 10.1006/jtbi.1993.1007; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Garbey M, 2013, J COMPUT PHYS, V244, P321, DOI 10.1016/j.jcp.2012.08.002; Garbey M, 2012, ACTA MECH SINICA-PRC, V28, P1186, DOI 10.1007/s10409-012-0133-4; Garbey M., 2014, COMPUTATIONAL SURG D; Geuzaine C, 2009, INT J NUMER METH ENG, V79, P1309, DOI 10.1002/nme.2579; Golub GH, 1999, SIAM J MATRIX ANAL A, V21, P185, DOI 10.1137/S0895479897326432; Gonzalez Ernest A, 2003, Breast J, V9, P385, DOI 10.1046/j.1524-4741.2003.09504.x; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Gutierrez R, 2011, BREAST SURGICAL TECHNIQUES AND INTERDISCIPLINARY MANAGEMENT, P975, DOI 10.1007/978-1-4419-6076-4_81; Haddadin IS, 2009, NMR BIOMED, V22, P65, DOI 10.1002/nbm.1217; Javierre E, 2009, INT J SOLIDS STRUCT, V46, P3597, DOI 10.1016/j.ijsolstr.2009.06.010; Javierre E, 2009, J MATH BIOL, V59, P605, DOI 10.1007/s00285-008-0242-7; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; Maas SA, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005694; MARTIN AD, 1994, INT J OBESITY, V18, P79; Monaco JL, 2003, CLIN PLAST SURG, V30, P1, DOI 10.1016/S0094-1298(02)00070-6; Myers R. H., 2009, RESPONSE SURFACE MET, V705; POPE TL, 1984, J CAN ASSOC RADIOL, V35, P365; Prendergast B, 2009, INT J RADIAT ONCOL, V74, P695, DOI 10.1016/j.ijrobp.2008.08.044; Rajagopal V, 2007, LECT NOTES COMPUT SC, V4791, P651; Rajagopal V, 2007, INT J NUMER METH ENG, V72, P1434, DOI 10.1002/nme.2045; Rzymski P, 2011, ARCH MED SCI, V7, P127, DOI 10.5114/aoms.2011.20617; Samani A, 2001, IEEE T MED IMAGING, V20, P271, DOI 10.1109/42.921476; Schnabel JA, 2003, IEEE T MED IMAGING, V22, P238, DOI 10.1109/TMI.2002.808367; Tanner C, 2006, MED PHYS, V33, P1758, DOI 10.1118/1.2198315; TAYLOR ME, 1995, INT J RADIAT ONCOL, V31, P753, DOI 10.1016/0360-3016(94)00480-3; Thanoon D, 2015, COMPUT METHOD BIOMEC, V18, P533, DOI 10.1080/10255842.2013.820716; Thanoon David, 2011, Proceedings of the ISCA 3rd International Conference on Bioinformatics and Computational Biology, P55; Thanoon D, 2010, COMPUTATIONAL SURGERY AND DUAL TRAINING, P249, DOI 10.1007/978-1-4419-1123-0_15; Veiga DF, 2010, PLAST RECONSTR SURG, V125, P811, DOI 10.1097/PRS.0b013e3181ccdac5; Waljee JF, 2008, J CLIN ONCOL, V26, P3331, DOI 10.1200/JCO.2007.13.1375; Woodworth PA, 2000, AM SURGEON, V66, P444; Zheng YP, 2000, MED BIOL ENG COMPUT, V38, P497, DOI 10.1007/BF02345743	50	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125006	10.1371/journal.pone.0125006	http://dx.doi.org/10.1371/journal.pone.0125006			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906048	Green Published, Green Submitted, gold			2022-12-27	WOS:000353332000099
J	Yang, H; Long, F; Zhang, Y; Yu, R; Zhang, P; Li, W; Li, S; Jin, X; Xia, J; Dong, L; Zhu, N; Huang, Y; Gong, Y; Chen, X				Yang, Haihua; Long, Feng; Zhang, Youzhi; Yu, Ronghuan; Zhang, Peng; Li, Wenjing; Li, Shuijun; Jin, Xianqiao; Xia, Jingwen; Dong, Liang; Zhu, Ning; Huang, Ying; Gong, Yi; Chen, Xiaodong			1 alpha,25-Dihydroxyvitamin D3 Induces Neutrophil Apoptosis through the p38 MAPK Signaling Pathway in Chronic Obstructive Pulmonary Disease Patients	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; VITAMIN-D; SYSTEMIC INFLAMMATION; COPD; ASTHMA; EXACERBATION	Background Reduced neutrophil apoptosis plays an important role in the pathogenesis of acute exacerbation chronic obstructive pulmonary disease (AECOPD). The p38 mitogen-activated protein kinase (MAPK) signaling pathway is involved in neutrophil apoptosis. 1 alpha,25-Dihydroxyvitamin D3 (1 alpha,25VitD3) can induce tumor cell apoptosis. The aim of this study was to assess the effects of 1 alpha,25VitD3 on peripheral blood neutrophil apoptosis in AECOPD and examine the role of the p38 MAPK signaling pathway. Methods The study enrolled 36 AECOPD patients and 36 healthy volunteers. Venous blood samples were obtained from both groups. Serum 25-hydroxyvitamin D (25-(OH) D) levels in peripheral venous blood were assayed using liquid chromatography-tandem mass spectrometry (LC-MS/MS); the neutrophils were separated and cultured with SB203580 (a p38 inhibitor) and 1 alpha,25VitD3. Neutrophil apoptosis was measured using flow cytometry, and phosphop-38 MAPK protein expression was detected by Western blot. Statistical analysis was performed using analysis of variance. Student's t-test and Pearson's correlation coefficient were used for the between-group differences and correlation analysis, respectively. Results The 25-(OH) D levels were lower in AECOPD patients than in healthy controls, and the peripheral blood neutrophil apoptosis results were similar. 1 alpha,25VitD3 increased the apoptosis rate and the level of phospho-p38 MAPK in peripheral blood neutrophils of AECOPD patients. SB203580 partly inhibited 1 alpha,25VitD3-induced peripheral blood neutrophil apoptosis and phospho-p38 MAPK overexpression. The 25-(OH) D levels were positively correlated with increased peripheral blood neutrophil apoptosis and phospho-p38 MAPK levels. In addition, expression of the phospho-p38 MAPK protein was also positively correlated with peripheral blood neutrophil apoptosis. Conclusion Our results suggest that 1 alpha,25VitD3 induces peripheral blood neutrophil apoptosis through the p38 MAPK signaling pathway in AECOPD patients.	[Yang, Haihua; Long, Feng; Zhang, Youzhi; Zhang, Peng; Li, Wenjing] Fudan Univ, Dept Resp Med, Huashan Hosp North, Shanghai 200433, Peoples R China; [Yu, Ronghuan; Huang, Ying] Xuhui Cent Hosp, Dept Resp Med, Shanghai, Peoples R China; [Li, Shuijun] Xuhui Cent Hosp, Dept Cent Lab, Shanghai, Peoples R China; [Jin, Xianqiao; Xia, Jingwen; Dong, Liang; Zhu, Ning; Gong, Yi; Chen, Xiaodong] Fudan Univ, Huashan Hosp, Dept Resp Med, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Gong, Y (corresponding author), Fudan Univ, Huashan Hosp, Dept Resp Med, Shanghai 200433, Peoples R China.	gongyi1978@hotmail.com; xiaodongchendoctor@163.com			Shanghai Municipal commission of Health and Family Planning of the Youth Scientific Research Project [20134Y003]; Xuhui District Center Hospital Project [2012XHCH07]; Huashan Hospital Project	Shanghai Municipal commission of Health and Family Planning of the Youth Scientific Research Project; Xuhui District Center Hospital Project; Huashan Hospital Project	This study was supported by 20000 yuan, http://www.wsjsw.gov.cn/wsj/n429/n432/n1487/n1508/userobject1ai123523.html, Shanghai Municipal commission of Health and Family Planning of the Youth Scientific Research Project, 20134Y003; 50000 yuan, 2012XHCH07 from Xuhui District Center Hospital Project; 10000 yuan, Huashan Hospital Project. The projects funding receiver is Haihua Yang. The funders had no role in study design, collection and analysis, decision to publish, or preparation of the manuscript.	Berg I, 2013, RESP MED, V107, P1578, DOI 10.1016/j.rmed.2013.05.010; Black PN, 2005, CHEST, V128, P3792, DOI 10.1378/chest.128.6.3792; Carboni I, 2012, CLIN TER, V163, pE441; Chen Tai C, 2011, ISRN Urol, V2011, P301490, DOI 10.5402/2011/301490; Chiang KC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/310872; Chung KF, 2011, CHEST, V139, P1470, DOI 10.1378/chest.10-1914; Finklea JD, 2011, ADV NUTR, V2, P244, DOI 10.3945/an.111.000398; Frasch SC, 1998, J BIOL CHEM, V273, P8389, DOI 10.1074/jbc.273.14.8389; Gaffey K, 2013, EUR RESPIR J, V42, P28, DOI 10.1183/09031936.00170711; de Tena JG, 2014, ARCH BRONCONEUMOL, V50, P179, DOI 10.1016/j.arbres.2013.11.023; Herr C, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-31; Hirsch D, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/598345; Hoenderdos K, 2013, AM J RESP CELL MOL, V48, P531, DOI 10.1165/rcmb.2012-0492TR; Janssens W, 2009, AM J RESP CRIT CARE, V179, P630, DOI 10.1164/rccm.200810-1576PP; Lehouck A, 2012, ANN INTERN MED, V156, P105, DOI 10.7326/0003-4819-156-2-201201170-00004; Linker-Israeli M, 2001, CLIN IMMUNOL, V99, P82, DOI 10.1006/clim.2000.4998; Oudijk EJD, 2005, THORAX, V60, P538, DOI 10.1136/thx.2004.034009; Oudijk EJD, 2003, EUR RESPIR J, V22, p5S, DOI 10.1183/09031936.03.00004603a; Oudijk EJD, 2006, RESP MED, V100, P1791, DOI 10.1016/j.rmed.2006.01.022; Persson LJP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038934; Pletz MWR, 2004, EUR RESPIR J, V23, P532, DOI 10.1183/09031936.04.00089004; Ratcliffe MJ, 2012, BMC PHARMACOL TOXICO, V13, DOI 10.1186/2050-6511-13-15; Takahashi K, 2002, IMMUNOPHARM IMMUNOT, V24, P335, DOI 10.1081/IPH-120014721; TESTA U, 1994, CANCER RES, V54, P4508; Vestbo J, 2012, CLIN RESPIR J, V6, P208, DOI 10.1111/crj.12002; Vestbo Jorgen, 2012, Zhonghua Yi Xue Za Zhi, V92, P937	26	19	22	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0120515	10.1371/journal.pone.0120515	http://dx.doi.org/10.1371/journal.pone.0120515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905635	Green Published, Green Submitted, gold			2022-12-27	WOS:000353332000005
J	Zhang, X; An, LJ; Nguyen, TH; Liang, H; Wang, R; Liu, XY; Li, TH; Qi, YF; Yu, F				Zhang, Xiang; An, Lijun; Thi Hung Nguyen; Liang, Huike; Wang, Rui; Liu, Xiayan; Li, Tianhong; Qi, Yafei; Yu, Fei			The Cloning and Functional Characterization of Peach CONSTANS and FLOWERING LOCUS T Homologous Genes PpCO and PpFT	PLOS ONE			English	Article							FLORAL INDUCTION; FT PROTEIN; TRANSCRIPTION FACTOR; ARABIDOPSIS; TIME; SIGNAL; INTEGRATION; INITIATION; REPRESSOR; PHLOEM	Flowering is an essential stage of plant growth and development. The successful transition to flowering not only ensures the completion of plant life cycles, it also serves as the basis for the production of economically important seeds and fruits. CONSTANS (CO) and FLOWERING LOCUS T (FT) are two genes playing critical roles in flowering time control in Arabidopsis. Through homology-based cloning and rapid-amplifications of cDNA ends (RACE), we obtained full-lengths cDNA sequences of Prunus Persica CO (PpCO) and Prunus Persica FT(PpFT) from peach (Prunus persica (L.) Batsch) and investigated their functions in flowering time regulation. PpCO and PpFT showed high homologies to Arabidopsis CO and FT at DNA, mRNA and protein levels. We showed that PpCO and PpFT were nucleus-localized and both showed transcriptional activation activities in yeast cells, consistent with their potential roles as transcription activators. Moreover, we established that the over-expression of PpCO could restore the late flowering phenotype of the Arabidopsis co-2 mutant, and the late flowering defect of the Arabidopsis ft-1 mutant can be rescued by the overexpression of PpFT, suggesting functional conservations of CO and FT genes in peach and Arabidopsis. Our results suggest that PpCO and PpFT are homologous genes of CO and FT in peach and they may function in regulating plant flowering time.	[Zhang, Xiang; An, Lijun; Thi Hung Nguyen; Liang, Huike; Wang, Rui; Liu, Xiayan; Qi, Yafei; Yu, Fei] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; [Zhang, Xiang; An, Lijun; Thi Hung Nguyen; Liang, Huike; Wang, Rui; Liu, Xiayan; Qi, Yafei; Yu, Fei] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China; [Li, Tianhong] China Agr Univ, Coll Agron & Biotechnol, Dept Fruit Sci, Beijing 100193, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; China Agricultural University	Yu, F (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China.	flyfeiyu@gmail.com		Wang, Rui/0000-0002-6196-0780	National Natural Science Foundation of China [31071073, 31170219, 31100864, 31300988, 31470290]; Natural Science Foundation of Shaanxi Province, China [2011JQ3004, 2012JQ3015, 2013JQ3014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province, China(Natural Science Foundation of Shaanxi Province)	This work was supported by funds from the National Natural Science Foundation of China (31071073, 31170219 to F.Y., 31100864 to X.L., 31300988 to Y.Q. and 31470290 to L.A.), and by grants from the Natural Science Foundation of Shaanxi Province, China (2011JQ3004 to X.L., 2012JQ3015 to Y.Q. and 2013JQ3014 to L.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Arus Pere, 2007, P357, DOI 10.1007/978-1-4020-6297-1_14; Blazquez MA, 2005, SCIENCE, V309, P1024, DOI 10.1126/science.1117203; Borden KLB, 1998, BIOCHEM CELL BIOL, V76, P351, DOI 10.1139/bcb-76-2-3-351; Chen J, 2012, GENE, V496, P110, DOI 10.1016/j.gene.2012.01.008; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Fukuda M, 2011, J PLANT PHYSIOL, V168, P1602, DOI 10.1016/j.jplph.2011.02.004; Hanzawa Y, 2005, P NATL ACAD SCI USA, V102, P7748, DOI 10.1073/pnas.0500932102; Hayama R, 2004, PLANT PHYSIOL, V135, P677, DOI 10.1104/pp.104.042614; Huang GW, 2011, PLANT MOL BIOL REP, V29, P352, DOI 10.1007/s11105-010-0240-y; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Khanna R, 2009, PLANT CELL, V21, P3416, DOI 10.1105/tpc.109.069088; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Lai ZB, 2011, PLANT CELL, V23, P3824, DOI 10.1105/tpc.111.090571; Laurie RE, 2011, PLANT PHYSIOL, V156, P2207, DOI 10.1104/pp.111.180182; Li D, 2008, DEV CELL, V15, P110, DOI 10.1016/j.devcel.2008.05.002; Martinez-Garcia JF, 2002, P NATL ACAD SCI USA, V99, P15211, DOI 10.1073/pnas.222390599; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Michaels SD, 2009, CURR OPIN PLANT BIOL, V12, P75, DOI 10.1016/j.pbi.2008.09.005; Milec Z, 2014, BIOTECHNOL ADV, V32, P200, DOI 10.1016/j.biotechadv.2013.09.008; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Onouchi H, 2000, PLANT CELL, V12, P885, DOI 10.1105/tpc.12.6.885; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; REDDY BA, 1992, TRENDS BIOCHEM SCI, V17, P344, DOI 10.1016/0968-0004(92)90308-V; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Song YH, 2010, CURR OPIN PLANT BIOL, V13, P594, DOI 10.1016/j.pbi.2010.05.004; Tan FC, 2006, PHYSIOL PLANTARUM, V128, P8, DOI 10.1111/j.1399-3054.2006.00724.x; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Valverde F, 2011, J EXP BOT, V62, P2453, DOI 10.1093/jxb/erq449; WHITESIDE ST, 1993, J CELL SCI, V104, P949; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Wilkie JD, 2008, J EXP BOT, V59, P3215, DOI 10.1093/jxb/ern188; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928; Yu F, 2008, PLANT CELL, V20, P1786, DOI 10.1105/tpc.107.054965; ZEEVAART JAD, 1977, PLANT PHYSIOL, V60, P747, DOI 10.1104/pp.60.5.747; Zhang JX, 2011, ACTA PHYSIOL PLANT, V33, P409, DOI 10.1007/s11738-010-0560-4	43	11	13	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124108	10.1371/journal.pone.0124108	http://dx.doi.org/10.1371/journal.pone.0124108			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905637	Green Submitted, gold, Green Published			2022-12-27	WOS:000353332000059
J	Burke, AK; Guthrie, LTC; Modise, T; Cormier, G; Jensen, RV; McCarter, LL; Stevens, AM				Burke, Alison Kernell; Guthrie, Leah T. C.; Modise, Thero; Cormier, Guy; Jensen, Roderick V.; McCarter, Linda L.; Stevens, Ann M.			OpaR Controls a Network of Downstream Transcription Factors in Vibrio parahaemolyticus BB22OP	PLOS ONE			English	Article							III SECRETION; CELL COMMUNICATION; UNITED-STATES; BACTERIAL; REGULATORS; HARVEYI; PROTEIN; LUXR; TOOL; RNA	Vibrio parahaemolyticus is an emerging world-wide human pathogen that is associated with food-borne gastroenteritis when raw or undercooked seafood is consumed. Expression of virulence factors in this organism is modulated by the phenomenon known as quorum sensing, which permits differential gene regulation at low versus high cell density. The master regulator of quorum sensing in V. parahaemolyticusis OpaR. OpaR not only controls virulence factor gene expression, but also the colony and cellular morphology associated with growth on a surface and biofilm formation. Whole transcriptome Next Generation sequencing (RNA-Seq) was utilized to determine the OpaR regulon by comparing strains BB22OP (opaR(+), LM5312) and BB22TR (opaR1, LM5674). This work, using the published V. parahaemolyticus BB22OP genome sequence, confirms and expands upon a previous microarray analysis for these two strains that used an Affymetrix GeneChip designed from the closely related V. parahaemolyticus RIMD2210633 genome sequence. Overall there was excellent correlation between the microarray and RNA-Seq data. Eleven transcription factors under OpaR control were identified by both methods and further confirmed by quantitative reverse transcription PCR (qRT-PCR) analysis. Nine of these transcription factors were demonstrated to be direct OpaR targets via in vitro electrophoretic mobility shift assays with purified hexahistidine-tagged OpaR. Identification of the direct and indirect targets of OpaR, including small RNAs, will enable the construction of a network map of regulatory interactions important for the switch between the nonpathogenic and pathogenic states.	[Burke, Alison Kernell; Guthrie, Leah T. C.; Modise, Thero; Jensen, Roderick V.; Stevens, Ann M.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA; [Cormier, Guy] Univ Georgia, Georgia Adv Comp Resource Ctr, Athens, GA 30602 USA; [McCarter, Linda L.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	Virginia Polytechnic Institute & State University; University System of Georgia; University of Georgia; University of Iowa	Stevens, AM (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	ams@vt.edu		Stevens, Ann/0000-0002-4942-0124	Fralin Life Sciences Institute; Virginia Bioinformatics Institute; Graduate Research Development Program; Life Sciences I Building Fund; Virginia Tech's Open Access Subvention Fund	Fralin Life Sciences Institute; Virginia Bioinformatics Institute; Graduate Research Development Program; Life Sciences I Building Fund; Virginia Tech's Open Access Subvention Fund	The work was supported by the Fralin Life Sciences Institute, Virginia Bioinformatics Institute, Graduate Research Development Program, and Life Sciences I Building Fund, and its publication was supported by Virginia Tech's Open Access Subvention Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARNQVIST A, 1992, MOL MICROBIOL, V6, P2443; BELAS R, 1986, J BACTERIOL, V167, P210, DOI 10.1128/jb.167.1.210-218.1986; Boles BR, 2002, J BACTERIOL, V184, P5946, DOI 10.1128/JB.184.21.5946-5954.2002; Brutinel ED, 2009, J BACTERIOL, V191, P3811, DOI 10.1128/JB.00002-09; Busenlehner LS, 2003, FEMS MICROBIOL REV, V27, P131, DOI 10.1016/S0168-6445(03)00054-8; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Croucher NJ, 2010, CURR OPIN MICROBIOL, V13, P619, DOI 10.1016/j.mib.2010.09.009; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; DePaola A, 2010, APPL ENVIRON MICROB, V76, P2754, DOI 10.1128/AEM.02590-09; Enos-Berlage JL, 2005, MOL MICROBIOL, V55, P1160, DOI 10.1111/j.1365-2958.2004.04453.x; Ferreira RBR, 2012, J BACTERIOL, V194, P914, DOI 10.1128/JB.05807-11; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gode-Potratz CJ, 2011, J BACTERIOL, V193, P4224, DOI 10.1128/JB.00432-11; Gode-Potratz CJ, 2011, MOL MICROBIOL, V79, P240, DOI 10.1111/j.1365-2958.2010.07445.x; Gode-Potratz CJ, 2010, J BACTERIOL, V192, P6025, DOI 10.1128/JB.00654-10; Guvener ZT, 2003, J BACTERIOL, V185, P5431, DOI 10.1128/JB.185.18.5431-5441.2003; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Jaques S, 2006, J BACTERIOL, V188, P2625, DOI 10.1128/JB.188.7.2625-2635.2006; Jensen R.V., 2013, GENOME ANNOUNC, V1; Joint I, 2007, PHILOS T R SOC B, V362, P1115, DOI 10.1098/rstb.2007.2038; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2013, NUCLEIC ACIDS RES, V41, pD233, DOI 10.1093/nar/gks1264; Livny Jonathan, 2007, V395, P475; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Mane SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-264; McCarter LL, 1998, J BACTERIOL, V180, P3166, DOI 10.1128/JB.180.12.3166-3173.1998; McLaughlin JB, 2005, NEW ENGL J MED, V353, P1463, DOI 10.1056/NEJMoa051594; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pompeani AJ, 2008, MOL MICROBIOL, V70, P76, DOI 10.1111/j.1365-2958.2008.06389.x; Ramachandran R, 2014, APPL ENVIRON MICROB, V80, P5790, DOI 10.1128/AEM.01489-14; Reen FJ, 2006, NAT REV MICROBIOL, V4, P697, DOI 10.1038/nrmicro1476; Salomon D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061086; Stewart BJ, 2003, J BACTERIOL, V185, P4508, DOI 10.1128/JB.185.15.4508-4518.2003; Tu KC, 2008, MOL MICROBIOL, V70, P896, DOI 10.1111/j.1365-2958.2008.06452.x; von Bodman SB, 2008, J BACTERIOL, V190, P4377, DOI 10.1128/JB.00486-08; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; Zhang YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034622	44	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0121863	10.1371/journal.pone.0121863	http://dx.doi.org/10.1371/journal.pone.0121863			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901572	Green Published, gold			2022-12-27	WOS:000353331500013
J	de Oliveira, SHP; Shi, JY; Deane, CM				de Oliveira, Saulo H. P.; Shi, Jiye; Deane, Charlotte M.			Building a Better Fragment Library for De Novo Protein Structure Prediction	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION	Fragment-based approaches are the current standard for de novo protein structure prediction. These approaches rely on accurate and reliable fragment libraries to generate good structural models. In this work, we describe a novel method for structure fragment library generation and its application in fragment-based de novo protein structure prediction. The importance of correct testing procedures in assessing the quality of fragment libraries is demonstrated. In particular, the exclusion of homologs to the target from the libraries to correctly simulate a de novo protein structure prediction scenario, something which surprisingly is not always done. We demonstrate that fragments presenting different predominant predicted secondary structures should be treated differently during the fragment library generation step and that exhaustive and random search strategies should both be used. This information was used to develop a novel method, Flib. On a validation set of 41 structurally diverse proteins, Flib libraries presents both a higher precision and coverage than two of the state-of-the-art methods, NNMake and HHFrag. Flib also achieves better precision and coverage on the set of 275 protein domains used in the two previous experiments of the the Critical Assessment of Structure Prediction (CASP9 and CASP10). We compared Flib libraries against NNMake libraries in a structure prediction context. Of the 13 cases in which a correct answer was generated, Flib models were more accurate than NNMake models for 10. "Flib is available for download at: http://www.stats.ox.ac.uk/research/proteins/resources".	[de Oliveira, Saulo H. P.; Deane, Charlotte M.] Univ Oxford, Dept Stat, Oxford OX1 3TG, Oxon, England; [Shi, Jiye] UCB Pharma, Dept Informat, Slough, Berks, England; [Shi, Jiye] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai, Peoples R China	University of Oxford; UCB Pharma SA; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS	de Oliveira, SHP (corresponding author), Univ Oxford, Dept Stat, Oxford OX1 3TG, Oxon, England.	saulo.deoliveira@dtc.ox.ac.uk		Deane, Charlotte/0000-0003-1388-2252	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) - Ciencia Sem Fronteiras [237656/2012-4]; Engineering and Physical Sciences Research Council [EP/G037280/1]; UCB Pharma	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) - Ciencia Sem Fronteiras(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UCB Pharma(UCB Pharma SA)	SHPO was funded by: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) - Ciencia Sem Fronteiras-Grant Number: 237656/2012-4 (http://www.cienciasemfronteiras.gov.br/web/csf). CMD was funded by: Engineering and Physical Sciences Research Council grant to System Approaches to Biomedical Sciences-Centre for Doctoral Training (http://www.epsrc.ac.uk/) Grant Number: EP/G037280/1. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. UCB Pharma provided support in the form of salaries for authors [JS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 2011, PROTEINS, DOI DOI 10.1002/PR0T.23215; [Anonymous], 2011, CASP9 P, V79, P1, DOI [10.1002/prot.23200, DOI 10.1002/PROT.23200]; [Anonymous], 2005, PROTEINS; [Anonymous], 2014, CASP10 P, V82, P1; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bonneau R, 2002, J MOL BIOL, V322, P65, DOI 10.1016/S0022-2836(02)00698-8; Bonneau R, 2001, PROTEINS, P119; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Choi YS, 2009, PROTEINS, V77, P14, DOI 10.1002/prot.22410; Choi YJ, 2013, PEERJ, V1, DOI 10.7717/peerj.1; Elcock AH, 2006, PLOS COMPUT BIOL, V2, P824, DOI 10.1371/journal.pcbi.0020098; Ellis JJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-172; Faraggi E, 2012, J COMPUT CHEM, V33, P259, DOI 10.1002/jcc.21968; Faraggi E, 2009, STRUCTURE, V17, P1515, DOI 10.1016/j.str.2009.09.006; Griep S, 2010, NUCLEIC ACIDS RES, V38, pD318, DOI 10.1093/nar/gkp786; Gront D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023294; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Holmes JB, 2004, PROTEIN SCI, V13, P1636, DOI 10.1110/ps.03494504; Jefferys BR, 2010, J MOL BIOL, V397, P1329, DOI 10.1016/j.jmb.2010.01.074; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Jones DT, 2003, PROTEINS, V53, P480, DOI 10.1002/prot.10542; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kalev I, 2011, BIOINFORMATICS, V27, P3110, DOI 10.1093/bioinformatics/btr541; Kolodny R, 2002, J MOL BIOL, V323, P297, DOI 10.1016/S0022-2836(02)00942-7; Kosciolek T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092197; Lee J, 2005, BIOPHYS CHEM, V115, P209, DOI 10.1016/j.bpc.2004.12.046; Li SC, 2008, BIOINFORMATICS, V24, pI182, DOI 10.1093/bioinformatics/btn165; Moult J, 2011, PROTEINS, V79, P1, DOI 10.1002/prot.23200; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Saunders R, 2010, PROTEINS, V78, P1282, DOI 10.1002/prot.22646; Shen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080493; Soding J, 2005, BIOINFORMATICS, P21; SRINIVASAN R, 1995, PROTEINS, V22, P81, DOI 10.1002/prot.340220202	36	17	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123998	10.1371/journal.pone.0123998	http://dx.doi.org/10.1371/journal.pone.0123998			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901595	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500069
J	Di Ianni, F; Merli, E; Burtini, F; Conti, V; Pelizzone, I; Di Lecce, R; Parmigiani, E; Squassino, GP; Del Bue, M; Lucarelli, E; Ramoni, R; Grolli, S				Di Ianni, Francesco; Merli, Elisa; Burtini, Francesca; Conti, Virna; Pelizzone, Igor; Di Lecce, Rosanna; Parmigiani, Enrico; Squassino, Gian Paolo; Del Bue, Maurizio; Lucarelli, Enrico; Ramoni, Roberto; Grolli, Stefano			Preparation and Application of an Innovative Thrombocyte/Leukocyte-Enriched Plasma to Promote Tissue Repair in Chelonians	PLOS ONE			English	Article							PLATELET-RICH PLASMA; GROWTH-FACTORS; REGENERATIVE MEDICINE; PRP; LEUKOCYTES; RELEASE; TENDONS; GEL	Platelet concentrates are widely used in mammalian regenerative medicine to improve tissue healing. Chelonians (Testudines) would benefit from the application of thrombocyte preparations to regenerate damaged tissues, since traumatic injuries are leading causes of morbidity and mortality for both wild-living and domesticated animals. The aim of this study was to establish a protocol that optimized the recovery of the thrombocytes from blood samples and to show the efficacy of thrombocyte-enriched plasma in chelonians. Peripheral blood samples were obtained from Testudo spp. (n = 12) and Trachemys scripta elegans (n = 10). Blood cells were fractionated by sodium diatrizoate-sodium polysucrose density gradient using a two-step centrifugation protocol. Thrombocytes and leukocytes were isolated and resuspended to obtain thrombocyte-leucocyte rich plasma (TLRP). The mean recovery of leukocytes and thrombocytes was 48.9% (+/- 4.0 SEM, n = 22) of the whole blood cell content. No statistically significant difference was observed between blood samples collected from different turtle species. The ability of TLRP to form a gel was evaluated by adding variable concentrations of calcium gluconate at room temperature and at 37 degrees C. A reliable and consistent clotting of the TLRP was obtained in glass tubes and dishes by adding 520% v/v of a 100 mg/ml solution of calcium gluconate. Furthermore, in order to test the clinical efficacy of TLRP, a preliminary evaluation was performed on four turtles (Testudo spp.) with traumatic injuries. In all the four animals, a successful clinical outcome was observed. The results demonstrated that a thrombocyte-enriched plasma, comparable to mammalian platelet rich plasma, can be prepared from chelonian blood samples. Furthermore, although the low number of cases presented does not allow definitive conclusions from a clinical point of view, their outcome suggests that TLRP application could be further investigated to improve the healing process of both soft and hard tissue injuries in chelonians.	[Di Ianni, Francesco; Merli, Elisa; Burtini, Francesca; Conti, Virna; Pelizzone, Igor; Di Lecce, Rosanna; Parmigiani, Enrico; Del Bue, Maurizio; Ramoni, Roberto; Grolli, Stefano] Univ Parma, Dept Vet Sci, I-43126 Parma, Italy; [Squassino, Gian Paolo] Clin Vet Ambulatorio Squassino, Asti, Italy; [Lucarelli, Enrico] Rizzoli Orthopaed Inst, Osteoarticular Regenerat Lab, I-40136 Bologna, Italy	University of Parma; IRCCS Istituto Ortopedico Rizzoli	Grolli, S (corresponding author), Univ Parma, Dept Vet Sci, Via Del Taglio 10, I-43126 Parma, Italy.	stefano.grolli@unipr.it	Lucarelli, Enrico/AAF-1612-2021; Enrico, Lucarelli/G-3588-2015	Lucarelli, Enrico/0000-0002-6681-6374; Enrico, Lucarelli/0000-0002-6681-6374; Grolli, Stefano/0000-0003-4380-5725				Andia I, 2012, OPER TECH ORTHOP, V22, P3, DOI 10.1053/j.oto.2011.09.005; Anitua E, 2012, J CONTROL RELEASE, V157, P29, DOI 10.1016/j.jconrel.2011.07.004; Barten S.L., 2006, REPTILE MED SURG, V2<feminine, P893; Bielecki T, 2012, CURR PHARM BIOTECHNO, V13, P1153, DOI 10.2174/138920112800624373; Bielecki T, 2012, CURR PHARM BIOTECHNO, V13, P1121, DOI 10.2174/138920112800624292; Bosch G, 2010, J ORTHOP RES, V28, P211, DOI 10.1002/jor.20980; Castillo TN, 2011, AM J SPORT MED, V39, P266, DOI 10.1177/0363546510387517; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe51, DOI 10.1016/j.tripleo.2005.07.010; Drago L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107813; Dunkel B, 2012, EQUINE VET J, V44, P346, DOI 10.1111/j.2042-3306.2011.00431.x; Ehrenfest DMD, 2009, TRENDS BIOTECHNOL, V27, P158, DOI 10.1016/j.tibtech.2008.11.009; Everts PA, 2008, EUR SURG RES, V40, P203, DOI 10.1159/000110862; Everts PAM, 2008, J BIOMED MATER RES A, V85A, P1135, DOI 10.1002/jbm.a.31570; Fleming GJ, 2008, J EXOT PET MED, V17, P246, DOI 10.1053/j.jepm.2008.08.001; Giraldo CE, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-29; Graziani F, 2006, CLIN ORAL IMPLAN RES, V17, P212, DOI 10.1111/j.1600-0501.2005.01203.x; Griffin XL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009496.pub2; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Martinez-Zapata MJ, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006899.pub2, 10.1002/14651858.CD006899.pub3]; Kishimori J., 2001, Exotic DVM, V3, P35; Kiwanuka E, 2012, CLIN PLAST SURG, V39, P239, DOI 10.1016/j.cps.2012.04.003; Lucarelli E, 2003, BIOMATERIALS, V24, P3095, DOI 10.1016/S0142-9612(03)00114-5; Mazzucco L, 2009, VOX SANG, V97, P110, DOI 10.1111/j.1423-0410.2009.01188.x; Mitchell Mark A., 2004, Veterinary Clinics of North America Exotic Animal Practice, V7, P123, DOI 10.1016/j.cvex.2003.08.006; Morgan DA, 2009, TISSUE CELL, V41, P299, DOI 10.1016/j.tice.2008.12.004; Nardini Giordano, 2013, Vet Clin North Am Exot Anim Pract, V16, P1, DOI 10.1016/j.cvex.2012.09.001; NATT MP, 1952, POULTRY SCI, V31, P735, DOI 10.3382/ps.0310735; Nurden AT, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2947; Renzi S, 2013, RES VET SCI, V95, P272, DOI 10.1016/j.rvsc.2013.01.017; Tavares-Dias Marcos, 2008, Acta Amaz., V38, P351, DOI 10.1590/S0044-59672008000200020; Tohidnezhad M, 2012, PLATELETS, V23, P217, DOI 10.3109/09537104.2011.610908; Weibrich G, 2005, INT J ORAL MAX IMPL, V20, P118; Werther K, 2002, SCAND J CLIN LAB INV, V62, P343, DOI 10.1080/00365510260296492	34	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122595	10.1371/journal.pone.0122595	http://dx.doi.org/10.1371/journal.pone.0122595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901960	gold, Green Published, Green Submitted			2022-12-27	WOS:000353331500023
J	Fernandez-Grandon, GM; Gezan, SA; Armour, JAL; Pickett, JA; Logan, JG				Fernandez-Grandon, G. Mandela; Gezan, Salvador A.; Armour, John A. L.; Pickett, John A.; Logan, James G.			Heritability of Attractiveness to Mosquitoes	PLOS ONE			English	Article							MALARIA; PREFERENCES; HUMANS; WOMEN	Female mosquitoes display preferences for certain individuals over others, which is determined by differences in volatile chemicals produced by the human body and detected by mosquitoes. Body odour can be controlled genetically but the existence of a genetic basis for differential attraction to insects has never been formally demonstrated. This study investigated heritability of attractiveness to mosquitoes by evaluating the response of Aedes aegypti (=Stegomyia aegypti) mosquitoes to odours from the hands of identical and nonidentical twins in a dual-choice assay. Volatiles from individuals in an identical twin pair showed a high correlation in attractiveness to mosquitoes, while non-identical twin pairs showed a significantly lower correlation. Overall, there was a strong narrow-sense heritability of 0.62 (SE 0.124) for relative attraction and 0.67 (0.354) for flight activity based on the average of ten measurements. The results demonstrate an underlying genetic component detectable by mosquitoes through olfaction. Understanding the genetic basis for attractiveness could create a more informed approach to repellent development.	[Fernandez-Grandon, G. Mandela; Logan, James G.] Univ London London Sch Hyg & Trop Med, Dept Dis Control, London WC1E 7HT, England; [Gezan, Salvador A.] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; [Armour, John A. L.] Univ Nottingham, Sch Life Sci, Nottingham NG7 2UH, England; [Pickett, John A.] Rothamsted Res, Biol Chem & Crop Protect Dept, Harpenden AL5 2JQ, Herts, England	University of London; London School of Hygiene & Tropical Medicine; State University System of Florida; University of Florida; University of Nottingham; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Logan, JG (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Dis Control, Keppel St, London WC1E 7HT, England.	James.Logan@LSHTM.ac.uk		Fernandez-Grandon, Mandela/0000-0002-2993-390X; Armour, John/0000-0002-8558-8506	Sir Halley Stewart Trust; Biotechnology and Biological Sciences Research Council (BBSRC) of the UK; Wellcome Trust; European Community; National Institute for Health Research (NIHR); Biomedical Research Centre	Sir Halley Stewart Trust; Biotechnology and Biological Sciences Research Council (BBSRC) of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Biomedical Research Centre	This study was funded by Sir Halley Stewart Trust. Rothamsted Research receives grant-aided support from the Biotechnology and Biological Sciences Research Council (BBSRC) of the UK. TwinsUK is funded by the Wellcome Trust, European Community's Seventh Framework Programme (FP7/2007-2013) and also receives support from the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell J, 2002, T ROY SOC TROP MED H, V96, P113, DOI 10.1016/S0035-9203(02)90271-3; DEJONG R, 1995, EXPERIENTIA, V51, P80, DOI 10.1007/BF01964925; Falconer D. S., 1996, Introduction to quantitative genetics.; Gilmour AR, 2010, AS REML USER GUIDE; Ives AR, 2005, J AM MOSQUITO CONTR, V21, P213, DOI 10.2987/8756-971X(2005)21[213:TVBAAH]2.0.CO;2; Lacroix R, 2005, PLOS BIOL, V3, P1590, DOI 10.1371/journal.pbio.0030298; Lefevre T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009546; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; Logan JG, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-239; Logan JG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-275; Olanga EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-6; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; Penn Dustin J., 2004, Biologist (London), V51, P207; PORT GR, 1980, B ENTOMOL RES, V70, P133, DOI 10.1017/S0007485300009834; Qiu YT, 2006, MED VET ENTOMOL, V20, P280, DOI 10.1111/j.1365-2915.2006.00627.x; Rajan TV, 2005, MED VET ENTOMOL, V19, P84, DOI 10.1111/j.0269-283X.2005.00544.x; Rebollar Tellez EA, 2005, FOLIA ENTOMOL MEX, V44, P247; Roberts SC, 2005, CHEM SENSES, V30, P651, DOI 10.1093/chemse/bji058; Stulp G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028991, 10.1371/journal.pone.0020497]; Verhulst NO, 2013, INFECT GENET EVOL, V18, P87, DOI 10.1016/j.meegid.2013.05.009; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Visscher PM, 2004, TWIN RES, V7, P670, DOI 10.1375/1369052042663742; Wedekind C, 1997, P ROY SOC B-BIOL SCI, V264, P1471, DOI 10.1098/rspb.1997.0204; Weisfeld GE, 2003, J EXP CHILD PSYCHOL, V85, P279, DOI 10.1016/S0022-0965(03)00061-4	25	28	29	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122716	10.1371/journal.pone.0122716	http://dx.doi.org/10.1371/journal.pone.0122716			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901606	Green Accepted, Green Published, gold			2022-12-27	WOS:000353331500029
J	Olesen, J; Boesgaard, T; Iliffe, TM				Olesen, Jorgen; Boesgaard, Tom; Iliffe, Thomas M.			The Unique Dorsal Brood Pouch of Thermosbaenacea (Crustacea, Malacostraca) and Description of an Advanced Developmental Stage of Tulumella unidens from the Yucatan Peninsula (Mexico), with a Discussion of Mouth Part Homologies to Other Malacostraca	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; EXTERNAL MORPHOLOGY; LARVAL DEVELOPMENT; BRANCHIOPODA; PERACARIDA; EPIPODITES; EVOLUTION; GILLS; MYSTACOCARIDA; CONCHOSTRACA	The Thermosbaenacea, a small taxon of crustaceans inhabiting subterranean waters, are unique among malacostracans as they brood their offspring dorsally under the carapace. This habit is of evolutionary interest but the last detailed report on thermosbaenacean development is more than 40 years old. Here we provide new observations on an ovigerous female of Tulumella unidens with advanced developmental stages in its brood chamber collected from an anchialine cave at the Yucatan Peninsula, which is only the third report on developmental stages of Thermosbaenacea and the first for the genus Tulumella. Significant in a wider crustacean context, we report and discuss hitherto unexplored lobate structures inside the brood chamber of the female originating at the first (maxilliped) and second thoracic segments, which are most likely modified epipods, perhaps serving as gills. At the posterior margin of carapace of the female are rows of large spines preventing the developing stages from falling out. The external morphology of the advanced developmental stages is described in much detail, providing information on e.g., carapace formation and early limb morphology. Among the hitherto unknown structures in the advanced developmental stages provided by this study are the presence of an embryonic dorsal organ and rudimentary 'naupliar processes' of the second antennae. Since most hypotheses on crustacean (and malacostracan and peracaridan) relationship rest on external limb morphology, we use early limb bud morphology of Tulumella to better establish thermosbaenacean limb homologies to those of other crustaceans, which is a necessary basis for future morphology based phylogenetic considerations.	[Olesen, Jorgen; Boesgaard, Tom] Univ Copenhagen, Nat Hist Museum, DK-2100 Copenhagen O, Denmark; [Iliffe, Thomas M.] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA	University of Copenhagen; Texas A&M University System	Olesen, J (corresponding author), Univ Copenhagen, Nat Hist Museum, Univ Pk 15, DK-2100 Copenhagen O, Denmark.	jolesen@snm.ku.dk	Olesen, Jørgen/A-3353-2013; Illife, Thomas/R-2252-2017	Olesen, Jørgen/0000-0001-9582-7083; Illife, Thomas/0000-0002-4342-5960; Olesen, Jes/0000-0002-6712-2702	Carlsberg Foundation	Carlsberg Foundation(Carlsberg Foundation)	The Carlsberg Foundation generously supported the collecting trip to the Yucatan Peninsula on which the material was collected. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER D, 1962, Q J MICROSC SCI, V103, P261; Borradaile L. A., 1907, Annals & Magazine of Natural History Series 7, V19; BOWMAN TE, 1988, P BIOL SOC WASH, V101, P221; Boxshall GA, 2004, BIOL REV, V79, P253, DOI 10.1017/S1464793103006274; Boxshall Geoff A., 2009, Arthropod Systematics & Phylogeny, V67, P229; Briggs DEG, 2004, P ROY SOC B-BIOL SCI, V271, P131, DOI 10.1098/rspb.2003.2593; CALS P, 1991, CAH BIOL MAR, V32, P173; Coineau N, 2013, CRUSTACEA REVISED A, V4, P557; Coutiere H, 1905, CR HEBD ACAD SCI, V141, P64; Elofsson R, 2008, ARTHROPOD STRUCT DEV, V37, P522, DOI 10.1016/j.asd.2008.05.002; FRYER G, 1983, PHILOS T ROY SOC B, V303, P229; Fryer G., 1964, EARTH ENV SCI T R SO, V66, P49; Gordon I, 1960, B BRIT MUS NAT HIST, V6, P285; Hansen H.J., 1893, ZOOL ANZ, V16, P193; Haug JT, 2011, J CRUSTACEAN BIOL, V31, P668, DOI 10.1651/11-3481.1; HONG SY, 1988, J NAT HIST, V22, P1005, DOI 10.1080/00222938800770641; Jaume D, 2008, HYDROBIOLOGIA, V595, P219, DOI 10.1007/s10750-007-9017-1; Lankester R., 1909, TREATISE ZOOLOGY 7, P1; Lerosey-Aubril R, 2013, BIOL REV, V88, P406, DOI 10.1111/brv.12011; Maas Andreas, 2009, Arthropod Systematics & Phylogeny, V67, P255; Martin JW, 2014, ATLAS OF CRUSTACEAN LARVAE, P8; Martin JW, 2014, ATLAS OF CRUSTACEAN LARVAE, P1; MARTIN JW, 1992, ACTA ZOOL-STOCKHOLM, V73, P357, DOI 10.1111/j.1463-6395.1992.tb01108.x; Moller OS, 2004, ZOOMORPHOLOGY, V123, P107, DOI 10.1007/s00435-003-0093-0; MULLER KJ, 1988, FOSSILS STRATA, V23, P1; Olesen J, 2005, J MORPHOL, V264, P131, DOI 10.1002/jmor.10202; Olesen J, 1996, HYDROBIOLOGIA, V330, P213, DOI 10.1007/BF00024209; Olesen J, 1999, ACTA ZOOL-STOCKHOLM, V80, P163, DOI 10.1046/j.1463-6395.1999.80220015.x; Olesen J, 1999, J NAT HIST, V33, P1789, DOI 10.1080/002229399299734; Olesen J, 2014, ATLAS OF CRUSTACEAN LARVAE, P58; Olesen J, 2014, ATLAS OF CRUSTACEAN LARVAE, P195; Olesen Jorgen, 2013, P103; Poore GCB, 2005, NAUPLIUS, V13, P1; Por Francis D., 2014, Subterranean Biology, V14, P63, DOI 10.3897/subtbiol.14.7927; Richter S, 2002, ZOOL ANZ, V241, P339, DOI 10.1078/0044-5231-00083; Richter S, 2001, J ZOOL SYST EVOL RES, V39, P113; Sars G.O., 1899, ACCOUNT CRUSTACEA NO, V2; Sars GO, 1895, ACCOUNT CRUSTACEA NO, VI; Sars GO, 1870, MONOGRAPHI NORGES KY, V1; Sars GO, 1885, CHALLENGER REPORT SC; Sars GO, 1899, ACCOUNT CRUSTACEA NO, V3; Siewing R., 1958, ABH MATH PHYS KGL, V7, P195; Stella E, 1955, P I ASS THEOR APPL L, V12, P464; Stella E, 1959, RIV BIOL PERUGIA, V52, P121; Stella E, 1953, HYDROBIOLOGIA, V5, P225; Wagner HP, 2012, CRUSTACEANA, V85, P1571, DOI 10.1163/156854012X651646; Wagner H.P., 1994, ZOOLOGISCHE VERHANDE, V291, P1; Walossek Dieter, 1993, Fossils and Strata, V32, P1; Waloszek D, 2014, PALAEONTOLOGY, V57, P909, DOI 10.1111/pala.12094; Wilson George D. F., 2009, Arthropod Systematics & Phylogeny, V67, P159; Wirkner CS, 2010, CLADISTICS, V26, P143, DOI 10.1111/j.1096-0031.2009.00278.x; Zhang XG, 2007, NATURE, V449, P595, DOI 10.1038/nature06138; ZILCH R, 1972, Internationale Revue der Gesamten Hydrobiologie, V57, P75, DOI 10.1002/iroh.19720570104; Zilch R., 1974, ZOOL JB ANAT, V93, P462; Zilch R., 1975, VERH DTSCH ZOOL GES, P121	55	7	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122463	10.1371/journal.pone.0122463	http://dx.doi.org/10.1371/journal.pone.0122463			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901753	Green Submitted, Green Published, gold			2022-12-27	WOS:000353331500022
J	Perez-Alvarez, MJ; Olavarria, C; Moraga, R; Baker, CS; Hamner, RM; Poulin, E				Jose Perez-Alvarez, Maria; Olavarria, Carlos; Moraga, Rodrigo; Baker, C. Scott; Hamner, Rebecca M.; Poulin, Elie			Microsatellite Markers Reveal Strong Genetic Structure in the Endemic Chilean Dolphin	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; POPULATION-STRUCTURE; HECTORS DOLPHIN; CEPHALORHYNCHUS-COMMERSONII; MOLECULAR-GENETICS; HABITAT SELECTION; COASTAL WATERS; ORCINUS-ORCA; DNA; MITOCHONDRIAL	Understanding genetic differentiation and speciation processes in marine species with high dispersal capabilities is challenging. The Chilean dolphin, Cephalorhynchus eutropia, is the only endemic cetacean of Chile and is found in two different coastal habitats: a northern habitat with exposed coastlines, bays and estuaries from Valparaiso (33 degrees 02'S) to Chiloe (42 degrees 00'S), and a southern habitat with highly fragmented inshore coastline, channels and fjords between Chiloe and Navarino Island (55 degrees 14'S). With the aim of evaluating the potential existence of conservation units for this species, we analyzed the genetic diversity and population structure of the Chilean dolphin along its entire range. We genotyped 21 dinucleotide microsatellites for 53 skin samples collected between 1998 and 2012 (swab: n = 8, biopsy: n = 38, entanglement n = 7). Bayesian clustering and spatial model analyses identified two genetically distinct populations corresponding to the northern and southern habitats. Genetic diversity levels were similar in the two populations (He: 0.42 v/s 0.45 for southern and northern populations, respectively), while effective size population was higher in the southern area (Ne: 101 v/s 39). Genetic differentiation between these two populations was high and significant (F-ST = 0.15 and R-ST = 0.19), indicating little or no current gene flow. Because of the absence of evident geographical barriers between the northern and southern populations, we propose that genetic differentiation may reflect ecological adaptation to the different habitat conditions and resource uses. Therefore, the two genetic populations of this endemic and Near Threatened species should be considered as different conservation units with independent management strategies.	[Jose Perez-Alvarez, Maria; Poulin, Elie] Univ Chile, Fac Ciencias, IEB, Santiago, Chile; [Jose Perez-Alvarez, Maria; Olavarria, Carlos; Moraga, Rodrigo] Ctr Invest Eutropia, Santiago, Chile; [Olavarria, Carlos] Fdn CEQUA, Punta Arenas, Chile; [Baker, C. Scott; Hamner, Rebecca M.] Oregon State Univ, Hatfield Marine Sci Ctr, Marine Mammal Inst, Newport, OR 97365 USA; [Baker, C. Scott; Hamner, Rebecca M.] Oregon State Univ, Hatfield Marine Sci Ctr, Dept Fisheries & Wildlife, Newport, OR 97365 USA	Universidad de Chile; Oregon State University; Oregon State University	Perez-Alvarez, MJ (corresponding author), Univ Chile, Fac Ciencias, IEB, Santiago, Chile.	mjose.perez@eutropia.cl	Poulin, Elie/C-2654-2012	Poulin, Elie/0000-0001-7736-0969; Perez-Alvarez, M.Jose/0000-0003-1440-8966	CONICYT Doctoral Thesis Scholarship [AT-24100074]; CONICYT Postdoctoral FONDECYT Program [3140513]; MECESUP [UCH0803]; INNOVA CORFO project PN Bernardo O'Higgins (Fundacion CEQUA); Aysen Biodiversity Project (Raleigh-CONAF); "Expedicion Fitz Roy" tourist company;  [ICM P05-002];  [PFB 023]	CONICYT Doctoral Thesis Scholarship; CONICYT Postdoctoral FONDECYT Program(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); MECESUP; INNOVA CORFO project PN Bernardo O'Higgins (Fundacion CEQUA)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT Regional/CEQUA); Aysen Biodiversity Project (Raleigh-CONAF); "Expedicion Fitz Roy" tourist company; ; 	This work was financially supported by CONICYT Doctoral Thesis Scholarship AT-24100074, *CONICYT Postdoctoral FONDECYT Program 3140513,* MECESUP UCH0803, Projects ICM P05-002 and PFB 023, INNOVA CORFO project PN Bernardo O'Higgins (Fundacion CEQUA), Aysen Biodiversity Project (Raleigh-CONAF), and the "Expedicion Fitz Roy" tourist company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASEN E, 1990, BIO-TECHNOL, V8, P1279, DOI 10.1038/nbt1290-1279; AGUAYOL A, 1975, J FISH RES BOARD CAN, V32, P1123, DOI 10.1139/f75-134; Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Amaral AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031482; Amaral AR, 2010, SC62SM2 INT WHAL COM; Ansmann IC, 2012, MOL ECOL, V21, P4472, DOI 10.1111/j.1365-294X.2012.05722.x; AVISE JC, 1989, TRENDS ECOL EVOL, V4, P279, DOI 10.1016/0169-5347(89)90203-6; AVISE JC, 1992, OIKOS, V63, P62, DOI 10.2307/3545516; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; AVISE JC, 1995, CONSERV BIOL, V9, P686, DOI 10.1046/j.1523-1739.1995.09030686.x; Baker AN, 2002, J ROY SOC NEW ZEAL, V32, P713, DOI 10.1080/03014223.2002.9517717; Berube M, 2000, MOL ECOL, V9, P2181; Brager S, 2003, MAR BIOL, V143, P233, DOI 10.1007/s00227-003-1068-x; Brager S, 2002, BIOL CONSERV, V108, P281, DOI 10.1016/S0006-3207(02)00124-6; Butler K, 2004, MOL ECOL, V13, P1589, DOI 10.1111/j.1365-294X.2004.02152.x; Caballero S, 2012, ANIM CONSERV, V15, P95, DOI 10.1111/j.1469-1795.2011.00493.x; Caldwell M, 2002, MOL ECOL NOTES, V2, P393, DOI 10.1046/j.1471-8286.2002.00270.x; Camus PA, 2001, REV CHIL HIST NAT, V74, P587, DOI 10.4067/S0716-078X2001000300008; Capella Juan J., 1999, Estudios Oceanologicos, V18, P65; Cardenas JC, 1986, MANUAL IDENTIFICACIO; Chikhi N., 2004, 5000 CNRS UMR U MONT; Cipriano F, 2011, MAR MAMMAL SCI, V27, P701, DOI 10.1111/j.1748-7692.2010.00434.x; Collet A, 1988, REP INT WHAL COMM, P119; Cunha HA, 2007, MOL ECOL NOTES, V7, P1229, DOI 10.1111/j.1471-8286.2007.01839.x; Dawson MN, 2001, J BIOGEOGR, V28, P723, DOI 10.1046/j.1365-2699.2001.00572.x; Dawson S.M., 1988, REPORTS INT WHALING, P315; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Escribano Rubén, 2003, Gayana (Concepc.), V67, P190; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fontaine MC, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-30; Fullard KJ, 2000, MOL ECOL, V9, P949, DOI 10.1046/j.1365-294x.2000.00957.x; Ge XJ, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-1; Gilson A, 1998, CALIF FISH GAME, V84, P159; Goodall R.N.P., 1988, Reports of the International Whaling Commission Special Issue, P3; Goodall R.N.P., 1980, REPORT INT WHALING C, V30, P445; Goodall RNP, 1988, REP INT WHAL COMM, P197; Goodall RNP, 1994, HDB MARINE MAMMALS, P269; Goodall RNP, 1994, HDB MARINE MAMMALS, P269; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; Hamner RM, 2012, CONSERV GENET, V13, P987, DOI 10.1007/s10592-012-0347-9; Harlin AD, 1999, MAR MAMMAL SCI, V15, P409, DOI 10.1111/j.1748-7692.1999.tb00810.x; Haye PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088613; Heinrich S, 2006, THESIS U ST ANDREWS; Hoelzel AR, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P736; Hoelzel AR, 1998, J HERED, V89, P451, DOI 10.1093/jhered/89.5.451; Hoelzel AR, 1998, J HERED, V89, P121, DOI 10.1093/jhered/89.2.121; Hoelzel AR, 2002, MARINE MAMMAL BIOLOGY: AN EVOLUTIONARY APPROACH, P325; Hoelzel AR, 2002, P ROY SOC B-BIOL SCI, V269, P1467, DOI 10.1098/rspb.2002.2033; IUCN, 2013, IUCN RED LIST THREAT; IUCN, 2006, IUCN RED LIST THREAT; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Krutzen M, 2002, MAR MAMMAL SCI, V18, P863, DOI 10.1111/j.1748-7692.2002.tb01078.x; Krutzen M, 2001, MOL ECOL NOTES, V1, P170, DOI 10.1046/j.1471-8278.2001.00065.x; Lescrauwaet Anne-Catherine, 1994, Reports of the International Whaling Commission Special Issue, V15, P485; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; Mendez M, 2010, MOL ECOL, V19, P2212, DOI 10.1111/j.1365-294X.2010.04647.x; Moller L, 2011, MAR BIOL, V158, P113, DOI 10.1007/s00227-010-1546-x; Moller LM, 2007, MAR FRESHWATER RES, V58, P640, DOI 10.1071/MF06218; Morgenthaler A, 2014, MAR MAMMAL SCI, V30, P782, DOI 10.1111/mms.12052; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Natoli A, 2005, P ROY SOC B-BIOL SCI, V272, P1217, DOI 10.1098/rspb.2005.3076; Natoli A, 2004, J EVOLUTION BIOL, V17, P363, DOI 10.1046/j.1420-9101.2003.00672.x; Neira S, 2004, J EXP MAR BIOL ECOL, V312, P349, DOI 10.1016/j.jembe.2004.07.011; New Zealand Department of Conservation Ministry of Fisheries, 2007, HECT MAUIS DOLPH THR; OBRIEN SJ, 1994, P NATL ACAD SCI USA, V91, P5748, DOI 10.1073/pnas.91.13.5748; Ojeda FP, 2000, REV CHIL HIST NAT, V73, P625; Oporto J, 1988, THESIS U AUSTRAL CHI; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; Perez-Alvarez MJ, 2007, NEW ZEAL J MAR FRESH, V41, P405, DOI 10.1080/00288330709509931; Pichler FB, 1998, CONSERV BIOL, V12, P676, DOI 10.1046/j.1523-1739.1998.96390.x; Pichler FB, 2000, P ROY SOC B-BIOL SCI, V267, P97, DOI 10.1098/rspb.2000.0972; Pichler FB, 2001, MOL ECOL, V10, P2215, DOI 10.1046/j.0962-1083.2001.01360.x; PICHLER FB, 2001, THESIS U AUCKLAND; Pichler Franz B., 2001, Revista de Biologia Marina y Oceanografia, V36, P117; PICKARD GL, 1973, OCEANOGRAPHY S PACIF, P95; Pimper LE, 2010, CONSERV GENET, V11, P2157, DOI 10.1007/s10592-010-0102-z; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; PRITCHARD JK, 2007, DOCUMENTATION STRUCT; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Rayment W, 2009, MAR MAMMAL SCI, V25, P537, DOI 10.1111/j.1748-7692.2008.00271.x; REYES J.C, 1997, B MUSEO NACL HIST NA, V46, P95; Ribeiro S, 2007, J MAR BIOL ASSOC UK, V87, P119, DOI 10.1017/S0025315407051594; ROBINEAU D, 1985, BIOL CONSERV, V31, P85, DOI 10.1016/0006-3207(85)90036-9; Robineau D, 2007, MAMMALIA, V71, P172, DOI 10.1515/MAMM.2007.034; Rooney AP, 1999, J MOL EVOL, V49, P682, DOI 10.1007/PL00006589; Rosel PE, 2009, MOL ECOL, V18, P5030, DOI 10.1111/j.1365-294X.2009.04413.x; Rosel PE, 1999, MOL ECOL, V8, pS41, DOI 10.1046/j.1365-294X.1999.00758.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SLOOTEN E, 1991, CAN J ZOOL, V69, P1701, DOI 10.1139/z91-235; Strub PT, 2005, SEA, P273; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; Valsecchi E, 1996, MOL ECOL, V5, P151, DOI 10.1111/j.1365-294X.1996.tb00301.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; van Vuuren BJ, 2002, ANIM CONSERV, V5, P303, DOI 10.1017/S1367943002004055; Viddi FA, 2010, ICES J MAR SCI, V67, P959, DOI 10.1093/icesjms/fsp288; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; Webber MA., 1993, FAO SPECIES IDENTIFI; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilson GA, 2003, GENETICS, V163, P1177; Yanez A. P., 1948, Revista de Biologia Marina Valparaiso, V1, P103	104	22	24	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123956	10.1371/journal.pone.0123956	http://dx.doi.org/10.1371/journal.pone.0123956			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898340	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600045
J	Kim, GH; Jeon, S; Im, K; Kwon, H; Lee, BH; Kim, GY; Jeong, H; Han, NE; Seo, SW; Cho, H; Noh, Y; Park, SE; Kim, H; Hwang, JW; Yoon, CW; Kim, HJ; Ye, BS; Chin, JH; Kim, JH; Suh, MK; Lee, JM; Kim, ST; Choi, MT; Kim, MS; Heilman, KM; Jeong, JH; Na, DL				Kim, Geon Ha; Jeon, Seun; Im, Kiho; Kwon, Hunki; Lee, Byung Hwa; Kim, Ga Young; Jeong, Hana; Han, Noh Eul; Seo, Sang Won; Cho, Hanna; Noh, Young; Park, Sang Eon; Kim, Hojeong; Hwang, Jung Won; Yoon, Cindy W.; Kim, Hee Jin; Ye, Byoung Seok; Chin, Ju Hee; Kim, Jung-Hyun; Suh, Mee Kyung; Lee, Jong Min; Kim, Sung Tae; Choi, Mun-Taek; Kim, Mun Sang; Heilman, Kenneth M.; Jeong, Jee Hyang; Na, Duk L.			Structural Brain Changes after Traditional and Robot-Assisted Multi-Domain Cognitive Training in Community-Dwelling Healthy Elderly	PLOS ONE			English	Article							CORTICAL THICKNESS; ORBITOFRONTAL CORTEX; ANTERIOR CINGULATE; CEREBRAL-CORTEX; MEMORY; PARCELLATION; ADULTHOOD; PATTERNS; SYSTEMS; NEGLECT	The purpose of this study was to investigate if multi-domain cognitive training, especially robot-assisted training, alters cortical thickness in the brains of elderly participants. A controlled trial was conducted with 85 volunteers without cognitive impairment who were 60 years old or older. Participants were first randomized into two groups. One group consisted of 48 participants who would receive cognitive training and 37 who would not receive training. The cognitive training group was randomly divided into two groups, 24 who received traditional cognitive training and 24 who received robot-assisted cognitive training. The training for both groups consisted of daily 90-min-session, five days a week for a total of 12 weeks. The primary outcome was the changes in cortical thickness. When compared to the control group, both groups who underwent cognitive training demonstrated attenuation of age related cortical thinning in the frontotemporal association cortices. When the robot and the traditional interventions were directly compared, the robot group showed less cortical thinning in the anterior cingulate cortices. Our results suggest that cognitive training can mitigate age-associated structural brain changes in the elderly.	[Kim, Geon Ha; Jeong, Jee Hyang] Ewha Womans Univ, Dept Neurol, Mokdong Hosp, Sch Med, Seoul, South Korea; [Kim, Geon Ha; Lee, Byung Hwa; Kim, Ga Young; Jeong, Hana; Seo, Sang Won; Kim, Hee Jin; Chin, Ju Hee; Kim, Jung-Hyun; Suh, Mee Kyung; Na, Duk L.] Sungkyunkwan Univ, Dept Neurol, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Jeon, Seun; Kwon, Hunki; Lee, Jong Min] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea; [Im, Kiho; Chin, Ju Hee] Harvard Univ, Div Newborn Med, Boston Childrens Hosp, Sch Med, Boston, MA USA; [Han, Noh Eul] Univ Ulsan, Dept Neurol, Asan Med Ctr, Coll Med, Seoul, South Korea; [Cho, Hanna] Yonsei Univ, Dept Neurol, Gangnam Severance Hosp, Coll Med, Seoul 120749, South Korea; [Noh, Young] Gachon Univ Gil, Med Ctr, Dept Neurol, Incheon, South Korea; [Park, Sang Eon; Kim, Hojeong; Hwang, Jung Won] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Seoul, South Korea; [Yoon, Cindy W.] Inha Univ, Dept Neurol, Inha Univ Hosp, Sch Med, Incheon, South Korea; [Ye, Byoung Seok] Yonsei Univ, Dept Neurol, Coll Med, Seoul 120749, South Korea; [Kim, Sung Tae] Sungkyunkwan Univ, Dept Radiol, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Choi, Mun-Taek] Sungkyunkwan Univ, Sch Mech Engn, Seoul, South Korea; [Kim, Mun Sang] Ctr Intelligent Robot Korea, Inst Sci & Technol, Seoul, South Korea; [Heilman, Kenneth M.] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Heilman, Kenneth M.] Vet Affairs Med Ctr, Gainesville, FL 32608 USA	Ewha Womans University; Sungkyunkwan University (SKKU); Samsung Medical Center; Hanyang University; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Ulsan; Asan Medical Center; Yonsei University; Yonsei University Health System; Gachon University; Sungkyunkwan University (SKKU); Samsung Medical Center; Inha University; Inha University Hospital; Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Korea Institute of Science & Technology (KIST); State University System of Florida; University of Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Na, DL (corresponding author), Sungkyunkwan Univ, Dept Neurol, Samsung Med Ctr, Sch Med, Seoul, South Korea.	dukna@skku.edu	Yoon, Cindy/HCJ-0079-2022; Jeon, Seun/AAK-3204-2020; Choi, Mun-Taek/N-2351-2014	Jeon, Seun/0000-0003-2817-3352; Choi, Mun-Taek/0000-0002-5025-8785; Cho, Hanna/0000-0001-5936-1546; Yoon, Cindy/0000-0002-4697-6610; Ye, Byoung Seok/0000-0003-0187-8440	Gaha Corporation; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A102065]; Samsung Medical Center Clinical Research Development Program [CRL-108011, CRS 110-14-1]; Korea Science and Engineering Foundation (KOSEF) NLRL program - Korean Government (MEST) [2011-0028333]	Gaha Corporation; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea; Samsung Medical Center Clinical Research Development Program(Samsung); Korea Science and Engineering Foundation (KOSEF) NLRL program - Korean Government (MEST)	This study was partly funded by Gaha Corporation through a research grant to Samsung Medical Center, a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A102065), grants from Samsung Medical Center Clinical Research Development Program (CRL-108011 & CRS 110-14-1), and a grant from the Korea Science and Engineering Foundation (KOSEF) NLRL program funded by the Korean Government (MEST) (2011-0028333). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Duk L.Na MD, PhD had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Final decisions on the study design, data collection, analysis and interpretation, and manuscript content were made by the authors at Samsung Medical Center, independent of Gaha Corporation or the Center for Intelligent Robotics at Korea Institute Science and Technology.	Ballmaier M, 2004, AM J PSYCHIAT, V161, P99, DOI 10.1176/appi.ajp.161.1.99; Barnard ND, 2014, NEUROBIOL AGING, V35, pS74, DOI 10.1016/j.neurobiolaging.2014.03.033; Bemelmans R, 2012, J AM MED DIR ASSOC, V13, P114, DOI 10.1016/j.jamda.2010.10.002; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chapman SB, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00075; Cheng Y, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-30; Cho H, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.01.004; Chun MY, 2012, KOREAN J FAM MED, V33, P144, DOI 10.4082/kjfm.2012.33.3.144; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Eckroth-Bucher M, 2009, AM J ALZHEIMERS DIS, V24, P234, DOI 10.1177/1533317509332624; Engvig A, 2010, NEUROIMAGE, V52, P1667, DOI 10.1016/j.neuroimage.2010.05.041; Fjell AM, 2009, CEREB CORTEX, V19, P2001, DOI 10.1093/cercor/bhn232; Gates N, 2010, CURR PSYCHIAT REP, V12, P20, DOI 10.1007/s11920-009-0085-y; Gates NJ, 2014, J ALZHEIMERS DIS, V42, pS551, DOI 10.3233/JAD-141302; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Hahn S., 2003, SEOUL NEUROPHSYCHOLO; Han C, 2008, ARCH GERONTOL GERIAT, V47, P302, DOI 10.1016/j.archger.2007.08.012; HEILMAN KM, 1972, NEUROLOGY, V22, P660, DOI 10.1212/WNL.22.6.660; Hellige JB, 1996, ACTA NEUROBIOL EXP, V56, P485; Holroyd CB, 2012, TRENDS COGN SCI, V16, P122, DOI 10.1016/j.tics.2011.12.008; Hurtz S, 2014, DEMENT GER COGN D EX, V4, P221, DOI 10.1159/000362872; Ilg R, 2008, J NEUROSCI, V28, P4210, DOI 10.1523/JNEUROSCI.5722-07.2008; Im K, 2008, NEUROSCI LETT, V436, P227, DOI 10.1016/j.neulet.2008.03.032; Im K, 2006, NEUROIMAGE, V31, P31, DOI 10.1016/j.neuroimage.2005.11.042; Jiang JY, 2014, NEUROIMAGE, V86, P203, DOI 10.1016/j.neuroimage.2013.08.022; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Ko HJ, 2011, GERIATR GERONTOL INT, V11, P267, DOI 10.1111/j.1447-0594.2010.00680.x; Krain AL, 2006, NEUROIMAGE, V32, P477, DOI 10.1016/j.neuroimage.2006.02.047; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kueider AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040588; Lee Y, 2010, INT PSYCHOGERIATR, V22, P174, DOI 10.1017/S1041610209991189; Lerch JP, 2005, CEREB CORTEX, V15, P995, DOI 10.1093/cercor/bhh200; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Liu Y, 2014, CEREB CORTEX; Luciana M, 2002, DEV NEUROPSYCHOL, V22, P595, DOI 10.1207/S15326942DN2203_3; McKee JL, 2014, J NEUROSCI, V34, P16065, DOI 10.1523/JNEUROSCI.1660-14.2014; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; MORECRAFT RJ, 1992, J COMP NEUROL, V323, P341, DOI 10.1002/cne.903230304; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nieuwenhuis ILC, 2011, BEHAV BRAIN RES, V218, P325, DOI 10.1016/j.bbr.2010.12.009; Nouchi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029676; Pieramico V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043901; Rebok GW, 2007, J GERONTOL B-PSYCHOL, V62, P53, DOI 10.1093/geronb/62.special_issue_1.53; Reddy R, 2006, IEEE INTELL SYST, V21, P24, DOI 10.1109/MIS.2006.57; Rudebeck PH, 2014, P NATL ACAD SCI USA, V111, P5391, DOI 10.1073/pnas.1317695111; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Seo SW, 2011, NEUROBIOL AGING, V32, P200, DOI 10.1016/j.neurobiolaging.2009.02.004; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith GE, 2009, J AM GERIATR SOC, V57, P594, DOI 10.1111/j.1532-5415.2008.02167.x; Szatkowska I, 2011, NEUROBIOL LEARN MEM, V96, P385, DOI 10.1016/j.nlm.2011.06.014; Tanji J, 2007, TRENDS COGN SCI, V11, P528, DOI 10.1016/j.tics.2007.09.007; Tun PA, 2010, PSYCHOL AGING, V25, P560, DOI 10.1037/a0019543; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Valenzuela M, 2009, AM J GERIAT PSYCHIAT, V17, P179, DOI 10.1097/JGP.0b013e3181953b57; Vossel S, 2014, NEUROSCIENTIST, V20, P150, DOI 10.1177/1073858413494269; WATSON RT, 1973, NEUROLOGY, V23, P1003, DOI 10.1212/WNL.23.9.1003; Wenger E, 2012, NEUROIMAGE, V59, P3389, DOI 10.1016/j.neuroimage.2011.11.015; Wu K, 2012, HUM BRAIN MAPP, V33, P552, DOI 10.1002/hbm.21232; Youn JC, 2002, INT J GERIATR PSYCH, V17, P797, DOI 10.1002/gps.699; Zhu WL, 2012, NEUROBIOL AGING, V33, P899, DOI 10.1016/j.neurobiolaging.2010.06.022; Zijdenbos A, 1996, LECT NOTES COMPUT SC, V1131, P439, DOI 10.1007/BFb0046984	62	52	54	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123251	10.1371/journal.pone.0123251	http://dx.doi.org/10.1371/journal.pone.0123251			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XJ	25898367	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600022
J	Mestre-Citrinovitz, AC; Kleff, V; Vallejo, G; Winterhager, E; Saragueta, P				Mestre-Citrinovitz, Ana C.; Kleff, Veronika; Vallejo, Griselda; Winterhager, Elke; Saragueeta, Patricia			A Suppressive Antagonism Evidences Progesterone and Estrogen Receptor Pathway Interaction with Concomitant Regulation of Hand2, Bmp2 and ERK during Early Decidualization	PLOS ONE			English	Article							STROMAL CELL DECIDUALIZATION; ENDOTHELIAL GROWTH-FACTOR; EMBRYO IMPLANTATION; UTERINE RECEPTIVITY; CYCLIN D3; MOUSE; EXPRESSION; PREGNANCY; ANGIOGENESIS; PROTEIN	Progesterone receptor and estrogen receptor participate in growth and differentiation of the different rat decidual regions. Steroid hormone receptor antagonists were used to study steroid regulation of decidualization. Here we describe a suppressive interaction between progesterone receptor (onapristone) and estrogen receptor (ICI182780) antagonists and their relation to a rescue phenomenon with concomitant regulation of Hand2, Bmp2 and p-ERK1/2 during the early decidualization steps. Phenotypes of decidua development produced by antagonist treatments were characterized by morphology, proliferation, differentiation, angiogenesis and expression of signaling molecules. We found that suppression of progesterone receptor activity by onapristone treatment resulted in resorption of the implantation sites with concomitant decrease in progesterone and estrogen receptors, PCNA, KI67 antigen, DESMIN, CCND3, CX43, Prl8a2, and signaling players such as transcription factor Hand2, Bmp2 mRNAs and p-ERK1/2. Moreover, FGF-2 and Vegfa increased as a consequence of onapristone treatment. Implantation sites from antagonist of estrogen receptor treated rats developed all decidual regions, but showed an anomalous blood vessel formation at the mesometrial part of the decidua. The deleterious effect of onapristone was partially counteracted by the impairment of estrogen receptor activity with rescue of expression levels of hormone steroid receptors, proliferation and differentiation markers, and the induction of a probably compensatory increase in signaling molecules Hand2, Bmp2 and ERK1/2 activation compared to oil treated controls. This novel drug interaction during decidualization could be applied to pathological endometrial cell proliferation processes to improve therapies using steroid hormone receptor targets.	[Mestre-Citrinovitz, Ana C.; Vallejo, Griselda; Saragueeta, Patricia] Consejo Nacl Invest Cient & Tecn, IByME, Inst Biol & Med Expt, RA-1033 Buenos Aires, DF, Argentina; [Kleff, Veronika] Univ Klinikum Duisburg Essen, Inst Anat, Essen, Germany; [Winterhager, Elke] Univ Klinikum Duisburg Essen, Inst Mol Biol, Essen, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Duisburg Essen; University of Duisburg Essen	Saragueta, P (corresponding author), Consejo Nacl Invest Cient & Tecn, IByME, Inst Biol & Med Expt, RA-1033 Buenos Aires, DF, Argentina.	sarag@dna.uba.ar		Mestre, Ana Cecilia/0000-0001-8027-3487	Agencia Nacional de Promocion Cientifica y Tecnologica Argentina [PID 88]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP); DAAD, Germany; SECYT, Argentina exchange program PROALAR	Agencia Nacional de Promocion Cientifica y Tecnologica Argentina(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); DAAD, Germany(Deutscher Akademischer Austausch Dienst (DAAD)); SECYT, Argentina exchange program PROALAR	This work was supported by grants to P.S. from the Agencia Nacional de Promocion Cientifica y Tecnologica (PID 88) Argentina, the Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 2012-2014), and by the DAAD, Germany and SECYT, Argentina exchange program PROALAR. P.S. is an established investigator from the Consejo Nacional de Investigaciones Cientificas y Tecnicas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SMK, 2007, DEVELOPMENT, V134, P407, DOI 10.1242/dev.02743; Bagchi IC, 2005, SEMIN REPROD MED, V23, P38, DOI 10.1055/s-2005-864032; Das A, 2009, P NATL ACAD SCI USA, V106, P12542, DOI 10.1073/pnas.0901647106; Das SK, 1999, J MOL ENDOCRINOL, V22, P91, DOI 10.1677/jme.0.0220091; DeLisser H M, 1993, Curr Top Microbiol Immunol, V184, P37; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; GLASSER SR, 1986, BIOL REPROD, V35, P463, DOI 10.1095/biolreprod35.2.463; Grummer R, 2004, BIOL REPROD, V71, P273, DOI 10.1095/biolreprod.103.024067; Huyen DV, 2011, REPRODUCTION, V142, P353, DOI 10.1530/REP-11-0060; Hyder SM, 1999, MOL ENDOCRINOL, V13, P806, DOI 10.1210/me.13.6.806; Kurihara I, 2007, PLOS GENET, V3, P1053, DOI 10.1371/journal.pgen.0030102; Laws MJ, 2008, DEVELOPMENT, V135, P2659, DOI 10.1242/dev.019810; Lee DK, 2010, MOL ENDOCRINOL, V24, P930, DOI 10.1210/me.2009-0531; Lee KY, 2007, MOL CELL BIOL, V27, P5468, DOI 10.1128/MCB.00342-07; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Li QX, 2011, SCIENCE, V331, P912, DOI 10.1126/science.1197454; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; MONTESANO R, 1986, P NATL ACAD SCI USA, V83, P7297, DOI 10.1073/pnas.83.19.7297; Paria BC, 2000, SEMIN CELL DEV BIOL, V11, P67, DOI 10.1006/scdb.2000.0153; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Rasmussen CA, 1997, BIOL REPROD, V56, P647, DOI 10.1095/biolreprod56.3.647; Srivastava RK, 1998, J MOL ENDOCRINOL, V21, P355, DOI 10.1677/jme.0.0210355; Tan J, 2002, MECH DEVELOP, V111, P99, DOI 10.1016/S0925-4773(01)00614-1; Thienel T, 2002, MOL HUM REPROD, V8, P465, DOI 10.1093/molehr/8.5.465; Tranguch S, 2005, CELL MOL LIFE SCI, V62, P1964, DOI 10.1007/s00018-005-5230-0; Vallejo G, 2011, BIOL REPROD, V84, P1063, DOI 10.1095/biolreprod.110.085928; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Winterhager E, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111690; Wu JJ, 2013, J CELL PHYSIOL, V228, P903, DOI 10.1002/jcp.24241; Ying Y, 2000, BIOL REPROD, V63, P1781, DOI 10.1095/biolreprod63.6.1781	31	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124756	10.1371/journal.pone.0124756	http://dx.doi.org/10.1371/journal.pone.0124756			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897495	Green Submitted, gold, Green Published			2022-12-27	WOS:000353212600083
J	Montali, A; Truglio, G; Martino, F; Ceci, F; Ferraguti, G; Ciociola, E; Maranghi, M; Gianfagna, F; Iacoviello, L; Strom, R; Lucarelli, M; Arca, M				Montali, Anna; Truglio, Gessica; Martino, Francesco; Ceci, Fabrizio; Ferraguti, Giampiero; Ciociola, Ester; Maranghi, Marianna; Gianfagna, Francesco; Iacoviello, Licia; Strom, Roberto; Lucarelli, Marco; Arca, Marcello			Atherogenic Dyslipidemia in Children: Evaluation of Clinical, Biochemical and Genetic Aspects	PLOS ONE			English	Article							FAMILIAL COMBINED HYPERLIPIDEMIA; DENSITY-LIPOPROTEIN CHOLESTEROL; METABOLIC SYNDROME; CHILDHOOD DETERMINANTS; CARDIOVASCULAR RISK; ADULT HEALTH; YOUNG FINNS; LIPASE; HEART; INSULIN	The precursors of atherogenic dyslipidemia (AD) are not well defined. Therefore, we investigated 62 non-obese, non-diabetic AD and 221 normolipemic children. Anthropometric parameters, blood pressure and biochemical measures were obtained in index children, their parents and all available siblings. The heritability (h(2)) of anthropometric and biochemical traits was estimated by SOLAR. Rare and common variants in APOA1 and LPL genes were screened by re-sequencing. Compared to normolipemic, AD children showed increased body mass index, waist circumference, plasma glucose, insulin, ApoB, HOMA-IR, hs-CRP and lower adiponectin (p<0.001 for all). Metabolic syndrome was present in 40% of AD while absent in controls. All traits (except adiponectin and hs-CRP) showed a strong familial aggregation, with plasma glucose having the highest heritability (89%). Overall, 4 LPLloss-of-function mutations were detected (p.Asp9Asn, p.Ser45Asn, p.Asn291Ser, p.Leu365Val) and their cumulative prevalence was higher in AD than in control children (0.073 vs. 0.026; P=0.038). The LPLp.S447* gain-of-function mutation, resulted to be less frequent in AD than in control children (0.064 vs. 0.126; P=0.082). No variant in the APOA1gene was found. Our data indicate that AD is a rather common dyslipidemia in childhood; it associates with metabolic abnormalities typical of insulin resistant state and shows a strong familial aggregation. LPLvariants may contribute to the development of AD phenotype.	[Montali, Anna; Truglio, Gessica; Ciociola, Ester; Maranghi, Marianna; Arca, Marcello] Univ Roma La Sapienza, Atherosclerosis Unit, Dept Internal Med & Allied Sci, I-00185 Rome, Italy; [Truglio, Gessica; Ceci, Fabrizio; Ferraguti, Giampiero; Strom, Roberto; Lucarelli, Marco] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00185 Rome, Italy; [Martino, Francesco] Univ Roma La Sapienza, Dept Pediat, I-00185 Rome, Italy; [Gianfagna, Francesco] Univ Insubria, Ctr Ric Epidemiol & Med Prevent, Varese, Italy; [Gianfagna, Francesco; Iacoviello, Licia] Ist Neurol Mediterraneo, Ist Ricovero & Cura Carattere Sci, Lab Mol & Nutr Epidemiol, Dept Epidemiol & Prevent, Pozzilli, Italy; [Lucarelli, Marco] Univ Roma La Sapienza, Cenci Bolognetti Fdn, Inst Pasteur, I-00185 Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; University of Insubria; IRCCS Neuromed; Fondazione Cenci Bolognetti; Sapienza University Rome	Arca, M (corresponding author), Univ Roma La Sapienza, Atherosclerosis Unit, Dept Internal Med & Allied Sci, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	marcelloarca@libero.it	Lucarelli, Marco/AAC-1667-2019; ARCA, Marcello/AAC-3883-2022; Iacoviello, Licia/AGX-7071-2022; Iacoviello, Licia/K-4676-2016; Gianfagna, Francesco/K-4561-2016; Siani, Alfonso/B-7925-2015	ARCA, Marcello/0000-0003-3786-0883; Iacoviello, Licia/0000-0003-0514-5885; Iacoviello, Licia/0000-0003-0514-5885; Gianfagna, Francesco/0000-0003-4615-0816; MARANGHI, MARIANNA/0000-0002-3117-7488; FERRAGUTI, Giampiero/0000-0001-6129-4071; CECI, Fabrizio/0000-0003-4051-4922; Lucarelli, Marco/0000-0002-5538-2494	Progetto Ateneo University of Rome La Sapienza [C26A042949]; MIUR [COFIN 2004065985_004]	Progetto Ateneo University of Rome La Sapienza; MIUR(Ministry of Education, Universities and Research (MIUR))	The study was supported by research grants from Progetto Ateneo 2004 University of Rome La Sapienza C26A042949 and COFIN 2004065985_004 from MIUR to M.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Barter P, 2007, J CLIN ENDOCR METAB, V92, P2041, DOI 10.1210/jc.2006-2219; Brian W, 2006, TROMB RES, V118, P49; Campagna F, 2008, ATHEROSCLEROSIS, V196, P356, DOI 10.1016/j.atherosclerosis.2006.11.015; Chan DC, 2011, EXPERT OPIN PHARMACO, V12, P13, DOI 10.1517/14656566.2010.502529; DeBruin TWA, 1996, EUR J CLIN INVEST, V26, P631, DOI 10.1111/j.1365-2362.1996.tb02146.x; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; Fisher RM, 1997, ATHEROSCLEROSIS, V135, P145, DOI 10.1016/S0021-9150(97)00199-8; Goldberg IJ, 1996, J LIPID RES, V37, P693; Goodman E, 2007, CIRCULATION, V115, P2316, DOI 10.1161/CIRCULATIONAHA.106.669994; Grundy Scott M, 2006, Clin Cornerstone, V8 Suppl 1, pS21, DOI 10.1016/S1098-3597(06)80005-0; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Grundy SM, 1997, CIRCULATION, V95, P1, DOI 10.1161/01.CIR.95.1.1; Krauss RM, 2004, MED CLIN N AM, V88, P897, DOI 10.1016/j.mcna.2004.04.004; Krauss RM, 2004, ENDOCRIN METAB CLIN, V33, P405, DOI 10.1016/j.ecl.2004.03.016; Kusunoki M, 2011, EUR J PHARMACOL, V668, P337, DOI 10.1016/j.ejphar.2011.06.040; Lee KE, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S94; Magnussen CG, 2008, CIRCULATION, V117, P32, DOI 10.1161/CIRCULATIONAHA.107.718981; Magnussen CG, 2009, J AM COLL CARDIOL, V53, P860, DOI 10.1016/j.jacc.2008.09.061; Martino F, 2013, INT J CARDIOL, V168, P1108, DOI 10.1016/j.ijcard.2012.11.045; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Menghetti E, 1999, J HYPERTENS, V17, P1363, DOI 10.1097/00004872-199917100-00002; Menotti A, 1995, G Ital Cardiol, V25, P1539; Miller M, 2004, CURR OPIN CARDIOL, V19, P380, DOI 10.1097/01.hco.0000126584.12520.b5; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Reaven GM, 2006, AM J CLIN NUTR, V83, P1237, DOI 10.1093/ajcn/83.6.1237; REYMER PWA, 1995, HUM MOL GENET, V4, P1543, DOI 10.1093/hmg/4.9.1543; Rip J, 2006, ARTERIOSCL THROM VAS, V26, P1236, DOI 10.1161/01.ATV.0000219283.10832.43; Robciuc MR, 2013, ARTERIOSCL THROM VAS, V33, P1706, DOI 10.1161/ATVBAHA.113.301397; Von Eynatten M, 2006, CLIN CHEM, V52, P853, DOI 10.1373/clinchem.2005.060509; Wagner AM, 2002, ACTA DIABETOL, V39, P215, DOI 10.1007/s005920200037; Watts GF, 2003, DIABETES, V52, P803, DOI 10.2337/diabetes.52.3.803; Wyszynski DF, 2005, AM J CARDIOL, V95, P194, DOI 10.1016/j.amjcard.2004.08.091; Feng Y, 2008, OBESITY, V16, P125, DOI 10.1038/oby.2007.22; Yu Y, 2005, J LIPID RES, V46, P2202, DOI 10.1194/jlr.M500137-JLR200	35	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0120099	10.1371/journal.pone.0120099	http://dx.doi.org/10.1371/journal.pone.0120099			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897955	Green Submitted, Green Published, gold			2022-12-27	WOS:000353212600004
J	Bae, JH; Kim, JM				Bae, Jeong Hun; Kim, Joon Mo			The Rate of Helicobacter pylori Seropositivity in a Group of Korean Patients with HLA-B27-Associated Acute Anterior Uveitis	PLOS ONE			English	Article							REACTIVE ARTHRITIS; ANKYLOSING-SPONDYLITIS; HLA-B27; INFECTION; PREVALENCE; ANTIBODIES; CHLAMYDIA; CELLS	Purpose To investigate an association between Helicobacter pylori seropositivity and HLA-B27-positive acute anterior uveitis (AAU) in Korean patients. Methods Retrospective analysis was performed with data from 106 patients previously diagnosed with AAU without clinical evidence of spondyloarthropathy. Serum immunoglobulin G antibodies to H. pylori were measured by enzyme-linked immunosorbent assay, and HLA typing was performed using polymerase chain reaction of DNA amplification. We included 72 non-uveitis patients and 35 age- and sex-matched healthy controls in the study. Results Of the 106 patients with AAU, 41 (38.7%) were HLA-B27-positive, and 45 (42.5%) were seropositive for H. pylori. Patients with HLA-B27-positive AAU had a significantly lower prevalence of H. pylori seropositivity compared to those with HLA-B27-negative AAU and healthy controls (24.4% vs. 53.8%, p = 0.003; 24.4% vs. 57.1%, p = 0.004, respectively). In the non-uveitis group, however, HLA-B27-positive patients exhibited similar H. pylori seropositivity prevalence to HLA-B27-negative patients and healthy controls (45.5% vs. 55.7%, p = 0.529; 45.5% vs. 57.1%, p = 0.497, respectively). In multivariate analysis, a low prevalence of H. pylori seropositivity was significantly associated with HLA-B27-positive AAU (odds ratio = 0.340, 95% confidence interval 0.135-0.855, p = 0.022). Conclusions Our results suggest an inverse association between H. pylori seropositivity and HLA-B27-positive AAU. Further investigation of this association is needed, given the low prevalence of H. pylori seropositivity observed in patients with HLA-B27-positive AAU.	[Bae, Jeong Hun; Kim, Joon Mo] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Ophthalmol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, JM (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Ophthalmol, Seoul, South Korea.	kjoonmo1@gmail.com						Arnold IC, 2011, J CLIN INVEST, V121, P3088, DOI 10.1172/JCI45041; Blankenberg-Sprenkels SHD, 1998, J RHEUMATOL, V25, P743; BREWERTON DA, 1973, LANCET, V2, P994, DOI 10.1016/S0140-6736(73)91090-8; Chang JH, 2005, SURV OPHTHALMOL, V50, P364, DOI 10.1016/j.survophthal.2005.04.003; Cotticelli L, 2006, EUR J OPHTHALMOL, V16, P274, DOI 10.1177/112067210601600213; El Miedany YM, 2005, JOINT BONE SPINE, V72, P135, DOI 10.1016/j.jbspin.2004.04.005; FELTKAMP TEW, 1995, BRIT J OPHTHALMOL, V79, P718, DOI 10.1136/bjo.79.8.718; HERMANN E, 1993, LANCET, V342, P646, DOI 10.1016/0140-6736(93)91760-J; Huhtinen M, 2002, ANN RHEUM DIS, V61, P1012, DOI 10.1136/ard.61.11.1012; INMAN RD, 1989, J IMMUNOL, V142, P4256; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; KAPASI K, 1992, J IMMUNOL, V148, P3554; KEAT A, 1987, LANCET, V1, P72; Khan MA, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0362-y; Kim JM, 2012, EYE, V26, P1504, DOI 10.1038/eye.2012.206; Konno Y, 1999, INVEST OPHTH VIS SCI, V40, P1838; Lin P, 2014, PLOS ONE, V9; LINSSEN A, 1991, INVEST OPHTH VIS SCI, V32, P2568; MARCHETTI M, 1995, SCIENCE, V267, P1655, DOI 10.1126/science.7886456; MATTILA L, 1994, BRIT J RHEUMATOL, V33, P1136; OH JW, 1999, J KOREAN OPHTHALMOL, V40, P104; Onal S, 2006, OCUL IMMUNOL INFLAMM, V14, P293, DOI 10.1080/09273940600977241; Otasevic L, 2007, OPHTHALMOLOGICA, V221, P6, DOI 10.1159/000096515; Reveille JD, 2001, CURR OPIN RHEUMATOL, V13, P265, DOI 10.1097/00002281-200107000-00004; Reveille JD, 2012, ARTHRITIS RHEUM-US, V64, P1407, DOI 10.1002/art.33503; Rudwaleit M, 2011, ANN RHEUM DIS, V70, P25, DOI 10.1136/ard.2010.133645; Sacca SC, 2006, INVEST OPHTH VIS SCI, V47, P501, DOI 10.1167/iovs.05-0323; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; WAKEFIELD D, 1983, CLIN EXP IMMUNOL, V51, P191; WAKEFIELD D, 1990, ARCH OPHTHALMOL-CHIC, V108, P219, DOI 10.1001/archopht.1990.01070040071033; Yim JY, 2007, HELICOBACTER, V12, P333, DOI 10.1111/j.1523-5378.2007.00504.x	31	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123924	10.1371/journal.pone.0123924	http://dx.doi.org/10.1371/journal.pone.0123924			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894610	gold, Green Published, Green Submitted			2022-12-27	WOS:000353211700064
J	Werner, S; van Aken, BC; Hulst, T; Frens, MA; van der Geest, JN; Struder, HK; Donchin, O				Werner, Susen; van Aken, Bernice C.; Hulst, Thomas; Frens, Maarten A.; van der Geest, Jos N.; Strueder, Heiko K.; Donchin, Opher			Awareness of Sensorimotor Adaptation to Visual Rotations of Different Size	PLOS ONE			English	Article							VISUOMOTOR ADAPTATION; EXPLICIT STRATEGY; INTERLIMB TRANSFER; PRISM ADAPTATION; IMPLICIT; CEREBELLAR; YOUNGER; SYSTEMS; MEMORY; ERROR	Previous studies on sensorimotor adaptation revealed no awareness of the nature of the perturbation after adaptation to an abrupt 30 degrees rotation of visual feedback or after adaptation to gradually introduced perturbations. Whether the degree of awareness depends on the magnitude of the perturbation, though, has as yet not been tested. Instead of using questionnaires, as was often done in previous work, the present study used a process dissociation procedure to measure awareness and unawareness. A naive, implicit group and a group of subjects using explicit strategies adapted to 20 degrees, 40 degrees and 60 degrees cursor rotations in different adaptation blocks that were each followed by determination of awareness and unawareness indices. The awareness index differed between groups and increased from 20 degrees to 60 degrees adaptation. In contrast, there was no group difference for the unawareness index, but it also depended on the size of the rotation. Early adaptation varied between groups and correlated with awareness: The more awareness a participant had developed the more the person adapted in the beginning of the adaptation block. In addition, there was a significant group difference for savings but it did not correlate with awareness. Our findings suggest that awareness depends on perturbation size and that aware and strategic processes are differentially involved during adaptation and savings. Moreover, the use of the process dissociation procedure opens the opportunity to determine awareness and unawareness indices in future sensorimotor adaptation research.	[Werner, Susen; Strueder, Heiko K.] German Sport Univ Cologne, Inst Movement & Neurosci, Cologne, Germany; [van Aken, Bernice C.; Hulst, Thomas; Frens, Maarten A.; van der Geest, Jos N.; Donchin, Opher] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Frens, Maarten A.] Erasmus Univ Coll, Rotterdam, Netherlands; [Donchin, Opher] Ben Gurion Univ Negev, Dept Biomed Engn, IL-84105 Beer Sheva, Israel	German Sport University Cologne; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Ben Gurion University	Werner, S (corresponding author), German Sport Univ Cologne, Inst Movement & Neurosci, Cologne, Germany.	werner@dshs-koeln.de	Donchin, Opher/A-4389-2008; Werner, Susen/AAN-6219-2021	Donchin, Opher/0000-0003-0963-4467; Hulst, Thomas/0000-0002-2952-0654; Werner, Susen/0000-0001-9664-4617; van Aken, Bernice/0000-0002-4135-7423; van der Geest, J/0000-0002-2870-4208	TC2N Interreg initiative award; C7 Marie Curie ITN award; Israel-Lower Saxony fund; Helmsley ABC Robotics Initiative of Ben-Gurion University	TC2N Interreg initiative award; C7 Marie Curie ITN award; Israel-Lower Saxony fund; Helmsley ABC Robotics Initiative of Ben-Gurion University	This work was supported by the TC2N Interreg initiative awarded to MAF and JNG, the C7 Marie Curie ITN awarded to MAF and by the Israel-Lower Saxony fund and the Helmsley ABC Robotics Initiative of Ben-Gurion University both awarded to OD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen BB, 2003, J COMP NEUROL, V466, P356, DOI 10.1002/cne.10884; Benson BL, 2011, J NEUROPHYSIOL, V105, P2843, DOI 10.1152/jn.00002.2011; Bergerbest D, 2002, MEM COGNITION, V30, P1252, DOI 10.3758/BF03213407; Bock O, 2006, EXP BRAIN RES, V169, P400, DOI 10.1007/s00221-005-0153-4; Bock O, 2005, EXP BRAIN RES, V160, P259, DOI 10.1007/s00221-004-2133-5; Bock O, 2001, EXP BRAIN RES, V138, P359, DOI 10.1007/s002210100704; Buch ER, 2003, LEARN MEMORY, V10, P55, DOI 10.1101/lm.50303; Cleeremans A., 1993, MECH IMPLICIT LEARNI; Cleeremans A, 2008, PROG BRAIN RES, V168, P19, DOI 10.1016/S0079-6123(07)68003-0; Criscimagna-Hemminger SE, 2010, J NEUROPHYSIOL, V103, P2275, DOI 10.1152/jn.00822.2009; de Xivry JJO, 2011, CEREB CORTEX, V21, P1475, DOI 10.1093/cercor/bhq192; Destrebecqz A, 2005, PROG BRAIN RES, V150, P69, DOI 10.1016/S0079-6123(05)50006-2; Destrebecqz A, 2001, PSYCHON B REV, V8, P343, DOI 10.3758/BF03196171; Destrebecqz A, 2003, COGNITIVE BRAIN RES, V16, P391, DOI 10.1016/S0926-6410(03)00053-3; Dimitrova A, 2008, BRAIN RES, V1198, P73, DOI 10.1016/j.brainres.2008.01.034; ERIKSEN CW, 1960, PSYCHOL REV, V67, P279, DOI 10.1037/h0041622; Fernandez-Ruiz J, 2000, COGNITIVE BRAIN RES, V9, P223, DOI 10.1016/S0926-6410(99)00057-9; FRENSCH PA, 1994, J EXP PSYCHOL LEARN, V20, P567, DOI 10.1037/0278-7393.20.3.567; Fu QF, 2008, CONSCIOUS COGN, V17, P185, DOI 10.1016/j.concog.2007.01.007; Galea JM, 2010, EXP BRAIN RES, V202, P473, DOI 10.1007/s00221-010-2158-x; Hatada Y, 2006, EXP BRAIN RES, V169, P417, DOI 10.1007/s00221-005-0159-y; Hegele M, 2013, PSYCHOL AGING, V28, P333, DOI 10.1037/a0031914; Hegele M, 2010, CONSCIOUS COGN, V19, P906, DOI 10.1016/j.concog.2010.05.005; Heuer H, 2008, PSYCHOL AGING, V23, P190, DOI 10.1037/0882-7974.23.1.190; Heuer H, 2011, J NEUROPHYSIOL, V106, P2078, DOI 10.1152/jn.00043.2011; Heuer H, 2011, EXP BRAIN RES, V211, P97, DOI 10.1007/s00221-011-2656-5; Hinder MR, 2008, BRAIN RES, V1197, P123, DOI 10.1016/j.brainres.2007.12.067; Huang VS, 2009, J NEUROPHYSIOL, V102, P931, DOI 10.1152/jn.00237.2009; Hussain SJ, 2014, J NEUROPHYSIOL, V111, P2414, DOI 10.1152/jn.00570.2013; Hwang EJ, 2006, EXP BRAIN RES, V173, P425, DOI 10.1007/s00221-006-0391-0; Ingram HA, 2000, EXP BRAIN RES, V132, P114, DOI 10.1007/s002219900322; Izawa J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002012; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; JAKOBSON LS, 1989, EXP BRAIN RES, V78, P575; Jimenez L, 1996, J EXP PSYCHOL LEARN, V22, P948, DOI 10.1037/0278-7393.22.4.948; JOHNSTON WA, 1991, J EXP PSYCHOL LEARN, V17, P210, DOI 10.1037/0278-7393.17.2.210; Kagerer FA, 1997, EXP BRAIN RES, V115, P557, DOI 10.1007/PL00005727; Kane KA, 2000, COGNITIVE BRAIN RES, V10, P19, DOI 10.1016/S0926-6410(00)00018-5; Karabanov A, 2008, J NEUROPHYSIOL, V100, P733, DOI 10.1152/jn.01303.2007; Kitago Tomoko, 2013, Handb Clin Neurol, V110, P93, DOI 10.1016/B978-0-444-52901-5.00008-3; Klassen J, 2005, EXP BRAIN RES, V164, P250, DOI 10.1007/s00221-005-2247-4; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Malfait N, 2004, J NEUROSCI, V24, P8084, DOI 10.1523/JNEUROSCI.1742-04.2004; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; McNay EC, 1998, LEARN MEMORY, V4, P411, DOI 10.1101/lm.4.5.411; Michel C, 2007, J COGNITIVE NEUROSCI, V19, P341, DOI 10.1162/jocn.2007.19.2.341; Morehead JR, 2013, TRANSLATIONAL COMPUT; Nisbett RE, 1977, PSYCHOL REV; Norman E, 2006, CONSCIOUS COGN, V15, P723, DOI 10.1016/j.concog.2005.06.003; Peled A, 2012, J MOTOR BEHAV, V44, P185, DOI 10.1080/00222895.2012.672349; REBER PJ, 1994, LEARN MEMORY, V1, P217; REINGOLD EM, 1990, MIND LANG, V5, P9, DOI DOI 10.1111/J.1468-0017.1990.TB00150.X; Schween R, 2014, EXP BRAIN RES, V232, P3007, DOI 10.1007/s00221-014-3992-z; Shabbott BA, 2010, EXP BRAIN RES, V203, P75, DOI 10.1007/s00221-010-2209-3; Shanks DR, 2005, PSYCHOL RES-PSYCH FO, V69, P369, DOI 10.1007/s00426-004-0211-8; SHANKS DR, 1994, BEHAV BRAIN SCI, V17, P367, DOI 10.1017/S0140525X00035032; Slachevsky A, 2001, J COGNITIVE NEUROSCI, V13, P332, DOI 10.1162/08989290151137386; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Sulzenbruck S, 2009, CONSCIOUS COGN, V18, P145, DOI 10.1016/j.concog.2008.12.001; Taylor JA, 2014, PROG BRAIN RES, V210, P217, DOI 10.1016/B978-0-444-63356-9.00009-1; Taylor JA, 2011, J NEUROPHYSIOL, V106, P3157, DOI 10.1152/jn.01008.2010; Taylor JA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001096; Taylor JA, 2010, CEREBELLUM, V9, P580, DOI 10.1007/s12311-010-0201-x; TORVIK A, 1986, J NEUROL SCI, V76, P283, DOI 10.1016/0022-510X(86)90176-0; Venkatakrishnan A, 2011, HUM MOVEMENT SCI, V30, P760, DOI 10.1016/j.humov.2010.08.020; Wang JS, 2011, J NEUROPHYSIOL, V106, P259, DOI 10.1152/jn.00254.2011; Werner S, 2007, EXP BRAIN RES, V178, P554, DOI 10.1007/s00221-007-0925-0; Werner S, 2014, EXP BRAIN RES, V232, P1145, DOI 10.1007/s00221-014-3824-1; Wilkinson L, 2004, J EXP PSYCHOL LEARN, V30, P354, DOI 10.1037/0278-7393.30.2.354; Willingham DB, 2002, J NEUROPHYSIOL, V88, P1451, DOI 10.1152/jn.2002.88.3.1451; WILLINGHAM DB, 1989, J EXP PSYCHOL LEARN, V15, P1047, DOI 10.1037/0278-7393.15.6.1047; Wong AL, 2011, NEUROSCI LETT, V500, P207, DOI 10.1016/j.neulet.2011.06.039; Woodruff-Pak DS, 2001, NEUROBIOL LEARN MEM, V76, P342, DOI 10.1006/nlme.2001.4026	74	53	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123321	10.1371/journal.pone.0123321	http://dx.doi.org/10.1371/journal.pone.0123321			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XA	25894396	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700034
J	Jungmann, PM; Ganter, C; Schaeffeler, CJ; Bauer, JS; Baum, T; Meier, R; Nittka, M; Pohlig, F; Rechl, H; von Eisenhart-Rothe, R; Rummeny, EJ; Woertler, K				Jungmann, Pia M.; Ganter, Carl; Schaeffeler, Christoph J.; Bauer, Jan S.; Baum, Thomas; Meier, Reinhard; Nittka, Mathias; Pohlig, Florian; Rechl, Hans; von Eisenhart-Rothe, Ruediger; Rummeny, Ernst J.; Woertler, Klaus			View-Angle Tilting and Slice-Encoding Metal Artifact Correction for Artifact Reduction in MRI: Experimental Sequence Optimization for Orthopaedic Tumor Endoprostheses and Clinical Application	PLOS ONE			English	Article							MAGNETIC-SUSCEPTIBILITY; MALIGNANT-TUMOR; LIMB-SALVAGE; OSTEOSARCOMA; REPLACEMENT; MANAGEMENT; RESECTION; FEMUR; ARTHROPLASTY; IMPLANTS	Background MRI plays a major role in follow-up of patients with malignant bone tumors. However, after limb salvage surgery, orthopaedic tumor endoprostheses might cause significant metalinduced susceptibility artifacts. Purposes To evaluate the benefit of view-angle tilting (VAT) and slice-encoding metal artifact correction (SEMAC) for MRI of large-sized orthopaedic tumor endoprostheses in an experimental model and to demonstrate clinical benefits for assessment of periprosthetic soft tissue abnormalities. Methods In an experimental setting, tumor endoprostheses (n=4) were scanned at 1.5T with three versions of optimized high-bandwidth turbo-spin-echo pulse sequences: (i) standard, (ii) VAT and (iii) combined VAT and SEMAC (VAT&SEMAC). Pulse sequences included coronal short-tau-inversion-recovery (STIR), coronal T1-weighted (w), transverse T1-w and T2-w TSE sequences. For clinical evaluation, VAT& SEMAC was compared to conventional metal artifact-reducing MR sequences (conventional MR) in n=25 patients with metal implants and clinical suspicion of tumor recurrence or infection. Diameters of artifacts were measured quantitatively. Qualitative parameters were assessed on a five-point scale (1=best, 5=worst): "image distortion", "artificial signal changes at the edges" and "diagnostic confidence". Imaging findings were correlated with pathology. T-tests and Wilcoxon-signed rank tests were used for statistical analyses. Results The true size of the prostheses was overestimated on MRI (P<0.05). A significant reduction of artifacts was achieved by VAT (P<0.001) and VAT&SEMAC (P=0.003) compared to the standard group. Quantitative scores improved in the VAT and VAT&SEMAC group (P<0.05). On clinical MR images, artifact diameters were significantly reduced in the VAT&SEMAC-group as compared with the conventional-group (P<0.001). Distortion and artificial signal changes were reduced and diagnostic confidence improved (P<0.05). In two cases, tumor-recurrence, in ten cases infection and in thirteen cases other pathologies were diagnosed. Conclusions Significant reduction of metallic artifacts was achieved by VAT and SEMAC. Clinical results suggest, that these new techniques will be beneficial for detecting periprosthetic pathologies during postoperative follow-up.	[Jungmann, Pia M.; Ganter, Carl; Schaeffeler, Christoph J.; Bauer, Jan S.; Baum, Thomas; Meier, Reinhard; Rummeny, Ernst J.; Woertler, Klaus] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiol, D-81675 Munich, Germany; [Schaeffeler, Christoph J.] Kantonsspital Graubuenden, Musculoskeletal Imaging, CH-7000 Chur, Switzerland; [Bauer, Jan S.] Tech Univ Munich, Klinikum Rechts Isar, Dept Neuroradiol, D-81675 Munich, Germany; [Nittka, Mathias] Siemens AG, Healthcare Sect, D-91052 Erlangen, Germany; [Pohlig, Florian; Rechl, Hans; von Eisenhart-Rothe, Ruediger] Tech Univ Munich, Klinikum Rechts Isar, Dept Orthopaed Surg, D-81675 Munich, Germany	Technical University of Munich; Kantonsspital Graubunden; Technical University of Munich; Siemens AG; Siemens Germany; Technical University of Munich	Jungmann, PM (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Radiol, Ismaninger Str 22, D-81675 Munich, Germany.	pia.jungmann@tum.de	Ganter, Carl/U-6895-2017; Baum, Thomas/M-6522-2014; Kirschke, Jan/E-2550-2012; von Eisenhart-Rothe, Ruediger/E-4839-2017; Meier, Reinhard/B-2882-2014	Ganter, Carl/0000-0002-6735-7448; Baum, Thomas/0000-0002-4574-5212; Kirschke, Jan/0000-0002-7557-0003; Meier, Reinhard/0000-0002-2169-4780; Jungmann, Pia/0000-0003-2198-3678; Pohlig, Florian/0000-0002-8867-2973	German Research Foundation (DFG); Technische Universitat Munchen within the funding programme Open Access Publishing	German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen within the funding programme Open Access Publishing	This work was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOULAFIA AJ, 1993, CANCER-AM CANCER SOC, V71, P3358, DOI 10.1002/1097-0142(19930515)71:10+<3358::AID-CNCR2820711738>3.0.CO;2-O; Beaman FD, 2013, SEMIN MUSCULOSKEL R, V17, P168, DOI 10.1055/s-0033-1343094; BERQUIST TH, 1989, CLIN ORTHOP RELAT R, P101; Butts K, 2005, MAGNET RESON MED, V53, P418, DOI 10.1002/mrm.20375; CHO ZH, 1988, MED PHYS, V15, P7, DOI 10.1118/1.596162; Choong PFM, 1996, ACTA ORTHOP SCAND, V67, P345, DOI 10.3109/17453679609002328; Clark JCM, 2008, J CANCER RES CLIN, V134, P281, DOI 10.1007/s00432-007-0330-x; ECKARDT JJ, 1991, CLIN ORTHOP RELAT R, P202; Fayad LM, 2012, RADIOLOGY, V265, P340, DOI 10.1148/radiol.12111740; GLUER CC, 1995, OSTEOPOROSIS INT, V5, P262, DOI 10.1007/BF01774016; Hargreaves BA, 2011, AM J ROENTGENOL, V197, P547, DOI 10.2214/AJR.11.7364; Kawai A, 1998, J BONE JOINT SURG AM, V80A, P636, DOI 10.2106/00004623-199805000-00004; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee MJ, 2007, RADIOGRAPHICS, V27, P791, DOI 10.1148/rg.273065087; Lu WM, 2009, MAGN RESON MED, V62, P66, DOI 10.1002/mrm.21967; Manaster B J, 2000, Radiology, V215 Suppl, P379; MORRIS HG, 1994, INT ORTHOP, V18, P90, DOI 10.1007/BF02484417; Oldrini G, 2011, J RADIOL, V92, P915, DOI 10.1016/j.jradio.2011.07.003; QUILL G, 1990, CLIN ORTHOP RELAT R, P242; Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854; SIM FH, 1995, CLIN ORTHOP RELAT R, P160; Simon MA, 2005, J BONE JOINT SURG AM, V87A, P2822, DOI 10.2106/JBJS.8712.cl; Starcukova J, 2008, DENT MATER, V24, P715, DOI 10.1016/j.dental.2007.07.002; Stradiotti P, 2009, EUR SPINE J, V18, pS102, DOI 10.1007/s00586-009-0998-5; Sutter R, 2013, AM J ROENTGENOL, V201, P1315, DOI 10.2214/AJR.13.10531; Sutter R, 2012, RADIOLOGY, V265, P204, DOI 10.1148/radiol.12112408; Viano AM, 2000, MAGN RESON IMAGING, V18, P287, DOI 10.1016/S0730-725X(99)00135-6; Wafa H, 2006, EXPERT REV ANTICANC, V6, P239, DOI 10.1586/14737140.6.2.239; WENDT RE, 1988, RADIOLOGY, V168, P837, DOI 10.1148/radiology.168.3.3406413	29	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124922	10.1371/journal.pone.0124922	http://dx.doi.org/10.1371/journal.pone.0124922			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909472	Green Published, Green Submitted, gold			2022-12-27	WOS:000353376800115
J	Achterberg, S; Kappelle, LJ; de Bakker, PIW; Traylor, M; Algra, A				Achterberg, Sefanja; Kappelle, L. Jaap; de Bakker, Paul I. W.; Traylor, Matthew; Algra, Ale		SMART Study Group; METASTROKE Consortium	No Additional Prognostic Value of Genetic Information in the Prediction of Vascular Events after Cerebral Ischemia of Arterial Origin: The PROMISe Study	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; ASPIRIN RESISTANCE; STROKE; RISK; ASSOCIATION; ATTACK; METAANALYSIS; VARIANTS	Background Patients who have suffered from cerebral ischemia have a high risk of recurrent vascular events. Predictive models based on classical risk factors typically have limited prognostic value. Given that cerebral ischemia has a heritable component, genetic information might improve performance of these risk models. Our aim was to develop and compare two models: one containing traditional vascular risk factors, the other also including genetic information. Methods and Results We studied 1020 patients with cerebral ischemia and genotyped them with the Illumina Immunochip. Median follow-up time was 6.5 years; the annual incidence of new ischemic events (primary outcome, n=198) was 3.0%. The prognostic model based on classical vascular risk factors had an area under the receiver operating characteristics curve (AUC-ROC) of 0.65 (95% confidence interval 0.61-0.69). When we added a genetic risk score based on prioritized SNPs from a genome-wide association study of ischemic stroke (using summary statistics from the METASTROKE study which included 12389 cases and 62004 controls), the AUC-ROC remained the same. Similar results were found for the secondary outcome ischemic stroke. Conclusions We found no additional value of genetic information in a prognostic model for the risk of ischemic events in patients with cerebral ischemia of arterial origin. This is consistent with a complex, polygenic architecture, where many genes of weak effect likely act in concert to influence the heritable risk of an individual to develop (recurrent) vascular events. At present, genetic information cannot help clinicians to distinguish patients at high risk for recurrent vascular events.	[Achterberg, Sefanja; Kappelle, L. Jaap; Algra, Ale] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Utrecht Stroke Ctr, Dept Neurol & Neurosurg, Utrecht, Netherlands; [de Bakker, Paul I. W.; Algra, Ale] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Med Genet, Utrecht, Netherlands; [Traylor, Matthew] Univ Cambridge, Clin Neurosci, Cambridge CB2 0QQ, England	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Cambridge	Achterberg, S (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Utrecht Stroke Ctr, Dept Neurol & Neurosurg, Utrecht, Netherlands.	s.achterberg-2@umcutrecht.nl	Boncoraglio, Giorgio Battista/B-8647-2011; de Bakker, Paul IW/B-8730-2009	Boncoraglio, Giorgio Battista/0000-0002-2551-525X; de Bakker, Paul IW/0000-0001-7735-7858; Hopewell, Jemma/0000-0002-3870-8018; Visseren, Frank/0000-0003-3951-5223; Seshadri, Sudha/0000-0001-6135-2622; Traylor, Matthew/0000-0001-6624-8621; Levi, Christopher/0000-0002-9474-796X; Mitchell, Braxton/0000-0003-4920-4744	Netherlands Heart Foundation [2005B031]; Dutch Brain Foundation [2008(1).10]; British Heart Foundation [FS/14/55/30806] Funding Source: researchfish	Netherlands Heart Foundation(Netherlands Heart Foundation); Dutch Brain Foundation; British Heart Foundation(British Heart Foundation)	S. Achterberg is supported in part by a grant from the Netherlands Heart Foundation, (grant No. 2005B031) and a grant from the Dutch Brain Foundation (project 2008(1).10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achterberg S, 2008, EUR NEUROL, V59, P243, DOI 10.1159/000115638; Adams RJ, 2003, STROKE, V34, P2310, DOI 10.1161/01.STR.0000090125.28466.E2; Alberts MJ, 2010, STROKE, V41, P2400, DOI 10.1161/STROKEAHA.110.595637; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Eikelboom JW, 2010, STROKE, V41, P2398, DOI 10.1161/STROKEAHA.110.593582; Gretarsdottir S, 2008, ANN NEUROL, V64, P402, DOI 10.1002/ana.21480; Gschwendtner A, 2009, ANN NEUROL, V65, P531, DOI 10.1002/ana.21590; Gudbjartsson DF, 2009, NAT GENET, V41, P876, DOI 10.1038/ng.417; Gurbel PA, 2012, CIRCULATION, V125, P1276, DOI 10.1161/CIRCULATIONAHA.111.031195; Kilarski LL, 2014, NEUROLOGY, V83, P678, DOI 10.1212/WNL.0000000000000707; Kuzniatsova N, 2012, ANN MED, V44, P773, DOI 10.3109/07853890.2011.605388; Pruissen DMO, 2009, CEREBROVASC DIS, V27, P290, DOI 10.1159/000199467; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Sharma P, 2013, J NEUROL NEUROSUR PS, V84, P1302, DOI 10.1136/jnnp-2012-304834; Simons PCG, 1999, EUR J EPIDEMIOL, V15, P773, DOI 10.1023/A:1007621514757; Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X; van Wijk I, 2005, LANCET, V365, P2098, DOI 10.1016/S0140-6736(05)66734-7; Wijnhoud AD, 2010, STROKE, V41, P2178, DOI 10.1161/STROKEAHA.110.580985; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	22	5	5	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0119203	10.1371/journal.pone.0119203	http://dx.doi.org/10.1371/journal.pone.0119203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906364	Green Published, gold			2022-12-27	WOS:000353332000003
J	Argyropoulos, C; Unruh, ML				Argyropoulos, Christos; Unruh, Mark L.			Analysis of Time to Event Outcomes in Randomized Controlled Trials by Generalized Additive Models	PLOS ONE			English	Article							ADJUSTED SURVIVAL CURVES; SHARED DECISION-MAKING; COVARIATE ADJUSTMENT; CLINICAL-TRIALS; MEMBRANE-PERMEABILITY; HEMODIALYSIS-PATIENTS; HAZARD RATIO; REGRESSION; DIALYSIS; DESIGN	Background Randomized Controlled Trials almost invariably utilize the hazard ratio calculated with a Cox proportional hazard model as a treatment efficacy measure. Despite the widespread adoption of HRs, these provide a limited understanding of the treatment effect and may even provide a biased estimate when the assumption of proportional hazards in the Cox model is not verified by the trial data. Additional treatment effect measures on the survival probability or the time scale may be used to supplement HRs but a framework for the simultaneous generation of these measures is lacking. Methods By splitting follow-up time at the nodes of a Gauss Lobatto numerical quadrature rule, techniques for Poisson Generalized Additive Models (PGAM) can be adopted for flexible hazard modeling. Straightforward simulation post-estimation transforms PGAM estimates for the log hazard into estimates of the survival function. These in turn were used to calculate relative and absolute risks or even differences in restricted mean survival time between treatment arms. We illustrate our approach with extensive simulations and in two trials: IPASS (in which the proportionality of hazards was violated) and HEMO a long duration study conducted under evolving standards of care on a heterogeneous patient population. Findings PGAM can generate estimates of the survival function and the hazard ratio that are essentially identical to those obtained by Kaplan Meier curve analysis and the Cox model. PGAMs can simultaneously provide multiple measures of treatment efficacy after a single data pass. Furthermore, supported unadjusted (overall treatment effect) but also subgroup and adjusted analyses, while incorporating multiple time scales and accounting for non-proportional hazards in survival data. Conclusions By augmenting the HR conventionally reported, PGAMs have the potential to support the inferential goals of multiple stakeholders involved in the evaluation and appraisal of clinical trial results under proportional and non-proportional hazards.	[Argyropoulos, Christos; Unruh, Mark L.] Univ New Mexico, Dept Internal Med, Div Nephrol, Albuquerque, NM 87131 USA	University of New Mexico	Argyropoulos, C (corresponding author), Univ New Mexico, Dept Internal Med, Div Nephrol, Albuquerque, NM 87131 USA.	argchris@hotmail.com	Argyropoulos, Christos/I-2803-2019	Argyropoulos, Christos/0000-0002-9679-7805	Baxter Healthcare International; Dialysis Clinic Incorporated; Fresenius Medical Care; Satellite Dialysis	Baxter Healthcare International; Dialysis Clinic Incorporated; Fresenius Medical Care; Satellite Dialysis	Drs. Christos Argyropoulos and Mark Unruh have previously received research support from Baxter Healthcare International, manufacturer of hemodialysis products including high flux dialyzers. Dr. Mark Unruh has previously received research support from Dialysis Clinic Incorporated, Fresenius Medical Care, and Satellite Dialysis. The corresponding author had full access to all the data and coordinated the decision to submit for publication. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Argyropoulos CP, 2014, KIDNEY INT, V86, P884, DOI 10.1038/ki.2014.249; Austin PC, 2010, J CLIN EPIDEMIOL, V63, P142, DOI 10.1016/j.jclinepi.2009.06.002; Bala MM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004704.pub3; Ballatori E, 2009, NEW ENGL J MED, V361, P2485, DOI 10.1056/NEJMc0909634; Bauman KE, 1999, PREV MED, V28, P426, DOI 10.1006/pmed.1998.0447; Belitz C, 2012, SOFTWARE BAYESIAN IN; Bender R, 2005, STAT MED, V24, P1713, DOI 10.1002/sim.2059; BRATLEY P, 1988, ACM T MATH SOFTWARE, V14, P88, DOI 10.1145/42288.214372; BRESLOW N, 1974, BIOMETRICS, V30, P89, DOI 10.2307/2529620; Breslow NE, 1972, J R STAT SOC B, V34, P216, DOI DOI 10.1111/J.2517-6161.1972.TB00900.X; Burton A, 2006, STAT MED, V25, P4279, DOI 10.1002/sim.2673; Caflisch R. E., 1998, Acta Numerica, V7, P1, DOI 10.1017/S0962492900002804; Cai T, 2002, J COMPUT GRAPH STAT, V11, P784, DOI 10.1198/106186002862; Cai TX, 2003, BIOMETRICS, V59, P570, DOI 10.1111/1541-0420.00067; Carstensen B, 2006, DEMOGRAPHY EPIDEMIOL; Case LD, 2002, ONCOLOGIST, V7, P181, DOI 10.1634/theoncologist.7-3-181; Chen PY, 2001, BIOMETRICS, V57, P1030, DOI 10.1111/j.0006-341X.2001.01030.x; Cheung AK, 2009, J AM SOC NEPHROL, V20, P462, DOI 10.1681/ASN.2009010030; Clase CM, 2001, NEPHROL DIAL TRANSPL, V16, P1925, DOI 10.1093/ndt/16.9.1925; CLAYTON DG, 1983, J R STAT SOC C-APPL, V32, P102; Committe for Medicinal Products for Human Use (CHMP), 2013, EMA2950502013 CHMP; Coulter A, 1997, J Health Serv Res Policy, V2, P112; COX DR, 1972, J R STAT SOC B, V34, P187; Crowther MJ, 2014, STAT MED, V33, P5280, DOI 10.1002/sim.6300; Crowther MJ, 2013, J STAT SOFTW, V53, P1; Davis P. J., 1984, METHODS NUMERICAL IN; Delgado MS, 2013, J APPL ECONOMET, V28, P1224, DOI 10.1002/jae.2362; Earle CC, 2000, MED DECIS MAKING, V20, P104, DOI 10.1177/0272989X0002000113; Eberly Lynn E, 2004, Clin Trials, V1, P148, DOI 10.1191/1740774504cn018oa; EFRON B, 1988, J AM STAT ASSOC, V83, P414, DOI 10.2307/2288857; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Elwyn G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5146; Fallin A, 2011, HEALTH EDUC RES, V26, P711, DOI 10.1093/her/cyr032; GAIL MH, 1986, BIOMETRICAL J, V28, P587, DOI 10.1002/bimj.4710280508; GAIL MH, 1984, BIOMETRIKA, V71, P431; Ghali WA, 2001, JAMA-J AM MED ASSOC, V286, P1494, DOI 10.1001/jama.286.12.1494; Gill JS, 2013, AM J TRANSPLANT, V13, P427, DOI 10.1111/j.1600-6143.2012.04323.x; GRAY RJ, 1994, BIOMETRICS, V50, P640, DOI 10.2307/2532779; GRAY RJ, 1992, J AM STAT ASSOC, V87, P942, DOI 10.2307/2290630; Greene T, 2000, CONTROL CLIN TRIALS, V21, P502, DOI 10.1016/S0197-2456(00)00062-3; Grosse Scott D, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P165, DOI 10.1586/14737167.8.2.165; Guyot P, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-9; Guyot P, 2011, VALUE HEALTH, V14, P640, DOI 10.1016/j.jval.2011.01.008; Hauck WW, 1998, CONTROL CLIN TRIALS, V19, P249, DOI 10.1016/S0197-2456(97)00147-5; Hedeker D, 2010, EUR ASSOC METHODOL S, P115; Higgins JPT, 2011, COCHRANE HDB SYSTEMA; HOLFORD TR, 1976, BIOMETRICS, V32, P587, DOI 10.2307/2529747; HOLFORD TR, 1980, BIOMETRICS, V36, P299, DOI 10.2307/2529982; Hong KS, 2011, CIRCULATION, V123, P2111, DOI 10.1161/CIRCULATIONAHA.109.934786; Kerr PG, 2013, NEPHROLOGY, V18, P485, DOI 10.1111/nep.12096; Kumar VA, 2014, KIDNEY INT, V86, P1016, DOI 10.1038/ki.2014.224; LAIRD N, 1981, J AM STAT ASSOC, V76, P231, DOI 10.2307/2287816; Lambert PC, 2009, STATA J, V9, P265, DOI 10.1177/1536867X0900900206; Latimer N., 2011, NICE DSU TECHNICAL S; Latimer NR, 2013, MED DECIS MAKING, V33, P743, DOI 10.1177/0272989X12472398; Locatelli F, 2008, BLOOD PURIFICAT, V26, P100, DOI 10.1159/000110574; Locatelli F, 2009, J AM SOC NEPHROL, V20, P645, DOI 10.1681/ASN.2008060590; Mactier R, 2007, CLIN PRACTICE GUIDEL; MALENKA DJ, 1993, J GEN INTERN MED, V8, P543, DOI 10.1007/BF02599636; Marra G, 2012, SCAND J STAT, V39, P53, DOI 10.1111/j.1467-9469.2011.00760.x; Messori A, 2000, CLIN DRUG INVEST, V20, P309, DOI 10.2165/00044011-200020050-00002; Messori A, 2008, BMJ; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; NHS National Quality Board, 2012, FRAM NHS PAT EXP; Niederreiter H., 1992, RANDOM NUMBER GENERA; Orsi C, 2007, BONE MARROW TRANSPL, V40, P643, DOI 10.1038/sj.bmt.1705790; Palmer SC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005016.pub2; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Persson I., 2002, ESSAYS ASSUMPTION PR; Piessens R., 1983, QUADPACK SUBROUTINE; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; Robinson BM, 2012, CLIN J AM SOC NEPHRO, V7, P1897, DOI 10.2215/CJN.04940512; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-152; Royston P, 2011, STAT MED, V30, P2409, DOI 10.1002/sim.4274; Ruppert D, 2009, ELECTRON J STAT, V3, P1193, DOI 10.1214/09-EJS525; Saquib N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4313; Schemper M, 2009, STAT MED, V28, P2473, DOI 10.1002/sim.3623; Seruga B, 2009, NEW ENGL J MED, V361, P2485; Shiroiwa T, 2010, HEALTH ECON, V19, P422, DOI 10.1002/hec.1481; Sorensen L, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-31; Spruance SL, 2004, ANTIMICROB AGENTS CH, V48, P2787, DOI 10.1128/AAC.48.8.2787-2792.2004; Tattersall J, 2010, NEPHROL DIAL TRANSPL, V25, P1230, DOI 10.1093/ndt/gfp626; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; Trevena LJ, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S7; Tsiatis AA, 2008, STAT MED, V27, P4658, DOI 10.1002/sim.3113; U.S. Renal Data System, 2013, USRDS 2013 ANN DAT R; Undurraga J, 2012, NEUROPSYCHOPHARMACOL, V37, P851, DOI 10.1038/npp.2011.306; Vonesh EF, 2006, KIDNEY INT, V70, pS3, DOI 10.1038/sj.ki.5001910; Wang J, 2009, NEW ENGL J MED, V361, P2486; WELLS FE, 1985, ANN CLIN BIOCHEM, V22, P304, DOI 10.1177/000456328502200314; Wilkinson B, 2004, PARALLEL PROGRAMMING; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Yu LM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-59; Zhang X, 2007, COMPUT METH PROG BIO, V88, P95, DOI 10.1016/j.cmpb.2007.07.010	96	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123784	10.1371/journal.pone.0123784	http://dx.doi.org/10.1371/journal.pone.0123784			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906075	gold, Green Published, Green Submitted			2022-12-27	WOS:000353332000045
J	Chimura, T; Launey, T; Yoshida, N				Chimura, Takahiko; Launey, Thomas; Yoshida, Nobuaki			Calpain-Mediated Degradation of Drebrin by Excitotoxicity In vitro and In vivo	PLoS One			English	Article							ACTIN-BINDING-PROTEIN; VASCULAR COGNITIVE IMPAIRMENT; ISCHEMIC BRAIN-DAMAGE; D-ASPARTATE RECEPTOR; NR2B-CONTAINING NMDA RECEPTORS; DENDRITIC SPINE MORPHOGENESIS; CHANNEL BLOCKER MEMANTINE; FOCAL CEREBRAL-ISCHEMIA; LONG-TERM POTENTIATION; ADULT-RAT BRAIN	The level of drebrin, an evolutionarily conserved f-actin-binding protein that regulates synaptic structure and function, is reduced in the brains of patients with chronic neurodegenerative diseases such as Alzheimer's disease (AD) and Down's syndrome (DS). It was suggested that excitotoxic neuronal death caused by overactivation of NMDA-type glutamate receptors (NMDARs) occurs in AD and DS; however, the relationship between excitotoxicity and drebrin loss is unknown. Here, we show that drebrin is a novel target of calpain-mediated proteolysis under excitotoxic conditions induced by the overactivation of NMDARs. In cultured rodent neurons, degradation of drebrin was confirmed by the detection of proteolytic fragments, as well as a reduction in the amount of full-length drebrin. Notably, the NMDA-induced degradation of drebrin in mature neurons occurred concomitantly with a loss of f-actin. Furthermore, pharmacological inhibition of f-actin loss facilitated the drebrin degradation, suggesting a functional linkage between f-actin and drebrin degradation. Biochemical analyses using purified drebrin and calpain revealed that calpain degraded drebrin directly in vitro. Furthermore, cerebral ischemia also induced the degradation of drebrin in vivo. These findings suggest that calpain-mediated degradation of drebrin is a fundamental pathology of neurodegenerative diseases mediated by excitotoxicity, regardless of whether they are acute or chronic. Drebrin regulates the synaptic clustering of NMDARs; therefore, degradation of drebrin under excitotoxic conditions may modulate NMDAR-mediated signal transductions, including pro-survival signaling. Overall, the results presented here provide novel insights into the molecular basis of cellular responses to excitotoxicity in vitro and in vivo.	[Chimura, Takahiko; Yoshida, Nobuaki] Univ Tokyo, Inst Med Sci, Lab Dev Genet, Ctr Expt Med & Syst Biol, Tokyo, Japan; [Launey, Thomas] RIKEN, Brain Sci Inst, Launey Res Unit, Wako, Saitama, Japan	University of Tokyo; RIKEN	Chimura, T (corresponding author), Univ Tokyo, Inst Med Sci, Lab Dev Genet, Ctr Expt Med & Syst Biol, Tokyo, Japan.	takahiko@ims.u-tokyo.ac.jp	Launey, Thomas/A-2605-2010	Launey, Thomas/0000-0001-9153-9260	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grant from Ministry of Education, Culture, Sports, Science and Technology, Japan [to TC and NY]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Aoki C, 2005, J COMP NEUROL, V483, P383, DOI 10.1002/cne.20449; ASADA H, 1994, J NEUROSCI RES, V38, P149, DOI 10.1002/jnr.490380205; Beppu K, 2014, NEURON, V81, P314, DOI 10.1016/j.neuron.2013.11.011; Biou V, 2008, EUR J NEUROSCI, V27, P2847, DOI 10.1111/j.1460-9568.2008.06269.x; Butkevich E, 2004, CURR BIOL, V14, P650, DOI 10.1016/j.cub.2004.03.063; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K; Chandler LJ, 2001, J BIOL CHEM, V276, P2627, DOI 10.1074/jbc.M003390200; Chen HSV, 1998, NEUROSCIENCE, V86, P1121, DOI 10.1016/S0306-4522(98)00163-8; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1988, J NEUROSCI, V8, P185; Counts SE, 2012, NEURODEGENER DIS, V10, P216, DOI 10.1159/000333122; Cui H, 2007, J NEUROSCI, V27, P9901, DOI 10.1523/JNEUROSCI.1464-07.2007; ELNASR MS, 1990, EUR J PHARMACOL, V185, P19, DOI 10.1016/0014-2999(90)90206-L; Etherton-Beer CD, 2014, MATURITAS, V79, P220, DOI 10.1016/j.maturitas.2014.06.004; Faddis BT, 1997, J NEUROSCI, V17, P951; FURUKAWA K, 1995, EXP NEUROL, V133, P153, DOI 10.1006/exnr.1995.1018; Furukawa K, 1997, J NEUROSCI, V17, P8178, DOI 10.1523/jneurosci.17-21-08178.1997; Gascon S, 2008, MOL PSYCHIATR, V13, P99, DOI 10.1038/sj.mp.4002017; Geraldo S, 2008, NAT CELL BIOL, V10, P1181, DOI 10.1038/ncb1778; GILL R, 1987, J NEUROSCI, V7, P3343; Gouix E, 2009, MOL CELL NEUROSCI, V40, P463, DOI 10.1016/j.mcn.2009.01.002; Guttmann RP, 2002, J PHARMACOL EXP THER, V302, P1023, DOI 10.1124/jpet.102.036962; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Harigaya Y, 1996, J NEUROSCI RES, V43, P87, DOI 10.1002/jnr.490430111; Hayashi K, 1996, J NEUROSCI, V16, P7161; Hayashi K, 1999, EXP CELL RES, V253, P673, DOI 10.1006/excr.1999.4663; ISHIKAWA R, 1994, J BIOL CHEM, V269, P29928; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; KOH JY, 1990, BRAIN RES, V533, P315, DOI 10.1016/0006-8993(90)91355-K; KOJIMA N, 1993, MOL BRAIN RES, V19, P101, DOI 10.1016/0169-328X(93)90154-H; Kojima N, 2010, NEUROSCIENCE, V165, P138, DOI 10.1016/j.neuroscience.2009.10.016; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Lesort M, 1997, NEUROSCI LETT, V221, P213, DOI 10.1016/S0304-3940(96)13310-3; Levine DA, 2011, NEUROTHERAPEUTICS, V8, P361, DOI 10.1007/s13311-011-0047-z; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Liu Z, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0027887, 10.1371/journal.pone.0019001]; Lu XY, 2000, NEUROSCI LETT, V286, P149, DOI 10.1016/S0304-3940(00)01101-0; Lynch DR, 2007, NEURON, V53, P317, DOI 10.1016/j.neuron.2007.01.014; MAEKAWA S, 1988, EXP CELL RES, V178, P127, DOI 10.1016/0014-4827(88)90384-9; MANN DMA, 1990, ACTA NEUROPATHOL, V80, P318, DOI 10.1007/BF00294651; MANN DMA, 1988, MECH AGEING DEV, V43, P99, DOI 10.1016/0047-6374(88)90041-3; McShane R., 2006, COCHRANE DATABASE SY, V2; MELDRUM BS, 1987, MED BIOL, V65, P153; Mikati MA, 2013, J BIOL CHEM, V288, P19926, DOI 10.1074/jbc.M113.472647; Mizui T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085367; Mizui T, 2009, J NEUROCHEM, V109, P611, DOI 10.1111/j.1471-4159.2009.05993.x; Nihashi T, 2001, ACTA NEUROCHIR, V143, P287, DOI 10.1007/s007010170109; Nishizawa Y, 2001, LIFE SCI, V69, P369, DOI 10.1016/S0024-3205(01)01142-0; O'Brien JT, 2003, LANCET NEUROL, V2, P89, DOI 10.1016/S1474-4422(03)00305-3; PARK CK, 1988, ANN NEUROL, V24, P543, DOI 10.1002/ana.410240411; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Ronicke R, 2011, NEUROBIOL AGING, V32, P2219, DOI 10.1016/j.neurobiolaging.2010.01.011; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Schroeter M, 2002, J NEUROSCI METH, V117, P43, DOI 10.1016/S0165-0270(02)00072-9; Sekino Y, 2006, MOL CELL NEUROSCI, V31, P493, DOI 10.1016/j.mcn.2005.11.003; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; SEUBERT P, 1989, BRAIN RES, V492, P366, DOI 10.1016/0006-8993(89)90921-9; Shim KS, 2002, NEUROSCI LETT, V324, P209, DOI 10.1016/S0304-3940(02)00210-0; Shiraishi-Yamaguchi Y, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-25; SHIRAO T, 1986, DEV BRAIN RES, V29, P233, DOI 10.1016/0165-3806(86)90099-4; Shirao T, 1990, Neurosci Res Suppl, V13, pS106, DOI 10.1016/0921-8696(90)90039-6; SHIRAO T, 1985, J NEUROCHEM, V44, P1210, DOI 10.1111/j.1471-4159.1985.tb08745.x; SIMAN R, 1989, J NEUROSCI, V9, P1579; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Song M, 2008, NEUROSCIENCE, V152, P670, DOI 10.1016/j.neuroscience.2007.10.068; Stieg PE, 1999, EUR J PHARMACOL, V375, P115, DOI 10.1016/S0014-2999(99)00214-9; SWAN JH, 1990, J CEREBR BLOOD F MET, V10, P343, DOI 10.1038/jcbfm.1990.63; Takahashi H, 2006, J NEUROCHEM, V97, P110, DOI 10.1111/j.1471-4159.2005.03536.x; Takahashi H, 2003, J NEUROSCI, V23, P6586; Talantova M, 2013, P NATL ACAD SCI USA, V110, pE2518, DOI 10.1073/pnas.1306832110; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Wang XL, 2013, NEUROTOXICOLOGY, V35, P106, DOI 10.1016/j.neuro.2013.01.003; Worth DC, 2013, J CELL BIOL, V202, P793, DOI 10.1083/jcb.201303005; Yamazaki H, 2014, J NEUROCHEM, V128, P507, DOI 10.1111/jnc.12486; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009	84	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125119	10.1371/journal.pone.0125119	http://dx.doi.org/10.1371/journal.pone.0125119			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905636	gold, Green Submitted, Green Published			2022-12-27	WOS:000353332000104
J	Lemesle, G; Maury, F; Beseme, O; Ovart, L; Amouyel, P; Lamblin, N; de Groote, P; Bauters, C; Pinet, F				Lemesle, Gilles; Maury, Fleur; Beseme, Olivia; Ovart, Lionel; Amouyel, Philippe; Lamblin, Nicolas; de Groote, Pascal; Bauters, Christophe; Pinet, Florence			Multimarker Proteomic Profiling for the Prediction of Cardiovascular Mortality in Patients with Chronic Heart Failure	PLOS ONE			English	Article							VENTRICULAR EJECTION FRACTION; RISK STRATIFICATION; SURVIVAL; SERUM; BIOMARKERS; PROTEINS; MODELS; CANCER	Risk stratification of patients with systolic chronic heart failure (HF) is critical to better identify those who may benefit from invasive therapeutic strategies such as cardiac transplantation. Proteomics has been used to provide prognostic information in various diseases. Our aim was to investigate the potential value of plasma proteomic profiling for risk stratification in HF. A proteomic profiling using surface enhanced laser desorption ionization - time of flight - mass spectrometry was performed in a case/control discovery population of 198 patients with systolic HF (left ventricular ejection fraction <45%): 99 patients who died from cardiovascular cause within 3 years and 99 patients alive at 3 years. Proteomic scores predicting cardiovascular death were developed using 3 regression methods: support vector machine, sparse partial least square discriminant analysis, and lasso logistic regression. Forty two ion m/z peaks were differentially intense between cases and controls in the discovery population and were used to develop proteomic scores. In the validation population, score levels were higher in patients who subsequently died within 3 years. Similar areas under the curves (0.66 - 0.68) were observed for the 3 methods. After adjustment on con-founders, proteomic scores remained significantly associated with cardiovascular mortality. Use of the proteomic scores allowed a significant improvement in discrimination of HF patients as determined by integrated discrimination improvement and net reclassification improvement indexes. In conclusion, proteomic analysis of plasma proteins may help to improve risk prediction in HF patients.	[Lemesle, Gilles; Maury, Fleur; Beseme, Olivia; Ovart, Lionel; Amouyel, Philippe; Lamblin, Nicolas; de Groote, Pascal; Bauters, Christophe; Pinet, Florence] INSERM, UMR1167, F-59045 Lille, France; [Lemesle, Gilles; Maury, Fleur; Beseme, Olivia; Ovart, Lionel; Amouyel, Philippe; Lamblin, Nicolas; de Groote, Pascal; Bauters, Christophe; Pinet, Florence] Inst Pasteur, F-59019 Lille, France; [Lemesle, Gilles; Beseme, Olivia; Amouyel, Philippe; Lamblin, Nicolas; de Groote, Pascal; Bauters, Christophe; Pinet, Florence] Univ Lille Nord France, Lille, France; [Lemesle, Gilles; Maury, Fleur; Ovart, Lionel; Amouyel, Philippe; Lamblin, Nicolas; de Groote, Pascal; Bauters, Christophe] CHRU Lille, F-59037 Lille, France; [Lemesle, Gilles; Amouyel, Philippe; Lamblin, Nicolas; Bauters, Christophe] Fac Med Lille, F-59045 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille	Pinet, F (corresponding author), INSERM, UMR1167, F-59045 Lille, France.	florence.pinet@pasteur-lille.fr	Pinet, Florence/F-2892-2013	Pinet, Florence/0000-0002-5471-1487; Amouyel, Philippe/0000-0001-9088-234X; Lemesle, Gilles/0000-0002-2917-9273; de Groote, Pascal/0000-0002-6211-0147; Bauters, christophe/0000-0001-8268-8467; LAMBLIN, NICOLAS/0000-0003-3754-1241	Agence Nationale de la Recherche" [ANR-11-EMMA-029-01]; E.U. FP7 HOMAGE [305507]	Agence Nationale de la Recherche"(French National Research Agency (ANR)); E.U. FP7 HOMAGE	This work was funded by Agence Nationale de la Recherche" (ANR-11-EMMA-029-01), E.U. FP7 HOMAGE (305507). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belluco C, 2007, ANN SURG ONCOL, V14, P2470, DOI 10.1245/s10434-007-9354-3; Boja ES, 2012, PROTEOMICS, V12, P1093, DOI 10.1002/pmic.201100387; Chung D., 2013, SPLS SPARSE PARTIAL; CINTRON G, 1993, CIRCULATION, V87, P17; de Groote P, 2004, EUR HEART J, V25, P656, DOI 10.1016/j.ehj.2004.01.010; de Groote P, 2004, J AM COLL CARDIOL, V43, P1584, DOI 10.1016/j.jacc.2003.11.059; de Groote P, 2014, CIRC-HEART FAIL, V7, P434, DOI 10.1161/CIRCHEARTFAILURE.113.000813; de Groote P, 2012, EUR HEART J, V33, P2672, DOI 10.1093/eurheartj/ehs080; Dubois E, 2011, PROTEOM CLIN APPL, V5, P57, DOI 10.1002/prca.201000056; Fertin M, 2010, PROTEOM CLIN APPL, V4, P654, DOI 10.1002/prca.200900178; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Guerrier L, 2006, J CHROMATOGR B, V833, P33, DOI 10.1016/j.jchromb.2005.12.048; Hernandez B, 2014, PROTEOMICS, V14, P1587, DOI 10.1002/pmic.201300377; Hillege HL, 2000, CIRCULATION, V102, P203, DOI 10.1161/01.CIR.102.2.203; Hoes A. W., 1998, European Heart Journal, V19, pL2; Jhund PS, 2009, CIRCULATION, V119, P515, DOI 10.1161/CIRCULATIONAHA.108.812172; Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i09, DOI 10.18637/JSS.V011.I09]; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mosterd A, 2007, HEART, V93, P1137, DOI 10.1136/hrt.2003.025270; Motiwala SR, 2014, CLIN CHEM, V60, P35, DOI 10.1373/clinchem.2013.202531; Myers J, 2014, INT J CARDIOL, V171, P265, DOI 10.1016/j.ijcard.2013.12.031; Nkuipou-Kenfack E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096955; Ouwerkerk W, 2014, JACC-HEART FAIL, V2, P429, DOI 10.1016/j.jchf.2014.04.006; Peterman S, 2014, PROTEOMICS, V14, P1445, DOI 10.1002/pmic.201300300; Petrik V, 2008, CLIN CHEM, V54, P713, DOI 10.1373/clinchem.2007.096792; Rahimi K, 2014, JACC-HEART FAIL, V2, P440, DOI 10.1016/j.jchf.2014.04.008; Thulasiraman V, 2005, ELECTROPHORESIS, V26, P3561, DOI 10.1002/elps.200500147; Vermaat JS, 2010, ANN ONCOL, V21, P1472, DOI 10.1093/annonc/mdp559	28	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0119265	10.1371/journal.pone.0119265	http://dx.doi.org/10.1371/journal.pone.0119265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905469	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000004
J	Melcer, T; Danielewska, ME; Iskander, DR				Melcer, Tomasz; Danielewska, Monika E.; Iskander, D. Robert			Wavelet Representation of the Corneal Pulse for Detecting Ocular Dicrotism	PLOS ONE			English	Article							INDENTATION PULSE; TIME-FREQUENCY; SYSTEM	Purpose To develop a reliable and powerful method for detecting the ocular dicrotism from non-invasively acquired signals of corneal pulse without the knowledge of the underlying cardiopulmonary information present in signals of ocular blood pulse and the electrical heart activity. Methods Retrospective data from a study on glaucomatous and age-related changes in corneal pulsation [PLOS ONE 9(7),(2014):e102814] involving 261 subjects was used. Continuous wavelet representation of the signal derivative of the corneal pulse was considered with a complex Gaussian derivative function chosen as mother wavelet. Gray-level Co-occurrence Matrix has been applied to the image (heat-maps) of CWT to yield a set of parameters that can be used to devise the ocular dicrotic pulse detection schemes based on the Conditional Inference Tree and the Random Forest models. The detection scheme was first tested on synthetic signals resembling those of a dicrotic and a non-dicrotic ocular pulse before being used on all 261 real recordings. Results A detection scheme based on a single feature of the Continuous Wavelet Transform of the corneal pulse signal resulted in a low detection rate. Conglomeration of a set of features based on measures of texture (homogeneity, correlation, energy, and contrast) resulted in a high detection rate reaching 93%. Conclusion It is possible to reliably detect a dicrotic ocular pulse from the signals of corneal pulsation without the need of acquiring additional signals related to heart activity, which was the previous state-of-the-art. The proposed scheme can be applied to other non-stationary biomedical signals related to ocular dynamics.	[Melcer, Tomasz; Danielewska, Monika E.; Iskander, D. Robert] Wroclaw Univ Technol, Dept Biomed Engn, PL-50370 Wroclaw, Poland	Wroclaw University of Science & Technology	Melcer, T (corresponding author), Wroclaw Univ Technol, Dept Biomed Engn, PL-50370 Wroclaw, Poland.	tomasz.melcer@pwr.edu.pl	Iskander, D Robert/E-3576-2017	Iskander, D Robert/0000-0002-5962-6206				Aha D.W., 1996, LEARNING DATALECTURE, P199, DOI DOI 10.1007/978-1-4612-2404-4_19; Asejczyk-Widlicka M, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-30; Boudaoud S, 2005, IEEE T SIGNAL PROCES, V53, P3644, DOI 10.1109/TSP.2005.855106; Bracic M, 1998, B MATH BIOL, V60, P919, DOI 10.1006/bulm.1998.0047; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Christopoulos C, 2000, IEEE T CONSUM ELECTR, V46, P1103, DOI 10.1109/30.920468; COHEN L, 1989, P IEEE, V77, P941, DOI 10.1109/5.30749; Danielewska ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102814; Danielewska ME, 2014, OPTOMETRY VISION SCI, V91, P54, DOI 10.1097/OPX.0000000000000113; Danielsson R, 2002, ANAL CHIM ACTA, V454, P167, DOI 10.1016/S0003-2670(01)01574-4; Dion C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054207; Ducla-Soares JL, 2007, EXP PHYSIOL, V92, P677, DOI 10.1113/expphysiol.2007.038026; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Elsheikh A, 2007, CURR EYE RES, V32, P11, DOI 10.1080/02713680601077145; Evans DW, 2002, GRAEF ARCH CLIN EXP, V240, P475, DOI 10.1007/s00417-002-0460-4; Gargour C, 2009, IEEE CIRC SYST MAG, V9, P57, DOI 10.1109/MCAS.2009.932556; GROSSMANN A, 1986, ANN I H POINCARE-PHY, V45, P293; Grunwald JE, 1998, ARCH OPHTHALMOL-CHIC, V116, P150; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; HORVEN I, 1972, NEUROLOGY, V22, P92, DOI 10.1212/WNL.22.1.92; HORVEN I, 1971, ARCH OPHTHALMOL-CHIC, V86, P5, DOI 10.1001/archopht.1971.01000010007002; Hothorn T, 2014, TECHNICAL REPORT; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Kasprzak HT, 2007, EYE, V21, P1212, DOI 10.1038/sj.eye.6702578; Kim M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097943; Kowalska MA, 2011, IEEE T BIO-MED ENG, V58, P674, DOI 10.1109/TBME.2010.2100819; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Licznerski TJ, 2011, ULTRASONICS, V51, P960, DOI 10.1016/j.ultras.2011.05.011; Mainardi LT, 2009, PHILOS T R SOC A, V367, P255, DOI 10.1098/rsta.2008.0188; MEADOWS WR, 1971, AM HEART J, V82, P596, DOI 10.1016/0002-8703(71)90328-0; NORTHROP RB, 1977, IEEE T BIO-MED ENG, V24, P139, DOI 10.1109/TBME.1977.326118; ORCHARD RC, 1980, CIRCULATION, V62, P1107, DOI 10.1161/01.CIR.62.5.1107; Pallikaris IG, 2005, INVEST OPHTH VIS SCI, V46, P409, DOI 10.1167/iovs.04-0162; Ravalico G, 1996, INVEST OPHTH VIS SCI, V37, P2645; SAKOE H, 1978, IEEE T ACOUST SPEECH, V26, P43, DOI 10.1109/TASSP.1978.1163055; SMITH D, 1986, BRIT HEART J, V56, P531; Unser M, 1996, P IEEE, V84, P626, DOI 10.1109/5.488704; Zeitz O, 2006, BRIT J OPHTHALMOL, V90, P1245, DOI 10.1136/bjo.2006.093633; ZUCKERMAN JL, 1977, INVEST OPHTH VIS SCI, V16, P1018	40	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124721	10.1371/journal.pone.0124721	http://dx.doi.org/10.1371/journal.pone.0124721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906236	Green Submitted, Green Published, gold			2022-12-27	WOS:000353332000083
J	Zieminska, K; Westoby, M; Wright, IJ				Zieminska, Kasia; Westoby, Mark; Wright, Ian J.			Broad Anatomical Variation within a Narrow Wood Density Range-A Study of Twig Wood across 69 Australian Angiosperms	PLOS ONE			English	Article							EMBOLISM REPAIR; SAPWOOD CAPACITANCE; JAPANESE HARDWOODS; XYLEM EMBOLISM; TRAITS; TREES; BIOMECHANICS; DIMENSIONS; STORAGE; STEMS	Objectives Just as people with the same weight can have different body builds, woods with the same wood density can have different anatomies. Here, our aim was to assess the magnitude of anatomical variation within a restricted range of wood density and explore its potential ecological implications. Methods Twig wood of 69 angiosperm tree and shrub species was analyzed. Species were selected so that wood density varied within a relatively narrow range (0.38- 0.62 g cm(-3)). Anatomical traits quantified included wood tissue fractions (fibres, axial parenchyma, ray parenchyma, vessels, and conduits with maximum lumen diameter below 15 mu m), vessel properties, and pith area. To search for potential ecological correlates of anatomical variation the species were sampled across rainfall and temperature contrasts, and several other ecologically-relevant traits were measured (plant height, leaf area to sapwood area ratio, and modulus of elasticity). Results Despite the limited range in wood density, substantial anatomical variation was observed. Total parenchyma fraction varied from 0.12 to 0.66 and fibre fraction from 0.20 to 0.74, and these two traits were strongly inversely correlated (r = -0.86, P < 0.001). Parenchyma was weakly (0.24 <= |r| <= 0.35, P < 0.05) or not associated with vessel properties nor with height, leaf area to sapwood area ratio, and modulus of elasticity (0.24 <= |r| <= 0.41, P < 0.05). However, vessel traits were fairly well correlated with height and leaf area to sapwood area ratio (0.47 <= |r| <= 0.65, all P < 0.001). Modulus of elasticity was mainly driven by fibre wall plus vessel wall fraction rather than by the parenchyma component. Conclusions Overall, there seem to be at least three axes of variation in xylem, substantially independent of each other: a wood density spectrum, a fibre-parenchyma spectrum, and a vessel area spectrum. The fibre-parenchyma spectrum does not yet have any clear or convincing ecological interpretation.	[Zieminska, Kasia; Westoby, Mark; Wright, Ian J.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia	Macquarie University	Zieminska, K (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	kasia.s.zieminska@gmail.com	Wright, Ian J/G-4979-2012; Yang, Da/L-6267-2013	Wright, Ian J/0000-0001-8338-9143; Yang, Da/0000-0001-7306-3289; Westoby, Mark/0000-0001-7690-4530	International Macquarie University; James Cook University	International Macquarie University; James Cook University	This study was funded by an International Macquarie University Research Excellence Scholarship awarded to Kasia Zieminska. Work at the Daintree Rainforest Observatory was sponsored by a James Cook University student grant awarded jointly to Kasia Zieminska and Julieta Rosell (for two separate projects). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameglio T, 2004, TREE PHYSIOL, V24, P785, DOI 10.1093/treephys/24.7.785; [Anonymous], 2009, GLOBAL WOOD DENSITY; BEERY WH, 1983, WOOD FIBER SCI, V15, P395; Brodersen CR, 2010, PLANT PHYSIOL, V154, P1088, DOI 10.1104/pp.110.162396; Burgert I, 2001, TREES-STRUCT FUNCT, V15, P168, DOI 10.1007/s004680000086; Carlquist S., 2001, COMP WOOD ANATOMY; Chapotin SM, 2006, AM J BOT, V93, P1251, DOI 10.3732/ajb.93.9.1251; CHATTAWAY MM, 1949, AUST J SCI RES SER B, V2, P227; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Cochard H, 2015, PLANT CELL ENVIRON, V38, P201, DOI 10.1111/pce.12391; Delzon S, 2014, NEW PHYTOL, V203, P355, DOI 10.1111/nph.12798; Evert RF., 2006, ESAUS PLANT ANATOMY, DOI [10.1002/0470047380, DOI 10.1002/0470047380]; Fan ZX, 2012, J ECOL, V100, P732, DOI 10.1111/j.1365-2745.2011.01939.x; Fichtler E, 2012, IAWA J, V33, P119, DOI 10.1163/22941932-90000084; Fortunel C, 2014, NEW PHYTOL, V202, P79, DOI 10.1111/nph.12632; FUJIWARA S, 1991, IAWA BULL, V12, P419, DOI 10.1163/22941932-90000544; FUJIWARA S, 1992, IAWA BULL, V13, P397, DOI 10.1163/22941932-90001295; GERLACH D., 1972, ZARYS MIKROTECHNIKI; GORDON R, 1987, J THEOR BIOL, V126, P419, DOI 10.1016/S0022-5193(87)80149-2; Grime J.P., 2006, PLANT STRATEGIES VEG; Grote K.H., 2009, SPRINGER HDB MECH EN, V1st; Grubb Peter J., 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P3, DOI 10.1078/1433-8319-00049; Hepworth DG, 2002, PHILOS T ROY SOC A, V360, P255, DOI 10.1098/rsta.2001.0927; Holbrook N. Michelle, 1995, P151; IAWA Committee, 1989, IAWA B N S, V10, P219, DOI DOI 10.1163/22941932-90000496; Jacobsen AL, 2007, J ECOL, V95, P171, DOI 10.1111/j.1365-2745.2006.01186.x; Martinez-Cabrera HI, 2011, AM J BOT, V98, P915, DOI 10.3732/ajb.1000335; Martinez-Cabrera HI, 2009, AM J BOT, V96, P1388, DOI 10.3732/ajb.0800237; Meinzer FC, 2003, PLANT CELL ENVIRON, V26, P1147, DOI 10.1046/j.1365-3040.2003.01039.x; Meinzer FC, 2008, TREE PHYSIOL, V28, P1609, DOI 10.1093/treephys/28.11.1609; Mitchell P, 2008, OECOLOGIA, V158, P385, DOI 10.1007/s00442-008-1152-5; Myers JA, 2007, J ECOL, V95, P383, DOI 10.1111/j.1365-2745.2006.01207.x; Nardini A, 2011, PLANT SCI, V180, P604, DOI 10.1016/j.plantsci.2010.12.011; Onoda Y, 2010, NEW PHYTOL, V185, P493, DOI 10.1111/j.1469-8137.2009.03088.x; Poorter L, 2010, NEW PHYTOL, V185, P481, DOI 10.1111/j.1469-8137.2009.03092.x; Pratt RB, 2007, NEW PHYTOL, V174, P787, DOI 10.1111/j.1469-8137.2007.02061.x; Rana R, 2009, TREES-STRUCT FUNCT, V23, P521, DOI 10.1007/s00468-008-0298-4; Richards AE, 2014, FUNCT ECOL, V28, P734, DOI 10.1111/1365-2435.12193; Rodriguez-Perez MA, 2011, J APPL POLYM SCI, V121, P2324, DOI 10.1002/app.33946; Romero C, 2008, CAN J FOREST RES, V38, P611, DOI 10.1139/X07-205; Rosell JA, 2014, NEW PHYTOL, V201, P486, DOI 10.1111/nph.12541; Salleo S, 2004, PLANT CELL ENVIRON, V27, P1065, DOI 10.1111/j.1365-3040.2004.01211.x; Scholz FG, 2007, PLANT CELL ENVIRON, V30, P236, DOI 10.1111/j.1365-3040.2006.01623.x; Secchi F, 2011, PLANT CELL ENVIRON, V34, P514, DOI 10.1111/j.1365-3040.2010.02259.x; SHIGO AL, 1984, ANNU REV PHYTOPATHOL, V22, P189, DOI 10.1146/annurev.py.22.090184.001201; Smith DM, 1967, 79 FPL US FOR SERV, V79; Sperry J, 2013, PLANT CELL ENVIRON, V36, P1916, DOI 10.1111/pce.12148; SPERRY JS, 1994, ECOLOGY, V75, P1736, DOI 10.2307/1939633; Spicer R, 2014, J EXP BOT, V65, P1829, DOI 10.1093/jxb/ert459; Torres-Ruiz JM, 2015, PLANT PHYSIOL, V167, P40, DOI 10.1104/pp.114.249706; Trifilo P, 2014, PLANT CELL ENVIRON, V37, P2491, DOI 10.1111/pce.12313; Trifilo P, 2014, TREE PHYSIOL, V34, P109, DOI 10.1093/treephys/tpt119; Tyree MT, 2002, XYLEM STRUCTURE AND; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Wheeler JK, 2013, PLANT CELL ENVIRON, V36, P1938, DOI 10.1111/pce.12139; Woodrum CL, 2003, AM J BOT, V90, P693, DOI 10.3732/ajb.90.5.693; Zanne AE, 2010, AM J BOT, V97, P207, DOI 10.3732/ajb.0900178; Zheng JM, 2013, ANN BOT-LONDON, V112, P927, DOI 10.1093/aob/mct153; Zieminska K, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt046; Zimmermann MH, 1979, IAWA B, V2-3, P51; Zwieniecki MA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00265	61	48	50	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124892	10.1371/journal.pone.0124892	http://dx.doi.org/10.1371/journal.pone.0124892			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906320	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000092
J	Ferreira, CEL; Luiz, OJ; Floeter, SR; Lucena, MB; Barbosa, MC; Rocha, CR; Rocha, LA				Ferreira, Carlos E. L.; Luiz, Osmar J.; Floeter, Sergio R.; Lucena, Marcos B.; Barbosa, Moyses C.; Rocha, Claudia R.; Rocha, Luiz A.			First Record of Invasive Lionfish (Pterois volitans) for the Brazilian Coast	PLOS ONE			English	Article							WESTERN ATLANTIC; FISH; SPP.; PATTERNS; INSIGHTS	The invasion of the northwestern Atlantic by the Indo-Pacific lionfish has developed extraordinarily fast, and is expected to cause one of the most negative ecological impacts among all marine invasions. In less than 30 years, lionfish have dramatically expanded their distribution range to an area encompassing the eastern coast of the USA, Bermuda, the entire Caribbean region and the Gulf of Mexico. The rapidity of the lionfish spread has raised concerns in other parts of the Atlantic that may be under the reach of the invasion. Despite the anticipation that lionfish would eventually extend their range throughout most of the eastern coast of South America, it had not been recorded in Brazil until now. Here we report the first lionfish appearance for the Brazilian coast and show that the individual collected by us is genetically linked to the invasive Caribbean population. Since small-range endemics are found in several locations in Brazil and are among the species that are most vulnerable to extinction, we recommend urgent control, management and education measures aimed at minimizing the effects of this impending invasion.	[Ferreira, Carlos E. L.; Lucena, Marcos B.; Barbosa, Moyses C.] Univ Fed Fluminense, Dept Biol Marinha, Niteroi, RJ, Brazil; [Luiz, Osmar J.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Floeter, Sergio R.] Univ Fed Santa Catarina, Dept Ecol & Zool, Florianopolis, SC, Brazil; [Rocha, Claudia R.; Rocha, Luiz A.] Calif Acad Sci, San Francisco, CA 94118 USA; [Rocha, Luiz A.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	Universidade Federal Fluminense; Macquarie University; Universidade Federal de Santa Catarina (UFSC); California Academy of Sciences; University of California System; University of California Santa Cruz	Rocha, LA (corresponding author), Calif Acad Sci, San Francisco, CA 94118 USA.	LRocha@calacademy.org	Rocha, Luiz/T-6326-2019; Floeter, S. R./B-1438-2012; Barbosa, Moysés/AAA-9096-2022	Floeter, S. R./0000-0002-3201-6504; Barbosa, Moysés/0000-0001-8842-2619; Rocha, Luiz/0000-0003-4011-569X; Ferreira, Carlos Eduardo/0000-0002-4311-0491	California Academy of Sciences; CNPQ (Brazilian National Research Agency); FAPERJ (Rio de Janeiro State research funding agency); ECOHUB (Brazilian ecological research funding agency)	California Academy of Sciences; CNPQ (Brazilian National Research Agency)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Rio de Janeiro State research funding agency)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); ECOHUB (Brazilian ecological research funding agency)	Financial support was provided by the California Academy of Sciences, CNPQ (Brazilian National Research Agency), FAPERJ (Rio de Janeiro State research funding agency) and ECOHUB (Brazilian ecological research funding agency).	Albins MA, 2013, ENVIRON BIOL FISH, V96, P1151, DOI 10.1007/s10641-011-9795-1; Betancur-R R, 2011, J BIOGEOGR, V38, P1281, DOI 10.1111/j.1365-2699.2011.02496.x; Claydon JAB, 2012, MAR ECOL PROG SER, V448, P119, DOI 10.3354/meps09534; Cote IM, 2014, PEERJ PREPRINTS, V2, DOI [DOI 10.7287/PEERJ.PREPRINTS.398V1, 10.7287/peerj.preprints.398v1]; Cote IM, 2013, BIOL CONSERV, V164, P50, DOI 10.1016/j.biocon.2013.04.014; de Leon R, 2013, ENDANGER SPECIES RES, V22, P175, DOI 10.3354/esr00542; Sampaio FDF, 2013, MAR POLICY, V42, P280, DOI 10.1016/j.marpol.2013.03.009; Frazer TK, 2012, REV FISH SCI, V20, P185, DOI 10.1080/10641262.2012.700655; Halpern BS, 2008, MAR ECOL PROG SER, V364, P147, DOI 10.3354/meps07553; Hamner RM, 2007, J FISH BIOL, V71, P214, DOI 10.1111/j.1095-8649.2007.01575.x; Jud ZR, 2015, ENVIRON BIOL FISH, V98, P135, DOI 10.1007/s10641-014-0242-y; Jud ZR, 2012, J EXP MAR BIOL ECOL, V414, P69, DOI 10.1016/j.jembe.2012.01.015; Kulbicki M, 2012, MAR ECOL PROG SER, V446, P189, DOI 10.3354/meps09442; Luiz OJ, 2013, MAR ECOL PROG SER, V485, P1, DOI 10.3354/meps10383; Rocha LA, 2003, J BIOGEOGR, V30, P1161, DOI 10.1046/j.1365-2699.2003.00900.x; Schofield PJ, 2010, AQUAT INVASIONS, V5, pS117, DOI 10.3391/ai.2010.5.S1.024; Valdez-Moreno M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036636	17	93	96	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123002	10.1371/journal.pone.0123002	http://dx.doi.org/10.1371/journal.pone.0123002			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901361	Green Submitted, Green Published, gold			2022-12-27	WOS:000353331500036
J	Iikura, M; Hojo, M; Koketsu, R; Watanabe, S; Sato, A; Chino, H; Ro, S; Masaki, H; Hirashima, J; Ishii, S; Naka, G; Takasaki, J; Izumi, S; Kobayashi, N; Yamaguchi, S; Nakae, S; Sugiyama, H				Iikura, Motoyasu; Hojo, Masayuki; Koketsu, Rikiya; Watanabe, Sho; Sato, Ayano; Chino, Haruka; Ro, Shoki; Masaki, Haruna; Hirashima, Junko; Ishii, Satoru; Naka, Go; Takasaki, Jin; Izumi, Shinyu; Kobayashi, Nobuyuki; Yamaguchi, Sachiko; Nakae, Susumu; Sugiyama, Haruhito			The Importance of Bacterial and Viral Infections Associated with Adult Asthma Exacerbations in Clinical Practice	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; TOLL-LIKE RECEPTOR-4; BRONCHIAL-ASTHMA; LUNG-DISEASES; RHINOVIRUS; RISK; ACTIVATION; EXPRESSION; CHILDREN; CELLS	Background Viral infection is one of the risk factors for asthma exacerbation. However, which pathogens are related to asthma exacerbation in adults remains unclear. Objective The relation between various infections and adult asthma exacerbations was investigated in clinical practice. Methods The study subjects included 50 adult inpatients due to asthma exacerbations and 20 stable outpatients for comparison. The pathogens from a nasopharyngeal swab were measured by multiplex PCR analysis. Results Asthma exacerbations occurred after a common cold in 48 inpatients. The numbers of patients with viral, bacterial, or both infections were 16, 9, and 9, respectively. The dominant viruses were rhinoviruses, respiratory syncytial virus, influenza virus, and metapneumovirus. The major bacteria were S. pneumoniae and H. influenzae. Compared to pathogen-free patients, the patients with pathogens were older and non-atopic and had later onset of disease, lower FeNO levels, lower IgE titers, and a higher incidence of comorbid sinusitis, COPD, or pneumonia. Compared to stable outpatients, asthma exacerbation inpatients had a higher incidence of smoking and comorbid sinusitis, COPD, or pneumonia. Viruses were detected in 50% of stable outpatients, but a higher incidence of rhinovirus, respiratory syncytial virus, and metapneumovirus infections was observed in asthma exacerbation inpatients. H. influenzae was observed in stable asthmatic patients. Other bacteria, especially S. pneumoniae, were important in asthma exacerbation inpatients. Conclusion Viral or bacterial infections were observed in 70% of inpatients with an asthma exacerbation in clinical practice. Infection with S. pneumoniae was related to adult asthma exacerbation.	[Iikura, Motoyasu; Hojo, Masayuki; Koketsu, Rikiya; Watanabe, Sho; Sato, Ayano; Chino, Haruka; Ro, Shoki; Masaki, Haruna; Hirashima, Junko; Ishii, Satoru; Naka, Go; Takasaki, Jin; Izumi, Shinyu; Kobayashi, Nobuyuki; Sugiyama, Haruhito] Natl Ctr Global Hlth & Med, Dept Resp Med, Tokyo, Japan; [Yamaguchi, Sachiko; Nakae, Susumu] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Syst Biol, Tokyo, Japan; [Nakae, Susumu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan	National Center for Global Health & Medicine - Japan; University of Tokyo; Japan Science & Technology Agency (JST)	Iikura, M (corresponding author), Natl Ctr Global Hlth & Med, Dept Resp Med, Tokyo, Japan.	iikura-tky@umin.ac.jp		Kitazawa, Haruna/0000-0001-7234-1275	National Center for Global Health and Medicine [22-120]; Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by a grant from the National Center for Global Health and Medicine (22-120 MI) and Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency (SN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, THORAX, V69, P1; Barnes PJ, 2005, EUR RESPIR J, V25, P552, DOI 10.1183/09031936.05.00117504; Beale J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009124; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Busse WW, 2007, EXPERT PANEL REPORT; Denlinger LC, 2011, AM J RESP CRIT CARE, V184, P1007, DOI 10.1164/rccm.201103-0585OC; Dickson RP, 2014, LANCET, V384, P691, DOI 10.1016/S0140-6736(14)61136-3; Drake Matthew G., 2012, Inflammation & Allergy Drug Targets, V11, P484; FitzGerald M, 2012, GLOBAL STRATEGY ASTH; HAHN DL, 1991, JAMA-J AM MED ASSOC, V266, P225, DOI 10.1001/jama.266.2.225; Hakonarson H, 1998, J CLIN INVEST, V102, P1732, DOI 10.1172/JCI4141; Iikura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068290; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Kvarnhammar AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068701; Legatzki A, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0466-0; Lieberman D, 2003, AM J RESP CRIT CARE, V167, P406, DOI 10.1164/rccm.200209-996OC; Matsumoto K, 2014, RESPIR INVESTIG, V52, P92, DOI 10.1016/j.resinv.2013.08.005; Mukhopadhyay S, 2014, RESPIROLOGY, V19, P508, DOI 10.1111/resp.12285; Nagase H, 2003, J IMMUNOL, V171, P3977, DOI 10.4049/jimmunol.171.8.3977; Ohta K, 2014, ALLERGOL INT, V63, P293, DOI 10.2332/allergolint.14-RAI-0766; Okimoto N, 2005, INTERNAL MED, V44, P79, DOI 10.2169/internalmedicine.44.79; Okumura S, 2003, BLOOD, V102, P2547, DOI 10.1182/blood-2002-12-3929; Papadopoulos NG, 2011, ALLERGY, V66, P458, DOI 10.1111/j.1398-9995.2010.02505.x; Papi A, 2000, J ALLERGY CLIN IMMUN, V105, P318, DOI 10.1016/S0091-6749(00)90082-4; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Soto-Quiros M, 2012, J ALLERGY CLIN IMMUN, V129, P1499, DOI 10.1016/j.jaci.2012.03.040; Tal G, 2004, J INFECT DIS, V189, P2057, DOI 10.1086/420830; Thomson NC, 2004, EUR RESPIR J, V24, P822, DOI 10.1183/09031936.04.00039004; Wark PAB, 2002, EUR RESPIR J, V19, P68, DOI 10.1183/09031936.02.00226302	30	55	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123584	10.1371/journal.pone.0123584	http://dx.doi.org/10.1371/journal.pone.0123584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901797	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500055
J	Melia, U; Vallverdu, M; Borrat, X; Valencia, JF; Jospin, M; Jensen, EW; Gambus, P; Caminal, P				Melia, Umberto; Vallverdu, Montserrat; Borrat, Xavier; Valencia, Jose Fernando; Jospin, Mathieu; Jensen, Erik Weber; Gambus, Pedro; Caminal, Pere			Prediction of Nociceptive Responses during Sedation by Linear and Non-Linear Measures of EEG Signals in High Frequencies	PLOS ONE			English	Article							AUTONOMIC INFORMATION-FLOW; AUDITORY-EVOKED POTENTIALS; BISPECTRAL INDEX; HEART-RATE; TIME-SERIES; DEPTH; PROPOFOL; ANESTHESIA; ENTROPY; ELECTROENCEPHALOGRAM	The level of sedation in patients undergoing medical procedures evolves continuously, affected by the interaction between the effect of the anesthetic and analgesic agents and the pain stimuli. The monitors of depth of anesthesia, based on the analysis of the electroencephalogram (EEG), have been progressively introduced into the daily practice to provide additional information about the state of the patient. However, the quantification of analgesia still remains an open problem. The purpose of this work is to improve the prediction of nociceptive responses with linear and non-linear measures calculated from EEG signal filtered in frequency bands higher than the traditional bands. Power spectral density and auto-mutual information function was applied in order to predict the presence or absence of the nociceptive responses to different stimuli during sedation in endoscopy procedure. The proposed measures exhibit better performances than the bispectral index (BIS). Values of prediction probability of P-k above 0.75 and percentages of sensitivity and specificity above 70% were achieved combining EEG measures from the traditional frequency bands and higher frequency bands.	[Melia, Umberto; Vallverdu, Montserrat; Caminal, Pere] Univ Politecn Cataluna, Dept ESAII, E-08028 Barcelona, Spain; [Melia, Umberto; Vallverdu, Montserrat; Jensen, Erik Weber; Caminal, Pere] Biomed Engn Res Ctr, Barcelona 08028, Spain; [Melia, Umberto; Vallverdu, Montserrat; Caminal, Pere] CIBER BBN, Barcelona 08028, Spain; [Borrat, Xavier; Gambus, Pedro] Hosp CLINIC Barcelona, Dept Anesthesiol, Syst Pharmacol Effect Control & Modeling SPEC M R, Barcelona, Spain; [Borrat, Xavier; Gambus, Pedro] Inst Invest Biomed August Pi Sunyer IDIBAPS, Neuroimmunol Res Program, Barcelona, Spain; [Valencia, Jose Fernando] Univ San Buenaventura, Dept Elect Engn, Cali, Colombia; [Jospin, Mathieu] Quantium Med SL, R&D Dept, Mataro, Spain; [Gambus, Pedro] Univ Calif San Francisco, Dept Anesthesia & Perioperat Med, San Francisco, CA 94143 USA	Universitat Politecnica de Catalunya; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of California System; University of California San Francisco	Melia, U (corresponding author), Univ Politecn Cataluna, Dept ESAII, Pau Gargallo 5, E-08028 Barcelona, Spain.	umberto.melia@upc.edu	Gambus, Pedro/AAF-1278-2020	Gambus, Pedro/0000-0001-8802-6237; borrat, xavier/0000-0002-9348-9284; Melia, Umberto/0000-0003-3033-0505; Valencia, Jose Fernando/0000-0003-2997-2121	CICYT [TEC2010-20886]; Spanish Government [FPU AP2009-0858]; End of Residency Award of Hospital CLINIC de Barcelona; FIS (Fondo de Investigaciones Sanitarias, Health Department, Government of Spain) [PI/050072, PS09/01209]	CICYT(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Spanish Government(Spanish GovernmentEuropean Commission); End of Residency Award of Hospital CLINIC de Barcelona; FIS (Fondo de Investigaciones Sanitarias, Health Department, Government of Spain)	CICYT grant TEC2010-20886, the Research Fellowship Grant FPU AP2009-0858 from the Spanish Government, the End of Residency Award of Hospital CLINIC de Barcelona (XB) and the FIS (Fondo de Investigaciones Sanitarias, Health Department, Government of Spain) grants no PI/050072 and PS09/01209 (PLG). The authors confirm that Quantium Medical only provided support in the form of salaries for authors MJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acharya UR, 2011, INT J NEURAL SYST, V21, P403, DOI 10.1142/S0129065711002912; Andrzejak RG, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.061907; ANTOGNINI JF, 1993, ANESTHESIOLOGY, V79, P1244, DOI 10.1097/00000542-199312000-00015; Becker K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008876; Bouillon TW, 2004, ANESTHESIOLOGY, V100, P1353, DOI 10.1097/00000542-200406000-00006; Bruhn J, 2000, ANESTHESIOLOGY, V92, P715, DOI 10.1097/00000542-200003000-00016; Chan MTV, 2013, J NEUROSURG ANESTH, V25, P33, DOI 10.1097/ANA.0b013e3182712fba; CHANG TL, 1988, ANESTH ANALG, V67, P521; Ching SN, 2010, P NATL ACAD SCI USA, V107, P22665, DOI 10.1073/pnas.1017069108; Chisholm CJ, 2006, MAYO CLIN PROC, V81, P46, DOI 10.4065/81.1.46; COHEN BA, 1977, MED BIOL ENG COMPUT, V15, P513, DOI 10.1007/BF02442278; COLLINS JG, 1995, TRENDS NEUROSCI, V18, P549, DOI 10.1016/0166-2236(95)98377-B; ECKMANN JP, 1992, PHYSICA D, V56, P185, DOI 10.1016/0167-2789(92)90023-G; Escudero J, 2009, PHYSIOL MEAS, V30, P187, DOI 10.1088/0967-3334/30/2/006; Ferenets R, 2007, ANESTHESIOLOGY, V106, P696, DOI 10.1097/01.anes.0000264790.07231.2d; Ferenets R, 2006, IEEE T BIO-MED ENG, V53, P1067, DOI 10.1109/TBME.2006.873543; Feshchenko VA, 2004, NEUROPSYCHOBIOLOGY, V50, P257, DOI 10.1159/000079981; Gambus PL, 2011, ANESTH ANALG, V112, P331, DOI 10.1213/ANE.0b013e3182025a70; Gifani P, 2007, J FRANKLIN I, V344, P212, DOI 10.1016/j.jfranklin.2006.08.004; Gill M, 2003, ANN EMERG MED, V41, P234, DOI 10.1067/mem.2003.53; Gray CM, 1996, SCIENCE, V274, P109, DOI 10.1126/science.274.5284.109; Gugino LA, 2001, BRIT J ANAESTH, V87, P421, DOI 10.1093/bja/87.3.421; Hindriks R, 2012, NEUROIMAGE, V60, P2323, DOI 10.1016/j.neuroimage.2012.02.042; Hoyer D, 2006, COMPUT METH PROG BIO, V81, P246, DOI 10.1016/j.cmpb.2006.01.002; Hoyer D, 2005, IEEE T BIO-MED ENG, V52, P584, DOI 10.1109/TBME.2005.844023; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Jeanne M, 2009, IEEE ENG MED BIO, P1840, DOI 10.1109/IEMBS.2009.5332598; Jensen EW, 1996, METHOD INFORM MED, V35, P256; Jeong J, 2001, CLIN NEUROPHYSIOL, V112, P827, DOI 10.1016/S1388-2457(01)00513-2; Jing H, 2000, BIOL CYBERN, V83, P391, DOI 10.1007/s004220000183; Jospin M, 2007, IEEE T BIO-MED ENG, V54, P840, DOI 10.1109/TBME.2007.893453; KAWABATA N, 1976, BIOL CYBERN, V22, P235, DOI 10.1007/BF00365089; Kreuer S, 2001, ANAESTHESIST, V50, P921, DOI 10.1007/s00101-001-0242-0; Kreuzer M, 2014, J CLIN MONIT COMPUT, V1, P1; Lalitha V, 2007, J MED SYST, V31, P445, DOI 10.1007/s10916-007-9083-y; Lapierre CD, 2013, SURVEY ANESTHESIOLOG, V57, P104; Leslie K, 2008, BRIT J ANAESTH, V101, P498, DOI 10.1093/bja/aen230; Li XL, 2008, CLIN NEUROPHYSIOL, V119, P2465, DOI 10.1016/j.clinph.2008.08.006; Litvan H, 2002, ANESTHESIOLOGY, V97, P351, DOI 10.1097/00000542-200208000-00011; Luginbuhl M, 2006, BRIT J ANAESTH, V96, P323, DOI 10.1093/bja/aei315; Magagnin V, 2011, PHYSIOL MEAS, V32, P1775, DOI 10.1088/0967-3334/32/11/S05; Mathews DM, 2012, ANESTH ANALG, V114, P759, DOI 10.1213/ANE.0b013e3182455ac2; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; Melia U, 2014, C ME DBIOL ENG COMPU, P623; Melia U, 2014, MUTUAL INFORM MEASUR, DOI [10.1016/j.medengphy.2015.01.002, DOI 10.1016/J.MEDENGPHY.2015.01.002]; Melia U, 2014, MED ENG PHYS, V36, P547, DOI 10.1016/j.medengphy.2013.11.014; Melia U, 2013, IEEE ENG MED BIO, P2547, DOI 10.1109/EMBC.2013.6610059; Pereda E, 1998, NEUROSCI LETT, V250, P91, DOI 10.1016/S0304-3940(98)00435-2; PERSSON J, 1977, IEEE T BIO-MED ENG, V24, P302, DOI 10.1109/TBME.1977.326232; Plattard D, 2000, Comput Aided Surg, V5, P246, DOI 10.3109/10929080009148893; Polson JS, 1996, ANESTHESIOLOGY, V85, pA466; Rampil IJ, 1998, ANESTHESIOLOGY, V89, P980, DOI 10.1097/00000542-199810000-00023; RAMSAY MAE, 1974, BRIT MED J, V2, P656, DOI 10.1136/bmj.2.5920.656; Rantanen M, 2006, BRIT J ANAESTH, V96, P367, DOI 10.1093/bja/ael005; Rautee R, 2004, P ANN INT IEEE EMBS, V26, P3481; Rehman N, 2010, P ROY SOC A-MATH PHY, V466, P1291, DOI 10.1098/rspa.2009.0502; Roca-Gonzalez J, 2009, IFMBE PROC, V22, P1272; SAVOLA MKT, 1991, ANESTHESIOLOGY, V75, P489, DOI 10.1097/00000542-199109000-00017; SIGL JC, 1994, J CLIN MONITOR, V10, P392, DOI 10.1007/BF01618421; Smith WD, 1996, ANESTHESIOLOGY, V84, P38, DOI 10.1097/00000542-199601000-00005; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Storm H, 2008, CURR OPIN ANESTHESIO, V21, P796, DOI 10.1097/ACO.0b013e3283183fe4; THEILER J, 1990, J OPT SOC AM A, V7, P1055, DOI 10.1364/JOSAA.7.001055; Valencia JF, 2012, ASA ANN M WASH DC US; Velly LJ, 2007, ANESTHESIOLOGY, V107, P202, DOI 10.1097/01.anes.0000270734.99298.b4; Viertio-Oja H, 2004, ACTA ANAESTH SCAND, V48, P154, DOI 10.1111/j.0001-5172.2004.00322.x; Wacker M, 2013, METHOD INFORM MED, V52, P279, DOI 10.3414/ME12-01-0083; Walling PT, 2006, ANESTHESIOLOGY, V105, P927, DOI 10.1097/00000542-200611000-00013; WATT RC, 1988, INT J CLIN MONIT COM, V5, P3, DOI 10.1007/BF01739226; Wells III WM, 1995, MED ROBOTICS COMPUTE, V1, P55, DOI [10.1002/ rcs. 369, DOI 10.1002/RCS.369]; Wong KFK, 2006, COMPUT BIOL MED, V36, P1327, DOI 10.1016/j.compbiomed.2005.10.001; YLIHANKALA A, 1994, BRIT J ANAESTH, V73, P174, DOI 10.1093/bja/73.2.174; Zikov T, 2006, IEEE T BIO-MED ENG, V53, P617, DOI 10.1109/TBME.2006.870255	73	6	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123464	10.1371/journal.pone.0123464	http://dx.doi.org/10.1371/journal.pone.0123464			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901571	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500053
J	Raby, GD; Clark, TD; Farrell, AP; Patterson, DA; Bett, NN; Wilson, SM; Willmore, WG; Suski, CD; Hinch, SG; Cooke, SJ				Raby, Graham D.; Clark, Timothy D.; Farrell, Anthony P.; Patterson, David A.; Bett, Nolan N.; Wilson, Samantha M.; Willmore, William G.; Suski, Cory D.; Hinch, Scott G.; Cooke, Steven J.			Facing the River Gauntlet: Understanding the Effects of Fisheries Capture and Water Temperature on the Physiology of Coho Salmon	PLOS ONE			English	Article							RELEASE ANGLING TOURNAMENTS; TROUT ONCORHYNCHUS-MYKISS; ADULT SOCKEYE-SALMON; BRIEF AIR EXPOSURE; EXHAUSTIVE EXERCISE; PACIFIC SALMON; RAINBOW-TROUT; ATLANTIC SALMON; LARGEMOUTH BASS; CLIMATE-CHANGE	An improved understanding of bycatchmortality can be achieved by complementing field studies with laboratory experiments that use physiological assessments. This study examined the effects of water temperature and the duration of net entanglement on physiological disturbance and recovery in coho salmon (Oncorhynchus kisutch) after release from a simulated beach seine capture. Heart rate was monitored using implanted electrocardiogram biologgers that allowed fish to swim freely before and after release. A subset of fish was recovered in respirometers to monitor metabolic recovery, and separate groups of fish were sacrificed at different times to assess blood and white muscle biochemistry. One hour after release, fish had elevated lactate in muscle and blood plasma, depleted tissue energy stores, and altered osmoregulatory status, particularly in warmer (15 vs. 10 degrees C) and longer (15 vs. 2 min) capture treatments. A significant effect of entanglement duration on blood and muscle metabolites remained after 4 h. Oxygen consumption rate recovered to baseline within 7-10 h. However, recovery of heart rate to routine levels was longer and more variable, with most fish taking over 10 h, and 33% of fish failing to recover within 24 h. There were no significant treatment effects on either oxygen consumption or heart rate recovery. Our results indicate that fishers should minimize handling time for bycatch and maximize oxygen supply during crowding, especially when temperatures are elevated. Physiological data, such as those presented here, can be used to understand mechanisms that underlie bycatch impairment and mortality, and thus inform best practices that ensure the welfare and conservation of affected species.	[Raby, Graham D.; Wilson, Samantha M.; Cooke, Steven J.] Carleton Univ, Dept Biol, Fish Ecol & Conservat Physiol Lab, Ottawa, ON K1S 5B6, Canada; [Raby, Graham D.; Wilson, Samantha M.; Cooke, Steven J.] Carleton Univ, Inst Environm Sci, Ottawa, ON K1S 5B6, Canada; [Clark, Timothy D.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Farrell, Anthony P.] Univ British Columbia, Dept Zool, Vancouver, BC V5Z 1M9, Canada; [Patterson, David A.] Simon Fraser Univ, Sch Resource & Environm Management, Cooperat Resource Management Inst, Fisheries & Oceans Canada,Sci Branch,Pacific Reg, Burnaby, BC V5A 1S6, Canada; [Bett, Nolan N.; Hinch, Scott G.] Univ British Columbia, Dept Forest & Conservat Sci, Pacific Salmon Ecol & Conservat Lab, Vancouver, BC V5Z 1M9, Canada; [Willmore, William G.] Carleton Univ, Inst Biochem, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Suski, Cory D.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA	Carleton University; Carleton University; Australian Institute of Marine Science; University of British Columbia; Fisheries & Oceans Canada; Simon Fraser University; University of British Columbia; Carleton University; University of Illinois System; University of Illinois Urbana-Champaign	Raby, GD (corresponding author), Carleton Univ, Dept Biol, Fish Ecol & Conservat Physiol Lab, Ottawa, ON K1S 5B6, Canada.	graham.d.raby@gmail.com	Clark, Timothy Darren/K-7129-2012; Cooke, Steven J/F-4193-2010	Clark, Timothy Darren/0000-0001-8738-3347; Cooke, Steven J/0000-0002-5407-0659; Suski, Cory/0000-0001-8280-873X; Raby, Graham/0000-0002-0549-4017	Natural Sciences and Engineering Research Council of Canada; Ocean Tracking Network Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ocean Tracking Network Canada	Research funding was provided by a Natural Sciences and Engineering Research Council of Canada Strategic Grant ( to SJC, SGH, WGW, and APF) and the Ocean Tracking Network Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WG, 1998, HYDROBIOLOGIA, V372, P233; Baker MR, 2009, J APPL ECOL, V46, P752, DOI 10.1111/j.1365-2664.2009.01673.x; Bradford MJ, 2010, CAN J FISH AQUAT SCI, V67, P673, DOI 10.1139/F10-017; Brett J.R., 1995, PHYSL ECOLOGY PACIFI, P3; Buchanan S, 2002, N AM J FISH MANAGE, V22, P1270, DOI 10.1577/1548-8675(2002)022<1270:RGNMOI>2.0.CO;2; Careau V, 2012, PHYSIOL BIOCHEM ZOOL, V85, P543, DOI 10.1086/666970; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Chopin FS, 1996, FISH RES, V28, P277, DOI 10.1016/0165-7836(96)00512-7; Clark TD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039079; Clark TD, 2011, J EXP BIOL, V214, P3074, DOI 10.1242/jeb.060517; Clark TD, 2009, J COMP PHYSIOL B, V179, P663, DOI 10.1007/s00360-009-0349-1; Colotelo AH, 2013, FISH RES, V137, P41, DOI 10.1016/j.fishres.2012.08.019; Cook KV, 2014, GEN COMP ENDOCR, V202, P44, DOI 10.1016/j.ygcen.2014.04.008; Cooke SJ, 2013, FISHERIES MANAG ECOL, V20, P268, DOI 10.1111/j.1365-2400.2012.00867.x; Cooke SJ, 2005, BIODIVERS CONSERV, V14, P1195, DOI 10.1007/s10531-004-7845-0; Cooke SJ, 2001, N AM J FISH MANAGE, V21, P333, DOI 10.1577/1548-8675(2000)020&lt;1033:EORGOT&gt;2.0.CO;2; Cooke SJ, 2003, T AM FISH SOC, V132, P1154, DOI 10.1577/T02-059; Cooke SJ, 2004, J APPL ICHTHYOL, V20, P28, DOI 10.1111/j.1439-0426.2004.00494.x; Cooke SJ, 2010, CONSERV LETT, V3, P159, DOI 10.1111/j.1755-263X.2010.00109.x; Crozier LG, 2008, EVOL APPL, V1, P252, DOI 10.1111/j.1752-4571.2008.00033.x; Davies RWD, 2009, MAR POLICY, V33, P661, DOI 10.1016/j.marpol.2009.01.003; Davis MW, 2002, CAN J FISH AQUAT SCI, V59, P1834, DOI 10.1139/F02-139; DFO, 2001, POL SEL FISH CAN PAC; Diggles BK, 2011, REV FISH BIOL FISHER, V21, P739, DOI 10.1007/s11160-011-9206-x; Donaldson MR, 2013, CAN J FISH AQUAT SCI, V70, P90, DOI 10.1139/cjfas-2012-0218; Donaldson MR, 2010, PHYSIOL BIOCHEM ZOOL, V83, P973, DOI 10.1086/656336; Donaldson MR, 2014, COMP BIOCHEM PHYS A, V173, P7, DOI 10.1016/j.cbpa.2014.02.019; Farrell AP, 2008, PHYSIOL BIOCHEM ZOOL, V81, P697, DOI 10.1086/592057; Farrell AP, 2001, CAN J FISH AQUAT SCI, V58, P2319, DOI 10.1139/cjfas-58-12-2319; Farrell AP, 2001, CAN J FISH AQUAT SCI, V58, P1932, DOI 10.1139/cjfas-58-10-1932; FERGUSON RA, 1992, CAN J FISH AQUAT SCI, V49, P1157, DOI 10.1139/f92-129; Ferrari MR, 2007, J HYDROL, V342, P336, DOI 10.1016/j.jhydrol.2007.06.002; Field A., 2012, DISCOVERING STAT USI; Gale MK, 2013, FISH FISH, V14, P1, DOI 10.1111/j.1467-2979.2011.00441.x; Gale MK, 2011, FISH RES, V112, P85, DOI 10.1016/j.fishres.2011.08.014; Galloway BJ, 2003, PHYSIOL BIOCHEM ZOOL, V76, P652, DOI 10.1086/376921; Hague MJ, 2011, GLOBAL CHANGE BIOL, V17, P87, DOI 10.1111/j.1365-2486.2010.02225.x; Hinch SG, 2012, J FISH BIOL, V81, P576, DOI 10.1111/j.1095-8649.2012.03360.x; Jain KE, 2003, J EXP BIOL, V206, P3569, DOI 10.1242/jeb.00588; Jeffries KM, 2012, PHYSIOL BIOCHEM ZOOL, V85, P62, DOI 10.1086/663770; Kelleher K., 2005, FAO FISH TECH PAP; Kieffer JD, 2010, COMP BIOCHEM PHYS A, V156, P163, DOI 10.1016/j.cbpa.2010.02.009; Kieffer JD, 2000, COMP BIOCHEM PHYS A, V126, P161, DOI 10.1016/S1095-6433(00)00202-6; Killen SS, 2006, T AM FISH SOC, V135, P557, DOI 10.1577/T05-168.1; Lewison RL, 2004, ECOL LETT, V7, P221, DOI 10.1111/j.1461-0248.2004.00573.x; Macdonald J., 2000, IMPRINT VARIES, P131; Marcalo A, 2006, MAR BIOL, V149, P1509, DOI 10.1007/s00227-006-0277-5; Martins EG, 2012, CAN J FISH AQUAT SCI, V69, P330, DOI 10.1139/F2011-154; Meka JM, 2005, FISH RES, V72, P311, DOI 10.1016/j.fishres.2004.10.006; Miller KM, 2014, EVOL APPL; Milligan CL, 1996, COMP BIOCHEM PHYS A, V113, P51, DOI 10.1016/0300-9629(95)02060-8; O'Connor CM, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00388.1; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Peterman RM, 2010, TECHNICAL REPORT; Piovano S, 2010, BIOL CONSERV, V143, P261, DOI 10.1016/j.biocon.2009.10.001; Raby GD, 2014, ECOL APPL, V24, P1803, DOI 10.1890/13-1885.1; Raby GD, 2012, J APPL ECOL, V49, P90, DOI 10.1111/j.1365-2664.2011.02073.x; Raby GD, 2011, BIOSCIENCE, V61, P271, DOI 10.1525/bio.2011.61.4.7; Robinson KA, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot015; Romero LM, 2001, P NATL ACAD SCI USA, V98, P7366, DOI 10.1073/pnas.131091498; Schreer JF, 2001, T AM FISH SOC, V130, P783, DOI 10.1577/1548-8659(2001)130<0783:CRTVFE>2.0.CO;2; Shultz AD, 2011, J EXP MAR BIOL ECOL, V402, P19, DOI 10.1016/j.jembe.2011.03.009; Suski CD, 2006, J FISH BIOL, V68, P120, DOI 10.1111/j.0022-1112.2006.00882.x; Suski CD, 2007, COMP BIOCHEM PHYS A, V148, P664, DOI 10.1016/j.cbpa.2007.08.018; Wilkie MP, 1997, CAN J FISH AQUAT SCI, V54, P503, DOI 10.1139/cjfas-54-3-503; Wilson SM, 2014, BIOL CONSERV, V171, P61, DOI 10.1016/j.biocon.2014.01.020; WOOD CM, 1983, J FISH BIOL, V22, P189, DOI 10.1111/j.1095-8649.1983.tb04739.x; WOOD CM, 1991, J EXP BIOL, V160, P285	68	29	29	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124023	10.1371/journal.pone.0124023	http://dx.doi.org/10.1371/journal.pone.0124023			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901952	Green Submitted, gold, Green Published			2022-12-27	WOS:000353331500071
J	Song, C; Song, S; Kim, JS; Oh, HK; Kim, DW; Lee, KW; Kim, JH; Eom, KY; Kim, IA; Kang, SB				Song, Changhoon; Song, Sanghyuk; Kim, Jae-Sung; Oh, Heung-Kwon; Kim, Duck-Woo; Lee, Keun-Wook; Kim, Jee Hyun; Eom, Keun-Yong; Kim, In Ah; Kang, Sung-Bum			Impact of Postoperative Chemoradiotherapy versus Chemotherapy Alone on Recurrence and Survival in Patients with Stage II and III Upper Rectal Cancer: A Propensity Score-Matched Analysis	PLOS ONE			English	Article							CIRCUMFERENTIAL RESECTION MARGIN; TOTAL MESORECTAL EXCISION; LOCAL RECURRENCE; PREOPERATIVE RADIOTHERAPY; NEOADJUVANT CHEMORADIOTHERAPY; POOLED ANALYSIS; TERM OUTCOMES; MRC CR07; TRIAL; CARCINOMA	Purpose To compare the impact of postoperative chemoradiotherapy (CRT) versus adjuvant chemotherapy alone on recurrence and survival in patients with stage II and III upper rectal cancer undergoing curative resection. Materials and Methods From our institutional database, 190 patients who underwent primary curative resection between 2003 and 2010 for stage II or III upper rectal cancer were identified. None of the patients received preoperative CRT. Of these, 136 patients received postoperative chemotherapy alone (the CTx group) and 54 patients received postoperative CRT (the CRT group). The CRT group had poorer prognostic features (pT4, pN2, poor differentiation, or involved resection margin) compared with the CTx group. To reduce the impact of treatment selection bias on treatment outcomes, propensity score-matching analysis was used. Results The matched cohort consisted of 50 CRT and 50 CTx patients with a median follow-up period of 76 and 63 months, respectively. In the matched cohort, CRT resulted in an improved 5-year local control (98.0% vs. 85.2%, p = 0.024) and overall survival rate (89.9% vs. 69.8%, p = 0.021) compared with CTx. In the subgroup analysis to identify subpopulations of patients that benefit most from receiving CRT, local recurrence did not occur in patients who did not have poor prognostic features regardless of the receipt of CRT. For patients with any poor prognostic features, CRT resulted in an improved 5-year local control compared with CTx (96.4% vs. 70.7%, p = 0.013). Conclusions After adjusting for clinicopathologic factors by propensity score-matching, postoperative CRT was associated with improved local control and overall survival in stage II and III upper rectal cancer. Our results suggest that surgery followed by chemotherapy alone is acceptable for patients who did not have poor prognostic features, while additional radiotherapy should be given for patients who have any poor prognostic features.	[Song, Changhoon; Song, Sanghyuk; Kim, Jae-Sung; Eom, Keun-Yong; Kim, In Ah] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Radiat Oncol, Songnam, South Korea; [Oh, Heung-Kwon; Kim, Duck-Woo; Kang, Sung-Bum] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Surg, Songnam, South Korea; [Lee, Keun-Wook; Kim, Jee Hyun] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Internal Med, Songnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, JS (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Radiat Oncol, Songnam, South Korea.	jskim@snubh.org	Oh, Heung-Kwon/S-1292-2019	Oh, Heung-Kwon/0000-0002-8066-2367; Song, Changhoon/0000-0002-0714-8775; Kim, Jae-Sung/0000-0001-5348-9178				[Anonymous], 2014, NCCN CLIN PRACT GUID; Beck DE, 2011, ASCRS TEXTBOOK OF COLON AND RECTAL SURGERY, SECOND EDITION, P1, DOI 10.1007/978-1-4419-1584-9; Bernstein TE, 2009, BRIT J SURG, V96, P1348, DOI 10.1002/bjs.6739; Chmielik E, 2006, INT J RADIAT ONCOL, V65, P182, DOI 10.1016/j.ijrobp.2005.11.039; Dent OF, 2011, COLORECTAL DIS, V13, P974, DOI 10.1111/j.1463-1318.2010.02358.x; Edge SB, 2010, AJCC CANC STAGING MA; Engstrom PF, 2009, J NATL COMPR CANC NE, V7, P838, DOI 10.6004/jnccn.2009.0057; Folkesson J, 2005, J CLIN ONCOL, V23, P5644, DOI 10.1200/JCO.2005.08.144; Gunderson LL, 2004, J CLIN ONCOL, V22, P1785, DOI 10.1200/JCO.2004.08.173; Gunderson LL, 2002, INT J RADIAT ONCOL, V54, P386, DOI 10.1016/S0360-3016(02)02945-0; Haviland A, 2007, PSYCHOL METHODS, V12, P247, DOI 10.1037/1082-989X.12.3.247; Jang NY, 2011, DIS COLON RECTUM, V54, P245, DOI 10.1007/DCR.0b013e3181fcee68; Kang SB, 2010, LANCET ONCOL, V11, P637, DOI 10.1016/S1470-2045(10)70131-5; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; Kwak JY, 2012, J GASTROINTEST SURG, V16, P1947, DOI 10.1007/s11605-012-1988-1; Lopez-Kostner F, 1998, SURGERY, V124, P612, DOI 10.1067/msy.1998.91361; Monson JRT, 2013, DIS COLON RECTUM, V56, P535, DOI 10.1097/DCR.0b013e31828cb66c; Mukai M, 2011, ONCOL REP, V26, P737, DOI 10.3892/or.2011.1343; Nagtegaal ID, 2002, AM J SURG PATHOL, V26, P350, DOI 10.1097/00000478-200203000-00009; PILIPSHEN SJ, 1984, CANCER-AM CANCER SOC, V53, P1354, DOI 10.1002/1097-0142(19840315)53:6<1354::AID-CNCR2820530623>3.0.CO;2-J; Polglase AL, 2001, DIS COLON RECTUM, V44, P947, DOI 10.1007/BF02235481; Quirke P, 2009, LANCET, V373, P821, DOI 10.1016/S0140-6736(09)60485-2; Rosenberg R, 2010, DIS COLON RECTUM, V53, P761, DOI 10.1007/DCR.0b013e3181cdb25a; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Schmiegel W, 2010, Z GASTROENTEROL, V48, P65, DOI 10.1055/s-0028-1109936; Sebag-Montefiore D, 2009, LANCET, V373, P811, DOI 10.1016/S0140-6736(09)60484-0; Taylor FGM, 2014, J CLIN ONCOL, V32, P34, DOI 10.1200/JCO.2012.45.3258; Tilney HS, 2009, DIS COLON RECTUM, V52, P1723, DOI 10.1007/DCR.0b013e3181b54fbd; Valentini V, 2011, J CLIN ONCOL, V29, P3163, DOI 10.1200/JCO.2010.33.1595	29	5	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123657	10.1371/journal.pone.0123657	http://dx.doi.org/10.1371/journal.pone.0123657			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902069	gold, Green Published, Green Submitted			2022-12-27	WOS:000353331500058
J	Zheng, C; Zhao, L; Wang, Y; Shen, JZ; Zhang, YF; Jia, SS; Li, YS; Ding, ZT				Zheng, Chao; Zhao, Lei; Wang, Yu; Shen, Jiazhi; Zhang, Yinfei; Jia, Sisi; Li, Yusheng; Ding, Zhaotang			Integrated RNA-Seq and sRNA-Seq Analysis Identifies Chilling and Freezing Responsive Key Molecular Players and Pathways in Tea Plant (Camellia sinensis)	PLOS ONE			English	Article							FALSE DISCOVERY RATE; COLD-ACCLIMATION; LOW-TEMPERATURE; ABIOTIC STRESS; TRANSCRIPTION FACTORS; GENE-EXPRESSION; GENOME-WIDE; MICRORNAS; ARABIDOPSIS; TOLERANCE	Tea [Camellia sinensis (L) O. Kuntze, Theaceae] is one of the most popular non-alcoholic beverages worldwide. Cold stress is one of the most severe abiotic stresses that limit tea plants' growth, survival and geographical distribution. However, the genetic regulatory network and signaling pathways involved in cold stress responses in tea plants remain unearthed. Using RNA-Seq, DGE and sRNA-Seq technologies, we performed an integrative analysis of miRNA and mRNA expression profiling and their regulatory network of tea plants under chilling (4 degrees C) and freezing (-5 degrees C) stress. Differentially expressed (DE) miRNA and mRNA profiles were obtained based on fold change analysis, miRNAs and target mRNAs were found to show both coherent and incoherent relationships in the regulatory network. Furthermore, we compared several key pathways (e.g., 'Photosynthesis'), GO terms (e.g., ` response to karrikin') and transcriptional factors (TFs, e.g., DREB1b/CBF1) which were identified as involved in the early chilling and/or freezing response of tea plants. Intriguingly, we found that karrikins, a new group of plant growth regulators, and beta-primeverosidase (BPR), a key enzyme functionally relevant with the formation of tea aroma might play an important role in both early chilling and freezing response of tea plants. Quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) analysis further confirmed the results from RNA-Seq and sRNA-Seq analysis. This is the first study to simultaneously profile the expression patterns of both miRNAs and mRNAs on a genome-wide scale to elucidate the molecular mechanisms of early responses of tea plants to cold stress. In addition to gaining a deeper insight into the cold resistant characteristics of tea plants, we provide a good case study to analyse mRNA/miRNA expression and profiling of non-model plant species using next-generation sequencing technology.	[Zheng, Chao; Zhao, Lei; Wang, Yu; Shen, Jiazhi; Zhang, Yinfei; Jia, Sisi; Ding, Zhaotang] Qingdao Agr Univ, Tea Res Inst, Qingdao, Shandong, Peoples R China; [Zheng, Chao; Zhao, Lei; Wang, Yu; Shen, Jiazhi; Zhang, Yinfei; Jia, Sisi; Ding, Zhaotang] Key Lab Genet Improvement & Breeding Hort Plants, Qingdao, Shandong, Peoples R China; [Li, Yusheng] Fruit & Tea Technol Extens Stn, Jinan, Shandong, Peoples R China	Qingdao Agricultural University	Ding, ZT (corresponding author), Qingdao Agr Univ, Tea Res Inst, Qingdao, Shandong, Peoples R China.	dzttea@163.com		Zheng, Chao/0000-0002-0290-2177	National Natural Science Foundation of China [31470027]; School Fund Project of Qingdao Agricultural University [631412]; Livelihood Project of Qingdao City [13-1-3-85-nsh]; Breeding Project of Shandong Province [2012LZ12-03, 2013LZ12-03, 2014LZ12-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); School Fund Project of Qingdao Agricultural University; Livelihood Project of Qingdao City; Breeding Project of Shandong Province	This research was supported by the National Natural Science Foundation of China (No. 31470027 to ZD), (School Fund Project of Qingdao Agricultural University, 631412, the Livelihood Project of Qingdao City (No. 13-1-3-85-nsh to ZD) and the Breeding Project of Shandong Province (No. 2012LZ12-03, 2013LZ12-03, 2014LZ12-03 to ZD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad P, 2008, J PLANT BIOL, V51, P167, DOI 10.1007/BF03030694; Akan Das, 2010, American Journal of Plant Sciences, V1, P77, DOI 10.4236/ajps.2010.12010; Barakat A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-481; Barrero-Gil J, 2013, PLANT SCI, V205, P48, DOI 10.1016/j.plantsci.2013.01.008; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhardwaj AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092456; Catala R, 2011, P NATL ACAD SCI USA, V108, P16475, DOI 10.1073/pnas.1107161108; Chen JH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-326; Chen L, 2007, EUPHYTICA, V154, P239, DOI 10.1007/s10681-006-9292-3; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Chitnis VR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087543; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; Curaba J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-120; Dong JX, 2003, PLANT MOL BIOL, V51, P21, DOI 10.1023/A:1020780022549; Du H, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00397; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fan GQ, 2014, BIOCHIMIE, V102, P68, DOI 10.1016/j.biochi.2014.02.008; Fang YJ, 2014, J EXP BOT, V65, P2119, DOI 10.1093/jxb/eru072; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Gomez-Anduro G, 2011, PLANT MOL BIOL, V77, P159, DOI 10.1007/s11103-011-9800-2; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffith M, 2004, TRENDS PLANT SCI, V9, P399, DOI 10.1016/j.tplants.2004.06.007; Guan QM, 2013, PLANT J, V74, P840, DOI 10.1111/tpj.12169; Haas BJ, 2010, NAT BIOTECHNOL, V28, P421, DOI 10.1038/nbt0510-421; Hare PD, 1998, PLANT CELL ENVIRON, V21, P535, DOI 10.1046/j.1365-3040.1998.00309.x; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Huang LB, 2005, ANN BOT-LONDON, V96, P755, DOI 10.1093/aob/mci228; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jain M, 2009, FEBS J, V276, P3148, DOI 10.1111/j.1742-4658.2009.07033.x; Jeon J, 2010, J BIOL CHEM, V285, P23369, DOI 10.1074/jbc.M109.096644; Jeong DH, 2013, J PLANT BIOL, V56, P187, DOI 10.1007/s12374-013-0213-4; Jeyaraj A, 2014, PLANT CELL REP, V33, P1053, DOI 10.1007/s00299-014-1589-4; Kaplan F, 2004, PLANT PHYSIOL, V135, P1674, DOI 10.1104/pp.104.040808; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kuo HF, 2011, PLANT PHYSIOL, V156, P1016, DOI 10.1104/pp.111.175265; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le TD, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-92; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Li XW, 2010, BIOCHEM BIOPH RES CO, V394, P354, DOI 10.1016/j.bbrc.2010.03.011; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039650; Ligterink W, 2001, INT REV CYTOL, V201, P209, DOI 10.1016/S0074-7696(01)01004-X; Lim CW, 2012, PLANT SCI, V187, P83, DOI 10.1016/j.plantsci.2012.01.013; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; LYNCH DV, 1987, PLANT PHYSIOL, V83, P761, DOI 10.1104/pp.83.4.761; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mizutani M, 2002, PLANT PHYSIOL, V130, P2164, DOI 10.1104/pp.102.011023; Mohanpuria P, 2012, MOL BIOL REP, V39, P3977, DOI 10.1007/s11033-011-1178-3; Monroy AF, 1998, PLANT J, V13, P653, DOI 10.1046/j.1365-313X.1998.00070.x; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Narusaka Y, 2004, PLANT MOL BIOL, V55, P327, DOI 10.1007/s11103-004-0685-1; Nelson DC, 2010, P NATL ACAD SCI USA, V107, P7095, DOI 10.1073/pnas.0911635107; Nuruzzaman M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00248; Pang T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-488; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Pennycooke JC, 2005, ENVIRON EXP BOT, V53, P225, DOI 10.1016/j.envexpbot.2004.04.002; Poldervaart MT, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072610, 10.1371/journal.pone.0082817]; Prabu G. R., 2010, Genomics Proteomics & Bioinformatics, V8, P113, DOI 10.1016/S1672-0229(10)60012-5; Provart NJ, 2003, PLANT PHYSIOL, V132, P893, DOI 10.1104/pp.103.021261; Rae L, 2011, PLANTA, V234, P429, DOI 10.1007/s00425-011-1414-z; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Ren LP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-844; Renaut J, 2004, PLANT BIOLOGY, V6, P81, DOI 10.1055/s-2004-815733; Smekalova V, 2014, BIOTECHNOL ADV, V32, P2, DOI 10.1016/j.biotechadv.2013.07.009; Smith SM, 2014, CURR OPIN PLANT BIOL, V21, P23, DOI 10.1016/j.pbi.2014.06.003; Song YP, 2013, PLANT CELL REP, V32, P1407, DOI 10.1007/s00299-013-1454-x; Soos V, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-236; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Suzuki N, 2006, PHYSIOL PLANTARUM, V126, P45, DOI 10.1111/j.0031-9317.2005.00582.x; Svensson JT, 2006, PLANT PHYSIOL, V141, P257, DOI 10.1104/pp.105.072645; Taoka K, 2004, PLANT J, V40, P462, DOI 10.1111/j.1365-313X.2004.02238.x; Thomashow MF, 1998, PLANT PHYSIOL, V118, P1, DOI 10.1104/pp.118.1.1; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tian DQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-827; Vasudevan S, 2012, WIRES RNA, V3, P311, DOI 10.1002/wrna.121; Vaucheret H, 2006, MOL CELL, V22, P129, DOI 10.1016/j.molcel.2006.03.011; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Wang C, 2011, PHYSIOL PLANTARUM, V143, P64, DOI 10.1111/j.1399-3054.2011.01481.x; Wang L, 2009, PLANT MOL BIOL REP, V27, P257, DOI 10.1007/s11105-008-0079-7; Wang XC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-415; Wang Y, 2012, PLANT CELL REP, V31, P27, DOI 10.1007/s00299-011-1136-5; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wen M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-140; Wu HJ, 2012, NUCLEIC ACIDS RES, V40, pW22, DOI 10.1093/nar/gks554; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xia J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-634; Yang CH, 2013, PLANT CELL ENVIRON, V36, P2207, DOI 10.1111/pce.12130; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; Zeeman SC, 2004, PLANT PHYSIOL, V135, P849, DOI 10.1104/pp.103.032631; Zhao ZG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-222; Zhu QW, 2013, J ZHEJIANG UNIV-SC B, V14, P916, DOI 10.1631/jzus.B1300006; Zou CS, 2010, J PLANT BIOL, V53, P400, DOI 10.1007/s12374-010-9129-4	106	64	70	6	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0125031	10.1371/journal.pone.0125031	http://dx.doi.org/10.1371/journal.pone.0125031			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901577	Green Submitted, gold, Green Published			2022-12-27	WOS:000353331500109
J	Ma, CX; Shan, GG; Liu, S				Ma, Changxing; Shan, Guogen; Liu, Song			Homogeneity Test for Correlated Binary Data	PLOS ONE			English	Article							STATISTICAL-METHODS; TRIALS; OPHTHALMOLOGY; PROPORTIONS; EQUALITY	In ophthalmologic studies, measurements obtained from both eyes of an individual are often highly correlated. Ignoring the correlation could lead to incorrect inferences. An asymptotic method was proposed by Tang and others (2008) for testing equality of proportions between two groups under Rosner's model. In this article, we investigate three testing procedures for general g >= 2 groups. Our simulation results show the score testing procedure usually produces satisfactory type I error control and has reasonable power. The three test procedures get closer when sample size becomes larger. Examples from ophthalmologic studies are used to illustrate our proposed methods.	[Ma, Changxing] SUNY Buffalo, Dept Biostat, Buffalo, NY 14214 USA; [Shan, Guogen] Univ Nevada, Sch Community Hlth Sci, Dept Environm & Occupat Hlth, Las Vegas, NV 89154 USA; [Liu, Song] Roswell Pk Canc Inst, Dept Biostat & Bioinformat, Buffalo, NY 14203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Roswell Park Cancer Institute	Ma, CX (corresponding author), SUNY Buffalo, Dept Biostat, Buffalo, NY 14214 USA.	cxma@buffalo.edu	Shan, Guogen/GQI-3293-2022					BODIAN CA, 1994, BIOMETRICS, V50, P183, DOI 10.2307/2533208; DALLAL GE, 1988, BIOMETRICS, V44, P253, DOI 10.2307/2531913; DONNER A, 1989, BIOMETRICS, V45, P605, DOI 10.2307/2531501; DONNER A, 1994, J STAT PLAN INFER, V42, P37, DOI 10.1016/0378-3758(94)90188-0; Rajavi Z, 2011, OPHTHALMOLOGY, V118, P1812, DOI 10.1016/j.ophtha.2011.01.049; ROSNER B, 1982, BIOMETRICS, V38, P105, DOI 10.2307/2530293; ROSNER B, 1988, BIOMETRICS, V44, P505, DOI 10.2307/2531863; Shan GG, 2014, STAT BIOPHARM RES, V6, P115, DOI 10.1080/19466315.2013.861767; SIMON R, 1985, CANCER TREAT REP, V69, P1375; Tang ML, 2006, STAT MED, V25, P2771, DOI 10.1002/sim.2425; Tang NS, 2008, COMPUT STAT DATA AN, V52, P3719, DOI 10.1016/j.csda.2007.12.017; Wilding GE, 2011, CONT CLIN TRIALS	12	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124337	10.1371/journal.pone.0124337	http://dx.doi.org/10.1371/journal.pone.0124337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897962	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600064
J	Ali, B; Gill, RA; Yang, S; Gill, MB; Farooq, MA; Liu, D; Daud, MK; Ali, S; Zhou, WJ				Ali, Basharat; Gill, Rafaqat A.; Yang, Su; Gill, Muhammad B.; Farooq, Muhammad A.; Liu, Dan; Daud, Muhammad K.; Ali, Shafaqat; Zhou, Weijun			Regulation of Cadmium-Induced Proteomic and Metabolic Changes by 5-Aminolevulinic Acid in Leaves of Brassica napus L.	PLOS ONE			English	Article							SALINITY-INDUCED CHANGES; ULTRASTRUCTURAL-CHANGES; ANTIOXIDATIVE ENZYMES; GENE-EXPRESSION; STRESS; ACCUMULATION; TOLERANCE; RESPONSES; TOXICITY; PROLINE	It is evident from previous reports that 5-aminolevulinic acid (ALA), like other known plant growth regulators, is effective in countering the injurious effects of heavy metal-stress in oilseed rape (Brassica napus L.). The present study was carried out to explore the capability of ALA to improve cadmium (Cd2+) tolerance in B. napus through physiological, molecular, and proteomic analytical approaches. Results showed that application of ALA helped the plants to adjust Cd2+-induced metabolic and photosynthetic fluorescence changes in the leaves of B. napus under Cd2+ stress. The data revealed that ALA treatment enhanced the gene expressions of antioxidant enzyme activities substantially and could increase the expression to a certain degree under Cd2+ stress conditions. In the present study, 34 protein spots were identified that differentially regulated due to Cd2+ and/or ALA treatments. Among them, 18 proteins were significantly regulated by ALA, including the proteins associated with stress related, carbohydrate metabolism, catalysis, dehydration of damaged protein, CO2 assimilation/photosynthesis and protein synthesis/regulation. From these 18 ALA-regulated proteins, 12 proteins were significantly down-regulated and 6 proteins were up-regulated. Interestingly, it was observed that ALA-induced the up-regulation of dihydrolipoyl dehydrogenase, light harvesting complex photo-system II subunit 6 and 30S ribosomal proteins in the presence of Cd2+ stress. In addition, it was also observed that ALA-induced the down-regulation in thioredoxin-like protein, 2, 3-bisphosphoglycerate, proteasome and thiamine thiazole synthase proteins under Cd2+ stress. Taken together, the present study sheds light on molecular mechanisms involved in ALA-induced Cd2+ tolerance in B. napus leaves and suggests a more active involvement of ALA in plant physiological processes than previously proposed.	[Ali, Basharat; Gill, Rafaqat A.; Yang, Su; Gill, Muhammad B.; Farooq, Muhammad A.; Liu, Dan; Daud, Muhammad K.; Zhou, Weijun] Zhejiang Univ, Inst Crop Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Ali, Basharat; Gill, Rafaqat A.; Yang, Su; Gill, Muhammad B.; Farooq, Muhammad A.; Liu, Dan; Daud, Muhammad K.; Zhou, Weijun] Zhejiang Univ, Zhejiang Key Lab Crop Germplasm, Hangzhou 310058, Zhejiang, Peoples R China; [Daud, Muhammad K.] Kohat Univ Sci & Technol, Dept Biotechnol & Genet Engn, Kohat 26000, Pakistan; [Ali, Shafaqat] Govt Coll Univ, Dept Environm Sci & Engn, Faisalabad 38000, Pakistan	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Zhejiang University; Zhejiang University; Kohat University of Science & Technology; Government College University Faisalabad	Zhou, WJ (corresponding author), Zhejiang Univ, Inst Crop Sci, Hangzhou 310058, Zhejiang, Peoples R China.	wjzhou@zju.edu.cn	Ali, Basharat/K-5274-2019; Khan, Muhammad Daud/AAF-1011-2021; Gill, Muhammad/AAT-8380-2020; Gill, Rafaqat Ali/ABG-3689-2021; Ali, Shafaqat/G-3298-2017; Gill, Rafaqat Ali/AAE-2960-2020; Farooq, Muhammad Ahsan/R-7334-2017; Ali, Basharat/M-4478-2017	Gill, Rafaqat Ali/0000-0001-6553-9312; Ali, Shafaqat/0000-0003-0272-7097; Farooq, Muhammad Ahsan/0000-0002-7183-2379; Ali, Basharat/0000-0002-5965-7352; Ali, Shafaqat/0000-0002-3773-5196	Special Fund for Agro-scientific Research in the Public Interest [201303022]; Jiangsu Collaborative Innovation Center for Modern Crop Production; National Natural Science Foundation of China [31170405, 31301678]; Science and Technology Department of Zhejiang Province [2012C12902-1, 2011R50026-25]	Special Fund for Agro-scientific Research in the Public Interest; Jiangsu Collaborative Innovation Center for Modern Crop Production; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Zhejiang Province	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest (201303022), Jiangsu Collaborative Innovation Center for Modern Crop Production, the National Natural Science Foundation of China (31170405, 31301678), and the Science and Technology Department of Zhejiang Province (2012C12902-1, 2011R50026-25).	Aebi H, 1984, Methods Enzymol, V105, P121; Ahsan N, 2009, PROTEOMICS, V9, P2602, DOI 10.1002/pmic.200800935; Ali B, 2014, IND CROP PROD, V52, P617, DOI 10.1016/j.indcrop.2013.11.033; Ali B, 2013, ENVIRON SCI POLLUT R, V20, P7256, DOI 10.1007/s11356-013-1735-5; Ali B, 2013, J PLANT GROWTH REGUL, V32, P604, DOI 10.1007/s00344-013-9328-6; Ali B, 2013, ECOTOX ENVIRON SAFE, V92, P271, DOI 10.1016/j.ecoenv.2013.02.006; Arnon DI, 1940, SOIL SCI, V50, P463; Asada K., 1994, CAUSES PHOTO OXIDATI; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Bah AM, 2010, J HAZARD MATER, V184, P191, DOI 10.1016/j.jhazmat.2010.08.023; Basile A, 2005, GENE, V356, P153, DOI 10.1016/j.gene.2005.04.017; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carpentier SC, 2005, PROTEOMICS, V5, P2497, DOI 10.1002/pmic.200401222; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; Dai QL, 2009, PLANT GROWTH REGUL, V59, P273, DOI 10.1007/s10725-009-9402-z; Daud MK, 2009, J HAZARD MATER, V161, P463, DOI 10.1016/j.jhazmat.2008.03.128; de Lacerda CF, 2003, ENVIRON EXP BOT, V49, P107, DOI 10.1016/S0098-8472(02)00064-3; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Durand TC, 2010, PROTEOMICS, V10, P349, DOI 10.1002/pmic.200900484; El-Tayeb MA, 2005, PLANT GROWTH REGUL, V45, P215, DOI 10.1007/s10725-005-4928-1; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; GUCCI R, 1991, PHYSIOL PLANTARUM, V83, P497, DOI 10.1111/j.1399-3054.1991.tb00126.x; HOPKINS W. G., 2008, INTRO PLANT PHYSL, VFourth; HULL HM, 1975, BOT REV, V41, P421, DOI 10.1007/BF02860832; Inostroza-Blancheteau C, 2011, PLANT PHYSIOL BIOCH, V49, P1005, DOI 10.1016/j.plaphy.2011.04.009; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Johnsen U, 2007, EXTREMOPHILES, V11, P647, DOI 10.1007/s00792-007-0094-x; Kanazawa S, 2000, PHYSIOL PLANTARUM, V109, P211, DOI 10.1034/j.1399-3054.2000.100214.x; Kieffer P, 2008, PROTEOMICS, V8, P2514, DOI 10.1002/pmic.200701110; Kirkham MB, 2006, GEODERMA, V137, P19, DOI 10.1016/j.geoderma.2006.08.024; Lage-Pinto F, 2008, ENVIRON EXP BOT, V64, P307, DOI 10.1016/j.envexpbot.2008.07.007; LATXAGUE L, 1991, J CHROMATOGR, V586, P166, DOI 10.1016/0021-9673(91)80037-H; Lin CC, 2000, PLANT GROWTH REGUL, V30, P151, DOI 10.1023/A:1006345126589; Liu D, 2011, J AGRON CROP SCI, V197, P284, DOI 10.1111/j.1439-037X.2011.00465.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Millan AF, 2009, ENVIRON EXP BOT, V65, P376, DOI 10.1016/j.envexpbot.2008.11.010; Machado CR, 1996, PLANT MOL BIOL, V31, P585, DOI 10.1007/BF00042231; Milone MT, 2003, ENVIRON EXP BOT, V50, P265, DOI 10.1016/S0098-8472(03)00037-6; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Naeem MS, 2011, ACTA PHYSIOL PLANT, V33, P517, DOI 10.1007/s11738-010-0575-x; Naeem MS, 2012, PLANT PHYSIOL BIOCH, V57, P84, DOI 10.1016/j.plaphy.2012.05.018; Najeeb U, 2011, J HAZARD MATER, V186, P565, DOI 10.1016/j.jhazmat.2010.11.037; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Nayyar H, 2003, BIOL PLANTARUM, V46, P275, DOI 10.1023/A:1022867030790; Nishihara E, 2003, J PLANT PHYSIOL, V160, P1085, DOI 10.1078/0176-1617-00991; Nwugo CC, 2008, PLANT SOIL, V311, P73, DOI 10.1007/s11104-008-9659-4; Nwugo CC, 2011, J PROTEOME RES, V10, P518, DOI 10.1021/pr100716h; Papazoglou EG, 2005, ENVIRON INT, V31, P243, DOI 10.1016/j.envint.2004.09.022; Rafiq MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111461; Ritz D, 2001, ANNU REV MICROBIOL, V55, P21, DOI 10.1146/annurev.micro.55.1.21; Romero-Puertas MC, 2007, J PLANT PHYSIOL, V164, P1346, DOI 10.1016/j.jplph.2006.06.018; ROYMACAULEY H, 1992, PHYSIOL PLANTARUM, V85, P90, DOI 10.1111/j.1399-3054.1992.tb05268.x; Sanita di Toppi L, 1999, ENVIRON EXP BOT, V41, P105, DOI 10.1016/S0098-8472(98)00058-6; Sung DY, 2009, PLANT J, V59, P802, DOI 10.1111/j.1365-313X.2009.03914.x; van Keulen H, 2008, ENVIRON EXP BOT, V63, P281, DOI 10.1016/j.envexpbot.2007.11.012; Wang LJ, 2005, J INTEGR PLANT BIOL, V47, P1084, DOI 10.1111/j.1744-7909.2005.00150.x; Wang LJ, 2004, PHYSIOL PLANTARUM, V121, P258, DOI 10.1111/j.0031-9317.2004.00319.x; Wang YS, 2005, PLANT CELL PHYSIOL, V46, P1915, DOI 10.1093/pcp/pci202; YEMM EW, 1955, ANALYST, V80, P209, DOI 10.1039/an9558000209; Yusuf M, 2008, J INTEGR PLANT BIOL, V50, P1096, DOI 10.1111/j.1744-7909.2008.00697.x; Zhang WF, 2008, J PLANT GROWTH REGUL, V27, P159, DOI 10.1007/s00344-008-9042-y; Zhang ZJ, 2006, PLANT GROWTH REGUL, V49, P27, DOI 10.1007/s10725-006-0011-9; Zhao L, 2011, CHEMOSPHERE, V85, P56, DOI 10.1016/j.chemosphere.2011.06.029; Zhou WJ, 1999, PLANT GROWTH REGUL, V27, P99, DOI 10.1023/A:1006165603300; Zhou WJ, 2001, CROP PRODUCTION, P153	67	121	124	5	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123328	10.1371/journal.pone.0123328	http://dx.doi.org/10.1371/journal.pone.0123328			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909456	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800034
J	Duthie, AB; Reid, JM				Duthie, A. Bradley; Reid, Jane M.			What Happens after Inbreeding Avoidance? Inbreeding by Rejected Relatives and the Inclusive Fitness Benefit of Inbreeding Avoidance	PLOS ONE			English	Article							SELF-FERTILIZATION; NO EVIDENCE; MATING-BEHAVIOR; POPULATION-SIZE; SEXUAL CONFLICT; GENETIC LOAD; DEPRESSION; EVOLUTION; PLANT; DISPERSAL	Avoiding inbreeding, and therefore avoiding inbreeding depression in offspring fitness, is widely assumed to be adaptive in systems with biparental reproduction. However, inbreeding can also confer an inclusive fitness benefit stemming from increased relatedness between parents and inbred offspring. Whether or not inbreeding or avoiding inbreeding is adaptive therefore depends on a balance between inbreeding depression and increased parent-offspring relatedness. Existing models of biparental inbreeding predict threshold values of inbreeding depression above which males and females should avoid inbreeding, and predict sexual conflict over inbreeding because these thresholds diverge. However, these models implicitly assume that if a focal individual avoids inbreeding, then both it and its rejected relative will subsequently outbreed. We show that relaxing this assumption of reciprocal outbreeding, and the assumption that focal individuals are themselves outbred, can substantially alter the predicted thresholds for inbreeding avoidance for focal males. Specifically, the magnitude of inbreeding depression below which inbreeding increases a focal male's inclusive fitness increases with increasing depression in the offspring of a focal female and her alternative mate, and it decreases with increasing relatedness between a focal male and a focal female's alternative mate, thereby altering the predicted zone of sexual conflict. Furthermore, a focal male's inclusive fitness gain from avoiding inbreeding is reduced by indirect opportunity costs if his rejected relative breeds with another relative of his. By demonstrating that variation in relatedness and inbreeding can affect intra- and intersexual conflict over inbreeding, our models lead to novel predictions for family dynamics. Specifically, parent-offspring conflict over inbreeding might depend on the alternative mates of rejected relatives, and male-male competition over inbreeding might lead to mixed inbreeding strategies. Making testable quantitative predictions regarding inbreeding strategies occurring in nature will therefore require new models that explicitly capture variation in relatedness and inbreeding among interacting population members.	[Duthie, A. Bradley; Reid, Jane M.] Univ Aberdeen, Sch Biol Sci, Inst Biol & Environm Sci, Aberdeen, Scotland	University of Aberdeen	Duthie, AB (corresponding author), Univ Aberdeen, Sch Biol Sci, Inst Biol & Environm Sci, Aberdeen, Scotland.	aduthie@abdn.ac.uk	yasin, jeshima k K/H-2912-2018; Duthie, A. Bradley/H-7211-2019	yasin, jeshima k K/0000-0003-4932-3866; Duthie, A. Bradley/0000-0001-8343-4995	European Research Council Grant; Royal Society University Research Fellowship	European Research Council Grant(European Research Council (ERC)); Royal Society University Research Fellowship(Royal Society of London)	This work was funded by a European Research Council Grant (http://erc.europa.eu/ercfunded-projects) and a Royal Society University Research Fellowship (www.royalsociety.org) to Jane M. Reid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala-Honkola O, 2009, J EVOLUTION BIOL, V22, P1396, DOI 10.1111/j.1420-9101.2009.01765.x; Armbruster P, 2005, HEREDITY, V95, P235, DOI 10.1038/sj.hdy.6800721; Arnqvist Goran, 2005, pUnpaginated; BARRETT SCH, 1991, NATURE, V352, P522, DOI 10.1038/352522a0; Billing AM, 2012, MOL ECOL, V21, P1487, DOI 10.1111/j.1365-294X.2012.05490.x; BLOUIN SF, 1988, TRENDS ECOL EVOL, V3, P230, DOI 10.1016/0169-5347(88)90164-4; Byers DL, 1999, ANNU REV ECOL SYST, V30, P479, DOI 10.1146/annurev.ecolsys.30.1.479; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; CHARLESWORTH B, 1980, J THEOR BIOL, V84, P655, DOI 10.1016/S0022-5193(80)80026-9; Charlesworth D, 2006, CURR BIOL, V16, pR726, DOI 10.1016/j.cub.2006.07.068; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; Cohen LB, 2004, ANIM BEHAV, V68, P1229, DOI 10.1016/j.anbehav.2003.12.021; Crnokrak P, 2002, EVOLUTION, V56, P2347, DOI 10.1111/j.0014-3820.2002.tb00160.x; Crnokrak P, 1999, HEREDITY, V83, P260, DOI 10.1038/sj.hdy.6885530; EMLEN ST, 1995, P NATL ACAD SCI USA, V92, P8092, DOI 10.1073/pnas.92.18.8092; Escobar JS, 2011, EVOLUTION, V65, P1233, DOI 10.1111/j.1558-5646.2011.01218.x; Evans MR, 2013, TRENDS ECOL EVOL, V28, P578, DOI 10.1016/j.tree.2013.05.022; Fisher RA, 1941, ANN EUGENIC, V11, P53, DOI 10.1111/j.1469-1809.1941.tb02272.x; Glemin S, 2003, EVOLUTION, V57, P2678; Goodwillie C, 2005, ANNU REV ECOL EVOL S, V36, P47, DOI 10.1146/annurev.ecolsys.36.091704.175539; Grafen A, 2006, J THEOR BIOL, V238, P541, DOI 10.1016/j.jtbi.2005.06.009; GRAFEN A, 1979, ANIM BEHAV, V27, P905, DOI 10.1016/0003-3472(79)90028-9; Haig D, 1999, EVOL HUM BEHAV, V20, P83, DOI 10.1016/S1090-5138(98)00042-7; Hamilton W.D., 1972, Annual Rev Ecol Syst, V3, P193, DOI 10.1146/annurev.es.03.110172.001205; Herlihy CR, 2004, EVOLUTION, V58, P2693, DOI 10.1111/j.0014-3820.2004.tb01622.x; Hinde CA, 2010, SCIENCE, V327, P1373, DOI 10.1126/science.1186056; Hirao AS, 2010, ANN BOT-LONDON, V105, P637, DOI 10.1093/aob/mcq018; Hoarau G, 2005, P ROY SOC B-BIOL SCI, V272, P497, DOI 10.1098/rspb.2004.2963; Holand O, 2007, BIOL LETTERS, V3, P36, DOI 10.1098/rsbl.2006.0575; Jamieson IG, 2009, BEHAV ECOL, V20, P575, DOI 10.1093/beheco/arp034; Jennions MD, 2004, EVOLUTION, V58, P2472; Keane B, 1996, BEHAV ECOL, V7, P480, DOI 10.1093/beheco/7.4.480; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kleven O, 2005, BIOL LETT-UK, V1, P389, DOI 10.1098/rsbl.2005.0376; Kokko H, 2006, EVOLUTION, V60, P467, DOI 10.1554/05-613.1; Kuriwada T, 2011, ETHOLOGY, V117, P822, DOI 10.1111/j.1439-0310.2011.01937.x; Kuriwada T, 2011, BEHAV ECOL SOCIOBIOL, V65, P1483, DOI 10.1007/s00265-011-1158-6; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; Lehmann L, 2003, AM NAT, V162, P638, DOI 10.1086/378823; LLOYD DG, 1992, INT J PLANT SCI, V153, P370, DOI 10.1086/297041; MICHOD RE, 1979, AM NAT, V114, P637, DOI 10.1086/283513; MILLS LS, 1994, AM NAT, V144, P412, DOI 10.1086/285684; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; NASON JD, 1995, EVOLUTION, V49, P307, DOI [10.1111/j.1558-5646.1995.tb02243.x, 10.2307/2410341]; Ohtsuki H, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0359; Olson LE, 2012, MOL ECOL, V21, P562, DOI 10.1111/j.1365-294X.2011.05389.x; Parker G.A., 1979, P123; Parker GA, 2006, PHILOS T R SOC B, V361, P235, DOI 10.1098/rstb.2005.1785; Parker GA, 1998, PHILOS T R SOC B, V353, P261, DOI 10.1098/rstb.1998.0208; Porcher E, 2005, J EVOLUTION BIOL, V18, P497, DOI 10.1111/j.1420-9101.2005.00905.x; Porcher E, 2009, J EVOLUTION BIOL, V22, P708, DOI 10.1111/j.1420-9101.2009.01705.x; Pusey A, 1996, TRENDS ECOL EVOL, V5347, P298; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; Puurtinen M, 2011, EVOLUTION, V65, P1501, DOI 10.1111/j.1558-5646.2010.01217.x; RALLS K, 1988, Conservation Biology, V2, P185, DOI 10.1111/j.1523-1739.1988.tb00169.x; Robinson SP, 2012, ANIM BEHAV, V84, P1169, DOI 10.1016/j.anbehav.2012.08.020; Roze D, 2014, EVOLUTION, V68, P137, DOI 10.1111/evo.12232; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Schmoll T, 2005, ANIM BEHAV, V69, P1013, DOI 10.1016/j.anbehav.2004.08.010; SCHULTZ ST, 1995, GENETICS, V141, P1209; Sharp SP, 2008, P ROY SOC B-BIOL SCI, V275, P2125, DOI 10.1098/rspb.2008.0398; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; SMITH JM, 1976, ANIM BEHAV, V24, P159, DOI 10.1016/S0003-3472(76)80110-8; Stucki D, 2013, EVOLUTION, V67, P3208, DOI 10.1111/evo.12187; Szulkin M, 2008, P R SOC B, V275, P703, DOI 10.1098/rspb.2007.0989; Szulkin M, 2013, TRENDS ECOL EVOL, V28, P205, DOI 10.1016/j.tree.2012.10.016; Tan CKW, 2012, ANIM BEHAV, V83, P1433, DOI 10.1016/j.anbehav.2012.03.015; Tennenhouse EM, 2014, ETHOLOGY, V120, P111, DOI 10.1111/eth.12187; Tsitrone A, 2003, AM NAT, V162, P318, DOI 10.1086/375542; UYENOYAMA MK, 1991, THEOR POPUL BIOL, V40, P173, DOI 10.1016/0040-5809(91)90052-H; UYENOYAMA MK, 1986, EVOLUTION, V40, P388, DOI 10.1111/j.1558-5646.1986.tb00479.x; UYENOYAMA MK, 1991, THEOR POPUL BIOL, V40, P14, DOI 10.1016/0040-5809(91)90045-H; Wang C, 2011, MOL ECOL, V20, P2851, DOI 10.1111/j.1365-294X.2011.05070.x; WASER PM, 1986, AM NAT, V128, P529, DOI 10.1086/284585; Welbergen JA, 2006, P ROY SOC B-BIOL SCI, V273, P2363, DOI 10.1098/rspb.2006.3591; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872	77	17	17	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125140	10.1371/journal.pone.0125140	http://dx.doi.org/10.1371/journal.pone.0125140			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909185	Green Published, Green Submitted, gold			2022-12-27	WOS:000353376800131
J	Stimac, M; Dolinsek, T; Lampreht, U; Cemazar, M; Sersa, G				Stimac, Monika; Dolinsek, Tanja; Lampreht, Ursa; Cemazar, Maja; Sersa, Gregor			Gene Electrotransfer of Plasmid with Tissue Specific Promoter Encoding shRNA against Endoglin Exerts Antitumor Efficacy against Murine TS/A Tumors by Vascular Targeted Effects	PLOS ONE			English	Article							IN-VIVO ELECTROPORATION; HUMAN SOLID TUMORS; CD105 MONOCLONAL-ANTIBODIES; ANTI-ANGIOGENIC THERAPY; LEWIS LUNG-CARCINOMA; ENDOTHELIAL-CELLS; INTRATUMORAL DELIVERY; MELANOMA TUMORS; INTERLEUKIN-12 GENE; COMPLETE REGRESSION	Vascular targeted therapies, targeting specific endothelial cell markers, are promising approaches for the treatment of cancer. One of the targets is endoglin, transforming growth factor-beta (TGF-beta) co-receptor, which mediates proliferation, differentiation and migration of endothelial cells forming neovasculature. However, its specific, safe and long-lasting targeting remains the challenge. Therefore, in our study we evaluated the transfection efficacy, vascular targeted effects and therapeutic potential of the plasmid silencing endoglin with the tissue specific promoter, specific for endothelial cells marker endothelin-1 (ET) (TS plasmid), in comparison to the plasmid with constitutive promoter (CON plasmid), in vitro and in vivo. Tissue specificity of TS plasmid was demonstrated in vitro on several cell lines, and its antiangiogenic efficacy was demonstrated by reducing tube formation of 2H11 endothelial cells. In vivo, on a murine mammary TS/A tumor model, we demonstrated good antitumor effect of gene electrotransfer (GET) of either of both plasmids in treatment of smaller tumors still in avascular phase of growth, as well as on bigger tumors, already well vascularized. In support to the observations on predominantly vascular targeted effects of endoglin, histological analysis has demonstrated an increase in necrosis and a decrease in the number of blood vessels in therapeutic groups. A significant antitumor effect was observed in tumors in avascular and vascular phase of growth, possibly due to both, the antiangiogenic and the vascular disrupting effect. Furthermore, the study indicates on the potential use of TS plasmid in cancer gene therapy since the same efficacy as of CON plasmid was determined.	[Stimac, Monika; Dolinsek, Tanja; Lampreht, Ursa; Cemazar, Maja; Sersa, Gregor] Inst Oncol Ljubljana, Dept Expt Oncol, Ljubljana, Slovenia; [Cemazar, Maja] Univ Primorska, Fac Hlth Sci, Izola, Slovenia	Institute of Oncology - Slovenia; University of Primorska	Sersa, G (corresponding author), Inst Oncol Ljubljana, Dept Expt Oncol, Ljubljana, Slovenia.	gsersa@onko-i.si	Savarin, Monika/V-5451-2017; Cemazar, Maja/K-6182-2013	Savarin, Monika/0000-0002-8316-8110; Cemazar, Maja/0000-0002-1418-1928	Slovenian Research Agency [P3-0003, J3-4211, J3-4259]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The authors acknowledge the financial support from the state budget by the Slovenian Research Agency (program no. P3-0003 (GS), projects no. J3-4211 (GS), J3-4259 (MC)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadvand D, 2009, MOL IMMUNOL, V46, P1814, DOI 10.1016/j.molimm.2009.01.021; Ahmadvand D, 2008, HYBRIDOMA, V27, P353, DOI 10.1089/hyb.2008.0014; Bagnato A, 2011, BRIT J PHARMACOL, V163, P220, DOI 10.1111/j.1476-5381.2011.01217.x; Bosnjak M, 2013, J MEMBRANE BIOL, V246, P803, DOI 10.1007/s00232-013-9550-y; Burrows FJ, 1995, CLIN CANCER RES, V1, P1623; Dallas NA, 2008, CLIN CANCER RES, V14, P1931, DOI 10.1158/1078-0432.CCR-07-4478; Dancer A, 2003, GENE THER, V10, P1170, DOI 10.1038/sj.gt.3301981; Danda R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083398; Daud AI, 2008, J CLIN ONCOL, V26, P5896, DOI 10.1200/JCO.2007.15.6794; Dean DA, 2013, J MEMBRANE BIOL, V246, P737, DOI 10.1007/s00232-013-9534-y; Dolinsek T, 2015, CURR GENE T IN PRESS; Dolinsek T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058723; Duff SE, 2003, FASEB J, V17, P984, DOI 10.1096/fj.02-0634rev; Elez R, 2003, ONCOGENE, V22, P69, DOI 10.1038/sj.onc.1206038; Faurie C, 2010, J GENE MED, V12, P117, DOI 10.1002/jgm.1414; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fonsatti E, 2010, CARDIOVASC RES, V86, P12, DOI 10.1093/cvr/cvp332; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Giering JC, 2008, MOL THER, V16, P1630, DOI 10.1038/mt.2008.144; Govinden R, 2003, PHARMACOL THERAPEUT, V98, P257, DOI 10.1016/S0163-7258(03)00035-4; Hanari N, 2007, ANTICANCER RES, V27, P2305; Heller L, 2013, CANCER GENE THER, V20, P695, DOI 10.1038/cgt.2013.71; Heller LC, 2011, CLINICAL ASPECTS OF ELECTROPORATION, P159, DOI 10.1007/978-1-4419-8363-3_14; Heller LC, 2002, TECHNOL CANCER RES T, V1, P205, DOI 10.1177/153303460200100305; Heller LC, 2010, CURR GENE THER, V10, P312; Huang C, 2008, EXPERT OPIN THER TAR, V12, P637, DOI 10.1517/14728222.12.5.637 ; Kishida T, 2003, MOL THER, V8, P738, DOI 10.1016/j.ymthe.2003.08.002; Kuzmin D, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-58; Li CG, 2000, FASEB J, V14, P55, DOI 10.1096/fasebj.14.1.55; Li F, 2011, ADV DRUG DELIVER REV, V63, P47, DOI 10.1016/j.addr.2010.11.003; Lucas ML, 2002, MOL THER, V5, P668, DOI 10.1006/mthe.2002.0601; Mali B, 2013, RADIOL ONCOL, V47, P32, DOI 10.2478/raon-2013-0002; Marrero B, 2014, TECHNOL CANCER RES T, V13, P551, DOI 10.7785/tcrtexpress.2013.600252; Matsuno F, 1999, CLIN CANCER RES, V5, P371; McCray AN, 2004, MOL THER, V9, pS363; Mitchell DC, 2010, J CELL BIOCHEM, V111, P543, DOI 10.1002/jcb.22764; Munoz R, 2013, CANCER IMMUNOL IMMUN, V62, P541, DOI 10.1007/s00262-012-1357-7; NANNI P, 1983, CLIN EXP METASTAS, V1, P373, DOI 10.1007/BF00121199; Nassiri F, 2011, ANTICANCER RES, V31, P2283; Niemisto A, 2005, IEEE T MED IMAGING, V24, P549, DOI 10.1109/TMI.2004.837339; Niu GL, 1999, CANCER RES, V59, P5059; Orlova VV, 2011, HISTOL HISTOPATHOL, V26, P1219, DOI 10.14670/HH-26.1219; Paganin-Gioanni A, 2011, P NATL ACAD SCI USA, V108, P10443, DOI 10.1073/pnas.1103519108; Papadakis ED, 2004, CURR GENE THER, V4, P89, DOI 10.2174/1566523044578077; Qiao J, 2002, GENE THER, V9, P168, DOI 10.1038/sj.gt.3301618; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; Rettig GR, 2012, MOL THER, V20, P483, DOI 10.1038/mt.2011.263; Roodink I, 2010, CANCER LETT, V299, P1, DOI 10.1016/j.canlet.2010.09.004; Rosen LS, 2014, CURR ONCOL REP, V16, DOI 10.1007/s11912-013-0365-x; Rosen LS, 2012, CLIN CANCER RES, V18, P4820, DOI 10.1158/1078-0432.CCR-12-0098; Sedlar A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-38; Seon BK, 2011, CURR DRUG DELIV, V8, P135; Seon BK, 1997, CLIN CANCER RES, V3, P1031; She XW, 2004, INT J CANCER, V108, P251, DOI 10.1002/ijc.11551; Shibata MA, 2008, CANCER GENE THER, V15, P776, DOI 10.1038/cgt.2008.43; Spanggaard I, 2013, HUM GENE THER CL DEV, V24, P99, DOI 10.1089/humc.2012.240; Tabata M, 1999, INT J CANCER, V82, P737, DOI 10.1002/(SICI)1097-0215(19990827)82:5<737::AID-IJC18>3.3.CO;2-#; Takahashi N, 2001, CANCER RES, V61, P7846; Tan GH, 2007, WORLD J GASTROENTERO, V13, P2479, DOI 10.3748/wjg.v13.i17.2479; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; Tesic N, 2013, J MEMBRANE BIOL, V246, P783, DOI 10.1007/s00232-013-9548-5; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tsujie M, 2008, INT J CANCER, V122, P2266, DOI 10.1002/ijc.23314; Tsujie M, 2006, INT J ONCOL, V29, P1087; Ugen KE, 2006, CANCER GENE THER, V13, P969, DOI 10.1038/sj.cgt.7700973; Uneda S, 2009, INT J CANCER, V125, P1446, DOI 10.1002/ijc.24482; Wannenes F, 2005, CANCER GENE THER, V12, P926, DOI 10.1038/sj.cgt.7700862; Xu Y, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-39	68	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124913	10.1371/journal.pone.0124913	http://dx.doi.org/10.1371/journal.pone.0124913			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909447	Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800114
J	Perry, G; Randle, JM; Koelewijn, L; Routley, BC; Singh, KD				Perry, Gavin; Randle, James M.; Koelewijn, Loes; Routley, Bethany C.; Singh, Krish D.			Linear Tuning of Gamma Amplitude and Frequency to Luminance Contrast: Evidence from a Continuous Mapping Paradigm	PLOS ONE			English	Article							PEAK FREQUENCY; OSCILLATIONS; CORTEX; MACAQUE; BAND; STRIATE; V1; MAGNETOENCEPHALOGRAPHY; VARIABILITY; SELECTIVITY	Individual differences in the visual gamma (30-100Hz) response and their potential as trait markers of underlying physiology (particularly related to GABAergic inhibition) have become a matter of increasing interest in recent years. There is growing evidence, however, that properties of the gamma response (e.g., its amplitude and frequency) are highly stimulus dependent, and that individual differences in the gamma response may reflect individual differences in the stimulus tuning functions of gamma oscillations. Here, we measured the tuning functions of gamma amplitude and frequency to luminance contrast in eighteen participants using MEG. We used a grating stimulus in which stimulus contrast was modulated continuously over time. We found that both gamma amplitude and frequency were linearly modulated by stimulus contrast, but that the gain of this modulation (as reflected in the linear gradient) varied across individuals. We additionally observed a stimulus-induced response in the beta frequency range (10-25Hz), but neither the amplitude nor the frequency of this response was consistently modulated by the stimulus over time. Importantly, we did not find a correlation between the gain of the gamma-band amplitude and frequency tuning functions across individuals, suggesting that these may be independent traits driven by distinct neurophysiological processes.	[Perry, Gavin; Randle, James M.; Koelewijn, Loes; Routley, Bethany C.; Singh, Krish D.] Cardiff Univ, Sch Psychol, Cardiff Univ Brain Imaging Ctr CUBRIC, Cardiff CF10 3AX, S Glam, Wales	Cardiff University	Perry, G (corresponding author), Cardiff Univ, Sch Psychol, Cardiff Univ Brain Imaging Ctr CUBRIC, Cardiff CF10 3AX, S Glam, Wales.	perryg@cf.ac.uk	Singh, Krish/D-1066-2009; Perry, Gavin/B-3759-2011	Perry, Gavin/0000-0003-0468-0421; Routley, Bethany/0000-0003-3462-4674; Singh, Krishna/0000-0002-3094-2475	MRC/EPSRC UK MEG Partnership award [MR/K005464/1]; MRC Doctoral Training Grant [MR/K501086/1]; MRC [MR/K005464/1] Funding Source: UKRI; Medical Research Council [MR/K005464/1] Funding Source: researchfish	MRC/EPSRC UK MEG Partnership award(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)Medical Research Council UK (MRC)); MRC Doctoral Training Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by an MRC/EPSRC UK MEG Partnership award (MR/K005464/1) and an MRC Doctoral Training Grant (MR/K501086/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjamian P, 2004, EUR J NEUROSCI, V20, P587, DOI 10.1111/j.1460-9568.2004.03495.x; Adjamian P, 2008, J VISION, V8, DOI 10.1167/8.7.4; ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Berens P, 2008, FRONT NEUROSCI-SWITZ, V2, P199, DOI 10.3389/neuro.01.037.2008; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Friedman-Hill S, 2000, CEREB CORTEX, V10, P1105, DOI 10.1093/cercor/10.11.1105; Gieselmann MA, 2008, EUR J NEUROSCI, V28, P447, DOI 10.1111/j.1460-9568.2008.06358.x; Hadjipapas A, 2007, NEUROIMAGE, V35, P518, DOI 10.1016/j.neuroimage.2007.01.002; Hall SD, 2005, CLIN NEUROPHYSIOL, V116, P1716, DOI 10.1016/j.clinph.2005.02.027; Hall SD, 2005, NEUROIMAGE, V26, P13, DOI 10.1016/j.neuroimage.2005.01.009; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; Hoogenboom N, 2006, NEUROIMAGE, V29, P764, DOI 10.1016/j.neuroimage.2005.08.043; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Jadi MP, 2014, P NATL ACAD SCI USA, V111, P6780, DOI 10.1073/pnas.1405300111; Jia XX, 2013, J NEUROSCI, V33, P17, DOI 10.1523/JNEUROSCI.1687-12.2013; Jia XX, 2011, J NEUROSCI, V31, P9390, DOI 10.1523/JNEUROSCI.0645-11.2011; Kleiner M, 2007, PERCEPTION, V36, P14; Koelewijn L, 2013, NEUROIMAGE, V79, P295, DOI 10.1016/j.neuroimage.2013.04.108; Koelewijn L, 2011, NEUROIMAGE, V54, P2983, DOI 10.1016/j.neuroimage.2010.11.045; Lee S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00869; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Muthukumaraswamy SD, 2013, NEUROIMAGE, V69, P223, DOI 10.1016/j.neuroimage.2012.12.038; Muthukumaraswamy SD, 2010, NEUROIMAGE, V49, P3349, DOI 10.1016/j.neuroimage.2009.11.045; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Perry G, 2014, EPILEPSY RES, V108, P1076, DOI 10.1016/j.eplepsyres.2014.04.012; Perry G, 2013, NEUROIMAGE, V68, P83, DOI 10.1016/j.neuroimage.2012.11.043; Pinotsis DA, 2014, NEUROIMAGE, V92, P143, DOI 10.1016/j.neuroimage.2014.01.047; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Ray S, 2010, NEURON, V67, P885, DOI 10.1016/j.neuron.2010.08.004; Roberts MJ, 2013, NEURON, V78, P523, DOI 10.1016/j.neuron.2013.03.003; Robinson S.E., 1999, RECENT ADV BIOMAGNET, P302; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; van Pelt S, 2012, J NEUROSCI, V32, P3388, DOI 10.1523/JNEUROSCI.5592-11.2012; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2	39	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124798	10.1371/journal.pone.0124798	http://dx.doi.org/10.1371/journal.pone.0124798			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906070	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000353332000090
J	Chang, YH; Korkola, J; Amin, DN; Moasser, MM; Carmena, JM; Gray, JW; Tomlin, CJ				Chang, Young Hwan; Korkola, James; Amin, Dhara N.; Moasser, Mark M.; Carmena, Jose M.; Gray, Joe W.; Tomlin, Claire J.			Disentangling Multidimensional Spatio-Temporal Data into Their Common and Aberrant Responses	PLOS ONE			English	Article							EXPRESSION; CHALLENGES; NETWORKS; AKT	With the advent of high-throughput measurement techniques, scientists and engineers are starting to grapple with massive data sets and encountering challenges with how to organize, process and extract information into meaningful structures. Multidimensional spatio-temporal biological data sets such as time series gene expression with various perturbations over different cell lines, or neural spike trains across many experimental trials, have the potential to acquire insight about the dynamic behavior of the system. For this potential to be realized, we need a suitable representation to understand the data. A general question is how to organize the observed data into meaningful structures and how to find an appropriate similarity measure. A natural way of viewing these complex high dimensional data sets is to examine and analyze the large-scale features and then to focus on the interesting details. Since the wide range of experiments and unknown complexity of the underlying system contribute to the heterogeneity of biological data, we develop a new method by proposing an extension of Robust Principal Component Analysis (RPCA), which models common variations across multiple experiments as the lowrank component and anomalies across these experiments as the sparse component. We show that the proposed method is able to find distinct subtypes and classify data sets in a robust way without any prior knowledge by separating these common responses and abnormal responses. Thus, the proposed method provides us a new representation of these data sets which has the potential to help users acquire new insight from data.	[Chang, Young Hwan; Tomlin, Claire J.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Korkola, James; Gray, Joe W.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Korkola, James; Gray, Joe W.] Oregon Hlth & Sci Univ, Ctr Spatial Syst Biomed, Portland, OR 97201 USA; [Amin, Dhara N.; Moasser, Mark M.] Univ Calif San Francisco, Dept Med, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA; [Carmena, Jose M.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Carmena, Jose M.] UCB UCSF Grad Program Bioengn, San Francisco, CA USA; [Tomlin, Claire J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Fac Scientist, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Oregon Health & Science University; Oregon Health & Science University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Tomlin, CJ (corresponding author), Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA.	tomlin@eecs.berkeley.edu	Gray, Joe/AAX-9549-2020	, James/0000-0002-0030-6216; Chang, Young Hwan/0000-0001-8764-1959	National Institutes of Health National Cancer Institute [5U54CA112970-08]; Stand Up To Cancer-American Association for Cancer Research Dream Team Translational Cancer Research Grant [SU2C-AACR-DT0408]; NIGMS; NSF [EFRI 1137267]; NATIONAL CANCER INSTITUTE [U54CA112970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615] Funding Source: NIH RePORTER	National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stand Up To Cancer-American Association for Cancer Research Dream Team Translational Cancer Research Grant; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health National Cancer Institute under the ICBP and PS-OC programs (5U54CA112970-08), by the Stand Up To Cancer-American Association for Cancer Research Dream Team Translational Cancer Research Grant SU2C-AACR-DT0408 to JWG, and by the NIGMS and by the NSF under grant EFRI 1137267. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin DN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000389; Androulakis IP, 2007, ANNU REV BIOMED ENG, V9, P205, DOI 10.1146/annurev.bioeng.9.060906.151904; Baraniuk RG, 2009, FOUND COMPUT MATH, V9, P51, DOI 10.1007/s10208-007-9011-z; Bingham E., 2001, KDD-2001. Proceedings of the Seventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P245, DOI 10.1145/502512.502546; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Candes EJ, 2011, J ACM, V58, DOI 10.1145/1970392.1970395; Chang YH, 2013, IEEE DECIS CONTR P, P2544, DOI 10.1109/CDC.2013.6760263; Chipman H, 2003, CLUSTERING MICROARRA; Churchland MM, 2007, J NEUROPHYSIOL, V97, P4235, DOI 10.1152/jn.00095.2007; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Dasgupta S., 2000, UNCERTAINTY ARTIFICI, P143; Deegalla S, 2006, ICMLA 2006: 5TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS, PROCEEDINGS, P245; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Hennessy Bryan T, 2010, Clin Proteomics, V6, P129, DOI 10.1007/s12014-010-9055-y; Liu JX, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S8-S3; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Marx V, 2013, NATURE, V496, P253, DOI 10.1038/498255a; Moasser M, 2012, UNDERSTANDING NETWOR; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Roy S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003252; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shiraishi Y, 2010, BIOINFORMATICS, V26, P1073, DOI 10.1093/bioinformatics/btq094; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Yadong Mu, 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2609, DOI 10.1109/CVPR.2011.5995369; Yu BM, 2009, J NEUROPHYSIOL, V102, P614, DOI 10.1152/jn.90941.2008; Zhou T, 2011, ARXIV111252152011	30	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0121607	10.1371/journal.pone.0121607	http://dx.doi.org/10.1371/journal.pone.0121607			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901353	Green Submitted, Green Published, gold			2022-12-27	WOS:000353331500012
J	Qiang, HP; Chen, ZH; Zhang, ZL; Wang, XM; Gao, HW; Wang, Z				Qiang, Haiping; Chen, Zhihong; Zhang, Zhengli; Wang, Xuemin; Gao, Hongwen; Wang, Zan			Molecular Diversity and Population Structure of a Worldwide Collection of Cultivated Tetraploid Alfalfa (Medicago sativa subsp sativa L.) Germplasm as Revealed by Microsatellite Markers	PLOS ONE			English	Article							GENETIC DIVERSITY; LINKAGE DISEQUILIBRIUM; FORAGE YIELD; PROGRAM	Information on genetic diversity and population structure of a tetraploid alfalfa collection might be valuable in effective use of the genetic resources. A set of 336 worldwide genotypes of tetraploid alfalfa (Medicago sativa subsp. sativa L.) was genotyped using 85 genome-wide distributed SSR markers to reveal the genetic diversity and population structure in the alfalfa. Genetic diversity analysis identified a total of 1056 alleles across 85 marker loci. The average expected heterozygosity and polymorphism information content values were 0.677 and 0.638, respectively, showing high levels of genetic diversity in the cultivated tetraploid alfalfa germplasm. Comparison of genetic characteristics across chromosomes indicated regions of chromosomes 2 and 3 had the highest genetic diversity. A higher genetic diversity was detected in alfalfa landraces than that of wild materials and cultivars. Two populations were identified by the model-based population structure, principal coordinate and neighbor-joining analyses, corresponding to China and other parts of the world. However, lack of strictly correlation between clustering and geographic origins suggested extensive germplasm exchanges of alfalfa germplasm across diverse geographic regions. The quantitative analysis of the genetic diversity and population structure in this study could be useful for genetic and genomic analysis and utilization of the genetic variation in alfalfa breeding.	[Qiang, Haiping; Zhang, Zhengli; Wang, Xuemin; Gao, Hongwen; Wang, Zan] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China; [Chen, Zhihong] Minist Agr, Natl Anim Husb Serv, Beijing 100125, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Ministry of Agriculture & Rural Affairs	Gao, HW (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China.	hongwengao@hotmail.com; wangzan@caas.cn			National Natural Science Foundation of China [31272495]; Agricultural Science and Technology Innovation Program of China [ASTIP-IAS10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Innovation Program of China	1 National Natural Science Foundation of China (No. 31272495) http://www.nsfc.gov.cn/, ZW. 2 Agricultural Science and Technology Innovation Program (ASTIP-IAS10) of China http://www.caas.cn/en/research/research_program/index.shtml, HWG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG JM, 1954, CAN J BOT, V32, P531, DOI 10.1139/b54-050; Bagavathiannan MV, 2010, EUPHYTICA, V173, P419, DOI 10.1007/s10681-010-0156-5; Bhandari HS, 2011, CROP SCI, V51, P1110, DOI 10.2135/cropsci2010.08.0492; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Brazauskas G, 2011, PLANT SCI, V181, P412, DOI 10.1016/j.plantsci.2011.06.013; Carelli M, 2009, PLANT BREEDING, V128, P271, DOI 10.1111/j.1439-0523.2008.01573.x; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Esselink GD, 2004, THEOR APPL GENET, V109, P402, DOI 10.1007/s00122-004-1645-5; Eujayl I, 2004, THEOR APPL GENET, V108, P414, DOI 10.1007/s00122-003-1450-6; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flajoulot S, 2005, THEOR APPL GENET, V111, P1420, DOI 10.1007/s00122-005-0074-4; Hong FZ., 2009, ALFALFA SCI; Jia GQ, 2013, J EXP BOT, V64, P3645, DOI 10.1093/jxb/ert198; Jin L, 2010, THEOR APPL GENET, V121, P475, DOI 10.1007/s00122-010-1324-7; Lamb JFS, 2006, CROP SCI, V46, P902, DOI 10.2135/cropsci2005.08-0236; Li XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084329; Li XH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-568; Li XH, 2011, PLANT GENOME-US, V4, P24, DOI 10.3835/plantgenome2010.09.0022; Lv J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046919; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Riday H, 2002, CROP SCI, V42, P716, DOI 10.2135/cropsci2002.0716; Robins JG, 2007, CROP SCI, V47, P1, DOI 10.2135/cropsci2005.11.0401; Sakiroglu M, 2010, THEOR APPL GENET, V121, P403, DOI 10.1007/s00122-010-1319-4; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Thrall PH, 2000, J HERED, V91, P348, DOI 10.1093/jhered/91.4.348; Tucak M, 2010, RUSS J GENET+, V46, P1314, DOI 10.1134/S1022795410110062; Tyagi P, 2014, THEOR APPL GENET, V127, P283, DOI 10.1007/s00122-013-2217-3; Wang CF, 2012, G3-GENES GENOM GENET, V2, P769, DOI 10.1534/g3.112.002907; Zhang DD, 2010, PLANT GENOME-US, V3, P117, DOI 10.3835/plantgenome2010.03.0004; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089; [No title captured]	35	28	31	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124592	10.1371/journal.pone.0124592	http://dx.doi.org/10.1371/journal.pone.0124592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901573	gold, Green Submitted, Green Published			2022-12-27	WOS:000353331500093
J	Temereva, EN; Tsitrin, EB				Temereva, Elena N.; Tsitrin, Eugeni B.			Modern Data on the Innervation of the Lophophore in Lingula anatina (Brachiopoda) Support the Monophyly of the Lophophorates	PLOS ONE			English	Article							NERVOUS-SYSTEM; PHORONIDA; ULTRASTRUCTURE; TENTACLES	Evolutionary relationships among members of the Lophophorata remain unclear. Traditionally, the Lophophorata included three phyla: Brachiopoda, Bryozoa or Ectoprocta, and Phoronida. All species in these phyla have a lophophore, which is regarded as a homologous structure of the lophophorates. Because the organization of the nervous system has been traditionally used to establish relationships among groups of animals, information on the organization of the nervous system in the lophophore of phoronids, brachiopods, and bryozoans may help clarify relationships among the lophophorates. In the current study, the innervation of the lophophore of the inarticulate brachiopod Lingula anatina is investigated by modern methods. The lophophore of L. anatina contains three brachial nerves: the main, accessory, and lower brachial nerves. The main brachial nerve is located at the base of the dorsal side of the brachial fold and gives rise to the cross neurite bundles, which pass through the connective tissue and connect the main and accessory brachial nerves. Nerves emanating from the accessory brachial nerve account for most of the tentacle innervation and comprise the frontal, latero-frontal, and latero-abfrontal neurite bundles. The lower brachial nerve gives rise to the abfrontal neurite bundles of the outer tentacles. Comparative analysis revealed the presence of many similar features in the organization of the lophophore nervous system in phoronids, brachiopods, and bryozoans. The main brachial nerve of L. anatina is similar to the dorsal ganglion of phoronids and the cerebral ganglion of bryozoans. The accessory brachial nerve of L. anatina is similar to the minor nerve ring of phoronids and the circumoral nerve ring of bryozoans. All lophophorates have intertentacular neurite bundles, which innervate adjacent tentacles. The presence of similar nerve elements in the lophophore of phoronids, brachiopods, and bryozoans supports the homology of the lophophore and the monophyly of the lophophorates.	[Temereva, Elena N.] Moscow MV Lomonosov State Univ, Fac Biol, Dept Invertebrate Zool, Moscow 119992, Russia; [Tsitrin, Eugeni B.] Russian Acad Sci, Inst Dev Biol, Moscow 117808, Russia	Lomonosov Moscow State University; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences	Temereva, EN (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Dept Invertebrate Zool, Moscow 119992, Russia.	temereva@mail.ru	Temereva, Elena/J-2814-2012	Temereva, Elena/0000-0001-7791-0553	Russian Foundation of Basic Research [14-04-00238, 15-34-20045]; Russian Scientific Fund [14-50-00029, 14-04-262];  [MD-5812.2015.4]	Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Scientific Fund(Russian Science Foundation (RSF)); 	This research was supported in part by several grants. The collection of material was done with support from the Russian Foundation of Basic Research (#14-04-00238, #15-34-20045), the TEM studies are conducted with support from the Russian Scientific Fund (14-50-00029). Innunocytochemical and 3-D investigations were done with support from the Russian Scientific Fund (#14-04-262), and the processing of the paper was supported by Grants of the President of Russia (#MD-5812.2015.4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1977, BIOL BRYOZOANS; Beklemishev V. N., 1944, PRINCIPLES COMP ANAT; Blochmann F., 1892, UNTERSUCHUNGEN BAU B, P1; Blochmann F, 1900, UNTERSUCHUNGEN BAU B, P1; Bullock H., 1965, STRUCTURE FUNCTION N, V1; Caldwell WH, 1882, P R SOC, V34, P371, DOI [10.1098/rspl.1882.0051, DOI 10.1098/RSPL.1882.0051]; Cohen BL, 2013, ZOOL J LINN SOC-LOND, V167, P82, DOI 10.1111/j.1096-3642.2012.00869.x; Emig C. C., 1976, Z ZOOLOGISCHE SYSEMT, V14, P1; EMIG CC, 1976, ZOOL SCR, V5, P133, DOI 10.1111/j.1463-6409.1976.tb00690.x; EMIG CC, 1977, B SOC ZOOL FR, V102, P341; Fernandez I, 1996, J MORPHOL, V230, P265, DOI 10.1002/(SICI)1097-4687(199612)230:3<265::AID-JMOR2>3.0.CO;2-D; Gerwerzhagen A., 1913, BEITRAGE KENNTNIS BR; GILMOUR THJ, 1978, CAN J ZOOL, V56, P2142, DOI 10.1139/z78-290; GILMOUR THJ, 1981, CAN J ZOOL, V59, P1539, DOI 10.1139/z81-209; GORDON DP, 1974, MAR BIOL, V27, P147; HALANYCH KM, 1995, SCIENCE, V267, P1641, DOI 10.1126/science.7886451; Hancock A., 1858, PHILOS T R SOC LONDO, V148, P791, DOI [10.1098/rstl.1858.0034, DOI 10.1098/RSTL.1858.0034]; Hatschek B., 1888, LEHRBUCH ZOOLOGIE; Hausdorf B, 2010, MOL PHYLOGENET EVOL, V55, P1121, DOI 10.1016/j.ympev.2009.12.022; Helmkampf M, 2008, MOL PHYLOGENET EVOL, V46, P206, DOI 10.1016/j.ympev.2007.09.004; Hyman LH., 1959, INVERTEBRATES, P516; JAMES MA, 1992, ADV MAR BIOL, V28, P175, DOI 10.1016/S0065-2881(08)60040-1; James MA, 1997, MICROSCOPIC ANATOMY, V13, P297; Malakhov V, 1998, VESTIMENTIFERANS GUT; Malakhov VV., 2007, PALEONTOL J, V5, P1, DOI [10.1017/S1477201906001957, DOI 10.1017/S1477201906001957]; Nesnidal MP, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-253; Nielsen C, 1998, MAR ECOL PROG SER, V168, P163, DOI 10.3354/meps168163; NIELSEN C, 1987, ACTA ZOOL-STOCKHOLM, V68, P205, DOI 10.1111/j.1463-6395.1987.tb00892.x; Nielsen C, 2002, INVERTEBR BIOL, V121, P255; PARDOS F, 1991, ACTA ZOOL-STOCKHOLM, V72, P81, DOI 10.1111/j.1463-6395.1991.tb00320.x; PARDOS F, 1993, CAN J ZOOL, V71, P1861, DOI 10.1139/z93-265; REED CG, 1977, CELL TISSUE RES, V185, P17; Santagata S, 2009, ZOOL J LINN SOC-LOND, V157, P34, DOI 10.1111/j.1096-3642.2009.00531.x; Schwaha T, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-23; Shunkina KV, 2015, FRONTIERS Z IN PRESS, DOI [10.1186/s12983-015-0098-9, DOI 10.1186/S12983-015-0098-9]; SILEN LARS, 1954, ARKIV ZOOL, V6, P1; Storch V., 1976, Zoologische Jb (Anat), V96, P225; Sutton MD, 2011, BIOL LETTERS, V7, P146, DOI 10.1098/rsbl.2010.0540; Temereva EN, 2010, RUSS J MAR BIOL+, V36, P109, DOI 10.1134/S1063074010020057; Temereva E. N., 2009, BIOLOGIYA MORYA-MARINE BIOLOGY, V35, P425; Temereva EN, 2009, RUSS J MAR BIOL+, V35, P388, DOI 10.1134/S1063074009050046; Temereva EN, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-35; Temereva EN, 2015, J ZOOLOGY IN PRESS, V295; Van Bemmelen JFV., 1883, JENA Z NATURW, V16, P88; Wang H, 2014, OLDEST GLOSSELLINE L, DOI [10.1080/11035897.2014.914969, DOI 10.1080/11035897.2014.914969]; Weber AV, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0089-2; Williams Alwyn, 1997, P7	47	34	35	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123040	10.1371/journal.pone.0123040	http://dx.doi.org/10.1371/journal.pone.0123040			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901745	gold, Green Published, Green Submitted			2022-12-27	WOS:000353331500038
J	Wolff, W; Schindler, S; Brand, R				Wolff, Wanja; Schindler, Sebastian; Brand, Ralf			The Effect of Implicitly Incentivized Faking on Explicit and Implicit Measures of Doping Attitude: When Athletes Want to Pretend an Even More Negative Attitude to Doping	PLOS ONE			English	Article							ASSOCIATION TEST; PERFORMANCE; VALIDITY; COGNITION	The Implicit Association Test (IAT) aims to measure participants' automatic evaluation of an attitude object and is useful especially for the measurement of attitudes related to socially sensitive subjects, e.g. doping in sports. Several studies indicate that IAT scores can be faked on instruction. But fully or semi-instructed research scenarios might not properly reflect what happens in more realistic situations, when participants secretly decide to try faking the test. The present study is the first to investigate IAT faking when there is only an implicit incentive to do so. Sixty-five athletes (22.83 years +/- 2.45; 25 women) were randomly assigned to an incentive-to-fake condition or a control condition. Participants in the incentive-to-fake condition were manipulated to believe that athletes with lenient doping attitudes would be referred to a tedious 45-minute anti-doping program. Attitudes were measured with the pictorial doping brief IAT (BIAT) and with the Performance Enhancement Attitude Scale (PEAS). A one-way MANOVA revealed significant differences between conditions after the manipulation in PEAS scores, but not in the doping BIAT. In the light of our hypothesis this suggests that participants successfully faked an exceedingly negative attitude to doping when completing the PEAS, but were unsuccessful in doing so on the reaction time-based test. This study assessed BIAT faking in a setting that aimed to resemble a situation in which participants want to hide their attempts to cheat. The two measures of attitude were differentially affected by the implicit incentive. Our findings provide evidence that the pictorial doping BIAT is relatively robust against spontaneous and naive faking attempts. (B) IATs might be less prone to faking than implied by previous studies.	[Wolff, Wanja; Brand, Ralf] Univ Potsdam, Div Sport & Exercise Psychol, Potsdam, Germany; [Schindler, Sebastian] Univ Bielefeld, Dept Psychol, D-33615 Bielefeld, Germany; [Schindler, Sebastian] Univ Bielefeld, Ctr Excellence Cognit Interact Technol CITEC, D-33615 Bielefeld, Germany	University of Potsdam; University of Bielefeld; University of Bielefeld	Brand, R (corresponding author), Univ Potsdam, Div Sport & Exercise Psychol, Potsdam, Germany.	ralf.brand@uni-potsdam.de	Schindler, Sebastian/D-1840-2012; Brand, Ralf/A-6079-2009; Wolff, Wanja/Q-6714-2019	Schindler, Sebastian/0000-0002-7054-5431; Wolff, Wanja/0000-0001-8130-0272; Brand, Ralf/0000-0003-3143-4816	German Federal Institute of Sport Science [IIA1-070302/12-13]	German Federal Institute of Sport Science	This research was funded by the German Federal Institute of Sport Science (IIA1-070302/12-13). The authors acknowledge support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Funds of Bielefeld University Library. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APA, 2002, AM PSYCHOL, V57, P569; Brand R, 2014, SUBST ABUSE TREAT PR, V9, DOI 10.1186/1747-597X-9-36; Brand R, 2014, SUBST ABUSE TREAT PR, V9, DOI 10.1186/1747-597X-9-7; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Cvencek D, 2010, BASIC APPL SOC PSYCH, V32, P302, DOI 10.1080/01973533.2010.519236; Egloff B, 2002, J PERS SOC PSYCHOL, V83, P1441, DOI 10.1037/0022-3514.83.6.1441; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; Fiedler K, 2005, BASIC APPL SOC PSYCH, V27, P307, DOI 10.1207/s15324834basp2704_3; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Gucciardi DF, 2010, PSYCHOL SPORT EXERC, V11, P479, DOI 10.1016/j.psychsport.2010.06.002; Kampfe N, 2009, PSYCHOL CRIME LAW, V15, P1, DOI 10.1080/10683160802010640; Karpinski A, 2006, J PERS SOC PSYCHOL, V91, P16, DOI 10.1037/0022-3514.91.1.16; Kim DY, 2003, SOC PSYCHOL QUART, V66, P83, DOI 10.2307/3090143; Ntoumanis N, 2014, SPORTS MED, V44, P1603, DOI 10.1007/s40279-014-0240-4; Ortega A, 2012, ARCH CLIN NEUROPSYCH, V27, P453, DOI 10.1093/arclin/acs038; Paulus DL, 1994, BALANCED INVENTORY D; Petroczi A., 2014, PERFORMANCE ENHANCEM, V2, P164, DOI DOI 10.1016/J; Petroczi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018804; Petroczi A, 2009, PSYCHOL SPORT EXERC, V10, P390, DOI 10.1016/j.psychsport.2008.11.001; Rohner J, 2013, J RES PERS, V47, P330, DOI 10.1016/j.jrp.2013.02.009; Rohner J, 2011, EXP PSYCHOL, V58, P464, DOI 10.1027/1618-3169/a000114; Schindler Sebastian, 2013, BMC Psychol, V1, P12, DOI 10.1186/2050-7283-1-12; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Sriram N, 2009, EXP PSYCHOL, V56, P283, DOI 10.1027/1618-3169.56.4.283; Steffens MC, 2004, EXP PSYCHOL, V51, P165, DOI 10.1027/1618-3169.51.3.165; Stieger S, 2011, PSYCHOL REP, V109, P219, DOI 10.2466/03.09.22.28.PR0.109.4.219-230; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909	31	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0118507	10.1371/journal.pone.0118507	http://dx.doi.org/10.1371/journal.pone.0118507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KV	25902142	Green Published, gold, Green Submitted			2022-12-27	WOS:000353331500002
J	Flood-Nichols, SK; Tinnemore, D; Huang, RR; Napolitano, PG; Ippolito, DL				Flood-Nichols, Shannon K.; Tinnemore, Deborah; Huang, Raywin R.; Napolitano, Peter G.; Ippolito, Danielle L.			Vitamin D Deficiency in Early Pregnancy	PLOS ONE			English	Article							25-HYDROXYVITAMIN D CONCENTRATIONS; GESTATIONAL DIABETES-MELLITUS; D SUPPLEMENTATION; MICRONUTRIENT SUPPLEMENTATION; RISK; PREECLAMPSIA; BIRTH; WOMEN; TIME; AGE	Objective Vitamin D deficiency is a common problem in reproductive-aged women in the United States. The effect of vitamin D deficiency in pregnancy is unknown, but has been associated with adverse pregnancy outcomes. The objective of this study was to analyze the relationship between vitamin D deficiency in the first trimester and subsequent clinical outcomes. Study Design This is a retrospective cohort study. Plasma was collected in the first trimester from 310 nulliparous women with singleton gestations without significant medical problems. Competitive enzymatic vitamin D assays were performed on banked plasma specimens and pregnancy outcomes were collected after delivery. Logistic regression was performed on patients stratified by plasma vitamin D concentration and the following combined clinical outcomes: preeclampsia, preterm delivery, intrauterine growth restriction, gestational diabetes, and spontaneous abortion. Results Vitamin D concentrations were obtained from 235 patients (mean age 24.3 years, range 18-40 years). Seventy percent of our study population was vitamin D insufficient with a serum concentration less than 30 ng/mL (mean serum concentration 27.6 ng/mL, range 13-71.6 ng/mL). Logistic regression was performed adjusting for age, race, body mass index, tobacco use, and time of year. Adverse pregnancy outcomes included preeclampsia, growth restriction, preterm delivery, gestational diabetes, and spontaneous abortion. There was no association between vitamin D deficiency and composite adverse pregnancy outcomes with an adjusted odds ratio of 1.01 (p value 0.738, 95% confidence intervals 0.961-1.057). Conclusion Vitamin D deficiency did not associate with adverse pregnancy outcomes in this study population. However, the high percentage of affected individuals highlights the prevalence of vitamin D deficiency in young, reproductive-aged women.	[Flood-Nichols, Shannon K.; Napolitano, Peter G.] Madigan Army Med Ctr, Div Maternal Fetal Med, Joint Base Lewis McChord, Tacoma, WA 98431 USA; [Tinnemore, Deborah; Huang, Raywin R.; Ippolito, Danielle L.] Madigan Army Med Ctr, Dept Clin Invest, Joint Base Lewis McChord, Tacoma, WA 98431 USA	Madigan Army Medical Center; Madigan Army Medical Center	Flood-Nichols, SK (corresponding author), Madigan Army Med Ctr, Div Maternal Fetal Med, Joint Base Lewis McChord, Tacoma, WA 98431 USA.	Shannon.Flood@us.army.mil						Abouzeid M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005394; Albrecht SS, 2010, DIABETES CARE, V33, P768, DOI 10.2337/dc09-1801; American College of Obstetricians and Gynecologists, 2011, OBSTET GYNECOL, V118, P197, DOI [DOI 10.1097/A0G.0B013E318227F06B, 10.1097/aog.0b013e318227f06b]; Ananth Cande V, 2013, BMJ, V347, pf6564, DOI 10.1136/bmj.f6564; Anna V, 2008, DIABETES CARE, V31, P2288, DOI 10.2337/dc08-1038; [Anonymous], 2010, Obstet Gynecol, V116, P1241, DOI 10.1097/AOG.0b013e3182004fcd; [Anonymous], 2009, Obstet Gynecol, V113, P748, DOI 10.1097/AOG.0b013e31819e9ee2; [Anonymous], 2002, INT J GYNECOL OBSTET, V78, P179; [Anonymous], 2012, OBSTET GYNECOL, V120, P964; Ashoor G, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.029; Azar M, 2011, DIABETES CARE, V34, P1258, DOI 10.2337/dc10-2145; Baker AM, 2012, DIABETES-METAB RES, V28, P164, DOI 10.1002/dmrr.1282; Baker AM, 2011, AM J PERINAT, V28, P667, DOI 10.1055/s-0031-1276731; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Bodnar LM, 2007, J CLIN ENDOCR METAB, V92, P3517, DOI 10.1210/jc.2007-0718; Bodnar LM, 2010, OBSTET GYNECOL SURV, V65, P273, DOI 10.1097/OGX.0b013e3181dbc55b; Bodnar LM, 2010, J NUTR, V140, P999, DOI 10.3945/jn.109.119636; BROOKE OG, 1980, BMJ-BRIT MED J, V280, P751, DOI 10.1136/bmj.280.6216.751; Brough L, 2010, BRIT J NUTR, V104, P437, DOI 10.1017/S0007114510000747; Burris HH, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-013-0451-3; Burris HH, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.022; Burris HH, 2012, ANN EPIDEMIOL, V22, P581, DOI 10.1016/j.annepidem.2012.04.015; Christesen HT, 2012, ACTA OBSTET GYN SCAN, V91, P1357, DOI 10.1111/aogs.12000; Christian P, 2003, AM J CLIN NUTR, V78, P1194, DOI 10.1093/ajcn/78.6.1194; Clifton-Bligh RJ, 2008, DIABETIC MED, V25, P678, DOI 10.1111/j.1464-5491.2008.02422.x; Committee on Practice Bulletins-obstetrics, 2013, OBSTET GYNECOL, V131, P49, DOI DOI 10.1097/01.AOG.0000433006.09219.F1; Dabelea D, 2005, DIABETES CARE, V28, P579, DOI 10.2337/diacare.28.3.579; DELVIN EE, 1986, J PEDIATR-US, V109, P328, DOI 10.1016/S0022-3476(86)80396-1; DeSisto CL, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130415; Dolea C, 2003, EVIDENCE INFORM PILI, P1; Dunlop AL, 2012, REPROD SCI, V19, P939, DOI 10.1177/1933719112438442; Farrant HJW, 2009, EUR J CLIN NUTR, V63, P646, DOI 10.1038/ejcn.2008.14; Fernandez-Alonso AM, 2012, INT J GYNECOL OBSTET, V116, P6, DOI 10.1016/j.ijgo.2011.07.029; Gernand AD, 2013, J CLIN ENDOCR METAB, V98, P398, DOI 10.1210/jc.2012-3275; Getahun D, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.11.017; Ginde AA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.036; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P176, DOI 10.1016/j.diabres.2013.11.003; Halhali A, 2000, J CLIN ENDOCR METAB, V85, P1828, DOI 10.1210/jc.85.5.1828; Haugen M, 2009, EPIDEMIOLOGY, V20, P720, DOI 10.1097/EDE.0b013e3181a70f08; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Hollis BW, 2013, CALCIFIED TISSUE INT, V92, P128, DOI 10.1007/s00223-012-9607-4; Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463; Hossein-nezhad A, 2013, MAYO CLIN PROC, V88, P720, DOI 10.1016/j.mayocp.2013.05.011; Hypponen E, 2007, EUR J CLIN NUTR, V61, P1136, DOI 10.1038/sj.ejcn.1602625; Johnson DD, 2011, AM J PERINAT, V28, P7, DOI 10.1055/s-0030-1262505; Katon J, 2014, J WOMENS HEALTH, V23, P792, DOI 10.1089/jwh.2013.4681; Kolusari A, 2008, J INT MED RES, V36, P1335, DOI 10.1177/147323000803600622; LABRIJIMESTAGHANMI H, 1988, J ENDOCRINOL INVEST, V11, P577, DOI 10.1007/BF03350185; Leffelaar ER, 2010, BRIT J NUTR, V104, P108, DOI 10.1017/S000711451000022X; Lifshitz F, 2007, PEDIAT ENDOCRINOLOGY, P1; Looker AC, 2008, AM J CLIN NUTR, V88, P1519, DOI 10.3945/ajcn.2008.26182; Maghbooli Z, 2008, DIABETES-METAB RES, V24, P27, DOI 10.1002/dmrr.737; Makgoba M, 2011, DIABETES CARE, V34, P1091, DOI 10.2337/dc10-2264; Martin JA, 2014, NCHS DATA BRIEF, P1; McCullough ML, 2009, J AM COLL NUTR, V28, P678, DOI 10.1080/07315724.2009.10719801; Merewood A, 2009, J CLIN ENDOCR METAB, V94, P940, DOI 10.1210/jc.2008-1217; Ness RB, 1996, AM J OBSTET GYNECOL, V175, P1365, DOI 10.1016/S0002-9378(96)70056-X; Pawley N, 2004, AM J CLIN NUTR, V80, p1748S, DOI 10.1093/ajcn/80.6.1748S; Powe CE, 2010, HYPERTENSION, V56, P758, DOI 10.1161/HYPERTENSIONAHA.110.158238; Roberts CL, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000101; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Robinson Christopher J, 2011, Am J Obstet Gynecol, V204, DOI 10.1016/j.ajog.2011.03.022; Romo Agustin, 2009, Pediatr Endocrinol Rev, V6 Suppl 3, P332; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Samadi AR, 1996, OBSTET GYNECOL, V87, P557, DOI 10.1016/0029-7844(95)00480-7; Sibai BM, 2003, SEMIN PERINATOL, V27, P239, DOI 10.1016/S0146-0005(03)00022-3; Wallis AB, 2008, AM J HYPERTENS, V21, P521, DOI 10.1038/ajh.2008.20; Wang XB, 2003, FERTIL STERIL, V79, P577, DOI 10.1016/S0015-0282(02)04694-0; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Wei SQ, 2013, J MATERN-FETAL NEO M, V26, P889, DOI 10.3109/14767058.2013.765849; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; Yetley EA, 2008, AM J CLIN NUTR, V88, p558S, DOI 10.1093/ajcn/88.2.558S; Zhang CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003753	75	56	60	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123763	10.1371/journal.pone.0123763	http://dx.doi.org/10.1371/journal.pone.0123763			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898021	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600041
J	Ho, MH; Chen, CH; Goodwin, JS; Wang, BY; Xie, H				Ho, Meng-Hsuan; Chen, Chin-Ho; Goodwin, J. Shawn; Wang, Bing-Yan; Xie, Hua			Functional Advantages of Porphyromonas gingivalis Vesicles	PLOS ONE			English	Article							OUTER-MEMBRANE VESICLES; EPITHELIAL-CELLS; PERIODONTAL PATHOGENS; BACTERIAL INVASION; FIMBRIAE; PROTEIN; DNA; BIOGENESIS; VIRULENCE; DISEASE	Porphyromonas gingivalis is a keystone pathogen of periodontitis. Outer membrane vesicles (OMVs) have been considered as both offense and defense components of this bacterium. Previous studies indicated that like their originating cells, P. gingivalis vesicles, are able to invade oral epithelial cells and gingival fibroblasts, in order to promote aggregation of some specific oral bacteria and to induce host immune responses. In the present study, we investigated the invasive efficiency of P. gingivalis OMVs and compared results with that of the originating cells. Results revealed that 70-90% of human primary oral epithelial cells, gingival fibroblasts, and human umbilical vein endothelial cells carried vesicles from P. gingivalis 33277 after being exposed to the vesicles for 1 h, while 20-50% of the host cells had internalized P. gingivalis cells. We also detected vesicle-associated DNA and RNA and a vesicle-mediated horizontal gene transfer in P. gingivalis strains, which represents a novel mechanism for gene transfer between P. gingivalis strains. Moreover, purified vesicles of P. gingivalis appear to have a negative impact on biofilm formation and the maintenance of Streptococcus gordonii. Our results suggest that vesicles are likely the best offence weapon of P. gingivalis for bacterial survival in the oral cavity and for induction of periodontitis.	[Ho, Meng-Hsuan; Xie, Hua] Meharry Med Coll, Sch Dent, Nashville, TN 37208 USA; [Chen, Chin-Ho] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Goodwin, J. Shawn] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Wang, Bing-Yan] Univ Texas Houston, Dept Periodont, Sch Dent, Hlth Sci Ctr Houston, Houston, TX USA	Meharry Medical College; Duke University; Meharry Medical College; University of Texas System; University of Texas Health Science Center Houston	Xie, H (corresponding author), Meharry Med Coll, Sch Dent, Nashville, TN 37208 USA.	hxie@mmc.edu			Public Health Service grant from NIDCR [DE020915, DE022428]; NIMHD [MD007593, MD007586]; National Center for Research Resources [UL1 RR024975-01]; National Center for Advancing Translational Sciences [2 UL1 TR000445-06]; NATIONAL CANCER INSTITUTE [U54CA163069] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975, S10RR025497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE022428, R21DE020915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R24DA036420] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007586, U54MD007593] Funding Source: NIH RePORTER	Public Health Service grant from NIDCR; NIMHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by Public Health Service grant DE020915 and DE022428 (HX) from NIDCR and by MD007593 and MD007586 from NIMHD. The project described was also supported by the National Center for Research Resources, grant UL1 RR024975-01, which is now mediated by the National Center for Advancing Translational Sciences under another agency number (grant 2 UL1 TR000445-06).	Beck J, 1996, J PERIODONTOL, V67, P1123, DOI 10.1902/jop.1996.67.10s.1123; Berleman J, 2013, ENVIRON MICROBIOL, V15, P347, DOI 10.1111/1462-2920.12048; Biller SJ, 2014, SCIENCE, V343, P183, DOI 10.1126/science.1243457; Bonnington KE, 2013, BIOCH BIOPHYS ACTA; Daep CA, 2008, INFECT IMMUN, V76, P3273, DOI 10.1128/IAI.00366-08; Daep CA, 2010, PEPTIDES, V31, P2173, DOI 10.1016/j.peptides.2010.08.014; Deatherage BL, 2009, MOL MICROBIOL, V72, P1395, DOI 10.1111/j.1365-2958.2009.06731.x; Elkaim R, 2008, J PERIODONTAL RES, V43, P224, DOI 10.1111/j.1600-0765.2007.01018.x; Furuta N, 2009, INFECT IMMUN, V77, P4187, DOI 10.1128/IAI.00009-09; GRENIER D, 1987, INFECT IMMUN, V55, P111, DOI 10.1128/IAI.55.1.111-117.1987; Grenier D, 2003, INFECT IMMUN, V71, P4742, DOI 10.1128/IAI.71.8.4742-4748.2003; Grenier D, 2013, INT J DENT, V2013, DOI 10.1155/2013/305476; Hajishengallis G, 2014, EUR J IMMUNOL, V44, P328, DOI 10.1002/eji.201344202; HANDLEY PS, 1986, ARCH ORAL BIOL, V31, P325, DOI 10.1016/0003-9969(86)90047-6; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; Inagaki S, 2006, INFECT IMMUN, V74, P5023, DOI 10.1128/IAI.00062-06; Kadurugamuwa JL, 1996, J BACTERIOL, V178, P2767, DOI 10.1128/jb.178.10.2767-2774.1996; Kamaguchi A, 2003, CURR MICROBIOL, V47, P485, DOI 10.1007/s00284-003-4069-6; Kerr JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091696; Klieve AV, 2005, APPL ENVIRON MICROB, V71, P4248, DOI 10.1128/AEM.71.8.4248-4253.2005; Kolling GL, 1999, APPL ENVIRON MICROB, V65, P1843; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kozarov E, 2006, MICROBES INFECT, V8, P687, DOI 10.1016/j.micinf.2005.09.004; Kozarov EV, 2005, ARTERIOSCL THROM VAS, V25, pE17, DOI 10.1161/01.ATV.0000155018.67835.1a; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Lamont RJ, 2002, PERIODONTOL 2000, V30, P61, DOI 10.1034/j.1600-0757.2002.03006.x; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lin XH, 2006, INFECT IMMUN, V74, P6011, DOI 10.1128/IAI.00797-06; LOSTORTO S, 1992, J PERIODONTAL RES, V27, P161; Maeda K, 2004, MICROBES INFECT, V6, P1163, DOI 10.1016/j.micinf.2004.06.005; Mantri CK, 2014, MICROBIOLOGYOPEN; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Nakao R, 2014, MICROBES INFECT, V16, P6, DOI 10.1016/j.micinf.2013.10.005; Nakao R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026163; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Park Y, 2005, INFECT IMMUN, V73, P3983, DOI 10.1128/IAI.73.7.3983-3989.2005; Qi MS, 2003, MICROB PATHOGENESIS, V35, P259, DOI 10.1016/j.micpath.2003.07.002; Rafferty B, 2011, J INTERN MED, V270, P273, DOI 10.1111/j.1365-2796.2011.02373.x; Reyes L, 2013, J PERIODONTOL, V84, pS30, DOI [10.1902/jop.2013.1340012, 10.1111/jcpe.12079]; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rumbo C, 2011, ANTIMICROB AGENTS CH, V55, P3084, DOI 10.1128/AAC.00929-10; Silverman RJ, 2010, INFECT IMMUN, V78, P4644, DOI 10.1128/IAI.00685-10; Tashiro Y, 2010, APPL ENVIRON MICROB, V76, P3732, DOI 10.1128/AEM.02794-09; Tribble GD, 2007, J BACTERIOL, V189, P6382, DOI 10.1128/JB.00460-07; Tribble GD, 2012, MBIO, V3, DOI 10.1128/mBio.00231-11; Tribble GD, 2010, PERIODONTOL 2000, V52, P68, DOI 10.1111/j.1600-0757.2009.00323.x; Veith PD, 2014, J PROTEOME RES; Velimirov Branko, 2011, Mob Genet Elements, V1, P80; Weinberg A, 1997, INFECT IMMUN, V65, P313, DOI 10.1128/IAI.65.1.313-316.1997; Yilmaz O, 2002, CELL MICROBIOL, V4, P305, DOI 10.1046/j.1462-5822.2002.00192.x; Zheng C, 2011, MOL ORAL MICROBIOL, V26, P388, DOI 10.1111/j.2041-1014.2011.00626.x	51	74	81	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123448	10.1371/journal.pone.0123448	http://dx.doi.org/10.1371/journal.pone.0123448			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897780	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600026
J	Khawaja, SG; Mushtaq, MH; Khan, SA; Akram, MU; Jamal, HU				Khawaja, Sajid Gul; Mushtaq, Mian Hamza; Khan, Shoab A.; Akram, M. Usman; Jamal, Habib Ullah			Designing Area Optimized Application-Specific Network-On-Chip Architectures while Providing Hard QoS Guarantees	PLOS ONE			English	Article							SYSTEMS	With the increase of transistors' density, popularity of System on Chip (SoC) has increased exponentially. As a communication module for SoC, Network on Chip (NoC) framework has been adapted as its backbone. In this paper, we propose a methodology for designing area-optimized application specific NoC while providing hard Quality of Service (QoS) guarantees for real time flows. The novelty of the proposed system lies in derivation of a Mixed Integer Linear Programming model which is then used to generate a resource optimal Network on Chip (NoC) topology and architecture while considering traffic and QoS requirements. We also present the micro-architectural design features used for enabling traffic and latency guarantees and discuss how the solution adapts for dynamic variations in the application traffic. The paper highlights the effectiveness of proposed method by generating resource efficient NoC solutions for both industrial and benchmark applications. The area-optimized results are generated in few seconds by proposed technique, without resorting to heuristics, even for an application with 48 traffic flows.	[Khawaja, Sajid Gul; Mushtaq, Mian Hamza; Khan, Shoab A.; Akram, M. Usman] Natl Univ Sci & Technol, Dept Comp Engn, Islamabad, Pakistan; [Jamal, Habib Ullah] Ghulam Ishaq Khan Inst, Topi, Pakistan	National University of Sciences & Technology - Pakistan; GIK Institute Engineering Science & Technology	Akram, MU (corresponding author), Natl Univ Sci & Technol, Dept Comp Engn, Islamabad, Pakistan.	usman.akram@ceme.nust.edu.pk	Akram, Muhammad Usman/AAD-7343-2020	Akram, Muhammad Usman/0000-0002-6208-7231; Khawaja, Sajid/0000-0002-2409-3470				Abderazek B. A., 2007, MATH MODEL MULTIOBJE, V36; Angiolini F., 2011, EMBEDDED SYSTEMS, P127; Atienza D, 2008, INTEGRATION, V41, P340, DOI 10.1016/j.vlsi.2007.12.002; Bjerregaard T, 2005, INT SYMP ASYNCHRON C, P34, DOI 10.1109/ASYNC.2005.7; Chan Jeremy, 2008, 13th Asia and South Pacific Design Automation Conference ASP-DAC 2008, P265; Goossens K, 2005, IEEE DES TEST COMPUT, V22, P414, DOI 10.1109/MDT.2005.99; Hansson A, 2009, IET COMPUT DIGIT TEC, V3, P398, DOI 10.1049/iet-cdt.2008.0093; Hansson A, 2011, DES AUTOM EMBED SYST, V15, P159, DOI 10.1007/s10617-011-9073-7; Melonit P., 2006, AREA POWER MODELING, P1; Minje Jun, 2008, 13th Asia and South Pacific Design Automation Conference ASP-DAC 2008, P583; Murali S, 2009, ASIA S PACIF DES AUT, P242, DOI 10.1109/ASPDAC.2009.4796487; Rahmati D., 2009, METHOD CALCULATING H, P579; Schmitt J. B., 2008, DELAY BOUNDS ARBITRA, P1669; Srinivasan K, 2004, PR IEEE COMP DESIGN, P422, DOI 10.1109/ICCD.2004.1347957; Srinivasan K, 2006, ISQED 2006: PROCEEDINGS OF THE 7TH INTERNATIONAL SYMPOSIUM ON QUALITY ELECTRONIC DESIGN, P352; Tino A, 2011, MICROPROCESS MICROSY, V35, P523, DOI 10.1016/j.micpro.2011.05.002; Wang XH, 2010, ACM T ARCHIT CODE OP, V7, DOI 10.1145/1736065.1736066; Wiggers M. H., 2009, APERIODIC MULTIPROCE	18	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0125230	10.1371/journal.pone.0125230	http://dx.doi.org/10.1371/journal.pone.0125230			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898016	Green Submitted, Green Published, gold			2022-12-27	WOS:000353212600101
J	de Jager, P; Chirwa, T; Naidoo, S; Perovic, O; Thomas, J				de Jager, Pieter; Chirwa, Tobias; Naidoo, Shan; Perovic, Olga; Thomas, Juno			Nosocomial Outbreak of New Delhi Metallo-beta-Lactamase-1-Producing Gram-Negative Bacteria in South Africa: A Case-Control Study	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; KLEBSIELLA-PNEUMONIAE; EMERGING CARBAPENEMASES; RISK-FACTORS; INFECTIONS; EMERGENCE; MORTALITY; NDM-1; 21ST-CENTURY	Objective New Delhi metallo-beta-lactamase (NDM)-producing Gram-negative bacteria have spread globally and pose a significant public health threat. There is a need to better define risk factors and outcomes of NDM-1 clinical infection. We assessed risk factors for nosocomial infection with NDM-1-producers and associated in-hospital mortality. Methods A matched case-control study was conducted during a nosocomial outbreak of NDM-1-producers in an adult intensive care unit (ICU) in South Africa. All patients from whom NDM-1-producers were identified were considered (n=105). Cases included patients admitted during the study period in whom NDM-1 producing Gram-negative bacteria were isolated from clinical specimens collected >= 48 hours after admission, and where surveillance definitions for healthcare-associated infections were met. Controls were matched for age, sex, date of hospital admission and intensive-care admission. Conditional logistic regression was used to identify risk factors for NDM-1 clinical infection and associated in-hospital mortality. Findings 38 cases and 68 controls were included. Klebsiella pneumoniae was the most common NDM-1-producer (28/38, 74%). Cases had longer mean hospital stays (44.0 vs. 13.3 days; P < 0.001) and ICU stays (32.5 vs. 8.3 days; P < 0.001). Adjusting for co-morbid disease, the in-hospital mortality of cases was significantly higher than controls (55.3% vs. 14.7%; AOR, 11.29; P < 0.001). Higher Charlson co-morbidity index score (5.2 vs. 4.1; AOR, 1.59; P = 0.005), mechanical ventilation days (7.47 vs. 0.94 days; AOR, 1.32; P = 0.003) and piperacillin/tazobactam exposure (11.03 vs. 1.05 doses; AOR, 1.08; P = 0.013) were identified as risk factors on multivariate analysis. Cases had a significantly higher likelihood of in-hospital mortality when the NDM-1-producer was Klebsiella pneumoniae (AOR, 16.57; P = 0.007), or when they had a bloodstream infection (AOR, 8.84; P = 0.041). Conclusion NDM- 1 infection is associated with significant in-hospital mortality. Risk factors for hospital-associated infection include the presence of co-morbid disease, mechanical ventilation and piperacillin/tazobactam exposure.	[de Jager, Pieter] Natl Inst Occupat Hlth, Natl Hlth Lab Serv, Epidemiol & Surveillance Unit, Johannesburg, South Africa; [de Jager, Pieter; Naidoo, Shan] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Dept Community Hlth, Johannesburg, South Africa; [Chirwa, Tobias] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Johannesburg, South Africa; [Perovic, Olga] Natl Inst Communicable Dis, Trop & Hosp Infect, Ctr Opportunist, Natl Hlth Lab Serv, Johannesburg, South Africa; [Perovic, Olga] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Dept Clin Microbiol & Infect Dis, Johannesburg, South Africa; [Thomas, Juno] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Outbreak Response Unit, Johannesburg, South Africa	National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; National Health Laboratory Service; National Institute for Communicable Diseases (NICD)	de Jager, P (corresponding author), Natl Inst Occupat Hlth, Natl Hlth Lab Serv, Epidemiol & Surveillance Unit, Johannesburg, South Africa.	Pieter.deJager@wits.ac.za	Perovic, Olga/AAN-8276-2021; Chirwa, Tobias/AAI-9087-2021		School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg	School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg	This work was supported by the School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Bonomo RA, 2011, CLIN INFECT DIS, V52, P485, DOI 10.1093/cid/ciq179; Borgia S, 2012, CLIN INFECT DIS, V55, pE109, DOI 10.1093/cid/cis737; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Brink AJ, 2012, J CLIN MICROBIOL, V50, P525, DOI 10.1128/JCM.05956-11; Castanheira M, 2011, ANTIMICROB AGENTS CH, V55, P1274, DOI 10.1128/AAC.01497-10; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Freire-Moran L, 2011, DRUG RESIST UPDATE, V14, P118, DOI 10.1016/j.drup.2011.02.003; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Higgins TL, 2007, CRIT CARE MED, V35, P827, DOI 10.1097/01.CCM.0000257337.63529.9F; Hirakata Y, 2003, CLIN INFECT DIS, V37, P26, DOI 10.1086/375594; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hyle EP, 2010, INFECT CONT HOSP EP, V31, P1242, DOI 10.1086/657138; Jacoby GA, 2005, NEW ENGL J MED, V352, P380, DOI 10.1056/NEJMra041359; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Livermore DM, 2009, J ANTIMICROB CHEMOTH, V64, P29, DOI 10.1093/jac/dkp255; Lowe CF, 2013, INFECT CONT HOSP EP, V34, P49, DOI 10.1086/668778; Marais E, 2006, SAMJ S AFR MED J, V96, P813; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; Molton JS, 2013, CLIN INFECT DIS, V56, P1310, DOI 10.1093/cid/cit020; Nordmann P, 2002, CLIN MICROBIOL INFEC, V8, P321, DOI 10.1046/j.1469-0691.2002.00401.x; Nordmann P, 2012, CLIN INFECT DIS, V54, P150, DOI 10.1093/cid/cir720; Nordmann P, 2011, TRENDS MICROBIOL, V19, P588, DOI 10.1016/j.tim.2011.09.005; Nordmann P, 2011, J ANTIMICROB CHEMOTH, V66, P689, DOI 10.1093/jac/dkq520; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Peleg AY, 2005, CLIN INFECT DIS, V41, P1549, DOI 10.1086/497831; Schwaber MJ, 2008, ANTIMICROB AGENTS CH, V52, P1028, DOI 10.1128/AAC.01020-07; Struelens MJ, 2010, EUROSURVEILLANCE, V15, P9; Szilagyi E, 2010, ACTA MICROBIOL IMM H, V57, P43, DOI 10.1556/AMicr.57.2010.1.4; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tuon FF, 2012, BRAZ J INFECT DIS, V16, P416, DOI 10.1016/j.bjid.2012.08.006; Walsh TR, 2010, INT J ANTIMICROB AG, V36, pS8, DOI 10.1016/S0924-8579(10)70004-2; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Zarkotou O, 2011, CLIN MICROBIOL INFEC, V17, P1798, DOI 10.1111/j.1469-0691.2011.03514.x	35	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123337	10.1371/journal.pone.0123337	http://dx.doi.org/10.1371/journal.pone.0123337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909482	Green Submitted, Green Published, gold			2022-12-27	WOS:000353376800035
J	Tonkin, JD; Shah, DN; Kuemmerlen, M; Li, FQ; Cai, Q; Haase, P; Jahnig, SC				Tonkin, Jonathan D.; Shah, Deep Narayan; Kuemmerlen, Mathias; Li, Fengqing; Cai, Qinghua; Haase, Peter; Jaehnig, Sonja C.			Climatic and Catchment-Scale Predictors of Chinese Stream Insect Richness Differ between Taxonomic Groups	PLOS ONE			English	Article							MACROINVERTEBRATE DIVERSITY; GLOBAL PATTERNS; HEADWATER STREAMS; SPECIES RICHNESS; LAND-USE; BIODIVERSITY; PRODUCTIVITY; DETERMINANTS; RIVER; DISTURBANCE	Little work has been done on large-scale patterns of stream insect richness in China. We explored the influence of climatic and catchment-scale factors on stream insect (Ephemeroptera, Plecoptera, Trichoptera; EPT) richness across mid-latitude China. We assessed the predictive ability of climatic, catchment land cover and physical structure variables on genus richness of EPT, both individually and combined, in 80 mid-latitude Chinese streams, spanning a 3899-m altitudinal gradient. We performed analyses using boosted regression trees and explored the nature of their influence on richness patterns. The relative importance of climate, land cover, and physical factors on stream insect richness varied considerably between the three orders, and while important for Ephemeroptera and Plecoptera, latitude did not improve model fit for any of the groups. EPT richness was linked with areas comprising high forest cover, elevation and slope, large catchments and low temperatures. Ephemeroptera favoured areas with high forest cover, medium-to-large catchment sizes, high temperature seasonality, and low potential evapotranspiration. Plecoptera richness was linked with low temperature seasonality and annual mean, and high slope, elevation and warm-season rainfall. Finally, Trichoptera favoured high elevation areas, with high forest cover, and low mean annual temperature, seasonality and aridity. Our findings highlight the variable role that catchment land cover, physical properties and climatic influences have on stream insect richness. This is one of the first studies of its kind in Chinese streams, thus we set the scene for more in-depth assessments of stream insect richness across broader spatial scales in China, but stress the importance of improving data availability and consistency through time.	[Tonkin, Jonathan D.; Shah, Deep Narayan; Kuemmerlen, Mathias; Li, Fengqing; Haase, Peter] Senckenberg Res Inst, Dept River Ecol & Conservat, Gelnhausen, Germany; [Tonkin, Jonathan D.; Shah, Deep Narayan; Kuemmerlen, Mathias; Li, Fengqing; Haase, Peter] Nat Hist Museum Frankfurt, Gelnhausen, Germany; [Tonkin, Jonathan D.; Shah, Deep Narayan; Kuemmerlen, Mathias; Li, Fengqing; Haase, Peter] Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Cai, Qinghua] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China; [Jaehnig, Sonja C.] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Dept Ecosyst Res, Berlin, Germany	Senckenberg Gesellschaft fur Naturforschung (SGN); Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Tonkin, JD (corresponding author), Senckenberg Res Inst, Dept River Ecol & Conservat, Gelnhausen, Germany.	jonathan.tonkin@senckenberg.de	Tonkin, Jonathan D/J-4120-2013; Haase, Peter/A-5644-2011; Jähnig, Sonja C/D-7126-2011; Kuemmerlen, Mathias/D-9093-2016	Tonkin, Jonathan D/0000-0002-6053-291X; Jähnig, Sonja C/0000-0002-6349-9561; Kuemmerlen, Mathias/0000-0003-1362-3701; Cai, Qinghua/0000-0002-0224-7256	Deutsche Bundesstiftung Umwelt (DBU); Hesse's Ministry of Environment; research funding program LOEWE (Landes-Offensive zur Entwicklung Wissenschaftlich-oekonomischer Exzellenz) of Hesse's Ministry of Higher Education, Research, and the Arts; German Federal Ministry of Education and Research; German Academic Exchange Service (BMBF) within the program 'Study and research for sustainability: Yangtze region'; Young scientist research award of the University of Duisburg-Essen, Germany; DFG (German Research Foundation) project 'Integrated modelling of the response of aquatic ecosystems to land use and climate change in the Poyang Lake region, China'", NSFC/DFG joint [F0 301/14-1, JA 1827/2-1]; Key Project of Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-YW-427]; National Natural Science Foundation of China [30330140]; German Academic Exchange Service (DAAD) within the program 'Study and research for sustainability: Yangtze region'	Deutsche Bundesstiftung Umwelt (DBU); Hesse's Ministry of Environment; research funding program LOEWE (Landes-Offensive zur Entwicklung Wissenschaftlich-oekonomischer Exzellenz) of Hesse's Ministry of Higher Education, Research, and the Arts; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Academic Exchange Service (BMBF) within the program 'Study and research for sustainability: Yangtze region'; Young scientist research award of the University of Duisburg-Essen, Germany; DFG (German Research Foundation) project 'Integrated modelling of the response of aquatic ecosystems to land use and climate change in the Poyang Lake region, China'", NSFC/DFG joint; Key Project of Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); German Academic Exchange Service (DAAD) within the program 'Study and research for sustainability: Yangtze region'(Deutscher Akademischer Austausch Dienst (DAAD))	This study was financed by Deutsche Bundesstiftung Umwelt (DBU), Hesse's Ministry of Environment, and the research funding program LOEWE (Landes-Offensive zur Entwicklung Wissenschaftlich-oekonomischer Exzellenz) of Hesse's Ministry of Higher Education, Research, and the Arts. During initial fieldwork SCJ was funded by the German Federal Ministry of Education and Research and German Academic Exchange Service (BMBF and DAAD) within the program 'Study and research for sustainability: Yangtze region' with a research fellowship, and by the Young scientist research award 2008 of the University of Duisburg-Essen, Germany. SCJ also acknowledges funding through the DFG (German Research Foundation) project 'Integrated modelling of the response of aquatic ecosystems to land use and climate change in the Poyang Lake region, China'" (F0 301/14-1, JA 1827/2-1) as part of the NSFC/DFG joint funding program 'Land Use and Water Resources Management under Changing Environmental Conditions', and support for fieldtrips within the framework of the DFG-NSF cooperation group 'EcoChange' (GZ465). QC and FL acknowledge funding by the Key Project of Knowledge Innovation Program of the Chinese Academy of Sciences (No. KZCX2-YW-427) and the National Natural Science Foundation of China (No. 30330140).	Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Astorga A, 2011, ECOGRAPHY, V34, P705, DOI 10.1111/j.1600-0587.2010.06427.x; Barber-James HM, 2008, HYDROBIOLOGIA, V595, P339, DOI 10.1007/s10750-007-9028-y; Barbour Michael T., 2006, Limnetica, V25, P839; Beche LA, 2009, BIODIVERS CONSERV, V18, P3909, DOI 10.1007/s10531-009-9688-1; Besemer K, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1760; Brittain J.E., 1990, MAYFLIES STONEFLIES, P1, DOI DOI 10.1007/978-94-009-2397-3_1; Brosse S, 2003, BIODIVERS CONSERV, V12, P2057, DOI 10.1023/A:1024107915183; Brown BL, 2010, J ANIM ECOL, V79, P571, DOI 10.1111/j.1365-2656.2010.01668.x; Buston PM, 2011, J ANIM ECOL, V80, P528, DOI 10.1111/j.1365-2656.2011.01803.x; Clarke A, 2008, FRESHWATER BIOL, V53, P1707, DOI 10.1111/j.1365-2427.2008.02041.x; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; de Moor FC, 2008, HYDROBIOLOGIA, V595, P393, DOI 10.1007/s10750-007-9113-2; Dudgeon D., 1999, TROPICAL ASIAN STREA; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Fang JY, 2012, ECOGRAPHY, V35, P1059, DOI 10.1111/j.1600-0587.2013.00161.x; Favre A, 2015, BIOL REV, V90, P236, DOI 10.1111/brv.12107; Finn DS, 2011, J N AM BENTHOL SOC, V30, P963, DOI 10.1899/11-012.1; Fochetti R, 2008, HYDROBIOLOGIA, V595, P365, DOI 10.1007/s10750-007-9031-3; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Fu CZ, 2003, BIODIVERS CONSERV, V12, P1649, DOI 10.1023/A:1023697714517; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Haidekker A, 2008, AQUAT ECOL, V42, P463, DOI 10.1007/s10452-007-9097-z; Harding JS, 1998, P NATL ACAD SCI USA, V95, P14843, DOI 10.1073/pnas.95.25.14843; Hastie T, 2009, ELEMENTS STAT LEARNI, DOI [10.1016/j.neunet.2009.04.005, DOI 10.1016/J.NEUNET.2009.04.005]; Heino J, 2003, J ANIM ECOL, V72, P425, DOI 10.1046/j.1365-2656.2003.00711.x; Heino J, 2008, ECOL ENTOMOL, V33, P614, DOI 10.1111/j.1365-2311.2008.01012.x; Heino Jani, 2009, Freshwater Reviews, V2, P1, DOI 10.1608/FRJ-2.1.1; Heino J, 2009, BIOL REV, V84, P39, DOI 10.1111/j.1469-185X.2008.00060.x; Hijmans R.J., 2013, DISMO SPECIES DISTRI, V0, P8; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Huston M. A., 1994, BIOL DIVERSITY; Jacobsen D, 2004, FRESHWATER BIOL, V49, P1293, DOI 10.1111/j.1365-2427.2004.01274.x; Jacobsen D, 2008, OECOLOGIA, V154, P795, DOI 10.1007/s00442-007-0877-x; Jahnig SC, 2010, J EARTH SCI-CHINA, V21, P876, DOI 10.1007/s12583-010-0140-y; Kondoh M, 2001, P ROY SOC B-BIOL SCI, V268, P269, DOI 10.1098/rspb.2000.1384; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Kuemmerlen M, 2014, ECOL MODEL, V277, P77, DOI 10.1016/j.ecolmodel.2014.01.020; Kuemmerlen M, 2012, HYDROL WASSERBEWIRTS, V56, P185, DOI 10.5675/HyWa_2012,4_3; Lehner B, 2006, HYDROSHEDS TECHNICAL; LENAT D R, 1988, Journal of the North American Benthological Society, V7, P222, DOI 10.2307/1467422; Li FQ, 2012, ECOL INDIC, V23, P394, DOI 10.1016/j.ecolind.2012.04.017; Li FQ, 2010, INT REV HYDROBIOL, V95, P171, DOI 10.1002/iroh.200911212; Liu JY, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021649; Mekong River Commission, 2006, ID FRESHW INV MEK RI; Morse J.C., 1994, AQUATIC INSECTS CHIN; Mykra H, 2007, GLOBAL ECOL BIOGEOGR, V16, P149, DOI 10.1111/j.1466-8238.2006.00272.x; Nesemann H, 2007, AQUATIC INVERTEBRATE; Pausas JG, 2001, J VEG SCI, V12, P153, DOI 10.2307/3236601; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; R Core Team, 2021, R LANGUAGE ENV STAT; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Schmalz B, 2015, ECOHYDROLOGY, V8, P1119, DOI 10.1002/eco.1569; Tang ZY, 2006, FRONT ECOL ENVIRON, V4, P347, DOI 10.1890/1540-9295(2006)004[0347:BICM]2.0.CO;2; de Figueroa JMT, 2010, BIODIVERS CONSERV, V19, P1269, DOI 10.1007/s10531-009-9753-9; Tonkin JD, 2014, FRESHWATER BIOL, V59, P1843, DOI 10.1111/fwb.12387; Tonkin JD, 2014, PEERJ, V2, DOI 10.7717/peerj.465; Tonkin JD, 2013, FUND APPL LIMNOL, V182, P283, DOI 10.1127/1863-9135/2013/0402; Tonkin JD, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00243.1; Tonkin JD, 2013, AQUAT ECOL, V47, P109, DOI 10.1007/s10452-013-9429-0; Tonkin JD, 2013, HYDROBIOLOGIA, V701, P159, DOI 10.1007/s10750-012-1248-0; Vinson MR, 2003, ECOGRAPHY, V26, P751, DOI 10.1111/j.0906-7590.2003.03397.x; Vinson MR, 1998, ANNU REV ENTOMOL, V43, P271, DOI 10.1146/annurev.ento.43.1.271; Wang X, 2011, J FRESHWATER ECOL, V27, P37; Wang ZH, 2012, ECOGRAPHY, V35, P1124, DOI 10.1111/j.1600-0587.2011.06781.x; Wang ZH, 2012, ECOGRAPHY, V35, P1160, DOI 10.1111/j.1600-0587.2012.07786.x; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Yule C.M., 2004, FRESHWATER INVERTEBR; Zhao SQ, 2006, ECOL RES, V21, P890, DOI 10.1007/s11284-006-0048-2; Zorner RJ, 2008, AGR ECOSYST ENVIRON, V126, P67, DOI 10.1016/j.agee.2008.01.014	72	12	12	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123250	10.1371/journal.pone.0123250	http://dx.doi.org/10.1371/journal.pone.0123250			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909190	Green Published, gold			2022-12-27	WOS:000353376800031
J	Kiguba, R; Karamagi, C; Waako, P; Ndagije, HB; Bird, SM				Kiguba, Ronald; Karamagi, Charles; Waako, Paul; Ndagije, Helen B.; Bird, Sheila M.			Rare, Serious, and Comprehensively Described Suspected Adverse Drug Reactions Reported by Surveyed Healthcare Professionals in Uganda	PLOS ONE			English	Article							HEMOPTYSIS	Background Lack of adequate detail compromises analysis of reported suspected adverse drug reactions (ADRs). We investigated how comprehensively Ugandan healthcare professionals (HCPs) described their most recent previous-month suspected ADR, and determined the characteristics of HCPs who provided comprehensive ADR descriptions. We also identified rare, serious, and unanticipated suspected ADR descriptions with medication safety-alerting potential. Methods During 2012/13, this survey was conducted in purposively selected Ugandan health facilities (public/private) including the national referral and six regional referral hospitals representative of all regions. District hospitals, health centres II to IV, and private health facilities in the catchment areas of the regional referral hospitals were conveniently selected. Healthcare professionals involved in prescribing, transcribing, dispensing, and administration of medications were approached and invited to self-complete a questionnaire on ADR reporting. Two-thirds of issued questionnaires (1,345/2,000) were returned. Results Ninety per cent (241/268) of HCPs who suspected ADRs in the previous month provided information on five higher-level descriptors as follows: body site (206), drug class (203), route of administration (127), patient age (133), and ADR severity (128). Comprehensiveness (explicit provision of at least four higher-level descriptors) was achieved by at least two-fifths (46%, 124/268) of HCPs. Received descriptions were more likely to be comprehensive from HCPs in private health facilities, regions other than central, and those not involved in teaching medical students. Overall, 106 serious and 51 rare previous-month suspected ADRs were described. The commonest serious and rare ADR was Stevens-Johnson syndrome (SJS); mostly associated with oral nevirapine or cotrimoxazole, but haemoptysis after diclofenac analgesia and paralysis after quinine injection were also described. Conclusion Surveyed Ugandan HCPs who had suspected at least one ADR in the previous month competently provided comprehensive ADR descriptions: more, indeed, than are received per annum nationally. Properly analyzed, and with local feed-back, voluntary ADR reports by HCPs could be an essential alerting tool for identifying rare and serious suspected ADRs in Uganda.	[Kiguba, Ronald; Waako, Paul] Makerere Univ, Coll Hlth Sci, Dept Pharmacol & Therapeut, Kampala, Uganda; [Karamagi, Charles] Makerere Univ, Coll Hlth Sci, Clin Epidemiol Unit, Kampala, Uganda; [Ndagije, Helen B.] Natl Drug Author, Natl Pharmacovigilance Ctr, Kampala, Uganda; [Bird, Sheila M.] MRC, Biostat Unit, Cambridge CB2 2BW, England	Makerere University; Makerere University; MRC Biostatistics Unit	Kiguba, R (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Pharmacol & Therapeut, Kampala, Uganda.	kiguba@gmail.com		Ndagije, Helen/0000-0001-5802-4791; Kiguba, Ronald/0000-0002-2636-4115	Training Health Researchers into Vocational Excellence (THRiVE) in East Africa [087540]; Wellcome Trust; OGAC, National Institutes of Health (NIH) and (Health Resources and Services Administration (HRSA) [5R24TW008886]; African Doctoral Dissertation Research Fellowship (ADDRF); Medical Research Council programme [MC_U105260794]; FOGARTY INTERNATIONAL CENTER [R24TW008886] Funding Source: NIH RePORTER; Medical Research Council [MC_U105260794] Funding Source: researchfish; MRC [MC_U105260794] Funding Source: UKRI	Training Health Researchers into Vocational Excellence (THRiVE) in East Africa; Wellcome Trust(Wellcome TrustEuropean Commission); OGAC, National Institutes of Health (NIH) and (Health Resources and Services Administration (HRSA); African Doctoral Dissertation Research Fellowship (ADDRF); Medical Research Council programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Training Health Researchers into Vocational Excellence (THRiVE) in East Africa, grant number 087540, funded by the Wellcome Trust to RK; grant number 5R24TW008886 supported by OGAC, National Institutes of Health (NIH) and (Health Resources and Services Administration (HRSA) to RK; and an African Doctoral Dissertation Research Fellowship (ADDRF) award 2013-2015 ADF 006 offered by the African Population and Health Research Centre (APHRC) in partnership with the International Development Research Centre (IDRC) to RK. In UK, SMB is funded by Medical Research Council programme number MC_U105260794. The work here reported is solely the responsibility of the authors and does not necessarily represent the official views of the supporting offices. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actavis UK Ltd, 2013, SUMM PROD CHAR QUIN; [Anonymous], 2009, TABLE GRADING SEVERI; [Anonymous], 2011, CAUSALITY ASSESSMENT; Barvaliya M, 2011, J POSTGRAD MED, V57, P115, DOI 10.4103/0022-3859.81865; BNF, 2013, BRIT NATL FORMULARY; Council for International Organizations of Medical Sciences, 1998, BEN RISK BAL MARK DR; Davies EC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004439; Ekure J, 2006, E CTR AFR J SURG, V12, P144; Etminan M, 2006, J CLIN PHARMACOL, V46, P6, DOI 10.1177/0091270005283285; Gavaza P, 2011, BRIT J CLIN PHARMACO, V72, P143, DOI 10.1111/j.1365-2125.2011.03944.x; Hazell L, 2006, DRUG SAFETY, V29, P385, DOI 10.2165/00002018-200629050-00003; Kiguba R, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005869; National Pharmacovigilance Centre, 2012, WHAT IS CURR PRACT P; National Pharmacovigilance Centre, 2010, WORK TOG PUBL HLTH P; Patel K J, 2007, BMC Clin Pharmacol, V7, P8, DOI 10.1186/1472-6904-7-8; Pradel Editions, 1994, ADVERSE DRUG REACTIO; StataCorp, 2011, STAT STAT SOFTW REL; Talisuna AO, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-50; Tumwikirize WA, 2011, AFR HEALTH SCI, V11, P72; Van Renterghem D, 2012, PHARMACOLOGY, V89, P103, DOI 10.1159/000336059; World Health Organization, 2005, WHO DRAFT GUID ADV E; World Health Organization Collaborating Centre for International Drug Monitoring (UMC), 2000, SAF MON MED PROD GUI; World Health Organization (WHO), DEF; World Health Organization (WHO)-Uppsala Monitoring Centre (UMC), 2011, DOC GRAD COMPL AR RE; Yiannakopoulou EC, 2011, PHARMACOLOGY, V87, P1, DOI 10.1159/000321728	25	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123974	10.1371/journal.pone.0123974	http://dx.doi.org/10.1371/journal.pone.0123974			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905889	Green Published, Green Submitted, gold			2022-12-27	WOS:000353332000053
J	Soleimanpour, H; Behringer, W; Tabrizi, JS; Sarahrudi, K; Golzari, SEJ; Hajdu, S; Rasouli, M; Nikakhtar, M; Esfanjani, RM				Soleimanpour, Hassan; Behringer, Wilhelm; Tabrizi, Jafar Sadegh; Sarahrudi, Kambiz; Golzari, Samad E. J.; Hajdu, Stefan; Rasouli, Maryam; Nikakhtar, Mehdi; Esfanjani, Robab Mehdizadeh			An Analytical Comparison of the Opinions of Physicians Working in Emergency and Trauma Surgery Departments at Tabriz and Vienna Medical Universities Regarding Family Presence during Resuscitation	PLoS One			English	Article							ATTITUDES	The present study evaluated the opinions of physicians working in the emergency and trauma surgery departments of Vienna Medical University, in Austria, and Tabriz Medical University, in Iran, regarding the presence of patients' relatives during resuscitation. In a descriptive-analytical study, the data obtained from questionnaires that had been distributed randomly to 40 specialists and residents at each of the participating universities were analyzed. The questionnaire consisted of two sections aimed at capturing the participants' demographic data, the participants' opinions regarding their support for the family's presence during resuscitation, and the multiple potential factors affecting the participants' attitudes, including health beliefs, triggers that could facilitate the procedure, self-efficacy, intellectual norms, and perceived behavioral control. The questionnaire also included a direct question (Question 16) on whether the participants approved of family presence. Each question could be answered using a Likert-type scale. The results showed that the mean scores for Question 16 were 4.31 +/- 0.64 and 3.57 +/- 1.31 for participants at Vienna and Tabriz universities, respectively. Moreover, physicians at Vienna University disapproved of the presence of patients' families during resuscitation to a higher extent than did those at Tabriz University (P = 0.018). Of the studied prognostic factors affecting the perspectives of Vienna Medical University's physicians, health beliefs (P = 0.000; B = 1.146), triggers (P = 0.000; B = 1.050), and norms (P = 0.000; B = 0.714) were found to be significant. Moreover, of the studied prognostic factors affecting the perspectives of Tabriz Medical University's physicians, health beliefs (P = 0.000; B = 0.875), triggers (P = 0.000; B = 1.11), self-efficacy (P = 0.001; B = 0.5), and perceived behavioral control (P = 0.03; B = 0.713) were significant. Most physicians at Vienna and Tabriz Medical universities were not open towards family members' presence during resuscitation.	[Soleimanpour, Hassan; Tabrizi, Jafar Sadegh] Tabriz Univ Med Sci, Tabriz Hlth Serv Management Res Ctr, Tabriz 51664, Iran; [Behringer, Wilhelm] Med Univ Vienna, Dept Emergency Med, Vienna Gen Hosp, A-1090 Vienna, Austria; [Sarahrudi, Kambiz; Hajdu, Stefan] Med Univ Vienna, Dept Traumatol, A-1090 Vienna, Austria; [Golzari, Samad E. J.] Tabriz Univ Med Sci, Cardiovasc Res Ctr, Tabriz 51664, Iran; [Rasouli, Maryam] Tabriz Univ Med Sci, Students Res Comm, Tabriz 51664, Iran; [Nikakhtar, Mehdi] Tabriz Univ Med Sci, Dept Emergency Med, Tabriz 51664, Iran; [Esfanjani, Robab Mehdizadeh] Tabriz Univ Med Sci, Neurosci Res Ctr, Tabriz 51664, Iran	Tabriz University of Medical Science; Medical University of Vienna; Medical University of Vienna; Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science	Soleimanpour, H (corresponding author), Tabriz Univ Med Sci, Tabriz Hlth Serv Management Res Ctr, Tabriz 51664, Iran.	soleimanpourh@tbzmed.ac.ir	Soleimanpour, Hassan/AAZ-4667-2020; tabrizi, jafarsadegh/L-5036-2017; Golzari, Samad EJ/L-5785-2017; Soleimanpour, Hassan/GRJ-1741-2022	Soleimanpour, Hassan/0000-0002-1311-4096; tabrizi, jafarsadegh/0000-0002-1458-8672; Golzari, Samad EJ/0000-0003-3815-8770; Behringer, Wilhelm/0000-0003-2261-3193				American Heart Association, 2005, CIRCULATION, V112; Baird G, 2014, EMERG MED J, V31, P889, DOI 10.1136/emermed-2012-201472; Boehm J., 2008, FAMILY PRESENCE RESU, V3; Boyd R, 2000, RESUSCITATION, V43, P171, DOI 10.1016/S0300-9572(99)00147-1; Duran CR, 2007, AM J CRIT CARE, V16, P270; Fishbein M., 1987, HEALTH EDUC RES, V2, P361; Jabre P, 2013, NEW ENGL J MED, V368, P1008, DOI 10.1056/NEJMoa1203366; Lam SN, 2007, HK J PAEDIAT, V12, P253; Meyers T A, 1998, J Emerg Nurs, V24, P400, DOI 10.1016/S0099-1767(98)70005-4; Offord R J, 1998, Intensive Crit Care Nurs, V14, P288, DOI 10.1016/S0964-3397(98)80690-3; Rosenstock I.M., 1990, HLTH BEHAV HLTH ED T, P39; SCHIFTER DE, 1985, J PERS SOC PSYCHOL, V49, P843, DOI 10.1037/0022-3514.49.3.843; Schwarzer R., 1992, SELF EFFICACY THOUGH, P217; SHANER K, 1997, ADVOCATE, V3, P3; Soleimanpour H, 2013, RESUSCITATION, V84, pE149, DOI 10.1016/j.resuscitation.2013.07.031; The American Heart Association in collaboration with the International Liaison Committee on Resuscitation, 2000, CIRCULATION, V102, pI291 ~342; Twibell RS, 2008, AM J CRIT CARE, V17, P101, DOI 10.4037/ajcc2008.17.2.101	17	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123765	10.1371/journal.pone.0123765	http://dx.doi.org/10.1371/journal.pone.0123765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905799	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000043
J	Swanepoel, LH; Somers, MJ; Dalerum, F				Swanepoel, Lourens H.; Somers, Michael J.; Dalerum, Fredrik			Functional Responses of Retaliatory Killing versus Recreational Sport Hunting of Leopards in South Africa	PLOS ONE			English	Article							PREDATION; CONSERVATION; CARNIVORES; DENSITIES; HABITAT; HARVEST; MODELS; RISK	Predation strategies in response to altering prey abundances can dramatically influence the demographic effects of predation. Despite this, predation strategies of humans are rarely incorporated into quantitative assessments of the demographic impacts of humans killing carnivores. This scarcity largely seems to be caused by a lack of data. In this study, we contrasted predation strategies exhibited by people involved in retaliatory killing and recreational sport hunting of leopards (Panthera pardus) in the Waterberg District Municipality, South Africa. We predicted a specialist predation strategy exemplified by a type II functional response for retaliatory killing, and a generalist strategy exemplified by a type III functional response for recreational sport hunting. We could not distinguish between a type I, a type II, or a type III functional response for retaliatory killing, but the most parsimonious model for recreational sport hunting corresponded to a type I functional response. Kill rates were consistently higher for retaliatory killing than for recreational sport hunting. Our results indicate that retaliatory killing of leopards may have severe demographic consequences for leopard populations, whereas the demographic consequences of recreational sport hunting likely are less dramatic.	[Swanepoel, Lourens H.; Somers, Michael J.] Univ Venda, Dept Zool, ZA-0950 Thohoyandou, South Africa; [Swanepoel, Lourens H.; Dalerum, Fredrik] Univ Pretoria, Ctr Wildlife Management, Hatfield Expt Farm, ZA-0028 Pretoria, South Africa; [Somers, Michael J.] Univ Pretoria, Ctr Invas Biol, ZA-0028 Pretoria, South Africa; [Dalerum, Fredrik] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0028 Pretoria, South Africa	University of Venda; University of Pretoria; University of Pretoria; University of Pretoria	Swanepoel, LH (corresponding author), Univ Venda, Dept Zool, Private Bag X5050, ZA-0950 Thohoyandou, South Africa.	lourens.swanepoel.univen@gmail.com	Swanepoel, L H/O-3226-2019; Dalerum, Fredrik/M-6068-2017; /A-1523-2008	Swanepoel, L H/0000-0002-9955-8076; Dalerum, Fredrik/0000-0001-9737-8242; /0000-0002-5836-8823	IFS [D/4984-1]; Wild Foundation [2008011]; Wilson Foundation; University of Pretoria; National Research Foundation (NRF) [74819, 88179]; NRF; MJS; DST-NRF Centre of Excellence for Invasion Biology and NRF	IFS(International Foundation for Science); Wild Foundation; Wilson Foundation; University of Pretoria; National Research Foundation (NRF); NRF; MJS; DST-NRF Centre of Excellence for Invasion Biology and NRF	This work was funded by IFS grant nr. D/4984-1 (www.ifs.se), Wild Foundation grant nr. 2008011 (www.wild.org), Wilson Foundation (www.thewilsonfoundation.org) and the University of Pretoria (www.up.ac.za). LHS was supported by the National Research Foundation (NRF; www.nrf.ac.za) grant nrs. 74819 & 88179, FD by a research fellowship from the University of Pretoria and NRF, and MJS by the DST-NRF Centre of Excellence for Invasion Biology and NRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abade L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096261; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANDERSSON M, 1977, OIKOS, V29, P591, DOI 10.2307/3543597; Balme GA, 2010, ANIM CONSERV, V13, P315, DOI 10.1111/j.1469-1795.2009.00342.x; Balme GA, 2009, BIOL CONSERV, V142, P2681, DOI 10.1016/j.biocon.2009.06.020; Balme GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035209; BANKS HT, 1987, OECOLOGIA, V74, P356, DOI 10.1007/BF00378930; Baty F, 2015, NLSTOOLS TOOLS NONLI; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Caro TM, 2009, BIOL CONSERV, V142, P909, DOI 10.1016/j.biocon.2008.12.018; Crawley M. J, 2002, STAT COMPUTING INTRO; Dalerum F, 2015, ARBOR IN PRESS; Dalerum F, 2008, J WILDLIFE MANAGE, V72, P1125, DOI 10.2193/2007-336; Daly B., 2005, CONSERVATION BREEDIN; De Klerk A., 2003, THESIS U PRETORIA; Development WR, 2005, AGR DEV STRAT WAT MU; Efford M, 2004, OIKOS, V106, P598, DOI 10.1111/j.0030-1299.2004.13043.x; Efford MG, 2013, OIKOS, V122, P918, DOI 10.1111/j.1600-0706.2012.20440.x; Eggleston DB, 2008, ECOL APPL, V18, P258, DOI 10.1890/06-1409.1; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elzhov TV, 2012, MINPACK IM R INTERFA; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Funston PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059044; GINSBERG JR, 1994, CONSERV BIOL, V8, P157, DOI 10.1046/j.1523-1739.1994.08010157.x; Henschel P., 2008, IUCN 2010 IUCN RED L; Holling C. S., 1959, Canadian Entomologist, V91, P385; Jeschke JM, 2004, BIOL REV, V79, P337, DOI 10.1017/S1464793103006286; JOHNSON BM, 1994, ECOL APPL, V4, P808, DOI 10.2307/1942010; Johnson PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012866; Karanth K.U., 2002, MONITORING TIGERS TH, DOI [10.1111/j.1523-1739.2003.01769.x, DOI 10.1111/J.1523-1739.2003.01769.X]; Karanth KU, 2004, ANIM CONSERV, V7, P285, DOI 10.1017/S1367943004001477; Korpimaki E, 1996, BIOSCIENCE, V46, P754, DOI 10.2307/1312851; Lindsey PA, 2011, NONDETRIMENT FINDING; Lindsey PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029332; Marchini S, 2012, BIOL CONSERV, V147, P213, DOI 10.1016/j.biocon.2012.01.002; Mateo-Tomas P, 2012, J APPL ECOL, V49, P376, DOI 10.1111/j.1365-2664.2012.02119.x; McManus JS, 2015, ORYX, V49, P687, DOI 10.1017/S0030605313001610; Milner JM, 2007, CONSERV BIOL, V21, P36, DOI 10.1111/j.1523-1739.2006.00591.x; Mucina L., 2006, VEGETATION S AFRICA; Ogada MO, 2003, CONSERV BIOL, V17, P1521, DOI 10.1111/j.1523-1739.2003.00061.x; Palazy L, 2012, ANIM CONSERV, V15, P4, DOI 10.1111/j.1469-1795.2011.00476.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; R Development Core Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; REAL LA, 1979, ECOLOGY, V60, P481, DOI 10.2307/1936067; REAL LA, 1977, AM NAT, V111, P289, DOI 10.1086/283161; Seitz RD, 2001, ECOLOGY, V82, P2435, DOI 10.1890/0012-9658(2001)082[2435:DDPHVA]2.0.CO;2; Smith R. M., 1978, ARNOLDIA, V8, P1; Swanepoel LH, 2013, ANIM CONSERV, V16, P41, DOI 10.1111/j.1469-1795.2012.00566.x; Swanepoel LH, 2013, THESIS U PRETORIA; Swanepoel LH, 2014, S AFR J WILDL RES, V44, P115, DOI 10.3957/056.044.0210; Thorn M, 2012, BIOL CONSERV, V150, P23, DOI 10.1016/j.biocon.2012.02.017; Tobler MW, 2014, ORYX, V48, P410, DOI 10.1017/S0030605312001652; Tobler MW, 2013, BIOL CONSERV, V159, P109, DOI 10.1016/j.biocon.2012.12.009; Tobler MW, 2010, CAMERA BASE VERSION; Van Deelen Timothy R., 2003, Human Dimensions of Wildlife, V8, P97, DOI 10.1080/10871200304306; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Zabel A, 2011, ENVIRON RESOUR ECON, V48, P287, DOI 10.1007/s10640-010-9411-4	58	11	12	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125539	10.1371/journal.pone.0125539	http://dx.doi.org/10.1371/journal.pone.0125539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905623	Green Published, Green Submitted, gold			2022-12-27	WOS:000353332000113
J	Alvarez-Clare, S; Mack, MC				Alvarez-Clare, Silvia; Mack, Michelle C.			Do Foliar, Litter, and Root Nitrogen and Phosphorus Concentrations Reflect Nutrient Limitation in a Lowland Tropical Wet Forest?	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; N-P STOICHIOMETRY; RAIN-FOREST; AMAZONIAN FORESTS; GROWTH; AVAILABILITY; RESPONSES; PATTERNS; RESORPTION; RATIOS	Understanding nutrient limitation of net primary productivity (NPP) is critical to predict how plant communities will respond to environmental change. Foliar nutrients, especially nitrogen and phosphorus concentrations ([N] and [P]) and their ratio, have been used widely as indicators of plant nutritional status and have been linked directly to nutrient limitation of NPP. In tropical systems, however, a high number of confounding factors can limit the ability to predict nutrient limitation-as defined mechanistically by NPP responses to fertilization-based on the stoichiometric signal of the plant community. We used a long-term full factorial N and P fertilization experiment in a lowland tropical wet forest in Costa Rica to explore how tissue (foliar, litter and root) [N] and [P] changed with fertilization, how different tree size classes and taxa influenced the community response, and how tissue nutrients related to NPP. Consistent with NPP responses to fertilization, there were no changes in community-wide foliar [N] and [P], two years after fertilization. Nevertheless, litterfall [N] increased with N additions and root [P] increased with P additions. The most common tree species (Pentaclethra macroloba) had 9% higher mean foliar [N] with NP additions and the most common palm species (Socratea exohrriza) had 15% and 19% higher mean foliar [P] with P and NP additions, respectively. Moreover, N:P ratios were not indicative of NPP responses to fertilization, either at the community or at the taxa level. Our study suggests that in these diverse tropical forests, tissue [N] and [P] are driven by the interaction of multiple factors and are not always indicative of the nutritional status of the plant community.	[Alvarez-Clare, Silvia; Mack, Michelle C.] Univ Florida, Sch Nat Resources & Environm, Dept Biol, Gainesville, FL USA	State University System of Florida; University of Florida	Alvarez-Clare, S (corresponding author), North Cent Coll, Dept Biol, Naperville, IL 60540 USA.	smalvarezclare@noctrl.edu			Doctoral Dissertation Enhancement Project grant from the National Science Foundation [0840298]	Doctoral Dissertation Enhancement Project grant from the National Science Foundation	This study was funded by a Doctoral Dissertation Enhancement Project grant (#0840298) from the National Science Foundation to MCM and SAC which was received between 2008 and 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren GI, 2004, ECOL LETT, V7, P185, DOI 10.1111/j.1461-0248.2004.00567.x; Agren GI, 2008, ANNU REV ECOL EVOL S, V39, P153, DOI 10.1146/annurev.ecolsys.39.110707.173515; Alvarez Clare S, 2012, THESIS U FLORIDA GAI; Alvarez-Clare S, 2013, ECOLOGY, V94, P1540, DOI 10.1890/12-2128.1; Andersen KM, 2010, FUNCT ECOL, V24, P1171, DOI 10.1111/j.1365-2435.2010.01731.x; Bonan GB, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042430; Campo J, 2003, J TROP ECOL, V19, P525, DOI 10.1017/S0266467403003572; CHAPIN FS, 1986, AM NAT, V127, P48, DOI 10.1086/284466; Clark DA, 2001, ECOL APPL, V11, P356, DOI 10.1890/1051-0761(2001)011[0356:MNPPIF]2.0.CO;2; Cleveland CC, 2011, ECOL LETT, V14, P939, DOI 10.1111/j.1461-0248.2011.01658.x; CUEVAS E, 1988, OECOLOGIA, V76, P222, DOI 10.1007/BF00379956; Davidson EA, 2004, ECOL APPL, V14, pS150; Davidson EA, 2007, NATURE, V447, P995, DOI 10.1038/nature05900; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Hattenschwiler S, 2008, NEW PHYTOL, V179, P165, DOI 10.1111/j.1469-8137.2008.02438.x; Harrington RA, 2001, ECOSYSTEMS, V4, P646, DOI 10.1007/s10021-001-0034-z; Hartshorn G, 1983, COSTA RICAN NATURAL; Hartshorn G.S., 1994, SELVA ECOLOGY NATURA; Hedin LO, 2004, P NATL ACAD SCI USA, V101, P10849, DOI 10.1073/pnas.0404222101; HENDERSON A, 1995, FIELD GUIDE PALMS AM; HERBERT DA, 1995, BIOGEOCHEMISTRY, V29, P223, DOI 10.1007/BF02186049; Hidaka A, 2011, J ECOL, V99, P849, DOI 10.1111/j.1365-2745.2011.01805.x; Huberty AF, 2006, OECOLOGIA, V149, P444, DOI 10.1007/s00442-006-0462-8; Jones JB, 1996, METHODS SOIL ANAL 3, P389; Kaspari M, 2008, ECOL LETT, V11, P35, DOI 10.1111/j.1461-0248.2007.01124.x; Kerkhoff AJ, 2006, AM NAT, V168, pE103, DOI 10.1086/507879; Kobe RK, 2005, ECOLOGY, V86, P2780, DOI 10.1890/04-1830; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; Kuo S, 1996, METHODS SOIL ANAL PA, V5, P869, DOI [10.2136/sssabookser5.3.c32, DOI 10.2136/SSSABOOKSER5.3.C32]; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; Mayor JR, 2014, J ECOL, V102, P36, DOI 10.1111/1365-2745.12190; MCDADE L. A., 1994, SELVA ECOLOGY NATURA; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Mirmanto E, 1999, PHILOS T ROY SOC B, V354, P1825, DOI 10.1098/rstb.1999.0524; Ostertag R, 2001, ECOLOGY, V82, P485, DOI 10.1890/0012-9658(2001)082[0485:EONAPA]2.0.CO;2; Ostertag R, 2010, PLANT SOIL, V334, P85, DOI 10.1007/s11104-010-0281-x; Reed SC, 2011, BIOGEOCHEMISTRY, V106, P323, DOI 10.1007/s10533-010-9522-6; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Reich PB, 2008, ECOL LETT, V11, P793, DOI 10.1111/j.1461-0248.2008.01185.x; Sancho F, 1990, ESTUDIO SUELOS FINCA; Santiago LS, 2012, J ECOL, V100, P309, DOI 10.1111/j.1365-2745.2011.01904.x; Schreeg LA, 2014, ECOLOGY, V95, P2062, DOI 10.1890/13-1671.1; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Sullivan BW, 2014, ECOLOGY, V95, P668, DOI 10.1890/13-0825.1; Tanner EVJ, 1998, ECOLOGY, V79, P10, DOI 10.1890/0012-9658(1998)079[0010:EIONLO]2.0.CO;2; Thornton PE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002868; Townsend AR, 2007, ECOLOGY, V88, P107, DOI 10.1890/0012-9658(2007)88[107:COFNRI]2.0.CO;2; Tully KL, 2013, ECOLOGY, V94, P930, DOI 10.1890/12-0781.1; van der Ploeg RR, 1999, SOIL SCI SOC AM J, V63, P1055, DOI 10.2136/sssaj1999.6351055x; Vergutz L, 2012, ECOL MONOGR, V82, P205, DOI 10.1890/11-0416.1; Vitousek, 2004, NUTR CYCLING LIMITAT; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; Vitousek PM, 1997, BIOGEOCHEMISTRY, V37, P63, DOI 10.1023/A:1005757218475; Wood TE, 2009, ECOLOGY, V90, P109, DOI 10.1890/07-1146.1; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright SJ, 2011, ECOLOGY, V92, P1616, DOI 10.1890/10-1558.1; Yuan ZY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1346; Zar J. H., 1996, BIOSTATISTICAL ANAL	62	25	28	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123796	10.1371/journal.pone.0123796	http://dx.doi.org/10.1371/journal.pone.0123796			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901750	Green Submitted, Green Published, gold			2022-12-27	WOS:000353331500062
J	Banerjee, R; Gupta, ND				Banerjee, Ritwik; Gupta, Nabanita Datta			Awareness Programs and Change in Taste-Based Caste Prejudice	PLOS ONE			English	Article							IMPLICIT ASSOCIATION TEST; DISCRIMINATION	Becker's theory of taste-based discrimination predicts that relative employment of the discriminated social group will improve if there is a decrease in the level of prejudice for the marginally discriminating employer. In this paper we experimentally test this prediction offered by Garry Becker in his seminal work on taste based discrimination, in the context of caste in India, with management students (potential employers in the near future) as subjects. First, we measure caste prejudice and show that awareness through a TV social program reduces implicit prejudice against the lower caste and the reduction is sustained over time. Second, we find that the treatment reduces the prejudice levels of those in the left tail of the prejudice distribution - the group which can potentially affect real outcomes as predicted by the theory. And finally, a larger share of the treatment group subjects exhibit favorable opinion about reservation in jobs for the lower caste.	[Banerjee, Ritwik; Gupta, Nabanita Datta] Aarhus Univ, Aarhus, Denmark	Aarhus University	Gupta, ND (corresponding author), Aarhus Univ, Aarhus, Denmark.	ndg@econ.au.dk		Datta Gupta, Nabanita/0000-0001-7904-445X	Danish Council for Independent Research, Ministry of Higher Education and Science, Denmark;  [DFF-1327-00037]	Danish Council for Independent Research, Ministry of Higher Education and Science, Denmark; 	The grant was obtained from Danish Council for Independent Research, Ministry of Higher Education and Science, Denmark. The grant number is the following: DFF-1327-00037. The website of the grant is: http://ufm.dk/en/research-and-innovation/funding-programmes-for-research-and-innovation/find-danish-funding-programmes/dff-the-danishcouncil-for-independent-research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altonji J.G., 1999, HDB LABOR EC, VVol.3, P3143; Anwar S, 2012, J ECON BEHAV ORGAN, V81, P268, DOI 10.1016/j.jebo.2011.10.008; Arrow K.J., 1973, DISCRIMINATION LABOR, P21; Banerjee A, 2009, J COMP ECON, V37, P14, DOI 10.1016/j.jce.2008.09.002; Banerjee R, 2014, INTERPRETATION BRIBE; Becker GS, 1957, EC DISCRIMINATION; Bertrand M, 2005, AM ECON REV, V95, P94, DOI 10.1257/000282805774670365; Bertrand M, 2004, AM ECON REV, V94, P991, DOI 10.1257/0002828042002561; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Carlsson M, 2011, EMPLOYER ATTITUDES M; Charles KK, 2008, J POLIT ECON, V116, P773, DOI 10.1086/593073; Clark CR, 2013, CAN J ECON, V46, P1606, DOI 10.1111/caje.12056; Dasgupta N, 2008, SOC COGNITION, V26, P122; Deshpande A, 2006, AFFIRMATIVE ACTION I; Deshpande A., 2003, BOUNDARIES CLAN COLO; Fershtman C, 2001, Q J ECON, V116, P351, DOI 10.1162/003355301556338; Gerber AS, 2011, AM POLIT SCI REV, V105, P135, DOI 10.1017/S000305541000047X; Glewwe P., 1999, EC SCH QUALITY INVES; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Hoffman SJ, 2013, BMJ-BRIT MED J, V12, P347; Kearney MS, 2014, MEDIA INFLUENCES SOC, P19795; La Ferrara E, 2012, AM ECON J-APPL ECON, V4, P1, DOI 10.1257/app.4.4.1; Lang K, 2012, J ECON LIT, V50, P959, DOI 10.1257/jel.50.4.959; Nosek BA, 2005, PERS SOC PSYCHOL B, V31, P166, DOI 10.1177/0146167204271418; Rooth DO, 2010, LABOUR ECON, V17, P523, DOI 10.1016/j.labeco.2009.04.005; Rudman LA, 2001, J PERS SOC PSYCHOL, V81, P856, DOI 10.1037/0022-3514.81.5.856; Siddique Z, 2011, LABOUR ECON, V18, pS146, DOI 10.1016/j.labeco.2011.07.002	27	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0118546	10.1371/journal.pone.0118546	http://dx.doi.org/10.1371/journal.pone.0118546			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KV	25902290	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500003
J	Morel, B; Rouffet, DM; Saboul, D; Rota, S; Clemencon, M; Hautier, CA				Morel, Baptiste; Rouffet, David M.; Saboul, Damien; Rota, Samuel; Clemencon, Michel; Hautier, Christophe A.			Peak Torque and Rate of Torque Development Influence on Repeated Maximal Exercise Performance: Contractile and Neural Contributions	PLOS ONE			English	Article							ELECTRICAL-STIMULATION; SHORTENING VELOCITY; PERIPHERAL FATIGUE; MUSCLE; COACTIVATION; INTERMITTENT; RESISTANCE; FREQUENCY; EXTENSION; BEHAVIOR	Rapid force production is critical to improve performance and prevent injuries. However, changes in rate of force/torque development caused by the repetition of maximal contractions have received little attention. The aim of this study was to determine the relative influence of rate of torque development (RTD) and peak torque (Tpeak) on the overall performance (i.e. mean torque, T-mean) decrease during repeated maximal contractions and to investigate the contribution of contractile and neural mechanisms to the alteration of the various mechanical variables. Eleven well-trained men performed 20 sets of 6-s isokinetic maximal knee extensions at 240 degrees.s(-1), beginning every 30 seconds. RTD, T-peak and T-mean as well as the Rate of EMG Rise (RER), peak EMG (EMG(peak)) and mean EMG (EMGmean) of the vastus lateralis were monitored for each contraction. A wavelet transform was also performed on raw EMG signal for instant mean frequency (if(mean)) calculation. A neuromuscular testing procedure was carried out before and immediately after the fatiguing protocol including evoked RTD (eRTD) and maximal evoked torque (eT(peak)) induced by high frequency doublet (100 Hz). T-mean decrease was correlated to RTD and T-peak decrease (R-2 =0.62; p<0.001; respectively beta=0.62 and beta=0.19). RER, eRTD and initial if(mean) (0-225 ms) decreased after 20 sets (respectively -21.1 +/- 14.1, -25 +/- 13%, and similar to 20%). RTD decrease was correlated to RER decrease (R-2 =0.36; p<0.05). The eT(peak) decreased significantly after 20 sets (24 +/- 5%; p<0.05) contrary to EMG(peak) (-3.2 +/- 19.5 %; p=0.71). Our results show that reductions of RTD explained part of the alterations of the overall performance during repeated moderate velocity maximal exercise. The reductions of RTD were associated to an impairment of the ability of the central nervous system to maximally activate the muscle in the first milliseconds of the contraction.	[Morel, Baptiste; Saboul, Damien; Rota, Samuel; Clemencon, Michel; Hautier, Christophe A.] Univ Lyon 1, Ctr Res & Innovat Sport, F-69622 Villeurbanne, France; [Rouffet, David M.] Victoria Univ, Inst Sport Exercise & Act Living, Melbourne, Vic 8001, Australia; [Saboul, Damien] Almerys, Clermont Ferrand, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Victoria University	Morel, B (corresponding author), Univ Lyon 1, Ctr Res & Innovat Sport, F-69622 Villeurbanne, France.	baptiste.morel@gmail.com	Morel, Baptiste/GNM-6701-2022; Rouffet, David/GLR-6007-2022	Rouffet, David/0000-0003-1105-2992; Morel, Baptiste/0000-0002-2872-6423; Clemencon, Michel/0000-0001-9495-0602; Saboul, Damien/0000-0003-1891-9077				Aagaard P, 2003, EXERC SPORT SCI REV, V31, P61, DOI 10.1097/00003677-200304000-00002; Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Amann M, 2013, J APPL PHYSIOL, V115, P355, DOI 10.1152/japplphysiol.00049.2013; Babault N, 2006, J APPL PHYSIOL, V100, P780, DOI 10.1152/japplphysiol.00737.2005; BIGLANDRITCHIE B, 1984, MUSCLE NERVE, V7, P691, DOI 10.1002/mus.880070902; Buckthorpe MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057549; Cairns SP, 2005, EXERC SPORT SCI REV, V33, P9; Cheng AJ, 2005, J APPL PHYSIOL, V99, P1446, DOI 10.1152/japplphysiol.00452.2005; Cheng AJ, 2010, MED SCI SPORT EXER, V42, P1651, DOI 10.1249/MSS.0b013e3181d6c5b5; Christian RJ, 2014, J APPL PHYSIOL, V117, P1063, DOI 10.1152/japplphysiol.00988.2013; Dalton BH, 2012, EXP GERONTOL, V47, P85, DOI 10.1016/j.exger.2011.10.010; Debold EP, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00151; DRAGANICH LF, 1989, J BONE JOINT SURG AM, V71A, P1075, DOI 10.2106/00004623-198971070-00015; Frere J, 2012, COMPUT METHOD BIOMEC, V15, P111, DOI 10.1080/10255842.2010.517199; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Girard O, 2013, EUR J APPL PHYSIOL, V113, P359, DOI 10.1007/s00421-012-2444-3; Girard O, 2011, SPORTS MED, V41, P673, DOI 10.2165/11590550-000000000-00000; Glaister M, 2005, SPORTS MED, V35, P757, DOI 10.2165/00007256-200535090-00003; Harwood B, 2012, J APPL PHYSIOL, V113, P1821, DOI 10.1152/japplphysiol.00879.2012; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Johnson ST, 2015, SCAND J MED SCI SPOR, V25, P623, DOI 10.1111/sms.12283; Lanza IR, 2004, J APPL PHYSIOL, V97, P967, DOI 10.1152/japplphysiol.01351.2003; Maciejewski H, 2013, SCAND J MED SCI SPOR, V23, P585, DOI 10.1111/j.1600-0838.2011.01423.x; MATHIASSEN SE, 1989, EUR J APPL PHYSIOL O, V59, P80, DOI 10.1007/BF02396584; Miller M, 1999, MUSCLE NERVE, V22, P1038, DOI 10.1002/(SICI)1097-4598(199908)22:8<1038::AID-MUS5>3.0.CO;2-R; Millet GY, 2012, NEUROMUSCULAR DISORD, V22, pS181, DOI 10.1016/j.nmd.2012.10.007; Minshull C, 2007, EUR J APPL PHYSIOL, V100, P469, DOI 10.1007/s00421-007-0448-1; Morel B, 2015, SCAND J MED SCI SPOR, V25, pE432, DOI 10.1111/sms.12358; PSEK JA, 1993, J APPL PHYSIOL, V74, P170, DOI 10.1152/jappl.1993.74.1.170; Racinais S, 2007, MED SCI SPORT EXER, V39, P268, DOI 10.1249/01.mss.0000251775.46460.cb; Taylor JL, 2000, J APPL PHYSIOL, V89, P305, DOI 10.1152/jappl.2000.89.1.305; Thorlund JB, 2008, SCAND J MED SCI SPOR, V18, P462, DOI 10.1111/j.1600-0838.2007.00710.x; Thorlund JB, 2009, INT J SPORTS MED, V30, P273, DOI 10.1055/s-0028-1104587; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Van Cutsem M, 1998, J PHYSIOL-LONDON, V513, P295, DOI 10.1111/j.1469-7793.1998.295by.x; von Tscharner V, 2000, J ELECTROMYOGR KINES, V10, P433, DOI 10.1016/S1050-6411(00)00030-4; Wakeling JM, 2009, J ELECTROMYOGR KINES, V19, P199, DOI 10.1016/j.jelekin.2007.09.006; Weir JP, 1998, EUR J APPL PHYSIOL O, V78, P555, DOI 10.1007/s004210050460	38	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0119719	10.1371/journal.pone.0119719	http://dx.doi.org/10.1371/journal.pone.0119719			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901576	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000353331500005
J	Ntui, VO; Kong, K; Khan, RS; Igawa, T; Janavi, GJ; Rabindran, R; Nakamura, I; Mii, M				Ntui, Valentine Otang; Kong, Kynet; Khan, Raham Sher; Igawa, Tomoko; Janavi, Gnanaguru Janaky; Rabindran, Ramalingam; Nakamura, Ikuo; Mii, Masahiro			Resistance to Sri Lankan Cassava Mosaic Virus (SLCMV) in Genetically Engineered Cassava cv. KU50 through RNA Silencing	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; WHITEFLY-TRANSMITTED GEMINIVIRUSES; PLUM-POX-VIRUS; MEDIATED RESISTANCE; TRANSGENIC CASSAVA; MESSENGER-RNA; COAT PROTEIN; SHOOT ORGANOGENESIS; ANTISENSE RNA; AV2 PRECOAT	Cassava ranks fifth among the starch producing crops of the world, its annual bioethanol yield is higher than for any other crop. Cassava cultivar KU50, the most widely grown cultivar for non-food purposes is susceptible to Sri Lankan cassava mosaic virus (SLCMV). The objective of this work was to engineer resistance to SLCMV by RNA interference (RNAi) in order to increase biomass yield, an important aspect for bioethanol production. Here, we produced transgenic KU50 lines expressing dsRNA homologous to the region between the AV2 and AV1 of DNA A of SLCMV. High level expression of dsRNA of SLCMV did not induce any growth abnormality in the transgenic plants. Transgenic lines displayed high levels of resistance to SLCMV compared to the wild-type plants and no virus load could be detected in uninoculated new leaves of the infected resistant lines after PCR amplification and RT-PCR analysis. The agronomic performance of the transgenic lines was unimpaired after inoculation with the virus as the plants presented similar growth when compared to the mock inoculated control plants and revealed no apparent reduction in the amount and weight of tubers produced. We show that the resistance is correlated with post-transcriptional gene silencing because of the production of transgene specific siRNA. The results demonstrate that transgenic lines exhibited high levels of resistance to SLCMV. This resistance coupled with the desirable yield components in the transgenic lines makes them better candidates for exploitation in the production of biomass as well as bioethanol.	[Ntui, Valentine Otang; Kong, Kynet; Khan, Raham Sher; Igawa, Tomoko; Nakamura, Ikuo; Mii, Masahiro] Chiba Univ, Lab Plant Cell Technol, Grad Sch Hort, Chiba, Japan; [Ntui, Valentine Otang] Univ Calabar, Fac Sci, Dept Genet Biotechnol, Calabar, Nigeria; [Kong, Kynet] Cambodia Agr Res & Dev Inst, Phnom Penh, Cambodia; [Khan, Raham Sher] Abdul Wali Khan Univ, Dept Biotechnol, Mardan, Pakistan; [Janavi, Gnanaguru Janaky; Rabindran, Ramalingam] Tamil Nadu Agr Univ, Hort Coll & Res Inst, Coimbatore 641003, Tamil Nadu, India	Chiba University; University of Calabar; Abdul Wali Khan University; Tamil Nadu Agricultural University	Ntui, VO (corresponding author), King Abdullah Univ Sci Technol, Ctr Desert Agr, Thuwal, Saudi Arabia.	ntuival@yahoo.com	Igawa, Tomoko/N-1578-2015; Khan, Raham S/A-5272-2015	Igawa, Tomoko/0000-0003-1829-6076; Mii, Masahiro/0000-0002-8312-3430; Ntui, Valentine/0000-0003-4709-8087	Japan Society for the Promotion of Science (JSPS); JSPS; Grants-in-Aid for Scientific Research [25840113] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported by Japan Society for the Promotion of Science (JSPS). V. O. Ntui is a recipient of JSPS fellowship.	Alabi O. J., 2011, CASSAVA MOSAIC DIS C, DOI DOI 10.1094/APSNETFEATURE-2011-0701; BENADA J, 1981, ROST VYROBA, V27, P131; Bonfim K, 2007, MOL PLANT MICROBE IN, V20, P717, DOI 10.1094/MPMI-20-6-0717; Bull SE, 2009, NAT PROTOC, V4, P1845, DOI 10.1038/nprot.2009.208; Bull SE, 2007, J GEN VIROL, V88, P1624, DOI 10.1099/vir.0.82662-0; Chellappan P, 2004, PLANT MOL BIOL, V56, P601, DOI 10.1007/s11103-004-0147-9; DEHAAN P, 1992, BIO-TECHNOL, V10, P1133, DOI 10.1038/nbt1092-1133; DENG D, 1994, ANN APPL BIOL, V125, P327, DOI 10.1111/j.1744-7348.1994.tb04973.x; Dutt N, 2005, ARCH VIROL, V150, P2101, DOI 10.1007/s00705-005-0579-9; FARGETTE D, 1988, TROP PEST MANAGE, V34, P89; FAUQUET C, 1990, PLANT DIS, V74, P404, DOI 10.1094/PD-74-0404; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hankoua BB, 2005, PLANT CELL TISS ORG, V82, P221, DOI 10.1007/s11240-005-0514-5; Hily JM, 2004, TRANSGENIC RES, V13, P427, DOI 10.1007/s11248-004-8702-3; HONG YG, 1993, J GEN VIROL, V74, P2437, DOI 10.1099/0022-1317-74-11-2437; Jansson C, 2009, APPL ENERG, V86, pS95, DOI 10.1016/j.apenergy.2009.05.011; Kalantidis K, 2002, MOL PLANT MICROBE IN, V15, P826, DOI 10.1094/MPMI.2002.15.8.826; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; Klas FE, 2006, TRANSGENIC RES, V15, P527, DOI 10.1007/s11248-006-9001-y; KRAPP A, 1993, PLANT J, V3, P817, DOI 10.1111/j.1365-313X.1993.00817.x; Krubphachaya P, 2007, J BIOCHEM MOL BIOL, V40, P404; Kundu JK, 2008, VIRUS GENES, V36, P215, DOI 10.1007/s11262-007-0176-y; Missiou A, 2004, MOL BREEDING, V14, P185, DOI 10.1023/B:MOLB.0000038006.32812.52; Mittal D, 2008, ARCH VIROL, V153, P2149, DOI 10.1007/s00705-008-0238-z; Mubin M, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-10; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nguyen TLT, 2007, ENVIRON SCI TECHNOL, V41, P4135, DOI 10.1021/es0620641; Ntui VO, 2013, TRANSGENIC RES, V22, P1191, DOI 10.1007/s11248-013-9721-8; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Padidam M, 1996, VIROLOGY, V224, P390, DOI 10.1006/viro.1996.0546; Patil BL, 2007, VIRUS RES, V124, P59, DOI 10.1016/j.virusres.2006.10.003; Patil BL, 2011, MOL PLANT PATHOL, V12, P31, DOI 10.1111/j.1364-3703.2010.00650.x; Robinson J, 2013, STANDING PANEL IMPAC, P1; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; Rothenstein D, 2007, VIROLOGY, V359, P137, DOI 10.1016/j.virol.2006.09.014; SAELIM L, 2006, GLOBAL J BIOTECHNOL, V1, P7; Sambrook J., 2001, MOL CLONING LAB MANU; Saunders K, 2002, VIROLOGY, V293, P63, DOI 10.1006/viro.2001.1251; Smith Neil A, 2012, Methods Mol Biol, V894, P155, DOI 10.1007/978-1-61779-882-5_11; STAMP JA, 1987, PLANT CELL TISS ORG, V10, P227, DOI 10.1007/BF00037307; TABLER M, 1993, NATO ADV SCI INST SE, V253, P237; TANAKA A, 1990, NUCLEIC ACIDS RES, V18, P6767, DOI 10.1093/nar/18.23.6767; Taylor N, 2004, PLANT MOL BIOL, V56, P671, DOI 10.1007/s11103-004-4872-x; Thomas PE, 2000, VIRUS RES, V71, P49, DOI 10.1016/S0168-1702(00)00187-8; Thresh JM, 1988, REV PLANT PATHOL, V77, P935; Vu TV, 2013, VIRUS RES, V172, P35, DOI 10.1016/j.virusres.2012.12.008; TRICOLI DM, 1995, BIO-TECHNOL, V13, P1458, DOI 10.1038/nbt1295-1458; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Vanderschuren H, 2007, PLANT MOL BIOL, V64, P549, DOI 10.1007/s11103-007-9175-6; Vanderschuren H, 2007, PLANT BIOTECHNOL J, V5, P207, DOI 10.1111/j.1467-7652.2006.00217.x; Vanderschuren H, 2009, PLANT MOL BIOL, V70, P265, DOI 10.1007/s11103-009-9472-3; Vanitharani R, 2004, J VIROL, V78, P9487, DOI 10.1128/JVI.78.17.9487-9498.2004; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Wang W, 2002, CASSAVA RES DEV ASIA; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Yadav JS, 2011, MOL PLANT PATHOL, V12, P677, DOI 10.1111/J.1364-3703.2010.00700.X; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhang P, 2005, PLANT BIOTECHNOL J, V3, P385, DOI 10.1111/j.1467-7652.2005.00132.x; Zhang P, 2001, PLANT CELL TISS ORG, V67, P47, DOI 10.1023/A:1011654128198	60	23	25	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0120551	10.1371/journal.pone.0120551	http://dx.doi.org/10.1371/journal.pone.0120551			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901740	Green Published, gold, Green Submitted			2022-12-27	WOS:000353331500006
J	Periyakoil, VS; Neri, E; Kraemer, H				Periyakoil, Vyjeyanthi S.; Neri, Eric; Kraemer, Helena			No Easy Talk: A Mixed Methods Study of Doctor Reported Barriers to Conducting Effective End-of-Life Conversations with Diverse Patients	PLOS ONE			English	Article							AFRICAN-AMERICAN PHYSICIANS; ETHNIC-DIFFERENCES; ORGANIZED MEDICINE; CARE; PERCEPTIONS; TRUST; RACE	Objective Though most patients wish to discuss end-of-life (EOL) issues, doctors are reluctant to conduct end-of-life conversations. Little is known about the barriers doctors face in conducting effective EOL conversations with diverse patients. This mixed methods study was undertaken to empirically identify barriers faced by doctors (if any) in conducting effective EOL conversations with diverse patients and to determine if the doctors' age, gender, ethnicity and medical sub-specialty influenced the barriers reported. Design Mixed-methods study of multi-specialty doctors caring for diverse, seriously ill patients in two large academic medical centers at the end of the training; data were collected from 2010 to 2012. Outcomes Doctor-reported barriers to EOL conversations with diverse patients. Results 1040 of 1234 potential subjects (84.3%) participated. 29 participants were designated as the development cohort for coding and grounded theory analyses to identify primary barriers. The codes were validated by analyses of responses from 50 randomly drawn subjects from the validation cohort (n=996 doctors). Qualitative responses from the validation cohort were coded and analyzed using quantitative methods. Only 0.01% doctors reported no barriers to conducting EOL conversations with patients. 99.99% doctors reported barriers with 85.7% finding it very challenging to conduct EOL conversations with all patients and especially so with patients whose ethnicity was different than their own. Asian-American doctors reported the most struggles (91.3%), followed by African Americans (85.3%), Caucasians (83.5%) and Hispanic Americans (79.3%) in conducting EOL conversations with their patients. The biggest doctor-reported barriers to effective EOL conversations are (i) language and medical interpretation issues, (ii) patient/family religio-spiritual beliefs about death and dying, (iii) doctors' ignorance of patients' cultural beliefs, values and practices, (iv) patient/family's cultural differences in truth handling and decision making, (v) patients' limited health literacy and (vi) patients' mistrust of doctors and the health care system. The doctors' ethnicity (Chi-Square = 12.77, DF = 4, p = 0.0125) and medical subspecialty (Chi-Square = 19.33, DF = 10, p = 0.036) influenced their reported barriers. Friedman's test used to examine participants relative ranking of the barriers across sub-groups identified significant differences by age group (F statistic = 303.5, DF = 5, p < 0.0001) and medical sub-specialty (F statistic = 163.7, DF = 5, p < 0.0001). Conclusions and Relevance Doctors report struggles with conducting effective EOL conversations with all patients and especially with those whose ethnicity is different from their own. It is vital to identify strategies to mitigate barriers doctors encounter in conducting effective EOL conversations with seriously ill patients and their families.	[Periyakoil, Vyjeyanthi S.; Neri, Eric; Kraemer, Helena] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Periyakoil, Vyjeyanthi S.] VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Periyakoil, VS (corresponding author), Stanford Univ, Sch Med, Palo Alto, CA 94304 USA.	periyakoil@stanford.edu			NIH [NIHMD/NIH: R25 MD006857]; Department of Veterans Affairs; Stanford University School of Medicine; NATIONAL CANCER INSTITUTE [R25CA115562] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R25MD006857] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Stanford University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Dr. Periyakoil's work is funded by the NIH (NIHMD/NIH: R25 MD006857), the Department of Veterans Affairs and Stanford University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Medical Association website, CURR PROC TERM COD B; ANDERSON JL, 1979, RHEUMATOL REHABIL, V18, P18, DOI 10.1093/rheumatology/18.1.18; Baker RB, 2008, JAMA-J AM MED ASSOC, V300, P306, DOI 10.1001/jama.300.3.306; Barnato AE, 2009, J GEN INTERN MED, V24, P695, DOI 10.1007/s11606-009-0952-6; Boulware LE, 2003, PUBLIC HEALTH REP, V118, P358, DOI 10.1016/S0033-3549(04)50262-5; Buss MK, 2011, CANCER-AM CANCER SOC, V117, P4304, DOI 10.1002/cncr.25952; Buss Mary K, 2007, J Support Oncol, V5, P237; Caracelli V.J, 1997, ADV MIXED METHOD EVA, DOI DOI 10.1002/EV.1069; Centers for Disease Control and Prevention, 2007, STAT AG HLTH AM 2007; Creswell J.W., 2018, QUAL INQ, V4; Creswell J.W., 2010, BEST PRACTICES MIXED; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Friedman M, 1940, ANN MATH STAT, V11, P86, DOI 10.1214/aoms/1177731944; Givens JL, 2010, ARCH INTERN MED, V170, P427, DOI 10.1001/archinternmed.2009.547; Goodman D. C., 2010, QUALITY END OF LIFE; Gordon HS, 2006, J CLIN ONCOL, V24, P904, DOI 10.1200/JCO.2005.03.1955; Greiner KA, 2003, J AM GERIATR SOC, V51, P970, DOI 10.1046/j.1365-2389.2003.51310.x; Hanchate A, 2009, ARCH INTERN MED, V169, P493, DOI 10.1001/archinternmed.2008.616; Hopp FP, 2000, J AM GERIATR SOC, V48, P658, DOI 10.1111/j.1532-5415.2000.tb04724.x; Kessels RPC, 2003, J ROY SOC MED, V96, P219, DOI 10.1258/jrsm.96.5.219; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Organization for Economic Cooperation and Development (OECD), COUNTR STAT PROF US; Peek ME, 2009, J GEN INTERN MED, V24, P1135, DOI 10.1007/s11606-009-1047-0; Periyakoil VS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098246; Periyakoil VS, 2013, J AM GERIATR SOC, V61, P440, DOI 10.1111/jgs.12145; Periyakoil VS, 2010, J PALLIAT MED, V13, P495, DOI 10.1089/jpm.2009.0279; Periyakoil VS, 2009, J PALLIAT MED, V12, P1125, DOI 10.1089/jpm.2009.0123; Schillinger D, 2003, ARCH INTERN MED, V163, P83, DOI 10.1001/archinte.163.1.83; Strauss A, 1990, BASICS QUALITATIVE R, DOI [10.1111/j.1365-2702.2009.02908.x, DOI 10.1111/J.1365-2702.2009.02908.X]; Tong A, INT J QUALITY HLTH C, V19, P349; Washington HA, 2009, J NATL MED ASSOC, V101, P513, DOI 10.1016/S0027-9684(15)30936-6; Welch LC, 2005, J AM GERIATR SOC, V53, P1145, DOI 10.1111/j.1532-5415.2005.53357.x; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yu W, HLTH SERVICES RES DE; Zhang BH, 2009, ARCH INTERN MED, V169, P480, DOI 10.1001/archinternmed.2008.587	36	76	78	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122321	10.1371/journal.pone.0122321	http://dx.doi.org/10.1371/journal.pone.0122321			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KV	25902309	Green Submitted, gold, Green Published			2022-12-27	WOS:000353331500019
J	Renault, R; Sukenik, N; Descroix, S; Malaquin, L; Viovy, JL; Peyrin, JM; Bottani, S; Monceau, P; Moses, E; Vignes, M				Renault, Renaud; Sukenik, Nirit; Descroix, Stephanie; Malaquin, Laurent; Viovy, Jean-Louis; Peyrin, Jean-Michel; Bottani, Samuel; Monceau, Pascal; Moses, Elisha; Vignes, Maeva			Combining Microfluidics, Optogenetics and Calcium Imaging to Study Neuronal Communication In Vitro	PLOS ONE			English	Article							2-PHOTON EXCITATION; CORTICAL NETWORKS; POPULATIONS; ACTIVATION; PLASTICITY; PATTERNS; POLARITY	In this paper we report the combination of microfluidics, optogenetics and calcium imaging as a cheap and convenient platform to study synaptic communication between neuronal populations in vitro. We first show that Calcium Orange indicator is compatible in vitro with a commonly used Channelrhodopsine-2 (ChR2) variant, as standard calcium imaging conditions did not alter significantly the activity of transduced cultures of rodent primary neurons. A fast, robust and scalable process for micro-chip fabrication was developed in parallel to build micro-compartmented cultures. Coupling optical fibers to each micro-compartment allowed for the independent control of ChR2 activation in the different populations without crosstalk. By analyzing the post-stimuli activity across the different populations, we finally show how this platform can be used to evaluate quantitatively the effective connectivity between connected neuronal populations.	[Renault, Renaud; Bottani, Samuel; Monceau, Pascal] Univ Paris Diderot, CNRS UMR 7057, MSC, F-75013 Paris, France; [Renault, Renaud; Descroix, Stephanie; Malaquin, Laurent; Viovy, Jean-Louis; Vignes, Maeva] UPMC, CNRS UMR 168, Inst Curie, Physicochim Curie,Ctr Rech, F-75248 Paris 05, France; [Renault, Renaud; Sukenik, Nirit; Moses, Elisha] Weizmann Inst Sci, Dept Complex Syst, Rehovot, Israel; [Peyrin, Jean-Michel; Vignes, Maeva] CNRS, UMR 8256, Biol Adaptat & Ageing, F-75005 Paris, France; [Peyrin, Jean-Michel; Vignes, Maeva] Univ Paris 06, Sorbonne Univ, UMR 8256, B2A,Inst Biol Paris Seine, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Weizmann Institute of Science; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Vignes, M (corresponding author), Univ Copenhagen, Nanosci Ctr, Univ Pk 5, DK-2100 Copenhagen, Denmark.	maeva.vignes@gmail.com	DESCROIX, Stephanie/AAN-8875-2021; MALAQUIN, LAURENT/B-4852-2016; Maeva, VIGNES L/Q-9495-2016	MALAQUIN, LAURENT/0000-0003-4791-3352; Maeva, VIGNES L/0000-0002-4768-9648; Peyrin, Jean-Michel/0000-0002-0108-1266; Peyrin, Jean-Michel/0000-0002-8705-8672; Viovy, Jean-Louis/0000-0002-8223-4040	European Commission; European Research Commission [321107]	European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Commission(European CommissionEuropean Commission Joint Research Centre)	Funding was provided by a grant of the European Commission: MicroDEG, ERA-NET Neuron JTC2012 "Novel Methods", http://www.neuron-eranet.eu/en/317.php, JMP; and a European Research Commission advanced grant: CellO, Nbr: 321107, JLV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselmi F, 2011, P NATL ACAD SCI USA, V108, P19504, DOI 10.1073/pnas.1109111108; Baruchi I, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.050901; Bernardinelli Y, 2011, J NEUROSCI, V31, P8905, DOI 10.1523/JNEUROSCI.6341-10.2011; Bernstein JG, 2011, TRENDS COGN SCI, V15, P592, DOI 10.1016/j.tics.2011.10.003; Bonifazi P, 2005, EUR J NEUROSCI, V22, P2953, DOI 10.1111/j.1460-9568.2005.04464.x; Breskin I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.188102; Brunello CA, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-11; Chao ZC, 2007, J NEURAL ENG, V4, P294, DOI 10.1088/1741-2560/4/3/015; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; Cohen O, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/18008; Dranias MR, 2013, J NEUROSCI, V33, P1940, DOI 10.1523/JNEUROSCI.2718-12.2013; Feinerman O, 2005, J NEUROPHYSIOL, V94, P3406, DOI 10.1152/jn.00264.2005; Feinerman O, 2008, NAT PHYS, V4, P967, DOI 10.1038/nphys1099; Gobel W, 2007, PHYSIOLOGY, V22, P358, DOI 10.1152/physiol.00032.2007; Goldin M, 2001, J NEUROSCI, V21, P186, DOI 10.1523/JNEUROSCI.21-01-00186.2001; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Hallstrom W, 2009, LANGMUIR, V25, P4343, DOI 10.1021/la900436e; Hattori S, 2010, ELECTR COMMUN JPN, V93, P17, DOI 10.1002/ecj.10240; Hinard V, 2012, J NEUROSCI, V32, P12506, DOI 10.1523/JNEUROSCI.2306-12.2012; Kanagasabapathi Thirukumaran T, 2011, Front Neuroeng, V4, P13, DOI 10.3389/fneng.2011.00013; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Marconi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034648; Marx V, 2014, NAT METHODS, V11, P1099, DOI 10.1038/nmeth.3149; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Mohanty SK, 2008, BIOPHYS J, V95, P3916, DOI 10.1529/biophysj.108.130187; Morin F, 2006, BIOSENS BIOELECTRON, V21, P1093, DOI 10.1016/j.bios.2005.04.020; Nathanson JL, 2009, NEUROSCIENCE, V161, P441, DOI 10.1016/j.neuroscience.2009.03.032; Odawara A, 2013, LAB CHIP, V13, P2040, DOI 10.1039/c3lc00036b; Orlandi JG, 2013, NAT PHYS, V9, P582, DOI [10.1038/NPHYS2686, 10.1038/nphys2686]; Pan LB, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046031; Papagiakoumou E, 2010, NAT METHODS, V7, P848, DOI [10.1038/NMETH.1505, 10.1038/nmeth.1505]; Park JW, 2013, LAB CHIP, V13, P509, DOI 10.1039/c2lc41081h; Pautot S, 2008, NAT METHODS, V5, P735, DOI 10.1038/nmeth.1236; Peyrin JM, 2011, LAB CHIP, V11, P3663, DOI 10.1039/c1lc20014c; Roth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033623; Roth S, 2012, SMALL, V8, P671, DOI 10.1002/smll.201102325; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; Stenger DA, 1998, J NEUROSCI METH, V82, P167, DOI 10.1016/S0165-0270(98)00047-8; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor AM, 2010, NEURON, V66, P57, DOI 10.1016/j.neuron.2010.03.022; Teller S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003796; Valley M, 2011, JOVE-J VIS EXP, P2; Vogt AK, 2004, J NEUROSCI METH, V134, P191, DOI 10.1016/j.jneumeth.2003.11.004; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Yang IH, 2011, J BIOMED MATER RES A, V97A, P451, DOI 10.1002/jbm.a.33082; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Yuste R, 2011, COLD SPRING HARBOR P; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	49	47	46	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0120680	10.1371/journal.pone.0120680	http://dx.doi.org/10.1371/journal.pone.0120680			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901914	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500007
J	Tan, JYL; Habib, NA; Chuah, YW; Yau, YH; Geifman-Shochat, S; Chen, WN				Tan, Jane Yi Lin; Habib, Nagy A.; Chuah, York Wieo; Yau, Yin Hoe; Geifman-Shochat, Susana; Chen, Wei Ning			Identification of Cellular Targets of MicroRNA-181a in HepG2 Cells: A New Approach for Functional Analysis of MicroRNAs	PLOS ONE			English	Article							CANCER; BIOGENESIS; EXPRESSION; ROLES	MicroRNAs (miRNAs) are known to play a part in regulating important cellular processes. They generally perform their regulatory function through their binding with mRNAs, ultimately leading to a repression of target protein expression levels. However, their roles in cellular processes are poorly understood due to the limited understanding of their specific cellular targets. Aberrant levels of miRNAs have been found in hepatocellular carcinoma (HCC) including miR-181a. Using bioinformatics analysis, cyclin-dependent kinase inhibitor 1B (CDKN1 beta) and transcriptional factor E2F7 were identified as potential targets of miR-181a. Validation analysis using surface plasmon resonance (SPR) showed a positive binding between miR-181a and the 3 ' UTRs of these two potential mRNA targets. In vivo luciferase assay further confirmed the positive miR-181a: mRNA bindings, where a significant decrease in luciferase activity was detected when HepG2 cells were co-transfected with the 3 ' UTR-containing reporter plasmids and miR-181a. The potential impact of miR-181a binding to its specific targets on the general cellular behavior was further investigated. Results showed that miR-181a significantly activated the MAPK/JNK pathway which regulates cell proliferation, supporting our recently reported findings. Inhibition of miR-181a, on the other hand, abolished the observed activation. Our findings open up a new approach in designing targeted functional analysis of miRNAs in cellular processes, through the identification of their cellular targets.	[Tan, Jane Yi Lin; Chen, Wei Ning] Nanyang Technol Univ, Coll Engn, Sch Chem & Biomed Engn, Singapore 639798, Singapore; [Habib, Nagy A.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, London, England; [Chuah, York Wieo; Yau, Yin Hoe; Geifman-Shochat, Susana] Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Imperial College London; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Chen, WN (corresponding author), Nanyang Technol Univ, Coll Engn, Sch Chem & Biomed Engn, Singapore 639798, Singapore.	WNChen@ntu.edu.sg	Hoe, YAU Yin/A-2817-2011	Hoe, YAU Yin/0000-0001-8136-2393; , Yang/0000-0002-6620-8897				Abdulhalim I, 2008, ELECTROMAGNETICS, V28, DOI 10.1080/02726340801921650; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; de Bruin A, 2003, J BIOL CHEM, V278, P42041, DOI 10.1074/jbc.M308105200; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Gramantieri L, 2007, LIVER INT, V27, P997, DOI 10.1111/j.1478-3231.2007.01544.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang SL, 2010, NUCLEIC ACIDS RES, V38, P7211, DOI 10.1093/nar/gkq564; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kato M, 2008, BIOL CELL, V100, P71, DOI 10.1042/BC20070078; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Leong KG, 2002, MOL CELL BIOL, V22, P2830, DOI 10.1128/MCB.22.8.2830-2841.2002; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Tan YLJ, 2012, CURR PROTEOMICS, V9, P262; Wang V, 2009, BIODRUGS, V23, P15, DOI 10.2165/00063030-200923010-00002; West J, 2010, ADV EXP MED BIOL, V661, P265, DOI 10.1007/978-1-60761-500-2_17	22	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123167	10.1371/journal.pone.0123167	http://dx.doi.org/10.1371/journal.pone.0123167			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901570	Green Published, gold			2022-12-27	WOS:000353331500045
J	Triboulet, S; Aude-Garcia, C; Armand, L; Collin-Faure, V; Chevallet, M; Diemer, H; Gerdil, A; Proamer, F; Strub, JM; Habert, A; Herlin, N; Van Dorsselaer, A; Carriere, M; Rabilloud, T				Triboulet, Sarah; Aude-Garcia, Catherine; Armand, Lucie; Collin-Faure, Veronique; Chevallet, Mireille; Diemer, Helene; Gerdil, Adele; Proamer, Fabienne; Strub, Jean-Marc; Habert, Aurelie; Herlin, Nathalie; Van Dorsselaer, Alain; Carriere, Marie; Rabilloud, Thierry			Comparative Proteomic Analysis of the Molecular Responses of Mouse Macrophages to Titanium Dioxide and Copper Oxide Nanoparticles Unravels Some Toxic Mechanisms for Copper Oxide Nanoparticles in Macrophages	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED PROTEINS; IMMOBILIZED PH GRADIENTS; HEME OXYGENASE-1 EXPRESSION; LUNG EPITHELIAL-CELLS; DOUBLE-STRAND BREAKS; INTRATRACHEAL INSTILLATION; OXIDATIVE STRESS; 2-DIMENSIONAL ELECTROPHORESIS; INFLAMMATORY RESPONSE; PERITONEAL-MACROPHAGES	Titanium dioxide and copper oxide nanoparticles are more and more widely used because of their catalytic properties, of their light absorbing properties (titanium dioxide) or of their biocidal properties (copper oxide), increasing the risk of adverse health effects. In this frame, the responses of mouse macrophages were studied. Both proteomic and targeted analyses were performed to investigate several parameters, such as phagocytic capacity, cytokine release, copper release, and response at sub toxic doses. Besides titanium dioxide and copper oxide nanoparticles, copper ions were used as controls. We also showed that the overall copper release in the cell does not explain per se the toxicity observed with copper oxide nanoparticles. In addition, both copper ion and copper oxide nanoparticles, but not titanium oxide, induced DNA strands breaks in macrophages. As to functional responses, the phagocytic capacity was not hampered by any of the treatments at non-toxic doses, while copper ion decreased the lipopolysaccharide-induced cytokine and nitric oxide productions. The proteomic analyses highlighted very few changes induced by titanium dioxide nanoparticles, but an induction of heme oxygenase, an increase of glutathione synthesis and a decrease of tetrahydrobiopterin in response to copper oxide nanoparticles. Subsequent targeted analyses demonstrated that the increase in glutathione biosynthesis and the induction of heme oxygenase (e.g. by lovastatin/monacolin K) are critical for macrophages to survive a copper challenge, and that the intermediates of the catecholamine pathway induce a strong cross toxicity with copper oxide nanoparticles and copper ions.	[Triboulet, Sarah] Univ Grenoble Alpes, Lab Chem & Biol Met, Grenoble, France; [Aude-Garcia, Catherine; Collin-Faure, Veronique; Chevallet, Mireille] CEA iRTSV, Lab Chem & Biol Met, Grenoble, France; [Aude-Garcia, Catherine; Rabilloud, Thierry] CNRS UMR5249, Lab Chem & Biol Met, Grenoble, France; [Armand, Lucie; Carriere, Marie] Univ Grenoble Alpes, Serv Chim Inorgan & Biol, Grenoble, France; [Armand, Lucie; Carriere, Marie] CEA, Grenoble, France; [Diemer, Helene; Strub, Jean-Marc; Van Dorsselaer, Alain] Univ Strasbourg, Lab Spectrometrie Masse BioOrgan LSMBO, Strasbourg, France; [Diemer, Helene; Strub, Jean-Marc; Van Dorsselaer, Alain] Inst Pluridisciplinaire Hubert Curien, CNRS UMR 7178, Strasbourg, France; [Gerdil, Adele; Habert, Aurelie; Herlin, Nathalie] CEA Saclay, Lab Francis Perrin, Unite Rech Associee 2453, CEA, F-91191 Gif Sur Yvette, France; [Proamer, Fabienne] Univ Strasbourg, Etab Francais Sang Alsace, Unite MIxte Rech S949, INSERM, Strasbourg, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Rabilloud, T (corresponding author), CNRS UMR5249, Lab Chem & Biol Met, Grenoble, France.	thierry.rabilloud@cea.fr	sara, oufella/GYE-3652-2022; carriere, marie/F-2149-2011	carriere, marie/0000-0001-8446-6462; Chevallet, Mireille/0000-0002-3001-8821; Strub, Jean-Marc/0000-0001-6224-3428	Commissariat a l'Energie Atomique; Programme transversal Toxicologie; NanoBioMet grant; Nanostress grant; Universite Grenoble Alpes; Ecole Doctorale Chimie et Sciences du Vivant; Labex Serenade	Commissariat a l'Energie Atomique(French Atomic Energy Commission); Programme transversal Toxicologie; NanoBioMet grant; Nanostress grant; Universite Grenoble Alpes; Ecole Doctorale Chimie et Sciences du Vivant; Labex Serenade	Support was provided by: Commissariat a l'Energie Atomique, Programme transversal Toxicologie, NanoBioMet and Nanostress grants, to TR; Universite Grenoble Alpes, Ecole Doctorale Chimie et Sciences du Vivant, PhD Fellowship program, to ST; Labex Serenade, to TR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL G, 1991, EUR J IMMUNOGENET, V18, P239, DOI 10.1111/j.1744-313X.1991.tb00024.x; Ahamed M, 2010, BIOCHEM BIOPH RES CO, V396, P578, DOI 10.1016/j.bbrc.2010.04.156; Baraibar MA, 2011, FREE RADICAL BIO MED, V51, P1522, DOI 10.1016/j.freeradbiomed.2011.06.032; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER AJ, 1995, ANAL BIOCHEM, V226, P80, DOI 10.1006/abio.1995.1194; Brown SW, 2003, J NEUROIMMUNOL, V135, P47, DOI 10.1016/S0165-5728(02)00435-6; Cha MH, 2007, MOL CELL PROTEOMICS, V6, P56, DOI 10.1074/mcp.M600234-MCP200; Chen HW, 2006, FASEB J, V20, P2393, DOI 10.1096/fj.06-6485fje; Chen JC, 2006, CELL SIGNAL, V18, P32, DOI 10.1016/j.cellsig.2005.03.016; Chen Y, 2005, J BIOL CHEM, V280, P33766, DOI 10.1074/jbc.M504604200; Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288; Chi DS, 2003, NITRIC OXIDE-BIOL CH, V8, P127, DOI 10.1016/S1089-8603(02)00148-9; Cho WS, 2010, ENVIRON HEALTH PERSP, V118, P1699, DOI 10.1289/ehp.1002201; Cronholm P, 2013, SMALL, V9, P970, DOI 10.1002/smll.201201069; Cuillel M, 2014, NANOSCALE, V6, P1707, DOI 10.1039/c3nr05041f; Dobrovolskaia MA, 2009, NAT NANOTECHNOL, V4, P411, DOI [10.1038/nnano.2009.175, 10.1038/NNANO.2009.175]; Duvigneau JC, 2008, LAB INVEST, V88, P70, DOI 10.1038/labinvest.3700691; Edelmann MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114390; Falck GCM, 2009, HUM EXP TOXICOL, V28, P339, DOI 10.1177/0960327109105163; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Flierl MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004414; FREEDMAN JH, 1989, J BIOL CHEM, V264, P5598; Ge Y, 2011, PROTEOMICS, V11, P2406, DOI 10.1002/pmic.201000741; Geiser M, 2008, AM J RESP CELL MOL, V38, P371, DOI 10.1165/rcmb.2007-0138OC; GIANAZZA E, 1989, ELECTROPHORESIS, V10, P806, DOI 10.1002/elps.1150101115; GORG A, 1987, ELECTROPHORESIS, V8, P122, DOI 10.1002/elps.1150080207; HAMILTON JA, 1980, ENVIRON HEALTH PERSP, V34, P69, DOI 10.1289/ehp.803469; Hanagata N, 2011, ACS NANO, V5, P9326, DOI 10.1021/nn202966t; Haniu H, 2010, TOXICOL APPL PHARM, V242, P256, DOI 10.1016/j.taap.2009.10.015; Herrmann AG, 2013, PROTEOMICS, V13, P3251, DOI 10.1002/pmic.201300056; HIDALGO J, 1991, HEPATOLOGY, V14, P648, DOI 10.1002/hep.1840140412; Jeon YM, 2011, J APPL TOXICOL, V31, P45, DOI 10.1002/jat.1566; Jeon YM, 2011, MOL CELL TOXICOL, V7, P283, DOI 10.1007/s13273-011-0034-9; Jugan ML, 2012, NANOTOXICOLOGY, V6, P501, DOI 10.3109/17435390.2011.587903; Karlsson HL, 2008, CHEM RES TOXICOL, V21, P1726, DOI 10.1021/tx800064j; Karlsson HL, 2009, TOXICOL LETT, V188, P112, DOI 10.1016/j.toxlet.2009.03.014; Klose J, 2002, NAT GENET, V30, P385, DOI 10.1038/ng861; Kobayashi N, 2009, TOXICOLOGY, V264, P110, DOI 10.1016/j.tox.2009.08.002; KUBOTA Y, 1994, INT J RADIAT BIOL, V65, P335, DOI 10.1080/09553009414550401; Lloyd DR, 1999, MUTAT RES-FUND MOL M, V424, P23, DOI 10.1016/S0027-5107(99)00005-6; Luche S, 2004, PROTEOMICS, V4, P551, DOI 10.1002/pmic.200300589; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Merkley MA, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-29; Midander K, 2009, SMALL, V5, P389, DOI 10.1002/smll.200801220; Moon EY, 2011, J IMMUNOTOXICOL, V8, P56, DOI 10.3109/1547691X.2010.543995; Morishige T, 2010, BIOCHEM BIOPH RES CO, V392, P160, DOI 10.1016/j.bbrc.2009.12.178; Moschini E, 2013, TOXICOL LETT, V222, P102, DOI 10.1016/j.toxlet.2013.07.019; Msiska Z, 2010, AM J RESP CELL MOL, V43, P210, DOI 10.1165/rcmb.2009-0062OC; Osier M, 1997, ENVIRON HEALTH PERSP, V105, P1265, DOI 10.2307/3433545; Osier M, 1997, FUND APPL TOXICOL, V40, P220, DOI 10.1006/faat.1997.2390; Ossola JO, 1997, ARCH BIOCHEM BIOPHYS, V337, P332, DOI 10.1006/abbi.1996.9788; Palomaki J, 2010, TOXICOLOGY, V267, P125, DOI 10.1016/j.tox.2009.10.034; Paris I, 2001, J NEUROCHEM, V77, P519, DOI 10.1046/j.1471-4159.2001.00243.x; Park EJ, 2009, TOXICOLOGY, V260, P37, DOI 10.1016/j.tox.2009.03.005; Park SK, 2011, J APPL TOXICOL, V31, P463, DOI 10.1002/jat.1658; Petrak J, 2008, PROTEOMICS, V8, P1744, DOI 10.1002/pmic.200700919; Piret JP, 2012, NANOSCALE, V4, P7168, DOI 10.1039/c2nr31785k; Piret JP, 2012, NANOTOXICOLOGY, V6, P789, DOI 10.3109/17435390.2011.625127; Plascencia-Villa G, 2012, INTEGR BIOL-UK, V4, P1358, DOI 10.1039/c2ib20172k; Prabhu BM, 2010, NANOTOXICOLOGY, V4, P150, DOI 10.3109/17435390903337693; RABILLOUD T, 1994, ELECTROPHORESIS, V15, P1552, DOI 10.1002/elps.11501501223; Rabilloud T, 1997, ELECTROPHORESIS, V18, P307, DOI 10.1002/elps.1150180303; Rivollier A, 2006, MOL CELL PROTEOMICS, V5, P726, DOI 10.1074/mcp.M500262-MCP200; Rousselet E, 2008, PROTEOMICS, V8, P2244, DOI 10.1002/pmic.200701067; SAKAI N, 1993, MOL PHARMACOL, V43, P6; SATO H, 1993, BIOCHIM BIOPHYS ACTA, V1148, P127, DOI 10.1016/0005-2736(93)90169-Z; Scherbart AM, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-31; Semisch A, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-10; Shaligram S, 2013, TOXICOL IN VITRO, V27, P844, DOI 10.1016/j.tiv.2012.12.026; Shukla RK, 2011, TOXICOL IN VITRO, V25, P231, DOI 10.1016/j.tiv.2010.11.008; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Snyder RD, 1998, MUTAT RES-FUND MOL M, V405, P1, DOI 10.1016/S0027-5107(98)00117-1; Song MO, 2005, MOL CELL BIOCHEM, V279, P141, DOI 10.1007/s11010-005-8286-0; SPENGLER RN, 1994, J IMMUNOL, V152, P3024; Srisook K, 2004, BIOCHEM PHARMACOL, V68, P1709, DOI 10.1016/j.bcp.2004.07.001; Srisook K, 2005, NITRIC OXIDE-BIOL CH, V12, P70, DOI 10.1016/j.niox.2004.12.002; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sund J, 2014, J PROTEOMICS, V108, P469, DOI 10.1016/j.jprot.2014.06.011; Taira M, 2010, J MATER SCI-MATER M, V21, P267, DOI 10.1007/s10856-009-3834-x; Tastet C, 2003, ELECTROPHORESIS, V24, P1787, DOI 10.1002/elps.200305400; Tian L, 1996, TOXICOL APPL PHARM, V141, P540, DOI 10.1006/taap.1996.0320; Triboulet S, 2014, NANOSCALE, V6, P6102, DOI 10.1039/c4nr00319e; Triboulet S, 2013, MOL CELL PROTEOMICS, V12, P3108, DOI 10.1074/mcp.M113.030742; Tuomela S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068415; Wang JY, 2009, NEUROTOXICOLOGY, V30, P926, DOI 10.1016/j.neuro.2009.09.005; Wang JJ, 2007, MUTAT RES-GEN TOX EN, V628, P99, DOI 10.1016/j.mrgentox.2006.12.003; Wang P, 2009, PROTEOMICS, V9, P2955, DOI 10.1002/pmic.200800826; Wang ZY, 2012, CHEM RES TOXICOL, V25, P1512, DOI 10.1021/tx3002093; Weatherby KE, 2003, INFECT IMMUN, V71, P22, DOI 10.1128/IAI.71.1.22-29.2003; Wilhelmi V, 2012, TOXICOL IN VITRO, V26, P323, DOI 10.1016/j.tiv.2011.12.006; Winkler W, 2008, MOL CELL PROTEOMICS, V7, P193, DOI 10.1074/mcp.M700137-MCP200; Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k; Yokohira M, 2008, TOXICOL PATHOL, V36, P620, DOI 10.1177/0192623308318214; Zafar KS, 2006, MOL PHARMACOL, V70, P1079, DOI 10.1124/mol.106.024703; Zhai SM, 2010, J BIOL INORG CHEM, V15, P259, DOI 10.1007/s00775-009-0594-5; Zucker RM, 2010, CYTOM PART A, V77A, P677, DOI 10.1002/cyto.a.20927	96	49	50	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124496	10.1371/journal.pone.0124496	http://dx.doi.org/10.1371/journal.pone.0124496			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902355	Green Published, gold, Green Submitted			2022-12-27	WOS:000353331500091
J	De Cobelli, F; Pezzetti, G; Margari, S; Esposito, A; Giganti, F; Agostini, G; Del Maschio, A				De Cobelli, Francesco; Pezzetti, Giulio; Margari, Sergio; Esposito, Antonio; Giganti, Francesco; Agostini, Giulia; Del Maschio, Alessandro			New Insights in Abdominal Pain in Paroxysmal Nocturnal Hemoglobinuria (PNH): A MRI Study	PLOS ONE			English	Article							COMPLEMENT INHIBITOR ECULIZUMAB; CHRONIC MESENTERIC ISCHEMIA; INTESTINAL INFARCTION; DIAGNOSIS; FLOW; MANAGEMENT; THROMBOSIS; HEMOLYSIS; CELLS	Introduction Abdominal pain in PNH has never been investigated by in-vivo imaging studies. With MRI, we aimed to assess mesenteric vessels flow and small bowel wall perfusion to investigate the ischemic origin of abdominal pain. Materials and Methods Six PNH patients with (AP) and six without (NOP) abdominal pain underwent MRI. In a blinded fashion, mean flow (MF, quantity of blood moving through a vessel within a second, in mL.s(-1)) and stroke volume (SV, volume of blood pumped out at each heart contraction, in mL) of Superior Mesenteric Vein (SMV) and Artery (SMA), areas under the curve at 60 (AUC(60)) and 90 seconds (AUC(90)) and K-trans were assessed by two operators. Results Mean total perfusion and flow parameters were lower in AP than in NOP group. AUC(60): 84.81 +/- 11.75 vs. 131.73 +/- 18.89 (P<0.001); AUC(90): 102.33 +/- 14.16 vs. 152.58 +/- 22.70 (P<0.001); K-trans: 0.0346 min(-1) +/- 0.0019 vs. 0.0521 +/- 0.0015 (P = 0.093 duodenum, 0.009 jejunum/ileum). SMV: MF 4.67 ml/s +/- 0.85 vs. 8.32 +/- 2.14 (P = 0.002); SV 3.85 ml +/- 0.76 vs. 6.55 +/- 1.57 (P = 0.02). SMA: MF 6.95 +/- 2.61 vs. 11.2 +/- 2.32 (P = 0.07); SV 6.52 +/- 2.19 vs. 8.78 +/- 1.63 (P = 0.07). We found a significant correlation between MF and SV of SMV and AUC(60) (MF: rho = 0.88, P<0.001; SV: rho = 0.644, P = 0.024), AUC(90) (MF: rho = 0.874, P<0.001; SV: rho = 0.774, P = 0.003) and K-trans (MF: rho = 0.734, P = 0.007; SV: rho = 0.581, P = 0.047). Conclusions Perfusion and flow MRI findings suggest that the impairment of small bowel blood supply is significantly associated with abdominal pain in PNH.	[De Cobelli, Francesco] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Dept Radiol, Milan, Italy; Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Ctr Expt Imaging, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	De Cobelli, F (corresponding author), Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Dept Radiol, Milan, Italy.	decobelli.francesco@hsr.it	Esposito, Antonio/AAZ-7967-2020; Esposito, Antonio/K-5088-2018; DE COBELLI, Francesco/AAC-6488-2022	Esposito, Antonio/0000-0002-1170-6266; Esposito, Antonio/0000-0002-1170-6266; DE COBELLI, Francesco/0000-0003-4014-3711; Giganti, Francesco/0000-0001-5218-6431	Alexion Pharmaceuticals Inc.	Alexion Pharmaceuticals Inc.	Alexion Pharmaceuticals Inc. provided financial support in the form of a grant. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. Alexion Pharmaceuticals Inc. had no involvement in the study design, the collection and the analysis of the data and results.	Adams T, 2002, DIGEST DIS SCI, V47, P58, DOI 10.1023/A:1013207318697; Audebert HJ, 2005, J NEUROL, V252, P1379, DOI 10.1007/s00415-005-0871-3; Barnes Stephanie L, 2012, Pharmaceutics, V4, P442, DOI 10.3390/pharmaceutics4030442; Barrett T, 2007, J MAGN RESON IMAGING, V26, P235, DOI 10.1002/jmri.20991; BLUM SF, 1966, NEW ENGL J MED, V274, P1137, DOI 10.1056/NEJM196605192742008; Borowitz MJ, 2010, CYTOM PART B-CLIN CY, V78B, P211, DOI 10.1002/cyto.b.20525; BURKART DJ, 1995, RADIOLOGY, V194, P801, DOI 10.1148/radiology.194.3.7862982; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; CROSBY WH, 1951, BLOOD, V6, P270, DOI 10.1182/blood.V6.3.270.270; de Latour RP, 2008, BLOOD, V112, P3099, DOI 10.1182/blood-2008-01-133918; Dolezel Z, 2004, PEDIATR NEPHROL, V19, P1177, DOI 10.1007/s00467-004-1563-4; DOUKAS MA, 1984, AM J HEMATOL, V16, P75, DOI 10.1002/ajh.2830160110; Evelhoch JL, 1999, JMRI-J MAGN RESON IM, V10, P254, DOI 10.1002/(SICI)1522-2586(199909)10:3<254::AID-JMRI5>3.0.CO;2-9; Giusti S, 2010, ABDOM IMAGING, V35, P646, DOI 10.1007/s00261-010-9624-6; GRALNICK HR, 1995, BRIT J HAEMATOL, V91, P697, DOI 10.1111/j.1365-2141.1995.tb05371.x; Grand DJ, 2013, RADIOL CLIN N AM, V51, P99, DOI 10.1016/j.rcl.2012.09.007; Haroon HA, 2004, J MAGN RESON IMAGING, V19, P527, DOI 10.1002/jmri.20045; Hernandez-Campo PM, 2006, CYTOM PART B-CLIN CY, V70B, P71, DOI 10.1002/cyto.b.20087; Hill A, 2013, BLOOD, V121, P4985, DOI 10.1182/blood-2012-09-311381; Hillmen P, 2004, NEW ENGL J MED, V350, P552, DOI 10.1056/NEJMoa031688; Hillmen P, 2007, BLOOD, V110, P4123, DOI 10.1182/blood-2007-06-095646; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; Holers VM, 2008, IMMUNOL REV, V223, P300, DOI 10.1111/j.1600-065X.2008.00641.x; Lauenstein TC, 2005, RADIOLOGY, V234, P569, DOI 10.1148/radiol.2342031002; Lee JW, 2013, INT J HEMATOL, V97, P749, DOI 10.1007/s12185-013-1346-4; LI KCP, 1995, RADIOLOGY, V194, P327, DOI 10.1148/radiology.194.2.7824706; LI KCP, 1994, RADIOLOGY, V190, P175, DOI 10.1148/radiology.190.1.8259400; MATHIEU D, 1995, BLOOD, V85, P3283, DOI 10.1182/blood.V85.11.3283.bloodjournal85113283; Naganawa S, 1994, Radiat Med, V12, P213; O'Connor JPB, 2011, BRIT J RADIOL, V84, pS112, DOI 10.1259/bjr/55166688; Parker C, 2005, BLOOD, V106, P3699, DOI 10.1182/blood-2005-04-1717; Richards SJ, 2007, CYTOM PART B-CLIN CY, V72B, P291, DOI 10.1002/cyto.b.20358; Socie G, 1996, LANCET, V348, P573, DOI 10.1016/S0140-6736(95)12360-1; Turkbey B, 2009, AM J ROENTGENOL, V193, P304, DOI 10.2214/AJR.09.2869; Wang HB, 2002, BLOOD, V100, P3897, DOI 10.1182/blood-2002-03-0799; Young NS, 2006, BLOOD, V108, p290A	36	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0122832	10.1371/journal.pone.0122832	http://dx.doi.org/10.1371/journal.pone.0122832			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897796	Green Submitted, gold, Green Published			2022-12-27	WOS:000353212600014
J	Huang, CC; Yang, H; Li, YM; Zou, J; Zhang, YM; Chen, X; Mi, Y; Zhang, ML				Huang, Changchun; Yang, Hao; Li, Yunmei; Zou, Jun; Zhang, YiMing; Chen, Xia; Mi, Yin; Zhang, Mingli			Investigating Changes in Land Use Cover and Associated Environmental Parameters in Taihu Lake in Recent Decades Using Remote Sensing and Geochemistry	PLOS ONE			English	Article							C-ORG/N RATIOS; ORGANIC-MATTER; EUTROPHICATION; RIVER; IMPACT; PHOSPHORUS; CLIMATE; CARBON; MODEL; DEFORESTATION	Humans have had a significant impact on the terrestrial pedosphere through activities such as agriculture and urbanization. The effects of human activities on land use and the related environmental changes were investigated through point and areal studies surrounding Meiliang Bay, which is an open area of extreme eutrophication in Taihu Lake, China. This study used remote sensing and environmental-tracer profiles [total nitrogen (TN), total phosphorus (TP), total organic carbon (TOC), grain size, and geochemical parameters] to determine the causes of changes in land use and the associated environmental parameters. The results of LUCCs (Land use/cover changes) indicate that over the past three decades, total farmland decreased by 862.49 km(2), with an annual decrement rate of 28.75 km(2)/year, and total urbanized land increased by 859.71 km(2), with an annual growth rate of 28.66 km(2)/year. The geochemical results indicate that the trophic state of Taihu Lake was persistently intensifying and that the TN, TP, and TOC concentrations increased twofold, threefold, and twofold, respectively, from 1949 to 2010. The sources of TN, TP, and TOC were highly similar after 1975. However, before 1974, TN and TP originated from different sources than TOC. The grassland and woodland around the lake retain nutrients and sand from the land of study area. The increase in urbanized land and tertiary industries significantly increased the sediment concentrations of TN, TP, and TOC after 1980.	[Huang, Changchun; Li, Yunmei] Nanjing Normal Univ, Jiangsu Ctr Collaborat Innovat Geog Informat Reso, Nanjing, Jiangsu, Peoples R China; [Huang, Changchun; Yang, Hao; Li, Yunmei; Zou, Jun; Zhang, YiMing; Chen, Xia; Mi, Yin; Zhang, Mingli] Nanjing Normal Univ, Sch Geog Sci, Nanjing, Jiangsu, Peoples R China; [Huang, Changchun; Yang, Hao] Nanjing Normal Univ, Jiangsu Prov Key Lab Mat Cycling & Pollut Control, Nanjing, Jiangsu, Peoples R China; [Huang, Changchun] Nanjing Normal Univ, Key Lab Virtual Geog Environm, Minist Educ, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing Normal University; Nanjing Normal University; Nanjing Normal University	Zhang, YM (corresponding author), Nanjing Normal Univ, Sch Geog Sci, Nanjing, Jiangsu, Peoples R China.	zhangyiming@njnu.edu.cn	huang, changchun/E-6580-2016; huang, changchun/E-6580-2016	huang, changchun/0000-0002-9833-5663; huang, changchun/0000-0002-4704-548X	National Natural Science Foundation of China [41201325, 41271343, 41030751]; Natural Science Funds of Provincial Universities [12KJB170005]; Ph.D. Program Foundation of the Ministry of Education of China [20123207120017]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Funds of Provincial Universities; Ph.D. Program Foundation of the Ministry of Education of China(Ministry of Education, China); Priority Academic Program Development of Jiangsu Higher Education Institutions	This study was supported by the National Natural Science Foundation of China (Grant Nos. 41201325, 41271343, and 41030751), the Natural Science Funds of Provincial Universities (Grant No. 12KJB170005), the Ph.D. Program Foundation of the Ministry of Education of China (Grant No. 20123207120017), and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Bala G, 2007, P NATL ACAD SCI USA, V104, P6550, DOI 10.1073/pnas.0608998104; Bengtsson J, 2011, OECOLOGIA, V165, P225, DOI 10.1007/s00442-010-1753-7; Bennett EM, 2001, BIOSCIENCE, V51, P227, DOI 10.1641/0006-3568(2001)051[0227:HIOEPA]2.0.CO;2; Berhe AA, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001790; Berthon V, 2013, J LIMNOL, V72, P417, DOI 10.4081/jlimnol.2013.e34; BONAN GB, 1992, NATURE, V359, P716, DOI 10.1038/359716a0; Costa MH, 2003, J HYDROL, V283, P206, DOI 10.1016/S0022-1694(03)00267-1; Davin EL, 2010, J CLIMATE, V23, P97, DOI 10.1175/2009JCLI3102.1; Digerfeldt G, 2000, PALAEOGEOGR PALAEOCL, V158, P65, DOI 10.1016/S0031-0182(00)00029-8; Dong XH, 2008, J PALEOLIMNOL, V40, P413, DOI 10.1007/s10933-007-9170-6; Feddema JJ, 2005, SCIENCE, V310, P1674, DOI 10.1126/science.1118160; Findlay S, 2013, ECOLOGY, V94, P117, DOI 10.1890/12-0464.1; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Galford GL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0171; Gooday AJ, 2009, BIOGEOSCIENCES, V6, P1707, DOI 10.5194/bg-6-1707-2009; Griffiths P, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/045024; Gusewell S, 2006, PLANT SOIL, V287, P131, DOI 10.1007/s11104-006-9050-2; Guo L, 2007, SCIENCE, V317, P1166, DOI 10.1126/science.317.5842.1166; Guzman G, 2013, J SOIL SEDIMENT, V13, P816, DOI 10.1007/s11368-013-0659-5; Hasler N, 2009, J CLIMATE, V22, P1124, DOI 10.1175/2008JCLI2157.1; Hua WJ, 2013, ADV CLIM CHANG RES, V4, P166, DOI 10.3724/SP.J.1248.2013.166; JACOBS M, 1988, TROPICAL RAIN FOREST; Kendall C, 2001, HYDROL PROCESS, V15, P1301, DOI 10.1002/hyp.216; Knibbs LD, 2014, ENVIRON RES, V135, P204, DOI 10.1016/j.envres.2014.09.011; Kunz MJ, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001538; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Lambin EF, 2003, ENVIRONMENT, V45, P22, DOI 10.1080/00139157.2003.10544695; Lawrence PJ, 2012, J CLIMATE, V25, P3071, DOI 10.1175/JCLI-D-11-00256.1; Matthews MW, 2012, REMOTE SENS ENVIRON, V124, P637, DOI 10.1016/j.rse.2012.05.032; Meisel S, 2011, FOSS REC, V14, P141, DOI 10.1002/mmng.201100004; Mizugaki S, 2006, CATENA, V68, P25, DOI 10.1016/j.catena.2006.03.014; Muller A, 1999, PALAEOGEOGR PALAEOCL, V145, P1, DOI 10.1016/S0031-0182(98)00094-7; Nadeu E, 2012, BIOGEOSCIENCES, V9, P1099, DOI 10.5194/bg-9-1099-2012; O'Reilly J, 2011, J ENVIRON RADIOACTIV, V102, P495, DOI 10.1016/j.jenvrad.2010.09.003; Olofsson P, 2013, REMOTE SENS ENVIRON, V129, P122, DOI 10.1016/j.rse.2012.10.031; PETERJOHN WT, 1984, ECOLOGY, V65, P1466, DOI 10.2307/1939127; Piao SL, 2007, P NATL ACAD SCI USA, V104, P15242, DOI 10.1073/pnas.0707213104; Pielke RA, 2005, SCIENCE, V310, P1625, DOI 10.1126/science.1120529; Polyakov VO, 2004, SOIL SCI, V169, P590, DOI 10.1097/01.ss.0000138414.84427.40; Qin B, 2008, LAKE TAIHU CHINA DYN; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; Rose NL, 2004, J PALEOLIMNOL, V32, P41, DOI 10.1023/B:JOPL.0000025282.06961.42; Schelske CL, 2006, LIMNOL OCEANOGR, V51, P728, DOI 10.4319/lo.2006.51.1_part_2.0728; Sherbinin A., 2002, LAND USE LAND COVER; SHUKLA J, 1990, SCIENCE, V247, P1322, DOI 10.1126/science.247.4948.1322; Snyder PK, 2004, CLIM DYNAM, V23, P279, DOI 10.1007/s00382-004-0430-0; Sundquist ET, 2011, APPL GEOCHEM, V26, pS259, DOI 10.1016/j.apgeochem.2011.03.118; Thomas AD, 1999, CATENA, V36, P283, DOI 10.1016/S0341-8162(99)00051-X; Townsend AR, 2003, FRONT ECOL ENVIRON, V1, P240, DOI 10.2307/3868011; Tu J, 2008, SCI TOTAL ENVIRON, V407, P358, DOI 10.1016/j.scitotenv.2008.09.031; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wang M., 2011, EOS T AM GEOPHYS UN, V89, P201, DOI [DOI 10.1029/2008EO220001, 10.1029/2008EO220001]; Wang M, 2012, ENVIRON SCI TECHNOL, V46, P4481, DOI 10.1021/es204183v; Wilkinson BH, 2007, GEOL SOC AM BULL, V119, P140, DOI 10.1130/B25899.1; Wu JL, 2006, HYDROBIOLOGIA, V563, P19, DOI 10.1007/s10750-005-9133-8; Xian G, 2009, REMOTE SENS ENVIRON, V113, P1133, DOI 10.1016/j.rse.2009.02.004; Xie HL, 2014, INT J ENV RES PUB HE, V11, P583, DOI 10.3390/ijerph110100583; [殷立琼 Yin Liqiong], 2005, [湖泊科学, Scientia Limnologica Sinica], V17, P139; Yu WH, 2011, APPL GEOGR, V31, P600, DOI 10.1016/j.apgeog.2010.11.019; Zhan CS, 2011, J PLANT ECOL, V4, P61, DOI 10.1093/jpe/rtr003; Zhang EL, 2010, J LIMNOL, V69, P235, DOI 10.4081/jlimnol.2010.235; Zhang H, 2008, ENVIRON SCI TECHNOL, V42, P2328, DOI 10.1021/es0720208; Zhou WH, 2014, ENVIRON RES, V135, P81, DOI 10.1016/j.envres.2014.08.025	63	7	7	7	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0120319	10.1371/journal.pone.0120319	http://dx.doi.org/10.1371/journal.pone.0120319			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898010	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600005
J	Kim, CK; Seol, YJ; Shin, Y; Lim, HM; Lee, GS; Kim, AR; Lee, TH; Lee, JH; Park, DS; Yoo, S; Kim, YH; Kim, YK				Kim, Chang-Kug; Seol, Young-Joo; Shin, Younhee; Lim, Hye-Min; Lee, Gang-Seob; Kim, A-Ram; Lee, Tae-Ho; Lee, Jae-Hee; Park, Dong-Suk; Yoo, Seungil; Kim, Yong-Hwan; Kim, Yong-Kab			Whole-Genome Resequencing and Transcriptomic Analysis to Identify Genes Involved in Leaf-Color Diversity in Ornamental Rice Plants	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; ANTHOCYANINS; SEQUENCE; IDENTIFICATION; BIOSYNTHESIS; DEFICIENCY; METABOLISM; GENERATION; ALIGNMENT; FAMILY	Rice field art is a large-scale art form in which people design rice fields using various kinds of ornamental rice plants with different leaf colors. Leaf color-related genes play an important role in the study of chlorophyll biosynthesis, chloroplast structure and function, and anthocyanin biosynthesis. Despite the role of different metabolites in the traditional relationship between leaf and color, comprehensive color-specific metabolite studies of ornamental rice have been limited. We performed whole-genome resequencing and transcriptomic analysis of regulatory patterns and genetic diversity among different rice cultivars to discover new genetic mechanisms that promote enhanced levels of various leaf colors. We resequenced the genomes of 10 rice leaf-color accessions to an average of 40x reads depth and >95% coverage and performed 30 RNA-seq experiments using the 10 rice accessions sampled at three developmental stages. The sequencing results yielded a total of 1,814 x 106 reads and identified an average of 713,114 SNPs per rice accession. Based on our analysis of the DNA variation and gene expression, we selected 47 candidate genes. We used an integrated analysis of the whole-genome resequencing data and the RNA-seq data to divide the candidate genes into two groups: genes related to macronutrient (i.e., magnesium and sulfur) transport and genes related to flavonoid pathways, including anthocyanidin biosynthesis. We verified the candidate genes with quantitative real-time PCR using transgenic T-DNA insertion mutants. Our study demonstrates the potential of integrated screening methods combined with genetic-variation and transcriptomic data to isolate genes involved in complex biosynthetic networks and pathways.	[Kim, Chang-Kug; Seol, Young-Joo; Lee, Tae-Ho; Lee, Jae-Hee; Park, Dong-Suk] Rural Dev Adm, NAAS, Genom Div, Jeonju, South Korea; [Shin, Younhee; Yoo, Seungil] Insilicogen Inc, Codes Div, Suwon, Gyeonggi Do, South Korea; [Lim, Hye-Min; Lee, Gang-Seob; Kim, A-Ram] RDA, NAAS, Biosafety Div, Jeonju, South Korea; [Kim, Yong-Hwan] Korea Inst Planning & Evaluat Technol Food Agr Fo, Policy Dev Off, Anyang, South Korea; [Kim, Yong-Kab] Wonkwang Univ, Sch Elect Informat Commun Engn, Iksan, South Korea	Rural Development Administration (RDA); Rural Development Administration (RDA); Wonkwang University	Kim, YK (corresponding author), Wonkwang Univ, Sch Elect Informat Commun Engn, Iksan, South Korea.	ykim@wonkwang.ac.kr			Research Program for Agricultural Science and Technology Development of the National Academy of Agricultural Science [PJ010112]; Next-Generation BioGreen 21 Program (SSAC), Rural Development Administration, Republic of Korea [PJ009614]; Insilicogen Inc.	Research Program for Agricultural Science and Technology Development of the National Academy of Agricultural Science; Next-Generation BioGreen 21 Program (SSAC), Rural Development Administration, Republic of Korea; Insilicogen Inc.	This study was conducted with support from the Research Program for Agricultural Science and Technology Development (Project No. PJ010112) of the National Academy of Agricultural Science, and the Next-Generation BioGreen 21 Program (SSAC, Grant No PJ009614), Rural Development Administration, Republic of Korea. Co-authors YS and SY are employed by Insilicogen Inc. Insilicogen Inc. provided support in the form of salaries for authors YS and SY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Davidian JC, 2010, MOL PLANT, V3, P314, DOI 10.1093/mp/ssq001; Deng XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099564; Ding YC, 2008, PEDOSPHERE, V18, P316, DOI 10.1016/S1002-0160(08)60021-1; Droux M, 2003, PLANT PHYSIOL BIOCH, V41, P619, DOI 10.1016/S0981-9428(03)00083-4; Gebert M, 2009, PLANT CELL, V21, P4018, DOI 10.1105/tpc.109.070557; Guigo R, 1998, J COMPUT BIOL, V5, P681, DOI 10.1089/cmb.1998.5.681; Jeong DH, 2006, PLANT J, V45, P123, DOI 10.1111/j.1365-313X.2005.02610.x; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kim CK, 2011, J APPL GENET, V52, P161, DOI 10.1007/s13353-011-0027-3; Kim CK, 2014, EVOL BIOINFORM, V10, DOI 10.4137/EBO.S14823; Kim C, 2010, BIOCHIP J, V4, P247, DOI 10.1007/s13206-010-4313-7; Kobayashi NI, 2013, PHYSIOL PLANTARUM, V148, P490, DOI 10.1111/ppl.12003; Kong JM, 2003, PHYTOCHEMISTRY, V64, P923, DOI 10.1016/S0031-9422(03)00438-2; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar S, 2011, FUNCT INTEGR GENOMIC, V11, P259, DOI 10.1007/s10142-010-0207-y; Li YH, 2012, RICE SCI, V19, P79, DOI 10.1016/S1672-6308(12)60025-0; Peng CL, 2006, SCI CHINA SER C, V49, P543, DOI 10.1007/s11427-006-2022-1; Sakuraba Y, 2013, PLANT J, V74, P122, DOI 10.1111/tpj.12110; Springob K, 2003, NAT PROD REP, V20, P288, DOI 10.1039/b109542k; Tanaka A, 2006, CURR OPIN PLANT BIOL, V9, P248, DOI 10.1016/j.pbi.2006.03.011; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Unno H, 2007, J BIOL CHEM, V282, P15812, DOI 10.1074/jbc.M700638200; Varinderpal-Singh, 2010, NUTR CYCL AGROECOSYS, V88, P361, DOI 10.1007/s10705-010-9363-7; Xie DY, 2004, ARCH BIOCHEM BIOPHYS, V422, P91, DOI 10.1016/j.abb.2003.12.011; Xu HX, 2007, RUSS J PLANT PHYSL+, V54, P741, DOI 10.1134/S1021443707060040; Xu JM, 2013, PLANT PHYSIOL, V161, P2036, DOI 10.1104/pp.112.210831; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang FT, 2013, RICE, V6, DOI 10.1186/1939-8433-6-7	33	9	10	7	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124071	10.1371/journal.pone.0124071	http://dx.doi.org/10.1371/journal.pone.0124071			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897514	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600047
J	Sasaki, Y; Usami, M; Sasayama, D; Okada, T; Iwadare, Y; Watanabe, K; Ushijima, H; Tanaka, T; Harada, M; Tanaka, H; Kodaira, M; Sugiyama, N; Sawa, T; Saito, K				Sasaki, Yoshinori; Usami, Masahide; Sasayama, Daimei; Okada, Takashi; Iwadare, Yoshitaka; Watanabe, Kyota; Ushijima, Hirokage; Tanaka, Tetsuya; Harada, Maiko; Tanaka, Hiromi; Kodaira, Masaki; Sugiyama, Nobuhiro; Sawa, Tetsuji; Saito, Kazuhiko			Concerns Expressed by Parents of Children with Pervasive Developmental Disorders for Different Time Periods of the Day: A Case-Control Study	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; OPPOSITIONAL DEFIANT; SYMPTOMS; AUTISM; RELIABILITY; ATOMOXETINE; VALIDITY	Background/Aim The Questionnaire: Children with Difficulties (QCD) is a parent-assessed questionnaire designed to evaluate child's difficulties in functioning during specific periods of the day. This study aimed to evaluate difficulties in daily functioning of children and adolescents with pervasive developmental disorder (PDD) using the QCD. Results were compared with those for a community sample. Methods A case-control design was used. The cases comprised elementary school students (182 males, 51 females) and junior high school students (100 males, 39 females) with PDD, whereas a community sample of elementary school students (568 males, 579 females) and junior high school students (180 males, 183 females) was enrolled as controls. Their behavior was assessed using the QCD, the Tokyo Autistic Behavior Scale (TABS), the ADHD-rating scale (ADHD-RS), and the Oppositional Defiant Behavior Inventory (ODBI) for elementary and junior high school students, respectively. Effects of gender and diagnosis on the QCD scores were analyzed. Correlation coefficients between QCD and TABS, ADHD-RS, and ODBI scores were analyzed. Results The QCD scores for the children with PDD were significantly lower compared with those from the community sample (P < 0.001). Significantly strong correlations were observed in more areas of the ADHD-RS and ODBI scores compared with the TABS scores. Conclusions Children with PDD experienced greater difficulties in completing basic daily activities; moreover, their QCD scores revealed stronger associations with their ADHD-RS and ODBI scores in comparison with their TABS scores. The difficulties of PDD, ADHD and OBDI symptoms combined in children makes it necessary to assess all diagnoses before any therapy for PDD is initiated in order to be able to evaluate its results properly.	[Sasaki, Yoshinori; Usami, Masahide; Iwadare, Yoshitaka; Watanabe, Kyota; Ushijima, Hirokage; Tanaka, Tetsuya; Harada, Maiko; Tanaka, Hiromi] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Child & Adolescent Psychiat, Chiba, Japan; [Sasayama, Daimei; Sugiyama, Nobuhiro] Shinshu Univ, Dept Psychiat, Matsumoto, Nagano 390, Japan; [Okada, Takashi] Nagoya Univ, Grad Sch Med, Dept Child & Adolescent Psychiat, Nagoya, Aichi 4648601, Japan; [Kodaira, Masaki; Saito, Kazuhiko] Aiiku Hosp, Aiiku Maternal & Child Hlth Ctr, Imperial Gift Fdn, Dept Child & Adolescent Mental Hlth, Tokyo, Japan; [Sawa, Tetsuji] Kitasato Univ, Grad Sch Med Sci, Dept Dev Psychiat, Tokyo, Japan	National Center for Global Health & Medicine - Japan; Shinshu University; Nagoya University; Saiseikai Imperial Gift Foundation, Inc.; Kitasato University	Sasaki, Y (corresponding author), Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Child & Adolescent Psychiat, Chiba, Japan.	lalala.ponyo@gmail.com	Sugiyama, Nobuhiro/C-6388-2008; Sugiyama, Nobuhiro/AFH-2358-2022; Usami, Masahide/G-1404-2015; OKADA, Takashi/M-8902-2014	Sugiyama, Nobuhiro/0000-0002-7134-7680; Usami, Masahide/0000-0002-1145-9971; Sasaki, Yoshinori/0000-0002-0816-4355; OKADA, Takashi/0000-0001-5580-9913				Achenbach TM, 1983, MANUAL CHILD BEHAV C; ADHD Rating Scale-IV: Checklists Norms and Clinical Interpretation, 2008, ADHD RATING SCALE 4; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Bauminger N, 2008, J ABNORM CHILD PSYCH, V36, P135, DOI 10.1007/s10802-007-9156-x; DuPaul G. J., 1998, ADHD RATING SCALE 4; Goto T., 2011, JPN J PEDIAT, V64, P99; Handen BL, 2000, J AUTISM DEV DISORD, V30, P245, DOI 10.1023/A:1005548619694; Harada Y, 2004, EUR CHILD ADOLES PSY, V13, P185, DOI 10.1007/s00787-004-0376-0; Holtmann M, 2007, PSYCHOPATHOLOGY, V40, P172, DOI 10.1159/000100007; KURITA H, 1990, JPN J PSYCHIAT NEUR, V44, P25; Lecavalier L, 2006, J INTELL DISABIL RES, V50, P172, DOI 10.1111/j.1365-2788.2005.00732.x; Lee DO, 2006, J CHILD ADOL PSYCHOP, V16, P737, DOI 10.1089/cap.2006.16.737; Loeber R, 2000, J AM ACAD CHILD PSY, V39, P1468, DOI 10.1097/00004583-200012000-00007; Mandy W, 2012, J AUTISM DEV DISORD, V42, P1304, DOI 10.1007/s10803-011-1356-0; Pliszka SR, 2006, J AM ACAD CHILD PSY, V45, P642, DOI 10.1097/01.chi.0000215326.51175.eb; Posey DJ, 2006, J CHILD ADOL PSYCHOP, V16, P599, DOI 10.1089/cap.2006.16.599; SAITO K, 2009, ATTENTION DEFICIET H; Troost PW, 2006, J CHILD ADOL PSYCHOP, V16, P611, DOI 10.1089/cap.2006.16.611; Usami M, 2013, CHILD ADOL PSYCH MEN, V7, DOI 10.1186/1753-2000-7-11; Yoshida Y, 2004, EUR CHILD ADOLES PSY, V13, P307, DOI 10.1007/s00787-004-0391-1	21	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124692	10.1371/journal.pone.0124692	http://dx.doi.org/10.1371/journal.pone.0124692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XJ	25898260	Green Published, gold			2022-12-27	WOS:000353212600080
J	Weddell, JC; Kwack, J; Imoukhuede, PI; Masud, A				Weddell, Jared C.; Kwack, JaeHyuk; Imoukhuede, P. I.; Masud, Arif			Hemodynamic Analysis in an Idealized Artery Tree: Differences in Wall Shear Stress between Newtonian and Non-Newtonian Blood Models	PLOS ONE			English	Article							FLUID-STRUCTURE INTERACTION; FINITE-ELEMENT-METHOD; ABDOMINAL AORTIC-ANEURYSMS; CORONARY-ARTERY; ISOGEOMETRIC ANALYSIS; CEREBRAL ANEURYSMS; FLOW; PROGRESSION; EXERCISE; RISK	Development of many conditions and disorders, such as atherosclerosis and stroke, are dependent upon hemodynamic forces. To accurately predict and prevent these conditions and disorders hemodynamic forces must be properly mapped. Here we compare a shear-rate dependent fluid (SDF) constitutive model, based on the works by Yasuda et al in 1981, against a Newtonian model of blood. We verify our stabilized finite element numerical method with the benchmark lid-driven cavity flow problem. Numerical simulations show that the Newtonian model gives similar velocity profiles in the 2-dimensional cavity given different height and width dimensions, given the same Reynolds number. Conversely, the SDF model gave dissimilar velocity profiles, differing from the Newtonian velocity profiles by up to 25% in velocity magnitudes. This difference can affect estimation in platelet distribution within blood vessels or magnetic nanoparticle delivery. Wall shear stress (WSS) is an important quantity involved in vascular remodeling through integrin and adhesion molecule mechanotransduction. The SDF model gave a 7.3-fold greater WSS than the Newtonian model at the top of the 3-dimensional cavity. The SDF model gave a 37.7-fold greater WSS than the Newtonian model at artery walls located immediately after bifurcations in the idealized femoral artery tree. The pressure drop across arteries reveals arterial sections highly resistive to flow which correlates with stenosis formation. Numerical simulations give the pressure drop across the idealized femoral artery tree with the SDF model which is approximately 2.3-fold higher than with the Newtonian model. In atherosclerotic lesion models, the SDF model gives over 1 Pa higher WSS than the Newtonian model, a difference correlated with over twice as many adherent monocytes to endothelial cells from the Newtonian model compared to the SDF model.	[Weddell, Jared C.; Imoukhuede, P. I.] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Kwack, JaeHyuk; Masud, Arif] Univ Illinois, Dept Civil Engn, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Weddell, JC (corresponding author), Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.	Jwedde3@illinois.edu	Imoukhuede, P I/T-7580-2017; Stefanadis, Christodoulos/ABH-2232-2020	Imoukhuede, P I/0000-0002-4257-1085; Stefanadis, Christodoulos/0000-0001-5974-6454	American Cancer Society, Illinois Division Basic Research Grant; National Science Foundation [OCI-0725070, ACI-1238993]; state of Illinois	American Cancer Society, Illinois Division Basic Research Grant(American Cancer Society); National Science Foundation(National Science Foundation (NSF)); state of Illinois	The authors would like to acknowledge the American Cancer Society, Illinois Division Basic Research Grant for funding support. This research is part of the Blue Waters sustained-petascale computing project, which is supported by the National Science Foundation (awards OCI-0725070 and ACI-1238993) and the state of Illinois. Blue Waters is a joint effort of the University of Illinois at Urbana-Champaign and its National Center for Supercomputing Applications. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Anand M, 2013, INT J ENG SCI, V72, P78, DOI 10.1016/j.ijengsci.2013.06.009; Argiento P, 2010, EUR RESPIR J, V35, P1273, DOI 10.1183/09031936.00076009; Argiento P, 2012, CHEST, V142, P1158, DOI 10.1378/chest.12-0071; Bazilevs Y, 2009, COMPUT METHOD APPL M, V198, P3534, DOI 10.1016/j.cma.2009.04.015; Birchall D, 2006, EUR RADIOL, V16, P1074, DOI 10.1007/s00330-005-0048-6; Boussel L, 2008, STROKE, V39, P2997, DOI 10.1161/STROKEAHA.108.521617; Boyd J, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2772250; BROOKS AN, 1982, COMPUT METHOD APPL M, V32, P199, DOI 10.1016/0045-7825(82)90071-8; Calderer R, 2010, COMPUT MECH, V46, P185, DOI 10.1007/s00466-010-0487-z; Cebral JR, 2005, AM J NEURORADIOL, V26, P2550; Cherry EM, 2010, MED PHYS, V37, P175, DOI 10.1118/1.3271344; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Chung B. J., 2004, THESIS U PITTSBURGH; COKELET GR, 1963, T SOC RHEOL, V7, P303, DOI 10.1122/1.548959; Cutri E, 2013, BIOMECH MODEL MECHAN, V12, P657, DOI 10.1007/s10237-012-0432-5; Darton NJ, 2008, NANOMED-NANOTECHNOL, V4, P19, DOI 10.1016/j.nano.2007.11.001; Ethier CR, 2002, ANN BIOMED ENG, V30, P461, DOI 10.1114/1.1468890; Filipovic N, 2011, J SERB SOC COMPUT ME, V5, P129; Fillinger MF, 2003, J VASC SURG, V37, P724, DOI 10.1067/mva.2003.213; Finley SD, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-193; Gerszten RE, 1998, CIRC RES, V82, P871; GHIA U, 1982, J COMPUT PHYS, V48, P387, DOI 10.1016/0021-9991(82)90058-4; GIBSON CM, 1993, ARTERIOSCLER THROMB, V13, P310, DOI 10.1161/01.ATV.13.2.310; Gijsen FJH, 1999, J BIOMECH, V32, P705, DOI 10.1016/S0021-9290(99)00014-7; Gitz E, 2013, HAEMATOLOGICA, V98, P1810, DOI 10.3324/haematol.2013.087221; Gnasso A, 1997, STROKE, V28, P993, DOI 10.1161/01.STR.28.5.993; Grundy SM, 1999, CIRCULATION, V100, P1481, DOI 10.1161/01.CIR.100.13.1481; HAYNES RH, 1959, AM J PHYSIOL, V197, P943, DOI 10.1152/ajplegacy.1959.197.5.943; Hoi YM, 2011, ANN BIOMED ENG, V39, P1414, DOI 10.1007/s10439-011-0255-z; Hossain SS, 2013, NANOMEDICINE-UK, V8, P343, DOI [10.2217/NNM.12.124, 10.2217/nnm.12.124]; Hossain SS, 2012, COMPUT MECH, V49, P213, DOI 10.1007/s00466-011-0633-2; HUGHES TJR, 1989, COMPUT METHOD APPL M, V73, P173, DOI 10.1016/0045-7825(89)90111-4; Johnston BM, 2004, J BIOMECH, V37, P709, DOI 10.1016/j.jbiomech.2003.09.016; Karmonik Christof, 2008, Technol Health Care, V16, P343; Kennedy JW, 1999, DIABETES, V48, P1192, DOI 10.2337/diabetes.48.5.1192; Kim S, 2011, ASME JSME KSME JOINT; Kim S., 2002, THESIS DREXEL U; Kornet L, 1999, ARTERIOSCL THROM VAS, V19, P2933, DOI 10.1161/01.ATV.19.12.2933; Kornet L, 2000, J VASC RES, V37, P112, DOI 10.1159/000025722; Ku DN, 1997, ANNU REV FLUID MECH, V29, P399, DOI 10.1146/annurev.fluid.29.1.399; Kwack J, 2014, COMPUT MECH, V53, P751, DOI 10.1007/s00466-013-0928-6; Kwack J, 2010, INT J ENG SCI, V48, P1413, DOI 10.1016/j.ijengsci.2010.09.007; Leung JH, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-33; LEWIS P, 1986, ULTRASOUND MED BIOL, V12, P777, DOI 10.1016/0301-5629(86)90075-X; LEWIS P, 1990, BRIT J SURG, V77, P183, DOI 10.1002/bjs.1800770220; Liu Biyue, 2011, Molecular & Cellular Biomechanics, V8, P73, DOI 10.3970/mcb.2011.008.073; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Martin D, 2009, BRIT J RADIOL, V82, pS33, DOI 10.1259/bjr/59367266; Masud A, 2006, COMPUT METHOD APPL M, V195, P1750, DOI 10.1016/j.cma.2005.05.048; Masud A, 2011, COMPUT METHOD APPL M, V200, P577, DOI 10.1016/j.cma.2010.08.012; Masud A, 2009, COMPUT MECH, V44, P145, DOI 10.1007/s00466-008-0362-3; MERRILL EW, 1967, J APPL PHYSIOL, V23, P178, DOI 10.1152/jappl.1967.23.2.178; Mihalef V, 2010, I S BIOMED IMAGING, P504, DOI 10.1109/ISBI.2010.5490298; Milde F, 2008, BIOPHYS J, V95, P3146, DOI 10.1529/biophysj.107.124511; Molla MM, 2012, MED ENG PHYS, V34, P1079, DOI 10.1016/j.medengphy.2011.11.013; Mugii N, 2009, RHEUMATOLOGY, V48, P696, DOI 10.1093/rheumatology/kep066; Naeije R, 2012, COMPR PHYSIOL, V2, P711, DOI 10.1002/cphy.c100091; Nixon AM, 2010, J NEUROSURG, V112, P1240, DOI 10.3171/2009.10.JNS09759; OLESEN SP, 1988, NATURE, V331, P168, DOI 10.1038/331168a0; Olgac U, 2009, AM J PHYSIOL-HEART C, V296, pH1969, DOI 10.1152/ajpheart.01182.2008; Owens RG, 2006, J NON-NEWTON FLUID, V140, P57, DOI 10.1016/j.jnnfm.2006.01.015; Papaioannou Theodoros G, 2005, Hellenic J Cardiol, V46, P9; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Rajagopal K.R., 1993, PITMAN RES NOTES MAT, V291, P129; Samady H, 2011, CIRCULATION, V124, P779, DOI 10.1161/CIRCULATIONAHA.111.021824; SCHMIDSCHONBEIN H, 1969, J APPL PHYSIOL, V26, P674, DOI 10.1152/jappl.1969.26.5.674; Scotti CM, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-64; Sequeira A., 2007, PORTRAIT STATE OF TH, P65; Shojima M, 2004, STROKE, V35, P2500, DOI 10.1161/01.STR.0000144648.89172.0f; Sigal RJ, 2004, DIABETES CARE, V27, P2518, DOI 10.2337/diacare.27.10.2518; Skyba DM, 1998, CIRCULATION, V98, P290, DOI 10.1161/01.CIR.98.4.290; SLIFE DM, 1990, AM J PHYSIOL, V258, pH1823, DOI 10.1152/ajpheart.1990.258.6.H1823; Steinman DA, 2003, J VASC SURG, V37, P1118, DOI 10.1067/mva.2003.122; Stone PH, 2003, CIRCULATION, V108, P438, DOI 10.1161/01.CIR.0000080882.35274.AD; TANGELDER GJ, 1986, CIRC RES, V59, P505, DOI 10.1161/01.RES.59.5.505; Tateshima S, 2003, STROKE, V34, P187, DOI 10.1161/01.STR.0000046456.26587.8B; Tian FB, 2013, COMPUT BIOL MED, V43, P1098, DOI 10.1016/j.compbiomed.2013.05.023; van Royen N, 2001, CARDIOVASC RES, V49, P543, DOI 10.1016/S0008-6363(00)00206-6; Vimmr J, 2010, MATH COMPUT SIMULAT, V80, P1324, DOI 10.1016/j.matcom.2009.01.004; WELLS RE, 1961, SCIENCE, V133, P763, DOI 10.1126/science.133.3455.763; Whaley M H, 1997, J Cardiopulm Rehabil, V17, P37, DOI 10.1097/00008483-199701000-00005; Wolters BJBM, 2005, MED ENG PHYS, V27, P871, DOI 10.1016/j.medengphy.2005.06.008; Yang C, 2007, CMES-COMP MODEL ENG, V19, P233; YASUDA K, 1981, RHEOL ACTA, V20, P163, DOI 10.1007/BF01513059; YOUNG DF, 1975, CIRC RES, V36, P735, DOI 10.1161/01.RES.36.6.735; Zhang YJ, 2007, COMPUT METHOD APPL M, V196, P2943, DOI 10.1016/j.cma.2007.02.009	88	24	24	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124575	10.1371/journal.pone.0124575	http://dx.doi.org/10.1371/journal.pone.0124575			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897758	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600073
J	Pfefferbaum, A; Zahr, NM; Mayer, D; Rohlfing, T; Sullivan, EV				Pfefferbaum, Adolf; Zahr, Natalie M.; Mayer, Dirk; Rohlfing, Torsten; Sullivan, Edith V.			Dynamic Responses of Selective Brain White Matter Fiber Tracts to Binge Alcohol and Recovery in the Rat	PLOS ONE			English	Article							TRAUMATIC AXONAL INJURY; DIFFUSION-TENSOR MRI; CORPUS-CALLOSUM; IN-VIVO; MICROSTRUCTURAL RECOVERY; PHYSICAL-DEPENDENCE; UNITED-STATES; ETHANOL; ANISOTROPY; DISRUPTION	To determine the dynamics of white matter vulnerability to excessive alcohol consumption, diffusion tensor imaging (DTI) was used in an animal model of alcohol exposure. Quantitative, in vivo fiber tracking results are presented from rats with DTI conducted at 3 time points: baseline; after 4 days of intragastric alcohol to blood alcohol levels of similar to 250mg/dL; and after one week of recovery. Binge alcohol followed by a week of sobriety resulted in rapidly reversible decreases in fractional anisotropy (FA), a measure of the coherence of fiber tracts, in callosal genu and fimbria-fornix but not splenium; and increases in mean diffusivity (MD), an index of freely diffusing water in tissue, selective to the fimbria-fornix. These effects were confirmed with tract-based spatial statistics (TBSS). The directionality of changes in DTI metrics reproduce those observed in human alcoholism. That a single exposure to binge alcohol can cause substantial transient changes detectable in DTI metrics demonstrates the potential for rapid neuroplasticity.	[Pfefferbaum, Adolf; Zahr, Natalie M.; Mayer, Dirk; Rohlfing, Torsten] SRI Int, Neurosci Program, Menlo Pk, CA 94025 USA; [Pfefferbaum, Adolf; Zahr, Natalie M.; Sullivan, Edith V.] Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Stanford, CA 94305 USA; [Mayer, Dirk] Univ Maryland, Dept Diagnost Radiol, Sch Med, Baltimore, MD 21201 USA	SRI International; Stanford University; University System of Maryland; University of Maryland Baltimore	Zahr, NM (corresponding author), SRI Int, Neurosci Program, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA.	nzahr@stanford.edu	Mayer, Dirk/AAJ-5906-2020; Zahr, Natalie/W-5292-2019; Sullivan, Edith V/ABD-5684-2021	Mayer, Dirk/0000-0001-7557-9019; Sullivan, Edith V/0000-0001-6739-3716	National Institute on Alcohol Abuse and Alcoholism: Integrative Neuroscience Initiative on Neuroscience (INIA) [AA005965, AA012388, AA017168, AA013521]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K05AA017168, R01AA012388, U01AA013521, R37AA005965, R01AA005965] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism: Integrative Neuroscience Initiative on Neuroscience (INIA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	National Institute on Alcohol Abuse and Alcoholism: AA005965, AA012388, AA017168, AA013521-Integrative Neuroscience Initiative on Neuroscience (INIA). SRI International is a nonprofit center (http://www.sri.com/about). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalsteinsson E, 2004, NEUROIMAGE, V22, P381, DOI 10.1016/j.neuroimage.2003.12.046; Alhassoon OM, 2012, ALCOHOL CLIN EXP RES, V36, P1922, DOI 10.1111/j.1530-0277.2012.01808.x; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Bell RL, 2006, ALCOHOL, V40, P3, DOI 10.1016/j.alcohol.2006.10.001; Bodammer N, 2004, MAGNET RESON MED, V51, P188, DOI 10.1002/mrm.10690; Chanraud S, 2010, NEUROPSYCHOL REV, V20, P209, DOI 10.1007/s11065-010-9129-7; Chanraud S, 2009, NEUROPSYCHOPHARMACOL, V34, P1223, DOI 10.1038/npp.2008.101; Chen CM, 2004, ALCOHOL RES HEALTH, V28, P269; Choe AS, 2012, NMR BIOMED, V25, P900, DOI 10.1002/nbm.1810; Chronik BA, 2000, MAGNET RESON MED, V44, P955, DOI 10.1002/1522-2594(200012)44:6<955::AID-MRM18>3.0.CO;2-1; Chronik B, 2000, MAGN RESON MATER PHY, V10, P131; DELAMONTE SM, 1988, ARCH NEUROL-CHICAGO, V45, P990, DOI 10.1001/archneur.1988.00520330076013; Dodero L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076655; Faingold Carl L, 2008, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0928s44; Gozzi A, 2013, NEUROIMAGE, V69, P112, DOI 10.1016/j.neuroimage.2012.12.015; Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004; Grant KA, 2003, PHARMACOL THERAPEUT, V100, P235, DOI 10.1016/j.pharmthera.2003.08.004; HARPER C, 1985, J NEUROL NEUROSUR PS, V48, P211, DOI 10.1136/jnnp.48.3.211; HARPER CG, 1988, BRIT J ADDICT, V83, P577; Harsan LA, 2007, J NEUROSCI RES, V85, P935, DOI 10.1002/jnr.21201; Hofstetter S, 2013, J NEUROSCI, V33, P12844, DOI 10.1523/JNEUROSCI.4520-12.2013; HUNT WA, 1977, J PHARMACOL EXP THER, V201, P103; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; Jones DK, 2010, DIFFUSION MRI THEORY; Kelso ML, 2011, NEUROSCIENCE, V197, P381, DOI 10.1016/j.neuroscience.2011.09.019; Kong LM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/798261; Konrad A, 2012, ALCOHOL ALCOHOLISM, V47, P118, DOI 10.1093/alcalc/agr157; Kril JJ, 1997, HEPATOLOGY, V26, P837, DOI 10.1053/jhep.1997.v26.pm0009328301; Li T K, 1987, Alcohol Alcohol Suppl, V1, P91; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MAJCHROWICZ E, 1975, PSYCHOPHARMACOLOGIA, V43, P245, DOI 10.1007/BF00429258; MAJCHROWICZ E, 1976, PSYCHOPHARMACOLOGY, V50, P107, DOI 10.1007/BF00430477; Martin-Fardon R, 2013, CURR TOP BEHAV NEURO, V13, P403, DOI 10.1007/7854_2012_202; Mayer D, 2007, NEUROIMAGE, V35, P1077, DOI 10.1016/j.neuroimage.2007.01.006; McBride WJ, 2010, ALCOHOL, V44, P171, DOI 10.1016/j.alcohol.2009.12.001; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Mori S, 1999, P 7 ISMRM PHIL, P320; NEEMAN M, 1991, MAGNET RESON MED, V21, P138, DOI 10.1002/mrm.1910210117; Neighbors C, 2006, INT J DRUG POLICY, V17, P304, DOI 10.1016/j.drugpo.2006.05.004; O'Brien CP, 2009, ALCOHOLISM DANA GUID; Oster SM, 2006, ALCOHOL, V38, P155, DOI 10.1016/j.alcohol.2006.06.001; PAULABARBOSA MM, 1985, BRAIN RES, V339, P195, DOI 10.1016/0006-8993(85)90645-6; Pfefferbaum A, 2000, MAGNET RESON MED, V44, P259, DOI 10.1002/1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6; Pfefferbaum A, 2003, MAGNET RESON MED, V49, P953, DOI 10.1002/mrm.10452; Pfefferbaum A, 2005, NEUROPSYCHOPHARMACOL, V30, P423, DOI 10.1038/sj.npp.1300623; Pfefferbaum A, 2004, J MAGN RESON IMAGING, V20, P779, DOI 10.1002/jmri.20181; Pfefferbaum A, 2002, NEUROIMAGE, V15, P708, DOI 10.1006/nimg.2001.1018; Pfefferbaum A, 2001, NEUROREPORT, V12, P1677, DOI 10.1097/00001756-200106130-00032; Pfefferbaum A, 2006, NEUROBIOL AGING, V27, P994, DOI 10.1016/j.neurobiolaging.2005.05.007; Pfefferbaum A, 2007, BRAIN, V130, P48, DOI 10.1093/brain/awl242; Pfefferbaum A, 2014, LANCET PSYCHIAT, V1, P202, DOI 10.1016/S2215-0366(14)70301-3; Pfefferbaum A, 2009, BIOL PSYCHIAT, V65, P680, DOI 10.1016/j.biopsych.2008.10.039; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Putzke J, 1998, MOL BRAIN RES, V62, P196, DOI 10.1016/S0169-328X(98)00253-8; Rodd ZA, 2004, PHARMACOL BIOCHEM BE, V79, P439, DOI 10.1016/j.pbb.2004.08.018; Rodd ZA, 2009, ADDICT BIOL, V14, P152, DOI 10.1111/j.1369-1600.2008.00140.x; Rohlfing T, 2003, IEEE T INF TECHNOL B, V7, P16, DOI 10.1109/TITB.2003.808506; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Rutledge PC, 2008, J CONSULT CLIN PSYCH, V76, P511, DOI 10.1037/0022-006X.76.3.511; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Satriotomo I, 2000, BRAIN RES, V879, P55, DOI 10.1016/S0006-8993(00)02729-3; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Sorg SF, 2012, BIOL PSYCHIAT, V71, P262, DOI 10.1016/j.biopsych.2011.09.022; Sullivan EV, 2006, CEREB CORTEX, V16, P1030, DOI 10.1093/cercor/bhj045; Sullivan EV, 2011, NEUROIMAGE, V57, P214, DOI 10.1016/j.neuroimage.2011.04.003; Sullivan EV, 2013, NEUROBIOLOG IN PRESS; TARNOWSKADZIDUSZKO E, 1995, FOLIA NEUROPATHOL, V33, P25; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Touquet R, 2008, EMERG MED J, V25, P752, DOI 10.1136/emj.2008.062711; URSO T, 1981, LIFE SCI, V28, P1053, DOI 10.1016/0024-3205(81)90752-9; USDHHS, 2006, ROL BIOM TREATM ALC; Xu DR, 2002, NEUROIMAGE, V17, P1131, DOI 10.1006/nimg.2002.1285; Yeh PH, 2009, PSYCHIAT RES-NEUROIM, V173, P22, DOI 10.1016/j.pscychresns.2008.07.012; Zahr NM, 2013, NEUROPSYCHOPHARMACOL, V38, P1121, DOI 10.1038/npp.2013.11; Zhai GH, 2003, RADIOLOGY, V229, P673, DOI 10.1148/radiol.2293021462	80	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124885	10.1371/journal.pone.0124885	http://dx.doi.org/10.1371/journal.pone.0124885			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894968	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700127
J	Rocke, E; Pachiadaki, MG; Cobban, A; Kujawinski, EB; Edgcomb, VP				Rocke, Emma; Pachiadaki, Maria G.; Cobban, Alec; Kujawinski, Elizabeth B.; Edgcomb, Virginia P.			Protist Community Grazing on Prokaryotic Prey in Deep Ocean Water Masses	PLOS ONE			English	Article							FLUORESCENTLY LABELED BACTERIA; NW MEDITERRANEAN SEA; PHAGOTROPHIC PROTISTS; MICROBIAL PROCESSES; AMINO-ACIDS; MARINE; PARTICLES; SELECTION; RATES; BACTERIOPLANKTON	Oceanic protist grazing at mesopelagic and bathypelagic depths, and their subsequent effects on trophic links between eukaryotes and prokaryotes, are not well constrained. Recent studies show evidence of higher than expected grazing activity by protists down to mesopelagic depths. This study provides the first exploration of protist grazing in the bathypelagic North Atlantic Deep Water (NADW). Grazing was measured throughout the water column at three stations in the South Atlantic using fluorescently-labeled prey analogues. Grazing in the deep Antarctic Intermediate water (AAIW) and NADW at all three stations removed 3.79% +/- 1.72% to 31.14% +/- 8.24% of the standing prokaryote stock. These results imply that protist grazing may be a significant source of labile organic carbon at certain meso- and bathypelagic depths.	[Rocke, Emma] Hong Kong Univ Sci & Technol, Dept Life Sci, Hong Kong, Hong Kong, Peoples R China; [Pachiadaki, Maria G.; Cobban, Alec; Edgcomb, Virginia P.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; [Cobban, Alec] Falmouth Acad, Falmouth Acad Internship Program, Falmouth, MA USA; [Kujawinski, Elizabeth B.] Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Woods Hole, MA 02543 USA	Hong Kong University of Science & Technology; Woods Hole Oceanographic Institution; Woods Hole Oceanographic Institution	Edgcomb, VP (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.	vedgcomb@whoi.edu	Edgcomb, Virginia/Q-2434-2019; Pachiadaki, Maria/AAW-2640-2021	Pachiadaki, Maria/0000-0003-2684-7501; Rocke, Emma/0000-0001-9514-9788; Edgcomb, Virginia/0000-0001-6805-381X; Cobban, Alec/0000-0001-9296-8147	National Science Foundation [OCE-1154320]; Woods Hole Oceanographic Institution; Ocean Life Institute; Deep Ocean Exploration Institute	National Science Foundation(National Science Foundation (NSF)); Woods Hole Oceanographic Institution; Ocean Life Institute; Deep Ocean Exploration Institute	Funding for the cruise was provided by the National Science Foundation (OCE-1154320) to EBK. Funding for the laboratory work was provided by contributions from the Woods Hole Oceanographic Institution Director of Research, Ocean Life Institute, and Deep Ocean Exploration Institute to VE. No individuals employed or contracted by the funders played any role in this study.	Aristegui J, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021863; Aristegui J, 2009, LIMNOL OCEANOGR, V54, P1501, DOI 10.4319/lo.2009.54.5.1501; Baker BJ, 2004, APPL ENVIRON MICROB, V70, P6264, DOI 10.1128/AEM.70.10.6264-6271.2004; Bochdansky AB, 2010, P NATL ACAD SCI USA, V107, P8287, DOI 10.1073/pnas.0913744107; Brenner R., 2002, BIOGEOCHEMISTRY MARI; Calbet A, 2004, LIMNOL OCEANOGR, V49, P51, DOI 10.4319/lo.2004.49.1.0051; Carlson CA, 2004, LIMNOL OCEANOGR, V49, P1073, DOI 10.4319/lo.2004.49.4.1073; Caron D.A, 1990, ECOLOGY MARINE PROTO; Cho BC, 2000, MAR ECOL PROG SER, V206, P23, DOI 10.3354/meps206023; CHO BC, 1988, NATURE, V332, P441, DOI 10.1038/332441a0; CULLEN JJ, 1982, CAN J FISH AQUAT SCI, V39, P791, DOI 10.1139/f82-108; del Giorgio PA, 2002, NATURE, V420, P379, DOI 10.1038/nature01165; Dolan JR, 1997, MAR GEOL, V139, P109, DOI 10.1016/S0025-3227(96)00106-5; FENCHEL T, 1980, LIMNOL OCEANOGR, V25, P733, DOI 10.4319/lo.1980.25.4.0733; Fenchel T, 1999, PROTIST, V150, P325, DOI 10.1016/S1434-4610(99)70033-7; FENCHEL T, 1982, MAR ECOL PROG SER, V8, P211, DOI 10.3354/meps008211; Fenchel T., 1986, Progress in Protistology, V1, P65; Ferrier-Pages C, 1998, OCEANOL ACTA, V21, P485, DOI 10.1016/S0399-1784(98)80032-7; FOWLER SW, 1986, PROG OCEANOGR, V16, P147, DOI 10.1016/0079-6611(86)90032-7; Fukuda H, 2007, AQUAT MICROB ECOL, V46, P203, DOI 10.3354/ame046203; GONZALEZ JM, 1990, APPL ENVIRON MICROB, V56, P583, DOI 10.1128/AEM.56.3.583-589.1990; Hammer A, 1999, PROTIST, V150, P375, DOI 10.1016/S1434-4610(99)70039-8; Hansell DA, 1998, NATURE, V395, P263, DOI 10.1038/26200; Jezbera J, 2005, FEMS MICROBIOL ECOL, V52, P351, DOI 10.1016/j.femsec.2004.12.001; Jurgens K., 2008, MICROB ECOL OCEAN, P383, DOI [DOI 10.1002/9780470281840.CH11, 10.1002/9780470281840.ch11]; LIGHTHILL J, 1976, SIAM REV, V18, P161, DOI 10.1137/1018040; Matz C, 2005, APPL ENVIRON MICROB, V71, P921, DOI 10.1128/AEM.71.2.921-929.2005; Matz C, 2001, APPL ENVIRON MICROB, V67, P814, DOI 10.1128/AEM.67.2.814-820.2001; Monger BC, 1999, LIMNOL OCEANOGR, V44, P1917, DOI 10.4319/lo.1999.44.8.1917; Morgan-Smith D, 2011, AQUAT MICROB ECOL, V65, P103, DOI 10.3354/ame01536; Nagata T, 2000, LIMNOL OCEANOGR, V45, P426, DOI 10.4319/lo.2000.45.2.0426; NAGATA T, 1991, LIMNOL OCEANOGR, V36, P433, DOI 10.4319/lo.1991.36.3.0433; Nagata T., 2000, MICROBIAL ECOLOGY OC, P121; Nagata T, 2010, DEEP-SEA RES PT II, V57, P1519, DOI 10.1016/j.dsr2.2010.02.019; Pachiadaki M, 2014, DEEP SEA RE IN PRESS; Pernice MC, 2014, ISME J; Reinthaler T, 2006, LIMNOL OCEANOGR, V51, P1262, DOI 10.4319/lo.2006.51.3.1262; SALAT J, 1994, MAR ECOL PROG SER, V104, P205, DOI 10.3354/meps104205; SANDERS RW, 1992, MAR ECOL PROG SER, V86, P1, DOI 10.3354/meps086001; SHERR BF, 1987, APPL ENVIRON MICROB, V53, P958, DOI 10.1128/AEM.53.5.958-965.1987; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; SHERR EB, 1987, NATURE, V325, P710, DOI 10.1038/325710a0; SHERR EB, 1994, MICROBIAL ECOL, V28, P223, DOI 10.1007/BF00166812; Strom SL, 1997, LIMNOL OCEANOGR, V42, P1364, DOI 10.4319/lo.1997.42.6.1364; Tanaka T, 2004, DEEP-SEA RES PT I, V51, P531, DOI 10.1016/j.dsr.2003.12.001; Tanaka T, 2002, DEEP-SEA RES PT II, V49, P2093, DOI 10.1016/S0967-0645(02)00029-2; TANAKA T, 2004, BIOGEOSCI DISCUSS, V1, P413; Unrein F, 2007, LIMNOL OCEANOGR, V52, P456, DOI 10.4319/lo.2007.52.1.0456; VAQUE D, 1994, MAR ECOL PROG SER, V109, P263, DOI 10.3354/meps109263; Verdugo P, 2010, DEEP-SEA RES PT II, V57, P1486, DOI 10.1016/j.dsr2.2010.03.002	50	16	18	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124505	10.1371/journal.pone.0124505	http://dx.doi.org/10.1371/journal.pone.0124505			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894547	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700100
J	Lin, CH; Shen, CY; Lee, JH; Huang, CS; Yang, CH; Kuo, WH; Chang, DY; Hsiung, CN; Kuo, KT; Chen, WW; Chen, IC; Wu, PF; Kuo, SH; Chen, CJ; Lu, YS; Cheng, AL				Lin, Ching-Hung; Shen, Chen-Yang; Lee, Jih-Hsiang; Huang, Chiun-Sheng; Yang, Chih-Hsin; Kuo, Wen-Hung; Chang, Dwan-Ying; Hsiung, Chia-Ni; Kuo, Kuan-Ting; Chen, Wei-Wu; Chen, I-Chun; Wu, Pei-Fang; Kuo, Sung-Hsin; Chen, Chien-Jen; Lu, Yen-Shen; Cheng, Ann-Lii			High Prevalence of the BIM Deletion Polymorphism in Young Female Breast Cancer in an East Asian Country	PLOS ONE			English	Article							CELL LUNG-CANCER; KINASE INHIBITORS; INDUCED APOPTOSIS; BCL-2 FAMILY; PROTEIN BIM; RESISTANCE; ANOIKIS; INDUCTION; DEATH; MORPHOGENESIS	Background A rapid surge of female breast cancer has been observed in young women in several East Asian countries. The BIM deletion polymorphism, which confers cell resistance to apoptosis, was recently found exclusively in East Asian people with prevalence rate of 12%. We aimed to evaluate the possible role of this genetic alteration in carcinogenesis of breast cancer in East Asians. Method Female healthy volunteers (n = 307), patients in one consecutive stage I-III breast cancer cohort (n = 692) and one metastatic breast cancer cohort (n = 189) were evaluated. BIM wild-type and deletion alleles were separately genotyped in genomic DNAs. Results Both cancer cohorts consistently showed inverse associations between the BIM deletion polymorphism and patient age (<= 35 y vs. 36-50 y vs. >50 y: 29% vs. 22% vs. 15%, P = 0.006 in the consecutive cohort, and 40% vs. 23% vs. 13%, P = 0.023 in the metastatic cohort). In healthy volunteers, the frequencies of the BIM deletion polymorphism were similar (13%-14%) in all age groups. Further analyses indicated that the BIM deletion polymorphism was not associated with specific clinicopathologic features, but it was associated with poor overall survival (adjusted hazard ratio 1.71) in the consecutive cohort. Conclusions BIM deletion polymorphism may be involved in the tumorigenesis of the early-onset breast cancer among East Asians.	[Lin, Ching-Hung; Lee, Jih-Hsiang; Yang, Chih-Hsin; Chang, Dwan-Ying; Chen, Wei-Wu; Chen, I-Chun; Wu, Pei-Fang; Kuo, Sung-Hsin; Lu, Yen-Shen; Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Lin, Ching-Hung; Lu, Yen-Shen; Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Internal Med, Taipei, Taiwan; [Shen, Chen-Yang] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Shen, Chen-Yang; Hsiung, Chia-Ni] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Shen, Chen-Yang] China Med Univ, Sch Publ Hlth, Taichung, Taiwan; [Huang, Chiun-Sheng; Kuo, Wen-Hung] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Yang, Chih-Hsin; Kuo, Sung-Hsin; Cheng, Ann-Lii] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei, Taiwan; [Yang, Chih-Hsin; Kuo, Sung-Hsin; Cheng, Ann-Lii] Natl Taiwan Univ, Coll Med, Canc Res Ctr, Taipei, Taiwan; [Kuo, Kuan-Ting] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Chen, Chien-Jen] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Defense Medical Center; Academia Sinica - Taiwan; China Medical University Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan	Cheng, AL (corresponding author), Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan.	alcheng@ntu.edu.tw	Yang, James Chih-Hsin/W-1587-2019; Chen, Chien-Jen/N-4723-2019; Chen, Chien-Jen/C-6976-2008	Chen, Tom Wei-Wu/0000-0003-4112-4029; Kuo, Sung-Hsin/0000-0003-0054-887X; Huang, Chiun-Sheng/0000-0002-6557-211X; KUO, WEN-HUNG/0000-0002-9881-4605; LIN, CHING-HUNG/0000-0003-2403-4056; Cheng, Ann-Lii/0000-0002-9152-6512; KUO, KUAN-TING/0000-0002-3657-1652; Chen, I-Chun/0000-0001-9342-7596; Lu, Yen-Shen/0000-0001-7461-1291	National Taiwan University, Taiwan [NTU-ICRP-103R7557]; National Center of Excellence for Clinical Trial and Research, Taiwan [DOH102-TD-B-001]	National Taiwan University, Taiwan(National Taiwan University); National Center of Excellence for Clinical Trial and Research, Taiwan	This study was supported by grants from the National Taiwan University, Taiwan (grant number: NTU-ICRP-103R7557, URL: (http://irice-ca.mc.ntu.edu.tw/aboutICECR.php), and the National Center of Excellence for Clinical Trial and Research, Taiwan (grant DOH102-TD-B-001, URL: (http://www.mohw.gov.tw/CHT/TDU/DM1_P.aspx?f_list_no=740&fod_list_no=0&doc_no=29307). ALC received the grants mentioned above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajabnoor GMA, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.139; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Cragg MS, 2008, J CLIN INVEST, V118, P3651, DOI 10.1172/JCI35437; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Deng J, 2007, CANCER RES, V67, P11867, DOI 10.1158/0008-5472.CAN-07-1961; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Isobe K, 2014, J THORAC ONCOL, V9, P483, DOI 10.1097/JTO.0000000000000125; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Lewis JS, 2005, JNCI-J NATL CANCER I, V97, P1746, DOI 10.1093/jnci/dji400; Lin CH, 2009, CANCER EPIDEM BIOMAR, V18, P1807, DOI 10.1158/1055-9965.EPI-09-0096; Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003; Matsuno RK, 2007, CANCER EPIDEM BIOMAR, V16, P1437, DOI 10.1158/1055-9965.EPI-07-0108; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Porter P, 2008, NEW ENGL J MED, V358, P213, DOI 10.1056/NEJMp0708307; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Rahmani M, 2009, BLOOD, V114, P4507, DOI 10.1182/blood-2008-09-177881; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Shen YC, 2005, CANCER EPIDEM BIOMAR, V14, P1986, DOI 10.1158/1055-9965.EPI-04-0932; Sim XL, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-261; Tan TT, 2005, CANCER CELL, V7, P227, DOI 10.1016/j.ccr.2005.02.008; Tanizaki J, 2011, ONCOGENE, V30, P4097, DOI 10.1038/onc.2011.111; Wang J, 2011, J BIOL CHEM, V286, P22384, DOI 10.1074/jbc.M111.239566; Whelan KA, 2010, MOL BIOL CELL, V21, P3829, DOI 10.1091/mbc.E10-04-0353; Wickenden JA, 2008, ONCOGENE, V27, P7150, DOI 10.1038/onc.2008.335; Woods NT, 2007, CANCER RES, V67, P10744, DOI 10.1158/0008-5472.CAN-07-3148; Yoo Keun-Young, 2006, Asian Pac J Cancer Prev, V7, P679; Yu JC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2821; Zhao MC, 2014, CANCER-AM CANCER SOC, V120, P2299, DOI 10.1002/cncr.28725	32	5	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124908	10.1371/journal.pone.0124908	http://dx.doi.org/10.1371/journal.pone.0124908			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909194	Green Submitted, Green Published, gold			2022-12-27	WOS:000353376800111
J	Pincus, NB; Reckhow, JD; Saleem, D; Jammeh, ML; Datta, SK; Myles, IA				Pincus, Nathan B.; Reckhow, Jensen D.; Saleem, Danial; Jammeh, Momodou L.; Datta, Sandip K.; Myles, Ian A.			Strain Specific Phage Treatment for Staphylococcus aureus Infection Is Influenced by Host Immunity and Site of Infection	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; LONG-TERM IMPACTS; BACTERIOPHAGE THERAPY; METHICILLIN-RESISTANT; HUMAN MICROBIOME; COCKTAIL; DISEASE; MICE; KERATINOCYTES; ANTIBIOTICS	The response to multi-drug resistant bacterial infections must be a global priority. While mounting resistance threatens to create what the World Health Organization has termed a "post-antibiotic era", the recent discovery that antibiotic use may adversely impact the microbiome adds further urgency to the need for new developmental approaches for anti-pathogen treatments. Methicillin-resistant Staphylococcus aureus (MRSA), in particular, has declared itself a serious threat within the United States and abroad. A potential solution to the problem of antibiotic resistance may not entail looking to the future for completely novel treatments, but instead looking into our history of bacteriophage therapy. This study aimed to test the efficacy, safety, and commercial viability of the use of phages to treat Staphylococcus aureus infections using the commercially available phage SATA-8505. We found that SATA-8505 effectively controls Staphylococcus aureus growth and reduces bacterial viability both in vitro and in a skin infection mouse model. However, this killing effect was not observed when phage was cultured in the presence of human whole blood. SATA-8505 did not induce inflammatory responses in peripheral blood mononuclear cultures. However, phage did induce IFN gamma production in primary human keratinocyte cultures and induced inflammatory responses in our mouse models, particularly in a mouse model of chronic granulomatous disease. Our findings support the potential efficacy of phage therapy, although regulatory and market factors may limit its wider investigation and use.	[Pincus, Nathan B.; Reckhow, Jensen D.; Saleem, Danial; Jammeh, Momodou L.; Datta, Sandip K.; Myles, Ian A.] NIAID, Bacterial Pathogenesis Unit, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Myles, IA (corresponding author), NIAID, Bacterial Pathogenesis Unit, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	mylesi@niaid.nih.gov	Myles, Ian/AAE-7623-2019	Myles, Ian/0000-0001-9316-3703; Datta, Sandip/0000-0003-0243-7815; Pincus, Nathan/0000-0002-3134-7176	Intramural Research Program of The National Institutes of Health; National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001043] Funding Source: NIH RePORTER	Intramural Research Program of The National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of The National Institutes of Health and The National Institute of Allergy and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MH, 1959, BACTERIOPHAGES; Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; Blaser M, 2013, NAT REV MICROBIOL, V11, P213, DOI 10.1038/nrmicro2973; Capparelli R, 2007, ANTIMICROB AGENTS CH, V51, P2765, DOI 10.1128/AAC.01513-06; Carvalho CM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-232; Chan BK, 2013, FUTURE MICROBIOL, V8, P769, DOI [10.2217/FMB.13.47, 10.2217/fmb.13.47]; Chhibber S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056022; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Fu WL, 2010, ANTIMICROB AGENTS CH, V54, P397, DOI 10.1128/AAC.00669-09; Hanberger H, 2011, INT J ANTIMICROB AG, V38, P331, DOI 10.1016/j.ijantimicag.2011.05.013; Holland SM, 2013, HEMATOL ONCOL CLIN N, V27, P89, DOI 10.1016/j.hoc.2012.11.002; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Klem J, 2013, ACTA MICROBIOL IMM H, V60, P411, DOI 10.1556/AMicr.60.2013.4.3; Kos VN, 2012, MBIO, V3, DOI 10.1128/mBio.00112-12; Kraushaar B, 2013, ARCH VIROL, V158, P2341, DOI 10.1007/s00705-013-1707-6; Lungren MP, 2013, BACTERIOPHAGE, V3; Matsuzaki S, 2003, J INFECT DIS, V187, P613, DOI 10.1086/374001; Matsuzaki Shigenobu, 2005, Journal of Infection and Chemotherapy, V11, P211, DOI 10.1007/s10156-005-0408-9; Merabishvili M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004944; Merril C, 2003, NAT REV DRUG DISCOV, V2, P489, DOI 10.1038/nrd1111; Merril CR, 1996, P NATL ACAD SCI USA, V93, P3188, DOI 10.1073/pnas.93.8.3188; Myles I, 2013, PLOS ONE, V9; Myles IA, 2013, J IMMUNOL, V191, P3200, DOI 10.4049/jimmunol.1301057; Myles IA, 2013, NAT IMMUNOL, V14, P804, DOI 10.1038/ni.2637; Myles IA, 2012, SEMIN IMMUNOPATHOL, V34, P181, DOI 10.1007/s00281-011-0301-9; O'Flaherty S, 2005, APPL ENVIRON MICROB, V71, P1836, DOI 10.1128/AEM.71.4.1836-1842.2005; Pastagia M, 2012, EMERG INFECT DIS, V18, P1072, DOI 10.3201/eid1807.101371; Pasternack GR, 2010, STAPHYLOCOCCUS AUREU; Perichon B, 2009, ANTIMICROB AGENTS CH, V53, P4580, DOI 10.1128/AAC.00346-09; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; Pirnay JP, 2015, PHARM RES; Rieber N, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/252460; ROUNTREE PM, 1955, J GEN MICROBIOL, V12, P275, DOI 10.1099/00221287-12-2-275; Ryan EM, 2011, J PHARM PHARMACOL, V63, P1253, DOI 10.1111/j.2042-7158.2011.01324.x; Schlievert PM, 2010, J ALLERGY CLIN IMMUN, V125, P39, DOI 10.1016/j.jaci.2009.10.039; Seo MD, 2012, BIOMOL THER, V20, P171, DOI 10.4062/biomolther.2012.20.2.171; Song E, 2011, CLIN MOL ALLERGY, V9, P10, DOI [10.1186/1476-7961-9-10, DOI 10.1186/1476-7961-9-10]; Sprenger A, 2013, MOL CELL PROTEOMICS, V12, P2509, DOI 10.1074/mcp.M112.025478; Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001; Takemura-Uchiyama I, 2014, MICROBES INFECT; Tanji Y, 2005, J BIOSCI BIOENG, V100, P280, DOI 10.1263/jbb.100.280; Tanji Y, 2004, APPL MICROBIOL BIOT, V64, P270, DOI 10.1007/s00253-003-1438-9; Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241; Thiel K, 2004, NAT BIOTECHNOL, V22, P31, DOI 10.1038/nbt0104-31; UDoHaH Services, 2013, ANT RES THREATS US 2; van Hal SJ, 2012, CLIN MICROBIOL REV, V25, P362, DOI 10.1128/CMR.05022-11; Vandersteegen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024418; World Health Organization, 2014, ANT RES GLOB REP SUR; Young R, 2000, TRENDS MICROBIOL, V8, P120, DOI 10.1016/S0966-842X(00)01705-4	52	46	47	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124280	10.1371/journal.pone.0124280	http://dx.doi.org/10.1371/journal.pone.0124280			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909449	Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800074
J	Cozzolino, D; Grandone, A; Cittadini, A; Palmiero, G; Esposito, G; De Bellis, A; Furlan, R; Perrotta, S; Perrone, L; Torella, D; del Giudice, EM				Cozzolino, Domenico; Grandone, Anna; Cittadini, Antonio; Palmiero, Giuseppe; Esposito, Giovanni; De Bellis, Annamaria; Furlan, Raffaello; Perrotta, Silverio; Perrone, Laura; Torella, Daniele; del Giudice, Emanuele Miraglia			Subclinical Myocardial Dysfunction and Cardiac Autonomic Dysregulation Are Closely Associated in Obese Children and Adolescents: The Potential Role of Insulin Resistance	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; VENTRICULAR-FUNCTION; MIXED MEAL; HYPERTENSION; METABOLISM; STANDARDS; WEIGHT; NERVE; RISK; MASS	Background The prevalence of obesity is increasing among children/adolescents. Subtle cardiovascular abnormalities, responsible for a higher mortality later in life, have been reported in obese children/adolescents. The aims of the study were to evaluate cardiovascular autonomic regulation, by means of spectrum analysis of R-R interval variability, and myocardial function, by means of standard and tissue Doppler echocardiography, in a group of non-hypertensive asymptomatic obese children and adolescents; furthermore, the influence of insulin resistance was tested. Subjects and Methods R-R interval variability was analyzed during both the 70 degrees head-up tilt and 24-hour electrocardiographic holter monitoring. Spectrum analysis of R-R interval variability provided the indices of sympathetic (low frequency [LFRR]) and vagal (high frequency [HFRR]) modulation of the sinoatrial node. Homeostasis model assessment of insulin resistance (HOMA-IR) was used to classify obese children/adolescents (n = 72) as insulin resistant (n = 37) and non-insulin resistant (n = 35). Results In obese subjects: a) left ventricular mass was significantly (p < 0.05) increased, whereas both the e/a ratio and the e'/a' ratio were decreased; b) at rest, HFRR was lower, and the LFRR/HFRR ratio was higher; c) during tilting, magnitude of tilt-induced inhibition of HFRR was lower; d) during 24-hour electrocardiographic holter monitoring, LFRR and the LFRR/ HFRR ratio were higher, whereas HFRR was lower; e) HOMA-IR inversely correlated with both the e'/a' ratio (r = -0.655; p < 0.001) and the tilt-induced LFRR/HFRR ratio (r = -0.933; p < 0.001); and, f) the e'/a' ratio correlated with the tilt-induced LFRR/HFRR ratio (r = 0.501; p < 0.001). Moreover, HFRR at rest, magnitude of tilt-induced HFRR reduction, and the e'/a' ratio in insulin resistant obese children/adolescents were markedly lower when compared with the remaining subjects. Conclusions Subclinical abnormalities of myocardial function and of cardiac autonomic regulation were closely associated in obese children/adolescents and both correlated with the degree of insulin resistance.	[Cozzolino, Domenico; Palmiero, Giuseppe] Univ Naples 2, Dept Internal Med, Naples, Italy; [Grandone, Anna; Perrotta, Silverio; Perrone, Laura; del Giudice, Emanuele Miraglia] Univ Naples 2, Dept Women Child & Gen & Specialized Surg, Naples, Italy; [Cittadini, Antonio] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy; [Esposito, Giovanni] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy; [De Bellis, Annamaria] Univ Naples 2, Dept Cardiothorac & Resp Sci, Naples, Italy; [Furlan, Raffaello] Univ Milan, Humanitas Res Hosp, Internal Med, Rozzano, Italy; [Torella, Daniele] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; University of Naples Federico II; University of Naples Federico II; Universita della Campania Vanvitelli; IRCCS Humanitas Research Hospital; University of Milan; Magna Graecia University of Catanzaro	Cozzolino, D (corresponding author), Univ Naples 2, Dept Internal Med, Naples, Italy.	domenico.cozzolino@unina2.it	Cittadini, Antonio/I-8426-2012; Furlan, Raffaello/AAH-3167-2021; del Giudice, Emanuele Muraglia/AAC-2824-2019; Palmiero, Giuseppe/I-1087-2019; ESPOSITO, Giovanni/F-2880-2010	Cittadini, Antonio/0000-0002-9905-9277; Furlan, Raffaello/0000-0001-5209-6786; Palmiero, Giuseppe/0000-0002-5102-7460; Perrotta, Silverio/0000-0001-6149-6845; DE BELLIS, Annamaria/0000-0002-0611-4506; GRANDONE, Anna/0000-0002-6343-4768; ESPOSITO, Giovanni/0000-0003-0565-7127; Perrone, Laura/0000-0002-8647-3938; TORELLA, Daniele/0000-0002-4915-5084				Baum P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054546; Bloomgarden ZT, 2002, DIABETES CARE, V25, P2088, DOI 10.2337/diacare.25.11.2088; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Cozzolino D, 1996, J CLIN ENDOCR METAB, V81, P713, DOI 10.1210/jc.81.2.713; Cozzolino D, 2014, J CLIN ENDOCR METAB, V99, P3199, DOI 10.1210/jc.2013-4211; Cozzolino D, 2010, J CLIN ENDOCR METAB, V95, P194, DOI 10.1210/jc.2009-1663; DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z; Di Salvo G, 2006, EUR HEART J, V27, P2689, DOI 10.1093/eurheartj/ehl163; Furlan R, 2000, CIRCULATION, V101, P886, DOI 10.1161/01.CIR.101.8.886; Greenstein AS, 2009, CIRCULATION, V119, P1661, DOI 10.1161/CIRCULATIONAHA.108.821181; Kiviniemi AM, 2007, ANN MED, V39, P54, DOI 10.1080/07853890600990375; Kurtoglu Selim, 2010, J Clin Res Pediatr Endocrinol, V2, P100, DOI 10.4274/jcrpe.v2i3.100; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Martini G, 2001, CLIN AUTON RES, V11, P87, DOI 10.1007/BF02322051; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Nikitin NP, 2003, J AM SOC ECHOCARDIOG, V16, P906, DOI 10.1016/S0894-7317(03)00279-7; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Pagani M, 1997, CIRCULATION, V95, P1441; Peterson LR, 2004, CIRCULATION, V109, P2191, DOI 10.1161/01.CIR.0000127959.28627.F8; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; Rabbone I, 2009, ACTA BIOMED, V1, P29; Reinehr T, 2006, METABOLISM, V55, P113, DOI 10.1016/j.metabol.2005.07.016; Santoro N, 2008, J HYPERTENS, V26, P1590, DOI 10.1097/HJH.0b013e32830413ed; Sasso FC, 2005, EUR HEART J, V26, P1205, DOI 10.1093/eurheartj/ehi271; SCAGLIONE R, 1992, EUR HEART J, V13, P738, DOI 10.1093/oxfordjournals.eurheartj.a060249; Scott EM, 2002, CLIN SCI, V102, P523, DOI 10.1042/CS20010239; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Thiyagarajan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041889; Ulloa L, 2005, NAT REV DRUG DISCOV, V4, P673, DOI 10.1038/nrd1797; Van Putte-Katier N, 2008, PEDIATR RES, V64, P205, DOI 10.1203/PDR.0b013e318176182b; Wong CY, 2006, J AM COLL CARDIOL, V47, P611, DOI 10.1016/j.jacc.2005.11.015; Zeybek C, 2009, PEDIATR CARDIOL, V30, P946, DOI 10.1007/s00246-009-9472-8; Zhang YM, 2011, HYPERTENSION, V57, P148, DOI 10.1161/HYPERTENSIONAHA.110.164178	33	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123916	10.1371/journal.pone.0123916	http://dx.doi.org/10.1371/journal.pone.0123916			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906397	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000048
J	Kakumoto, K; Ikeda, JI; Okada, M; Morii, E; Oneyama, C				Kakumoto, Kyoko; Ikeda, Jun-Ichiro; Okada, Masato; Morii, Eiichi; Oneyama, Chitose			mLST8 Promotes mTOR-Mediated Tumor Progression	PLoS One			English	Article							TRANSLATION INITIATION; PI3K-AKT-MTOR PATHWAY; GENETIC-VARIATIONS; SIGNALING PATHWAY; BLADDER-CANCER; KINASE; RAPTOR; TOR; PHOSPHORYLATION; MICRORNA	The activity of the mechanistic target of rapamycin (mTOR) is elevated in various types of human cancers, implicating a role in tumor progression. However, the molecular mechanisms underlying mTOR upregulation remain unclear. In this study, we found that the expression of mLST8, a required subunit of both mTOR complex 1 (mTORC1) and complex 2 (mTORC2), was upregulated in several human colon and prostate cancer cell lines and tissues. Knockdown of mLST8 significantly suppressed mTORC1 and mTORC2 complex formation, and it also inhibited tumor growth and invasiveness in human colon carcinoma (HCT116) and prostate cancer (LNCaP) cells. Overexpression of mLST8 induced anchor-age-independent cell growth in normal epithelial cells (HaCaT), although mLST8 knockdown had no effect on normal cell growth. mLST8 knockdown reduced mTORC2-mediated phosphorylation of AKT in both cancer and normal cells, whereas it potently inhibited mTORC1-mediated phosphorylation of 4E-BP1 specifically in cancer cells. These results suggest that mLST8 plays distinct roles in normal and cancer cells, depending upon its expression level, and that mLST8 upregulation may contribute to tumor progression by constitutively activating both the mTORC1 and mTORC2 pathways.	[Kakumoto, Kyoko; Okada, Masato; Oneyama, Chitose] Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, Suita, Osaka 565, Japan; [Ikeda, Jun-Ichiro; Morii, Eiichi] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka, Japan	Osaka University; Osaka University	Oneyama, C (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, Suita, Osaka 565, Japan.	coneyama@biken.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Exciting Leading-Edge Research Project at Osaka University	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Exciting Leading-Edge Research Project at Osaka University	This work was supported by a Grant-in-aid for P-DIRECT from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and by The Exciting Leading-Edge Research Project at Osaka University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Armengol G, 2007, CANCER RES, V67, P7551, DOI 10.1158/0008-5472.CAN-07-0881; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Chen M, 2009, CARCINOGENESIS, V30, P2047, DOI 10.1093/carcin/bgp258; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Evren S, 2011, J CLIN PATHOL, V64, P683, DOI 10.1136/jclinpath-2011-200083; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Frey JW, 2014, CELL SIGNAL, V26, P313, DOI 10.1016/j.cellsig.2013.11.009; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; He J, 2013, MOL CARCINOGEN, V52, P70, DOI 10.1002/mc.22013; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Lin J, 2010, CANCER PREV RES, V3, P505, DOI 10.1158/1940-6207.CAPR-09-0263; Liu PD, 2013, NAT CELL BIOL, V15, P1340, DOI 10.1038/ncb2860; Liu Qingsong, 2009, Drug Discov Today Ther Strateg, V6, P47; Madhunapantula SV, 2007, CANCER RES, V67, P3626, DOI 10.1158/0008-5472.CAN-06-4234; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Nakashima A, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-24; Nawroth R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027509; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Oneyama C, 2012, ONCOGENE, V31, P1623, DOI 10.1038/onc.2011.367; Oneyama C, 2011, ONCOGENE, V30, P3489, DOI 10.1038/onc.2011.63; Oneyama C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080300; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Slattery ML, 2010, CARCINOGENESIS, V31, P1604, DOI 10.1093/carcin/bgq142; Tsuruta T, 2011, CANCER RES, V71, P6450, DOI 10.1158/0008-5472.CAN-11-0364; Uesugi A, 2011, CANCER RES, V71, P5765, DOI 10.1158/0008-5472.CAN-11-0368; Xu JF, 2013, CANCER-AM CANCER SOC, V119, P2247, DOI 10.1002/cncr.28023; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206	39	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0119015	10.1371/journal.pone.0119015	http://dx.doi.org/10.1371/journal.pone.0119015			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906254	Green Submitted, gold, Green Published			2022-12-27	WOS:000353332000002
J	Lin, YH; Yuan, J; Pei, HD; Liu, TZ; Ann, DK; Lou, ZK				Lin, Yi-Hui; Yuan, Jian; Pei, Huadong; Liu, Tongzheng; Ann, David K.; Lou, Zhenkun			KAP1 Deacetylation by SIRT1 Promotes Non-Homologous End-Joining Repair	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; HOMOLOGOUS RECOMBINATION; CELL-CYCLE; CHROMATIN RELAXATION; CALORIE RESTRICTION; 53BP1; PROTEIN; BRCA1; ATM	Homologous recombination and non-homologous end joining are two major DNA double-strand-break repair pathways. While HR-mediated repair requires a homologous sequence as the guiding template to restore the damage site precisely, NHEJ-mediated repair ligates the DNA lesion directly and increases the risk of losing nucleotides. Therefore, how a cell regulates the balance between HR and NHEJ has become an important issue for maintaining genomic integrity over time. Here we report that SIRT1-dependent KAP1 deacetylation positively regulates NHEJ. We show that up-regulation of KAP1 attenuates HR efficiency while promoting NHEJ repair. Moreover, SIRT1-mediated KAP1 deacetylation further enhances the effect of NHEJ by stabilizing its interaction with 53BP1, which leads to increased 53BP1 focus formation in response to DNA damage. Taken together, our study suggests a SIRT1-KAP1 regulatory mechanism for HR-NHEJ repair pathway choice.	[Lin, Yi-Hui] Mayo Grad Sch, Dept Biochem & Mol Biol, Rochester, MN USA; [Yuan, Jian] Tongji Univ, Sch Med, Res Ctr Translat Med, Shanghai 200092, Peoples R China; [Yuan, Jian] Tongji Univ, Sch Med, China East Hosp, Key Lab Arrhythmias,Minist Educ, Shanghai 200092, Peoples R China; [Pei, Huadong] Beijing Inst Radiat Med, State Key Lab Prote, Beijing Proteome Res Ctr, Beijing, Peoples R China; [Liu, Tongzheng; Lou, Zhenkun] Mayo Clin, Dept Oncol, Div Oncol Res, Rochester, MN 55905 USA; [Ann, David K.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Pharmacol, Duarte, CA USA; [Ann, David K.] City Hope Natl Med Ctr, Beckman Res Inst, Irell & Manella Grad Sch Biol Sci, Duarte, CA USA	Mayo Clinic; Tongji University; Tongji University; Academy of Military Medical Sciences - China; Mayo Clinic; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Lou, ZK (corresponding author), Mayo Clin, Dept Oncol, Div Oncol Res, Rochester, MN 55905 USA.	lou.zhenkun@mayo.edu		Yuan, Jian/0000-0002-2801-8849	National Institutes of Health [CA130996, CA129344, CA148940]; Mayo Graduate School; NATIONAL CANCER INSTITUTE [R01CA130996, R01CA129344, R01CA148940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Graduate School; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants CA130996, CA129344, and CA148940 (to ZL). YL acknowledges fellowship funding from Mayo Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Bosch-Presegue L, 2011, MOL CELL, V42, P210, DOI 10.1016/j.molcel.2011.02.034; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Cao L, 2009, MOL CELL, V35, P534, DOI 10.1016/j.molcel.2009.06.037; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cruz-Garcia A, 2014, CELL REP, V9, P451, DOI 10.1016/j.celrep.2014.08.076; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Fan W, 2010, MOL CELL, V39, P247, DOI 10.1016/j.molcel.2010.07.006; Fattah F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000855; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Garvin AJ, 2013, EMBO REP, V14, P975, DOI 10.1038/embor.2013.141; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Harding SM, 2012, CELL CYCLE, V11, P1432, DOI 10.4161/cc.19824; Hinz JM, 2005, DNA REPAIR, V4, P782, DOI 10.1016/j.dnarep.2005.03.005; Huber LJ, 2001, MOL CELL BIOL, V21, P4005, DOI 10.1128/MCB.21.12.4005-4015.2001; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Jeong J, 2007, EXP MOL MED, V39, P8, DOI 10.1038/emm.2007.2; Jowsey PA, 2004, J BIOL CHEM, V279, P55562, DOI 10.1074/jbc.M411021200; Kahyo T, 2008, FEBS LETT, V582, P2479, DOI 10.1016/j.febslet.2008.06.031; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Law IKM, 2009, PROTEOMICS, V9, P2444, DOI 10.1002/pmic.200800738; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Li K, 2008, J BIOL CHEM, V283, P7590, DOI 10.1074/jbc.M709707200; Li XZ, 2010, MOL CELL BIOL, V30, P5335, DOI 10.1128/MCB.00350-10; Li X, 2007, J BIOL CHEM, V282, P36177, DOI 10.1074/jbc.M706912200; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Liu JP, 2012, CELL CYCLE, V11, P2643, DOI 10.4161/cc.20957; Liu TZ, 2014, MOL CELL, V56, P681, DOI 10.1016/j.molcel.2014.10.007; Lottersberger F, 2013, P NATL ACAD SCI USA, V110, P2146, DOI 10.1073/pnas.1222617110; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mascle XH, 2007, J BIOL CHEM, V282, P10190, DOI 10.1074/jbc.M611429200; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Ming M, 2010, P NATL ACAD SCI USA, V107, P22623, DOI 10.1073/pnas.1010377108; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Rai R, 2010, EMBO J, V29, P2598, DOI 10.1038/emboj.2010.142; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Roseaulin L, 2008, EMBO J, V27, P1378, DOI 10.1038/emboj.2008.65; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Schlegel BP, 2006, CANCER RES, V66, P5181, DOI 10.1158/0008-5472.CAN-05-3209; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Snouwaert JN, 1999, ONCOGENE, V18, P7900, DOI 10.1038/sj.onc.1203334; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Thompson LH, 2002, MUTAT RES-FUND MOL M, V509, P49, DOI 10.1016/S0027-5107(02)00224-5; Thorslund T, 2007, ONCOGENE, V26, P7720, DOI 10.1038/sj.onc.1210870; Uhl M, 2010, DNA REPAIR, V9, P383, DOI 10.1016/j.dnarep.2009.12.020; Vaitiekunaite R, 2007, MECH AGEING DEV, V128, P650, DOI 10.1016/j.mad.2007.09.004; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang CG, 2007, J BIOL CHEM, V282, P29902, DOI 10.1074/jbc.M704757200; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wang Z, 2013, ONCOGENE, V32, P589, DOI 10.1038/onc.2012.83; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; White D, 2012, MOL CANCER RES, V10, P401, DOI 10.1158/1541-7786.MCR-11-0134; White DE, 2006, CANCER RES, V66, P11594, DOI 10.1158/0008-5472.CAN-06-4138; Xia ZF, 2001, J BIOL CHEM, V276, P2708, DOI 10.1074/jbc.M007665200; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zgheib O, 2009, MOL CELL BIOL, V29, P1050, DOI 10.1128/MCB.01011-08; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	94	40	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123935	10.1371/journal.pone.0123935	http://dx.doi.org/10.1371/journal.pone.0123935			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905708	Green Submitted, Green Published, gold			2022-12-27	WOS:000353332000051
J	Pomraning, KR; Wei, SW; Karagiosis, SA; Kim, YM; Dohnalkova, AC; Arey, BW; Bredeweg, EL; Orr, G; Metz, TO; Baker, SE				Pomraning, Kyle R.; Wei, Siwei; Karagiosis, Sue A.; Kim, Young-Mo; Dohnalkova, Alice C.; Arey, Bruce W.; Bredeweg, Erin L.; Orr, Galya; Metz, Thomas O.; Baker, Scott E.			Comprehensive Metabolomic, Lipidomic and Microscopic Profiling of Yarrowia lipolytica during Lipid Accumulation Identifies Targets for Increased Lipogenesis	PLOS ONE			English	Article							PROTEIN EXPRESSION; YEAST; ACID; TOOL; GLUCOSE; MICROORGANISMS; BIOSYNTHESIS; CEREVISIAE; SECRETION	Yarrowia lipolytica is an oleaginous ascomycete yeast that accumulates large amounts of lipids and has potential as a biofuel producing organism. Despite a growing scientific literature focused on lipid production by Y. lipolytica, there remain significant knowledge gaps regarding the key biological processes involved. We applied a combination of metabolomic and lipidomic profiling approaches as well as microscopic techniques to identify and characterize the key pathways involved in de novo lipid accumulation from glucose in batch cultured, wild-type Y. lipolytica. We found that lipids accumulated rapidly and peaked at 48 hours during the five day experiment, concurrent with a shift in amino acid metabolism. We also report that exhaustion of extracellular sugars coincided with thickening of the cell wall, suggesting that genes involved in cell wall biogenesis may be a useful target for improving the efficiency of lipid producing yeast strains.	[Pomraning, Kyle R.; Dohnalkova, Alice C.; Arey, Bruce W.; Bredeweg, Erin L.; Orr, Galya; Baker, Scott E.] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA; [Wei, Siwei; Kim, Young-Mo; Metz, Thomas O.] Pacific NW Natl Lab, Fundamental & Comp Sci Directorate, Richland, WA 99352 USA; [Karagiosis, Sue A.] Pacific NW Natl Lab, Energy & Environm Directorate, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Baker, SE (corresponding author), Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA.	Scott.Baker@pnnl.gov	Kim, Young-Mo/AAG-2866-2019; Baker, Scott E/X-2065-2018; Baker, Scott E./ABB-1635-2020; Kim, Young-Mo/D-3282-2009	Kim, Young-Mo/0000-0002-8972-7593; Baker, Scott E/0000-0001-5085-3106; Baker, Scott E./0000-0001-5085-3106; Kim, Young-Mo/0000-0002-8972-7593; Bredeweg, Erin/0000-0001-7827-8342; Metz, Tom/0000-0001-6049-3968; Pomraning, Kyle/0000-0003-2324-2881	US Department of Energy Office of Biological and Environmental Research Genome Science Program; US Department of Energy [DE-AC05-76RL01830]; Office of Biological and Environmental Research	US Department of Energy Office of Biological and Environmental Research Genome Science Program(United States Department of Energy (DOE)); US Department of Energy(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The research performed in this study was funded by the US Department of Energy Office of Biological and Environmental Research Genome Science Program. It was conducted at Pacific Northwest National Laboratory operated by Battelle for the US Department of Energy under Contract DE-AC05-76RL01830. The research was performed using Environmental Molecular Sciences Laboratory (EMSL), a DOE Office of Science User Facility sponsored by the Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory. KRP is a William R. Wiley Postdoctoral Fellow at EMSL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageitos JM, 2011, APPL MICROBIOL BIOT, V90, P1219, DOI 10.1007/s00253-011-3200-z; Athenstaedt K, 2006, PROTEOMICS, V6, P1450, DOI 10.1002/pmic.200500339; Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; Beopoulos A, 2011, APPL MICROBIOL BIOT, V90, P1193, DOI 10.1007/s00253-011-3212-8; Beopoulos A, 2009, PROG LIPID RES, V48, P375, DOI 10.1016/j.plipres.2009.08.005; Beopoulos A, 2008, APPL ENVIRON MICROB, V74, P7779, DOI 10.1128/AEM.01412-08; Beopoulos A, 2009, BIOCHIMIE, V91, P692, DOI 10.1016/j.biochi.2009.02.004; Bionutrients BD, 2006, BIONUTRIENTS BD TM T, P28; Blazeck J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4131; Christen S, 2011, FEMS YEAST RES, V11, P263, DOI 10.1111/j.1567-1364.2010.00713.x; Cooper T., 1982, MOL BIOL YEAST SACCH, P39, DOI DOI 10.1101/087969180.11B.39; DeLuna A, 2001, J BIOL CHEM, V276, P43775, DOI 10.1074/jbc.M107986200; Durrett TP, 2008, PLANT J, V54, P593, DOI 10.1111/j.1365-313X.2008.03442.x; Finogenova TV, 2005, APPL BIOCHEM MICRO+, V41, P418, DOI 10.1007/s10438-005-0076-7; FRANKERINKER D, 1983, Z ALLG MIKROBIOL, V23, P9, DOI 10.1002/jobm.3630230103; Gao XL, 2012, ANAL BIOANAL CHEM, V402, P2923, DOI 10.1007/s00216-012-5773-5; Garay LA, 2014, J AGR FOOD CHEM, V62, P2709, DOI 10.1021/jf4042134; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Hein EM, 2012, METABOLITES, V2, P254, DOI 10.3390/metabo2010254; Hiller K, 2009, ANAL CHEM, V81, P3429, DOI 10.1021/ac802689c; Jaitly N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-87; Kelly RT, 2006, ANAL CHEM, V78, P7796, DOI 10.1021/ac061133r; Kim YM, 2013, MOL BIOSYST, V9, P1522, DOI 10.1039/c3mb25598k; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Knothe G, 2005, FUEL PROCESS TECHNOL, V86, P1059, DOI 10.1016/j.fuproc.2004.11.002; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; LaMarche BL, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-49; Madzak C, 2004, J BIOTECHNOL, V109, P63, DOI 10.1016/j.jbiotec.2003.10.027; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Mironczuk AM, 2014, J IND MICROBIOL BIOT, V41, P57, DOI 10.1007/s10295-013-1380-5; Morin N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027966; Nicaud JM, 2002, FEMS YEAST RES, V2, P371, DOI 10.1111/j.1567-1364.2002.tb00106.x; OGRYDZIAK DM, 1988, CRIT REV BIOTECHNOL, V8, P177, DOI 10.3109/07388558809147555; OOGAKI M, 1983, AGR BIOL CHEM TOKYO, V47, P2619, DOI 10.1080/00021369.1983.10865999; Papanikolaou S, 2003, CURR MICROBIOL, V46, P398, DOI 10.1007/s00284-002-3907-2; Papanikolaou S, 2002, APPL MICROBIOL BIOT, V58, P308, DOI 10.1007/s00253-001-0897-0; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Ratledge C, 2004, BIOCHIMIE, V86, P807, DOI 10.1016/j.biochi.2004.09.017; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sitepu IR, 2014, APPL MICROBIOL BIOT, V98, P7645, DOI 10.1007/s00253-014-5944-8; Sitepu IR, 2013, BIORESOURCE TECHNOL, V144, P360, DOI 10.1016/j.biortech.2013.06.047; Tai M, 2013, METAB ENG, V15, P1, DOI 10.1016/j.ymben.2012.08.007; Tomaszewska L, 2012, J IND MICROBIOL BIOT, V39, P1333, DOI 10.1007/s10295-012-1145-6; Zhao C, 2014, BIOCHEM ENG J, V82, P63, DOI 10.1016/j.bej.2013.11.004	44	43	44	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123188	10.1371/journal.pone.0123188	http://dx.doi.org/10.1371/journal.pone.0123188			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905710	Green Published, Green Submitted, gold			2022-12-27	WOS:000353332000024
J	Taketani, Y; Mayama, C; Suzuki, N; Wada, A; Oka, T; Inamochi, K; Nomoto, Y				Taketani, Yukako; Mayama, Chihiro; Suzuki, Noriyuki; Wada, Akiko; Oka, Tatsuhiro; Inamochi, Kazuya; Nomoto, Yohei			Transient but Significant Visual Field Defects after Robot-Assisted Laparoscopic Radical Prostatectomy in Deep Trendelenburg Position	PLOS ONE			English	Article							ISCHEMIC OPTIC NEUROPATHY; LUMBAR SPINE SURGERY; INTRAOCULAR-PRESSURE; NATURAL-HISTORY; SEVOFLURANE; DESFLURANE; PROPOFOL; FEATURES; PATTERN; BYPASS	Background Robot-assisted laparoscopic radical prostatectomy (RALP) is a minimally invasive surgical procedure for prostate cancer. During RALP, the patient must be in a steep Trendelenburg (head-down) position, which leads to a significant increase in intraocular pressure (IOP). The association of RALP with visual field sensitivity, however, has not been prospectively studied. The purpose of this study was to evaluate prospectively the visual field, retinal nerve fiber layer (RNFL) thickness, and optic disc morphology in 50 normal eyes of 25 male patients that underwent RALP. Methods The subjects were 25 males among 33 consecutive patients who underwent uneventful RALP under general anesthesia in our hospital. Visual field tests using the Humphrey visual field analyzer 30-2 SITA-standard program were performed before, 7 days after, and 1-3 months after RALP. IOP was measured before, during, and after RALP; and ophthalmologic examinations, including slit-lamp, fundus examination, and optical coherence tomography (OCT), were scheduled before and 7 days after surgery. Results IOP was significantly increased during RALP up to 29.4 mmHg (P<0.01). Postoperative local visual field defects were detected in 7 eyes of 7 subjects dominantly in the lower hemifield without abnormal findings in the optic nerve head or retina, and the visual field recovered to normal within 3 months after surgery. General factors associated with RALP, IOP, RNFL thickness, or optic disc parameters did not differ significantly between eyes with and without postoperative visual field defects, and parameters of OCT measurements were not altered after surgery. Conclusion Transient but significant unilateral visual field defects were found in 28% of the subjects examined. The probable cause are the increased IOP and altered perfusion during surgery and ophthalmologic examinations are therefore suggested before and after RALP.	[Taketani, Yukako; Mayama, Chihiro] Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan; [Taketani, Yukako; Inamochi, Kazuya; Nomoto, Yohei] Asahi Gen Hosp, Dept Ophthalmol, Chiba, Japan; [Suzuki, Noriyuki] Asahi Gen Hosp, Dept Urol, Chiba, Japan; [Wada, Akiko; Oka, Tatsuhiro] Asahi Gen Hosp, Dept Anesthesiol, Chiba, Japan; [Inamochi, Kazuya] Tokyo Metropolitan Police Hosp, Dept Ophthalmol, Tokyo, Japan	University of Tokyo	Mayama, C (corresponding author), Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan.	cmayama-tky@umin.ac.jp		taketani, yukako/0000-0001-6424-3579				Anderson DR., 1999, AUTOMATED STATIC PER; ARNOLD AC, 1994, J NEURO-OPHTHALMOL, V14, P66; Awad H, 2012, J CLIN ANESTH, V24, P494, DOI 10.1016/j.jclinane.2012.03.003; Awad H, 2009, ANESTH ANALG, V109, P473, DOI 10.1213/ane.0b013e3181a9098f; Bushley DM, 2000, AM J OPHTHALMOL, V129, P668, DOI 10.1016/S0002-9394(00)00366-4; Chan CKM, 2009, BRIT J OPHTHALMOL, V93, P731, DOI 10.1136/bjo.2008.143297; Chen XG, 2001, ANESTH ANALG, V93, P1489, DOI 10.1097/00000539-200112000-00029; Colotto A, 1996, INVEST OPHTH VIS SCI, V37, P2663; Gerling J, 1998, GRAEF ARCH CLIN EXP, V236, P188, DOI 10.1007/s004170050062; Hayreh SS, 2008, OPHTHALMOLOGY, V115, P298, DOI 10.1016/j.ophtha.2007.05.027; Hayreh SS, 2005, ARCH OPHTHALMOL-CHIC, V123, P1554, DOI 10.1001/archopht.123.11.1554; Hayreh SS, 2004, EYE, V18, P1188, DOI 10.1038/sj.eye.6701562; HAYREH SS, 1994, AM J OPHTHALMOL, V118, P766, DOI 10.1016/S0002-9394(14)72557-7; Hoff JM, 2010, ACTA OPHTHALMOL, V88, P490, DOI 10.1111/j.1755-3768.2008.01458.x; Hoshikawa Y, 2014, BRIT J OPHTHALMOL, V98, P305, DOI 10.1136/bjophthalmol-2013-303536; KATZ DM, 1994, ARCH OPHTHALMOL-CHIC, V112, P925, DOI 10.1001/archopht.1994.01090190073024; LARKIN DFP, 1987, BRIT J OPHTHALMOL, V71, P344, DOI 10.1136/bjo.71.5.344; Lestar M, 2011, ANESTH ANALG, V113, P1069, DOI 10.1213/ANE.0b013e3182075d1f; LINDER BJ, 1988, INVEST OPHTH VIS SCI, V29, P1492; Molloy Bonnie Lee, 2011, AANA J, V79, P115; Murphy MA, 2003, OPHTHALMOLOGY, V110, P1454, DOI 10.1016/S0161-6420(03)00480-9; Rassweiler J, 2006, EUR UROL, V49, P612, DOI 10.1016/j.eururo.2005.12.054; RIZZO JF, 1987, AM J OPHTHALMOL, V103, P808; Royse CF, 2011, ANAESTHESIA, V66, P455, DOI 10.1111/j.1365-2044.2011.06704.x; Sadaba Luis M, 2006, BMC Ophthalmol, V6, P32, DOI 10.1186/1471-2415-6-32; Trible JR, 1997, ARCH OPHTHALMOL-CHIC, V115, P1523, DOI 10.1001/archopht.1997.01100160693005; Weber ED, 2007, J NEURO-OPHTHALMOL, V27, P285, DOI 10.1097/WNO.0b013e31815b9f67; Weiss HS, 2001, ARCH OPHTHALMOL-CHIC, V119, P774; Yoo YC, 2014, CAN J ANESTH, V61, P322, DOI 10.1007/s12630-014-0112-2	29	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123361	10.1371/journal.pone.0123361	http://dx.doi.org/10.1371/journal.pone.0123361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906167	Green Submitted, Green Published, gold			2022-12-27	WOS:000353332000028
J	Villela, DAM; Codeco, CT; Figueiredo, F; Garcia, GA; Maciel-de-Freitas, R; Struchiner, CJ				Villela, Daniel A. M.; Codeco, Claudia T.; Figueiredo, Felipe; Garcia, Gabriela A.; Maciel-de-Freitas, Rafael; Struchiner, Claudio J.			A Bayesian Hierarchical Model for Estimation of Abundance and Spatial Density of Aedes aegypti	PLOS ONE			English	Article							RIO-DE-JANEIRO; MARK-RELEASE-RECAPTURE; DAILY SURVIVAL RATES; POPULATION-SIZE; DENGUE VECTOR; DISPERSAL; CULICIDAE; DIPTERA; VILLAGE; BRAZIL	Strategies to minimize dengue transmission commonly rely on vector control, which aims to maintain Ae. aegypti density below a theoretical threshold. Mosquito abundance is traditionally estimated from mark-release-recapture (MRR) experiments, which lack proper analysis regarding accurate vector spatial distribution and population density. Recently proposed strategies to control vector-borne diseases involve replacing the susceptible wild population by genetically modified individuals' refractory to the infection by the pathogen. Accurate measurements of mosquito abundance in time and space are required to optimize the success of such interventions. In this paper, we present a hierarchical probabilistic model for the estimation of population abundance and spatial distribution from typical mosquito MRR experiments, with direct application to the planning of these new control strategies. We perform a Bayesian analysis using the model and data from two MRR experiments performed in a neighborhood of Rio de Janeiro, Brazil, during both low-and high-dengue transmission seasons. The hierarchical model indicates that mosquito spatial distribution is clustered during the winter (0.99 mosquitoes/premise 95% CI: 0.80-1.23) and more homogeneous during the high abundance period (5.2 mosquitoes/premise 95% CI: 4.3-5.9). The hierarchical model also performed better than the commonly used Fisher-Ford's method, when using simulated data. The proposed model provides a formal treatment of the sources of uncertainty associated with the estimation of mosquito abundance imposed by the sampling design. Our approach is useful in strategies such as population suppression or the displacement of wild vector populations by refractory Wolbachia-infected mosquitoes, since the invasion dynamics have been shown to follow threshold conditions dictated by mosquito abundance. The presence of spatially distributed abundance hotspots is also formally addressed under this modeling framework and its knowledge deemed crucial to predict the fate of transmission control strategies based on the replacement of vector populations.	[Villela, Daniel A. M.; Codeco, Claudia T.; Figueiredo, Felipe; Struchiner, Claudio J.] Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, Brazil; [Garcia, Gabriela A.; Maciel-de-Freitas, Rafael] Fundacao Oswaldo Cruz, Dept Entomol, Lab Transmissores Hematozoarios, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Villela, DAM (corresponding author), Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, Brazil.	dvillela@fiocruz.br	Figueiredo, Felipe/L-9463-2015; Struchiner, Claudio J/M-9360-2013; Villela, Daniel/AAG-6445-2019; Maciel-de-Freitas, Rafael/J-1997-2012; Struchiner, Claudio Jose/HGB-9492-2022	Figueiredo, Felipe/0000-0002-7309-9844; Struchiner, Claudio J/0000-0003-2114-847X; Villela, Daniel/0000-0001-8371-2959; Maciel-de-Freitas, Rafael/0000-0002-2198-6492	Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative of the Bill and Melinda Gates Foundation; CNPq-Brazil [PRONEX Dengue 550030/2010-7]; FAPERJ [Rede Dengue-E26-110.977/2011]	Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative of the Bill and Melinda Gates Foundation; CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study was partially supported by grants received from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative of the Bill and Melinda Gates Foundation, from CNPq-Brazil (PRONEX Dengue 550030/2010-7) and from FAPERJ (Rede Dengue-E26-110.977/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, MOSQUITO ECOLOGY FIE; Baber I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010270; BAILEY NTJ, 1952, J ANIM ECOL, V21, P120, DOI 10.2307/1913; Barton NH, 2011, AM NAT, V178, pE48, DOI 10.1086/661246; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Buonaccorsi JP, 2003, J MED ENTOMOL, V40, P6, DOI 10.1603/0022-2585-40.1.6; Cianci D, 2013, J MED ENTOMOL, V50, P533, DOI 10.1603/ME12126; Consoli R. A. G. B., 1994, PRINCIPAIS MOSQUITOS; Cooch E., 2013, PROGRAM MARK GENTLE; Costantini C, 1996, MED VET ENTOMOL, V10, P203, DOI 10.1111/j.1365-2915.1996.tb00733.x; David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019; Dowdeswell WH, 1940, ANN EUGENIC, V10, P123, DOI 10.1111/j.1469-1809.1940.tb02242.x; Edman JD, 1998, J MED ENTOMOL, V35, P578, DOI 10.1093/jmedent/35.4.578; Focks D.A., 2004, REV ENTOMOLOGICAL SA; Focks DA, 1997, AM J TROP MED HYG, V56, P159, DOI 10.4269/ajtmh.1997.56.159; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; Gatrell AC, 1996, T I BRIT GEOGR, V21, P256, DOI 10.2307/622936; Getis A, 2010, ADV SPAT SCI, P203, DOI 10.1007/978-3-642-01976-0_15; Grimm V, 1999, ECOL MODEL, V115, P129, DOI 10.1016/S0304-3800(98)00188-4; Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005; Jeffery JAL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000552; JUDSON OP, 1994, TRENDS ECOL EVOL, V9, P9, DOI 10.1016/0169-5347(94)90225-9; Keeling MJ, 2003, HEREDITY, V91, P382, DOI 10.1038/sj.hdy.6800343; Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2; Laake JL, 2013, METHODS ECOL EVOL, V4, P885, DOI 10.1111/2041-210X.12065; Maciel-De-Freitas R, 2007, MED VET ENTOMOL, V21, P284, DOI 10.1111/j.1365-2915.2007.00694.x; Maciel-De-Freitas R, 2008, CAD SAUDE PUBLICA, V24, P2747, DOI 10.1590/S0102-311X2008001200003; Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659; Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017; Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508; MCDONALD PT, 1977, J MED ENTOMOL, V14, P42, DOI 10.1093/jmedent/14.1.42; Morrison AC, 1998, AM J TROP MED HYG, V58, P287, DOI 10.4269/ajtmh.1998.58.287; Olanratmanee P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001913; Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327; Plummer M., 2003, P 3 INT WORKSH DISTR; Royle JA, 2011, METHODS ECOL EVOL, V2, P602, DOI 10.1111/j.2041-210X.2011.00116.x; Royle J. Andrew, 2012, Journal of Ornithology, V152, pS521, DOI 10.1007/s10336-010-0619-4; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588; Toure YT, 1998, MED VET ENTOMOL, V12, P74, DOI 10.1046/j.1365-2915.1998.00071.x; TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263; Tsuda Y, 2001, J MED ENTOMOL, V38, P93, DOI 10.1603/0022-2585-38.1.93; van Dyk DA, 2001, J COMPUT GRAPH STAT, V10, P1, DOI 10.1198/10618600152418584; Williams C, 2012, MED VET ENTOMOLOGY; Williams CR, 2008, J MED ENTOMOL, V45, P1173, DOI 10.1603/0022-2585(2008)45[1173:REOAAP]2.0.CO;2; Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730	50	22	22	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123794	10.1371/journal.pone.0123794	http://dx.doi.org/10.1371/journal.pone.0123794			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906323	Green Published, Green Submitted, gold			2022-12-27	WOS:000353332000047
J	Ho, KM; Rao, S; Burrell, M; Weeramanthri, TS				Ho, Kwok M.; Rao, Sudhakar; Burrell, Maxine; Weeramanthri, Tarun S.			The Journey from Traffic Offender to Severe Road Trauma Victim: Destiny or Preventive Opportunity?	PLOS ONE			English	Article							TIME-SERIES; INJURIES; OFFENSES; ALCOHOL	Background Road trauma is a leading cause of death and injury in young people. Traffic offences are common, but their importance as a risk indicator for subsequent road trauma is unknown. This cohort study assessed whether severe road trauma could be predicted by a history of prior traffic offences. Methodology and Principal Findings Clinical data of all adult road trauma patients admitted to the Western Australia (WA) State Trauma Centre between 1998 and 2013 were linked to traffic offences records at the WA Department of Transport. The primary outcomes were alcohol exposure prior to road trauma, severe trauma (defined by Injury Severity Score > 15), and intensive care admission (ICU) or death, analyzed by logistic regression. Traffic offences directly leading to the road trauma admissions were excluded. Of the 10,330 patients included (median age 34 years-old, 78% male), 1955 (18.9%) had alcohol-exposure before road trauma, 2415 (23.4%) had severe trauma, 1360 (13.2%) required ICU admission, and 267 (2.6%) died. Prior traffic offences were recorded in 6269 (60.7%) patients. The number of prior traffic offences was significantly associated with alcohol-related road trauma (odds ratio [OR] per offence 1.03, 95% confidence interval [CI] 1.02-1.05), severe trauma (OR 1.13, 95% CI 1.14-1.15), and ICU admission or death (OR 1.10, 95% CI 1.08-1.11). Drink-drinking, seat-belt, and use of handheld electronic device offences were specific offences strongly associated with road trauma leading to ICU admission or death-all in a 'dose-related' fashion. For those who recovered from road trauma after an ICU admission, there was a significant reduction in subsequent traffic offences (mean difference 1.8, 95% CI 1.5 to 2.0) and demerit points (mean difference 7.0, 95% CI 6.5 to 7.6) compared to before the trauma event. Significance Previous traffic offences were a significant risk factor for alcohol-related road trauma and severe road trauma leading to ICU admission or death.	[Ho, Kwok M.] Royal Perth Hosp, Dept Intens Care Med, Perth, WA 6001, Australia; [Ho, Kwok M.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Ho, Kwok M.] Murdoch Univ, Perth, WA, Australia; [Rao, Sudhakar; Burrell, Maxine] Royal Perth Hosp, State Trauma Unit, Perth, WA 6001, Australia; [Weeramanthri, Tarun S.] Western Australia Dept Hlth, Publ Hlth & Clin Serv Div, Perth, WA, Australia	Royal Perth Hospital; University of Western Australia; Murdoch University; Royal Perth Hospital	Ho, KM (corresponding author), Royal Perth Hosp, Dept Intens Care Med, Perth, WA 6001, Australia.	kwok.ho@health.wa.gov.au	Ho, Kwok M./E-3546-2010	Ho, Kwok M./0000-0002-6705-6004				[Anonymous], 2007, LANCET, V369, P1319; Banfield JM, 2011, J TRAUMA, V70, P732, DOI 10.1097/TA.0b013e31820783a3; Boufous S, 2010, INJURY PREV, V16, P275, DOI 10.1136/ip.2009.024877; Butler JS, 2007, LANCET, V369, P2160, DOI 10.1016/S0140-6736(07)61012-5; Butler JS, 2006, IRISH J MED SCI, V175, P20, DOI 10.1007/BF03168994; Gargett S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-270; Ho KM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-279; Ho KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031776; Ho KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003226; Novoa AM, 2011, B WORLD HEALTH ORGAN, V89, P422, DOI 10.2471/BLT.10.082180; Novoa AM, 2010, AM J PUBLIC HEALTH, V100, P2220, DOI 10.2105/AJPH.2010.192104; Schermer CR, 2008, J TRAUMA, V65, P1000, DOI 10.1097/TA.0b013e318182f76b; Schermer CR, 2006, J TRAUMA, V60, P29, DOI 10.1097/01.ta.0000199420.12322.5d; Summala H, 2014, ACCIDENT ANAL PREV, V73, P27, DOI 10.1016/j.aap.2014.08.008; Toroyan T, 2013, LANCET, V381, P977, DOI 10.1016/S0140-6736(13)60606-6; World Health Organization, 2009, GLOB STAT REP ROAD S	16	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122652	10.1371/journal.pone.0122652	http://dx.doi.org/10.1371/journal.pone.0122652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902197	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500026
J	Le Cabec, A; Tang, N; Tafforeau, P				Le Cabec, Adeline; Tang, Nancy; Tafforeau, Paul			Accessing Developmental Information of Fossil Hominin Teeth Using New Synchrotron Microtomography-Based Visualization Techniques of Dental Surfaces and Interfaces	PLOS ONE			English	Article							MODERN HUMANS; LIFE-HISTORY; HISTOLOGICAL RECONSTRUCTION; AUSTRALOPITHECUS-SEDIBA; DEVELOPING DENTITION; ENAMEL HYPOPLASIA; CROSS-STRIATIONS; GROWTH; AGE; STRESS	Quantification of dental long-period growth lines (Retzius lines in enamel and Andresen lines in dentine) and matching of stress patterns (internal accentuated lines and hypoplasias) are used in determining crown formation time and age at death in juvenile fossil hominins. They yield the chronology employed for inferences of life history. Synchrotron virtual histology has been demonstrated as a non-destructive alternative to conventional invasive approaches. Nevertheless, fossil teeth are sometimes poorly preserved or physically inaccessible, preventing observation of the external expression of incremental lines (perikymata and periradicular bands). Here we present a new approach combining synchrotron virtual histology and high quality three-dimensional rendering of dental surfaces and internal interfaces. We illustrate this approach with seventeen permanent fossil hominin teeth. The outer enamel surface and enamel-dentine junction (EDJ) were segmented by capturing the phase contrast fringes at the structural interfaces. Three-dimensional models were rendered with Phong's algorithm, and a combination of directional colored lights to enhance surface topography and the pattern of subtle variations in tissue density. The process reveals perikymata and linear enamel hypoplasias on the entire crown surface, including unerupted teeth. Using this method, highly detailed stress patterns at the EDJ allow precise matching of teeth within an individual's dentition when virtual histology is not sufficient. We highlight that taphonomical altered enamel can in particular cases yield artificial subdivisions of perikymata when imaged using X-ray microtomography with insufficient resolution. This may complicate assessments of developmental time, although this can be circumvented by a careful analysis of external and internal structures in parallel. We further present new crown formation times for two unerupted canines from South African Australopiths, which were found to form over a rather surprisingly long time (>4.5 years). This approach provides tools for maximizing the recovery of developmental information in teeth, especially in the most difficult cases.	[Le Cabec, Adeline; Tafforeau, Paul] ESRF, F-38043 Grenoble 9, France; [Le Cabec, Adeline; Tang, Nancy] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Le Cabec, Adeline] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Tang, Nancy] Icahn Sch Med Mt Sinai, Exposure Biol Lab, Dept Prevent Med, New York, NY 10029 USA	European Synchrotron Radiation Facility (ESRF); Harvard University; Max Planck Society; Icahn School of Medicine at Mount Sinai	Le Cabec, A (corresponding author), ESRF, 71 Ave Martyrs,CS 40220, F-38043 Grenoble 9, France.	adeline.le-cabec@esrf.fr; paul.tafforeau@esrf.fr	LE CABEC, Adeline/I-1661-2019	LE CABEC, Adeline/0000-0001-6948-4726; Tafforeau, Paul/0000-0002-5962-1683	NSF [BCS 1126470]; Harvard University; European Synchrotron Radiation Facility [Ec697]; Direct For Social, Behav & Economic Scie [1126470] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Harvard University; European Synchrotron Radiation Facility; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was funded by NSF Grant BCS 1126470, Harvard University, and the European Synchrotron Radiation Facility (Ec697). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel RL, 2012, PALAEONTOL ELECTRON, V15; Antoine D, 2000, EVALUATING PERIODICI; Antoine D, 2009, J ANAT, V214, P45, DOI 10.1111/j.1469-7580.2008.01010.x; Asper H, 1916, SCHWEIZ VJSCHR ZAHNH, V26, P275; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Betz O, 2007, J MICROSC-OXFORD, V227, P51, DOI 10.1111/j.1365-2818.2007.01785.x; BEYNON AD, 1991, AM J PHYS ANTHROPOL, V86, P189, DOI 10.1002/ajpa.1330860208; Bocaege E, 2010, AM J PHYS ANTHROPOL, V141, P498, DOI 10.1002/ajpa.21233; BOYDE A, 1990, MG PRIMATOL, V14, P229; Boyde A, 1963, 3 INT M FOR IMM MED, P36; BROMAGE TG, 1985, NATURE, V317, P525, DOI 10.1038/317525a0; Bronnikov AV, 2002, J OPT SOC AM A, V19, P472, DOI 10.1364/JOSAA.19.000472; Bronnikov AV, 2006, P EUR C COMP VIS GRA; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; Dean Christopher, 1999, Cambridge Studies in Biological and Evolutionary Anthropology, V25, P111; Dean MC, 2006, P ROY SOC B-BIOL SCI, V273, P2799, DOI 10.1098/rspb.2006.3583; Dean MC, 2014, ANN HUM BIOL, V41, P358, DOI 10.3109/03014460.2014.923047; Dean MC, 2010, PHILOS T R SOC B, V365, P3397, DOI 10.1098/rstb.2010.0052; DEAN MC, 1986, AM J PHYS ANTHROPOL, V70, P301, DOI 10.1002/ajpa.1330700305; DEAN MC, 1993, AM J PHYS ANTHROPOL, V91, P401, DOI 10.1002/ajpa.1330910402; Dean MC, 1996, ARCH ORAL BIOL, V41, P233, DOI 10.1016/0003-9969(95)00137-9; Dean MC, 1998, J HUM EVOL, V35, P401, DOI 10.1006/jhev.1998.0243; DEAN MC, 1989, FOLIA PRIMATOL, V53, P160; Dean MC., 1995, STRUCTURE FUNCTION E, P239; Dean MC., 1993, INT J OSTEOARCHAEOL, V3, P249, DOI [10.1002/oa.1390030404, DOI 10.1002/OA.1390030404]; Dirks W, 2002, AM J PHYS ANTHROPOL, V118, P239, DOI 10.1002/ajpa.10089; Elhechmi I, 2013, BIOMED OPT EXPRESS, V4, P2124, DOI 10.1364/BOE.4.002124; FitzGerald C. M., 1995, THESIS U CAMBRIDGE; Fitzgerald Charles M., 2000, BIOL ANTHR HUMAN SKE, P237; FitzGerald CM, 1998, J HUM EVOL, V35, P371, DOI 10.1006/jhev.1998.0232; GOODMAN AH, 1990, YEARB PHYS ANTHROPOL, V33, P59; Guatelli-Steinberg D, 2001, EVOL ANTHROPOL, V10, P138, DOI 10.1002/evan.1027; Gysi A., 1939, DENT DIG, V37, P661; Hassett BR, 2014, AM J PHYS ANTHROPOL, V153, P463, DOI 10.1002/ajpa.22445; Hillson S, 1997, AM J PHYS ANTHROPOL, V104, P89, DOI 10.1002/(SICI)1096-8644(199709)104:1<89::AID-AJPA6>3.0.CO;2-8; Hogg RT, 2010, THESIS CIRY U NEW YO; Huda T, 1994, INT J OSTEOARCHAEOL, V4, P49; KAWASAKI K, 1979, ARCH ORAL BIOL, V24, P939, DOI 10.1016/0003-9969(79)90221-8; Kolliker A, 1854, MIKROSKOPISCHE ANATO; Le Cabec A, 2014, AM J PHYS ANTHROPOL, V153, P166; LECABEC A, 2014, P EUR SOC STUD DRUG, V3, P103; Mahoney P, 2012, AM J PHYS ANTHROPOL, V147, P637, DOI 10.1002/ajpa.22029; Moggi-Cecchi J, 1998, AM J PHYS ANTHROPOL, V106, P425, DOI 10.1002/(SICI)1096-8644(199808)106:4<425::AID-AJPA2>3.0.CO;2-I; NEWMAN HN, 1974, ARCH ORAL BIOL, V19, P1135, DOI 10.1016/0003-9969(74)90242-8; NEWMAN HN, 1993, J ROY SOC MED, V86, P61; Pantke H, 1957, STOMA, V10, P32; PHONG BT, 1975, COMMUN ACM, V18, P311, DOI 10.1145/360825.360839; Pickerill H.P., 1913, DENT COSMOS, V55, P969; Preiswerk G, 1895, THESIS U BASEL; Reid DJ, 1998, J HUM EVOL, V35, P463, DOI 10.1006/jhev.1998.0233; Reid DJ, 2000, AM J PHYS ANTHROPOL, V113, P135; Retzius A., 1837, ARCH ANAT PHYSL, V1837, P486; Richards GD, 2012, AM J PHYS ANTHROPOL, V149, P172, DOI 10.1002/ajpa.22103; RISNES S, 1984, SCAND J DENT RES, V92, P1; Risnes S, 1998, J HUM EVOL, V35, P331, DOI 10.1006/jhev.1998.0229; RISNES S, 1990, ANAT RECORD, V226, P135, DOI 10.1002/ar.1092260203; ROSE JC, 1977, AM J PHYS ANTHROPOL, V46, P439, DOI 10.1002/ajpa.1330460309; ROSE JC, 1978, AM J PHYS ANTHROPOL, V49, P511, DOI 10.1002/ajpa.1330490411; ROSE JC, 1979, HUM BIOL, V51, P139; Rozzi FR, 1998, J HUM EVOL, V35, P543, DOI 10.1006/jhev.1998.0250; Schwartz GT, 2006, INT J PRIMATOL, V27, P1201, DOI 10.1007/s10764-006-9051-2; Schwartz GT, 2012, CURR ANTHROPOL, V53, pS395, DOI 10.1086/667591; Schwartz GT, 2001, INT J PRIMATOL, V22, P837, DOI 10.1023/A:1012073601808; Schwartz GT, 2001, AM J PHYS ANTHROPOL, V115, P269, DOI 10.1002/ajpa.1081; SKINNER M, 1991, J FORENSIC SCI, V36, P939; Skinner MF, 2012, AM J PHYS ANTHROPOL, V149, P468, DOI 10.1002/ajpa.22145; Smith BH, 1994, YEARB PHYS ANTHROPOL, V37, P177, DOI DOI 10.1002/AJPA.1330370608; Smith TM, 2008, EVOL ANTHROPOL, V17, P213, DOI 10.1002/evan.20176; Smith TM, 2007, P NATL ACAD SCI USA, V104, P20220, DOI 10.1073/pnas.0707051104; Smith TM, 2008, J HUM EVOL, V54, P205, DOI 10.1016/j.jhevol.2007.09.020; Smith TM, 2007, P NATL ACAD SCI USA, V104, P6128, DOI 10.1073/pnas.0700747104; Smith TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118118; Smith TM, 2014, AM J PHYS ANTHROPOL, V153, P243; Smith TM, 2010, P NATL ACAD SCI USA, V107, P20923, DOI 10.1073/pnas.1010906107; Smith TM, 2009, FRONT ORAL BIOL, V13, P86, DOI 10.1159/000242397; Smith TM., 2004, THESIS STONY BROOK U; Suwa G, 2009, SCIENCE, V326, P94, DOI 10.1126/science.1175824; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Tafforeau P, 2013, P EUR SOC STUD DRUG, V2, P224; Tafforeau P, 2008, J HUM EVOL, V54, P272, DOI 10.1016/j.jhevol.2007.09.018; Tafforeau P, 2007, PALAEOGEOGR PALAEOCL, V246, P206, DOI 10.1016/j.palaeo.2006.10.001; Tafforeau P, 2012, J HUM EVOL, V62, P424, DOI 10.1016/j.jhevol.2012.01.001; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; YAMASHITA Y, 1983, MECHANISMS TOOTH ENA, P91	84	39	39	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123019	10.1371/journal.pone.0123019	http://dx.doi.org/10.1371/journal.pone.0123019			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901602	Green Submitted, Green Published, gold			2022-12-27	WOS:000353331500037
J	Ma, HY; Yang, HY; Liang, ZW; Ooi, MKJ				Ma, Hongyuan; Yang, Haoyu; Liang, Zhengwei; Ooi, Mark K. J.			Effects of 10-Year Management Regimes on the Soil Seed Bank in Saline-Alkaline Grassland	PLOS ONE			English	Article							SONGNEN PLAIN; ENVIRONMENTAL-FACTORS; BIODIVERSITY LOSS; SODIC SOIL; VEGETATION; RESTORATION; DYNAMICS; DISTURBANCE; LAND; SUCCESSION	Background Management regimes for vegetation restoration of degraded grasslands can significantly affect the process of ecological succession. However, few studies have focused on variation in the soil seed bank during vegetation restoration under different management regimes, especially in saline-alkaline grassland habitats. Our aim was to provide insights into the ecological effects of grassland management regimes on soil seed bank composition and vegetation establishment in mown, fenced, transplanted and natural grassland sites, all dominated by the perennial rhizomatous grass Leymus chinensis. Methodology We studied species composition and diversity in both the soil seed bank and aboveground vegetation in differently managed grasslands in Northeast China. An NMDS (nonmetric multidimensional scaling) was used to evaluate the relationship between species composition, soil seed banks, aboveground vegetation and soil properties. Principal Findings Fenced and mown grassland sites had high density and species richness in both the soil seed bank and aboveground vegetation. The Transplanted treatment exhibited the highest vegetation growth and seed production of the target species L. chinensis. Seeds of L. chinensis in the soil occurred only in transplanted and natural grassland. Based on the NMDS analysis, the number of species in both the soil seed bank and aboveground vegetation were significantly related to soil Na+, Cl-, RSC (residual sodium carbonate), alkalinity, ESP (exchangeable sodium percentage) and AP (available phosphorus). Conclusions Soil seed bank composition and diversity in the saline-alkaline grassland were significantly affected by the management regimes implemented, and were also significantly related to the aboveground vegetation and several soil properties. Based on vegetative growth, reproductive output and maintenance of soil seed bank, the transplanting was identified as the most effective method for relatively rapid restoration of the target species L. chinensis. This approach could be beneficial for the restoration of dominant species in a wide range of degraded grassland ecosystems.	[Ma, Hongyuan; Yang, Haoyu; Liang, Zhengwei] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Changchun, Peoples R China; [Ma, Hongyuan; Yang, Haoyu; Liang, Zhengwei] DaanSod Land Expt Stn China, Daan, Peoples R China; [Ooi, Mark K. J.] Univ Wollongong, Inst Conservat Biol, Sch Biol Sci, Wollongong, NSW, Australia	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; University of Wollongong	Liang, ZW (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Changchun, Peoples R China.	liangzhengwei@neigae.ac.cn	Ooi, Mark K J/A-4779-2012	Ooi, Mark K J/0000-0002-3046-0417	National Natural Science Foundation of China [41371260]; National Basic Research Program of China [2015CB150802]; Australian Research Council Linkage Project [LP110100527]; Program of Science and Technology development of Jilin province [20140204050SF]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Australian Research Council Linkage Project(Australian Research Council); Program of Science and Technology development of Jilin province	This work was financed by the National Natural Science Foundation of China (41371260), the National Basic Research Program of China (Grant No. 2015CB150802), Australian Research Council Linkage Project grant (LP110100527) and Program of Science and Technology development of Jilin province (20140204050SF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, ACTA ECOL SIN, DOI DOI 10.1016/J.CHNAES.2009.04.004; Aradottir AL, 2012, J APPL ECOL, V49, P439, DOI 10.1111/j.1365-2664.2012.02123.x; Bakker JP, 1996, J VEG SCI, V7, P165, DOI 10.2307/3236316; Begon M, 1986, ECOLOGY INDIVIDUALS; Bologna PAX, 2012, J COASTAL RES, V28, P99, DOI 10.2112/JCOASTRES-D-10-00062.1; Bossuyt B, 2008, J VEG SCI, V19, P875, DOI 10.3170/2008-8-18462; Brys R, 2004, J APPL ECOL, V41, P1080, DOI 10.1111/j.0021-8901.2004.00981.x; Budelsky RA, 2004, PLANT ECOL, V175, P91, DOI 10.1023/B:VEGE.0000048102.72101.50; Busso CA, 2009, ENVIRON EXP BOT, V67, P188, DOI 10.1016/j.envexpbot.2009.01.003; Cooper EJ, 2003, ARCT ANTARCT ALP RES, V35, P369, DOI 10.1657/1523-0430(2003)035[0369:FHODOB]2.0.CO;2; De Steven D, 2007, WETLANDS, V27, P972, DOI 10.1672/0277-5212(2007)27[972:TNDPTF]2.0.CO;2; Deng W, 2006, REGIONAL ECOENVIRONM; Erfanzadeh R, 2010, PLANT ECOL, V206, P335, DOI 10.1007/s11258-009-9646-8; Fenner M., 2005, ECOLOGY SEEDS; Frieswyk CB, 2006, CAN J BOT, V84, P1882, DOI 10.1139/B06-100; Fu PY, 1995, KEYS PLANTS NE CHINA; Gokalp Z, 2010, AFR J AGR RES, V5, P1127; Gonzalez-Alday J, 2009, ECOL ENG, V35, P1062, DOI 10.1016/j.ecoleng.2009.03.007; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Hopfensperger KN, 2007, OIKOS, V116, P1438, DOI [10.1111/j.2007.0030-1299.15818.x, 10.1111/j.0030-1299.2007.15818.x]; Jacquemyn H, 2003, BIOL CONSERV, V111, P137, DOI 10.1016/S0006-3207(02)00256-2; Jacquemyn H, 2011, BIOL CONSERV, V144, P416, DOI 10.1016/j.biocon.2010.09.020; Janssens F, 1998, PLANT SOIL, V202, P69, DOI 10.1023/A:1004389614865; Jiang SC, 2010, APPL VEG SCI, V13, P47, DOI 10.1111/j.1654-109X.2009.01048.x; Kalamees R, 2002, ECOLOGY, V83, P1017, DOI 10.1890/0012-9658(2002)083[1017:TROTSB]2.0.CO;2; Koch MA, 2011, FLORA, V206, P52, DOI 10.1016/j.flora.2010.01.010; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Le Stradic S, 2014, APPL VEG SCI, V17, P109, DOI 10.1111/avsc.12058; Lee KS, 2008, MAR POLLUT BULL, V56, P1015, DOI 10.1016/j.marpolbul.2008.02.010; Liang ZhengWei, 2008, Journal of Jilin Agricultural University, V30, P517; Luzuriaga AL, 2005, ACTA OECOL, V27, P57, DOI 10.1016/j.actao.2004.09.003; Ma HY, 2014, PAK J BOT, V46, P1147; Ma MJ, 2013, PLANT SOIL, V369, P283, DOI 10.1007/s11104-012-1560-5; Ma MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101458; Ma MJ, 2010, FLORA, V205, P128, DOI 10.1016/j.flora.2009.02.006; Martins AM, 2007, ECOL ENG, V31, P165, DOI 10.1016/j.ecoleng.2007.05.008; Matus G, 2005, FLORA, V200, P296, DOI 10.1016/j.flora.2004.12.002; MILBERG P, 1995, OIKOS, V72, P3, DOI 10.2307/3546031; Mitlacher K, 2009, J VEG SCI, V5, P63; Oksanen J, 2012, MULTIVARIATE ANAL EC; Orth RJ, 1999, AQUAT BOT, V64, P77, DOI 10.1016/S0304-3770(99)00007-8; Pakeman RJ, 2005, J VEG SCI, V16, P121, DOI 10.1111/j.1654-1103.2005.tb02345.x; Renton M, 2011, ANN BOT-LONDON, V108, P1213, DOI 10.1093/aob/mcr131; Schmiede R, 2009, BIOL CONSERV, V142, P404, DOI 10.1016/j.biocon.2008.11.001; Shang ZH, 2008, LAND DEGRAD DEV, V19, P554, DOI 10.1002/ldr.861; Shen YX, 2007, SEED SCI RES, V17, P99, DOI 10.1017/S0960258507708139; Smith SE, 2000, J RANGE MANAGE, V53, P550, DOI 10.2307/4003657; Solomon TB, 2006, S AFR J BOT, V72, P263, DOI 10.1016/j.sajb.2005.09.003; Sternberg M, 2003, J VEG SCI, V14, P375, DOI 10.1658/1100-9233(2003)014[0375:EOGOSS]2.0.CO;2; Stroh M, 2002, PHYTOCOENOLOGIA, V32, P595, DOI 10.1127/0340-269X/2002/0032-0595; Szabo Andras, 2011, Ecological Questions, V14, P65, DOI 10.12775/v10090-011-0019-2; TerHeerdt GNJ, 1996, FUNCT ECOL, V10, P144, DOI 10.2307/2390273; Valko O, 2014, AGR ECOSYST ENVIRON, V182, P80, DOI 10.1016/j.agee.2013.06.012; Vecrin MP, 2007, J NAT CONSERV, V15, P59, DOI 10.1016/j.jnc.2006.10.001; Wang GD, 2013, RESTOR ECOL, V21, P801, DOI 10.1111/rec.12015; Yang F, 2011, INT J ENV RES PUB HE, V8, P374, DOI 10.3390/ijerph8020374; Yu JB, 2010, CLEAN-SOIL AIR WATER, V38, P1010, DOI 10.1002/clen.201000276; ZEDLER JB, 1990, AUST J ECOL, V15, P57, DOI 10.1111/j.1442-9993.1990.tb01021.x; Zedler JB, 2003, PLANT SOIL, V253, P259, DOI 10.1023/A:1024599203741; Zedler JB, 2008, RESTOR ECOL, V16, P249, DOI 10.1111/j.1526-100X.2007.00268.x; Zeiter M, 2013, AGR ECOSYST ENVIRON, V171, P55, DOI 10.1016/j.agee.2013.03.009; Zhan X, 2007, J ARID ENVIRON, V68, P298, DOI 10.1016/j.jaridenv.2006.05.012	62	10	16	5	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122319	10.1371/journal.pone.0122319	http://dx.doi.org/10.1371/journal.pone.0122319			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902145	Green Published, gold, Green Submitted			2022-12-27	WOS:000353331500018
J	Ma, QG; Zhang, WK				Ma, Qingguo; Zhang, Wuke			Public Mood and Consumption Choices: Evidence from Sales of Sony Cameras on Taobao	PLOS ONE			English	Article								Previous researchers have tried to predict social and economic phenomena with indicators of public mood, which were extracted from online data. This method has been proved to be feasible in many areas such as financial markets, economic operations and even national suicide numbers. However, few previous researches have examined the relationship between public mood and consumption choices at society level. The present study paid attention to the "Diaoyu Island" event, and extracted Chinese public mood data toward Japan from Sina MicroBlog (the biggest social media in China), which demonstrated a significant cross-correlation between the public mood variable and sales of Sony cameras on Taobao (the biggest Chinese e-business company). Afterwards, several candidate predictors of sales were examined and finally three significant stepwise regression models were obtained. Results of models estimation showed that significance (F-statistics), R-square and predictive accuracy (MAPE) all improved due to inclusion of public mood variable. These results indicate that public mood is significantly associated with consumption choices and may be of value in sales forecasting for particular products.	[Ma, Qingguo; Zhang, Wuke] Zhejiang Univ, Sch Management, Hangzhou 310003, Zhejiang, Peoples R China; [Ma, Qingguo; Zhang, Wuke] Zhejiang Univ, Neuromanagment Lab, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Ma, QG (corresponding author), Zhejiang Univ, Sch Management, Hangzhou 310003, Zhejiang, Peoples R China.	maqingguo3669@zju.edu.cn			State Education Ministry of China [09JZD0006]; National Natural Science Foundation of China [71371167]; State Education Ministry	State Education Ministry of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Education Ministry	This work was supported by grant No. 09JZD0006 from the State Education Ministry of China as a key project, No. 71371167 from the National Natural Science Foundation of China, and obtained the financial support from 985 Project from the State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Asur S., 2010, 2010 IEEE WIC ACM IN; Bollen J., 2011, ICWSM, V5; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Cook S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023610, 10.1371/journal.pone.0025407]; Dugas AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056176; Mao Huina, 2011, ARXIV PREPRINT ARXIV; McIver DJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003581; Ortiz JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018687; Tumasjan A., ICWSM2010, P178; Won HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061809	11	6	6	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123129	10.1371/journal.pone.0123129	http://dx.doi.org/10.1371/journal.pone.0123129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902358	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500043
J	Murray, DC; Coghlan, ML; Bunce, M				Murray, Daithi C.; Coghlan, Megan L.; Bunce, Michael			From Benchtop to Desktop: Important Considerations when Designing Amplicon Sequencing Workflows	PLOS ONE			English	Article							ENVIRONMENTAL DNA; ARCTIC VEGETATION; PCR; ALIGNMENT; ANCIENT; AMPLIFICATION; COMMUNITIES; PERFORMANCE; PENGUINS; SYSTEMS	Amplicon sequencing has been the method of choice in many high-throughput DNA sequencing (HTS) applications. To date there has been a heavy focus on the means by which to analyse the burgeoning amount of data afforded by HTS. In contrast, there has been a distinct lack of attention paid to considerations surrounding the importance of sample preparation and the fidelity of library generation. No amount of high-end bioinformatics can compensate for poorly prepared samples and it is therefore imperative that careful attention is given to sample preparation and library generation within workflows, especially those involving multiple PCR steps. This paper redresses this imbalance by focusing on aspects pertaining to the benchtop within typical amplicon workflows: sample screening, the target region, and library generation. Empirical data is provided to illustrate the scope of the problem. Lastly, the impact of various data analysis parameters is also investigated in the context of how the data was initially generated. It is hoped this paper may serve to highlight the importance of pre-analysis workflows in achieving meaningful, future-proof data that can be analysed appropriately. As amplicon sequencing gains traction in a variety of diagnostic applications from forensics to environmental DNA (eDNA) it is paramount workflows and analytics are both fit for purpose.	[Murray, Daithi C.; Coghlan, Megan L.; Bunce, Michael] Curtin Univ, Trace & Environm DNA Lab, Dept Environm & Agr, Perth, WA 6845, Australia	Curtin University	Bunce, M (corresponding author), Curtin Univ, Trace & Environm DNA Lab, Dept Environm & Agr, Perth, WA 6845, Australia.	michael.bunce@curtin.edu.au		Bunce, Michael/0000-0002-0302-4206	Australian Research Council [FT0991741, DP120103725]	Australian Research Council(Australian Research Council)	MB was funded from the Australian Research Council grant FT0991741 and DP120103725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen K, 2012, MOL ECOL, V21, P1966, DOI 10.1111/j.1365-294X.2011.05261.x; Archer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049602; Baird DJ, 2012, MOL ECOL, V21, P2039, DOI 10.1111/j.1365-294X.2012.05519.x; Benjamini Y, 2012, SUMMARIZING CORRECTI; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Blankenberg D., 2001, GALAXY WEB BASED GEN; Bohmann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021441; Borgstrom E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019119; Bronner IF, 2001, IMPROVED PROTOCOLS I; Budowle B, 2014, INVESTIGATIVE GENETI, V5, P1, DOI [10.1186/2041-2223-5-1, DOI 10.1186/2041-2223-5-1]; Bunce M., 2011, ANCIENT DNA METHODS, P121; Burgar JM, 2014, MOL ECOL, V23, P3605, DOI 10.1111/mec.12531; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Bybee SM, 2011, GENOME BIOL EVOL, V3, P1312, DOI 10.1093/gbe/evr106; Campo DS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S5-S4; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062856; Clarke LJ, 2014, MOL ECOL RESOUR, V14, P117, DOI 10.1111/1755-0998.12162; Coghlan ML, 2012, PLOS GENET, V8, P436, DOI 10.1371/journal.pgen.1002657; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; Cooper Alan, 1994, P149; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; de Carcer DA, 2011, APPL ENVIRON MICROB, V77, P6310, DOI 10.1128/AEM.05146-11; Deagle BE, 2014, BIOL LETT, V10; Deagle BE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000831; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; DEANGELIS MM, 1995, NUCLEIC ACIDS RES, V23, P4742, DOI 10.1093/nar/23.22.4742; Ding T, 2014, NATURE, V509, P357, DOI 10.1038/nature13178; Drummond AJ, 2011, GENEIOUS V7 1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Faircloth BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042543; Ficetola G.F., 2014, MOL ECOLOGY RESOURCE; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gonzalez A, 2012, CURR OPIN BIOTECH, V23, P64, DOI 10.1016/j.copbio.2011.11.028; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hunter AA, 2012, SOURCE CODE BIOL MED, V7, DOI 10.1186/1751-0473-7-1; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kircher M, 2010, BIOESSAYS, V32, P524, DOI 10.1002/bies.200900181; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; Liu JJ, 2014, SOIL BIOL BIOCHEM, V70, P113, DOI 10.1016/j.soilbio.2013.12.014; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Lundin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010029; Mason OU, 2014, ISME J, V8, P1464, DOI 10.1038/ismej.2013.254; Meadow JF, 2013, PEERJ, V1, DOI 10.7717/peerj.53; Murray DC, 2013, SCI REP-UK, V3, DOI 10.1038/srep03371; Murray DC, 2012, QUATERNARY SCI REV, V58, P135, DOI 10.1016/j.quascirev.2012.10.021; Murray DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025776; PAABO S, 1990, J BIOL CHEM, V265, P4718; Piry S, 2012, MOL ECOL RESOUR, V12, P1151, DOI 10.1111/j.1755-0998.2012.03171.x; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Porter TM, 2013, MOL ECOL RESOUR, V13, P798, DOI 10.1111/1755-0998.12124; Quail MA, 2012, ELECTROPHORESIS, V33, P3521, DOI 10.1002/elps.201200128; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Quemere E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058971; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Razgour O, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.49; Robasky K, 2014, NAT REV GENET, V15, P56, DOI 10.1038/nrg3655; Roche, 2009, TECHN B AMPL FUS PRI, P1, DOI [10.1038/ajg.2008.97, DOI 10.1038/AJG.2008.97]; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Sajantila A, 2015, INVESTIGATIVE GENETI, V5, P17; Salter S, 2014, REAGENT CONTAMINATIO; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Smith DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090234; Sonstebo JH, 2010, MOL ECOL RESOUR, V10, P1009, DOI 10.1111/j.1755-0998.2010.02855.x; Sun B, 2014, ECOL EVOL, V4, P1073, DOI 10.1002/ece3.1006; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor HR, 2012, MOL ECOL RESOUR, V12, P377, DOI 10.1111/j.1755-0998.2012.03119.x; Taylor PG, 1996, MOL BIOL EVOL, V13, P283, DOI 10.1093/oxfordjournals.molbev.a025566; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Tridico Silvana R, 2014, Investig Genet, V5, P16, DOI 10.1186/s13323-014-0016-5; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Varley KE, 2008, GENOME RES, V18, P1844, DOI 10.1101/gr.078204.108; White NE, 2014, DIVERS DISTRIB, V20, P1208, DOI 10.1111/ddi.12202; Willerslev E, 2014, NATURE, V506, P47, DOI 10.1038/nature12921	94	102	103	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124671	10.1371/journal.pone.0124671	http://dx.doi.org/10.1371/journal.pone.0124671			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902146	Green Submitted, Green Published, gold			2022-12-27	WOS:000353331500098
J	Qiu, TY; Xiao, H; Zhang, QC; Qiu, JX; Yang, YY; Wu, DF; Cao, ZW; Zhu, RX				Qiu, Tianyi; Xiao, Han; Zhang, Qingchen; Qiu, Jingxuan; Yang, Yiyan; Wu, Dingfeng; Cao, Zhiwei; Zhu, Ruixin			Proteochemometric Modeling of the Antigen-Antibody Interaction: New Fingerprints for Antigen, Antibody and Epitope-Paratope Interaction	PLOS ONE			English	Article							PROTEIN-BINDING SITES; CRYSTAL-STRUCTURE; SPACE; RECOGNITION; PREDICTION; INHIBITORS; INTERFACE; ALIGNMENT; PATTERNS; SURFACES	Despite the high specificity between antigen and antibody binding, similar epitopes can be recognized or cross-neutralized by paratopes of antibody with different binding affinities. How to accurately characterize this slight variation which may or may not change the antigen-antibody binding affinity is a key issue in this area. In this report, by combining cylinder model with shell structure model, a new fingerprint was introduced to describe both the structural and physical-chemical features of the antigen and antibody protein. Furthermore, beside the description of individual protein, the specific epitope-paratope interaction fingerprint (EPIF) was developed to reflect the bond and the environment of the antigen-antibody interface. Finally, Proteochemometric Modeling of the antigen-antibody interaction was established and evaluated on 429 antigen-antibody complexes. By using only protein descriptors, our model achieved the best performance (R-2 = 0: 91; Q(test)(2) = 0: 68) among peers. Further, together with EPIF as a new cross-term, our model (R-2 = 0: 92; Q(2) test = 0: 74) can significantly outperform peers with multiplication of ligand and protein descriptors as a cross-term (R2 <= 0.81; Q(test)(2) <= 0: 44). Results illustrated that: 1) our newly designed protein fingerprints and EPIF can better describe the antigen-antibody interaction; 2) EPIF is a better and specific cross-term in Proteochemometric Modeling for antigen-antibody interaction. The fingerprints designed in this study will provide assistance to the description of antigen-antibody binding, and in future, it may be valuable help for the high-throughput antibody screening. The algorithm is freely available on request.	[Qiu, Tianyi; Zhang, Qingchen; Qiu, Jingxuan; Yang, Yiyan; Wu, Dingfeng; Cao, Zhiwei; Zhu, Ruixin] Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China; [Xiao, Han] Univ Helsinki, Dept Comp Sci, FI-00014 Helsinki, Finland; [Cao, Zhiwei] Shanghai Ctr Bioinformat Technol, Shanghai 201203, Peoples R China; [Zhu, Ruixin] Liaoning Univ Tradit Chinese Med, Sch Pharm, Dalian 116600, Liaoning, Peoples R China	Tongji University; University of Helsinki; Chinese Academy of Sciences; Liaoning University of Traditional Chinese Medicine	Cao, ZW (corresponding author), Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China.	zwcao@tongji.edu.cn; rxzhu@tongji.edu.cn	, 金石为开/AFU-9737-2022	Zhu, Ruixin/0000-0002-5070-6453	National Natural Science Foundation of China [31200986, 31171272]; Ministry of Science and Technology China [2010CB833601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea)	This work was supported in part by grants from National Natural Science Foundation of China (31200986, 31171272) and Ministry of Science and Technology China (2010CB833601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bock ME, 2007, J COMPUT BIOL, V14, P285, DOI 10.1089/cmb.2006.0145; Chen Y, 1999, J MOL BIOL, V293, P865, DOI 10.1006/jmbi.1999.3192; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Goldsby, 2003, IMM, P57; Hoffmann B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-99; Huang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041698; Ivanciuc O, 2002, BIOINFORMATICS, V18, P1358, DOI 10.1093/bioinformatics/18.10.1358; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Konc J, 2010, BIOINFORMATICS, V26, P1160, DOI 10.1093/bioinformatics/btq100; Lapins M, 2009, J CHEM INF MODEL, V49, P1202, DOI 10.1021/ci800453k; Lapins M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-181; Lapinsh M, 2005, BIOINFORMATICS, V21, P4289, DOI 10.1093/bioinformatics/bti703; Lapinsh M, 2003, J MED CHEM, V46, P2572, DOI 10.1021/jm020945m; Lapinsh M, 2002, MOL PHARMACOL, V61, P1465, DOI 10.1124/mol.61.6.1465; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Macindoe G, 2010, NUCLEIC ACIDS RES, V38, pW445, DOI 10.1093/nar/gkq311; Mordalski S, 2011, BIOORG MED CHEM LETT, V21, P6816, DOI 10.1016/j.bmcl.2011.09.027; Muller KR, 2005, J CHEM INF MODEL, V45, P249, DOI 10.1021/ci049737o; Muller YA, 1998, STRUCTURE, V6, P1153, DOI 10.1016/S0969-2126(98)00116-6; Nisius B, 2012, J BIOTECHNOL, V159, P123, DOI 10.1016/j.jbiotec.2011.12.005; Roitt I., 2001, IMMUNOLOGY; Schalon C, 2008, PROTEINS, V71, P1755, DOI 10.1002/prot.21858; Shulman-Peleg A, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-43; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Stroembergsson H, 2008, J CHEM INF MODEL, V48, P2278, DOI 10.1021/ci800200e; Sun J, 2011, IMMUNOME RES, V7, P1; Sun J, 2009, NUCLEIC ACIDS RES, V37, pW612, DOI 10.1093/nar/gkp417; Tharakaraman K, 2013, CELL, V153, P1475, DOI 10.1016/j.cell.2013.05.035; Tian C, 2014, CHEM BIOL DRUG DES, V83, P610, DOI 10.1111/cbdd.12274; van Westen GJP, 2011, MEDCHEMCOMM, V2, P16, DOI 10.1039/c0md00165a; Weill N, 2010, J CHEM INF MODEL, V50, P123, DOI 10.1021/ci900349y; Wu Di, 2010, Immunome Res, V6 Suppl 1, pS1, DOI 10.1186/1745-7580-6-S1-S1; Wu DF, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-212; Xie L, 2008, P NATL ACAD SCI USA, V105, P5441, DOI 10.1073/pnas.0704422105; Xue WW, 2012, J COMPUT CHEM, V33, P527, DOI 10.1002/jcc.22887; Yao XJ, 2004, J CHEM INF COMP SCI, V44, P1257, DOI 10.1021/ci049965i; Yin SY, 2009, P NATL ACAD SCI USA, V106, P16622, DOI 10.1073/pnas.0906146106; YSERN X, 1994, J MOL BIOL, V238, P496	40	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122416	10.1371/journal.pone.0122416	http://dx.doi.org/10.1371/journal.pone.0122416			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901362	gold, Green Submitted, Green Published			2022-12-27	WOS:000353331500020
J	Yu, ZL; Li, W; Hou, DR; Zhou, L; Deng, YY; Tian, M; Feng, XL				Yu, Zhuling; Li, Wei; Hou, Deren; Zhou, Lin; Deng, Yanyao; Tian, Mi; Feng, Xialu			Relationship between Adiponectin Gene Polymorphisms and Late-Onset Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; TYPE-2 DIABETES-MELLITUS; LINKAGE DISEQUILIBRIUM; INSULIN-RESISTANCE; METABOLIC SYNDROME; SERUM ADIPONECTIN; ASSOCIATION; VARIANTS; OBESITY; TRAITS	In recent years, researchers have found that adiponectin (ANP) plays an important role in the pathogenesis of Alzheimer's disease (AD), and low serum concentrations of ANP are associated with AD. Higher plasma ANP level have a protective effect against the development of cognitive decline, suggesting that ANP may affect AD onset. Meanwhile, accumulating evidence supports the crucial role of ANP in the pathogenesis of AD. To study the relationship between ANP gene polymorphisms (rs266729, -11377C>G and rs1501299, G276T) and late-onset AD (LOAD), we carried out a case-control study that included 201 LOAD patients and 257 healthy control subjects. Statistically significant differences were detected in the genotype and allelotype frequency distributions of rs266729 and rs1501299 between the LOAD group and the control group, with a noticeable increase in the G and T allelotype frequency distributions in the LOAD group (P < 0.05). Logistic regression analysis using recessive model and additive model revealed that the rs266729 GG and rs1501299 TT genotypes are associated with a greater risk of LOAD. Haplotype analysis identified four haplotypes: CG, CT, GG, and GT. The frequencies of the CT and GG haplotypes were not significantly different (P > 0.05) between the LOAD group and control group, whereas the CG and GT haplotypes were significantly different (P < 0.05), suggesting a negative correlation between the CG haplotype and LOAD onset (OR = 0.74, 95% CI = 0.57-0.96, P = 0.022), and a positive correlation between the GT haplotype and LOAD onset (OR = 2.29, 95% CI = 1.42-3.68, P = 0.005). Therefore, we speculated that the rs266729 and rs1501299 of ANP gene polymorphisms and the GT and CG haplotypes were associated with LOAD.	[Yu, Zhuling; Li, Wei; Hou, Deren; Deng, Yanyao; Tian, Mi; Feng, Xialu] Cent S Univ, Dept Neurol, Xiangya Hosp 3, Changsha, Hunan, Peoples R China; [Li, Wei] First Hosp Changsha, Dept Nerve Med Ctr, Changsha, Peoples R China; [Zhou, Lin] Cent S Univ, Dept Geriatr Neurol, Xiangya Hosp, Changsha, Hunan, Peoples R China	Central South University; Central South University	Hou, DR (corresponding author), Cent S Univ, Dept Neurol, Xiangya Hosp 3, Changsha, Hunan, Peoples R China.	hou0718@126.com			Science and Technology Project of the Science and Technology Agency, Hunan Province, China [2014SK3090]; Specialized research funds for the Health care program of Hunan Province, China [A2013-01]	Science and Technology Project of the Science and Technology Agency, Hunan Province, China; Specialized research funds for the Health care program of Hunan Province, China	The study was supported by the Science and Technology Project of the Science and Technology Agency, Hunan Province, China (No. 2014SK3090) and the Specialized research funds for the Health care program of Hunan Province, China (No. A2013-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052354; Chu HY, 2013, DIABETES-METAB RES, V29, P532, DOI 10.1002/dmrr.2424; Gulcelik NE, 2013, MINERVA ENDOCRINOL, V38, P203; Jeon BT, 2009, BRAIN RES REV, V61, P81, DOI 10.1016/j.brainresrev.2009.05.002; Kamogawa K, 2010, DEMENT GERIATR COGN, V30, P432, DOI 10.1159/000321985; Li FYL, 2011, ACTA PHYSIOL, V203, P167, DOI 10.1111/j.1748-1716.2010.02216.x; Lin CH, 2012, CHINESE J PHYSIOL, V55, P405, DOI [10.4077/CJP.2011.AMM081, 10.4077/CJP.2012.BAA081]; Liu ML, 2012, DIABETES, V61, P2776, DOI 10.2337/db12-0169; Masaki T, 2012, METABOLISM, V61, P1197, DOI 10.1016/j.metabol.2012.01.016; Mtiraoui N, 2012, DIABETES RES CLIN PR, V97, P290, DOI 10.1016/j.diabres.2012.02.015; Pakaski M, 2014, J ALZHEIMERS DIS, V38, P371, DOI 10.3233/JAD-131139; Pei HF, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0373-x; Psilopanagioti A, 2009, NEUROENDOCRINOLOGY, V89, P38, DOI 10.1159/000151396; Qiu G, 2011, AGE, V33, P155, DOI 10.1007/s11357-010-9173-5; Ramya K, 2013, GENE, V532, P253, DOI 10.1016/j.gene.2013.09.012; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Teixeira AL, 2013, NEUROMOL MED, V15, P115, DOI 10.1007/s12017-012-8201-2; Tong GX, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-67; van Echten-Deckert G, 2012, PROG LIPID RES, V51, P378, DOI 10.1016/j.plipres.2012.07.001; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Zadjali F, 2013, GENE, V527, P663, DOI 10.1016/j.gene.2013.06.057; Ziemke F, 2010, AM J CLIN NUTR, V91, p258S, DOI 10.3945/ajcn.2009.28449C	22	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0125186	10.1371/journal.pone.0125186	http://dx.doi.org/10.1371/journal.pone.0125186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902149	Green Submitted, Green Published, gold			2022-12-27	WOS:000353331500114
J	Andris, C; Lee, D; Hamilton, MJ; Martino, M; Gunning, CE; Selden, JA				Andris, Clio; Lee, David; Hamilton, Marcus J.; Martino, Mauro; Gunning, Christian E.; Selden, John Armistead			The Rise of Partisanship and Super-Cooperators in the US House of Representatives	PLOS ONE			English	Article							COMMUNITY STRUCTURE; PARTY POLARIZATION; NETWORK ANALYSIS; DYNAMICS; POLITICS	It is widely reported that partisanship in the United States Congress is at an historic high. Given that individuals are persuaded to follow party lines while having the opportunity and incentives to collaborate with members of the opposite party, our goal is to measure the extent to which legislators tend to form ideological relationships with members of the opposite party. We quantify the level of cooperation, or lack thereof, between Democrat and Republican Party members in the U.S. House of Representatives from 1949-2012. We define a network of over 5 million pairs of representatives, and compare the mutual agreement rates on legislative decisions between two distinct types of pairs: those from the same party and those formed of members from different parties. We find that despite short-term fluctuations, partisanship or non-cooperation in the U.S. Congress has been increasing exponentially for over 60 years with no sign of abating or reversing. Yet, a group of representatives continue to cooperate across party lines despite growing partisanship.	[Andris, Clio] Penn State Univ, Dept Geog, University Pk, PA 16802 USA; [Lee, David] MIT, Dept Urban Studies & Planning, Cambridge, MA 02139 USA; [Lee, David] MIT, Senseable City Lab, Cambridge, MA 02139 USA; [Hamilton, Marcus J.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Hamilton, Marcus J.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA; [Martino, Mauro] IBM Thomas J Watson Res Ctr, Cambridge, MA USA; [Gunning, Christian E.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Selden, John Armistead] US Senate, Budget Comm, Washington, DE USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); The Santa Fe Institute; Arizona State University; Arizona State University-Tempe; International Business Machines (IBM); University of North Carolina; North Carolina State University	Andris, C (corresponding author), Penn State Univ, Dept Geog, University Pk, PA 16802 USA.	clio@psu.edu	Lee, David/AAA-1948-2020; Lee, David/N-8988-2017	Lee, David/0000-0003-0447-8573; Gunning, Christian/0000-0001-6403-6553	National Institute of Biomedical Imaging and Bioengineering (NIBIB), a component of the National Institutes of Health (NIH) [T32EB009414]; John Templeton Foundation [15075]; National Defense Science and Engineering Graduate (NDSEG) Fellowship-Army Research Office; IBM Thomas J. Watson Research Center; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009414] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering (NIBIB), a component of the National Institutes of Health (NIH); John Templeton Foundation; National Defense Science and Engineering Graduate (NDSEG) Fellowship-Army Research Office; IBM Thomas J. Watson Research Center; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), a component of the National Institutes of Health (NIH) (grant no T32EB009414) (to CEG), http://www.nibib.nih.gov/; John Templeton Foundation (grant no 15075) http://www.templeton.org/(to CA, MJH); and National Defense Science and Engineering Graduate (NDSEG) Fellowship-Army Research Office (to CA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. IBM Thomas J. Watson Research Center provided support in the form of a salary for author MM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	BARNES J, 1986, NATURE, V324, P446, DOI 10.1038/324446a0; Carroll R, 2009, POLIT ANAL, V17, P261, DOI 10.1093/pan/mpp005; Carrubba CJ, 2000, AM J POLIT SCI, V44, P261, DOI 10.2307/2669309; Carson JL, 2007, AM POLIT RES, V35, P878, DOI 10.1177/1532673X07304263; Cho WKT, 2010, J POLIT, V72, P124, DOI 10.1017/S002238160999051X; Clinton J, 2004, AM POLIT SCI REV, V98, P355, DOI 10.1017/S0003055404001194; Cohen GL, 2003, J PERS SOC PSYCHOL, V85, P808, DOI 10.1037/0022-3514.85.5.808; Cox Gary, 2005, SETTING AGENDA RESPO; Cox GW, 2002, AM J POLIT SCI, V46, P477, DOI 10.2307/3088393; Fleisher R, 2004, BRIT J POLIT SCI, V34, P429, DOI 10.1017/s0007123404000122; Fowler JH, 2006, POLIT ANAL, V14, P456, DOI 10.1093/pan/mpl002; Harbridge L, 2011, AM J POLIT SCI, V55, P494, DOI 10.1111/j.1540-5907.2011.00517.x; Iyengar S, 2009, J COMMUN, V59, P19, DOI 10.1111/j.1460-2466.2008.01402.x; Jenkins JA, 1999, AM J POLIT SCI, V43, P1144, DOI 10.2307/2991821; KRACKHARDT D, 1988, SOC PSYCHOL QUART, V51, P123, DOI 10.2307/2786835; Lee FE, 2003, AM J POLIT SCI, V47, P714, DOI 10.1111/1540-5907.00050; McCarty Nolan, 2006, WALRAS PARETO LECT; Nokken TP, 2000, LEGIS STUD QUART, V25, P417, DOI 10.2307/440414; Office of the Clerk of the U. S. House of Representatives Roll Call Votes, 2014, ROLL CALL VOT; Ornstein Norman J., 2013, VITAL STAT C; POOLE KT, 1984, J POLIT, V46, P1061, DOI 10.2307/2131242; Poole KT., 1997, C POLITICAL EC HIST; Porter MA, 2005, P NATL ACAD SCI USA, V102, P7057, DOI 10.1073/pnas.0500191102; Porter MA, 2007, PHYSICA A, V386, P414, DOI 10.1016/j.physa.2007.07.039; Roberts JM, 2003, AM J POLIT SCI, V47, P305, DOI 10.1111/1540-5907.00021; Rosenstone Steven., 1993, MOBILIZATION PARTICI; Snowe OJ, 2013, HARVARD J LEGIS, V50, P21; Snyder JM, 2000, AM J POLIT SCI, V44, P193, DOI 10.2307/2669305; Theriault SM, 2006, PARTY POLIT, V12, P483, DOI 10.1177/1354068806064730; Theriault SM, 2011, J POLIT, V73, P1011, DOI 10.1017/S0022381611000752; Theriault Sean M., 2008, PARTY POLARIZATION I, P142; Viser M., 2013, THIS C GOING LEAST P; Waugh AS, 2011, PREPRINT; Zhang Y, 2008, PHYSICA A, V387, P1705, DOI 10.1016/j.physa.2007.11.004	34	65	66	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123507	10.1371/journal.pone.0123507	http://dx.doi.org/10.1371/journal.pone.0123507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XJ	25897956	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600028
J	Belay, M; Legesse, M; Mihret, A; Bekele, Y; Ottenhoff, THM; Franken, KLMC; Bjune, G; Abebe, F				Belay, Mulugeta; Legesse, Mengistu; Mihret, Adane; Bekele, Yonas; Ottenhoff, Tom H. M.; Franken, Kees L. M. C.; Bjune, Gunnar; Abebe, Fekadu			Pro- and Anti-Inflammatory Cytokines against Rv2031 Are Elevated during Latent Tuberculosis: A Study in Cohorts of Tuberculosis Patients, Household Contacts and Community Controls in an Endemic Setting	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; DORMANCY REGULON; HSPX PROTEIN; RESPONSES; ANTIGENS; CONVERSIONS; RECOGNITION; VACCINATION; PERSISTENCE	Tuberculosis (TB) is among the leading causes of morbidity and mortality. The causative agent, Mycobacterium tuberculosis (Mtb), has evolved virulent factors for entry, survival, multiplication and immune evasion. Rv2031 (also called alpha crystallin, hspX, 16-kDa antigen), one of the most immunogenic latency antigens, is believed to play a key role in long-term viability of Mtb. Here, we report the dynamics of pro-inflammatory (IFN-gamma, TNF-alpha) and anti-inflammatory (IL-10) cytokines against Rv2031 using whole blood assay in human cohorts in a TB endemic setting. Cytokine responses to ESAT-6-CFP-10 were also measured for comparison. Blood samples were collected from smear positive pulmonary TB patients and their contacts at baseline, 6 and 12 months, and from community controls at entry. At baseline, 54.4% of controls and 73.2% of contacts were QFT-GIT test positive. Baseline IFN-gamma, TNF-alpha and IL-10 responses to Rv2031 were significantly higher in controls compared to contacts and untreated patients (p<0.001). Furthermore, untreated patients had significantly higher TNF-alpha and IL-10 responses to Rv2031 compared to contacts (p<0.001). In contacts and treated patients, IFN-gamma, TNF-alpha and IL-10 responses to Rv2031 significantly increased over 12 months (p<0.0001) and became comparable with the corresponding levels in controls. There was a positive and significant correlation between Rv2031 and ESAT-6-CFP-10 specific cytokine responses in each study group. The fact that the levels of IFN-gamma, TNF-alpha and IL-10 against Rv2031 were highest during latent TB infection may indicate their potential as markers of protection against TB. Taken together, the findings of this study suggest the potential of IFN-gamma, TNF-alpha and IL-10 against Rv2031 as biomarkers of the host response to Mtb during convalescence from, and the absence of, active tuberculosis.	[Belay, Mulugeta; Legesse, Mengistu] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Belay, Mulugeta; Bjune, Gunnar; Abebe, Fekadu] Univ Oslo, Inst Hlth & Soc, Dept Community Med, Oslo, Norway; [Mihret, Adane; Bekele, Yonas] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Ottenhoff, Tom H. M.; Franken, Kees L. M. C.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands	Addis Ababa University; University of Oslo; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Belay, M (corresponding author), Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia.	mulg2002@yahoo.com	Franken, Kees/ABA-7095-2021; Bekele, Yonas/AAN-6710-2021	Franken, Kees/0000-0002-4747-6060; Mihret, Adane/0000-0003-3183-4772	Research Council of Norway	Research Council of Norway(Research Council of Norway)	This study was funded by the Research Council of Norway (http://www.forskningsradet.no/en/The_Research_Council/1138785832539). FA and GB received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe F, 2012, CLIN EXP IMMUNOL, V169, P213, DOI 10.1111/j.1365-2249.2012.04614.x; Belay M, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0654-5; Bentrup KHZ, 2001, TRENDS MICROBIOL, V9, P597, DOI 10.1016/S0966-842X(01)02238-7; Chauhan P, 2013, SCI REP-UK, V3, DOI 10.1038/srep01821; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; del Corral H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008257; Demissie A, 2006, CLIN VACCINE IMMUNOL, V13, P179, DOI 10.1128/CVI.13.2.179-186.2006; Dey B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023360; Dey B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018773; Geluk A, 2007, INFECT IMMUN, V75, P2914, DOI 10.1128/IAI.01990-06; Jeon BY, 2011, MICROBES INFECT, V13, P284, DOI 10.1016/j.micinf.2010.11.002; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Mamo Gezahegne, 2014, Ethiop Med J, VSuppl 1, P15; Manabe YC, 2000, NAT MED, V6, P1327, DOI 10.1038/82139; MOH, 2007, GUID HIV COUNS TEST; MOH, 2012, GUID CLIN PROGR MAN; Cavalcanti YVN, 2012, PULM MED, V2012, DOI 10.1155/2012/745483; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; Population and Census Commission, 2007, SUMM STAT REP 2007 P; Raja A, 2004, INDIAN J MED RES, V120, P213; Ringshausen FC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-220; Roupie V, 2007, INFECT IMMUN, V75, P941, DOI 10.1128/IAI.01137-06; Shi CW, 2010, VACCINE, V28, P5237, DOI 10.1016/j.vaccine.2010.05.063; Shi LB, 2003, P NATL ACAD SCI USA, V100, P241, DOI 10.1073/pnas.0136863100; Vekemans J, 2004, INFECT IMMUN, V72, P381, DOI 10.1128/IAI.72.1.381-388.2004; WHO, 2014, GLOB TUB REP 2014; Wilkinson RJ, 1998, SCAND J IMMUNOL, V48, P403; Ying YA, 1996, J BACTERIOL, V178, P4484, DOI 10.1128/jb.178.15.4484-4492.1996; Yuan Y, 1998, P NATL ACAD SCI USA, V95, P9578, DOI 10.1073/pnas.95.16.9578	29	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124134	10.1371/journal.pone.0124134	http://dx.doi.org/10.1371/journal.pone.0124134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897840	Green Submitted, gold, Green Published			2022-12-27	WOS:000353212600051
J	Sasai, T; Morino, K; Tanaka, G; Almendral, JA; Aihara, K				Sasai, Takeyuki; Morino, Kai; Tanaka, Gouhei; Almendral, Juan A.; Aihara, Kazuyuki			Robustness of Oscillatory Behavior in Correlated Networks	PLOS ONE			English	Article							SCALE-FREE NETWORKS; ART.; SYNCHRONIZATION; GRAPHS	Understanding network robustness against failures of network units is useful for preventing large-scale breakdowns and damages in real-world networked systems. The tolerance of networked systems whose functions are maintained by collective dynamical behavior of the network units has recently been analyzed in the framework called dynamical robustness of complex networks. The effect of network structure on the dynamical robustness has been examined with various types of network topology, but the role of network assortativity, or degree- degree correlations, is still unclear. Here we study the dynamical robustness of correlated (assortative and disassortative) networks consisting of diffusively coupled oscillators. Numerical analyses for the correlated networks with Poisson and power-law degree distributions show that network assortativity enhances the dynamical robustness of the oscillator networks but the impact of network disassortativity depends on the detailed network connectivity. Furthermore, we theoretically analyze the dynamical robustness of correlated bimodal networks with two-peak degree distributions and show the positive impact of the network assortativity.	[Sasai, Takeyuki; Morino, Kai; Tanaka, Gouhei; Aihara, Kazuyuki] Univ Tokyo, Grad Sch Informat Sci & Technol, Tokyo 1138656, Japan; [Tanaka, Gouhei; Aihara, Kazuyuki] Univ Tokyo, Grad Sch Engn, Tokyo 1138656, Japan; [Tanaka, Gouhei; Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan; [Almendral, Juan A.] Univ Rey Juan Carlos, Complex Syst Grp, Madrid 28933, Spain; [Almendral, Juan A.] Univ Politecn Madrid, Ctr Biomed Technol, Madrid 28223, Spain	University of Tokyo; University of Tokyo; University of Tokyo; Universidad Rey Juan Carlos; Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB)	Tanaka, G (corresponding author), Univ Tokyo, Grad Sch Engn, Tokyo 1138656, Japan.	gouhei@sat.t.u-tokyo.ac.jp	Almendral, Juan/ABC-8025-2021; Tanaka, Gouhei/Y-3230-2019	Almendral, Juan/0000-0003-1100-7446; Tanaka, Gouhei/0000-0002-6223-4406	JSPS KAKENHI [24700222, 26730127]; Aihara Innovative Mathematical Modelling Project; Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Aihara Innovative Mathematical Modelling Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was partially supported by JSPS KAKENHI Grant No. 24700222 (GT) and 26730127 (KM) as well as the Aihara Innovative Mathematical Modelling Project, the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy (CSTP) (GT, KM, and KA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A, 2008, DYNAMICAL PROCESSES, V1; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boguna M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.028701; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Callaway DS, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.041902; Cohen R., 2010, COMPLEX NETWORKS STR; D'Agostino G, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/68006; Daido H, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.104101; Daido H, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/10002; Daido H, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052907; Daido H, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016215; ERDOS P, 1960, B INT STATIST INST, V38, P343; Filatrella G, 2008, EUR PHYS J B, V61, P485, DOI 10.1140/epjb/e2008-00098-8; Goltsev AV, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051105; Guckenheimer J, 2013, APPL MATH SCI, V42; Hasegawa T, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042809; He ZW, 2013, PHYSICA A, V392, P4181, DOI 10.1016/j.physa.2013.05.005; Huang WW, 2014, CHAOS, V24, DOI 10.1063/1.4881215; Kruse K, 2005, CURR OPIN CELL BIOL, V17, P20, DOI 10.1016/j.ceb.2004.12.007; Markovic R, 2014, CHAOS SOLITON FRACT, V69, P14, DOI 10.1016/j.chaos.2014.08.008; McGraw PN, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.015101; Morino K, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032909; Morino K, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056208; Nagata M, 2014, EUR PHYS J-SPEC TOP, V223, P2549, DOI 10.1140/epjst/e2014-02215-x; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Noh JD, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026116; Pazo D, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.055202; Shiraki Y, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036101; Sorrentino F, 2006, PHYSICA D, V224, P123, DOI 10.1016/j.physd.2006.09.030; Tanaka G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05522; Tanaka G, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052906; Tanaka G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00232; Tanaka G, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.035202; Tanaka Gouhei, 2015, MATH APPROACHES BIOL, P29; Tanizawa T, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.047101; Thakur B, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042904; Valdez LD, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/38001; Vazquez A, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.015101; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Winfree A. T., 2001, GEOMETRY BIOL TIME, V12; Xulvi-Brunet R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066102	48	20	20	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123722	10.1371/journal.pone.0123722	http://dx.doi.org/10.1371/journal.pone.0123722			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894574	Green Accepted, Green Published, gold			2022-12-27	WOS:000353211700051
J	Wang, Y; Shaulsky, G				Wang, Yue; Shaulsky, Gad			TgrC1 Has Distinct Functions in Dictyostelium Development and Allorecognition	PLOS ONE			English	Article							CELL-CELL ADHESION; DISCOIDEUM; DIFFERENTIATION; LAGC; GENE; AGGREGATION; EXPRESSION; BINDING; GP150; DNA	The cell adhesion glycoproteins, TgrB1 and TgrC1, are essential for Dictyostelium development and allorecognition, but it has been impossible to determine whether their pleiotropic roles are due to one common function or to distinct functions in separate pathways. Mutations in the respective genes, tgrB1 and tgrC1, abrogate both development and allorecognition and the defects cannot be suppressed by activation of the cyclic AMP dependent protein kinase PKA, a central regulator of Dictyostelium development. Here we report that mutations in genes outside the known PKA pathway partially suppress the tgrC1-null developmental defect. We separated the pleiotropic roles of tgrC1 by testing the effects of a suppression mutation, stc(ins)A under different conditions. stcA(ins) modified only the developmental defect of tgrC1(-) but not the allorecognition defect, suggesting that the two functions are separable. The suppressor mutant phenotype also revealed that tgrC1 regulates stalk differentiation in a cell-autonomous manner and spore differentiation in a non-cell-autonomous manner. Moreover, stcA(ins) did not modify the developmental defect of tgrB1(-), but the less robust phenotype of tgrB1(-) obscures the possible role of stcA relative to tgrB1.	[Wang, Yue; Shaulsky, Gad] Baylor Coll Med, Grad Program Struct Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Shaulsky, Gad] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Shaulsky, G (corresponding author), Baylor Coll Med, Grad Program Struct Computat Biol & Mol Biophys, Houston, TX 77030 USA.	gadi@bcm.edu		Shaulsky, Gad/0000-0002-0532-0551	National Institute of General Medical Sciences [R01 GM084992]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084992] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grant number R01 GM084992 from the National Institute of General Medical Sciences (http://www.nigms.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjard C, 1998, DEV BIOL, V193, P146, DOI 10.1006/dbio.1997.8804; Anjard C, 2011, EUKARYOT CELL, V10, P956, DOI 10.1128/EC.05053-11; Benabentos R, 2009, CURR BIOL, V19, P567, DOI 10.1016/j.cub.2009.02.037; Chen G, 2013, BIOCHEM J, V452, P259, DOI 10.1042/BJ20121674; DYNES JL, 1994, GENE DEV, V8, P948, DOI 10.1101/gad.8.8.948; GAO EN, 1992, J BIOL CHEM, V267, P9409; GELTOSKY JE, 1979, CELL, V18, P391, DOI 10.1016/0092-8674(79)90058-8; HARWOOD AJ, 1993, DEVELOPMENT, V118, P1041; Hirose S, 2011, SCIENCE, V333, P467, DOI 10.1126/science.1203903; Huang EY, 2006, DEVELOPMENT, V133, P449, DOI 10.1242/dev.02240; Iranfar N, 2006, DEV BIOL, V290, P460, DOI 10.1016/j.ydbio.2005.11.035; Katoh M, 2006, EUKARYOT CELL, V5, P18, DOI 10.1128/EC.5.1.18-25.2006; KAY RR, 1983, NATURE, V303, P242, DOI 10.1038/303242a0; Kibler K, 2003, DEV BIOL, V264, P506, DOI 10.1016/j.ydbio.2003.08.025; KUSPA A, 1989, P NATL ACAD SCI USA, V86, P8917, DOI 10.1073/pnas.86.22.8917; Ostrowski EA, 2008, PLOS BIOL, V6, P2376, DOI 10.1371/journal.pbio.0060287; SHAULSKY G, 1993, DEV BIOL, V160, P85, DOI 10.1006/dbio.1993.1288; Shaulsky G, 1996, P NATL ACAD SCI USA, V93, P15260, DOI 10.1073/pnas.93.26.15260; SHAULSKY G, 1995, GENE DEV, V9, P1111, DOI 10.1101/gad.9.9.1111; Siu CH, 2004, SEMIN CELL DEV BIOL, V15, P633, DOI 10.1016/j.semcdb.2004.09.004; Thompson CRL, 2000, MOL CELL, V6, P1509, DOI 10.1016/S1097-2765(00)00147-7; VOLLRATH D, 1988, P NATL ACAD SCI USA, V85, P6027, DOI 10.1073/pnas.85.16.6027; Wang B, 1997, SCIENCE, V277, P251, DOI 10.1126/science.277.5323.251; Wang J, 2000, DEV BIOL, V227, P734, DOI 10.1006/dbio.2000.9881	24	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124270	10.1371/journal.pone.0124270	http://dx.doi.org/10.1371/journal.pone.0124270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894230	gold, Green Published, Green Submitted			2022-12-27	WOS:000353211700084
J	Philip, S; Isaakidis, P; Sagili, KD; Meharunnisa, A; Mrithyunjayan, S; Kumar, AMV				Philip, Sairu; Isaakidis, Petros; Sagili, Karuna D.; Meharunnisa, Asanarupillai; Mrithyunjayan, Sunilkumar; Kumar, Ajay M. V.			"They Know, They Agree, but They Don't Do"-The Paradox of Tuberculosis Case Notification by Private Practitioners in Alappuzha District, Kerala, India	PLOS ONE			English	Article							PUBLIC-HEALTH; PARTNERSHIP	Background Despite being a recognized standard of tuberculosis (TB) care internationally, mandatory TB case notification brings forth challenges from the private sector. Only three TB cases were notified in 2013 by private practitioners compared to 2000 TB cases notified yearly from the public sector in Alappuzha district. The study objective was to explore the knowledge, opinion and barriers regarding TB Notification among private practitioners offering TB services in Alappuzha, Kerala state, India. Methods & Findings This was a mixed-methods study with quantitative (survey) and qualitative components conducted between December 2013 and July 2014. The survey, using a structured questionnaire, among 169 private practitioners revealed that 88% were aware of mandatory notification. All patient-related details requested in the notification form (except government-issued identification number) were perceived to be important and easy to provide by more than 80% of practitioners. While more than 95% felt that notification should be mandatory, punitive action in case of failure to notify was considered unnecessary by almost two third. General practitioners (98%) were more likely to be aware of notification than specialists (84 %). (P<0.01). Qualitative purposive personal interviews (n=34) were carried out among private practitioners and public health providers. On thematic framework analysis of the responses, barriers to TB notification were grouped into three themes: 'private provider misconceptions about notification', 'patient confidentiality, and stigma and discrimination' and 'lack of cohesion and coordination between public and private sector'. Private practitioners did not consider it necessary to notify TB cases treated with daily regimen. Conclusion Communication strategies like training, timely dissemination of information of policy changes and one-to-one dialogue with private practitioners to dispel misconceptions may enhance TB notification. Trust building strategies like providing feedback about referred cases from private sector, health personnel visit or a liaison private doctor may ensure compliance to public health activities.	[Philip, Sairu; Meharunnisa, Asanarupillai] Govt TD Med Coll, Alappuzha, Kerala, India; [Isaakidis, Petros] Medecins Sans Frontieres, Operat Res Unit, Delhi, India; [Sagili, Karuna D.; Kumar, Ajay M. V.] South East Asia Reg Off, Int Union TB & Lung Dis, New Delhi, India; [Mrithyunjayan, Sunilkumar] State TB Training & Demonstrat Ctr, Directorate Hlth Serv, State TB Cell, Thiruvananthapuram, Kerala, India		Philip, S (corresponding author), Govt TD Med Coll, Alappuzha, Kerala, India.	sairuphilip09@gmail.com		Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531; Isaakidis, Petros/0000-0002-7881-1554	American People through the United States Agency for International Development (USAID); SORT IT programme; State Board of Medical Research (SBMR) Unit of Government T.D. Medical College, Alappuzha	American People through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); SORT IT programme; State Board of Medical Research (SBMR) Unit of Government T.D. Medical College, Alappuzha	Funding for the operational research course was made possible by the support of the American People through the United States Agency for International Development (USAID). The contents of this paper do not necessarily reflect the views of USAID, the United States Government, or International Union Against Tuberculosis and Lung Disease (The Union). The training for research methodology was received in National Operations Research Course from the Structured Operational Research and Training Initiative (SORT IT), a global partnership led by the Special Programme for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR). The model is based on a course developed jointly by the International Union Against Tuberculosis and Lung Disease (The Union) and Medecins sans Frontieres. The support for this publication is from a specific SORT IT programme which was jointly developed and implemented by: The Union South-East Asia Regional Office, New Delhi, India, and the Centre for Operational Research, The Union, Paris, France and Operational Research Unit (LUXOR), Medecins Sans Frontieres, Brussels Operational Center, India. The funds required to conduct the study in Alappuzha was provided by the State Board of Medical Research (SBMR) Unit of Government T.D. Medical College, Alappuzha. SBMR funds are utilised to promote research activities among faculty of the institution. The funders had no role in study design, data collection, analysis and interpretation of data, decision to publish or preparation of the manuscript.	[Anonymous], 2012, GUIDANCE TB NOTIFICA; Attride-Stirling J, 2001, QUAL RES, V1, P385, DOI DOI 10.1177/146879410100100307; Chughtai AA, 2009, EMHJ, V19, P213; Dandona R, 2004, NATL MED J INDIA, V17, P292; Dewan PK, 2006, BMJ-BRIT MED J, V332, P574, DOI 10.1136/bmj.38738.473252.7C; Hollo V, 2011, EURO SURVEILL, V16; Karki DK, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-84; Kumar MKA, 2005, INT J TUBERC LUNG D, V9, P870; Newell JN, 2004, B WORLD HEALTH ORGAN, V82, P92; Satyanarayana S, 2011, PLOS ONE, P9; Saw Saw, 2009, Health Res Policy Syst, V7, P19, DOI 10.1186/1478-4505-7-19; Tan HF, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-11; TB INDIA, 2013, ANN STAT REP; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Ullah AZ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001534; Universal Access to TB Care, PRACT GUID PROGR MAN; Uplekar M, 2001, LANCET, V358, P912, DOI 10.1016/S0140-6736(01)06076-7; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; Vyas RM, 2003, INT J TUBERC LUNG D, V7, P543; World Health Organization, GLOB TUB REP 2013	20	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123286	10.1371/journal.pone.0123286	http://dx.doi.org/10.1371/journal.pone.0123286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909330	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800032
J	Becker, AAMJ; Janssens, GPJ; Snauwaert, C; Hesta, M; Huys, G				Becker, Anne A. M. J.; Janssens, Geert P. J.; Snauwaert, Cindy; Hesta, Myriam; Huys, Geert			Integrated Community Profiling Indicates Long-Term Temporal Stability of the Predominant Faecal Microbiota in Captive Cheetahs	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; REAL-TIME PCR; GRADIENT GEL-ELECTROPHORESIS; VERTEBRATE GUT MICROBIOTA; CLOSTRIDIUM-PERFRINGENS; ACINONYX-JUBATUS; INTESTINAL MICROBIOTA; BACTERIAL-POPULATIONS; PROBIOTIC PRODUCTS; PANTHERA-TIGRIS	Understanding the symbiotic relationship between gut microbes and their animal host requires characterization of the core microbiota across populations and in time. Especially in captive populations of endangered wildlife species such as the cheetah (Acinonyx jubatus), this knowledge is a key element to enhance feeding strategies and reduce gastrointestinal disorders. In order to investigate the temporal stability of the intestinal microbiota in cheetahs under human care, we conducted a longitudinal study over a 3-year period with bimonthly faecal sampling of 5 cheetahs housed in two European zoos. For this purpose, an integrated 16S rRNA DGGE-clone library approach was used in combination with a series of real-time PCR assays. Our findings disclosed a stable faecal microbiota, beyond intestinal community variations that were detected between zoo sample sets or between animals. The core of this microbiota was dominated by members of Clostridium clusters I, XI and XIVa, with mean concentrations ranging from 7.5-9.2 log10 CFU/g faeces and with significant positive correlations between these clusters (P<0.05), and by Lactobacillaceae. Moving window analysis of DGGE profiles revealed 23.3-25.6% change between consecutive samples for four of the cheetahs. The fifth animal in the study suffered from intermediate episodes of vomiting and diarrhea during the monitoring period and exhibited remarkably more change (39.4%). This observation may reflect the temporary impact of perturbations such as the animal's compromised health, antibiotic administration or a combination thereof, which temporarily altered the relative proportions of Clostridium clusters I and XIVa. In conclusion, this first long-term monitoring study of the faecal microbiota in feline strict carnivores not only reveals a remarkable compositional stability of this ecosystem, but also shows a qualitative and quantitative similarity in a defined set of faecal bacterial lineages across the five animals under study that may typify the core phylogenetic microbiome of cheetahs.	[Becker, Anne A. M. J.; Huys, Geert] Univ Ghent, Fac Sci, Dept Biochem & Microbiol, Microbiol Lab, B-9000 Ghent, Belgium; [Snauwaert, Cindy; Huys, Geert] Univ Ghent, Fac Sci, Dept Biochem & Microbiol, BCCM LMG Bacteria Collect, B-9000 Ghent, Belgium; [Becker, Anne A. M. J.; Janssens, Geert P. J.; Hesta, Myriam] Univ Ghent, Fac Vet Med, Dept Nutr Genet & Ethol, Anim Nutr Lab, Merelbeke, Belgium	Ghent University; Ghent University; Ghent University	Becker, AAMJ (corresponding author), Univ Ghent, Fac Sci, Dept Biochem & Microbiol, Microbiol Lab, B-9000 Ghent, Belgium.	Anne.Becker@UGent.be	Janssens, Geert/C-2264-2008; Huys, Geert R.B./V-8633-2019; Huys, Geert/M-6781-2019	Huys, Geert R.B./0000-0002-7092-4837; Hesta, Myriam/0000-0001-9423-9765	Special Research Fund of Ghent University (Belgium) [BOF/10/2JO/254, BOF11/24J/122]; Morris Animal Foundation (USA) [D12ZO-404]	Special Research Fund of Ghent University (Belgium)(Ghent University); Morris Animal Foundation (USA)	Our work was kindly supported by the Special Research Fund of Ghent University (Belgium), Grants BOF/10/2JO/254 and BOF11/24J/122 (http://www.ugent.be), and by the Morris Animal Foundation (USA), Grant D12ZO-404 (http://www.morrisanimalfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allen ME, 2004, ZOO BIOL, V23, P475, DOI 10.1002/zoo.20029; Amato KR, 2013, ISME J, V7, P1344, DOI 10.1038/ismej.2013.16; [Anonymous], 1994, P ASS REPTILE AMPHIB, P301; Barc MC, 2004, ANTIMICROB AGENTS CH, V48, P1365, DOI 10.1128/AAC.48.4.1365-1368.2004; Barry KA, 2012, J PROTEOME RES, V11, P5924, DOI 10.1021/pr3006809; Becker AAMJ, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-43; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Biagi E, 2012, AGE, V34, P247, DOI 10.1007/s11357-011-9217-5; Bolnick DI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5500; Brinkman BM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.101; Buddington RK, 2011, J ANIM SCI, V89, P1506, DOI 10.2527/jas.2010-3705; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Degnan PH, 2012, P NATL ACAD SCI USA, V109, P13034, DOI 10.1073/pnas.1110994109; Dierenfeld E.S., 2002, NUTR COMPOSITION WHO; El Aidy S, 2013, BIOESSAYS, V35, P913, DOI 10.1002/bies.201300073; Endo A, 2010, ANAEROBE, V16, P590, DOI 10.1016/j.anaerobe.2010.10.005; Fahey GC, 2008, ANNU REV NUTR, V28, P425, DOI 10.1146/annurev.nutr.28.061807.155325; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Glad T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-10; Greiner T, 2011, TRENDS ENDOCRIN MET, V22, P117, DOI 10.1016/j.tem.2011.01.002; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Hayward MW, 2006, J ZOOL, V270, P615, DOI 10.1111/j.1469-7998.2006.00184.x; Huys Geert, 2008, Interdiscip Perspect Infect Dis, V2008, P597603, DOI 10.1155/2008/597603; Jores J, 2008, J WILDLIFE DIS, V44, P155, DOI 10.7589/0090-3558-44.1.155; Kawata Ken, 2008, Zoologische Garten, V78, P17, DOI 10.1016/j.zoolgart.2008.09.004; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kohl KD, 2014, FEMS MICROBIOL ECOL, V90, P883, DOI 10.1111/1574-6941.12442; Kotsch V, 2002, WIEN TIERARZTL MONAT, V89, P341; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Lubbs DC, 2009, J ANIM PHYSIOL AN N, V93, P113, DOI 10.1111/j.1439-0396.2007.00788.x; Marker LL, 2014, INT CHEETAH STUDBOOK; Masco L, 2007, INT J FOOD MICROBIOL, V113, P351, DOI 10.1016/j.ijfoodmicro.2006.07.021; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Menke S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00526; Minamoto Yasushi, 2012, Animal Health Research Reviews, V13, P64, DOI 10.1017/S1466252312000060; Munson L, 2005, J WILDLIFE DIS, V41, P542, DOI 10.7589/0090-3558-41.3.542; Nelson TM, 2013, ENVIRON MICROBIOL, V15, P1132, DOI 10.1111/1462-2920.12022; Pfaffl M.W., 2004, A Z QUANT PCR, P87; PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x; Plantinga EA, 2011, BRIT J NUTR, V106, pS35, DOI 10.1017/S0007114511002285; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Ritchie LE, 2008, FEMS MICROBIOL ECOL, V66, P590, DOI 10.1111/j.1574-6941.2008.00609.x; Schloss PD, 2012, GUT MICROBES, V3, P383, DOI 10.4161/gmic.21008; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwab C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027905; Schwab C, 2011, CAN J MICROBIOL, V57, P177, DOI 10.1139/W10-113; Schwab C, 2009, CAN J MICROBIOL, V55, P1335, DOI 10.1139/W09-083; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Silva ROS, 2014, ANAEROBE, V28, P207, DOI 10.1016/j.anaerobe.2014.06.012; Simpson JM, 2002, MICROB ECOL, V44, P186, DOI 10.1007/s00248-002-0001-z; Smalla K, 2007, J MICROBIOL METH, V69, P470, DOI 10.1016/j.mimet.2007.02.014; Song YL, 2004, APPL ENVIRON MICROB, V70, P6459, DOI 10.1128/AEM.70.11.6459-6465.2004; Temmerman R, 2003, APPL ENVIRON MICROB, V69, P220, DOI 10.1128/AEM.69.1.220-226.2003; Tun HM, 2012, J MICROBIOL METH, V88, P369, DOI 10.1016/j.mimet.2012.01.001; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; Vester BM, 2008, P COMP NUTR SOC 2008, P243; Vester BM, 2010, ZOO BIOL, V29, P432, DOI 10.1002/zoo.20275; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Whitehouse-Tedd K., 2012, P 14 ANN BIAZA RES S, P9; Wittebolle L, 2008, APPL ENVIRON MICROB, V74, P286, DOI 10.1128/AEM.01006-07; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zeira O, 2012, J ZOO WILDLIFE MED, V43, P666, DOI 10.1638/2011-0265R.1; Zentek J, 2003, J ANIM PHYSIOL AN N, V87, P397, DOI 10.1046/j.0931-2439.2003.00451.x; Zhang YL, 2012, J ZOO WILDLIFE MED, V43, P394, DOI 10.1638/2010-0197.1	72	8	9	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123933	10.1371/journal.pone.0123933	http://dx.doi.org/10.1371/journal.pone.0123933			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905625	Green Published, Green Submitted, gold			2022-12-27	WOS:000353332000050
J	Leite, JP; Duarte, M; Paiva, AM; Ferreira-da-Silva, F; Matias, PM; Nunes, OC; Gales, L				Leite, Jose P.; Duarte, Marcia; Paiva, Ana M.; Ferreira-da-Silva, Frederico; Matias, Pedro M.; Nunes, Olga C.; Gales, Luis			Structure-Guided Engineering of Molinate Hydrolase for the Degradation of Thiocarbamate Pesticides	PLoS One			English	Article							HERBICIDE MOLINATE; DIFFRACTION DATA; AMIDOHYDROLASE; MINERALIZATION; SUPERFAMILY; SOFTWARE; CRYSTALS	Molinate is a recalcitrant thiocarbamate used to control grass weeds in rice fields. The recently described molinate hydrolase, from Gulosibacter molinativorax ON4T, plays a key role in the only known molinate degradation pathway ending in the formation of innocuous compounds. Here we report the crystal structure of recombinant molinate hydrolase at 2.27 angstrom. The structure reveals a homotetramer with a single mononuclear metal-dependent active site per monomer. The active site architecture shows similarities with other amidohydrolases and enables us to propose a general acid-base catalysis mechanism for molinate hydrolysis. Molinate hydrolase is unable to degrade bulkier thiocarbamate pesticides such as thiobencarb which is used mostly in rice crops. Using a structural-based approach, we were able to generate a mutant (Arg187Ala) that efficiently degrades thiobencarb. The engineered enzyme is suitable for the development of a broader thiocarbamate bioremediation system.	[Leite, Jose P.; Ferreira-da-Silva, Frederico; Gales, Luis] Univ Porto, Inst Invest & Inovacao Saude, P-4100 Oporto, Portugal; [Leite, Jose P.; Duarte, Marcia; Ferreira-da-Silva, Frederico; Gales, Luis] Univ Porto, Inst Biol Mol & Celular, P-4100 Oporto, Portugal; [Duarte, Marcia; Paiva, Ana M.; Nunes, Olga C.] Univ Porto, Fac Engn, LEPABE Lab Proc Engn Environm Biotechnol & Energy, P-4100 Oporto, Portugal; [Matias, Pedro M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, P-2781901 Oeiras, Portugal; [Matias, Pedro M.] IBET, P-2781901 Oeiras, Portugal; [Gales, Luis] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade Nova de Lisboa; Universidade do Porto	Gales, L (corresponding author), Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	lgales@ibmc.up.pt	Matias, Pedro M/B-7180-2008; Leite, José P./AAF-4209-2021; Silva, Frederico F/K-3820-2013; Gales, Luis/J-8716-2013	Matias, Pedro M/0000-0001-6170-451X; Silva, Frederico F/0000-0002-8890-4228; Gales, Luis/0000-0002-8352-6539; Leite, Jose P./0000-0001-5063-515X; Nunes, Olga/0000-0003-4742-2537	FEDER funds through the Operational Competitiveness Programme - COMPETE; National Funds through FCT - Fundacao para a Ciencia e a Tecnologia [PEst-OE/EQB/LA0004/2011, FCOMP-01-0124-FEDER-027883 (PTDC/AAGTEC/3909/2012FCOMP)]	FEDER funds through the Operational Competitiveness Programme - COMPETE; National Funds through FCT - Fundacao para a Ciencia e a Tecnologia	This work was funded by FEDER funds through the Operational Competitiveness Programme - COMPETE and by National Funds through FCT - Fundacao para a Ciencia e a Tecnologia grants PEst-OE/EQB/LA0004/2011 (PMM) and FCOMP-01-0124-FEDER-027883 (PTDC/AAGTEC/3909/2012FCOMP).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Barreiros L, 2003, ENVIRON MICROBIOL, V5, P944, DOI 10.1046/j.1462-2920.2003.00492.x; Barreiros L, 2008, MICROBIOL-SGM, V154, P1038, DOI 10.1099/mic.0.2007/015297-0; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dao FX, 2009, BIOCHEMISTRY-US, V48, P4567, DOI [10.1021/bi900453u, DOI 10.1021/BI900453U]; Dao FX, 2009, BIOCHEMISTRY-US, V48, P3730, DOI [10.1021/bi900111q, DOI 10.1021/BI900111Q]; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Du XL, 2005, FEBS LETT, V579, P6140, DOI 10.1016/j.febslet.2005.09.086; Duarte M, 2011, J BACTERIOL, V193, P5810, DOI 10.1128/JB.05054-11; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans G, 2001, J APPL CRYSTALLOGR, V34, P82, DOI 10.1107/S0021889800014655; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Khurana JL, 2009, BIOCHEM J, V418, P431, DOI 10.1042/BJ20081488; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAGY I, 1995, J BACTERIOL, V177, P676, DOI 10.1128/jb.177.3.676-687.1995; Nunes OC, 2013, APPL MICROBIOL BIOT, V97, P10275, DOI 10.1007/s00253-013-5316-9; Schrodinger L., 2020, PYMOL; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Vincent F, 2004, J BIOL CHEM, V279, P2809, DOI 10.1074/jbc.M310165200; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Weeks CM, 2002, Z KRISTALLOGR, V217, P686, DOI 10.1524/zkri.217.12.686.20659	26	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123430	10.1371/journal.pone.0123430	http://dx.doi.org/10.1371/journal.pone.0123430			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905461	Green Published, Green Submitted, gold			2022-12-27	WOS:000353332000031
J	Li, YQ; Deng, XW; Huang, ZH; Xiang, WH; Yan, WD; Lei, PF; Zhou, XL; Peng, CH				Li, Yan-qiong; Deng, Xiang-wen; Huang, Zhi-hong; Xiang, Wen-hua; Yan, Wen-de; Lei, Pi-feng; Zhou, Xiao-lu; Peng, Chang-hui			Development and Evaluation of Models for the Relationship between Tree Height and Diameter at Breast Height for Chinese-Fir Plantations in Subtropical China	PLOS ONE			English	Article							PINE PLANTATIONS; BLACK SPRUCE; AGED STANDS; GROWTH; EQUATIONS; CURVE; BANKSIANA	Tree diameter at breast height (dbh) and height are the most important variables used in forest inventory and management as well as forest carbon-stock estimation. In order to identify the key stand variables that influence the tree height-dbh relationship and to develop and validate a suit of models for predicting tree height, data from 5961 tree samples aged from 6 years to 53 years and collected from 80 Chinese-fir plantation plots were used to fit 39 models, including 33 nonlinear models and 6 linear models, were developed and evaluated into two groups. The results showed that composite models performed better in height estimate than one-independent-variable models. Nonlinear composite Model 34 and linear composite Model 6 were recommended for predicting tree height in Chinese fir plantations with a dbh range between 4 cm and 40 cm when the dbh data for each tree and the quadratic mean dbh of the stand (Dq) and mean height of the stand (Hm) were available. Moreover, Hm could be estimated by using the formula Hm=11.707xln(Dq)-18.032. Clearly, Dq was the primary stand variable that influenced the height-dbh relationship. The parameters of the models varied according to stand age and site. The inappropriate application of provincial or regional height-dbh models for predicting small tree height at local scale may result in larger uncertainties. The method and the recommended models developed in this study were statistically reliable for applications in growth and yield estimation for even-aged Chinese- fir plantation in Huitong and Changsha. The models could be extended to other regions and to other tree species only after verification in subtropical China.	[Li, Yan-qiong; Deng, Xiang-wen; Huang, Zhi-hong; Xiang, Wen-hua; Yan, Wen-de; Lei, Pi-feng; Zhou, Xiao-lu; Peng, Chang-hui] Cent South Univ Forestry & Technol, Fac Life Sci & Technol, Changsha 410004, Hunan, Peoples R China; [Deng, Xiang-wen; Huang, Zhi-hong; Xiang, Wen-hua; Yan, Wen-de; Lei, Pi-feng] Natl Engn Lab Appl Technol Forestry & Ecol South, Changsha 410004, Hunan, Peoples R China; [Zhou, Xiao-lu; Peng, Chang-hui] Univ Quebec, Dept Biol Sci, Inst Environm Sci, Montreal, PQ H3C 3P8, Canada	Central South University of Forestry & Technology; University of Quebec; University of Quebec Montreal	Deng, XW (corresponding author), Cent South Univ Forestry & Technol, Fac Life Sci & Technol, Changsha 410004, Hunan, Peoples R China.	dxwfree@126.com	Lei, Pifeng/AAB-4847-2020	Li, Yanqiong/0000-0002-3362-7366; deng, xiang wen/0000-0002-9399-1231	state forestry special fund for non-profit industries of China [201404316]	state forestry special fund for non-profit industries of China	This work was supported by the state forestry special fund for non-profit industries of China [201404316] (http://www.hymof.net.cn/).	Arcangeli C, 2014, FORESTRY, V87, P177, DOI 10.1093/forestry/cpt041; BAILEY RL, 1980, CAN J FOREST RES, V10, P117, DOI 10.1139/x80-021; Ban DC, 1994, FOR RES, V7, P512; BATES DM, 1980, J ROY STAT SOC B MET, V42, P1; BUFORD MA, 1986, FOREST SCI, V32, P812; Burkhart HE, 1974, GROWTH MODELS TREE S, P128; Castedo-Dorado F, 2006, FOREST ECOL MANAG, V229, P202, DOI 10.1016/j.foreco.2006.04.028; Castedo-Doradoa F, 2005, ANN FOREST SCI, V62, P455, DOI 10.1051/forest:2005042; Colbert KC, 2002, NORTH J APPL FOR, V19, P171, DOI 10.1093/njaf/19.4.171; Cox F., 1994, MODELOS PARAMETRIZAD; CURTIS RO, 1967, FOREST SCI, V13, P365; CURTIS RO, 1970, FOREST SCI, V16, P403; CURTIS RO, 1981, PNW128 USDA FOR SERV; Cutini A., 2013, iForest, V6, P331; FARR WA, 1989, CAN J FOREST RES, V19, P1203, DOI 10.1139/x89-181; HAFLEY WL, 1977, CAN J FOREST RES, V7, P481, DOI 10.1139/x77-062; HARRISON W C, 1986, Southern Journal of Applied Forestry, V10, P99; Henriksen H. A., 1950, Dansk Skovforeningens Tidsskrift, V35, P193; HUANG SM, 1992, CAN J FOREST RES, V22, P1297, DOI 10.1139/x92-172; Huang SM, 2000, FOREST ECOL MANAG, V129, P125, DOI 10.1016/S0378-1127(99)00151-6; Hui G, 1999, MODELLING FOREST DEV; Kearsley E, 2014, NATURE COMMUNICATION, V4, P226; Lang A. C., 2014, iForest, V7, P19, DOI 10.3832/ifor1033-007; Larsen DR, 1987, 49 OR STAT U FOR ER; LARSON BC, 1986, CAN J FOREST RES, V16, P367, DOI 10.1139/x86-063; Leduc D, 2009, SOUTH J APPL FOR, V33, P164, DOI 10.1093/sjaf/33.4.164; Lei XD, 2009, FOREST CHRON, V85, P43, DOI 10.5558/tfc85043-1; Lei YC, 2001, REMARKS HEIGHT DIAME; Lopez-Sancheza CA, 2003, ANN FOREST SCI, V60, P237, DOI 10.1051/forest:2003015; Mehtatalo L, 2004, CAN J FOREST RES, V34, P131, DOI 10.1139/X03-207; Mirkovic D, 1958, GLASNIK SUMARSKOG FA, V13; Moravie MA, 1999, FOREST ECOL MANAG, V117, P221, DOI 10.1016/S0378-1127(98)00480-0; Newton RF, 2007, FOREST ECOL MANAG, V247, P149, DOI 10.1016/j.foreco.2007.04.029; Pan WC, 1979, J CENTRAL S FORESTRY, V4, P1; Pascoa F, 1987, THESIS; Pearl R, 1920, P NATL ACAD SCI USA, V6, P275, DOI 10.1073/pnas.6.6.275; Peng CH, 2004, NORTH J APPL FOR, V21, P83, DOI 10.1093/njaf/21.2.83; Prodan M, 1968, FOREST BIOMETRICS, P341; Ratkowsky D.A, 1990, HDB NONLINEAR REGRES; RATKOWSKY DA, 1986, BIOMETRICS, V42, P575, DOI 10.2307/2531207; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Rojo A, 2005, FORESTRY, V78, P385, DOI 10.1093/forestry/cpi030; SCHREUDER HT, 1979, FOREST SCI, V25, P25; Seber G., 1989, NONLINEAR REGRESSION; Sharma M, 2004, SCAND J FOREST RES, V19, P442, DOI 10.1080/02827580410030163; SIBBESEN E, 1981, J SOIL SCI, V32, P67, DOI 10.1111/j.1365-2389.1981.tb01686.x; SLOBODA B, 1993, ALLG FORST JAGDZTG, V164, P225; Stage A.R, 1975, INT164 USDA FOR SERV; STAGE ALBERT R., 1963, FOREST SCI, V9, P167; Stankova TV, 2013, ANN FOR RES, V56, P149; Stoffels A., 1953, Nederlandsch Boschbouwtijdschrift, V25, P190; Temesgen H, 2004, EUR J FOR RES, V123, P45, DOI 10.1007/s10342-004-0020-z; Vanclay JK, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009063; VANCLAY JK, 1995, FOREST SCI, V41, P7, DOI 10.1093/forestscience/41.1.7; Vargas-Larreta B, 2009, FORESTRY, V82, P445, DOI 10.1093/forestry/cpp016; Wang CH, 1988, 51 OR STAT U FOR RES; Watts SB, 1983, FORESTRY HDB BRIT CO; Winsor CP, 1932, P NATL ACAD SCI USA, V18, P1, DOI 10.1073/pnas.18.1.1; Wykoff W.R., 1982, INT122 USDA FOR SERV; Xu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104012; YANG RC, 1978, CAN J FOREST RES, V8, P424, DOI 10.1139/x78-062; ZEIDE B, 1989, CAN J FOREST RES, V19, P1283, DOI 10.1139/x89-195; Zhang LJ, 2002, FOREST CHRON, V78, P530, DOI 10.5558/tfc78530-4; Zhao MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055376	64	32	35	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125118	10.1371/journal.pone.0125118	http://dx.doi.org/10.1371/journal.pone.0125118			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905458	Green Submitted, Green Published, gold			2022-12-27	WOS:000353332000103
J	Lima, VD; Graf, I; Beckwith, CG; Springer, S; Altice, FL; Coombs, D; Kim, B; Messina, L; Montaner, JSG; Spaulding, A				Lima, Viviane D.; Graf, Isabell; Beckwith, Curt G.; Springer, Sandra; Altice, Frederick L.; Coombs, Daniel; Kim, Brian; Messina, Lauren; Montaner, Julio S. G.; Spaulding, Anne			The Impact of Implementing a Test, Treat and Retain HIV Prevention Strategy in Atlanta among Black Men Who Have Sex with Men with a History of Incarceration: A Mathematical Model	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PUBLIC-HEALTH; INFECTED PRISONERS; ANAL INTERCOURSE; UNDIAGNOSED HIV; HIGH PREVALENCE; HOMOSEXUAL-MEN; UNITED-STATES; RISK; TRANSMISSION	Background Annually, 10 million adults transition through prisons or jails in the United States (US) and the prevalence of HIV among entrants is three times higher than that for the country as a whole. We assessed the potential impact of increasing HIV Testing/Treatment/Retention (HIV-TTR) in the community and within the criminal justice system (CJS) facilities, coupled with sexual risk behavior change, focusing on black men-who-have-sex-with-men, 15-54 years, in Atlanta, USA. Methods We modeled the effect of a HIV-TTR strategy on the estimated cumulative number of new (acquired) infections and mortality, and on the HIV prevalence at the end of ten years. We additionally assessed the effect of increasing condom use in all settings. Results In the Status Quo scenario, at the end of 10 years, the cumulative number of new infections in the community, jail and prison was, respectively, 9246, 77 and 154 cases; HIV prevalence was 10815, 69 and 152 cases, respectively; and the cumulative number of deaths was 2585, 18 and 34 cases, respectively. By increasing HIV-TTR coverage, the cumulative number of new infections could decrease by 15% in the community, 19% in jail, and 8% in prison; HIV prevalence could decrease by 8%, 9% and 7%, respectively; mortality could decrease by 20%, 39% and 18%, respectively. Based on the model results, we have shown that limited use and access to condoms have contributed to the HIV incidence and prevalence in all settings. Conclusions Aggressive implementation of a CJS-focused HIV-TTR strategy has the potential to interrupt HIV transmission and reduce mortality, with benefit to the community at large. To maximize the impact of these interventions, retention in treatment, including during the period after jail and prison release, and increased condom use was vital for decreasing the burden of the HIV epidemic in all settings.	[Lima, Viviane D.; Montaner, Julio S. G.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Lima, Viviane D.; Montaner, Julio S. G.] Univ British Columbia, Fac Med, Div Aids, Dept Med, Vancouver, BC, Canada; [Graf, Isabell] Simon Fraser Univ, Dept Math, Burnaby, BC V5A 1S6, Canada; [Beckwith, Curt G.] Brown Univ, Miriam Hosp, Alpert Med Sch, Providence, RI USA; [Springer, Sandra; Altice, Frederick L.] Yale Univ, Sch Med, AIDS Program, Infect Dis Sect, New Haven, CT USA; [Altice, Frederick L.] Yale Univ, Div Epidemiol Microbial Dis, Sch Publ Hlth, New Haven, CT USA; [Coombs, Daniel] Univ British Columbia, Dept Math, Vancouver, BC, Canada; [Kim, Brian; Messina, Lauren; Spaulding, Anne] Emory Univ, Sch Med, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; Simon Fraser University; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Yale University; Yale University; University of British Columbia; Emory University; Rollins School Public Health	Lima, VD (corresponding author), British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	vlima@cfenet.ubc.ca	Springer, Sandra/ABC-4569-2020	Coombs, Daniel/0000-0002-8038-6278; Altice, Frederick/0000-0002-7860-693X	National Institute of Drug Abuse; US National Institute on Drug Abuse [R03 DA033851, R01 DA025943, R01 DA029910, R01 DA033679, R01 DA030762, K24 DA017072]; Canadian Institutes of Health Research (CIHR) [MOP-125948]; Michael Institute for Health Research; British Columbia Ministry of Health; US National Institutes of Health [R01 DA036307]; National Institute of Allergy and Infectious Diseases through the Emory Center for AIDS Research [P30 AI050409];  [R01 DA021525];  [R01 DA27211];  [R01 DA030768]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033679, R01DA036307, K02DA032322, R01DA027211, R01DA025943, R01DA021525, K24DA017072, R01DA029910, R01DA030762, R03DA033851, R01DA030768] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Institute for Health Research; British Columbia Ministry of Health; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases through the Emory Center for AIDS Research; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	CB, SS, AS, FA, VDL and JM received grant supplements through the National Institute of Drug Abuse for the Criminal Justice Modeling Project. The parent grants for these supplements were R01 DA021525, R01 DA27211 and R01 DA030768. In addition, VDL is supported by a grant from the US National Institute on Drug Abuse (R03 DA033851), a grant from the Canadian Institutes of Health Research (CIHR; MOP-125948), by a Scholar Award from the Michael Institute for Health Research and a New Investigator award from CIHR. JM is supported with grants paid to his institution by the British Columbia Ministry of Health and by the US National Institutes of Health (R01 DA036307). FA is supported through different grants from the US National Institute of Drug Abuse (R01 DA025943, R01 DA029910, R01 DA033679, R01 DA030762 and K24 DA017072). AS is supported through a grant from the National Institute of Allergy and Infectious Diseases through the Emory Center for AIDS Research (P30 AI050409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff AL, 2013, AIDS BEHAV, V17, P156, DOI 10.1007/s10461-012-0372-1; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P421; AVERT, 2014, PRIS HIV AIDS; Baggaley RF, 2010, AIDS, V24, P2418, DOI 10.1097/QAD.0b013e32833dbdfd; Baillargeon J, 2009, JAMA-J AM MED ASSOC, V301, P848, DOI 10.1001/jama.2009.202; Beck A., 2013, SEXUAL VICTIMIZATION; Beckwith C, 2014, AIDS PATIENT CARE ST, V28, P183, DOI 10.1089/apc.2013.0357; Beckwith CG, 2012, AM J PUBLIC HEALTH, V102, pS184, DOI 10.2105/AJPH.2011.300514; Beckwith CG, 2010, JAIDS-J ACQ IMM DEF, V55, pS49, DOI 10.1097/QAI.0b013e3181f9c0f7; Booker CA, 2013, AIDS BEHAV, V17, P128, DOI 10.1007/s10461-012-0354-3; Brewer RA, 2014, AM J PUBLIC HEALTH, V104, P448, DOI 10.2105/AJPH.2013.301786; Carson EA, 2013, 243920 NCJ US DEP JU; Carson EA, 2012, B NCJ; Centers for Disease Control and Prevention, 2013, HIV SURV S REP; Centers for Disease Control and Prevention, 2012, EST HIV INC US 2007; Centers for Disease Control and Prevention, 2011, HIV SURV REP; Chen Mi, 2012, MMWR Suppl, V61, P57; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; de Voux A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037603; Department of Health and Human Services, 2014, GUIDELINES USE ANTIR; Draine J, 2011, AIDS CARE, V23, P366, DOI 10.1080/09540121.2010.507738; Flanigan TP, 2008, CLIN INFECT DIS, V47, P1366, DOI 10.1086/592754; Flanigan TP, 2010, JAIDS-J ACQ IMM DEF, V55, pS78, DOI 10.1097/QAI.0b013e3181fbc94f; Fu JJ, 2013, AIDS BEHAV, V17, P145, DOI 10.1007/s10461-013-0590-1; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Georgia Department of Public Health, 2008, GEORG HIV AIDS SURV; Georgia Department of Public Health, 2012, 2012 HIV FACT SHEET; Georgia Department of Public Health, 2009, GEORG HIV AIDS SURV; Georgia Department of Public Health, 2010, 2010 HIV FACT SHEET; Georgia Department of Public Health, 2010, GEORG HIV AIDS SURV; Georgia Department of Public Health, 2011, 2011 HIV FACT SHEET; Georgia Department of Public Health, 2008, 2008 HIV FACT SHEET; Georgia Department of Public Health, 2009, 2009 HIV FACT SHEET; Ginder S, 2013, MORTALITY LOCAL JAIL; Guerino P, 2011, 236095 NCJ US DEP JU; Jafa K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005416; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Kelley CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053284; Khan MR, 2008, ANN EPIDEMIOL, V18, P403, DOI 10.1016/j.annepidem.2007.12.003; Khan MR, 2008, J URBAN HEALTH, V85, P100, DOI 10.1007/s11524-007-9237-8; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413; Lima V, 2011, 18 C RETR OPP INF FE; Lima VD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010991; Lyons T, 2014, J CORRECT HEALTH CAR, V20, P105, DOI 10.1177/1078345813518630; Mao LM, 2011, SEX TRANSM INFECT, V87, P489, DOI 10.1136/sextrans-2011-050041; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Maruschak LM, 2009, HIV PRISONS JAILS SE; Maruschak LM, 2012, HIV PRISONS JAILS SE; Metsch LR, 2008, CLIN INFECT DIS, V47, P577, DOI 10.1086/590153; Meyer JP, 2014, JAMA INTERN MED, V174, P721, DOI 10.1001/jamainternmed.2014.601; Meyer JP, 2014, LANCET HIV; Minton T. D., 2014, JAIL INMATES MIDYEAR; Montague BT, 2012, VIRULENCE, V3, P319, DOI 10.4161/viru.20432; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; National Centre for Primary Care, 2004, GEORG MIN HLTH HLTH; Nunn A, 2011, CLIN INFECT DIS, V53, P499, DOI 10.1093/cid/cir418; Office of Health Indicators for Planning (OHIP), 2013, ONL AN STAT INF SYST; PANTALEO G, 1993, NEW ENGL J MED, V328, P327, DOI 10.1056/NEJM199302043280508; Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312; Pinkerton SD, 1997, SOC SCI MED, V44, P1303, DOI 10.1016/S0277-9536(96)00258-4; Rosenberg ES, 2013, JAIDS-J ACQ IMM DEF, V63, P514, DOI 10.1097/QAI.0b013e318294bcce; Rosenberg ES, 2012, SEX TRANSM DIS, V39, P741, DOI 10.1097/OLQ.0b013e31825ec09b; Siegler AJ, 2013, JAIDS-J ACQ IMM DEF, V64, P307, DOI 10.1097/QAI.0b013e3182a0e880; Smith D, 2013, 20 C RETR OPP INF MA; Spaulding AC, 2011, 1 INT TREATM PREV WO; Spaulding AC, 2014, INTRO CORRECTIONS HI; Spaulding AC, 2013, AIDS BEHAV, V17, P203, DOI 10.1007/s10461-012-0341-8; Spaulding AC, 2013, AIDS BEHAV, V17, P100, DOI 10.1007/s10461-012-0339-2; Spaulding AC, 2013, MMWR-MORBID MORTAL W, V62, P495; Spaulding AC, 2009, PLOS ONE, V4, pA16, DOI 10.1371/journal.pone.0007558; Springer SA, 2004, CLIN INFECT DIS, V38, P1754, DOI 10.1086/421392; Springer SA, 2011, CLIN INFECT DIS, V53, P469, DOI 10.1093/cid/cir446; Stein MS, 2013, AIDS BEHAV, V17, P108, DOI 10.1007/s10461-012-0340-9; Sullivan PS, 2014, ARCH SEX BEHAV, V43, P173, DOI 10.1007/s10508-013-0214-x; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Tieu HV, 2012, 19 INT AIDS C JUL 22; United States Census Bureau, 2013, POP EST 2013; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; West HC, 2010, 231675 NCJ US DEP JU; Westergaard RP, 2013, CURR OPIN INFECT DIS, V26, P10, DOI 10.1097/QCO.0b013e32835c1dd0; Westergaard RP, 2011, CLIN INFECT DIS, V53, P725, DOI 10.1093/cid/cir491; Western B, 2010, INCARCERATION SOCIAL; Williams BG, 2011, CURR HIV RES, V9, P367, DOI 10.2174/157016211798038533; Wohl DA, 2013, JAMA-J AM MED ASSOC, V310, P2198, DOI 10.1001/jama.2013.280740; Zelenev A, 2013, AIDS BEHAV, V17, P181, DOI 10.1007/s10461-013-0472-6; Zuckerman RA, 2004, J INFECT DIS, V190, P156, DOI 10.1086/421246	87	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123482	10.1371/journal.pone.0123482	http://dx.doi.org/10.1371/journal.pone.0123482			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905725	gold, Green Submitted, Green Published			2022-12-27	WOS:000353332000033
J	Tripette, J; Nguyen, C; Allard, L; Robillard, P; Soulez, G; Cloutier, G				Tripette, Julien; Linh-Chi Nguyen; Allard, Louise; Robillard, Pierre; Soulez, Gilles; Cloutier, Guy			In Vivo Venous Assessment of Red Blood Cell Aggregate Sizes in Diabetic Patients with a Quantitative Cellular Ultrasound Imaging Method: Proof of Concept	PLoS One			English	Article							ACUTE-PHASE PROTEINS; ERYTHROCYTE AGGREGATION; HEMORHEOLOGICAL DISORDERS; RBC AGGREGATION; SHEAR RATE; MELLITUS; DISEASE; DETERMINANT; FIBRINOGEN; ESTIMATOR	Background Diabetic patients present higher level of red blood cell (RBC) aggregation contributing to the development of vascular complications. While it has been suggested that this hematology/rheology parameter could bring additional prognostic information for the management of those patients, RBC aggregation screening is not included as a clinical practice. Most medical centers are not equipped to measure properly this parameter, although sedimentation tests can bring some indication. Here, we aimed at evaluating the feasibility of using ultrasound to assess in-vivohyper-aggregation in type 2 diabetic patients. Research design and methods Seventeen diabetic patients and 15 control subjects underwent ultrasound measurements of RBC aggregation in both cephalic and great saphenous veins. Non-invasive in-vivo ultrasound measurements were performed using a newly developed cellular imaging technique, the structure factor size and attenuation estimator (SFSAE). Comparisons with an ex-vivogold standard rheometry technique were done, along with measurements of pro-aggregating plasma molecule concentrations. Results In-vivo RBC aggregation was significantly higher in diabetic patients compared with controls for cephalic vein measurements, while a trend (p = 0.055) was noticed in the great saphenous vein. SFSAE measurements were correlated with gold standard in-vitromeasures, fibrinogen and C-reactive protein plasma concentrations. Conclusion RBC aggregation can be measured in-vivo in diabetic patients using ultrasound. Prospective studies are needed to determine whether the SFSAE method could help clinicians in the early management of vascular complications in this patient population.	[Tripette, Julien; Linh-Chi Nguyen; Allard, Louise; Cloutier, Guy] Univ Montreal Hosp CRCHUM, Res Ctr, Lab Biorheol & Med Ultrason, Quebec City, PQ, Canada; [Linh-Chi Nguyen; Soulez, Gilles; Cloutier, Guy] Univ Montreal, Inst Biomed Engn, Quebec City, PQ, Canada; [Robillard, Pierre; Soulez, Gilles] Univ Montreal Hosp CHUM, Dept Radiol, Quebec City, PQ, Canada; [Robillard, Pierre; Soulez, Gilles; Cloutier, Guy] Univ Montreal, Dept Radiol Radiooncol & Nucl Med, Quebec City, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Cloutier, G (corresponding author), Univ Montreal Hosp CRCHUM, Res Ctr, Lab Biorheol & Med Ultrason, Quebec City, PQ, Canada.	guy.cloutier@umontreal.ca	tripette, julien/AAC-5414-2019; Soulez, Gilles/F-2834-2013	tripette, julien/0000-0002-5669-5337; 	Canadian Institutes of Health Research [MOP-84358]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding of this study was provided by the Canadian Institutes of Health Research (grant number MOP-84358). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Baskurt O, 2008, MICROCIRCULATION, V15, P585, DOI 10.1080/10739680802107447; Cloutier G, 1996, IEEE T BIO-MED ENG, V43, P441, DOI 10.1109/10.488792; Cloutier G, 2008, DIABETES CARE, V31, P1400, DOI 10.2337/dc07-1802; Foresto P, 2000, MEDICINA-BUENOS AIRE, V60, P570; Franceschini E, 2008, J ACOUST SOC AM, V123, pEL85, DOI 10.1121/1.2896115; Franceschini E, 2010, J ACOUST SOC AM, V127, P1104, DOI 10.1121/1.3277200; Gabbay IE, 2014, MED HYPOTHESES, V82, P57, DOI 10.1016/j.mehy.2013.11.005; Hardeman MR, 2007, BIOMED HEALTH RES, V69, P242; Khodabandehlou T, 2004, CLIN HEMORHEOL MICRO, V30, P219; Khodabandehlou T, 2003, Int J Low Extrem Wounds, V2, P13, DOI 10.1177/1534734603002001003; Khodabandehlou T, 1996, CLIN HEMORHEOL, V16, P303; Le Devehat C, 2004, CLIN HEMORHEOL MICRO, V30, P297; LEDEVEHAT C, 1990, INT ANGIOL, V9, P11; Maharshak N, 2009, INFLAMM BOWEL DIS, V15, P707, DOI 10.1002/ibd.20838; Mantskava M, 2006, CLIN HEMORHEOL MICRO, V35, P307; Mchedlishvili G, 2001, JPN J PHYSIOL, V51, P19, DOI 10.2170/jjphysiol.51.19; Meiselman HJ, 2006, CLIN HEMORHEOL MICRO, V35, P37; Momtselidze N, 2006, CLIN HEMORHEOL MICRO, V35, P261; Neu B, 2007, BIOMED HEALTH RES, V69, P114; Rosenson RS, 2011, ATHEROSCLEROSIS, V218, P13, DOI 10.1016/j.atherosclerosis.2011.06.029; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Saldanha C, 2013, CLIN HEMORHEOL MICRO, V53, P39, DOI 10.3233/CH-2012-1574; Schmid-Schonbein H., 1990, TIJDSCHR NVKC, V15, P88; Tripette J, 2013, CRIT CARE MED, V41, pE171, DOI 10.1097/CCM.0b013e31828a2354; Weng XD, 1996, AM J PHYSIOL-HEART C, V271, pH2346, DOI 10.1152/ajpheart.1996.271.6.H2346; Weng XD, 1998, THROMB HAEMOSTASIS, V80, P903, DOI 10.1055/s-0037-1615386; Yu FTH, 2011, J THROMB HAEMOST, V9, P481, DOI 10.1111/j.1538-7836.2010.04164.x; Yu FTH, 2007, J ACOUST SOC AM, V122, P645, DOI 10.1121/1.2735805; Yu FTH, 2009, BIORHEOLOGY, V46, P343, DOI 10.3233/BIR-2009-0546	30	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124712	10.1371/journal.pone.0124712	http://dx.doi.org/10.1371/journal.pone.0124712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906140	gold, Green Published, Green Submitted			2022-12-27	WOS:000353332000082
J	Wang, W; Fromm, M				Wang, Wei; Fromm, Michael			Sphingolipids Are Required for Efficient Triacylglycerol Loss in Conjugated Linoleic Acid Treated Adipocytes	PLOS ONE			English	Article							NF-KAPPA-B; WHITE ADIPOSE-TISSUE; ENDOTHELIAL-CELLS; SPHINGOSINE 1-PHOSPHATE; MEDIATED ACTIVATION; BODY-COMPOSITION; CERAMIDE; MICE; TRANS-10; APOPTOSIS	Conjugated linoleic acid (CLA) reduces adiposity in human and mouse adipocytes. This outcome is achieved through a variety of biological responses including increased energy expenditure and fatty acid oxidation, increased inflammation, repression of fatty acid biosynthesis, attenuated glucose transport, and apoptosis. In the current study, profiling of 261 metabolites was conducted to gain new insights into the biological pathways responding to CLA in 3T3-L1 adipocytes. Sphinganine and sphingosine levels were observed to be highly elevated in CLA treated adipocytes. Exogenous chemicals that increased endogenous ceramide levels decreased lipid levels in adipocytes, and activated AMP-activated protein kinase (AMPK) as well as NF-kappa B, both of which are typically activated in CLA treated adipocytes. Concurrent inhibition of ceramide de novo biosynthesis and recycling from existing sphingolipid pools attenuated the lipid lowering effect normally associated with responses to CLA, implicating ceramides as an important component of the lipid lowering response in CLA treated adipocytes.	[Wang, Wei] Univ Nebraska, Dept Anim Sci, Lincoln, NE USA; [Fromm, Michael] Univ Nebraska, Ctr Biotechnol, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Fromm, M (corresponding author), Univ Nebraska, Ctr Biotechnol, Lincoln, NE 68588 USA.	mfromm2@unl.edu		wang, wei/0000-0002-6642-9358	Center for Biotechnology	Center for Biotechnology	This work was supported by the Center for Biotechnology (WW and MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera-Romero A, 2013, BIOCH BIOPHYS ACTA; Castro BM, 2014, PROG LIPID RES; Choi KM, 2011, BIOL PHARM BULL, V34, P912, DOI 10.1248/bpb.34.912; Chung SK, 2005, J BIOL CHEM, V280, P38445, DOI 10.1074/jbc.M508159200; Gondai T, 2008, NUCLEIC ACIDS RES, V36, P5426, DOI 10.1093/nar/gkn547; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Gupta V, 2010, J LIPID RES, V51, P866, DOI 10.1194/jlr.D002949; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hargrave-Barnes KM, 2008, OBESITY, V16, P2245, DOI 10.1038/oby.2008.338; Hla T, 2012, CELL METAB, V16, P420, DOI 10.1016/j.cmet.2012.06.017; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; House RL, 2005, OBES REV, V6, P247, DOI 10.1111/j.1467-789X.2005.00198.x; House RL, 2005, PHYSIOL GENOMICS, V21, P351, DOI 10.1152/physiolgenomics.00244.2004; Jiang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048874; Jiang S, 2011, J NUTR BIOCHEM, V22, P656, DOI 10.1016/j.jnutbio.2010.05.005; Jiang S, 2009, J NUTR, V139, P2244, DOI 10.3945/jn.109.112417; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Kennedy A, 2010, J NUTR BIOCHEM, V21, P171, DOI 10.1016/j.jnutbio.2009.08.003; Kennedy A, 2009, J LIPID RES, V50, P225, DOI 10.1194/jlr.M800258-JLR200; Kilroy G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006940; Kim HS, 2000, BIOCHEM BIOPH RES CO, V270, P76, DOI 10.1006/bbrc.2000.2373; Kogot-Levin A, 2013, BIOCHIMIE; Krishnamurthy K, 2007, J LIPID RES, V48, P968, DOI 10.1194/jlr.D600043-JLR200; LaRosa PC, 2007, PHYSIOL GENOMICS, V31, P544, DOI 10.1152/physiolgenomics.00156.2007; LaRosa PC, 2006, PHYSIOL GENOMICS, V27, P282, DOI 10.1152/physiolgenomics.00076.2006; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Medler TR, 2008, AM J RESP CELL MOL, V38, P639, DOI 10.1165/rcmb.2007-0274OC; Moon MH, 2012, EXP MOL MED, V44, P603, DOI 10.3858/emm.2012.44.10.069; O'Sullivan MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095566; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Obsen T, 2012, J NUTR BIOCHEM, V23, P580, DOI 10.1016/j.jnutbio.2011.02.014; Oh E, 2014, ARCH DERMATOL RES, V306, P339, DOI 10.1007/s00403-013-1434-6; Papineau D, 2003, METABOLISM, V52, P987, DOI 10.1016/S0026-0495(03)00165-3; Park Y, 1997, LIPIDS, V32, P853, DOI 10.1007/s11745-997-0109-x; Park Y, 1999, LIPIDS, V34, P235, DOI 10.1007/s11745-999-0358-8; Poirier H, 2006, DIABETES, V55, P1634, DOI 10.2337/db06-0036; Pyne NJ, 2013, CANCER CELL, V23, P5, DOI 10.1016/j.ccr.2012.12.005; Schwartz DM, 2007, J LIPID RES, V48, P2514, DOI 10.1194/jlr.D700017-JLR200; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Terpstra AHM, 2002, J NUTR, V132, P940, DOI 10.1093/jn/132.5.940; Tsuboyama-Kasaoka N, 2000, DIABETES, V49, P1534, DOI 10.2337/diabetes.49.9.1534; Viehaber G, 2001, GLYCOBIOLOGY, V11, P451; Wu DY, 2007, J IMMUNOL, V179, P4829, DOI 10.4049/jimmunol.179.7.4829; Xu F, 2010, APPL BIOCHEM BIOTECH, V160, P197, DOI 10.1007/s12010-008-8505-8; Yamashita-Sugahara Y, 2013, J BIOL CHEM, V288, P4522, DOI 10.1074/jbc.M112.440792; Yang G, 2009, AM J PHYSIOL-ENDOC M, V297, pE211, DOI 10.1152/ajpendo.91014.2008; Zhang WL, 2013, PROSTAG OTH LIPID M, V106, P62, DOI 10.1016/j.prostaglandins.2013.06.001	48	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0119005	10.1371/journal.pone.0119005	http://dx.doi.org/10.1371/journal.pone.0119005			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906159	Green Published, gold			2022-12-27	WOS:000353332000001
J	Yan, H; Liang, CZ; Li, ZY; Liu, ZL; Miao, BL; He, CG; Sheng, LX				Yan, Hong; Liang, Cunzhu; Li, Zhiyong; Liu, Zhongling; Miao, Bailing; He, Chunguang; Sheng, Lianxi			Impact of Precipitation Patterns on Biomass and Species Richness of Annuals in a Dry Steppe	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; SEASONAL ENVIRONMENTAL VARIATION; CLIMATE-CHANGE; ABOVEGROUND PRODUCTIVITY; RAINFALL VARIABILITY; INNER-MONGOLIA; NORTH-AMERICAN; SEED DORMANCY; ANNUAL PLANTS; RESPONSES	Annuals are an important component part of plant communities in arid and semiarid grassland ecosystems. Although it is well known that precipitation has a significant impact on productivity and species richness of community or perennials, nevertheless, due to lack of measurements, especially long-term experiment data, there is little information on how quantity and patterns of precipitation affect similar attributes of annuals. This study addresses this knowledge gap by analyzing how quantity and temporal patterns of precipitation affect aboveground biomass, interannual variation aboveground biomass, relative aboveground biomass, and species richness of annuals using a 29-year dataset from a dry steppe site at the Inner Mongolia Grassland Ecosystem Research Station. Results showed that aboveground biomass and relative aboveground biomass of annuals increased with increasing precipitation. The coefficient of variation in aboveground biomass of annuals decreased significantly with increasing annual and growing-season precipitation. Species richness of annuals increased significantly with increasing annual precipitation and growing-season precipitation. Overall, this study highlights the importance of precipitation for aboveground biomass and species richness of annuals.	[Yan, Hong; He, Chunguang; Sheng, Lianxi] NE Normal Univ, State Environm Protect, Key Lab Wetland Ecol & Vegetat Restorat, Changchun, Peoples R China; [Liang, Cunzhu; Li, Zhiyong; Liu, Zhongling; Miao, Bailing] Inner Mongolia Univ, Sch Ecol & Environm Sci, Hohhot, Peoples R China; [Miao, Bailing] Meteorol Res Inst Inner Mongolia, Hohhot, Peoples R China	Northeast Normal University - China; Inner Mongolia University	Sheng, LX (corresponding author), NE Normal Univ, State Environm Protect, Key Lab Wetland Ecol & Vegetat Restorat, Changchun, Peoples R China.	shenglx@nenu.edu.cn			Special Funds of the State Environmental Protection Public Welfare Industry [2011467032]; Natural Science Foundation of China [31160476, 31160119]; National Key Basic Research Program of China [2010CB950602]; Enhancing Comprehensive Strength Project of Inner Mongolia University [14020202]	Special Funds of the State Environmental Protection Public Welfare Industry; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Enhancing Comprehensive Strength Project of Inner Mongolia University	Research was funded by the Special Funds of the State Environmental Protection Public Welfare Industry (Project NO. 2011467032), Natural Science Foundation of China (Project NO. 31160476 and 31160119), National Key Basic Research Program of China (Project NO. 2010CB950602), and the Enhancing Comprehensive Strength Project of Inner Mongolia University (Project NO. 14020202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt SK, 2006, PLANT SOIL, V285, P1, DOI 10.1007/s11104-006-9097-0; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; BASKIN CC, 1993, J ECOL, V81, P551, DOI 10.2307/2261533; Berg N, 2012, GEODERMA, V185, P6, DOI 10.1016/j.geoderma.2012.03.023; BERTILLER MB, 1991, J ARID ENVIRON, V21, P1; Brown G, 2003, PLANT ECOL, V165, P53, DOI 10.1023/A:1021425308451; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Chesson P, 2004, OECOLOGIA, V141, P236, DOI 10.1007/s00442-004-1551-1; Dieleman JA, 1998, SCI HORTIC-AMSTERDAM, V76, P183, DOI 10.1016/S0304-4238(98)00131-9; Dreesen FE, 2012, ENVIRON EXP BOT, V79, P21, DOI 10.1016/j.envexpbot.2012.01.005; DUNCAN DA, 1975, J RANGE MANAGE, V28, P327, DOI 10.2307/3897788; Fay PA, 2000, ECOSYSTEMS, V3, P308, DOI 10.1007/s100210000028; FOX GA, 1990, AM J BOT, V77, P1508, DOI 10.2307/2444763; FREAS KE, 1983, J ECOL, V71, P211, DOI 10.2307/2259973; Fry EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057027; Gonzalez-Astorga J, 2000, PLANT ECOL, V151, P253, DOI 10.1023/A:1026570623406; Guo QF, 2002, J VEG SCI, V13, P575, DOI 10.1111/j.1654-1103.2002.tb02084.x; GUTIERREZ JR, 1987, ECOLOGY, V68, P2032, DOI 10.2307/1939894; Hou YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070114; Huxman TE, 2004, NATURE, V429, P651, DOI 10.1038/nature02561; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Jongen M, 2011, AGR FOREST METEOROL, V151, P595, DOI 10.1016/j.agrformet.2011.01.008; Kidron GJ, 2014, J HYDROL, V508, P128, DOI 10.1016/j.jhydrol.2013.10.045; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Knapp AK, 2006, OECOLOGIA, V149, P456, DOI 10.1007/s00442-006-0468-2; Lane DR, 1998, J VEG SCI, V9, P239, DOI 10.2307/3237123; LAUENROTH WK, 1992, ECOL APPL, V2, P397, DOI 10.2307/1941874; Ma WH, 2010, SCI CHINA LIFE SCI, V53, P841, DOI 10.1007/s11427-010-4020-6; Ma WH, 2010, J PLANT RES, V123, P509, DOI 10.1007/s10265-009-0302-0; Mathias A, 2013, THEOR POPUL BIOL, V84, P56, DOI 10.1016/j.tpb.2012.11.009; Miranda JD, 2011, J ARID ENVIRON, V75, P1302, DOI 10.1016/j.jaridenv.2011.04.022; Miranda JD, 2009, J VEG SCI, V20, P269, DOI 10.1111/j.1654-1103.2009.05680.x; Muldavin EH, 2008, OECOLOGIA, V155, P123, DOI 10.1007/s00442-007-0880-2; MULROY TW, 1977, BIOSCIENCE, V27, P109, DOI 10.2307/1297607; Padilla FM, 2007, FUNCT ECOL, V21, P489, DOI 10.1111/j.1365-2435.2007.01267.x; PITT MD, 1978, ECOLOGY, V59, P336, DOI 10.2307/1936378; Polley HW, 2013, RANGELAND ECOL MANAG, V66, P493, DOI 10.2111/REM-D-12-00068.1; Quevedo-Robledo L, 2010, J ARID ENVIRON, V74, P167, DOI 10.1016/j.jaridenv.2009.08.002; Rivas-Arancibia SP, 2006, J ARID ENVIRON, V67, P416, DOI 10.1016/j.jaridenv.2006.03.005; Robertson TR, 2009, NEW PHYTOL, V181, P230, DOI 10.1111/j.1469-8137.2008.02643.x; Robinson TMP, 2013, OIKOS, V122, P727, DOI 10.1111/j.1600-0706.2012.20655.x; Salve R, 2011, J HYDROL, V410, P51, DOI 10.1016/j.jhydrol.2011.09.003; Solbreck C, 2012, BASIC APPL ECOL, V13, P414, DOI 10.1016/j.baae.2012.07.003; Swemmer AM, 2007, J ECOL, V95, P780, DOI 10.1111/j.1365-2745.2007.01237.x; Wenninger EJ, 2008, J ARID ENVIRON, V72, P24, DOI 10.1016/j.jaridenv.2007.04.005; Whitehead D, 2004, FOREST ECOL MANAG, V193, P113, DOI 10.1016/j.foreco.2004.01.026; Whitford WG, 1995, ENVIRON MONIT ASSESS, V37, P319, DOI 10.1007/BF00546898; Williams KJ, 1998, OIKOS, V81, P463, DOI 10.2307/3546768; Xia Y, 2010, J ARID ENVIRON, V74, P378, DOI 10.1016/j.jaridenv.2009.08.016; Xu ZZ, 2014, PLANTA, V239, P421, DOI 10.1007/s00425-013-1987-9; Xu ZZ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-21; Yoneyama T, 2001, PLANT CELL ENVIRON, V24, P133, DOI 10.1046/j.1365-3040.2001.00663.x; Yuan Fei, 2008, Yingyong Shengtai Xuebao, V19, P2168; Zavaleta ES, 2003, ECOL MONOGR, V73, P585, DOI 10.1890/02-4053; Zhang BC, 2013, CLIMATIC CHANGE, V118, P197, DOI 10.1007/s10584-012-0622-2; Zhao LJ, 2013, ECOL ENG, V60, P116, DOI 10.1016/j.ecoleng.2013.07.022; Zhu H, 2014, ECOL ENTOMOL, V39, P453, DOI 10.1111/een.12120	59	49	53	10	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125300	10.1371/journal.pone.0125300	http://dx.doi.org/10.1371/journal.pone.0125300			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906187	gold, Green Published, Green Submitted			2022-12-27	WOS:000353332000109
J	Desmond, MJ; Pritchard, DW; Hepburn, CD				Desmond, Matthew J.; Pritchard, Daniel W.; Hepburn, Christopher D.			Light Limitation within Southern New Zealand Kelp Forest Communities	PLOS ONE			English	Article							MACROCYSTIS-PYRIFERA; GIANT-KELP; MARINE MACROALGAE; PHOTOSYNTHETIC PERFORMANCE; HOLOCENE VEGETATION; DEPTH ZONATION; STEWART ISLAND; WATER-MOVEMENT; GROWTH-RATE; NITROGEN	Light is the fundamental driver of primary productivity in the marine environment. Reduced light availability has the potential to alter the distribution, community composition, and productivity of key benthic primary producers, potentially reducing habitat and energy provision to coastal food webs. We compared the underwater light environment of macroalgal dominated shallow subtidal rocky reef habitats on a coastline modified by human activities with a coastline of forested catchments. Key metrics describing the availability of photosynthetically active radiation (PAR) were determined over 295 days and were related to macroalgal depth distribution, community composition, and standing biomass patterns, which were recorded seasonally. Light attenuation was more than twice as high in shallow subtidal zones along the modified coast. Macroalgal biomass was 2-5 times greater within forested sites, and even in shallow water (2m) a significant difference in biomass was observed. Longterm light dose provided the best explanation for differences in observed biomass between modified and forested coasts, with light availability over the study period differing by 60 and 90 mol photons m(-2) at 2 and 10 metres, respectively. Higher biomass on the forested coast was driven by the presence of larger individuals rather than species diversity or density. This study suggests that commonly used metrics such as species diversity and density are not as sensitive as direct measures of biomass when detecting the effects of light limitation within macroalgal communities.	[Desmond, Matthew J.; Pritchard, Daniel W.; Hepburn, Christopher D.] Univ Otago, Dept Marine Sci, Dunedin, New Zealand	University of Otago	Desmond, MJ (corresponding author), Univ Otago, Dept Marine Sci, Dunedin, New Zealand.	matthew.j.desmond@gmail.com		Pritchard, Daniel/0000-0001-8335-5971	Tertiary Education Commission; University of Otago	Tertiary Education Commission; University of Otago	This study was funded in part by a Tertiary Education Commission scholarship to MJD. All additional funding was provided by the University of Otago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Anthony KRN, 2004, LIMNOL OCEANOGR, V49, P2201, DOI 10.4319/lo.2004.49.6.2201; Aumack CF, 2007, J PHYCOL, V43, P853, DOI 10.1111/j.1529-8817.2007.00383.x; Borum J, 1996, OIKOS, V76, P406, DOI 10.2307/3546213; Bruno JF, 2005, ECOL LETT, V8, P1165, DOI 10.1111/j.1461-0248.2005.00823.x; Brzezinski MA, 2013, OCEANOGRAPHY, V26, P114, DOI 10.5670/oceanog.2013.53; Casas G, 2004, BIOL INVASIONS, V6, P411, DOI 10.1023/B:BINV.0000041555.29305.41; Chadderton WL, 2000, NEW ZEAL J MAR FRESH, V34, P487, DOI 10.1080/00288330.2000.9516951; Collings GJ, 1998, AUST J BOT, V46, P657; Colombo-Pallotta MF, 2006, J PHYCOL, V42, P1225, DOI 10.1111/j.1529-8817.2006.00287.x; Connell SD, 2005, MAR ECOL PROG SER, V289, P53, DOI 10.3354/meps289053; Connell SD, 2008, MAR ECOL PROG SER, V360, P63, DOI 10.3354/meps07526; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; DAYTON PK, 1984, ECOL MONOGR, V54, P253, DOI 10.2307/1942498; Dean PR, 2007, J PHYCOL, V43, P1138, DOI 10.1111/j.1529-8817.2007.00416.x; DUGGINS DO, 1989, SCIENCE, V245, P170, DOI 10.1126/science.245.4914.170; Fairhead VA, 2004, MAR BIOL, V145, P415, DOI 10.1007/s00227-004-1330-x; Gattuso JP, 2006, BIOGEOSCIENCES, V3, P489, DOI 10.5194/bg-3-489-2006; GERARD VA, 1988, MAR BIOL, V97, P25, DOI 10.1007/BF00391242; Gorgula SK, 2004, MAR BIOL, V145, P613, DOI 10.1007/s00227-004-1335-5; Hader DP, 1997, PHOTOCHEM PHOTOBIOL, V66, P1, DOI 10.1111/j.1751-1097.1997.tb03132.x; HANELT D, 1993, MAR ECOL PROG SER, V97, P31, DOI 10.3354/meps097031; Hepburn CD, 2011, GLOBAL CHANGE BIOL, V17, P2488, DOI 10.1111/j.1365-2486.2011.02411.x; Hepburn CD, 2006, HYDROBIOLOGIA, V560, P373, DOI 10.1007/s10750-005-1573-7; Hepburn CD, 2007, MAR ECOL PROG SER, V339, P99, DOI 10.3354/meps339099; Hurd CL, 2004, PHYCOL RES, V52, P80, DOI 10.1111/j.1440-183.2004.00331.x; Johansson G, 2002, MAR ECOL PROG SER, V244, P63, DOI 10.3354/meps244063; Kerswell AP, 2006, ECOLOGY, V87, P2479, DOI 10.1890/0012-9658(2006)87[2479:GBPOBM]2.0.CO;2; Koch EM, 2001, ESTUARIES, V24, P1, DOI 10.2307/1352808; Konar B, 2009, MAR ECOL-EVOL PERSP, V30, P63, DOI 10.1111/j.1439-0485.2008.00259.x; Krause-Jensen D, 1998, LIMNOL OCEANOGR, V43, P396, DOI 10.4319/lo.1998.43.3.0396; Levin PS, 2002, ECOLOGY, V83, P3182, DOI 10.2307/3071852; Ling SD, 2008, OECOLOGIA, V156, P883, DOI 10.1007/s00442-008-1043-9; Long MH, 2012, LIMNOL OCEANOGR-METH, V10, P416, DOI 10.4319/lom.2012.10.416; LUNING K, 1979, HELGOLAND WISS MEER, V32, P403, DOI 10.1007/BF02277985; Madsen JD, 2001, HYDROBIOLOGIA, V444, P71, DOI 10.1023/A:1017520800568; MARKAGER S, 1992, MAR ECOL PROG SER, V88, P83, DOI 10.3354/meps088083; MCGLONE MS, 1995, J ROY SOC NEW ZEAL, V25, P1, DOI 10.1080/03014223.1995.9517480; McGlone MS, 1996, NEW ZEAL J BOT, V34, P369; Miller RJ, 2011, LIMNOL OCEANOGR, V56, P119, DOI 10.4319/lo.2011.56.1.0119; Neto AI, 2001, HELGOLAND MAR RES, V55, P101, DOI 10.1007/s101520100074; Oigman-Pszczol SS, 2004, MAR ECOL-P S Z N I, V25, P173, DOI 10.1111/j.1439-0485.2004.00018.x; Palumbi SR, 2009, FRONT ECOL ENVIRON, V7, P204, DOI 10.1890/070135; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pritchard DW, 2014, REV, P1; Pritchard DW, 2013, J PHYCOL, V13, P1; RAMUS J, 1977, MAR BIOL, V42, P293, DOI 10.1007/BF00402191; RAMUS J, 1976, MAR BIOL, V37, P223, DOI 10.1007/BF00387607; Raven JA, 2000, J MAR BIOL ASSOC UK, V80, P1, DOI 10.1017/S0025315499001526; Reed DC, 2008, ECOLOGY, V89, P2493, DOI 10.1890/07-1106.1; Reed DC, 2011, ECOLOGY, V92, P2108, DOI 10.1890/11-0377.1; Ruffin KK, 1998, ESTUAR COAST SHELF S, V47, P579, DOI 10.1006/ecss.1998.0366; SCHIEL DR, 1990, HYDROBIOLOGIA, V192, P59, DOI 10.1007/BF00006227; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Stephens TA, 2014, MAR ECOL PROG SER, V515, P97, DOI 10.3354/meps10974; Van Duin EHS, 2001, HYDROBIOLOGIA, V444, P25, DOI 10.1023/A:1017512614680; Walling DE, 2006, GEOMORPHOLOGY, V79, P192, DOI 10.1016/j.geomorph.2006.06.019; Wang R, 2012, NATURE, V492, P419, DOI 10.1038/nature11655; Wernberg T, 2003, DIVERS DISTRIB, V9, P427, DOI 10.1046/j.1472-4642.2003.00048.x; Wernberg T, 2011, CURR BIOL, V21, P1828, DOI 10.1016/j.cub.2011.09.028; Wernberg T, 2008, ESTUAR COAST SHELF S, V76, P265, DOI 10.1016/j.ecss.2007.07.008	62	37	37	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123676	10.1371/journal.pone.0123676	http://dx.doi.org/10.1371/journal.pone.0123676			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902185	gold, Green Published, Green Submitted			2022-12-27	WOS:000353331500059
J	Peng, Y; Yang, WQ; Li, J; Wang, B; Zhang, C; Yue, K; Wu, FZ				Peng, Yan; Yang, Wanqin; Li, Jun; Wang, Bin; Zhang, Chuan; Yue, Kai; Wu, Fuzhong			Contribution of Soil Fauna to Foliar Litter-Mass Loss in Winter in an Ecotone between Dry Valley and Montane Forest in the Upper Reaches of the Minjiang River	PLOS ONE			English	Article							SNOW COVER; DECOMPOSITION; CLIMATE; TEMPERATURE; STRESS; QUALITY; TRAITS; GROWTH; CARBON; TUNDRA	Litter decomposition during winter can provide essential nutrients for plant growth in the subsequent growing season, which plays important role in preventing the expansion of dry areas and maintaining the stability of ecotone ecosystems. However, limited information is currently available on the contributions of soil fauna to litter decomposition during winter in such ecosystems. Therefore, a field experiment that included litterbags with two different mesh sizes (0.04 mm and 3 mm) was conducted to investigate the contribution of soil fauna to the loss of foliar litter mass in winter from November 2013 to April 2014 along the upper reaches of the Minjiang River. Two litter types of the dominant species were selected in each ecosystem: cypress (Cupressus chengiana) and oak (Quercus baronii) in ecotone; cypress (Cupressus chengiana) and clovershrub (Campylotropis macrocarpa) in dry valley; and fir (Abies faxoniana) and birch (Betula albosinensis) in montane forest. Over one winter incubation, foliar litter lost 6.0%-16.1%, 11.4%-26.0%, and 6.4%-8.5% of initial mass in the ecotone, dry valley and montane forest, respectively. Soil fauna showed obvious contributions to the loss of foliar litter mass in all of the ecosystems. The highest contribution (48.5%-56.8%) was observed in the ecotone, and the lowest contribution (0.4%-25.8%) was observed in the montane forest. Compared with other winter periods, thawing period exhibited higher soil fauna contributions to litter mass loss in ecotone and dry valley, but both thawing period and freezing period displayed higher soil fauna contributions in montane forest. Statistical analysis demonstrated that the contribution of soil fauna was significantly correlated with temperature and soil moisture during the winter-long incubation. These results suggest that temperature might be the primary control factor in foliar litter decomposition, but more active soil fauna in the ecotone could contribute more in litter decomposition and its related ecological processes in this region.	[Peng, Yan; Yang, Wanqin; Li, Jun; Wang, Bin; Zhang, Chuan; Yue, Kai; Wu, Fuzhong] Sichuan Agr Univ, Long Term Res Stn Alpine Forest Ecosyst, Key Lab Ecol Forestry Engn, Inst Ecol & Forestry, Chengdu 611130, Sichuan, Peoples R China	Sichuan Agricultural University	Wu, FZ (corresponding author), Sichuan Agr Univ, Long Term Res Stn Alpine Forest Ecosyst, Key Lab Ecol Forestry Engn, Inst Ecol & Forestry, Chengdu 611130, Sichuan, Peoples R China.	wufzchina@163.com	Yue, Kai/N-6962-2017; Li, Jun/GWR-0996-2022	Yue, Kai/0000-0002-7709-8523; Li, Jun/0000-0001-6459-4117	National Natural Science Foundation of China [31270498, 31170423]; National Key Technologies R D of China [2011BAC09B05]; Sichuan Youth Sci-tech Foundation [2012JQ0008, 2012JQ0059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies R D of China(National Key Technology R&D Program); Sichuan Youth Sci-tech Foundation	This research was financially supported by the National Natural Science Foundation of China (31270498 and 31170423), National Key Technologies R & D of China (2011BAC09B05), and Sichuan Youth Sci-tech Foundation (2012JQ0008 and 2012JQ0059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey RG, 2004, ENVIRON MANAGE, V34, pS14, DOI 10.1007/s00267-003-0163-6; Banon S, 2004, SCI HORTIC-AMSTERDAM, V101, P333, DOI 10.1016/j.scienta.2003.11.007; Baptist F, 2010, PLANT SOIL, V328, P397, DOI 10.1007/s11104-009-0119-6; Berg B., 2014, PLANT ECOL, V3; Bhunia A, 2013, S ASIAN J MANAG, V20, P154; Bo Tan, 2010, Acta Ecologica Sinica, V30, P93; Bokhorst S, 2010, SOIL BIOL BIOCHEM, V42, P611, DOI 10.1016/j.soilbio.2009.12.011; Brandt LA, 2010, ECOSYSTEMS, V13, P765, DOI 10.1007/s10021-010-9353-2; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; David JF, 2014, SOIL BIOL BIOCHEM, V76, P109, DOI 10.1016/j.soilbio.2014.05.009; Edwards AC, 2007, QUATERN INT, V162, P172, DOI 10.1016/j.quaint.2006.10.027; Flora Ebo S, 1999, FLORA EBOS FLORA SIC; Garcia-Palacios P, 2013, ECOL LETT, V16, P1045, DOI 10.1111/ele.12137; Gonzalez G, 2001, ECOLOGY, V82, P955, DOI 10.1890/0012-9658(2001)082[0955:SFAPLD]2.0.CO;2; Gracas M. A., 2005, METHODS STUDY LITTER; Haimi J, 2005, APPL SOIL ECOL, V30, P104, DOI 10.1016/j.apsoil.2005.02.006; Heemsbergen DA, 2004, SCIENCE, V306, P1019, DOI 10.1126/science.1101865; Hunter MD, 2003, PEDOBIOLOGIA, V47, P101, DOI 10.1078/0031-4056-00174; Kage H, 2004, EUR J AGRON, V20, P379, DOI 10.1016/S1161-0301(03)00061-3; Li X., 2014, Acta Ecologica Sinica - International Journal, V34, P290, DOI 10.1016/j.chnaes.2014.09.001; Liu B, 2001, SHENG TAI XUE BAO, V31, P58; [刘彬 Liu Bin], 2012, [水土保持学报, Journal of Soil and Water Conservation], V26, P121; Lu R.K, 1999, SOIL ARGROCHEMISTRY; Maestre FT, 2005, J ECOL, V93, P748, DOI 10.1111/j.1365-2745.2005.01017.x; Makkonen M, 2012, ECOL LETT, V15, P1033, DOI 10.1111/j.1461-0248.2012.01826.x; Meyer III WM, 2001, SOIL BIOL BIOCHEM, V43, P206; Odum E., 2004, FUNDAMENTALS ECOLOGY, V5th; Prescott CE, 2010, BIOGEOCHEMISTRY, V101, P133, DOI 10.1007/s10533-010-9439-0; Schneider T, 2012, ISME J, V6, P1749, DOI 10.1038/ismej.2012.11; Shaw MR, 2001, ECOL APPL, V11, P1206, DOI 10.2307/3061022; Sjogersten S, 2004, PLANT SOIL, V262, P215, DOI 10.1023/B:PLSO.0000037044.63113.fe; Song XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068858; Sponseller RA, 2006, ECOSYSTEMS, V9, P344, DOI 10.1007/s10021-005-0167-6; Swift M.J., 1979, DECOMPOSITION TERRES, V5; TAKEDA H, 1988, PEDOBIOLOGIA, V32, P221; [唐家良 TANG Jialiang], 2009, [山地学报, Journal of Mountain Science], V27, P531; TAYLOR BR, 1988, SOIL BIOL BIOCHEM, V20, P657, DOI 10.1016/0038-0717(88)90150-2; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; WALSH JE, 1985, MON WEATHER REV, V113, P756, DOI 10.1175/1520-0493(1985)113<0756:IOSCAS>2.0.CO;2; Wang Q, 1997, CHINESE BIODIVERSITY, V5, P126; Wang SJ, 2010, ECOL RES, V25, P1113, DOI 10.1007/s11284-010-0736-9; Ward SE, 2015, ECOLOGY, V96, P113, DOI 10.1890/14-0292.1; Wu F, 2014, BIOGEOSCIENCES, V11, P6871, DOI 10.5194/bg-11-6871-2014; Wu FZ, 2009, J ARID ENVIRON, V73, P1067, DOI 10.1016/j.jaridenv.2009.06.007; Wu FZ, 2010, ACTA OECOL, V36, P135, DOI 10.1016/j.actao.2009.11.002; Xin WD, 2012, J ARID ENVIRON, V77, P90, DOI 10.1016/j.jaridenv.2011.10.001; Yang QP, 2014, PLANT SOIL, V374, P449, DOI 10.1007/s11104-013-1882-y; Yang WQ, 2005, PEDOSPHERE, V15, P653; Yang XD, 2009, SOIL BIOL BIOCHEM, V41, P910, DOI 10.1016/j.soilbio.2008.12.028; Zhu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062073; Zhu JX, 2012, SCAND J FOREST RES, V27, P586, DOI 10.1080/02827581.2012.670726; Zwahlen C, 2007, PLANT SOIL, V300, P245, DOI 10.1007/s11104-007-9410-6	52	7	12	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124605	10.1371/journal.pone.0124605	http://dx.doi.org/10.1371/journal.pone.0124605			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901894	Green Submitted, gold, Green Published			2022-12-27	WOS:000353331500095
J	Al Kayal, T; Panetta, D; Canciani, B; Losi, P; Tripodi, M; Burchielli, S; Ottoni, P; Salvadori, PA; Soldani, G				Al Kayal, Tamer; Panetta, Daniele; Canciani, Barbara; Losi, Paola; Tripodi, Maria; Burchielli, Silvia; Ottoni, Priscilla; Salvadori, Piero Antonio; Soldani, Giorgio			Evaluation of the Effect of a Gamma Irradiated DBM-Pluronic F127 Composite on Bone Regeneration in Wistar Rat	PLOS ONE			English	Article							DRUG-DELIVERY; BLOCK-COPOLYMERS; FIBRIN SEALANT; MATRIX; STERILIZATION; SUBSTITUTES; MARROW; GRAFTS; DEFECT; OSTEOINDUCTIVITY	Demineralized bone matrix (DBM) is widely used for bone regeneration. Since DBM is prepared in powder form its handling properties are not optimal and limit the clinical use of this material. Various synthetic and biological carriers have been used to enhance the DBM handling. In this study we evaluated the effect of gamma irradiation on the physical-chemical properties of Pluronic and on bone morphogenetic proteins (BMPs) amount in DBM samples. In vivo studies were carried out to investigate the effect on bone regeneration of a gamma irradiated DBM-Pluronic F127 (DBM-PF127) composite implanted in the femur of rats. Gamma irradiation effects (25 kGy) on physical-chemical properties of Pluronic F127 were investigated by rheological and infrared analysis. The BMP-2/BMP-7 amount after DBM irradiation was evaluated by ELISA. Bone regeneration capacity of DBM-PF127 containing 40% (w/w) of DBM was investigated in transcortical holes created in the femoral diaphysis of Wistar rat. Bone porosity, repaired bone volume and tissue organization were evaluated at 15, 30 and (0 days by Micro-CT and histological analysis. The results showed that gamma irradiation did not induce significant modification on physical-chemical properties of Pluronic, while a decrease in BMP-2/BMP-7 amount was evidenced in sterilized DBM. Micro-CT and histological evaluation at day 15 post-implantation revealed an interconnected trabeculae network in medullar cavity and cellular infiltration and vascularization of DBM-PF127 residue. In contrast a large rate of not connected trabeculae was observed in Pluronic filled and unfilled defects. At 30 and 90 days the DBM-PF127 samples shown comparable results in term of density and thickness of the new formed tissue respect to unfilled defect. In conclusion a gamma irradiated DBM-PF127 composite, although it may have undergone a significant decrease in the concentration of BMPs, was able to maintains bone regeneration capability.	[Al Kayal, Tamer; Panetta, Daniele; Losi, Paola; Tripodi, Maria; Ottoni, Priscilla; Salvadori, Piero Antonio; Soldani, Giorgio] CNR, Inst Clin Physiol, I-56100 Pisa, Italy; [Canciani, Barbara] Univ & IRCCS AOU San Martino IST, Natl Inst Canc Res, DIMES, Genoa, Italy; [Burchielli, Silvia] CNR, Tuscany G Monasterio Fdn, I-56100 Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Genoa; IRCCS AOU San Martino IST; Consiglio Nazionale delle Ricerche (CNR)	Al Kayal, T (corresponding author), CNR, Inst Clin Physiol, I-56100 Pisa, Italy.	alkayal.tamer@ifc.cnr.it	Panetta, Daniele/A-8580-2013; Salvadori, Piero A/B-2342-2012; Canciani, Barbara/AAJ-6943-2020	Panetta, Daniele/0000-0002-4184-0175; Salvadori, Piero A/0000-0001-6114-1059; Canciani, Barbara/0000-0003-1942-1174; Al Kayal, Tamer/0000-0002-5700-5326				Angle SR, 2012, J MUSCULOSKEL NEURON, V12, P28; [Anonymous], [No title captured]; Araujo MVF, 2010, CLIN ORAL IMPLAN RES, V21, P632, DOI 10.1111/j.1600-0501.2009.01864.x; Bano I, 2014, INT J BIOL MACROMOL, V65, P81, DOI 10.1016/j.ijbiomac.2014.01.015; Barbieri D, 2011, ACTA BIOMATER, V7, P2007, DOI 10.1016/j.actbio.2011.01.017; Batrakova EV, 2008, J CONTROL RELEASE, V130, P98, DOI 10.1016/j.jconrel.2008.04.013; Clokie CML, 2002, J CRANIOFAC SURG, V13, P111, DOI 10.1097/00001665-200201000-00026; Cory E, 2010, J BIOMECH, V43, P953, DOI 10.1016/j.jbiomech.2009.10.047; Di Bella C, 2010, CLIN ORTHOP RELAT R, V468, P3047, DOI 10.1007/s11999-010-1430-5; Dorati R, 2008, AAPS PHARMSCITECH, V9, P718, DOI 10.1208/s12249-008-9103-3; DORPEMA JW, 1990, RADIAT PHYS CHEM, V35, P357; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Dumortier G, 2006, PHARM RES-DORDR, V23, P2709, DOI 10.1007/s11095-006-9104-4; Dziedzic-Goclawska Anna, 2005, Cell and Tissue Banking, V6, P201, DOI 10.1007/s10561-005-0338-x; El-Bagory I.M., 2010, AUST J BASIC APPL SC, V4, P4490; Elluru M, 2013, POLYMER, V54, P2088, DOI 10.1016/j.polymer.2013.02.017; Escobar-Chavez JJ, 2006, J PHARM PHARM SCI, V9, P339; Gertzman AA, 2005, STERILISATION TISSUE, P151; Groeneveld EHJ, 1999, J BIOMED MATER RES, V48, P393, DOI 10.1002/(SICI)1097-4636(1999)48:4<393::AID-JBM1>3.0.CO;2-C; HABAL MB, 1994, CLIN PLAST SURG, V21, P525; HALLFELDT KKJ, 1992, UNFALLCHIRURG, V95, P313; Han B, 2008, J ORTHOP RES, V26, P75, DOI 10.1002/jor.20478; Hayzlett M, 2005, STERILISATION TISSUE, P117; Jayasuriya AC, 2009, J MATER SCI-MATER M, V20, P1637, DOI 10.1007/s10856-009-3738-9; Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3; Katz JM, 2009, J BIOMED MATER RES B, V89B, P127, DOI 10.1002/jbm.b.31195; Keles H, 2014, VIB SPECTROSC, V71, P76, DOI 10.1016/j.vibspec.2014.01.012; Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025; LASA C, 1995, PLAST RECONSTR SURG, V96, P1409, DOI 10.1097/00006534-199511000-00027; Lelovas PP, 2008, COMPARATIVE MED, V58, P424; Li XD, 2006, BIOMATERIALS, V27, P2426, DOI 10.1016/j.biomaterials.2005.11.040; Li YY, 2013, MAT SCI ENG C-MATER, V33, P2698, DOI 10.1016/j.msec.2013.02.036; Lippens E, 2010, TISSUE ENG PT A, V16, P617, DOI [10.1089/ten.tea.2009.0418, 10.1089/ten.TEA.2009.0418]; Ma WD, 2008, DRUG DEV IND PHARM, V34, P258, DOI 10.1080/03639040701580622 ; Panetta D, 2012, PHYS MEDICA, V28, P166, DOI 10.1016/j.ejmp.2011.03.006; Pekkarinen T, 2004, INT ORTHOP, V28, P97, DOI 10.1007/s00264-003-0524-z; Qiu QQ, 2008, J BIOMED MATER RES A, V87A, P373, DOI 10.1002/jbm.a.31790; Qiu QQ, 2007, J BIOMED MATER RES B, V81B, P516, DOI 10.1002/jbm.b.30692; Russel W. M. S., 1959, PRINC HUM EXP TECH; Sandhu HS, 1999, ORTHOP CLIN N AM, V30, P685, DOI 10.1016/S0030-5898(05)70120-6; Schwartz Z, 2008, CLIN ORAL IMPLAN RES, V19, P1233, DOI 10.1111/j.1600-0501.2008.01582.x; Schwartz Z, 2007, CLIN ORAL IMPLAN RES, V18, P204, DOI 10.1111/j.1600-0501.2006.01303.x; SCHWARZ N, 1989, CLIN ORTHOP RELAT R, P282; Takikawa S, 2003, J BIOMED MATER RES A, V65A, P37, DOI 10.1002/jbm.a.10345; Tian M, 2012, ACTA BIOMATER, V8, P753, DOI 10.1016/j.actbio.2011.10.030; Trojani C, 2006, BIOMATERIALS, V27, P3256, DOI 10.1016/j.biomaterials.2006.01.057; Wildemann B., 2007, Cell and Tissue Banking, V8, P107, DOI 10.1007/s10561-006-9021-0; Zhou AJJ, 2007, J CRANIOFAC SURG, V18, P1264, DOI 10.1097/scs.0b013e318158cb1a; Ziran Bruce, 2005, Am J Orthop (Belle Mead NJ), V34, P329	49	18	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0125110	10.1371/journal.pone.0125110	http://dx.doi.org/10.1371/journal.pone.0125110			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897753	Green Submitted, Green Published, gold			2022-12-27	WOS:000353212600097
J	Chen, R; Yan, JC; Liu, PJ; Wang, ZQ				Chen, Rui; Yan, Jinchuan; Liu, Peijing; Wang, Zhongqun			Effects of Thiazolidinedione Therapy on Inflammatory Markers of Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							IMPROVE VASCULAR FUNCTION; PEROXISOME PROLIFERATOR; ROSIGLITAZONE TREATMENT; PLAQUE INFLAMMATION; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; GLYCEMIC CONTROL; DOUBLE-BLIND; PIOGLITAZONE; MELLITUS	Background Inflammation is a common feature in patients with type 2 diabetes mellitus (T2DM). This meta-analysis aimed to assess the influence of thiazolidinedione (TZD) therapy on the circulating levels of inflammatory markers in patients with T2DM. Methods and Results We searched the databases Medline, Embase, ScienceDirect, Web of Science, Springer-Link, and the Cochrane Library for randomized controlled trials (RCTs) that examined the effects of thiazolidinedione vs. a placebo on patients with T2DM. The main outcomes were absolute changes in levels of circulating inflammatory markers. Twenty-seven RCTs were included and data were analyzed using a fixed-effect model or a random-effect model based on heterogeneity. Pooled results indicated that circulating levels of high-sensitivity C reactive protein (hsCRP; SMD = -0.65, 95% CI = -0.98 to -0.32, p < 0.01), monocyte chemoattractant protein-1 (MCP-1; WMD = -54.19, 95% CI = -73.86 to -34.52, p < 0.01), von Willebrand factor% (vWF%; WMD = -8.18, 95% CI = -13.54 to -2.81, p 0.01), fibrinogen (SMD = -0.26, 95% CI = -0.41 to -0.11, p < 0.01) and E-selectin(WMD = -3.57, 95% CI = -5.59 to -1.54, p < 0.01) were significantly decreased after TZD therapy. However, interleukin-6 (IL-6), matrix metalloproteinase-9 (MMP-9), soluble CD40 ligand, plasminogen activator inhibitor 1 (PAI-1) and intercellular adhesion molecule (ICAM-1) were not significantly affected. Subgroup analyses of PAI-1, vWF% and fibrinogen in terms of trial drugs showed significant reductions for rosiglitazone (all p valuses<0.05), but not pioglitazone treatment. Conversely, the E-selectin (p < 0.01) lowering effect only existed in the pioglitazone group. Further, rosiglitazone and pioglitazone treatment reduced serum hsCRP and MCP-1 but had no marked effects on MMP-9, IL-6 and ICAM-1. Conclusions Limited evidence suggested that TZD therapy had anti-inflammatory property that might contribute to its beneficial effect on inflammatory state in patients with type 2 diabetes.	[Chen, Rui; Yan, Jinchuan; Liu, Peijing; Wang, Zhongqun] Jiangsu Univ, Affiliated Hosp, Dept Cardiol, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University	Yan, JC (corresponding author), Jiangsu Univ, Affiliated Hosp, Dept Cardiol, Zhenjiang, Jiangsu, Peoples R China.	yanjinchuan@hotmail.com			Natural Science Foundation; development health engineering of Jiangsu Province [BK2011486, LJ201116]; National Natural Science Foundation of China [81170279, 81370409]; Key Laboratory of Cardiovascular disease of Zhenjiang [SS2012002]	Natural Science Foundation(National Natural Science Foundation of China (NSFC)); development health engineering of Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Cardiovascular disease of Zhenjiang	This project was supported by the Natural Science Foundation and the development health engineering of Jiangsu Province (BK2011486, LJ201116) and National Natural Science Foundation of China (81170279, 81370409) and Key Laboratory of Cardiovascular disease of Zhenjiang (SS2012002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2006, AM J PHYSIOL-RENAL, V290, pF600, DOI 10.1152/ajprenal.00289.2005; Andreozzi F, 2006, DIABETES, V55, P2021, DOI 10.2337/db06-0063; Bertrand OF, 2010, ATHEROSCLEROSIS, V211, P565, DOI 10.1016/j.atherosclerosis.2010.06.005; Celinski K, 2012, J PHYSIOL PHARMACOL, V63, P631; Chan DT, 2011, NEPHROL DIAL TRANSPL, V26, P3543, DOI 10.1093/ndt/gfr049; Colmers IN, 2012, CAN MED ASSOC J, V184, pE675, DOI 10.1503/cmaj.112102; Cruz NG, 2013, DIABETES RES CLIN PR, V99, P85, DOI 10.1016/j.diabres.2012.09.003; Davidson JA, 2007, CLIN THER, V29, P1900, DOI 10.1016/j.clinthera.2007.09.011; Derosa G, 2010, J CLIN PHARM THER, V35, P565, DOI 10.1111/j.1365-2710.2009.01132.x; Fidan E, 2011, ACTA DIABETOL, V48, P297, DOI 10.1007/s00592-011-0276-y; Finn AV, 2009, AM HEART J, V157, DOI 10.1016/j.ahj.2008.11.013; Forst T, 2008, ATHEROSCLEROSIS, V197, P311, DOI 10.1016/j.atherosclerosis.2007.05.006; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Gada E, 2013, AM HEART J, V165, P609, DOI 10.1016/j.ahj.2013.01.006; Goldberg RB, CYTOKINE CYTOKINE LI; Gruzdeva O, 2013, J INFLAMM RES, V6, P83, DOI 10.2147/JIR.S43081; Haffner SM, 2002, CIRCULATION, V106, P679, DOI 10.1161/01.CIR.0000025403.20953.23; Halvorsen B, 2010, EUR J ENDOCRINOL, V162, P267, DOI 10.1530/EJE-09-0706; Hanefeld M, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-65; Hartemann-Heurtier A, 2009, DIABETES RES CLIN PR, V86, P37, DOI 10.1016/j.diabres.2009.06.028; Hong SJ, 2010, ARTERIOSCL THROM VAS, V30, P2655, DOI 10.1161/ATVBAHA.110.212670; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Imig JD, 2012, EXP BIOL MED, V237, P1402, DOI 10.1258/ebm.2012.012225; Kelly AS, 2007, VASC MED, V12, P311, DOI 10.1177/1358863x07084200; Kharazmkia A, 2014, IRAN J KIDNEY DIS, V8, P408; Kiyici S, 2009, DIABETES RES CLIN PR, V86, P44, DOI 10.1016/j.diabres.2009.07.004; Klingenberg R, 2012, CURR PHARM DESIGN, V18, P4358, DOI 10.2174/138161212802481219; Langenfeld MR, 2005, CIRCULATION, V111, P2525, DOI 10.1161/01.CIR.0000165072.01672.21; Marfella R, 2006, DIABETES, V55, P622, DOI 10.2337/diabetes.55.03.06.db05-0832; Martens FMAC, 2006, EUR HEART J, V27, P1605, DOI 10.1093/eurheartj/ehl079; Meisner F, 2006, ARTERIOSCL THROM VAS, V26, P845, DOI 10.1161/01.ATV.0000203511.66681.7f; Mizoguchi M, 2011, JACC-CARDIOVASC IMAG, V4, P1110, DOI 10.1016/j.jcmg.2011.08.007; Monroy A, 2009, DIABETOLOGIA, V52, P2169, DOI 10.1007/s00125-009-1451-3; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561; Ogasawara D, 2009, CIRC J, V73, P343, DOI 10.1253/circj.CJ-08-0699; Paneni F, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0419-z; Pfutzner A, 2005, J AM COLL CARDIOL, V45, P1925, DOI 10.1016/j.jacc.2005.03.041; Pop-Busui R, 2009, METABOLISM, V58, P989, DOI 10.1016/j.metabol.2009.02.020; Ramkalawan H, 2012, INFLAMMATION, V35, P1338, DOI 10.1007/s10753-012-9447-4; Ren LQ, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-10; Schalkwijk CG, 2005, CLIN SCI, V109, P143, DOI 10.1042/CS20050025; Schondorf Thomas, 2011, J Diabetes Sci Technol, V5, P426; Stocker DJ, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.11.005; Subramani PA, 2013, ENDOCR METAB IMMUNE, V13, P175, DOI 10.2174/18715303113139990003; Tousoulis D, 2007, INT J CARDIOL, V115, P203, DOI 10.1016/j.ijcard.2006.03.011; Tripathy D, 2013, DIABETOLOGIA, V56, P2153, DOI 10.1007/s00125-013-2976-z; van den Oever IAM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/792393; Virdis A, 2014, MATURITAS, V78, P179, DOI 10.1016/j.maturitas.2014.04.012; Yener S, 2009, MED PRIN PRACT, V18, P266, DOI 10.1159/000215722; Yu J, 2007, METABOLISM, V56, P1396, DOI 10.1016/j.metabol.2007.05.011	50	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123703	10.1371/journal.pone.0123703	http://dx.doi.org/10.1371/journal.pone.0123703			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897968	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600040
J	Lindwall, F; Faubert, P; Rinnan, R				Lindwall, Frida; Faubert, Patrick; Rinnan, Riikka			Diel Variation of Biogenic Volatile Organic Compound Emissions- A field Study in the Sub, Low and High Arctic on the Effect of Temperature and Light	PLOS ONE			English	Article							MONOTERPENE EMISSIONS; ISOPRENE EMISSION; PLANT VOLATILES; INNER-MONGOLIA; SCOTS PINE; VEGETATION; VOC; TUNDRA; BIOSYNTHESIS; EXCHANGE	Many hours of sunlight in the midnight sun period suggest that significant amounts of biogenic volatile organic compounds (BVOCs) may be released from arctic ecosystems during night-time. However, the emissions from these ecosystems are rarely studied and limited to point measurements during daytime. We measured BVOC emissions during 24-hour periods in the field using a push-pull chamber technique and collection of volatiles in adsorbent cartridges followed by analysis with gas chromatography-mass spectrometry. Five different arctic vegetation communities were examined: high arctic heaths dominated by Salix arctica and Cassiope tetragona, low arctic heaths dominated by Salix glauca and Betula nana and a subarctic peatland dominated by the moss Warnstorfia exannulata and the sedge Eriophorum russeolum. We also addressed how climate warming affects the 24-hour emission and how the daytime emissions respond to sudden darkness. The emissions from the high arctic sites were lowest and had a strong diel variation with almost no emissions during night-time. The low arctic sites as well as the subarctic site had a more stable release of BVOCs during the 24-hour period with night-time emissions in the same range as those during the day. These results warn against overlooking the night period when considering arctic emissions. During the day, the quantity of BVOCs and the number of different compounds emitted was higher under ambient light than in darkness. The monoterpenes alpha-fenchene, alpha -phellandrene, 3-carene and alpha-terpinene as well as isoprene were absent in dark measurements during the day. Warming by open top chambers increased the emission rates both in the high and low arctic sites, forewarning higher emissions in a future warmer climate in the Arctic.	[Lindwall, Frida; Rinnan, Riikka] Univ Copenhagen, Dept Biol, Terr Ecol sect, Copenhagen, Denmark; [Lindwall, Frida; Rinnan, Riikka] Univ Copenhagen, Ctr Permafrost, Dept Geosci & Nat Resource Management, Copenhagen, Denmark; [Faubert, Patrick] Univ Quebec Chicoutimi, Dept Sci Fondamentales, Chaire Ecoconseil, Chicoutimi, PQ, Canada	University of Copenhagen; University of Copenhagen; University of Quebec; University of Quebec Chicoutimi	Lindwall, F (corresponding author), Univ Copenhagen, Dept Biol, Terr Ecol sect, Copenhagen, Denmark.	frida.lindwall@bio.ku.dk	Rinnan, Riikka/AAB-8552-2019; Faubert, Patrick/L-2555-2019; Rinnan, Riikka/C-9771-2010	Rinnan, Riikka/0000-0001-7222-700X; Rinnan, Riikka/0000-0001-7222-700X; Faubert, Patrick/0000-0003-0237-3188; lindstein, frida/0000-0002-3981-5966	Villum foundation; Emil Aaltonen Foundation; Danish Council for Independent Research \ Natural Sciences; Danish National Research Foundation [CENPERM DNRF100]; Villum Fonden [00007189] Funding Source: researchfish	Villum foundation(Villum Fonden); Emil Aaltonen Foundation; Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF)); Danish National Research Foundation(Danmarks Grundforskningsfond); Villum Fonden(Villum Fonden)	Financial support was given to RR by the Villum foundation, the Emil Aaltonen Foundation and the Danish Council for Independent Research vertical bar Natural Sciences. The Danish National Research Foundation supported the activities within the Center for Permafrost (CENPERM DNRF100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen H, 2011, AGR FOREST METEOROL, V151, P682, DOI 10.1016/j.agrformet.2010.12.010; Agelopoulos NG, 2000, J CHEM ECOL, V26, P497, DOI 10.1023/A:1005473825335; Ammann C, 2004, INT J MASS SPECTROM, V239, P87, DOI 10.1016/j.ijms.2004.08.012; AREY J, 1995, ATMOS ENVIRON, V29, P2977, DOI 10.1016/1352-2310(95)00137-N; Atkinson R, 2000, ATMOS ENVIRON, V34, P2063, DOI 10.1016/S1352-2310(99)00460-4; Bai JH, 2006, ATMOS ENVIRON, V40, P5753, DOI 10.1016/j.atmosenv.2006.05.019; Bokhorst S, 2013, GLOBAL CHANGE BIOL, V19, P64, DOI 10.1111/gcb.12028; Chapin FS, 2000, GLOBAL CHANGE BIOL, V6, P211, DOI 10.1046/j.1365-2486.2000.06022.x; Ciccioli P, 1999, J GEOPHYS RES-ATMOS, V104, P8077, DOI 10.1029/1998JD100026; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; Dudareva N, 2005, P NATL ACAD SCI USA, V102, P933, DOI 10.1073/pnas.0407360102; Duhl TR, 2008, BIOGEOSCIENCES, V5, P761, DOI 10.5194/bg-5-761-2008; Ehn M, 2014, NATURE, V506, P476, DOI 10.1038/nature13032; Ekberg A, 2009, BIOGEOSCIENCES, V6, P601, DOI 10.5194/bg-6-601-2009; Ellebjerg SM, 2008, ADV ECOL RES, V40, P249, DOI 10.1016/S0065-2504(07)00011-6; Fares S, 2013, ENVIRON SCI TECHNOL, V47, P11073, DOI 10.1021/es4022156; Faubert P, 2012, PLANT SOIL, V352, P199, DOI 10.1007/s11104-011-0989-2; Faubert P, 2010, ATMOS ENVIRON, V44, P4432, DOI 10.1016/j.atmosenv.2010.07.039; Faubert P, 2010, ECOSYSTEMS, V13, P860, DOI 10.1007/s10021-010-9362-1; Faubert P, 2010, NEW PHYTOL, V187, P199, DOI 10.1111/j.1469-8137.2010.03270.x; Funk JL, 2004, PLANT CELL ENVIRON, V27, P747, DOI 10.1111/j.1365-3040.2004.01177.x; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Hakola H, 2012, ATMOS CHEM PHYS, V12, P11665, DOI 10.5194/acp-12-11665-2012; Hakola H, 2003, ATMOS ENVIRON, V37, P1623, DOI 10.1016/S1352-2310(03)00014-1; Hakola H, 2001, BOREAL ENVIRON RES, V6, P237; Harley P, 2013, BIOL CONTROLS MODELS, V5, P181; He NP, 2005, J INTEGR PLANT BIOL, V47, P13, DOI 10.1111/j.1744-7909.2005.00004.x; Hillel D., 1982, INTRO SOIL PHYS; Hudson JMG, 2011, GLOBAL CHANGE BIOL, V17, P1013, DOI 10.1111/j.1365-2486.2010.02294.x; Insam H, 2010, BIOL FERT SOILS, V46, P199, DOI 10.1007/s00374-010-0442-3; Kesselmeier J, 1999, J ATMOS CHEM, V33, P23, DOI 10.1023/A:1006127516791; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Laothawornkitkul J, 2009, NEW PHYTOL, V183, P27, DOI 10.1111/j.1469-8137.2009.02859.x; Leff JW, 2008, SOIL BIOL BIOCHEM, V40, P1629, DOI 10.1016/j.soilbio.2008.01.018; Liu XY, 2004, ANALYST, V129, P55, DOI 10.1039/b311998j; Loivamaki M, 2007, PLANT PHYSIOL, V143, P540, DOI 10.1104/pp.106.092759; McBean G, 2005, ARCTIC CLIMATE IMPAC; McKinney KA, 2011, ATMOS CHEM PHYS, V11, P4807, DOI 10.5194/acp-11-4807-2011; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Niinemets U, 2004, TRENDS PLANT SCI, V9, P180, DOI 10.1016/j.tplants.2004.02.006; Niinemets U, 2014, PLANT CELL ENVIRON, V37, P1790, DOI 10.1111/pce.12322; Patankar R, 2013, ECOL EVOL, V3, P375, DOI 10.1002/ece3.467; Penuelas J, 2003, TRENDS PLANT SCI, V8, P105, DOI 10.1016/S1360-1385(03)00008-6; Penuelas J, 2014, PLANT CELL ENVIRON, V37, P1866, DOI 10.1111/pce.12340; Petron G, 2001, GEOPHYS RES LETT, V28, P1707, DOI 10.1029/2000GL011583; Pressley S, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005523; Rinnan R, 2014, PLANT CELL ENVIRON, V37, P1776, DOI 10.1111/pce.12320; Rinne J, 2005, BOREAL ENVIRON RES, V10, P425; Ruuskanen TM, 2005, BOREAL ENVIRON RES, V10, P553; Schollert M, 2014, POLAR BIOL, V37, P237, DOI 10.1007/s00300-013-1427-0; Starr G, 2003, ECOLOGY, V84, P1415, DOI 10.1890/02-3154; Svenningsson B, 2008, TELLUS B, V60, P353, DOI [10.1111/j.1600-0889.2008.00351.x, 10.3402/tellusb.v60i3.16929]; Taipale R, 2011, BIOGEOSCIENCES, V8, P2247, DOI 10.5194/bg-8-2247-2011; Tiiva P, 2008, NEW PHYTOL, V180, P853, DOI 10.1111/j.1469-8137.2008.02587.x; Walker DA, 2005, J VEG SCI, V16, P267, DOI 10.1111/j.1654-1103.2005.tb02365.x; Wiberley AE, 2009, PLANT CELL ENVIRON, V32, P939, DOI 10.1111/j.1365-3040.2009.01980.x; Zini CA, 2001, ANAL CHEM, V73, P4729, DOI 10.1021/ac0103219	59	24	24	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123610	10.1371/journal.pone.0123610	http://dx.doi.org/10.1371/journal.pone.0123610			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897519	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000353212600035
J	Zhu, QD; Song, YL; Zhang, GS; Ju, L; Zhang, JG; Yu, YG; Niu, N; Wang, JW; Ma, SC				Zhu, Qidi; Song, Yulong; Zhang, Gaisheng; Ju, Lan; Zhang, Jiao; Yu, Yongang; Niu, Na; Wang, Junwei; Ma, Shoucai			De Novo Assembly and Transcriptome Analysis of Wheat with Male Sterility Induced by the Chemical Hybridizing Agent SQ-1	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; CLOFENCET; RICE; HETEROSIS; GENE; TOOL; IMPROVEMENT; EXPRESSION; RESOLUTION; PROTEINS	Wheat (Triticum aestivum L.), one of the world's most important food crops, is a strictly autogamous (self-pollinating) species with exclusively perfect flowers. Male sterility induced by chemical hybridizing agents has increasingly attracted attention as a tool for hybrid seed production in wheat; however, the molecular mechanisms of male sterility induced by the agent SQ-1 remain poorly understood due to limited whole transcriptome data. Therefore, a comparative analysis of wheat anther transcriptomes for male fertile wheat and SQ-1-induced male sterile wheat was carried out using next-generation sequencing technology. In all, 42,634,123 sequence reads were generated and were assembled into 82,356 high-quality unigenes with an average length of 724 bp. Of these, 1,088 unigenes were significantly differentially expressed in the fertile and sterile wheat anthers, including 643 up-regulated unigenes and 445 down-regulated unigenes. The differentially expressed unigenes with functional annotations were mapped onto 60 pathways using the Kyoto Encyclopedia of Genes and Genomes database. They were mainly involved in coding for the components of ribosomes, photosynthesis, respiration, purine and pyrimidine metabolism, amino acid metabolism, glutathione metabolism, RNA transport and signal transduction, reactive oxygen species metabolism, mRNA surveillance pathways, protein processing in the endoplasmic reticulum, protein export, and ubiquitin-mediated proteolysis. This study is the first to provide a systematic overview comparing wheat anther transcriptomes of male fertile wheat with those of SQ-1-induced male sterile wheat and is a valuable source of data for future research in SQ-1-induced wheat male sterility.	[Zhu, Qidi; Song, Yulong; Zhang, Gaisheng; Ju, Lan; Zhang, Jiao; Yu, Yongang; Niu, Na; Wang, Junwei; Ma, Shoucai] Northwest A&F Univ, Natl Yangling Agr Biotechnol & Breeding Ctr, Yangling Branch State,Wheat Improvement Ctr, Wheat Breeding Engn Res Ctr,Minist Educ,Key Lab C, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Zhang, GS (corresponding author), Northwest A&F Univ, Natl Yangling Agr Biotechnol & Breeding Ctr, Yangling Branch State,Wheat Improvement Ctr, Wheat Breeding Engn Res Ctr,Minist Educ,Key Lab C, Yangling, Shaanxi, Peoples R China.	zhanggsh58@aliyun.com			National High Tech Research and Development Program of China (863 Program) [2011AA10A106]; National Natural Science Foundation of China [31171611, 31371697]; Key Scientific and Technological Innovation Special Projects of Shaanxi province [2014KTZB02-01-02, 2011KTZB02-01-01]	National High Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Scientific and Technological Innovation Special Projects of Shaanxi province	This work was supported by National High Tech Research and Development Program of China (863 Program) (No. 2011AA10A106), National Natural Science Foundation of China (No. 31171611, 31371697), the Key Scientific and Technological Innovation Special Projects of Shaanxi province (No. 2014KTZB02-01-02, 2011KTZB02-01-01).	Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bushuk W, 1998, EUPHYTICA, V100, P137, DOI 10.1023/A:1018368316547; Cardoso-Silva CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088462; Chakraborty K, 2005, J AGR FOOD CHEM, V53, P7899, DOI 10.1021/jf051458t; Chakraborty K, 2005, J AGR FOOD CHEM, V53, P3468, DOI 10.1021/jf050187j; Chen XiaoWen, 2011, Journal of Triticeae Crops, V31, P630; Chen ZJ, 2010, TRENDS PLANT SCI, V15, P57, DOI 10.1016/j.tplants.2009.12.003; Clark JD, 2004, ORG PROCESS RES DEV, V8, P176, DOI 10.1021/op034123q; Couee I, 2006, J EXP BOT, V57, P449, DOI 10.1093/jxb/erj027; [邓泱泱 DENG Yangyang], 2006, [计算机工程, Computer Engineering], V32, P71; Dong Jian, 2013, Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao, V29, P948; Dong X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072178; Fu DH, 2014, EUPHYTICA, V197, P161, DOI 10.1007/s10681-014-1103-7; Fu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057686; Goff SA, 2013, CURR OPIN PLANT BIOL, V16, P221, DOI 10.1016/j.pbi.2013.03.009; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hansey CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033071; Havey MJ, 2004, MOLECULAR BIOLOGY AND BIOTECHNOLOGY OF PLANT ORGANELLES: CHLOROPLASTS AND MITOCHONDRIA, P623, DOI 10.1007/978-1-4020-3166-3_23; Horgan FG, 2013, ENTOMOL EXP APPL, V148, P1, DOI 10.1111/eea.12080; Huang MD, 2009, PLANT PHYSIOL, V149, P694, DOI 10.1104/pp.108.131128; Hwa CM, 2008, EUPHYTICA, V160, P287, DOI 10.1007/s10681-007-9621-1; Jiao WB, 2013, PLANT J, V75, P954, DOI 10.1111/tpj.12254; Kamran A, 2014, EUPHYTICA, V197, P1, DOI 10.1007/s10681-014-1075-7; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kempe K, 2014, P NATL ACAD SCI USA, V111, P9097, DOI 10.1073/pnas.1402836111; Kempe K, 2011, MOL BREEDING, V27, P417, DOI 10.1007/s11032-011-9555-0; Kindred DR, 2005, EUPHYTICA, V142, P149, DOI 10.1007/s10681-005-1250-y; Lal R, 2007, ADV AGRON, V93, P69, DOI 10.1016/S0065-2113(06)93002-8; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065209; [刘宏伟 Liu Hongwei], 2003, [西北农林科技大学学报. 自然科学版, Journal of northwest sci-tech university of agriculture and forestry], V31, P15; Liu HZ, 2014, ACTA PHYSIOL PLANT, V36, P1473, DOI 10.1007/s11738-014-1525-9; Longin CFH, 2013, THEOR APPL GENET, V126, P2791, DOI 10.1007/s00122-013-2172-z; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Parodi PC, 2009, CIENC INVESTIG AGRAR, V36, P267; Pauly A, 2013, COMPR REV FOOD SCI F, V12, P413, DOI 10.1111/1541-4337.12019; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Sheng Ying, 2011, Scientia Agricultura Sinica, V44, P3937; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Vasil IK, 2007, PLANT CELL REP, V26, P1133, DOI 10.1007/s00299-007-0338-3; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Wang Jun-sheng, 2009, Xibei Zhiwu Xuebao, V29, P1351; Wang JunWei, 2005, Journal of Triticeae Crops, V25, P37; [王振华 Wang Zhenhua], 2003, [西北农林科技大学学报. 自然科学版, Journal of northwest sci-tech university of agriculture and forestry], V31, P43; Wei MingMing, 2009, Molecular Plant Breeding, V7, P679; Wong MML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-342; Wu SW, 2010, CHINESE SCI BULL, V55, P1463, DOI 10.1007/s11434-010-3106-7; Zhai LL, 2014, MOL BREEDING, V33, P611, DOI 10.1007/s11032-013-9978-x; Zhang LongYu, 2011, Acta Agronomica Sinica, V37, P620; Zhang Ming-Zhu, 2010, Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao, V26, P740; Zhou Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091740; Zhu QD, 2013, CHINESE J ANAL CHEM, V41, P565, DOI 10.3724/SP.J.1096.2013.21026; Zhu QD, 2012, CHINESE J ANAL CHEM, V40, P462, DOI 10.3724/SP.J.1096.2012.10820	56	14	18	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123556	10.1371/journal.pone.0123556	http://dx.doi.org/10.1371/journal.pone.0123556			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898130	Green Submitted, Green Published, gold			2022-12-27	WOS:000353212600030
J	Adela, R; Nethi, SK; Bagul, PK; Barui, AK; Mattapally, S; Kuncha, M; Patra, CR; Reddy, PNC; Banerjee, SK				Adela, Ramu; Nethi, Susheel Kumar; Bagul, Pankaj K.; Barui, Ayan K.; Mattapally, Saidulu; Kuncha, Madhusudan; Patra, Chitta R.; Reddy, P. Naveen Chander; Banerjee, Sanjay K.			Hyperglycaemia Enhances Nitric Oxide Production in Diabetes: A Study from South Indian Patients	PLOS ONE			English	Article							HIGH GLUCOSE; SYNTHASE ACTIVITY; SUPEROXIDE; INDIVIDUALS; ENDOTHELIUM; DYSFUNCTION; EXPRESSION; LIVER	Background We have previously reported that increased glucose levels were associated with higher serum nitric oxide (NO) levels in fructose-fed insulin resistant rats. However, the relationship between hyperglycemia and serum NO level was not clear. Therefore, the present study was designed to find the association between hyperglycemia and serum NO levels in Type 2 diabetic (T2DM) patients and T2DM with cardiovascular complication. Methods Endothelial cells (HUVEC) were treated with of D-glucose (10-100mM), and NO levels and NOS gene expression was measured. Hyperglycaemia was induced in Sprague-Dawley rats, and serum NO levels were measured after 8 weeks. For clinical evaluation, five groups of patients were recruited: Control (CT, n=48), Type 2 diabetes (T2DM, n=26), T2DM with hypertension (DMHT, n=46), Coronary artery diseases (CAD, n=29) and T2DM with coronary artery diseases (DMCD, n=38). NO (nitrite + nitrate) levels were measured from human serum. Results We found a significant (p<0.05) and dose-dependent increase in NO levels in HUVEC cells after 4 hours of high glucose exposure. eNOS and iNOS gene expression was increased in HUVEC cells after different concentrations and time periods of glucose treatment. We also observed significant (149.1 +/- 25 mu M, p<0.01) increase in serum NO levels in hyperglycaemic rats compared to control (76.6 +/- 13.2 mu M). Serum NO level was significantly higher in T2DM (111.8 mu M (81.7-122.4), p<0.001) and DMCD patients ((129.4 mu M (121.2-143.5), p<0.001) but not in CAD patients (76.4 mu M (70.5-87)), as compared to control (68.2 mu M (56.4-82.3)). We found significantly lower NO levels (83.5 mu M (60.5-122.9)) in subjects suffering from diabetes since more than 5 years, compared to subjects (115.3 mu M (75.2-127.1), p<0.001) with less than 5 years. Conclusion In conclusion, high NO levels were observed in South Indian diabetic patients. Higher glucose levels in serum might be responsible for activation of endothelial cells to enhance NO levels.	[Adela, Ramu; Bagul, Pankaj K.; Mattapally, Saidulu; Kuncha, Madhusudan; Banerjee, Sanjay K.] CSIR, IICT, Div Med Chem & Pharmacol, Hyderabad 500007, Andhra Pradesh, India; [Reddy, P. Naveen Chander] Mediciti Hosp, Div Cardiol, Hyderabad 500063, Andhra Pradesh, India; CSIR, IICT, Lipid Sci & Technol Div, Biomat Grp, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT)	Banerjee, SK (corresponding author), THSTI, Drug Discovery Res Ctr, Translat Hlth Sci, Faridabad 121001, India.	banerjees74@hotmail.com	Nethi, Susheel/GLN-2719-2022; Dr. Pankaj K. Bagul, M.S Pharm/I-3867-2012; Nethi, Susheel Kumar/S-9324-2019; Saidulu, Mattapally/J-5811-2018; Barui, Ayan Kumar/E-5408-2012	Nethi, Susheel/0000-0002-4138-1618; Nethi, Susheel Kumar/0000-0002-4138-1618; Saidulu, Mattapally/0000-0002-2788-3187; Barui, Ayan Kumar/0000-0003-4475-1183; Adela, Ramu/0000-0003-0909-2557; Banerjee, Sanjay k/0000-0002-0044-0984; Banerjee, Sanjay/0000-0002-0008-0480	Department of Biotechnology (DBT) [BT/HRD/35/02/2006]; Department of Science and Technology (DST), New Delhi [SR/S2/RJN-04/2010, GAP0305]; DST, New Delhi;  [D43 TW 009078]; FOGARTY INTERNATIONAL CENTER [D43TW009078] Funding Source: NIH RePORTER	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Department of Science and Technology (DST), New Delhi(Department of Science & Technology (India)); DST, New Delhi(Department of Science & Technology (India)); ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	SKB is grateful to Department of Biotechnology (DBT) for providing Ramalingaswami Fellowship (BT/HRD/35/02/2006). CRP is grateful to Department of Science and Technology (DST), New Delhi for 'Ramanujan Fellowship grant'(SR/S2/RJN-04/2010; GAP0305). RA is a scholar in the Fogarty International Center of the National Institutes of Health training program under Award Number D43 TW 009078. SKN is thankful to DST, New Delhi for supporting with junior research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktug H, 2012, TURK J MED SCI, V42, P830, DOI 10.3906/sag-1104-38; American Diabetes Association, 2012, DIABETES CARE, V35, P564; American Heart Association-Metabolic Syndrome, 2011, MET SYNDR; Amrita G, 2011, INT J APPL BASIC MED, V1, P31, DOI [10.4103/ 2229- 516X. 81977, DOI 10.4103/2229-516X.81977]; Avogaro A, 2011, DIABETES CARE, V34, pS285, DOI 10.2337/dc11-s239; Barui AK, 2012, NANOSCALE, V4, P7861, DOI 10.1039/c2nr32369a; Cai SJ, 2005, CARDIOVASC RES, V65, P823, DOI 10.1016/j.cardiores.2004.10.040; Camilletti A, 2001, AM J HYPERTENS, V14, P382, DOI 10.1016/S0895-7061(00)01297-8; Chandra M, 2003, Indian J Clin Biochem, V18, P150, DOI 10.1007/BF02867381; Chien WY, 2005, DIABETES METAB, V31, P63, DOI 10.1016/S1262-3636(07)70168-4; Cosentino F, 1997, CIRCULATION, V96, P25; Das L, 2014, J TRANSL INTERN MED, V2, P36, DOI 10.4103/2224-4018.129503; DOMINICZAK AF, 1995, HYPERTENSION, V25, P1202, DOI 10.1161/01.HYP.25.6.1202; Donmez G, 2002, JPN J PHYSIOL, V52, P435, DOI 10.2170/jjphysiol.52.435; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; FAJANS SS, 1990, DIABETES CARE, V13, P49, DOI 10.2337/diacare.13.1.49; Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340; GRUNFELD S, 1995, HYPERTENSION, V26, P854, DOI 10.1161/01.HYP.26.6.854; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Higashino H, 2007, CLIN EXP PHARMACOL P, V34, P725, DOI 10.1111/j.1440-1681.2007.04617.x; Hoshiyama M, 2003, NEPHRON EXP NEPHROL, V95, pE62, DOI 10.1159/000073673; Ishii N, 2001, J AM SOC NEPHROL, V12, P1630, DOI 10.1681/ASN.V1281630; Kassab A, 2012, BIOCHIMIE, V94, P1837, DOI 10.1016/j.biochi.2012.01.020; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Kwok W, 2009, AM J PHYSIOL-GASTR L, V297, pG930, DOI 10.1152/ajpgi.00106.2009; LERMAN A, 1992, CIRCULATION, V86, P12; Liu XJ, 2013, EXP THER MED, V6, P361, DOI 10.3892/etm.2013.1166; Madhumitha H, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-1; Maejima K, 2001, J DIABETES COMPLICAT, V15, P135, DOI 10.1016/S1056-8727(01)00144-1; Mason RP, 2012, BRIT J CLIN PHARMACO, V74, P141, DOI 10.1111/j.1365-2125.2012.04189.x; Michael JF, 2008, CLIN DIABETES, V26, P277; Monti LD, 2003, DIABETES, V52, P1270, DOI 10.2337/diabetes.52.5.1270; Node K, 1997, HYPERTENSION, V30, P405, DOI 10.1161/01.HYP.30.3.405; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Padiya R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094228; Patra CR, 2011, NANO LETT, V11, P4932, DOI 10.1021/nl2028766; Pieper GM, 1998, HYPERTENSION, V31, P1047, DOI 10.1161/01.HYP.31.5.1047; Pietroa ND, 2013, ATHEROSCLEROSIS, V226, P88, DOI [10.1016/j.atherosclerosis.2012.10.062, DOI 10.1016/J.ATHER0SCLER0SIS.2012.10.062]; SAGAR S, 1992, MOL CELL BIOCHEM, V111, P103; Shiekh Gazalla Ayub, 2011, J Cardiovasc Dis Res, V2, P172, DOI 10.4103/0975-3583.85264; Sugita H, 2002, AM J PHYSIOL-ENDOC M, V282, pE386, DOI 10.1152/ajpendo.00087.2001; Tanaka J, 2009, DIABETES, V58, P2344, DOI 10.2337/db09-0167; Tessari P, 2010, DIABETES, V59, P2152, DOI 10.2337/db09-1772; Tschudi MR, 1996, HYPERTENSION, V27, P32, DOI 10.1161/01.HYP.27.1.32; Versari D, 2009, DIABETES CARE, V32, pS314, DOI 10.2337/dc09-S330; Yang PX, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.003; Zangeneh Farhad, 2006, Endocr Pract, V12, P388; Zhang X, 2014, NITRIC OXIDE-BIOL CH, V40, P10, DOI 10.1016/j.niox.2014.05.001	49	61	64	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0125270	10.1371/journal.pone.0125270	http://dx.doi.org/10.1371/journal.pone.0125270			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894234	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700136
J	Hernandez, MO; Mantis, NJ				Hernandez, Maria Olga; Mantis, Nicholas J.			Phenotypic Analysis of a Population of IgA(+) Cells in the Follicle-Associated Epithelium of Mouse Peyer's Patches	PLOS ONE			English	Article							DENDRITIC CELLS; T-CELLS; B-CELLS; SUBEPITHELIAL DOME; CHOLERA-TOXIN; SECRETORY IGA; MURINE; TRANSPORT; BACTERIA; MIGRATION	The follicle-associated epithelium (FAE) selectively transports prions, viruses, pathogenic bacteria, commensal microflora, and even secretory IgA (SIgA)-immune complexes from the intestinal lumen to underlying gut-associated lymphoid tissues like Peyer's patches. The FAE consists of a single layer of columnar epithelial cells that includes enterocytes and M (microfold) cells, intermingled with dendritic cells (DCs), macrophages, and naive and memory B and T lymphocytes. In this report we describe a population of IgA(+) cells that reside within and immediately below the FAE in mouse Peyer's patches. Immunofluorescence microscopy analysis indicated that the FAE-associated IgA(+) cells were negative for surface antigen markers specific for B cells (B220), T cells (CD3), DCs (CD11c), and plasma cells (CD138). The IgA(+) cells were also negative Ki-67 and IRF4, indicating that they are not mature B cells or plasma cells. The IgA(+) cells were, however, often found in close proximity to DCs, leading us to speculate that the population of IgA(+) cells in the FAE constitutes an atypical subset of B cells involved in mucosal antigen surveillance and/or immune recall.	[Hernandez, Maria Olga; Mantis, Nicholas J.] New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY 12208 USA; [Mantis, Nicholas J.] SUNY Albany, Dept Biomed Sci, Albany, NY 12208 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Mantis, NJ (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY 12208 USA.	nicholas.mantis@health.ny.gov		Mantis, Nicholas/0000-0002-5083-8640	National Institutes of Health from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01HD061916]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061916] Funding Source: NIH RePORTER	National Institutes of Health from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institutes of Health grant R01HD061916 (to NJM) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD; https://www.nichd.nih.gov/Pages/index.aspx). MOH was the recipient of Supplement to Support Diversity in Science under the auspices of R01HD061916. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlawat S, 2014, MICROSC MICROANAL, V20, P198, DOI 10.1017/S1431927613013640; Anosova NG, 2008, MUCOSAL IMMUNOL, V1, P59, DOI 10.1038/mi.2007.7; Beier R, 1998, AM J PHYSIOL-GASTR L, V275, pG130, DOI 10.1152/ajpgi.1998.275.1.G130; Bergmann B, 2013, SCAND J IMMUNOL, V78, P149, DOI 10.1111/sji.12073; Brandtzaeg P, 2005, IMMUNOL REV, V206, P32, DOI 10.1111/j.0105-2896.2005.00283.x; Brandtzaeg P, 1999, IMMUNOL TODAY, V20, P141, DOI 10.1016/S0167-5699(98)01413-3; Chabot S, 2006, J IMMUNOL, V176, P4275, DOI 10.4049/jimmunol.176.7.4275; De Jesus M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091002; De Jesus M, 2013, JOVE-J VIS EXP, DOI 10.3791/50167; ERMAK TH, 1990, IMMUNOLOGY, V71, P530; FARSTAD IN, 1994, IMMUNOLOGY, V83, P457; Gohda M, 2008, J IMMUNOL, V180, P5335, DOI 10.4049/jimmunol.180.8.5335; Gonzalez-Hernandez MB, 2013, J VIROL, V87, P12685, DOI 10.1128/JVI.02378-13; Hopkins SA, 2000, CELL MICROBIOL, V2, P59; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Johansen FE, 1999, J EXP MED, V190, P915, DOI 10.1084/jem.190.7.915; Johansen FE, 2001, J IMMUNOL, V167, P5185, DOI 10.4049/jimmunol.167.9.5185; Kelsall BL, 1996, J EXP MED, V183, P237, DOI 10.1084/jem.183.1.237; Kujala P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002449; Kunisawa J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2718; Lelouard H, 2012, GASTROENTEROLOGY, V142, P592, DOI 10.1053/j.gastro.2011.11.039; Lelouard H, 2010, GASTROENTEROLOGY, V138, P173, DOI 10.1053/j.gastro.2009.09.051; Mantis N., 1999, Immunology Letters, V69, P42; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; Mantis NJ, 2010, IMMUNOL INVEST, V39, P383, DOI 10.3109/08820131003622635; Nakato G, 2009, DNA RES, V16, P227, DOI 10.1093/dnares/dsp013; Neutra MR, 1999, SEMIN IMMUNOL, V11, P171, DOI 10.1006/smim.1999.0173; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Rey J, 2004, J IMMUNOL, V172, P3026, DOI 10.4049/jimmunol.172.5.3026; Ruedl C, 1996, EUR J IMMUNOL, V26, P1801, DOI 10.1002/eji.1830260821; Schmidt TH, 2013, J EXP MED, V210, P1099, DOI 10.1084/jem.20122574; Shreedhar VK, 2003, INFECT IMMUN, V71, P504, DOI 10.1128/IAI.71.1.504-509.2003; Takakura I, 2011, AM J PATHOL, V179, P1301, DOI 10.1016/j.ajpath.2011.05.058; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Tonry JH, 2013, MICROBES INFECT, V15, P37, DOI 10.1016/j.micinf.2012.10.004; Willis SN, 2014, J IMMUNOL, V192, P3200, DOI 10.4049/jimmunol.1303216; WOLF JL, 1981, SCIENCE, V212, P471, DOI 10.1126/science.6259737; Yamanaka T., 1999, Immunology Letters, V69, P42; Yamanaka T, 2003, J IMMUNOL, V170, P816, DOI 10.4049/jimmunol.170.2.816; Yamanaka T, 2001, EUR J IMMUNOL, V31, P107, DOI 10.1002/1521-4141(200101)31:1<107::AID-IMMU107>3.0.CO;2-4; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	43	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124111	10.1371/journal.pone.0124111	http://dx.doi.org/10.1371/journal.pone.0124111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894545	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700074
J	Kao, J; Gold, KD; Zarrili, G; Copel, E; Silverman, AJ; Ramsaran, SS; Yens, D; Ryu, S				Kao, Johnny; Gold, Kenneth D.; Zarrili, Gina; Copel, Emily; Silverman, Andrew J.; Ramsaran, Shanata S.; Yens, David; Ryu, Samuel			Clinical Predictors of Survival for Patients with Stage IV Cancer Referred to Radiation Oncology	PLOS ONE			English	Article							STEREOTACTIC BODY RADIOTHERAPY; PALLIATIVE RADIOTHERAPY; PROGNOSTIC-FACTORS; EXTRACRANIAL OLIGOMETASTASES; HOSPITALIZED-PATIENTS; CONCURRENT SUNITINIB; PERFORMANCE STATUS; LIFE EXPECTANCY; THERAPY; MODEL	Background There is an urgent need for a robust, clinically useful predictive model for survival in a heterogeneous group of patients with metastatic cancer referred to radiation oncology. Methods From May 2012 to August 2013, 143 consecutive patients with stage IV cancer were prospectively evaluated by a single radiation oncologist. We retrospectively analyzed the effect of 29 patient, laboratory and tumor-related prognostic factors on overall survival using univariate analysis. Variables that were statistically significant on univariate analysis were entered into a multivariable Cox regression to identify independent predictors of overall survival. Results The median overall survival was 5.5 months. Four prognostic factors significantly predicted survival on multivariable analysis including ECOG performance status (0-1 vs. 2 vs. 3-4), number of active tumors (1 to 5 vs. >= 6), albumin levels (>= 3.4 vs. 2.4 to 3.3 vs. <2.4 and primary tumor site (Breast, Kidney or Prostate vs. Other). Risk group stratification was performed by assigning points for adverse prognostic factors resulting in very low, low, intermediate and high risk groups. The median survival was >31.4 months for very low risk patients compared to 14.5 months for low risk, 4.1 months for intermediate risk and 1.2 months for high risk (p<0.001). Conclusions These data suggest that a model that considers performance status, extent of disease, primary tumor site and serum albumin represents a simple model to accurately predict survival for patients with stage IV cancer who are potential candidates for radiation therapy.	[Kao, Johnny; Silverman, Andrew J.; Ramsaran, Shanata S.] Good Samaritan Hosp Med Ctr, Dept Radiat Oncol, New York, NY 10022 USA; [Gold, Kenneth D.] Good Samaritan Hosp Med Ctr, Div Hematol & Med Oncol, New York, NY USA; [Zarrili, Gina; Copel, Emily] Good Samaritan Hosp Med Ctr, Div Palliat Med, New York, NY USA; [Yens, David] New York Coll Osteopath Med, Dept Educ Dev & Assessment, Old Westbury, NY USA; [Ryu, Samuel] Stony Brook Univ Med, Dept Radiat Oncol, Stony Brook, NY USA	New York Institute Technology; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital	Kao, J (corresponding author), Good Samaritan Hosp Med Ctr, Dept Radiat Oncol, New York, NY 10022 USA.	Johnny.kao@chsli.org						Anderson F, 1996, J PALLIAT CARE, V12, P5, DOI 10.1177/082585979601200102; Barbot AC, 2008, J CLIN ONCOL, V26, P2538, DOI 10.1200/JCO.2007.14.9518; Chow E, 2002, INT J RADIAT ONCOL, V53, P1291, DOI 10.1016/S0360-3016(02)02832-8; Chow E, 2008, J CLIN ONCOL, V26, P5863, DOI 10.1200/JCO.2008.17.1363; Christakis NA, 1996, NEW ENGL J MED, V335, P172, DOI 10.1056/NEJM199607183350306; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Corbin KS, 2013, J CLIN ONCOL, V31, P1384, DOI 10.1200/JCO.2012.45.9651; Feliu J, 2011, JNCI-J NATL CANCER I, V103, P1613, DOI 10.1093/jnci/djr388; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; Glare PA, 2004, J CLIN ONCOL, V22, P4823, DOI 10.1200/JCO.2004.12.056; Glare Paul, 2005, J Support Oncol, V3, P331; GRABOWSKI CM, 1992, RADIOLOGY, V184, P329, DOI 10.1148/radiology.184.2.1377829; Gripp S, 2010, CANCER-AM CANCER SOC, V116, P3251, DOI 10.1002/cncr.25112; Guadagnolo BA, 2013, J CLIN ONCOL, V31, P80, DOI 10.1200/JCO.2012.45.0585; JANISCH L, 1994, CANCER-AM CANCER SOC, V74, P1965, DOI 10.1002/1097-0142(19941001)74:7<1965::AID-CNCR2820740723>3.0.CO;2-1; Kao J, 2015, TECHNOL CANCER RES T, V14, P547, DOI 10.7785/tcrt.2012.500426; Kao J, 2014, TARGET ONCOL, V9, P145, DOI 10.1007/s11523-013-0280-y; Kao J, 2009, CANCER-AM CANCER SOC, V115, P3571, DOI 10.1002/cncr.24412; Krishnan MS, 2014, CANCER-AM CANCER SOC, V120, P134, DOI 10.1002/cncr.28408; Lamont EB, 2003, JAMA-J AM MED ASSOC, V290, P98, DOI 10.1001/jama.290.1.98; Ma C, 2010, EUR J CANCER, V46, P3175, DOI 10.1016/j.ejca.2010.06.126; MALTONI M, 1994, EUR J CANCER, V30A, P764, DOI 10.1016/0959-8049(94)90289-5; Maltoni M, 2005, J CLIN ONCOL, V23, P6240, DOI 10.1200/JCO.2005.06.866; Milano MT, 2008, CANCER-AM CANCER SOC, V112, P650, DOI 10.1002/cncr.23209; Morita T, 1999, SUPPORT CARE CANCER, V7, P128, DOI 10.1007/s005200050242; Rades D, 2005, J CLIN ONCOL, V23, P3366, DOI 10.1200/JCO.2005.04.754; REUBEN DB, 1988, ARCH INTERN MED, V148, P1586, DOI 10.1001/archinte.148.7.1586; Rosenthal Mark A., 1993, Palliative Medicine, V7, P199, DOI 10.1177/026921639300700306; Salama JK, 2012, CANCER-AM CANCER SOC, V118, P2962, DOI 10.1002/cncr.26611; Tree AC, 2013, LANCET ONCOL, V14, pE28, DOI 10.1016/S1470-2045(12)70510-7; Weichselbaum RR, 2011, NAT REV CLIN ONCOL, V8, P378, DOI 10.1038/nrclinonc.2011.44	31	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124329	10.1371/journal.pone.0124329	http://dx.doi.org/10.1371/journal.pone.0124329			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894552	gold, Green Published, Green Submitted			2022-12-27	WOS:000353211700087
J	Wang, QD; Zhang, M; Xu, M; Gu, WQ; Xi, Y; Qi, L; Li, B; Wang, WQ				Wang, Qidi; Zhang, Min; Xu, Min; Gu, Weiqiong; Xi, Yun; Qi, Lu; Li, Biao; Wang, Weiqing			Brown Adipose Tissue Activation Is Inversely Related to Central Obesity and Metabolic Parameters in Adult Human	PLOS ONE			English	Article							DIET-INDUCED OBESITY; CARDIOVASCULAR-DISEASE; VISCERAL ADIPOSITY; BODY FATNESS; FAT; SUSCEPTIBILITY; THERMOGENESIS; TEMPERATURE; PREVALENCE; ABLATION	Background Recent studies have shown that adult human possess active brown adipose tissue (BAT), which might be important in affecting obesity. However, the supporting evidence on the relationship between BAT and central obesity and metabolic profile in large population based studies is sparse. Methodology/Principal Findings We studied 4011 (2688 males and 1323 females) tumor-free Chinese adults aged 18-89 for BAT activities, visceral/subcutaneous fat areas (VFA/SFA), waist circumferences (WC) and metabolic parameters. We found that the prevalence of BAT was around 2.7% in our study participants, with a significant sexual difference (5.5% in the females vs. 1.3% in the males; p<0.0001). BAT detection was increased in low temperature and declined in elderly subjects. The BAT positive subjects had lower BMI (P<0.0001), less SFA (P<0.01), VFA (P<0.0001), WC (P<0.0001), lower fasting glucose and triglyceride levels (both P<0.01) and increased HDL cholesterol concentrations (P<0.0001), compared with the BAT negative subjects. Robust logistic regression revealed that after adjustment for covariates (including age, sex, BMI, VFA, SFA and WC), age and BMI in the males (0.92 [95% CI, 0.88-0.96] and 0.84 [95% CI, 0.75-0.96], both P <= 0.008) while age and VFA in the females (0.87 [95% CI, 0.83-0.91] and 0.98 [95% CI, 0.97-0.99], respectively, P<0.05) were independently associated with detectable BAT. Conclusions/Significance Our data suggest that decreased amount of active BAT might be associated with accumulation of visceral fat content and unfavorable metabolic outcomes.	[Wang, Qidi; Xu, Min; Gu, Weiqiong; Wang, Weiqing] Shanghai Jiao Tong Univ, Rui Jin Hosp, Shanghai Key Lab Endocrine Tumors, Sch Med, Shanghai 200030, Peoples R China; [Wang, Qidi; Xu, Min; Gu, Weiqiong; Wang, Weiqing] Shanghai Jiao Tong Univ, Rui Jin Hosp, Shanghai Clin Ctr Endocrine & Metab Dis, Dept Endocrine & Metab Dis,Sch Med, Shanghai 200030, Peoples R China; [Zhang, Min; Xi, Yun; Li, Biao] Shanghai Jiao Tong Univ, Rui Jin Hosp, Dept Nucl Med, Sch Med, Shanghai 200030, Peoples R China; [Qi, Lu] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Harvard University; Harvard T.H. Chan School of Public Health	Wang, WQ (corresponding author), Shanghai Jiao Tong Univ, Rui Jin Hosp, Shanghai Key Lab Endocrine Tumors, Sch Med, Shanghai 200030, Peoples R China.	wqingw@hotmail.com		Zhang, Min/0000-0001-5812-9518	National Natural Science Foundation of China [81370875]; National Leading Clinical Discipline Project (Medical Imaging); Discipline Leaders Climbing Project of Ruijin Hosptial	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Leading Clinical Discipline Project (Medical Imaging); Discipline Leaders Climbing Project of Ruijin Hosptial	This study was supported by grants from the National Natural Science Foundation of China (No. 81370875), National Leading Clinical Discipline Project (Medical Imaging) and Discipline Leaders Climbing Project of Ruijin Hosptial. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, VOLUME VIEWER 2 USER, V2, P399; Au-Yong ITH, 2009, DIABETES, V58, P2583, DOI 10.2337/db09-0833; Bakker LEH, 2014, LANCET DIABETES ENDO, V2, P210, DOI 10.1016/S2213-8587(13)70156-6; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Boyko EJ, 2000, DIABETES CARE, V23, P465, DOI 10.2337/diacare.23.4.465; Bray GA, 2006, J MED CHEM, V49, P4001, DOI 10.1021/jm0680124; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COPPACK SW, 1994, J LIPID RES, V35, P177; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DESPRES JP, 1988, J CLIN EPIDEMIOL, V41, P889, DOI 10.1016/0895-4356(88)90106-0; DONAHUE RP, 1987, LANCET, V2, P1215; DULLOO AG, 1984, CAN J PHYSIOL PHARM, V62, P235, DOI 10.1139/y84-035; Espeland MA, 1997, J CLIN ENDOCR METAB, V82, P1549, DOI 10.1210/jc.82.5.1549; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; HAARBO J, 1991, METABOLISM, V40, P1323, DOI 10.1016/0026-0495(91)90037-W; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; Hany TF, 2002, EUR J NUCL MED MOL I, V29, P1393, DOI 10.1007/s00259-002-0902-6; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Kanaya AM, 2004, DIABETES CARE, V27, P1375, DOI 10.2337/diacare.27.6.1375; Kontani Y, 2005, AGING CELL, V4, P147, DOI 10.1111/j.1474-9726.2005.00157.x; Kozak LP, 2010, CELL METAB, V11, P263, DOI 10.1016/j.cmet.2010.03.009; LARSSON B, 1984, BRIT MED J, V288, P1401, DOI 10.1136/bmj.288.6428.1401; Lee P, 2014, DIABETES, V63, P3686, DOI 10.2337/db14-0513; Lee P, 2010, AM J PHYSIOL-ENDOC M, V299, pE601, DOI 10.1152/ajpendo.00298.2010; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; de Morentin PBM, 2014, CELL METAB, V20, P41, DOI 10.1016/j.cmet.2014.03.031; Matsushita M, 2014, INT J OBESITY, V38, P812, DOI 10.1038/ijo.2013.206; Nakayama K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074720; Nedergaard J, 2010, ANN NY ACAD SCI, V1212, pE20, DOI 10.1111/j.1749-6632.2010.05905.x; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Spiegelman BM, 2013, DIABETES, V62, P1774, DOI 10.2337/db12-1665; Stefan N, 2009, NEW ENGL J MED, V361, P416; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang QD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021006, 10.1371/journal.pone.0028114]; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yoneshiro T, 2015, ANN MED, V47, P133, DOI 10.3109/07853890.2014.911595; Yoneshiro T, 2011, OBESITY, V19, P1755, DOI 10.1038/oby.2011.125; Yoshizumi T, 1999, RADIOLOGY, V211, P283, DOI 10.1148/radiology.211.1.r99ap15283; Zhang QY, 2013, WIEN KLIN WOCHENSCHR, V125, P687, DOI 10.1007/s00508-013-0431-2; Zhang ZY, 2014, EUR J ENDOCRINOL, V170, P359, DOI 10.1530/EJE-13-0712; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546; Zukotynski KA, 2010, EUR J NUCL MED MOL I, V37, P1854, DOI 10.1007/s00259-010-1485-2	50	77	79	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123795	10.1371/journal.pone.0123795	http://dx.doi.org/10.1371/journal.pone.0123795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894250	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700058
J	Fu, S; Liang, Y; Lin, YB; Wang, F; Huang, MY; Zhang, ZC; Wang, J; Cen, WJ; Shao, JY				Fu, Sha; Liang, Ying; Lin, Yong-Bin; Wang, Fang; Huang, Ma-Yan; Zhang, Zi-Chen; Wang, Jing; Cen, Wen-Jian; Shao, Jian-Yong			The Frequency and Clinical Implication of ROS1 and RET Rearrangements in Resected Stage IIIA-N2 Non-Small Cell Lung Cancer Patients	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; EML4-ALK FUSION GENE; TARGETING ROS1; ALK; INHIBITOR; MUTATIONS; IDENTIFICATION; RESISTANCE; LANDSCAPE; SURVIVAL	To evaluate the frequency and clinicopathological features of ROS1 and RET rearrangements in N2 node positive stage IIIA (IIIA-N2) non-small cell lung cancer (NSCLC) patients, we retrospectively screened 204 cases with a tissue microarray (TMA) panel by fluorescent in situ hybridization (FISH), and confirmed by direct sequencing and immunohistochemistry (IHC). The relationship between ROS1 or RET rearrangements, clinicopathological features, and prognostic factors were analyzed in resected stage IIIA-N2 NSCLC. Of the 204 cases, 4 cases were confirmed with ROS1 rearrangement, but no RET rearrangement was detected. All 4 ROS1-rearranged cases were adenocarcinomas. The predominant pathological type was acinar pattern in ROS1-rearranged tumors, except for 1 case harboring a mixture acinar and mucous tumor cells. Variants of ROS1 rearrangement were SDC4ROS1 (E2:E32), SDC4-ROS1 (E4:E32) and SDC4-ROS1 (E4:E34). There was no significant association between ROS1 rearrangement and clinicopathological characteristics. In this cohort, multivariate analysis for overall survival (OS) indicated that squamous cell carcinoma and lobectomy were independent predictors of poor prognosis; R0 surgical resection and non-pleural invasion were independent predictors of good prognosis. In resected stage IIIA-N2 NSCLC patients, ROS1-rearranged cases tended to occur in younger patients with adenocarcinomas. The prognosis of resected stage IIIA-N2 is generally considered poor, but patients with ROS1 rearrangement will benefit from the targeted therapy.	[Fu, Sha; Wang, Fang; Zhang, Zi-Chen; Wang, Jing; Cen, Wen-Jian; Shao, Jian-Yong] Sun Yat Sen Univ, Ctr Canc, Dept Mol Diagnost, State Key Lab Oncol South China,Collaborat Innova, Guangzhou 510060, Guangdong, Peoples R China; [Liang, Ying] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, State Key Lab Oncol South China,Collaborat Innova, Guangzhou 510060, Guangdong, Peoples R China; [Lin, Yong-Bin] Sun Yat Sen Univ, Ctr Canc, Dept Thorac Surg, State Key Lab Oncol South China,Collaborat Innova, Guangzhou 510060, Guangdong, Peoples R China; [Huang, Ma-Yan] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, State Key Lab Oncol South China,Collaborat Innova, Guangzhou 510060, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Shao, JY (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Mol Diagnost, State Key Lab Oncol South China,Collaborat Innova, Guangzhou 510060, Guangdong, Peoples R China.	shaojy@sysucc.org.cn	wang, fang/GYD-4295-2022		National High Technology Research and Development Program of China (863 Program) [2012AA02A502]; State Key Laboratory Grant at Sun Yat-sen University Cancer Center	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); State Key Laboratory Grant at Sun Yat-sen University Cancer Center	This work was supported in part by National High Technology Research and Development Program of China (863 Program) (2012AA02A502) for study design, data collection and analysis. A State Key Laboratory Grant at Sun Yat-sen University Cancer Center was used for study design hand data analysis. The funders had no role in the decision to publish or in the preparation of the manuscript.	Asai N, 2006, PATHOL INT, V56, P164, DOI 10.1111/j.1440-1827.2006.01942.x; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; BIRCHMEIER C, 1990, P NATL ACAD SCI USA, V87, P4799, DOI 10.1073/pnas.87.12.4799; Cai W, 2013, ANN ONCOL, V24, P1822, DOI 10.1093/annonc/mdt071; Camidge DR, 2010, CLIN CANCER RES, V16, P5581, DOI 10.1158/1078-0432.CCR-10-0851; Cha YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103333; Chin LP, 2012, J THORAC ONCOL, V7, P1625, DOI 10.1097/JTO.0b013e31826baf83; Davies KD, 2012, CLIN CANCER RES, V18, P4570, DOI 10.1158/1078-0432.CCR-12-0550; Drilon A, 2013, CANCER DISCOV, V3, P630, DOI 10.1158/2159-8290.CD-13-0035; Esfahani K, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00174; Friboulet L, 2014, CANCER DISCOV, V4, P662, DOI 10.1158/2159-8290.CD-13-0846; Gerber David E, 2014, Am Soc Clin Oncol Educ Book, pe353, DOI 10.14694/EdBook_AM.2014.34.e353; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Horn L, 2009, J CLIN ONCOL, V27, P4232, DOI 10.1200/JCO.2009.23.6661; Ichinose Y, 2001, LUNG CANCER-J IASLC, V34, P29, DOI 10.1016/S0169-5002(01)00207-0; Inamura K, 2009, MODERN PATHOL, V22, P508, DOI 10.1038/modpathol.2009.2; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lee HJ, 2013, ANN SURG ONCOL, V20, P200, DOI 10.1245/s10434-012-2553-6; Li CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028204; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Ou SHI, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00058; Pan YJ, 2014, LUNG CANCER, V84, P121, DOI 10.1016/j.lungcan.2014.02.007; Pao W, 2012, NAT MED, V18, P349, DOI 10.1038/nm.2697; Perner S, 2008, NEOPLASIA, V10, P298, DOI 10.1593/NEO.07878; Riely GJ, 2006, CLIN CANCER RES, V12, P7232, DOI 10.1158/1078-0432.CCR-06-0658; Rimkunas VM, 2012, CLIN CANCER RES, V18, P4449, DOI 10.1158/1078-0432.CCR-11-3351; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Shaw AT, 2012, J CLIN ONCOL, V23, P7508; Shen L, 2014, NEW ENGL J MED, V370, P2537, DOI 10.1056/NEJMc1404894; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stinchcombe TE, 2006, ONCOLOGIST, V11, P809, DOI 10.1634/theoncologist.11-7-809; Takeuchi K, 2008, CLIN CANCER RES, V14, P6618, DOI 10.1158/1078-0432.CCR-08-1018; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Tanaka F, 2000, EUR J CARDIO-THORAC, V18, P147, DOI 10.1016/S1010-7940(00)00490-5; Tuononen K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/757490; Veeramachaneni NK, 2012, ANN THORAC SURG, V94, P922, DOI 10.1016/j.athoracsur.2012.04.087; Wang XQ, 2013, BBA-PROTEINS PROTEOM, V1834, P2205, DOI 10.1016/j.bbapap.2012.10.008; Yoshida A, 2013, AM J SURG PATHOL, V37, P554, DOI 10.1097/PAS.0b013e3182758fe6; Yoshida A, 2011, AM J SURG PATHOL, V35, P1226, DOI 10.1097/PAS.0b013e3182233e06; Zhang YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064821; Zhu ZH, 2009, J CLIN ONCOL, V27, P1091, DOI 10.1200/JCO.2008.16.6991	50	13	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124354	10.1371/journal.pone.0124354	http://dx.doi.org/10.1371/journal.pone.0124354			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905642	gold, Green Submitted, Green Published			2022-12-27	WOS:000353332000068
J	Garner, MJ; Carson, C; Lingohr, EJ; Fazil, A; Edge, VL; Waddell, JT				Garner, Michael J.; Carson, Carolee; Lingohr, Erika J.; Fazil, Aamir; Edge, Victoria L.; Waddell, Jan Trumble			An Assessment of Antimicrobial Resistant Disease Threats in Canada	PLoS One			English	Article							SETTING PRIORITIES; CLOSTRIDIUM-DIFFICILE; DECISION-MAKING; RISK-FACTORS; INFECTION	Background Antimicrobial resistance (AMR) of infectious agents is a growing concern for public health organizations. Given the complexity of this issue and how widespread the problem has become, resources are often insufficient to address all concerns, thus prioritization of AMR pathogens is essential for the optimal allocation of risk management attention. Since the epidemiology of AMR pathogens differs between countries, country-specific assessments are important for the determination of national priorities. Objective To develop a systematic and transparent approach to AMR risk prioritization in Canada. Methods Relevant AMR pathogens in Canada were selected through a transparent multi-step consensus process (n=32). Each pathogen was assessed using ten criteria: incidence, mortality, case-fatality, communicability, treatability, clinical impact, public/political attention, ten-year projection of incidence, economic impact, and preventability. For each pathogen, each criterion was assigned a numerical score of 0, 1, or 2, and multiplied by criteria-specific weighting determined through researcher consensus of importance. The scores for each AMR pathogen were summed and ranked by total score, where a higher score indicated greater importance. A sensitivity analysis was conducted to determine the effects of changing the criteria-specific weights. Results The AMR pathogen with the highest total weighted score was extended spectrum B-lactamase-producing (ESBL) Enterobacteriaceae (score=77). When grouped by percentile, ESBL Enterobacteriaceae, Clostridium difficile, carbapenem-resistant Enterobacteriaceae, and methicillin-resistant Staphylococcus aureus were in the 80-100(th) percentile. Conclusion This assessment provides useful information for prioritising public health strategies regarding AMR resistance at the national level in Canada. As the AMR environment and challenges change over time and space, this systematic and transparent approach can be adapted for use by other stakeholders domestically and internationally. Given the complexity of influences, resource availability and multiple stakeholders, regular consideration of AMR activities in the public health realm is essential for appropriate and responsible prioritisation of risk management that optimises the health and security of the population.	[Garner, Michael J.; Lingohr, Erika J.; Edge, Victoria L.; Waddell, Jan Trumble] Publ Hlth Agcy Canada, Populat Hlth Assessment & Scenarios Team, Ottawa, ON, Canada; [Carson, Carolee; Fazil, Aamir] Publ Hlth Agcy Canada, Lab Foodborne Zoonoses, Guelph, ON, Canada	Public Health Agency of Canada; Public Health Agency of Canada	Garner, MJ (corresponding author), Publ Hlth Agcy Canada, Populat Hlth Assessment & Scenarios Team, Ottawa, ON, Canada.	michael.garner@phac-aspc.gc.ca		Edge, Victoria/0000-0002-2830-8395				Balabanova Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025691; Berra S, 2010, INT J TECHNOL ASSESS, V26, P217, DOI 10.1017/S0266462310000012; BRANS JP, 1985, MANAGE SCI, V31, P647, DOI 10.1287/mnsc.31.6.647; D-sight, 2010, D SIGHT DESKT VERS 4; Doherty J A, 2000, Can J Infect Dis, V11, P21; Doherty J A, 2006, Can Commun Dis Rep, V32, P211; Fazil A, 2008, J FOOD PROTECT, V71, P2323, DOI 10.4315/0362-028X-71.11.2323; Fleurence RL, 2004, HEALTH POLICY, V69, P1, DOI 10.1016/j.healthpol.2003.11.002; Garner MJ, 2014, 16 INT C INF DIS APR; Kleinkauf N., 2013, RISK ASSESSMENT IMPA; Lo Vecchio A, 2012, CURR OPIN GASTROEN, V28, P1, DOI 10.1097/MOG.0b013e32834bc9a9; Microsoft Corporation, 2022, MICR EXC COMP SOFTW; Ng V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072172; Nuyens Y, 2007, B WORLD HEALTH ORGAN, V85, P319, DOI 10.2471/BLT.06.032375; Ruzante JM, 2010, RISK ANAL, V30, P724, DOI 10.1111/j.1539-6924.2009.01278.x; Safdar N, 2002, ANN INTERN MED, V136, P834, DOI 10.7326/0003-4819-136-11-200206040-00013; World Health Organization, 2014, ANT RES GLOB REP SUR; World Health Organization, 2003, WHO M BUCH ROM 21 23	18	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125155	10.1371/journal.pone.0125155	http://dx.doi.org/10.1371/journal.pone.0125155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905797	gold, Green Published, Green Submitted			2022-12-27	WOS:000353332000106
J	Stolz, E; Burkert, N; Grossschadl, F; Rasky, E; Stronegger, WJ; Freidl, W				Stolz, Erwin; Burkert, Nathalie; Grossschaedl, Franziska; Rasky, Eva; Stronegger, Willibald J.; Freidl, Wolfgang			Determinants of Public Attitudes towards Euthanasia in Adults and Physician-Assisted Death in Neonates in Austria: A National Survey	PLOS ONE			English	Article							EUROPEAN COUNTRIES; SUICIDE; ACCEPTANCE; TRENDS; END; AUTHORITARIANISM; INDIVIDUALISM; NETHERLANDS; CARE	Background Euthanasia remains a controversial topic in both public discourses and legislation. Although some determinants of acceptance of euthanasia and physician-assisted death have been identified in previous studies, there is still a shortage of information whether different forms of euthanasia are supported by the same or different sub-populations and whether authoritarian personality dispositions are linked to attitudes towards euthanasia. Methods A large, representative face-to-face survey was conducted in Austria in 2014 (n = 1,971). Respondents faced three scenarios of euthanasia and one of physician assisted death differing regarding the level of specificity, voluntariness and subject, requiring either approval or rejection: (1) abstract description of euthanasia, (2) abstract description of physician-assisted suicide, (3) the case of euthanasia of a terminally-ill 79-year old cancer patient, and (4) the case of non-voluntary, physician assisted death of a severely disabled or ill neonate. A number of potential determinants for rejection ordered in three categories (socio-demographic, personal experience, orientations) including authoritarianism were tested via multiple logistic regression analyses. Results Rejection was highest in the case of the neonate (69%) and lowest for the case of the older cancer patient (35%). A consistent negative impact of religiosity on the acceptance across all scenarios and differential effects for socio-economic status, area of residence, religious confession, liberalism, and authoritarianism were found. Individuals with a stronger authoritarian personality disposition were more likely to reject physician-assisted suicide for adults but at the same time also more likely to approve of physician-assisted death of a disabled neonate. Conclusion Euthanasia in adults was supported by a partially different sub-population than assisted death of disabled neonates.	[Stolz, Erwin; Burkert, Nathalie; Grossschaedl, Franziska; Rasky, Eva; Stronegger, Willibald J.; Freidl, Wolfgang] Med Univ Graz, Inst Social Med & Epidemiol, Graz, Austria	Medical University of Graz	Freidl, W (corresponding author), Med Univ Graz, Inst Social Med & Epidemiol, Graz, Austria.	wolfgang.freidl@medunigraz.at	Stronegger, Willibald J./C-2425-2018	Stronegger, Willibald J./0000-0003-3496-1208; Stolz, Erwin/0000-0001-7393-1568; Grossschadl, Franziska/0000-0002-6726-0443				Adorno Theodor W., 1995, STUDIEN ZUM AUTORITA; Boehnke K, 2004, ENCY APPL PSYCHOL, V1, P251; Buiting HM, 2012, J MED ETHICS, V38, P267, DOI 10.1136/medethics-2011-100066; Burkhardt S, 2006, MED SCI LAW, V46, P287, DOI 10.1258/rsmmsl.46.4.287; Chambaere K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1055; Cohen J, 2006, EUR J PUBLIC HEALTH, V16, P663, DOI 10.1093/eurpub/ckl042; Cohen J, 2006, SOC SCI MED, V63, P743, DOI 10.1016/j.socscimed.2006.01.026; Cohen J, 2013, EUR J PUBLIC HEALTH, V23, P378, DOI 10.1093/eurpub/cks186; Czech Herwig, 2014, HUMAN SUBJECTS RES H, P109; Duncan OD, 2006, J MED ETHICS, V32, P266, DOI 10.1136/jme.2004.011072; Freidl W, 2000, LANCET, V356, P1994, DOI 10.1016/S0140-6736(05)72973-1; Freidl W, 2006, INT J MENT HEALTH, V35, P30, DOI 10.2753/IMH0020-7411350303; Frileux S, 2003, J MED ETHICS, V29, P330, DOI 10.1136/jme.29.6.330; Grassi L, 1999, J PAIN SYMPTOM MANAG, V17, P188, DOI 10.1016/S0885-3924(98)00155-9; Hagelin J, 2004, J MED ETHICS, V30, P521, DOI 10.1136/jme.2002.002543; Hudson L, 2009, J PAEDIATR CHILD H, V8, P508; Inghelbrecht E, 2009, INT J NURS STUD, V46, P1209, DOI 10.1016/j.ijnurstu.2009.02.009; Institut fur empirische Sozialforschung GmbH (IFES), 2014, STUD ZUM THEM LEB; Jaspers E, 2007, INT J PUBLIC OPIN R, V19, P451, DOI 10.1093/ijpor/edm029; Kemmelmeier M, 1999, J APPL SOC PSYCHOL, V29, P2613, DOI 10.1111/j.1559-1816.1999.tb00128.x; Kemmelmeier M, 2002, J APPL SOC PSYCHOL, V32, P60, DOI 10.1111/j.1559-1816.2002.tb01420.x; Lotto L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031735; MacDonald WL, 1998, SOC SCI MED, V46, P73, DOI 10.1016/S0277-9536(97)00146-9; Moulton BW, 2004, J LAW MED ETHICS, V32, P2, DOI 10.1111/j.1748-720X.2004.tb00172.x; O'Neill C, 2003, SOC SCI MED, V57, P721, DOI 10.1016/S0277-9536(02)00421-5; Oesterreich D, 2005, POLIT PSYCHOL, V26, P275, DOI 10.1111/j.1467-9221.2005.00418.x; Peretti-Watel P, 2003, BRIT MED J, V327, P595, DOI 10.1136/bmj.327.7415.595; Rietjens JAC, 2005, SOC SCI MED, V61, P1723, DOI 10.1016/j.socscimed.2005.03.024; Ryynanen OP, 2002, PUBLIC HEALTH, V116, P322, DOI 10.1038/sj.ph.1900875; Seale C, 2009, PALLIATIVE MED, V23, P205, DOI 10.1177/0269216308102041; SINGER PA, 1995, SOC SCI MED, V41, P1517, DOI 10.1016/0277-9536(95)00057-E; Stack S, 1996, OMEGA-J DEATH DYING, V34, P71; Stack S, 2011, J SCI STUD RELIG, V50, P289, DOI 10.1111/j.1468-5906.2011.01568.x; Steck N, 2013, MED CARE, V51, P938, DOI 10.1097/MLR.0b013e3182a0f427; Stronegger WJ, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-26; SuarezAlmazor ME, 1997, J CLIN ONCOL, V15, P418, DOI 10.1200/JCO.1997.15.2.418; Teisseyre N, 2005, SOC SCI MED, V60, P357, DOI 10.1016/j.socscimed.2004.05.016; Teisseyre N, 2010, MONASH BIOETH REV, V14, P1; Televantos A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-878; Verbakel E, 2010, PUBLIC OPIN QUART, V74, P109, DOI 10.1093/poq/nfp074; Verhagen E, 2005, NEW ENGL J MED, V352, P959, DOI 10.1056/NEJMp058026; Watzka C, 2008, VEREIN SOZIALGESCHIC, P147; 2008, MOSBYS MED DICT	43	13	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124320	10.1371/journal.pone.0124320	http://dx.doi.org/10.1371/journal.pone.0124320			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KZ	25906265	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000065
J	Leelawattanachai, J; Kwon, KW; Michael, P; Ting, R; Kim, JY; Jin, MM				Leelawattanachai, Jeerapond; Kwon, Keon-Woo; Michael, Praveesuda; Ting, Richard; Kim, Ju-Young; Jin, Moonsoo M.			Side-by-Side Comparison of Commonly Used Biomolecules That Differ in Size and Affinity on Tumor Uptake and Internalization	PLOS ONE			English	Article							MOLECULAR-SIZE; IN-VIVO; TARGETED DELIVERY; CANCER; BIODISTRIBUTION; PHARMACOKINETICS; NANOPARTICLES; INFLAMMATION; FRAGMENTS; EFFICACY	The ability to use a systemically injected agent to image tumor is influenced by tumor characteristics such as permeability and vascularity, and the size, shape, and affinity of the imaging agent. In this study, six different imaging biomolecules, with or without specificity to tumor, were examined for tumor uptake and internalization at the whole body, ex-vivo tissue, and cellular levels: antibodies, antibody fragments (Fab), serum albumin, and streptavidin. The time of peak tumor uptake was dependent solely on the size of molecules, suggesting that molecular size is the major factor that influences tumor uptake by its effect on systemic clearance and diffusion into tumor. Affinity to tumor antigen failed to augment tumor uptake of Fab above non-specific accumulation, which suggests that Fab fragments of typical monoclonal antibodies may fall below an affinity threshold for use as molecular imaging agents. Despite abundant localization into the tumor, albumin and streptavidin were not found on cell surface or inside cells. By comparing biomolecules differing in size and affinity, our study highlights that while pharmacokinetics are a dominant factor in tumor uptake for biomolecules, affinity to tumor antigen is required for tumor binding and internalization.	[Leelawattanachai, Jeerapond; Michael, Praveesuda; Jin, Moonsoo M.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA; [Kwon, Keon-Woo; Ting, Richard; Jin, Moonsoo M.] Weill Cornell Med Coll, Dept Radiol, New York, NY 10065 USA; [Kim, Ju-Young] Kangwon Natl Univ, Dept Adv Mat Engn, Samcheok, South Korea; [Leelawattanachai, Jeerapond] Natl Sci & Technol Dev Agcy, Natl Nanotechnol Ctr, Pathum Thani 12120, Thailand; [Jin, Moonsoo M.] Dongguk Univ, Dept Biomed Engn, Seoul 100715, South Korea	Cornell University; Cornell University; Kangwon National University; National Science & Technology Development Agency - Thailand; National Nanotechnology Center (NANOTEC); Dongguk University	Jin, MM (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.	moj2005@med.cornell.edu			NIH [R01CA178007]; Ministry of Science, ICT & Future Planning [121S-4-3-0353]; Republic of Korea; Royal Thai Government Scholarship; NATIONAL CANCER INSTITUTE [R01CA178007] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Republic of Korea; Royal Thai Government Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH R01CA178007, the Ministry of Science, ICT & Future Planning (#121S-4-3-0353), Republic of Korea, and the Royal Thai Government Scholarship (J.L.).	Adams GP, 1999, J IMMUNOL METHODS, V231, P249, DOI 10.1016/S0022-1759(99)00161-1; Aggarwal P, 2009, ADV DRUG DELIVER REV, V61, P428, DOI 10.1016/j.addr.2009.03.009; Andrew SM, 2003, FRAGMENTATION IMMUNO; Austin CD, 2004, MOL BIOL CELL, V15, P5268, DOI 10.1091/mbc.E04-07-0591; Bartlett DW, 2007, P NATL ACAD SCI USA, V104, P15549, DOI 10.1073/pnas.0707461104; Casey JL, 1996, BRIT J CANCER, V74, P1397, DOI 10.1038/bjc.1996.555; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; Chauhan VP, 2013, NAT MATER, V12, P958, DOI 10.1038/nmat3792; Chen XY, 2011, BIOMATERIALS, V32, P7651, DOI 10.1016/j.biomaterials.2011.06.030; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; DeNardo SJ, 2003, CLIN CANCER RES, V9, p3854S; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Fouliard S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00192; Heneweer C, 2011, J NUCL MED, V52, P625, DOI 10.2967/jnumed.110.083998; Hussain T, 2014, ADV DRUG DELIVER REV, V66, P90, DOI 10.1016/j.addr.2013.09.007; Jaffer FA, 2005, JAMA-J AM MED ASSOC, V293, P855, DOI 10.1001/jama.293.7.855; Jain R, 1999, IEEE MULTIMEDIA, V6, P1, DOI 10.1109/MMUL.1999.809225; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; James ML, 2012, PHYSIOL REV, V92, P897, DOI 10.1152/physrev.00049.2010; Kang S, 2013, GENE THER, V20, P1042, DOI 10.1038/gt.2013.29; Kenanova V, 2005, CANCER RES, V65, P622; Kircher MF, 2012, MOL ONCOL, V6, P182, DOI 10.1016/j.molonc.2012.02.005; Lammers T, 2012, J CONTROL RELEASE, V161, P175, DOI 10.1016/j.jconrel.2011.09.063; Lim SB, 2012, J CONTROL RELEASE, V163, P34, DOI 10.1016/j.jconrel.2012.06.002; Owens DE, 2006, INT J PHARMACEUT, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010; Park S, 2013, BIOMATERIALS, V34, P598, DOI 10.1016/j.biomaterials.2012.10.004; Park S, 2010, BIOMATERIALS, V31, P7766, DOI 10.1016/j.biomaterials.2010.06.038; Pirollo KF, 2008, TRENDS BIOTECHNOL, V26, P552, DOI 10.1016/j.tibtech.2008.06.007; Pisal DS, 2010, J PHARM SCI-US, V99, P2557, DOI 10.1002/jps.22054; Qi JY, 2014, MOL IMMUNOL, V57, P59, DOI 10.1016/j.molimm.2013.08.002; ROSEBROUGH SF, 1993, NUCL MED BIOL, V20, P663, DOI 10.1016/0969-8051(93)90037-U; Rudin M, 2003, NAT REV DRUG DISCOV, V2, P123, DOI 10.1038/nrd1007; Sanna V, 2014, INT J NANOMED, V9, P467, DOI 10.2147/IJN.S36654; Sapra Puja, 2005, Current Drug Delivery, V2, P369, DOI 10.2174/156720105774370159; Schmidt MM, 2009, MOL CANCER THER, V8, P2861, DOI 10.1158/1535-7163.MCT-09-0195; SHARKEY RM, 1990, CANCER RES, V50, P2330; Shen BQ, 2012, NAT BIOTECHNOL, V30, P184, DOI 10.1038/nbt.2108; Shi JJ, 2011, ACCOUNTS CHEM RES, V44, P1123, DOI 10.1021/ar200054n; Springer TA, 1994, INTERCELLULAR ADHESI, P1; Weissleder R, 2006, SCIENCE, V312, P1168, DOI 10.1126/science.1125949; Weng KC, 2008, NANO LETT, V8, P2851, DOI 10.1021/nl801488u; Yao ZS, 1998, JNCI-J NATL CANCER I, V90, P25, DOI 10.1093/jnci/90.1.25; YUAN F, 1995, CANCER RES, V55, P3752; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007	45	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124440	10.1371/journal.pone.0124440	http://dx.doi.org/10.1371/journal.pone.0124440			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901755	gold, Green Published, Green Submitted			2022-12-27	WOS:000353331500086
J	Lin, WC; Chang, WT; Chang, TY; Shin, JW				Lin, Wei-Chen; Chang, Wei-Ting; Chang, Tsuey-Yu; Shin, Jyh-Wei			The Pathogenesis of Human Cervical Epithelium Cells Induced by Interacting with Trichomonas vaginalis	PLOS ONE			English	Article							NF-KAPPA-B; ENTAMOEBA-HISTOLYTICA; TRITRICHOMONAS-FETUS; SECRETORY PRODUCTS; IL-8 PRODUCTION; INFECTION; NEUTROPHILS; INTERLEUKIN-8; EXPRESSION; CYTOTOXICITY	Background Trichomonas vaginalis is a protozoan parasite that occurs in the urogenital-vaginal tract and is the primary causative agent of trichomoniasis, a common sexually transmitted disease in humans. The aggregation of this protozoan tends to destroy epithelial cells and induce pathogenesis. Principal Findings This study cultured T. vaginalis and human cervical epithelial cells (Z172) under the same conditions in the experiments. Following co-culturing for ten hours, the protozoans became attached to Z172, such that the cells presented a round shape and underwent shrinkage. Time-lapse recording and flow cytometry on interacted Z172 revealed that 70% had been disrupted, 18% presented a necrosis-like morphology and 8% showed signs of apoptosis. Gene expression profiling revealed in the seven inflammatory Z172 genes as well as in T. vaginalis genes that code for adhesion proteins 65 and 65-1. Significance These results suggest that cytopathogenic effects progress while Z172 is in contact with T. vaginalis, and the resulting morphological changes can be categorized as disruption.	[Lin, Wei-Chen; Chang, Wei-Ting; Chang, Tsuey-Yu; Shin, Jyh-Wei] Natl Cheng Kung Univ, Dept Parasitol, Tainan 70101, Taiwan	National Cheng Kung University	Shin, JW (corresponding author), Natl Cheng Kung Univ, Dept Parasitol, Tainan 70101, Taiwan.	hippo@mail.ncku.edu.tw	Shin, Jerry/AAO-2515-2021; Lin, Wei-Chen/Y-6149-2019	Lin, Wei-Chen/0000-0001-7223-5931	Ministry of Education, Taiwan, R. O. C.	Ministry of Education, Taiwan, R. O. C.(Ministry of Education, Taiwan)	This research was supported by the Ministry of Education, Taiwan, R. O. C. The Aim for the Top University Project to the National Cheng Kung University (NCKU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira Shizuo, 2002, Arerugi, V51, P352; Al-Sadi RM, 2007, J IMMUNOL, V178, P4641, DOI 10.4049/jimmunol.178.7.4641; Alvarez-Sanchez ME, 2000, MICROB PATHOGENESIS, V28, P193, DOI 10.1006/mpat.1999.0336; ARROYO R, 1992, MOL MICROBIOL, V6, P853, DOI 10.1111/j.1365-2958.1992.tb01536.x; BENCHIMOL M, 1990, J SUBMICR CYTOL PATH, V22, P39; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Crouch ML, 1999, MICROBIOL-SGM, V145, P2835, DOI 10.1099/00221287-145-10-2835; Danesh Irving S., 1995, Journal of Emergency Medicine, V13, P51, DOI 10.1016/0736-4679(94)00112-X; DIAMOND LS, 1995, J EUKARYOT MICROBIOL, V42, P277, DOI 10.1111/j.1550-7408.1995.tb01579.x; ECKMANN L, 1995, J CLIN INVEST, V96, P1269, DOI 10.1172/JCI118161; Fichorova RN, 2006, INFECT IMMUN, V74, P5773, DOI 10.1128/IAI.00631-06; Fiori PL, 1997, INFECT IMMUN, V65, P5142, DOI 10.1128/IAI.65.12.5142-5148.1997; Fiori PL, 1996, MICROB PATHOGENESIS, V20, P109, DOI 10.1006/mpat.1996.0010; Garcia AF, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-116; Guenthner PC, 2005, INFECT IMMUN, V73, P4155, DOI 10.1128/IAI.73.7.4155-4160.2005; Hardwick JCH, 2004, GASTROENTEROLOGY, V126, P111, DOI 10.1053/j.gastro.2003.10.067; HEATH JP, 1981, BRIT J VENER DIS, V57, P106; Kerekes A, 2000, Orv Hetil, V141, P1821; Koch S, 2009, ANN NY ACAD SCI, V1165, P220, DOI 10.1111/j.1749-6632.2009.04025.x; KRIEGER JN, 1985, INFECT IMMUN, V50, P778, DOI 10.1128/IAI.50.3.778-786.1985; Kucknoor A, 2005, CELL MICROBIOL, V7, P887, DOI 10.1111/j.1462-5822.2005.00522.x; Kucknoor AS, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-5; Kucknoor AS, 2005, INFECT IMMUN, V73, P6472, DOI 10.1128/IAI.73.10.6472-6478.2005; Kucknoor AS, 2007, CELL MICROBIOL, V9, P2586, DOI 10.1111/j.1462-5822.2007.00979.x; Lin WC, 2009, GENOMICS, V93, P487, DOI 10.1016/j.ygeno.2009.01.004; Lustig G, 2013, INFECT IMMUN, V81, P1411, DOI 10.1128/IAI.01244-12; Madico G, 1998, J CLIN MICROBIOL, V36, P3205, DOI 10.1128/JCM.36.11.3205-3210.1998; Mason PR, 2005, EPIDEMIOL INFECT, V133, P315, DOI 10.1017/S0950268804003127; Mavedzenge SN, 2010, SEX TRANSM DIS, V37, P460, DOI 10.1097/OLQ.0b013e3181cfcc4b; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; Nam YH, 2011, MICROBES INFECT, V13, P1211, DOI 10.1016/j.micinf.2011.07.006; Okumura CYM, 2008, CELL MICROBIOL, V10, P2078, DOI 10.1111/j.1462-5822.2008.01190.x; Ong SJ, 2006, EUKARYOT CELL, V5, P391, DOI 10.1128/EC.5.2.391-399.2006; PINDAK FF, 1993, GENITOURIN MED, V69, P35; Ryu JS, 2004, INFECT IMMUN, V72, P1326, DOI 10.1128/IAI.72.3.1326-1332.2004; Schwebke JR, 2004, CLIN MICROBIOL REV, V17, P794, DOI 10.1128/CMR.17.4.794-803.2004; SHAIO MF, 1994, J INFECT DIS, V170, P1638, DOI 10.1093/infdis/170.6.1638; SHAIO MF, 1992, INFECT IMMUN, V60, P4475, DOI 10.1128/IAI.60.11.4475-4482.1992; SHAIO MF, 1995, PARASITE IMMUNOL, V17, P127, DOI 10.1111/j.1365-3024.1995.tb01014.x; SHAIO MF, 1995, INFECT IMMUN, V63, P3864, DOI 10.1128/IAI.63.10.3864-3870.1995; Silva FCE, 1998, EXP PARASITOL, V88, P240, DOI 10.1006/expr.1998.4227; Trintis J, 2010, INT J STD AIDS, V21, P606, DOI 10.1258/ijsa.2010.010174; Twu O, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003482; Van Der Pol B, 2008, J INFECT DIS, V197, P548, DOI 10.1086/526496; Nam YH, 2011, KOREAN J PARASITOL, V49, P291, DOI 10.3347/kjp.2011.49.3.291	45	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124087	10.1371/journal.pone.0124087	http://dx.doi.org/10.1371/journal.pone.0124087			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901354	gold, Green Submitted, Green Published			2022-12-27	WOS:000353331500076
J	Trombley, MP; Post, DMB; Rinker, SD; Reinders, LM; Fortney, KR; Zwickl, BW; Janowicz, DM; Baye, FM; Katz, BP; Spinola, SM; Bauer, ME				Trombley, Michael P.; Post, Deborah M. B.; Rinker, Sherri D.; Reinders, Lorri M.; Fortney, Kate R.; Zwickl, Beth W.; Janowicz, Diane M.; Baye, Fitsum M.; Katz, Barry P.; Spinola, Stanley M.; Bauer, Margaret E.			Phosphoethanolamine Transferase LptA in Haemophilus ducreyi Modifies Lipid A and Contributes to Human Defensin Resistance In Vitro	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; NEISSERIA-GONORRHOEAE; CATHELICIDIN RESISTANCE; PERIPLASMIC GLUCANS; SERUM RESISTANCE; HUMAN-MODEL; LIPOPOLYSACCHARIDE; IDENTIFICATION; INFECTION; DELETION	Haemophilus ducreyi resists the cytotoxic effects of human antimicrobial peptides (APs), including alpha-defensins, beta-defensins, and the cathelicidin LL-37. Resistance to LL-37, mediated by the sensitive to antimicrobial peptide (Sap) transporter, is required for H. ducreyi virulence in humans. Cationic APs are attracted to the negatively charged bacterial cell surface. In other gram-negative bacteria, modification of lipopolysaccharide or lipooligosaccharide (LOS) by the addition of positively charged moieties, such as phosphoethanolamine (PEA), confers AP resistance by means of electrostatic repulsion. H. ducreyi LOS has PEA modifications at two sites, and we identified three genes (lptA, ptdA, and ptdB) in H. ducreyi with homology to a family of bacterial PEA transferases. We generated non-polar, unmarked mutants with deletions in one, two, or all three putative PEA transferase genes. The triple mutant was significantly more susceptible to both alpha-and beta-defensins; complementation of all three genes restored parental levels of AP resistance. Deletion of all three PEA transferase genes also resulted in a significant increase in the negativity of the mutant cell surface. Mass spectrometric analysis revealed that LptA was required for PEA modification of lipid A; PtdA and PtdB did not affect PEA modification of LOS. In human inoculation experiments, the triple mutant was as virulent as its parent strain. While this is the first identified mechanism of resistance to alpha-defensins in H. ducreyi, our in vivo data suggest that resistance to cathelicidin LL-37 may be more important than defensin resistance to H. ducreyi pathogenesis.	[Trombley, Michael P.; Rinker, Sherri D.; Fortney, Kate R.; Spinola, Stanley M.; Bauer, Margaret E.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Post, Deborah M. B.; Reinders, Lorri M.] Buck Inst Res Aging, Novato, CA USA; [Zwickl, Beth W.; Janowicz, Diane M.; Spinola, Stanley M.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Baye, Fitsum M.; Katz, Barry P.] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN 46202 USA; [Baye, Fitsum M.; Katz, Barry P.] Richard M Fairbanks Sch Publ Hlth, Dept Biostat, Indianapolis, IN USA; [Spinola, Stanley M.] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Spinola, Stanley M.] Indiana Univ Sch Med, Ctr Immunobiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Buck Institute for Research on Aging; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Bauer, ME (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	mebauer@iupui.edu			Public Health Service [R21 AI096056]; National Institutes of Health; Indiana University-Purdue University at Indianapolis; Research Support Funds Grant; National Institutes of Health [R01 AI024616, 1S10RR029446, R01 AI027863, UL RR052761]; Indiana Clinical and Translational Sciences Institute; Indiana Clinical Research Center; Indiana University Immunology and Infectious Disease Training Program, National Institutes of Health [T32 AI060519]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027863, R21AI096056, R01AI024616, T32AI060519] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University-Purdue University at Indianapolis; Research Support Funds Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana Clinical and Translational Sciences Institute; Indiana Clinical Research Center; Indiana University Immunology and Infectious Disease Training Program, National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant R21 AI096056 (to M.E.B.) from the National Institutes of Health (www.nih.gov) and an Indiana University-Purdue University at Indianapolis (www.iupui.edu) Research Support Funds Grant (to M.E.B.). Work by D.M.P and L.M.R. was supported by National Institutes of Health (www.nih.gov) grant R01 AI024616. Mass spectrometric instrumentation for this study was provided by the mass spectrometry core at the Buck Institute for Research on Aging (www.buckinstitute.org) and at the University of California-San Francisco (www.ucsf.edu) Sandler-Moore mass spectrometry core facility. The Waters Synapt mass spectrometer was purchased with funds from National Institutes of Health (www.nih.gov) shared instrumentation grant 1S10RR029446. The human challenge experiments were supported by National Institutes of Health (www.nih.gov) grant R01 AI027863 (to S.M.S.), the Indiana Clinical and Translational Sciences Institute (www.indianactsi.org), and the Indiana Clinical Research Center (www.indianactsi.org/programs/icrc), National Institutes of Health (www.nih.gov) grant UL RR052761. M.P.T. was supported by the Indiana University Immunology and Infectious Disease Training Program, National Institutes of Health (www.nih.gov) grant T32 AI060519. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas FE, 2006, J BIOL CHEM, V281, P27712, DOI 10.1074/jbc.M604324200; Al-Tawfiq JA, 2000, J INFECT DIS, V181, P1049, DOI 10.1086/315309; Al-Tawfiq JA, 1998, J INFECT DIS, V178, P1684, DOI 10.1086/314483; Al-Tawfiq JA, 1999, J INFECT DIS, V179, P1283, DOI 10.1086/314732; Al-Tawfiq JA, 2000, SEX TRANSM DIS, V27, P111, DOI 10.1097/00007435-200002000-00009; Allen S, 2005, INFECT IMMUN, V73, P5291, DOI 10.1128/IAI.73.9.5291-5300.2005; Annan Naa Torshie, 2005, Expert Rev Anti Infect Ther, V3, P295, DOI 10.1586/14787210.3.2.295; Apicella Michael A., 2008, V431, P3; Bauer ME, 2006, MICROBES INFECT, V8, P2465, DOI 10.1016/j.micinf.2006.06.001; Bauer ME, 2000, INFECT IMMUN, V68, P2309, DOI 10.1128/IAI.68.4.2309-2314.2000; Bauer ME, 2001, INFECT IMMUN, V69, P2549, DOI 10.1128/IAI.69.4.2549-2557.2001; Bohin JP, 2000, FEMS MICROBIOL LETT, V186, P11, DOI 10.1016/S0378-1097(00)00110-5; Bontemps-Gallo S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/371429; Bozue JA, 1998, FEMS MICROBIOL LETT, V164, P269, DOI 10.1111/j.1574-6968.1998.tb13097.x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cox AD, 2003, J BACTERIOL, V185, P3270, DOI 10.1128/JB.185.11.3270-3277.2003; Cullen TW, 2013, INFECT IMMUN, V81, P430, DOI 10.1128/IAI.01046-12; Cullen TW, 2012, J BIOL CHEM, V287, P3326, DOI 10.1074/jbc.M111.321737; Elkins C, 2000, INFECT IMMUN, V68, P1608, DOI 10.1128/IAI.68.3.1608-1619.2000; Gunn JS, 2001, J ENDOTOXIN RES, V7, P57, DOI 10.1177/09680519010070011001; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Hiltke TJ, 1999, MICROB PATHOGENESIS, V26, P93, DOI 10.1006/mpat.1998.0250; Hobbs MM, 2013, MBIO, V4, DOI 10.1128/mBio.00892-13; Kim SH, 2006, MICROBIOL-SGM, V152, P657, DOI 10.1099/mic.0.28692-0; Kregiel D, 2012, J IND MICROBIOL BIOT, V39, P1881, DOI 10.1007/s10295-012-1193-y; Leduc I, 2004, INFECT IMMUN, V72, P3418, DOI 10.1128/IAI.72.6.3418-3428.2004; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; Lee S, 2009, BMB REP, V42, P769, DOI 10.5483/BMBRep.2009.42.12.769; Lewis LA, 2009, INFECT IMMUN, V77, P1112, DOI 10.1128/IAI.01280-08; Mackinnon FG, 2002, MOL MICROBIOL, V43, P931, DOI 10.1046/j.1365-2958.2002.02754.x; McBride WJH, 2008, AUSTRALAS J DERMATOL, V49, P98, DOI 10.1111/j.1440-0960.2008.00439.x; MELAUGH W, 1994, BIOCHEMISTRY-US, V33, P13070, DOI 10.1021/bi00248a016; Mitja O, 2014, LANCET GLOB HEALTH, V2, pE235, DOI 10.1016/S2214-109X(14)70019-1; Mount KLB, 2007, ANTIMICROB AGENTS CH, V51, P3391, DOI 10.1128/AAC.00473-07; Mount KLB, 2010, INFECT IMMUN, V78, P1176, DOI 10.1128/IAI.01014-09; Packiam M, 2014, INFECT IMMUN, V82, P2170, DOI 10.1128/IAI.01504-14; Post DAB, 2007, INFECT IMMUN, V75, P113, DOI 10.1128/IAI.01016-06; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; Rinker SD, 2012, J INFECT DIS, V206, P1407, DOI 10.1093/infdis/jis525; Rinker SD, 2011, INFECT IMMUN, V79, P2324, DOI 10.1128/IAI.01316-10; Spinola SM, 2002, INFECT IMMUN, V70, P1667, DOI 10.1128/IAI.70.4.1667-1676.2002; SPINOLA SM, 1994, J INFECT DIS, V169, P1146, DOI 10.1093/infdis/169.5.1146; Spinola SM, 1996, J INFECT DIS, V173, P394, DOI 10.1093/infdis/173.2.394; Spinola SM, 2010, INFECT IMMUN, V78, P3898, DOI 10.1128/IAI.00432-10; Tamayo R, 2005, J BACTERIOL, V187, P3391, DOI 10.1128/JB.187.10.3391-3399.2005; Tracy E, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-101; TREES DL, 1995, CLIN MICROBIOL REV, V8, P357, DOI 10.1128/CMR.8.3.357; Tzeng YL, 2005, J BACTERIOL, V187, P5387, DOI 10.1128/JB.187.15.5387-5396.2005; Ussher JE, 2007, CLIN INFECT DIS, V44, pE85, DOI 10.1086/515404; vd Winkel J G, 1987, Nephrol Dial Transplant, V2, P280; Wood GE, 1999, INFECT IMMUN, V67, P3740, DOI 10.1128/IAI.67.8.3740-3749.1999	51	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124373	10.1371/journal.pone.0124373	http://dx.doi.org/10.1371/journal.pone.0124373			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902140	Green Published, gold, Green Submitted			2022-12-27	WOS:000353331500082
J	van Gurp, J; van Selm, M; Vissers, K; van Leeuwen, E; Hasselaar, J				van Gurp, Jelle; van Selm, Martine; Vissers, Kris; van Leeuwen, Evert; Hasselaar, Jeroen			How Outpatient Palliative Care Teleconsultation Facilitates Empathic Patient-Professional Relationships: A Qualitative Study	PLOS ONE			English	Article							CANCER-PATIENTS; MEDICALISATION; COMMUNICATION	Objective The problems and needs of advanced cancer patients and proxies normally increase as the disease progresses. Home-based advanced cancer patients and their proxies benefit from collaborations between primary care physicians and hospital-based palliative care specialists when confronted with complex problems in the last phase of life. Telemedicine might facilitate direct, patient-centered communication between patients and proxies, primary care physicians, and specialist palliative care teams (SPCTs). This study focuses on the impact of teleconsultation technologies on the relationships between home-based palliative care patients and hospital-based palliative care specialists. Methods This work consists of a qualitative study among patients, family members, and caregivers that utilizes long-term direct observations, semi-structured interviews, and open interviews following the observations. Results The analysis of the empirical data resulted in three key concepts that describe the impact of teleconsultation on the patient-professional relationship in palliative homecare: transcending the institutional walls of home and hospital; transparency of teleconsultation technology; and technologized, intimate patient-professional relationships. Teleconsultation offers (1) condensed encounters between home-based palliative care patients and distant professionals, (2) a unique insight into the patients' daily lives for palliative care specialists, and (3) long-term interaction that results in trustful relationships and experiences of intimacy and relief. Conclusions Teleconsultation fits the practice of home-based palliative care. Teleconsultation can, if well applied, facilitate computer-mediated but empathic patient-palliative care specialist relationships, which enable professional care attuned to the patient's context as well as patient involvement. This article proposes a teleconsultation implementation guide for optimal use of teleconsultation in daily palliative care practice.	[van Gurp, Jelle; Vissers, Kris; Hasselaar, Jeroen] Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol Pain & Palliat Med, NL-6525 ED Nijmegen, Netherlands; [van Selm, Martine] Univ Amsterdam, Amsterdam Sch Commun Res, Amsterdam, Netherlands; [van Leeuwen, Evert] Radboud Univ Nijmegen, Med Ctr, Dept IQ Healthcare Ethics Sect, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; University of Amsterdam; Radboud University Nijmegen	van Gurp, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol Pain & Palliat Med, NL-6525 ED Nijmegen, Netherlands.	Jelle.vanGurp@radboudumc.nl	Vissers, Kris C.P./D-3569-2009; van Gurp, Jelle/P-6169-2015; Vissers, Kris/H-8110-2014; Leeuwen, E./H-8068-2014; Hasselaar, Jeroen/C-9446-2011; van Selm, Martine/AAY-3721-2021; van Gurp, Jelle/AAW-9371-2021	Vissers, Kris C.P./0000-0002-2919-6356; van Gurp, Jelle/0000-0002-9904-2571; Vissers, Kris/0000-0002-2919-6356; Leeuwen, E./0000-0001-6356-3917; van Selm, Martine/0000-0001-9188-4021; van Gurp, Jelle/0000-0002-9904-2571	Netherlands Organisation for Scientific Research (NWO) [313-99-120]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by Netherlands Organisation for Scientific Research (NWO). File number 313-99-120. URL: http://www.nwo.nl/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarshi E, 2011, J PAIN SYMPTOM MANAG, V41, P436, DOI 10.1016/j.jpainsymman.2010.04.016; Bruera E, 2012, ONCOLOGIST, V17, P267, DOI 10.1634/theoncologist.2011-0219; Charmaz K., 2014, INTRO QUALITATIVE ME, V2nd ed.; Clark D, 2002, BRIT MED J, V324, P905, DOI 10.1136/bmj.324.7342.905; COLLIS E, 2013, BMJ-BRIT MED J, V347, P23993, DOI DOI 10.1136/BMJ.F4085; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Demiris George, 2006, Nurs Adm Q, V30, P56; Downie, 2006, PHILOS PALLIATIVE CA; Esterle L, 2013, INT J MED INFORM, V82, P684, DOI 10.1016/j.ijmedinf.2013.04.006; Floriani CA, 2012, PALLIAT SUPPORT CARE, V10, P295, DOI 10.1017/S1478951511001039; Frank AW, 2001, QUAL HEALTH RES, V11, P353, DOI 10.1177/104973201129119154; GOLDCOPD.org, GLOB STRAT DIAGN MAN; GUBA EG, 1981, ECTJ-EDUC COMMUN TEC, V29, P75; Gysels Marjolein, 2008, BMC Med Ethics, V9, P7, DOI 10.1186/1472-6939-9-7; Ihde D, 1979, TECHNIQUES PRAXIS PH; Karnofsky DA, 1949, EVALUATION CHEMOTHER, P191; KENDALL M, 2009, BMJ-BRIT MED J, V339, DOI DOI 10.1136/BMJ.B4122; Kendall M, 2006, FAM PRACT, V23, P644, DOI 10.1093/fampra/cml035; Kidd L, 2010, J TELEMED TELECARE, V16, P394, DOI 10.1258/jtt.2010.091108; Kroenke K, 2010, JAMA-J AM MED ASSOC, V304, P163, DOI 10.1001/jama.2010.944; Lopez D, 2009, SOCIOL REV, V56, P181, DOI 10.1111/j.1467-954X.2009.00822.x; Matusitz J, 2007, HEALTH COMMUN, V21, P73, DOI 10.1080/10410230701283439; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Murray SA, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3702; Peterson Mark Allen, 2003, ANTHR MASS COMMUNICA; Pivodic L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084440; Pols J., 2012, CARE DISTANCE CLOSEN; Pols J, 2011, SCI TECHNOL HUM VAL, V36, P451, DOI 10.1177/0162243910366134; Quill TE, 2013, NEW ENGL J MED, V368, P1173, DOI 10.1056/NEJMp1215620; Sandman L., 2005, GOOD DEATH VALUE DEA; Seymour JE, 1999, SOC SCI MED, V49, P691, DOI 10.1016/S0277-9536(99)00170-7; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Turkle S., 2012, ALONE TOGETHER WHY W; van Gurp J, 2013, PATIENT EDUC COUNS, V93, P504, DOI 10.1016/j.pec.2013.07.002; van Gurp J, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-12; Watanabe SM, 2013, SUPPORT CARE CANCER, V21, P1201, DOI 10.1007/s00520-012-1649-7; Whitten Pamela, 2004, Am J Hosp Palliat Care, V21, P191, DOI 10.1177/104990910402100307; Worldwide Palliative Care Alliance, GLOB ATL PALL CAR EN	39	37	37	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124387	10.1371/journal.pone.0124387	http://dx.doi.org/10.1371/journal.pone.0124387			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KV	25902263	gold, Green Published, Green Submitted			2022-12-27	WOS:000353331500083
J	Zhang, GQ; Li, MH; Su, YY; Chen, LJ; Lan, SR; Liu, ZJ				Zhang, Guo-Qiang; Li, Ming-He; Su, Yong-Yu; Chen, Li-Jun; Lan, Si-Ren; Liu, Zhong-Jian			A New Myco-Heterotrophic Genus, Yunorchis, and the Molecular Phylogenetic Relationships of the Tribe Calypsoeae (Epidendroideae, Orchidaceae) Inferred from Plastid and Nuclear DNA Sequences	PLOS ONE			English	Article							RECIRCUMSCRIPTION; CORALLORHIZA; INCONGRUENCE; EVOLUTION; UTILITY; NUMBER; PLANTS; MATK	We identified a new holomycotrophic orchid that is related to the myco-heterotrophic Calypsoeae. Because chloroplast genes are primarily lacking or are highly divergent, key morphological characters are either reduced or lost from many myco-heterotrophs, and the phylogenetic relationships of weakly supported paraphyletic Calypsoeae within Epidendroideae have been poorly understood in previous molecular systematic studies. Using chloroplast rbcL, psaB, and matK and nuclear Xdh and ITS sequences, we determined the circumscription and systematic positions of the new orchid and the tribe. The results indicate that the epidendroid taxa include most of the clades that are successively sister to the grade of clades representing previously recognized tribes. Calypsoeae comprising four well-supported clades with 12 genera (except for the previous temporarily placed Wullschlaegelia) is supported as a monophyletic and sister clade to Epidendreae (excluding Coeliinae). The new orchid is nested in Calypsoeae and is a sister to Dactylostalix and/or Calypso. This new holomycotrophic orchid presents a subumbel inflorescence that grows underground, and flower with a long pedicel reputing the ground to open and two fragments at the base of the hook, which are obviously morphologically different from those of Calypsoeae. To accommodate this species in the current generic circumscription, a new genus Yunorchis was created.	[Zhang, Guo-Qiang; Su, Yong-Yu; Chen, Li-Jun; Liu, Zhong-Jian] Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China; [Zhang, Guo-Qiang; Su, Yong-Yu; Chen, Li-Jun; Liu, Zhong-Jian] Orchid Conservat & Res Ctr Shenzhen, Shenzhen, Peoples R China; [Zhang, Guo-Qiang; Li, Ming-He; Lan, Si-Ren; Liu, Zhong-Jian] Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou, Fujian, Peoples R China; [Su, Yong-Yu; Liu, Zhong-Jian] South China Agr Univ, Coll Forestry, Guangzhou, Guangdong, Peoples R China; [Zhang, Guo-Qiang; Li, Ming-He; Lan, Si-Ren] Fujian Agr & Forestry Univ, Orchid Conservat & Res Ctr, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; South China Agricultural University; Fujian Agriculture & Forestry University	Lan, SR (corresponding author), Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou, Fujian, Peoples R China.	lkzx@fafu.edu.cn; liuzj@sinicaorchid.org	Zhang, Guo-Qiang/AAG-6817-2019	Zhang, Guo-Qiang/0000-0001-6439-019X	Science and Technology Project of Guangdong [2011B060400011]; Scientific Research Foundation of the Graduate School of Fujian Agriculture and Forestry University [1122yb006]	Science and Technology Project of Guangdong; Scientific Research Foundation of the Graduate School of Fujian Agriculture and Forestry University	Funds were provided by the Science and Technology Project of Guangdong (Grant No. 2011B060400011) and the Scientific Research Foundation of the Graduate School of Fujian Agriculture and Forestry University (Grant No. 1122yb006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidartondo MI, 2005, NEW PHYTOL, V167, P335, DOI 10.1111/j.1469-8137.2005.01429.x; Cameron KM, 2004, MOL PHYLOGENET EVOL, V31, P1157, DOI 10.1016/j.ympev.2003.10.010; Cameron KM, 2003, BRITTONIA, V55, P214, DOI 10.1663/0007-196X(2003)055[0214:ROTMFP]2.0.CO;2; Carlsward BS, 2006, AM J BOT, V93, P770, DOI 10.3732/ajb.93.5.770; Chase M.W., 2003, ORCHID CONSERV, P69; Chen SC, 1999, FLORA REIPUBLIC POPU, P18; Cunningham CW, 1997, MOL BIOL EVOL, V14, P733, DOI 10.1093/oxfordjournals.molbev.a025813; Delannoy E, 2011, MOL BIOL EVOL, V28, P2077, DOI 10.1093/molbev/msr028; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; Freudenstein JV, 2004, AM J BOT, V91, P149, DOI 10.3732/ajb.91.1.149; FREUDENSTEIN JV, 1994, AM J BOT, V81, P1449, DOI 10.2307/2445318; Freudenstein JV, 1996, AM J BOT, V83, P813, DOI 10.2307/2446258; Freudensteinia JV, 2008, AM J BOT, V95, P498, DOI 10.3732/ajb.95.4.498; Gorniak M, 2010, MOL PHYLOGENET EVOL, V56, P784, DOI 10.1016/j.ympev.2010.03.003; Guo YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038788; LEAKE JR, 1994, NEW PHYTOL, V127, P171, DOI 10.1111/j.1469-8137.1994.tb04272.x; Martos F, 2009, NEW PHYTOL, V184, P668, DOI 10.1111/j.1469-8137.2009.02987.x; Merckx V, 2008, P ROY SOC B-BIOL SCI, V275, P1029, DOI 10.1098/rspb.2007.1622; Merckx V, 2009, ANN BOT-LONDON, V104, P1255, DOI 10.1093/aob/mcp235; Merckx V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-178; Neubig KM, 2009, PLANT SYST EVOL, V277, P75, DOI 10.1007/s00606-008-0105-0; Pridgeon A.M., 2014, GENERA ORCHIDACEARUM, V6; Pridgeon AM, 2005, GENERA ORCHIDACEARUM, V4, P89; Pridgeon AM, 2009, GENERA ORCHIDACEARUM, V5; Rokas A, 2005, MOL BIOL EVOL, V22, P1337, DOI 10.1093/molbev/msi121; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stern WL, 2008, LANKESTERIANA, V8, P105, DOI DOI 10.15517/LANK.V8I1.3201; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Szlachetko DL, 1995, FRAGM FLOR GEOBOT S3; van den Berg C, 2005, AM J BOT, V92, P613, DOI 10.3732/ajb.92.4.613; Xiang XG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087625; Zhai JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060371; Zhang GQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060097	35	10	11	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123382	10.1371/journal.pone.0123382	http://dx.doi.org/10.1371/journal.pone.0123382			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902264	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500051
J	Zhang, JZ; Li, C; Tang, XF; Lu, QP; Sa, RN; Zhang, HF				Zhang, Jize; Li, Cong; Tang, Xiangfang; Lu, Qingping; Sa, Renna; Zhang, Hongfu			High Concentrations of Atmospheric Ammonia Induce Alterations in the Hepatic Proteome of Broilers (Gallus gallus): An iTRAQ-Based Quantitative Proteomic Analysis	PLOS ONE			English	Article							GENE-EXPRESSION; LIVER; ACID; APOPTOSIS; PATHWAYS; INJURY; ATP	With the development of the poultry industry, ammonia, as a main contaminant in the air, is causing increasing problems with broiler health. To date, most studies of ammonia toxicity have focused on the nervous system and the gastrointestinal tract in mammals. However, few detailed studies have been conducted on the hepatic response to ammonia toxicity in poultry. The molecular mechanisms that underlie these effects remain unclear. In the present study, our group applied isobaric tags for relative and absolute quantitation (iTRAQ)based quantitative proteomic analysis to investigate changes in the protein profile change in hepatic tissue of broilers exposed to high concentrations of atmospheric ammonia, with the goal of characterizing the molecular mechanisms of chronic liver injury from exposure to high ambient levels of ammonia. Overall, 30 differentially expressed proteins that are involved in nutrient metabolism (energy, lipid, and amino acid), immune response, transcriptional and translational regulation, stress response, and detoxification were identified. In particular, two of these proteins, beta-1 galactosidase (GLB1) and a kinase (PRKA) anchor protein 8-like (AKAP8 L), were previously suggested to be potential biomarkers of chronic liver injury. In addition to the changes in the protein profile, serum parameters and histochemical analyses of hepatic tissue also showed extensive hepatic damage in ammoniaexposed broilers. Altogether, these findings suggest that longtime exposure to high concentrations of atmospheric ammonia can trigger chronic hepatic injury in broilers via different mechanisms, providing new information that can be used for intervention using nutritional strategies in the future.	[Zhang, Jize; Li, Cong; Tang, Xiangfang; Lu, Qingping; Sa, Renna; Zhang, Hongfu] Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Zhang, HF (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China.	zhanghf6565@vip.sina.com			Chinese National Science and Technology Pillar Program [2012BAD39B0]; Special Fund for Innovation Team of the Chinese Academy of Agricultural Sciences [ASTTP-IAS07]	Chinese National Science and Technology Pillar Program; Special Fund for Innovation Team of the Chinese Academy of Agricultural Sciences	This research was supported by the Chinese National Science and Technology Pillar Program (No: 2012BAD39B0) and the Special Fund for Innovation Team of the Chinese Academy of Agricultural Sciences (No: ASTTP-IAS07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astle J, 2007, J NUTR, V137, P2787, DOI 10.1093/jn/137.12.2787; Bertrand FE, 1996, J IMMUNOL, V156, P4240; Bobermin LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052164; Chaika NV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032996; Chen JY, 2013, J NUTR BIOCHEM, V24, P1889, DOI 10.1016/j.jnutbio.2013.05.006; Choi Hee Young, 2009, Cancer Genomics & Proteomics, V6, P263; DANIELLO A, 1993, J BIOL CHEM, V268, P26941; Desert C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-611; Dixit SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023677; Diz AP, 2009, ELECTROPHORESIS, V30, P2967, DOI 10.1002/elps.200900210; Esbaugh AJ, 2006, RESP PHYSIOL NEUROBI, V154, P185, DOI 10.1016/j.resp.2006.03.007; Flowers MT, 2009, CLIN CHEM, V55, P2071, DOI 10.1373/clinchem.2009.135152; GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5; Hakimov HA, 2009, PROTEOMICS, V9, P4000, DOI 10.1002/pmic.200900049; Huang JB, 2013, J AGR FOOD CHEM, V61, P8565, DOI 10.1021/jf402004x; Jagannathan M, 2012, J CELL SCI, V125, P133, DOI 10.1242/jcs.089938; Jia B, 2014, LIVER INT, V34, P748, DOI 10.1111/liv.12365; Ke Q, 2012, J ZHEJIANG UNIV-SC B, V13, P695, DOI 10.1631/jzus.B1100362; Kleinman MT, 2008, TOXICOL LETT, V178, P127, DOI 10.1016/j.toxlet.2008.03.001; Luo JJ, 2013, J PROTEOMICS, V91, P226, DOI 10.1016/j.jprot.2013.07.017; Maier KG, 2010, J VASC SURG, V51, P1238, DOI 10.1016/j.jvs.2009.11.073; Matsumoto T, 2012, J BIOCHEM, V151, P541, DOI 10.1093/jb/mvs023; Miles DM, 2004, POULTRY SCI, V83, P1650, DOI 10.1093/ps/83.10.1650; Modrego J, 2013, EUR J NUTR, V52, P847, DOI 10.1007/s00394-012-0392-7; Nakagawa H., 2012, PATHOL RES INT, V2012; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Nemeth E, 2009, SEMIN IMMUNOPATHOL, V31, P333, DOI 10.1007/s00281-009-0173-4; Newman DR, 2000, RNA, V6, P861, DOI 10.1017/S1355838200992446; Nikam A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066094; Nishikawa T, 2014, J HEPATOL, V60, P1203, DOI 10.1016/j.jhep.2014.02.014; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pogorelova TN, 2011, B EXP BIOL MED+, V151, P567; Polyzos S, 2012, IMMUNO GASTROENTEROL, V1, P119; Ramadoss J, 2012, REPROD TOXICOL, V34, P538, DOI 10.1016/j.reprotox.2012.08.008; REINITZ E, 1986, ANN RHEUM DIS, V45, P431, DOI 10.1136/ard.45.5.431; Saller E, 1999, EMBO J, V18, P4424, DOI 10.1093/emboj/18.16.4424; Scheri RC, 2009, TOXICOL LETT, V191, P20, DOI 10.1016/j.toxlet.2009.07.029; Serra MP, 2014, INT J RADIAT BIOL, V90, P876, DOI 10.3109/09553002.2014.922714; Shao CX, 2010, MOL CELL PROTEOMICS, V9, P313, DOI 10.1074/mcp.M900260-MCP200; Shawcross DL, 2007, METAB BRAIN DIS, V22, P125, DOI 10.1007/s11011-006-9042-1; Sherlock L, 2012, BRIT POULTRY SCI, V53, P439, DOI 10.1080/00071668.2012.707310; Skowronska M, 2013, NEUROCHEM INT, V62, P731, DOI 10.1016/j.neuint.2012.10.013; St Peter SD, 2002, LIVER TRANSPLANT, V8, P21, DOI 10.1053/jlts.2002.30344; Su LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054237; Trauner M, 1998, NEW ENGL J MED, V339, P1217, DOI 10.1056/NEJM199810223391707; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang JJ, 2006, J NUTR, V136, P1759, DOI 10.1093/jn/136.7.1759; Wei FX, 2012, J ANIM VET ADV, V11, P3641; Witkowska D., 2006, Archiv fur Tierzucht, V49, P249; Yahav S, 2004, ANIM RES, V53, P289, DOI 10.1051/animres:2004015; Yamada J, 2005, AMINO ACIDS, V28, P273, DOI 10.1007/s00726-005-0181-1; Yang L, 2010, COMP BIOCHEM PHYS C, V151, P204, DOI 10.1016/j.cbpc.2009.10.010; Yang X, 2012, ONCOL REP, V28, P283, DOI 10.3892/or.2012.1767; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yoo Dong Ryeol, 2009, Cancer Genomics & Proteomics, V6, P269; Young TA, 2006, ALCOHOL ALCOHOLISM, V41, P254, DOI 10.1093/alcalc/agl017; Zhang JZ, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-22; Zi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074229	59	28	35	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123596	10.1371/journal.pone.0123596	http://dx.doi.org/10.1371/journal.pone.0123596			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901992	Green Submitted, Green Published, gold			2022-12-27	WOS:000353331500056
J	Reix, CE; Dikshit, AK; Hockenhull, J; Parker, RMA; Banerjee, A; Burn, CC; Pritchard, JC; Whay, HR				Reix, Christine E.; Dikshit, Amit K.; Hockenhull, Jo; Parker, Richard M. A.; Banerjee, Anindo; Burn, Charlotte C.; Pritchard, Joy C.; Whay, Helen R.			A Two-Year Participatory Intervention Project with Owners to Reduce Lameness and Limb Abnormalities in Working Horses in Jaipur, India	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; DEVELOPING-COUNTRIES; HEALTH; DONKEYS; WELFARE; MULES	Background Participatory methods are increasingly used in international human development, but scientific evaluation of their efficacy versus a control group is rare. Working horses support families in impoverished communities. Lameness and limb abnormalities are highly prevalent in these animals and a cause for welfare concern. We aimed to stimulate and evaluate improvements in lameness and limb abnormalities in horses whose owners took part in a 2-year participatory intervention project to reduce lameness (PI) versus a control group (C) in Jaipur, India. Methodology/Principal Findings In total, 439 owners of 862 horses participated in the study. PI group owners from 21 communities were encouraged to meet regularly to discuss management and work practices influencing lameness and poor welfare and to track their own progress in improving these. Lameness examinations (41 parameters) were conducted at the start of the study (Baseline), and after 1 year and 2 years. Results were compared with control horses from a further 21 communities outside the intervention. Of the 149 horses assessed on all three occasions, PI horses showed significantly (P<0.05) greater improvement than C horses in 20 parameters, most notably overall lameness score, measures of sole pain and range of movement on limb flexion. Control horses showed slight but significantly greater improvements in four parameters, including frog quality in fore and hindlimbs. Conclusions/Significance This participatory intervention succeeded in improving lameness and some limb abnormalities in working horses, by encouraging changes in management and work practices which were feasible within owners' socioeconomic and environmental constraints. Demonstration of the potentially sustainable improvements achieved here should encourage further development of participatory intervention approaches to benefit humans and animals in other contexts.	[Reix, Christine E.; Hockenhull, Jo; Parker, Richard M. A.; Whay, Helen R.] Univ Bristol, Sch Vet Sci, North Somerset, England; [Dikshit, Amit K.] Maharani Farm, Help Suffering, Jaipur, Rajasthan, India; [Banerjee, Anindo] Praxis Inst Participatory Practices, New Delhi, India; [Burn, Charlotte C.] Univ London Royal Vet Coll, Dept Vet Clin Sci, Ctr Anim Welf, London NW1 0TU, Herts, England; [Pritchard, Joy C.] Anim Int Dev, Banwell, North Somerset, England; [Pritchard, Joy C.] Brooke, London, England	University of Bristol; University of London; University of London Royal Veterinary College	Whay, HR (corresponding author), Univ Bristol, Sch Vet Sci, Langford House, North Somerset, England.	bec.whay@bristol.ac.uk	Banerjee, Anindo/GVT-8729-2022	Hockenhull, Jo/0000-0002-9224-7304; Burn, Charlotte/0000-0002-8734-8610; Parker, Richard/0000-0002-3933-9728	Brooke	Brooke	The study was funded by The Brooke (www.thebrooke.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAIR JG, 1984, J APPL PSYCHOL, V69, P334, DOI 10.1037/0021-9010.69.2.334; Ashley FH, 2005, EQUINE VET J, V37, P565, DOI 10.2746/042516405775314826; Broster CE, 2009, EQUINE VET J, V41, P474, DOI 10.2746/042516409X373907; Broster CE, 2010, P 6 INT C WORK EQ NE, P9; Burn CC, 2010, VET J, V186, P385, DOI 10.1016/j.tvjl.2009.09.016; FAOSTAT Food and Agricultural Organisation Statistical Database, 2010, FAOSTAT FOOD AGR ORG; Fidiel MM, 2006, P 5 INT C WORK EQ 30, P360; Fuller CJ, 2006, VET J, V171, P281, DOI 10.1016/j.tvjl.2004.10.012; Geor RJ, 2008, J EQUINE VET SCI, V28, P753, DOI 10.1016/j.jevs.2008.10.016; Guha K, 2010, P 6 INT C WORK EQ NE, P5; Hagmann J, 1999, 94 ODI AGR RES EXT N; KUMAR S., 2002, METHODS COMMUNITY PA, P23; Landsberger HA, 1958, HAWTHORNE REVISITED; Main DCJ, 2012, J DAIRY SCI, V95, P2946, DOI 10.3168/jds.2011-4678; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Murthy K.S., 2006, P 5 INT C WORK EQ FU, P445; Nutbeam D, 1998, HEALTH PROMOT INT, V13, P27, DOI 10.1093/heapro/13.1.27; Pradhan SK, 2006, P 6 INT C WORK EQ 29, P44; Pritchard J, 2011, SHARING LOAD GUIDE I; Pritchard JC, 2005, PREV VET MED, V69, P265, DOI 10.1016/j.prevetmed.2005.02.002; Rasbash J, 2009, USERS GUIDE MLWIN V2, V2, P10; Rasbash J., 2010, MLWIN VERSION 2 22; Rodriguez PAV, 2006, P 5 INT C WORK EQ 30, P407; Steele F, 2008, J R STAT SOC A STAT, V171, P5; Tsutsumi A, 2009, J OCCUP ENVIRON MED, V51, P554, DOI 10.1097/JOM.0b013e3181a24d28; Upjohn MM, 2013, PREV VET MED, V108, P313, DOI 10.1016/j.prevetmed.2012.11.008; Upjohn MM, 2014, VET J, V199, P210, DOI 10.1016/j.tvjl.2013.09.065; Whay HR, 2007, ANIM WELFARE, V16, P117; Whay HR, 2010, IMPROVING ANIMAL WEL, P227	29	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124342	10.1371/journal.pone.0124342	http://dx.doi.org/10.1371/journal.pone.0124342			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898014	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600065
J	Gorzer, I; Jaksch, P; Kundi, M; Seitz, T; Klepetko, W; Puchhammer-Stockl, E				Goerzer, Irene; Jaksch, Peter; Kundi, Michael; Seitz, Tamara; Klepetko, Walter; Puchhammer-Stoeckl, Elisabeth			Pre-Transplant Plasma Torque Teno Virus Load and Increase Dynamics after Lung Transplantation	PLOS ONE			English	Article							TT VIRUS; ALEMTUZUMAB CAMPATH-1H; MONONUCLEAR-CELLS; VIREMIA; IMMUNOSUPPRESSION; REPLICATION; CHILDREN; ANELLOVIRUSES; MAINTENANCE; KINETICS	Background The human Torque Teno virus (TTV) causes persistent viremia in most immunocompetent individuals. Elevated TTV levels are observed after solid organ transplantation and are related to the extent of immunosuppression especially during the phase of maintenance immunosuppression. However, the extent to which the TTV increase in the early phase post-transplantation is associated with the patient's immunosuppressive state is unclear. Objectives In this study, we assessed the TTV increase dynamics in detail during the first three months after lung transplantation under a defined immunosuppressive regimen and in relation to the pre-transplant TTV level. Study Design Forty-six lung transplant recipients (LTRs) were included in this prospective longitudinal study. All received alemtuzumab induction combined with tacrolimus and corticosteroids immunosuppressive therapy. Plasma TTV DNA was monitored before transplantation and regularly within the first three months post-transplantation (n = 320 samples; mean sampling interval: 12.2 days). Results In 43/46 LTRs (93%), TTV DNA was detectable before transplantation (median 4.4 log(10) copies/mL; range: 2.0-6.4). All 46 LTRs showed a TTV increase post-transplantation, which followed a sigmoidal-shaped curve before the median peak level of 9.4 log(10) copies/ mL (range: 7.6-10.7) was reached at a median of day 67 (range: 41-92). The individual TTV DNA doubling times (range: 1.4-20.1 days) significantly correlated with the pre-transplant TTV levels calculated over 30 or 60 days post-transplantation (r = 0.61, 0.54, respectively; both P < 0.001), but did not correlate with the mean tacrolimus blood levels. Pre-transplant TTV levels were not associated with time and level of the patients' post-transplant TTV peak load. Conclusion The TTV level may be used to mirror the state of immunosuppression only after the patients' initial peak TTV level is reached.	[Goerzer, Irene; Seitz, Tamara; Puchhammer-Stoeckl, Elisabeth] Med Univ Vienna, Dept Virol, Vienna, Austria; [Jaksch, Peter; Klepetko, Walter] Med Univ Vienna, Div Thorac Surg, Vienna, Austria; [Kundi, Michael] Med Univ Vienna, Inst Environm Hlth, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Puchhammer-Stockl, E (corresponding author), Med Univ Vienna, Dept Virol, Vienna, Austria.	elisabeth.puchhammer@meduniwien.ac.at		Gorzer, Irene/0000-0003-1936-0404; jaksch, peter/0000-0003-4635-3242				Beland K, 2014, J INFECT DIS, V209, P247, DOI 10.1093/infdis/jit423; Biagini P, 2009, CURR TOP MICROBIOL, V331, P21; Burra P, 2008, TRANSPL INT, V21, P972, DOI 10.1111/j.1432-2277.2008.00714.x; Chen TT, 2013, J GEN VIROL, V94, P409, DOI 10.1099/vir.0.046862-0; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; Emery VC, 1999, J EXP MED, V190, P177, DOI 10.1084/jem.190.2.177; Focosi D, 2015, J GEN VIROL, V96, P115, DOI 10.1099/vir.0.070094-0; Focosi D, 2014, J INFECT DIS, V210, P667, DOI 10.1093/infdis/jiu209; Focosi D, 2010, J CLIN VIROL, V47, P189, DOI 10.1016/j.jcv.2009.11.027; Gorzer I, 2014, J HEART LUNG TRANSPL, V33, P320, DOI 10.1016/j.healun.2013.12.007; Haloschan M, 2014, AGE, V36, DOI 10.1007/s11357-014-9716-2; Kincaid RP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003818; Kirk AD, 2003, TRANSPLANTATION, V76, P120, DOI 10.1097/01.TP.0000071362.99021.D9; Maggi F, 2001, J VIROL, V75, P11999, DOI 10.1128/JVI.75.24.11999-12004.2001; Maggi F, 2005, J MED VIROL, V75, P358, DOI 10.1002/jmv.20278; Maggi F, 2003, J VIROL, V77, P2418, DOI 10.1128/JVI.77.4.2418-2425.2003; Maggi F, 2009, CURR TOP MICROBIOL, V331, P65; Maggi F, 2001, J MED VIROL, V64, P190, DOI 10.1002/jmv.1035; Maggi F, 2010, J VIROL, V84, P6891, DOI 10.1128/JVI.00273-10; Magliocca JF, 2006, TRANSPLANT INT, V19, P705, DOI 10.1111/j.1432-2277.2006.00343.x; Mankotia DS, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-96; Mariscal LF, 2002, VIROLOGY, V301, P121, DOI 10.1006/viro.2002.1545; Moen EM, 2003, J MED VIROL, V70, P177, DOI 10.1002/jmv.10356; Okamoto H, 2009, CURR TOP MICROBIOL, V331, P1, DOI 10.1007/978-3-540-70972-5_1; Pearl JP, 2005, AM J TRANSPLANT, V5, P465, DOI 10.1111/j.1600-6143.2005.00759.x; Rocchi J, 2009, VIROLOGY, V394, P235, DOI 10.1016/j.virol.2009.08.036; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Tyagi AK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-191; Zheng H, 2007, J VIROL, V81, P11917, DOI 10.1128/JVI.01101-07	30	60	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0122975	10.1371/journal.pone.0122975	http://dx.doi.org/10.1371/journal.pone.0122975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894323	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700019
J	Vicente, CSL; Ikuyo, Y; Shinya, R; Mota, M; Hasegawa, K				Vicente, Claudia S. L.; Ikuyo, Yoriko; Shinya, Ryoji; Mota, Manuel; Hasegawa, Koichi			Catalases Induction in High Virulence Pinewood Nematode Bursaphelenchus xylophilus under Hydrogen Peroxide-Induced Stress	PLOS ONE			English	Article							WOOD NEMATODE; HAEMONCHUS-CONTORTUS; ANTIOXIDANT ENZYMES; APHELENCHOIDIDAE; PEROXIREDOXIN; POPULATIONS; EXPRESSION; RESISTANCE; INFECTION; DISEASE	Considered an EPPO A2 quarantine pest, Bursaphelenchus xylophilus is the causal agent of the pine wilt disease and the most devastating plant parasitic nematode attacking coniferous trees in the world. In the early stages of invasion, this nematode has to manage host defence mechanisms, such as strong oxidative stress. Only successful, virulent nematodes are able to tolerate the basal plant defences, and furthermore migrate and proliferate inside of the host tree. In this work, our main objective was to understand to what extent B. xylophilus catalases are involved in their tolerance to oxidative stress and virulence, using as oxidant agent the reactive oxygen species hydrogen peroxide (H2O2). After 24 hours of exposure, high virulence isolates of B. xylophilus could withstand higher H2O2 concentrations in comparison with low virulence B. xylophilus and B. mucronatus, corroborating our observation of Bxy-ctl-1 and Bxy-ctl-2 catalase up-regulation under the same experimental conditions. Both catalases are expressed throughout the nematode intestine. In addition, transgenic strains of Caenorhabditis elegans overexpressing B. xylophilus catalases were constructed and evaluated for survival under similar conditions as previously. Our results suggest that catalases of high virulence B. xylophilus were crucial for nematode survival under prolonged exposure to in vitro oxidative stress, highlighting their adaptive response, which could contribute to their success in host conditions.	[Vicente, Claudia S. L.; Ikuyo, Yoriko; Shinya, Ryoji; Hasegawa, Koichi] Chubu Univ, Coll Biosci & Biotechnol, Dept Environm Biol, Kasugai, Aichi 487, Japan; [Vicente, Claudia S. L.; Mota, Manuel] Univ Evora, Dept Biol, Inst Ciencias Agr & Ambientais Mediterran, Evora, Portugal; [Shinya, Ryoji] CALTECH, HHMI, Pasadena, CA 91125 USA; [Shinya, Ryoji] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	Chubu University; University of Evora; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Hasegawa, K (corresponding author), Chubu Univ, Coll Biosci & Biotechnol, Dept Environm Biol, Kasugai, Aichi 487, Japan.	koichihasegawa@isc.chubu.ac.jp	Vicente, Cláudia SL/X-5058-2019; Vicente, Claudia/C-6226-2019; Mota, Manuel/G-6031-2019	Vicente, Cláudia SL/0000-0002-3865-5358; Vicente, Claudia/0000-0002-3865-5358; Mota, Manuel/0000-0002-4145-5031; Shinya, Ryoji/0000-0002-2450-3054	Japan Society for Science Promotion (JSPS) [P14394]; Heiwa Nakajima Foundation; FEDER Funds through the Operational Programme for Competitiveness Factors - COMPETE and National Funds through FCT - Foundation for Science and Technology [C/AGR/UI0115/2011]; EU Plant Health policy, European Union [FP7-KBBE-2010-4]; Grants-in-Aid for Scientific Research [26450204] Funding Source: KAKEN	Japan Society for Science Promotion (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Heiwa Nakajima Foundation; FEDER Funds through the Operational Programme for Competitiveness Factors - COMPETE and National Funds through FCT - Foundation for Science and Technology; EU Plant Health policy, European Union; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for Science Promotion (JSPS - reference P14394) postdoctoral fellowship to CSLV; the Heiwa Nakajima Foundation, international joint research grant; the European Project REPHRAME - Development of improved methods for detection, control and eradication of pine wood nematode in support of EU Plant Health policy, European Union Seventh Framework Programme FP7-KBBE-2010-4; and FEDER Funds through the Operational Programme for Competitiveness Factors - COMPETE and National Funds through FCT - Foundation for Science and Technology under the Strategic Project PEst-C/AGR/UI0115/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa T, 2003, ENVIRON ENTOMOL, V32, P96, DOI 10.1603/0046-225X-32.1.96; Aikawa T, 2007, NEMATOLOGY, V9, P371, DOI 10.1163/156854107781352007; Asai E, 2005, FOREST PATHOL, V35, P135, DOI 10.1111/j.1439-0329.2004.00396.x; Bellafiore S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000192; BRENNER S, 1974, GENETICS, V77, P71; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; de Boer JM, 1998, J NEMATOL, V30, P309; Dubreuil G, 2011, INT J PARASITOL, V41, P385, DOI 10.1016/j.ijpara.2010.10.008; Futai K, 2013, ANNU REV PHYTOPATHOL, V51, P61, DOI 10.1146/annurev-phyto-081211-172910; Guo M, 2012, J BACTERIOL, V194, P5054, DOI 10.1128/JB.00999-12; He L, 2010, J NANJING U NATUR SC, V06; Henkle-Duhrsen K, 2001, MOL BIOCHEM PARASIT, V114, P129, DOI 10.1016/S0166-6851(01)00252-3; Hirao T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-13; Kikuchi T, 2004, FEBS LETT, V572, P201, DOI 10.1016/j.febslet.2004.07.039; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; KIYOHARA T, 1990, FOREST SCI, V36, P1061; Kotze AC, 2003, INT J PARASITOL, V33, P393, DOI 10.1016/S0020-7519(03)00012-2; Kotze AC, 2001, INT J PARASITOL, V31, P1563, DOI 10.1016/S0020-7519(01)00303-4; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Molinari S, 1997, J NEMATOL, V29, P153; Molinari S, 2005, NEMATROPICA, V35, P88; Molinari S, 2009, NEMATOLOGY, V11, P689, DOI 10.1163/156854108X399317; Mota M., 2008, PINE WILT DIS WORLDW; Olahova M, 2008, P NATL ACAD SCI USA, V105, P19839, DOI 10.1073/pnas.0805507105; OU XU, 1995, EXP PARASITOL, V80, P530, DOI 10.1006/expr.1995.1065; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petriv OI, 2004, J BIOL CHEM, V279, P19996, DOI 10.1074/jbc.M400207200; Quan LJ, 2008, J INTEGR PLANT BIOL, V50, P2, DOI 10.1111/j.1744-7909.2007.00599.x; Robertson L, 2000, MOL BIOCHEM PARASIT, V111, P41, DOI 10.1016/S0166-6851(00)00295-4; Rozen S, 2000, BIOINFORMATICS METHO; SANTOS CSS, 2012, EUR J PLANT PATHOL, V0132, P00407, DOI DOI 10.1007/s10658-011-9886-z; Shinya R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067377; Shinya R, 2012, APPL ENTOMOL ZOOL, V47, P341, DOI 10.1007/s13355-012-0124-8; Shinya R, 2010, PHYTOPATHOLOGY, V100, P1289, DOI 10.1094/PHYTO-04-10-0109; Takemoto S, 2008, PINE WILT DIS; Vicente C, 2012, EUR J PLANT PATHOL, V133, P89, DOI 10.1007/s10658-011-9924-x; Vicente CSL, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-299	38	26	29	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123839	10.1371/journal.pone.0123839	http://dx.doi.org/10.1371/journal.pone.0123839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894519	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000353211700060
J	Killoran, RC; Fan, JS; Yang, DW; Shilton, BH; Choy, WY				Killoran, Ryan C.; Fan, Jingsong; Yang, Daiwen; Shilton, Brian H.; Choy, Wing-Yiu			Structural Analysis of the 14-3-3 zeta/Chibby Interaction Involved in Wnt/beta-Catenin Signaling	PLOS ONE			English	Article							NUCLEAR-EXPORT SIGNALS; BETA-CATENIN; INTRINSIC DISORDER; CRYSTAL-STRUCTURE; 14-3-3 PROTEINS; BINDING; COMPLEX; CHIBBY; INSIGHTS; TARGET	The partially disordered Chibby (Cby) is a conserved nuclear protein that antagonizes the Wnt/beta-catenin signaling pathway. By competing with the Tcf/Lef family proteins for binding to beta-catenin, Cby abrogates the beta-catenin-mediated transcription of Wnt signaling genes. Additionally, upon phosphorylation on S20 by the kinase Akt, Cby forms a complex with 14-3-3 to facilitate the nuclear export of beta-catenin, which represents another crucial mechanism for the regulation of Wnt signaling. To obtain a mechanistic understanding of the 14-3-3/Cby interaction, we have extensively characterized the complex using X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and isothermal titration calorimetry (ITC). The crystal structure of the human 14-3-3 zeta/Cby protein-peptide complex reveals a canonical binding mode; however the residue at the + 2 position from the phosphorylated serine is shown to be uniquely oriented relative to other solved structures of 14-3-3 complexes. Our ITC results illustrate that although the phosphorylation of S20 is essential for Cby to recognize 14-3-3, residues flanking the phosphorylation site also contribute to the binding affinity. However, as is commonly observed in other 14-3-3/phosphopeptide crystal structures, residues of Cby flanking the 14-3-3 binding motif lack observable electron density. To obtain a more detailed binding interface, we have completed the backbone NMR resonance assignment of 14-3-3 zeta. NMR titration experiments reveal that residues outside of the 14-3-3 conserved binding cleft, namely a flexible loop consisting of residues 203-210, are also involved in binding Cby. By using a combined X-ray and NMR approach, we have dissected the molecular basis of the 14-3-3/Cby interaction.	[Killoran, Ryan C.; Shilton, Brian H.; Choy, Wing-Yiu] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada; [Fan, Jingsong; Yang, Daiwen] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Western University (University of Western Ontario); National University of Singapore	Choy, WY (corresponding author), Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada.	jchoy4@uwo.ca	Shilton, Brian H/A-6667-2011; Choy, Wing-Yiu/O-7608-2017; yang, daiwen/H-8408-2012	Choy, Wing-Yiu/0000-0002-2124-7278; yang, daiwen/0000-0002-6804-0071	Canadian Institutes of Health Research (CIHR) [MOP 74679]; Natural Sciences and Engineering Research (NSERC) [RGPIN 06372-2014]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Canadian Institutes of Health Research (CIHR; MOP 74679; WYC) and Natural Sciences and Engineering Research (NSERC; RGPIN 06372-2014; WYC). We thank Kevin Leung for useful discussions on our Xray crystallography experiments. We thank the Biomolecular NMR Facility, Macromolecular Crystallography Facility and the Biomolecular Interaction and Conformation Facility at the University of Western Ontario for their assistance and use of the facilities. We also acknowledge and thank the support from the NMR facility at the National University of Singapore.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Benzinger A, 2005, CELL RES, V15, P219, DOI 10.1038/sj.cr.7290290; Bonet R, 2013, J MOL BIOL, V425, P3060, DOI 10.1016/j.jmb.2013.05.024; Bustos DM, 2006, PROTEINS, V63, P35, DOI 10.1002/prot.20888; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; Das RK, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003091; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Guo Y, 2012, PHYSIOL RES, V61, P337, DOI 10.33549/physiolres.932289; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Keller R., 2004, COMPUTER AIDED RESON, V1; Kim W, 2013, BIOCHEM J, V450, P9, DOI 10.1042/BJ20121284; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kostelecky B, 2009, EMBO REP, V10, P983, DOI 10.1038/embor.2009.150; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Li FQ, 2008, J CELL BIOL, V181, P1141, DOI 10.1083/jcb.200709091; Li FQ, 2010, MOL BIOL CELL, V21, P311, DOI 10.1091/mbc.E09-05-0437; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Matta A, 2012, EXPERT OPIN THER TAR, V16, P515, DOI 10.1517/14728222.2012.668185; Mofunanya A, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-41; Mokhtarzada S, 2011, BIOCHEMISTRY-US, V50, P715, DOI 10.1021/bi101236z; Molzan M, 2013, ACS CHEM BIOL, V8, P1869, DOI 10.1021/cb4003464; Molzan M, 2012, FEBS J, V279, P563, DOI 10.1111/j.1742-4658.2011.08445.x; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; Mori Mattia, 2013, Drug Discov Today Technol, V10, pe541, DOI 10.1016/j.ddtec.2012.10.001; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Ottmann C, 2013, BIOORGAN MED CHEM, V21, P4058, DOI 10.1016/j.bmc.2012.11.028; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Schumacher B, 2010, ACTA CRYSTALLOGR F, V66, P978, DOI 10.1107/S1744309110025479; Skjevik AA, 2014, J MOL BIOL, V426, P150, DOI 10.1016/j.jmb.2013.09.012; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Thakur R, 2013, J CELL MOL MED, V17, P449, DOI 10.1111/jcmm.12033; Uhart M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00010; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Williams DM, 2011, BIOCHEM J, V437, P493, DOI 10.1042/BJ20102178; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Yao H, 2011, EXPERT OPIN THER TAR, V15, P873, DOI 10.1517/14728222.2011.577418; Zhai JB, 2001, J BIOL CHEM, V276, P41318, DOI 10.1074/jbc.M107709200	55	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123934	10.1371/journal.pone.0123934	http://dx.doi.org/10.1371/journal.pone.0123934			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909186	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800051
J	Andrissi, L; Petraglia, F; Giuliani, A; Severi, FM; Angioni, S; Valensise, H; Vannuccini, S; Comoretto, N; Tambone, V				Andrissi, Laura; Petraglia, Felice; Giuliani, Alessandro; Severi, Filiberto Maria; Angioni, Stefano; Valensise, Herbert; Vannuccini, Silvia; Comoretto, Nunziata; Tambone, Vittoradolfo			The Influence of Doctor-Patient and Midwife-Patient Relationship in Quality Care Perception of Italian Pregnant Women: An Exploratory Study	PLOS ONE			English	Article								Background The study focuses on the perceived nature/technique opposition in pregnancy and delivery emerging from gynaecologist/midwife/pregnant woman relationships. We developed a cross-sectional survey to identify, by means of a multidimensional data-driven approach, the main latent concepts structuring the between items correlation correspondent to the different general opinions present in the data set. The obtained results can set the basis to improve patient satisfaction while decreasing healthcare costs. Methods The sample is made of 90 pregnant women within 24-48 hours after natural or operative birth, from three maternity units in Italy. Women filled in a questionnaire about their relationship with gynaecologist and midwife during pregnancy and hospital stay for delivery. Results Participation rate approached 100%. The emerging factorial structure gave a proof-ofconcept of the hypothesis of 'nature vs. technique' as the main dimension shaping women opinions. The results highlighted the role of midwife as the 'link' between the natural and technical dimension of birth. The quality of welcome and the establishing of an empathic relation between mother and healthcare professional was shown to decrease further request of care in the post-partum period. Conclusions The "fault plane" between nature and technique is a very critical zone for litigation. Women are particularly sensitive to the consideration and attention they receive at their admission in the hospital, as well as to the quality of human relationship with midwife. The perceived quality of welcome scaled with a decreased need of additional care and, more in general, with a more faithful attitude towards health professionals. We hypothesize that increasing the quality of welcome can exert an effect on both welfare costs and litigation. This opens the way (through an extension of this pilot study to wider populations) to relevant ameliorative actions on quality of care at practically null cost.	[Andrissi, Laura; Comoretto, Nunziata; Tambone, Vittoradolfo] Univ Campus Biomed, Inst Philosophy Sci & Technol Act, Rome, Italy; [Petraglia, Felice; Severi, Filiberto Maria; Vannuccini, Silvia] Univ Siena, Dept Mol & Dev Med, Obstet & Gynecol, I-53100 Siena, Italy; [Giuliani, Alessandro] Ist Super Sanita, Environm & Hlth Dept, I-00161 Rome, Italy; [Angioni, Stefano] Univ Cagliari, Dept Surg Maternal Fetal Med & Imaging, Div Gynaecol Obstet & Pathophysiol Human Reprod, Cagliari, Italy; [Valensise, Herbert] Univ Roma Tor Vergata, Dept Obstet & Gynecol, Rome, Italy	University Campus Bio-Medico - Rome Italy; University of Siena; Istituto Superiore di Sanita (ISS); University of Cagliari; University of Rome Tor Vergata	Giuliani, A (corresponding author), Ist Super Sanita, Environm & Hlth Dept, Viale Regina Elena 299, I-00161 Rome, Italy.	alessandro.giuliani@iss.it	Vannuccini, Silvia/J-8927-2019; Giuliani, Alessandro/K-7589-2016; Andrissi, LAURA/S-9919-2019; Vannuccini, Silvia/L-9140-2016; Petraglia, Felice/D-4373-2019; Giuliani, Alessandro/AAF-1740-2020; Angioni, Stefano/B-7938-2014; Valensise, Herbert/AAC-1345-2019; SEVERI, Filiberto Maria/K-6586-2016	Vannuccini, Silvia/0000-0001-5790-587X; Giuliani, Alessandro/0000-0002-4640-804X; Vannuccini, Silvia/0000-0001-5790-587X; Petraglia, Felice/0000-0002-8851-625X; Giuliani, Alessandro/0000-0002-4640-804X; Angioni, Stefano/0000-0002-2314-0028; Tambone, Vittoradolfo/0000-0002-9231-9523; Valensise, Herbert/0000-0003-4764-544X; SEVERI, Filiberto Maria/0000-0002-0892-4561				Beauchamp TL, 2004, PRINCIPLES BIOMEDICA; Bowling A., 2001, MEASURING DIS REV DI; Bratman M., 2007, STRUCTURE AGENCY ESS; BRATMAN ME, 1993, ETHICS, V104, P97, DOI 10.1086/293577; COX DR, 1972, J ROY STAT SOC C-APP, V21, P113, DOI 10.2307/2346482; Friele RD, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-106; Giuliani A, 2000, BIOPHYS J, V78, P136, DOI 10.1016/S0006-3495(00)76580-5; Hearnshaw H, 2004, BRIT MED J, V328, P140, DOI 10.1136/bmj.328.7432.140; HICKSON GB, 1992, JAMA-J AM MED ASSOC, V267, P1359, DOI 10.1001/jama.267.10.1359; Kline TJB, 2008, QUAL SAF HEALTH CARE, V17, P346, DOI 10.1136/qshc.2007.024281; Lawn JE, 2005, WORLD HLTH REPORT 20, P61; Moore R. A., 2012, HDB PAIN PALLIATIVE; O'Cathain A, 2011, BMJ QUAL SAF, V20, P134, DOI 10.1136/bmjqs.2009.036574; Odent M., 2006, AGRICOLTORE GINECOLO, VIl; Proctor S, 1998, BIRTH-ISS PERINAT C, V25, P85, DOI 10.1046/j.1523-536x.1998.00085.x; Rodriguez HP, 2008, INT J QUAL HEALTH C, V20, P5, DOI 10.1093/intqhc/mzm065; Sahmer K, 2005, ST CLASS DAT ANAL, P208, DOI 10.1007/3-540-28084-7_22; Sarle W. S., 1990, SAS STAT USERS GUIDE, V4th; Siyambalapitiya Sajith, 2007, Int J Nurs Pract, V13, P107, DOI 10.1111/j.1440-172X.2007.00613.x; Tambone V., 2000, PROBLEMI BIOETICA DE, P81; Taraska JM, 1994, LEGAL GUIDE PHYS, P57; Thomson G, 2011, QUALITATIVE RES MIDW; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; World Medical Association Declaration Of Helsinki, 2008, 59 WMA GEN ASS SEOUL; Yeh J, 2010, CLIN MED INSIGHTS-WO, V3, P23, DOI 10.4137/CMWH.S5870	25	3	4	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124353	10.1371/journal.pone.0124353	http://dx.doi.org/10.1371/journal.pone.0124353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KZ	25905494	gold, Green Published, Green Submitted			2022-12-27	WOS:000353332000067
J	Green, DJ; Whitehorne, IBJ; Middleton, HA; Morrissey, CA				Green, David J.; Whitehorne, Ivy B. J.; Middleton, Holly A.; Morrissey, Christy A.			Do American Dippers Obtain a Survival Benefit from Altitudinal Migration?	PLOS ONE			English	Article							LIFE-HISTORY; ERITHACUS-RUBECULA; PARTIAL MIGRANT; PREDATION RISK; CLIMATE-CHANGE; POPULATION; EVOLUTION; COSTS; CONSEQUENCES; TEMPERATE	Studies of partial migrants provide an opportunity to assess the cost and benefits of migration. Previous work has demonstrated that sedentary American dippers (residents) have higher annual productivity than altitudinal migrants that move to higher elevations to breed. Here we use a ten-year (30 period) mark-recapture dataset to evaluate whether migrants offset their lower productivity with higher survival during the migration-breeding period when they occupy different habitat, or early and late-winter periods when they coexist with residents. Mark-recapture models provide no evidence that apparent monthly survival of migrants is higher than that of residents at any time of the year. The best-supported model suggests that monthly survival is higher in the migration-breeding period than winter periods. Another well-supported model suggested that residency conferred a survival benefit, and annual apparent survival (calculated from model weighted monthly apparent survival estimates using the Delta method) of residents (0.511 +/- 0.038SE) was slightly higher than that of migrants (0.487 +/- 0.032). Winter survival of American dippers was influenced by environmental conditions; monthly apparent survival increased as maximum daily flow rates increased and declined as winter temperatures became colder. However, we found no evidence that environmental conditions altered differences in winter survival of residents and migrants. Since migratory American dippers have lower productivity and slightly lower survival than residents our data suggests that partial migration is likely an outcome of competition for limited nest sites at low elevations, with less competitive individuals being forced to migrate to higher elevations in order to breed.	[Green, David J.; Whitehorne, Ivy B. J.; Middleton, Holly A.; Morrissey, Christy A.] Simon Fraser Univ, Dept Biol Sci, Ctr Wildlife Ecol, Burnaby, BC V5A 1S6, Canada; [Morrissey, Christy A.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada	Simon Fraser University; University of Saskatchewan	Green, DJ (corresponding author), Simon Fraser Univ, Dept Biol Sci, Ctr Wildlife Ecol, Burnaby, BC V5A 1S6, Canada.	djgreen@sfu.ca	Green, David J/B-5096-2012	Morrissey, Christy/0000-0001-8128-4209	NSERC [DJG-RGPIN-2014-05798]; NSERC PGS-M (IBJW); Environment Canada	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC PGS-M (IBJW); Environment Canada(CGIAR)	Funding for this study was provided by an NSERC Discovery Grant (DJG-RGPIN-2014-05798), an NSERC PGS-M (IBJW), and Environment Canada under the Georgia Basin Ecosystem Initiative (http://www.sustainable.org/governance/policiesordinances-a-taxes/551-the-georgia-basinecosystem-initiative) (CAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAENSEN F, 1990, J ANIM ECOL, V59, P1077, DOI 10.2307/5033; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; BERGERUD AT, 1984, CAN J ZOOL, V62, P1566, DOI 10.1139/z84-229; Blem C.R., 1980, P175; Bloch AM, 2010, CAN J ZOOL, V88, P1113, DOI 10.1139/Z10-079; Boyle WA, 2008, OECOLOGIA, V155, P397, DOI 10.1007/s00442-007-0897-6; Brodersen J, 2008, ECOLOGY, V89, P1195, DOI 10.1890/07-1318.1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chapman BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061223; Chiu MC, 2008, FRESHWATER BIOL, V53, P1335, DOI 10.1111/j.1365-2427.2008.01968.x; Combreau O, 2001, ANIM CONSERV, V4, P133, DOI 10.1017/S1367943001001160; Cooch E, 2012, PROGRAM MARK GENTLE, V11th; COX GW, 1985, AM NAT, V126, P451, DOI 10.1086/284432; COX GW, 1968, EVOLUTION, V22, P180, DOI 10.1111/j.1558-5646.1968.tb03461.x; Dingle H, 1996, ANIMAL MIGRATION BIO; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Environment Canada, 2010, NAT CLIM DAT INF ARC; Fretwell S., 1980, P517; Garwood JM, 2009, WILSON J ORNITHOL, V121, P600, DOI 10.1676/08-117.1; Gillis EA, 2008, ECOLOGY, V89, P1687, DOI 10.1890/07-1122.1; Gourlay-Larour ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096478; Grayson KL, 2009, J ZOOL, V279, P71, DOI 10.1111/j.1469-7998.2009.00591.x; Grayson KL, 2011, ECOLOGY, V92, P1236, DOI 10.1890/11-0133.1; Grayson KL, 2009, ECOLOGY, V90, P306, DOI 10.1890/08-0935.1; Green DJ, 2009, WILSON J ORNITHOL, V121, P141, DOI 10.1676/07-163.1; Hebblewhite M, 2007, OECOLOGIA, V152, P377, DOI 10.1007/s00442-007-0661-y; Hebblewhite M, 2011, OIKOS, V120, P1860, DOI 10.1111/j.1600-0706.2011.19436.x; Kingery HE, 1996, BIRDS N AM 229; Kinnison MT, 2001, EVOLUTION, V55, P1656, DOI 10.1111/j.0014-3820.2001.tb00685.x; Klaassen RHG, 2014, J ANIM ECOL, V83, P176, DOI 10.1111/1365-2656.12135; Larkin LA, 2007, CONDOR, V109, P949; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; LEVEY DJ, 1992, AM NAT, V140, P447, DOI 10.1086/285421; Leyrer J, 2013, J ORNITHOL, V154, P933, DOI 10.1007/s10336-013-0959-y; Loison A, 2002, J APPL STAT, V29, P289, DOI 10.1080/02664760120108665; LUNDBERG P, 1988, TRENDS ECOL EVOL, V3, P172, DOI 10.1016/0169-5347(88)90035-3; Mackas RH, 2010, CAN J ZOOL, V88, P369, DOI 10.1139/Z10-013; Marzolin G, 2002, J WILDLIFE MANAGE, V66, P1023, DOI 10.2307/3802934; McKinnon L, 2010, SCIENCE, V327, P326, DOI 10.1126/science.1183010; Middleton HA, 2006, J AVIAN BIOL, V37, P169, DOI 10.1111/j.2006.0908-8857.03514.x; Middleton HA, 2008, CAN J ZOOL, V86, P875, DOI 10.1139/Z08-069; Morrissey CA, 2004, CONDOR, V106, P815, DOI 10.1650/7455; Morrissey CA, 2004, CAN J ZOOL, V82, P800, DOI 10.1139/Z04-042; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Nilsson ALK, 2006, GLOBAL CHANGE BIOL, V12, P2014, DOI 10.1111/j.1365-2486.2006.01237.x; Olsson IC, 2006, ECOL LETT, V9, P645, DOI 10.1111/j.1461-0248.2006.00909.x; ROFF DA, 1991, AM ZOOL, V31, P205; Saether BE, 2000, SCIENCE, V287, P854, DOI 10.1126/science.287.5454.854; Salgado-Ortiz J, 2008, AUK, V125, P402, DOI 10.1525/auk.2008.07012; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Skov C, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1178; Stearns S.C., 1992, pi; SWALES S, 1986, CAN J ZOOL, V64, P1506, DOI 10.1139/z86-225; Telleria JL, 2001, ARDEA, V89, P363; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Water Survey of Canada, 2010, HYDAT HIST DAT STAT; Whitehorne I, 2010, WATERBIRDS, V33, P461, DOI 10.1675/063.033.0405; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461	58	15	15	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125734	10.1371/journal.pone.0125734	http://dx.doi.org/10.1371/journal.pone.0125734			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905712	Green Published, Green Submitted, gold			2022-12-27	WOS:000353332000114
J	Guo, SS; Guo, YM; Ergun, A; Lu, L; Walker, WA; Ganguli, K				Guo, Shuangshuang; Guo, Yuming; Ergun, Ayla; Lu, Lei; Walker, W. Allan; Ganguli, Kriston			Secreted Metabolites of Bifidobacterium infantis and Lactobacillus acidophilus Protect Immature Human Enterocytes from IL-1 beta-Induced Inflammation: A Transcription Profiling Analysis	PLOS ONE			English	Article							NF-KAPPA-B; NECROTIZING ENTEROCOLITIS; PROBIOTICS REDUCE; TIGHT JUNCTIONS; MODULATION; INTESTINE; APOPTOSIS; RESPONSES; GG; ACTIVATION	Combination regimens of Bifidobacterium infantis and Lactobacillus acidophilus have been demonstrated to prevent necrotizing enterocolitis (NEC) in clinical trials. However, the molecular mechanisms responsible for this protective effect are not well understood. Additionally, conditioned media from individual cultures of these two probiotics show strain specific modulation of inflammation using in vitro human intestinal NEC models. Here we report a transcription profiling analysis of gene expression in immature human fetal intestinal epithelial cells (H4 cells) pretreated with conditioned media from B. infantis (BCM) or L. acidophilus (LCM) prior to IL-1 beta stimulation. Compared with control media, the two probiotic-conditioned media (PCM) treatments altered the expression of hundreds of genes involved in the immune response, apoptosis and cell survival, cell adhesion, the cell cycle, development and angiogenesis. In IL-1 beta-stimulated cells, PCM treatment decreased the upregulation of genes in the NF-kappa B activation pathway and downregulated genes associated with extracellular matrix (ECM) remodeling. Compared with LCM, BCM showed more significant modulatory effects on ECM remodeling, reflected by a lower p value. IL-6 and IL-8 production was significantly reduced in IL-1 beta-stimulated cells pretreated with PCM (p<0.05), which was consistent with their altered gene expression. Western blot analysis showed that compared with IL-1 beta stimulation alone, PCM treatment attenuated the decrease of cytoplasmic I kappa B alpha and NF-kappa B p65 levels as well as the increase of nuclear NF-kappa B p65 levels in the stimulated cells (p<0.05). In conclusion, PCM treatment exerted anti-inflammatory effects in immature human fetal enterocytes primarily by modulating genes in the NF-kappa B signaling and ECM remodeling pathways. Additionally, some components of these signaling pathways, particularly the ECM remodeling pathway, were more profoundly affected by BCM than LCM.	[Guo, Shuangshuang; Guo, Yuming] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100094, Peoples R China; [Guo, Shuangshuang; Walker, W. Allan; Ganguli, Kriston] Massachusetts Gen Hosp Children, Mucosal Immunol & Biol Res Ctr, Charlestown, MA 02129 USA; [Guo, Shuangshuang; Walker, W. Allan; Ganguli, Kriston] Harvard Univ, Sch Med, Charlestown, MA USA; [Ergun, Ayla] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Lu, Lei] Univ Chicago, Dept Pediat, Sect Neonatol, Chicago, IL 60637 USA	China Agricultural University; Harvard University; Harvard University; Massachusetts General Hospital; University of Chicago	Walker, WA (corresponding author), Massachusetts Gen Hosp Children, Mucosal Immunol & Biol Res Ctr, Charlestown, MA 02129 USA.	wwalker@partners.org; kganguli@partners.org			National Institutes of Health [R01-HD012437, R01-HD059126, P01-DK033506, P30-DK040561]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD012437, R01HD059126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, P01DK033506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from National Institutes of Health R01-HD012437; R01-HD059126; P01-DK033506 and P30-DK040561. WAW received the funding. The URL of National Institutes of Health is http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audy J, 2012, BENEF MICROBES, V3, P273, DOI 10.3920/BM2012.0027; Bergmann KR, 2013, AM J PATHOL, V182, P1595, DOI 10.1016/j.ajpath.2013.01.013; Borriello SP, 2003, CLIN INFECT DIS, V36, P775, DOI 10.1086/368080; Borthakur A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075664; Chan KYY, 2014, ANN SURG, V260, P1128, DOI 10.1097/SLA.0000000000000374; Claud EC, 2001, FASEB J, V15, P1398, DOI 10.1096/fj.00-0833hyp; Claud EC, 2007, AM J PHYSIOL-GASTR L, V292, pG1411, DOI 10.1152/ajpgi.00557.2006; Esposito E, 2009, J NUTR, V139, P905, DOI 10.3945/jn.108.101808; Fanaro S, 2003, ACTA PAEDIATR, V92, P48; Fu LZ, 2005, J BIOL CHEM, V280, P27856, DOI 10.1074/jbc.M413275200; Ganguli K, 2013, AM J PHYSIOL-GASTR L, V304, pG132, DOI 10.1152/ajpgi.00142.2012; Ganguli K, 2011, J CLIN GASTROENTEROL, V45, pS133, DOI 10.1097/MCG.0b013e318228b799; Garrido-Mesa N, 2011, BIOCHEM PHARMACOL, V82, P1891, DOI 10.1016/j.bcp.2011.09.004; Gewolb IH, 1999, ARCH DIS CHILD-FETAL, V80, pF167, DOI 10.1136/fn.80.3.F167; Grave GD, 2007, PEDIATR RES, V62, P510, DOI 10.1203/PDR.0b013e318142580a; Henry MCW, 2009, ANNU REV MED, V60, P111, DOI 10.1146/annurev.med.60.050207.092824; Joint FAO/ WHO Working Group, 2002, GUID EV PROB FOOD; Kanarek N, 2012, IMMUNOL REV, V246, P77, DOI 10.1111/j.1600-065X.2012.01098.x; Khailova L, 2010, AM J PHYSIOL-GASTR L, V299, pG1118, DOI 10.1152/ajpgi.00131.2010; Khailova L, 2009, AM J PHYSIOL-GASTR L, V297, pG940, DOI 10.1152/ajpgi.00141.2009; Kleessen B, 1995, ACTA PAEDIATR, V84, P1347, DOI 10.1111/j.1651-2227.1995.tb13567.x; Kumar A, 2014, GUT MICROBES, V5, P152, DOI 10.4161/gmic.27877; Land MH, 2005, PEDIATRICS, V115, P178, DOI 10.1542/peds.2004-2137; Lin HC, 2005, PEDIATRICS, V115, P1, DOI 10.1542/peds.2004-1463; Lin HC, 2008, PEDIATRICS, V122, P693, DOI 10.1542/peds.2007-3007; Lin PW, 2008, PEDIATR RES, V64, P511, DOI 10.1203/PDR.0b013e3181827c0f; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Liu YY, 2012, AM J PHYSIOL-GASTR L, V302, pG608, DOI 10.1152/ajpgi.00266.2011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacPherson C, 2014, APPL ENVIRON MICROB, V80, P1692, DOI 10.1128/AEM.03411-13; Montalto M, 2004, DIGESTION, V69, P225, DOI 10.1159/000079152; Moorthy G, 2007, NUTRITION, V23, P424, DOI 10.1016/j.nut.2007.03.003; Nanthakumar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017776; Nanthakumar NN, 2003, AM J PHYSIOL-REG I, V285, pR162, DOI 10.1152/ajpregu.00721.2001; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; O'Hara AM, 2006, IMMUNOLOGY, V118, P202, DOI 10.1111/j.1365-2567.2006.02358.x; O'Mahony C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000112; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Parikh AA, 1997, J SURG RES, V69, P139, DOI 10.1006/jsre.1997.5061; Pasparakis M, 2012, IMMUNOL REV, V246, P346, DOI 10.1111/j.1600-065X.2012.01109.x; Petrof EO, 2009, INFLAMM BOWEL DIS, V15, P1537, DOI 10.1002/ibd.20930; Quinones JL, 2002, DEV BIOL, V250, P181, DOI 10.1006/dbio.2002.0778; Raffetto JD, 2008, BIOCHEM PHARMACOL, V75, P346, DOI 10.1016/j.bcp.2007.07.004; Sanderson IR, 1996, P NATL ACAD SCI USA, V93, P7717, DOI 10.1073/pnas.93.15.7717; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shiou SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065108; Stepanova VV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P109, DOI 10.1023/A:1013912500373; Tao Y, 2006, AM J PHYSIOL-CELL PH, V290, pC1018, DOI 10.1152/ajpcell.00131.2005; Tien MT, 2006, J IMMUNOL, V176, P1228, DOI 10.4049/jimmunol.176.2.1228; Weng MQ, 2014, AM J PHYSIOL-GASTR L, V306, pG779, DOI 10.1152/ajpgi.00183.2013; Yanagihara S, 2012, J MED FOOD, V15, P511, DOI 10.1089/jmf.2012.0040; Yang YJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-38; Yin CY, 2010, DEV CELL, V18, P973, DOI 10.1016/j.devcel.2010.05.009	55	31	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124549	10.1371/journal.pone.0124549	http://dx.doi.org/10.1371/journal.pone.0124549			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906317	Green Published, Green Submitted, gold			2022-12-27	WOS:000353332000074
J	Monaco, A; Cattaneo, R; Mesin, L; Ortu, E; Giannoni, M; Pietropaoli, D				Monaco, Annalisa; Cattaneo, Ruggero; Mesin, Luca; Ortu, Eleonora; Giannoni, Mario; Pietropaoli, Davide			Dysregulation of the Descending Pain System in Temporomandibular Disorders Revealed by Low-Frequency Sensory Transcutaneous Electrical Nerve Stimulation: A Pupillometric Study	PLOS ONE			English	Article							BOVINE IRIS SPHINCTER; LOCUS-COERULEUS; FUNCTIONAL CONNECTIVITY; DYNAMIC PUPILLOMETRY; PERIAQUEDUCTAL GRAY; OPIOID RECEPTORS; EVOKED PAIN; ULF-TENS; MODULATION; MUSCLE	Using computerized pupillometry, our previous research established that the autonomic nervous system (ANS) is dysregulated in patients suffering from temporomandibular disorders (TMDs), suggesting a potential role for ANS dysfunction in pain modulation and the etiology of TMD. However, pain modulation hypotheses for TMD are still lacking. The periaqueductal gray (PAG) is involved in the descending modulation of defensive behavior and pain through mu, k and delta opioid receptors. Transcutaneous electrical nerve stimulation (TENS) has been extensively used for pain relief, as low-frequency stimulation can activate mu receptors. Our aim was to use pupillometry to evaluate the effect of low-frequency TENS stimulation of mu receptors on opioid descending pathways in TMD patients. In accordance with the Research Diagnostic Criteria for TMD, 18 females with myogenous TMD and 18 matched-controls were enrolled. All subjects underwent subsequent pupillometric evaluations under dark and light conditions before, soon after (end of stimulation) and long after (recovery period) sensorial TENS. The overall statistics derived from the darkness condition revealed no significant differences in pupil size between cases and controls; indeed, TENS stimulation significantly reduced pupil size in both groups. Controls, but not TMD patients, displayed significant differences in pupil size before compared with after TENS. Under light conditions, TMD patients presented a smaller pupil size compared with controls; the pupil size was reduced only in the controls. Pupil size differences were found before and during TENS and before and after TENS in the controls only. Pupillometry revealed that stimulating the descending opioid pathway with low-frequency sensory TENS of the fifth and seventh pairs of cranial nerves affects the peripheral target. The TMD patients exhibited a different pattern of response to TENS stimulation compared with the controls, suggesting that impaired modulation of the descending pain system may be involved in TMD.	[Monaco, Annalisa; Cattaneo, Ruggero; Ortu, Eleonora; Giannoni, Mario; Pietropaoli, Davide] Univ Aquila, Dept Life Hlth & Environm Sci, Dent Unit, St Salvatore Hosp, I-67100 Laquila, Italy; [Mesin, Luca] Politecn Torino, Dept Elect & Telecommun, Turin, Italy	University of L'Aquila; Polytechnic University of Turin	Pietropaoli, D (corresponding author), Univ Aquila, Dept Life Hlth & Environm Sci, Dent Unit, St Salvatore Hosp, Bldg Delta 6,Via Vetoio, I-67100 Laquila, Italy.	davide.pietropaoli@univaq.it	Pietropaoli, Davide/V-6668-2019; mesin, luca/B-7457-2013	Pietropaoli, Davide/0000-0001-9585-1809; mesin, luca/0000-0002-8239-2348; Ortu, Eleonora/0000-0002-9550-2155; Monaco, Annalisa/0000-0002-9567-4459; Giannoni, Mario/0000-0003-4305-970X				Ainsworth L, 2006, PAIN, V120, P182, DOI 10.1016/j.pain.2005.10.030; Alnaes D, 2014, J VISION, V14, DOI 10.1167/14.4.1; Aston-Jones G, 2005, J COMP NEUROL, V493, P99, DOI 10.1002/cne.20723; Aston-Jones G, 2005, SLEEP MED, V6, pS3, DOI 10.1016/S1389-9457(05)80002-4; Ayesh EE, 2007, EXP BRAIN RES, V179, P415, DOI 10.1007/s00221-006-0801-3; Bar KJ, 2009, J NEUROL SCI, V279, P9, DOI 10.1016/j.jns.2009.01.010; Bandler R, 2000, BRAIN RES BULL, V53, P95, DOI 10.1016/S0361-9230(00)00313-0; Berridge CW, 2012, SLEEP MED REV, V16, P187, DOI 10.1016/j.smrv.2011.12.003; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Brightwell JJ, 2009, NEUROSCIENCE, V160, P174, DOI 10.1016/j.neuroscience.2009.02.023; Bruehl S, 2009, NEUROSCI BIOBEHAV R, V33, P475, DOI 10.1016/j.neubiorev.2008.12.003; Chen H, 2013, J PAIN, V14, P983, DOI 10.1016/j.jpain.2013.03.011; Chipaila N, 2014, CRANIO, V32, P118, DOI 10.1179/0886963413Z.00000000018; Cooper BC, 2008, CRANIO, V26, P104, DOI 10.1179/crn.2008.015; Cooper BC, 2011, CRANIO, V29, P237, DOI 10.1179/crn.2011.034; Curtis AL, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-13-j0001.2001; Desantana JM, 2009, NEUROSCIENCE, V163, P1233, DOI 10.1016/j.neuroscience.2009.06.056; DeSantana Josimari M, 2008, Curr Rheumatol Rep, V10, P492; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; Eliav E, 2003, PAIN, V104, P481, DOI 10.1016/S0304-3959(03)00077-0; Eze-Nliam CM, 2011, J OROFAC PAIN, V25, P232; Fliegert F, 2005, EUR J CLIN PHARMACOL, V61, P257, DOI 10.1007/s00228-005-0920-y; Gabay S, 2011, ATTEN PERCEPT PSYCHO, V73, P123, DOI 10.3758/s13414-010-0015-4; Graeff FG, 2012, BRAZ J MED BIOL RES, V45, P366, DOI 10.1590/S0100-879X2012007500036; Gutstein HB, 2006, GOODMAN GILMANS PHAR, P547; Hayashi N, 2010, J PHYSIOL ANTHROPOL, V29, P119, DOI 10.2114/jpa2.29.119; Heinricher MM, 2009, BRAIN RES REV, V60, P214, DOI 10.1016/j.brainresrev.2008.12.009; Hou RH, 2005, PSYCHOPHARMACOLOGY, V181, P537, DOI 10.1007/s00213-005-0013-8; Ichesco E, 2012, HEADACHE, V52, P441, DOI 10.1111/j.1526-4610.2011.01998.x; ISHIGAKI H, 1991, Journal of Human Ergology, V20, P61; Ishimatsu M, 1996, J NEUROSCI, V16, P5196; Jain S, 2011, PARKINSONISM RELAT D, V17, P119, DOI 10.1016/j.parkreldis.2010.11.005; Jankelson B, 1969, Sci Educ Bull, V2, P29; Johnson M, 2007, PAIN, V130, P157, DOI 10.1016/j.pain.2007.02.007; Kalra A, 2001, J PHARMACOL EXP THER, V298, P257; Kamyszek G, 2001, CRANIO, V19, P162, DOI 10.1080/08869634.2001.11746165; Katch E M, 1986, Anesth Prog, V33, P156; Keay KA, 2001, NEUROSCI LETT, V313, P17, DOI 10.1016/S0304-3940(01)02226-1; Keivanidou A, 2010, CARDIOL J, V17, P65; Kobayashi S, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00136; KONCHAK PA, 1988, ANGLE ORTHOD, V58, P343; Korszun A, 2002, J DENT RES, V81, P279, DOI 10.1177/154405910208100411; Larson MD, 2008, CLIN NEUROPHYSIOL, V119, P1358, DOI 10.1016/j.clinph.2008.01.106; Light KC, 2009, J PAIN, V10, P542, DOI 10.1016/j.jpain.2008.12.006; Linnman C, 2012, NEUROIMAGE, V60, P505, DOI 10.1016/j.neuroimage.2011.11.095; Lumb BM, 2002, EXP PHYSIOL, V87, P281, DOI 10.1113/eph8702356; Maixner W, 1998, PAIN, V76, P71, DOI 10.1016/S0304-3959(98)00028-1; Maixner W, 1995, PAIN, V63, P341, DOI 10.1016/0304-3959(95)00068-2; Maixner W, 2011, J PAIN, V12, pT75, DOI 10.1016/j.jpain.2011.09.002; Matouskova O, 2011, J CLIN PHARM THER, V36, P513, DOI 10.1111/j.1365-2710.2010.01203.x; Mazei-Robison MS, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012070; Monaco A, 2014, CRANIO, V32, P139, DOI 10.1179/0886963413Z.00000000022; Monaco A, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-168; Monaco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045424; Monaco A, 2012, J ELECTROMYOGR KINES, V22, P463, DOI 10.1016/j.jelekin.2011.12.008; Muppidi S, 2013, CLIN AUTON RES, V23, P297, DOI 10.1007/s10286-013-0209-7; Murillo R, 2004, METHOD FIND EXP CLIN, V26, P271; Murphy PR, 2014, HUM BRAIN MAPP, V35, P4140, DOI 10.1002/hbm.22466; Nebel MB, 2010, J PAIN, V11, P1083, DOI 10.1016/j.jpain.2010.02.021; Nikolaou A, 2008, PSYCHOPHARMACOLOGY, V196, P167, DOI 10.1007/s00213-007-0949-y; Nilsson AM, 2010, ACTA ODONTOL SCAND, V68, P284, DOI 10.3109/00016357.2010.494620; Ossipov MH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/561761; PATIL PN, 1991, J OCUL PHARMACOL, V7, P297, DOI 10.1089/jop.1991.7.297; Ploner M, 2011, CEREB CORTEX, V21, P719, DOI 10.1093/cercor/bhq146; Ploner M, 2010, P NATL ACAD SCI USA, V107, P355, DOI 10.1073/pnas.0906186106; Preuschoff K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00115; Radhakrishnan R, 2003, PAIN, V105, P205, DOI 10.1016/S0304-3959(03)00207-0; Rodrigues Delaine, 2004, Braz. oral res., V18, P290, DOI 10.1590/S1806-83242004000400003; Schmidt JE, 2009, J OROFAC PAIN, V23, P230; Sluka KA, 1999, J PHARMACOL EXP THER, V289, P840; Sluka KA, 2003, J PAIN, V4, P109, DOI 10.1054/jpai.2003.434; Staud R, 2012, EXPERT REV NEUROTHER, V12, P577, DOI [10.1586/ern.12.41, 10.1586/ERN.12.41]; Steinhauer SR, 2004, INT J PSYCHOPHYSIOL, V52, P77, DOI 10.1016/j.ijpsycho.2003.12.005; Stone EA, 2011, BRAIN RES REV, V67, P193, DOI 10.1016/j.brainresrev.2011.02.002; Suvinen TI, 2005, EUR J PAIN, V9, P613, DOI 10.1016/j.ejpain.2005.01.012; Svensson P, 2001, PAIN, V92, P399, DOI 10.1016/S0304-3959(01)00284-6; Szabadi E, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00094; TACHADO SD, 1989, INVEST OPHTH VIS SCI, V30, P2232; Tarjan R., 1972, SIAM Journal on Computing, V1, P146, DOI 10.1137/0201010; Topalkara A, 2006, EUR J PHARMACOL, V548, P144, DOI 10.1016/j.ejphar.2006.08.014; Valentino RJ, 2008, EUR J PHARMACOL, V583, P194, DOI 10.1016/j.ejphar.2007.11.062; Valentino RJ, 2001, PSYCHOPHARMACOLOGY, V158, P331, DOI 10.1007/s002130000673; Verster JC, 2006, CLIN J PAIN, V22, P499, DOI 10.1097/01.ajp.0000202981.28915.b2; Weissman-Fogel I, 2011, PAIN, V152, P384, DOI 10.1016/j.pain.2010.10.046; Wilhelm B, 1998, SLEEP, V21, P258; Wilhelm B, 2001, J SLEEP RES, V10, P1, DOI 10.1046/j.1365-2869.2001.00239.x; Yamamoto K, 2013, ENVIRON HEALTH PREV, V18, P361, DOI 10.1007/s12199-013-0331-0; Younger JW, 2010, PAIN, V149, P222, DOI 10.1016/j.pain.2010.01.006	88	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0122826	10.1371/journal.pone.0122826	http://dx.doi.org/10.1371/journal.pone.0122826			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905862	Green Published, Green Submitted, gold			2022-12-27	WOS:000353332000017
J	Nagata, N; Sakamoto, K; Arai, T; Niikura, R; Shimbo, T; Shinozaki, M; Ihana, N; Sekine, K; Okubo, H; Watanabe, K; Sakurai, T; Yokoi, C; Yanase, M; Akiyama, J; Uemura, N; Noda, M				Nagata, Naoyoshi; Sakamoto, Kayo; Arai, Tomohiro; Niikura, Ryota; Shimbo, Takuro; Shinozaki, Masafumi; Ihana, Noriko; Sekine, Katsunori; Okubo, Hidetaka; Watanabe, Kazuhiro; Sakurai, Toshiyuki; Yokoi, Chizu; Yanase, Mikio; Akiyama, Junichi; Uemura, Naomi; Noda, Mitsuhiko			Effect of Body Mass Index and Intra-Abdominal Fat Measured by Computed Tomography on the Risk of Bowel Symptoms	PLOS ONE			English	Article							GASTROINTESTINAL-TRACT SYMPTOMS; OBESITY; PREVALENCE; ADULTS	Background This study aims to investigate the association between body mass index (BMI) or intra-abdominal fat measured by computed tomography (CT) and bowel symptoms. Method A cohort of 958 Japanese adults who underwent colonoscopy and CT and completed questionnaires after excluding colorectal diseases was analyzed. Six symptoms (constipation, diarrhea, loose stools, hard stools, fecal urgency, and incomplete evacuation) using a 7-point Likert scale were evaluated between baseline and second questionnaire for test-retest reliability. Associations between BMI, visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), and symptom score were analyzed by a rank-ordered logistic model, adjusting for age, sex, smoking, and alcohol consumption, hypertension, diabetes mellitus, and dyslipidemia. Results Some bowel symptom scores were significantly (p < 0.05) different between the age groups, sexes, smoking, and alcohol consumption. In multivariate analysis, constipation was associated with low BMI (p < 0.01), low VAT area (p = 0.01), and low SAT area (p < 0.01). Moreover, hard stools was associated with low BMI (p < 0.01) and low SAT area (p < 0.01). The remaining symptoms were not significantly associated with BMI or intra-abdominal fat. Test-retest reliability of bowel symptom scores with a mean duration of 7.5 months was good (mean kappa, 0.672). Conclusions Both low BMI and low abdominal fat accumulation appears to be useful indicators of increased risk for constipation and hard stools. The long-term test-retest reliability of symptom score suggests that bowel symptoms relevant to BMI or visceral fat remain consistent over several months.	[Nagata, Naoyoshi; Niikura, Ryota; Sekine, Katsunori; Okubo, Hidetaka; Watanabe, Kazuhiro; Sakurai, Toshiyuki; Yokoi, Chizu; Yanase, Mikio; Akiyama, Junichi] Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Shinjuku Ku, Tokyo 1628655, Japan; [Sakamoto, Kayo; Arai, Tomohiro; Shinozaki, Masafumi] Natl Ctr Global Hlth & Med, Dept Diagnost Radiol, Shinjuku Ku, Tokyo 1628655, Japan; [Shimbo, Takuro] Natl Ctr Global Hlth & Med, Int Clin Res Ctr, Res Inst, Dept Clin Res & Informat,Shinjuku Ku, Tokyo 1628655, Japan; [Ihana, Noriko; Uemura, Naomi] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Ichikawa, Chiba 2728516, Japan; [Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Diabet Res Ctr, Diabet Res, Shinjuku Ku, Tokyo 1628655, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Nagata, N (corresponding author), Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	nnagata_ncgm@yahoo.co.jp	Noda, Mitsuhiko/W-3905-2019	Noda, Mitsuhiko/0000-0003-0413-4631	Ministry of Health, Labour and Welfare of Japan [H25-016]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was funded by Health Sciences Research Grants (Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus H25-016) from the Ministry of Health, Labour and Welfare of Japan. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews EB, 2005, ALIMENT PHARM THER, V22, P935, DOI 10.1111/j.1365-2036.2005.02671.x; Aro P, 2005, GUT, V54, P1377, DOI 10.1136/gut.2004.057497; Burton C, 2011, PSYCHOL MED, V41, P555, DOI 10.1017/S0033291710001017; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; Campbell AK, 2010, TOXICOLOGY, V278, P268, DOI 10.1016/j.tox.2010.09.001; Collins SM, 2014, NAT REV GASTRO HEPAT, V11, P497, DOI 10.1038/nrgastro.2014.40; CROWELL MD, 1994, AM J GASTROENTEROL, V89, P387; Delgado-Aros S, 2004, AM J GASTROENTEROL, V99, P1801, DOI 10.1111/j.1572-0241.2004.30887.x; DIMENAS E, 1995, SCAND J GASTROENTERO, V30, P1046, DOI 10.3109/00365529509101605; El-Serag HB, 2014, GUT, V63, P220, DOI 10.1136/gutjnl-2012-304189; El-Serag HB, 2005, AM J GASTROENTEROL, V100, P1243, DOI 10.1111/j.1572-0241.2005.41703.x; Engsbro AL, 2013, AM J GASTROENTEROL, V108, P972, DOI 10.1038/ajg.2013.15; Eslick GD, 2012, OBES REV, V13, P469, DOI 10.1111/j.1467-789X.2011.00969.x; Farzaneh N, 2013, ANN MED HEALTH SCI R, V3, P391, DOI 10.4103/2141-9248.117958; Goebel-Stengel M, 2014, J NEUROGASTROENTEROL, V20, P228, DOI [10.5056/jnm.2014.20.2.228, 10.5056/jnm.20.2.228]; Goodpaster BH, 2002, CURR OPIN CLIN NUTR, V5, P481, DOI 10.1097/00075197-200209000-00005; Han SH, 2006, J GASTROEN HEPATOL, V21, P1687, DOI 10.1111/j.1440-1746.2006.04269.x; Heizer WD, 2009, J AM DIET ASSOC, V109, P1204, DOI 10.1016/j.jada.2009.04.012; Henningsen P, 2008, J PSYCHOSOM RES, V64, P625, DOI 10.1016/j.jpsychores.2008.02.015; Hoddinott P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005524; Koch CA, 2008, EUR J GASTROEN HEPAT, V20, P822, DOI 10.1097/MEG.0b013e3282f5f75e; Kubo M, 2011, NEUROGASTROENT MOTIL, V23, P249, DOI 10.1111/j.1365-2982.2010.01640.x; Lee SY, 2009, DIGESTION, V79, P196, DOI 10.1159/000211715; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Moayyedi P, 2008, DIGEST DIS SCI, V53, P2293, DOI 10.1007/s10620-008-0410-z; Nagata N, 2014, INT J CANC; Nam SY, 2010, GASTROENTEROLOGY, V139, P1902, DOI 10.1053/j.gastro.2010.08.019; Nam Su Youn, 2010, J Neurogastroenterol Motil, V16, P47, DOI 10.5056/jnm.2010.16.1.47; Reding KW, 2013, AM J GASTROENTEROL, V108, P270, DOI 10.1038/ajg.2012.414; Shiotani A, 2006, J GASTROENTEROL, V41, P562, DOI 10.1007/s00535-006-1805-2; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; SVEDLUND J, 1988, DIGEST DIS SCI, V33, P129, DOI 10.1007/BF01535722; Talley NJ, 2004, AM J GASTROENTEROL, V99, P1807, DOI 10.1111/j.1572-0241.2004.30388.x; Talley NJ, 2004, NEUROGASTROENT MOTIL, V16, P413, DOI 10.1111/j.1365-2982.2004.00530.x; THAETE FL, 1995, INT J OBESITY, V19, P464; Wiklund IK, 2003, SCAND J GASTROENTERO, V38, P947, DOI 10.1080/00365520310004209; Zhao YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043749	38	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123993	10.1371/journal.pone.0123993	http://dx.doi.org/10.1371/journal.pone.0123993			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906052	gold, Green Published, Green Submitted			2022-12-27	WOS:000353332000054
J	van der Flier, A; Liu, Z; Tan, SY; Chen, K; Drager, D; Liu, TY; Patarroyo-White, S; Jiang, HY; Light, DR				van der Flier, Arjan; Liu, Zhan; Tan, Siyuan; Chen, Kai; Drager, Douglas; Liu, Tongyao; Patarroyo-White, Susannah; Jiang, Haiyan; Light, David R.			FcRn Rescues Recombinant Factor VIII Fc Fusion Protein from a VWF Independent FVIII Clearance Pathway in Mouse Hepatocytes	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; COAGULATION-FACTOR-VIII; PEGYLATED FACTOR-VIII; PROLONGED ACTIVITY; FACTOR-IX; ENDOTHELIAL-CELLS; IGG HOMEOSTASIS; PLASMA-LEVELS; HALF-LIFE; RECEPTOR	We recently developed a longer lasting recombinant factor VIII-Fc fusion protein, rFVIIIFc, to extend the half-life of replacement FVIII for the treatment of people with hemophilia A. In order to elucidate the biological mechanism for the elongated half-life of rFVIIIFc at a cellular level we delineated the roles of VWF and the tissue-specific expression of the neonatal Fc receptor (FcRn) in the biodistribution, clearance and cycling of rFVIIIFc. We find the tissue biodistribution is similar for rFVIIIFc and rFVIII and that liver is the major clearance organ for both molecules. VWF reduces the clearance and the initial liver uptake of rFVIIIFc. Pharma-cokinetic studies in FcRn chimeric mice show that FcRn expressed in somatic cells (hepatocytes or liver sinusoidal endothelial cells) mediates the decreased clearance of rFVIIIFc, but FcRn in hematopoietic cells (Kupffer cells) does not affect clearance. Immunohistochemical studies show that when rFVIII or rFVIIIFc is in dynamic equilibrium binding with VWF, they mostly co localize with VWF in Kupffer cells and macrophages, confirming a major role for liver macrophages in the internalization and clearance of the VWF-FVIII complex. In the absence of VWF a clear difference in cellular localization of VWF-free rFVIII and rFVIIIFc is observed and neither molecule is detected in Kupffer cells. Instead, rFVIII is observed in hepatocytes, indicating that free rFVIII is cleared by hepatocytes, while rFVIIIFc is observed as a diffuse liver sinusoidal staining, suggesting recycling of free-rFVIIIFc out of hepatocytes. These studies reveal two parallel linked clearance pathways, with a dominant pathway in which both rFVIIIFc and rFVIII complexed with VWF are cleared mainly by Kupffer cells without FcRn cycling. In contrast, the free fraction of rFVIII or rFVIIIFc unbound by VWF enters hepatocytes, where FcRn reduces the degradation and clearance of rFVIIIFc relative to rFVIII by cycling rFVIIIFc back to the liver sinusoid and into circulation, enabling the elongated half-life of rFVIIIFc.	[van der Flier, Arjan; Liu, Zhan; Tan, Siyuan; Chen, Kai; Drager, Douglas; Liu, Tongyao; Patarroyo-White, Susannah; Jiang, Haiyan; Light, David R.] Biogen, Hematol Res, Cambridge, MA 02142 USA	Biogen	Light, DR (corresponding author), Biogen, Hematol Res, Cambridge, MA 02142 USA.	david.light@biogen.com		van der Flier, Arjan/0000-0002-6911-9291				Akilesh S, 2007, J IMMUNOL, V179, P4580, DOI 10.4049/jimmunol.179.7.4580; Antoni G, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-102; Baker K, 2013, CELL MOL LIFE SCI, V70, P1319, DOI 10.1007/s00018-012-1100-8; Berntorp E, 2012, LANCET, V379, P1447, DOI 10.1016/S0140-6736(11)61139-2; BI L, 1995, NAT GENET, V10, P119, DOI 10.1038/ng0595-119; BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; Borchiellini A, 1996, BLOOD, V88, P2951, DOI 10.1182/blood.V88.8.2951.bloodjournal8882951; Bovenschen N, 2005, BLOOD, V106, P906, DOI 10.1182/blood-2004-11-4230; Butenas S, 2010, THROMB RES, V126, P119, DOI 10.1016/j.thromres.2010.04.004; Chang CH, 2008, IN VIVO, V22, P693; Christianson GJ, 2012, MABS-AUSTIN, V4, P208, DOI 10.4161/mabs.4.2.19397; Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524; Denis CV, 2008, THROMB HAEMOSTASIS, V99, P271, DOI 10.1160/TH07-10-0629; Dong JF, 2005, J THROMB HAEMOST, V3, P1710, DOI 10.1111/j.1538-7836.2005.01360.x; Dumont JA, 2012, BLOOD, V119, P3024, DOI 10.1182/blood-2011-08-367813; Everett LA, 2014, BLOOD, V123, P3697, DOI 10.1182/blood-2014-02-554501; Fahs SA, 2014, BLOOD, V123, P3706, DOI 10.1182/blood-2014-02-555151; FAY PJ, 1991, J BIOL CHEM, V266, P2172; Federici AB, 2003, HAEMATOLOGICA, V88; Froh M, 2003, CURR PROTOC TOXICOL; Gadisseur A, 2009, ACTA HAEMATOL-BASEL, V121, P71, DOI 10.1159/000214846; Gopalakrishnan R, 2010, J THROMB HAEMOST, V8, P301, DOI 10.1111/j.1538-7836.2009.03696.x; Gui T, 2002, BLOOD, V100, P153, DOI 10.1182/blood.V100.1.153; Israel EJ, 1996, IMMUNOLOGY, V89, P573, DOI 10.1046/j.1365-2567.1996.d01-775.x; Kanaji S, 2012, J THROMB HAEMOST, V10, P1646, DOI 10.1111/j.1538-7836.2012.04797.x; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Kobayashi K, 2009, GASTROENTEROLOGY, V137, P1746, DOI 10.1053/j.gastro.2009.07.059; KOEDAM JA, 1988, J CLIN INVEST, V82, P1236, DOI 10.1172/JCI113721; Kontermann RE, 2011, CURR OPIN BIOTECH, V22, P868, DOI 10.1016/j.copbio.2011.06.012; Kuo TT, 2011, MABS-AUSTIN, V3, P422, DOI 10.4161/mabs.3.5.16983; Kuo TT, 2010, J CLIN IMMUNOL, V30, P777, DOI 10.1007/s10875-010-9468-4; Lenting PJ, 2007, J THROMB HAEMOST, V5, P1353, DOI 10.1111/j.1538-7836.2007.02572.x; Lenting PJ, 2010, HAEMOPHILIA, V16, P194, DOI 10.1111/j.1365-2516.2010.02320.x; Lenting PJ, 2010, HAEMOPHILIA, V16, P6, DOI 10.1111/j.1365-2516.2008.01864.x; Lillicrap D, 2013, BLOOD, V122, P3735, DOI 10.1182/blood-2013-06-498303; Liu ZL, 2014, BLOOD, V124, P4223; Mahlangu J, 2014, BLOOD, V123, P317, DOI 10.1182/blood-2013-10-529974; Medesan C, 1997, J IMMUNOL, V158, P2211; Mei BS, 2010, BLOOD, V116, P270, DOI 10.1182/blood-2009-11-254755; Montoyo HP, 2009, P NATL ACAD SCI USA, V106, P2788, DOI 10.1073/pnas.0810796106; Mordenti J, 1996, TOXICOL APPL PHARM, V136, P75, DOI 10.1006/taap.1996.0008; Nakata K, 2010, BIOCHEM BIOPH RES CO, V395, P238, DOI 10.1016/j.bbrc.2010.03.170; National Research Council, 2011, GUIDE CARE USE LAB A; Navarrete A, 2009, J THROMB HAEMOST, V7, P1816, DOI 10.1111/j.1538-7836.2009.03571.x; Nonaka H, 2007, DEV DYNAM, V236, P2258, DOI 10.1002/dvdy.21227; Ogawara K, 1999, J CONTROL RELEASE, V59, P15, DOI 10.1016/S0168-3659(99)00015-2; Peters RT, 2013, J THROMB HAEMOST, V11, P132, DOI 10.1111/jth.12076; Peters RT, 2010, BLOOD, V115, P2057, DOI 10.1182/blood-2009-08-239665; Powell JS, 2012, BLOOD, V119, P3031, DOI 10.1182/blood-2011-09-382846; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; Rastegarlari G, 2012, BLOOD, V119, P2126, DOI 10.1182/blood-2011-08-373605; Rath T., 2013, CRIT REV BIOTECHNOL, V1, P1; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Rydz N, 2013, BLOOD, V121, P5228, DOI 10.1182/blood-2012-10-457507; Sarafanov AG, 2001, J BIOL CHEM, V276, P11970, DOI 10.1074/jbc.M008046200; Sarin Hemant, 2010, J Angiogenes Res, V2, P14, DOI 10.1186/2040-2384-2-14; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Shapiro AD, 2014, J THROMB HAEMOST, V12, P1788, DOI 10.1111/jth.12723; Shi Q, 2012, HAEMOPHILIA, V18, P639, DOI 10.1111/j.1365-2516.2011.02735.x; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; SODETZ JM, 1977, J BIOL CHEM, V252, P5538; Stennicke HR, 2013, BLOOD, V121, P2108, DOI 10.1182/blood-2012-01-407494; Tang L, 2013, HAEMOPHILIA, V19, P539, DOI 10.1111/hae.12116; Terraube V, 2010, HAEMOPHILIA, V16, P3, DOI 10.1111/j.1365-2516.2009.02005.x; van Schooten CJ, 2008, BLOOD, V112, P1704, DOI 10.1182/blood-2008-01-133181; VLOT AJ, 1995, BLOOD, V85, P3150, DOI 10.1182/blood.V85.11.3150.bloodjournal85113150; Vlot AJ, 1996, BLOOD, V87, P1809; Wisse E, 2008, GENE THER, V15, P1193, DOI 10.1038/gt.2008.60	71	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124930	10.1371/journal.pone.0124930	http://dx.doi.org/10.1371/journal.pone.0124930			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905473	gold, Green Published, Green Submitted			2022-12-27	WOS:000353332000094
J	Wang, L; Velazquez, H; Chang, J; Safirstein, R; Desir, GV				Wang, Ling; Velazquez, Heino; Chang, John; Safirstein, Robert; Desir, Gary V.			Identification of a Receptor for Extracellular Renalase	PLOS ONE			English	Article							MEMBRANE CALCIUM-ATPASE; BLOOD-PRESSURE; HYPERTENSION; ASSOCIATION; SURVIVAL; OXIDASE; STROKE; GENE; AKI	Background An increased risk for developing essential hypertension, stroke and diabetes is associated with single nucleotide gene polymorphisms in renalase, a newly described secreted flavoprotein with oxidoreductase activity. Gene deletion causes hypertension, and aggravates acute ischemic kidney (AKI) and cardiac injury. Independent of its intrinsic enzymatic activities, extracellular renalase activates MAPK signaling and prevents acute kidney injury (AKI) in wild type (WT) mice. Therefore, we sought to identity the receptor for extracellular renalase. Methods and Results RP-220 is a previously identified, 20 amino acids long renalase peptide that is devoid of any intrinsic enzymatic activity, but it is equally effective as full-length recombinant renalase at protecting against toxic and ischemic injury. Using biotin transfer studies with RP-220 in the human proximal tubular cell line HK-2 and protein identification by mass spectrometry, we identified PMCA4b as a renalase binding protein. This previously characterized plasma membrane ATPase is involved in cell signaling and cardiac hypertrophy. Co-immunoprecipitation and co-immunolocalization confirmed protein-protein interaction between endogenous renalase and PMCA4b. Down-regulation of endogenous PMCA4b expression by siRNA transfection, or inhibition of its enzymatic activity by the specific peptide inhibitor caloxin 1b each abrogated RP-220 dependent MAPK signaling and cytoprotection. In control studies, these maneuvers had no effect on epidermal growth factor mediated signaling, confirming specificity of the interaction between PMCA4b and renalase. Conclusions PMCA4b functions as a renalase receptor, and a key mediator of renalase dependent MAPK signaling.	[Wang, Ling; Velazquez, Heino; Chang, John; Safirstein, Robert; Desir, Gary V.] Yale Univ, Dept Med, VACHS, New Haven, CT 06520 USA; [Wang, Ling] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Div Renal, Shanghai 200030, Peoples R China	Yale University; Shanghai Jiao Tong University	Desir, GV (corresponding author), Yale Univ, Dept Med, VACHS, New Haven, CT 06520 USA.	gary.desir@yale.edu			Bessor Pharma Company; VA Connecticut; National Institutes of Health [RC1DK086465, RC1DK086402, R01DK081037]; National Basic Research Program of China 973 Program [2012CB517600, 2012CB517602]; Shanghai Health Bureau [ZXSNXD-CC-ZDYJ002]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079310, RC1DK086465, RC1DK086402, R01DK081037] Funding Source: NIH RePORTER	Bessor Pharma Company; VA Connecticut; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Basic Research Program of China 973 Program(National Basic Research Program of China); Shanghai Health Bureau; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Research grants from Bessor Pharma Company, VA Connecticut (H.V, R.S. and G.V.D.), National Institutes of Health grant RC1DK086465, RC1DK086402 and R01DK081037 (G.V.D), National Basic Research Program of China 973 Program 2012CB517600 and 2012CB517602, and Shanghai Health Bureau ZXSNXD-CC-ZDYJ002 (W.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armesilla AL, 2004, J BIOL CHEM, V279, P31318, DOI 10.1074/jbc.M307557200; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Beaupre BA, 2015, BIOCHEMISTRY-US, V54, P795, DOI 10.1021/bi5013436; Buch MH, 2005, J BIOL CHEM, V280, P29479, DOI 10.1074/jbc.M501326200; Buraczynska M, 2011, NEUROMOL MED, V13, P321, DOI 10.1007/s12017-011-8158-6; Cartwright EJ, 2007, ANN NY ACAD SCI, V1099, P247, DOI 10.1196/annals.1387.007; Desir GV, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002634; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013496; Kim HJ, 2012, J CELL BIOL, V199, P1145, DOI 10.1083/jcb.201204067; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lee HT, 2013, J AM SOC NEPHROL, V24, P445, DOI 10.1681/ASN.2012090943; Li G, 2008, CIRCULATION, V117, P1277, DOI 10.1161/CIRCULATIONAHA.107.732032; Malyszko J, 2012, RENAL FAILURE, V34, P727, DOI 10.3109/0886022X.2012.681534; Milani M, 2011, J MOL BIOL, V411, P463, DOI 10.1016/j.jmb.2011.06.010; Mohamed TMA, 2013, J MOL CELL CARDIOL, V63, P57, DOI 10.1016/j.yjmcc.2013.07.007; Pande J, 2008, J CELL MOL MED, V12, P1049, DOI 10.1111/j.1582-4934.2008.00140.x; Roulston A, 1998, J BIOL CHEM, V273, P10232, DOI 10.1074/jbc.273.17.10232; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Wang L, 2014, J AM SOC NEPHROL, V25, P1226, DOI 10.1681/ASN.2013060665; Wu X, 2009, J CLIN INVEST, V119, P976, DOI 10.1172/JCI36693; Wu YL, 2011, KIDNEY INT, V79, P853, DOI 10.1038/ki.2010.488; Xu JC, 2005, J CLIN INVEST, V115, P1275, DOI 10.1172/JCI200524066; Zhao Q, 2007, J MOL MED, V85, P877, DOI 10.1007/s00109-006-0151-4	23	44	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0122932	10.1371/journal.pone.0122932	http://dx.doi.org/10.1371/journal.pone.0122932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906147	gold, Green Published, Green Submitted			2022-12-27	WOS:000353332000019
J	Zhu, L; Yu, H; Liu, SY; Xiao, XS; Dong, WH; Chen, YN; Xu, W; Zhu, T				Zhu, Lin; Yu, Hong; Liu, Shi-Yuan; Xiao, Xiang-Sheng; Dong, Wei-Hua; Chen, Yi-Nan; Xu, Wei; Zhu, Tong			Prognostic Value of Tissue Inhibitor of Metalloproteinase-2 Expression in Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							MATRIX METALLOPROTEINASES; ADENOCARCINOMA; INVASION; TIMP-1; MATRIX-METALLOPROTEINASE-9; METASTASIS; SURVIVAL	Background and Objectives Tissue inhibitor of metalloproteinase-2 (TIMP-2) is a small secretory glycoprotein with antimatrix metalloproteinase activity. Data on the value of TIMP-2 as a prognostic factor in nonsmall cell lung cancer (NSCLC) are discordant and remain controversial. A systematic review and meta-analysis was performed to explore this issue. Methods We identified the relevant literature by searching the PubMed, EMBASE, Web of Science, China National Knowledge Infrastructure, SinoMed, and Wanfang Data databases (search terms: "non-small cell lung cancer" or "NSCLC" or "Lung Carcinoma, Non-Small-Cell", "Tissue Inhibitor of Metalloproteinase-2" or "TIMP-2", and "prognosis" or "prognostic" or "survive") for updates prior to March 1, 2014. The pooled hazard ratio (HR) of overall survival with a 95% confidence interval (95% CI) was used to evaluate the strength of the association between positive TIMP-2 expression and survival in patients with NSCLC. Results We included 12 studies in our systematic review; five studies involving 399 patients with NSCLC were meta-analyzed. The pooled HR of all included patients was 0.57 (95% CI: 0.43-0.77), and the HRs of subgroup analysis according to stage (I-IV), testing method (immunohistochemistry) and high TIMP-2 expression percentage (<50%) were 0.63 (95% CI: 0.43-0.92), 0.55 (95% CI: 0.41-0.74), and 0.50 (95% CI: 0.28-0.88), respectively. These data suggested that high TIMP-2 expression is associated with favorable prognosis in NSCLC. The meta-analysis did not reveal heterogeneity or publication bias. Conclusions TIMP-2 expression indicates favorable prognosis in patients with NSCLC; as a protective factor, it could help predict outcome and may guide clinical therapy in the future.	[Zhu, Lin; Yu, Hong; Liu, Shi-Yuan; Xiao, Xiang-Sheng; Dong, Wei-Hua; Chen, Yi-Nan] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Med Imaging, Shanghai, Peoples R China; [Xu, Wei] Second Mil Med Univ Lib, Dept Periodicals, Shanghai, Peoples R China; [Zhu, Tong] Shanghai United Imaging Healthcare Co Ltd, Dept Business Mkt, Shanghai, Peoples R China	Naval Medical University	Yu, H (corresponding author), Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Med Imaging, Shanghai, Peoples R China.	yuhongphd@163.com	xu, wei/HHD-2891-2022; xiao, xiang/GWU-6035-2022		National Natural Science Foundation of China [81071155, 81271572]; Shanghai Municipal Health Bureau Foundation [2012020]; Shanghai United Imaging Healthcare Co., Ltd.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Health Bureau Foundation; Shanghai United Imaging Healthcare Co., Ltd.	This work was supported by grants from the National Natural Science Foundation of China (code: 81071155 and 81271572) and the Shanghai Municipal Health Bureau Foundation (code: 2012020). This funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Tong Zhu is employed by Shanghai United Imaging Healthcare Co., Ltd. Shanghai United Imaging Healthcare Co., Ltd. provided support in the form of salary for author TZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Buyukcelik Abdullah, 2004, N Engl J Med, V350, P2008; Cao JW, 2010, J GUANGXI MED U; Davies KJ, 2014, INT J BREAST CANCER, V2014, DOI 10.1155/2014/839094; GIEDL J, 1983, THORAC CARDIOV SURG, V31, P71, DOI 10.1055/s-2007-1020298; Grunnet M, 2012, LUNG CANCER, V76, P138, DOI 10.1016/j.lungcan.2011.11.012; Guedez L, 2012, J IMMUNOTHER, V35, P502, DOI 10.1097/CJI.0b013e3182619c8e; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang AL, 2014, ASIAN PAC J CANCER P, V15, P8143, DOI 10.7314/APJCP.2014.15.19.8143; Iniesta P, 2007, ONCOL REP, V17, P217; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; JOHNSON BE, 1993, CHEST, V103, pS1, DOI 10.1378/chest.103.1_Supplement.1S; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kumaki F, 2001, AM J PATHOL, V159, P2125, DOI 10.1016/S0002-9440(10)63064-7; Le Chevalier T, 2010, ANN ONCOL, V21, P196, DOI 10.1093/annonc/mdq376; Li HG, 2001, CONTROL INSTRUMENTS, V28, P31; Lim BJ, 2010, MOL MED REP, V3, P43, DOI 10.3892/mmr_00000216; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lv ZQ, 2006, J SUN YAT SEN UNIV M, P200; Ma J, 2014, INT J CLIN EXP PATHO, V7, P246; Michael M, 1999, J CLIN ONCOL, V17, P1802, DOI 10.1200/JCO.1999.17.6.1802; Miyake H, 2014, UROL ONCOL-SEMIN ORI, V32, P584, DOI 10.1016/j.urolonc.2014.01.016; Peng WJ, 2012, CLIN CHIM ACTA, V413, P1121, DOI 10.1016/j.cca.2012.03.012; Qian QA, 2010, CANCER INVEST, V28, P661, DOI 10.3109/07357901003735634; Qian Z, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-442; Sakashita S, 2014, SEMIN ONCOL, V41, P28, DOI 10.1053/j.seminoncol.2013.12.008; Sela-Passwell NA, 2012, NAT MED, V18, P143, DOI 10.1038/nm.2582; STETLERSTEVENSON WG, 1989, J BIOL CHEM, V264, P17374; Suemitsu R, 2004, SURG TODAY, V34, P896, DOI 10.1007/s00595-004-2853-y; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tirino V, 2009, EUR J CARDIO-THORAC, V36, P446, DOI 10.1016/j.ejcts.2009.03.063; Williamson PR, 2002, STAT MED, V21, P3337, DOI 10.1002/sim.1303; Wu DW, 2012, AM J PATHOL, V181, P1796, DOI 10.1016/j.ajpath.2012.07.032; Wu KC, 2012, ANTICANCER RES, V32, P4833; Xie ZM, 2007, J SUN YAT SEN U; Xue PP, 2014, CHEM-BIOL INTERACT, V209, P25, DOI 10.1016/j.cbi.2013.11.014; Yang DY, 2005, FOREIGN MED SCI RESP, P407; Ylisirnio S, 2000, ANTICANCER RES, V20, P1311; Zhang LG, 2004, CHIN J ANAT, P31; Zhou JH, 2006, IEEE INFOCOM 2006, P23; Zhu ZH, 2009, J CLIN ONCOL, V27, P1091, DOI 10.1200/JCO.2008.16.6991	41	19	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124230	10.1371/journal.pone.0124230	http://dx.doi.org/10.1371/journal.pone.0124230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905787	Green Submitted, Green Published, gold			2022-12-27	WOS:000353332000061
J	Brady, RA; Bruno, VM; Burns, DL				Brady, Rebecca A.; Bruno, Vincent M.; Burns, Drusilla L.			RNA-Seq Analysis of the Host Response to Staphylococcus aureus Skin and Soft Tissue Infection in a Mouse Model	PLOS ONE			English	Article							REGULATES INNATE IMMUNITY; UNITED-STATES; KERATIN 1; INFLAMMATION; EXPRESSION; NEUTROPHILS; ACTIVATION; MECHANISMS; GAMMA	Staphylococcus aureus is a leading cause of skin and soft tissue infections (SSTI), which are primarily self-limiting. We conducted a comprehensive analysis of the host transcriptome during a S. aureus SSTI to provide insight on the protective mechanisms that thwart these infections. We utilized a murine SSTI model in which one ear is epicutaneously challenged while the other is not. We then harvested these infected and uninfected ears, as well as ears from naive mice, at one, four, and seven days post-challenge, and performed RNA sequencing (RNA-seq) using the Illumina platform. RNA-seq data demonstrated a robust response at the site of infection. Comparison of gene expression profiles between infected ears and the non-infected ears of challenged mice defined the local response to infection, while comparisons of expression profiles of non-infected ears from challenged mice to ears of naive mice revealed changes in gene expression levels away from the site indicative of a systemic response. Over 1000 genes exhibited increased expression locally at all tested time points. The local response was more robust than the systemic response. Through evaluation of the RNA-seq data using the Upstream Regulator Analytic as part of the Ingenuity Pathway Analysis software package, we found that changes in the activation and inhibition of regulatory pathways happen first locally, and lag behind systemically. The activated pathways are highly similar at all three time points during SSTI, suggesting a stable global response over time. Transcript increases and pathway activation involve pro- and anti-inflammatory mediators, chemotaxis, cell signaling, keratins, and TH1/TH17 cytokines. Transcript decreases and pathway inhibition demonstrate that metabolic genes and anti-inflammatory pathways are repressed. These data provide insight on the host responses that may aid in resolution of this self-limited S. aureus infection, and may shed light on potential immune correlates of protection for staphylococcal SSTI.	[Brady, Rebecca A.; Burns, Drusilla L.] US FDA, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Bruno, Vincent M.] Univ Maryland, Inst Genome Sci, Baltimore, MD 21201 USA	US Food & Drug Administration (FDA); University System of Maryland; University of Maryland Baltimore	Brady, RA (corresponding author), US FDA, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	Rebecca.Brady@fda.hhs.gov			Intramural Research Program of the Center for Biologics Evaluation and Research, Food and Drug Administration; National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); Department of Health and Human Services [HHSN272200900009C]	Intramural Research Program of the Center for Biologics Evaluation and Research, Food and Drug Administration; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services	This work was supported by the Intramural Research Program of the Center for Biologics Evaluation and Research, Food and Drug Administration. The sequencing for this project was funded by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), and Department of Health and Human Services under contract number HHSN272200900009C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bixel G, 2004, BLOOD, V104, P3205, DOI 10.1182/blood-2004-03-1184; Bolling MC, 2010, BRIT J DERMATOL, V162, P875, DOI 10.1111/j.1365-2133.2009.09617.x; Brady BL, 2013, IMMUNOL CELL BIOL, V91, P331, DOI 10.1038/icb.2013.19; Brady RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063040; Bratke K, 2005, EUR J IMMUNOL, V35, P2608, DOI 10.1002/eji.200526122; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Carow B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00058; Cho JS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003047; Cho JS, 2011, J INVEST DERMATOL, V131, P907, DOI 10.1038/jid.2010.417; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Cogen AL, 2010, J INVEST DERMATOL, V130, P192, DOI 10.1038/jid.2009.243; DePianto D, 2010, NAT GENET, V42, P910, DOI 10.1038/ng.665; Gasiorowski RE, 2013, IMMUNOL LETT, V149, P93, DOI 10.1016/j.imlet.2012.10.005; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Haim M, 2010, MICROBIOL-SGM, V156, P3710, DOI 10.1099/mic.0.034413-0; Hunold K, 2012, IMMUNOBIOLOGY, V217, P982, DOI 10.1016/j.imbio.2012.01.013; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Krespi YP, 2012, AM J OTOLARYNG, V33, P572, DOI 10.1016/j.amjoto.2012.02.002; Kuijpers TW, 2010, J CLIN INVEST, V120, P214, DOI 10.1172/JCI40231; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Lessard JC, 2013, P NATL ACAD SCI USA, V110, P19537, DOI 10.1073/pnas.1309576110; Li YK, 2013, J BIOL CHEM, V288, P16225, DOI 10.1074/jbc.M113.454538; Liu WL, 2010, P NATL ACAD SCI USA, V107, P11056, DOI 10.1073/pnas.1001269107; Mocca CP, 2014, CLIN VACCINE IMMUNOL; Molne L, 2000, INFECT IMMUN, V68, P6162, DOI 10.1128/IAI.68.11.6162-6167.2000; Montgomery CP, 2014, INFECT IMMUN, V82, P2125, DOI 10.1128/IAI.01491-14; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Nakahira M, 2002, J IMMUNOL, V168, P1146, DOI 10.4049/jimmunol.168.3.1146; Nippe N, 2011, J INVEST DERMATOL, V131, P125, DOI 10.1038/jid.2010.282; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646; Plaut RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059232; Prabhakara R, 2013, INFECT IMMUN, V81, P1306, DOI 10.1128/IAI.01304-12; Roth W, 2012, J CELL SCI, V125, P5269, DOI 10.1242/jcs.116574; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Thorn CF, 2002, J IMMUNOL, V169, P399, DOI 10.4049/jimmunol.169.1.399; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Walker JA, 2008, IMMUNOLOGY, V123, P314, DOI 10.1111/j.1365-2567.2007.02752.x; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	47	18	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124877	10.1371/journal.pone.0124877	http://dx.doi.org/10.1371/journal.pone.0124877			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901897	Green Submitted, Green Published, gold			2022-12-27	WOS:000353331500103
J	Clennin, MN; Payne, JPW; Rienzi, EG; Lavie, CJ; Blair, SN; Pate, RR; Sui, XM				Clennin, Morgan N.; Payne, Jonathan P. W.; Rienzi, Edgardo G.; Lavie, Carl J.; Blair, Steven N.; Pate, Russell R.; Sui, Xuemei			Association between Cardiorespiratory Fitness and Health-Related Quality of Life among Patients at Risk for Cardiovascular Disease in Uruguay	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CLINICAL CARDIOLOGY; PUBLIC-HEALTH; MENTAL-HEALTH; EXERCISE; INACTIVITY; STATEMENT; ADULTS; REHABILITATION; PERCEPTIONS	To date, few studies have examined the relationship between cardiorespiratory fitness (CRF) and health-related quality of life (HRQoL) in populations at high risk for developing cardiovascular disease (CVD). Purpose To examine the association between objectively measured CRF and physical and mental components of HRQoL in a Uruguayan cohort at risk for developing CVD. Methods Patient data records from 2002-2012 at the Calidad de Vida Center were examined. To assess CRF, participants performed a submaximal exercise test. During the evaluation, participants also completed the SF-36, a HRQoL measure comprised of eight dimensions that are summarized by physical and mental component scores (PCS and MCS, respectively). ANCOVA was used to examine the relationship between HRQoL dimensions and CRF. Logistic regression was then used to compare the odds of having a HRQoL component score above the norm across CRF. All analyses were performed separately for males and females with additional stratified analyses across age and BMI conducted among significant trends. Results A total of 2,302 subjects were included in the analysis. Among females, a significant relationship was observed between CRF and vitality, physical functioning, physical role, bodily pain, and general health dimensions. However, for males the only dimension found to be significantly associated with CRF was physical health. After adjusting for potential con-founders, a significant linear trend (p<0.001) for PCS scores above the norm across CRF levels was observed for females only. Conclusion Among females with one or more risk factors for developing CVD, higher levels of CRF were positively associated with the vitality and physical dimensions of HRQoL, as well as the overall PCS. However, among males the only dimension associated with CRF was physical functioning. Future studies should examine this relationship among populations at risk for developing CVD in more detail and over time.	[Clennin, Morgan N.; Payne, Jonathan P. W.; Blair, Steven N.; Pate, Russell R.; Sui, Xuemei] Univ S Carolina, Arnold Sch Publ Hlth, Dept Exercise Sci, Columbia, SC 29208 USA; [Rienzi, Edgardo G.] Asociac Espanola, Ctr Calidad Vida, Especialista Med Deporte, Montevideo, Uruguay; [Lavie, Carl J.] Univ Queensland, Sch Med, Ochsner Clin School, John Ochsner Heart & Vasc Inst,Dept Cardiovasc Di, New Orleans, LA USA; [Lavie, Carl J.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Dept Prevent Med, Baton Rouge, LA USA; [Blair, Steven N.] Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Ochsner Health System; University of Queensland; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Sui, XM (corresponding author), Univ S Carolina, Arnold Sch Publ Hlth, Dept Exercise Sci, Columbia, SC 29208 USA.	msui@mailbox.sc.edu	Lavie, Carl J/A-6014-2011		La Banca Company in Uruguay	La Banca Company in Uruguay	Funding for this project was provided through an unrestricted grant from the La Banca Company in Uruguay. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Sports Medicine, 2003, ACSMS GUID EX TEST P; Annoni I, 2013, SPORT SCI HLTH S, V9, P73; [Anonymous], 2007, CIRCULATION, DOI DOI 10.1161/CIRCULATIONAHA.107.185649; Bennett WL, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-110; Beyler N, 2008, P SURV RES METH SECT, P3282; Bize R, 2007, PREV MED, V45, P401, DOI 10.1016/j.ypmed.2007.07.017; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; Blair SN, 2009, BRIT J SPORT MED, V43, P1; Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003; Bouchard C, 1998, MED SCI SPORT EXER, V30, P252, DOI 10.1097/00005768-199802000-00013; Brand R, 2006, SOZ PRAVENTIV MED, V51, P14, DOI 10.1007/s00038-005-0002-z; Chai WW, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-83; Chodzko-Zajko W, 2009, AM J LIFESTYLE MED, V3, P20, DOI 10.1177/1559827608325456; Deaton C, 2011, EUR J CARDIOVASC NUR, V10, pS5, DOI 10.1016/S1474-5151(11)00111-3; Eriksen L, 2013, PREV MED, V57, P900, DOI 10.1016/j.ypmed.2013.09.024; Fletcher GF, 1996, CIRCULATION, V94, P857, DOI 10.1161/01.CIR.94.4.857; Galper DI, 2006, MED SCI SPORT EXER, V38, P173, DOI 10.1249/01.mss.0000180883.32116.28; Gillison FB, 2006, HEALTH EDUC RES, V21, P836, DOI 10.1093/her/cyl139; Hakkinen A, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-15; Hamer M, 2009, BRIT J SPORT MED, V43, P1111, DOI 10.1136/bjsm.2008.046243; Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089; Lavie C J, 2000, J Cardiopulm Rehabil, V20, P235, DOI 10.1097/00008483-200007000-00004; Lee DC, 2010, BRIT J SPORT MED, V10, P684; Lindholm E, 2003, QUAL LIFE RES, V12, P575, DOI 10.1023/A:1025034919526; Martin CK, 2009, ARCH INTERN MED, V169, P269, DOI 10.1001/archinternmed.2008.545; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Mendis S., 2011, GLOBAL ATLAS CARDIOV, P1, DOI [10.1016/S0022-3476(51)80275-0., DOI 10.1016/S0022-3476(51)80275-0.]; O'Donovan G, 2010, J SPORT SCI, V28, P573, DOI 10.1080/02640411003671212; Olivares PR, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-117; Perales F, 2014, QUAL LIFE RES, P1; Petrou S, 2008, HEALTH ECON, V17, P127, DOI 10.1002/hec.1242; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Rejeski WJ, 2006, OBESITY, V14, P870, DOI 10.1038/oby.2006.101; Sanchez-Villegas A, 2012, BRIT J SPORT MED, V46, P443, DOI 10.1136/bjsm.2010.081836; Shibata A, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-64; Sloan RA, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-47; Strijk JE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-684; Takata Y, 2010, ARCH GERONTOL GERIAT, V50, P272, DOI 10.1016/j.archger.2009.04.005; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Wanderley FAC, 2011, QUAL LIFE RES, V20, P1371, DOI 10.1007/s11136-011-9875-x; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1167, DOI 10.1016/S0895-4356(98)00108-5; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Ware JE, 2001, SF 36 PHYS MENTAL HL; World Health Organization (WHO), 2009, GLOB HLTH RISK MORT	47	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123989	10.1371/journal.pone.0123989	http://dx.doi.org/10.1371/journal.pone.0123989			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KV	25901358	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500068
J	Omar, HR; Mirsaeidi, M; Socias, S; Sprenker, C; Caldeira, C; Camporesi, EM; Mangar, D				Omar, Hesham R.; Mirsaeidi, Mehdi; Socias, Stephanie; Sprenker, Collin; Caldeira, Christiano; Camporesi, Enrico M.; Mangar, Devanand			Plasma Free Hemoglobin Is an Independent Predictor of Mortality among Patients on Extracorporeal Membrane Oxygenation Support	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; LIFE-SUPPORT; HEMOLYSIS; SURGERY; PUMPS; PROGNOSIS; SYSTEMS; IMPACT; BYPASS	Background Hemolysis is common in all extracorporeal circuits as evident by the elevated plasma free hemoglobin (PFHb) level. We investigated whether increased hemolysis during extracorporeal membrane oxygenation (ECMO) is an independent mortality predictor. Methods We performed a retrospective observational study of consecutive subjects who received ECMO at a tertiary care facility from 2007-2013 to investigate independent predictors of in hospital mortality. We examined variables related to patient demographics, comorbidities, markers of hemolysis, ECMO characteristics, transfusion requirements, and complications. 24-hour PFHb>50 mg/dL was used as a marker of severe hemolysis. Results 154 patients received ECMO for cardiac (n=115) or pulmonary (n=39) indications. Patients' mean age was 51 years and 75.3% were males. Compared to nonsurvivors, survivors had lower pre-ECMO lactic acid (p=0.026), lower 24-hour lactic acid (p=0.023), shorter ECMO duration (P=0.01), fewer RBC transfusions on ECMO (p=0.008) and lower level of PFHb 24-hours post ECMO implantation (p=0.029). 24-hour PFHb>50 mg/dL occurred in 3.9 % versus 15.5% of survivors and nonsurvivors, respectively, p=0.002. A Cox proportional hazard analysis identified PFHb>50 mg/dL 24-hours post ECMO as an independent predictor of mortality (OR=3.4, 95% confidence interval: 1.3 - 8.8, p=0.011). Conclusion PFHb>50 mg/dL checked 24-hour post ECMO implantation is a useful tool to predict mortality. We propose the routine checking of PFHb 24-hours after ECMO initiation for early identification and treatment of the cause of hemolysis.	[Omar, Hesham R.] Mercy Med Ctr, Dept Internal Med, Clinton, IA USA; [Mirsaeidi, Mehdi] Univ Illinois, Dept Med, Div Pulm Crit Care Sleep & Allergy, Chicago, IL 60607 USA; [Socias, Stephanie; Sprenker, Collin] Florida Gulf To Bay Anesthesiol Associates, Dept Res, Tampa, FL USA; [Caldeira, Christiano] Florida Adv Cardiothorac Surg, Dept Cardiothorac Surg, Tampa, FL USA; [Camporesi, Enrico M.] Univ S Florida, FGTBA & TEAMHlth, Tampa, FL USA; [Mangar, Devanand] Tampa Gen Hosp, FGTBA, TEAMHlth, Dept Anesthesia, Tampa, FL 33606 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; State University System of Florida; University of South Florida; Tampa General Hospital	Mirsaeidi, M (corresponding author), Univ Illinois, Dept Med, Div Pulm Crit Care Sleep & Allergy, Chicago, IL 60607 USA.	mmirsae@uic.edu		Mirsaeidi, Mehdi/0000-0001-5298-8442	NIH [5 T32 HL 82547-7]; Florida Gulf-to-Bay Anesthesiology Associates; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL082547] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Gulf-to-Bay Anesthesiology Associates; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Mehdi Mirsaeidi was supported by NIH grant 5 T32 HL 82547-7. Florida Gulf-to-Bay Anesthesiology Associates provided support in the form of salaries for authors Collin Sprenker, Enrico M. Camporesi, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	An Y, 2006, WORLD J GASTROENTERO, V12, P6722, DOI 10.3748/wjg.v12.i41.6722; Aubron C, 2013, CRIT CARE, V17, DOI 10.1186/cc12681; Bennett M, 2004, PERFUSION-UK, V19, P107, DOI 10.1191/0267659104pf729oa; Bottrell S, 2014, PERFUSION-UK, V29, P411, DOI 10.1177/0267659113509000; Chen YS, 2003, J AM COLL CARDIOL, V41, P197, DOI 10.1016/S0735-1097(02)02716-X; Chen YC, 2011, ANN THORAC SURG, V91, P137, DOI 10.1016/j.athoracsur.2010.08.063; Conrad SA, 2005, ASAIO J, V51, P4, DOI 10.1097/01.mat.0000151922.67540.E9; Cruz-Landeira A, 2002, J ANAL TOXICOL, V26, P67, DOI 10.1093/jat/26.2.67; Davis CL, 1999, J AM SOC NEPHROL, V10, P2396; Gbadegesin R, 2009, PEDIATR NEPHROL, V24, P589, DOI 10.1007/s00467-008-1047-z; Jeffers A, 2006, FREE RADICAL BIO MED, V41, P1557, DOI 10.1016/j.freeradbiomed.2006.08.017; Kawahito S, 2002, ASAIO J, V48, P636, DOI 10.1097/00002480-200211000-00010; Kielstein JT, 2013, NEPHROL DIAL TRANSPL, V28, P86, DOI 10.1093/ndt/gfs398; Lawson D Scott, 2005, Pediatr Crit Care Med, V6, P573, DOI 10.1097/01.PCC.0000163282.63992.13; Lin CY, 2007, ANN THORAC SURG, V84, P1256, DOI 10.1016/j.athoracsur.2007.05.045; Lin CY, 2006, NEPHROL DIAL TRANSPL, V21, P2867, DOI 10.1093/ndt/gfl326; Meyer AD, 2012, PEDIATR CRIT CARE ME, V13, pE255, DOI 10.1097/PCC.0b013e31823c98ef; Mumby S, 2001, BBA-MOL BASIS DIS, V1537, P204, DOI 10.1016/S0925-4439(01)00070-9; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Rastan AJ, 2010, J THORAC CARDIOV SUR, V139, P302, DOI 10.1016/j.jtcvs.2009.10.043; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; SMITH A, 2013, EXPOSITORY TIMES, V28, P54, DOI DOI 10.1177/0267659112457969; Toomasian JM, 2011, PERFUSION-UK, V26, P5, DOI 10.1177/0267659110396015; Vercaemst Leen, 2008, J Extra Corpor Technol, V40, P257; Watanabe N, 2007, ARTIF ORGANS, V31, P352, DOI 10.1111/j.1525-1594.2007.00392.x; Windsant ICV, 2011, J THORAC CARDIOV SUR, V142, P1, DOI 10.1016/j.jtcvs.2011.02.012; Wu MY, 2008, RESUSCITATION, V79, P54, DOI 10.1016/j.resuscitation.2008.05.002	27	85	87	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124034	10.1371/journal.pone.0124034	http://dx.doi.org/10.1371/journal.pone.0124034			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902047	gold, Green Published, Green Submitted			2022-12-27	WOS:000353331500072
J	De Decker, S; Lam, R; Packer, RMA; Gielen, IMVL; Volk, HA				De Decker, Steven; Lam, Richard; Packer, Rowena M. A.; Gielen, Ingrid M. V. L.; Volk, Holger A.			Thoracic and Lumbar Vertebral Bone Mineral Density Changes in a Natural Occurring Dog Model of Diffuse Idiopathic Skeletal Hyperostosis	PLOS ONE			English	Article							ANKYLOSING-SPONDYLITIS; COMPUTED-TOMOGRAPHY; RISK-FACTORS; OSTEOPOROSIS; FRACTURES; FEATURES; CT	Ankylosing spinal disorders can be associated with alterations in vertebral bone mineral density (BMD). There is however controversy about vertebral BMD in patients wuse idiopathic skeletal hyperostosis (DISH). DISH in Boxer dogs has been considered a natural occurring disease model for DISH in people. The purpose of this study was to compare vertebral BMD between Boxers with and without DISH. Fifty-nine Boxers with (n=30) or without (n=29) DISH that underwent computed tomography were included. Vertebral BMD was calculated for each thoracic and lumbar vertebra by using an earlier reported and validated protocol. For each vertebral body, a region of interest was drawn on the axial computed tomographic images at three separate locations: immediately inferior to the superior end plate, in the middle of the vertebral body, and superior to the inferior end plate. Values from the three axial slices were averaged to give a mean Hounsfield Unit value for each vertebral body. Univariate statistical analysis was performed to identify factors to be included in a multivariate model. The multivariate model including all dogs demonstrated that vertebral DISH status (Coefficient 24.63; 95% CI 16.07 to 33.19; p < 0.001), lumbar vertebrae (Coefficient -17.25; 95% CI -23.42 to -11.09; p < 0.01), and to a lesser extent higher age (Coefficient -0.56; 95% CI -1.07 to -0.05; p = 0.03) were significant predictors for vertebral BMD. When the multivariate model was repeated using only dogs with DISH, vertebral DISH status (Coefficient 20.67; 95% CI, 10.98 to 30.37; p < 0.001) and lumbar anatomical region (Coefficient -38.24; 95% CI, -47.75 to -28.73; p < 0.001) were again predictors for vertebral BMD but age was not. The results of this study indicate that DISH can be associated with decreased vertebral BMD. Further studies are necessary to evaluate the clinical importance and pathophysiology of this finding.	[De Decker, Steven; Lam, Richard; Packer, Rowena M. A.; Volk, Holger A.] Univ London, Royal Vet Coll, Dept Clin Sci & Serv, Hatfield AL9 7TA, Herts, England; [Gielen, Ingrid M. V. L.] Univ Ghent, Fac Vet Med, Dept Vet Med Imaging & Small Anim Orthopaed, B-9820 Ghent, Belgium	University of London; University of London Royal Veterinary College; Ghent University	De Decker, S (corresponding author), Univ London, Royal Vet Coll, Dept Clin Sci & Serv, Hawkshead Lane, Hatfield AL9 7TA, Herts, England.	sdedecker@rvc.ac.uk	Volk, Holger Andreas/B-9965-2011	Volk, Holger Andreas/0000-0002-7312-638X; Packer, Rowena/0000-0002-9988-9828				Baskan BM, 2010, RHEUMATOL INT, V30, P375, DOI 10.1007/s00296-009-0975-7; Berthelot JM, 2013, JOINT BONE SPINE, V80, P592, DOI 10.1016/j.jbspin.2013.03.013; Caron T, 2010, SPINE, V35, pE458, DOI 10.1097/BRS.0b013e3181cc764f; De Decker S, 2014, VET REC, V174, DOI 10.1136/vr.102492; Di Franco M, 2000, CLIN RHEUMATOL, V19, P188, DOI 10.1007/s100670050153; Diederichs G, 2011, OSTEOPOROSIS INT, V22, P1789, DOI 10.1007/s00198-010-1409-9; El Maghraoui A, 1999, J RHEUMATOL, V26, P2205; Engelke K, 2008, J CLIN DENSITOM, V11, P123, DOI 10.1016/j.jocd.2007.12.010; Eser P, 2010, RHEUMATOLOGY, V49, P977, DOI 10.1093/rheumatology/keq014; GRATACOS J, 1994, BRIT J RHEUMATOL, V33, P927; Holton KF, 2011, SEMIN ARTHRITIS RHEU, V41, P131, DOI 10.1016/j.semarthrit.2011.01.001; Jun JB, 2006, J RHEUMATOL, V33, P1637; Klingberg E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3833; Kranenburg HJC, 2014, ILAR J, V55, P150, DOI 10.1093/ilar/ilu012; Kranenburg Hendrik-Jan C, 2011, Vet J, V190, pe84, DOI 10.1016/j.tvjl.2011.04.008; Lau RYC, 2011, J OSTEOPOROS, V2011, DOI 10.4061/2011/293808; Lee S, 2013, J KOREAN NEUROSURG S, V54, P384, DOI 10.3340/jkns.2013.54.5.384; Liu WG, 2012, J VASC INTERV RADIOL, V23, P1143, DOI 10.1016/j.jvir.2012.06.019; Lubberts E, 2003, J IMMUNOL, V170, P2655, DOI 10.4049/jimmunol.170.5.2655; Mader R, 2013, NAT REV RHEUMATOL, V9, P741, DOI 10.1038/nrrheum.2013.165; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Maruotti N, 2014, REUMATISMO, V66, P125, DOI 10.4081/reumatismo.2014.785; Meredith DS, 2013, SPINE, V38, P415, DOI 10.1097/BRS.0b013e31826ff084; Mosekilde L, 2000, NEURON, V1, P2; Ortega M, 2012, VET RADIOL ULTRASOUN, V53, P128, DOI 10.1111/j.1740-8261.2011.01891.x; Pickhardt PJ, 2013, ANN INTERN MED, V158, P588, DOI 10.7326/0003-4819-158-8-201304160-00003; Pickhardt PJ, 2011, J BONE MINER RES, V26, P2194, DOI 10.1002/jbmr.428; RESNICK D, 1976, RADIOLOGY, V119, P559, DOI 10.1148/119.3.559; RIGGS BL, 1981, J CLIN INVEST, V67, P328, DOI 10.1172/JCI110039; Rutherford O., 1990, PHYSIOTHERAPY, V76, P522; Sahin G, 2002, J WOMEN HEALTH GEN-B, V11, P801, DOI 10.1089/15409990260430945; Sambrook PN, 2012, THER ADV MUSCULOSKEL, V4, P287, DOI 10.1177/1759720X12441276; Schoenfeld AJ, 2011, SPINE J, V11, P257, DOI 10.1016/j.spinee.2011.01.018; Schreiber JJ, 2014, FOCUS, P37, DOI 10.3171/2014_5.FOCUS1483; Schreiber JJ, 2011, J BONE JOINT SURG AM, V93A, P1057, DOI 10.2106/JBJS.J.00160; Takata Shinjiro, 2001, Journal of Medical Investigation, V48, P147; UEBELHART D, 1995, PARAPLEGIA, V33, P669, DOI 10.1038/sc.1995.140; Unnanuntana A, 2010, J BONE JOINT SURG AM, V92A, P743, DOI 10.2106/JBJS.I.00919; Westerveld LA, 2014, SPINE J, V14, P729, DOI 10.1016/j.spinee.2013.06.038; Westerveld LA, 2009, EUR SPINE J, V18, P145, DOI 10.1007/s00586-008-0764-0; Westerveld LA, 2009, RHEUMATOLOGY, V48, P1133, DOI 10.1093/rheumatology/kep177	41	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124166	10.1371/journal.pone.0124166	http://dx.doi.org/10.1371/journal.pone.0124166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898128	Green Published, gold			2022-12-27	WOS:000353212600054
J	Kim, SH; Kim, SH; Joung, JY; Lee, GK; Hong, EK; Kang, KM; Yu, A; Nam, BH; Chung, J; Seo, HK; Park, WS; Lee, KH				Kim, Sung Han; Kim, Soo Hee; Joung, Jae Young; Lee, Geon Kook; Hong, Eun Kyung; Kang, Kyung Min; Yu, Ami; Nam, Byung Ho; Chung, Jinsoo; Seo, Ho Kyung; Park, Weon Seo; Lee, Kang Hyun			Overexpression of ERG and Wild-Type PTEN Are Associated with Favorable Clinical Prognosis and Low Biochemical Recurrence in Prostate Cancer	PLOS ONE			English	Article							ANTIBODY-BASED DETECTION; PSA RECURRENCE; RADICAL PROSTATECTOMY; FUSION; EXPRESSION; PROGRESSION; IMMUNOHISTOCHEMISTRY; REARRANGEMENTS; ONCOPROTEIN; MORTALITY	Objectives The aim of this study was to investigate the expression of two commonly altered genes ERG and PTEN in prostate cancer (PC) and evaluate their prognostic significance. Despite conflicting published results, TMPRSS2-ERG gene fusion and PTEN loss are generally considered unfavorable markers for PC progression. Materials and Methods Of the 762 prostatic adenocarcinoma specimens obtained from radical prostatectomy, 613 without neoadjuvant hormone therapy were included in tissue microarrays for quantitatively assessment of ERG and PTEN expression via immunohistochemistry. Statistical analysis of the association between such expression and clinicopathological parameters, including clinical prognosis, was performed with a p-value of <0.05 considered significant. Results During a median follow-up period of 44.0 months, 132 (21.5%) patients developed biochemical recurrence (BCR). ERG overexpression and PTEN loss were observed in 145 (23.7%) and 253 (41.3%) cases, respectively. BCR-free survival was significantly better in patients with ERG overexpression (p=0.005), but unfavorable among those with PTEN loss (p=0.142). Sub-group analysis revealed that patients with PTEN loss and negative ERG expression had the worst BCR-free survival outcome (p=0.021). Furthermore, multivariate analysis identified prostate-specific antigen level (>= 10 ng/mL), Gleason score (>6), pathologic T stage (>= T3), positive surgical margin, and extraprostatic capsule extension as significant risk factors for BCR (p<0.05). Conclusions Our results indicated that ERG overexpression was associated with favorable BCR-free survival after radical prostatectomy for PC, whereas PTEN loss was with unfavorable outcomes.	[Kim, Sung Han; Joung, Jae Young; Chung, Jinsoo; Seo, Ho Kyung; Park, Weon Seo; Lee, Kang Hyun] Res Inst, Ctr Prostate Canc, Dept Urol, Goyang, Gyeonggi Do, South Korea; [Kim, Sung Han; Joung, Jae Young; Lee, Geon Kook; Hong, Eun Kyung; Chung, Jinsoo; Seo, Ho Kyung; Park, Weon Seo; Lee, Kang Hyun] Natl Canc Ctr Hosp, Goyang, Gyeonggi Do, South Korea; [Kim, Soo Hee] Yonsei Univ, Severance Hosp, Dept Pathol, Seoul 120749, South Korea; [Lee, Geon Kook; Hong, Eun Kyung; Park, Weon Seo] Res Inst, Ctr Prostate Canc, Dept Pathol, Goyang, Gyeonggi Do, South Korea; [Kang, Kyung Min; Yu, Ami] Natl Canc Ctr, Biometr Res Branch, Goyang, Gyeonggi Do, South Korea; [Nam, Byung Ho] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Control & Policy, Goyang, Gyeonggi Do, South Korea	National Cancer Center - Korea (NCC); Yonsei University; Yonsei University Health System; National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Park, WS (corresponding author), Res Inst, Ctr Prostate Canc, Dept Urol, Goyang, Gyeonggi Do, South Korea.	thymus@ncc.re.kr; uroonco@ncc.re.kr		KIM, Sung Han/0000-0002-1689-5203	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [20110010731]; Korean National Cancer Center Grant [1210110, 1310330]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Korean National Cancer Center Grant	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (20110010731) and by the Korean National Cancer Center Grants (nos. 1210110 and 1310330).	Al Bashir S, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-21; Antonarakis ES, 2012, CANCER-AM CANCER SOC, V118, P6063, DOI 10.1002/cncr.27689; Attard G, 2008, ONCOGENE, V27, P253, DOI 10.1038/sj.onc.1210640; Bismar TA, 2012, EUR J CANCER, V48, P538, DOI 10.1016/j.ejca.2012.01.001; Carver BS, 2009, NATURE, V457, pE1, DOI 10.1038/nature07738; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chaux A, 2011, AM J SURG PATHOL, V35, P1014, DOI 10.1097/PAS.0b013e31821e8761; Cookson MS, 2007, J UROLOGY, V177, P540, DOI 10.1016/j.juro.2006.10.097; Demichelis F, 2007, ONCOGENE, V26, P4596, DOI 10.1038/sj.onc.1210237; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Falzarano SM, 2011, J UROLOGY, V185, P489, DOI 10.1016/j.juro.2010.09.093; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Furusato B, 2011, PATHOL INT, V61, P409, DOI 10.1111/j.1440-1827.2011.02675.x; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Grupp K, 2013, EXP MOL PATHOL, V95, P227, DOI 10.1016/j.yexmp.2013.08.002; Han B, 2009, MODERN PATHOL, V22, P1083, DOI 10.1038/modpathol.2009.69; Hoogland AM, 2012, MODERN PATHOL, V25, P471, DOI 10.1038/modpathol.2011.176; Kim J, 2012, BBA-REV CANCER, V1825, P186, DOI 10.1016/j.bbcan.2011.12.003; Kimura T, 2012, PATHOL INT, V62, P742, DOI 10.1111/pin.12006; Krohn A, 2012, AM J PATHOL, V181, P401, DOI 10.1016/j.ajpath.2012.04.026; Leinonen KA, 2013, CANC EPIDEMIOLO 1127; Magi-Galluzzi C, 2011, PROSTATE, V71, P489, DOI 10.1002/pros.21265; Mao XY, 2010, CANCER RES, V70, P5207, DOI 10.1158/0008-5472.CAN-09-4074; Minner S, 2011, CLIN CANCER RES, V17, P5878, DOI 10.1158/1078-0432.CCR-11-1251; Mosquera JM, 2009, CLIN CANCER RES, V15, P4706, DOI 10.1158/1078-0432.CCR-08-2927; Nagle RB, 2013, PROSTATE, V73, P1233, DOI 10.1002/pros.22675; Park K, 2010, NEOPLASIA, V12, P590, DOI 10.1593/neo.10726; Perner S, 2007, AM J SURG PATHOL, V31, P882, DOI 10.1097/01.pas.0000213424.38503.aa; Petrovics G, 2005, ONCOGENE, V24, P3847, DOI 10.1038/sj.onc.1208518; Reid AHM, 2012, MODERN PATHOL, V25, P902, DOI 10.1038/modpathol.2011.207; Rubin MA, 2011, J CLIN ONCOL, V29, P3659, DOI 10.1200/JCO.2011.35.1916; Saramaki OR, 2008, CLIN CANCER RES, V14, P3395, DOI 10.1158/1078-0432.CCR-07-2051; Sim HG, 2005, EUR J CANCER, V41, P834, DOI 10.1016/j.ejca.2004.12.033; Spencer ES, 2013, PROSTATE, V73, P905, DOI 10.1002/pros.22636; Sreenath Taduru L, 2011, J Carcinog, V10, P37, DOI 10.4103/1477-3163.91122; Suh JH, 2012, KOREAN J PATHOL, V46, P423, DOI 10.4132/KoreanJPathol.2012.46.5.423; Tomlins SA, 2012, ARCH PATHOL LAB MED, V136, P935, DOI 10.5858/arpa.2011-0424-OA; van Leenders GJLH, 2011, MODERN PATHOL, V24, P1128, DOI 10.1038/modpathol.2011.65; Verdu M, 2013, VIRCHOWS ARCH, V462, P639, DOI 10.1007/s00428-013-1415-3; Vogel UF, 2006, AM J CLIN PATHOL, V126, P342, DOI 10.1309/F2Q38DXN1V1V4GQM; Yoshimoto M, 2008, MODERN PATHOL, V21, P1451, DOI 10.1038/modpathol.2008.96	41	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0122498	10.1371/journal.pone.0122498	http://dx.doi.org/10.1371/journal.pone.0122498			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897494	gold, Green Submitted, Green Published			2022-12-27	WOS:000353212600011
J	Rathore, DK; Nair, D; Raza, S; Saini, S; Singh, R; Kumar, A; Tripathi, R; Ramji, S; Batra, A; Aggarwal, KC; Chellani, HK; Arya, S; Bhatla, N; Paul, VK; Aggarwal, R; Agarwal, N; Mehta, U; Sopory, S; Natchu, UCM; Bhatnagar, S; Bal, V; Rath, S; Wadhwa, N				Rathore, Deepak K.; Nair, Deepa; Raza, Saimah; Saini, Savita; Singh, Reeta; Kumar, Amit; Tripathi, Reva; Ramji, Siddarth; Batra, Aruna; Aggarwal, Kailash C.; Chellani, Harish K.; Arya, Sugandha; Bhatla, Neerja; Paul, Vinod K.; Aggarwal, Ramesh; Agarwal, Nidhi; Mehta, Umesh; Sopory, Shailaja; Natchu, Uma Chandra Mouli; Bhatnagar, Shinjini; Bal, Vineeta; Rath, Satyajit; Wadhwa, Nitya			Underweight Full-Term Indian Neonates Show Differences in Umbilical Cord Blood Leukocyte Phenotype: A Cross-Sectional Study	PLOS ONE			English	Article							TRANSITIONAL B-CELLS; BIRTH-WEIGHT; LYMPHOCYTE SUBPOPULATIONS; INTRAUTERINE GROWTH; IMMUNE-RESPONSE; PRETERM INFANTS; INFECTION; ASSOCIATION; ZINC; VACCINATION	Background While infections are a major cause of neonatal mortality in India even in full-term neonates, this is an especial problem in the large proportion (similar to 20%) of neonates born underweight (or small-for-gestational-age; SGA). One potential contributory factor for this susceptibility is the possibility that immune system maturation may be affected along with intrauterine growth retardation. Methods In order to examine the possibility that differences in immune status may underlie the susceptibility of SGA neonates to infections, we enumerated the frequencies and concentrations of 22 leukocyte subset populations as well as IgM and IgA levels in umbilical cord blood from full-term SGA neonates and compared them with values from normal-weight (or appropriate-for-gestational-age; AGA) full-term neonates. We eliminated most SGA-associated risk factors in the exclusion criteria so as to ensure that AGA-SGA differences, if any, would be more likely to be associated with the underweight status itself. Results An analysis of 502 such samples, including 50 from SGA neonates, showed that SGA neonates have significantly fewer plasmacytoid dendritic cells (pDCs), a higher myeloid DC (mDC) to pDC ratio, more natural killer (NK) cells, and higher IgM levels in cord blood in comparison with AGA neonates. Other differences were also observed such as tendencies to lower CD4:CD8 ratios and greater prominence of inflammatory monocytes, mDCs and neutrophils, but while some of them had substantial differences, they did not quite reach the standard level of statistical significance. Conclusions These differences in cellular lineages of the immune system possibly reflect stress responses in utero associated with growth restriction. Increased susceptibility to infections may thus be linked to complex immune system dysregulation rather than simply retarded immune system maturation.	[Rathore, Deepak K.; Nair, Deepa; Raza, Saimah; Singh, Reeta; Kumar, Amit; Sopory, Shailaja; Natchu, Uma Chandra Mouli; Bhatnagar, Shinjini; Bal, Vineeta; Rath, Satyajit; Wadhwa, Nitya] Translat Hlth Sci & Technol Inst, Pediat Biol Ctr, Gurgaon, Haryana, India; [Saini, Savita; Paul, Vinod K.; Aggarwal, Ramesh] All India Inst Med Sci, Dept Pediat, New Delhi, India; [Tripathi, Reva] Maulana Azad Med Coll, Dept Obstet & Gynecol, New Delhi, India; [Ramji, Siddarth] Maulana Azad Med Coll, Dept Neonatol, New Delhi, India; [Batra, Aruna] Vardhman Mahavir Med Coll & Safdarjung Hosp, Dept Obstet & Gynecol, New Delhi, India; [Aggarwal, Kailash C.; Chellani, Harish K.; Arya, Sugandha] Vardhman Mahavir Med Coll & Safdarjung Hosp, Dept Pediat, New Delhi, India; [Bhatla, Neerja] All India Inst Med Sci, Dept Obstet & Gynecol, New Delhi, India; [Agarwal, Nidhi] Gen Hosp, Dept Obstet & Gynecol, Gurgaon, Haryana, India; [Mehta, Umesh] Gen Hosp, Dept Pediat, Gurgaon, Haryana, India; [Bal, Vineeta; Rath, Satyajit] Natl Inst Immunol, New Delhi 110067, India	Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); All India Institute of Medical Sciences (AIIMS) New Delhi; Maulana Azad Medical College; Maulana Azad Medical College; Vardhman Mahavir Medical College & Safdarjung Hospital; Vardhman Mahavir Medical College & Safdarjung Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Wadhwa, N (corresponding author), Translat Hlth Sci & Technol Inst, Pediat Biol Ctr, Gurgaon, Haryana, India.	nitya.wadhwa@thsti.res.in		bhatnagar, shinjini/0000-0003-1703-5296; Bhatla, Neerja/0000-0002-3894-2795	Translational Health Science and Technology Institute, Gurgaon, Haryana, India	Translational Health Science and Technology Institute, Gurgaon, Haryana, India	The study was supported by Translational Health Science and Technology Institute, Gurgaon, Haryana, India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Perin MCAA, 2012, VACCINE, V30, P6521, DOI 10.1016/j.vaccine.2012.08.056; Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Altman M, 2012, BMJ OPEN, P2, DOI [10.1136/bmjopen-2012-001152, DOI 10.1136/BMJ0PEN-2012-001152]; Amarilyo G, 2011, J PERINATOL, V31, P30, DOI 10.1038/jp.2010.53; [Anonymous], 1967, PEDIATRICS, V39, P935; [Anonymous], NAT NEON FOR IND SAV; [Anonymous], NAT FAM HLTH SURV NF; [Anonymous], 2013, 2013 STAT SNAPSH CHI; [Anonymous], IMPR NEWB SURV IND; AVRECH OM, 1994, INT ARCH ALLERGY IMM, V103, P160, DOI 10.1159/000236622; Bao SY, 2010, AM J PHYSIOL-LUNG C, V298, pL744, DOI 10.1152/ajplung.00368.2009; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Baxter D, 2010, HUM VACCINES, V6, P494, DOI 10.4161/hv.6.6.12008; Belnoue E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085302; Bhatnagar S, 2012, LANCET, V379, P2072, DOI 10.1016/S0140-6736(12)60477-2; BOERSMA ER, 1981, ARCH DIS CHILD, V56, P31, DOI 10.1136/adc.56.1.31; Bonnelykke K, 2010, J ALLERGY CLIN IMMUN, V126, P657, DOI 10.1016/j.jaci.2010.06.027; Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P836, DOI 10.1111/j.1471-0528.1998.tb10227.x; Cekmez F, 2011, VACCINE, V29, P3096, DOI 10.1016/j.vaccine.2011.02.073; Chatrath R, 1997, J TROP PEDIATRICS, V43, P345, DOI 10.1093/tropej/43.6.345; Chung JB, 2003, TRENDS IMMUNOL, V24, P343, DOI 10.1016/S1471-4906(03)00119-4; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Correa-Rocha R, 2012, PEDIATR RES, V71, P590, DOI 10.1038/pr.2012.6; Covens K, 2013, BLOOD, V121, P5176, DOI 10.1182/blood-2012-12-471953; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Cuss AK, 2006, J IMMUNOL, V176, P1506, DOI 10.4049/jimmunol.176.3.1506; D'Angio CT, 2007, PEDIATRICS, V119, pE574, DOI 10.1542/peds.2006-2241; D'Arena G, 1998, HAEMATOLOGICA, V83, P197; Egan JFX, 2011, PRENATAL DIAG, V31, P560, DOI 10.1002/pd.2747; Elghetany MT, 2002, BLOOD CELL MOL DIS, V28, P260, DOI 10.1006/bcmd.2002.0513; Faridi MMA, 2009, HUM VACCINES, V5, P690, DOI 10.4161/hv.5.10.9317; GOOD RA, 1964, ADV IMMUNOL, V4, P1, DOI 10.1016/S0065-2776(08)60706-3; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; HAMBIDGE KM, 1990, J TRACE ELEM ELECT H, V4, P229; Hou L, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0372-4; Huang L, 2010, INT REV IMMUNOL, V29, P133, DOI 10.3109/08830180903349669; Indian Council of Medical Re- search & UNICEF, 2014, IMPR NEWB SURV IND; Jourdan M, 2011, J IMMUNOL, V187, P3931, DOI 10.4049/jimmunol.1101230; Kumar A, 2014, EUR J PEDIATR, V173, P1083, DOI 10.1007/s00431-014-2293-7; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Li JR, 2013, CELL MOL IMMUNOL, V10, P437, DOI 10.1038/cmi.2013.31; LUBCHENCO LO, 1963, PEDIATRICS, V32, P793; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Malik S, 2007, PEDIATRICS, V119, pE976, DOI 10.1542/peds.2006-2742; Maloney KF, 2012, FETAL PEDIATR PATHOL, V31, P319, DOI 10.3109/15513815.2012.659391; Marr N, 2014, J IMMUNOL, V192, P948, DOI 10.4049/jimmunol.1302007; Mazor-Dray E, 2009, J MATERN-FETAL NEO M, V22, P124, DOI 10.1080/14767050802488246; Mollah A H, 2012, Mymensingh Med J, V21, P109; Montoya CJ, 2007, IMMUNOLOGY, V122, P1, DOI 10.1111/j.1365-2567.2007.02647.x; Moore SE, 2008, VACCINE, V26, P158, DOI 10.1016/j.vaccine.2007.11.007; Nicholson JKA, 1996, CYTOMETRY, V26, P16; Peoples JD, 2009, AM J PERINAT, V26, P647, DOI 10.1055/s-0029-1220788; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Schuller SS, 2013, J LEUKOCYTE BIOL, V93, P781, DOI 10.1189/jlb.1011525; Shankar AH, 1998, AM J CLIN NUTR, V68, p447S, DOI 10.1093/ajcn/68.2.447S; Sharma AA, 2012, CLIN IMMUNOL, V145, P61, DOI 10.1016/j.clim.2012.08.006; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Simchen MJ, 2000, AM J PERINAT, V17, P187, DOI 10.1055/s-2000-9423; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284; Troger B, 2013, NEONATOLOGY, V103, P199, DOI 10.1159/000343260; Vedmedovska N, 2010, GYNECOL OBSTET INVES, V70, P291, DOI 10.1159/000314020; Vermeulen F, 2010, CLIN VACCINE IMMUNOL, V17, P258, DOI 10.1128/CVI.00328-09; Vuorte J, 2001, CYTOMETRY, V43, P290, DOI 10.1002/1097-0320(20010401)43:4<290::AID-CYTO1061>3.0.CO;2-X; Walker JC, 2011, SCAND J IMMUNOL, V73, P53, DOI 10.1111/j.1365-3083.2010.02473.x; Wilson K, 2011, VACCINE, V29, P8267, DOI 10.1016/j.vaccine.2011.08.107; Xiong F, 2012, J MATERN-FETAL NEO M, V25, P2773, DOI 10.3109/14767058.2012.715219; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165	71	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123589	10.1371/journal.pone.0123589	http://dx.doi.org/10.1371/journal.pone.0123589			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898362	Green Submitted, gold, Green Published			2022-12-27	WOS:000353212600034
J	Thomas, KS; Stuart, B; O'Leary, CJ; Schmitt, J; Paul, C; Williams, HC; Langan, S				Thomas, Kim S.; Stuart, Beth; O'Leary, Caroline J.; Schmitt, Jochen; Paul, Carle; Williams, Hywel C.; Langan, Sinead			Validation of Treatment Escalation as a Definition of Atopic Eczema Flares	PLOS ONE			English	Article							OUTCOME MEASURES; SEVERITY SCORE; DERMATITIS; CHILDREN; SYSTEM; CORTICOSTEROIDS; MULTICENTER; PHOBIA; TOOL	Background Atopic eczema (AE) is a chronic disease with flares and remissions. Long-term control of AE flares has been identified as a core outcome domain for AE trials. However, it is unclear how flares should be defined and measured. Objective To validate two concepts of AE flares based on daily reports of topical medication use: (i) escalation of treatment and (ii) days of topical anti-inflammatory medication use (topical corticosteroids and/or calcineurin inhibitors). Methods Data from two published AE studies (studies A (n = 336) and B (n = 60)) were analysed separately. Validity and feasibility of flare definitions were assessed using daily global bother (scale 0 to 10) as the reference standard. Intra-class correlations were reported for continuous variables, and odds ratios and area under the receiver operator characteristic (ROC) curve for binary outcome measures. Results Good agreement was found between both AE flare definitions and change in global bother: area under the ROC curve for treatment escalation of 0.70 and 0.73 in studies A and B respectively, and area under the ROC curve of 0.69 for topical anti-inflammatory medication use (Study A only). Significant positive relationships were found between validated severity scales (POEM, SASSAD, TIS) and the duration of AE flares occurring in the previous week POEM and SASSAD rose by half a point for each unit increase in number of days in flare. Smaller increases were observed on the TIS scale. Completeness of daily diaries was 95% for Study A and 60% for Study B over 16 weeks). Conclusion Both definitions were good proxy indicators of AE flares. We found no evidence that 'escalation of treatment' was a better measure of AE flares than 'use of topical anti-inflammatory medications'. Capturing disease flares in AE trials through daily recording of medication use is feasible and appears to be a good indicator of long-term control.	[Thomas, Kim S.; Schmitt, Jochen; Williams, Hywel C.] Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham NG7 2RD, England; [Stuart, Beth] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [O'Leary, Caroline J.] MRC, Clin Trials Unit, London, England; [Schmitt, Jochen] Tech Univ Dresden, Med Fac Carl Gustav Carus, Ctr Evidence Based Healthcare, Dresden, Germany; [Paul, Carle] Univ Toulouse 3, INSERM 1056, Dermatol, F-31062 Toulouse, France; [Langan, Sinead] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England	University of Nottingham; University of Southampton; Medical Research Council Clinical Trials Unit; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of London; London School of Hygiene & Tropical Medicine	Thomas, KS (corresponding author), Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham NG7 2RD, England.	Kim.thomas@nottingham.ac.uk		williams, hywel/0000-0002-5646-3093; Langan, Sinead/0000-0002-7022-7441; Stuart, Beth/0000-0001-5432-7437; Thomas, Kim/0000-0001-7785-7465; Paul, Carle/0000-0003-0165-5263	National Institute for Health Research, Health Technology Assessment (NIHR HTA) Programme [HTA 05/16]; NIHR Clinician Scientist Fellowship [NIHR/CS/010/014]	National Institute for Health Research, Health Technology Assessment (NIHR HTA) Programme(National Institute for Health Research (NIHR)); NIHR Clinician Scientist Fellowship	This study uses data that was first collected in a national trial funded by the National Institute for Health Research, Health Technology Assessment (NIHR HTA) Programme, project number HTA 05/16 (http://www.journalslibrary.nihr.ac.uk/hta/volume-15/issue-8), and through a study funded through an NIHR Clinician Scientist Fellowship awarded to Doctor Langan, grant number: NIHR/CS/010/014. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett SJ, 2012, ANN RHEUMATIC DIS; Becker D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020566; BerthJones J, 1996, BRIT J DERMATOL, V135, P25, DOI 10.1111/j.1365-2133.1996.tb00706.x; Bingham CO, 2009, J RHEUMATOL, V36, P2335, DOI 10.3899/jrheum.090369; Boers M, 1998, J RHEUMATOL, V25, P198; Boguniewicz M, 2008, J PEDIATR-US, V152, P854, DOI 10.1016/j.jpeds.2007.11.031; Chalmers JR, 2014, BR J DERMATOL; Charman C, 2003, CLIN DERMATOL, V21, P193, DOI 10.1016/S0738-081X(02)00368-1; Charman CR, 2013, BRIT J DERMATOL, V169, P1326, DOI 10.1111/bjd.12590; Charman CR, 2004, ARCH DERMATOL, V140, P1513, DOI 10.1001/archderm.140.12.1513; Cloutier MM, 2012, J ALLERGY CLIN IMMUN, V129, pS24, DOI 10.1016/j.jaci.2011.12.980; Fuhlbrigge A, 2012, J ALLERGY CLIN IMMUN, V129, pS34, DOI 10.1016/j.jaci.2011.12.983; Greenlaw SM, 2010, SKIN RES TECHNOL, V16, P253, DOI 10.1111/j.1600-0846.2010.00431.x; Kojima R, 2013, PEDIATR DERMATOL, V30, P29, DOI 10.1111/j.1525-1470.2012.01808.x; Langan SM, 2014, BRIT J DERMATOL, V170, P548, DOI 10.1111/bjd.12747; Langan SM, 2009, BRIT J DERMATOL, V161, P640, DOI 10.1111/j.1365-2133.2009.09320.x; Langan SM, 2006, ARCH DERMATOL, V142, P1190, DOI 10.1001/archderm.142.9.1190; Peserico A, 2008, BRIT J DERMATOL, V158, P801, DOI 10.1111/j.1365-2133.2008.08436.x; Schmitt J, 2011, BRIT J DERMATOL, V164, P415, DOI 10.1111/j.1365-2133.2010.10030.x; Schmitt J, 2014, J INVEST DERMATOL; Schmitt J, 2012, ALLERGY, V67, P1111, DOI 10.1111/j.1398-9995.2012.02874.x; Sigurgeirsson B, 2008, J EUR ACAD DERMATOL, V22, P1290, DOI 10.1111/j.1468-3083.2008.02785.x; Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1; Thomas KS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000395; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x; Wiren K, 2009, J EUR ACAD DERMATOL, V23, P1267, DOI 10.1111/j.1468-3083.2009.03303.x; Wolkerstorfer A, 1999, ACTA DERM-VENEREOL, V79, P356; Zaki I, 1996, BRIT J DERMATOL, V135, P21, DOI 10.1111/j.1365-2133.1996.tb00705.x	28	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124770	10.1371/journal.pone.0124770	http://dx.doi.org/10.1371/journal.pone.0124770			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897763	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000353212600085
J	Darfour-Oduro, KA; Megens, HJ; Roca, AL; Groenen, MAM; Schook, LB				Darfour-Oduro, Kwame A.; Megens, Hendrik-Jan; Roca, Alfred L.; Groenen, Martien A. M.; Schook, Lawrence B.			Adaptive Evolution of Toll-Like Receptors (TLRs) in the Family Suidae	PLOS ONE			English	Article							INNATE IMMUNE-SYSTEM; AMINO-ACID SITES; PHYLOGENETIC ANALYSIS; PATTERN-RECOGNITION; CRYSTAL-STRUCTURE; SELECTION; GENES; SUBSTITUTION; COMPLEX; BINDING	Members of the family Suidae have diverged over extended evolutionary periods in diverse environments, suggesting that adaptation in response to endemic infectious agents may have occurred. Toll-like receptors (TLRs) comprise a multigene family that acts as the first line of defense against infectious microbes at the host-environment interface. We hypothesized that across the Suidae, positive selection mediated by infectious agents has contributed to the evolution of TLR diversity. Thus, we analyzed Sus scrofa, Sus barbatus, Sus verrucosus, Sus celebensis, Sus scebifrons, Babyrousa babyrussa, Potamochoerus larvatus, Potamochoerus porcus and Phacochoerus africanus genomes. Specifically, analyses were performed to identify evidence of positive selection using Maximum likelihood (ML) methods within a phylogenetic framework for bacterial and viral sensing Suidae TLR extracellular domains. Our analyses did not reveal evidence of positive selection for TLR3 and TLR7, suggesting strong functional conservation among these two genes for members of the Suidae. Positive selection was inferred for Suidae TLR1, TLR2, TLR6 and TLR8 evolution. ML methods identified amino acid sites of the bacterial sensing TLR1, TLR2, TLR6 and the viral sensing TLR8 to be under persistent positive selection. Some of these sites are in close proximity to functionally relevant sites, further strengthening the case for pathogen mediated selection for these sites. The branch leading to the genus Sus demonstrated evidence of episodic positive selection for TLR1, indicating selection mediated by infectious agents encountered within the specific geographic origin of the Sus. These results indicate that species of the Suidae have positively selected residues within functional domains of TLRs reflective of prior infections. Thus, TLR genes represent candidates for experimental validation to determine their functional role in antibacterial and antiviral activity within members of the Suidae.	[Darfour-Oduro, Kwame A.; Roca, Alfred L.; Schook, Lawrence B.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Megens, Hendrik-Jan; Groenen, Martien A. M.] Wageningen Univ, Anim Breeding & Genom Ctr, NL-6700 AP Wageningen, Netherlands	University of Illinois System; University of Illinois Urbana-Champaign; Wageningen University & Research	Schook, LB (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	schook@uillinois.edu	Groenen, Martien/D-8408-2012; Megens, Hendrik-Jan/E-9676-2010; Megens, Hendrik-Jan/M-5300-2019	Groenen, Martien/0000-0003-0484-4545; Megens, Hendrik-Jan/0000-0002-3619-7533; Megens, Hendrik-Jan/0000-0002-3619-7533; Schook, Lawrence/0000-0002-6580-8364; Roca, Alfred/0000-0001-9217-5593	U.S. Department of Agriculture (USDA) Agriculture Research Service (ARS) [USDA/ARS 58-5438-2-307]	U.S. Department of Agriculture (USDA) Agriculture Research Service (ARS)	This work was funded by the U.S. Department of Agriculture (USDA) Agriculture Research Service (ARS) grant USDA/ARS 58-5438-2-307 to LBS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguileta G, 2010, MOL ECOL, V19, P292, DOI 10.1111/j.1365-294X.2009.04454.x; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alcaide M, 2011, MOL BIOL EVOL, V28, P1703, DOI 10.1093/molbev/msq351; Areal H, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-368; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Ben-Ali M, 2011, HUM MUTAT, V32, P643, DOI 10.1002/humu.21486; Bosse M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003100; Dawson HD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-332; de Matos AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081864; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Ferrer-Admetlla A, 2008, J IMMUNOL, V181, P1315, DOI 10.4049/jimmunol.181.2.1315; Fornuskova A, 2014, ECOL EVOL, V4, P2931, DOI 10.1002/ece3.1137; Fornuskova A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-194; Fowler ME, 1996, REV SCI TECH OIE, V15, P141, DOI 10.20506/rst.15.1.913; Frantz LAF, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r107; Govindaraj RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025118; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Grubb P, 2005, MAMMAL SPECIES WORLD, P637; Grueber CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089632; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; Jepson A, 1997, INFECT IMMUN, V65, P872, DOI 10.1128/IAI.65.3.872-876.1997; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kingdon J, 2011, KINGDON FIELD GUIDE, V4th; Klein J, 2000, NEW ENGL J MED, V343, P702, DOI 10.1056/NEJM200009073431006; Lipscomb LA, 1998, PROTEIN SCI, V7, P765, DOI 10.1002/pro.5560070326; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Morgan CC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-39; Mukherjee S, 2009, P NATL ACAD SCI USA, V106, P7073, DOI 10.1073/pnas.0811357106; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nielsen R, 1998, GENETICS, V148, P929; Niknafs N, 2013, HUM GENET, V132, P1235, DOI 10.1007/s00439-013-1325-0; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Patel MR, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001282; Pedersen A, 2007, CONSERVATION BIOL; Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; Rothenburg S, 2009, NAT STRUCT MOL BIOL, V16, P63, DOI 10.1038/nsmb.1529; Shinkai H, 2006, IMMUNOGENETICS, V58, P324, DOI 10.1007/s00251-005-0068-z; Smith NGC, 2003, J MOL EVOL, V57, P467, DOI 10.1007/s00239-003-2500-z; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Weber ANR, 2004, J BIOL CHEM, V279, P34589, DOI 10.1074/jbc.M403830200; Wei TD, 2009, PROTEIN SCI, V18, P1684, DOI 10.1002/pro.186; Werling D, 2003, VET IMMUNOL IMMUNOP, V91, P1, DOI 10.1016/S0165-2427(02)00228-3; Wlasiuk G, 2010, MOL BIOL EVOL, V27, P2172, DOI 10.1093/molbev/msq104; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	52	21	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124069	10.1371/journal.pone.0124069	http://dx.doi.org/10.1371/journal.pone.0124069			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894218	gold, Green Published, Green Submitted			2022-12-27	WOS:000353211700071
J	Dasgupta, T; Coram, RJ; Stillwagon, SJ; Ladd, AN				Dasgupta, Twishasri; Coram, Ryan J.; Stillwagon, Samantha J.; Ladd, Andrea N.			Gene Expression Analyses during Spontaneous Reversal of Cardiomyopathy in Mice with Repressed Nuclear CUG-BP, Elav-Like Family (CELF) Activity in Heart Muscle	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; PHOSPHOLAMBAN GENE; DILATED CARDIOMYOPATHY; CARDIAC-FUNCTION; BINDING PROTEIN; MOUSE; CONTRACTILITY; OVEREXPRESSION; HYPERTROPHY; MODULATION	CUG-BP, Elav-like family (CELF) proteins regulate cell type-and developmental stage-specific alternative splicing in the heart. Repression of CELF-mediated splicing activity via expression of a nuclear dominant negative CELF protein in heart muscle was previously shown to induce dysregulation of alternative splicing, cardiac dysfunction, cardiac hypertrophy, and dilated cardiomyopathy in MHC-CELF Delta transgenic mice. A "mild" line of MHC-CELF Delta mice that expresses a lower level of the dominant negative protein exhibits cardiac dysfunction and myopathy at a young age, but spontaneously recovers normal cardiac function and heart size with age despite the persistence of splicing defects. To the best of our knowledge, this was the first example of a genetically induced cardiomyopathy that spontaneously recovers without intervention. In this study, we explored the basis for this recovery. We examined whether a transcriptional program regulated by serum response factor (SRF) that is dysregulated in juvenile MHC-CELF Delta mice is restored in the mild line with age, and evaluated global changes in gene expression by microarray analyses. We found that differences in gene expression between the mild line and wild type hearts are greatly reduced in older animals, including a partial recovery of SRF target gene expression. We did not find evidence of a new compensatory pathway being activated in the mild line with age, and propose that recovery may occur due to developmental stage-specific compatibility of CELF-dependent splice variants with the cellular environment of the cardiomyocyte.	[Dasgupta, Twishasri; Coram, Ryan J.; Stillwagon, Samantha J.; Ladd, Andrea N.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Ladd, AN (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA.	ladda@ccf.org			National Institutes of Health [1R01HL089376]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant to ANL from the National Institutes of Health (1R01HL089376). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balza RO, 2006, J BIOL CHEM, V281, P6498, DOI 10.1074/jbc.M509487200; Belevych AE, 2013, CARDIOVASC RES, V98, P240, DOI 10.1093/cvr/cvt024; Bround MJ, 2012, CARDIOVASC RES, V96, P372, DOI 10.1093/cvr/cvs260; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Chen F, 2002, CELL, V110, P713, DOI 10.1016/S0092-8674(02)00932-7; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Dasgupta T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056590; Dasgupta T, 2012, WIRES RNA, V3, P104, DOI 10.1002/wrna.107; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Haghighi K, 2012, J MOL CELL CARDIOL, V52, P773, DOI 10.1016/j.yjmcc.2011.11.012; Harrell MD, 2007, PHYSIOL GENOMICS, V28, P273, DOI 10.1152/physiolgenomics.00163.2006; Ho TH, 2005, HUM MOL GENET, V14, P1539, DOI 10.1093/hmg/ddi162; HOIT BD, 1995, CIRC RES, V77, P632, DOI 10.1161/01.RES.77.3.632; Hossain GS, 2003, J BIOL CHEM, V278, P30317, DOI 10.1074/jbc.M212897200; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; KIM WS, 1991, FEBS LETT, V293, P142, DOI 10.1016/0014-5793(91)81171-4; Kodde IF, 2007, COMP BIOCHEM PHYS A, V146, P26, DOI 10.1016/j.cbpa.2006.09.014; KOMURO I, 1988, CIRC RES, V62, P1075, DOI 10.1161/01.RES.62.6.1075; Koshelev M, 2010, HUM MOL GENET, V19, P1066, DOI 10.1093/hmg/ddp570; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Ladd AN, 2005, DEV DYNAM, V233, P783, DOI 10.1002/dvdy.20382; Ladd AN, 2005, MOL CELL BIOL, V25, P6267, DOI 10.1128/MCB.25.14.6267-6278.2005; Lorita J, 2010, J PHYSIOL BIOCHEM, V66, P55, DOI 10.1007/s13105-010-0009-7; Lorita J, 2009, GROWTH FACTORS, V27, P203, DOI 10.1080/08977190902913731; Luo WS, 1996, CIRC RES, V78, P839, DOI 10.1161/01.RES.78.5.839; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; Medin M, 2007, EUR J HEART FAIL, V9, P37, DOI 10.1016/j.ejheart.2006.04.007; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Nelson TJ, 2005, J MOL CELL CARDIOL, V39, P479, DOI 10.1016/j.yjmcc.2005.05.004; Palmer BM, 2005, HEART FAIL REV, V10, P187, DOI 10.1007/s10741-005-5249-1; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Razafsky D, 2009, J CELL BIOL, V186, P461, DOI 10.1083/jcb.200906068; ROZICH JD, 1995, J MOL CELL CARDIOL, V27, P485, DOI 10.1016/S0022-2828(08)80044-2; Sayer G, 2014, CARDIOL CLIN, V32, P21, DOI 10.1016/j.ccl.2013.09.002; Shieh JTC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019481; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; Siedner S, 2003, J PHYSIOL-LONDON, V548, P493, DOI 10.1113/JPHYSIOL.2002.036509; Terenzi F, 2009, J MOL CELL CARDIOL, V46, P395, DOI 10.1016/j.yjmcc.2008.10.030; Verma SK, 2013, J BIOL CHEM, V288, P35372, DOI 10.1074/jbc.M113.507426; Wang GS, 2007, J CLIN INVEST, V117, P2802, DOI 10.1172/JCI32308; Warkman AS, 2012, CYTOSKELETON, V69, P324, DOI 10.1002/cm.21029; Zhang XM, 2003, AM J PHYSIOL-REG I, V285, pR552, DOI 10.1152/ajpregu.00631.2002; Zou YZ, 2011, HYPERTENSION, V58, P1099, DOI 10.1161/HYPERTENSIONAHA.111.173500	47	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124462	10.1371/journal.pone.0124462	http://dx.doi.org/10.1371/journal.pone.0124462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894229	Green Submitted, Green Published, gold			2022-12-27	WOS:000353211700097
J	de Munnik, SM; Kooistra, AJ; van Offenbeek, J; Nijmeijer, S; de Graaf, C; Smit, MJ; Leurs, R; Vischer, HF				de Munnik, Sabrina M.; Kooistra, Albert J.; van Offenbeek, Jody; Nijmeijer, Saskia; de Graaf, Chris; Smit, Martine J.; Leurs, Rob; Vischer, Henry F.			The Viral G Protein-Coupled Receptor ORF74 Hijacks beta-Arrestins for Endocytic Trafficking in Response to Human Chemokines	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; 5 CCR5 PHOSPHORYLATION; INVERSE AGONISTS; HIV ENTRY; LIGAND; DESENSITIZATION; INHIBITION; EXPRESSION; RESIDUES; HELIX-8	Kaposi's sarcoma-associated herpesvirus-infected cells express the virally encoded G protein-coupled receptor ORF74. Although ORF74 is constitutively active, it binds human CXC chemokines that modulate this basal activity. ORF74-induced signaling has been demonstrated to underlie the development of the angioproliferative tumor Kaposi's sarcoma. Whereas G protein-dependent signaling of ORF74 has been the subject of several studies, the interaction of this viral GPCR with beta-arrestins has hitherto not been investigated. Bioluminescence resonance energy transfer experiments demonstrate that ORF74 recruits beta-arrestins and subsequently internalizes in response to human CXCL1 and CXCL8, but not CXCL10. Internalized ORF74 traffics via early endosomes to recycling and late endosomes. Site-directed mutagenesis and homology modeling identified four serine and threonine residues at the distal end of the intracellular carboxyl-terminal of ORF74 that are required for beta-arrestin recruitment and subsequent endocytic trafficking. Hijacking of the human endocytic trafficking machinery is a previously unrecognized action of ORF74.	[de Munnik, Sabrina M.; Kooistra, Albert J.; van Offenbeek, Jody; Nijmeijer, Saskia; de Graaf, Chris; Smit, Martine J.; Leurs, Rob; Vischer, Henry F.] Vrije Univ Amsterdam, AIMMS, Dept Chem & Pharmaceut Sci, Div Med Chem, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Vischer, HF (corresponding author), Vrije Univ Amsterdam, AIMMS, Dept Chem & Pharmaceut Sci, Div Med Chem, Amsterdam, Netherlands.	h.f.vischer@vu.nl	Kooistra, Albert J./H-1135-2016; Leurs, Rob/AAC-8508-2022; Leurs, Rob/ABB-4299-2021; de Graaf, Chris/J-8549-2017	Kooistra, Albert J./0000-0001-5514-6021; Leurs, Rob/0000-0003-1354-2848; de Graaf, Chris/0000-0002-1226-2150; Nijmeijer, Saskia/0000-0001-8037-4659; Smit, Martine/0000-0003-2713-0238	ECHO Grant from Netherlands Organization for Scientific Research (NWO) [700.58.008]	ECHO Grant from Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by ECHO Grant 700.58.008 from the Netherlands Organization for Scientific Research (NWO) (www.nwo.nl). RL and HFV received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KH, 2010, BIOCHEMISTRY-US, V49, P502, DOI 10.1021/bi901619r; [Anonymous], 2012, 1010; Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; Azzi S, 2014, ONCOGENE, V33, P5609, DOI 10.1038/onc.2013.503; Azzi SG, 2014, RECEPTORS CLIN INVES, V1, P149; Bais C, 1998, NATURE, V391, P86, DOI 10.1038/34193; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Berchiche YA, 2011, MOL PHARMACOL, V79, P488, DOI 10.1124/mol.110.068486; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Brandt SM, 2002, J BIOL CHEM, V277, P17291, DOI 10.1074/jbc.M108232200; Canals M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034192; Chaisuparat R, 2008, CANCER RES, V68, P8361, DOI 10.1158/0008-5472.CAN-08-0878; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chiou CJ, 2002, J VIROL, V76, P3421, DOI 10.1128/JVI.76.7.3421-3439.2002; Dahl ME, 2008, J PHARMACOL EXP THER, V327, P926, DOI 10.1124/jpet.108.142695; Fan H, 2013, INNATE IMMUNITY; Feng H, 2010, J VIROL, V84, P3351, DOI 10.1128/JVI.01939-09; Fox JM, 2011, BLOOD, V117, P1851, DOI 10.1182/blood-2010-05-287474; Geras-Raaka E, 1998, J EXP MED, V187, P801, DOI 10.1084/jem.187.5.801; Gimenez LE, 2012, J BIOL CHEM, V287, P9028, DOI 10.1074/jbc.M111.311803; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Gurevich VV, 2013, PROG MOL BIOL TRANSL, V118, P57, DOI 10.1016/B978-0-12-394440-5.00003-6; Ho HH, 2001, J BIOL CHEM, V276, P1376, DOI 10.1074/jbc.M007885200; Holst PJ, 2001, J CLIN INVEST, V108, P1789, DOI 10.1172/JCI13622; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hu SS, 2013, MOL BIOL REP, V40, P1065, DOI 10.1007/s11033-012-2148-0; Huttenrauch F, 2002, J BIOL CHEM, V277, P30769, DOI 10.1074/jbc.M204033200; Innamorati G, 1998, P NATL ACAD SCI USA, V95, P2222, DOI 10.1073/pnas.95.5.2222; Jensen DD, 2013, J BIOL CHEM, V288, P22942, DOI 10.1074/jbc.M113.455774; Kang DS, 2014, CURR OPIN CELL BIOL, V27, P63, DOI 10.1016/j.ceb.2013.11.005; Katragadda M, 2004, BBA-BIOMEMBRANES, V1663, P74, DOI 10.1016/j.bbamem.2004.01.012; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Krishna AG, 2002, BIOCHEMISTRY-US, V41, P8298, DOI 10.1021/bi025534m; Lagos D, 2008, CELL HOST MICROBE, V4, P470, DOI 10.1016/j.chom.2008.09.012; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Lan TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017361; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Luttrell LM, 2002, J CELL SCI, V115, P455; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; MACIEJEWSKI PM, 1995, J BIOL CHEM, V270, P27661, DOI 10.1074/jbc.270.46.27661; Marchese A, 2014, CURR OPIN CELL BIOL, V27, P72, DOI 10.1016/j.ceb.2013.11.011; McLean KA, 2004, VIROLOGY, V325, P241, DOI 10.1016/j.virol.2004.04.027; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Mueller SG, 1997, J BIOL CHEM, V272, P8207, DOI 10.1074/jbc.272.13.8207; Nakajima K, 2012, MOL PHARMACOL, V82, P575, DOI 10.1124/mol.112.080358; Nijmeijer S, 2010, J BIOL CHEM, V285, P29632, DOI 10.1074/jbc.M110.115618; Oppermann M, 1999, J BIOL CHEM, V274, P8875, DOI 10.1074/jbc.274.13.8875; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pollok-Kopp B, 2003, J BIOL CHEM, V278, P2190, DOI 10.1074/jbc.M209844200; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Rosenkilde MM, 1999, J BIOL CHEM, V274, P956, DOI 10.1074/jbc.274.2.956; Rosenkilde MM, 2000, MOL PHARMACOL, V57, P602, DOI 10.1124/mol.57.3.602; Rosethorne EM, 2011, MOL PHARMACOL, V79, P749, DOI 10.1124/mol.110.068395; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Salahpour Ali, 2012, Front Endocrinol (Lausanne), V3, P105, DOI 10.3389/fendo.2012.00105; Scholten DJ, 2012, BRIT J PHARMACOL, V166, P898, DOI 10.1111/j.1476-5381.2011.01648.x; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Smit MJ, 2002, J VIROL, V76, P1744, DOI 10.1128/JVI.76.4.1744-1752.2002; Sodhi A, 2000, CANCER RES, V60, P4873; Sodhi A, 2004, P NATL ACAD SCI USA, V101, P4821, DOI 10.1073/pnas.0400835101; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Tobin AB, 2008, BRIT J PHARMACOL, V153, pS167, DOI 10.1038/sj.bjp.0707662; Unal H, 2012, TRENDS PHARMACOL SCI, V33, P79, DOI 10.1016/j.tips.2011.09.007; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Verzijl D, 2006, J BIOL CHEM, V281, P35327, DOI 10.1074/jbc.M606877200; Vischer HF, 2014, NAT REV DRUG DISCOV, V13, P123, DOI 10.1038/nrd4189; Waldhoer M, 2003, J BIOL CHEM, V278, P19473, DOI 10.1074/jbc.M213179200; Watts AO, 2013, J BIOL CHEM, V288, P7169, DOI 10.1074/jbc.M112.406108; Yeatman HR, 2014, J BIOL CHEM, V289, P15856, DOI 10.1074/jbc.M113.536672; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034	74	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124486	10.1371/journal.pone.0124486	http://dx.doi.org/10.1371/journal.pone.0124486			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894435	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700099
J	Kilembe, W; Wall, KM; Mokgoro, M; Mwaanga, A; Dissen, E; Kamusoko, M; Phiri, H; Sakulanda, J; Davitte, J; Reddy, T; Brockman, M; Ndung'u, T; Allen, S				Kilembe, William; Wall, Kristin M.; Mokgoro, Mammekwa; Mwaanga, Annie; Dissen, Elisabeth; Kamusoko, Miriam; Phiri, Hilda; Sakulanda, Jean; Davitte, Jonathan; Reddy, Tarylee; Brockman, Mark; Ndung'u, Thumbi; Allen, Susan			Knowledge of HIV Serodiscordance, Transmission, and Prevention among Couples in Durban, South Africa	PLOS ONE			English	Article							DISCORDANT COUPLES; SEXUAL-BEHAVIOR; ZAMBIA; LUSAKA; SEROCONVERSION; INFECTIONS; PREVALENCE; ENROLLMENT; RWANDA	Objective Couples' voluntary HIV counseling and testing (CVCT) significantly decreases HIV transmission within couples, the largest risk group in sub-Saharan Africa, but it is not currently offered in most HIV testing facilities. To roll out such an intervention, understanding locale-specific knowledge barriers is critical. In this study, we measured knowledge of HIV serodiscordance, transmission, and prevention before and after receipt of CVCT services in Durban. Design Pre- and post-CVCT knowledge surveys were administered to a selection of individuals seeking CVCT services. Methods Changes in knowledge scores were assessed with McNemar Chi-square tests for balanced data and generalized estimating equation methods for unbalanced data. Results The survey included 317 heterosexual black couples (634 individuals) who were primarily Zulu (87%), unemployed (47%), and had at least a secondary level education (78%). 28% of couples proved to be discordant. Only 30% of individuals thought serodiscordance between couples was possible pre-CVCT compared to 95% post-CVCT. One-third thought there was at least one benefit of CVCT pre-CVCT, increasing to 96% post-CVCT. Overall, there were positive changes in knowledge about HIV transmission and prevention. However, many respondents thought all HIV positive mothers give birth to babies with AIDS (64% pre-CVCT, 59% post-CVCT) and that male circumcision does not protect negative men against HIV (70% pre-CVCT, 67% post-CVCT). Conclusions CVCT was well received and was followed by improvements in understanding of discordance, the benefits of joint testing, and HIV transmission. Country-level health messaging would benefit from targeting gaps in knowledge about serodiscordance, vertical transmission, and male circumcision.	[Kilembe, William; Wall, Kristin M.; Mwaanga, Annie; Dissen, Elisabeth; Phiri, Hilda; Sakulanda, Jean; Davitte, Jonathan; Allen, Susan] Emory Univ, Sch Med, Dept Pathol & Lab Med, Rwanda Zambia HIV Res Grp, Atlanta, GA 30322 USA; [Kilembe, William; Wall, Kristin M.; Mwaanga, Annie; Dissen, Elisabeth; Phiri, Hilda; Sakulanda, Jean; Davitte, Jonathan; Allen, Susan] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Wall, Kristin M.] Emory Univ, Laney Grad Sch, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Mokgoro, Mammekwa; Kamusoko, Miriam; Ndung'u, Thumbi] Univ KwaZulu Natal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Reddy, Tarylee] MRC, Biostat Unit, Durban, South Africa; [Brockman, Mark] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Brockman, Mark] Simon Fraser Univ, Fac Sci, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Ndung'u, Thumbi] Univ KwaZulu Natal, KwaZulu Natal Res Inst TB & HIV K RITH, Durban, South Africa	Emory University; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; University of Kwazulu Natal; Simon Fraser University; Simon Fraser University; University of Kwazulu Natal	Wall, KM (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Rwanda Zambia HIV Res Grp, Atlanta, GA 30322 USA.	kmwall@emory.edu	; Brockman, Mark/D-1669-2016	Ndung'u, Thumbi/0000-0003-2962-3992; Reddy, Tarylee/0000-0002-9521-2692; Brockman, Mark/0000-0001-6432-1426	Canadian Global Health Research Initiative (GHRI) International Development Research Centre [107017-001]; Emory Center for AIDS Research [P30 AI050409]; AIDS International Training and Research Program Fogarty International Center [D43 TW001042]; FOGARTY INTERNATIONAL CENTER [D43TW001042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER	Canadian Global Health Research Initiative (GHRI) International Development Research Centre; Emory Center for AIDS Research; AIDS International Training and Research Program Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Canadian Global Health Research Initiative (GHRI) International Development Research Centre (Project Number: 107017-001), the Emory Center for AIDS Research (P30 AI050409), and the AIDS International Training and Research Program Fogarty International Center (D43 TW001042).	Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; Allen S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-349; Becker S, 2010, AIDS BEHAV, V14, P558, DOI 10.1007/s10461-009-9607-1; Boeras DI, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-18; Castle S, 2003, HEALTH POLICY PLANN, V18, P146, DOI 10.1093/heapol/czg019; CDC, 2011, COUPL HIV COUNS TEST; Chemaitelly H, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18765; Chomba E, 2008, JAIDS-J ACQ IMM DEF, V47, P108, DOI 10.1097/QAI.0b013e31815b2d67; Delate R, 2010, 2 NAT HIV COMM SURV; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Guthrie BL, 2007, CURR HIV RES, V5, P416, DOI 10.2174/157016207781023992; HIRA SK, 1990, J ACQ IMMUN DEF SYND, V3, P83; Human Sciences Research Council, 2009, S AFR NAT HIV PREV I; KAMENGA M, 1991, AIDS, V5, P61, DOI 10.1097/00002030-199101000-00009; Kelley AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019573; Kempf MC, 2008, JAIDS-J ACQ IMM DEF, V47, P116, DOI 10.1097/QAI.0b013e31815d2f3f; King R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-801; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Matthews LT, 2013, AIDS BEHAV, V17, P461, DOI 10.1007/s10461-011-0068-y; Parker L, 2014, CULTURE HLTH SEXUALI, P1; Peltzer K, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-174; Relief TPsEPfA, 2013, NEXT GEN IND REF GUI; Salaam- Blyther T., 2006, GLOBAL FUND FIGHT AI; Tabana H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066390; Tanser F, 2011, LANCET, V378, P247, DOI 10.1016/S0140-6736(11)60779-4; The Global Fund to Fight AIDS TaM, 2014, COR LIST IND; UNAIDS, 2012, HIV AIDS EST 2012; Wall K, 2012, AIDS, V26, P217, DOI 10.1097/QAD.0b013e32834dc593; Wall KM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001171; WHO, 2014, GEND IN HIV WHO; World Health Organization, 2012, GUID OR PREEXP PROPH	33	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124548	10.1371/journal.pone.0124548	http://dx.doi.org/10.1371/journal.pone.0124548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894583	gold, Green Submitted, Green Published			2022-12-27	WOS:000353211700103
J	Kuster, DJ; Liu, CY; Fang, Z; Ponder, JW; Marshall, GR				Kuster, Daniel J.; Liu, Chengyu; Fang, Zheng; Ponder, Jay W.; Marshall, Garland R.			High-Resolution Crystal Structures of Protein Helices Reconciled with Three-Centered Hydrogen Bonds and Multipole Electrostatics	PLOS ONE			English	Article							HYDRATION FREE-ENERGIES; ALPHA-HELIX; MOLECULAR-DYNAMICS; ATOMIC MULTIPOLE; CONFORMATIONAL-ANALYSIS; REFINEMENT APPLICATION; FORCE-FIELDS; PEPTIDE; CRYSTALLOGRAPHY; DIPOLE	Theoretical and experimental evidence for non-linear hydrogen bonds in protein helices is ubiquitous. In particular, amide three-centered hydrogen bonds are common features of helices in high-resolution crystal structures of proteins. These high-resolution structures (1.0 to 1.5 angstrom nominal crystallographic resolution) position backbone atoms without significant bias from modeling constraints and identify Phi = -62 degrees, Psi = -43 as the consensus backbone torsional angles of protein helices. These torsional angles preserve the atomic positions of alpha-beta carbons of the classic Pauling alpha-helix while allowing the amide carbonyls to form bifurcated hydrogen bonds as first suggested by Nemethy et al. in 1967. Molecular dynamics simulations of a capped 12-residue oligoalanine in water with AMOEBA (Atomic Multipole Optimized Energetics for Biomolecular Applications), a second-generation force field that includes multipole electrostatics and polarizability, reproduces the experimentally observed high-resolution helical conformation and correctly reorients the amide-bond carbonyls into bifurcated hydrogen bonds. This simple modification of backbone torsional angles reconciles experimental and theoretical views to provide a unified view of amide three-centered hydrogen bonds as crucial components of protein helices. The reason why they have been overlooked by structural biologists depends on the small crankshaft-like changes in orientation of the amide bond that allows maintenance of the overall helical parameters (helix pitch (p) and residues per turn (n)). The Pauling 3.6(13) alpha-helix fits the high-resolution experimental data with the minor exception of the amide-carbonyl electron density, but the previously associated backbone torsional angles (Phi, Psi) needed slight modification to be reconciled with three-atom centered H-bonds and multipole electrostatics. Thus, a new standard helix, the 3.6(13/10)-, Nemethy- or N-helix, is proposed. Due to the use of constraints from monopole force fields and assumed secondary structures used in low-resolution refinement of electron density of proteins, such structures in the PDB often show linear hydrogen bonding.	[Kuster, Daniel J.; Fang, Zheng] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Liu, Chengyu; Ponder, Jay W.] Washington Univ, Dept Chem, St Louis, MO 63130 USA; [Marshall, Garland R.] Washington Univ, Dept Biochem & Mol Biophys, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Marshall, GR (corresponding author), Washington Univ, Dept Biochem & Mol Biophys, St Louis, MO 63130 USA.	garlandm@gmail.com		Fang, Zheng/0000-0003-2372-0839; Marshall, Garland/0000-0002-3098-0332	National Institutes of Health (NIH) [R01-GM068460]; Department of Defense [HDTRA1-09-CHEM-BIO-BAA]; Ewing Marion Kauffman Foundation; Department of Biomedical Engineering at Washington University; NSF [CHE-0535675]; NIH [R01-GM6955302]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069553, R01GM068460, R01GM106974] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Ewing Marion Kauffman Foundation; Department of Biomedical Engineering at Washington University; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	GRM acknowledges support from National Institutes of Health (NIH) (R01-GM068460) and the Department of Defense (HDTRA1-09-CHEM-BIO-BAA. DJK acknowledges fellowship support from the Ewing Marion Kauffman Foundation and the Department of Biomedical Engineering at Washington University. JWP acknowledges support from the NSF (CHE-0535675) and NIH (R01-GM6955302). The funders had no role in study design, data collection	Aravinda S, 2008, CHEM BIODIVERS, V5, P1238, DOI 10.1002/cbdv.200890112; ARNOTT S, 1966, J MOL BIOL, V21, P371, DOI 10.1016/0022-2836(66)90105-7; ARNOTT S, 1967, J MOL BIOL, V30, P209, DOI 10.1016/0022-2836(67)90253-7; BAUR WH, 1965, ACTA CRYSTALLOGR, V19, P909, DOI 10.1107/S0365110X65004632; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Best RB, 2008, BIOPHYS J, V95, pL7, DOI 10.1529/biophysj.108.132696; BLUNDELL T, 1983, NATURE, V306, P281, DOI 10.1038/306281a0; Bour P, 2002, BIOPOLYMERS, V65, P45, DOI 10.1002/bip.10224; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cardamone S, 2014, PHYS CHEM CHEM PHYS, V16, P10367, DOI 10.1039/c3cp54829e; Choudhary A, 2011, PROTEIN SCI, V20, P1077, DOI 10.1002/pro.627; DONOHUE J, 1953, P NATL ACAD SCI USA, V39, P470, DOI 10.1073/pnas.39.6.470; Eisenberg D, 2003, P NATL ACAD SCI USA, V100, P11207, DOI 10.1073/pnas.2034522100; Fain A. V., 2001, Biophysics, V46, P921; Fain A. V., 2008, Biophysics, V53, P125, DOI 10.1134/S0006350908020024; Feldblum ES, 2014, P NATL ACAD SCI USA, V111, P4085, DOI 10.1073/pnas.1319827111; Felder CE, 2007, NUCLEIC ACIDS RES, V35, pW512, DOI 10.1093/nar/gkm307; Fenn TD, 2011, STRUCTURE, V19, P523, DOI 10.1016/j.str.2011.01.015; Fenn TD, 2010, BIOPHYS J, V98, P2984, DOI 10.1016/j.bpj.2010.02.057; HODGKIN EE, 1990, BIOPOLYMERS, V30, P533, DOI 10.1002/bip.360300506; HOL WGJ, 1985, PROG BIOPHYS MOL BIO, V45, P149, DOI 10.1016/0079-6107(85)90001-X; Hollingsworth SA, 2009, PROTEIN SCI, V18, P1321, DOI 10.1002/pro.133; Hovmoller S, 2002, ACTA CRYSTALLOGR D, V58, P768, DOI 10.1107/S0907444902003359; Hunt NT, 2007, J AM CHEM SOC, V129, P3168, DOI 10.1021/ja066289n; IUPAC-IUB, 1970, BIOCHEMISTRY-US, V9, P3471; Jeffrey G.A., 2012, HYDROGEN BONDING BIO; Jelsch C, 2000, P NATL ACAD SCI USA, V97, P3171, DOI 10.1073/pnas.97.7.3171; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KARLE IL, 1989, P NATL ACAD SCI USA, V86, P765, DOI 10.1073/pnas.86.3.765; KARLE IL, 1989, BIOCHEMISTRY-US, V28, P6696, DOI 10.1021/bi00442a024; KARLE IL, 1994, PROTEIN SCI, V3, P1547, DOI 10.1002/pro.5560030920; KARLE IL, 1993, BIOPOLYMERS, V33, P827, DOI 10.1002/bip.360330511; KENDREW JC, 1959, FED PROC, V18, P740; Kuster DJ, 2009, UNIFYING MODEL HELIC; Liu C, 2014, PROTEINS IN PRESS; MARSHALL GR, 1972, CIRC RES, V31, pI143; MARSHALL GR, 1990, P NATL ACAD SCI USA, V87, P487, DOI 10.1073/pnas.87.1.487; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MIYAZAWA T, 1961, J POLYM SCI, V55, P215, DOI 10.1002/pol.1961.1205516121; Morozov AV, 2004, P NATL ACAD SCI USA, V101, P6946, DOI 10.1073/pnas.0307578101; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NEMETHY G, 1967, NATURE, V214, P363, DOI 10.1038/214363a0; Nicholls RA, 2012, ACTA CRYSTALLOGR D, V68, P404, DOI 10.1107/S090744491105606X; Panman MR, 2013, NAT CHEM, V5, P929, DOI [10.1038/NCHEM.1744, 10.1038/nchem.1744]; Parra RD, 2001, CHEM-EUR J, V7, P4352, DOI 10.1002/1521-3765(20011015)7:20<4352::AID-CHEM4352>3.0.CO;2-L; PATERSON Y, 1981, J AM CHEM SOC, V103, P2947, DOI 10.1021/ja00401a007; Patriksson A, 2008, PHYS CHEM CHEM PHYS, V10, P2073, DOI 10.1039/b716554d; PAULING L, 1950, J AM CHEM SOC, V72, P5349, DOI 10.1021/ja01167a545; PAULING L, 1951, P NATL ACAD SCI USA, V37, P282, DOI 10.1073/pnas.37.5.282; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; Penev ES, 2009, COMPUT PHYS COMMUN, V180, P2013, DOI 10.1016/j.cpc.2009.06.005; PERUTZ M F, 1960, Brookhaven Symp Biol, V13, P165; PERUTZ MF, 1951, NATURE, V167, P1053, DOI 10.1038/1671053a0; Ponder J.W, 2014, TINKER SOFTWARE TOOL; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Ponder JW, 2010, J PHYS CHEM IN PRESS; PREISSNER R, 1991, FEBS LETT, V288, P192, DOI 10.1016/0014-5793(91)81032-4; Quine JR, 1999, J MOL STRUC-THEOCHEM, V460, P53, DOI 10.1016/S0166-1280(98)00306-6; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Ren PY, 2011, J CHEM THEORY COMPUT, V7, P3143, DOI 10.1021/ct200304d; Ren PY, 2003, J PHYS CHEM B, V107, P5933, DOI 10.1021/jp027815+; Ripoll DR, 2005, P NATL ACAD SCI USA, V102, P7559, DOI 10.1073/pnas.0502754102; Rozas I, 1998, J PHYS CHEM A, V102, P9925, DOI 10.1021/jp9824813; SCHERAGA HA, 1985, P NATL ACAD SCI USA, V82, P5585, DOI 10.1073/pnas.82.17.5585; Schmidt A, 2011, ACTA CRYSTALLOGR F, V67, P424, DOI 10.1107/S1744309110052607; Schnieders MJ, 2009, ACTA CRYSTALLOGR D, V65, P952, DOI 10.1107/S0907444909022707; Sengupta D, 2005, STRUCTURE, V13, P849, DOI 10.1016/j.str.2005.03.010; SHAMALA N, 1978, J CHEM SOC CHEM COMM, P996, DOI 10.1039/c39780000996; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Shimizu K, 2005, J PHYS CHEM A, V109, P11322, DOI 10.1021/jp054673l; SHOEMAKER KR, 1985, P NATL ACAD SCI USA, V82, P2349, DOI 10.1073/pnas.82.8.2349; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; SMYTHE ML, 1993, J AM CHEM SOC, V115, P11594, DOI 10.1021/ja00077a067; SMYTHE ML, 1995, J AM CHEM SOC, V117, P5445, DOI 10.1021/ja00125a003; STICKLE DF, 1992, J MOL BIOL, V226, P1143, DOI 10.1016/0022-2836(92)91058-W; Stockmayer WH, 1967, PURE APPL CHEM, V15; Stone AJ, 2005, J CHEM THEORY COMPUT, V1, P1128, DOI 10.1021/ct050190+; STONE AJ, 1981, CHEM PHYS LETT, V83, P233, DOI 10.1016/0009-2614(81)85452-8; Stone AJ, 2008, SCIENCE, V321, P787, DOI 10.1126/science.1158006; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; TUCKERMAN ME, 1991, J CHEM PHYS, V94, P1465, DOI 10.1063/1.460004; Welsh E, 2004, SET COMPUTATIONAL TO; WIBERG KB, 1994, J ORG CHEM, V59, P6817, DOI 10.1021/jo00101a050; Wieczorek R, 2004, J AM CHEM SOC, V126, P14198, DOI 10.1021/ja048831i; Williams D.E., 2007, REV COMPUT CHEM, V2, P219; WILLIAMS DE, 1988, J COMPUT CHEM, V9, P745, DOI 10.1002/jcc.540090705; Wlodawer A, 2008, FEBS J, V275, P1, DOI 10.1111/j.1742-4658.2007.06178.x; Yang JH, 1999, ORG LETT, V1, P11, DOI 10.1021/ol9900010; Yuan YN, 2014, J COMPUT CHEM, V35, P343, DOI 10.1002/jcc.23469; Zheng XG, 2012, J AM CHEM SOC, V134, P15970, DOI 10.1021/ja306803v	92	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123146	10.1371/journal.pone.0123146	http://dx.doi.org/10.1371/journal.pone.0123146			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894612	Green Submitted, Green Published, gold			2022-12-27	WOS:000353211700023
J	Abebe, SM; Berhane, Y; Worku, A; Getachew, A				Abebe, Solomon Mekonnen; Berhane, Yemane; Worku, Alemayehu; Getachew, Assefa			Prevalence and Associated Factors of Hypertension: A Crossectional Community Based Study in Northwest Ethiopia	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; BLOOD-PRESSURE; FASTING GLUCOSE; RISK; AFRICA	Background Hypertension, being the root cause of many of the body sytem and organs failure, remains to be a major public health challenge globally. Though the problem is huge in both developed and developing countries, data are scarce in developing countries like Ethiopia. Therefore, this study was aimed to determine the magnitude and associated factors of hypertension in North West Ethiopia. Methods A cross-sectional survey was conducted on adults aged 35 years and above in the rural and urban communities of Dabat district and Gondar town in 2012. The data were collected using the WHO STEPwise strategy. Hypertension was defined as having a Systolic blood pressure of >= 140 mmHg and/or a Diastolic BP of >= 90mmHg or a reported use of anti-hypertensive medications for raised blood pressure. Prevalence was computed with a 95% confidence interval. Selected risk factors were assessed using a biviarete logistic regression. Results A total of 2200 participants were included in the study. The median age (+/- SD) was 47 (+/- 12.4) years. The overall prevalence of hypertension was found to be 27.9%[95% CI 26.0, 29.8], with the proportion in the urban and rural residents being 30.7% and 25.3% respectively. The prevalence of hypertension was 29.3% for women and 26.3% for men. Out of the 598 hypertensive patients 241 (40.3%) had blood pressure measurements, and 99 (16.6%) had known hypertension and were on treatment. The proportion of systolic and diastolic hypertension in this subgroup of adults was 133(6.2%). The multivariable logistic regression analysis showed older age (AOR = 1.06; 1.05, 1.07), raised fasting glucose (AOR = 1.01; 1.001, 1.01), alcohol consumption (AOR = 1.71; 1.24, 2.36), and raised BMI (AOR = 1.07; 1.04, 1.10) were significantly associated with hypertension. Conclusion The prevalence of hypertension was considerably higher in rural areas than previously reported. The health system needs to develop strategies to increase the reach of relevant screening and diagnostic services to both rural and urban populations.	[Abebe, Solomon Mekonnen] Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia; [Berhane, Yemane] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia; [Worku, Alemayehu] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia; [Getachew, Assefa] Univ Gondar, Sch Med, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar; Addis Continental Institute of Public Health; Addis Ababa University; University of Gondar	Abebe, SM (corresponding author), Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia.	solomekonnen@yahoo.com	Berhane, Yemane/ABB-8154-2020	Berhane, Yemane/0000-0002-2527-1339	World Health Organization; Addis Continental Institute of Public Health	World Health Organization(World Health Organization); Addis Continental Institute of Public Health	Partial funding for this study was received from the World Health Organization and the Addis Continental Institute of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe SM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-97; Abu Sayeed M, 2004, DIABETES CARE, V27, P1054, DOI 10.2337/diacare.27.5.1054; Admassu M., 2011, ETHIOPIAN J HLTH BIO, V4, P1; Agyemang C, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-114; Agyemang C, 2006, PUBLIC HEALTH, V120, P525, DOI 10.1016/j.puhe.2006.02.002; Akhmedjonov A, 2013, DRUG ALCOHOL REV, V32, P248, DOI 10.1111/j.1465-3362.2012.00521.x; [Anonymous], 2012, LANCET, V379, P2213, DOI 10.1016/S0140-6736(12)60960-X; [Anonymous], 2007, SUMMARY STAT REPORT; Awoke A, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-113; Chen L, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050052; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cooper Richard S, 2003, Ethn Dis, V13, pS48; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Fuster, 2010, PROMOTING CARDIOVASC; Gierach Marcin, 2014, ISRN Endocrinol, V2014, P514589, DOI 10.1155/2014/514589; Hillbom M, 2011, CURR HYPERTENS REP, V13, P208, DOI 10.1007/s11906-011-0194-y; Kim HK, 2013, DIABETES CARE, V36, P328, DOI 10.2337/dc12-0587; Longo-Mbenza B, 2008, EUR J CARDIOV PREV R, V15, P503, DOI 10.1097/HJR.0b013e3282f21640; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Nshisso LD, 2012, DIABETES METAB SYND, V6, P36, DOI 10.1016/j.dsx.2012.05.005; Osei K, 2004, DIABETES CARE, V27, P1439, DOI 10.2337/diacare.27.6.1439; Peter Lloyd-Sherlock, 2014, INT J EPIDEMIOL, V1; Rguibi M, 2006, PUBLIC HEALTH NUTR, V9, P722, DOI 10.1079/PHN2005866; Sayeed M A, 2007, Bangladesh Med Res Counc Bull, V33, P1; Sobngwi E, 2004, INT J EPIDEMIOL, V33, P769, DOI 10.1093/ije/dyh044; Tesfaye F, 2007, J HUM HYPERTENS, V21, P28, DOI 10.1038/sj.jhh.1002104; Tesfaye F, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-39; Tran A., 2011, INT J HYPERTENSION; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Yanai H, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-10	31	94	95	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125210	10.1371/journal.pone.0125210	http://dx.doi.org/10.1371/journal.pone.0125210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909382	Green Published, Green Submitted, gold			2022-12-27	WOS:000353376800133
J	Fossati, E; Narcross, L; Ekins, A; Falgueyret, JP; Martin, VJJ				Fossati, Elena; Narcross, Lauren; Ekins, Andrew; Falgueyret, Jean-Pierre; Martin, Vincent J. J.			Synthesis of Morphinan Alkaloids in Saccharomyces cerevisiae	PLOS ONE			English	Article							OPIUM POPPY; PAPAVER-SOMNIFERUM; DIOXYGENASES CATALYZE; MOLECULAR-CLONING; O-DEMETHYLATION; BIOSYNTHESIS; ENZYME; SYNTHASE; PATHWAY; METABOLISM	Morphinan alkaloids are the most powerful narcotic analgesics currently used to treat moderate to severe and chronic pain. The feasibility of morphinan synthesis in recombinant Saccharomyces cerevisiae starting from the precursor (R, S)-norlaudanosoline was investigated. Chiral analysis of the reticuline produced by the expression of opium poppy methyltransferases showed strict enantioselectivity for (S)-reticuline starting from (R, S)-norlaudanosoline. In addition, the P. somniferum enzymes salutaridine synthase (PsSAS), salutaridine reductase (PsSAR) and salutaridinol acetyltransferase (PsSAT) were functionally co-expressed in Saccharomyces cerevisiae and optimization of the pH conditions allowed for productive spontaneous rearrangement of salutaridinol-7-O-acetate and synthesis of thebaine from (R)-reticuline. Finally, we reconstituted a 7-gene pathway for the production of codeine and morphine from (R)-reticuline. Yeast cell feeding assays using (R)-reticuline, salutaridine or codeine as substrates showed that all enzymes were functionally co-expressed in yeast and that activity of salutaridine reductase and codeine-O-demethylase likely limit flux to morphine synthesis. The results of this study describe a significant advance for the synthesis of morphinans in Saccharomyces cerevisiae and pave the way for their complete synthesis in recombinant microbes.	[Fossati, Elena; Narcross, Lauren; Ekins, Andrew; Martin, Vincent J. J.] Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada; [Fossati, Elena; Narcross, Lauren; Ekins, Andrew; Falgueyret, Jean-Pierre; Martin, Vincent J. J.] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada	Concordia University - Canada; Concordia University - Canada	Martin, VJJ (corresponding author), Concordia Univ, Dept Biol, 1455 De Maisonneuve Blvd W, Montreal, PQ H3G 1M8, Canada.	vincent.martin@concordia.ca			Genome Canada; Genome Quebec; Canada Research Chair	Genome Canada(Genome Canada); Genome Quebec; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was financially supported by Genome Canada (http://www.genomecanada.ca) and Genome Quebec (http://www.genomequebec.com). VJJM is supported by a Canada Research Chair (http://www.chairs-chaires.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabo T, 2011, J R SOC INTERFACE, V8, P1635, DOI 10.1098/rsif.2011.0148; Beaudoin GAW, 2014, PLANTA, V240, P19, DOI 10.1007/s00425-014-2056-8; Biancofiore Giuseppe, 2006, Ther Clin Risk Manag, V2, P229, DOI 10.2147/tcrm.2006.2.3.229; De Luca V, 2012, SCIENCE, V336, P1658, DOI 10.1126/science.1217410; DEEKNAMKUL W, 1992, PHYTOCHEMISTRY, V31, P813, DOI 10.1016/0031-9422(92)80020-F; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Facchini PJ, 2012, TRENDS BIOTECHNOL, V30, P127, DOI 10.1016/j.tibtech.2011.10.001; Facchini PJ, 1996, PLANT PHYSIOL, V112, P1669, DOI 10.1104/pp.112.4.1669; Farrow SC, 2013, J BIOL CHEM, V288, P28997, DOI 10.1074/jbc.M113.488585; Fisinger U, 2007, NAT PROD COMMUN, V2, P249; Fossati E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4283; GERARDY R, 1993, PHYTOCHEMISTRY, V34, P125, DOI 10.1016/S0031-9422(00)90793-3; Gesell A, 2009, J BIOL CHEM, V284, P24432, DOI 10.1074/jbc.M109.033373; Gietz RD, 2007, NAT PROTOC, V2, P1, DOI 10.1038/nprot.2007.17; Hagel JM, 2013, PLANT CELL PHYSIOL, V54, P647, DOI 10.1093/pcp/pct020; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; Hirata K, 2004, PHYTOCHEMISTRY, V65, P1039, DOI 10.1016/j.phytochem.2004.02.015; Ilari A, 2009, J BIOL CHEM, V284, P897, DOI 10.1074/jbc.M803738200; INCB Supply of opiate raw materials and demand for opiates for medical and scientific purposes, 2013, ESTIM WORLD REQUIR 2, V3, P92; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; Kim EY, 2014, BIOTECHNOL J, V9, P348, DOI 10.1002/biot.201300391; KRAUS PFX, 1995, P NATL ACAD SCI USA, V92, P2071, DOI 10.1073/pnas.92.6.2071; Millgate AG, 2004, NATURE, V431, P413, DOI 10.1038/431413a; Nakagawa A, 2014, SCI REP-UK, V4, DOI 10.1038/srep06695; Nakagawa A, 2012, BIOENGINEERED, V3, P49, DOI [10.4161/bbug.3.1.18446, 10.1038/ncomms1327]; Nakagawa A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1327; Sabarna K., 2006, THESIS MARTIN LUTHER; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; THEUNS HG, 1984, PHYTOCHEMISTRY, V23, P1157, DOI 10.1016/S0031-9422(00)82630-8; Thodey K, 2014, NAT CHEM BIOL, V10, P837, DOI [10.1038/NCHEMBIO.1613, 10.1038/nchembio.1613]; Unterlinner B, 1999, PLANT J, V18, P465, DOI 10.1046/j.1365-313X.1999.00470.x; Weng JK, 2012, SCIENCE, V336, P1667, DOI 10.1126/science.1217411; Xiao M, 2013, J BIOTECHNOL, V166, P122, DOI 10.1016/j.jbiotec.2013.04.004; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730; Ziegler J, 2009, J BIOL CHEM, V284, P26758, DOI 10.1074/jbc.M109.030957	36	65	77	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124459	10.1371/journal.pone.0124459	http://dx.doi.org/10.1371/journal.pone.0124459			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905794	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000070
J	Gagnon, P; Casaburi, R; Saey, D; Porszasz, J; Provencher, S; Milot, J; Bourbeau, J; O'Donnell, DE; Maltais, F				Gagnon, Philippe; Casaburi, Richard; Saey, Didier; Porszasz, Janos; Provencher, Steeve; Milot, Julie; Bourbeau, Jean; O'Donnell, Denis E.; Maltais, Francois			Cluster Analysis in Patients with GOLD 1 Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							DAILY PHYSICAL-ACTIVITY; MILD COPD; EXERCISE; DYSPNEA; PREVALENCE; PHENOTYPES; VALUES	Background We hypothesized that heterogeneity exists within the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 1 spirometric category and that different subgroups could be identified within this GOLD category. Methods Pre-randomization study participants from two clinical trials were symptomatic/asymptomatic GOLD 1 chronic obstructive pulmonary disease (COPD) patients and healthy controls. A hierarchical cluster analysis used pre-randomization demographics, symptom scores, lung function, peak exercise response and daily physical activity levels to derive population subgroups. Results Considerable heterogeneity existed for clinical variables among patients with GOLD 1 COPD. All parameters, except forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC), had considerable overlap between GOLD 1 COPD and controls. Three-clusters were identified: cluster I (18 [15%] COPD patients; 105 [85%] controls); cluster II (45 [80%] COPD patients; 11 [20%] controls); and cluster III (22 [92%] COPD patients; 2 [8%] controls). Apart from reduced diffusion capacity and lower baseline dyspnea index versus controls, cluster I COPD patients had otherwise preserved lung volumes, exercise capacity and physical activity levels. Cluster II COPD patients had a higher smoking history and greater hyperinflation versus cluster I COPD patients. Cluster III COPD patients had reduced physical activity versus controls and clusters I and II COPD patients, and lower FEV1/FVC versus clusters I and II COPD patients. Conclusions The results emphasize heterogeneity within GOLD 1 COPD, supporting an individualized therapeutic approach to patients.	[Gagnon, Philippe; Saey, Didier; Provencher, Steeve; Milot, Julie; Maltais, Francois] Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Casaburi, Richard; Porszasz, Janos] Univ Calif Los Angeles, Med Ctr, Rehabil Clin Trials Ctr, Los Angeles Biomed Res Inst Harbor, Torrance, CA 90509 USA; [Bourbeau, Jean] McGill Univ, Resp Epidemiol & Clin Res Unit, Montreal Chest Inst, Montreal, PQ, Canada; [O'Donnell, Denis E.] Queens Univ, Kingston, ON, Canada; [O'Donnell, Denis E.] Kingston Gen Hosp, Kingston, ON K7L 2V7, Canada	Laval University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; McGill University; Queens University - Canada; Queens University - Canada	Maltais, F (corresponding author), Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.	Francois.Maltais@fmed.ulaval.ca	Saey, Didier/F-7963-2014		Canadian Institutes of Health Research (CIHR) [MOP-84091]; Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI); Pfizer Inc.	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI)(Boehringer Ingelheim); Pfizer Inc.(Pfizer)	This work was supported by a Canadian Institutes of Health Research (CIHR; http://cihr-irsc.gc.ca/e/193.html) grant MOP-84091 and by an unrestricted research grant from Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Pfizer Inc. who were given the opportunity to check the data used in the manuscript for factual accuracy only and were not involved in the study design, data collection, analysis or interpretation. Writing, editorial support and formatting assistance was provided by Jane M. Gilbert, BSc CMPP, of Envision Scientific Solutions, which was contracted and compensated by BIPI and Pfizer Inc for these services.	Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Burgel PR, 2010, EUR RESPIR J, V36, P531, DOI 10.1183/09031936.00175109; Coronell C, 2004, EUR RESPIR J, V24, P129, DOI 10.1183/09031936.04.00079603; Deesomchok A, 2010, COPD, V7, P428, DOI 10.3109/15412555.2010.528087; Eagan TML, 2004, EUR RESPIR J, V23, P589, DOI 10.1183/09031936.04.00041204; Gagnon P, 2012, RESP MED, V106, P1695, DOI 10.1016/j.rmed.2012.08.021; GANDEVIA B., 1957, THORAX, V12, P290, DOI 10.1136/thx.12.4.290; Garcia-Rio F, 2012, CHEST, V142, P338, DOI 10.1378/chest.11-2014; Global Initiative for Chronic Obstructive Lung Disease, 2006, GLOB STRAT DIAGN MAN; Global Initiative for Chronic Obstructive Lung Disease, 2014, GLOB STRAT DIAGN MAN; Gnanadesikan R., 1982, UTILITAS MATH A, V21A, P75; Guenette JA, 2011, RESP PHYSIOL NEUROBI, V177, P218, DOI 10.1016/j.resp.2011.04.011; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Kerstjens HAM, 2004, AM J RESP CRIT CARE, V170, P212, DOI 10.1164/rccm.2405010; Macklem PT, 2010, EUR RESPIR J, V35, P676, DOI 10.1183/09031936.00120609; MAHLER DA, 1984, CHEST, V85, P751, DOI 10.1378/chest.85.6.751; Mannino DM, 2007, THORAX, V62, P237, DOI 10.1136/thx.2006.068379; McLachlan G J, 1992, Stat Methods Med Res, V1, P27, DOI 10.1177/096228029200100103; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; O'Donnell DE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096574; Ofir D, 2008, AM J RESP CRIT CARE, V177, P622, DOI 10.1164/rccm.200707-1064OC; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Petsonk EL, 2007, THORAX, V62, P1107; Porszasz J, 2003, MED SCI SPORT EXER, V35, P1596, DOI 10.1249/01.MSS.0000084593.56786.DA; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Seymour JM, 2010, EUR RESPIR J, V36, P81, DOI 10.1183/09031936.00104909; SINGH SJ, 1992, THORAX, V47, P1019, DOI 10.1136/thx.47.12.1019; Spruit MA, 2013, AM J RESP CRIT CARE, V188, pE13, DOI 10.1164/rccm.201309-1634ST; SUE DY, 1984, CLIN CHEST MED, V5, P89; Swanney MP, 2008, THORAX, V63, P1046, DOI 10.1136/thx.2008.098483; Troosters T, 2010, RESP MED, V104, P1005, DOI 10.1016/j.rmed.2010.01.012; Van Remoortel H, 2013, THORAX, V68, P962, DOI 10.1136/thoraxjnl-2013-203534; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Waschki B, 2011, CHEST, V140, P331, DOI 10.1378/chest.10-2521; Watz H, 2009, EUR RESPIR J, V33, P262, DOI 10.1183/09031936.00024608; Weatherall M, 2010, EUR RESPIR J, V36, P472, DOI 10.1183/09031936.00035210	40	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123626	10.1371/journal.pone.0123626	http://dx.doi.org/10.1371/journal.pone.0123626			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906326	gold, Green Published, Green Submitted			2022-12-27	WOS:000353332000038
J	Jin, XL; Sun, Y; Yang, HY; Li, J; Yu, SN; Chang, XY; Lu, ZH; Chen, J				Jin, Xianglan; Sun, Yang; Yang, Haiyan; Li, Ji; Yu, Shuangni; Chang, Xiaoyan; Lu, Zhaohui; Chen, Jie			Deregulation of the MiR-193b-KRAS Axis Contributes to Impaired Cell Growth in Pancreatic Cancer	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DUCTAL ADENOCARCINOMA; ACINAR-CELLS; RAS ACTIVITY; K-RAS; MICRORNA FUNCTIONS; ANIMAL DEVELOPMENT; EXOCRINE PANCREAS; TUMOR-SUPPRESSOR; ONCOGENIC KRAS	Modulation of KRAS activity by upstream signals has revealed a promising new approach for pancreatic cancer therapy; however, it is not clear whether microRNA-associated KRAS axis is involved in the carcinogenesis of pancreatic cancer. Here, we identified miR-193b as a tumor-suppressive miRNA in pancreatic ductal adenocarcinoma (PDAC). Expression analyses revealed that miR-193b was downregulated in (10/11) PDAC specimens and cell lines. Moreover, we found that miR-193b functioned as a cell-cycle brake in PDAC cells by inducing G1-phase arrest and reducing the fraction of cells in S phase, thereby leading to dampened cell proliferation. miR-193b also modulated the malignant transformation phenotype of PDAC cells by suppressing anchorage-independent growth. Mechanistically, KRAS was verified as a direct effector of miR-193b, through which the AKT and ERK pathways were modulated and cell growth of PDAC cells was suppressed. Taken together, our findings indicate that miR-193b-mediated deregulation of the KRAS axis is involved in pancreatic carcinogenesis, and suggest that miR-193b could be a potentially effective target for PDAC therapy.	[Chen, Jie] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pathol, Beijing 100730, Peoples R China; Tsinghua Univ, Peking Union Med Coll, Beijing 100084, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tsinghua University	Chen, J (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pathol, Beijing 100730, Peoples R China.	xhblk@163.com			National Natural Science Foundation of China [81172334, 30471970]; National Key Technology RD program [2006BAI02A14]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD program(National Key Technology R&D Program)	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81172334 and 30471970) (URL: http://www.nsfc.gov.cn/), and the National Key Technology R&D program (No. 2006BAI02A14) (URL: http://www.most.gov.cn/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; American Cancer Society, 2012, CANC FACTS FIG 2012, P19; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Balmanno K, 1999, ONCOGENE, V18, P3085, DOI 10.1038/sj.onc.1202647; BANSAL P, 1995, GASTROENTEROLOGY, V109, P247, DOI 10.1016/0016-5085(95)90291-0; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chen JM, 2010, AM J PATHOL, V176, P2520, DOI 10.2353/ajpath.2010.091061; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Collins MA, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00407; Collins MA, 2014, GASTROENTEROLOGY, V146, P822, DOI 10.1053/j.gastro.2013.11.052; Collins MA, 2012, J CLIN INVEST, V122, P639, DOI 10.1172/JCI59227; Collisson EA, 2012, CANCER DISCOV, V2, P685, DOI 10.1158/2159-8290.CD-11-0347; Daniluk J, 2012, J CLIN INVEST, V122, P1519, DOI 10.1172/JCI59743; di Magliano MP, 2013, GASTROENTEROLOGY, V144, P1220, DOI 10.1053/j.gastro.2013.01.071; Eser S, 2014, BRIT J CANCER, V111, P817, DOI 10.1038/bjc.2014.215; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Hu HJ, 2012, ACTA BIOCH BIOPH SIN, V44, P424, DOI [10.1093/abbs/gms018, 10.1093/abbs/gms018.]; Ikeda Y, 2012, MOL CANCER RES, V10, P259, DOI 10.1158/1541-7786.MCR-11-0035; Iliopoulos D, 2011, CANCER RES, V71, P5144, DOI 10.1158/0008-5472.CAN-11-0425; Ji BA, 2009, GASTROENTEROLOGY, V137, P1072, DOI 10.1053/j.gastro.2009.05.052; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Kowalski J, 2007, CANCER GENET CYTOGEN, V178, P26, DOI 10.1016/j.cancergencyto.2007.06.004; Lanuti P, 2006, J IMMUNOL METHODS, V315, P37, DOI 10.1016/j.jim.2006.06.015; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Logsdon CD, 2009, CLIN GASTROENTEROL H, V7, pS40, DOI 10.1016/j.cgh.2009.07.040; Loukopoulos P, 2007, CANCER SCI, V98, P392, DOI 10.1111/j.1349-7006.2007.00395.x; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; Mazzon E, 2012, PANCREAS, V41, P560, DOI 10.1097/MPA.0b013e31823acd56; PARSA I, 1985, CANCER RES, V45, P1285; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Rooman I, 2012, GUT, V61, P449, DOI 10.1136/gut.2010.235804; Satoh J, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-17; Seton-Rogers S, 2012, NAT REV CANCER, V12, P739, DOI 10.1038/nrc3383; Sohn D, 2011, CELL DEATH DIFFER, V18, P1664, DOI 10.1038/cdd.2011.34; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang CP, 2014, HISTOPATHOLOGY, V64, P567, DOI 10.1111/his.12283; Wu WG, 2009, EUR J CANCER PREV, V18, P50, DOI 10.1097/CEJ.0b013e328305a07a; Xu CW, 2010, EUR J CANCER, V46, P2828, DOI 10.1016/j.ejca.2010.06.127; Yu SN, 2010, CANCER RES, V70, P6015, DOI 10.1158/0008-5472.CAN-09-4531; Zhao WG, 2010, CARCINOGENESIS, V31, P1726, DOI 10.1093/carcin/bgq160; Zhu LQ, 2007, AM J PATHOL, V171, P263, DOI 10.2353/ajpath.2007.061176	52	37	38	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125515	10.1371/journal.pone.0125515	http://dx.doi.org/10.1371/journal.pone.0125515			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905463	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000112
J	Li, Y; Wang, H; Li, XB				Li, Ying; Wang, Hong; Li, Xiao Bing			Fractional Vegetation Cover Estimation Based on an Improved Selective Endmember Spectral Mixture Model	PLOS ONE			English	Article							REMOTE-SENSING ESTIMATION; REGION; BASIN	Vegetation is an important part of ecosystem and estimation of fractional vegetation cover is of significant meaning to monitoring of vegetation growth in a certain region. With Landsat TM images and HJ-1B images as data source, an improved selective endmember linear spectral mixture model (SELSMM) was put forward in this research to estimate the fractional vegetation cover in Huangfuchuan watershed in China. We compared the result with the vegetation coverage estimated with linear spectral mixture model (LSMM) and conducted accuracy test on the two results with field survey data to study the effectiveness of different models in estimation of vegetation coverage. Results indicated that: (1) the RMSE of the estimation result of SELSMM based on TM images is the lowest, which is 0.044. The RMSEs of the estimation results of LSMM based on TM images, SELSMM based on HJ-1B images and LSMM based on HJ-1B images are respectively 0.052, 0.077 and 0.082, which are all higher than that of SELSMM based on TM images; (2) the R-2 of SELSMM based on TM images, LSMM based on TM images, SELSMM based on HJ-1B images and LSMM based on HJ-1B images are respectively 0.668, 0.531, 0.342 and 0.336. Among these models, SELSMM based on TM images has the highest estimation accuracy and also the highest correlation with measured vegetation coverage. Of the two methods tested, SELSMM is superior to LSMM in estimation of vegetation coverage and it is also better at unmixing mixed pixels of TM images than pixels of HJ-1B images. So, the SELSMM based on TM images is comparatively accurate and reliable in the research of regional fractional vegetation cover estimation.	[Li, Ying; Wang, Hong; Li, Xiao Bing] Beijing Normal Univ, Coll Resources Sci & Technol, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China; [Li, Ying] CERI Eco Technol Co Ltd, Beijing, Peoples R China	Beijing Normal University	Wang, H (corresponding author), Beijing Normal Univ, Coll Resources Sci & Technol, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China.	wanghong@bnu.edu.cn			National Natural Science Foundation of China [41471350]; National Key Basic Research Program of China [2014CB138803]; Funds for Creative Research Groups of China [41321001]; Sate Key Laboratory of Earth Surface processes and Resource Ecology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Funds for Creative Research Groups of China(Science Fund for Creative Research Groups); Sate Key Laboratory of Earth Surface processes and Resource Ecology	This work was supported by the National Natural Science Foundation of China (No. 41471350), the National Key Basic Research Program of China (2014CB138803), the Funds for Creative Research Groups of China (41321001) and Sate Key Laboratory of Earth Surface processes and Resource Ecology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buyantuyev A, 2007, INT J REMOTE SENS, V28, P269, DOI 10.1080/01431160600658149; [陈峰 Chen Feng], 2010, [遥感信息, Remote Sensing Information], P22; [丛浩 CONG Hao], 2006, [中国图象图形学报, Journal of image and graphics], V11, P1092; Dawelbait M, 2012, J ARID ENVIRON, V80, P45, DOI 10.1016/j.jaridenv.2011.12.011; Gitelson AA, 2002, REMOTE SENS ENVIRON, V80, P76, DOI 10.1016/S0034-4257(01)00289-9; Gong Jian-zhou, 2007, Yingyong Shengtai Xuebao, V18, P575; Hostert P, 2003, REMOTE SENS ENVIRON, V87, P183, DOI 10.1016/S0034-4257(03)00145-7; Li M.M., 2003, METHOD VEGETATION FR; Li X, 2008, QUANTITIVE RETRIEVAL; Li Xiao-song, 2010, Yingyong Shengtai Xuebao, V21, P152; Liu Jun-hui, 2008, Yingyong Shengtai Xuebao, V19, P2016; Oki K, 2011, COMPUT ELECTRON AGR, V79, P30, DOI 10.1016/j.compag.2011.08.001; Purevdorj T, 1998, INT J REMOTE SENS, V19, P3519, DOI 10.1080/014311698213795; Qi J, 2000, AGR FOREST METEOROL, V105, P55, DOI 10.1016/S0168-1923(00)00195-7; RIDD MK, 1995, INT J REMOTE SENS, V16, P2165, DOI 10.1080/01431169508954549; Roberts DA, 1998, REMOTE SENS ENVIRON, V65, P267, DOI 10.1016/S0034-4257(98)00037-6; Sellers PJ, 1996, J CLIMATE, V9, P706, DOI 10.1175/1520-0442(1996)009<0706:ARLSPF>2.0.CO;2; Silvan-Cardenas JL, 2010, REMOTE SENS ENVIRON, V114, P1777, DOI 10.1016/j.rse.2010.04.003; Theau J, 2005, REMOTE SENS ENVIRON, V94, P232, DOI 10.1016/j.rse.2004.10.008; Wang G, 2002, INT J REMOTE SENS, V23, P3649, DOI 10.1080/01431160110114538; Wu Chang-guang, 2012, Yingyong Shengtai Xuebao, V23, P1728; Wu K, 2011, OPT ENG, V20, P114; [吴柯 WU Ke], 2007, [遥感学报, Journal of Remote Sensing], V11, P20; Xiao JF, 2005, REMOTE SENS ENVIRON, V98, P237, DOI 10.1016/j.rse.2005.07.011; [邢著荣 XING Zhu-rong], 2009, [遥感技术与应用, Remote Sensing Technology and Application], V24, P849; Yang Xiao-qiong, 2008, Yingyong Shengtai Xuebao, V19, P1860; Yang ZP, 2011, J GEOGR SCI, V21, P979, DOI 10.1007/s11442-011-0894-x; Zhang LP, 2010, IEEE T GEOSCI REMOTE, V48, P2633, DOI 10.1109/TGRS.2010.2040284; Zhang XueXia, 2008, Journal of Beijing Forestry University, V30, P164; Zhang Yan, 2002, Yingyong Shengtai Xuebao, V13, P1033; [张云霞 Zhang Yun Xia], 2003, [地球科学进展, Advance in Earth Sciences], V18, P85; Zhao CaiXia, 2005, Acta Phytoecologica Sinica, V29, P68; Zhu Jing-Fang, 2011, Chinese Journal of Plant Ecology, V35, P615, DOI 10.3724/SP.J.1258.2011.00615; Zhu WB, 2012, J GEOGR SCI, V22, P346, DOI 10.1007/s11442-012-0931-4	34	13	15	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124608	10.1371/journal.pone.0124608	http://dx.doi.org/10.1371/journal.pone.0124608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905772	gold, Green Published, Green Submitted			2022-12-27	WOS:000353332000079
J	Borlak, J; Singh, PK; Rittelmeyer, I				Borlak, Juergen; Singh, Prafull Kumar; Rittelmeyer, Ina			Regulation of Liver Enriched Transcription Factors in Rat Hepatocytes Cultures on Collagen and EHS Sarcoma Matrices	PLOS ONE			English	Article							ALVEOLAR EPITHELIAL-CELLS; DISEASE CANDIDATE GENES; IN-VITRO; SANDWICH CONFIGURATION; HEPATOMA-CELL; EXPRESSION; INDUCTION; HEPATOTOXICITY; DIFFERENTIATION; PROGRESSION	Liver-enriched transcription factors (LETF) play a crucial role in the control of liver-specific gene expression and for hepatocytes to retain their molecular and cellular functions complex interactions with extra cellular matrix (ECM) are required However, during cell isolation ECM interactions are disrupted and for hepatocytes to regain metabolic competency cells are cultured on ECM substrata. The regulation of LETFs in hepatocytes cultured on different ECM has not been studied in detail. We therefore compared two common sources of ECM and evaluated cellular morphology and hepatocyte differentiation by investigating DNA binding activity of LETFs at gene specific promoters and marker genes of hepatic metabolism. Furthermore, we studied testosterone metabolism and albumin synthesis to assess the metabolic competence of cell cultures. Despite significant difference in morphological appearance and except for HNF1 beta (p<0.001) most LETFs and several of their target genes did not differ in transcript expression after Bonferroni adjustment when cultured on collagen or Matrigel. Nonetheless, Western blotting revealed HNF1 beta, HNF3 alpha, HNF3 gamma, HNF4 alpha, HNF6 and the smaller subunits of C/EBP alpha and C/EBP beta to be more abundant on Matrigel cultured cells. Likewise, DNA binding activity of HNF3 alpha, HNF3 beta, HNF4 alpha, HNF6 and gene expression of hepatic lineage markers were increased on Matrigel cultured hepatocytes. To further investigate hepatic gene regulation, the effects of Aroclor 1254 treatment, e.g. a potent inducer of xenobiotic defense were studied in vivo and in vitro. The gene expression of C/EBP-alpha increased in rat liver and hepatocytes cultured on collagen and this treatment induced DNA binding activity of HNF4 alpha, C/EBP alpha and C/EBP beta and gene expression of CYP1A1 and CYP1A2 in vivo and in vitro. Taken collectively, two sources of ECM greatly affected hepatocyte morphology, activity of liver enriched transcription factors, hepatic gene expression and metabolic competency that should be considered when used in cell biology studies and drug toxicity testing.	[Borlak, Juergen; Singh, Prafull Kumar; Rittelmeyer, Ina] Hannover Med Sch, Ctr Pharmacol & Toxicol, Hannover, Germany	Hannover Medical School	Borlak, J (corresponding author), Hannover Med Sch, Ctr Pharmacol & Toxicol, Hannover, Germany.	Borlak.Juergen@mh-hannover.de			Virtual Liver Network of the German Federal Ministry of Education and Research (BMBF) [0316154]	Virtual Liver Network of the German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The authors' gratefully acknowledge support from The Virtual Liver Network (grant 031 6154) of the German Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Benton G, 2011, INT J CANCER, V128, P1751, DOI 10.1002/ijc.25781; Berthiaume F, 1996, FASEB J, V10, P1471, DOI 10.1096/fasebj.10.13.8940293; Bierwolf J, 2011, BIOTECHNOL BIOENG, V108, P141, DOI 10.1002/bit.22924; BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5; Borlak J, 2005, DRUG METAB DISPOS, V33, P1108, DOI 10.1124/dmd.105.003723; Borlak J, 2004, XENOBIOTICA, V34, P935, DOI 10.1080/00498250400008363; Borlak J, 2003, XENOBIOTICA, V33, P655, DOI 10.1080/0049825031000093600; Borlak J, 2001, BIOCHEM PHARMACOL, V61, P145, DOI 10.1016/S0006-2952(00)00537-2; Borlak R, 2003, TOXICOL APPL PHARM, V188, P81, DOI 10.1016/S0041-008X(02)00075-3; BOROK Z, 1995, AM J RESP CELL MOL, V12, P50, DOI 10.1165/ajrcmb.12.1.7811470; CARON JM, 1990, MOL CELL BIOL, V10, P1239, DOI 10.1128/MCB.10.3.1239; DIPERSIO CM, 1991, MOL CELL BIOL, V11, P4405, DOI 10.1128/MCB.11.9.4405; DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628; ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626; Garaguso I, 2008, PROTEOMICS, V8, P2583, DOI 10.1002/pmic.200701147; Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; Harris AJ, 2004, TOXICOL MECH METHOD, V14, P257, DOI 10.1080/15376520490434629; Hartung T, 2012, ALTEX-ALTERN ANIM EX, V29, P119, DOI 10.14573/altex.2012.2.119; Hayashi Y, 1999, J CLIN PATHOL-MOL PA, V52, P19; Hewitt NJ, 2007, DRUG METAB REV, V39, P159, DOI 10.1080/03602530601093489; Iwahori T, 2003, HEPATOLOGY, V37, P665, DOI 10.1053/jhep.2003.50094; Kel AE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r36; Kheolamai P, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-35; Nguyen-Ngoc KV, 2012, P NATL ACAD SCI USA, V109, pE2595, DOI 10.1073/pnas.1212834109; Laurent T, 2012, BIOL OPEN, V1, P958, DOI 10.1242/bio.20121438; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; Lazarevich N. L., 2010, Experimental Oncology, V32, P167; LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72; LeCluyse EL, 2012, CRIT REV TOXICOL, V42, P501, DOI 10.3109/10408444.2012.682115; LIU JK, 1991, MOL CELL BIOL, V11, P773, DOI 10.1128/MCB.11.2.773; Luhe A, 2005, MUTAT RES-FUND MOL M, V575, P102, DOI 10.1016/j.mrfmmm.2005.02.009; Meredith C, 2003, XENOBIOTICA, V33, P511, DOI 10.1080/0049825031000085960; Mitaka T, 1998, INT J EXP PATHOL, V79, P393, DOI 10.1046/j.1365-2613.1998.00083.x; Moghe PV, 1996, BIOMATERIALS, V17, P373, DOI 10.1016/0142-9612(96)85576-1; Niehof M, 2005, MOL PHARMACOL, V67, P604, DOI 10.1124/mol.104.008672; Niehof M, 2008, DIABETES, V57, P1069, DOI 10.2337/db07-1065; Niehof M, 2008, GASTROENTEROLOGY, V134, P1191, DOI 10.1053/j.gastro.2008.01.027; Niehof M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016319; Niehof M, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-68; NISHIYORI A, 1994, J BIOL CHEM, V269, P1323; ODA H, 1995, BIOCHEM BIOPH RES CO, V212, P800, DOI 10.1006/bbrc.1995.2039; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Olsavsky KM, 2007, TOXICOL APPL PHARM, V222, P42, DOI 10.1016/j.taap.2007.03.032; Sakai Y, 2010, CELLS TISSUES ORGANS, V191, P281, DOI 10.1159/000272316; Santangelo L, 2011, HEPATOLOGY, V53, P2063, DOI 10.1002/hep.24280; Schrem H, 2004, PHARMACOL REV, V56, P291, DOI 10.1124/pr.56.2.5; Schrem H, 2002, PHARMACOL REV, V54, P129, DOI 10.1124/pr.54.1.129; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shulman Maria, 2013, Methods Mol Biol, V945, P287, DOI 10.1007/978-1-62703-125-7_17; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soldatow VY, 2013, TOXICOL RES-UK, V2, P23, DOI 10.1039/c2tx20051a; Swift B, 2010, DRUG METAB REV, V42, P446, DOI 10.3109/03602530903491881; Thum T, 2008, ARCH TOXICOL, V82, P89, DOI 10.1007/s00204-007-0234-1; Tuschl G, 2006, TOXICOLOGY, V218, P205, DOI 10.1016/j.tox.2005.10.017; Ukairo O, 2013, J BIOCHEM MOL TOXIC, V27, P204, DOI 10.1002/jbt.21469; Wang S, 2008, TISSUE ENG PT A, V14, P227, DOI 10.1089/tea.2007.0143; Weltmeier F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021667; Xu CJ, 2005, ARCH PHARM RES, V28, P249, DOI 10.1007/BF02977789; Xu G, 2001, Zhonghua Wai Ke Za Zhi, V39, P948	61	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124867	10.1371/journal.pone.0124867	http://dx.doi.org/10.1371/journal.pone.0124867			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901575	gold, Green Published, Green Submitted			2022-12-27	WOS:000353331500101
J	Brendel, C; Teichler, S; Millahn, A; Stiewe, T; Krause, M; Stabla, K; Ross, P; Huynh, M; Illmer, T; Mernberger, M; Barckhausen, C; Neubauer, A				Brendel, Cornelia; Teichler, Sabine; Millahn, Axel; Stiewe, Thorsten; Krause, Michael; Stabla, Kathleen; Ross, Petra; Huynh, Minh; Illmer, Thomas; Mernberger, Marco; Barckhausen, Christina; Neubauer, Andreas			Oncogenic NRAS Primes Primary Acute Myeloid Leukemia Cells for Differentiation	PLOS ONE			English	Article							N-RAS GENE; HEMATOPOIETIC PROGENITOR CELLS; HIGH-DOSE CYTARABINE; MYELODYSPLASTIC SYNDROME; ACTIVATING MUTATIONS; SENSITIVE DETECTION; EXPRESSION PROFILE; POOR-PROGNOSIS; DNA-DAMAGE; FLT3	RAS mutations are frequently found among acute myeloid leukemia patients (AML), generating a constitutively active signaling protein changing cellular proliferation, differentiation and apoptosis. We have previously shown that treatment of AML patients with high-dose cytarabine is preferentially beneficial for those harboring oncogenic RAS. On the basis of a murine AML cell culture model, we ascribed this effect to a RAS-driven, p53-dependent induction of differentiation. Hence, in this study we sought to confirm the correlation between RAS status and differentiation of primary blasts obtained from AML patients. The gene expression signature of AML blasts with oncogenic NRAS indeed corresponded to a more mature profile compared to blasts with wildtype RAS, as demonstrated by gene set enrichment analysis (GSEA) and real-time PCR analysis of myeloid ecotropic viral integration site 1 homolog (MEIS1) in a unique cohort of AML patients. In addition, in vitro cell culture experiments with established cell lines and a second set of primary AML cells showed that oncogenic NRAS mutations predisposed cells to cytarabine (AraC) driven differentiation. Taken together, our findings show that AML with inv(16) and NRAS mutation have a differentiation gene signature, supporting the notion that NRAS mutation may predispose leukemic cells to AraC induced differentiation. We therefore suggest that promotion of differentiation pathways by specific genetic alterations could explain the superior treatment outcome after therapy in some AML patient subgroups. Whether a differentiation gene expression status may generally predict for a superior treatment outcome in AML needs to be addressed in future studies.	[Brendel, Cornelia; Teichler, Sabine; Millahn, Axel; Stabla, Kathleen; Ross, Petra; Huynh, Minh; Barckhausen, Christina; Neubauer, Andreas] Univ Marburg, Dept Hematol Oncol & Immunol, Marburg, Germany; [Brendel, Cornelia; Teichler, Sabine; Millahn, Axel; Stabla, Kathleen; Ross, Petra; Huynh, Minh; Barckhausen, Christina; Neubauer, Andreas] Univ Clin Giessen & Marburg, Marburg, Germany; [Stiewe, Thorsten; Krause, Michael; Mernberger, Marco] Univ Marburg, Mol Oncol, Marburg, Germany; [Illmer, Thomas] Tech Univ Dresden, Univ Clin, Med Clin 1, D-01062 Dresden, Germany	Philipps University Marburg; University Hospital of Giessen & Marburg; Philipps University Marburg; Technische Universitat Dresden	Neubauer, A (corresponding author), Univ Marburg, Dept Hematol Oncol & Immunol, Marburg, Germany.	neubauer@mailer.uni-marburg.de	Brendel, Cornelia/U-5901-2019	Brendel, Cornelia/0000-0003-1612-9557; Stiewe, Thorsten/0000-0003-0134-7826	von Behring-Rontgen Foundation [51-0057]; Deutsche Forschungsgemeinschaft [DFG SFB TRR17, KFO210]; German Carreras Leukemia Foundation [AH 06-01, AR08/05v, RO6/31]; Bundesministerium fur Bildung und Forschung [NGFNplus PKL-01GS0880-11]; European Research Council	von Behring-Rontgen Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Carreras Leukemia Foundation; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); European Research Council(European Research Council (ERC)European Commission)	The study was supported by the von Behring-Rontgen Foundation, grant no. 51-0057 to AN, Deutsche Forschungsgemeinschaft, grant no. DFG SFB TRR17 to AN, KFO210 to C. Brendel and AN; German Carreras Leukemia Foundation, grant no. AH 06-01 und AR08/05v to AN and RO6/31 to C. Brendel; Bundesministerium fur Bildung und Forschung, grant no. NGFNplus PKL-01GS0880-11 to AN and ST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TS acknowledges support by the European Research Council.	Bacher U, 2006, BLOOD, V107, P3847, DOI 10.1182/blood-2005-08-3522; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; BENE MC, 1995, LEUKEMIA, V9, P1783; Bowen DT, 2005, BLOOD, V106, P2113, DOI 10.1182/blood-2005-03-0867; Bowen DT, 2003, BLOOD, V101, P2770, DOI 10.1182/blood-2002-01-0228; Brendel C, 2005, GENE EXPRESSION, V12, P245, DOI 10.3727/000000005783992043; Chan IT, 2004, CELL CYCLE, V3, P536; Chung E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028350; COGHLAN DW, 1994, LEUKEMIA, V8, P1682; Croonquist PA, 2003, BLOOD, V102, P2581, DOI 10.1182/blood-2003-04-1227; DeMelo MB, 1997, LEUKEMIA LYMPHOMA, V24, P309, DOI 10.3109/10428199709039018; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Ewald B, 2008, ONCOGENE, V27, P6522, DOI 10.1038/onc.2008.316; Fikaris AJ, 2006, J BIOL CHEM, V281, P34759, DOI 10.1074/jbc.M606737200; Garcia-Orti L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047717; Illmer T, 2005, CLIN CANCER RES, V11, P3217, DOI 10.1158/1078-0432.CCR-04-2232; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jaatinen T, 2006, STEM CELLS, V24, P631, DOI 10.1634/stemcells.2005-0185; Kiyoi H, 1999, BLOOD, V93, P3074; Krypuy M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-295; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Meshinchi S, 2003, BLOOD, V102, P1474, DOI 10.1182/blood-2003-01-0137; Meyer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007768; Moriya K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037892; NEUBAUER A, 1994, BLOOD, V83, P1603; Neubauer A, 2008, J CLIN ONCOL, V26, P4603, DOI 10.1200/JCO.2007.14.0418; PAQUETTE RL, 1993, BLOOD, V82, P590, DOI 10.1182/blood.V82.2.590.bloodjournal822590; Pineault N, 2002, EXP HEMATOL, V30, P49, DOI 10.1016/S0301-472X(01)00757-3; Ritter M, 2006, LEUKEMIA, V20, P437, DOI 10.1038/sj.leu.2404093; Ritter M, 1997, BRIT J HAEMATOL, V98, P969, DOI 10.1046/j.1365-2141.1997.2933107.x; Schaich M, 2001, BRIT J HAEMATOL, V112, P300, DOI 10.1046/j.1365-2141.2001.02562.x; Schaich M, 2013, J CLIN ONCOL, V31, P2094, DOI 10.1200/JCO.2012.46.4743; Scholl C, 2008, SEMIN ONCOL, V35, P336, DOI 10.1053/j.seminoncol.2008.04.004; Shen SW, 2004, EXP HEMATOL, V32, P852, DOI 10.1016/j.exphem.2004.06.001; Shen S, 2007, EXP HEMATOL, V35, P908, DOI 10.1016/j.exphem.2007.02.011; Shih LY, 2004, LEUKEMIA, V18, P466, DOI 10.1038/sj.leu.2403274; Stirewalt DL, 2001, BLOOD, V97, P3589, DOI 10.1182/blood.V97.11.3589; Thiede C, 1996, NUCLEIC ACIDS RES, V24, P983, DOI 10.1093/nar/24.5.983; Valk PJM, 2004, HAEMATOLOGICA, V89, P106; Weisberg E, 2009, DRUG RESIST UPDATE, V12, P81, DOI 10.1016/j.drup.2009.04.001	40	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123181	10.1371/journal.pone.0123181	http://dx.doi.org/10.1371/journal.pone.0123181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901794	gold, Green Published, Green Submitted			2022-12-27	WOS:000353331500047
J	Pascolutti, M; Campitelli, M; Nguyen, B; Pham, N; Gorse, AD; Quinn, RJ				Pascolutti, Mauro; Campitelli, Marc; Bao Nguyen; Ngoc Pham; Gorse, Alain-Dominique; Quinn, Ronald J.			Capturing Nature's Diversity	PLOS ONE			English	Article							DRUG DISCOVERY; CHEMICAL SPACE; PRODUCTS; CHEMISTRY; DESIGN; LIBRARIES; FRAGMENTS	Natural products are universally recognized to contribute valuable chemical diversity to the design of molecular screening libraries. The analysis undertaken in this work, provides a foundation for the generation of fragment screening libraries that capture the diverse range of molecular recognition building blocks embedded within natural products. Physicochemical properties were used to select fragment-sized natural products from a database of known natural products (Dictionary of Natural Products). PCA analysis was used to illustrate the positioning of the fragment subset within the property space of the non-fragment sized natural products in the dataset. Structural diversity was analysed by three distinct methods: atom function analysis, using pharmacophore fingerprints, atom type analysis, using radial fingerprints, and scaffold analysis. Small pharmacophore triplets, representing the range of chemical features present in natural products that are capable of engaging in molecular interactions with small, contiguous areas of protein binding surfaces, were analysed. We demonstrate that fragment-sized natural products capture more than half of the small pharmacophore triplet diversity observed in non fragment-sized natural product datasets. Atom type analysis using radial fingerprints was represented by a self-organizing map. We examined the structural diversity of non-flat fragment-sized natural product scaffolds, rich in sp3 configured centres. From these results we demonstrate that 2-ring fragment-sized natural products effectively balance the opposing characteristics of minimal complexity and broad structural diversity when compared to the larger, more complex fragment-like natural products. These naturally-derived fragments could be used as the starting point for the generation of a highly diverse library with the scope for further medicinal chemistry elaboration due to their minimal structural complexity. This study highlights the possibility to capture a high proportion of the individual molecular interaction motifs embedded within natural products using a fragment screening library spanning 422 structural clusters and comprised of approximately 2800 natural products.	[Pascolutti, Mauro; Campitelli, Marc; Bao Nguyen; Ngoc Pham; Gorse, Alain-Dominique; Quinn, Ronald J.] Griffith Univ, Eskitis Inst Drug Discovery, Brisbane, Qld 4111, Australia; [Gorse, Alain-Dominique] Univ Queensland, QFAB Bioinformat, Brisbane, Qld, Australia	Griffith University; University of Queensland	Quinn, RJ (corresponding author), Griffith Univ, Eskitis Inst Drug Discovery, Brisbane, Qld 4111, Australia.	r.quinn@griffith.edu.au	Gorse, Alain-Dominique JP/G-2444-2010; Gorse, Dominique/GRJ-6993-2022; Quinn, Ronald J/A-7931-2008	Quinn, Ronald J/0000-0002-4022-2623; Gorse, Alain-Dominique/0000-0003-1230-4194	Bill & Melinda Gates Foundation [OPP100837, POO1035218]; ARC [LP120100485]; Chemi-Biology Computational Platform for Lead Discovery in Infectious Disease [LE120100071]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); ARC(Australian Research Council); Chemi-Biology Computational Platform for Lead Discovery in Infectious Disease	The authors acknowledge financial support from Bill & Melinda Gates Foundation Grand Challenges Explorations Grant (OPP100837 and POO1035218), ARC Linkage LE (LP120100485) and Chemi-Biology Computational Platform for Lead Discovery in Infectious Disease (LE120100071).	Bohacek RS, 1996, MED RES REV, V16, P3, DOI 10.1002/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.0.CO;2-6; Chen HM, 2012, MEDCHEMCOMM, V3, P312, DOI 10.1039/c2md00238h; Congreve M, 2003, DRUG DISCOV TODAY, V8, P876, DOI 10.1016/S1359-6446(03)02831-9; Congreve M, 2008, J MED CHEM, V51, P3661, DOI 10.1021/jm8000373; Erlanson DA, 2004, J MED CHEM, V47, P3463, DOI 10.1021/jm040031v; FARNSWORTH NR, 1985, B WORLD HEALTH ORGAN, V63, P965; Feher M, 2003, J CHEM INF COMP SCI, V43, P218, DOI 10.1021/ci0200467; Ganesan A, 2008, CURR OPIN CHEM BIOL, V12, P306, DOI 10.1016/j.cbpa.2008.03.016; Glen RC, 2006, IDRUGS, V9, P199; Grabowski K, 2007, CURR CHEM BIOL, V1, P115, DOI DOI 10.2174/187231307779814066; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; Vu H, 2013, ACS CHEM BIOL, V8, P2654, DOI 10.1021/cb400582b; Hung AW, 2011, P NATL ACAD SCI USA, V108, P6799, DOI 10.1073/pnas.1015271108; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Langdon SR, 2011, J CHEM INF MODEL, V51, P2174, DOI 10.1021/ci2001428; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lopez-Vallejo F, 2012, DRUG DISCOV TODAY, V17, P718, DOI 10.1016/j.drudis.2012.04.001; Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e; McGregor MJ, 1999, J CHEM INF COMP SCI, V39, P569, DOI 10.1021/ci980159j; Murray CW, 2009, NAT CHEM, V1, P187, DOI [10.1038/NCHEM.217, 10.1038/nchem.217]; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Over B, 2013, NAT CHEM, V5, P21, DOI [10.1038/NCHEM.1506, 10.1038/nchem.1506]; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Schuffenhauer A, 2007, J CHEM INF MODEL, V47, P47, DOI 10.1021/ci600338x; Tajabadi F., 2013, SPRINGER SCI REV, V1, P141; Tian S, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-5; Wetzel S, 2007, CHIMIA, V61, P355, DOI 10.2533/chimia.2007.355	29	32	35	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0120942	10.1371/journal.pone.0120942	http://dx.doi.org/10.1371/journal.pone.0120942			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902039	gold, Green Published, Green Submitted			2022-12-27	WOS:000353331500008
J	Carpenter, JS; Robillard, R; Lee, RSC; Hermens, DF; Naismith, SL; White, D; Whitwell, B; Scott, EM; Hickie, IB				Carpenter, Joanne S.; Robillard, Rebecca; Lee, Rico S. C.; Hermens, Daniel F.; Naismith, Sharon L.; White, Django; Whitwell, Bradley; Scott, Elizabeth M.; Hickie, Ian B.			The Relationship between Sleep-Wake Cycle and Cognitive Functioning in Young People with Affective Disorders	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; OBSESSIVE-COMPULSIVE DISORDER; MENTAL-HEALTH-SERVICES; REST-ACTIVITY PATTERNS; CIRCADIAN-RHYTHMS; BIPOLAR DISORDER; ANXIETY DISORDERS; PSYCHIATRIC-DISORDERS; EARLY-ONSET; MEMORY	Although early-stage affective disorders are associated with both cognitive dysfunction and sleep-wake disruptions, relationships between these factors have not been specifically examined in young adults. Sleep and circadian rhythm disturbances in those with affective disorders are considerably heterogeneous, and may not relate to cognitive dysfunction in a simple linear fashion. This study aimed to characterise profiles of sleep and circadian disturbance in young people with affective disorders and examine associations between these profiles and cognitive performance. Actigraphy monitoring was completed in 152 young people (16-30 years; 66% female) with primary diagnoses of affective disorders, and 69 healthy controls (18-30 years; 57% female). Patients also underwent detailed neuropsychological assessment. Actigraphy data were processed to estimate both sleep and circadian parameters. Overall neuropsychological performance in patients was poor on tasks relating to mental flexibility and visual memory. Two hierarchical cluster analyses identified three distinct patient groups based on sleep variables and three based on circadian variables. Sleep clusters included a 'long sleep' cluster, a 'disrupted sleep' cluster, and a 'delayed and disrupted sleep' cluster. Circadian clusters included a 'strong circadian' cluster, a 'weak circadian' cluster, and a 'delayed circadian' cluster. Medication use differed between clusters. The 'long sleep' cluster displayed significantly worse visual memory performance compared to the 'disrupted sleep' cluster. No other cognitive functions differed between clusters. These results highlight the heterogeneity of sleep and circadian profiles in young people with affective disorders, and provide preliminary evidence in support of a relationship between sleep and visual memory, which may be mediated by use of antipsychotic medication. These findings have implications for the personalisation of treatments and improvement of functioning in young adults early in the course of affective illness.	[Carpenter, Joanne S.; Robillard, Rebecca; Lee, Rico S. C.; Hermens, Daniel F.; Naismith, Sharon L.; White, Django; Whitwell, Bradley; Scott, Elizabeth M.; Hickie, Ian B.] Univ Sydney, Clin Res Unit, Brain & Mind Res Inst, Camperdown, NSW, Australia	University of Sydney	Hickie, IB (corresponding author), Univ Sydney, Clin Res Unit, Brain & Mind Res Inst, Camperdown, NSW, Australia.	ian.hickie@sydney.edu.au	Stevens, David/F-4683-2015; Robillard, Rebecca/G-9045-2017; Hickie, Ian B/K-8975-2015	Hickie, Ian B/0000-0001-8832-9895; Hermens, Daniel/0000-0002-8570-2663; Naismith, Sharon/0000-0001-9076-2778; Carpenter, Joanne/0000-0002-9766-6700	National Health and Medical Research Council Program Grant [566529]; Australian Fellowship [464914]; NSW Health Mental Health and Drug Alcohol Office; National Health and Medical Research Council Clinical Development Award [1008117]; Fonds de la recherche en sante du Quebec; NHMRC Centre of Research Excellence in Optimising Early Interventions for Young People with Emerging Mood Disorders [1061043]	National Health and Medical Research Council Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Australian Fellowship; NSW Health Mental Health and Drug Alcohol Office; National Health and Medical Research Council Clinical Development Award; Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); NHMRC Centre of Research Excellence in Optimising Early Interventions for Young People with Emerging Mood Disorders(National Health and Medical Research Council (NHMRC) of Australia)	IBH was funded by a National Health and Medical Research Council Program Grant (No. 566529) and Australian Fellowship (No. 464914). DFH was supported by a grant from NSW Health Mental Health and Drug & Alcohol Office. SLN was funded by a National Health and Medical Research Council Clinical Development Award (No. 1008117). RR received a postdoctoral training award from the Fonds de la recherche en sante du Quebec. RSCL and JSC were supported by the NHMRC Centre of Research Excellence in Optimising Early Interventions for Young People with Emerging Mood Disorders (No. 1061043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen E, 2005, J PSYCHIAT RES, V39, P207, DOI 10.1016/j.jpsychires.2004.06.001; Ankers D, 2009, J CLIN PSYCHOL, V65, P1071, DOI 10.1002/jclp.20608; APA, 1980, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890423349, DOI 10.1176/APPI.BOOKS.9780890423349]; Arico D, 2010, SLEEP MED, V11, P791, DOI 10.1016/j.sleep.2010.02.009; Armitage R, 2004, J AM ACAD CHILD PSY, V43, P761, DOI 10.1097/01.chi.0000122731.72597.4e; Arts B, 2011, ACTA PSYCHIAT SCAND, V123, P190, DOI 10.1111/j.1600-0447.2010.01601.x; Astill RG, 2012, PSYCHOL BULL, V138, P1109, DOI 10.1037/a0028204; Augustinavicius JLS, 2014, J AFFECT DISORDERS, V158, P11, DOI 10.1016/j.jad.2013.12.009; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Bearden CE, 2006, PSYCHIAT RES, V142, P139, DOI 10.1016/j.psychres.2005.08.010; BENCA RM, 1992, ARCH GEN PSYCHIAT, V49, P651; Benitez A, 2012, CLIN NEUROPSYCHOL, V26, P214, DOI 10.1080/13854046.2012.658439; Blatter K, 2007, PHYSIOL BEHAV, V90, P196, DOI 10.1016/j.physbeh.2006.09.009; BORGEN FH, 1987, J COUNS PSYCHOL, V34, P456, DOI 10.1037/0022-0167.34.4.456; Rocha PMB, 2013, COMPR PSYCHIAT, V54, P1003, DOI 10.1016/j.comppsych.2013.04.006; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; Bruni O, 2012, SLEEP, V35, P649, DOI 10.5665/sleep.1824; BURKE KC, 1990, ARCH GEN PSYCHIAT, V47, P511; Cajochen C, 2003, J NEUROENDOCRINOL, V15, P432, DOI 10.1046/j.1365-2826.2003.00989.x; Castaneda AE, 2008, J AFFECT DISORDERS, V106, P1, DOI 10.1016/j.jad.2007.06.006; Chase RM, 2011, BEHAV SLEEP MED, V9, P224, DOI 10.1080/15402002.2011.606768; Couyoumdjian A, 2010, J SLEEP RES, V19, P64, DOI 10.1111/j.1365-2869.2009.00774.x; Depp CA, 2012, BIPOLAR DISORD, V14, P217, DOI 10.1111/j.1399-5618.2012.01011.x; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Dittmann S, 2008, BIPOLAR DISORD, V10, P877, DOI 10.1111/j.1399-5618.2008.00640.x; Dolsen MR, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0471-y; Donaldson S, 2003, J CLIN PSYCHIAT, V64, P86, DOI 10.4088/JCP.v64n0116; Fortier-Brochu E, 2012, SLEEP MED REV, V16, P83, DOI 10.1016/j.smrv.2011.03.008; Geiger A, 2012, NEUROREPORT, V23, P93, DOI 10.1097/WNR.0b013e32834e7e8f; Geoffroy PA, 2014, J AFFECT DISORDERS, V158, P1, DOI 10.1016/j.jad.2014.01.012; Glozier N, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-33; Goder R, 2007, NEUROPSYCHOBIOLOGY, V55, P36, DOI 10.1159/000103574; Goder R, 2011, J SLEEP RES, V20, P544, DOI 10.1111/j.1365-2869.2011.00914.x; GOLDMAN HH, 1992, AM J PSYCHIAT, V149, P1148; Gonzalez R, 2014, J CLIN PSYCHIAT, V75, pE317, DOI 10.4088/JCP.13m08506; Gruber J, 2011, J AFFECT DISORDERS, V134, P416, DOI 10.1016/j.jad.2011.05.016; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Harvey AG, 2011, CLIN PSYCHOL REV, V31, P225, DOI 10.1016/j.cpr.2010.04.003; Harvey AG, 2009, CLIN PSYCHOL-SCI PR, V16, P256, DOI 10.1111/j.1468-2850.2009.01164.x; Hasler BP, 2010, PSYCHIAT RES, V178, P205, DOI 10.1016/j.psychres.2010.04.027; Hermens DF, 2010, EARLY INTERV PSYCHIA, V4, P227, DOI 10.1111/j.1751-7893.2010.00194.x; Hickie I, 2005, BRIT J PSYCHIAT, V186, P197, DOI 10.1192/bjp.186.3.197; Hickie IB, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-125; Houthoofd SAMK, 2008, CLIN THER, V30, P1565, DOI 10.1016/j.clinthera.2008.09.014; Hsiao FH, 2010, PSYCHONEUROENDOCRINO, V35, P503, DOI 10.1016/j.psyneuen.2009.08.019; Huang YL, 2002, PHYSIOL BEHAV, V76, P597, DOI 10.1016/S0031-9384(02)00733-3; Jamrozinski K, 2009, ACTA PSYCHIAT SCAND, V119, P365, DOI 10.1111/j.1600-0447.2008.01320.x; Kelly Y, 2013, J EPIDEMIOL COMMUN H, V67, P926, DOI 10.1136/jech-2012-202024; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; Lee J., 2006, PSYCHIAT INVEST, V3, P55; Lee RSC, 2014, J PSYCHIATR RES, V57, P1, DOI 10.1016/j.jpsychires.2014.06.019; Lee RSC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058176; Lee RSC, 2012, J AFFECT DISORDERS, V140, P113, DOI 10.1016/j.jad.2011.10.023; Leistedt SJ, 2013, EUR NEUROPSYCHOPHARM, V23, P55, DOI 10.1016/j.euroneuro.2012.10.011; Li SX, 2012, SLEEP, V35, P1153, DOI 10.5665/sleep.2008; Li SX, 2013, PSYCHONEUROENDOCRINO, V38, P2789, DOI 10.1016/j.psyneuen.2013.07.009; Lim ASP, 2012, SLEEP, V35, P633, DOI 10.5665/sleep.1820; Manglick M, 2013, AUST NZ J PSYCHIAT, V47, P556, DOI 10.1177/0004867413481630; Mann-Wrobel MC, 2011, BIPOLAR DISORD, V13, P334, DOI 10.1111/j.1399-5618.2011.00935.x; Marler MR, 2006, STAT MED, V25, P3893, DOI 10.1002/sim.2466; Maziade M, 2011, SCHIZOPHRENIA BULL, V37, P1218, DOI 10.1093/schbul/sbq026; Meyers J. E., 1995, REY COMPLEX FIGURE T; MONTELEONE P, 1994, ACTA PSYCHIAT SCAND, V89, P411, DOI 10.1111/j.1600-0447.1994.tb01538.x; Monti JM, 2004, SLEEP MED REV, V8, P133, DOI 10.1016/S1087-0792(02)00158-2; Muller J, 2005, J ANXIETY DISORD, V19, P1, DOI 10.1016/j.janxdis.2003.12.001; NAIR NPV, 1984, PROG NEURO-PSYCHOPH, V8, P715, DOI 10.1016/0278-5846(84)90044-7; Naismith SL, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.47; Naismith SL, 2011, J AFFECT DISORDERS, V132, P139, DOI 10.1016/j.jad.2011.02.027; Naismith SL, 2009, J AFFECT DISORDERS, V116, P139, DOI 10.1016/j.jad.2008.11.017; Nandi A, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-31; Nota JA, 2015, NEUROSCI BIOBEHAV R, V51, P100, DOI 10.1016/j.neubiorev.2015.01.002; Olley A, 2007, J AFFECT DISORDERS, V104, P15, DOI 10.1016/j.jad.2007.02.023; Ong SH, 2006, J AFFECT DISORDERS, V96, P1, DOI 10.1016/j.jad.2006.05.025; Oosterman JM, 2009, J SLEEP RES, V18, P129, DOI 10.1111/j.1365-2869.2008.00704.x; Paelecke-Habermann Y, 2005, J AFFECT DISORDERS, V89, P125, DOI 10.1016/j.jad.2005.09.006; Papadimitriou GN, 2005, INT REV PSYCHIATR, V17, P229, DOI 10.1080/09540260500104524; Perlman CA, 2006, BIPOLAR DISORD, V8, P271, DOI 10.1111/j.1399-5618.2006.00330.x; Plante DT, 2012, PSYCHIAT RES-NEUROIM, V201, P240, DOI 10.1016/j.pscychresns.2012.03.001; Purcell R, 1997, PSYCHOL MED, V27, P1277, DOI 10.1017/S0033291797005448; Rajaratnam SMW, 2004, J PHYSIOL-LONDON, V561, P339, DOI 10.1113/jphysiol.2004.073742; Rickert P, 1998, WMS 3 LIST LEARNING; Robillard R, 2013, EUR PSYCHIAT, V28, P412, DOI 10.1016/j.eurpsy.2013.04.001; Robillard R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087763; Robillard R, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0402-3; Robillard R, 2013, J AFFECT DISORDERS, V145, P260, DOI 10.1016/j.jad.2012.06.006; Rock P, 2014, CHRONOBIOL INT, V31, P290, DOI 10.3109/07420528.2013.843542; Rouch I, 2005, ERGONOMICS, V48, P1282, DOI 10.1080/00140130500241670; RUBIN RT, 1992, ARCH GEN PSYCHIAT, V49, P558; SAHAKIAN BJ, 1992, J ROY SOC MED, V85, P399; Schabus M, 2006, EUR J NEUROSCI, V23, P1738, DOI 10.1111/j.1460-9568.2006.04694.x; Schmidt C, 2007, COGN NEUROPSYCHOL, V24, P755, DOI 10.1080/02643290701754158; Scott E, 2009, AUSTRALAS PSYCHIATRY, V17, P189, DOI 10.1080/10398560802657322; Scott EM, 2012, MED J AUSTRALIA, V196, P136, DOI 10.5694/mja11.10481; Snyder HR, 2013, PSYCHOL BULL, V139, P81, DOI 10.1037/a0028727; Srinivasan V, 2012, J NEUROPSYCH CLIN N, V24, P290, DOI 10.1176/appi.neuropsych.11090216; Strauss E., 2006, COMPENDIUM NEUROPSYC; Sutter C, 2012, NEUROPSYCHOLOGY, V26, P768, DOI 10.1037/a0030033; Sylvia LG, 2012, J PSYCHOPHARMACOL, V26, P1108, DOI 10.1177/0269881111421973; Tombaugh TN., 1998, COMPENDIUM NEUROPSYC; Tucker AM, 2010, SLEEP, V33, P47, DOI 10.1093/sleep/33.1.47; Turner Jo, 2007, World Psychiatry, V6, P108; Valdez P., 2012, CHRONOPHYSIOLOGY THE, V2, P12, DOI [10.2147/cpt.s32586, DOI 10.2147/CPT.S32586]; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; van Mill JG, 2010, J CLIN PSYCHIAT, V71, P239, DOI 10.4088/JCP.09m05218gry; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wechsler D., 2001, WECHSLER TEST ADULT; Weiland-Fiedler P, 2004, J AFFECT DISORDERS, V82, P253, DOI 10.1016/j.jad.2003.10.009; Wichniak A, 2013, INT REV PSYCHIATR, V25, P632, DOI 10.3109/09540261.2013.812067; Withall A, 2009, PSYCHOL MED, V39, P393, DOI 10.1017/S0033291708003620; Woodward ND, 2005, INT J NEUROPSYCHOPH, V8, P457, DOI 10.1017/S146114570500516X; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Wulff K, 2009, CURR OPIN GENET DEV, V19, P237, DOI 10.1016/j.gde.2009.03.007; Xu GY, 2012, J AFFECT DISORDERS, V136, P328, DOI 10.1016/j.jad.2011.11.029; Zalta AK, 2013, DEPRESS ANXIETY, V30, P1114, DOI 10.1002/da.22170	115	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124710	10.1371/journal.pone.0124710	http://dx.doi.org/10.1371/journal.pone.0124710			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XJ	25898321	Green Submitted, Green Published, gold			2022-12-27	WOS:000353212600081
J	Lee, PS; Sing, KW; Wilson, JJ				Lee, Ping-Shin; Sing, Kong-Wah; Wilson, John-James			Reading Mammal Diversity from Flies: The Persistence Period of Amplifiable Mammal mtDNA in Blowfly Guts (Chrysomya megacephala) and a New DNA Mini-Barcode Target	PLOS ONE			English	Article							MOLECULAR METHODS; TRAP; PCR; IDENTIFICATION; AMPLIFICATION; MALAYSIA; PRIMERS; ENHANCE; CLIMATE; CARRION	Most tropical mammal species are threatened or data-deficient. Data collection is impeded by the traditional monitoring approaches which can be laborious, expensive and struggle to detect cryptic diversity. Monitoring approaches using mammal DNA derived from invertebrates are emerging as cost- and time-effective alternatives. As a step towards development of blowfly-derived DNA as an effective method for mammal monitoring in the biodiversity hotspot of Peninsular Malaysia, our objectives were (i) to determine the persistence period of amplifiable mammal mtDNA in blowfly guts through a laboratory feeding experiment (ii) to design and test primers that can selectively amplify mammal COI DNA mini-barcodes in the presence of high concentrations of blowfly DNA. The persistence period of amplifiable mammal mtDNA in blowfly guts was 24 h to 96 h post-feeding indicating the need for collecting flies within 24 h of capture to detect mammal mtDNA of sufficient quantity and quality. We designed a new primer combination for a COI DNA mini-barcode that did not amplify blowfly DNA and showed 89% amplification success for a dataset of mammals from Peninsular Malaysia. The short (205 bp) DNA mini-barcode could distinguish most mammal species (including separating dark taxa) and is of suitable length for high-throughput sequencing. Our new DNA mini-barcode target and a standardized trapping protocol with retrieval of blowflies every 24 h could point the way forward in the development of blowfly-derived DNA as an effective method for mammal monitoring.	[Lee, Ping-Shin; Sing, Kong-Wah; Wilson, John-James] Univ Malaya, Fac Sci, Inst Biol Sci, Museum Zool, Kuala Lumpur 50603, Malaysia; [Lee, Ping-Shin; Sing, Kong-Wah; Wilson, John-James] Univ Malaya, Fac Sci, Inst Biol Sci, Ecol & Biodivers Program, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya	Lee, PS (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Museum Zool, Kuala Lumpur 50603, Malaysia.	pingshin@um.edu.my; johnwilson@um.edu.my	Wilson, John-James/C-4656-2012; Lee, Ping Shin/G-4378-2014	Wilson, John-James/0000-0002-3583-3550; 	Nagao Natural Environment Foundation Japan; Ministry of Higher Education Fundamental Research Grant Scheme [FP042-2014A]	Nagao Natural Environment Foundation Japan; Ministry of Higher Education Fundamental Research Grant Scheme	This study was supported by grants from the Nagao Natural Environment Foundation Japan to LPS and the Ministry of Higher Education Fundamental Research Grant Scheme (FP042-2014A) to JJW and Yong Kien Thai (UM). The funding bodies had no role in the design, in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.	Abbasi I, 2009, VECTOR-BORNE ZOONOT, V9, P79, DOI 10.1089/vbz.2008.0064; Akbarzadeh K, 2012, J ARTHROPOD-BORNE DI, V6, P119; Amat Eduardo, 2010, Acta Amaz., V40, P397, DOI 10.1590/S0044-59672010000200018; Arif IA, 2011, GENET MOL RES, V10, P3559, DOI 10.4238/2011.October.31.3; Azwandi A, 2013, TROP BIOMED, V30, P481; Bataille A, 2012, INFECT GENET EVOL, V12, P1831, DOI 10.1016/j.meegid.2012.07.019; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Brodie JF, 2009, SCIENCE, V326, P364, DOI 10.1126/science.326_364b; Calvignac-Spencer S, 2013, BIOESSAYS, V35, P1004, DOI 10.1002/bies.201300060; Calvignac-Spencer S, 2013, MOL ECOL, V22, P915, DOI 10.1111/mec.12183; Campbell G, 2011, BIOL LETTERS, V7, P723, DOI 10.1098/rsbl.2011.0155; Campobasso CP, 2005, AM J FOREN MED PATH, V26, P161, DOI 10.1097/01.pag.0000163832.05939.59; Carew ME, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-45; Ceballos G, 2009, P NATL ACAD SCI USA, V106, P3841, DOI 10.1073/pnas.0812419106; Davison A, 2002, J ZOOL, V257, P141, DOI 10.1017/S0952836902000730; Davison GWH, 2007, P SEM WORKSH STAT BI, P3; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fonturbel FE, 2010, MAMM BIOL, V75, P294, DOI 10.1016/j.mambio.2009.03.012; Francis CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012575; Gariepy TD, 2012, MOL ECOL RESOUR, V12, P646, DOI 10.1111/j.1755-0998.2012.03140.x; Hanner R., 2009, DATA STANDARDS BARCO; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hobson RP, 1932, J EXP BIOL, V9, P128; Ivanova Natalia V, 2012, Methods Mol Biol, V858, P153, DOI 10.1007/978-1-61779-591-6_8; Jansen PA, 2010, SCIENCE, V327, P30, DOI 10.1126/science.327.5961.30-a; Kent RJ, 2009, MOL ECOL RESOUR, V9, P4, DOI 10.1111/j.1755-0998.2008.02469.x; Lambert TD, 2005, J MAMMAL, V86, P982, DOI 10.1644/1545-1542(2005)86[982:VISMSR]2.0.CO;2; Lyimo IN, 2009, TRENDS PARASITOL, V25, P189, DOI 10.1016/j.pt.2009.01.005; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Mumma MA, 2014, MOL ECOL RESOUR, V14, P100, DOI 10.1111/1755-0998.12153; Muturi CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017284; NORRIS KR, 1965, ANNU REV ENTOMOL, V10, P47, DOI 10.1146/annurev.en.10.010165.000403; Pinol J, 2014, MOL ECOL RESOUR, V14, P18, DOI 10.1111/1755-0998.12156; Powell RA, 2003, ILAR J, V44, P259, DOI 10.1093/ilar.44.4.259; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schnell IB, 2012, CURR BIOL, V22, pR262, DOI 10.1016/j.cub.2012.02.058; Scholtz AJ, 2000, J S AFR VET ASSOC, V71, P148; Shen YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057125; Shokralla S, 2014, MOL ECOL RESOUR, V14, P892, DOI 10.1111/1755-0998.12236; Sing KW, 2013, RAFFLES B ZOOL, P211; Stadhouders R, 2010, J MOL DIAGN, V12, P109, DOI 10.2353/jmoldx.2010.090035; Stein ED, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095525; Stenglein JL, 2010, MOL ECOL RESOUR, V10, P109, DOI 10.1111/j.1755-0998.2009.02670.x; Syaripuddin K, 2014, ECOTOXICOLOGY, V23, P1164, DOI 10.1007/s10646-014-1258-y; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanabe S, 2007, BIOSCI BIOTECH BIOCH, V71, P3131, DOI 10.1271/bbb.70683; Torre I, 2010, HYSTRIX, V21, P147, DOI 10.4404/hystrix-21.2-4462; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; VOGT W G, 1974, Journal of the Australian Entomological Society, V13, P249; Whitworth T, 2010, ZOOTAXA, P1; Wilson JJ, 2014, GENET MOL RES, V13, P920, DOI 10.4238/2014.February.19.2; Wilson John James, 2012, Methods Mol Biol, V858, P17, DOI 10.1007/978-1-61779-591-6_3	56	28	29	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123871	10.1371/journal.pone.0123871	http://dx.doi.org/10.1371/journal.pone.0123871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898278	gold, Green Published, Green Submitted			2022-12-27	WOS:000353212600044
J	Smith, MC; Gomulkiewicz, R; Mack, RN				Smith, Melissa C.; Gomulkiewicz, Richard; Mack, Richard N.			Potential Role of Masting by Introduced Bamboos in Deer Mice (Peromyscus maniculatus) Population Irruptions Holds Public Health Consequences	PLOS ONE			English	Article							SIN-NOMBRE-VIRUS; BIOLOGICAL-CONTROL AGENTS; IXODES-PACIFICUS; SEED PRODUCTION; EXTRA FOOD; RODENT; LONG; HANTAVIRUS; INVASIONS; PATTERNS	We hypothesized that the ongoing naturalization of frost/shade tolerant Asian bamboos in North America could cause environmental consequences involving introduced bamboos, native rodents and ultimately humans. More specifically, we asked whether the eventual masting by an abundant leptomorphic ("running") bamboo within Pacific Northwest coniferous forests could produce a temporary surfeit of food capable of driving a population irruption of a common native seed predator, the deer mouse (Peromyscus maniculatus), a hantavirus carrier. Single-choice and cafeteria-style feeding trials were conducted for deer mice with seeds of two bamboo species (Bambusa distegia and Yushania brevipaniculata), wheat, Pinus ponderosa, and native mixed diets compared to rodent laboratory feed. Adult deer mice consumed bamboo seeds as readily as they consumed native seeds. In the cafeteria-style feeding trials, Y. brevipaniculata seeds were consumed at the same rate as native seeds but more frequently than wheat seeds or rodent laboratory feed. Females produced a median litter of 4 pups on a bamboo diet. Given the ability of deer mice to reproduce frequently whenever food is abundant, we employed our feeding trial results in a modified Rosenzweig-MacArthur consumer-resource model to project the population-level response of deer mice to a suddenly available/rapidly depleted supply of bamboo seeds. The simulations predict rodent population irruptions and declines similar to reported cycles involving Asian and South American rodents but unprecedented in deer mice. Following depletion of a mast seed supply, the incidence of Sin Nombre Virus (SNV) transmission to humans could subsequently rise with dispersal of the peridomestic deer mice into nearby human settlements seeking food.	[Smith, Melissa C.] USDA ARS, Invas Plant Res Lab, Ft Lauderdale, FL 33314 USA; [Gomulkiewicz, Richard; Mack, Richard N.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA	United States Department of Agriculture (USDA); Washington State University	Smith, MC (corresponding author), USDA ARS, Invas Plant Res Lab, 3225 Coll Ave, Ft Lauderdale, FL 33314 USA.	Melissa.Smith@ars.usda.gov			USDA-APHIS contract [1081001205CA]; National Science Foundation [DMS 0540524, DEB 1354264]; Direct For Biological Sciences [1354264] Funding Source: National Science Foundation	USDA-APHIS contract; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by USDA-APHIS contract #1081001205CA to Washington State University and greatly facilitated by A.V. Tasker. RG was supported in part by National Science Foundation grants DMS 0540524 and DEB 1354264. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, ORNAMENTAL BAMBOOS; [Anonymous], 1980, SOIL SURVEY WHITMAN; [Anonymous], SOIL SURVEY LATAH CO; Aplin K, 2010, RODENT OUTBREAKS ECO, P13; Bartolomucci A, 2003, PSYCHONEUROENDOCRINO, V28, P540, DOI 10.1016/S0306-4530(02)00039-2; Belmain S. R., 2010, RODENT OUTBREAKS ECO, P49; BERRYMAN AA, 1992, ECOLOGY, V73, P1530, DOI 10.2307/1940005; Biggs JR, 2000, J MAMMAL, V81, P676, DOI 10.1644/1545-1542(2000)081<0676:ROEVTS>2.3.CO;2; Blackwell GL, 2003, OIKOS, V100, P601, DOI 10.1034/j.1600-0706.2003.11026.x; Botten J, 2001, COMPARATIVE MED, V51, P314; BURGDORFER W, 1985, AM J TROP MED HYG, V34, P925, DOI 10.4269/ajtmh.1985.34.925; Calisher CH, 2002, CROAT MED J, V43, P330; Calisher CH, 2007, J WILDLIFE DIS, V43, P1, DOI 10.7589/0090-3558-43.1.1; CHAMBERS JC, 1994, ANNU REV ECOL SYST, V25, P263, DOI 10.1146/annurev.es.25.110194.001403; CLARE FRANK H., 1938, JOUR MAMMAL, V19, P230, DOI 10.2307/1374620; Clotfelter ED, 2007, OECOLOGIA, V154, P493, DOI 10.1007/s00442-007-0859-z; Curran JM, 2013, HOTELLING; DAUBENMIRE R., 1970, Technical Bulletin. Washington Agricultural Experiment Station; Daubenmire R, 1968, FOREST VEGETATION WA; Dizney L, 2010, J WILDLIFE DIS, V46, P433, DOI 10.7589/0090-3558-46.2.433; Douangboupha B, 2003, ACIAR MONOGRAPH, V96, P103; Douglass RJ, 2006, J WILDLIFE DIS, V42, P813, DOI 10.7589/0090-3558-42.4.813; DOYLE AT, 1990, J MAMMAL, V71, P14, DOI 10.2307/1381312; Engelthaler DM, 1999, EMERG INFECT DIS, V5, P87, DOI 10.3201/eid0501.990110; Everett R., 1990, Proceedings of the Vertebrate Pest Conference, V14, P186; Fan D, 2000, SCI SILVAE SIN, V36, P57; Franklin DC, 2004, J BIOGEOGR, V31, P773, DOI 10.1111/j.1365-2699.2003.01057.x; FRANKLIN J. F., 1973, NATURAL VEGETATION O; FRENCH NR, 1968, ECOLOGY, V49, P1172, DOI 10.2307/1934507; GASHWILER JS, 1979, AM MIDL NAT, V102, P95, DOI 10.2307/2425070; GILBERT BS, 1981, OECOLOGIA, V51, P326, DOI 10.1007/BF00540901; Gratani L, 2008, FLORA, V203, P77, DOI 10.1016/j.flora.2007.11.002; GUNTHER PM, 1983, NORTHWEST SCI, V57, P32; Hiltbrunner E, 2014, OECOLOGIA, V176, P11, DOI 10.1007/s00442-014-2991-x; Horne BV, 1982, ECOLOGY, V63, P992, DOI [10.2307/1937239, DOI 10.2307/1937239]; Jaksic FM, 2003, AUSTRAL ECOL, V28, P237, DOI 10.1046/j.1442-9993.2003.01271.x; JAMESON EW, 1953, J MAMMAL, V34, P44, DOI 10.2307/1375943; JAMESON EW, 1952, J MAMMAL, V33, P50, DOI 10.2307/1375640; JANZEN DH, 1976, ANNU REV ECOL SYST, V7, P347, DOI 10.1146/annurev.es.07.110176.002023; Johnson DR, 1961, NW SCI, V61, P37; Johnson DR, 1987, NW SCI US; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Kelly D, 1997, OIKOS, V78, P143, DOI 10.2307/3545810; Kitzberger T, 2007, ECOLOGY, V88, P2541, DOI 10.1890/06-1587.1; Kon H, 2005, J ECOL, V93, P1148, DOI 10.1111/j.1365-2745.2005.01040.x; Krannitz Pamela G., 2004, Western North American Naturalist, V64, P208; Lalnunmawia F., 2005, Journal of Bamboo and Rattan, V4, P317, DOI 10.1163/156915905775008390; LANE RS, 1991, ANNU REV ENTOMOL, V36, P587, DOI 10.1146/annurev.en.36.010191.003103; Li Zhao-hua, 2006, Journal of Forestry Research (Harbin), V17, P293, DOI 10.1007/s11676-006-0067-4; Liebhold A, 2004, OIKOS, V104, P156, DOI 10.1111/j.0030-1299.2004.12722.x; Liebhold AM, 2012, FRONT ECOL ENVIRON, V10, P135, DOI 10.1890/110198; Lockwood JR, 1998, OECOLOGIA, V116, P475, DOI 10.1007/s004420050612; Luis AD, 2010, J ANIM ECOL, V79, P462, DOI 10.1111/j.1365-2656.2009.01646.x; Mack Richard N., 2011, NeoBiota, V9, P13, DOI 10.3897/neobiota.9.1156; Mack RN, 2003, INT J PLANT SCI, V164, pS185, DOI 10.1086/368399; MAKITA A, 1993, ECOL RES, V8, P215, DOI 10.1007/BF02348534; MANLY BFJ, 1993, OECOLOGIA, V93, P149, DOI 10.1007/BF00321205; Maron JL, 2010, ECOLOGY, V91, P3719, DOI 10.1890/10-0160.1; Maser C, 1981, 133 USDA PNW FOR SER, P496; Mills James N., 2002, Morbidity and Mortality Weekly Report, V51, P1; Minton MS, 2010, OECOLOGIA, V164, P399, DOI 10.1007/s00442-010-1667-4; Morrison ML, 1998, SOUTHWEST NAT, V43, P123; Murua R., 1996, Boletin de la Sociedad de Biologia de Concepcion, V67, P37; Nag S, 1999, Environ Hist Camb, V5, P245, DOI 10.3197/096734099779568317; Ohrnberger D, 1999, BAMBOOS WORLD ANNOTA; Orrock JL, 2011, AM NAT, V177, P691, DOI 10.1086/659632; Ortega YK, 2004, ECOL APPL, V14, P241, DOI 10.1890/02-5276; Oshima Y., 1961, Bot. Mag., V74, P280; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; PATTON BD, 1988, J RANGE MANAGE, V41, P232, DOI 10.2307/3899174; Pearson DE, 2006, ECOL LETT, V9, P443, DOI 10.1111/j.1461-0248.2006.00896.x; Pearson DE, 2008, ECOL APPL, V18, P321, DOI 10.1890/07-0766.1; PEAVEY CA, 1995, J PARASITOL, V81, P175, DOI 10.2307/3283916; R Development Core Team, 2014, R LANG ENV STAT COMP; REAL LA, 1979, ECOLOGY, V60, P481, DOI 10.2307/1936067; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; Rundel PW, 2014, BIOL INVASIONS, V16, P663, DOI 10.1007/s10530-013-0614-9; Ruscoe WA, 2004, NEW ZEAL J ECOL, V28, P259; SIEG CH, 1986, NORTHWEST SCI, V60, P81; Simberloff D, 2005, TRENDS ECOL EVOL, V20, P216, DOI 10.1016/j.tree.2005.02.008; Smith AL, 2014, BIOL INVASIONS, V16, P1325, DOI 10.1007/s10530-013-0585-x; Smith MC, 2013, BIOL INVASIONS, V15, P2081, DOI 10.1007/s10530-013-0434-y; SULLIVAN TP, 1979, CAN J ZOOL, V57, P1636, DOI 10.1139/z79-215; TAITT MJ, 1981, J ANIM ECOL, V50, P111, DOI 10.2307/4035; Tallmon DA, 2003, ECOL APPL, V13, P1193, DOI 10.1890/02-5111; TAYLOR AH, 1988, AM J BOT, V75, P1065, DOI 10.2307/2443774; Timm RM, 1994, PREVENTION CONTROL W, pB47; TISDALE EW, 1947, ECOLOGY, V28, P346, DOI 10.2307/1931227; Tsuyuzaki S, 1996, AM J BOT, V83, P1422, DOI 10.2307/2446097; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; UEMURA S, 1989, VEGETATIO, V82, P127, DOI 10.1007/BF00045026; Vandermeer J, 2010, SCI ED KNOWL, V3, P15; VITOUSEK PM, 1987, SCIENCE, V238, P802, DOI 10.1126/science.238.4828.802; Witmer G, 2007, INTEGR ZOOL, V2, P154, DOI 10.1111/j.1749-4877.2007.00058.x; Wobeser G, 2007, J WILDLIFE DIS, V43, P23, DOI 10.7589/0090-3558-43.1.23; Wolff JO, 1996, J MAMMAL, V77, P850, DOI 10.2307/1382690; WOLFF JO, 1985, CAN J ZOOL, V63, P1548, DOI 10.1139/z85-230; Yunger JA, 2002, J MAMMAL, V83, P267, DOI 10.1644/1545-1542(2002)083<0267:ROTLDP>2.0.CO;2	99	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124419	10.1371/journal.pone.0124419	http://dx.doi.org/10.1371/journal.pone.0124419			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898267	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600068
J	Suresh, RV; Ma, Z; Sunagar, R; Bhatty, V; Banik, S; Catlett, SV; Gosselin, EJ; Malik, M; Bakshi, CS				Suresh, Ragavan Varadharajan; Ma, Zhuo; Sunagar, Raju; Bhatty, Vivek; Banik, Sukalyani; Catlett, Sally V.; Gosselin, Edmund J.; Malik, Meenakshi; Bakshi, Chandra Shekhar			Preclinical Testing of a Vaccine Candidate against Tularemia	PLOS ONE			English	Article							SUBSPECIES TULARENSIS STRAIN; FRANCISELLA-TULARENSIS; SCHU S4; INTRAMACROPHAGE SURVIVAL; MICROBIAL ANTIOXIDANTS; RESPIRATORY TULAREMIA; AEROSOL CHALLENGE; OXIDATIVE STRESS; PURINE AUXOTROPH; DELETION MUTANTS	Tularemia is caused by a gram-negative, intracellular bacterial pathogen, Francisella tularensis (Ft). The history weaponization of Ft in the past has elevated concerns that it could be used as a bioweapon or an agent of bioterrorism. Since the discovery of Ft, three broad approaches adopted for tularemia vaccine development have included inactivated, live attenuated, or subunit vaccines. Shortcomings in each of these approaches have hampered the development of a suitable vaccine for prevention of tularemia. Recently, we reported an oxidant sensitive mutant of Ft LVS in putative EmrA1 (FTL_0687) secretion protein. The emrA1 mutant is highly sensitive to oxidants, attenuated for intramacrophage growth and virulence in mice. We reported that EmrA1 contributes to oxidant resistance by affecting the secretion of antioxidant enzymes SodB and KatG. This study investigated the vaccine potential of the emrA1 mutant in prevention of respiratory tularemia caused by Ft LVS and the virulent SchuS4 strain in C57BL/6 mice. We report that emrA1 mutant is safe and can be used at an intranasal (i.n.) immunization dose as high as 1x10(6) CFU without causing any adverse effects in immunized mice. The emrA1 mutant is cleared by vaccinated mice by day 14-21 post-immunization, induces minimal histopathological lesions in lungs, liver and spleen and a strong humoral immune response. The emrA1 mutant vaccinated mice are protected against 1000-10,000LD(100) doses of i.n. Ft LVS challenge. Such a high degree of protection has not been reported earlier against respiratory challenge with Ft LVS using a single immunization dose with an attenuated mutant generated on Ft LVS background. The emrA1 mutant also provides partial protection against i.n. challenge with virulent Ft SchuS4 strain in vaccinated C57BL/6 mice. Collectively, our results further support the notion that antioxidants of Ft may serve as potential targets for development of effective vaccines for prevention of tularemia.	[Suresh, Ragavan Varadharajan; Bhatty, Vivek; Banik, Sukalyani; Bakshi, Chandra Shekhar] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Ma, Zhuo; Catlett, Sally V.; Malik, Meenakshi] Albany Coll Pharm & Hlth Sci, Albany, NY 12208 USA; [Sunagar, Raju; Gosselin, Edmund J.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	New York Medical College; Albany College of Pharmacy & Health Sciences; Albany Medical College	Malik, M (corresponding author), Albany Coll Pharm & Hlth Sci, Albany, NY 12208 USA.	Meenakshi.Malik@acphs.edu; Shekhar_Bakshi@nymc.edu	Malik, Meenakshi/F-1501-2015	Malik, Meenakshi/0000-0003-0051-4485; Ma, Zhuo/0000-0002-9766-8239	National Institutes of Health [P01AI056320, R56AI101109-01, R15AI107698-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056320, R15AI107698, R56AI101109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in whole or in part, by National Institutes of Health Grants P01AI056320 (CSB, EJG), R56AI101109-01 (CSB), and R15AI107698-01 (MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson H, 2006, J MED MICROBIOL, V55, P263, DOI 10.1099/jmm.0.46313-0; ANTHONY LSD, 1987, MICROB PATHOGENESIS, V2, P3, DOI 10.1016/0882-4010(87)90110-0; Ashtekar AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050460; Bakshi CS, 2008, VACCINE, V26, P5276, DOI 10.1016/j.vaccine.2008.07.051; Bakshi CS, 2006, J BACTERIOL, V188, P6443, DOI 10.1128/JB.00266-06; Baron SD, 2007, INFECT IMMUN, V75, P2152, DOI 10.1128/IAI.01606-06; BELYI YF, 1995, APMIS, V103, P107, DOI 10.1111/j.1699-0463.1995.tb01085.x; Broussard LA, 2001, MOL DIAGN, V6, P323, DOI 10.1054/modi.2001.29155; BURKE DS, 1977, J INFECT DIS, V135, P55, DOI 10.1093/infdis/135.1.55; Chu P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004439; Conlan JW, 2007, ANN NY ACAD SCI, V1105, P325, DOI 10.1196/annals.1409.012; Conlan JW, 2010, VACCINE, V28, P1824, DOI 10.1016/j.vaccine.2009.12.001; De Pascalis Roberto, 2012, PLoS Pathog, V8, pe1002494, DOI 10.1371/journal.ppat.1002494; Dotson RJ, 2013, J BIOL CHEM, V288, P23844, DOI 10.1074/jbc.M113.490086; Edwards KM, 2001, AM J RESP CRIT CARE, V164, P2213, DOI 10.1164/ajrccm.164.12.2106093; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Eneslatt K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032367; Eyles JE, 2008, MICROB PATHOGENESIS, V44, P164, DOI 10.1016/j.micpath.2007.08.009; Forslund AL, 2006, MOL MICROBIOL, V59, P1818, DOI 10.1111/j.1365-2958.2006.05061.x; FORTIER AH, 1991, INFECT IMMUN, V59, P2922, DOI 10.1128/IAI.59.9.2922-2928.1991; Fulop M, 1996, FEMS IMMUNOL MED MIC, V13, P245, DOI 10.1111/j.1574-695X.1996.tb00245.x; Gallagher-Smith Melissa, 2004, Clin Lab Sci, V17, P35; Hornick R, 2001, NEW ENGL J MED, V345, P1637, DOI 10.1056/NEJM200111293452211; HORNICK RB, 1966, BACTERIOL REV, V30, P532, DOI 10.1128/MMBR.30.3.532-538.1966; Kernodle DS, 2010, CLIN INFECT DIS, V51, P177, DOI 10.1086/653533; Lamps LW, 2004, MODERN PATHOL, V17, P489, DOI 10.1038/modpathol.3800087; Lavine CL, 2007, EUR J IMMUNOL, V37, P3007, DOI 10.1002/eji.200737620; Li J, 2007, MICROBIOL-SGM, V153, P3141, DOI 10.1099/mic.0.2007/006460-0; Ma Z, 2014, MOL MICROBIOL, V91, P976, DOI 10.1111/mmi.12509; Mahawar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061539; Mahawar M, 2012, J BIOL CHEM, V287, P25216, DOI 10.1074/jbc.M112.367672; Melillo AA, 2010, J BIOL CHEM, V285, P27553, DOI 10.1074/jbc.M110.144394; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Pechous R, 2006, INFECT IMMUN, V74, P4452, DOI 10.1128/IAI.00666-06; Pechous RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002487; Qin AP, 2009, INFECT IMMUN, V77, P152, DOI 10.1128/IAI.01113-08; Rawool DB, 2008, J IMMUNOL, V180, P5548, DOI 10.4049/jimmunol.180.8.5548; Rockx-Brouwer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037752; Ryden P, 2013, MOL IMMUNOL, V54, P58, DOI 10.1016/j.molimm.2012.10.043; Sadagopal S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005531; Salomonsson E, 2009, INFECT IMMUN, V77, P3424, DOI 10.1128/IAI.00196-09; Sammons-Jackson WL, 2008, DNA CELL BIOL, V27, P387, DOI 10.1089/dna.2007.0687; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; Tempel R, 2006, INFECT IMMUN, V74, P5095, DOI 10.1128/IAI.00598-06; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Vogel G, 2003, SCIENCE, V302, P222, DOI 10.1126/science.302.5643.222	46	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124326	10.1371/journal.pone.0124326	http://dx.doi.org/10.1371/journal.pone.0124326			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897786	gold, Green Submitted, Green Published			2022-12-27	WOS:000353212600062
J	Bausch-Fluck, D; Hofmann, A; Bock, T; Frei, AP; Cerciello, F; Jacobs, A; Moest, H; Omasit, U; Gundry, RL; Yoon, C; Schiess, R; Schmidt, A; Mirkowska, P; Hartlova, A; Van Eyk, JE; Bourquin, JP; Aebersold, R; Boheler, KR; Zandstra, P; Wollscheid, B				Bausch-Fluck, Damaris; Hofmann, Andreas; Bock, Thomas; Frei, Andreas P.; Cerciello, Ferdinando; Jacobs, Andrea; Moest, Hansjoerg; Omasit, Ulrich; Gundry, Rebekah L.; Yoon, Charles; Schiess, Ralph; Schmidt, Alexander; Mirkowska, Paulina; Haertlova, Anetta; Van Eyk, Jennifer E.; Bourquin, Jean-Pierre; Aebersold, Ruedi; Boheler, Kenneth R.; Zandstra, Peter; Wollscheid, Bernd			A Mass Spectrometric-Derived Cell Surface Protein Atlas	PLOS ONE			English	Article							PLASMA-MEMBRANE PROTEOMICS; MONOCLONAL-ANTIBODY; ANALYSIS REVEALS; STEM-CELLS; IDENTIFICATION; DATABASE; MARKERS; DISEASE; QUANTIFICATION; PREDICTION	Cell surface proteins are major targets of biomedical research due to their utility as cellular markers and their extracellular accessibility for pharmacological intervention. However, information about the cell surface protein repertoire (the surfaceome) of individual cells is only sparsely available. Here, we applied the Cell Surface Capture (CSC) technology to 41 human and 31 mouse cell types to generate a mass-spectrometry derived Cell Surface Protein Atlas (CSPA) providing cellular surfaceome snapshots at high resolution. The CSPA is presented in form of an easy-to-navigate interactive database, a downloadable data matrix and with tools for targeted surfaceome rediscovery (http://wlab.ethz.ch/cspa). The cellular surfaceome snapshots of different cell types, including cancer cells, resulted in a combined dataset of 1492 human and 1296 mouse cell surface glycoproteins, providing experimental evidence for their cell surface expression on different cell types, including 136 G-protein coupled receptors and 75 membrane receptor tyrosine-protein kinases. Integrated analysis of the CSPA reveals that the concerted biological function of individual cell types is mainly guided by quantitative rather than qualitative surfaceome differences. The CSPA will be useful for the evaluation of drug targets, for the improved classification of cell types and for a better understanding of the surfaceome and its concerted biological functions in complex signaling microenvironments.	[Bausch-Fluck, Damaris; Hofmann, Andreas; Bock, Thomas; Frei, Andreas P.; Cerciello, Ferdinando; Jacobs, Andrea; Moest, Hansjoerg; Omasit, Ulrich; Schiess, Ralph; Schmidt, Alexander; Mirkowska, Paulina; Aebersold, Ruedi; Wollscheid, Bernd] ETH, Inst Mol Syst Biol, Zurich, Switzerland; [Cerciello, Ferdinando] Univ Zurich Hosp, Mol Oncol Lab, CH-8091 Zurich, Switzerland; [Gundry, Rebekah L.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Yoon, Charles; Zandstra, Peter] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Mirkowska, Paulina; Bourquin, Jean-Pierre] Univ Children Hosp Zurich, Oncol Res Lab, Zurich, Switzerland; [Haertlova, Anetta] Univ Def, Fac Mil Hlth Sci, Ctr Adv Studies, Hradec Kralove, Czech Republic; [Van Eyk, Jennifer E.] Johns Hopkins Univ, Sch Med, Dept Med Biol Chem & Biomed Engn, Baltimore, MD USA; [Aebersold, Ruedi] Ctr Syst Physiol & Metab Dis, Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, Zurich, Switzerland; [Boheler, Kenneth R.] Univ Hong Kong, LKS Fac Med, SCRMC, Hong Kong, Hong Kong, Peoples R China; [Boheler, Kenneth R.] Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD USA; [Wollscheid, Bernd] ETH, BMPP, Dept Hlth Sci & Technol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital; Medical College of Wisconsin; University of Toronto; University Children's Hospital Zurich; University of Defence - Czech Republic; Johns Hopkins University; University of Zurich; University of Hong Kong; Johns Hopkins University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Wollscheid, B (corresponding author), ETH, Inst Mol Syst Biol, Zurich, Switzerland.	wbernd@ethz.ch	Bourquin, Jean-Pierre/C-2802-2011; Gundry, Rebekah/K-6080-2019; Wollscheid, Bernd/E-8909-2010	Bourquin, Jean-Pierre/0000-0001-6571-6227; Wollscheid, Bernd/0000-0002-3923-1610; Cerciello, Ferdinando/0000-0001-8987-5732; Bock, Thomas Klaus Christian/0000-0002-9314-5318; Hartlova, Anetta/0000-0002-8152-4361; Gundry, Rebekah L./0000-0002-9263-833X	National Center of Competence in Research Neural Plasticity and Repair of the Swiss National Science Foundation; Center for Proteomics; InfectX; BIP project within the Swiss Initiative in Systems Biology; Ph.D. Program in Molecular Life Sciences in Zurich; Neuroscience Center Zurich Fellowship; Interdisciplinary PhD Project of SystemsX.ch; Swiss Initiative of Systems Biology; MD-PhD fellowship of the Swiss National Science Foundation; Advanced European Research Council [233226]; Swiss National Science Foundation [3100A0-107679]; National Institutes of Health (NIH) [U01CA152813]; NATIONAL CANCER INSTITUTE [U01CA152813] Funding Source: NIH RePORTER	National Center of Competence in Research Neural Plasticity and Repair of the Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); Center for Proteomics; InfectX; BIP project within the Swiss Initiative in Systems Biology; Ph.D. Program in Molecular Life Sciences in Zurich; Neuroscience Center Zurich Fellowship; Interdisciplinary PhD Project of SystemsX.ch; Swiss Initiative of Systems Biology; MD-PhD fellowship of the Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); Advanced European Research Council(European Research Council (ERC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Center of Competence in Research Neural Plasticity and Repair of the Swiss National Science Foundation, Center for Proteomics, http://www.nccr-neuro.uzh.ch (BW); InfectX and BIP project within the Swiss Initiative in Systems Biology, http://www.systemsx.ch/projects/research-technology-and-development-projects/completed-rtd-projects/infectx-2010-201 (BW); Mueller Fellowship from the Ph.D. Program in Molecular Life Sciences in Zurich (AH); Neuroscience Center Zurich Fellowship, http://www.neuroscience.ethz.ch/education/grant_applications (TB); Interdisciplinary PhD Project of SystemsX.ch, the Swiss Initiative of Systems Biology, Project 2 2009, http://www.systemsx.ch/projects/interdisciplinary-phd-projects/iphd-projects-2009/(HM); MD-PhD fellowship of the Swiss National Science Foundation, http://www.snf.ch/en/funding/careers/md-phd-programme/Pages/default.aspx (FC); Advanced European Research Council grant #233226, http://erc.europa.eu/funding-and-grants (RA); Swiss National Science Foundation (grant #3100A0-107679), http://www.snf.ch/en/funding/(RA); National Institutes of Health (NIH Grant #U01CA152813), http://grants.nih.gov/grants/oer. htm (RA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2008, PROTEOMICS, V8, P4946, DOI 10.1002/pmic.200800312; Andersson O, 2005, J PROTEOME RES, V4, P758, DOI 10.1021/pr049776f; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Autelitano F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110316; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Baselga J, 1999, SEMIN ONCOL, V26, P78; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Belov L, 2001, CANCER RES, V61, P4483; Berg JV, 2013, J EXP MED, V210, P2803, DOI 10.1084/jem.20130678; Bock T, 2011, FRONTIERS BIOSCIENCE; Bock T, 2012, J PROTEOME RES, V11, P4885, DOI 10.1021/pr300360a; Bodenmiller B, 2008, NAT BIOTECHNOL, V26, P1339, DOI 10.1038/nbt1208-1339; Boheler KR, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.05.002; Boysen G, 2012, NEOPLASIA, V14, P535, DOI 10.1596/neo.12130; CHUANG W, 1990, DEV BIOL, V137, P219, DOI 10.1016/0012-1606(90)90249-I; Clough T, 2009, J PROTEOME RES, V8, P5275, DOI 10.1021/pr900610q; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; Conn EM, 2008, J BIOL CHEM, V283, P26518, DOI 10.1074/jbc.M803337200; da Cunha JPC, 2009, P NATL ACAD SCI USA, V106, P16752, DOI 10.1073/pnas.0907939106; Deeb SJ, 2014, MOL CELL PROTEOMICS, V13, P240, DOI 10.1074/mcp.M113.033977; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Dormeyer W, 2008, J PROTEOME RES, V7, P2936, DOI 10.1021/pr800056j; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Elschenbroich S, 2010, EXPERT REV PROTEOMIC, V7, P141, DOI 10.1586/EPR.09.97; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Freitas RA, 2005, NANOMED-NANOTECHNOL, V1, P2, DOI 10.1016/j.nano.2004.11.003; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Gundry RL, 2008, PROTEOM CLIN APPL, V2, P892, DOI 10.1002/prca.200780122; Gundry RL, 2009, MOL CELL PROTEOMICS, V8, P2555, DOI 10.1074/mcp.M900195-MCP200; Hartmann J, 2012, J BIOL CHEM, V287, P31527, DOI 10.1074/jbc.M111.304238; Hofmann A, 2010, BLOOD, V116, pE26, DOI 10.1182/blood-2010-02-271270; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Ikeda Masami, 2002, In Silico Biology, V2, P19; Josic D, 2007, PROTEOMICS, V7, P3010, DOI 10.1002/pmic.200700139; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kandasamy K, 2009, NUCLEIC ACIDS RES, V37, pD773, DOI 10.1093/nar/gkn701; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kim Y, 2011, METHODS MOL BIOL, V748, P227, DOI 10.1007/978-1-61779-139-0_16; Lam H, 2008, NAT METHODS, V5, P873, DOI 10.1038/NMETH.1254; Leth-Larsen R, 2010, MOL CELL PROTEOMICS, V9, P1369, DOI 10.1074/mcp.R900006-MCP200; Lewandrowski U, 2009, BLOOD, V114, pE10, DOI 10.1182/blood-2009-02-203828; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mirkowska P, 2013, BLOOD, V121, pE149, DOI 10.1182/blood-2012-11-468702; Moest H, 2013, BBA-MOL CELL BIOL L, V1831, P1208, DOI 10.1016/j.bbalip.2013.04.001; Obermair FJ, 2010, STEM CELL RES, V5, P131, DOI 10.1016/j.scr.2010.05.001; Omasits U, 2013, BIOINFORMATICS; Peirce MJ, 2004, MOL CELL PROTEOMICS, V3, P56, DOI 10.1074/mcp.M300064-MCP200; Picotti P, 2010, NAT METHODS, V7, P43, DOI [10.1038/NMETH.1408, 10.1038/nmeth.1408]; Prior MJ, 2011, J PROTEOME RES, V10, P4970, DOI 10.1021/pr200446r; Roesli C, 2006, NAT PROTOC, V1, P192, DOI 10.1038/nprot.2006.29; Rugg-Gunn PJ, 2012, DEV CELL, V22, P887, DOI 10.1016/j.devcel.2012.01.005; Savas JN, 2011, TRENDS BIOCH SCI; Schmidt A, 2008, MOL CELL PROTEOMICS, V7, P2138, DOI 10.1074/mcp.M700498-MCP200; SCHWAB U, 1982, NATURE, V299, P65, DOI 10.1038/299065a0; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwartz SM, 1999, CIRC RES, V84, P1234, DOI 10.1161/01.RES.84.10.1234; Scott SD, 1998, CANCER PRACT, V6, P195, DOI 10.1046/j.1523-5394.1998.006003195.x; Siuti N, 2007, NAT METHODS, V4, P817, DOI 10.1038/NMETH1097; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Stahl-Zeng J, 2007, MOL CELL PROTEOMICS, V6, P1809, DOI 10.1074/mcp.M700132-MCP200; Sun Y, 2012, ANAL BIOCHEM, V424, P45, DOI 10.1016/j.ab.2012.01.034; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Ziegler A, 2011, LUNG CANC IN PRESS; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012; Zola H, 2006, MOL MED, V12, P312, DOI 10.2119/2006-00081.Zola	70	200	202	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0121314	10.1371/journal.pone.0121314	http://dx.doi.org/10.1371/journal.pone.0121314			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894527	Green Published, gold, Green Accepted			2022-12-27	WOS:000353211700009
J	Hattenrath-Lehmann, TK; Marcoval, MA; Mittlesdorf, H; Goleski, JA; Wang, ZH; Haynes, B; Morton, SL; Gobler, CJ				Hattenrath-Lehmann, Theresa K.; Marcoval, Maria A.; Mittlesdorf, Heidi; Goleski, Jennifer A.; Wang, Zhihong; Haynes, Bennie; Morton, Steve L.; Gobler, Christopher J.			Nitrogenous Nutrients Promote the Growth and Toxicity of Dinophysis acuminata during Estuarine Bloom Events	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; PROROCENTRUM-LIMA DINOPHYCEAE; DIARRHETIC SHELLFISH TOXINS; OKADAIC ACID; LONG-ISLAND; NEW-YORK; AUREOCOCCUS-ANOPHAGEFFERENS; COCHLODINIUM-POLYKRIKOIDES; PHYTOPLANKTON COMMUNITIES; ALEXANDRIUM-CATENELLA	Diarrhetic Shellfish Poisoning (DSP) is a globally significant human health syndrome most commonly caused by dinoflagellates within the genus Dinophysis. While blooms of harmful algae have frequently been linked to excessive nutrient loading, Dinophysis is a mixotrophic alga whose growth is typically associated with prey availability. Consequently, field studies of Dinophysis and nutrients have been rare. Here, the temporal dynamics of Dinophysis acuminata blooms, DSP toxins, and nutrients (nitrate, ammonium, phosphate, silicate, organic compounds) were examined over four years within two New York estuaries (Meeting-house Creek and Northport Bay). Further, changes in the abundance and toxicity of D. acuminata were assessed during a series of nutrient amendment experiments performed over a three year period. During the study, Dinophysis acuminata blooms exceeding one million cells L-1 were observed in both estuaries. Highly significant (p<0.001) forward step-wise multivariate regression models of ecosystem observations demonstrated that D. acuminata abundances were positively dependent on multiple environmental parameters including ammonium (p = 0.007) while cellular toxin content was positively dependent on ammonium (p = 0.002) but negatively dependent on nitrate (p<0.001). Nitrogen- (N) and phosphorus- (P) containing inorganic and organic nutrients significantly enhanced D. acuminata densities in nearly all (13 of 14) experiments performed. Ammonium significantly increased cell densities in 10 of 11 experiments, while glutamine significantly enhanced cellular DSP content in 4 of 5 experiments examining this compound. Nutrients may have directly or indirectly enhanced D. acuminata abundances as densities of this mixotroph during experiments were significantly correlated with multiple members of the planktonic community (phytoflagellates and Mesodinium). Collectively, this study demonstrates that nutrient loading and more specifically N-loading promotes the growth and toxicity of D. acuminata populations in coastal zones.	[Hattenrath-Lehmann, Theresa K.; Marcoval, Maria A.; Mittlesdorf, Heidi; Goleski, Jennifer A.; Gobler, Christopher J.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Southampton, NY 11794 USA; [Wang, Zhihong; Haynes, Bennie; Morton, Steve L.] NOAA, Natl Ocean Serv, Marine Biotoxins Program, Charleston, SC USA; [Marcoval, Maria A.] Univ Nacl Mar del Plata, Estac Costera JJ Nagera, Dept Ciencias Marinas FCEyN, Mar Del Plata, Buenos Aires, Argentina; [Marcoval, Maria A.] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National University of Mar del Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Gobler, CJ (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Southampton, NY 11794 USA.	christopher.gobler@stonybrook.edu			New York State Department of Environmental Conservation, New York Sea Grant [R/CMB-38-NYCT]; NOAA's Monitoring and Event Response to Harmful Algal Blooms (MERHAB) program [NA11NOS4780027]	New York State Department of Environmental Conservation, New York Sea Grant; NOAA's Monitoring and Event Response to Harmful Algal Blooms (MERHAB) program	The authors gratefully acknowledge support from the New York State Department of Environmental Conservation, New York Sea Grant (R/CMB-38-NYCT) and NOAA's Monitoring and Event Response to Harmful Algal Blooms (MERHAB) program (NA11NOS4780027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Anderson DM, 2012, ANNU REV MAR SCI, V4, P143, DOI 10.1146/annurev-marine-120308-081121; Anderson DM, 2008, HARMFUL ALGAE, V8, P39, DOI 10.1016/j.hal.2008.08.017; BOYNTON WR, 1985, MAR ECOL PROG SER, V23, P45, DOI 10.3354/meps023045; BOYNTON WR, 1995, ESTUARIES, V18, P285, DOI 10.2307/1352640; BRZEZINSKI MA, 1985, J PHYCOL, V21, P347; Burgess V, 2001, ENVIRON INT, V27, P275, DOI 10.1016/S0160-4120(01)00058-7; Burkholder JM, 2008, HARMFUL ALGAE, V8, P77, DOI 10.1016/j.hal.2008.08.010; Campbell L, 2010, J PHYCOL, V46, P66, DOI 10.1111/j.1529-8817.2009.00791.x; Collos Y, 2007, HARMFUL ALGAE, V6, P781, DOI 10.1016/j.hal.2007.04.003; Davidson K, 2012, ESTUAR COAST SHELF S, V115, P399, DOI 10.1016/j.ecss.2012.09.019; Deeds JR, 2010, TOXICON, V55, P1138, DOI 10.1016/j.toxicon.2010.01.003; DELMAS D, 1992, MAR ECOL PROG SER, V89, P53, DOI 10.3354/meps089053; DICKEY RW, 1992, TOXICON, V30, P355, DOI 10.1016/0041-0101(92)90877-8; DORTCH Q, 1990, MAR ECOL PROG SER, V61, P183, DOI 10.3354/meps061183; Dyhrman ST, 2003, LIMNOL OCEANOGR, V48, P647, DOI 10.4319/lo.2003.48.2.0647; Freudenthal A, 1988, J SHELLFISH RES, V7, P157; Fux E, 2011, TOXICON, V57, P275, DOI 10.1016/j.toxicon.2010.12.002; Gayoso AM, 2002, J SHELLFISH RES, V21, P461; Gerssen A, 2009, J CHROMATOGR A, V1216, P1421, DOI 10.1016/j.chroma.2008.12.099; GIACOBBE MG, 1995, AQUAT MICROB ECOL, V9, P63, DOI 10.3354/ame009063; Glibert PM, 2006, ECOL STU AN, V189, P163, DOI 10.1007/978-3-540-32210-8_13; Glibert Patricia M., 2005, Oceanography, V18, P136; Glibert PM, 2006, BIOGEOCHEMISTRY, V77, P441, DOI 10.1007/s10533-005-3070-5; Gobler CJ, 2012, HARMFUL ALGAE, V17, P64, DOI 10.1016/j.hal.2012.03.001; Gobler CJ, 2006, ESTUAR COAST SHELF S, V68, P127, DOI 10.1016/j.ecss.2006.02.001; Gobler CJ, 2004, HARMFUL ALGAE, V3, P471, DOI 10.1016/j.hal.2004.06.013; Gobler CJ, 2003, LIMNOL OCEANOGR, V48, P2314, DOI 10.4319/lo.2003.48.6.2314; Gobler CJ, 2001, MAR ECOL PROG SER, V217, P299, DOI 10.3354/meps217299; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Hansen PJ, 2013, HARMFUL ALGAE, V28, P126, DOI 10.1016/j.hal.2013.06.004; Hattenrath TK, 2010, HARMFUL ALGAE, V9, P402, DOI 10.1016/j.hal.2010.02.003; Hattenrath-Lehmann TK, 2013, HARMFUL ALGAE, V26, P33, DOI 10.1016/j.hal.2013.03.005; Heisler J, 2008, HARMFUL ALGAE, V8, P3, DOI 10.1016/j.hal.2008.08.006; Horner RA, 1997, LIMNOL OCEANOGR, V42, P1076, DOI 10.4319/lo.1997.42.5_part_2.1076; Jeong HJ, 2005, AQUAT MICROB ECOL, V40, P133, DOI 10.3354/ame040133; Jin D, 2008, HARMFUL ALGAE, V7, P772, DOI 10.1016/j.hal.2008.03.002; Jin D, 2008, OCEAN COAST MANAGE, V51, P420, DOI 10.1016/j.ocecoaman.2008.01.004; Johansson N, 1996, 7 INT C TOX PHYT; JONES MN, 1984, WATER RES, V18, P643, DOI 10.1016/0043-1354(84)90215-X; Kalaitzis JA, 2010, TOXICON, V56, P244, DOI 10.1016/j.toxicon.2009.09.001; Koch F, 2014, HARMFUL ALGAE, V33, P41, DOI 10.1016/j.hal.2014.01.003; Koch F, 2013, LIMNOL OCEANOGR, V58, P1761, DOI 10.4319/lo.2013.58.5.1761; Koch F, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00363; Koukaras K, 2004, J PLANKTON RES, V26, P445, DOI 10.1093/plankt/fbh042; Lee JS, 1989, J APPL PHYCOL, V1, P147, DOI 10.1007/BF00003877; Maranda L, 2007, HARMFUL ALGAE, V6, P632, DOI 10.1016/j.hal.2006.12.006; Mulholland MR, 2002, LIMNOL OCEANOGR, V47, P1094, DOI 10.4319/lo.2002.47.4.1094; Nagai S, 2011, J PHYCOL, V47, P1326, DOI 10.1111/j.1529-8817.2011.01076.x; Nielsen LT, 2013, HARMFUL ALGAE, V23, P34, DOI 10.1016/j.hal.2012.12.004; Nielsen LT, 2012, MAR ECOL PROG SER, V471, P37, DOI 10.3354/meps10027; Park MG, 2006, AQUAT MICROB ECOL, V45, P101, DOI 10.3354/ame045101; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Quilliam MA, 1991, P 2 CAN WORKSH HARMF; RAO DVS, 1993, MAR ECOL PROG SER, V97, P117; Reguera B, 2014, MAR DRUGS, V12, P394, DOI 10.3390/md12010394; Reguera B, 2012, HARMFUL ALGAE, V14, P87, DOI 10.1016/j.hal.2011.10.016; Seeyave S, 2009, MAR ECOL PROG SER, V379, P91, DOI 10.3354/meps07898; Sjoqvist CO, 2011, J EUKARYOT MICROBIOL, V58, P365, DOI 10.1111/j.1550-7408.2011.00559.x; SMAYDA TJ, 1990, TOXIC MARINE PHYTOPLANKTON, P29; Smith JL, 2012, HARMFUL ALGAE, V19, P125, DOI 10.1016/j.hal.2012.06.008; Souto ML, 2001, TOXICON, V39, P659, DOI 10.1016/S0041-0101(00)00190-2; STEENHUIS TS, 1985, J HYDROL, V79, P145, DOI 10.1016/0022-1694(85)90190-8; Stoecker D, 2006, ECOL STU AN, V189, P177, DOI 10.1007/978-3-540-32210-8_14; Suzuki T, 2003, J CHROMATOGR A, V992, P141, DOI 10.1016/S0021-9673(03)00324-8; Suzuki T, 2011, ANAL SCI, V27, P571, DOI 10.2116/analsci.27.571; Swanson KM, 2010, HARMFUL ALGAE, V9, P190, DOI 10.1016/j.hal.2009.10.001; Tang YZ, 2010, P NATL ACAD SCI USA, V107, P20756, DOI 10.1073/pnas.1009566107; Tango P., 2004, HARMFUL ALGAE 2002, P358; Todd ECD, 1997, REV SCI TECH OIE, V16, P661, DOI 10.20506/rst.16.2.1058; Tong MM, 2011, HARMFUL ALGAE, V10, P254, DOI 10.1016/j.hal.2010.10.005; Townsend DW, 2005, DEEP-SEA RES PT II, V52, P2593, DOI 10.1016/j.dsr2.2005.06.027; Trainer VL, 2013, MAR DRUGS, V11, P1815, DOI 10.3390/md11061815; VALDERRAMA JC, 1981, MAR CHEM, V10, P109, DOI 10.1016/0304-4203(81)90027-X; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Vanucci S, 2010, HARMFUL ALGAE, V9, P590, DOI 10.1016/j.hal.2010.04.009; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Xu J, 2012, HARMFUL ALGAE, V16, P89, DOI 10.1016/j.hal.2012.02.006; Young C, 2013, HYDROGEOL J, V21, P1773, DOI 10.1007/s10040-013-1038-4	79	35	36	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124148	10.1371/journal.pone.0124148	http://dx.doi.org/10.1371/journal.pone.0124148			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894567	gold, Green Published, Green Submitted			2022-12-27	WOS:000353211700076
J	Lindfield, R; Knight, A; Bwonya, D				Lindfield, Robert; Knight, Abigail; Bwonya, Daniel			An Approach to Assessing Patient Safety in Hospitals in Low-Income Countries	PLOS ONE			English	Article								Objective The aim of the study was to assess non-technical aspects of patient safety practices using non-participant observation in different clinical areas. Design Qualitative study using non-participant observation and thematic analysis. Setting Two eye care units in Uganda. Participants Staff members in each hospital. Main outcome measures A set of observations of patient safety practices by staff members in clinical areas that were then coded using thematic analysis. Results Twenty codes were developed that explained patient safety practices in the hospitals based on the observations. These were grouped into four themes: the team, the environment, patient- centred care and the process. The complexity of patient safety in each hospital was described using narrative reports to support the thematic analysis. Overall both hospitals demonstrated good patient safety practices however areas for improvement were staff-patient communication, the presence and use of protocols and a focus on consistent practice. Conclusions This is the first holistic assessment of patient safety practices in a low-income setting. The methods allowed the complexity of patient safety to be understood and explained with areas of concern highlighted. The next step will be to develop a useful and easy to use tool to measure patient safety practices in low-income settings.	[Lindfield, Robert; Knight, Abigail] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Bwonya, Daniel] Ruharo Mission Hosp, Dept Ophthalmol, Mbarara, Uganda	University of London; London School of Hygiene & Tropical Medicine	Lindfield, R (corresponding author), London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England.	robert.lindfield@lshtm.ac.uk			Sightsavers an international eye charity	Sightsavers an international eye charity	This study was funded by Sightsavers an international eye charity (www.sightsavers.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, SUMM EV PAT SAF IMPL; Battles JB, 2003, QUAL SAF HEALTH CARE, V12, pII2, DOI 10.1136/qhc.12.suppl_2.ii2; Boyatzis R. E., 1998, TRANSFORMING QUALITA, DOI 10.1191/1478088706qp063oa; Carpenter KB, 2010, QUAL SAF HEALTH CARE, V19, P48, DOI 10.1136/qshc.2008.031088; Dixon-Woods M, 2010, CURR OPIN CRIT CARE, V16, P639, DOI 10.1097/MCC.0b013e32833ef5ef; Engel L, 2013, J PALLIAT MED, V16, P295, DOI 10.1089/jpm.2012.0419; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Jaycock P, 2009, EYE, V23, P38, DOI 10.1038/sj.eye.6703015; Lindfield R, 2012, INDIAN J OPHTHALMOL, V60, P464, DOI 10.4103/0301-4738.100552; Liu C, 2006, EYE, V20, P273, DOI 10.1038/sj.eye.6701990; Ministry of Health, 2011, NAT QUAL IMPR FRAM S; Murray CJL, 2001, MEASURING OVERALL HL; Sethi AK, 2012, INFECT CONT HOSP EP, V33, P917, DOI 10.1086/667389; Vincent C, 1998, BRIT MED J, V316, P1154, DOI 10.1136/bmj.316.7138.1154; Vincent C, 2004, ANN SURG, V239, P475, DOI 10.1097/01.sla.0000118753.22830.41; Wegner W, 2012, REV LAT-AM ENFERM, V20, P427, DOI 10.1590/S0104-11692012000300002	16	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0121628	10.1371/journal.pone.0121628	http://dx.doi.org/10.1371/journal.pone.0121628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894554	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000353211700010
J	Zhang, SD; Ling, LZ; Zhang, QF; Xu, JD; Cheng, L				Zhang, Shu-Dong; Ling, Li-Zhen; Zhang, Quan-Fang; Xu, Jian-Di; Cheng, Le			Evolutionary Comparison of Two Combinatorial Regulators of SBP-Box Genes, MiR156 and MiR529, in Plants	PLOS ONE			English	Article							NUCLEOTIDE POLYMORPHISM; MOLECULAR EVOLUTION; GENOME DUPLICATION; SMALL RNAS; MICRORNAS; ARABIDOPSIS; FASTER; DROSHA; RATES	A complete picture of the evolution of miRNA combinatorial regulation requires the synthesis of information on all miRNAs and their targets. MiR156 and miR529 are two combinatorial regulators of squamosa promoter binding protein-like (SBP-box) genes. Previous studies have clarified the evolutionary dynamics of their targets; however, there have been no reports on the evolutionary patterns of two miRNA regulators themselves to date. In this study, we investigated the evolutionary differences between these two miRNA families in extant land plants. Our work found that miR529 precursor, especially of its mature miRNA sequence, has a higher evolutionary rate. Such accelerating evolution of miR529 has significantly effects on its structural stability, and sequence conservation against existence of itself. By contrast, miR156 evolves more rapidly in loop region of the stable secondary structure, which may contribute to its functional diversity. Moreover, miR156 and miR529 genes have distinct rates of loss after identical duplication events. MiR529 genes have a higher average loss rate and asymmetric loss rate in duplicated gene pairs, indicating preferred miR529 gene losses become another predominant mode of inactivation, that are implicated in the contraction of this family. On the contrary, duplicated miR156 genes have a low loss rate, and could serve as another new source for functional diversity. Taken together, these results provide better insight into understanding the evolutionary divergence of miR156 and miR529 family in miRNA combinational regulation network.	[Zhang, Shu-Dong] Germplasm Bank Wild Species, Kunming 650201, Peoples R China; [Ling, Li-Zhen; Cheng, Le] BGI Shenzhen, BGI Yunnan, Kunming 650106, Peoples R China; [Zhang, Quan-Fang] Shandong Acad Agr Sci, Biotech Res Ctr, Jinan 250100, Peoples R China; [Xu, Jian-Di] Shandong Acad Agr Sci, Shandong Rice Res Inst, Jinan 250100, Peoples R China	Beijing Genomics Institute (BGI); Shandong Academy of Agricultural Sciences; Shandong Academy of Agricultural Sciences	Ling, LZ (corresponding author), BGI Shenzhen, BGI Yunnan, Kunming 650106, Peoples R China.	linglizhen@genomics.cn; chengle@genomics.cn			National Natural Science Foundation of China [31200172]; Promotive Research Fund for Excellent Young and Middle-Aged Scientists of Shandong Province [BS2013SW003]; Special Fund for BGI-Yunnan's High Throughput Sequencing Platform (P. R. China, Yunnan Provincial Science and Technology Department) [2013 DA008]; Research of High Throughput Sequencing Technology in the Application of Prevention and Control of the Mediterranean Anemia High-Risk Groups (P.R. China, Yunnan Province) [2014FC003]; Cultivation of Backup Young and Middle-Aged Academic Technology Leaders in Yunnan Province (P.R. China, Yunnan Province) [2014HB053]; Application of Genomics Technology in Notoginseng Breeding (P.R. China, Yunnan Province) [2014BC005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Promotive Research Fund for Excellent Young and Middle-Aged Scientists of Shandong Province; Special Fund for BGI-Yunnan's High Throughput Sequencing Platform (P. R. China, Yunnan Provincial Science and Technology Department); Research of High Throughput Sequencing Technology in the Application of Prevention and Control of the Mediterranean Anemia High-Risk Groups (P.R. China, Yunnan Province); Cultivation of Backup Young and Middle-Aged Academic Technology Leaders in Yunnan Province (P.R. China, Yunnan Province); Application of Genomics Technology in Notoginseng Breeding (P.R. China, Yunnan Province)	This work was supported by the National Natural Science Foundation of China (grant no. 31200172), Promotive Research Fund for Excellent Young and Middle-Aged Scientists of Shandong Province (BS2013SW003), Special Fund for BGI-Yunnan's High Throughput Sequencing Platform (P. R. China, Yunnan Provincial Science and Technology Department, 2013 DA008), The Research of High Throughput Sequencing Technology in the Application of Prevention and Control of the Mediterranean Anemia High-Risk Groups (P.R. China, Yunnan Province, 2014FC003), The Cultivation of Backup Young and Middle-Aged Academic Technology Leaders in Yunnan Province (P.R. China, Yunnan Province, 2014HB053), and The Application of Genomics Technology in Notoginseng Breeding (P.R. China, Yunnan Province, 2014BC005). BGI provided support in the form of salaries for authors L-ZL and LC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Barakat A, 2007, PLANT J, V51, P991, DOI 10.1111/j.1365-313X.2007.03197.x; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Byrne KP, 2007, GENETICS, V175, P1341, DOI 10.1534/genetics.106.066951; Cai B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-79; Chuck G, 2010, DEVELOPMENT, V137, P1243, DOI 10.1242/dev.048348; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Guo XJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-97; Jeong DH, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r145; Jeong DH, 2011, PLANT CELL, V23, P4185, DOI 10.1105/tpc.111.089045; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Ling LZ, 2012, GENETICA, V140, P317, DOI 10.1007/s10709-012-9684-3; Liu G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003592; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Managadze D, 2011, GENOME BIOL EVOL, V3, P1390, DOI 10.1093/gbe/evr116; Mohammed J, 2013, RNA, V19, P1295, DOI 10.1261/rna.039248.113; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Preston JC, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00080; Shen Y, 2011, P NATL ACAD SCI USA, V108, P15942, DOI 10.1073/pnas.1110098108; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Wang CM, 2013, INT J BIOL SCI, V9, P578, DOI 10.7150/ijbs.6357; Wang S, 2007, FEBS LETT, V581, P4789, DOI 10.1016/j.febslet.2007.09.002; Wang XY, 2005, NEW PHYTOL, V165, P937, DOI 10.1111/j.1469-8137.2004.01293.x; Yampolsky LY, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-2; Yang J, 2005, MOL BIOL EVOL, V22, P2113, DOI 10.1093/molbev/msi206; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang XX, 2010, NUCLEIC ACIDS RES, V38, P7689, DOI 10.1093/nar/gkq645; Zheng Y, 2012, NUCLEIC ACIDS RES, V40, DOI [10.1155/2012/360358, 10.1093/nar/gkr1092]; Zhu Y, 2012, BMC GENOMICS, V13	39	21	21	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124621	10.1371/journal.pone.0124621	http://dx.doi.org/10.1371/journal.pone.0124621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909360	Green Submitted, Green Published, gold			2022-12-27	WOS:000353376800093
J	Donnelier, J; Braun, ST; Dolzhanskaya, N; Ahrendt, E; Braun, AP; Velinov, M; Braun, JEA				Donnelier, Julien; Braun, Samuel T.; Dolzhanskaya, Natalia; Ahrendt, Eva; Braun, Andrew P.; Velinov, Milen; Braun, Janice E. A.			Increased Expression of the Large Conductance, Calcium-Activated K+ (BK) Channel in Adult-Onset Neuronal Ceroid Lipofuscinosis	PLoS One			English	Article							CYSTEINE-STRING-PROTEIN; CSP-ALPHA; AUTOSOMAL-DOMINANT; MODULATION; EXOCYTOSIS; NEURODEGENERATION; PHOSPHORYLATION; DEGENERATION; AGGREGATION; DROSOPHILA	Cysteine string protein (CSP alpha) is a presynaptic J protein co-chaperone that opposes neurodegeneration. Mutations in CSP alpha (i.e., Leu115 to Arg substitution or deletion (Delta) of Leu116) cause adult neuronal ceroid lipofuscinosis (ANCL), a dominantly inherited neurodegenerative disease. We have previously demonstrated that CSP alpha limits the expression of large conductance, calcium-activated K+ (BK) channels in neurons, which may impact synaptic excitability and neurotransmission. Here we show by western blot analysis that expression of the pore-forming BK alpha subunit is elevated similar to 2.5 fold in the post-mortem cortex of a 36-year-old patient with the Leu116. CSP alpha mutation. Moreover, we find that the increase in BK alpha subunit level is selective for ANCL and not a general feature of neurodegenerative conditions. While reduced levels of CSP alpha are found in some postmortem cortex specimens from Alzheimer's disease patients, we find no concomitant increase in BK alpha subunit expression in Alzheimer's specimens. Both CSP alpha monomer and oligomer expression are reduced in synaptosomes prepared from ANCL cortex compared with control. In a cultured neuronal cell model, CSP alpha oligomers are short lived. The results of this study indicate that the Leu116 Delta mutation leads to elevated BK alpha subunit levels in human cortex and extend our initial work in rodent models demonstrating the modulation of BK alpha subunit levels by the same CSP alpha mutation. While the precise sequence of pathogenic events still remains to be elucidated, our findings suggest that dysregulation of BK channels may contribute to neurodegeneration in ANCL.	[Donnelier, Julien; Braun, Samuel T.; Ahrendt, Eva; Braun, Janice E. A.] Univ Calgary, Dept Biochem & Mol Biol, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada; [Dolzhanskaya, Natalia; Braun, Andrew P.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Velinov, Milen] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Velinov, Milen] New York State Inst Basic Res Dev Disabil, Staten Isl, NY 10314 USA	University of Calgary; University of Calgary; Yeshiva University; Albert Einstein College of Medicine; Institute for Basic Research in Developmental Disabilities	Braun, JEA (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada.	braunj@ucalgary.ca			New York State Office of People with Developmental Disabilities (OPWDD); NSERC; APRI/ASANT	New York State Office of People with Developmental Disabilities (OPWDD); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); APRI/ASANT	The authors have received funding from the New York State Office of People with Developmental Disabilities (OPWDD), as well as NSERC and APRI/ASANT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrendt E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086586; Benitez BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026741; Boal F, 2011, FASEB J, V25, P132, DOI 10.1096/fj.09-152033; BRAUN JEA, 1995, NEUROPHARMACOLOGY, V34, P1361, DOI 10.1016/0028-3908(95)00114-L; Braun JEA, 1996, J BIOL CHEM, V271, P25989, DOI 10.1074/jbc.271.42.25989; Chamberlain LH, 1998, MOL BIOL CELL, V9, P2259, DOI 10.1091/mbc.9.8.2259; Chamberlain LH, 1997, BIOCHEM J, V322, P853, DOI 10.1042/bj3220853; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Donnelier J, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00116; Evans GJO, 2002, BIOCHEM J, V364, P343, DOI 10.1042/BJ20020123; Evans GJO, 2001, J BIOL CHEM, V276, P47877, DOI 10.1074/jbc.M108186200; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Garcia-Junco-Clemente P, 2010, J NEUROSCI, V30, P7377, DOI 10.1523/JNEUROSCI.0924-10.2010; Greaves J, 2012, J BIOL CHEM, V287, P37330, DOI 10.1074/jbc.M112.389098; GUNDERSEN CB, 1994, J BIOL CHEM, V269, P19197; Kakkar V, 2012, CURR TOP MED CHEM, V12, P2479; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kashyap SS, 2014, HUM MOL GENET, V23, P5916, DOI 10.1093/hmg/ddu316; Koutras C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00191; Kyle BD, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00316; Kyle BD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02447; Leveque C, 1998, J BIOL CHEM, V273, P13488, DOI 10.1074/jbc.273.22.13488; Rozas JL, 2012, NEURON, V74, P151, DOI 10.1016/j.neuron.2012.02.019; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; Miller LC, 2003, J CELL SCI, V116, P2967, DOI 10.1242/jcs.00595; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; Nie ZP, 1999, J NEUROSCI, V19, P10270; Noskova L, 2011, AM J HUM GENET, V89, P241, DOI 10.1016/j.ajhg.2011.07.003; Sakisaka T, 2002, EMBO J, V21, P6125, DOI 10.1093/emboj/cdf603; Sharma M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004028; Sharma M, 2012, EMBO J, V31, P829, DOI 10.1038/emboj.2011.467; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Sims KB, 2011, NEW ENGL J MED, V364, P1062, DOI 10.1056/NEJMcpc1013927; Stahl B, 1999, EUR J CELL BIOL, V78, P375, DOI 10.1016/S0171-9335(99)80079-X; Swayne LA, 2005, MOL CELL NEUROSCI, V30, P339, DOI 10.1016/j.mcn.2005.07.016; Swayne LA, 2003, BIOCHEM BIOPH RES CO, V300, P921, DOI 10.1016/S0006-291X(02)02964-9; Velinov M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029729; Xu FL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011045; Zhang YQ, 2014, BBA-MOL BASIS DIS, V1842, P2136, DOI 10.1016/j.bbadis.2014.07.009; Zhang YQ, 2012, NEURON, V74, P136, DOI 10.1016/j.neuron.2012.01.029; Zhao X, 2008, CELL MOL LIFE SCI, V65, P2385, DOI 10.1007/s00018-008-8089-z; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	42	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125205	10.1371/journal.pone.0125205	http://dx.doi.org/10.1371/journal.pone.0125205			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905915	Green Submitted, Green Published, gold			2022-12-27	WOS:000353332000107
J	Sadi, G; Baloglu, MC; Pektas, MB				Sadi, Gokhan; Baloglu, Mehmet Cengiz; Pektas, Mehmet Bilgehan			Differential Gene Expression in Liver Tissues of Streptozotocin-Induced Diabetic Rats in Response to Resveratrol Treatment	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; OXIDATIVE STRESS; KIDNEY; ANTIOXIDANT; ACID; SUPPLEMENTATION	This study was conducted to elucidate the genome-wide gene expression profile in streptozotocin induced diabetic rat liver tissues in response to resveratrol treatment and to establish differentially expressed transcription regulation networks with microarray technology. In addition to measure the expression levels of several antioxidant and detoxification genes, real-time quantitative polymerase chain reaction (qRT-PCR) was also used to verify the microarray results. Moreover, gene and protein expressions as well as enzymatic activities of main antioxidant enzymes; superoxide dismutase (SOD-1 and SOD-2) and glutathione Stransferase (GST-Mu) were analyzed. Diabetes altered 273 genes significantly and 90 of which were categorized functionally which suggested that genes in cellular catalytic activities, oxidation-reduction reactions, co-enzyme binding and terpenoid biosynthesis were dominated by up-regulated expression in diabetes. Whereas; genes responsible from cellular carbohydrate metabolism, regulation of transcription, cell signal transduction, calcium independent cell-to-cell adhesion and lipid catabolism were down-regulated. Resveratrol increased the expression of 186 and decreased the expression of 494 genes in control groups. While cellular and extracellular components, positive regulation of biological processes, biological response to stress and biotic stimulants, and immune response genes were up-regulated, genes responsible from proteins present in nucleus and nucleolus were mainly down-regulated. The enzyme assays showed a significant decrease in diabetic SOD-1 and GST-Mu activities. The qRT-PCR and Western-blot results demonstrated that decrease in activity is regulated at gene expression level as both mRNA and protein expressions were also suppressed. Resveratrol treatment normalized the GST activities towards the control values reflecting a post-translational effect. As a conclusion, global gene expression in the liver tissues is affected by streptozotocin induced diabetes in several specific pathways. The present data suggest the presence of several processes which contribute and possibly interact to impair liver functions in type 1 diabetes, several of which are potentially amenable to therapeutic interventions with resveratrol.	[Sadi, Gokhan] Karamanoglu Mehmetbey Univ, Kamil Ozdag Sci Fac, Dept Biol, Karaman, Turkey; [Baloglu, Mehmet Cengiz] Kastamonu Univ, Fac Engn, Dept Genet & Bioengn, Kastamonu, Turkey; [Pektas, Mehmet Bilgehan] Afyon Kocatepe Univ, Fac Med, Dept Med Pharm, Afyon, Turkey	Karamanoglu Mehmetbey University; Kastamonu University; Afyon Kocatepe University	Sadi, G (corresponding author), Karamanoglu Mehmetbey Univ, Kamil Ozdag Sci Fac, Dept Biol, Karaman, Turkey.	sadi@kmu.edu.tr	Sadi, Gökhan/AAK-5468-2021; PEKTAŞ, MEHMET BİLGEHAN/L-9912-2014; PEKTAŞ, MEHMET BİLGEHAN/V-7886-2017; Baloglu, Mehmet Cengiz/P-7411-2016; Baloglu, Mehmet Cengiz/P-2803-2019	PEKTAŞ, MEHMET BİLGEHAN/0000-0001-9790-8397; Baloglu, Mehmet Cengiz/0000-0003-2976-7224; Baloglu, Mehmet Cengiz/0000-0003-2976-7224; Sadi, Gokhan/0000-0002-6422-1203	Scientific and Technological Research Council of Turkey [112T159]	Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	Funding was provided by Scientific and Technological Research Council of Turkey (TUBITAK-http://www.tubitak.gov.tr/en) with grant number of 112T159. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de la Lastral CA, 2007, BIOCHEM SOC T, V35, P1156, DOI 10.1042/BST0351156; Arinc E, 2007, FOOD CHEM TOXICOL, V45, P107, DOI 10.1016/j.fct.2006.07.026; Baur JA, 2010, MECH AGEING DEV, V131, P261, DOI 10.1016/j.mad.2010.02.007; Brasnyo P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316; Bree AJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE194, DOI 10.1152/ajpendo.91041.2008; Chin YT, 2014, ONCOTARGET, V5, P12891, DOI 10.18632/oncotarget.2632; Dominguez B, 2013, INT IMMUNOPHARMACOL, V15, P588, DOI 10.1016/j.intimp.2013.01.024; Ghanim H, 2010, J CLIN ENDOCR METAB, V95, pE1, DOI 10.1210/jc.2010-0482; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Harati K, 2015, ANTICANCER RES, V35, P767; Jones SB, 2005, CANCER EPIDEM BIOMAR, V14, P596, DOI 10.1158/1055-9965.EPI-04-0398; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Konings E, 2014, INT J OBESITY, V38, P470, DOI 10.1038/ijo.2013.155; Kume E, 2005, EXP TOXICOL PATHOL, V56, P235, DOI 10.1016/j.etp.2004.09.002; Leon-Galicia I, 2013, EUR J CANCER PREV, V22, P11, DOI 10.1097/CEJ.0b013e328353edcb; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Marques FZ, 2009, INT J BIOCHEM CELL B, V41, P2125, DOI 10.1016/j.biocel.2009.06.003; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Palsamy P, 2011, BBA-MOL BASIS DIS, V1812, P719, DOI 10.1016/j.bbadis.2011.03.008; Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498; Raza H, 2011, FEBS J, V278, P4243, DOI 10.1111/j.1742-4658.2011.08358.x; Sadi G, 2008, MOL CELL BIOCHEM, V309, P109, DOI 10.1007/s11010-007-9648-6; Sadi G, 2013, TURK J BIOCHEM, V38, P92, DOI 10.5505/tjb.2013.96720; Sadi G, 2012, DIABETES-METAB RES, V28, P228, DOI 10.1002/dmrr.1302; Schmatz R, 2012, BIOCHIMIE, V94, P374, DOI 10.1016/j.biochi.2011.08.005; Seven A, 2004, YONSEI MED J, V45, P703, DOI 10.3349/ymj.2004.45.4.703; Signorelli P, 2005, J NUTR BIOCHEM, V16, P449, DOI 10.1016/j.jnutbio.2005.01.017; Szkudelska K, 2010, EUR J PHARMACOL, V635, P1, DOI 10.1016/j.ejphar.2010.02.054; Szkudelski T, 2011, ANN NY ACAD SCI, V1215, P34, DOI 10.1111/j.1749-6632.2010.05844.x; Thirunavukkarasu M, 2007, FREE RADICAL BIO MED, V43, P720, DOI 10.1016/j.freeradbiomed.2007.05.004; Towbin H, 1992, Biotechnology, V24, P145; van Lunteren E, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-5; van Lunteren E, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-43; Venturini CD, 2010, OXID MED CELL LONGEV, V3, P434, DOI 10.4161/oxim.3.6.14741; Vlachogianni IC, 2015, FOOD CHEM, V177, P165, DOI 10.1016/j.foodchem.2014.12.092; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057766; Zhang JD, 2006, BIOCHEM J, V397, P519, DOI 10.1042/BJ20050977; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	41	24	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124968	10.1371/journal.pone.0124968	http://dx.doi.org/10.1371/journal.pone.0124968			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905778	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000097
J	Jochems, A; Yoshida, M				Jochems, Arthur; Yoshida, Motoharu			A Robust In Vivo-Like Persistent Firing Supported by a Hybrid of Intracellular and Synaptic Mechanisms	PLOS ONE			English	Article							SHORT-TERM-MEMORY; HIPPOCAMPAL ACETYLCHOLINE-RELEASE; ANTERIOR CINGULATE CORTEX; SPATIAL WORKING-MEMORY; CA3 PYRAMIDAL CELLS; PREFRONTAL CORTEX; ENTORHINAL CORTEX; CHOLINERGIC MODULATION; AUTOASSOCIATIVE MEMORY; NEURAL ACTIVITY	Persistent firing is believed to support short-term information retention in the brain. Established hypotheses make use of the recurrent synaptic connectivity to support persistent firing. However, this mechanism is known to suffer from a lack of robustness. On the other hand, persistent firing can be supported by an intrinsic cellular mechanism in multiple brain areas. However, the consequences of having both the intrinsic and the synaptic mechanisms (a hybrid model) on persistent firing remain largely unknown. The goal of this study is to investigate whether a hybrid neural network model with these two mechanisms has advantages over a conventional recurrent network based model. Our computer simulations were based on in vitro recordings obtained from hippocampal CA3 pyramidal cells under cholinergic receptor activation. Calcium activated non-specific cationic (CAN) current supported persistent firing in the Hodgkin-Huxley style cellular models. Our results suggest that the hybrid model supports persistent firing within a physiological frequency range over a wide range of different parameters, eliminating parameter sensitivity issues generally recognized in network based persistent firing. In addition, persistent firing in the hybrid model is substantially more robust against distracting inputs, can coexist with theta frequency oscillations, and supports pattern completion.	[Jochems, Arthur; Yoshida, Motoharu] Ruhr Univ Bochum, Int Grad Sch Neurosci, Bochum, Germany; [Yoshida, Motoharu] Ruhr Univ Bochum, Fac Psychol, Mercator Res Grp Struct Memory, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Yoshida, M (corresponding author), Ruhr Univ Bochum, Int Grad Sch Neurosci, Bochum, Germany.	motoharu.yoshida@rub.de			German Research Foundation (DFG) [YO177/4-1]; International Graduate School of Neuroscience at Ruhr-University Bochum	German Research Foundation (DFG)(German Research Foundation (DFG)); International Graduate School of Neuroscience at Ruhr-University Bochum	This work was supported by the German Research Foundation (DFG) project YO177/4-1 and the International Graduate School of Neuroscience at Ruhr-University Bochum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron GB, 2001, SYNAPSE, V42, P199, DOI 10.1002/syn.10004; Acquas E, 1996, J NEUROSCI, V16, P3089; Anagnostaras SG, 2003, NAT NEUROSCI, V6, P51, DOI 10.1038/nn992; [Anonymous], 1998, NEURAL NETWORKS BRAI; Arnold DB, 1997, EXP BRAIN RES, V113, P57, DOI 10.1007/BF02454142; Axmacher N, 2007, J NEUROSCI, V27, P7807, DOI 10.1523/JNEUROSCI.0962-07.2007; Bang SJ, 2009, J NEUROSCI, V29, P4346, DOI 10.1523/JNEUROSCI.0069-09.2009; BENNETT MR, 1994, PHILOS T R SOC B, V343, P167, DOI 10.1098/rstb.1994.0019; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Camperi M, 1998, J COMPUT NEUROSCI, V5, P383, DOI 10.1023/A:1008837311948; COLOMBO M, 1994, BEHAV NEUROSCI, V108, P443, DOI 10.1037/0735-7044.108.3.443; Croxson PL, 2011, NAT NEUROSCI, V14, P1510, DOI 10.1038/nn.2971; DESTEXHE A, 1994, J NEUROPHYSIOL, V72, P803, DOI 10.1152/jn.1994.72.2.803; Disterhoft JF, 1999, LIFE SCI, V64, P541, DOI 10.1016/S0024-3205(98)00599-2; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Fadda F, 1996, EUR J PHARMACOL, V307, pR1, DOI 10.1016/0014-2999(96)00289-0; Fall CP, 2006, J COMPUT NEUROSCI, V20, P97, DOI 10.1007/s10827-006-4791-8; Farovik A, 2010, LEARN MEMORY, V17, P801, DOI 10.1101/lm.1616209; Fransen E, 2002, J NEUROSCI, V22, P1081, DOI 10.1523/JNEUROSCI.22-03-01081.2002; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; GALIANA HL, 1984, J NEUROPHYSIOL, V51, P210, DOI 10.1152/jn.1984.51.2.210; Gold AE, 2005, HIPPOCAMPUS, V15, P808, DOI 10.1002/hipo.20103; Goldman MS, 2003, CEREB CORTEX, V13, P1185, DOI 10.1093/cercor/bhg095; Griffin AL, 2004, BEHAV NEUROSCI, V118, P403, DOI 10.1037/0735-7044.118.2.403; Griffin AL, 2004, LEARN MEMORY, V11, P604, DOI 10.1101/lm.78404; Gutkin BS, 2001, J COMPUT NEUROSCI, V11, P121, DOI 10.1023/A:1012837415096; Hampson RE, 2004, P NATL ACAD SCI USA, V101, P3184, DOI 10.1073/pnas.0400162101; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hironaka N, 2001, BRAIN RES, V901, P143, DOI 10.1016/S0006-8993(01)02338-1; Hsieh LT, 2011, J NEUROSCI, V31, P10803, DOI 10.1523/JNEUROSCI.0828-11.2011; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; Jensen O, 1996, LEARN MEMORY, V3, P243, DOI 10.1101/lm.3.2-3.243; Jensen O, 1996, LEARN MEMORY, V3, P257, DOI 10.1101/lm.3.2-3.257; Jochems A, 2013, EUR J NEUROSCI, V38, P2250, DOI 10.1111/ejn.12236; Kinoshita-Kawada M, 2005, PFLUG ARCH EUR J PHY, V450, P345, DOI 10.1007/s00424-005-1419-1; Knauer B, 2013, HIPPOCAMPUS, V23, P820, DOI 10.1002/hipo.22136; Koene RA, 2008, BRAIN RES, V1202, P54, DOI 10.1016/j.brainres.2007.06.067; Koene RA, 2007, CEREB CORTEX, V17, P1766, DOI 10.1093/cercor/bhl088; Kremin T, 2007, NEUROSCIENCE, V149, P760, DOI 10.1016/j.neuroscience.2007.07.007; Kubota K, 1971, J NEUROPHYSIOL; Kuzmiski JB, 2001, J NEUROSCI, V21, P8707, DOI 10.1523/JNEUROSCI.21-22-08707.2001; Lee I, 2002, NAT NEUROSCI, V5, P162, DOI 10.1038/nn790; Leutgeb S, 2007, LEARN MEMORY, V14, P745, DOI 10.1101/lm.703907; Magistretti J, 2004, J NEUROPHYSIOL, V92, P1644, DOI 10.1152/jn.00036.2004; Major G, 2004, CURR OPIN NEUROBIOL, V14, P675, DOI 10.1016/j.conb.2004.10.017; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McEchron MD, 2003, J NEUROSCI, V23, P1535, DOI 10.1523/JNEUROSCI.23-04-01535.2003; McEchron MD, 2001, J NEUROPHYSIOL, V86, P1839, DOI 10.1152/jn.2001.86.4.1839; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Meyer JJ, 1996, PHYSIOL BEHAV, V60, P1199, DOI 10.1016/S0031-9384(96)00211-9; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; Miller EK, 1996, J NEUROSCI, V16, P5154; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Navaroli VL, 2012, HIPPOCAMPUS, V22, P1392, DOI 10.1002/hipo.20975; OKANE D, 1992, J PHYS A-MATH GEN, V25, P5055, DOI 10.1088/0305-4470/25/19/018; Papoutsi A, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00161; Phelan KD, 2013, MOL PHARMACOL, V83, P429, DOI 10.1124/mol.112.082271; Pospischil M, 2008, BIOL CYBERN, V99, P427, DOI 10.1007/s00422-008-0263-8; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Reboreda A, 2011, ADV EXP MED BIOL, V704, P595, DOI 10.1007/978-94-007-0265-3_32; Renart A, 2003, NEURON, V38, P473, DOI 10.1016/S0896-6273(03)00255-1; Schon K, 2004, J NEUROSCI, V24, P11088, DOI 10.1523/JNEUROSCI.3807-04.2004; Schwabedal JTC, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.022715; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; SOLOMON PR, 1986, BEHAV NEUROSCI, V100, P729, DOI 10.1037/0735-7044.100.5.729; Suzuki WA, 1997, J NEUROPHYSIOL, V78, P1062, DOI 10.1152/jn.1997.78.2.1062; Symes A, 2009, NEURAL NETWORKS, V22, P1079, DOI 10.1016/j.neunet.2009.07.017; Tahvildari B, 2007, HIPPOCAMPUS, V17, P257, DOI 10.1002/hipo.20270; Tegner J, 2002, BIOL CYBERN, V87, P471, DOI 10.1007/s00422-002-0363-9; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Vogt KE, 2001, J NEUROSCI, V21, P75, DOI 10.1523/JNEUROSCI.21-01-00075.2001; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Wang M, 2013, NEURON, V77, P736, DOI 10.1016/j.neuron.2012.12.032; Wang XJ, 1999, J NEUROSCI, V19, P9587; WATANABE T, 1985, BRAIN RES, V325, P241, DOI 10.1016/0006-8993(85)90320-8; Weiss C, 1996, HIPPOCAMPUS, V6, P192, DOI 10.1002/(SICI)1098-1063(1996)6:2<192::AID-HIPO9>3.0.CO;2-R; Wiebe SP, 1997, HIPPOCAMPUS, V7, P656, DOI 10.1002/(SICI)1098-1063(1997)7:6<656::AID-HIPO7>3.0.CO;2-C; WILLSHAW DJ, 1990, PHILOS T R SOC B, V329, P205, DOI 10.1098/rstb.1990.0165; Yoshida M, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00010; Young BJ, 1997, J NEUROSCI, V17, P5183; Zhang ZZ, 2011, HIPPOCAMPUS, V21, P386, DOI 10.1002/hipo.20755; Zhang ZZ, 2010, CEREB CORTEX, V20, P2948, DOI 10.1093/cercor/bhq043; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	86	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123799	10.1371/journal.pone.0123799	http://dx.doi.org/10.1371/journal.pone.0123799			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901969	gold, Green Published, Green Submitted			2022-12-27	WOS:000353331500063
J	Li, JL; Hou, J; Sun, L; Wilkins, JM; Lu, Y; Niederhuth, CE; Merideth, BR; Mawhinney, TP; Mossine, VV; Greenlief, CM; Walker, JC; Folk, WR; Hannink, M; Lubahn, DB; Birchler, JA; Cheng, JL				Li, Jilong; Hou, Jie; Sun, Lin; Wilkins, Jordan Maximillian; Lu, Yuan; Niederhuth, Chad E.; Merideth, Benjamin Ryan; Mawhinney, Thomas P.; Mossine, Valeri V.; Greenlief, C. Michael; Walker, John C.; Folk, William R.; Hannink, Mark; Lubahn, Dennis B.; Birchler, James A.; Cheng, Jianlin			From Gigabyte to Kilobyte: A Bioinformatics Protocol for Mining Large RNA-Seq Transcriptomics Data	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; STATISTICAL-METHODS; PROTEIN FUNCTION; SEQUENCES; ALIGNMENT; COMPLEX; SEARCH; FEXACT	RNA-Seq techniques generate hundreds of millions of short RNA reads using next-generation sequencing (NGS). These RNA reads can be mapped to reference genomes to investigate changes of gene expression but improved procedures for mining large RNA-Seq datasets to extract valuable biological knowledge are needed. RNAMiner-a multi-level bio-informatics protocol and pipeline-has been developed for such datasets. It includes five steps: Mapping RNA-Seq reads to a reference genome, calculating gene expression values, identifying differentially expressed genes, predicting gene functions, and constructing gene regulatory networks. To demonstrate its utility, we applied RNAMiner to datasets generated from Human, Mouse, Arabidopsis thaliana, and Drosophila melanogaster cells, and successfully identified differentially expressed genes, clustered them into cohesive functional groups, and constructed novel gene regulatory networks. The RNAMiner web service is available at http://calla.rnet.missouri.edu/rnaminer/index.html.	[Li, Jilong; Hou, Jie; Cheng, Jianlin] Univ Missouri, Dept Comp Sci, Columbia, MO 65211 USA; [Li, Jilong; Lu, Yuan; Mossine, Valeri V.; Greenlief, C. Michael; Folk, William R.; Hannink, Mark; Lubahn, Dennis B.; Cheng, Jianlin] Univ Missouri, MU Bot Ctr, Columbia, MO USA; [Sun, Lin; Niederhuth, Chad E.; Walker, John C.; Birchler, James A.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Wilkins, Jordan Maximillian; Lu, Yuan; Merideth, Benjamin Ryan; Mawhinney, Thomas P.; Mossine, Valeri V.; Folk, William R.; Hannink, Mark; Lubahn, Dennis B.] Univ Missouri, Dept Biochem, Columbia, MO USA; [Greenlief, C. Michael] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Cheng, Jianlin] Univ Missouri, Inst Informat, Columbia, MO USA; [Cheng, Jianlin] Univ Missouri, C Bond Life Sci Ctr, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Cheng, JL (corresponding author), Univ Missouri, Dept Comp Sci, Columbia, MO 65211 USA.	chengji@missouri.edu	Cheng, Jianlin/N-8209-2013	Cheng, Jianlin/0000-0003-0305-2853; Hou, Jie/0000-0002-8584-5154; Folk, William/0000-0003-2216-3233; Niederhuth, Chad/0000-0003-3268-9079; Mawhinney, Thomas/0000-0002-1807-2550	NIH Botanical Center grant from the National Center for Complementary and Alternative Medicines (NCCAM) [P50AT006273]; Office of Dietary Supplements (ODS); National Cancer Institute (NCI); NIH [R01GM093123]; NSF CAREER grant [DBI1149224]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P50AT006273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093123] Funding Source: NIH RePORTER	NIH Botanical Center grant from the National Center for Complementary and Alternative Medicines (NCCAM); Office of Dietary Supplements (ODS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CAREER grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was made possible by an NIH Botanical Center grant (P50AT006273) from the National Center for Complementary and Alternative Medicines (NCCAM), the Office of Dietary Supplements (ODS), and the National Cancer Institute (NCI), a NIH R01 grant (R01GM093123), and a NSF CAREER grant (DBI1149224). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCCAM, ODS, NCI, the National Institutes of Health, or the National Science Foundation.	Agresti A, 2002, CATEGORICAL DATA ANA, P91; Agresti A, 1990, CATEGORICAL DATA ANA, P59; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders S., 2010, HTSEQ ANAL HIGH THRO; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BATEMAN A, 2004, NUCLEIC ACIDS RES, V32, P276; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Chen G, 2011, SCI CHINA LIFE SCI, V54, P1121, DOI 10.1007/s11427-011-4255-x; CLARKSON DB, 1993, ACM T MATH SOFTWARE, V19, P484, DOI 10.1145/168173.168412; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Fang ZD, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-26; Fisher R., 1970, STAT METHODS RES WOR; Fisher RA, 1935, J R STAT SOC, V98, P39, DOI 10.2307/2342435; FISHER RA, 1962, AUST J STAT, V4, P41; Foster BA, 1997, CANCER RES, V57, P3325; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goff SA, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00034; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kvam VM, 2012, AM J BOT, V99, P248, DOI 10.3732/ajb.1100340; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; MEHTA CR, 1986, ACM T MATH SOFTWARE, V12, P154, DOI 10.1145/6497.214326; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mossine VV, 2007, J AGR FOOD CHEM, V55, P10373, DOI 10.1021/jf072092i; Niederhuth CE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-37; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Patefield W. M., 1981, APPL STAT, V30, P91, DOI DOI 10.2307/2346669; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Sun L, 2013, P NATL ACAD SCI USA, V110, P16514, DOI 10.1073/pnas.1316041110; Sun L, 2013, P NATL ACAD SCI USA, V110, P7383, DOI 10.1073/pnas.1305638110; Sun L, 2013, P NATL ACAD SCI USA, V110, pE808, DOI 10.1073/pnas.1222542110; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van De Wiel MA, 2013, BIOSTATISTICS, V14, P113, DOI 10.1093/biostatistics/kxs031; Wang L, 2010, BRIEF FUNCT GENOMICS, V9, P118, DOI 10.1093/bfgp/elp057; Wang Z, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S3-S3; Wang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017906; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zhu MZ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-278; Zhu MZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-437	50	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0125000	10.1371/journal.pone.0125000	http://dx.doi.org/10.1371/journal.pone.0125000			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902288	Green Published, gold			2022-12-27	WOS:000353331500107
J	Nakajima, R; Yamamoto, H; Kawagucci, S; Takaya, Y; Nozaki, T; Chen, C; Fujikura, K; Miwa, T; Takai, K				Nakajima, Ryota; Yamamoto, Hiroyuki; Kawagucci, Shinsuke; Takaya, Yutaro; Nozaki, Tatsuo; Chen, Chong; Fujikura, Katsunori; Miwa, Tetsuya; Takai, Ken			Post-Drilling Changes in Seabed Landscape and Megabenthos in a Deep-Sea Hydrothermal System, the Iheya North Field, Okinawa Trough	PLOS ONE			English	Article							FAROE-SHETLAND CHANNEL; HYDRAULIC CONDUCTIVITY; BENTHIC COMMUNITIES; VENTS; ASSEMBLAGES; DISTURBANCE; CHEMISTRY; ECOSYSTEM; IMPACTS; ECOLOGY	There has been an increasing interest in seafloor exploitation such as mineral mining in deep-sea hydrothermal fields, but the environmental impact of anthropogenic disturbance to the seafloor is poorly known. In this study, the effect of such anthropogenic disturbance by scientific drilling operations (IODP Expedition 331) on seabed landscape and megafaunal habitation was surveyed for over 3 years using remotely operated vehicle video observation in a deep-sea hydrothermal field, the Iheya North field, in the Okinawa Trough. We focused on observations from a particular drilling site (Site C0014) where the most dynamic change of landscape and megafaunal habitation was observed among the drilling sites of IODP Exp. 331. No visible hydrothermal fluid discharge had been observed at the sedimentary seafloor at Site C0014, where Calyptogena clam colonies were known for more than 10 years, before the drilling event. After drilling commenced, the original Calyptogena colonies were completely buried by the drilling deposits. Several months after the drilling, diffusing high-temperature hydrothermal fluid began to discharge from the sedimentary subseafloor in the area of over 20 m from the drill holes, 'artificially' creating a new hydrothermal vent habitat. Widespread microbial mats developed on the seafloor with the diffusing hydrothermal fluids and the galatheid crab Shinkaia crosnieri endemic to vents dominated the new vent community. The previously soft, sedimentary seafloor was hardened probably due to barite/gypsum mineralization or silicification, becoming rough and undulated with many fissures after the drilling operation. Although the effects of the drilling operation on seabed landscape and megafaunal composition are probably confined to an area of maximally 30 m from the drill holes, the newly established hydrothermal vent ecosystem has already lasted 2 years and is like to continue to exist until the fluid discharge ceases and thus the ecosystem in the area has been altered for long-term.	[Nakajima, Ryota; Fujikura, Katsunori] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Marine Biodivers Res, Yokosuka, Kanagawa 2370061, Japan; [Yamamoto, Hiroyuki; Kawagucci, Shinsuke; Takaya, Yutaro; Nozaki, Tatsuo; Miwa, Tetsuya; Takai, Ken] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Res & Dev Ctr Submarine Resources, Yokosuka, Kanagawa 2370061, Japan; [Kawagucci, Shinsuke; Takai, Ken] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Lab Ocean Earth Life Evolut Res OELE, Yokosuka, Kanagawa 2370061, Japan; [Kawagucci, Shinsuke; Takai, Ken] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Subsurface Geobiol Anal & Res D SUGAR, Yokosuka, Kanagawa 2370061, Japan; [Nozaki, Tatsuo] Univ Tokyo, Sch Engn, Dept Syst Innovat, Bunkyo Ku, Tokyo 1138656, Japan; [Chen, Chong] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Miwa, Tetsuya] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Marine Technol & Engn Ctr MARITEC, Yokosuka, Kanagawa 2370061, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Tokyo; University of Oxford; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Nakajima, R (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Marine Biodivers Res, 2-15 Natsushima, Yokosuka, Kanagawa 2370061, Japan.	nakajimar@jamstec.go.jp	kawagucci, shinsuke/H-6047-2013; Kawagucci, Shinsuke/O-7813-2019; Chen, Chong/F-7489-2019	kawagucci, shinsuke/0000-0002-7807-024X; Chen, Chong/0000-0002-5035-4021; Nozaki, Tatsuo/0000-0001-6523-6231; Takaya, Yutaro/0000-0003-4046-6780	Environment Research and Technology Development Fund (S9) of the Ministry of the Environment, Japan	Environment Research and Technology Development Fund (S9) of the Ministry of the Environment, Japan	RN acknowledges the Environment Research and Technology Development Fund (S9) of the Ministry of the Environment, Japan (http://s9.conservationecology.asia). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEELE W V, 1986, Nuclear and Chemical Waste Management, V6, P81, DOI 10.1016/0191-815X(86)90091-4; Arellano SM, 2010, MAR ECOL PROG SER, V414, P131, DOI 10.3354/meps08717; BLOUNT CW, 1969, GEOCHIM COSMOCHIM AC, V33, P227, DOI 10.1016/0016-7037(69)90140-9; BLOUNT CW, 1977, AM MINERAL, V62, P942; Boschen RE, 2013, OCEAN COAST MANAGE, V84, P54, DOI 10.1016/j.ocecoaman.2013.07.005; Copley JTP, 1999, MAR ECOL-P S Z N I, V20, P291, DOI 10.1046/j.1439-0485.1999.2034076.x; Currie DR, 2005, MAR ENVIRON RES, V59, P217, DOI 10.1016/j.marenvres.2004.05.001; Dattagupta S, 2004, LIMNOL OCEANOGR, V49, P1144, DOI 10.4319/lo.2004.49.4.1144; Dumas P, 2009, J EXP MAR BIOL ECOL, V368, P161, DOI 10.1016/j.jembe.2008.10.002; Fujikura K., 2008, DEEP SEA LIFE BIOL O; Gates AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044114; Glover AG, 2003, ENVIRON CONSERV, V30, P219, DOI 10.1017/S0376892903000225; Jannasch H.W., 1995, GEOPHYS MONOGR SER, V91, P273, DOI DOI 10.1029/GM091P0273; Jones DOB, 2007, MAR BIOL, V151, P1731, DOI 10.1007/s00227-007-0606-3; Jones DOB, 2007, DEEP-SEA RES PT I, V54, P1111, DOI 10.1016/j.dsr.2007.04.001; Jones DOB, 2012, MAR ECOL PROG SER, V461, P71, DOI 10.3354/meps09827; Jones DOB, 2012, J MAR BIOL ASSOC UK, V92, P245, DOI 10.1017/S0025315411001123; Kawagucci S, 2013, GEOCHEM GEOPHY GEOSY, V14, P4774, DOI 10.1002/2013GC004895; Kawagucci S, 2011, GEOCHEM J, V45, P109; KENNEY TC, 1992, CAN GEOTECH J, V29, P364, DOI 10.1139/t92-042; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Mengerink KJ, 2014, SCIENCE, V344, P696, DOI 10.1126/science.1251458; MOHAMEDEEN H, 1989, J EXP MAR BIOL ECOL, V134, P1, DOI 10.1016/0022-0981(90)90053-F; Nakagawa S, 2005, FEMS MICROBIOL ECOL, V54, P141, DOI 10.1016/j.femsec.2005.03.007; Nakajima R, 2014, JAMSTEC REP RES DVE, V19, P59, DOI DOI 10.5918/JAMSTECR.19.59; Nakajima R, 2014, DIVERS DISTRIB, V20, P1160, DOI 10.1111/ddi.12204; Okoshi Kenji, 2003, Japanese Journal of Benthology, V58, P77; Rogers AD, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001234; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; Sivapullaiah PV, 2000, CAN GEOTECH J, V37, P406, DOI 10.1139/cgj-37-2-406; Smith W. F., 2006, FDN MAT SCI ENG; Takai K., 2011, P IODP, DOI [10.2204/iodp.proc.331.2011, DOI 10.2204/IODP.PROC.331.2011]; Takai K, 2012, SCI DRILL, V13, P19, DOI 10.5194/sd-13-19-2012; Tokeshi M, 2011, J OCEANOGR, V67, P651, DOI 10.1007/s10872-011-0065-9; Trannum HC, 2010, J EXP MAR BIOL ECOL, V383, P111, DOI 10.1016/j.jembe.2009.12.004; Tsuji T, 2012, J VOLCANOL GEOTH RES, V213, P41, DOI 10.1016/j.jvolgeores.2011.11.007; TUNNICLIFFE V, 1992, AM SCI, V80, P336; TUNNICLIFFE V, 1991, OCEANOGR MAR BIOL, V29, P319; Ueno H, 2003, JAMSTEC J DEEP SEA R, V22, P49; Van Dover C., 2011, ENV MANAGEMENT DEEP; Van Dover CL, 2012, MAR POLICY, V36, P378, DOI 10.1016/j.marpol.2011.07.002; Van Dover CL, 2014, MAR ENVIRON RES, V102, P59, DOI 10.1016/j.marenvres.2014.03.008; Watanabe H, 2010, TOP GEOBIOL, V33, P379, DOI 10.1007/978-90-481-9572-5_12	43	28	28	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123095	10.1371/journal.pone.0123095	http://dx.doi.org/10.1371/journal.pone.0123095			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902075	Green Submitted, Green Published, gold			2022-12-27	WOS:000353331500041
J	Xu, Y; Furutani, S; Ihara, M; Ling, Y; Yang, XY; Kai, K; Hayashi, H; Matsuda, K				Xu, Yan; Furutani, Shogo; Ihara, Makoto; Ling, Yun; Yang, Xinling; Kai, Kenji; Hayashi, Hideo; Matsuda, Kazuhiko			Meroterpenoid Chrodrimanins Are Selective and Potent Blockers of Insect GABA-Gated Chloride Channels	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; TALAROMYCES SP; RECEPTOR; RESISTANCE; DIELDRIN; NEONICOTINOIDS; IDENTIFICATION; OOCYTES; YO-2	Meroterpenoid chrodrimanins, produced from Talaromyces sp. YO-2, are known to paralyze silkworm (Bombyx mori) larvae, but their target is unknown. We have investigated the actions of chrodrimanin B on ligand-gated ion channels of silkworm larval neurons using patch-clamp electrophysiology. Chrodrimanin B had no effect on membrane currents when tested alone at 1 mu M. However, it completely blocked the.-aminobutyric acid (GABA)-induced current and showed less pronounced actions on acetylcholine-and L-glutamate-induced currents, when delivered at 1 mu M for 1 min prior to co-application with transmitter GABA. Thus, chrodrimanins were also tested on a wild-type isoform of the B. mori GABA receptor (GABAR) RDL using two-electrode voltage-clamp electrophysiology. Chrodrimanin B attenuated the peak current amplitude of the GABA response of RDL with an IC50 of 1.66 nM. The order of the GABAR-blocking potency of chrodrimanins B > D > A was in accordance with their reported insecticidal potency. Chrodrimanin B had no open channel blocking action when tested at 3 nM on the GABA response of RDL. Co-application with 3 nM chrodrimanin B shifted the GABA concentration response curve to a higher concentration and further increase of chrodrimanin B concentration to10 nM; it reduced maximum current amplitude of the GABA response, pointing to a high-affinity competitive action and a lower affinity non-competitive action. The A282S; T286V double mutation of RDL, which impairs the actions of fipronil, hardly affected the blocking action of chrodrimanin B, indicating a binding site of chrodrimanin B distinct from that of fipronil. Chrodrimanin B showed approximately 1,000-fold lower blocking action on human alpha 1 beta 2 gamma 2 GABAR compared to RDL and thus is a selective blocker of insect GABARs.	[Xu, Yan; Ling, Yun; Yang, Xinling] China Agr Univ, Coll Sci, Dept Appl Chem, Beijing 100193, Peoples R China; [Furutani, Shogo; Ihara, Makoto; Matsuda, Kazuhiko] Kinki Univ, Fac Agr, Dept Appl Biol Chem, Nara 6318505, Japan; [Kai, Kenji; Hayashi, Hideo] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Naka Ku, Sakai, Osaka 5998531, Japan	China Agricultural University; Kindai University (Kinki University); Osaka Metropolitan University	Matsuda, K (corresponding author), Kinki Univ, Fac Agr, Dept Appl Biol Chem, 3327-204 Nakamachi, Nara 6318505, Japan.	kmatsuda@nara.kindai.ac.jp	Matsuda, Kazuhiko/AAX-4926-2020; Yang, xinling/HHC-1621-2022; Hayashi, Hideo/AAI-1910-2020; Ihara, Makoto/Q-7204-2016	Kai, Kenji/0000-0002-4036-9959; Ihara, Makoto/0000-0002-6403-0781	JSPS [21310147, 26292031]; MEXT [S1101035]; China Scholarship Council [201206350101]; National Natural Science Foundation of China [21272266]; Grants-in-Aid for Scientific Research [26292031] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); China Scholarship Council(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	KM was supported in part by JSPS KAKENHI Grant Numbers 21310147, 26292031 and MEXT Strategic Project to Support the Formation of Research Bases at Private Universities: Matching Fund Subsidy Grant Number S1101035. YX was supported by the China Scholarship Council File Number 201206350101. YL was supported by the National Natural Science Foundation of China Grant Number 21272266.	AKAIKE N, 1985, EXPERIENTIA, V41, P70; CHYB S, 1995, J CHEM ECOL, V21, P313, DOI 10.1007/BF02036720; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; FFRENCHCONSTANT RH, 1991, P NATL ACAD SCI USA, V88, P7209, DOI 10.1073/pnas.88.16.7209; Gisselmann G, 2002, NAT NEUROSCI, V5, P11, DOI 10.1038/nn787; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; Hayashi H, 2012, BIOSCI BIOTECH BIOCH, V76, P1765, DOI 10.1271/bbb.120365; Hayashi H, 2012, BIOSCI BIOTECH BIOCH, V76, P745, DOI 10.1271/bbb.110858; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hirata K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018354; Hosie AM, 1996, BRIT J PHARMACOL, V119, P1577, DOI 10.1111/j.1476-5381.1996.tb16075.x; HOSIE AM, 1995, BRAIN RES, V693, P257, DOI 10.1016/0006-8993(95)00605-P; Ihara M, 2003, NEUROPHARMACOLOGY, V45, P133, DOI 10.1016/S0028-3908(03)00134-5; Kuriyama T, 2005, PESTIC BIOCHEM PHYS, V81, P176, DOI 10.1016/j.pestbp.2004.11.008; Kuriyama T, 2002, BIOORGAN MED CHEM, V10, P1873, DOI 10.1016/S0968-0896(02)00011-1; Liu GY, 2014, BIOORGAN MED CHEM, V22, P4637, DOI 10.1016/j.bmc.2014.07.021; Matsuda K, 1999, BRIT J PHARMACOL, V127, P1305, DOI 10.1038/sj.bjp.0702663; NAGATA K, 1994, J PHARMACOL EXP THER, V269, P164; Nakao T, 2013, INSECT BIOCHEM MOLEC, V43, P366, DOI 10.1016/j.ibmb.2013.02.002; Schnizler K, 2005, J BIOL CHEM, V280, P16254, DOI 10.1074/jbc.M411759200; Shimomura M, 2006, MOL PHARMACOL, V70, P1255, DOI 10.1124/mol.106.026815; SHIRAI Y, 1995, NEUROSCI LETT, V189, P1, DOI 10.1016/0304-3940(95)11432-V; Zheng YC, 2002, J BIOL CHEM, V277, P2000, DOI 10.1074/jbc.M107635200	24	21	31	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122629	10.1371/journal.pone.0122629	http://dx.doi.org/10.1371/journal.pone.0122629			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902139	Green Published, gold, Green Submitted			2022-12-27	WOS:000353331500025
J	Kizil, C; Iltzsche, A; Thomas, AK; Bhattarai, P; Zhang, YX; Brand, M				Kizil, Caghan; Iltzsche, Anne; Thomas, Alvin Kuriakose; Bhattarai, Prabesh; Zhang, Yixin; Brand, Michael			Efficient Cargo Delivery into Adult Brain Tissue Using Short Cell-Penetrating Peptides	PLOS ONE			English	Article							END-RULE PEPTIDES; NEUROGENESIS; PROTEIN; MECHANISMS; EXPRESSION; BINDING; SIRNA; RNA	Zebrafish brains can regenerate lost neurons upon neurogenic activity of the radial glial progenitor cells (RGCs) that reside at the ventricular region. Understanding the molecular events underlying this ability is of great interest for translational studies of regenerative medicine. Therefore, functional analyses of gene function in RGCs and neurons are essential. Using cerebroventricular microinjection (CVMI), RGCs can be targeted efficiently but the penetration capacity of the injected molecules reduces dramatically in deeper parts of the brain tissue, such as the parenchymal regions that contain the neurons. In this report, we tested the penetration efficiency of five known cell-penetrating peptides (CPPs) and identified two-polyR and Trans - that efficiently penetrate the brain tissue without overt toxicity in a dose-dependent manner as determined by TUNEL staining and L-Plastin immunohistochemistry. We also found that polyR peptide can help carry plasmid DNA several cell diameters into the brain tissue after a series of coupling reactions using DBCO-PEG4-maleimide-based Michael's addition and azide-mediated copper-free click reaction. Combined with the advantages of CVMI, such as rapidness, reproducibility, and ability to be used in adult animals, CPPs improve the applicability of the CVMI technique to deeper parts of the central nervous system tissues.	[Kizil, Caghan; Bhattarai, Prabesh] German Ctr Neurodegenerat Dis DZNE Dresden Helmho, D-01307 Dresden, Germany; [Kizil, Caghan; Iltzsche, Anne; Brand, Michael] Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden CRTD Cluster, D-01307 Dresden, Germany; [Thomas, Alvin Kuriakose; Zhang, Yixin] Tech Univ Dresden, Ctr Mol Bioengn, B CUBE, D-01307 Dresden, Germany; [Brand, Michael] Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden	Brand, M (corresponding author), Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden CRTD Cluster, Fetscherstr 105, D-01307 Dresden, Germany.	michael.brand@biotec.tu-dresden.de	Kizil, Caghan/AFG-2073-2022; Kizil, Caghan/J-6923-2015; Brand, Michael/A-5509-2010; Thomas, Alvin Kuriakose/I-7638-2018	Kizil, Caghan/0000-0002-8164-9762; Kizil, Caghan/0000-0002-8164-9762; Brand, Michael/0000-0001-5711-6512; Thomas, Alvin Kuriakose/0000-0002-8544-4983; Bhattarai, Prabesh/0000-0003-2991-5514	Deutsche Forschungsgemeinschaft [SFB-655-A3]; European Union (Zf-Health); Technische Universitat Dresden; German Centre for Neurodegenerative Diseases (DZNE) within Helmholtz Association; Leibniz Association [SAW-2011-IPF-2]; BMBF BioLithoMorphie project [03Z2E511]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union (Zf-Health); Technische Universitat Dresden; German Centre for Neurodegenerative Diseases (DZNE) within Helmholtz Association; Leibniz Association; BMBF BioLithoMorphie project(Federal Ministry of Education & Research (BMBF))	This work was supported by Deutsche Forschungsgemeinschaft (SFB-655-A3), The European Union (Zf-Health), and Technische Universitat Dresden (AI, CK, MB), German Centre for Neurodegenerative Diseases (DZNE) within Helmholtz Association (CK), and Leibniz Association (SAW-2011-IPF-2 project) and BMBF BioLithoMorphie project 03Z2E511 (AKT, YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Brand Michael, 2002, P7; Cardozo AK, 2007, BBA-BIOMEMBRANES, V1768, P2222, DOI 10.1016/j.bbamem.2007.06.003; Chapouton P, 2010, METHOD CELL BIOL, V100, P73, DOI 10.1016/B978-0-12-384892-5.00004-9; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Gros E, 2006, BBA-BIOMEMBRANES, V1758, P384, DOI 10.1016/j.bbamem.2006.02.006; Hans S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004640; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Jarver P, 2013, MOL THER-NUCL ACIDS, V1, pe27; Jewett JC, 2010, CHEM SOC REV, V39, P1272, DOI 10.1039/b901970g; Jones SW, 2005, BRIT J PHARMACOL, V145, P1093, DOI 10.1038/sj.bjp.0706279; Juliano R, 2008, NUCLEIC ACIDS RES, V36, P4158, DOI 10.1093/nar/gkn342; Kizil C, 2013, JOVE-J VIS EXP, DOI 10.3791/50415; Kizil C, 2012, DEV CELL, V23, P1230, DOI 10.1016/j.devcel.2012.10.014; Kizil C, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-27; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Kizil C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027395; Knopf F, 2010, P NATL ACAD SCI USA, V107, P19933, DOI 10.1073/pnas.1007799107; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Lindgren M, 2011, METHODS MOL BIOL, V683, P3, DOI 10.1007/978-1-60761-919-2_1; Malesevic M, 2010, ANGEW CHEM INT EDIT, V49, P213, DOI 10.1002/anie.200904529; Mende F, 2011, ANGEW CHEM INT EDIT, V50, P1232, DOI 10.1002/anie.201005180; Muratovska A, 2004, FEBS LETT, V558, P63, DOI 10.1016/S0014-5793(03)01505-9; Nitin N, 2004, J BIOL INORG CHEM, V9, P706, DOI 10.1007/s00775-004-0560-1; Pantos A, 2008, BBA-BIOMEMBRANES, V1778, P811, DOI 10.1016/j.bbamem.2007.12.003; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156; ROY S, 1990, GENE DEV, V4, P1365, DOI 10.1101/gad.4.8.1365; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Snyder Eric L, 2005, Expert Opin Drug Deliv, V2, P43, DOI 10.1517/17425247.2.1.43; Strassberger V, 2010, PROTEOMICS, V10, P3544, DOI 10.1002/pmic.201000308; Teesalu T, 2009, P NATL ACAD SCI USA, V106, P16157, DOI 10.1073/pnas.0908201106; Torchilin VP, 2008, BIOPOLYMERS, V90, P604, DOI 10.1002/bip.20989; Torchilin VP, 2008, ADV DRUG DELIVER REV, V60, P548, DOI 10.1016/j.addr.2007.10.008; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Wieduwild R, 2013, J AM CHEM SOC, V135, P2919, DOI 10.1021/ja312022u; Zanuy D, 2013, J STRUCT BIOL, V182, P78, DOI 10.1016/j.jsb.2013.02.006; Zatsepin TS, 2005, CURR PHARM DESIGN, V11, P3639, DOI 10.2174/138161205774580769; Zhang YX, 2002, BIOCHEMISTRY-US, V41, P11868, DOI 10.1021/bi0262395	43	17	18	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124073	10.1371/journal.pone.0124073	http://dx.doi.org/10.1371/journal.pone.0124073			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894337	Green Submitted, Green Published, gold			2022-12-27	WOS:000353211700072
J	Song, LL; Zeng, W; Wu, AM; Picard, K; Lampugnani, ER; Cheetamun, R; Beahan, C; Cassin, A; Lonsdale, A; Doblin, MS; Bacic, A				Song, Lili; Zeng, Wei; Wu, Aimin; Picard, Kelsey; Lampugnani, Edwin R.; Cheetamun, Roshan; Beahan, Cherie; Cassin, Andrew; Lonsdale, Andrew; Doblin, Monika S.; Bacic, Antony			Asparagus Spears as a Model to Study Heteroxylan Biosynthesis during Secondary Wall Development	PLOS ONE			English	Article							PLANT-CELL WALLS; GLUCURONOXYLAN BIOSYNTHESIS; XYLAN BIOSYNTHESIS; ARABIDOPSIS-THALIANA; MUTANTS REVEALS; STORAGE; WHEAT; OFFICINALIS; PROTEINS; SEQUENCE	Garden asparagus (Asparagus officinalis L.) is a commercially important crop species utilized for its excellent source of vitamins, minerals and dietary fiber. However, after harvest the tissue hardens and its quality rapidly deteriorates because spear cell walls become rigidified due to lignification and substantial increases in heteroxylan content. This latter observation prompted us to investigate the in vitro xylan xylosyltransferase (XylT) activity in asparagus. The current model system for studying heteroxylan biosynthesis, Arabidopsis, whilst a powerful genetic system, displays relatively low xylan XylT activity in in vitro microsomal preparations compared with garden asparagus therefore hampering our ability to study the molecular mechanism(s) of heteroxylan assembly. Here, we analyzed physiological and biochemical changes of garden asparagus spears stored at 4 degrees C after harvest and detected a high level of xylan XylT activity that accounts for this increased heteroxylan. The xylan XylT catalytic activity is at least thirteen-fold higher than that reported for previously published species, including Arabidopsis and grasses. A biochemical assay was optimized and up to seven successive Xyl residues were incorporated to extend the xylotetraose (Xyl(4)) acceptor backbone. To further elucidate the xylan biosynthesis mechanism, we used RNA-seq to generate an Asparagus reference transcriptome and identified five putative xylan biosynthetic genes (AoIRX9, AoIRX9-L, AoIRX10, AoIRX14_A, AoIRX14_B) with AoIRX9 having an expression profile that is distinct from the other genes. We propose that Asparagus provides an ideal biochemical system to investigate the biochemical aspects of heteroxylan biosynthesis and also offers the additional benefit of being able to study the lignification process during plant stem maturation.	[Song, Lili] Zhejiang A&F Univ, Nurturing Stn State Key Lab Subtrop Silviculture, Hangzhou 311300, Zhejiang, Peoples R China; [Song, Lili; Zeng, Wei; Picard, Kelsey; Lampugnani, Edwin R.; Cheetamun, Roshan; Beahan, Cherie; Cassin, Andrew; Lonsdale, Andrew; Doblin, Monika S.; Bacic, Antony] Univ Melbourne, Sch Bot, ARC Ctr Excellence Plant Cell Walls, Parkville, Vic 3010, Australia; [Wu, Aimin] South China Agr Univ, Coll Forestry, Guangzhou 510642, Guangdong, Peoples R China; [Bacic, Antony] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia	Zhejiang A&F University; University of Melbourne; South China Agricultural University; University of Melbourne	Song, LL (corresponding author), Zhejiang A&F Univ, Nurturing Stn State Key Lab Subtrop Silviculture, Hangzhou 311300, Zhejiang, Peoples R China.	lilis2013@163.com; msdoblin@unimelb.edu.au; abacic@unimelb.edu.au	Wu, Aimin/AAG-9747-2020; Doblin, Monika/AAO-6801-2021; Lampugnani, Edwin/AAF-4238-2019; Zeng, Wei/AAZ-7073-2021	Wu, Aimin/0000-0001-8322-8833; Lampugnani, Edwin/0000-0002-3666-7240; Zeng, Wei/0000-0001-6898-1210; Bacic, Tony/0000-0001-7483-8605; Lonsdale, Andrew/0000-0002-0292-2880; Picard, Kelsey/0000-0001-8341-3545	Australia Research Council [CE110001007]; ARC [DP110100410]; Victorian Life Sciences Computation Initiative (VLSCI) [VR0191]; National Natural Science Foundation of China [31170165]	Australia Research Council(Australian Research Council); ARC(Australian Research Council); Victorian Life Sciences Computation Initiative (VLSCI); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by a grant from the Australia Research Council to the ARC Centre of Excellence in Plant Cell Walls (WZ, KP, EL, CB, AC, AL, MSD and AB) (CE110001007); ARC DP110100410 (EL and AB), the Victorian Life Sciences Computation Initiative (VLSCI) grant number VR0191 on its Peak Computing Facility at the University of Melbourne, an initiative of the Victorian Government, Australia and the National Natural Science Foundation of China (LS) (grant no. 31170165). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwael H, 2011, ANAL METHODS-UK, V3, P62, DOI 10.1039/c0ay00516a; BACIC A, 1980, CARBOHYD RES, V82, P372, DOI 10.1016/S0008-6215(00)85713-4; BAILEY RW, 1966, P NATL ACAD SCI USA, V56, P1586, DOI 10.1073/pnas.56.5.1586; Brown DM, 2007, PLANT J, V52, P1154, DOI 10.1111/j.1365-313X.2007.03307.x; Brown DM, 2009, PLANT J, V57, P732, DOI 10.1111/j.1365-313X.2008.03729.x; Busse-Wicher M, 2014, PLANT J, V79, P492, DOI 10.1111/tpj.12575; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Chen XW, 2013, MOL PLANT, V6, P570, DOI 10.1093/mp/sss135; Chiniquy D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00083; DALESSANDRO G, 1981, PLANTA, V151, P61, DOI 10.1007/BF00384238; Doblin MS, 2010, FUNCT PLANT BIOL, V37, P357, DOI 10.1071/FP09279; Ebringerova A, 2000, MACROMOL RAPID COMM, V21, P542; Faik A, 2010, PLANT PHYSIOL, V153, P396, DOI 10.1104/pp.110.154237; FEINGOLD DS, 1959, J BIOL CHEM, V234, P488; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; HAARD NF, 1974, J FOOD SCI, V39, P452, DOI 10.1111/j.1365-2621.1974.tb02923.x; Hao ZY, 2014, CRIT REV BIOCHEM MOL, V49, P212, DOI 10.3109/10409238.2014.889651; Hornblad E, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-3; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Ishikawa M, 2000, PLANTA, V210, P782, DOI 10.1007/s004250050680; Jensen JK, 2014, PLANT J, V80, P207, DOI 10.1111/tpj.12641; JOHANSSON MH, 1977, WOOD SCI TECHNOL, V11, P251, DOI 10.1007/BF00356924; Johnson MTJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050226; Kuhl JC, 2005, GENOME, V48, P1052, DOI 10.1139/G05-073; Kuhl JC, 2004, PLANT CELL, V16, P114, DOI 10.1105/tpc.017202; Kuroyama H, 2001, PLANTA, V213, P231, DOI 10.1007/s004250000499; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CH, 2007, PLANT CELL PHYSIOL, V48, P1659, DOI 10.1093/pcp/pcm155; Lee CH, 2007, PLANT CELL PHYSIOL, V48, P1624, DOI 10.1093/pcp/pcm135; Lee C, 2012, PLANT CELL PHYSIOL, V53, P1934, DOI 10.1093/pcp/pcs138; Lee C, 2012, PLANT CELL PHYSIOL, V53, P135, DOI 10.1093/pcp/pcr158; Lee C, 2010, PLANT PHYSIOL, V153, P526, DOI 10.1104/pp.110.155309; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Luo ZS, 2008, EUR FOOD RES TECHNOL, V226, P635, DOI 10.1007/s00217-007-0595-y; Malm E, 2010, CARBOHYD RES, V345, P97, DOI 10.1016/j.carres.2009.10.020; Mazumder K, 2010, CARBOHYD RES, V345, P2183, DOI 10.1016/j.carres.2010.07.034; Mortimer JC, 2010, P NATL ACAD SCI USA, V107, P17409, DOI 10.1073/pnas.1005456107; Oikawa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015481; Papadopoulou PP, 2002, ACTA HORTIC, P647, DOI 10.17660/ActaHortic.2002.579.114; Pena MJ, 2007, PLANT CELL, V19, P549, DOI 10.1105/tpc.106.049320; Pettolino FA, 2012, NAT PROTOC, V7, P1590, DOI 10.1038/nprot.2012.081; Piston F, 2010, PLANTA, V231, P677, DOI 10.1007/s00425-009-1077-1; Rasmussen S, 1999, PLANT CELL, V11, P1537, DOI 10.1105/tpc.11.8.1537; Ratnayake S, 2014, CARBOHYD RES, V386, P23, DOI 10.1016/j.carres.2013.12.013; Ren YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105014; Rennie EA, 2014, CURR OPIN BIOTECH, V26, P100, DOI 10.1016/j.copbio.2013.11.013; Rodriguez R, 1999, J AGR FOOD CHEM, V47, P3551, DOI 10.1021/jf981295r; SUZUKI K, 1991, PLANT CELL PHYSIOL, V32, P303, DOI 10.1093/oxfordjournals.pcp.a078079; Tzoumaki MV, 2009, FOOD CHEM, V117, P55, DOI 10.1016/j.foodchem.2009.03.076; Urbanowicz BR, 2014, PLANT J, V80, P197, DOI 10.1111/tpj.12643; Villanueva-Suarez MJ, 1999, J AGR FOOD CHEM, V47, P3832, DOI 10.1021/jf980888z; WALDRON KW, 1992, PHYTOCHEMISTRY, V31, P1931, DOI 10.1016/0031-9422(92)80336-D; WALDRON KW, 1990, PHYSIOL PLANTARUM, V80, P576, DOI [10.1034/j.1399-3054.1990.800413.x, 10.1111/j.1399-3054.1990.tb05681.x]; WALDRON KW, 1983, BIOCHEM J, V213, P115, DOI 10.1042/bj2130115; Wu AM, 2010, PLANT PHYSIOL, V153, P542, DOI 10.1104/pp.110.154971; Wu AM, 2009, PLANT J, V57, P718, DOI 10.1111/j.1365-313X.2008.03724.x; Xiong GY, 2013, MOL PLANT, V6, P1373, DOI 10.1093/mp/sst014; Yokoyama R, 2004, PLANT CELL PHYSIOL, V45, P1111, DOI 10.1093/pcp/pch151; Zeng W, 2008, PLANT PHYSIOL, V147, P78, DOI 10.1104/pp.107.115576; Zeng W, 2010, PLANT PHYSIOL, V154, P78, DOI 10.1104/pp.110.159749; Zhong RQ, 2005, PLANT CELL, V17, P3390, DOI 10.1105/tpc.105.035501; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399	63	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123878	10.1371/journal.pone.0123878	http://dx.doi.org/10.1371/journal.pone.0123878			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894575	Green Published, gold			2022-12-27	WOS:000353211700062
J	Dhanaraj, B; Papanna, MK; Adinarayanan, S; Vedachalam, C; Sundaram, V; Shanmugam, S; Sekar, G; Menon, PA; Wares, F; Swaminathan, S				Dhanaraj, Baskaran; Papanna, Mohan Kumar; Adinarayanan, Srividya; Vedachalam, Chandrasekaran; Sundaram, Vijayaraj; Shanmugam, Shivakumar; Sekar, Gomathi; Menon, Pradeep Aravindan; Wares, Fraser; Swaminathan, Soumya			Prevalence and Risk Factors for Adult Pulmonary Tuberculosis in a Metropolitan City of South India	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; DOTS PROGRAM; COMMUNITY	Background The present study measured the community prevalence and risk factors of adult pulmonary tuberculosis (PTB) in Chennai city, and also studied geographical distribution and the presence of different M. tuberculosis strains in the survey area. Methods A community-based cross sectional survey was carried out from July 2010 to October 2012 in Chennai city. Prevalence of bacteriologically positive PTB was estimated by direct standardization method. Univariate and multivariate analyses were carried out to identify significant risk factors. Drug susceptibility testing and spoligotyping was performed on isolated M. tuberculosis strains. Mapping of PTB cases was done using geographic positioning systems. Results Of 59,957 eligible people, 55,617 were screened by X-ray and/or TB symptoms and the prevalence of smear, culture, and bacteriologically positive PTB was estimated to be 228 (95% CI 189-265), 259 (95% CI 217-299) and 349 (95% CI 330-428) per 100,000 population, respectively. Prevalence of smear, culture, and bacteriologically positive PTB was highest amongst men aged 55-64 years. Multivariate analysis showed that occurrence of both culture and bacteriologically positive PTB disease was significantly associated with: age >35 years, past history of TB treatment, BMI <18.5 Kgs/m(2), solid cooking fuel, and being a male currently consuming alcohol. The most frequent spoligotype family was East African Indian. Spatial distribution showed that a high proportion of patients were clustered in the densely populated north eastern part of the city. Conclusion Our findings demonstrate that TB is a major public health problem in this urban area of south India, and support the use of intensified case finding in high risk groups. Undernutrition, slum dwelling, indoor air pollution and alcohol intake are modifiable risk factors for TB disease.	[Dhanaraj, Baskaran; Adinarayanan, Srividya; Vedachalam, Chandrasekaran; Sundaram, Vijayaraj; Shanmugam, Shivakumar; Sekar, Gomathi; Menon, Pradeep Aravindan; Swaminathan, Soumya] Natl Inst Res TB, Madras, Tamil Nadu, India; [Papanna, Mohan Kumar] Natl Ctr Dis Control, India EIS Programme, New Delhi, India; [Wares, Fraser] World Hlth Org, Global TB Programme, Geneva, Switzerland	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); National Centre for Disease Control (NCDC); World Health Organization	Swaminathan, S (corresponding author), Natl Inst Res TB, Madras, Tamil Nadu, India.	doctorsoumya@yahoo.com			United States Agency for International Development (USAID) under Model DOTS Project [MDP TSA-2010/103409]; Indian Council of Medical Research	United States Agency for International Development (USAID) under Model DOTS Project(United States Agency for International Development (USAID)); Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	The analysis and presentation of the data was supported in part by the World Health Organization, with financial assistance provided by the United States Agency for International Development (USAID), under the Model DOTS Project (Grant no: MDP TSA-2010/103409). Additional funding was provided by the Indian Council of Medical Research.	ADELSTEIN A. M., 1967, Tubercle, V48, P219, DOI 10.1016/S0041-3879(67)80026-6; Azhar GS, 2012, LUNG INDIA, V29, P147, DOI 10.4103/0970-2113.95320; Borgdorff MW, 2000, INT J TUBERC LUNG D, V4, P123; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Central TB Division Ministry of Health & Family Welfare, 2013, GOVT IND REV TB CONT; Chadha VK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042625; Chandramouli C, 2003, 3 INT C ENV HLTH CHE; Floyd S, 2013, EMERG THEMES EPIDEMI, V10, DOI 10.1186/1742-7622-10-10; Glaziou P, 2008, INT J TUBERC LUNG D, V12, P1003; Gopi PG, 2003, INT J TUBERC LUNG D, V7, P1154; Government of India, 2013, PRIM CENS ABSTR SLUM; Gupta K.A., 2010, J GEOGRAPHY REGIONAL, V3, P365; Gustafson P, 2004, INT J EPIDEMIOL, V33, P163, DOI 10.1093/ije/dyh026; ICMR, TUB IND SAMPL SURV 1, P1; Jacobson JM, 1992, ALCOHOL HEALTH RES W, V16, P39; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kan XH, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-498; Kolappan C, 2007, INT J TUBERC LUNG D, V11, P999; Kolappan C, 2013, Indian J Tuberc, V60, P168; Kulkarni S, 2005, RES MICROBIOL, V156, P588, DOI 10.1016/j.resmic.2005.01.005; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Rajapaksa US, 2008, T ROY SOC TROP MED H, V102, P997, DOI 10.1016/j.trstmh.2008.04.025; Rao VG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043225; Shanmugam S, 2011, INFECT GENET EVOL, V11, P980, DOI 10.1016/j.meegid.2011.03.011; Shetty N, 2006, INT J TUBERC LUNG D, V10, P80; Shprykov A S, 1994, Probl Tuberk, P26; Singh UB, 2004, EMERG INFECT DIS, V10, P1138, DOI 10.3201/eid1006.030575; Singh UB, 2007, INFECT GENET EVOL, V7, P441, DOI 10.1016/j.meegid.2007.01.003; Sopori ML, 1998, ADV EXP MED BIOL, V437, P279; Thomas A, 2005, INT J TUBERC LUNG D, V9, P556; World Health Organization, 2011, TUB PREV SURV HDB LI; YU GP, 1988, TUBERCLE, V69, P105, DOI 10.1016/0041-3879(88)90072-4	34	56	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124260	10.1371/journal.pone.0124260	http://dx.doi.org/10.1371/journal.pone.0124260			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905900	gold, Green Published, Green Submitted			2022-12-27	WOS:000353332000062
J	Lin, JC; Wang, CC; Jiang, RS; Wang, WY; Liu, SA				Lin, Jin-Ching; Wang, Chen-Chi; Jiang, Rong-San; Wang, Wen-Yi; Liu, Shih-An			Impact of Somatic Mutations in the D-Loop of Mitochondrial DNA on the Survival of Oral Squamous Cell Carcinoma Patients	PLoS One			English	Article							CANCER; BETEL; NECK; HEAD; POLYMORPHISMS; TUMORS	Objectives The aim of this study was to investigate somatic mutations in the D-loop of mitochondrial DNA (mtDNA) and their impact on survival in oral squamous cell carcinoma patients. Materials and Methods Surgical specimen confirmed by pathological examination and corresponding non-cancerous tissues were collected from 120 oral squamous cell carcinoma patients. The sequence in the D-loop of mtDNA from non-cancerous tissues was compared with that from paired cancer samples and any sequence differences were recognized as somatic mutations. Results Somatic mutations in the D-loop of mtDNA were identified in 75 (62.5%) oral squamous cell carcinoma patients and most of them occurred in the poly-C tract. Although there were no significant differences in demographic and tumor-related features between participants with and without somatic mutation, the mutation group had a better survival rate (5 year disease-specific survival rate: 64.0% vs. 43.0%, P = 0.0266). Conclusion Somatic mutation in D-loop of mtDNA was associated with a better survival in oral squamous cell carcinoma patients.	[Lin, Jin-Ching] Taichung Vet Gen Hosp, Dept Radiat Oncol, Taichung, Taiwan; [Wang, Chen-Chi; Jiang, Rong-San; Liu, Shih-An] Taichung Vet Gen Hosp, Dept Otolaryngol, Taichung, Taiwan; [Lin, Jin-Ching; Wang, Chen-Chi; Liu, Shih-An] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan; [Wang, Wen-Yi] Hung Kuang Univ, Dept Nursing, Taichung, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Hungkuang University	Liu, SA (corresponding author), Taichung Vet Gen Hosp, Dept Otolaryngol, Taichung, Taiwan.	an1654@seed.net.tw			National Science Council [NSC 98-2314-B-075A-005-MY3]; Ministry of Health and Welfare, Taiwan, Republic of China [MOHW103-TD-B-111-10]	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Health and Welfare, Taiwan, Republic of China	This study was supported by grants from the National Science Council, (NSC 98-2314-B-075A-005-MY3) and the Ministry of Health and Welfare, (MOHW103-TD-B-111-10), Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Challen C, 2011, BRIT J CANCER, V104, P1319, DOI 10.1038/bjc.2011.96; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chatterjee A, 2011, CANCER PREV RES, V4, P638, DOI 10.1158/1940-6207.CAPR-10-0326; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; Chung CH, 2009, CLIN CANCER RES, V15, P6758, DOI 10.1158/1078-0432.CCR-09-0784; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; Ha PK, 2002, CLIN CANCER RES, V8, P2260; Hsu SH, 2013, HEAD NECK-J SCI SPEC, V35, P1801, DOI 10.1002/hed.23242; Lai CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065578; Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011; Lee HC, 2004, MUTAT RES-FUND MOL M, V547, P71, DOI 10.1016/j.mrfmmm.2003.12.011; Lee HC, 2001, MUTAT RES-GEN TOX EN, V493, P67, DOI 10.1016/S1383-5718(01)00160-7; Lievre A, 2006, BRIT J CANCER, V94, P692, DOI 10.1038/sj.bjc.6602993; Liu SA, 2012, EUR ARCH OTO-RHINO-L, V269, P1665, DOI 10.1007/s00405-011-1806-5; Mambo E, 2003, P NATL ACAD SCI USA, V100, P1838, DOI 10.1073/pnas.0437910100; Mondal R, 2013, ORAL ONCOL, V49, P345, DOI 10.1016/j.oraloncology.2012.11.003; Pai CY, 2006, FORENSIC SCI INT, V156, P124, DOI 10.1016/j.forsciint.2004.12.021; Pande P, 2002, ORAL ONCOL, V38, P491, DOI 10.1016/S1368-8375(01)00090-2; Prior SL, 2006, CARCINOGENESIS, V27, P945, DOI 10.1093/carcin/bgi326; Tan DJ, 2004, ANN NY ACAD SCI, V1011, P310, DOI 10.1196/annals.1293.030; Uchida F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056381; Uzawa K, 2012, ONCOTARGET, V3, P670; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Yin PH, 2010, MITOCHONDRION, V10, P174, DOI 10.1016/j.mito.2009.12.147; Zhang RX, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-155; Zhou SY, 2007, P NATL ACAD SCI USA, V104, P7540, DOI 10.1073/pnas.0610818104	26	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124322	10.1371/journal.pone.0124322	http://dx.doi.org/10.1371/journal.pone.0124322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906372	Green Submitted, gold, Green Published			2022-12-27	WOS:000353332000066
J	Talukder, AK; Ravishankar, S; Sasmal, K; Gandham, S; Prabhukumar, J; Achutharao, PH; Barh, D; Blasi, F				Talukder, Asoke K.; Ravishankar, Shashidhar; Sasmal, Krittika; Gandham, Santhosh; Prabhukumar, Jyothsna; Achutharao, Prahalad H.; Barh, Debmalya; Blasi, Francesco			XomAnnotate: Analysis of Heterogeneous and Complex Exome-A Step towards Translational Medicine	PLOS ONE			English	Article							COPY-NUMBER VARIATION; BREAST-CANCER; GENE-EXPRESSION; CELL-ADHESION; PATHWAYS; GENOME; ENRICHMENT; DISCOVERY; FRAMEWORK; SURVIVAL	In translational cancer medicine, implicated pathways and the relevant master genes are of focus. Exome's specificity, processing-time, and cost advantage makes it a compelling tool for this purpose. However, analysis of exome lacks reliable combinatory analysis tools and techniques. In this paper we present XomAnnotate -a meta-and functional-analysis software for exome. We compared UnifiedGenotyper, Freebayes, Delly, and Lumpy algorithms that were designed for whole-genome and combined their strengths in XomAnnotate for exome data through meta-analysis to identify comprehensive mutation profile (SNPs/SNVs, short inserts/deletes, and SVs) of patients. The mutation profile is annotated followed by functional analysis through pathway enrichment and network analysis to identify most critical genes and pathways implicated in the disease genesis. The efficacy of the software is verified through MDS and clustering and tested with available 11 familial nonBRCA1/ BRCA2 breast cancer exome data. The results showed that the most significantly affected pathways across all samples are cell communication and antigen processing and presentation. ESCO1, HYAL1, RAF1 and PRKCA emerged as the key genes. Network analysis further showed the purine and propanotate metabolism pathways along with RAF1 and PRKCA genes to be master regulators in these patients. Therefore, XomAnnotate is able to use exome data to identify entire mutation landscape, pathways, and the master genes accurately with wide concordance from earlier microarray and wholegenome studies -making it a suitable biomedical software for using exome in nextgeneration translational medicine.	[Talukder, Asoke K.; Ravishankar, Shashidhar; Sasmal, Krittika; Gandham, Santhosh; Prabhukumar, Jyothsna; Achutharao, Prahalad H.; Barh, Debmalya] InterpretOmics India Pvt Ltd, Bangalore 560008, Karnataka, India; [Barh, Debmalya] Inst Integrat Om & Appl Biotechnol, Ctr Genom & Appl Gene Technol, Purba Medinipur 721172, W Bengal, India; [Blasi, Francesco] IFOM Fdn Ist FIRC Oncol Mol, Lab Transcript Regulat Dev & Canc, Milan, Italy	IFOM - FIRC Institute of Molecular Oncology	Talukder, AK (corresponding author), InterpretOmics India Pvt Ltd, 329,7th Main,HAL 2nd Stage, Bangalore 560008, Karnataka, India.	asoke.talukder@interpretomics.co	Barh, Debmalya/O-4246-2015; Ravishankar, Shashidhar/AAL-2036-2021	Barh, Debmalya/0000-0002-2557-7768; Blasi, Francesco/0000-0001-9406-1784	InterpretOmics, Pvt. Ltd.	InterpretOmics, Pvt. Ltd.	The project was funded by InterpretOmics, Pvt. Ltd. The funder provided support in the form of salaries for authors AKT, SR, KS, SG, JP, PHA, DB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agresti A., 2010, ANAL ORDINAL CATEGOR, DOI [DOI 10.1002/9780470594001, 10.1002/9780470594001]; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Backenroth D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku345; Cartegni L, 2009, NAT REV GENET, V220, P538; Chen Yidong, 2005, Curr Protoc Bioinformatics, VChapter 7, DOI 10.1002/0471250953.bi0711s10; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Collins FS, 2013, NEW ENGL J MED, V369, P2369, DOI 10.1056/NEJMp1314561; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; D'Antonio M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S11; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Emery LA, 2009, AM J PATHOL, V175, P1292, DOI 10.2353/ajpath.2009.090115; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; FISHER JC, 1951, CANCER, V4, P916, DOI 10.1002/1097-0142(195109)4:5<916::AID-CNCR2820040504>3.0.CO;2-7; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Garrison E., 2012, PREPRINT; Gillis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017258; Gonzalez-Angulo AM, 2012, CLIN CANCER RES, V18, P1109, DOI 10.1158/1078-0432.CCR-11-2762; Gu ZG, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-56; Heng HHQ, 2009, J CELL PHYSIOL, V220, P538, DOI 10.1002/jcp.21799; Herrmann F, 2004, CANCER RES, V64, P215, DOI 10.1158/0008-5472.CAN-2522-2; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Hou FJ, 2005, MOL BIOL CELL, V16, P3908, DOI 10.1091/mbc.E04-12-1063; Hou JP, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0056-8; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber W, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S8; Gracia-Aznarez FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055681; Jones ME, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3206; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Latapy M, 2008, SOC NETWORKS, V30, P31, DOI 10.1016/j.socnet.2007.04.006; Layer RM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r84; Leontovich AA, 2012, INT J ONCOL, V40, P1858, DOI 10.3892/ijo.2012.1407; Li JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095217; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Liu Y, 2012, CANCER IMMUNOL IMMUN, V61, P789, DOI 10.1007/s00262-011-1137-9; Lonne GK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-76; Luedeke M, 2009, CANCER EPIDEM BIOMAR, V18, P3030, DOI 10.1158/1055-9965.EPI-09-0772; Ma'ayan A, 2007, MT SINAI J MED, V74, P27, DOI 10.1002/msj.20002; Mardinoglu A, 2012, J INTERN MED, V271, P142, DOI 10.1111/j.1365-2796.2011.02493.x; McCormick F, 2004, NATURE, V428, P267, DOI 10.1038/428267a; Nagano Makoto, 2012, Int J Cell Biol, V2012, P310616, DOI 10.1155/2012/310616; Newman MEJ, 2000, CONDMAT0011144 ARXIV; Paschos KA, 2009, CELL SIGNAL, V21, P665, DOI 10.1016/j.cellsig.2009.01.006; Price JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063313; R Core Team, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUR0IMAGE.2011.01.013]; Rabbani B, 2014, J HUM GENET, V59, P5, DOI 10.1038/jhg.2013.114; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Robins G., 2004, Computational & Mathematical Organization Theory, V10, P69, DOI 10.1023/B:CMOT.0000032580.12184.c0; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; Schramm G, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-39; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Shlien A, 2009, GENOME MED, V1, DOI 10.1186/gm62; Sindi SS, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r22; Singh-Blom UM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058977; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; TABIBZADEH SS, 1990, J CLIN ENDOCR METAB, V71, P740, DOI 10.1210/jcem-71-3-740; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Tan JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022836; Viola T, 2011, CELL MOL LIFE SCI, V68, P1131, DOI 10.1007/s00018-010-0600-7; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wei P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046887; Yan Q, 2013, TRANSL MED, V3, pe120, DOI [10.4172/2161-1025.1000e120, DOI 10.4172/2161-1025.1000E120]	68	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123569	10.1371/journal.pone.0123569	http://dx.doi.org/10.1371/journal.pone.0123569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905921	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000035
J	Balboa-Castillo, T; Lopez-Garca, E; Leon-Munoz, LM; Perez-Tasigchana, RF; Banegas, JR; Rodriguez-Artalejo, F; Guallar-Castillon, P				Balboa-Castillo, Teresa; Lopez-Garca, Esther; Leon-Munoz, Luz M.; Perez-Tasigchana, Raul F.; Ramon Banegas, Jose; Rodriguez-Artalejo, Fernando; Guallar-Castillon, Pilar			Chocolate and Health-Related Quality of Life: A Prospective Study	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; DARK CHOCOLATE; BLOOD-PRESSURE; SHORT-TERM; INSULIN SENSITIVITY; OLDER-ADULTS; COCOA; MOOD; METAANALYSIS	Background Chocolate consumption has been associated with a short-term reduction in blood pressure and cholesterol, and improvement of insulin sensitivity; however, participants could not be aware of presenting hypertension or hypercholesterolemia. Moreover, the effect of chocolate on mental health is uncertain. This study assessed the association of regular chocolate consumption with the physical (PCS) and mental (MCS) components of health-related quality of life (HRQL). Materials and methods We analyzed data from a cohort of 4599 individuals recruited in 2008-2010 and followed-up once prospectively to January 2013 (follow-up mean: 3.5 years). Regular chocolate consumption was assessed at baseline with a validated diet history. HRQL was assessed with the SF-12 v. 2 at baseline and at follow-up. Analyses were performed with linear regression and adjusted for the main confounders, including HRQL at baseline. Results At baseline, 72% of the study participants did not consume chocolate, 11% consumed <10 g/day and 17% >10 g/day. Chocolate consumption at baseline did not show an association with PCS and MCS of the SF-12 measured three years later. Compared to those who did not consume chocolate, the PCS scores were similar in those who consumed >10g/day (beta: -0.07; 95% confidence interval (95% CI): -0.94 to 0.80) and in those who consumed >10g/day (beta: 0.02; 95% CI:-0.71 to 0.75); corresponding figures for the MCS were 0.29; 95% CI: -0.67 to 1.26, and -0.57; 95% CI: -1.37 to 0.23. Similar results were found for sex, regardless of obesity, hypertension, hypercholesterolemia, diabetes or depression. Conclusions No evidence was found of an association between chocolate intake and the physical or mental components of HRQL.	[Balboa-Castillo, Teresa] Univ La Frontera, Sch Med, Dept Publ Hlth, Temuco, Chile; [Lopez-Garca, Esther; Leon-Munoz, Luz M.; Perez-Tasigchana, Raul F.; Ramon Banegas, Jose; Rodriguez-Artalejo, Fernando; Guallar-Castillon, Pilar] Univ Autonoma Madrid IdiPaz, CIBERESP, Sch Med, Dept Prevent Med & Publ Hlth, Madrid, Spain	Universidad de La Frontera; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Guallar-Castillon, P (corresponding author), Univ Autonoma Madrid IdiPaz, CIBERESP, Sch Med, Dept Prevent Med & Publ Hlth, Madrid, Spain.	mpilar.guallar@uam.es	Guallar-Castillon, Pilar/F-1533-2016; León-Muñoz, Luz M/H-8275-2017; Lopez-Garcia, Esther/A-8894-2019	Guallar-Castillon, Pilar/0000-0003-4759-6713; Perez Tasigchana, Raul Francisco/0000-0001-5718-6879; Leon-Munoz, Luz Maria/0000-0001-5447-5907	Sanofi-Aventis; FIS (Ministry of Health of Spain) [09/162, PI11/01379, PI12/1166]; Catedra UAM de Epidemiologia y Control del Riesgo Cardiovascular	Sanofi-Aventis(Sanofi-Aventis); FIS (Ministry of Health of Spain); Catedra UAM de Epidemiologia y Control del Riesgo Cardiovascular	Baseline data collection (ENRICA study) was funded by Sanofi-Aventis. Data collection during follow-up was funded by FIS grant 09/162 (Ministry of Health of Spain). Funding specific for this analysis was obtained from FIS grants PI11/01379 and PI12/1166 (Ministry of Health of Spain), and from the "Catedra UAM de Epidemiologia y Control del Riesgo Cardiovascular". The study funders had no role in study design or in the collection, analysis, and interpretation of data. The authors have sole responsibility for the manuscript content. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS30, DOI 10.1053/apmr.2000.20621; Banegas JR, 2006, AM J HYPERTENS, V19, P686, DOI 10.1016/j.amjhyper.2006.01.015; Barkeling B, 2002, INT J OBESITY, V26, P1239, DOI 10.1038/sj.ijo.0802034; Benton D, 1999, PUBLIC HEALTH NUTR, V2, P403, DOI 10.1017/S1368980099000555; Bruinsma K, 1999, J AM DIET ASSOC, V99, P1249, DOI 10.1016/S0002-8223(99)00307-7; Buijsse B, 2006, ARCH INTERN MED, V166, P411, DOI 10.1001/.411; Buitrago-Lopez A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4488; Crews WD, 2008, AM J CLIN NUTR, V87, P872, DOI 10.1093/ajcn/87.4.872; Cuenca-Garcia M, 2013, NUTRITION; Desch S, 2010, AM J HYPERTENS, V23, P97, DOI 10.1038/ajh.2009.213; Di Castelnuovo A, 2012, EUR J INTERN MED, V23, P15, DOI 10.1016/j.ejim.2011.07.014; Ding EL, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-2; Pena MEY, 2010, EUR J PUBLIC HEALTH, V20, P78, DOI 10.1093/eurpub/ckp098; Fernandez-Murga L, 2011, MATURITAS, V69, P312, DOI 10.1016/j.maturitas.2011.05.011; Golomb BA, 2012, ARCH INTERN MED, V172, P519, DOI 10.1001/archinternmed.2011.2100; Gomez Candera C, 2007, GUIA VISUAL ALIMENTO; Grassi D, 2005, AM J CLIN NUTR, V81, P611; Grassi D, 2008, J NUTR, V138, P1671, DOI 10.1093/jn/138.9.1671; Guallar-Castillon P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086074; Gutierrez-Fisac JL, 2012, OBES REV, V13, P388, DOI 10.1111/j.1467-789X.2011.00964.x; Hooper L, 2012, AM J CLIN NUTR, V95, P740, DOI 10.3945/ajcn.111.023457; International cocoa Organization (ICCO) webside, EX COMM 146 M WORLD; Jia L, 2010, AM J CLIN NUTR, V92, P218, DOI 10.3945/ajcn.2009.28202; Khan N, 2012, NUTR METAB CARDIOVAS, V22, P1046, DOI 10.1016/j.numecd.2011.02.001; Macht M, 2002, APPETITE, V39, P147, DOI 10.1006/appe.2002.0499; Macht M, 2007, APPETITE, V49, P667, DOI 10.1016/j.appet.2007.05.004; Macht M, 2006, APPETITE, V46, P332, DOI 10.1016/j.appet.2006.01.014; MOLLER SE, 1992, PHARMACOL TOXICOL, V71, P61, DOI 10.1111/j.1600-0773.1992.tb01630.x; Myint PK, 2006, ANN EPIDEMIOL, V16, P492, DOI 10.1016/j.annepidem.2005.04.005; Otero-Rodriguez A, 2010, QUAL LIFE RES, V19, P15, DOI 10.1007/s11136-009-9561-4; Parker G, 2006, J AFFECT DISORDERS, V92, P149, DOI 10.1016/j.jad.2006.02.007; Pols MA, 1997, INT J EPIDEMIOL, V26, pS181, DOI 10.1093/ije/26.suppl_1.S181; Ried K, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-39; Rodriguez-Artalejo F, 2005, ARCH INTERN MED, V165, P1274, DOI 10.1001/archinte.165.11.1274; Rodriguez-Artalejo F, 2011, REV ESP CARDIOL, V64, P876, DOI 10.1016/j.recesp.2011.05.019; Rose N, 2010, ARCH INTERN MED, V170, P699, DOI 10.1001/archinternmed.2010.78; SABELLI HC, 1995, J NEUROPSYCH CLIN N, V7, P6; Schmidt S, 2012, MED CLIN-BARCELONA, V139, P613, DOI 10.1016/j.medcli.2011.10.024; Shrime MG, 2011, J NUTR, V141, P1982, DOI 10.3945/jn.111.145482; Singh JA, 2005, SEMIN ARTHRITIS RHEU, V34, P755, DOI 10.1016/j.semarthrit.2004.08.001; Strandberg TE, 2008, EUR J CLIN NUTR, V62, P247, DOI 10.1038/sj.ejcn.1602707; THAYER RE, 1987, J PERS SOC PSYCHOL, V52, P119, DOI 10.1037/0022-3514.52.1.119; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Ul-Haq Z, 2013, OBESITY, V21, pE322, DOI 10.1002/oby.20107; Vilagut G, 2008, MED CLIN-BARCELONA, V130, P726, DOI 10.1157/13121076; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Zhang ZZ, 2013, INT J CARDIOL, V168, P5448, DOI 10.1016/j.ijcard.2012.12.036; 1997, INT J EPIDEMIOL S1, V26, pS91	48	5	5	0	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123161	10.1371/journal.pone.0123161	http://dx.doi.org/10.1371/journal.pone.0123161			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KV	25901348	Green Published, gold, Green Submitted			2022-12-27	WOS:000353331500044
J	Courtois, EA; Gaucher, P; Chave, J; Schmeller, DS				Courtois, Elodie A.; Gaucher, Philippe; Chave, Jerome; Schmeller, Dirk S.			Widespread Occurrence of Bd in French Guiana, South America	PLOS ONE			English	Article							FUNGUS BATRACHOCHYTRIUM-DENDROBATIDIS; POPULATION DECLINES; AMPHIBIAN DECLINES; CHYTRIDIOMYCOSIS; PATHOGEN; DYNAMICS; EXTINCTIONS; PREVALENCE; AUSTRALIA; INFECTION	The amphibian chytrid fungus Batrachochytrium dendrobatidis (Bd) is a purported agent of decline and extinction of many amphibian populations worldwide. Its occurrence remains poorly documented in many tropical regions, including the Guiana Shield, despite the area's high amphibian diversity. We conducted a comprehensive assessment of Bd in French Guiana in order to (1) determine its geographical distribution, (2) test variation of Bd prevalence among species in French Guiana and compare it to earlier reported values in other South American anuran species (http://www.bd-maps.net; 123 species from 15 genera) to define sentinel species for future work, (3) track changes in prevalence through time and (4) determine if Bd presence had a negative effect on one selected species. We tested the presence of Bd in 14 species at 11 sites for a total of 1053 samples (306 in 2009 and 747 in 2012). At least one Bd-positive individual was found at eight out of 11 sites, suggesting a wide distribution of Bd in French Guiana. The pathogen was not uniformly distributed among the studied amphibian hosts, with Dendrobatidae species displaying the highest prevalence (12.4%) as compared to Bufonidae (2.6%) and Hylidae (1.5%). In contrast to earlier reported values, we found highest prevalence for three Dendrobatidae species and two of them displayed an increase in Bd prevalence from 2009 to 2012. Those three species might be the sentinel species of choice for French Guiana. For Dendrobates tinctorius, of key conservation value in the Guiana Shield, smaller female individuals were more likely to be infected, suggesting either that frogs can outgrow their chytrid infections or that the disease induces developmental stress limiting growth. Generally, our study supports the idea that Bd is more widespread than previously thought and occurs at remote places in the lowland forest of the Guiana shield.	[Courtois, Elodie A.] Ctr Natl Rech Sci CNRS Moulis, Stn Ecol Expt, Unite Serv & Rech USR 2936, St Girons, France; [Courtois, Elodie A.; Gaucher, Philippe] Ctr Natl Rech Sci Guyane, Unite Serv & Rech USR 3456, Cayenne, French Guiana; [Chave, Jerome] Unite Mixte Rech UMR 5174, Lab Ecol & Diversite Biol, Toulouse, France; [Schmeller, Dirk S.] Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany; [Schmeller, Dirk S.] Univ Toulouse, Lab Ecol Fonct & Environm Ecolab, Toulouse, France; [Schmeller, Dirk S.] CNRS, EcoLab, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Courtois, EA (corresponding author), Ctr Natl Rech Sci CNRS Moulis, Stn Ecol Expt, Unite Serv & Rech USR 2936, St Girons, France.	courtoiselodie@gmail.com	Schmeller, Dirk S/F-4324-2010; Schmeller, Dirk S./S-6431-2019	Schmeller, Dirk S/0000-0002-3860-9933; Schmeller, Dirk S./0000-0002-3860-9933	Investissement d'Avenir (CEBA) [ANR-10-LABX-25-01]; Investissement d'Avenir (TULIP) [ANR-10-LABX-0041]; BioDiversa-project RACE (Risk Assessment of Chytridiomycosis to European amphibian biodiversity); AMAZONIE research program	Investissement d'Avenir (CEBA)(French National Research Agency (ANR)); Investissement d'Avenir (TULIP)(French National Research Agency (ANR)); BioDiversa-project RACE (Risk Assessment of Chytridiomycosis to European amphibian biodiversity); AMAZONIE research program	This work has benefited from two "Investissement d'Avenir" grants managed by the Agence Nationale de la Recherche (CEBA, ref. ANR-10-LABX-25-01 and TULIP, ref. ANR-10-LABX-0041) and benefitted through the use of the Nouragues station of material and technical support from USR 3456 and AnaEE-S infrastructure (ANR-11-INBS-0001). This work was financially supported by a grant from the AMAZONIE research program and from the BioDiversa-project RACE (Risk Assessment of Chytridiomycosis to European amphibian biodiversity) to DSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, BIOL CONSERV; Bancila RI, 2010, AMPHIBIA-REPTILIA, V31, P558, DOI 10.1163/017353710X518405; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bielby J, 2008, CONSERV LETT, V1, P82, DOI 10.1111/j.1755-263X.2008.00015.x; Bletz MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08633; BONGERS F, 2001, NOURAGUES DYNAMICS P; Bourke J, 2010, DIS AQUAT ORGAN, V92, P217, DOI 10.3354/dao02239; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Buck JC, 2011, BIODIVERS CONSERV, V20, P3549, DOI 10.1007/s10531-011-0147-4; Collins JP, 2003, DIVERS DISTRIB, V9, P89, DOI 10.1046/j.1472-4642.2003.00012.x; Courtois EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067486; Courtois Elodie A., 2012, PHYLLOMEDUSA, V11, P63; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Geiger CC, 2011, AMPHIBIA-REPTILIA, V32, P276, DOI 10.1163/017353711X556970; Gower DJ, 2013, ECOHEALTH, V10, P173, DOI 10.1007/s10393-013-0831-9; Hero JM, 2004, HERPETOL J, V14, P175; Herrera RA, 2005, DIS AQUAT ORGAN, V64, P247, DOI 10.3354/dao064247; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Kilburn VL, 2010, ECOHEALTH, V7, P537, DOI 10.1007/s10393-010-0634-1; Kosch Tiffany A., 2012, Herpetological Review, V43, P288; Kriger KM, 2008, AUSTRAL ECOL, V33, P1022, DOI 10.1111/j.1442-9993.2008.01872.x; Kriger KM, 2007, DIVERS DISTRIB, V13, P781, DOI 10.1111/j.1472-4642.2007.00394.x; Lamirande EW, 2002, P 6 INT S PATH REPT, P3; Lampo Margarita, 2008, Herpetological Review, V39, P449; Lescure J., 2001, ATLAS AMPHIBIENS GUY; Lips KR, 2005, BIOTROPICA, V37, P163, DOI 10.1111/j.1744-7429.2005.00023.x; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; Lotters S., 2007, POISON FROGS BIOL SP; Luger M, 2008, STUD NEOTROP FAUNA E, V43, P177, DOI 10.1080/01650520802239531; Mazzoni R, 2003, EMERG INFECT DIS, V9, P1188; McCracken Shawn, 2009, Herpetological Review, V40, P190; Carnaval ACOD, 2006, ECOHEALTH, V3, P41, DOI 10.1007/s10393-005-0008-2; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Parris MJ, 2004, ECOLOGY, V85, P3385, DOI 10.1890/04-0383; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Pistoni Juliana, 2010, South American Journal of Herpetology, V5, P51, DOI 10.2994/057.005.0106; Rebollar EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095484; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Ringler M, 2009, BEHAV ECOL SOCIOBIOL, V63, P1281, DOI 10.1007/s00265-009-0793-7; RON SR, 2000, FROGLOG, V42, P2; Schmeller DS, 2014, CURR BIOL, V24, P176, DOI 10.1016/j.cub.2013.11.032; Skerratt LF, 2008, DIS AQUAT ORGAN, V80, P85, DOI 10.3354/dao01923; Solis R, 2010, BIOL INVASIONS, V12, P1641, DOI 10.1007/s10530-009-9577-2; Spitzen-van der Sluijs A, 2011, AMPHIBIA-REPTILIA, V32, P419, DOI 10.1163/017353711X579830; Stevenson LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073830; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tobler U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010927; Flechas SV, 2012, ECOHEALTH, V9, P298, DOI 10.1007/s10393-012-0771-9; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Walker SF, 2010, ECOL LETT, V13, P372, DOI 10.1111/j.1461-0248.2009.01434.x; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x	56	14	16	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0125128	10.1371/journal.pone.0125128	http://dx.doi.org/10.1371/journal.pone.0125128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902035	Green Published, gold, Green Submitted			2022-12-27	WOS:000353331500112
J	Li, X; Yang, YC; Gao, B; Zhang, M				Li, Xuan; Yang, Yuechao; Gao, Bin; Zhang, Min			Stimulation of Peanut Seedling Development and Growth by Zero-Valent Iron Nanoparticles at Low Concentrations	PLOS ONE			English	Article							REMEDIATION; DEFICIENCY; PLANTS; PARTICLES; REDUCTION; EXPOSURE; STRESS; NZVI	Because of its strong pollutant degradation ability, nanoscale zerovalent iron (NZVI) has been introduced to soils and groundwater for remediation purposes, but its impacts on plants are still not very clear. In this work, the effects of low concentration (10-320 mu mol/L) NZVI particles on seed germination and growth of peanut plants were evaluated. The exposure of peanut seeds to NZVI at all the tested concentrations altered the seed germination activity, especially the development of seedlings. In comparison with the deionized water treated controls (CK), all of the NZVI treatments had significantly larger average lengths. Further investigations with transmission electron microscopy (TEM) and thermogravimetric analysis (TGA) suggested that NZVI particles may penetrate the peanut seed coats to increase the water uptake to stimulate seed germination. The growth experiments showed that although NZVI at a relatively high concentration (320 mu mol/L) showed phytotoxicity to the peanut plants, the lower concentrations of NZVI particles stimulated the growth and root development of the plants. At certain concentrations (e.g., 40 and 80 mu mol/L), the NZVI treated samples were even better than the ethylenediaminetetraacetate-iron (EDTA-Fe) solution, a commonly used iron nutrient solution, in stimulating the plant growth. This positive effect was probably due to the uptake of NZVI by the plants, as indicated in the TEM analyses. Because low concentrations of NZVI particles stimulated both the seedling development and growth of peanut, they might be used to benefit the growth of peanuts in large-scale agricultural settings.	[Li, Xuan; Yang, Yuechao; Zhang, Min] Shandong Agr Univ, Natl Engn Lab Efficient Utilizat Soil & Fertilize, Natl Engn & Technol Res Ctr Slow & Controlled Rel, Coll Resources & Environm, Tai An 271018, Shandong, Peoples R China; [Yang, Yuechao] Univ Florida, Dept Soil & Water Sci, Trop Res & Educ Ctr, Homestead, FL USA; [Gao, Bin] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL USA	Shandong Agricultural University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Yang, YC (corresponding author), Shandong Agr Univ, Natl Engn Lab Efficient Utilizat Soil & Fertilize, Natl Engn & Technol Res Ctr Slow & Controlled Rel, Coll Resources & Environm, Tai An 271018, Shandong, Peoples R China.	yangyuechao2010@163.com	Gao, Bin/B-8027-2010	Gao, Bin/0000-0003-3769-0191; Yang, Yuechao/0000-0003-4045-0252	major agricultural application technology innovation projects of Shandong Province; Science Tackles Key Problems of Shandong Province [2009GG10006002]; Natural Science Foundation of Shandong Province [Y2008.D29]; Key Projects in the National Science & Technology Pillar Program [2011BAD11B01, 2011BAD11B02]; Key Projects in the National "948" Program [2011-G30]	major agricultural application technology innovation projects of Shandong Province; Science Tackles Key Problems of Shandong Province; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Key Projects in the National Science & Technology Pillar Program; Key Projects in the National "948" Program	This work was partially supported by the major agricultural application technology innovation projects of Shandong Province, the Science Tackles Key Problems of Shandong Province (Grant No. 2009GG10006002), the Natural Science Foundation of Shandong Province (Grant No. Y2008.D29), the Key Projects in the National Science & Technology Pillar Program (2011BAD11B01,2011BAD11B02), and the Key Projects in the National "948" Program (Grant No. 2011-G30).	Adeleye AS, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1418-7; Barnes RJ, 2010, J HAZARD MATER, V184, P73, DOI 10.1016/j.jhazmat.2010.08.006; delaGuardia MD, 1996, J EXP BOT, V47, P669, DOI 10.1093/jxb/47.5.669; Diao MH, 2009, WATER RES, V43, P5243, DOI 10.1016/j.watres.2009.08.051; Ding H, 2009, PHYSIOL PLANTARUM, V136, P274, DOI 10.1111/j.1399-3054.2009.01219.x; El-Temsah YS, 2012, CHEMOSPHERE, V89, P76, DOI 10.1016/j.chemosphere.2012.04.020; El-Temsah YS, 2012, ENVIRON TOXICOL, V27, P42, DOI 10.1002/tox.20610; FAGERIA NK, 1990, PESQUI AGROPECU BRAS, V25, P553; HOAGLAND DR, 1950, AGR EXP STN CIRC, V347, P1036; Huber DL, 2005, SMALL, V1, P482, DOI 10.1002/smll.200500006; Josko I, 2013, CRIT REV ENV SCI TEC, V43, P2581, DOI 10.1080/10643389.2012.694329; Karn B, 2011, CIENC SAUDE COLETIVA, V16, P165, DOI 10.1590/S1413-81232011000100020; Karn B, 2009, ENVIRON HEALTH PERSP, V117, P1823, DOI 10.1289/ehp.0900793; Khodakovskaya M, 2009, ACS NANO, V3, P3221, DOI 10.1021/nn900887m; Khodakovskaya MV, 2012, ACS NANO, V6, P2128, DOI 10.1021/nn204643g; Kim JH, 2014, ENVIRON SCI TECHNOL, V48, P3477, DOI 10.1021/es4043462; Lee C, 2008, ENVIRON SCI TECHNOL, V42, P4927, DOI 10.1021/es800408u; Lin SJ, 2009, SMALL, V5, P1128, DOI 10.1002/smll.200801556; Sacca ML, 2013, MICROB ECOL, V66, P806, DOI 10.1007/s00248-013-0269-1; Ma XM, 2013, SCI TOTAL ENVIRON, V443, P844, DOI 10.1016/j.scitotenv.2012.11.073; Nurmi JT, 2005, ENVIRON SCI TECHNOL, V39, P1221, DOI 10.1021/es049190u; Ponder SM, 2000, ENVIRON SCI TECHNOL, V34, P2564, DOI 10.1021/es9911420; Tang SCN, 2013, WATER RES, V47, P2613, DOI 10.1016/j.watres.2013.02.039; Teja AS, 2009, PROG CRYST GROWTH CH, V55, P22, DOI 10.1016/j.pcrysgrow.2008.08.003; Tosco T, 2014, J CLEAN PROD, V77, P10, DOI 10.1016/j.jclepro.2013.12.026; Trujillo-Reyes J, 2014, J HAZARD MATER, V267, P255, DOI 10.1016/j.jhazmat.2013.11.067; VANWONTERGHEM J, 1986, NATURE, V322, P622, DOI 10.1038/322622a0; Watanabe T, 2009, J PLANT NUTR, V32, P1164, DOI 10.1080/01904160902943189; Wulandari C, 2014, J PLANT NUTR, V37, P50, DOI 10.1080/01904167.2013.837178; Yan WL, 2013, ENVIRON SCI-PROC IMP, V15, P63, DOI [10.1039/c2em30691c, 10.1039]; Ylivainio K, 2004, J PLANT NUTR SOIL SC, V167, P602, DOI 10.1002/jpln.200420412; Zhang WX, 2003, J NANOPART RES, V5, P323, DOI 10.1023/A:1025520116015; Zhou DX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037363	33	83	90	6	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122884	10.1371/journal.pone.0122884	http://dx.doi.org/10.1371/journal.pone.0122884			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901959	gold, Green Published, Green Submitted			2022-12-27	WOS:000353331500031
J	Pile, V; Barnhofer, T; Wild, J				Pile, Victoria; Barnhofer, Thorsten; Wild, Jennifer			Updating versus Exposure to Prevent Consolidation of Conditioned Fear	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE-BEHAVIOR THERAPY; ANXIETY DISORDERS; INDIVIDUAL-DIFFERENCES; TRAUMATIC MEMORIES; EXTINCTION; PTSD; RECONSOLIDATION; VETERANS; IMAGES	Targeting the consolidation of fear memories following trauma may offer a promising method for preventing the development of flashbacks and other unwanted re-experiencing symptoms that characterise Posttraumatic Stress Disorder (PTSD). Research has demonstrated that performing visuo-spatial tasks after analogue trauma can block the consolidation of fear memory and reduce the frequency of flashbacks. However, no research has yet used verbal techniques to alter memories during the consolidation window. This is surprising given that the most effective treatments for PTSD are verbally-based with exposure therapy and trauma-focused cognitive behavioural therapy gaining the most evidence of efficacy. Psychological therapies aim to reduce the conditioned fear response, which is in keeping with the preliminary finding that an increased propensity for fear conditioning may be a vulnerability factor for PTSD. Our research had two aims. We investigated the degree to which individual differences in fear conditioning predict the development of PTSD symptoms. We also compared the preventative effects of two clinically informed psychological techniques administered during the consolidation window: exposure to the trauma memory and updating the meaning of the trauma. 115 healthy participants underwent a fear conditioning paradigm in which traumatic film stimuli (unconditioned stimuli) were paired with neutral stimuli (conditioned stimuli). Participants were randomly allocated to an updating, exposure or control group to compare the effects on the conditioned fear response and on PTSD symptomatology. The results showed that stronger conditioned responses at acquisition significantly predicted the development of PTSD symptoms. The updating group, who verbally devalued the unconditioned stimulus within the consolidation window, experienced significantly lower levels of PTSD symptoms during follow-up than the exposure and control groups. These findings are consistent with clinical interventions for chronic PTSD and have important implications for identifying those at risk as well as for designing novel early interventions to prevent the development of PTSD.	[Pile, Victoria; Barnhofer, Thorsten] Kings Coll London, Inst Psychiat, Dept Psychol, London WC2R 2LS, England; [Wild, Jennifer] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of London; King's College London; University of Oxford	Wild, J (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	jennifer.wild@psy.ox.ac.uk		Wild, Jennifer/0000-0001-5463-1711; Pile, Victoria/0000-0002-9177-2844	Wellcome Trust [069777]	Wellcome Trust(Wellcome TrustEuropean Commission)	Work by JW is supported through Wellcome Trust grant 069777 (http://www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenauer H, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-127; Aikins DE, 2011, PSYCHIAT RES, V188, P453, DOI 10.1016/j.psychres.2011.05.009; Arntz A, 2007, J BEHAV THER EXP PSY, V38, P345, DOI 10.1016/j.jbtep.2007.10.006; Arntz A, 2011, COGN BEHAV PRACT, V18, P466, DOI 10.1016/j.cbpra.2011.04.006; Blake D. D, 1990, CLINICIAN ADMINISTER; Blanchard EB, 2002, J TRAUMA STRESS, V15, P199, DOI 10.1023/A:1015299126858; BOUTON ME, 1979, LEARN MOTIV, V10, P445, DOI 10.1016/0023-9690(79)90057-2; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Brewin CR, 2010, PSYCHOL REV, V117, P210, DOI 10.1037/a0018113; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Bryant RA, 1999, AM J PSYCHIAT, V156, P1780; Bryant RA, 2008, ARCH GEN PSYCHIAT, V65, P659, DOI 10.1001/archpsyc.65.6.659; Clark D., 1998, BEHAV COGN PSYCHOTH, V26, P303; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; Dalgleish T, 2006, J ABNORM PSYCHOL, V115, P467, DOI 10.1037/0021-843X.115.3.467; DAVEY GCL, 1989, BEHAV RES THER, V27, P521, DOI 10.1016/0005-7967(89)90086-7; Davison AC, 2006, BOOTSTRAP METHODS AN; Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007; Dibbets P, 2012, J BEHAV THER EXP PSY, V43, P614, DOI 10.1016/j.jbtep.2011.08.006; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Ehlers A, 1998, J TRAUMA STRESS, V11, P457, DOI 10.1023/A:1024448511504; Ehlers A, 2008, NORD J PSYCHIAT, V62, P11, DOI 10.1080/08039480802315608; Field AP, 2006, CLIN PSYCHOL REV, V26, P857, DOI 10.1016/j.cpr.2005.05.010; Foa EB, 2006, J TRAUMA STRESS, V19, P29, DOI 10.1002/jts.20096; Greenberg LS, 2006, J CLIN PSYCHOL, V62, P611, DOI 10.1002/jclp.20252; Guthrie RM, 2006, PSYCHOSOM MED, V68, P307, DOI 10.1097/01.psy.0000208629.67653.cc; Hagenaars MA, 2012, J BEHAV THER EXP PSY, V43, P808, DOI 10.1016/j.jbtep.2011.09.005; Holmes EA, 2004, J EXP PSYCHOL GEN, V133, P3, DOI 10.1037/0096-3445.133.1.3; Holmes EA, 2008, ACTA PSYCHOL, V127, P553, DOI 10.1016/j.actpsy.2007.11.002; Holmes EA, 2007, J BEHAV THER EXP PSY, V38, P297, DOI 10.1016/j.jbtep.2007.10.007; Holmes EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004153; Hunt M, 2007, J BEHAV THER EXP PSY, V38, P329, DOI 10.1016/j.jbtep.2007.09.001; Hunt MG, 1998, BEHAV RES THER, V36, P361, DOI 10.1016/S0005-7967(98)00017-5; Hupbach A, 2007, LEARN MEMORY, V14, P47, DOI 10.1101/lm.365707; Keane TM, 1998, J CONSULT CLIN PSYCH, V66, P914, DOI 10.1037/0022-006X.66.6.914; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kindt M, 2013, BIOL PSYCHOL, V92, P43, DOI 10.1016/j.biopsycho.2011.09.016; Kleim B, 2010, PSYCHOSOM MED, V72, P917, DOI 10.1097/PSY.0b013e3181f8894b; Krans J, 2009, MEMORY, V17, P809, DOI 10.1080/09658210903130780; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Kubzansky LD, 2007, ARCH GEN PSYCHIAT, V64, P109, DOI 10.1001/archpsyc.64.1.109; Laposa JM, 2006, BEHAV RES THER, V44, P925, DOI 10.1016/j.brat.2005.07.003; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; Lommen MJJ, 2013, BEHAV RES THER, V51, P63, DOI 10.1016/j.brat.2012.11.004; Lukaschek K, 2013, J PSYCHOSOM RES, V74, P340, DOI 10.1016/j.jpsychores.2012.12.011; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Mineka S, 2006, AM PSYCHOL, V61, P10, DOI 10.1037/0003-066X.61.1.10; Mineka S, 2008, ACTA PSYCHOL, V127, P567, DOI 10.1016/j.actpsy.2007.11.007; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Myers KM, 2006, LEARN MEMORY, V13, P216, DOI 10.1101/lm.119806; Nader Karim, 2013, Dialogues Clin Neurosci, V15, P475; Norrholm SD, 2008, BEHAV NEUROSCI, V122, P1016, DOI 10.1037/a0012604; Orr SP, 2000, J ABNORM PSYCHOL, V109, P290, DOI 10.1037//0021-843X.109.2.290; Orr SP, 2000, J AFFECT DISORDERS, V61, P225, DOI 10.1016/S0165-0327(00)00340-2; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Pavlov I.P., 1927, CONDITIONED REFLEXES; Pineles SL, 2009, PSYCHOPHYSIOLOGY, V46, P984, DOI 10.1111/j.1469-8986.2009.00852.x; Pitman RK, 1996, COMPR PSYCHIAT, V37, P409, DOI 10.1016/S0010-440X(96)90024-3; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; RESCORLA RA, 1973, J COMP PHYSIOL PSYCH, V82, P137, DOI 10.1037/h0033815; Richards JM, 2000, J PERS SOC PSYCHOL, V79, P410, DOI 10.1037//0022-3514.79.3.410; Rothbaum BG, 2008, AM J EMERG MED, V26, P326, DOI 10.1016/j.ajem.2007.07.006; Rothbaum BO, 2012, BIOL PSYCHIAT, V72, P957, DOI 10.1016/j.biopsych.2012.06.002; Rothbaum BO, 2003, ANN NY ACAD SCI, V1008, P112, DOI 10.1196/annals.1301.012; ROTHBAUM BO, 1992, J TRAUMA STRESS, V5, P455, DOI 10.1007/BF00977239; Schartau PES, 2009, J ABNORM PSYCHOL, V118, P15, DOI 10.1037/a0012906; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Shalev AY, 2012, ARCH GEN PSYCHIAT, V69, P166, DOI 10.1001/archgenpsychiatry.2011.127; Shalev AY, 1998, ARCH GEN PSYCHIAT, V55, P553, DOI 10.1001/archpsyc.55.6.553; SHALEV AY, 1993, PSYCHOSOM MED, V55, P413, DOI 10.1097/00006842-199309000-00003; Smeets G, 1997, ANXIETY STRESS COPIN, V10, P245, DOI 10.1080/10615809708249303; Spielberger CD, 1983, MANUAL FOR THE STATE; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; SQUIRE LR, 1981, ANNU REV PHARMACOL, V21, P323, DOI 10.1146/annurev.pa.21.040181.001543; Stein MB, 1997, AM J PSYCHIAT, V154, P1114; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Watkins E, 2004, BEHAV RES THER, V42, P1037, DOI 10.1016/j.brat.2004.01.009; Watson JB, 1920, J EXP PSYCHOL, V3, P1, DOI 10.1037/h0069608; Weiss Daniel S., 1997, P399; Whelton WJ, 2004, CLIN PSYCHOL PSYCHOT, V11, P58, DOI 10.1002/cpp.392; Wild J, 2008, BEHAV THER, V39, P47, DOI 10.1016/j.beth.2007.04.003; Wild J, 2007, J BEHAV THER EXP PSY, V38, P386, DOI 10.1016/j.jbtep.2007.07.003; Wild J, 2011, COGN BEHAV PRACT, V18, P433, DOI 10.1016/j.cbpra.2011.03.002; Woud ML, 2012, EMOTION, V12, P778, DOI 10.1037/a0024992; Xue Y, 2012, AM J CARDIOL, V109, P1215, DOI 10.1016/j.amjcard.2011.11.063; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61; Zeng XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101589; Zinbarg RE, 1998, J PERS SOC PSYCHOL, V74, P1024, DOI 10.1037/0022-3514.74.4.1024	94	8	9	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122971	10.1371/journal.pone.0122971	http://dx.doi.org/10.1371/journal.pone.0122971			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KV	25902141	gold, Green Published, Green Submitted			2022-12-27	WOS:000353331500034
J	Regland, B; Forsmark, S; Halaouate, L; Matousek, M; Peilot, B; Zachrisson, O; Gottfries, CG				Regland, Bjorn; Forsmark, Sara; Halaouate, Lena; Matousek, Michael; Peilot, Birgitta; Zachrisson, Olof; Gottfries, Carl-Gerhard			Response to Vitamin B12 and Folic Acid in Myalgic Encephalomyelitis and Fibromyalgia	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; NMDA RECEPTOR; MEGALIN; HOMOCYSTEINE; CLASSIFICATION	Background Patients with myalgic encephalomyelitis (ME, also called chronic fatigue syndrome) may respond most favorably to frequent vitamin B12 injections, in vital combination with oral folic acid. However, there is no established algorithm for individualized optimal dosages, and rate of improvement may differ considerably between responders. Objective To evaluate clinical data from patients with ME, with or without fibromyalgia, who had been on B12 injections at least once a week for six months and up to several years. Methods 38 patients were included in a cross-sectional survey. Based on a validated observer's rating scale, they were divided into Good (n = 15) and Mild (n = 23) responders, and the two groups were compared from various clinical aspects. Results Good responders had used significantly more frequent injections (p<0.03) and higher doses of B12 (p < 0.03) for a longer time (p<0.0005), higher daily amounts of oral folic acid (p<0.003) in good relation with the individual MTHFR genotype, more often thyroid hormones (p<0.02), and no strong analgesics at all, while 70% of Mild responders (p<0.0005) used analgesics such as opioids, duloxetine or pregabalin on a daily basis. In addition to ME, the higher number of patients with fibromyalgia among Mild responders was bordering on significance (p<0.09). Good responders rated themselves as "very much" or "much" improved, while Mild responders rated "much" or "minimally" improved. Conclusions Dose-response relationship and long-lasting effects of B12/folic acid support a true positive response in the studied group of patients with ME/fibromyalgia. It's important to be alert on co-existing thyroid dysfunction, and we suspect a risk of counteracting interference between B12/folic acid and certain opioid analgesics and other drugs that have to be demethylated as part of their metabolism. These issues should be considered when controlled trials for ME and fibromyalgia are to be designed.	[Regland, Bjorn; Forsmark, Sara; Halaouate, Lena; Matousek, Michael; Peilot, Birgitta; Zachrisson, Olof; Gottfries, Carl-Gerhard] Gothenburg Univ, Gottfries Clin, Inst Neurosci & Physiol, Gothenburg, Sweden	University of Gothenburg	Regland, B (corresponding author), Gothenburg Univ, Gottfries Clin, Inst Neurosci & Physiol, Gothenburg, Sweden.	bjorn.regland@neuro.gu.se						Bickel MH, 1963, LIFE SCI, V2, P247; Birch CS, 2009, FREE RADICAL BIO MED, V47, P184, DOI 10.1016/j.freeradbiomed.2009.04.023; Birn H, 2005, FEBS J, V272, P4423, DOI 10.1111/j.1742-4658.2005.04857.x; Bizzaro N, 2014, AUTOIMMUN REV, V13, P565, DOI 10.1016/j.autrev.2014.01.042; Brenu EW, 2014, J CLIN CELL IMMUNOL, V5, P228, DOI [10.4172/2155-9899.1000228, DOI 10.4172/2155-9899.1000228]; Carruthers BM, 2003, J CHRONIC FATIGUE SY, V11, P7, DOI [DOI 10.1300/J092V11N01_02, 10.1300/J092v11n01_02]; Chango A, 2000, BRIT J NUTR, V83, P593, DOI 10.1017/S0007114500000751; de Vega WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104757; DICKENSON AH, 1987, NEUROPHARMACOLOGY, V26, P1235, DOI 10.1016/0028-3908(87)90275-9; Elfaitouri A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081155; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gena P, 2010, ENVIRON HEALTH PERSP, V118, P1551, DOI 10.1289/ehp.0901874; Grond S, 2004, CLIN PHARMACOKINET, V43, P879, DOI 10.2165/00003088-200443130-00004; Lipton SA, 1997, P NATL ACAD SCI USA, V94, P5923, DOI 10.1073/pnas.94.11.5923; Marzolo MP, 2011, BIOL RES, V44, P89, DOI 10.4067/S0716-97602011000100012; Massoudi Mehran S., 1995, Annals of Epidemiology, V5, P229, DOI 10.1016/1047-2797(94)00110-F; Moestrup SK, 1996, P NATL ACAD SCI USA, V93, P8612, DOI 10.1073/pnas.93.16.8612; Nijs J, 2012, EUR J CLIN INVEST, V42, P203, DOI 10.1111/j.1365-2362.2011.02575.x; Ogino S, 2003, J HUM GENET, V48, P1, DOI 10.1007/s100380300000; OLNEY JW, 1987, BRAIN RES BULL, V19, P597, DOI 10.1016/0361-9230(87)90077-3; PARDRIDGE WM, 1976, J NEUROCHEM, V27, P333, DOI 10.1111/j.1471-4159.1976.tb01595.x; Regland B, 1997, SCAND J RHEUMATOL, V26, P301, DOI 10.3109/03009749709105320; Rietsema WJ, 2014, J AM GERIATR SOC, V62, P1611, DOI 10.1111/jgs.12966; Sousa MM, 2000, J BIOL CHEM, V275, P38176, DOI 10.1074/jbc.M002886200; Suarez-Moreira E, 2009, J AM CHEM SOC, V131, P15078, DOI 10.1021/ja904670x; Vollset SE, 2013, LANCET, V381, P1029, DOI 10.1016/S0140-6736(12)62001-7; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Zachrisson O, 2002, J PSYCHOSOM RES, V52, P501, DOI 10.1016/S0022-3999(01)00315-4	28	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124648	10.1371/journal.pone.0124648	http://dx.doi.org/10.1371/journal.pone.0124648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902009	Green Submitted, Green Published, gold			2022-12-27	WOS:000353331500096
J	Singh, S; Chand, S; Singh, NK; Sharma, TR				Singh, Sangeeta; Chand, Suresh; Singh, N. K.; Sharma, Tilak Raj			Genome-Wide Distribution, Organisation and Functional Characterization of Disease Resistance and Defence Response Genes across Rice Species	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; ARABIDOPSIS-THALIANA; EXPRESSION ANALYSIS; MILDEW RESISTANCE; ENCODING GENES; REPEAT GENES; EVOLUTION; IDENTIFICATION; ANALOGS; DIVERSITY	The resistance (R) genes and defense response (DR) genes have become very important resources for the development of disease resistant cultivars. In the present investigation, genome-wide identification, expression, phylogenetic and synteny analysis was done for R and DR-genes across three species of rice viz: Oryza sativa ssp indica cv 93-11, Oryza sativa ssp japonica and wild rice species, Oryza brachyantha. We used the in silico approach to identify and map 786 R-genes and 167 DR-genes, 672 R-genes and 142 DR-genes, 251 R-genes and 86 DR-genes in the japonica, indica and O. brachyanth a genomes, respectively. Our analysis showed that 60.5% and 55.6% of the R-genes are tandemly repeated within clusters and distributed over all the rice chromosomes in indica and japonica genomes, respectively. The phylogenetic analysis along with motif distribution shows high degree of conservation of R- and DR-genes in clusters. In silico expression analysis of R-genes and DR-genes showed more than 85% were expressed genes showing corresponding EST matches in the databases. This study gave special emphasis on mechanisms of gene evolution and duplication for R and DR genes across species. Analysis of paralogs across rice species indicated 17% and 4.38% R-genes, 29% and 11.63% DR-genes duplication in indica and Oryza brachyantha, as compared to 20% and 26% duplication of R-genes and DR-genes in japonica respectively. We found that during the course of duplication only 9.5% of R- and DR-genes changed their function and rest of the genes have maintained their identity. Syntenic relationship across three genomes inferred that more orthology is shared between indica and japonica genomes as compared to brachyantha genome. Genome wide identification of R-genes and DR-genes in the rice genome will help in allele mining and functional validation of these genes, and to understand molecular mechanism of disease resistance and their evolution in rice and related species.	[Singh, Sangeeta; Singh, N. K.; Sharma, Tilak Raj] Natl Res Ctr Plant Biotechnol, New Delhi 110012, India; [Singh, Sangeeta; Chand, Suresh] Devi Ahilya Univ, Sch Life Sci, Indore 452017, Madhya Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB); Devi Ahilya University	Sharma, TR (corresponding author), Natl Res Ctr Plant Biotechnol, Pusa Campus, New Delhi 110012, India.	trsharma@nrcpb.org	Singh, Nouratan/N-9377-2017	Singh, Nouratan/0000-0002-8063-8375; SINGH, SANGEETA/0000-0003-3600-9982	Indian Council of Agricultural Research (ICAR, NPTC Project); Department of Biotechnology, Government of India	Indian Council of Agricultural Research (ICAR, NPTC Project); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Financial support to TRS for this project was provided by Indian Council of Agricultural Research (ICAR, NPTC Project), http://www.icar.org.in/, and the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameline-Torregrosa C, 2008, PLANT PHYSIOL, V146, P5, DOI 10.1104/pp.107.104588; [Anonymous], 2005, BMC BIOL, V3, P1; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bai JF, 2002, GENOME RES, V12, P1871, DOI 10.1101/gr.454902; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Baker B, 1997, SCIENCE, V276, P726, DOI 10.1126/science.276.5313.726; Barbosa-Da-Silva A, 2005, GENET MOL BIOL, V28, P562, DOI 10.1590/S1415-47572005000400011; Baumgarten A, 2003, GENETICS, V165, P309; Benko-Iseppon AM, 2003, THEOR APPL GENET, V107, P379, DOI 10.1007/s00122-003-1260-x; Bittner-Eddy PD, 2000, PLANT J, V21, P177, DOI 10.1046/j.1365-313x.2000.00664.x; Botella MA, 1997, PLANT J, V12, P1197, DOI 10.1046/j.1365-313X.1997.12051197.x; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Channamallikarjuna V, 2010, MOL BREEDING, V25, P155, DOI 10.1007/s11032-009-9316-5; Chen G, 2007, J BIOSCIENCES, V32, P713, DOI 10.1007/s12038-007-0071-7; Chen JF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2596; Chen QH, 2010, J MOL EVOL, V70, P137, DOI 10.1007/s00239-009-9316-4; Cheng XA, 2010, GENET MOL BIOL, V33, P292, DOI 10.1590/S1415-47572010005000036; Cordero JC, 2002, THEOR APPL GENET, V104, P1283, DOI 10.1007/s00122-001-0821-0; Dai LY, 2007, J INTEGR PLANT BIOL, V49, P112, DOI 10.1111/j.1744-7909.2006.00413.x; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Ellis J, 2000, CURR OPIN PLANT BIOL, V3, P278, DOI 10.1016/S1369-5266(00)00080-7; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Ghazi IA, 2009, J BIOSCIENCES, V34, P251, DOI 10.1007/s12038-009-0029-z; Glynn NC, 2008, PEST MANAG SCI, V64, P48, DOI 10.1002/ps.1469; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HammondKosack KE, 1997, ANNU REV PLANT PHYS, V48, P575, DOI 10.1146/annurev.arplant.48.1.575; Jinling Liu, 2007, Journal of Genetics and Genomics, V34, P765, DOI 10.1016/S1673-8527(07)60087-3; Jones JDG, 2001, CURR OPIN PLANT BIOL, V4, P281, DOI 10.1016/S1369-5266(00)00174-6; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Kohler A, 2008, PLANT MOL BIOL, V66, P619, DOI 10.1007/s11103-008-9293-9; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Ku HM, 2000, P NATL ACAD SCI USA, V97, P9121, DOI 10.1073/pnas.160271297; Kuang H, 2004, PLANT CELL, V16, P2870, DOI 10.1105/tpc.104.025502; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Lin HN, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-18; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Meyers BC, 1998, PLANT CELL, V10, P1817, DOI 10.1105/tpc.10.11.1817; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Monosi B, 2004, THEOR APPL GENET, V109, P1434, DOI 10.1007/s00122-004-1758-x; Mun JH, 2009, MOL GENET GENOMICS, V282, P617, DOI 10.1007/s00438-009-0492-0; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ohtsuki A, 2006, J THEOR BIOL, V238, P780, DOI 10.1016/j.jtbi.2005.06.030; Ou S. H, 1985, RICE DIS; Palomino C, 2006, GENOME, V49, P1227, DOI 10.1139/G06-071; Pryor T, 1993, ADV PLANT PATHOL, V10, P281; Radwan O, 2008, MOL GENET GENOMICS, V280, P111, DOI 10.1007/s00438-008-0346-1; Rawal HC, 2013, INT J GENOMICS, V2013, DOI 10.1155/2013/678969; Richly E, 2002, MOL BIOL EVOL, V19, P76, DOI 10.1093/oxfordjournals.molbev.a003984; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Singh NK, 2012, J PLANT BIOCHEM BIOT, V21, P98, DOI 10.1007/s13562-011-0088-8; Soriano JM, 2005, THEOR APPL GENET, V110, P980, DOI 10.1007/s00122-005-1920-0; Sun Q, 2001, GENETICS, V158, P423; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan XP, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-56; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Throude M, 2009, NUCLEIC ACIDS RES, V37, P1248, DOI 10.1093/nar/gkn1048; Wanderley-Nogueira AC, 2007, GENET MOL RES, V6, P866; Wang XY, 2007, GENETICS, V177, P1753, DOI 10.1534/genetics.107.073197; Wei FS, 2002, PLANT CELL, V14, P1903, DOI 10.1105/tpc.002238; Winter P, 2000, THEOR APPL GENET, V101, P1155, DOI 10.1007/s001220051592; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Xu Q, 2008, GENETICS, V178, P2081, DOI 10.1534/genetics.107.086421; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yang SH, 2008, MOL GENET GENOMICS, V280, P187, DOI 10.1007/s00438-008-0355-0; Yang SH, 2008, THEOR APPL GENET, V116, P165, DOI 10.1007/s00122-007-0656-4; Zhou T, 2004, MOL GENET GENOMICS, V271, P402, DOI 10.1007/s00438-004-0990-z	71	26	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0125964	10.1371/journal.pone.0125964	http://dx.doi.org/10.1371/journal.pone.0125964			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902056	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500120
J	Lee, JW; Park, HS; Park, SA; Ryu, SH; Meng, W; Jurgensmeier, JM; Kurie, JM; Hong, WK; Boyer, JL; Herbst, RS; Koo, JS				Lee, Jong Woo; Park, Hee Sun; Park, Sin-Aye; Ryu, Seung-Hee; Meng, Wuyi; Juergensmeier, Juliane M.; Kurie, Jonathan M.; Hong, Waun Ki; Boyer, Julie L.; Herbst, Roy S.; Koo, Ja Seok			A Novel Small-Molecule Inhibitor Targeting CREB-CBP Complex Possesses Anti-Cancer Effects along with Cell Cycle Regulation, Autophagy Suppression and Endoplasmic Reticulum Stress	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; MUCIN GENE-EXPRESSION; RETINOIC ACID; IDENTIFICATION; ACTIVATOR; DISEASE	Lung adenocarcinoma, the most common subtype of lung cancer, is the leading cause of cancer death worldwide. Despite attempts for the treatment of lung cancer which have been accumulating, promising new therapies are still needed. Here, we found that cyclic-AMP response element-binding protein (CREB)-CREB binding protein (CBP) transcription factors complex inhibitor, Naphthol AS-TR phosphate (NASTRp), is a potential therapeutic agent for lung cancer. We show that NASTRp inhibited oncogenic cell properties through cell cycle arrest with concomitant suppression of tumor-promoting autophagy with down-regulations of Atg5-12 and Atg7, and accumulation of p62 in human lung cancer cell lines. In addition, NASTRp induced expression of endoplasmic reticulum stress markers such as DDIT3/CHOP, and led to apoptosis along with Bim induction. These findings suggest that transcription factor/co-activator complex, CREB-CBP, can be a potential therapeutic target and its inhibition could be a novel therapeutic strategy for lung cancer.	[Lee, Jong Woo; Park, Hee Sun; Park, Sin-Aye; Juergensmeier, Juliane M.; Boyer, Julie L.; Herbst, Roy S.; Koo, Ja Seok] Yale Univ, Sch Med, Yale Comprehens Canc Ctr, Sect Med Oncol,Dept Internal Med, New Haven, CT 06520 USA; [Ryu, Seung-Hee] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Meng, Wuyi] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Kurie, Jonathan M.; Hong, Waun Ki] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Herbst, Roy S.; Koo, Ja Seok] Yale Comprehens Canc Ctr, Translat Res Program, New Haven, CT 06520 USA	Yale University; University of Ulsan; Asan Medical Center; Yale University; University of Texas System; UTMD Anderson Cancer Center; Yale University	Koo, JS (corresponding author), Yale Univ, Sch Med, Yale Comprehens Canc Ctr, Sect Med Oncol,Dept Internal Med, New Haven, CT 06520 USA.	jpeter.koo@yale.edu	Koo, J Peter/AAE-6700-2019; Park, Sin-Aye/E-2303-2019	Park, Hee Sun/0000-0002-9730-8524; Park, Sin-Aye/0000-0003-2456-3572	National Cancer Institute [R01-CA126801]; Yale Comprehensive Cancer Center; National Cancer Institute Cancer Center [CA-16359]; NATIONAL CANCER INSTITUTE [P30CA016359, R01CA126801] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Yale Comprehensive Cancer Center; National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute grant R01-CA126801 (JSK), a Pilot Grant from the Yale Comprehensive Cancer Center (JSK), and National Cancer Institute Cancer Center Support Grant CA-16359 (to Yale Comprehensive Cancer Center).	Aggarwal S, 2008, CANCER RES, V68, P981, DOI 10.1158/0008-5472.CAN-06-0249; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Baurin N, 2004, J CHEM INF COMP SCI, V44, P643, DOI 10.1021/ci034260m; Beier F, 1999, P NATL ACAD SCI USA, V96, P1433, DOI 10.1073/pnas.96.4.1433; Best JL, 2004, P NATL ACAD SCI USA, V101, P17622, DOI 10.1073/pnas.0406374101; Cheng JC, 2008, BLOOD, V111, P1182, DOI 10.1182/blood-blood-2007-04-083600; Conkright MD, 2005, TRENDS CELL BIOL, V15, P457, DOI 10.1016/j.tcb.2005.07.007; DALBY A, 1992, J CHEM INF COMP SCI, V32, P244, DOI 10.1021/ci00007a012; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Guo JY, 2013, GENE DEV, V27, P1447, DOI 10.1101/gad.219642.113; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Kasper LH, 2010, EMBO J, V29, P3660, DOI 10.1038/emboj.2010.235; Kim SW, 2007, MOL CELL BIOL, V27, P6933, DOI 10.1128/MCB.02385-06; Kim SW, 2007, CANCER RES, V67, P6565, DOI 10.1158/0008-5472.CAN-06-2783; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Koo JS, 1999, BIOCHEM J, V338, P351, DOI 10.1042/0264-6021:3380351; Lee J, 2011, CANCER PREV RES, V4, P1306, DOI 10.1158/1940-6207.CAPR-10-0364; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Moreno CS, 1999, IMMUNITY, V10, P143, DOI 10.1016/S1074-7613(00)80015-1; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Parker D, 1996, MOL CELL BIOL, V16, P694; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Ritchie DW, 2010, BIOINFORMATICS, V26, P2398, DOI 10.1093/bioinformatics/btq444; Seo HS, 2008, CANCER RES, V68, P6065, DOI 10.1158/0008-5472.CAN-07-5376; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sun HX, 2008, CANCER PREV RES, V1, P316, DOI 10.1158/1940-6207.CAPR-07-0002; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5	36	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0122628	10.1371/journal.pone.0122628	http://dx.doi.org/10.1371/journal.pone.0122628			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897662	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600012
J	Lin, MB; Sun, W; Gong, W; Zhou, ZY; Ding, YS; Hou, Q				Lin, Mingbao; Sun, Wei; Gong, Wan; Zhou, Zhiyu; Ding, Yasi; Hou, Qi			Methylophiopogonanone A Protects against Cerebral Ischemia/Reperfusion Injury and Attenuates Blood-Brain Barrier Disruption In Vitro	PLOS ONE			English	Article							ARTERY OCCLUSION; ISCHEMIA; STROKE; EDEMA; MODEL; HOMOISOFLAVONOIDS; EXPRESSION; TRIALS	Methylophiopogonanone A (MO-A), an active homoisoflavonoid of the Chinese herb Ophiopogon japonicus which has been shown to have protective effects on cerebral ischemia/reperfusion (I/R) injury, has been demonstrated to have anti-inflammatory and anti-oxidative properties. However, little is known about its role in cerebral I/R injury. Therefore, in this study, by using a middle cerebral artery occlusion (MCAO) and reperfusion rat model, the effect of MO-A on cerebral I/R injury was examined. The results showed that MO-A treatment reduced infarct volume and brain edema, improved neurological deficit scores, reversed animal body weight decreases, and increased animal survival time in the stroke groups. Western blotting showed that MO-A suppressed MMP-9, but restored the expression of claudin-3 and claudin-5. Furthermore, transmission electron microscopy were monitored to determine the blood-brain barrier (BBB) alterations in vitro. The results showed that MO-A markedly attenuated BBB damage in vitro. Additionally, MO-A inhibited ROS production in ECs and MMP-9 release in differentiated THP-1 cells in vitro, and suppressed ICAM-1 and VCAM-1 expression in ECs and leukocyte/EC adhesion. In conclusion, our data indicate that MO-A has therapeutic potential against cerebral I/R injury through its ability to attenuate BBB disruption by regulating the expression of MMP-9 and tight junction proteins.	[Lin, Mingbao; Ding, Yasi; Hou, Qi] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100730, Peoples R China; [Lin, Mingbao; Ding, Yasi; Hou, Qi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Sun, Wei] Capital Med Univ, Beijing Friendship Hosp, Clin Lab Ctr, Beijing, Peoples R China; [Gong, Wan] Zhejiang Chinese Med Univ, Coll Basic Med Sci, Hangzhou, Zhejiang, Peoples R China; [Zhou, Zhiyu] Jiangxi Univ Tradit Chinese Med, Coll Basic Med Sci, Nanchang, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; Zhejiang Chinese Medical University; Jiangxi University of Traditional Chinese Medicine	Hou, Q (corresponding author), Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100730, Peoples R China.	houq@imm.ac.cn			National Twelfth-Five Year Research Program of China [2012ZX09301002001002]; National Natural Science Foundation of China [81473398]; scientific research foundation of Beijing Friendship Hospital [Z20140512030022]	National Twelfth-Five Year Research Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); scientific research foundation of Beijing Friendship Hospital	The current study was supported by research grants from the National Twelfth-Five Year Research Program of China (2012ZX09301002001002), the National Natural Science Foundation of China (Grant No. 81473398) and the scientific research foundation of Beijing Friendship Hospital (Z20140512030022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Cheng Yu Dennis, 2004, NeuroRx, V1, P36, DOI 10.1007/BF03206566; Chopp M, 1996, J CEREBR BLOOD F MET, V16, P578, DOI 10.1097/00004647-199607000-00007; Curry SH, 2003, ANN NY ACAD SCI, V993, P69, DOI 10.1111/j.1749-6632.2003.tb07512.x; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Gasche Y, 2001, J CEREBR BLOOD F MET, V21, P1393, DOI 10.1097/00004647-200112000-00003; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; Gu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061641; Guan T, 2013, EUR J PHARMACOL, V714, P303, DOI 10.1016/j.ejphar.2013.07.036; Jin G, 2008, STROKE, V39, P2538, DOI 10.1161/STROKEAHA.108.514927; Khatri R, 2012, NEUROLOGY, V79, pS52, DOI 10.1212/WNL.0b013e3182697e70; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Li LH, 2013, CHIN J NAT MEDICINES, V11, P222, DOI [10.1016/S1875-5364(13)60020-5, 10.3724/SP.J.1009.2013.00222]; Li N, 2012, FITOTERAPIA, V83, P1042, DOI 10.1016/j.fitote.2012.05.011; Lijnen HR, 2001, THROMB HAEMOSTASIS, V86, P324; Lin YN, 2010, J PHARMACEUT BIOMED, V52, P757, DOI 10.1016/j.jpba.2010.02.016; Liu FD, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/464701; Liu Y, 2014, BRAIN RES, V1544, P45, DOI 10.1016/j.brainres.2013.11.031; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Miyazaki T, 2011, STROKE, V42, P1097, DOI 10.1161/STROKEAHA.110.598359; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; Sasaki Masanori, 2009, V549, P187, DOI 10.1007/978-1-60327-931-4_13; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Strbian D, 2008, NEUROSCIENCE, V153, P175, DOI 10.1016/j.neuroscience.2008.02.012; Wang Q, 2009, STROKE, V40, P2157, DOI 10.1161/STROKEAHA.108.541490; Wang ZF, 2011, J CEREBR BLOOD F MET, V31, P52, DOI 10.1038/jcbfm.2010.195; Wardlaw JM, 2009, ANN NEUROL, V65, P194, DOI 10.1002/ana.21549; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Zehendner CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082823; Zhang RL, 1999, STROKE, V30, P624, DOI 10.1161/01.STR.30.3.624; Zhou Yi-Feng, 2008, Chinese Journal of Natural Medicines, V6, P201, DOI 10.3724/SP.J.1009.2008.00201; Zhu HR, 2010, NEUROPHARMACOLOGY, V59, P70, DOI 10.1016/j.neuropharm.2010.03.017	35	33	37	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124558	10.1371/journal.pone.0124558	http://dx.doi.org/10.1371/journal.pone.0124558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897666	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600072
J	Rocco, ML; Balzamino, BO; Passeri, PP; Micera, A; Aloe, L				Rocco, Maria Luisa; Balzamino, Bijorn Omar; Passeri, Pamela Petrocchi; Micera, Alessandra; Aloe, Luigi			Effect of Purified Murine NGF on Isolated Photoreceptors of a Rodent Developing Retinitis Pigmentosa	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; RETINAL GANGLION-CELLS; ROYAL-COLLEGE; SURGEONS RAT; ANIMAL-MODEL; DEGENERATION; NEUROTROPHINS; EYE; EXPRESSION; P75	A number of different studies have shown that neurotrophins, including nerve growth factor (NGF) support the survival of retinal ganglion neurons during a variety if insults. Recently, we have reported that that eye NGF administration can protect also photoreceptor degeneration in a mice and rat with inherited retinitis pigmentosa. However, the evidence that NGF acts directly on photoreceptors and that other retinal cells mediate the NGF effect could not be excluded. In the present study we have isolated retinal cells from rats with inherited retinitis pigmentosa (RP) during the post-natal stage of photoreceptor degenerative. In presence of NGF, these cells are characterized by enhanced expression of NGF-receptors and rhodopsin, the specific marker of photoreceptor and better cell survival, as well as neuritis outgrowth. Together these observations support the hypothesis that NGF that NGF acts directly on photoreceptors survival and prevents photoreceptor degeneration as previously suggested by in vivo studies.	[Rocco, Maria Luisa; Passeri, Pamela Petrocchi; Aloe, Luigi] CNR, Inst Cell Biol & Neurobiol, Rome, Italy; [Balzamino, Bijorn Omar; Micera, Alessandra] IRCCS, GB Bietti Fdn, Rome, Italy; [Passeri, Pamela Petrocchi] Univ Roma Tor Vergata, Dept Med Syst, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia; University of Rome Tor Vergata	Aloe, L (corresponding author), CNR, Inst Cell Biol & Neurobiol, Rome, Italy.	luigi.aloe@cnr.it	Micera, Alessandra/J-3373-2013; balzamino, bijorn omar/A-4433-2013	balzamino, bijorn omar/0000-0002-2254-1647	project "NGF on Retinitis Pigmentosa" [RF-2010-2318561]; Italian Ministry of Health and Fondazione Roma (Italy)	project "NGF on Retinitis Pigmentosa"; Italian Ministry of Health and Fondazione Roma (Italy)(Fondazione Roma)	This study was partially supported by the project "NGF on Retinitis Pigmentosa" (RF-2010-2318561) to L. Aloe and M.L. Rocco. The findings of this study are part of the PhD program of M.L.R (University Tor Vergata, Rome, Italy). B.O. Balzamino and A. Micera were supported by the Italian Ministry of Health and Fondazione Roma (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola T, 2003, NEUROSCI LETT, V345, P37, DOI 10.1016/S0304-3940(03)00491-9; Amendola T, 2002, ARCH ITAL BIOL, V140, P81; Angelucci C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050804; BARDE Y-A, 1990, Progress in Growth Factor Research, V2, P237, DOI 10.1016/0955-2235(90)90021-B; BOCCHINI V, 1969, P NATL ACAD SCI USA, V64, P787, DOI 10.1073/pnas.64.2.787; Bourne M C, 1938, Br J Ophthalmol, V22, P613, DOI 10.1136/bjo.22.10.613; CARMIGNOTO G, 1989, J NEUROSCI, V9, P1263; CHAN KY, 1981, J NEUROSCI, V1, P1155; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Chen Q, 2015, GROWTH FACTORS, V24, P1; Coassin M, 2008, GRAEF ARCH CLIN EXP, V246, P1743, DOI 10.1007/s00417-008-0913-5; Colafrancesco V, 2011, ANN I SUPER SANITA, V47, P284, DOI 10.4415/ANN_11_03_08; DUNAIEF JL, 1995, HUM GENE THER, V6, P1225, DOI 10.1089/hum.1995.6.9-1225; el-Hifnawi E, 1989, Prog Clin Biol Res, V314, P343; FAKTOROVICH EG, 1990, NATURE, V347, P83, DOI 10.1038/347083a0; FISCHER W, 1987, NATURE, V329, P65, DOI 10.1038/329065a0; Frade JM, 1999, MICROSC RES TECHNIQ, V45, P243, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<243::AID-JEMT8>3.0.CO;2-S; Gouras P, 1999, INVEST OPHTH VIS SCI, V32, P1704; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Katai N, 2006, JPN J OPHTHALMOL, V50, P121, DOI 10.1007/s10384-005-0296-7; Lambiase A, 1996, GRAEF ARCH CLIN EXP, V234, pS96, DOI 10.1007/BF02343055; Lambiase A, 2009, ANN I SUPER SANITA, V45, P439; Lambiase A, 2009, P NATL ACAD SCI USA, V106, P13469, DOI 10.1073/pnas.0906678106; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; Lenzi L, 2005, VISION RES, V45, P1491, DOI 10.1016/j.visres.2004.12.020; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LI L, 1993, NAT GENET, V5, P413, DOI 10.1038/ng1293-413; Little CW, 1996, INVEST OPHTH VIS SCI, V37, P204; Lohr HR, 2006, EXP EYE RES, V83, P380, DOI 10.1016/j.exer.2006.01.014; LOPEZ R, 1989, INVEST OPHTH VIS SCI, V30, P586; Mantelli F, 2014, EUR J OPHTHALMOL, V24, P247, DOI 10.5301/ejo.5000359; McAllister AK, 2001, CELL MOL LIFE SCI, V58, P1054, DOI 10.1007/PL00000920; MEAKIN SO, 1992, TRENDS NEUROSCI, V15, P323, DOI 10.1016/0166-2236(92)90047-C; Micera A, 2004, CYTOKINE GROWTH F R, V15, P411, DOI 10.1016/j.cytogfr.2004.09.003; Micera A, 2007, CYTOKINE GROWTH F R, V18, P245, DOI 10.1016/j.cytogfr.2007.04.004; Micera A, 2006, EXP EYE RES, V83, P747, DOI 10.1016/j.exer.2006.03.010; Musarella MA, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/753547; PERRY J, 1995, CURR EYE RES, V14, P585, DOI 10.3109/02713689508998406; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; SILIPRANDI R, 1993, INVEST OPHTH VIS SCI, V34, P3232; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; STOECKEL K, 1975, BRAIN RES, V89, P1, DOI 10.1016/0006-8993(75)90129-8; Strauss O, 1998, ACTA ANAT, V162, P101; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; von Bartheld CS, 1998, HISTOL HISTOPATHOL, V13, P437, DOI 10.14670/HH-13.437; Zaccaro MC, 2001, J BIOL CHEM, V276, P31023, DOI 10.1074/jbc.M104630200	47	20	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124810	10.1371/journal.pone.0124810	http://dx.doi.org/10.1371/journal.pone.0124810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897972	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600088
J	Tsutsui, I; Miyoshi, T; Sukchai, H; Pinphoo, P; Aueumneoy, D; Meeanan, C; Songphatkaew, J; Klomkling, S; Yamaguchi, I; Ganmanee, M; Sudo, H; Hamano, K				Tsutsui, Isao; Miyoshi, Tatsuo; Sukchai, Halethichanok; Pinphoo, Piyarat; Aueumneoy, Dusit; Meeanan, Chonlada; Songphatkaew, Jaruwan; Klomkling, Sirimas; Yamaguchi, Iori; Ganmanee, Monthon; Sudo, Hiroyuki; Hamano, Kaoru			Ecological and Morphological Profile of Floating Spherical Cladophora socialis Aggregations in Central Thailand	PLOS ONE			English	Article							RNA GENE-SEQUENCES; CHLOROPHYTA; ULTRASTRUCTURE; PHYLOGENY	The unique beauty of spherical aggregation forming algae has attracted much attention from both the scientific and lay communities. Several aegagropilous seaweeds have been identified to date, including the plants of genus Cladophora and Chaetomorpha. However, this phenomenon remains poorly understood. In July 2013, a mass occurrence of spherical Cladophora aggregations was observed in a salt field reservoir in Central Thailand. The aims of the present study were to describe the habitat of the spherical aggregations and confirm the species. We performed a field survey, internal and external morphological observations, pyrenoid ultrastructure observations, and molecular sequence analysis. Floating spherical Cladophora aggregations (1-8 cm in diameter) were observed in an area similar to 560 m(2), on the downwind side of the reservoir where there was water movement. Individual filaments in the aggregations were entangled in each other; consequently, branches growing in different directions were observed within a clump. We suggest that water movement and morphological characteristics promote the formation of spherical aggregations in this species. The molecular sequencing results revealed that the study species was highly homologous to both Cladophora socialis and C. coelothrix. However, the diameter of the apical cells in the study species was less than that of C. coelothrix. The pyrenoid ultrastructure was more consistent with that of Cladophora socialis. We conclude that the study species is Cladophora socialis. This first record of spherical aggregations in this species advances our understanding of these formations. However, further detailed physical measurements are required to fully elucidate the mechanism behind these spherical formations.	[Tsutsui, Isao; Sudo, Hiroyuki] JIRCAS, Div Fisheries, Tsukuba, Ibaraki, Japan; [Miyoshi, Tatsuo; Hamano, Kaoru] Natl Res Inst Fisheries & Environm Inland Sea, Res Ctr Marine Invertebrates, Onomichi, Hiroshima, Japan; [Sukchai, Halethichanok; Meeanan, Chonlada; Klomkling, Sirimas] KMITL, SCORL, Bangkok, Thailand; [Tsutsui, Isao; Pinphoo, Piyarat; Aueumneoy, Dusit; Songphatkaew, Jaruwan; Ganmanee, Monthon] KMITL, Dept Anim Prod & Fisheries, Bangkok, Thailand; [Yamaguchi, Iori] Fukuoka Inst Technol, Dept Life Environm & Mat Sci, Fukuoka, Japan	Japan International Research Center for Agricultural Sciences; Japan Fisheries Research & Education Agency (FRA); King Mongkuts Institute of Technology Ladkrabang; King Mongkuts Institute of Technology Ladkrabang; Fukuoka Institute of Technology	Tsutsui, I (corresponding author), JIRCAS, Div Fisheries, Tsukuba, Ibaraki, Japan.	cong@affrc.go.jp			international research project "Development of aquaculture technologies for suitable and equitable production of aquatic products in tropical coastal areas"	international research project "Development of aquaculture technologies for suitable and equitable production of aquatic products in tropical coastal areas"	This study was funded and performed as part of the international research project "Development of aquaculture technologies for suitable and equitable production of aquatic products in tropical coastal areas" conducted by the Faculty of Agricultural Technology, KMITL and the Fisheries Division, JIRCAS. The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott IA, 2004, BISHOP MUSEUM B BOT, V4, P260; ArthurC.Mathieson, 2002, ALGAE, V17, P283; BACH SD, 1978, MAR POLLUT BULL, V9, P34, DOI 10.1016/0025-326X(78)90529-5; BAKKER FT, 1994, MOL PHYLOGENET EVOL, V3, P365, DOI 10.1006/mpev.1994.1043; Berry S, 2014, YAHOO NEWS      0929; Boedeker C, 2012, J PHYCOL, V48, P808, DOI 10.1111/j.1529-8817.2012.01145.x; Boedeker C, 2010, BIOSCIENCE, V60, P187, DOI 10.1525/bio.2010.60.3.5; Boedeker C, 2010, AQUAT BOT, V92, P75, DOI 10.1016/j.aquabot.2009.10.006; Boedeker C, 2009, AQUAT ECOL, V43, P891, DOI 10.1007/s10452-009-9231-1; Burrows, 1991, SEAWEEDS BRIT ISLES; CHAN K, 1978, PHYCOLOGIA, V17, P419, DOI 10.2216/i0031-8884-17-4-419.1; Cocquyt E, 2010, MOL BIOL EVOL, V27, P2052, DOI 10.1093/molbev/msq091; Dawes C., 2008, SEAWEEDS FLORIDA, V1; GIBBS SP, 1962, J ULTRA MOL STRUCT R, V7, P262, DOI 10.1016/S0022-5320(62)90022-9; Guiry MD, 2014, ALGAEBASE; Hanyuda T, 2002, J PHYCOL, V38, P564, DOI 10.1046/j.1529-8817.2002.01151.x; Hasegawa Y, 1978, OCCURRENCE SEAWATER, V19, P5; Hori T, 1967, SCI REPT TOKYO KYO B, V12, P225; Ichihara K, 2013, PHYCOLOGIA, V52, P398, DOI 10.2216/12-102.1; KUROGI M, 1980, Japanese Journal of Phycology, V28, P168; Leliaert F, 2003, EUR J PHYCOL, V38, P233, DOI 10.1080/1364253031000136376; Leliaert F, 2003, NOVA HEDWIGIA, V76, P45, DOI 10.1127/0029-5035/2003/0076-0045; Leliaert F., 2007, GREEN SEAWEEDS BRITA, P131; Leliaert F, 2007, MOL PHYLOGENET EVOL, V44, P1237, DOI 10.1016/j.ympev.2007.04.016; Lewin J., 1966, PHYCOLOGIA, V6, P1, DOI [10.2216/i0031-8884-6-1-1.1, DOI 10.2216/I0031-8884-6-1-1.1]; Littler D.S., 1989, MARINE PLANTS CARIBB; Mathieson AC, 2000, RHODORA, V102, P202; Matsuyama K, 2000, MEM NATN SCI MUS TOK, V34, P139; Matsuyama Kazuyo, 1998, Journal of Japanese Botany, V73, P279; Matsuyama-Serisawa K, 2009, MOUNT FUJI RES, V3, P13; Miyaji K, 1999, PHYCOLOGIA, V38, P267, DOI 10.2216/i0031-8884-38-4-267.1; NIIYAMA Y, 1989, PHYCOLOGIA, V28, P70, DOI 10.2216/i0031-8884-28-1-70.1; Niiyama Y, 1986, JAP J PHYCOL, V34, P216; Provasoli L, 1966, CULTURES COLLECTIONS, P63; Sakai Y, 1964, SCI PAPERS I ALGALOG; Sano O, 1994, MARIMO RES, V3, P26; SCOTT JL, 1976, CAN J BOT, V54, P1546, DOI 10.1139/b76-169; Thai Meteorological Department, 2014, CLIM DAT PER 2 UNPUB; Thiamdao S, 2012, CHIANG MAI J SCI, V39, P300; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Togashi T, 2014, SCI REP, V4, P1; van den Hoek C, 2000, NAT SCI MUS MONOGRAP, V19; VANDENHOEK C, 1984, PHYCOLOGIA, V23, P39, DOI 10.2216/i0031-8884-23-1-39.1; Wang XY, 1989, JAPANEE J PHYCOLGY, V37, P57; WITTMANN W, 1965, STAIN TECHNOL, V40, P161, DOI 10.3109/10520296509116398	45	7	7	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124997	10.1371/journal.pone.0124997	http://dx.doi.org/10.1371/journal.pone.0124997			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898393	Green Submitted, Green Published, gold			2022-12-27	WOS:000353212600094
J	Blaen, PJ; Jia, L; Peh, KSH; Field, RH; Balmford, A; MacDonald, MA; Bradbury, RB				Blaen, Phillip J.; Jia, Li; Peh, Kelvin S. -H.; Field, Rob H.; Balmford, Andrew; MacDonald, Michael A.; Bradbury, Richard B.			Rapid Assessment of Ecosystem Services Provided by Two Mineral Extraction Sites Restored for Nature Conservation in an Agricultural Landscape in Eastern England	PLOS ONE			English	Article							BENEFITS	Despite growing recognition that mineral sites restored for nature conservation can enhance local biodiversity, the wider societal benefits provided by this type of restoration relative to alternative options are not well understood. This study addresses this research gap by quantifying differences in ecosystem services provision under two common mineral site after-uses: nature conservation and agriculture. Using a combination of site-specific primary field data, benefits transfer and modelling, we show that for our sites restoration for nature conservation provides a more diverse array of ecosystem services than would be delivered under an agricultural restoration scenario. We also explore the effects of addressing different conservation targets, which we find alter the provision of ecosystem services on a service- specific basis. Highly species-focused intervention areas are associated with increased carbon storage and livestock grazing provision, whereas non-intervention areas are important for carbon sequestration, fishing, recreation and flood risk mitigation. The results of this study highlight the wider societal importance of restored mineral sites and may help conservation managers and planners to develop future restoration strategies that provide benefits for both biodiversity and human well-being.	[Blaen, Phillip J.; Field, Rob H.; MacDonald, Michael A.; Bradbury, Richard B.] RSPB, RSPB Ctr Conservat Sci, Sandy SG19 2DL, Beds, England; [Blaen, Phillip J.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham B15 2TT, W Midlands, England; [Jia, Li] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Peh, Kelvin S. -H.; Balmford, Andrew] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge CB2 3EJ, England; [Peh, Kelvin S. -H.] Univ Southampton, Inst Life Sci, Southampton SO17 1BJ, Hants, England	Royal Society for Protection of Birds; University of Birmingham; University of Hong Kong; University of Cambridge; University of Southampton	Blaen, PJ (corresponding author), RSPB, RSPB Ctr Conservat Sci, Sandy SG19 2DL, Beds, England.	p.j.blaen@bham.ac.uk	Peh, Kelvin/C-3408-2013; field, rob/M-4442-2019	Peh, Kelvin/0000-0002-2921-1341; field, rob/0000-0002-0194-6872; Blaen, Phillip/0000-0001-5748-3072; Bradbury, Richard/0000-0002-1245-2763; Balmford, Andrew/0000-0002-0144-3589	INTERREG North-West Europe programme - EU European Regional Development Fund [293J RESTORE]	INTERREG North-West Europe programme - EU European Regional Development Fund	PJB was supported by: INTERREG North-West Europe programme (financed by the EU European Regional Development Fund). www.nweurope.eu. Grant code: 293J RESTORE. All other authors received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard V, 2007, AGR ECOSYST ENVIRON, V121, P47, DOI 10.1016/j.agee.2006.12.004; Alonso I, 2012, NATURAL ENGLAND RES; Anderson-Teixeira KJ, 2011, GLOBAL CHANGE BIOL, V17, P425, DOI 10.1111/j.1365-2486.2010.02220.x; [Anonymous], 2007, CLIMATE CHANGE 2007; Arnberger A, 2011, LANDSCAPE RES, V36, P19, DOI 10.1080/01426397.2010.536204; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Bateman IJ, 2011, ENVIRON RESOUR ECON, V48, P177, DOI 10.1007/s10640-010-9418-x; Benes J, 2003, CONSERV BIOL, V17, P1058, DOI 10.1046/j.1523-1739.2003.02092.x; Bide T, 2013, UK MINERALS YB 2013; Birch JC, 2010, P NATL ACAD SCI USA, V107, P21925, DOI 10.1073/pnas.1003369107; Burkhard B, 2012, ECOL INDIC, V21, P17, DOI 10.1016/j.ecolind.2011.06.019; Couwenberg J., 2011, Mires and Peat, V8, P2; Couwenberg J., 2008, EMISSION REDUCTIONS; Davies A. M., 2006, NATURE MINERALS MINE; De Groot RS, 2013, CONSERV BIOL, V27, P1286, DOI 10.1111/cobi.12158; DEFRA, STRUCT AGR IND ENGL; DEFRA, 2014, AGR UK; DEFRA, 2010, FERT MAN RB209; Environment Agency England, 2014, GREAT OUS RIV DISCH; Fischer J, 2008, FRONT ECOL ENVIRON, V6, P382, DOI 10.1890/070019; Fisher B, 2011, BIODIVERS CONSERV, V20, P2461, DOI 10.1007/s10531-011-9998-y; Forster P., 2007, CLIMATE CHANGE 2007, DOI DOI 10.1103/PHYSREVB.77.220407; HAWKE CJ, 1996, REEDBED MANAGEMENT C; Hudson C., 2008, RSPB OUSE FEN MANAGE; Humphries Rowell Associates Ltd. Needingworth Environmental Statement Section, 1999, NEED QUARR WETL HA 2; Intergovernmental Panel on Climate Change, GUIDELINES NATL GREE, V4; Johnson AI, 1967, SPECIFIC YIELD COMPI; Kaltenborn BP, 2002, LANDSCAPE URBAN PLAN, V59, P1, DOI 10.1016/S0169-2046(01)00243-2; Kangas K, 2010, ECOL APPL, V20, P1775, DOI 10.1890/09-0399.1; Kareiva P, 2012, BIOSCIENCE, V62, P962, DOI 10.1525/bio.2012.62.11.5; King H., 2013, INTRO ECOSYSTEM SERV; Lal R, 2004, ENVIRON INT, V30, P981, DOI 10.1016/j.envint.2004.03.005; Lang B, 2012, FARM BUSINESS SURVEY; Lienhoop N, 2009, WATER RESOUR MANAG, V23, P965, DOI 10.1007/s11269-008-9309-x; Metzger MJ, 2006, AGR ECOSYST ENVIRON, V114, P69, DOI 10.1016/j.agee.2005.11.025; Miller SM, 2013, P NATL ACAD SCI USA, V110, P20018, DOI 10.1073/pnas.1314392110; Morey E, 2008, ECOL ECON, V68, P536, DOI 10.1016/j.ecolecon.2008.05.015; Morison J., 2012, UNDERSTANDING CARBON, P1; Office for National Statistics, 2011, 2011 CENS POP AN; Peh KSH, 2013, ECOSYST SERV, V5, pE51, DOI 10.1016/j.ecoser.2013.06.003; Peh KSH, 2014, ECOL EVOL, V4, P3875, DOI 10.1002/ece3.1248; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Plummer ML, 2009, FRONT ECOL ENVIRON, V7, P38, DOI 10.1890/080091; Posthumus H, 2010, ECOL ECON, V69, P1510, DOI 10.1016/j.ecolecon.2010.02.011; Pretty JN, 2006, ENVIRON SCI TECHNOL, V40, P1114, DOI 10.1021/es051670d; RATCLIFFE DA, 1974, PROC R SOC LON SER-A, V339, P355, DOI 10.1098/rspa.1974.0126; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Santoul F, 2004, BIODIVERS CONSERV, V13, P1231, DOI 10.1023/B:BIOC.0000018154.02096.4b; Seppelt R, 2011, J APPL ECOL, V48, P630, DOI 10.1111/j.1365-2664.2010.01952.x; Thomas MV, 2011, BIOGEOSCIENCES, V8, P1595, DOI 10.5194/bg-8-1595-2011; Wells M.P., 1997, EC PERSPECTIVES NATU	52	66	68	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0121010	10.1371/journal.pone.0121010	http://dx.doi.org/10.1371/journal.pone.0121010			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894293	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000353211700007
J	Hiyoshi, Y; Schetter, AJ; Okayama, H; Inamura, K; Anami, K; Nguyen, GH; Horikawa, I; Hawkes, JE; Bowman, ED; Leung, SY; Harris, CC				Hiyoshi, Yukiharu; Schetter, Aaron J.; Okayama, Hirokazu; Inamura, Kentaro; Anami, Katsuhiro; Nguyen, Giang H.; Horikawa, Izumi; Hawkes, Jason E.; Bowman, Elise D.; Leung, Suet Yi; Harris, Curtis C.			Increased MicroRNA-34b and-34c Predominantly Expressed in Stromal Tissues Is Associated with Poor Prognosis in Human Colon Cancer	PLOS ONE			English	Article							MIR-34A; IDENTIFICATION; METHYLATION; SURVIVAL; MIRNAS; LOOP	The microRNA-34 family (miR-34a, -34b and -34c) have been reported to be tumor suppressor microRNAs (miRNAs) that are regulated by the TP53 and DNA hypermethylation. However, the expression, regulation, and prognostic value of the miR-34 family have not been systematically studied in colon cancer. To elucidate the roles of miR-34 family in colon carcinogenesis, miR-34a/b/c were measured in tumors and adjacent noncancerous tissues from 159 American and 113 Chinese colon cancer patients using quantitative RT-PCR, and we examined associations between miR-34a/b/c expression with TNM staging, cancer-specific mortality, TP53 mutation status and Affymetrix microarray data. All miR-34 family members were significantly increased in colon tumors, counter to the proposed tumor suppressor role for these miRNAs. Increased miR-34b/c were observed in more advanced tumors in two independent cohorts and increased expression of miR-34b/c was associated with poor cancer-specific mortality. While the expression of miR-34 family was not associated with TP53 mutation status, TP53 transcriptional activity was associated with miR-34a/b/c expression that is consistent with the proposed regulation of miR-34a/b/c by TP53. To examine where the miR-34 family is expressed, the expression of miR-34 family was compared between epitheliums and stromal tissues using laser microdissection technique. The expression of miR-34b/c was increased significantly in stromal tissues, especially in cancer stroma, compared with epithelial tissue. In conclusion, increased miR-34b/c predominantly expressed in stromal tissues is associated with poor prognosis in colon cancer. MiR-34 may contribute to cancer-stromal interaction associated with colon cancer progression.	[Hiyoshi, Yukiharu; Schetter, Aaron J.; Okayama, Hirokazu; Inamura, Kentaro; Anami, Katsuhiro; Nguyen, Giang H.; Horikawa, Izumi; Hawkes, Jason E.; Bowman, Elise D.; Leung, Suet Yi; Harris, Curtis C.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Harris, CC (corresponding author), NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	curtis_harris@nih.gov	Inamura, Kentaro/G-4229-2018; Leung, Suet Yi/C-4340-2009; Leung, Suet Yi/T-9620-2019	Inamura, Kentaro/0000-0001-6444-3861; Okayama, Hirokazu/0000-0003-0966-4746; Leung, Suet Yi/0000-0001-8614-4619; Hawkes, Jason E./0000-0001-5870-181X	NATIONAL CANCER INSTITUTE [ZIABC011492] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Bu PC, 2013, CELL STEM CELL, V12, P602, DOI 10.1016/j.stem.2013.03.002; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Concepcion CP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002797; COSTA A, 1995, J PATHOL, V176, P45, DOI 10.1002/path.1711760108; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gao W, 2011, J CANCER RES CLIN, V137, P557, DOI 10.1007/s00432-010-0918-4; Hagman Z, 2010, INT J CANCER, V127, P2768, DOI 10.1002/ijc.25269; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Jamieson NB, 2012, CLIN CANCER RES, V18, P534, DOI 10.1158/1078-0432.CCR-11-0679; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Katada T, 2009, INT J ONCOL, V34, P537, DOI 10.3892/ijo_00000179; Lee CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007314; Liu W, 2007, WORLD J GASTROENTERO, V13, P497, DOI 10.3748/wjg.v13.i4.497; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mathe E, 2012, INT J CANCER, V131, P760, DOI 10.1002/ijc.26403; Merkel O, 2010, P NATL ACAD SCI USA, V107, P16228, DOI 10.1073/pnas.1009719107; Nakatani F, 2012, J PATHOL, V226, P796, DOI 10.1002/path.3007; Nishida N, 2012, CLIN CANCER RES, V18, P3054, DOI 10.1158/1078-0432.CCR-11-1078; Roy S, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-58; Siemens H, 2011, CELL CYCLE, V10, P4256, DOI 10.4161/cc.10.24.18552; Svoboda M, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-31; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Vogt M, 2011, VIRCHOWS ARCH, V458, P313, DOI 10.1007/s00428-010-1030-5; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang MJ, 2012, MED ONCOL, V29, P3113, DOI 10.1007/s12032-012-0241-9; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu JM, 2012, CARCINOGENESIS, V33, P519, DOI 10.1093/carcin/bgr304; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Zhang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007826	38	40	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124899	10.1371/journal.pone.0124899	http://dx.doi.org/10.1371/journal.pone.0124899			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894979	gold, Green Submitted, Green Published			2022-12-27	WOS:000353211700128
J	Hoppe, AL; Raghavan, ML; Hasan, DM				Hoppe, Anna L.; Raghavan, Madhavan L.; Hasan, David M.			Comparison of the Association of Sac Growth and Coil Compaction with Recurrence in Coil Embolized Cerebral Aneurysms	PLOS ONE			English	Article							RUPTURED INTRACRANIAL ANEURYSMS; GUGLIELMI DETACHABLE COILS; ENDOVASCULAR TREATMENT; RECANALIZATION; EXPERIENCE	Background and Purpose In recurrent cerebral aneurysms treated by coil embolization, coil compaction is regarded as the presumptive mechanism. We test the hypothesis that aneurysm growth is the primary recurrence mechanism. We also test the hypothesis that the coil mass will translate a measurable extent when recurrence occurs. Methods An objective, quantitative image analysis protocol was developed to determine the volumes of aneurysms and coil masses during initial and follow-up visits from 3D rotational angiograms. The population consisted of 15 recurrence and 12 non-recurrence control aneurysms initially completely coiled at a single center. An investigator sensitivity study was performed to assess the objectivity of the methods. Paired Wilcoxon tests (p<0.05, one-tailed) were performed to assess for aneurysm and coil growth. The translation of the coil mass center at follow-up was computed. A Mann Whitney U-Test (p<0.05, one-tailed) was used to compare translation of coil mass centers between recurrence and control subjects. Results Image analysis protocol was found to be insensitive to the investigator. Aneurysm growth was evident in the recurrence cohort (p=0.003) but not the control (p=0.136). There was no evidence of coil compaction in either the recurrence or control cohorts (recurrence: p=0.339; control: p=0.429). The translation of the coil mass centers was found to be significantly larger in the recurrence cohort than the control cohort (p=0.047). Conclusion Aneurysm sac growth, not coil compaction, was the primary mechanism of recurrence following successful coil embolization. The coil mass likely translates to a measurable extent when recurrence occurs and has the potential to serve as a non-angiographic recurrence marker.	[Hoppe, Anna L.; Raghavan, Madhavan L.] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA; [Hasan, David M.] Univ Iowa, Carver Coll Med, Dept Neurosurg, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Hasan, DM (corresponding author), Univ Iowa, Carver Coll Med, Dept Neurosurg, Iowa City, IA 52242 USA.	david-hasan@uiowa.edu		hasan, david/0000-0002-8335-5442	NIH/NINDS [R03NS079227-01A1]; NIH/NHLBI [R01HL083475];  [K08NS082363-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS079227, K08NS082363] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants from NIH/NINDS R03NS079227-01A1 (DH), NIH/NHLBI R01HL083475 (MLR) and K08NS082363-01A1 (DH).	Abdihalim M, 2014, J NEUROIMAGING, V24, P171, DOI 10.1111/j.1552-6569.2012.00786.x; Bavinzski G, 1999, J NEUROSURG, V91, P284, DOI 10.3171/jns.1999.91.2.0284; Byrne JV, 1999, J NEUROSURG, V90, P656, DOI 10.3171/jns.1999.90.4.0656; De Craene M, 2008, SPIE MED IMAGING 200; Ford MD, 2009, BRIT J RADIOL, V82, pS55, DOI 10.1259/bjr/67593727; Gallas S, 2005, AM J NEURORADIOL, V26, P1723; Hasan DM, 2012, STROKE, V43, P866, DOI 10.1161/STROKEAHA.111.637827; Hwang GJ, 2000, INTERV NEURORADIOL, V6, P195, DOI 10.1177/159101990000600304; Kang HS, 2006, NEUROSURGERY, V58, P60, DOI 10.1227/01.NEU.0000194188.51731.13; Lorensen W, 1987, 14 ANN C COMP GRAPH; Mericle RA, 1998, J NEUROSURG, V89, P142, DOI 10.3171/jns.1998.89.1.0142; Murayama Y, 2003, J NEUROSURG, V98, P959, DOI 10.3171/jns.2003.98.5.0959; OSHER S, 1988, J COMPUT PHYS, V79, P12, DOI 10.1016/0021-9991(88)90002-2; Otsu N., 1975, AUTOMATICA, V11, P62; Raymond J, 2003, STROKE, V34, P1398, DOI 10.1161/01.STR.0000073841.88563.E9; Sluzewski M, 2004, RADIOLOGY, V231, P653, DOI 10.1148/radiol.2313030460	16	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123017	10.1371/journal.pone.0123017	http://dx.doi.org/10.1371/journal.pone.0123017			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894532	Green Submitted, gold, Green Published			2022-12-27	WOS:000353211700021
J	Ortiz, D; Guiguemde, WA; Johnson, A; Elya, C; Anderson, J; Clark, J; Connelly, M; Yang, L; Min, J; Sato, Y; Guy, RK; Landfear, SM				Ortiz, Diana; Guiguemde, W. Armand; Johnson, Alex; Elya, Carolyn; Anderson, Johanna; Clark, Julie; Connelly, Michele; Yang, Lei; Min, Jaeki; Sato, Yuko; Guy, R. Kiplin; Landfear, Scott M.			Identification of Selective Inhibitors of the Plasmodium falciparum Hexose Transporter PfHT by Screening Focused Libraries of Anti-Malarial Compounds	PLOS ONE			English	Article							MALARIA PARASITE; VALIDATION; ARTEMISININ; RESISTANCE	Development of resistance against current antimalarial drugs necessitates the search for novel drugs that interact with different targets and have distinct mechanisms of action. Malaria parasites depend upon high levels of glucose uptake followed by inefficient metabolic utilization via the glycolytic pathway, and the Plasmodium falciparum hexose transporter PfHT, which mediates uptake of glucose, has thus been recognized as a promising drug target. This transporter is highly divergent from mammalian hexose transporters, and it appears to be a permease that is essential for parasite viability in intra-erythrocytic, mosquito, and liver stages of the parasite life cycle. An assay was developed that is appropriate for high throughput screening against PfHT based upon heterologous expression of PfHT in Leishmania mexicana parasites that are null mutants for their endogenous hexose transporters. Screening of two focused libraries of antimalarial compounds identified two such compounds that are high potency selective inhibitors of PfHT compared to human GLUT1. Additionally, 7 other compounds were identified that are lower potency and lower specificity PfHT inhibitors but might nonetheless serve as starting points for identification of analogs with more selective properties. These results further support the potential of PfHT as a novel drug target.	[Ortiz, Diana; Johnson, Alex; Elya, Carolyn; Anderson, Johanna; Sato, Yuko; Landfear, Scott M.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Guiguemde, W. Armand; Clark, Julie; Connelly, Michele; Yang, Lei; Min, Jaeki; Guy, R. Kiplin] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA	Oregon Health & Science University; St Jude Children's Research Hospital	Landfear, SM (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA.	landfear@ohsu.edu	Guy, Rodney/J-7107-2013	Guy, Rodney/0000-0002-9638-2060; Elya, Carolyn/0000-0002-9634-0303; Sato, Yuko/0000-0002-2177-5820; Min, Jaeki/0000-0002-0083-3198; Johnson, Alexander/0000-0002-4040-9797	National Institutes of Health [1 R01 AI079092, 5 UL1 RR024140 05]; Department of Defense [W81XWH-09-1-0429]; SML Medicines for Malaria Venture [MMV12-0038]; Lebanese Syrian Associated Charities; St. Jude Children's Research Hospital; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); SML Medicines for Malaria Venture; Lebanese Syrian Associated Charities; St. Jude Children's Research Hospital; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health, 1 R01 AI079092, SML; National Institutes of Health, 5 UL1 RR024140 05, SML, URL: http://www.ohsu.edu/xd/research/centers-institutes/octri/; Department of Defense, W81XWH-09-1-0429, SML Medicines for Malaria Venture, MMV12-0038, SML, URL: http://www.mmv.org/; Lebanese Syrian Associated Charities and St. Jude Children's Research Hospital, RKG, URL: www.stjude.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIDON GL, 1995, PHARMACEUT RES, V12, P413, DOI 10.1023/A:1016212804288; Blume M, 2011, FASEB J, V25, P1218, DOI 10.1096/fj.10-173278; Cammack N, 2011, SCIENCE, V333, P705, DOI 10.1126/science.1210875; Cornish-Bowden A., 1995, FUNDAMENTALS ENZYME; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; Delves M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001169; Di L, 2006, INT J PHARMACEUT, V317, P54, DOI 10.1016/j.ijpharm.2006.03.007; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Feistel T, 2008, MOL BIOCHEM PARASIT, V162, P71, DOI 10.1016/j.molbiopara.2008.07.005; Foth BJ, 2005, MOL MICROBIOL, V55, P39, DOI 10.1111/j.1365-2958.2004.04407.x; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Goktug AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049386; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; IOVANNISCI DM, 1984, MOL CELL BIOL, V4, P1013, DOI 10.1128/MCB.4.6.1013; Joet T, 2003, P NATL ACAD SCI USA, V100, P7476, DOI 10.1073/pnas.1330865100; Lang-Unnasch N, 1998, ANNU REV MICROBIOL, V52, P561, DOI 10.1146/annurev.micro.52.1.561; Lu C, 2006, DRUG METAB DISPOS, V34, P1600, DOI 10.1124/dmd.106.010793; Mahindroo N, 2010, BIOORGAN MED CHEM, V18, P4801, DOI 10.1016/j.bmc.2010.05.001; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Patel Asha Parbhu, 2008, Travel Med Infect Dis, V6, P58, DOI 10.1016/j.tmaid.2008.01.005; Plowe CV, 2007, CLIN INFECT DIS, V44, P1075, DOI 10.1086/512743; Rakesh, 2012, BIOORGAN MED CHEM, V20, P6063, DOI 10.1016/j.bmc.2012.08.023; Ritz C, 2005, J STAT SOFTW, V12, P1; Seyfang A, 2000, J BIOL CHEM, V275, P5687, DOI 10.1074/jbc.275.8.5687; Slavic K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-165; Slavic K, 2011, ANTIMICROB AGENTS CH, V55, P2824, DOI 10.1128/AAC.01739-10; Slavic K, 2010, MOL MICROBIOL, V75, P1402, DOI 10.1111/j.1365-2958.2010.07060.x; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Spangenberg T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062906; Staines HM, 2010, TRENDS PARASITOL, V26, P284, DOI 10.1016/j.pt.2010.03.004; TERKUILE BH, 1992, J PROTOZOOL, V39, P555; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; Woodrow CJ, 1999, J BIOL CHEM, V274, P7272, DOI 10.1074/jbc.274.11.7272; Yu YJ, 2011, J VIROL, V85, P1573, DOI 10.1128/JVI.01967-10; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang YQ, 2010, BIOORGAN MED CHEM, V18, P2756, DOI 10.1016/j.bmc.2010.02.013	38	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123598	10.1371/journal.pone.0123598	http://dx.doi.org/10.1371/journal.pone.0123598			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894322	Green Submitted, gold, Green Published			2022-12-27	WOS:000353211700046
J	Xu, XH; Du, CG; Li, HH; Du, J; Yan, X; Peng, L; Li, GY; Chen, ZJ				Xu, Xinghua; Du, Chigang; Li, Huihui; Du, Jing; Yan, Xue; Peng, Lina; Li, Guangyao; Chen, Zi-Jiang			Association of VEGF Genetic Polymorphisms with Recurrent Spontaneous Abortion Risk: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ENDOTHELIAL GROWTH-FACTOR; PREGNANCY LOSS; POPULATION STRATIFICATION; SPONTANEOUS MISCARRIAGE; PROTEIN-LEVELS; IDENTIFICATION; WOMEN; RECEPTORS; LETHALITY; GENOTYPE	Background Studies of the associations between the genetic polymorphisms of the vascular endothelial growth factor (VEGF) gene and recurrent spontaneous abortion (RSA) have revealed conflicting results. The present meta-analysis was performed to provide a more precise estimation of these relationships and to explore potential sources of heterogeneity that may have influenced the reported disparities. Methods An extensive literature search for relevant studies was conducted on PubMed, Embase, and The Cochrane Library through June 6, 2014. Crude odds ratio (OR) with 95% confidence intervals were calculated. Results 10 case-control studies including 1,832 RSA patients and 2,271 healthy controls were identified. Meta-analysis indicated that rs1570360, rs3025039, rs2010963, and rs3025020 polymorphisms in the VEGF gene correlated with elevated RSA risk. The rs1570360 variant was statistically significantly relevant to RSA risk among non-Asian populations. Interestingly, the rs3025039 variant was statistically significantly relevant to RSA risk among Asian populations. Conclusions The current meta-analysis indicates that rs1570360, rs3025039, rs2010963, and rs3025020 polymorphisms increase RSA susceptibility. Moreover, rs1570360 and rs3025039 polymorphisms may play various roles in RSA susceptibility in various geographic groups.	[Xu, Xinghua; Du, Jing; Peng, Lina] Liaocheng Peoples Hosp, Dept Gynecol & Obstet, Liaocheng 252000, Peoples R China; [Xu, Xinghua; Du, Jing; Chen, Zi-Jiang] Shandong Univ, Shandong Prov Hosp, Ctr Reprod Med, Jinan 250021, Peoples R China; [Xu, Xinghua; Du, Jing; Chen, Zi-Jiang] Shandong Prov Key Lab Reprod Med, Jinan 250021, Peoples R China; [Xu, Xinghua; Du, Jing; Chen, Zi-Jiang] Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan 250021, Peoples R China; [Xu, Xinghua; Du, Jing] Minist Educ, Key Lab Reprod Endocrinol, Jinan 250021, Peoples R China; [Du, Chigang] Liaocheng Peoples Hosp, Dept Neurosurg, Liaocheng 252000, Peoples R China; [Li, Huihui; Chen, Zi-Jiang] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Ctr Reprod Med, Shanghai 200127, Peoples R China; [Li, Huihui; Chen, Zi-Jiang] Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai 200127, Peoples R China; [Yan, Xue] Tianjin Third Cent Hosp, Dept Gynecol & Obstet, Tianjin 300170, Peoples R China; [Li, Guangyao] Liaocheng Peoples Hosp, Dept Hematol, Liaocheng 252000, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shanghai Jiao Tong University	Li, GY (corresponding author), Liaocheng Peoples Hosp, Dept Hematol, Liaocheng 252000, Peoples R China.	lcrmyy@163.com; chenzijiang@hotmail.com	Yan, Junhao/AAH-8310-2019; Li, Yuan/GXV-1310-2022; Chen, Zi-Jiang/GOE-6119-2022	Chen, Zi-Jiang/0000-0001-6637-6631				Aggarwal S, 2011, REPROD BIOMED ONLINE, V22, P59, DOI 10.1016/j.rbmo.2010.08.005; Al-Khateeb GM, 2011, FERTIL STERIL, V95, P2471, DOI 10.1016/j.fertnstert.2011.03.010; Almawi WY, 2013, HUM REPROD, V28, P2628, DOI 10.1093/humrep/det308; Baruffi RLR, 2013, FERTIL STERIL, V100, pS112, DOI 10.1016/j.fertnstert.2013.07.1669; Bautch VL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006452; Brogan IJ, 1999, HUM IMMUNOL, V60, P1245, DOI 10.1016/S0198-8859(99)00132-9; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carrington B, 2005, CURR OPIN OBSTET GYN, V17, P591, DOI 10.1097/01.gco.0000194112.86051.26; Coulam CB, 2008, AM J REPROD IMMUNOL, V59, P301, DOI 10.1111/j.1600-0897.2007.00515.x; De Falco S, 2012, EXP MOL MED, V44, P1, DOI 10.3858/emm.2012.44.1.025; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eller AG, 2011, J REPROD IMMUNOL, V88, P48, DOI 10.1016/j.jri.2010.06.159; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Franco JG, 2013, FERTIL STERIL, V100, pS307, DOI 10.1016/j.fertnstert.2013.07.1001; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806, DOI 10.1210/mend-5-12-1806; Jelkmann W, 2001, CLIN CHEM, V47, P617; Lee HH, 2010, FERTIL STERIL, V93, P1244, DOI 10.1016/j.fertnstert.2008.11.017; Lewis Cathryn M, 2012, Cold Spring Harb Protoc, V2012, P297, DOI 10.1101/pdb.top068163; Luo L, 2013, J MATERN-FETAL NEO M, V26, P686, DOI 10.3109/14767058.2012.746305; Magdoud K, 2012, HUM REPROD, V27, P1536, DOI 10.1093/humrep/des033; Medford ARL, 2009, CHEST, V136, P457, DOI 10.1378/chest.09-0383; Mohammadi Mojgan, 2009, Iran J Immunol, V6, P119, DOI IJIv6i3A2; Papaoglou D, 2005, FERTIL STERIL, V83, P959, DOI 10.1016/j.fertnstert.2004.12.017; Plaisier M, 2009, HUM REPROD, V24, P185, DOI 10.1093/humrep/den296; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Samli H, 2012, GENET MOL RES, V11, P4739, DOI 10.4238/2012.December.17.6; Samli H, 2011, HUM REPROD, V26, pI158; Serre D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001382; Sotiriadis A, 2007, OBSTET GYNECOL, V109, P1146, DOI 10.1097/01.AOG.0000260873.94196.d6; Stephenson MD, 1996, FERTIL STERIL, V66, P24; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Su MT, 2014, J ASSIST REPROD GEN, V31, P699, DOI 10.1007/s10815-014-0223-2; Su MT, 2011, HUM REPROD, V26, P758, DOI 10.1093/humrep/deq401; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Torry DS, 2004, AM J REPROD IMMUNOL, V51, P257, DOI 10.1111/j.1600-0897.2004.00154.x; Traina E, 2009, AM J REPROD IMMUNOL, V62, P210; Traina E, 2011, J REPROD IMMUNOL, V88, P53, DOI 10.1016/j.jri.2010.07.006; Vailhe B, 1999, HUM REPROD, V14, P1628, DOI 10.1093/humrep/14.6.1628; Vuorela P, 2000, MOL HUM REPROD, V6, P276, DOI 10.1093/molehr/6.3.276; Watson CJ, 2000, CYTOKINE, V12, P1232, DOI 10.1006/cyto.2000.0692; Xing XY, 2011, AM J REPROD IMMUNOL, V65, P521, DOI 10.1111/j.1600-0897.2010.00924.x; Yamada H, 2001, SEMIN THROMB HEMOST, V27, P121, DOI 10.1055/s-2001-14070; Zhang BZ, 2012, GENE, V507, P1, DOI 10.1016/j.gene.2012.06.049	46	24	27	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123696	10.1371/journal.pone.0123696	http://dx.doi.org/10.1371/journal.pone.0123696			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894555	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700049
J	Decaris, ML; Emson, CL; Li, K; Gatmaitan, M; Luo, F; Cattin, J; Nakamura, C; Holmes, WE; Angel, TE; Peters, MG; Turner, SM; Hellerstein, MK				Decaris, Martin L.; Emson, Claire L.; Li, Kelvin; Gatmaitan, Michelle; Luo, Flora; Cattin, Jerome; Nakamura, Corelle; Holmes, William E.; Angel, Thomas E.; Peters, Marion G.; Turner, Scott M.; Hellerstein, Marc K.			Turnover Rates of Hepatic Collagen and Circulating Collagen-Associated Proteins in Humans with Chronic Liver Disease	PLOS ONE			English	Article							ISOTOPOMER DISTRIBUTION ANALYSIS; EXTRACELLULAR-MATRIX; MASS-SPECTROMETRY; PROTEOMIC ANALYSIS; NATURAL-HISTORY; IN-VIVO; FIBROSIS; PROGRESSION; FIBROGENESIS; BIOPSIES	Accumulation and degradation of scar tissue in fibrotic liver disease occur slowly, typically over many years. Direct measurement of fibrogenesis, the rate of scar tissue deposition, may provide valuable therapeutic and prognostic information. We describe here results from a pilot study utilizing in vivo metabolic labeling to measure the turnover rate of hepatic collagen and collagen-associated proteins in plasma for the first time in human subjects. Eight subjects with chronic liver disease were labeled with daily oral doses of (H2O)-H-2 for up to 8 weeks prior to diagnostic liver biopsy and plasma collection. Tandem mass spectrometry was used to measure the abundance and fractional synthesis rate (FSR) of proteins in liver and blood. Relative protein abundance and FSR data in liver revealed marked differences among subjects. FSRs of hepatic type I and III collagen ranged from 0.2-0.6% per day (half-lives of 4 months to a year) and correlated significantly with worsening histologic fibrosis. Analysis of plasma protein turnover revealed two collagen-associated proteins, lumican and transforming growth factor beta-induced-protein (TGFBI), exhibiting FSRs that correlated significantly with FSRs of hepatic collagen. In summary, this is the first direct measurement of liver collagen turnover in vivo in humans and suggests a high rate of collagen remodeling in advanced fibrosis. In addition, the FSRs of collagen-associated proteins in plasma are measurable and may provide a novel strategy for monitoring hepatic fibrogenesis rates.	[Decaris, Martin L.; Emson, Claire L.; Li, Kelvin; Gatmaitan, Michelle; Luo, Flora; Cattin, Jerome; Nakamura, Corelle; Holmes, William E.; Angel, Thomas E.; Turner, Scott M.; Hellerstein, Marc K.] KineMed Inc, Dept Fibrosis, Emeryville, CA 94608 USA; [Hellerstein, Marc K.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Peters, Marion G.] Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco	Decaris, ML (corresponding author), KineMed Inc, Dept Fibrosis, Emeryville, CA 94608 USA.	mdecaris@kinemed.com; sturner@kinemed.com		Cattin, Jerome/0000-0002-8988-4265	KineMed, Inc.; UCSF Liver Center [P30 DK026743]; National Cancer Institute at the NIH [SBIR 1 R43 CA110965-01]; NATIONAL CANCER INSTITUTE [R43CA110965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	KineMed, Inc.; UCSF Liver Center; National Cancer Institute at the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Experimental studies were funded by KineMed, Inc. (www.kinemed.com), the UCSF Liver Center (P30 DK026743; http://livercenter.ucsf.edu), and the National Cancer Institute at the NIH (SBIR 1 R43 CA110965-01; http://www.cancer.gov). Study design, data collection and analysis, decision to publish, or preparation of the manuscript were carried out by KineMed, Inc.	Angel TE, 2012, CHEM SOC REV, V41, P3912, DOI 10.1039/c2cs15331a; Baker ES, 2014, MOL CELL PROTEOMICS, V13, P1119, DOI 10.1074/mcp.M113.034595; Baranova A, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-91; BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; Boers W, 2006, J BIOL CHEM, V281, P16289, DOI 10.1074/jbc.M600711200; Charlton M, 2009, HEPATOLOGY, V49, P1375, DOI 10.1002/hep.22927; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; Decaris ML, 2014, MOL CELL PROTEOMICS, V13, P1741, DOI 10.1074/mcp.M113.037267; Diamond DL, 2007, HEPATOLOGY, V46, P649, DOI 10.1002/hep.21751; Fassio E, 2004, HEPATOLOGY, V40, P820, DOI 10.1002/hep.20410; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Gonzalez-Casas R, 2009, WORLD J GASTROENTERO, V15, P4653, DOI 10.3748/wjg.15.4653; Hellerstein MK, 1999, AM J PHYSIOL-ENDOC M, V276, pE1146, DOI 10.1152/ajpendo.1999.276.6.E1146; Hellerstein MK, 2004, CURR OPIN MOL THER, V6, P249; Hoefs JC, 2011, GASTROENTEROLOGY, V141, P900, DOI 10.1053/j.gastro.2011.06.007; Kasumov T, 2011, ANAL BIOCHEM, V412, P47, DOI 10.1016/j.ab.2011.01.021; Kim MY, 2014, WORLD J GASTROENTERO, V20, P4300, DOI 10.3748/wjg.v20.i15.4300; Krishnan A, 2012, LAB INVEST, V92, P1712, DOI 10.1038/labinvest.2012.121; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Lee YA, 2014, ANTIVIR RES, V107, P23, DOI 10.1016/j.antiviral.2014.03.012; Mitchell C, 2009, AM J PATHOL, V175, P1929, DOI 10.2353/ajpath.2009.090332; Neuschwander-Tetri BA, 2014, LANCET, DOI [10.1016/S0140-6736(08)61345-8, DOI 10.1016/S0140-6736(08)61345-8]; Papageorgopoulos C, 1999, ANAL BIOCHEM, V267, P1, DOI 10.1006/abio.1998.2958; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Price JC, 2012, MOL CELL PROTEOMICS, V11, P1801, DOI 10.1074/mcp.M112.021204; Price JC, 2012, ANAL BIOCHEM, V420, P73, DOI 10.1016/j.ab.2011.09.007; Rashid ST, 2012, J PROTEOME RES, V11, P4052, DOI 10.1021/pr3000927; Stephen S, 2012, EXPERT REV GASTROENT, V6, P163, DOI [10.1586/EGH.11.97, 10.1586/egh.11.97]	29	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123311	10.1371/journal.pone.0123311	http://dx.doi.org/10.1371/journal.pone.0123311			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909381	Green Published, gold, Green Submitted			2022-12-27	WOS:000353376800033
J	Bian, Z; Shixia, C; Duan, T				Bian, Zheng; Shixia, Chenzi; Duan, Tao			First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia	PLOS ONE			English	Article							UTERINE ARTERY DOPPLER; PLACENTA GROWTH-FACTOR; GESTATIONAL HYPERTENSION; ANGIOGENIC FACTORS; NULLIPAROUS WOMEN; EARLY-PREGNANCY; CLINICAL RISK; 2ND-TRIMESTER; DISORDERS	Background Placental growth factor (PGF), soluble fms-like tyrosine kinase 1 (sFLT1) and asymmetric dimethylarginine (ADMA) are involved in the pathogenesis of preeclampsia. Abnormal maternal sFLT1, PGF and ADMA levels are detectable weeks before the onset of preeclampsia. Objective To investigate sFLT1, PGF and ADMA in the first trimester of pregnancy as predictors of preeclampsia. Methods In this prospective nested case-control study, 740 pregnant women enrolled at 12-16 weeks of gestation and followed up until 6 weeks after delivery at the Shanghai First Maternity and Infant Health Hospital of Tongji University between January 2010 and December 2012. Forty-four women developed preeclampsia. Urinary proteins were measured using 24-hour collection or dipsticks. sFLT1, PGF and ADMA were measured by ELISA in the first trimester. Pulsatility index (PI) was measured by Doppler ultrasound in the second trimester. Results First-trimester serum sFLT1 and ADMA levels of women who developed preeclampsia were significantly higher compared with women with normal pregnancies (sFLT1: 0.321 +/- 0.023 vs. 0.308 +/- 0.019 ng/ml, P = 0.001; ADMA: 0.86 +/- 0.16 vs. 0.68 +/- 0.20 mu M, P<0.001). First-trimester serum PGF levels of women who developed preeclampsia were significantly lower than in women with normal pregnancies (115.72 +/- 32.55 vs. 217.30 +/- 74.48 pg/ml, P<0.001). Multiple logistic regression and receiver-operating characteristic curves identified first-trimester PGF and ADMA to be sensitive and selective predictors of preeclampsia (area under the curve [AUC]: 0.902), as well as second-trimester uterine artery pulse index (AUC: 0.836). Conclusion In the first trimester, maternal serum sFLT1, PGF and ADMA levels, as well as second-trimester uterine artery PI, could predict preeclampsia.	[Bian, Zheng; Shixia, Chenzi; Duan, Tao] Tongji Univ, Shanghai Matern & Infant Hlth Hosp 1, Dept Obstet & Gynecol, Shanghai 200092, Peoples R China	Tongji University	Duan, T (corresponding author), Tongji Univ, Shanghai Matern & Infant Hlth Hosp 1, Dept Obstet & Gynecol, Shanghai 200092, Peoples R China.	tduan@yahoo.com			Key Disciplines Group Construction Project of Pudong Health Bureau of Shanghai [PWZxq2014-02]	Key Disciplines Group Construction Project of Pudong Health Bureau of Shanghai	The study was supported by Key Disciplines Group Construction Project of Pudong Health Bureau of Shanghai (Grant No.: PWZxq2014-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell S, 2000, ACTA OBSTET GYN SCAN, V79, P631, DOI 10.1034/j.1600-0412.2000.079008631.x; CAMPBELL S, 1983, LANCET, V1, P675; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; D'Anna R, 2005, OBSTET GYNECOL, V106, P340, DOI 10.1097/01.AOG.0000168441.79050.03; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Gallos ID, 2013, BJOG-INT J OBSTET GY, V120, P1321, DOI 10.1111/1471-0528.12375; Gao YQ, 2009, B WORLD HEALTH ORGAN, V87, P913, DOI 10.2471/BLT.08.060426; Hertig A, 2004, CLIN CHEM, V50, P1702, DOI 10.1373/clinchem.2004.036715; Holmes VA, 2011, DIABETES CARE, V34, P1683, DOI 10.2337/dc11-0244; Kenny LC, 2014, HYPERTENSION, V64, P644, DOI 10.1161/HYPERTENSIONAHA.114.03578; Lapaire O, 2010, EUR J OBSTET GYN R B, V151, P122, DOI 10.1016/j.ejogrb.2010.04.009; Leeman L, 2008, AM FAM PHYSICIAN, V78, P93; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lim JH, 2008, OBSTET GYNECOL, V111, P1403, DOI 10.1097/AOG.0b013e3181719b7a; Lindheimer MD, 2009, J CLIN HYPERTENS, V11, P214, DOI 10.1111/j.1751-7176.2009.00085.x; Magee LA, 2014, J OBSTET GYNAECOL CA, V36, P416, DOI 10.1016/S1701-2163(15)30588-0; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; McKeeman GC, 2004, AM J OBSTET GYNECOL, V191, P1240, DOI 10.1016/j.ajog.2004.03.004; Metz TD, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.04.027; Nilsen RM, 2012, OBSTET GYNECOL, V119, P1243, DOI 10.1097/AOG.0b013e318255004e; Noorbakhsh Marjan, 2013, ISRN Obstet Gynecol, V2013, P104213, DOI 10.1155/2013/104213; North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875; Papageorghiou AT, 2001, ULTRASOUND OBST GYN, V18, P441, DOI 10.1046/j.0960-7692.2001.00572.x; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Roberts JM, 2000, SEMIN PERINATOL, V24, P24, DOI 10.1016/S0146-0005(00)80050-6; ROBERTSON WB, 1967, J PATHOL BACTERIOL, V93, P581, DOI 10.1002/path.1700930219; Savvidou MD, 2003, LANCET, V361, P1511, DOI 10.1016/S0140-6736(03)13177-7; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sibai BM, 2007, AM J OBSTET GYNECOL, V197, P1, DOI 10.1016/j.ajog.2007.04.021; Sibai BM, 2003, OBSTET GYNECOL, V102, P181, DOI 10.1016/S0029-7844(03)00475-7; Spencer K, 2007, ULTRASOUND OBST GYN, V29, P128, DOI 10.1002/uog.3876; Su YN, 2001, OBSTET GYNECOL, V97, P898, DOI 10.1016/S0029-7844(01)01341-2; Taylor RN, 2003, AM J OBSTET GYNECOL, V188, P177, DOI 10.1067/mob.2003.111; Tidwell SC, 2001, AM J OBSTET GYNECOL, V184, P1267, DOI 10.1067/mob.2001.113129; Vainio M, 2005, ACTA OBSTET GYN SCAN, V84, P1062, DOI 10.1111/j.0001-6349.2005.00889.x; Widmer M, 2007, OBSTET GYNECOL, V109, P168, DOI 10.1097/01.AOG.0000249609.04831.7c	37	45	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124684	10.1371/journal.pone.0124684	http://dx.doi.org/10.1371/journal.pone.0124684			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906026	Green Published, Green Submitted, gold			2022-12-27	WOS:000353332000081
J	Chan, R; Wong, VWS; Chu, WCW; Wong, GLH; Li, LS; Leung, J; Chim, AML; Yeung, DKW; Sea, MMM; Woo, J; Chan, FKL; Chan, HLY				Chan, Ruth; Wong, Vincent Wai-Sun; Chu, Winnie Chiu-Wing; Wong, Grace Lai-Hung; Li, Liz Sin; Leung, Jason; Chim, Angel Mei-Ling; Yeung, David Ka-Wai; Sea, Mandy Man-Mei; Woo, Jean; Chan, Francis Ka-Leung; Chan, Henry Lik-Yuen			Higher Estimated Net Endogenous Acid Production May Be Associated with Increased Prevalence of Nonalcoholic Fatty Liver Disease in Chinese Adults in Hong Kong	PLoS One			English	Article							ASIA-PACIFIC REGION; GROWTH-FACTOR-I; METABOLIC-ACIDOSIS; ENERGY-INTAKE; HIGH-PROTEIN; DIET; HORMONE; POPULATION; CIRRHOSIS; RATS	Nonalcoholic fatty liver disease (NAFLD) has been associated with reduced growth hormone levels and signaling. Such hormonal changes also occur in metabolic acidosis. Since mild metabolic acidosis can be diet induced, diet-induced acid load may constitute a nutritional factor with possible influence on NAFLD development. This study explored whether a higher diet-induced acid load is associated with an increased likelihood of NAFLD. Apparently healthy Chinese adults (330 male, 463 female) aged 19-72 years were recruited through population screening between 2008 and 2010 in a cross-sectional population-based study in Hong Kong. Estimated net endogenous acid production (NEAP) was calculated using Frassetto's method and potential renal acid load (PRAL) was calculated using Remer's method based on dietary data from a food frequency questionnaire. NAFLD was defined as intrahepatic triglyceride content at >5% by proton-magnetic resonance spectroscopy. Possible advanced fibrosis was defined as liver stiffness at >7.9 kPa by transient elastography. Multivariate logistic regression models were used to examine the association between each measure of dietary acid load and prevalent NAFLD or possible advanced fibrosis with adjustment for potential anthropometric and lifestyle factors. 220 subjects (27.7%) were diagnosed with NAFLD. Estimated NEAP was positively associated with the likelihood of having NAFLD after adjustment for age, sex, body mass index, current drinker status and the presence of metabolic syndrome [OR (95% CI) = 1.25 (1.02-1.52), p = 0.022]. The association was slightly attenuated but remained significant when the model was further adjusted for other dietary variables. No association between PRAL and NAFLD prevalence was observed. Both estimated NEAP and PRAL were not associated with the presence of possible advance fibrosis. Our findings suggest that there may be a modest association between diet-induced acid load and NAFLD. More studies are needed to ascertain the link between diet-induced acid load and NAFLD and to investigate the underlying mechanisms.	[Chan, Ruth; Wong, Vincent Wai-Sun; Chu, Winnie Chiu-Wing; Wong, Grace Lai-Hung; Li, Liz Sin; Chim, Angel Mei-Ling; Sea, Mandy Man-Mei; Woo, Jean; Chan, Francis Ka-Leung; Chan, Henry Lik-Yuen] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Chan, Ruth; Sea, Mandy Man-Mei; Woo, Jean] Chinese Univ Hong Kong, Ctr Nutr Studies, Hong Kong, Hong Kong, Peoples R China; [Wong, Vincent Wai-Sun; Wong, Grace Lai-Hung; Chim, Angel Mei-Ling; Chan, Francis Ka-Leung; Chan, Henry Lik-Yuen] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Chu, Winnie Chiu-Wing] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Hong Kong, Hong Kong, Peoples R China; [Leung, Jason] Chinese Univ Hong Kong, Jockey Club Ctr Osteoporosis Care & Control, Hong Kong, Hong Kong, Peoples R China; [Yeung, David Ka-Wai] Chinese Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Chan, R (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	ruthchansm@cuhk.edu.hk	Chan, Ruth/K-4995-2014; Chan, Francis K. L./F-4851-2010; Chu, Winnie CW/F-8449-2014; Chan, Henry Lik-Yuen/B-9636-2008; Woo, Jean/K-2625-2014; Wong, Grace LH/L-8586-2014; Wong, Vincent WS/K-3864-2014	Chan, Francis K. L./0000-0001-7388-2436; Chu, Winnie CW/0000-0003-4962-4132; Chan, Henry Lik-Yuen/0000-0002-7790-1611; Woo, Jean/0000-0001-7593-3081; Wong, Grace LH/0000-0002-2863-9389; Wong, Vincent WS/0000-0003-2215-9410; Chan, Ruth/0000-0002-5725-4066	Health and Health Services Research Fund; Government of Hong Kong SAR [07080081]; Centre for Nutritional Studies; Chinese University of Hong Kong	Health and Health Services Research Fund; Government of Hong Kong SAR; Centre for Nutritional Studies; Chinese University of Hong Kong(Chinese University of Hong Kong)	The study was supported by funding from the Health and Health Services Research Fund sponsored by the Government of Hong Kong SAR (Reference number 07080081) and the Centre for Nutritional Studies, under the auspices of The Chinese University of Hong Kong. The Centre for Nutritional Studies did have a role in the data collection and analysis.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Amarapurkar DN, 2007, J GASTROEN HEPATOL, V22, P788, DOI 10.1111/j.1440-1746.2007.05042.x; Blouet C, 2006, J NUTR, V136, P1849, DOI 10.1093/jn/136.7.1849; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Caldwell SH, 1999, HEPATOLOGY, V29, P664, DOI 10.1002/hep.510290347; Centre for Food Safety, 2006, NUTR INF INQ; CHALLA A, 1993, AM J PHYSIOL, V265, pE547, DOI 10.1152/ajpendo.1993.265.4.E547; Chan RSM, 2009, EUR J CLIN NUTR, V63, P505, DOI 10.1038/ejcn.2008.3; Chitturi S, 2011, J GASTROEN HEPATOL, V26, P163, DOI 10.1111/j.1440-1746.2010.06548.x; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x; Frassetto LA, 1998, AM J CLIN NUTR, V68, P576, DOI 10.1093/ajcn/68.3.576; Frassetto LA, 2007, J NUTR, V137, P1491, DOI 10.1093/jn/137.6.1491; Frassetto LA, 2006, J NEPHROL, V19, pS33; Gannon MC, 2011, METABOLISM, V60, P1300, DOI 10.1016/j.metabol.2011.01.016; Hamaguchi M, 2007, WORLD J GASTROENTERO, V13, P1579, DOI 10.3748/wjg.v13.i10.1579; Ichikawa T, 2007, HEPATOL INT, V1, P287, DOI 10.1007/s12072-007-9007-4; Kargulewicz A, 2014, PRZ GASTROENTEROL, V9, P18, DOI 10.5114/pg.2014.40845; Krupp D, 2012, J NUTR, V142, P313, DOI 10.3945/jn.111.150540; McCarthy EM, 2012, J ACAD NUTR DIET, V112, P401, DOI 10.1016/j.jada.2011.10.007; Mitch WE, 2006, J NEPHROL, V19, pS70; Mouzaki M, 2012, J CLIN GASTROENTEROL, V46, P457, DOI 10.1097/MCG.0b013e31824cf51e; Pichon L, 2006, J NUTR, V136, P1256, DOI 10.1093/jn/136.5.1256; Pizzorno J, 2010, BRIT J NUTR, V103, P1185, DOI 10.1017/S0007114509993047; Remer T, 2000, SEMIN DIALYSIS, V13, P221, DOI 10.1046/j.1525-139x.2000.00062.x; Remer T, 2003, AM J CLIN NUTR, V77, P1255, DOI 10.1093/ajcn/77.5.1255; Takahashi Y, 2012, ENDOCR J, V59, P955, DOI 10.1507/endocrj.EJ12-0322; Wiederkehr MR, 2004, NEPHROL DIAL TRANSPL, V19, P1190, DOI 10.1093/ndt/gfh096; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Wong VWS, 2006, CLIN GASTROENTEROL H, V4, P1154, DOI 10.1016/j.cgh.2006.06.011; Wong VWS, 2012, J HEPATOL, V56, P533, DOI 10.1016/j.jhep.2011.09.013; Wong VWS, 2012, GUT, V61, P409, DOI 10.1136/gutjnl-2011-300342; Wong VWS, 2011, GUT, V60, P1721, DOI 10.1136/gut.2011.242016; Wong VWS, 2011, GUT, V60, P829, DOI 10.1136/gut.2011.237974; Wong VWS, 2010, HEPATOLOGY, V51, P454, DOI 10.1002/hep.23312; Woo J, 1997, NUTR RES, V17, P1633, DOI 10.1016/S0271-5317(97)00170-X; Xu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044136; Yang Y., 2002, CHINA FOOD COMPOSITI, V2002nd ed.; Yang YX, 2004, CHINA FOOD COMPOSITI	39	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0122406	10.1371/journal.pone.0122406	http://dx.doi.org/10.1371/journal.pone.0122406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905490	Green Submitted, gold, Green Published			2022-12-27	WOS:000353332000013
J	Mougin, B; Tian, RBD; Drancourt, M				Mougin, Benjamin; Tian, Roger B. D.; Drancourt, Michel			Tropical Plant Extracts Modulating the Growth of Mycobacterium ulcerans	PLOS ONE			English	Article							BURULI ULCER; ENVIRONMENT; DISEASE; FLUORESCENCE; TUBERCULOSIS; MYCOLACTONE; INFECTION; EVOLUTION; CAMEROON; CULTURE	Mycobacterium ulcerans, the etiologic agent of Buruli ulcer, has been detected on aquatic plants in endemic tropical regions. Here, we tested the effect of several tropical plant extracts on the growth of M. ulcerans and the closely related Mycobacterium marinum. M. ulcerans and M. marinum were inoculated on Middlebrook 7H11 medium with and without extracts from tropical aquatic plants, including Ammannia gracilis, Crinum calamistratum, Echinodorus africanus, Vallisneria nana and Vallisneria torta. Delay of detection of the first colony and the number of colonies at day 7 (M. marinum) or day 16 (M. ulcerans) were used as endpoints. The first M. ulcerans colonies were detected at 8 +/- 0 days on control Middlebrook 7H11 medium, 6.34 +/- 0.75 days on A. gracilis-enriched medium (p<0.01), 6 +/- 1 days on E. africanus- and V. torta-enriched media (p<0.01), 6 +/- 0 days on V. nana-enriched medium (p<0.01) and 5.67 +/- 0.47 days on C. calamistratum-enriched medium (p<0.01). Furthermore, the number of detected colonies was significantly increased in C. calamistratum-and E. africanus-enriched media at each time point compared to Middlebrook 7H11 (p<0.05). V. nana- and V. torta-enriched media significantly increased the number of detected colonies starting from day 6 and day 10, respectively (p<0.001). At the opposite, A. gracilis-enriched medium significantly decreased the number of detected colonies starting from day 8 PI (p<0.05). In conclusion, some aquatic plant extracts, could be added as adjuvants to the Middlebrook 7H11 medium for the culturing of M. marinum and M. ulcerans.	[Mougin, Benjamin; Tian, Roger B. D.; Drancourt, Michel] Aix Marseille Univ, Inserm 1095, IRD 198, URMITE,UMR CNRS 7278, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Drancourt, M (corresponding author), Aix Marseille Univ, Inserm 1095, IRD 198, URMITE,UMR CNRS 7278, Marseille, France.	michel.drancourt@univ-amu.fr						Adekambi T, 2003, J CLIN MICROBIOL, V41, P5699, DOI 10.1128/JCM.41.12.5699-5708.2003; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P145; Bouricha M, 2014, INT J INFECT DIS, V21, P17, DOI 10.1016/j.ijid.2013.11.020; Bratschi MW, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002756; CLARK HF, 1963, J BACTERIOL, V86, P1057, DOI 10.1128/JB.86.5.1057-1069.1963; Dailloux M, 1999, WATER RES, V33, P2219, DOI 10.1016/S0043-1354(98)00466-7; El Khechine A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024720; FRICKER MD, 1992, J MICROSC-OXFORD, V166, P29, DOI 10.1111/j.1365-2818.1992.tb01505.x; Fyfe JAM, 2007, APPL ENVIRON MICROB, V73, P4733, DOI 10.1128/AEM.02971-06; George KM, 1999, SCIENCE, V283, P854, DOI 10.1126/science.283.5403.854; Ghodbane R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04236; Kaser M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-177; Kenu E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003279; LANG M, 1991, RADIAT ENVIRON BIOPH, V30, P333, DOI 10.1007/BF01210517; Marion E, 2011, EMERG INFECT DIS, V17, P551, DOI 10.3201/eid1703.091859; Marsollier L, 2004, APPL ENVIRON MICROB, V70, P1097, DOI 10.1128/AEM.70.2.1097-1103.2004; Merritt RW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000911; Nakanaga K, 2011, J CLIN MICROBIOL, V49, P3829, DOI 10.1128/JCM.00783-11; Noeske J, 2004, AM J TROP MED HYG, V70, P520, DOI 10.4269/ajtmh.2004.70.520; Patino S, 2008, J CLIN MICROBIOL, V46, P3296, DOI [10.1128/JCM.02183-08, 10.1128/JCM.02183-07]; Petrini B, 2006, Eur J Clin Microbiol Infect Dis, V25, P609, DOI 10.1007/s10096-006-0201-4; Portaels F, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000178; Qi WH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000580; Williamson HR, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001506; World Health Organization, 2013, BUR ULC; YENTSCH CS, 1963, DEEP-SEA RES, V10, P221, DOI 10.1016/0011-7471(63)90358-9; Yip MJ, 2007, J BACTERIOL, V189, P2021, DOI 10.1128/JB.01442-06	27	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124626	10.1371/journal.pone.0124626	http://dx.doi.org/10.1371/journal.pone.0124626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905816	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000080
J	Dong, H; Zhang, L; Qian, ZL; Zhu, XH; Zhu, GS; Chen, YQ; Xie, XY; Ye, QH; Zang, J; Ren, ZG; Ji, QS				Dong, Hua; Zhang, Lan; Qian, Ziliang; Zhu, Xuehua; Zhu, Guanshan; Chen, Yunqin; Xie, Xiaoying; Ye, Qinghai; Zang, Jie; Ren, Zhenggang; Ji, Qunsheng			Identification of HBV-MLL4 Integration and Its Molecular Basis in Chinese Hepatocellular Carcinoma	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; LIVER-CANCER; INFECTION; GENE; EPIDEMIOLOGY; PREVENTION; MUTATIONS; RISK; MLL2	To gain molecular insights of HBV integration that may contribute to HCC tumorigenesis, we performed whole transcriptome sequencing and whole genome copy number profiling of hepatocellular carcinoma (HCC) samples from 50 Chinese patients. We identified a total of 33 HBV-human integration sites in 16 of 44 HBV-positive HCC tissues, which were enriched in HBV genotype C-infected patients. In addition, significantly recurrent HBV-MLL4 integration (18%; 8/44) was found in this cohort of patients. Using long-range PCR and Sanger sequencing, we comprehensively characterized gDNA and cDNA sequences that encode for the HBV-MLL4 transcripts, and we revealed that HBV integration into MLL4 exons led to much higher mRNA expression of MLL4 than the integration into MLL4 introns due to an alternative splicing mechanism. Moreover, the HBV-MLL4 integration occurred almost exclusively in CTNNB1 and TP53 wild-type patients. The integration was also associated with a distinct gene expression profile. In conclusion, this is the first report on the molecular basis of the MLL4 integration driving MLL4 over-expression. HBV-MLL4 integration occurred frequently in Chinese HCC patients, representing a unique molecular segment for HCC with HBV infection.	[Dong, Hua; Qian, Ziliang; Zhu, Xuehua; Zhu, Guanshan; Zang, Jie; Ji, Qunsheng] AstraZeneca Asian & Emerging Market iMed, Shanghai, Peoples R China; [Zhang, Lan; Xie, Xiaoying; Ye, Qinghai; Ren, Zhenggang] Fudan Univ, Minist Educ, Liver Canc Inst, Zhongshan Hosp,Key Lab Carcinogenesis & Canc Inva, Shanghai 200433, Peoples R China; [Chen, Yunqin] AstraZeneca, R&D Informat, Shanghai, Peoples R China	Fudan University; AstraZeneca	Ren, ZG (corresponding author), Fudan Univ, Minist Educ, Liver Canc Inst, Zhongshan Hosp,Key Lab Carcinogenesis & Canc Inva, Shanghai 200433, Peoples R China.	ren.zhenggang@zs-hospital.sh.cn; qsji18@yahoo.com			AstraZeneca	AstraZeneca(AstraZeneca)	This study was sponsored by AstraZeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors [HD, ZQ, XZ, GZ, YC, JZ and QJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ansari KI, 2012, BRIT J CANCER, V107, P315, DOI 10.1038/bjc.2012.263; Aspinall EJ, 2011, OCCUP MED-OXFORD, V61, P531, DOI 10.1093/occmed/kqr136; Chu CM, 2000, J GASTROEN HEPATOL, V15, pE25, DOI 10.1046/j.1440-1746.2000.02097.x; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Farinati F, 2006, AM J GASTROENTEROL, V101, P524, DOI 10.1111/j.1572-0241.2006.00443.x; Ge HY, 2011, BIOINFORMATICS, V27, P1922, DOI 10.1093/bioinformatics/btr310; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Huntsman DG, 1999, ONCOGENE, V18, P7975, DOI 10.1038/sj.onc.1203291; Ji X, 2012, MOL CELL, V45, P433, DOI 10.1016/j.molcel.2012.02.003; Jiang ZS, 2012, GENOME RES, V22, P593, DOI 10.1101/gr.133926.111; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; KRaC WH, 1998, HEPATITIS B VIRUS; Kremsdorf D, 2006, ONCOGENE, V25, P3823, DOI 10.1038/sj.onc.1209559; Lau CC, 2014, CANCER CELL, V25, P335, DOI 10.1016/j.ccr.2014.01.030; Lu T, 2013, WORLD J GASTROENTERO, V19, P8887, DOI 10.3748/wjg.v19.i47.8887; McGlynn KA, 2011, CLIN LIVER DIS, V15, P223, DOI 10.1016/j.cld.2011.03.006; Merican I, 2000, J GASTROEN HEPATOL, V15, P1356, DOI 10.1046/j.1440-1746.2000.0150121356.x; Moolla N, 2002, J VIRAL HEPATITIS, V9, P323, DOI 10.1046/j.1365-2893.2002.00381.x; Paraskevis D, 2013, HEPATOLOGY, V57, P908, DOI 10.1002/hep.26079; Saigo K, 2008, HUM MUTAT, V29, P703, DOI 10.1002/humu.20701; Sherman M, 2010, SEMIN LIVER DIS, V30, P3, DOI 10.1055/s-0030-1247128; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Szymanska K, 2009, CANCER EPIDEM BIOMAR, V18, P1638, DOI 10.1158/1055-9965.EPI-08-1102; Toh ST, 2013, CARCINOGENESIS, V34, P787, DOI 10.1093/carcin/bgs406; Voronkov A, 2013, CURR PHARM DESIGN, V19, P634, DOI 10.2174/138161213804581837; Wang Z, 2010, TRANSL ONCOL, V3, P1, DOI 10.1593/tlo.09250; Welzel TM, 2011, HEPATOLOGY, V54, P463, DOI 10.1002/hep.24397; Zhang XC, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-168	30	38	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123175	10.1371/journal.pone.0123175	http://dx.doi.org/10.1371/journal.pone.0123175			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901726	Green Submitted, Green Published, gold			2022-12-27	WOS:000353331500046
J	Haile, LA; Puig, M; Kelley-Baker, L; Verthelyi, D				Haile, Lydia Asrat; Puig, Montserrat; Kelley-Baker, Logan; Verthelyi, Daniela			Detection of Innate Immune Response Modulating Impurities in Therapeutic Proteins	PLOS ONE			English	Article							AMEBOCYTE LYSATE ASSAY; VITRO PYROGEN TEST; WHOLE-BLOOD; MONONUCLEAR-CELLS; RABBIT PYROGEN; IMMUNOGENICITY; ENDOTOXIN; LIPOPOLYSACCHARIDE; ACTIVATION; INDICATORS	Therapeutic proteins can contain multiple impurities, some of which are variants of the product, while others are derived from the cell substrate and the manufacturing process. Such impurities, even when present at trace levels, have the potential to activate innate immune cells in peripheral blood or embedded in tissues causing expression of cytokines and chemokines, increasing antigen uptake, facilitating processing and presentation by antigen presenting cells, and fostering product immunogenicity. Currently, while products are tested for host cell protein content, assays to control innate immune response modulating impurities (IIRMIs) in products are focused mainly on endotoxin and nucleic acids, however, depending on the cell substrate and the manufacturing process, numerous other IIRMI could be present. In these studies we assess two approaches that allow for the detection of a broader subset of IIRMIs. In the first, we use commercial cell lines transfected with Toll like receptors (TLR) to detect receptor-specific agonists. This method is sensitive to trace levels of IIRMI and provides information of the type of IIRMIs present but is limited by the availability of stably transfected cell lines and requires pre-existing knowledge of the IIRMIs likely to be present in the product. Alternatively, the use of a combination of macrophage cell lines of human and mouse origin allows for the detection of a broader spectrum of impurities, but does not identify the source of the activation. Importantly, for either system the lower limit of detection (LLOD) of impurities was similar to that of PBMC and it was not modified by the therapeutic protein tested, even in settings where the product had inherent immune modulatory properties. Together these data indicate that a cell-based assay approach could be used to screen products for the presence of IIRMIs and inform immunogenicity risk assessments, particularly in the context of comparability exercises.	[Haile, Lydia Asrat; Puig, Montserrat; Kelley-Baker, Logan; Verthelyi, Daniela] US FDA, Immunol Lab, Div Biotechnol Review & Res 3, Off Biotechnol Prod,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Verthelyi, D (corresponding author), US FDA, Immunol Lab, Div Biotechnol Review & Res 3, Off Biotechnol Prod,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.	daniela.verthelyi@fda.hhs.gov			Food and Drug Administration	Food and Drug Administration(United States Department of Health & Human Services)	The work was funded by the Food and Drug Administration. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alving CR, 2002, VACCINE, V20, pS56, DOI 10.1016/S0264-410X(02)00174-3; Baker Matthew P, 2010, Self Nonself, V1, P314, DOI 10.4161/self.1.4.13904; Brennan TV, 2012, BLOOD, V120, P2899, DOI 10.1182/blood-2011-07-368720; Chen L, 2013, J PHARMACEUT BIOMED, V80, P180, DOI 10.1016/j.jpba.2013.03.011; Chirmule N, 2012, AAPS J, V14, P296, DOI 10.1208/s12248-012-9340-y; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Daneshian M, 2006, J IMMUNOL METHODS, V313, P169, DOI 10.1016/j.jim.2006.04.009; Eperon S, 1996, J IMMUNOL METHODS, V194, P121, DOI 10.1016/0022-1759(96)00073-7; Eperon S, 1997, J IMMUNOL METHODS, V207, P135, DOI 10.1016/S0022-1759(97)00112-9; Gao JJ, 2001, J IMMUNOL, V166, P6855, DOI 10.4049/jimmunol.166.11.6855; Hasiwa N, 2013, ALTEX-ALTERN ANIM EX, V30, P169, DOI 10.14573/altex.2013.2.169; Huang LY, 2009, J CLIN MICROBIOL, V47, P3427, DOI 10.1128/JCM.00373-09; Jounai N, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2012.00168; Kikkert R, 2008, J IMMUNOL METHODS, V336, P45, DOI 10.1016/j.jim.2008.03.010; Klinman DM, 2004, IMMUNOL REV, V199, P201, DOI 10.1111/j.0105-2896.2004.00148.x; Koyama S, 2009, EXPERT REV VACCINES, V8, P1099, DOI 10.1586/ERV.09.57; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lai CY, 2014, VACCINE, V32, P5593, DOI 10.1016/j.vaccine.2014.07.104; Lee S, 2013, NAT BIOTECHNOL, V31, P220, DOI 10.1038/nbt.2528; Li N, 2015, SCI REPORTS IN PRESS; Moesby L, 1999, INT J PHARM, V191, P141, DOI 10.1016/S0378-5173(99)00294-X; Moura-Alves P, 2014, NATURE, V512, P387, DOI 10.1038/nature13684; Nakagawa Y, 2002, CLIN DIAGN LAB IMMUN, V9, P588, DOI 10.1128/CDLI.9.3.588-597.2002; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Peters M, 2012, INNATE IMMUN-LONDON, V18, P694, DOI 10.1177/1753425912436590; Poole S, 1988, Dev Biol Stand, V69, P121; Sato S, 2002, INT IMMUNOL, V14, P783, DOI 10.1093/intimm/dxf046; Schellekens H, 2002, NAT REV DRUG DISCOV, V1, P457, DOI 10.1038/nrd818; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Singh SK, 2011, J PHARM SCI-US, V100, P354, DOI 10.1002/jps.22276; Swanson Steven J, 2006, J Immunotoxicol, V3, P165, DOI 10.1080/15476910600908852; Tallant T, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-33; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Verthelyi D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015252; Zaitseva M, 2012, VACCINE, V30, P4859, DOI 10.1016/j.vaccine.2012.05.002; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324	38	46	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0125078	10.1371/journal.pone.0125078	http://dx.doi.org/10.1371/journal.pone.0125078			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901912	gold, Green Published, Green Submitted			2022-12-27	WOS:000353331500111
J	Aureli, D; Contardi, A; Giaccio, B; Jicha, B; Lemorini, C; Madonna, S; Magri, D; Marano, F; Milli, S; Modesti, V; Palombo, MR; Rocca, R				Aureli, Daniele; Contardi, Antonio; Giaccio, Biagio; Jicha, Brian; Lemorini, Cristina; Madonna, Sergio; Magri, Donatella; Marano, Federica; Milli, Salvatore; Modesti, Valerio; Palombo, Maria Rita; Rocca, Roxane			Palaeoloxodon and Human Interaction: Depositional Setting, Chronology and Archaeology at the Middle Pleistocene Ficoncella Site (Tarquinia, Italy)	PLOS ONE			English	Article							SABATINI VOLCANIC DISTRICT; ELEPHANT CARCASS; MONTI SABATINI; CUT MARKS; RECORD; BASIN; TAPHONOMY; APENNINES; INTERVAL; HISTORY	The Ficoncella site in northern Latium (Italy) represents a unique opportunity to investigate the modalities of a short occupation in an alluvial setting during the Lower Palaeolithic. The small excavation area yielded a lithic assemblage, a carcass of Palaeoloxodon antiquus, and some other faunal remains. The main objectives of the study are to better characterize the depositional context where the Palaeoloxodonand the lithic assemblage occur, and to evaluate with greater precision the occupation dynamics. A 25 m-long well was drilled just above the top of the terrace of the Ficoncella site and faunal and lithic remains were analyzed with current and innovative techniques. The archaeological site contains floodplain deposits as it is located next to a small incised valley that feeds into a larger valley of the Mignone River. A tephra layer capping the site is 40Ar/39Ar dated to 441 +/- 8 ka. Collectively, the geochronologic, tephrochronologic and geologic data, suggest the site was occupied during MIS 13. The new results should prompt further research at Ficoncella in order to improve our understanding of the dynamics of human settlement in Europe during the Early to Middle Pleistocene.	[Aureli, Daniele] Univ Siena, Dipartimento Sci Fis Terra & Ambiente, UR Preistoria & Antropol, I-53100 Siena, Italy; [Contardi, Antonio; Modesti, Valerio] Museo Civ A Klitsche Grange, I-00051 Rome, Italy; [Giaccio, Biagio] CNR, Ist Geol Ambientale & Geoingn, I-00016 Rome, Italy; [Jicha, Brian] Univ Wisconsin, Dept Geosci, Madison, WI USA; [Lemorini, Cristina] Univ Roma La Sapienza, Dipartimento Sci Antichita, I-00185 Rome, Italy; [Madonna, Sergio] Univ Viterbo, Dipartimento Sci & Tecnol Agr Foreste Nat & Engn, I-01100 Viterbo, Italy; [Magri, Donatella] Univ Roma La Sapienza, Dipartimento Biol Ambientale, I-00185 Rome, Italy; [Marano, Federica; Milli, Salvatore; Palombo, Maria Rita] Univ Roma La Sapienza, Dipartimento Sci Terra, I-00185 Rome, Italy; [Aureli, Daniele; Rocca, Roxane] ArScAn Equipe AnTET, UMR 7041, F-92023 Paris, France	University of Siena; Consiglio Nazionale delle Ricerche (CNR); Istituto di Geologia Ambientale e Geoingegneria (IGAG-CNR); University of Wisconsin System; University of Wisconsin Madison; Sapienza University Rome; Tuscia University; Sapienza University Rome; Sapienza University Rome; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS)	Aureli, D (corresponding author), Univ Siena, Dipartimento Sci Fis Terra & Ambiente, UR Preistoria & Antropol, Via Laterina 8, I-53100 Siena, Italy.	danieleaureli1@gmail.com	Madonna, Sergio/AAC-8278-2020; lemorini, cristina/ABD-5327-2020; Rocca, Roxane/J-8220-2015; Magri, Donatella/E-8885-2011; Giaccio, Biagio/B-2561-2017	lemorini, cristina/0000-0002-6998-1615; Rocca, Roxane/0000-0002-8947-4151; Magri, Donatella/0000-0001-7254-593X; Giaccio, Biagio/0000-0002-7007-9127; AURELI, DANIELE/0000-0002-7807-6123; Palombo, Maria Rita/0000-0002-2104-2176	Ministero dei Beni Culturali; Soprintendenza per i Beni Archeologici dell'Etruria meridionale; Fondazione Cassa di Risparmio di Civitavecchia - Cariciv	Ministero dei Beni Culturali; Soprintendenza per i Beni Archeologici dell'Etruria meridionale; Fondazione Cassa di Risparmio di Civitavecchia - Cariciv	The excavations at the site of Ficoncella were made possible thanks to the grant of the Ministero dei Beni Culturali, in collaboration with the Soprintendenza per i Beni Archeologici dell'Etruria meridionale, financial aid from the Fondazione Cassa di Risparmio di Civitavecchia - Cariciv and logistical and administration support of the municipality of Allumiere. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agam A, 2014, QUATERNARY IN PRESS; Ambrosetti P, 1981, GEOGR FIS DIN QUAT, V4, P104; Ambrosetti P, 1978, MEMORIE SOC GEOLOGIC, V19, P573; Anzidel AP, 2012, QUATERN INT, V255, P171, DOI 10.1016/j.quaint.2011.06.005; Arzarello M, 2014, IN PRESS; Arzarello M, 2012, QUATERN INT, V267, P56, DOI 10.1016/j.quaint.2011.01.042; Aureli D, 2012, QUATERN INT, V255, P29, DOI 10.1016/j.quaint.2011.06.052; Barberi F., 1994, MEM DESCR CARTA GEOL, V49, P77; Barsky D, 2010, QUATERN INT, V223, P71, DOI 10.1016/j.quaint.2009.12.005; Ben-Dor M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028689; Berthelet A, 2001, WORLD ELEPHANTS, P176; BERTRAN P, 1995, J ARCHAEOL SCI, V22, P521, DOI 10.1006/jasc.1995.0050; Bertran P, 2012, J ARCHAEOL SCI, V39, P3148, DOI 10.1016/j.jas.2012.04.055; Biddittu I, 2001, WORLD ELEPHANTS, P91; Blott SJ, 2008, SEDIMENTOLOGY, V55, P31, DOI 10.1111/j.1365-3091.2007.00892.x; Blum M, 2013, EARTH-SCI REV, V116, P128, DOI 10.1016/j.earscirev.2012.09.003; Boeda E, 2013, PALEO HIST OBJETS LI; Boeda E., 1997, THESIS U PARIS X NAN; Boeda E., 1990, PAL O, V2, P43, DOI DOI 10.3406/PAL.1990.988; Boeda E., 2001, IND OUTILS BIFACIAUX, P51; Boschian G, 2014, QUATERNARY IN PRESS; Bosi C, 1990, ROMA AIQUA CTR STUDI; Bridge JS, 2008, EARTH SURF PROCESSES; Cannell A, 2014, LITHIC TECHNOL, V39, P39, DOI 10.1179/0197726113Z.00000000031; Carbonell E, 2008, NATURE, V452, P465, DOI 10.1038/nature06815; Carboni M.G., 1994, Memorie Descrittive della Carta Geologica d'Italia, V49, P177; Cavinato G.P., 1994, MEM DESCR CARTA GEOL, V49, P63; Cavinato GP, 1992, STUDI GEOLOGICI CAME, V1992, P109, DOI DOI 10.15165/STUDGE0CAM-1204; Chaix L., 2000, RECENT RES STONE AGE, P33; Chavaillon J, 2001, WORLD ELEPHANTS, P191; Chiocchini U, 1998, B SERVIZIO GEOLOGICA, V117, P33; Cioni R., 1993, B SOC GEOL ITAL, V112, P251; Clark JD, 1970, QUATERNARIA, V13, P305; Collinson JD, 1996, BLACKWELL SCI, P688; Conato V, 1980, GEOL ROMANA, V19, P181; Crochet JY, 2009, CR PALEVOL, V8, P725, DOI 10.1016/j.crpv.2009.06.004; de Lumley H, 2004, ANTHROPOLOGIE, V108, P185, DOI 10.1016/j.anthro.2004.05.003; de Rita D, 2002, QUATERN INT, V95-6, P141, DOI 10.1016/S1040-6182(02)00035-6; de Rita D., 1993, QUAD RIC SCI, V114, P33; De Rita D, 1995, VOLCANO ALBAN HILLS, P33; de Rita D, 1997, B SOC GEOL ITAL, V116, P143; de Wit HA, 1978, SOILS GRASSLAND TYPE, P300; Delagnes A, 2006, J ANTHROPOL ARCHAEOL, V25, P448, DOI 10.1016/j.jaa.2006.03.002; Doglioni C., 2004, MEM DESCR CARTA GEOL, V44, P147; Fazzini P, 1972, MEM SOC GEOL ITAL, V21, P65; Funiciello R, 1976, B SOC GEOL ITAL, V95, P831; Galli P, 2014, B SEISMOLOGICAL SOC, V105, DOI [10.1785/0120120029, DOI 10.1785/0120120029]; Gautier A, 2012, J AFR ARCHAEOL, V10, P165, DOI 10.3213/2191-5784-10222; Giaccio B, 2014, J QUATERNARY SCI, V29, P232, DOI 10.1002/jqs.2696; Gile LH, 1981, ALBUQUERQUE NEW MEXI, V39; Goren-Inbar N., 1994, PALEORIENT, V20, P99, DOI DOI 10.3406/PALEO.1994.4604; Inizan M.-L., 1995, TECHNOLOGIE PIERRE T; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Karner DB, 2001, J VOLCANOL GEOTH RES, V107, P185, DOI 10.1016/S0377-0273(00)00258-4; Kretzoi M, 1990, SITE MAN AND CULTURE; Kuiper KF, 2008, SCIENCE, V320, P500, DOI 10.1126/science.1154339; LEAKEY M D, 1971, P306; Lemorini C, 2001, P 1 INT C WORLD EL, P57; Lemorini C., 2010, ANTIQUITY, V84, P325; Locardi E, 1976, GEOL ROMANA, V15, P279; Mai DH, 1983, LANDES MUSEM VORGE, V36; MALINVERNO A, 1986, TECTONICS, V5, P227, DOI 10.1029/TC005i002p00227; de Castro JMB, 2013, QUATERN INT, V295, P102, DOI 10.1016/j.quaint.2012.02.036; Mariani M., 1988, MEM SOC GEOL ITAL, V41, P519; Marra F, 2014, QUATERNARY SCI REV, V94, P74, DOI 10.1016/j.quascirev.2014.04.010; Mazza PPA, 2006, J ARCHAEOL SCI, V33, P1310, DOI 10.1016/j.jas.2006.01.006; Mazza PPA, 1998, B SOC PALEONTOL ITAL, V36, P381; Meyers SR, 2012, GEOLOGY, V40, P7, DOI 10.1130/G32261.1; Milli S, 2005, QUATERN INT, V126, P251, DOI 10.1016/j.quaint.2004.04.025; Milli S, 2008, SPECIAL PUBLICATION, V1, P67; Milli S, 2013, SEDIMENT GEOL, V284, P159, DOI 10.1016/j.sedgeo.2012.12.003; Milli Salvatore, 1997, Geologica Romana, V33, P99; Moncel MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075529; Munno R, 2001, GEOGR PHYS QUATERN, V55, P87, DOI 10.7202/005659ar; Palladino DM, 2014, J VOLCANOL GEOTH RES, V281, P12, DOI 10.1016/j.jvolgeores.2014.05.020; Palombo MR, 2013, QUATERN INT, V295, P13, DOI 10.1016/j.quaint.2011.12.019; Palombo MR, 2010, ELEFANTENREICH FOSSI, P219; Palombo MR, 2007, COLLANA B PALETNOLOG, P35, DOI [10.1007/ s10856- 015- 5398- 2, DOI 10.1007/S10856-015-5398-2]; Espigares MP, 2013, QUATERN INT, V295, P113, DOI 10.1016/j.quaint.2012.09.032; Peretto C, 1997, LANTHROPOLOGIE, V10, P597; Peretto C, 1994, LA SPERIMENTAZIONE; Petrosino P, 2014, J VOLCANOL GEOTH RES, V274, P34, DOI 10.1016/j.jvolgeores.2014.01.014; Piperno M, 1999, NOTARCHIRICO SITO PL; Piperno M, 2001, WORLD ELEPHANTS, P230; Posamentier HW, 1999, 210 SEPM, V82, P210; Potts R, 1999, J HUM EVOL, V37, P747, DOI 10.1006/jhev.1999.0344; Rabinovich R, 2012, QUATERN INT, V276, P183, DOI 10.1016/j.quaint.2012.05.009; Radmilli AM, 1996, PIU ANTICO GIACIMENT; Retallack GJ, 2005, GEOLOGY, V33, P333, DOI 10.1130/G21263.1; Retallack GJ, 1991, MIOCENE PALOESOLS AP; Retallack GJ, 1990, INTRO PALEOPEDOLOGY; Rocca R, 2013, THESIS; Rodriguez J, 2013, QUATERN INT, V295, P48, DOI 10.1016/j.quaint.2011.09.023; Roebroeks W, 1988, FIND SCATTERS EARLY, V21; Rots V, 2010, METHODOLOGY; Sacca D, 2012, QUATERN INT, V276, P27, DOI 10.1016/j.quaint.2012.03.055; Saegusa H, 2008, MID AWASH SER, V1, P193; Sahnouni M, 2013, J HUM EVOL, V64, P137, DOI 10.1016/j.jhevol.2012.10.007; Savelli C, 2002, J GEODYN, V34, P99, DOI 10.1016/S0264-3707(02)00026-1; Scandone P., 1979, B SOC GEOL ITAL, V98, P27; Scott GR, 2009, NATURE, V461, P82, DOI 10.1038/nature08214; SEHGAL JL, 1972, GEODERMA, V8, P59, DOI 10.1016/0016-7061(72)90032-8; Smith Geoff M., 2012, Journal of Taphonomy, V10, P373; Smith GHS, 2006, SPECIAL PUBLICATION, V36; Sottili G, 2004, J VOLCANOL GEOTH RES, V135, P361, DOI 10.1016/j.jvolgeores.2004.03.019; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; Stiner MC, 2011, J HUM EVOL, V60, P213, DOI 10.1016/j.jhevol.2010.10.006; Toro-Moyano I, 2013, J HUM EVOL, V65, P1, DOI 10.1016/j.jhevol.2013.01.012; Valensi P, 2004, BAR INT SERIES, V1272, P75; Vallverdu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103634; Villa P, 2005, QUATERN INT, V126, P223, DOI 10.1016/j.quaint.2004.03.001; Villa P., 1999, ROLE EARLY HUMANS AC, V42, P197; White PA, 2012, QUATERN INT, V276, P287, DOI 10.1016/j.quaint.2012.07.025; Yravedra J, 2010, J ARCHAEOL SCI, V37, P2469, DOI 10.1016/j.jas.2010.05.007	114	36	36	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124498	10.1371/journal.pone.0124498	http://dx.doi.org/10.1371/journal.pone.0124498			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898322	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600069
J	Baltich, J; Maurer, C; Nigg, BM				Baltich, Jennifer; Maurer, Christian; Nigg, Benno M.			Increased Vertical Impact Forces and Altered Running Mechanics with Softer Midsole Shoes	PLOS ONE			English	Article							GROUND REACTION FORCES; CRUCIATE LIGAMENT INJURY; TIBIAL STRESS-FRACTURE; JOINT STIFFNESS; LEG STIFFNESS; GENDER-DIFFERENCES; ANKLE JOINT; KNEE; KINEMATICS; FOOTWEAR	To date it has been thought that shoe midsole hardness does not affect vertical impact peak forces during running. This conclusion is based partially on results from experimental data using homogeneous samples of participants that found no difference in vertical impact peaks when running in shoes with different midsole properties. However, it is currently unknown how apparent joint stiffness is affected by shoe midsole hardness. An increase in apparent joint stiffness could result in a harder landing, which should result in increased vertical impact peaks during running. The purpose of this study was to quantify the effect of shoe midsole hardness on apparent ankle and knee joint stiffness and the associated vertical ground reaction force for age and sex subgroups during heel-toe running. 93 runners (male and female) aged 16-75 years ran at 3.33 +/- 0.15 m/s on a 30 m-long runway with soft, medium and hard midsole shoes. The vertical impact peak increased as the shoe midsole hardness decreased (mean(SE); soft: 1.70BW(0.03), medium: 1.64BW(0.03), hard: 1.54BW(0.03)). Similar results were found for the apparent ankle joint stiffness where apparent stiffness increased as the shoe midsole hardness decreased (soft: 2.08BWm/degrees x 100 (0.05), medium: 1.92 BWm/degrees x 100 (0.05), hard: 1.85 BWm/degrees x 100 (0.05)). Apparent knee joint stiffness increased for soft (1.06BWm/degrees x 100 (0.04)) midsole compared to the medium (0.95BWm/degrees x 100 (0.04)) and hard (0.96BWm/degrees x 100 (0.04)) midsoles for female participants. The results from this study confirm that shoe midsole hardness can have an effect on vertical impact force peaks and that this may be connected to the hardness of the landing. The results from this study may provide useful information regarding the development of cushioning guidelines for running shoes.	[Baltich, Jennifer; Maurer, Christian; Nigg, Benno M.] Univ Calgary, Fac Kinesiol, HPL, Calgary, AB, Canada	University of Calgary	Baltich, J (corresponding author), Univ Calgary, Fac Kinesiol, HPL, Calgary, AB, Canada.	jbaltich@ucalgary.ca	Maurer, Christian/AAS-9688-2020	Maurer, Christian/0000-0002-8426-813X	Decathlon (Oxylane Group, France)	Decathlon (Oxylane Group, France)	This study was part of a project sponsored by Decathlon (now Oxylane Group, France). This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The funders had a role in the study design. They did not have a role in the data analysis, decision to publish, or preparation of this manuscript.	Bennell K, 2004, MED SCI SPORT EXER, V36, P397, DOI 10.1249/01.MSS.0000117116.90297.E1; Bishop M, 2006, J ATHL TRAINING, V41, P387; Chambon N, 2014, GAIT POSTURE, V40, P58, DOI 10.1016/j.gaitpost.2014.02.005; Chumanov ES, 2008, CLIN BIOMECH, V23, P1260, DOI 10.1016/j.clinbiomech.2008.07.011; CLARKE TE, 1983, INT J SPORTS MED, V4, P247, DOI 10.1055/s-2008-1026043; Creaby MW, 2008, MED SCI SPORT EXER, V40, P1669, DOI 10.1249/MSS.0b013e31817571ae; Crossley K, 1999, MED SCI SPORT EXER, V31, P1088, DOI 10.1097/00005768-199908000-00002; Denoth J., 1986, BIOMECHANICS RUNNING, P63; Derrick TR, 1998, MED SCI SPORT EXER, V30, P128, DOI 10.1097/00005768-199801000-00018; Dixon SJ, 2006, CLIN BIOMECH, V21, P412, DOI 10.1016/j.clinbiomech.2005.11.009; Farley CT, 1998, J APPL PHYSIOL, V85, P1044, DOI 10.1152/jappl.1998.85.3.1044; Ferris DP, 1999, J BIOMECH, V32, P787, DOI 10.1016/S0021-9290(99)00078-0; Ford KR, 2011, J APPL BIOMECH, V27, P215, DOI 10.1123/jab.27.3.215; Fukuchi R, 2008, J SPORT SCI, V26, P1447, DOI 10.1080/02640410802209018; Gabriel RC, 2008, PHYS THER SPORT, V9, P16, DOI 10.1016/j.ptsp.2007.08.002; GRIMSTON SK, 1991, INT J SPORT BIOMECH, V7, P293, DOI 10.1123/ijsb.7.3.293; Grimston Susan K., 1994, Journal of Biomechanics, V27, P668, DOI 10.1016/0021-9290(94)90983-0; Hamill J, 2014, EUR J SPORT SCI, V14, P130, DOI 10.1080/17461391.2012.728249; Hamill J, 2011, FOOTWEAR SCI, V3, P33, DOI 10.1080/19424280.2010.542187; Hardin EC, 2004, MED SCI SPORT EXER, V36, P838, DOI 10.1249/01.MSS.0000126605.65966.40; Hardin EC, 2002, RES Q EXERCISE SPORT, V73, P125, DOI 10.1080/02701367.2002.10609001; Heiderscheit BC, 2011, MED SCI SPORT EXER, V43, P296, DOI 10.1249/MSS.0b013e3181ebedf4; Hewett TE, 2000, SPORTS MED, V29, P313, DOI 10.2165/00007256-200029050-00003; LATASH ML, 1993, HUM MOVEMENT SCI, V12, P653, DOI 10.1016/0167-9457(93)90010-M; Lephart SM, 2002, CLIN ORTHOP RELAT R, P162; Mercer JA, 2005, J SPORT SCI MED, V4, P144; Milner CE, 2006, MED SCI SPORT EXER, V38, P323, DOI 10.1249/01.mss.0000183477.75808.92; Myer GD, 2009, CLIN J SPORT MED, V19, P3, DOI 10.1097/JSM.0b013e318190bddb; NIGG BM, 1987, J BIOMECH, V20, P951, DOI 10.1016/0021-9290(87)90324-1; NIGG BM, 1988, AM J SPORT MED, V16, P70, DOI 10.1177/036354658801600113; Nigg BM, 1983, BIOMECHANICS, P1041; Queen RM, 2009, AM J SPORT MED, V37, P390, DOI 10.1177/0363546508324967; Rozzi SL, 1999, AM J SPORT MED, V27, P312, DOI 10.1177/03635465990270030801; Sell TC, 2006, AM J SPORT MED, V34, P43, DOI 10.1177/0363546505278696; Sell TC, 2012, ACL INJURIES FEMALE, P109; Stefanyshyn DJ, 1998, J APPL BIOMECH, V14, P292, DOI 10.1123/jab.14.3.292; Sutton K, 2013, J AM ACAD ORTHOP SUR, V21, P3, DOI [10.5435/JAAOS-21-01-3, DOI 10.5435/JAAOS-21-01-3]; VANDERVOORT AA, 1986, J APPL PHYSIOL, V61, P361, DOI 10.1152/jappl.1986.61.1.361; Von Tscharner V, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054063, DOI 10.1371/JOURNAL.PONE.0054063]; Zifchock RA, 2006, J BIOMECH, V39, P2792, DOI 10.1016/j.jbiomech.2005.10.003	40	61	62	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0125196	10.1371/journal.pone.0125196	http://dx.doi.org/10.1371/journal.pone.0125196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897963	Green Submitted, gold, Green Published			2022-12-27	WOS:000353212600100
J	Goossens, D; Buck, BJ; Teng, YX; McLaurin, BT				Goossens, Dirk; Buck, Brenda J.; Teng, Yuanxin; McLaurin, Brett T.			Surface and Airborne Arsenic Concentrations in a Recreational Site near Las Vegas, Nevada, USA	PLOS ONE			English	Article							DUST EMISSIONS; NELLIS DUNES; AREA	Elevated concentrations of arsenic, up to 7058 mu g g(-1) in topsoil and bedrock, and more than 0.03 mu g m(-3) in air on a 2-week basis, were measured in the Nellis Dunes Recreation Area (NDRA), a very popular off-road area near Las Vegas, Nevada, USA. The elevated arsenic concentrations in the topsoil and bedrock are correlated to outcrops of yellow sandstone belonging to the Muddy Creek Formation (approximate to 10 to 4 Ma) and to faults crossing the area. Mineralized fluids moved to the surface through the faults and deposited the arsenic. A technique was developed to calculate airborne arsenic concentrations from the arsenic content in the topsoil. The technique was tested by comparing calculated with measured concentrations at 34 locations in the NDRA, for 3 periods of 2 weeks each. We then applied it to calculate airborne arsenic concentrations for more than 500 locations all over the NDRA. The highest airborne arsenic concentrations occur over sand dunes and other zones with a surficial layer of aeolian sand. Ironically these areas show the lowest levels of arsenic in the topsoil. However, they are highly susceptible to wind erosion and emit very large amounts of sand and dust during episodes of strong winds, thereby also emitting much arsenic. Elsewhere in the NDRA, in areas not or only very slightly affected by wind erosion, airborne arsenic levels equal the background level for airborne arsenic in the USA, approximately 0.0004 mu gm(-3). The results of this study are important because the NDRA is visited by more than 300,000 people annually.	[Goossens, Dirk; Buck, Brenda J.; Teng, Yuanxin] Univ Nevada, Dept Geosci, Las Vegas, NV 89154 USA; [Goossens, Dirk] Katholieke Univ Leuven, Dept Earth & Environm Sci, Geog Res Grp, Leuven, Belgium; [McLaurin, Brett T.] Bloomsburg Univ Penn, Dept Environm Geog & Geol Sci, Bloomsburg, PA 17815 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; KU Leuven; Pennsylvania State System of Higher Education (PASSHE); Bloomsburg University of Pennsylvania	Goossens, D (corresponding author), Univ Nevada, Dept Geosci, Las Vegas, NV 89154 USA.	Dirk.Goossens@ees.kuleuven.be	Buck, Brenda J/G-5200-2011		Bureau of Land Management [L11AC20058]	Bureau of Land Management	This project was funded by the Bureau of Land Management (URL: http://www.blm.gov/nv/st/en/fo/lvfo.html), Grant number: L11AC20058, Grant awarded to BB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALL AL, 1983, AM IND HYG ASSOC J, V44, P341, DOI 10.1080/15298668391404941; Beard L.S., 2007, 20071010 US GEOL SUR; BLM, 2004, LAS VEG VALL DISP BO; Briggs P.H., 2002, ANAL METHODS CHEM AN; Buck BJ, 2014, NELLIS DUNES RECREAT, P101; Castor SB, 2001, COLORADO RIVER ORIGI, V12, P77; Derbyshire E, 2007, AMBIO, V36, P73, DOI 10.1579/0044-7447(2007)36[73:NMDAHH]2.0.CO;2; Dolgilevich MJ, 2001, P INT S WORKSH WIND, P6; FRYREAR DW, 1986, J SOIL WATER CONSERV, V41, P117; Goossens D, 2012, J ARID ENVIRON, V78, P80, DOI 10.1016/j.jaridenv.2011.10.015; Goossens D, 2011, ASSESSMENT DUST EMIS; Goossens D, 2012, AEOLIAN RES, V5, P43, DOI 10.1016/j.aeolia.2012.03.002; Goossens D, 2011, EARTH SURF PROC LAND, V36, P610, DOI 10.1002/esp.2080; Goossens D, 2009, J ENVIRON MANAGE, V90, P3458, DOI 10.1016/j.jenvman.2009.05.031; Goossens D, 2009, GEOMORPHOLOGY, V107, P118, DOI 10.1016/j.geomorph.2008.12.001; Kabata-Pendias Alina, 2010, P1; McDowell MA., 2008, NATL HLTH STAT REPOR; McLaurin BT, 2011, GEOSPHERE, V7, P260, DOI 10.1130/GES00593.1; Morman SA, 2013, AEOLIAN RES, V9, P203, DOI 10.1016/j.aeolia.2012.12.001; Reimann C, 2009, APPL GEOCHEM, V24, P1147, DOI 10.1016/j.apgeochem.2009.03.013; Soukup D, 2012, AEOLIAN RES, V5, P77, DOI 10.1016/j.aeolia.2011.11.001; Spivey S., 2008, LAS VEGAS REV J 0317; Sultan B, 2005, PLOS MED, V2, P43, DOI 10.1371/journal.pmed.0020006; Suta B.E., 1978, 50 CRESS; USEPA, 2007, 6020A USEPA; Van Pelt RS, 2007, ENVIRON MONIT ASSESS, V130, P3, DOI 10.1007/s10661-006-9446-8	26	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124271	10.1371/journal.pone.0124271	http://dx.doi.org/10.1371/journal.pone.0124271			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897667	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600060
J	Kipfmueller, F; Schneider, J; Prusseit, J; Dimitriou, I; Zur, B; Franz, AR; Bartmann, P; Mueller, A				Kipfmueller, Florian; Schneider, Jessica; Prusseit, Julia; Dimitriou, Ioanna; Zur, Berndt; Franz, Axel R.; Bartmann, Peter; Mueller, Andreas			Role of Neutrophil CD64 Index as a Screening Marker for Late-Onset Sepsis in Very Low Birth Weight Infants	PLOS ONE			English	Article							C-REACTIVE PROTEIN; UNNECESSARY ANTIBIOTIC-THERAPY; SENSITIVE DIAGNOSTIC MARKER; NEONATAL SEPSIS; NEWBORN-INFANTS; NECROTIZING ENTEROCOLITIS; NOSOCOMIAL INFECTION; OXIDATIVE STRESS; BRAIN-INJURY; PRETERM	Introduction The role of CD64 in late onset sepsis (LOS) in preterm infants has been described in several studies. Aim of this study was to investigate whether CD64 expression is increased in the days before clinical manifestation of LOS. Methods Patients with birth weight below 1,500g were eligible for study participation. During routine blood sampling CD64 index was determined between day of life 4 and 28. Patients were allocated to one of four groups: (1) blood-culture positive sepsis, (2) clinical sepsis, (3) symptoms of infection without biochemical evidence of infection, or (4) patients without suspected infection. Kinetics of CD64 expression were compared during a period before and after the day of infection in the respective groups. Results 50 infants were prospectively enrolled and allocated to each group as follows: group (1) n = 7; group (2) n = 10; group (3) n = 8; and group (4) n = 25. CD64 index was elevated in 57% of patients in group (1) at least two days before infection. In contrast only 20% in the clinical sepsis group and 0% in group (3) had an elevated CD64 index in the days before infection. 10 of the 25 patients in the control group (4) presented increased CD64 index values during the study period. Conclusions The CD64 index might be a promising marker to detect LOS before infants demonstrate signs or symptoms of infection. However, larger prospective studies are needed to define optimal cut-off values and to investigate the role of non-infectious inflammation in this patient group.	[Kipfmueller, Florian; Schneider, Jessica; Prusseit, Julia; Franz, Axel R.; Bartmann, Peter; Mueller, Andreas] Univ Childrens Hosp Bonn, Dept Neonatol & Pediat Crit Care, Bonn, Germany; [Dimitriou, Ioanna] Univ Hosp Bonn, Dept Med Biometry Informat & Epidemiol, Bonn, Germany; [Zur, Berndt] Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn	Kipfmueller, F (corresponding author), Univ Childrens Hosp Bonn, Dept Neonatol & Pediat Crit Care, Bonn, Germany.	florian.kipfmueller@ukb.uni-bonn.de	Franz, Axel/AAC-8067-2022	Franz, Axel/0000-0001-5066-0857				Adams-Chapman I, 2006, CURR OPIN INFECT DIS, V19, P290, DOI 10.1097/01.qco.0000224825.57976.87; Bartels DB, 2007, ARCH DIS CHILD-FETAL, V92, P449; Been JV, 2011, BJOG-INT J OBSTET GY, V118, P113, DOI 10.1111/j.1471-0528.2010.02751.x; Bekhof J, 2013, EUR J PEDIATR, V172, P501, DOI 10.1007/s00431-012-1910-6; Bhandari V, 2008, PEDIATRICS, V121, P129, DOI 10.1542/peds.2007-1308; Bohrer B, 2010, J PEDIATR-US, V156, P16, DOI 10.1016/j.jpeds.2009.07.027; Cai ZW, 2004, PEDIATR RES, V56, P377, DOI 10.1203/01.PDR.0000134249.92944.14; Dimoula A, 2014, CLIN INFECT DIS, V58, P820, DOI 10.1093/cid/cit936; Du JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102647; Elawady S, 2014, J INVEST MED, V62, P644, DOI 10.2310/JIM.0000000000000060; ERBE DV, 1990, MOL IMMUNOL, V27, P57, DOI 10.1016/0161-5890(90)90060-D; Fjaertoft G, 2005, ACTA PAEDIATR, V94, P295, DOI 10.1111/j.1651-2227.2005.tb03072.x; Fjaertoft G, 1999, PEDIATR RES, V45, P871, DOI 10.1203/00006450-199906000-00016; Franz AR, 2004, PEDIATRICS, V114, P1, DOI 10.1542/peds.114.1.1; Franz AR, 1999, PEDIATRICS, V104, P447, DOI 10.1542/peds.104.3.447; Groselj-Grenc M, 2009, INTENS CARE MED, V35, P1950, DOI 10.1007/s00134-009-1637-7; Groselj-Grenc M, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/202646; Hoffmann JJML, 2011, BIOCHEM MEDICA, V21, P282; Hornik CP, 2012, EARLY HUM DEV, V88, pS69, DOI 10.1016/S0378-3782(12)70019-1; HUIZINGA TWJ, 1991, BLOOD, V77, P2088; Icardi M, 2009, J CLIN MICROBIOL, V47, P3914, DOI 10.1128/JCM.00628-09; KERST JM, 1993, BLOOD, V81, P1457; Kramer BW, 2004, PEDIATR RES, V55, P764, DOI 10.1203/01.PDR.0000120678.72485.19; Kuster H, 1998, LANCET, V352, P1271, DOI 10.1016/S0140-6736(98)08148-3; Kuypers E, 2012, AM J PHYSIOL-LUNG C, V302, pL380, DOI 10.1152/ajplung.00338.2011; Lam HS, 2013, CLIN CHEM, V59, P1753, DOI 10.1373/clinchem.2013.209536; Lavoie PM, 2010, PEDIATR RES, V68, P248, DOI 10.1203/00006450-201011001-00485; Layseca-Espinosa E, 2002, PEDIAT ALLERG IMM-UK, V13, P319, DOI 10.1034/j.1399-3038.2002.01064.x; Leistner R, 2013, KLIN PADIATR, V225, P75, DOI 10.1055/s-0033-1334886; Levy O, 2000, BLOOD, V96, P2664; Mazzucchelli I, 2013, PEDIATR CRIT CARE ME, V14, P178, DOI 10.1097/PCC.0b013e31826e726d; Mestan K, 2009, J MATERN-FETAL NEO M, V22, P379, DOI 10.1080/14767050802609759; Morsy Amal A, 2008, Egypt J Immunol, V15, P53; Ng PC, 2006, CURR OPIN PEDIATR, V18, P125, DOI 10.1097/01.mop.0000193293.87022.4c; Ng PC, 2010, CLIN PERINATOL, V37, P599, DOI 10.1016/j.clp.2010.05.005; Ng PC, 2004, PEDIATR RES, V56, P796, DOI 10.1203/01.PDR.0000142586.47798.5E; Ng PC, 1997, ARCH DIS CHILD-FETAL, V77, pF221, DOI 10.1136/fn.77.3.F221; Ng PC, 2002, PEDIATR RES, V51, P296, DOI 10.1203/00006450-200203000-00006; RODWELL RL, 1988, J PEDIATR-US, V112, P761, DOI 10.1016/S0022-3476(88)80699-1; Schrag SJ, 2006, PEDIATR INFECT DIS J, V25, P939, DOI 10.1097/01.inf.0000239267.42561.06; Schrag SJ, 2006, PEDIATRICS, V118, P570, DOI 10.1542/peds.2005-3083; Soni S, 2013, PEDIATR INFECT DIS J, V32, pE33, DOI 10.1097/INF.0b013e31826faede; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Stoll BJ, 1996, J PEDIATR-US, V129, P63, DOI 10.1016/S0022-3476(96)70191-9; Streimish I, 2012, PEDIATR INFECT DIS J, V31, P777, DOI 10.1097/INF.0b013e318256fb07; Streimish I, 2014, AM J PERINAT, V31, P21, DOI 10.1055/s-0033-1334453; Strunk T, 2014, LANCET INFECT DIS, V14, P751, DOI 10.1016/S1473-3099(14)70710-8; Vento M, 2009, PEDIATRICS, V124, pE439, DOI 10.1542/peds.2009-0434; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6; Wang K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082700; Yeung MY, 2006, ACTA PAEDIATR, V95, P153, DOI 10.1080/08035250500301133	52	16	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124634	10.1371/journal.pone.0124634	http://dx.doi.org/10.1371/journal.pone.0124634			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894336	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700110
J	Wan, SG; Wu, YS; Zhou, XC; Chen, YB; An, JZ; Yu, XH; Zhang, HQ; Yang, HS; Xing, JL				Wan, Shaogui; Wu, Yousheng; Zhou, Xingchun; Chen, Yibing; An, Jiaze; Yu, Xiaohe; Zhang, Huiqing; Yang, Hushan; Xing, Jinliang			Polymorphisms in Genes of Tricarboxylic Acid Cycle Key Enzymes Are Associated with Early Recurrence of Hepatocellular Carcinoma	PLOS ONE			English	Article							INTRAHEPATIC RECURRENCE; RISK-FACTORS; SDHD GENE; MUTATIONS; CANCER; RESECTION; METABOLISM; EXPRESSION; MANAGEMENT	Alterations of activity and expression in tricarboxylic acid (TCA) cycle key enzymes have been indicated in several malignancies, including hepatocellular carcinoma (HCC). They play an important role in the progression of cancer. However, the impact of single nucleotide polymorphisms (SNPs) in genes encoding these key enzymes on the recurrence of HCC has not been investigated. In this study, we genotyped 17 SNPs in genes encoding TCA cycle key enzymes and analyzed their association with recurrence-free survival (RFS) in a cohort of 492 Chinese HCC patients by Cox proportional hazard model and survival tree analysis. We identified 7 SNPs in SDHC, SDHD, FH, and IDH2 genes to be significantly associated with the RFS of HCC patients. Moreover, all these SNPs were associated with the early recurrence (within 2 years after surgery) risk of diseases. Cumulative effect analysis showed that these SNPs exhibited a dose-dependent effect on the overall and early recurrence. Further stratified analysis suggested that number of risk genotypes modified the protective effect on HCC recurrence conferred by transcatheter arterial chemoembolization treatment. Finally, the survival tree analysis revealed that SNP rs10789859 in SDHD gene was the primary factor contributing to HCC recurrence in our population. To the best of our knowledge, we for the first time observed the association between SNPs in genes encoding TCA cycle key enzymes and HCC recurrence risk. Further observational and functional studies are needed to validate our findings and generalize its clinical usage.	[Wan, Shaogui] Henan Univ, Pharmaceut Coll, Inst Pharm, Kaifeng, Henan, Peoples R China; [Wu, Yousheng; Zhou, Xingchun; Chen, Yibing; Xing, Jinliang] Fourth Mil Med Univ, Expt Teaching Ctr Basic Med, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [An, Jiaze] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Shaanxi, Peoples R China; [Yu, Xiaohe] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Intervent Radiol, Shanghai, Peoples R China; [Zhang, Huiqing] Fourth Mil Med Univ, Tangdu Hosp, Dept Pain Treatment, Xian 710032, Peoples R China; [Yang, Hushan] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Med Oncol, Div Populat Sci, Philadelphia, PA 19107 USA	Henan University; Air Force Military Medical University; Air Force Military Medical University; Naval Medical University; Air Force Military Medical University; Jefferson University	Yang, HS (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Med Oncol, Div Populat Sci, Philadelphia, PA 19107 USA.	hushan.yang@jefferson.edu; xingjinliang@163.com			Program for New Century Excellent Talents in University of China; National Natural Science Foundation [81171966]; National Key Technologies R&D Program of China [2011ZX09307-001-04]; NATIONAL CANCER INSTITUTE [R03CA153099, R21CA159047, P30CA056036] Funding Source: NIH RePORTER	Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program of China(National Key Technology R&D Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Program for New Century Excellent Talents in University of China, National Natural Science Foundation (No. 81171966) and National Key Technologies R&D Program of China (No. 2011ZX09307-001-04) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; BELGHITI J, 1991, ANN SURG, V214, P114, DOI 10.1097/00000658-199108000-00004; Cardaci Simone, 2012, Int J Cell Biol, V2012, P161837, DOI 10.1155/2012/161837; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Fukuda H, 2002, CARCINOGENESIS, V23, P2019, DOI 10.1093/carcin/23.12.2019; Habano W, 2003, ONCOL REP, V10, P1375; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hirawake H, 1999, BBA-BIOENERGETICS, V1412, P295, DOI 10.1016/S0005-2728(99)00071-7; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Ishizawa T, 2008, GASTROENTEROLOGY, V134, P1908, DOI 10.1053/j.gastro.2008.02.091; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Marrero JA, 2005, HEPATOLOGY, V41, P707, DOI 10.1002/hep.20636; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Rahbari NN, 2011, ANN SURG, V253, P453, DOI 10.1097/SLA.0b013e31820d944f; Raimundo N, 2011, TRENDS MOL MED, V17, P641, DOI 10.1016/j.molmed.2011.06.001; Roayaie S, 2009, GASTROENTEROLOGY, V137, P850, DOI 10.1053/j.gastro.2009.06.003; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Ulrich CM, 2003, NAT REV CANCER, V3, P912, DOI 10.1038/nrc1233; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang M, 2013, J CLIN INVEST, V123, P3652, DOI 10.1172/JCI67228; Yen KE, 2010, ONCOGENE, V29, P6409, DOI 10.1038/onc.2010.444; Yu XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093416; Yuan P, 2014, CANCER SCI, V105, P825, DOI 10.1111/cas.12428	30	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124471	10.1371/journal.pone.0124471	http://dx.doi.org/10.1371/journal.pone.0124471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894340	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700098
J	Yakoub, AM; Shukla, D				Yakoub, Abraam M.; Shukla, Deepak			Herpes Simplex Virus-1 Fine-Tunes Host's Autophagic Response to Infection: A Comprehensive Analysis in Productive Infection Models	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; MONITORING AUTOPHAGY; CELLULAR AUTOPHAGY; ANTIVIRAL DEFENSE; HSV-1 INFECTION; REPLICATION; ENTRY; LC3; HERPESVIRUSES; SEQUENCE	Herpes simplex virus-1 (HSV-1) infection causes severe conditions, with serious complications, including corneal blindness from uncontrolled ocular infections. An important cellular defense mechanism against HSV-1 infection is autophagy. The autophagic response of the host cell was suggested to be regulated by HSV-1. In this study, we performed a detailed analysis of autophagy in multiple HSV-1-targeted cell types, and under various infection conditions that recapitulate a productive infection model. We found that autophagy was slightly inhibited in one cell type, while in other cell types autophagy maintained its basal levels mostly unchanged during productive infection. This study refines the concept of HSV-1-mediated autophagy regulation to imply either inhibition, or prevention of activation, of the innate immune pathway.	[Yakoub, Abraam M.; Shukla, Deepak] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Yakoub, Abraam M.; Shukla, Deepak] Univ Illinois, Med Ctr, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Shukla, D (corresponding author), Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA.	dshukla@uic.edu		Shukla, Deepak/0000-0002-3039-6953	NIH [EY023058];  [EY01792]; NATIONAL EYE INSTITUTE [R21EY023058, P30EY001792] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by a NIH grant (EY023058) to DS and a core grant (EY01792). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x; Alexander DE, 2007, J VIROL, V81, P12128, DOI 10.1128/JVI.01356-07; Aoun P, 2003, INVEST OPHTH VIS SCI, V44, P2999, DOI 10.1167/iovs.02-1060; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Banatvala JE, 2011, LANCET INFECT DIS, V11, P80, DOI 10.1016/S1473-3099(11)70012-3; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Cavignac Y, 2010, VIRUSES-BASEL, V2, P314, DOI 10.3390/v2010314; Choi J, 2005, INVEST OPHTH VIS SCI, V46, P214, DOI 10.1167/iovs.04-0765; CHOU J, 1990, J VIROL, V64, P1014, DOI 10.1128/JVI.64.3.1014-1020.1990; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Eng KE, 2010, AUTOPHAGY, V6, P634, DOI 10.4161/auto.6.5.12112; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Gobeil PAM, 2012, MBIO, V3, DOI 10.1128/mBio.00267-12; Jaishankar D, 2015, J VIROL, V89, P1932, DOI 10.1128/JVI.02979-14; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kuballa P, 2012, ANNU REV IMMUNOL, V30, P611, DOI 10.1146/annurev-immunol-020711-074948; Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Le Sage V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042636; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; McFarlane S, 2011, J VIROL, V85, P4212, DOI 10.1128/JVI.02435-10; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nakashima A, 2006, VIROLOGY, V349, P254, DOI 10.1016/j.virol.2006.03.029; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Prentice E, 2004, J BIOL CHEM, V279, P10136, DOI 10.1074/jbc.M306124200; Rasmussen SB, 2011, J IMMUNOL, V187, P5268, DOI 10.4049/jimmunol.1100949; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; Roizman B, 2013, ANNU REV MICROBIOL, V67, P355, DOI 10.1146/annurev-micro-092412-155654; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Szpara ML, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002282; Szpara ML, 2010, J VIROL, V84, P5303, DOI 10.1128/JVI.00312-10; Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176; Tanida I, 2008, AUTOPHAGY, V4, P131, DOI 10.4161/auto.5233; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tiwari V, 2015, MOLECULES, V20, P2707, DOI 10.3390/molecules20022707; Tumbarello DA, 2012, NAT CELL BIOL, V14, P1024, DOI 10.1038/ncb2589; Wan GH, 2008, J BIOL CHEM, V283, P21540, DOI 10.1074/jbc.M800214200; Watson G, 2012, VIROLOGY, V433, P528, DOI 10.1016/j.virol.2012.08.043; Whitley RJ, 2001, LANCET, V357, P1513, DOI 10.1016/S0140-6736(00)04638-9; Yakoub AM, 2014, J VIROL, V88, P12915, DOI 10.1128/JVI.02071-14; Ying HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047307; Yordy B, 2013, AUTOPHAGY, V9, P236, DOI 10.4161/auto.22506; Yordy B, 2012, CELL HOST MICROBE, V12, P334, DOI 10.1016/j.chom.2012.07.013; Zhou Z, 2009, AUTOPHAGY, V5, P321, DOI 10.4161/auto.5.3.7406	50	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124646	10.1371/journal.pone.0124646	http://dx.doi.org/10.1371/journal.pone.0124646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894397	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700111
J	Chung, WW; Chua, SS; Lai, PSM; Morisky, DE				Chung, Wen Wei; Chua, Siew Siang; Lai, Pauline Siew Mei; Morisky, Donald E.			The Malaysian Medication Adherence Scale (MALMAS): Concurrent Validity Using a Clinical Measure among People with Type 2 Diabetes in Malaysia	PLOS ONE			English	Article							PREDICTIVE-VALIDITY; NONADHERENCE; HOSPITALIZATION; INDIVIDUALS; SENSITIVITY; POPULATION; MELLITUS; THERAPY; RATES; KEY	Medication non-adherence is a prevalent problem worldwide but up to today, no gold standard is available to assess such behavior. This study was to evaluate the psychometric properties, particularly the concurrent validity of the English version of the Malaysian Medication Adherence Scale (MALMAS) among people with type 2 diabetes in Malaysia. Individuals with type 2 diabetes, aged 21 years and above, using at least one anti-diabetes agent and could communicate in English were recruited. The MALMAS was compared with the 8-item Morisky Medication Adherence Scale (MMAS-8) to assess its convergent validity while concurrent validity was evaluated based on the levels of glycated hemoglobin (HbA1C). Participants answered the MALMAS twice: at baseline and 4 weeks later. The study involved 136 participants. The MALMAS achieved acceptable internal consistency (Cronbach's alpha=0.565) and stable reliability as the test-retest scores showed fair correlation (Spearman's rho=0.412). The MALMAS has good correlation with the MMAS-8 (Spearman's rho=0.715). Participants who were adherent to their anti-diabetes medications had significantly lower median HbA1C values than those who were non-adherence (7.90 versus 8.55%, p=0.032). The odds of participants who were adherent to their medications achieving good glycemic control was 3.36 times (95% confidence interval: 1.09-10.37) of those who were non-adherence. This confirms the concurrent validity of the MALMAS. The sensitivity of the MALMAS was 88.9% while its specificity was 29.6%. The findings of this study further substantiates the reliability and validity of the MALMAS, in particular its concurrent validity and sensitivity for assessing medication adherence of people with type 2 diabetes in Malaysia.	[Chung, Wen Wei; Chua, Siew Siang] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Chung, Wen Wei] Univ Malaya, Med Ctr, Dept Pharm, Kuala Lumpur, Malaysia; [Lai, Pauline Siew Mei] Univ Malaya, Fac Med, Primary Care Res Grp UMPCRG, Dept Primary Care Med, Kuala Lumpur, Malaysia; [Morisky, Donald E.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Community Hlth Sci, Los Angeles, CA USA	Universiti Malaya; Universiti Malaya; Universiti Malaya; University of California System; University of California Los Angeles	Chua, SS (corresponding author), Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia.	chuass@um.edu.my	Chua, Siew Siang/B-9778-2010; Morisky, Donald/AAU-4679-2021; Chua, Siew Siang/AAH-9218-2021; Lai, Pauline Siew Mei/B-1031-2012	Lai, Pauline Siew Mei/0000-0002-9940-9644	University of Malaya Research Grant [RG 457/12HTM]	University of Malaya Research Grant	This study was supported by the University of Malaya Research Grant (RG 457/12HTM) which was awarded to SSC. (URL: http://umresearch.um.edu.my/mainpage.php?module=Maklumat&kategori=86&id=62&papar=1) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qazaz HK, 2010, DIABETES RES CLIN PR, V90, P216, DOI 10.1016/j.diabres.2010.08.012; Balkrishnan R, 2003, CLIN THER, V25, P2958, DOI 10.1016/S0149-2918(03)80347-8; Bowling A, 2009, RES METHODS HLTH INV, DOI [10.7748/ns.29.14.32.s36, DOI 10.7748/NS.29.14.32.S36]; Chesney MA, 2000, CLIN INFECT DIS, V30, pS171, DOI 10.1086/313849; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Chua SS., 2013, J PHARM PHARM SCI, V5, P790; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohen JS, 2001, ARCH INTERN MED, V161, P880, DOI 10.1001/archinte.161.6.880; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; DeVellis R., 1991, SCALE DEV THEORY APP; Donnan PT, 2002, DIABETIC MED, V19, P279, DOI 10.1046/j.1464-5491.2002.00689.x; Fischer MA, 2010, J GEN INTERN MED, V25, P284, DOI 10.1007/s11606-010-1253-9; Goff SL, 2008, J GEN INTERN MED, V23, P236, DOI 10.1007/s11606-007-0470-3; Grant RW, 2003, DIABETES CARE, V26, P1408, DOI 10.2337/diacare.26.5.1408; Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836; Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; Kane S, 2008, DIGEST DIS SCI, V53, P1020, DOI 10.1007/s10620-007-9968-0; Krapek K, 2004, ANN PHARMACOTHER, V38, P1357, DOI 10.1345/aph.1D612; Krousel-Wood M, 2004, CURR OPIN CARDIOL, V19, P357, DOI 10.1097/01.hco.0000126978.03828.9e; Krousel-Wood M, 2009, AM J MANAG CARE, V15, P59; Laditka SB, 2001, ARCH INTERN MED, V161, P1301, DOI 10.1001/archinte.161.10.1301; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Lau DT, 2004, DIABETES CARE, V27, P2149, DOI 10.2337/diacare.27.9.2149; Lerman I, 2005, ARCH MED RES, V36, P300, DOI 10.1016/j.arcmed.2004.12.001; Li WW, 2012, J CLIN NURS, V21, P1816, DOI 10.1111/j.1365-2702.2012.04088.x; Lingam R, 2002, ACTA PSYCHIAT SCAND, V105, P164, DOI 10.1034/j.1600-0447.2002.1r084.x; Lu M, 2008, AIDS BEHAV, V12, P86, DOI 10.1007/s10461-007-9261-4; Manias E, 2007, ANN PHARMACOTHER, V41, P764, DOI 10.1345/aph.1H623; Marcum ZA, 2013, RES SOC ADMIN PHARM, V9, P817, DOI 10.1016/j.sapharm.2012.12.002; Marcum ZA, 2013, JAMA-J AM MED ASSOC, V310, P1506, DOI 10.1001/jama.2013.277311; Marcum ZA, 2013, JAMA-J AM MED ASSOC, V309, P2105, DOI 10.1001/jama.2013.4638; Martin Leslie R, 2005, Ther Clin Risk Manag, V1, P189; Moons KGM, 1997, EPIDEMIOLOGY, V8, P12, DOI 10.1097/00001648-199701000-00002; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; MORISKY DE, 1990, HEALTH EDUC QUART, V17, P253, DOI 10.1177/109019819001700303; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Morisky DE, 2011, J CLIN EPIDEMIOL, V64, P255, DOI 10.1016/j.jclinepi.2010.09.002; Odegard PS, 2007, DIABETES EDUCATOR, V33, P1014, DOI 10.1177/0145721707308407; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Schectman JM, 2002, DIABETES CARE, V25, P1015, DOI 10.2337/diacare.25.6.1015; Schlenk Elizabeth A, 2004, J Gerontol Nurs, V30, P33; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Sodergard B, 2006, J CLIN PHARM THER, V31, P605, DOI 10.1111/j.1365-2710.2006.00782.x; Sokol MC, 2005, MED CARE, V43, P521, DOI 10.1097/01.mlr.0000163641.86870.af; Streiner DL, 1995, HLTH MEASUREMENT SCA, DOI [10.1097/DBP.0b013e31819670fa, DOI 10.1097/DBP.0B013E31819670FA]; Sushil S., 2010, EUR J SCI RES, V46, P172; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Wood B, 2012, US PHARM, V37, P3; World Health Organization, 2003, NONC DIS MENT HLTH A	49	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124275	10.1371/journal.pone.0124275	http://dx.doi.org/10.1371/journal.pone.0124275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909363	Green Published, gold			2022-12-27	WOS:000353376800073
J	Stoner, SA; Arenella, PB; Hendershot, CS				Stoner, Susan A.; Arenella, Pamela B.; Hendershot, Christian S.			Randomized Controlled Trial of a Mobile Phone Intervention for Improving Adherence to Naltrexone for Alcohol Use Disorders	PLOS ONE			English	Article							MEDICATION COMPLIANCE; CLINICAL-TRIAL; DOUBLE-BLIND; DEPENDENCE; PHARMACOTHERAPY; THERAPY; PREDICTORS; EFFICACY	Background Naltrexone is a front-line treatment for alcohol use disorders, but its efficacy is limited by poor medication adherence. This randomized controlled trial evaluated whether a mobile health intervention could improve naltrexone adherence. Methods Treatment-seeking participants with an alcohol use disorder (N = 76) were randomized to intervention and control conditions. All participants received naltrexone (50 mg/day) with a medication event monitoring system (MEMS) and a prepaid smartphone, and received a daily text message querying medication side effects, alcohol use, and craving. Those in the intervention arm received additional medication reminders and adherence assessment via text message. Results The primary outcome, proportion of participants with adequate adherence (defined as >= 80% of prescribed doses taken through Week 8), did not differ between groups in intent-to-treat analyses (p = .34). Mean adherence at study midpoint (Week 4) was 83% in the intervention condition and 77% in the control condition (p = .35). Survival analysis found that the intervention group sustained adequate adherence significantly longer (M = 19 days [95% CI = 0.0-44.0]) than those in the control group (M = 3 days [95% CI = 0.0-8.1]) during the first month of treatment (p = .04). Medication adherence did not predict drinking outcomes. Conclusions These results suggest that in the context of daily monitoring and assessment via cell phone, additional text message reminders do not further improve medication adherence. Although this initial trial does not provide support for the efficacy of text messaging to improve adherence to pharmacotherapy for alcohol use disorders, additional trials with larger samples and alternate designs are warranted.	[Stoner, Susan A.] Univ Washington, Alcohol & Drug Abuse Inst, Seattle, WA 98195 USA; [Arenella, Pamela B.] Univ New Mexico, Dept Psychiat, Albuquerque, NM 87131 USA; [Hendershot, Christian S.] Campbell Family Mental Hlth Res Inst, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Hendershot, Christian S.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Hendershot, Christian S.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Hendershot, Christian S.] Mind Res Network & Lovelace Biomed & Environm Res, Albuquerque, NM USA	University of Washington; University of Washington Seattle; University of New Mexico; University of Toronto; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; Lovelace Respiratory Research Institute	Stoner, SA (corresponding author), Univ Washington, Alcohol & Drug Abuse Inst, Seattle, WA 98195 USA.	sastoner@uw.edu	Hendershot, Christian S./C-1638-2009; Hendershot, Christian/C-8485-2011	Hendershot, Christian S./0000-0002-5328-2035; Stoner, Susan/0000-0001-8548-219X; Arenella, Pamela/0000-0003-3135-973X	National Institute on Alcohol Abuse and Alcoholism (NIAAA) [HHSN275201000011C]	National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by a Small Business Innovation Research contract # HHSN275201000011C from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) to Talaria, Inc. (Principal Investigator, Dr. Stoner). NIAAA had no role in the design, conduct, or reporting of this study. Talaria, Inc., has closed and donated its technology to the Alcohol and Drug Abuse Institute at the University of Washington. Drs. Stoner, Arenella, and Hendershot report no financial relationships with commercial	Anton RF, 2008, NEW ENGL J MED, V359, P715, DOI 10.1056/NEJMct0801733; Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; Baros AM, 2007, ALCOHOL CLIN EXP RES, V31, P596, DOI 10.1111/j.1530-0277.2007.00343.x; Brown ES, 2009, ALCOHOL CLIN EXP RES, V33, P1863, DOI 10.1111/j.1530-0277.2009.01024.x; Chick J, 2000, ALCOHOL ALCOHOLISM, V35, P587, DOI 10.1093/alcalc/35.6.587; Cramer J, 2003, VALUE HEALTH, V6, P566, DOI 10.1046/j.1524-4733.2003.65269.x; Dimeff LA, 2010, OXFORD HDB CLIN PSYC, P618, DOI DOI 10.1093/OXFORDHB/9780195366884.013.0028; Dowshen N, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2015; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; First MB, 2002, STRUCTURED CLIN INTE; Flannery BA, 1999, ALCOHOL CLIN EXP RES, V23, P1289, DOI 10.1097/00000374-199908000-00001; Gurvich EM, 2013, ALCOHOL ALCOHOL; Heron KE, 2010, BRIT J HEALTH PSYCH, V15, P1, DOI 10.1348/135910709X466063; Killeen TK, 2004, ALCOHOL CLIN EXP RES, V28, P1710, DOI 10.1097/01.ALC.0000145688.30448.2C; Kranzler HR, 2000, NEUROPSYCHOPHARMACOL, V22, P493, DOI 10.1016/S0893-133X(99)00135-9; Kranzler HR, 2000, ALCOHOL ALCOHOLISM, V35, P537, DOI 10.1093/alcalc/35.6.537; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Linn AJ, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1738; Mark TL, 2003, ADDICTION, V98, P617, DOI 10.1046/j.1360-0443.2003.00377.x; Monti PM, 2001, ALCOHOL CLIN EXP RES, V25, P1634, DOI 10.1111/j.1530-0277.2001.tb02170.x; Oslin DW, 2008, ALCOHOL CLIN EXP RES, V32, P1299, DOI 10.1111/j.1530-0277.2008.00698.x; Pettinati HM, 2006, J CLIN PSYCHOPHARM, V26, P610, DOI 10.1097/01.jcp.0000245566.52401.20; Pettinati HM, 2000, J ADDICT DIS, V19, P71, DOI 10.1300/J069v19n01_06; Pettinati HM, 2004, COMBINE MONOGRAPH SE, V2, DOI [10.1001/jama.2014.15939, DOI 10.1001/JAMA.2014.15939]; Rainie L, 2009, INTERNET BROADBAND C; Reid SC, 2005, J STUD ALCOHOL, V66, P833, DOI 10.15288/jsa.2005.66.833; Rosner S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001867.pub3; Rohsenow DJ, 2000, ALCOHOL CLIN EXP RES, V24, P1542, DOI 10.1097/00000374-200010000-00012; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Simoni JM, 2009, JAIDS-J ACQ IMM DEF, V52, P465, DOI 10.1097/QAI.0b013e3181b9300c; SKINNER HA, 1982, J ABNORM PSYCHOL, V91, P199, DOI 10.1037/0021-843X.91.3.199; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; Stoner SA, 2012, ADDICT SCI CLIN PRAC, V7, DOI 10.1186/1940-0640-7-9; Swift R, 2011, J STUD ALCOHOL DRUGS, V72, P1012, DOI 10.15288/jsad.2011.72.1012; VOLPICELLI J, 2001, COMBINING MED PSYCHO; Volpicelli JR, 1997, ARCH GEN PSYCHIAT, V54, P737; Zweben A, 2008, ALCOHOL CLIN EXP RES, V32, P1661, DOI 10.1111/j.1530-0277.2008.00743.x	38	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124613	10.1371/journal.pone.0124613	http://dx.doi.org/10.1371/journal.pone.0124613			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG6AH	25909320	Green Published, Green Submitted, gold			2022-12-27	WOS:000353376800092
J	Cao, Z; McGow, DP; Shepherd, C; Lindsay, JG				Cao, Zhenbo; McGow, Donna P.; Shepherd, Colin; Lindsay, J. Gordon			Improved Catenated Structures of Bovine Peroxiredoxin III F190L Reveal Details of Ring-Ring Interactions and a Novel Conformational State	PLoS One			English	Article							MOLECULAR CHAPERONE FUNCTION; CYSTEINE-SULFINIC ACID; MYCOBACTERIUM-TUBERCULOSIS; ANTIOXIDANT DEFENSE; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; SITE CYSTEINE; MITOCHONDRIAL; INTERMEDIATE	Mitochondrial 2-cys peroxiredoxin III (PrxIII) is a key player in antioxidant defence reducing locally-generated H2O2 to H2O. A Phe to Leu (F190L) mutation in the C-terminal alpha-helix of PrxIII, mimicking that found in some bacteria and parasites, increases its resistance to hyperoxidation but has no obvious influence on peroxidase activity. Here we report on the oxidized and reduced crystal structures of bovine PrxIII F190L at 2.4 angstrom and 2.2 angstrom, respectively. Both structures exist as two-ring catenanes with their dodecameric rings inclined at 55o to each other, similar to that previously reported for PrxIII C168S. The new higher-resolution structures reveal details of the complex network of H-bonds stabilising the inter-toroid contacts. In addition, Arg123, the key conserved residue, that normally interacts with the catalytic cys (Cp, cys 47) is found in a distinct conformation extending away from the Cp while the characteristic Arg-Glu-Arg network, underpinning the active-site geometry also displays a distinctive arrangement, not observed previously. This novel active-site organisation may provide new insights into the dynamics of the large-scale conformational changes occurring between oxidized and reduced states.	[Cao, Zhenbo; McGow, Donna P.; Shepherd, Colin; Lindsay, J. Gordon] Univ Glasgow, CMVLS, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland	University of Glasgow	Lindsay, JG (corresponding author), Univ Glasgow, CMVLS, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland.	Gordon.Lindsay@glasgow.ac.uk	Shepherd, Colin/AAF-8927-2019	Shepherd, Colin/0000-0003-3334-3379	BBSRC [BB/F001851/1]; Biotechnology and Biological Sciences Research Council [BB/F001851/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was fully supported by a grant from the BBSRC (BB/F001851/1).	Ardini M, 2014, NANOSCALE, V6, P8052, DOI 10.1039/c4nr01526f; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Cao ZB, 2005, STRUCTURE, V13, P1661, DOI 10.1016/j.str.2005.07.021; Cao Zhenbo, 2007, V44, P295; Cao Z, 2007, J MOL BIOL, V372, P1022, DOI 10.1016/j.jmb.2007.07.018; Cao ZB, 2011, J BIOL CHEM, V286, P42257, DOI 10.1074/jbc.M111.298810; Chuang MH, 2006, P NATL ACAD SCI USA, V103, P2552, DOI 10.1073/pnas.0510770103; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gourlay LJ, 2003, J BIOL CHEM, V278, P32631, DOI 10.1074/jbc.M303862200; Guimaraes BG, 2005, J BIOL CHEM, V280, P25735, DOI 10.1074/jbc.M503076200; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Hall A, 2010, J MOL BIOL, V402, P194, DOI 10.1016/j.jmb.2010.07.022; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Haynes AC, 2013, J BIOL CHEM, V288, P29714, DOI 10.1074/jbc.M113.473470; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Li S, 2005, J MOL BIOL, V346, P1035, DOI 10.1016/j.jmb.2004.12.046; Lim JC, 2008, J BIOL CHEM, V283, P28873, DOI 10.1074/jbc.M804087200; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nagy P, 2011, J BIOL CHEM, V286, P18048, DOI 10.1074/jbc.M111.232355; Noh YH, 2009, J BIOL CHEM, V284, P8470, DOI 10.1074/jbc.M808981200; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; van Eldijk MB, 2013, CHEM COMMUN, V49, P7770, DOI 10.1039/c3cc43219j; Wang X, 2012, BIOCHEM J, V441, P113, DOI 10.1042/BJ20110380; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	31	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123303	10.1371/journal.pone.0123303	http://dx.doi.org/10.1371/journal.pone.0123303			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906064	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000353332000027
J	Chen, CL; Mahjoubfar, A; Jalali, B				Chen, Claire Lifan; Mahjoubfar, Ata; Jalali, Bahram			Optical Data Compression in Time Stretch Imaging	PLOS ONE			English	Article							TRANSFORMATION; LIGHT	Time stretch imaging offers real-time image acquisition at millions of frames per second and subnanosecond shutter speed, and has enabled detection of rare cancer cells in blood with record throughput and specificity. An unintended consequence of high throughput image acquisition is the massive amount of digital data generated by the instrument. Here we report the first experimental demonstration of real-time optical image compression applied to time stretch imaging. By exploiting the sparsity of the image, we reduce the number of samples and the amount of data generated by the time stretch camera in our proof-of-concept experiments by about three times. Optical data compression addresses the big data predicament in such systems.	[Chen, Claire Lifan; Mahjoubfar, Ata; Jalali, Bahram] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA; [Chen, Claire Lifan; Mahjoubfar, Ata; Jalali, Bahram] Calif NanoSyst Inst, Los Angeles, CA USA; [Jalali, Bahram] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Chen, CL (corresponding author), Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA.	l.chen@ucla.edu	jalali, bahram/AFK-2299-2022		Office of Naval Research (ONR) MURI Program on Optical Computing; Nantworks LLC	Office of Naval Research (ONR) MURI Program on Optical Computing; Nantworks LLC	This work was partially supported by the Office of Naval Research (ONR) MURI Program on Optical Computing and by Nantworks LLC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam J, 2013, OPT EXPRESS, V21, P28960, DOI 10.1364/OE.21.028960; Asghari MH, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4868539; Asghari MH, 2013, APPL OPTICS, V52, P6735, DOI 10.1364/AO.52.006735; Bosworth BT, 2013, OPT LETT, V38, P4892, DOI 10.1364/OL.38.004892; Bosworth BT, 2014, C LAS EL OSA; Chan J, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4902986; Chen CL, 2014, CONF LASER ELECTR; Chen H, 2014, C LAS EL OSA; Chen Y, 2014, OPT LETT, V39, P2222, DOI 10.1364/OL.39.002222; Di Carlo D, 2007, P NATL ACAD SCI USA, V104, P18892, DOI 10.1073/pnas.0704958104; Di Carlo D, 2009, LAB CHIP, V9, P3038, DOI 10.1039/b912547g; Diebold ED, 2013, NAT PHOTONICS, V7, P806, DOI [10.1038/NPHOTON.2013.245, 10.1038/nphoton.2013.245]; Diebold ED, 2011, OPT EXPRESS, V19, P23809, DOI 10.1364/OE.19.023809; Goda K, 2013, NAT PHOTONICS, V7, P102, DOI [10.1038/NPHOTON.2012.359, 10.1038/nphoton.2012.359]; Goda K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00445; Goda K, 2009, NATURE, V458, P1145, DOI 10.1038/nature07980; Goda K, 2012, P NATL ACAD SCI USA, V109, P11630, DOI 10.1073/pnas.1204718109; Gupta V, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.4731647; Jalali B, 2011, OPT PHOTONICS NEWS, V5, P24; Jalali B, 2014, OPTICA, V1, P23, DOI 10.1364/OPTICA.1.000023; Lau AKS, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.7.076001; Liang YH, 2013, OPT EXPRESS, V21, P25700, DOI 10.1364/OE.21.025700; Mahjoubfar A, 2014, PROC SPIE, V8972, DOI 10.1117/12.2040881; Mahjoubfar A, 2013, PROC SPIE, V8611, DOI 10.1117/12.2003135; Mahjoubfar A, 2013, J OPT SOC AM A, V30, P2124, DOI 10.1364/JOSAA.30.002124; Mahjoubfar A, 2013, BIOMED OPT EXPRESS, V4, P1618, DOI 10.1364/BOE.4.001618; Mahjoubfar A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3563707; Ng W, 2014, GOMACTECH 14 CHARL S; Nichols JM, 2011, OPT EXPRESS, V19, P7339, DOI 10.1364/OE.19.007339; Qian F, 2009, OPT COMMUN, V282, P4672, DOI 10.1016/j.optcom.2009.08.056; Shapiro HM, 2003, PRACTICAL FLOW CYTOM; Solli DR, 2007, NATURE, V450, P1054, DOI 10.1038/nature06402; Valley GC, 2012, OPT LETT, V37, P4675, DOI 10.1364/OL.37.004675; Wei XM, 2014, OPT LETT, V39, P5989, DOI 10.1364/OL.39.005989; Wong TTW, 2014, SCI REP-UK, V4, DOI 10.1038/srep03656; Yazaki A, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4885147; Zhang C, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4890861	37	39	41	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125106	10.1371/journal.pone.0125106	http://dx.doi.org/10.1371/journal.pone.0125106			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906244	gold, Green Published, Green Submitted			2022-12-27	WOS:000353332000101
J	Manohar, CM; Prabhawathi, V; Sivakumar, PM; Doble, M				Manohar, Cynthya Maria; Prabhawathi, Veluchamy; Sivakumar, Ponnurengam Malliappan; Doble, Mukesh			Design of a Papain Immobilized Antimicrobial Food Package with Curcumin as a Crosslinker	PLOS ONE			English	Article							GLUCOSE-OXIDASE; ESSENTIAL OIL; CHITOSAN; FILMS; RESAZURIN; DIFFUSION; BIOFILMS; PEPTIDE; GROWTH	Contamination of food products by spoilage and pathogenic microorganisms during post process handling is one of the major causes for food spoilage and food borne illnesses. The present green sustainable approach describes the covalent immobilization of papain to LDPE (low density polyethylene), HDPE (high density polyethylene), LLDPE (linear low density polyethylene) and PCL (polycaprolactam) with curcumin as the photocrosslinker. About 50% of curcumin and 82-92% of papain were successfully immobilized on these polymers. After 30 days, the free enzyme retained 87% of its original activity, while the immobilized enzyme retained more than 90% of its activity on these polymers. Papain crosslinked to LLDPE exhibited the best antibiofilm properties against Acinetobacter sp. KC119137.1 and Staphylococcus aureus NCIM 5021 when compared to the other three polymers, because of the highest amount of enzyme immobilized on this surface. Papain acts by damaging the cell membrane. The enzyme is able to reduce the amount of carbohydrate and protein contents in the biofilms formed by these organisms. Meat wrapped with the modified LDPE and stored at 4 degrees C showed 9 log reduction of these organisms at the end of the seventh day when compared to samples wrapped with the bare polymer. This method of cross-linking can be used on polymers with or without functional groups and can be adopted to bind any type of antimicrobial agent.	[Manohar, Cynthya Maria; Prabhawathi, Veluchamy; Sivakumar, Ponnurengam Malliappan; Doble, Mukesh] Indian Inst Technol, Bhupat & Jyoti Mehta Sch BioSci, Dept Biotechnol, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Doble, M (corresponding author), Indian Inst Technol, Bhupat & Jyoti Mehta Sch BioSci, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	mukeshd@iitm.ac.in		Sivakumar, Ponnurengam Malliappan/0000-0002-5880-9596; Veluchamy, Prabhawathi/0000-0002-9703-5714; Doble, Mukeshd/0000-0002-4335-0698				Amri Ezekiel, 2012, American Journal of Biochemistry and Biotechnology, V8, P99, DOI 10.3844/ajbbsp.2012.99.104; Arkatkar A, 2010, INT BIODETER BIODEGR, V64, P530, DOI 10.1016/j.ibiod.2010.06.002; Beeley JA, 2000, BRIT DENT J, V188, P427, DOI 10.1038/sj.bdj.4800501a; Beevers C., 2011, BOT TARGETS THER, V1, P5, DOI [10.2147/btat.s17244, DOI 10.2147/BTAT.S17244]; Besse NG, 2004, INT J FOOD MICROBIOL, V91, P119, DOI 10.1016/S0168-1605(03)00375-1; Brase S, 2005, ANGEW CHEM INT EDIT, V44, P5188, DOI 10.1002/anie.200400657; Bueno C, 2002, PHOTOCHEM PHOTOBIOL, V76, P385; Calzolai L, 2012, FOOD ADDIT CONTAM A, V29, P1183, DOI 10.1080/19440049.2012.689777; Candan F, 2003, J ETHNOPHARMACOL, V87, P215, DOI 10.1016/S0378-8741(03)00149-1; Cerqueira MA, 2012, FOOD HYDROCOLLOID, V27, P175, DOI 10.1016/j.foodhyd.2011.07.007; Chau CF, 2007, TRENDS FOOD SCI TECH, V18, P269, DOI 10.1016/j.tifs.2007.01.007; Choi JH, 2005, LWT-FOOD SCI TECHNOL, V38, P417, DOI 10.1016/j.lwt.2004.07.004; Dankbar DM, 2006, ANAL BIOANAL CHEM, V386, P1967, DOI 10.1007/s00216-006-0871-x; Doyle RJ, 2000, MICROBES INFECT, V2, P391, DOI 10.1016/S1286-4579(00)00328-2; Ercolini D, 2010, FOOD MICROBIOL, V27, P137, DOI 10.1016/j.fm.2009.09.006; Erdogan B, 2004, J AM CHEM SOC, V126, P3678, DOI 10.1021/ja0320020; Eshamah H, 2014, MEAT SCI, V96, P1494, DOI 10.1016/j.meatsci.2013.12.010; Fajardo P, 2010, J FOOD ENG, V101, P349, DOI 10.1016/j.jfoodeng.2010.06.029; Fu GL, 2012, TALANTA, V97, P438, DOI 10.1016/j.talanta.2012.04.059; Fucinos C, 2012, J FOOD SCI, V77, pN21, DOI 10.1111/j.1750-3841.2012.02781.x; Gamage GR, 2009, FOOD RES INT, V42, P832, DOI 10.1016/j.foodres.2009.03.012; Gemili S, 2009, J FOOD ENG, V90, P453, DOI 10.1016/j.jfoodeng.2008.07.014; Han C, 2013, MEAT SCI, V157, P239; Hanusova K, 2013, CENT EUR J CHEM, V11, P1066, DOI 10.2478/s11532-013-0241-4; Hauser C, 2011, PROC FOOD SCI, V1, P197, DOI 10.1016/j.profoo.2011.09.031; Iseppi R, 2008, INT J FOOD MICROBIOL, V123, P281, DOI 10.1016/j.ijfoodmicro.2007.12.015; Kondyurin AV, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/126170; Lapidot A, 2006, INT J FOOD MICROBIOL, V109, P229, DOI 10.1016/j.ijfoodmicro.2006.01.012; Le Loir Yves, 2003, Genet Mol Res, V2, P63; Li B, 2013, MAR DRUGS, V11, P1534, DOI 10.3390/md11051534; Liggieri C, 2009, ACTA BIOCH BIOPH SIN, V41, P154, DOI 10.1093/abbs/gmn018; Lim K, 2013, ACS APPL MATER INTER, V5, P6412, DOI 10.1021/am401629p; Limjaroen P, 2003, J PLAST FILM SHEET, V19, P95, DOI 10.1177/8756087903039409; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manso S, 2013, FOOD CONTROL, V30, P370, DOI 10.1016/j.foodcont.2012.07.018; Mateo C, 2002, BIOTECHNOL PROGR, V18, P629, DOI 10.1021/bp010171n; Mohan PRK, 2012, VIB SPECTROSC, V62, P77, DOI 10.1016/j.vibspec.2012.05.002; Morvay A. A., 2011, Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. Veterinary Medicine, V68, P245; Muriel-Galet V, 2012, INT J FOOD MICROBIOL, V157, P239, DOI 10.1016/j.ijfoodmicro.2012.05.009; Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8; Nwinyi OC, 2010, AFR J AGR RES, V5, P1531; Orgaz B, 2011, INT J MOL SCI, V12, P817, DOI 10.3390/ijms12010817; Ouattara B, 2000, J FOOD SCI, V65, P768, DOI 10.1111/j.1365-2621.2000.tb13584.x; Prabhu V., 2014, P JOINT M PME 38 PME, V5, P1; Quintavalla S, 2002, MEAT SCI, V62, P373, DOI 10.1016/S0309-1740(02)00121-3; Rajandas H, 2012, POLYM TEST, V31, P1094, DOI 10.1016/j.polymertesting.2012.07.015; Ramos M, 2012, J FOOD ENG, V109, P513, DOI 10.1016/j.jfoodeng.2011.10.031; Robertson GL, 2012, FOOD PACKAGING PRINC, V3; Rooney M. L., 1995, ACTIVE FOOD PACKAGIN; Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006; Sharma K., 2012, INT J DRUG DEV RES, V4, P375; Simoes M, 2010, LWT-FOOD SCI TECHNOL, V43, P573, DOI 10.1016/j.lwt.2009.12.008; Siracusa V, 2008, TRENDS FOOD SCI TECH, V19, P634, DOI 10.1016/j.tifs.2008.07.003; Sivakumar PM, 2010, COLLOID SURFACE B, V81, P439, DOI 10.1016/j.colsurfb.2010.07.037; STEVENSON DE, 1991, BIOTECHNOL BIOENG, V37, P519, DOI 10.1002/bit.260370605; Sung SY, 2014, FOOD CONTROL, V39, P214, DOI 10.1016/j.foodcont.2013.11.020; Suppakul P, 2011, LWT-FOOD SCI TECHNOL, V44, P1888, DOI 10.1016/j.lwt.2011.03.024; Tang WT, 2013, EUR FOOD RES TECHNOL, V237, P591, DOI 10.1007/s00217-013-2034-6; TIWARI NP, 1972, J FOOD SCI, V37, P901, DOI 10.1111/j.1365-2621.1972.tb03698.x; Tripathi S, 2009, INT J BIOL MACROMOL, V45, P372, DOI 10.1016/j.ijbiomac.2009.07.006; Trouillet JL, 1998, AM J RESP CRIT CARE, V157, P531, DOI 10.1164/ajrccm.157.2.9705064; Veluchamy P, 2011, J AGR FOOD CHEM, V59, P10869, DOI 10.1021/jf201124v; Wu Y, 2007, FOOD MICROBIOLOGY SA, V72, P369	63	27	28	4	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0121665	10.1371/journal.pone.0121665	http://dx.doi.org/10.1371/journal.pone.0121665			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906061	gold, Green Published, Green Submitted			2022-12-27	WOS:000353332000009
J	Swarts, DC; Koehorst, JJ; Westra, ER; Schaap, PJ; van der Oost, J				Swarts, Daan C.; Koehorst, Jasper J.; Westra, Edze R.; Schaap, Peter J.; van der Oost, John			Effects of Argonaute on Gene Expression in Thermus thermophilus	PLOS ONE			English	Article							CRISPR-CAS SYSTEMS; SILENCING COMPLEX; ADAPTIVE IMMUNITY; PROTEINS; DNA; INTERFERENCE; EVOLUTION; TRANSCRIPTOME; CLEAVAGE; GENOME	Background Eukaryotic Argonaute proteins mediate RNA-guided RNA interference, allowing both regulation of host gene expression and defense against invading mobile genetic elements. Recently, it has become evident that prokaryotic Argonaute homologs mediate DNA-guided DNA interference, and play a role in host defense. Argonaute of the bacterium Thermus thermophilus (TtAgo) targets invading plasmid DNA during and after transformation. Using small interfering DNA guides, TtAgo can cleave single and double stranded DNAs. Although TtAgo additionally has been demonstrated to cleave RNA targets complementary to its DNA guide in vitro, RNA targeting by TtAgo has not been demonstrated in vivo. Methods To investigate if TtAgo also has the potential to control RNA levels, we analyzed RNA-seq data derived from cultures of four T. thermophilus strain HB27 variants: wild type, TtAgo knockout (Delta ago), and either strain transformed with a plasmid. Additionally we determined the effect of TtAgo on expression of plasmid-encoded RNA and plasmid DNA levels. Results In the absence of exogenous DNA (plasmid), TtAgo presence or absence had no effect on gene expression levels. When plasmid DNA is present, TtAgo reduces plasmid DNA levels 4-fold, and a corresponding reduction of plasmid gene transcript levels was observed. We therefore conclude that TtAgo interferes with plasmid DNA, but not with plasmid-encoded RNA. Interestingly, TtAgo presence stimulates expression of specific endogenous genes, but only when exogenous plasmid DNA was present. Specifically, the presence of TtAgo directly or indirectly stimulates expression of CRISPR loci and associated genes, some of which are involved in CRISPR adaptation. This suggests that TtAgo-mediated interference with plasmid DNA stimulates CRISPR adaptation.	[Swarts, Daan C.; Westra, Edze R.; van der Oost, John] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Koehorst, Jasper J.; Schaap, Peter J.] Wageningen Univ, Lab Syst & Synthet Biol, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	van der Oost, J (corresponding author), Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands.	john.vanderoost@wur.nl	Swarts, Daan/Z-6262-2019; van+der+Oost, John/Y-2548-2019; Koehorst, Jasper Jan/Z-1697-2019	Swarts, Daan/0000-0003-4412-9191; Koehorst, Jasper Jan/0000-0001-8172-8981; Schaap, Peter/0000-0002-4346-6084	TOP grant from the Netherlands Organisation for Scientific Research (NWO) [NWO-TOP 854.10.003]	TOP grant from the Netherlands Organisation for Scientific Research (NWO)	This study was financially supported by a TOP grant from the Netherlands Organisation for Scientific Research (NWO) to John van der Oost (NWO-TOP 854.10.003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agari Y, 2010, J MOL BIOL, V395, P270, DOI 10.1016/j.jmb.2009.10.057; Best A, 2013, ECOL EVOL, V3, P2223, DOI 10.1002/ece3.611; Blesa A, 2015, J BACTERIOL, V197, P138, DOI 10.1128/JB.02113-14; Bronkhorst AW, 2014, CURR OPIN VIROL, V7, P19, DOI 10.1016/j.coviro.2014.03.010; Bruggemann H, 2006, J BIOTECHNOL, V124, P654, DOI 10.1016/j.jbiotec.2006.03.043; Cava F, 2008, ENVIRON MICROBIOL, V10, P605, DOI 10.1111/j.1462-2920.2007.01482.x; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Copeland A, 2012, SIGMA; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Dupuis ME, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3087; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Harrison E, 2012, TRENDS MICROBIOL, V20, P262, DOI 10.1016/j.tim.2012.04.003; Heler R, 2014, MOL MICROBIOL, V93, P1, DOI 10.1111/mmi.12640; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kawamata T, 2010, TRENDS BIOCHEM SCI, V35, P368, DOI 10.1016/j.tibs.2010.03.009; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Makarova KS, 2009, BIOLOGY DIRECT, V4; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Ohyama H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-386; Olovnikov I, 2013, MOL CELL, V51, P594, DOI 10.1016/j.molcel.2013.08.014; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Plagens A, 2012, J BACTERIOL, V194, P2491, DOI 10.1128/JB.00206-12; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Sheng G, 2014, P NATL ACAD SCI USA, V111, P652, DOI 10.1073/pnas.1321032111; Swarts DC, 2014, NAT STRUCT MOL BIOL, V21, P743, DOI 10.1038/nsmb.2879; Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Westra ER, 2012, ANNU REV GENET, V46, P311, DOI 10.1146/annurev-genet-110711-155447; Westra ER, 2015, CURRENT BIOLOGY IN P; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	37	27	27	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124880	10.1371/journal.pone.0124880	http://dx.doi.org/10.1371/journal.pone.0124880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902012	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500104
J	Woo, HM; Lee, JM; Yim, S; Jeong, YJ				Woo, Hye-Min; Lee, Jin-Moo; Yim, Sanggyu; Jeong, Yong-Joo			Isolation of Single-Stranded DNA Aptamers That Distinguish Influenza Virus Hemagglutinin Subtype H1 from H5	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; MEDIATED MEMBRANE-FUSION; AVIAN INFLUENZA; RNA APTAMER; NUCLEOTIDE-SEQUENCES; RECEPTOR-BINDING; WEB SERVER; PROTEIN; QUADRUPLEX; POLYMERASE	Surface protein hemagglutinin (HA) mediates the binding of influenza virus to host cell receptors containing sialic acid, facilitating the entry of the virus into host cells. Therefore, the HA protein is regarded as a suitable target for the development of influenza virus detection devices. In this study, we isolated single-stranded DNA (ssDNA) aptamers binding to the HA1 subunit of subtype H1 (H1-HA1), but not to the HA1 subunit of subtype H5 (H5-HA1), using a counter-systematic evolution of ligands by exponential enrichment (counterSELEX) procedure. Enzyme-linked immunosorbent assay and surface plasmon resonance studies showed that the selected aptamers bind tightly to H1-HA1 with dissociation constants in the nanomolar range. Western blot analysis demonstrated that the aptamers were binding to H1-HA1 in a concentration-dependent manner, yet were not binding to H5-HA1. Interestingly, the selected aptamers contained G-rich sequences in the central random nucleotides region. Further biophysical analysis showed that the G-rich sequences formed a G-quadruplex structure, which is a distinctive structure compared to the starting ssDNA library. Using flow cytometry analysis, we found that the aptamers did not bind to the receptor- binding site of H1-HA1. These results indicate that the selected aptamers that distinguish H1-HA1 from H5-HA1 can be developed as unique probes for the detection of the H1 subtype of influenza virus.	[Woo, Hye-Min; Lee, Jin-Moo; Yim, Sanggyu; Jeong, Yong-Joo] Kookmin Univ, Dept Bio & Nanochem, Seoul 136702, South Korea	Kookmin University	Jeong, YJ (corresponding author), Kookmin Univ, Dept Bio & Nanochem, Seoul 136702, South Korea.	jeongyj@kookmin.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2A10061193]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	YJJ was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2A10061193).	ALEXANDER DJ, 1995, J COMP PATHOL, V112, P105, DOI 10.1016/S0021-9975(05)80054-4; Brody E N, 2000, J Biotechnol, V74, P5, DOI 10.1016/S1389-0352(99)00004-5; Bunka DHJ, 2010, CURR OPIN PHARMACOL, V10, P557, DOI 10.1016/j.coph.2010.06.009; Cheng CS, 2008, BIOCHEM BIOPH RES CO, V366, P670, DOI 10.1016/j.bbrc.2007.11.183; Chizmadzhev YA, 2004, BIOELECTROCHEMISTRY, V63, P129, DOI 10.1016/j.bioelechem.2003.10.016; Cho SJ, 2011, J BIOSCI BIOENG, V112, P535, DOI 10.1016/j.jbiosc.2011.08.014; Fukuda H, 2005, GENES CELLS, V10, P953, DOI 10.1111/j.1365-2443.2005.00896.x; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Gopinath SCB, 2006, J GEN VIROL, V87, P479, DOI 10.1099/vir.0.81508-0; Gopinath SCB, 2006, J BIOCHEM, V140, P667, DOI 10.1093/jb/mvj203; Hamilton BS, 2012, VIRUSES-BASEL, V4, P1144, DOI 10.3390/v4071144; HARDIN CC, 1992, BIOCHEMISTRY-US, V31, P833, DOI 10.1021/bi00118a028; HIGUCHI RG, 1989, NUCLEIC ACIDS RES, V17, P5865, DOI 10.1093/nar/17.14.5865; JENISON RD, 1994, SCIENCE, V263, P1425, DOI 10.1126/science.7510417; Jeon SH, 2004, J BIOL CHEM, V279, P48410, DOI 10.1074/jbc.M409059200; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Kwon HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097574; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee MS, 2001, J VIROL METHODS, V97, P13, DOI 10.1016/S0166-0934(01)00301-9; Luo GX, 1996, VIROLOGY, V226, P66, DOI 10.1006/viro.1996.0628; Menendez C, 2012, NUCLEIC ACIDS RES, V40, pW96, DOI 10.1093/nar/gks422; Munch M, 2001, ARCH VIROL, V146, P87, DOI 10.1007/s007050170193; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Ozalp VC, 2015, ANAL CHIM ACTA, V853, P533, DOI 10.1016/j.aca.2014.10.010; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Park SY, 2011, NUCLEIC ACID THER, V21, P395, DOI 10.1089/nat.2011.0321; Samji Tasleem, 2009, Yale Journal of Biology and Medicine, V82, P153; Shum KT, 2008, CHEMBIOCHEM, V9, P3037, DOI 10.1002/cbic.200800491; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Song SP, 2008, TRAC-TREND ANAL CHEM, V27, P108, DOI 10.1016/j.trac.2007.12.004; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Starick E, 2000, J VET MED B, V47, P295, DOI 10.1046/j.1439-0450.2000.00386.x; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Suenaga E, 2014, ACTA BIOMATER, V10, P1314, DOI 10.1016/j.actbio.2013.12.034; Theis MG, 2004, P NATL ACAD SCI USA, V101, P11221, DOI 10.1073/pnas.0402901101; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Tombelli S, 2005, BIOELECTROCHEMISTRY, V67, P135, DOI 10.1016/j.bioelechem.2004.04.011; Tombelli S, 2007, BIOMOL ENG, V24, P191, DOI 10.1016/j.bioeng.2007.03.003; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vairamani M, 2003, J AM CHEM SOC, V125, P42, DOI 10.1021/ja0284299; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; Woo HM, 2013, ANTIVIR RES, V100, P337, DOI 10.1016/j.antiviral.2013.09.004; Wu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046393; Zhao FL, 2015, BIOSENS BIOELECTRON, V66, P238, DOI 10.1016/j.bios.2014.11.024; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	47	18	19	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0125060	10.1371/journal.pone.0125060	http://dx.doi.org/10.1371/journal.pone.0125060			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901739	gold, Green Published, Green Submitted			2022-12-27	WOS:000353331500110
J	Ding, YQ; Yang, YJ; Yang, XX; Zhang, TH; Qiu, XH; He, X; Wang, WB; Wang, L; Sui, H				Ding, Yongqing; Yang, Yanjie; Yang, Xiuxian; Zhang, Tiehui; Qiu, Xiaohui; He, Xin; Wang, Wenbo; Wang, Lin; Sui, Hong			The Mediating Role of Coping Style in the Relationship between Psychological Capital and Burnout among Chinese Nurses	PLOS ONE			English	Article							STRESS; MODERATOR; CONFLICT; SUPPORT	Background Burnout is recognized as an occupational hazard, and nursing has a high risk of burnout. This study aims to explore the relationship between psychological capital (PsyCap) and burnout among Chinese nurses and the mediating role of coping style in this relationship. Methods A total of 1,496 nurses (effective response rate: 80.11%) from two large general hospitals in Daqing City of China were selected as participants. Data were collected via the Chinese Maslach Burnout Inventory (CMBI), the psychological capital questionnaire (PCQ-24), the Chinese Trait Coping Style Questionnaire (TCSQ) and demographic and caregiver-patient relationship. Hierarchical linear regression analyses were performed to explore the mediating role of positive coping and negative coping, and we used the Bootstrap method to confirm the mediating effect. Results Self-efficacy, hope, resilience and optimism of nurses were all negatively related with emotional exhaustion, depersonalization and reduced personal accomplishment among Chinese nurses. Positive coping partially mediated the relationship between hope/optimism and emotional exhaustion and between self-efficacy/optimism and reduced personal accomplishment. Negative coping fully mediated the relationship between self-efficacy and emotional exhaustion, and in the regression model self-efficacy was positively correlated with emotional exhaustion. And negative coping also partially mediated the relationship between hope/optimism and emotional exhaustion and between optimism and depersonalization. Conclusion PsyCap had effects on burnout and coping style was a mediator in this relationship among Chinese nurses. Nurses who had a strong sense of self-efficacy adopted more negative coping style, which in turn would lead to higher levels of emotional exhaustion. These findings shed light on the influence of negative coping on burnout, and positive coping was a positive resource for fighting against nurses' burnout. Hence, in order to avoid negative coping style, improve skill of coping and enhance PsyCap of nurses, active interventions should be developed in the future.	[Ding, Yongqing; Yang, Yanjie; Yang, Xiuxian; Qiu, Xiaohui; Wang, Wenbo; Wang, Lin] Harbin Med Univ, Coll Publ Hlth, Dept Psychol, Harbin, Peoples R China; [Ding, Yongqing] Harbin Med Univ, Affiliated Hosp 1, Daqing, Heilongjiang Pr, Peoples R China; [Zhang, Tiehui] Harbin Med Univ, Affiliated Hosp 1, Dept Surg, Daqing, Heilongjiang Pr, Peoples R China; [He, Xin] Harbin Med Univ, Affiliated Hosp 1, Dept Pediat, Daqing, Heilongjiang Pr, Peoples R China; [Sui, Hong] Harbin Med Univ, Coll Publ Hlth, Dept Hlth Stat, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Yang, YJ (corresponding author), Harbin Med Univ, Coll Publ Hlth, Dept Psychol, Harbin, Peoples R China.	yanjie1965@163.com			National Natural Science Foundation of China [81473054, 81202213]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (81473054) to Prof. Yanjie Yang and the National Natural Science Foundation of China (81202213) to Xiuxian Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola K, 2009, J AFFECT DISORDERS, V115, P150, DOI 10.1016/j.jad.2008.09.021; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Cardenas V, 2013, SCHIZOPHRENIA BULL, V39, P908, DOI 10.1093/schbul/sbs004; Carmona C, 2006, J OCCUP ORGAN PSYCH, V79, P85, DOI 10.1348/096317905X40808; Carod-Artal F. J., 2013, BURNOUT SYNDROME INT, P15; Carver CS, 2010, ANNU REV PSYCHOL, V61, P679, DOI 10.1146/annurev.psych.093008.100352; Chen R, 2013, BEIJ 2013 JMS 10 ANN; [成颢 Cheng Hao], 2012, [中华行为医学与脑科学杂志, Chinese Journal of Behavioral Medicine and Brain Science], V21, P262; Cheung F, 2011, INT J STRESS MANAGE, V18, P348, DOI 10.1037/a0025787; Cohen J., 2003, APPL MULTIPLE REGRES; Dasgupta P, 2012, J HEALTH MANAG, V14, P513, DOI 10.1177/0972063412468980; Devereux J, 2009, J APPL RES INTELLECT, V22, P561, DOI 10.1111/j.1468-3148.2009.00509.x; Dong Y.H ., 2010, STUDIES PSYCHOL BEHA, V8, P58, DOI DOI 10.3969/J.ISSN.1672-0628.2010.01.011; Duygun T, 2003, TURK PSIKOL DERG, V18, P37; Eccles JS, 2002, ANNU REV PSYCHOL, V53, P109, DOI 10.1146/annurev.psych.53.100901.135153; Folkman S, 2004, ANNU REV PSYCHOL, V55, P745, DOI 10.1146/annurev.psych.55.090902.141456; Garcia-Campayo J, 2014, PLOS ONE, V9; Garrosa E., 2013, BURNOUT EXPERTS PREV, P201, DOI [DOI 10.1007/978-1-4614-4391-9_13, 10.1007/978-1-4614-4391-9_13]; Honkonen T, 2006, J PSYCHOSOM RES, V61, P59, DOI 10.1016/j.jpsychores.2005.10.002; Isaksson KE, 2013, BMC PUBLIC HEALTH, V10, P213; Kurz AS, 2014, RES DEV DISABIL, V35, P2359, DOI 10.1016/j.ridd.2014.06.003; Laschinger HKS, 2012, INT J NURS STUD, V49, P282, DOI 10.1016/j.ijnurstu.2011.09.004; LAZARUS RS, 1993, ANNU REV PSYCHOL, V44, P1, DOI 10.1146/annurev.ps.44.020193.000245; Li J, 2008, CHINESE MENTAL HLTH, V16, P1406; Li L, 2011, PROCEEDINGS OF 2011 INTERNATIONAL SYMPOSIUM - THE FEMALE SURVIVAL AND DEVELOPMENT, P221; Li Y.X., 2005, PSYCHOL EXPLORATION, V25, P70, DOI DOI 10.3969/j.issn.1003-5184.2005.04.015; Li Yan-ping, 2007, Yaoxue Xuebao, V42, P392; Lievens I, 2014, J ADV NURS, V70, P651, DOI 10.1111/jan.12229; Luthans F, 2004, ORGAN DYN, V33, P143, DOI 10.1016/j.orgdyn.2004.01.003; Luthans F., 2007, PSYCHOL CAPITAL DEV; Luthans F., 2004, BUS HORIZONS, V47, P45, DOI [10.1016/j.bushor.2003.11.007, DOI 10.1016/J.BUSHOR.2003.11.007]; Luthans KW, 2005, J NURS ADMIN, V35, P304; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Ning ZS, 2014, CHINESE J CONT NEURO, V14, P117, DOI DOI 10.3969/j.issn.1672-6731.2014.02.009; Peng JX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0084193, 10.1371/journal.pone.0082465]; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Ribeiro Vivian F, 2014, Int Arch Med, V7, P22, DOI 10.1186/1755-7682-7-22; Schwarzer R, 2003, POSITIVE PSYCHOLOGICAL ASSESSMENT: HANDBOOK OF MODELS AND MEASURES, P393, DOI 10.1037/10612-025; Tennant C, 2001, J PSYCHOSOM RES, V51, P697, DOI 10.1016/S0022-3999(01)00255-0; Toker S, 2012, PSYCHOSOM MED, V74, P840, DOI 10.1097/PSY.0b013e31826c3174; Wang XM, 2012, PROCEEDINGS OF THE FIRST INTERNATIONAL SYMPOSIUM ON PUBLIC HUMAN RESOURCE MANAGEMENT, P33; Wang Y, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-915; Wang Y, 2012, J OCCUP HEALTH, V54, P232, DOI 10.1539/joh.11-0243-OA; Wu H, 2010, J ADV NURS, V66, P627, DOI 10.1111/j.1365-2648.2009.05203.x; Zhang TT, 2011, 2011 SECOND INTERNATIONAL CONFERENCE ON EDUCATION AND SPORTS EDUCATION (ESE 2011), VOL I, P31	45	143	155	5	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0122128	10.1371/journal.pone.0122128	http://dx.doi.org/10.1371/journal.pone.0122128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XJ	25898257	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600008
J	Lood, C; Tyden, H; Gullstrand, B; Klint, C; Wenglen, C; Nielsen, CT; Heegaard, NHH; Jonsen, A; Kahn, R; Bengtsson, AA				Lood, Christian; Tyden, Helena; Gullstrand, Birgitta; Klint, Cecilia; Wenglen, Christina; Nielsen, Christoffer T.; Heegaard, Niels H. H.; Jonsen, Andreas; Kahn, Robin; Bengtsson, Anders A.			Type I Interferon-Mediated Skewing of the Serotonin Synthesis Is Associated with Severe Disease in Systemic Lupus Erythematosus	PLOS ONE			English	Article							PLATELET SEROTONIN; INDOLEAMINE 2,3-DIOXYGENASE; PLASMA SEROTONIN; HUMAN MONOCYTES; ACTIVATION; 5-HYDROXYTRYPTAMINE; MICROPARTICLES; PATHOGENESIS; INFLAMMATION; EXPRESSION	Serotonin, a highly pro-inflammatory molecule released by activated platelets, is formed by tryptophan. Tryptophan is also needed in the production of kynurenine, a process mediated by the type I interferon (IFN)-regulated rate-limiting enzyme indoleamine 2,3-dioxygenase (IDO). The aim of this study was to investigate levels of serotonin in patients with the autoimmune disease systemic lupus erythematosus (SLE), association to clinical phenotype and possible involvement of IDO in regulation of serotonin synthesis. Serotonin levels were measured in serum and plasma from patients with SLE (n=148) and healthy volunteers (n=79) by liquid chromatography and ELISA, as well as intracellularly in platelets by flow cytometry. We found that SLE patients had decreased serotonin levels in serum (p=0.01) and platelets (p<0.0001) as compared to healthy individuals. SLE patients with ongoing type I IFN activity, as determined by an in- house reporter assay, had decreased serum levels of serotonin (p=0.0008) as well as increased IDO activity (p<0.0001), as determined by the kynurenine/tryptophan ratio measured by liquid chromatography. Furthermore, SLE sera induced IDO expression in WISH cells in a type I IFN-dependent manner (p=0.008). Also platelet activation contributed to reduce overall availability of serotonin levels in platelets and serum (p<0.05). Decreased serum serotonin levels were associated with severe SLE with presence of anti-dsDNA antibodies and nephritis. In all, reduced serum serotonin levels in SLE patients were related to severe disease phenotype, including nephritis, suggesting involvement of important immunopathological processes. Further, our data suggest that type I IFNs, present in SLE sera, are able to up-regulate IDO expression, which may lead to decreased serum serotonin levels.	[Lood, Christian; Tyden, Helena; Jonsen, Andreas; Bengtsson, Anders A.] Lund Univ, Dept Clin Sci Lund, Rheumatol Sect, Lund, Sweden; [Lood, Christian; Tyden, Helena; Jonsen, Andreas; Bengtsson, Anders A.] Skane Univ Hosp, Lund, Sweden; [Gullstrand, Birgitta] Lund Univ, Dept Lab Med Lund, Microbiol Sect, Sect Microbiol Immunol & Glycobiol, Lund, Sweden; [Klint, Cecilia; Wenglen, Christina] AnaMar AB, Lund, Sweden; [Nielsen, Christoffer T.; Heegaard, Niels H. H.] Statens Serum Inst, Dept Clin Biochem Immunol & Genet, DK-2300 Copenhagen, Denmark; [Kahn, Robin] Lund Univ, Dept Pediat, Clin Sci Lund, Lund, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Statens Serum Institut; Lund University	Lood, C (corresponding author), Lund Univ, Dept Clin Sci Lund, Rheumatol Sect, Lund, Sweden.	loodc@uw.edu	Lood, Christian/H-5670-2019	Lood, Christian/0000-0002-6171-1952	Medical Faculty at Lund University; Crafoord Foundation; Greta and Johan Kock's Foundation; King Gustaf V's 80th Birthday Foundation; Lund University Hospital; Swedish Rheumatism Association; Swedish Society of Medicine; Foundation of the National Board of Health and Welfare; Osterlund's Foundation	Medical Faculty at Lund University; Crafoord Foundation; Greta and Johan Kock's Foundation; King Gustaf V's 80th Birthday Foundation; Lund University Hospital; Swedish Rheumatism Association; Swedish Society of Medicine; Foundation of the National Board of Health and Welfare; Osterlund's Foundation	The study was supported by grants from the Medical Faculty at Lund University, The Crafoord Foundation, Greta and Johan Kock's Foundation, King Gustaf V's 80th Birthday Foundation, Lund University Hospital, the Swedish Rheumatism Association, Swedish Society of Medicine, the Foundation of the National Board of Health and Welfare and Osterlund's Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. CKL, CWE contributed to the design of the study and to the preparation of the manuscript. The collaboration was purely scientific and focused on basic science related to disease mechanisms. AnaMar did not provide support in the form of salaries for authors others then its employees (CKL and CWE). The specific roles of these authors are articulated in the 'author contributions' section. There were no AnaMar compounds involved in the study and AnaMar has no current interest in SLE.	Bengtsson AA, 2000, LUPUS, V9, P664, DOI 10.1191/096120300674499064; Bengtsson AA, 2012, ARTHRITIS RHEUM-US, V64, P1579, DOI 10.1002/art.33493; Boilard E, 2012, NAT REV RHEUMATOL, V8, P534, DOI 10.1038/nrrheum.2012.118; Campbell BM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00012; Cloutier N, 2012, BLOOD, V120, P1334, DOI 10.1182/blood-2012-02-413047; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; Crow MK, 2003, ARTHRITIS RES THER, V5, P279, DOI 10.1186/ar1015; de las Casas-Engel M, 2013, J IMMUNOL, V190, P2301, DOI 10.4049/jimmunol.1201133; Duerschmied D, 2013, BLOOD, V121, P1008, DOI 10.1182/blood-2012-06-437392; Durk T, 2005, INT IMMUNOL, V17, P599, DOI 10.1093/intimm/dxh242; Eloranta ML, 2009, ARTHRITIS RHEUM-US, V60, P2418, DOI 10.1002/art.24686; FUKAMI MH, 1978, J CELL BIOL, V77, P389, DOI 10.1083/jcb.77.2.389; Furuzawa-Carballeda J, 2011, EUR J CLIN INVEST, V41, P1037, DOI 10.1111/j.1365-2362.2011.02491.x; Gladman DD, 2002, J RHEUMATOL, V29, P288; Hua J, 2006, ARTHRITIS RHEUM-US, V54, P1906, DOI 10.1002/art.21890; Ito T, 2000, CIRCULATION, V102, P2522, DOI 10.1161/01.CIR.102.20.2522; Iversen LV, 2013, J IMMUNOL METHODS, V388, P49, DOI 10.1016/j.jim.2012.12.001; KANAI H, 1989, J MED, V20, P371; Kim JJ, 2013, J IMMUNOL, V190, P4795, DOI 10.4049/jimmunol.1201887; Krishnadas Rajeev, 2011, J Med Case Rep, V5, P112, DOI 10.1186/1752-1947-5-112; Leffler J, 2012, J IMMUNOL, V188, P3522, DOI 10.4049/jimmunol.1102404; Leon-Ponte M, 2007, BLOOD, V109, P3139, DOI 10.1182/blood-2006-10-052787; Li N, 1997, BLOOD COAGUL FIBRIN, V8, P517, DOI 10.1097/00001721-199711000-00006; Lood C, 2012, LUPUS, V21, P1423, DOI 10.1177/0961203312457210; Lood C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099386; Lood C, 2010, BLOOD, V116, P1951, DOI 10.1182/blood-2010-03-274605; MEYERHOFF J, 1981, ARTHRITIS RHEUM, V24, P1495, DOI 10.1002/art.1780241207; Nau F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075426; Ni W, 2006, CLIN EXP PHARMACOL P, V33, P575, DOI 10.1111/j.1440-1681.2006.04410.x; Nielsen CT, 2011, ARTHRITIS RHEUM-US, V63, P3067, DOI 10.1002/art.30499; Ostergaard O, 2012, J PROTEOME RES, V11, P2154, DOI 10.1021/pr200901p; PARBTANI A, 1980, CLIN NEPHROL, V14, P164; PARBTANI A, 1980, CLIN NEPHROL, V14, P112; Perez-De La Cruz Veronica, 2007, CNS & Neurological Disorders-Drug Targets, V6, P398; Pertovaara M, 2007, CLIN EXP IMMUNOL, V150, P274, DOI 10.1111/j.1365-2249.2007.03480.x; Ronnblom L, 2008, LUPUS, V17, P394, DOI 10.1177/0961203308090020; Ronnblom L, 2013, CURR OPIN RHEUMATOL, V25, P248, DOI 10.1097/BOR.0b013e32835c7e32; Ronnblom L, 2011, UPSALA J MED SCI, V116, P227, DOI 10.3109/03009734.2011.624649; Sarac H, 2012, J NEUROIMMUNOL, V251, P87, DOI 10.1016/j.jneuroim.2012.06.011; Schafer A, 2010, J HEPATOL, V52, P10, DOI 10.1016/j.jhep.2009.10.007; Shajib MS, 2015, ACTA PHYSIOL, V213, P561, DOI 10.1111/apha.12430; Shajib MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072774; SHIMIZU T, 1978, J BIOL CHEM, V253, P4700; Soga F, 2007, J INVEST DERMATOL, V127, P1947, DOI 10.1038/sj.jid.5700824; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Thevandavakkam MA, 2010, CNS NEUROL DISORD-DR, V9, P791; Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x; Widner B, 2000, IMMUNOBIOLOGY, V201, P621, DOI 10.1016/S0171-2985(00)80079-0; Yu BN, 2008, J PHARMACOL EXP THER, V327, P316, DOI 10.1124/jpet.108.143461; ZELLER J, 1983, ARTHRITIS RHEUM, V26, P532, DOI 10.1002/art.1780260413	50	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0125109	10.1371/journal.pone.0125109	http://dx.doi.org/10.1371/journal.pone.0125109			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897671	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600096
J	Rajamuthiah, R; Fuchs, BB; Conery, AL; Kim, W; Jayamani, E; Kwon, B; Ausubel, FM; Mylonakis, E				Rajamuthiah, Rajmohan; Fuchs, Beth Burgwyn; Conery, Annie L.; Kim, Wooseong; Jayamani, Elamparithi; Kwon, Bumsup; Ausubel, Frederick M.; Mylonakis, Eleftherios			Repurposing Salicylanilide Anthelmintic Drugs to Combat Drug Resistant Staphylococcus aureus	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; PSEUDOMONAS-AERUGINOSA; VIRULENCE FACTORS; MODEL HOST; INTRINSIC RESISTANCE; EFFLUX PUMP(S); INHIBITORS; EVOLUTION; MRSA; IDENTIFICATION	Staphylococcus aureus is a Gram-positive bacterium that has become the leading cause of hospital acquired infections in the US. Repurposing Food and Drug Administration (FDA) approved drugs for antimicrobial therapy involves lower risks and costs compared to de novo development of novel antimicrobial agents. In this study, we examined the antimicrobial properties of two commercially available anthelmintic drugs. The FDA approved drug niclosamide and the veterinary drug oxyclozanide displayed strong in vivo and in vitro activity against methicillin resistant S. aureus (minimum inhibitory concentration (MIC): 0.125 and 0.5 mu g/ml respectively; minimum effective concentration: <= 0.78 mu g/ml for both drugs). The two drugs were also effective against another Gram-positive bacteria Enterococcus faecium (MIC 0.25 and 2 mu g/ml respectively), but not against the Gram-negative species Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter aerogenes. The in vitro antimicrobial activity of niclosamide and oxyclozanide were determined against methicillin, vancomycin, linezolid or daptomycin resistant S. aureus clinical isolates, with MICs at 0.0625-0.5 and 0.125-2 mu g/ml for niclosamide and oxyclozanide respectively. A time-kill study demonstrated that niclosamide is bacteriostatic, whereas oxyclozanide is bactericidal. Interestingly, oxyclozanide permeabilized the bacterial membrane but neither of the anthelmintic drugs exhibited demonstrable toxicity to sheep erythrocytes. Oxyclozanide was non-toxic to HepG2 human liver carcinoma cells within the range of its in vitro MICs but niclosamide displayed toxicity even at low concentrations. These data show that the salicylanilide anthelmintic drugs niclosamide and oxyclozanide are suitable candidates for mechanism of action studies and further clinical evaluation for treatment of staphylococcal infections.	[Rajamuthiah, Rajmohan; Fuchs, Beth Burgwyn; Kim, Wooseong; Jayamani, Elamparithi; Mylonakis, Eleftherios] Brown Univ, Alpert Med Sch, Rhode Isl Hosp, Div Infect Dis, Providence, RI 02912 USA; [Kwon, Bumsup] Brown Univ, Alpert Med Sch, Rhode Isl Hosp, Div Neurol, Providence, RI 02912 USA; [Rajamuthiah, Rajmohan; Conery, Annie L.; Jayamani, Elamparithi; Ausubel, Frederick M.; Mylonakis, Eleftherios] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Mylonakis, E (corresponding author), Brown Univ, Alpert Med Sch, Rhode Isl Hosp, Div Infect Dis, Providence, RI 02912 USA.	emylonakis@lifespan.org	Kim, Wooseong/A-9256-2017; Kim, Wooseong/AAQ-3221-2020	Kim, Wooseong/0000-0002-4597-8374; Kim, Wooseong/0000-0002-4597-8374	National Institutes of Health [P01 AI083214, R01 AI085581]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grant P01 AI083214 to EM and FMA and National Institutes of Health grant R01 AI085581 to FMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS P, 1982, PHARMACOL THERAPEUT, V19, P245, DOI 10.1016/0163-7258(82)90064-X; [Anonymous], 2003, REP WHO EXP COMM, P0512; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Begun J, 2005, INFECT IMMUN, V73, P872, DOI 10.1128/IAI.73.2.872-877.2005; Benfield T, 2007, CLIN MICROBIOL INFEC, V13, P257, DOI 10.1111/j.1469-0691.2006.01589.x; Boneca IG, 2003, EXPERT OPIN THER TAR, V7, P311, DOI 10.1517/14728222.7.3.311; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; CAMPBELL WC, 1986, J PARASITOL, V72, P45, DOI 10.2307/3281795; Carlson-Banning KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069646; (CDC) CfDCaP, 2011, REP EM INF PROGR NET; Cheng TJR, 2010, BIOORGAN MED CHEM, V18, P8512, DOI 10.1016/j.bmc.2010.10.036; Chopra S, 2010, J ANTIMICROB CHEMOTH, V65, P2598, DOI 10.1093/jac/dkq353; Cuddy Suzanne M, 2008, Plast Surg Nurs, V28, P168, DOI 10.1097/PSN.0b013e31818ea7ca; Day SR, 2012, VIRULENCE, V3, P576, DOI 10.4161/viru.22120; Desalermos A, 2014, J INFECT DIS; Desalermos A, 2011, EXPERT OPIN DRUG DIS, V6, P645, DOI 10.1517/17460441.2011.573781; Ewbank JJ, 2011, DIS MODEL MECH, V4, P300, DOI 10.1242/dmm.006684; Feng Y, 2008, FEMS MICROBIOL REV, V32, P23, DOI 10.1111/j.1574-6976.2007.00086.x; French GL, 2006, J ANTIMICROB CHEMOTH, V58, P1107, DOI 10.1093/jac/dkl393; FROYD G, 1968, BRIT VET J, V124, P116, DOI 10.1016/S0007-1935(17)39505-2; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Gottlieb GS, 2000, J AM COLL SURGEONS, V190, P50, DOI 10.1016/S1072-7515(99)00211-2; Haste NM, 2011, ANTIMICROB AGENTS CH, V55, P3305, DOI 10.1128/AAC.01211-10; Hilliard JJ, 1999, ANTIMICROB AGENTS CH, V43, P1693, DOI 10.1128/AAC.43.7.1693; Hu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070702; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; Isnansetyo A, 2003, ANTIMICROB AGENTS CH, V47, P480, DOI 10.1128/AAC.47.2.480-488.2003; Jayamani E, 2015, ANTIMICROB AGENTS CH, V59, P1733, DOI 10.1128/AAC.04198-14; Jones RN, 2003, SEMIN RESP CRIT CARE, V24, P121, DOI 10.1055/s-2003-37923; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kirienko NV, 2013, CELL HOST MICROBE, V13, P406, DOI 10.1016/j.chom.2013.03.003; Koh JJ, 2013, BBA-BIOMEMBRANES, V1828, P834, DOI 10.1016/j.bbamem.2012.09.004; Kratky M, 2015, BIOORGAN MED CHEM, V23, P868, DOI 10.1016/j.bmc.2014.12.019; Kratky M, 2013, MOLECULES, V18, P3674, DOI 10.3390/molecules18043674; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Kwon B, 2014, HUM MOL GENET, V23, P3681, DOI 10.1093/hmg/ddu077; LI XZ, 1994, ANTIMICROB AGENTS CH, V38, P1732, DOI 10.1128/AAC.38.8.1732; LI XZ, 1994, ANTIMICROB AGENTS CH, V38, P1742, DOI 10.1128/AAC.38.8.1742; Lindsay JA, 2010, INT J MED MICROBIOL, V300, P98, DOI 10.1016/j.ijmm.2009.08.013; Lu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029290; Macielag MJ, 1998, J MED CHEM, V41, P2939, DOI 10.1021/jm9803572; MACK D, 1994, INFECT IMMUN, V62, P3244, DOI 10.1128/IAI.62.8.3244-3253.1994; Martin RJ, 1997, VET J, V154, P11, DOI 10.1016/S1090-0233(05)80005-X; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Moy TI, 2009, ACS CHEM BIOL, V4, P527, DOI 10.1021/cb900084v; Mylonakis E, 2007, PLOS PATHOG, V3, P859, DOI 10.1371/journal.ppat.0030101; Nair D, 2011, J BACTERIOL, V193, P2332, DOI 10.1128/JB.00027-11; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Pauk K, 2013, BIOORGAN MED CHEM, V21, P6574, DOI 10.1016/j.bmc.2013.08.029; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rajamuthiah R, 2014, VIRULENCE, V5, P697, DOI 10.4161/viru.29091; Rajamuthiah R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089189; Rice LB, 2010, INFECT CONT HOSP EP, V31, pS7, DOI 10.1086/655995; Rosch JW, 2010, J CLIN INVEST, V120, P627, DOI 10.1172/JCI39843; ROY R M, 1971, Tropical Animal Health and Production, V3, P26, DOI 10.1007/BF02356681; Schaberle TF, 2014, TRENDS MICROBIOL, V22, P165, DOI 10.1016/j.tim.2013.12.007; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Sifri CD, 2006, INFECT IMMUN, V74, P1091, DOI 10.1128/IAI.74.2.1091-1096.2006; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Swan GE, 1999, J S AFR VET ASSOC, V70, P61; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tanaka-Hino M, 2002, EMBO REP, V3, P56, DOI 10.1093/embo-reports/kvf001; Tao HL, 2014, NAT MED, V20, P1263, DOI 10.1038/nm.3699; Tomizawa M, 2013, ONCOTARGETS THER, V6, P1685, DOI 10.2147/OTT.S50065; VANDENBOSSCHE H, 1979, ARCH INT PHYSIOL BIO, V87, P851; Weaver AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097742; Wu KY, 2012, CAN J INFECT DIS MED, V23, P130, DOI 10.1155/2012/543817; Ye TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085887; Zhu ZW, 2011, J ENZYM INHIB MED CH, V26, P37, DOI 10.3109/14756361003671060	72	99	104	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124595	10.1371/journal.pone.0124595	http://dx.doi.org/10.1371/journal.pone.0124595			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897961	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600076
J	Khairoun, M; van den Heuvel, M; van den Berg, BM; Sorop, O; de Boer, R; van Ditzhuijzen, NS; Bajema, IM; Baelde, HJ; Zandbergen, M; Duncker, DJ; Rabelink, TJ; Reinders, MEJ; van der Giessen, WJ; Rotmans, JI				Khairoun, Meriem; van den Heuvel, Mieke; van den Berg, Bernard M.; Sorop, Oana; de Boer, Rients; van Ditzhuijzen, Nienke S.; Bajema, Ingeborg M.; Baelde, Hans J.; Zandbergen, Malu; Duncker, Dirk J.; Rabelink, Ton J.; Reinders, Marlies E. J.; van der Giessen, Wim J.; Rotmans, Joris I.			Early Systemic Microvascular Damage in Pigs with Atherogenic Diabetes Mellitus Coincides with Renal Angiopoietin Dysbalance	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; KIDNEY-TRANSPLANTATION; EARLY ATHEROSCLEROSIS; IN-VIVO; EXPRESSION; NEPHROPATHY; RETINOPATHY; GROWTH; VEGF; DYSFUNCTION	Background Diabetes mellitus (DM) is associated with a range of microvascular complications including diabetic nephropathy (DN). Microvascular abnormalities in the kidneys are common histopathologic findings in DN, which represent one manifestation of ongoing systemic microvascular damage. Recently, sidestream dark-field (SDF) imaging has emerged as a noninvasive tool that enables one to visualize the microcirculation. In this study, we investigated whether changes in the systemic microvasculature induced by DM and an atherogenic diet correlated spatiotemporally with renal damage. Methods Atherosclerotic lesion development was triggered in streptozotocin-induced DM pigs (140 mg/kg body weight) by administering an atherogenic diet for approximately 11 months. Fifteen months following induction of DM, microvascular morphology was visualized in control pigs (n = 7), non-diabetic pigs fed an atherogenic diet (ATH, n = 5), and DM pigs fed an atherogenic diet (DM+ATH, n = 5) using SDF imaging of oral mucosal tissue. Subsequently, kidneys were harvested from anethesized pigs and the expression levels of well-established markers for microvascular integrity, such as Angiopoietin-1 (Angpt1) and Angiopoietin-2 (Angpt2) were determined immunohistochemically, while endothelial cell (EC) abundance was determined by immunostaining for von Willebrand factor (vWF). Results Our study revealed an increase in the capillary tortuosity index in DM+ATH pigs (2.31 +/- 0.17) as compared to the control groups (Controls 0.89 +/- 0.08 and ATH 1.55 +/- 0.11; p<0.05). Kidney biopsies showed marked glomerular lesions consisting of mesangial expansion and podocyte lesions. Furthermore, we observed a disturbed Angpt2/Angpt1balance in the cortex of the kidney, as evidenced by increased expression of Angpt2 in DM+ATH pigs as compared to Control pigs (p<0.05). Conclusion In the setting of DM, atherogenesis leads to the augmentation of mucosal capillary tortuosity, indicative of systemic microvascular damage. Concomitantly, a dysbalance in renal angiopoietins was correlated with the development of diabetic nephropathy. As such, our studies strongly suggest that defects in the systemic microvasculature mirror the accumulation of microvascular damage in the kidney.	[Khairoun, Meriem; van den Berg, Bernard M.; de Boer, Rients; Rabelink, Ton J.; Reinders, Marlies E. J.; Rotmans, Joris I.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [van den Berg, Bernard M.; Rabelink, Ton J.; Reinders, Marlies E. J.; Rotmans, Joris I.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Res, Leiden, Netherlands; [Bajema, Ingeborg M.; Baelde, Hans J.; Zandbergen, Malu] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [van den Heuvel, Mieke; Sorop, Oana; van Ditzhuijzen, Nienke S.; Duncker, Dirk J.; van der Giessen, Wim J.] Erasmus MC, Dept Cardiol, Div Expt Cardiol, Rotterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC	Rotmans, JI (corresponding author), Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands.	j.i.rotmans@lumc.nl	Reinders, Marlies/AAF-2710-2019; van den berg, bernard m/D-8444-2014; Rotmans, Joris I./G-8866-2014; Rabelink, Ton J./A-5316-2008	Rotmans, Joris I./0000-0001-9682-6234; Rabelink, Ton J./0000-0001-6780-5186; Reinders, Marlies/0000-0001-9543-567X; van den Berg, Bernard/0000-0002-5726-5777; baelde, Hans/0000-0002-1214-500X	Netherlands CardioVascular Research Initiative [CVON2014-11: RECONNECT]; European Commission [MEDIA-261409]	Netherlands CardioVascular Research Initiative; European Commission(European CommissionEuropean Commission Joint Research Centre)	This project was in part supported by grants from the Netherlands CardioVascular Research Initiative (CVON2014-11: RECONNECT) and from the European Commission (FP7-Health-2010; MEDIA-261409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baelde HJ, 2007, KIDNEY INT, V71, P637, DOI 10.1038/sj.ki.5002101; Baelde HJ, 2004, AM J KIDNEY DIS, V43, P636, DOI 10.1053/j.ajkd.2003.12.028; BARNES JL, 1995, J HISTOCHEM CYTOCHEM, V43, P895, DOI 10.1177/43.9.7642963; Bonnet F, 2000, DIABETES METAB, V26, P254; Cooper ME, 1999, DIABETES, V48, P2229, DOI 10.2337/diabetes.48.11.2229; Cumbie BC, 2007, VASC HEALTH RISK MAN, V3, P823; David S, 2010, NEPHROL DIAL TRANSPL, V25, P2571, DOI 10.1093/ndt/gfq060; David S, 2009, AM J KIDNEY DIS, V53, P770, DOI 10.1053/j.ajkd.2008.11.030; Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008; Djaberi R, 2012, DIAB VASC DIS RES; Edwards MS, 2005, AM J KIDNEY DIS, V46, P214, DOI 10.1053/j.ajkd.2005.05.005; Feng DL, 2000, DIABETES CARE, V23, P1694, DOI 10.2337/diacare.23.11.1694; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Gerrity RG, 2001, DIABETES, V50, P1654, DOI 10.2337/diabetes.50.7.1654; Goedhart PT, 2007, OPT EXPRESS, V15, P15101, DOI 10.1364/OE.15.015101; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Hohenstein B, 2006, KIDNEY INT, V69, P1654, DOI 10.1038/sj.ki.5000294; Ishidoya S, 2002, J UROLOGY, V167, P1503, DOI 10.1016/S0022-5347(05)65353-0; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Kalani M, 2008, VASC HEALTH RISK MAN, V4, P1061, DOI 10.2147/VHRM.S3920; Khairoun M, 2013, AM J TRANSPLANT, V13, P1272, DOI 10.1111/ajt.12182; Khairoun M, 2013, AM J PHYSIOL-RENAL, V305, pF901, DOI 10.1152/ajprenal.00542.2012; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Kim KL, 2006, CARDIOVASC RES, V72, P394, DOI 10.1016/j.cardiores.2006.08.002; Koopmans SJ, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-64; Koopmans SJ, 2006, METABOLISM, V55, P960, DOI 10.1016/j.metabol.2006.03.004; Kuryliszyn-Moskal A, 2011, FOLIA HISTOCHEM CYTO, V49, P104, DOI 10.5603/FHC.2011.0015; Lassila M, 2007, DIABETOLOGIA, V50, P1315, DOI 10.1007/s00125-007-0652-x; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Nadar SK, 2005, J INTERN MED, V258, P336, DOI 10.1111/j.1365-2796.2005.01550.x; Nakamura S, 2000, KIDNEY INT, V58, P251, DOI 10.1046/j.1523-1755.2000.00160.x; Patel JI, 2005, BRIT J OPHTHALMOL, V89, P480, DOI 10.1136/bjo.2004.049940; Paueksakon P, 2002, KIDNEY INT, V61, P2142, DOI 10.1046/j.1523-1755.2002.00384.x; Rizkalla B, 2005, J HYPERTENS, V23, P153, DOI 10.1097/00004872-200501000-00026; Sasongko MB, 2011, DIABETOLOGIA, V54, P2409, DOI 10.1007/s00125-011-2200-y; Sasongko MB, 2012, AM J OPHTHALMOL, V153, P176, DOI 10.1016/j.ajo.2011.06.005; Stefansson S, 2003, CURR PHARM DESIGN, V9, P1545, DOI 10.2174/1381612033454621; STEFFES MW, 1989, DIABETES, V38, P1077, DOI 10.2337/diabetes.38.9.1077; Sugaru E, 2005, AM J PHYSIOL-RENAL, V289, pF998, DOI 10.1152/ajprenal.00065.2005; Sugaru E, 2006, AM J PHYSIOL-RENAL, V290, pF813, DOI 10.1152/ajprenal.00357.2005; Taneja D, 2010, J LIPID RES, V51, P1464, DOI 10.1194/jlr.M002972; Targher G, 2005, DIABETIC MED, V22, P999, DOI 10.1111/j.1464-5491.2005.01562.x; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Thompson J, 2011, AM J PATHOL, V179, P1179, DOI 10.1016/j.ajpath.2011.05.016; Tooke JE, 1996, CARDIOVASC RES, V32, P764, DOI 10.1016/S0008-6363(96)00091-0; Trouw LA, 2004, J CLIN INVEST, V114, P679, DOI 10.1172/JCI200421075; van den Heuvel M, 2012, AM J PHYSIOL-HEART C, V302, pH85, DOI 10.1152/ajpheart.00311.2011; van der Pol P, 2012, AM J TRANSPLANT, V12, P877, DOI 10.1111/j.1600-6143.2011.03887.x; van Ditzhuijzen NS, 2011, NETH HEART J, V19, P442, DOI 10.1007/s12471-011-0187-0	50	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0121555	10.1371/journal.pone.0121555	http://dx.doi.org/10.1371/journal.pone.0121555			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909188	Green Submitted, Green Published, gold			2022-12-27	WOS:000353376800011
J	Burnett, RD; Roberts, LJ				Burnett, Ryan D.; Roberts, L. Jay			A Quantitative Evaluation of the Conservation Umbrella of Spotted Owl Management Areas in the Sierra Nevada	PLOS ONE			English	Article							MIXED-CONIFER FOREST; LAKE TAHOE BASIN; BIRD COMMUNITIES; NATIONAL-PARK; CALIFORNIA; FIRE; LANDSCAPE; DYNAMICS; OCCUPANCY; FLAGSHIPS	Whether by design or default, single species management often serves as an umbrella for species with similar habitat requirements. In recent decades the focus of National Forest management in the Sierra Nevada of California has shifted towards increasing closed canopy mature forest conditions through the protection of areas occupied by the California Spotted Owl (Strix occidentalis occidentalis). To evaluate the implications of these habitat changes and the potential umbrella resulting from a system of owl reserves on the broader avian community, we estimated occupancy of birds inside and outside of Spotted Owl Home Range Core Areas in northeastern California. We used point count data in a multi-species hierarchical Bayesian model incorporating the detection history of 81 species over a two-year time period (2005-2006). A small set of vegetation cover and topography covariates were included in the model to account for broad differences in habitat conditions, as well as a term identifying whether or not a site was within a Core Area. Seventeen species had a negative Core Area effect, seven had a positive effect, and the rest were not significant. Estimated species richness was significantly different with 23.1 species per 100 m radius circle outside Core Areas and 21.7 inside Core Areas. The majority of the species negatively associated with Core Areas are tied to early successional and other disturbance-dependent habitats. Conservation and climate vulnerability rankings were mixed. On average we found higher scores (greater risk) for the species positively associated with Core Areas, but a larger number of species with the highest scores were negatively associated with Core Areas. We discuss the implications for managing the Sierra Nevada ecosystem and illustrate the role of monitoring broader suites of species in guiding management of large complex ecosystems.	[Burnett, Ryan D.; Roberts, L. Jay] Point Blue Conservat Sci, Petaluma, CA 94954 USA		Burnett, RD (corresponding author), Point Blue Conservat Sci, Petaluma, CA 94954 USA.	rburnett@pointblue.org			United States Department of Agriculture Forest Service Pacific Southwest Region Resources Legacy Fund [2012-0334]; United States Forest Service	United States Department of Agriculture Forest Service Pacific Southwest Region Resources Legacy Fund; United States Forest Service(United States Department of Agriculture (USDA)United States Forest Service)	This study was supported by the United States Department of Agriculture Forest Service Pacific Southwest Region Resources Legacy Fund Grant #2012-0334. Part of the funding for data collection was provided by the United States Forest Service whose land management this study evaluates. The authors adhered to the Point Blue policy on scientific ethics and do not believe the source of funding influenced this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman B, 2007, RAINFOREST BIRDS LAN, P2006; Altman B, 2000, BIRDS N AM ONLINE; Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; [Anonymous], 2006, ARCGIS 9 2; [Anonymous], 2000, ARCVIEW GIS 3 2A; Barbour M, 2002, J VEG SCI, V13, P461, DOI 10.1111/j.1654-1103.2002.tb02073.x; Beardsley D, 1999, 516 PNW PAC NW RES S; Beaty RM, 2008, FOREST ECOL MANAG, V255, P707, DOI 10.1016/j.foreco.2007.09.044; BEEDY EC, 1981, CONDOR, V83, P97, DOI 10.2307/1367415; Berigan WJ, 2012, J FOREST, V110, P299, DOI 10.5849/jof.11-018; Betts MG, 2010, ECOL APPL, V20, P2116, DOI 10.1890/09-1305.1; Blakesley JA, 2010, WILDLIFE MONOGR, P1; Bock CE, 2004, FRONT ECOL ENVIRON, V2, P403, DOI 10.2307/3868428; Bond Monica L., 2013, Western Birds, V44, P114; Brawn JD, 2001, ANNU REV ECOL SYST, V32, P251, DOI 10.1146/annurev.ecolsys.32.081501.114031; Burnett RD, 2012, PRBO CONSERVATION SC, V1912; Burnett RD, 2007, PRBO CONSERVATION SC, V1869; California Partners in Flight, 2002, CON FOR BIRD CONS PL; CALWATER, 1999, CAL WAT VERS 2 2; Chase Mary K., 2005, U S Forest Service General Technical Report PSW, V191, P130; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Fleishman E, 2000, ECOL APPL, V10, P569, DOI 10.1890/1051-0761(2000)010[0569:ANMFSO]2.0.CO;2; Franklin J.F., 1996, SIERRA NEVADA ECOSYS, VVolume 37, P627, DOI DOI 10.3996/012012-JFWM-002.S9);; FRANKLIN JF, 1994, ECOL APPL, V4, P208; Gardali T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029507; Gelman A., 2007, DATA ANAL USING REGR; HUTTO RL, 1995, CONSERV BIOL, V9, P1041, DOI [10.1046/j.1523-1739.1995.9051041.x, 10.1046/j.1523-1739.1995.9051033.x-i1]; Hutto RL, 1998, AVIAN CONSERVATION: RESEARCH AND MANAGEMENT, P75; Innes RJ, 2007, J MAMMAL, V88, P1523, DOI 10.1644/07-MAMM-A-002R.1; Johnson MD, 2007, CONDOR, V109, P489, DOI 10.1650/8347.1; Jones BE, 2005, RESTOR ECOL, V13, P373, DOI 10.1111/j.1526-100X.2005.00046.x; Keating KA, 2007, J WILDLIFE MANAGE, V71, P1344, DOI 10.2193/2006-359; Kery M, 2008, J APPL ECOL, V45, P589, DOI 10.1111/j.1365-2664.2007.01441.x; Kleinbaum D.G., 2008, APPL REGRESSION ANAL; Lambeck RJ, 1997, CONSERV BIOL, V11, P849, DOI 10.1046/j.1523-1739.1997.96319.x; LANDRES PB, 1988, CONSERV BIOL, V2, P316, DOI 10.1111/j.1523-1739.1988.tb00195.x; Lee DE, 2012, CONDOR, V114, P792, DOI 10.1525/cond.2012.110147; Mallek C, 2013, ECOSPHERE, V4, DOI [10.1890/ES13-00217, 10.1890/ES13-00217.1]; Mayer K.E., 1988, GUIDE WILDLIFE HABIT; McDonald P.M, 1976, USDA PAC SW; MCGARIGAL K, 1995, ECOL MONOGR, V65, P235, DOI 10.2307/2937059; Miller C, 1999, ECOSYSTEMS, V2, P76, DOI 10.1007/s100219900060; Miller JD, 2009, ECOSYSTEMS, V12, P16, DOI 10.1007/s10021-008-9201-9; MINNICH RA, 1995, CONSERV BIOL, V9, P902, DOI 10.1046/j.1523-1739.1995.09040902.x; Nagel TA, 2005, J TORREY BOT SOC, V132, P442, DOI 10.3159/1095-5674(2005)132[442:FAPOMC]2.0.CO;2; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Panjabi A.O., 2005, PARTNERS FLIGHT TECH; PARSONS DJ, 1979, FOREST ECOL MANAG, V2, P21, DOI 10.1016/0378-1127(79)90034-3; Plummer M., 2013, PACKAGE RJAGS COMPRE; R Core Team, 2021, R LANGUAGE ENV STAT; Ralph C. John, 1995, U S Forest Service General Technical Report PSW, V149, P161; Ralph CJ, 1993, 144 PSWGTR USDA FOR; RAPHAEL MG, 1987, CONDOR, V89, P614, DOI 10.2307/1368651; Roberge JM, 2004, CONSERV BIOL, V18, P76, DOI 10.1111/j.1523-1739.2004.00450.x; Rogers PC, 2007, NAT AREA J, V27, P183, DOI 10.3375/0885-8608(2007)27[183:AITSNR]2.0.CO;2; Sauer JD, N AM BREEDING BIRD S; SCHIECK J, 1995, CONSERV BIOL, V9, P1072, DOI [10.1046/j.1523-1739.1995.9051072.x, 10.1046/j.1523-1739.1995.9051059.x-i1]; Shuford W.D, 2008, STUDIES W BIRDS, V1, P254; Siegel RB, 2003, WILSON BULL, V115, P155, DOI 10.1676/02-103; Sierra Nevada Ecosystem Project, 1999, SIERR NEV REG DIG EL; Simberloff D, 1998, BIOL CONSERV, V83, P247, DOI 10.1016/S0006-3207(97)00081-5; Skinner CN, 1996, SIERRA NEVADA ECOSYS, V2, P1041; Smith JR, 2009, THESIS U CALIFORNIA; Stephens SL, 2007, FOREST ECOL MANAG, V251, P205, DOI 10.1016/j.foreco.2007.06.005; Stine P, 2002, FIRE FUELS MANAGEMEN; Su Y.-S, 2011, R2JAGS PACKAGE RUNNI; Swanson ME, 2014, FOREST ECOL MANAG, V324, P160, DOI 10.1016/j.foreco.2014.03.046; Taylor AH, 2000, J BIOGEOGR, V27, P87, DOI 10.1046/j.1365-2699.2000.00353.x; Tewksbury JJ, 1998, ECOLOGY, V79, P2890, DOI 10.1890/0012-9658(1998)079[2890:BPDNDW]2.0.CO;2; USDA, 2004, SIERR NEV FOR PLAN A; USDA, 2007, SIERR NEV FOR MAN IN; [USDA] US DEPARTMENT OF AGRICULTURE, 2001, SIERR NEV FOR PLAN A; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; VANKAT JL, 1978, J BIOGEOGR, V5, P377, DOI 10.2307/3038030; VERNER J, 1989, AUK, V106, P447; White AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063088; Wiens JA, 2008, BIOSCIENCE, V58, P241, DOI 10.1641/B580310; Zipkin EF, 2010, BIOL CONSERV, V143, P479, DOI 10.1016/j.biocon.2009.11.016	78	14	15	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123778	10.1371/journal.pone.0123778	http://dx.doi.org/10.1371/journal.pone.0123778			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905920	Green Submitted, gold, Green Published			2022-12-27	WOS:000353332000044
J	Lee, HS; Kwon, HS; Park, DE; Woo, YD; Kim, HY; Kim, HR; Cho, SH; Min, KU; Kang, HR; Chang, YS				Lee, Hyun Seung; Kwon, Hyouk-Soo; Park, Da-Eun; Woo, Yeon Duk; Kim, Hye Young; Kim, Hang-Rae; Cho, Sang-Heon; Min, Kyung-Up; Kang, Hye-Ryun; Chang, Yoon-Seok			Thalidomide Inhibits Alternative Activation of Macrophages In Vivo and In Vitro: A Potential Mechanism of Anti-Asthmatic Effect of Thalidomide	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; EOSINOPHILIC AIRWAY INFLAMMATION; MULTIPLE-MYELOMA; EPITHELIAL-CELLS; SEVERE ASTHMA; EXPRESSION; LUNG; HYPERRESPONSIVENESS; PHARMACOKINETICS; CHITINASE	Background Thalidomide is known to have anti-inflammatory and immunomodulatory actions. However, the effect and the anti-asthmatic mechanism of thalidomide in the pathogenesis of asthmatic airways are not fully understood. Objective This study is designed to determine the effect and the potential mechanism of thalidomide in the pathogenesis of asthmatic airways using animal model of allergic asthma. Methods Six-week-old female BALB/C mice were sensitized with alum plus ovalbumin (OVA) and were exposed to OVA via intranasal route for 3 days for challenge. Thalidomide 200 mg/kg was given via gavage twice a day from a day before the challenge and airway hyperresponsivenss (AHR), airway inflammatory cells, and cytokines in bronchoalveolar lavage fluids (BALF) were evaluated. The expression levels of pro-inflammatory cytokines and other mediators were evaluated using ELISA, real time (RT)-qPCR, and flow cytometry. CRL-2456, alveolar macrophage cell line, was used to test the direct effect of thalidomide on the activation of macrophages in vitro. Results The mice with thalidomide treatment showed significantly reduced levels of allergen-induced BALF and lung inflammation, AHR, and the expression of a number of pro-inflammatory cytokines and mediators including Th2 related, IL-17 cytokines, and altered levels of allergen-specific IgG1/IgG2a. Of interesting note, thalidomide treatment significantly reduced expression levels of allergen-or Th2 cytokine-stimulated alternative activation of macrophages in vivo and in vitro. Conclusion These studies highlight a potential use of thalidomide in the treatment of allergic diseases including asthma. This study further identified a novel inhibitory effect of thalidomide on alternative activation of macrophages as a potential mechanism of anti-asthmatic effect of thalidomide.	[Lee, Hyun Seung; Kwon, Hyouk-Soo; Park, Da-Eun; Cho, Sang-Heon; Min, Kyung-Up; Kang, Hye-Ryun] Seoul Natl Univ, Med Res Ctr, Inst Allergy & Clin Immunol, Seoul, South Korea; [Kwon, Hyouk-Soo; Cho, Sang-Heon; Min, Kyung-Up; Kang, Hye-Ryun] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Woo, Yeon Duk; Kim, Hye Young] Seoul Natl Univ, Coll Med, Dept Med Sci, Seoul 151, South Korea; [Kim, Hang-Rae] Seoul Natl Univ, Coll Med, Dept Anat, Seoul 151, South Korea; [Chang, Yoon-Seok] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lee, HS (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Allergy & Clin Immunol, Seoul, South Korea.	helenmed@snu.ac.kr; addchang@snu.ac.kr	Kim, Hye Young/AAF-7609-2020; Chang, Yoon-Seok/J-5628-2012; Kim, Hang-Rae/J-5448-2012	Kim, Hye Young/0000-0001-5978-512X; Chang, Yoon-Seok/0000-0003-3157-0447; Kim, Hang-Rae/0000-0002-3983-6193	Korea Research Foundation - Korean Government (MOEHRD) [KRF-2006-E00149]; Seoul National University Hospital [04-2011-1170]	Korea Research Foundation - Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaNational Research Foundation of KoreaKorean Government); Seoul National University Hospital	This work was supported financially by the Korea Research Foundation Grant funded by the Korean Government (MOEHRD) (KRF-2006-E00149) and by a grant from Seoul National University Hospital (04-2011-1170).	Asano T, 2010, BIOL PHARM BULL, V33, P1028, DOI 10.1248/bpb.33.1028; Boorsma CE, 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/769214, DOI 10.1155/2013/769214]; Calabrese L, 2000, AM J MED, V108, P487, DOI 10.1016/S0002-9343(99)00408-8; CHEN TL, 1989, DRUG METAB DISPOS, V17, P402; Chung F, 2004, CLIN CANCER RES, V10, P5949, DOI 10.1158/1078-0432.CCR-04-0421; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; Cohn L, 1998, J IMMUNOL, V161, P3813; CORRIGAN CJ, 1988, LANCET, V1, P1129; Dong L, 2008, J ASTHMA, V45, P648, DOI 10.1080/02770900802126941; Donnelly S, 2008, FASEB J, V22, P4022, DOI 10.1096/fj.08-106278; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Hashimoto Y, 2008, ARCH PHARM, V341, P536, DOI 10.1002/ardp.200700217; Homer RJ, 2006, AM J PHYSIOL-LUNG C, V291, pL502, DOI 10.1152/ajplung.00364.2005; Kamikawa R, 2006, BIOL PHARM BULL, V29, P2331, DOI 10.1248/bpb.29.2331; Kay AB, 2006, CHEM IMMUNOL ALLERGY, V91, P59; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Kwon HS, THESIS U SEOUL NATL; La Flamme AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046989; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lilly CM, 1997, J CLIN INVEST, V99, P1767, DOI 10.1172/JCI119341; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Mikita T, 1996, MOL CELL BIOL, V16, P5811; Moller DR, 1997, J IMMUNOL, V159, P5157; Moon KA, 2007, INT IMMUNOL, V19, P1371, DOI 10.1093/intimm/dxm108; MOREIRA AL, 1993, J EXP MED, V177, P1675, DOI 10.1084/jem.177.6.1675; Nagarkar DR, 2010, J IMMUNOL, V185, P2525, DOI 10.4049/jimmunol.1000286; Nair MG, 2005, INFECT IMMUN, V73, P385, DOI 10.1128/IAI.73.1.385-394.2005; Nair MG, 2003, IMMUNOL LETT, V85, P173, DOI 10.1016/S0165-2478(02)00225-0; North ML, 2009, AM J PHYSIOL-LUNG C, V296, pL911, DOI 10.1152/ajplung.00025.2009; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; SAMPAIO EP, 1991, J EXP MED, V173, P699, DOI 10.1084/jem.173.3.699; Sun Y, 2008, LUNG, V186, P375, DOI 10.1007/s00408-008-9099-1; Tavares JL, 1997, RESP MED, V91, P31, DOI 10.1016/S0954-6111(97)90134-7; Tsai YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064105; Vargaftig BB, 2003, AM J PHYSIOL-LUNG C, V284, pL260, DOI 10.1152/ajplung.00226.2002; Vercelli D, 2003, J CLIN INVEST, V111, P1815, DOI 10.1172/JCI200318908; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; WALKER C, 1991, J ALLERGY CLIN IMMUN, V88, P935, DOI 10.1016/0091-6749(91)90251-I; Winkler C, 2014, BMC IMMUNOL, V15, DOI 10.1186/1471-2172-15-12; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336; Zimmermann N, 2003, J CLIN INVEST, V111, P1863, DOI 10.1172/JCI200317912	42	17	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123094	10.1371/journal.pone.0123094	http://dx.doi.org/10.1371/journal.pone.0123094			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905462	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000022
J	Moravcova, L; Pysek, P; Jarosik, V; Pergl, J				Moravcova, Lenka; Pysek, Petr; Jarosik, Vojtech; Pergl, Jan			Getting the Right Traits: Reproductive and Dispersal Characteristics Predict the Invasiveness of Herbaceous Plant Species	PLOS ONE			English	Article							RELATIVE GROWTH-RATE; INVASION SUCCESS; ALIEN PLANTS; PROPAGULE PRESSURE; BIOLOGICAL INVASIONS; RESIDENCE TIME; PHENOTYPIC PLASTICITY; NATURALIZED PLANTS; INTRODUCED PLANTS; SEEDLING GROWTH	To better understand the effect of species traits on plant invasion, we collected comparative data on 20 reproductive and dispersal traits of 93 herbaceous alien species in the Czech Republic, central Europe, introduced after 1500 A. D. We explain plant invasion success, expressed by two measures: invasiveness, i.e. whether the species is naturalized but noninvasive, or invasive; and dominance in plant communities expressed as the mean cover in vegetation plots. We also tested how important reproductive and dispersal traits are in models including other characteristics generally known to predict invasion outcome, such as plant height, life history and residence time. By using regression/ classification trees we show that the biological traits affect invasion success at all life stages, from reproduction (seed production) to dispersal (propagule properties), and the ability to compete with resident species (height). By including species traits information not usually available in multispecies analyses, we provide evidence that traits do play important role in determining the outcome of invasion and can be used to distinguish between alien species that reach the final stage of the invasion process and dominate the local communities from those that do not. No effect of taxonomy ascertained in regression and classification trees indicates that the role of traits in invasiveness should be assessed primarily at the species level.	[Moravcova, Lenka; Pysek, Petr; Jarosik, Vojtech; Pergl, Jan] Acad Sci Czech Republ, Inst Bot, Dept Invas Ecol, CS-25243 Pruhonice, Czech Republic; [Pysek, Petr; Jarosik, Vojtech] Charles Univ Prague, Fac Sci, Dept Ecol, CR-11636 Prague 1, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Charles University Prague	Moravcova, L (corresponding author), Acad Sci Czech Republ, Inst Bot, Dept Invas Ecol, CS-25243 Pruhonice, Czech Republic.	lenka.moravcova@ibot.cas.cz	Pysek, Petr/B-1957-2012; Pergl, Jan/H-1071-2011	Pergl, Jan/0000-0002-0045-1974	Czech Science Foundation (Centre of Excellence PLADIAS) [206/05/0323, 14-36079G]; Academy of Sciences of the Czech Republic [RVO 67985939]; Ministry of Education, Youth, and Sports of the Czech Republic	Czech Science Foundation (Centre of Excellence PLADIAS); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This study was funded by the Czech Science Foundation (grant no. 206/05/0323 and project no. 14-36079G, Centre of Excellence PLADIAS), long-term research development project RVO 67985939 (Academy of Sciences of the Czech Republic), institutional resources of the Ministry of Education, Youth, and Sports of the Czech Republic, and PP acknowledges the support of a Praemium Academiae award from the Academy of Sciences of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askew AP, 1997, FUNCT ECOL, V11, P121, DOI 10.1046/j.1365-2435.1997.00049.x; Baker H. G., 1965, The genetics of colonizing species., P147; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Blackburn TM, 2009, ECOGRAPHY, V32, P83, DOI 10.1111/j.1600-0587.2008.05661.x; Breiman L., 2017, CLASSIFICATION REGRE; Bucharova A, 2009, J ECOL, V97, P230, DOI 10.1111/j.1365-2745.2008.01469.x; Burns JH, 2006, BIOL INVASIONS, V8, P797, DOI 10.1007/s10530-005-3838-5; Cadotte MW, 2006, ECOSCIENCE, V13, P388, DOI 10.2980/i1195-6860-13-3-388.1; Cadotte MW, 2006, BIOL INVASIONS, V8, P809, DOI 10.1007/s10530-005-3839-4; Cassey P, 2004, P ROY SOC B-BIOL SCI, V271, pS405, DOI 10.1098/rsbl.2004.0199; Cassey P, 2004, J BIOGEOGR, V31, P277, DOI 10.1046/j.0305-0270.2003.00979.x; Castro SA, 2005, DIVERS DISTRIB, V11, P183, DOI 10.1111/j.1366-9516.2005.00145.x; Castro-Diez P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100254; Chytry M, 2003, PRESLIA, V75, P1; Chytry M, 2009, DIVERS DISTRIB, V15, P98, DOI 10.1111/j.1472-4642.2008.00515.x; Chytry M, 2008, ECOLOGY, V89, P1541, DOI 10.1890/07-0682.1; Chytry M, 2008, J APPL ECOL, V45, P448, DOI 10.1111/j.1365-2664.2007.01398.x; Colautti RI, 2004, DIVERS DISTRIB, V10, P135, DOI 10.1111/j.1366-9516.2004.00061.x; Colautti RI, 2005, CAN J FISH AQUAT SCI, V62, P950, DOI 10.1139/F05-002; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Couvreur M, 2004, SEED SCI RES, V14, P147, DOI 10.1079/SSR2004164; Crawley M. J, 2002, STAT COMPUTING INTRO; Crawley MJ, 1996, PHILOS T R SOC B, V351, P1251, DOI 10.1098/rstb.1996.0108; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; DAEHLER CC, 2000, BIOL INVASIONS, V2, P93, DOI DOI 10.1023/A:1010002005024; Daehler CC, 2006, PRESLIA, V78, P389; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Dawson W, 2009, J ECOL, V97, P657, DOI 10.1111/j.1365-2745.2009.01519.x; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Dehnen-Schmutz K, 2007, DIVERS DISTRIB, V13, P527, DOI 10.1111/j.1472-4642.2007.00359.x; Dietz H, 2006, ECOLOGY, V87, P1359, DOI 10.1890/0012-9658(2006)87[1359:RTCPCD]2.0.CO;2; Egler FE, 1983, CE PHILLIPS HERBARIU, V6; Ellenberg H., 1988, Vegetation ecology of Central Europe.; FENNER M, 1983, NEW PHYTOL, V95, P697, DOI 10.1111/j.1469-8137.1983.tb03533.x; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Funk JL, 2008, J ECOL, V96, P1162, DOI 10.1111/j.1365-2745.2008.01435.x; GAUDET CL, 1988, NATURE, V334, P242, DOI 10.1038/334242a0; Godoy O, 2014, ECOLOGY, V95, P726, DOI 10.1890/13-1157.1; Gordon Doria R., 2010, Plant Protection Quarterly, V25, P56; Grime J. P., 1979, Plant strategies and vegetation processes.; GRIME JP, 1975, J ECOL, V63, P393, DOI 10.2307/2258728; Grime JP., 2014, COMP PLANT ECOLOGY F; Grotkopp E, 2010, J APPL ECOL, V47, P1320, DOI 10.1111/j.1365-2664.2010.01878.x; Grotkopp Eva, 1998, American Journal of Botany, V85, P34; Hamilton MA, 2005, ECOL LETT, V8, P1066, DOI 10.1111/j.1461-0248.2005.00809.x; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hejda M, 2009, J ECOL, V97, P393, DOI 10.1111/j.1365-2745.2009.01480.x; Henery ML, 2001, OIKOS, V92, P479, DOI 10.1034/j.1600-0706.2001.920309.x; Hochachka WM, 2007, J WILDLIFE MANAGE, V71, P2427, DOI 10.2193/2006-503; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Hulme PE, 2011, TRENDS ECOL EVOL, V26, P318, DOI 10.1016/j.tree.2011.03.018; Hunt R, 2002, ANN BOT-LONDON, V90, P485, DOI 10.1093/aob/mcf214; Jarosik V, 2011, ENCY BIOL INVASIONS, P104; Jeschke JM, 2008, ECOGRAPHY, V31, P124, DOI 10.1111/j.2007.0906-7590.05343.x; Jeschke JM, 2006, GLOBAL CHANGE BIOL, V12, P1608, DOI 10.1111/j.1365-2486.2006.01213.x; Kolar CS, 2002, SCIENCE, V298, P1233, DOI 10.1126/science.1075753; Kubesova M, 2010, PRESLIA, V82, P81; Kueffer C, 2013, NEW PHYTOL, V200, P615, DOI 10.1111/nph.12415; Kuster EC, 2008, J ECOL, V96, P860, DOI 10.1111/j.1365-2745.2008.01406.x; Lavergne S, 2004, OIKOS, V107, P505, DOI 10.1111/j.0030-1299.2004.13423.x; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lockwood JL, 2009, DIVERS DISTRIB, V15, P904, DOI 10.1111/j.1472-4642.2009.00594.x; Moles AT, 2004, J ECOL, V92, P384, DOI 10.1111/j.0022-0477.2004.00880.x; Moravcova L, 2010, PRESLIA, V82, P365; Muth NZ, 2007, J ECOL, V95, P1001, DOI 10.1111/j.1365-2745.2007.01268.x; Muth NZ, 2006, AM J BOT, V93, P188, DOI 10.3732/ajb.93.2.188; Perrings C, 2005, TRENDS ECOL EVOL, V20, P212, DOI 10.1016/j.tree.2005.02.011; Phillips ML, 2010, PRESLIA, V82, P465; Pysek P, 2005, INVASIVE PLANTS: ECOLOGICAL AND AGRICULTURAL ASPECTS, P77, DOI 10.1007/3-7643-7380-6_5; Pysek P, 2004, TAXON, V53, P131, DOI 10.2307/4135498; Pysek P, 2008, TRENDS ECOL EVOL, V23, P237, DOI 10.1016/j.tree.2008.02.002; Pysek Petr, 2007, V193, P97; Pysek P, 2012, PRESLIA, V84, P575; Pysek P, 2012, PRESLIA, V84, P155; Pysek P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024890; Pysek Petr, 2002, Preslia (Prague), V74, P97; Pysek P, 2009, ECOLOGY, V90, P2734, DOI 10.1890/08-0857.1; Pysek P, 2009, DIVERS DISTRIB, V15, P891, DOI 10.1111/j.1472-4642.2009.00602.x; Reich PB, 1998, FUNCT ECOL, V12, P327, DOI 10.1046/j.1365-2435.1998.00208.x; Rejmanek M, 1996, BIOL CONSERV, V78, P171, DOI 10.1016/0006-3207(96)00026-2; Rejmanek M., 2005, Invasive alien species: a new synthesis, P161; Rejmanek M, 2000, AUSTRAL ECOL, V25, P497, DOI 10.1046/j.1442-9993.2000.01080.x; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Richardson DM, 2008, DIVERS DISTRIB, V14, P161, DOI 10.1111/j.1472-4642.2007.00464.x; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Richardson DM, 2012, NEW PHYTOL, V196, P383, DOI 10.1111/j.1469-8137.2012.04292.x; Richardson DM, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P409; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Ross LC, 2008, PERSPECT PLANT ECOL, V10, P251, DOI 10.1016/j.ppees.2008.06.001; Rouget M, 2003, AM NAT, V162, P713, DOI 10.1086/379204; Roy J., 1990, BIOL INVASIONS EUROP, P335; Ruprecht E, 2014, BIOL INVASIONS, V16, P1359, DOI 10.1007/s10530-013-0574-0; Schaefer H, 2011, ECOL LETT, V14, P389, DOI 10.1111/j.1461-0248.2011.01600.x; Schaminee JHJ, 2009, PRESLIA, V81, P173; Schmidt JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017391; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Skalova H, 2012, ANN BOT-LONDON, V110, P1429, DOI 10.1093/aob/mcr316; Sokal R.R., 2012, BIOMETRY; Steinberg G, 1997, CLASSIFICATION REGRE; STEINBERG G, 1995, CART TREE STRUCTURED; Steinberg G, 2006, CART 6 0 USERS MANUA; Stevens P.F., ANGIOSPERM PHYLOGENY; Swanborough P, 1996, FUNCT ECOL, V10, P176, DOI 10.2307/2389841; Thiele J, 2010, J VEG SCI, V21, P213, DOI 10.1111/j.1654-1103.2009.01139.x; Thompson K, 1995, ECOGRAPHY, V18, P390, DOI 10.1111/j.1600-0587.1995.tb00142.x; Thompson K, 2011, TRENDS ECOL EVOL, V26, P155, DOI 10.1016/j.tree.2011.01.007; van Kleunen M, 2011, TRENDS ECOL EVOL, V26, P317, DOI 10.1016/j.tree.2011.03.019; van Kleunen M, 2010, ECOL LETT, V13, P947, DOI 10.1111/j.1461-0248.2010.01503.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Westoby M, 1996, PHILOS T R SOC B, V351, P1309, DOI 10.1098/rstb.1996.0114; WILLIAMSON M, 1993, EXPERIENTIA, V49, P219, DOI 10.1007/BF01923529; Williamson M, 2009, DIVERS DISTRIB, V15, P158, DOI 10.1111/j.1472-4642.2008.00528.x; Williamson M, 2006, BIOL INVASIONS, V8, P1561, DOI 10.1007/s10530-005-5849-7; Wilson JRU, 2007, DIVERS DISTRIB, V13, P11, DOI 10.1111/j.1366-9516.2006.00302.x; Wu SH, 2005, TAXON, V54, P133, DOI 10.2307/25065311	116	65	69	1	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123634	10.1371/journal.pone.0123634	http://dx.doi.org/10.1371/journal.pone.0123634			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906399	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000039
J	Ortiz, MS; Myers, HF; Schetter, CD; Rodriguez, CJ; Seeman, TE				Ortiz, Manuel S.; Myers, Hector F.; Schetter, Christine Dunkel; Rodriguez, Carlos J.; Seeman, Teresa E.			Psychosocial Predictors of Metabolic Syndrome among Latino Groups in the Multi-Ethnic Study of Atherosclerosis (MESA)	PLOS ONE			English	Article							MEXICAN-AMERICAN WOMEN; STRESSFUL LIFE EVENTS; DEPRESSIVE SYMPTOMS; CARDIOVASCULAR-DISEASE; PSYCHIATRIC-DISORDERS; SOCIAL SUPPORT; RISK-FACTORS; PREVALENCE; HEALTH; ACCULTURATION	Objective We sought to determine the contribution of psychological variables to risk for metabolic syndrome (MetS) among Latinos enrolled in the Multi-Ethnic Study of Atherosclerosis (MESA), and to investigate whether social support moderates these associations, and whether inflammatory markers mediate the association between psychological variables and MetS. Research design and methods Cross-sectional analyses at study baseline were conducted with a national Latino cohort (n = 1,388) that included Mexican Americans, Dominican Americans, Puerto Rican Americans and Central/South Americans. Hierarchical logistic regression analyses were conducted to test the effects of psychosocial variables (chronic stress, depressive symptoms, and social support) on MetS. In addition, separate subgroup-specific models, controlling for nationality, age, gender, socioeconomic position, language spoken at home, exercise, smoking and drinking status, and testing for the effects of chronic stress, depressive symptoms and inflammation (IL-6, CRP, fibrinogen) in predicting risk for MetS were conducted. Results In the overall sample, high chronic stress independently predicted risk for MetS, however this association was found to be significant only in Mexican Americans and Puerto Rican Americans. Social support did not moderate the associations between chronic stress and MetS for any group. Chronic stress was not associated with inflammatory markers in either the overall sample or in each group. Conclusions Our results suggest a differential contribution of chronic stress to the prevalence of MetS by national groups.	[Ortiz, Manuel S.] Univ La Frontera, Dept Psychol, Temuco, Chile; [Myers, Hector F.] Vanderbilt Univ, Ctr Med Hlth & Soc & Psychol, Nashville, TN 37235 USA; [Schetter, Christine Dunkel] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Rodriguez, Carlos J.] Wake Forest Univ, Bowman Gray Sch Med, Dept Med, Div Publ Hlth Sci, Winston Salem, NC 27103 USA; [Seeman, Teresa E.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Universidad de La Frontera; Vanderbilt University; University of California System; University of California Los Angeles; Wake Forest University; Wake Forest Baptist Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ortiz, MS (corresponding author), Univ La Frontera, Dept Psychol, Temuco, Chile.	manuel.ortiz@ufrontera.cl	Ortiz, Manuel/G-1044-2019	Ortiz, Manuel/0000-0002-7749-0699	National Heart, Lung, and Blood Institute [N01 HC95159, N01 HC-95160, N1HC95161, UL1-RR-024156, N01 HC-95162, UL1-RR-025005, N01 HC-95163, N01 HC-95164, N01 HC95165, N01HC95166]; NCRR [UL1-RR-024156, UL1-RR-025005]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095159, N01HC095166, N01HC095162, N01HC095165, N01HC095161, N01HC095163, N01HC095160, N01HC095164] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005, UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R13HL095166, R43HL095161] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by contracts N01 HC95159; N01 HC-95160; N1HC95161; UL1-RR- 024156; N01 HC-95162; UL1-RR-025005; N01 HC-95163; N01 HC-95164; N01 HC95165; N01HC95166 from the National Heart, Lung, and Blood Institute and by grants UL1-RR-024156 and UL1-RR-025005 from NCRR. The authors thank the other investigators, the staff, and the participants of the MESA study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegria M, 2007, SOC SCI MED, V65, P214, DOI 10.1016/j.socscimed.2007.03.026; Alegria M, 2007, AM J PUBLIC HEALTH, V97, P68, DOI 10.2105/AJPH.2006.087205; Allison MA, 2008, AM J EPIDEMIOL, V167, P962, DOI 10.1093/aje/kwm402; Araujo BY, 2006, HISPANIC J BEHAV SCI, V28, P245, DOI 10.1177/0739986305285825; Ayala GX, 2005, J AM DIET ASSOC, V105, P38, DOI 10.1016/j.jada.2004.10.023; Berkman LF, 2000, AM HEART J, V139, P1; Berlin I, 2012, TOB INDUC DIS, V10, DOI 10.1186/1617-9625-10-9; Bertoni AG, 2010, DIABETES CARE, V33, P804, DOI 10.2337/dc09-1679; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bird HR, 2001, J ABNORM CHILD PSYCH, V29, P465, DOI 10.1023/A:1012279707372; Bonilla C, 2004, HUM GENET, V115, P57, DOI 10.1007/s00439-004-1125-7; Bonilla C, 2004, ANN HUM GENET, V68, P139, DOI 10.1046/j.1529-8817.2003.00084.x; Bromberger JT, 1996, PSYCHOL AGING, V11, P207, DOI 10.1037/0882-7974.11.2.207; CDC, 2006, MMWR-MORBID MORTAL W, V55, P177; *CDC, 2004, MMWR-MORBID MORTAL W, V53, P941; Chandola T, 2006, BMJ-BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; Cohen BE, 2010, PSYCHIAT RES, V175, P133, DOI 10.1016/j.psychres.2009.02.004; Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D; Delaney JAC, 2010, HYPERTENSION, V55, P408, DOI 10.1161/HYPERTENSIONAHA.109.139824; Dixon LB, 2000, AM J EPIDEMIOL, V152, P548, DOI 10.1093/aje/152.6.548; Ford ES, 2010, J DIABETES, V2, P180, DOI 10.1111/j.1753-0407.2010.00078.x; Gallo LC, 2009, PSYCHOSOM MED, V71, P756, DOI 10.1097/PSY.0b013e3181b0d2b4; Gregory-Mercado KY, 2006, ETHNIC DIS, V16, P89; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Iversen LB, 2012, EUR J EPIDEMIOL, V27, P119, DOI 10.1007/s10654-012-9659-9; Jiang W, 2005, AM HEART J, V150, P871, DOI 10.1016/j.ahj.2005.01.041; Luppino FS, 2011, PSYCHOSOM MED, V73, P257, DOI 10.1097/PSY.0b013e31820a59c0; Mulvaney-Day NE, 2007, SOC SCI MED, V64, P477, DOI 10.1016/j.socscimed.2006.08.030; Page RL, 2004, JOGNN-J OBST GYN NEO, V33, P783, DOI 10.1177/0884217504270595; Pakalska-Korcala A, 2008, KARDIOL POL, V66, P500; Pyykkonen AJ, 2010, DIABETES CARE, V33, P378, DOI 10.2337/dc09-1027; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raikkonen K, 2007, DIABETES CARE, V30, P872, DOI 10.2337/dc06-1857; Ranjit N, 2007, ARCH INTERN MED, V167, P174, DOI 10.1001/archinte.167.2.174; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Schneiderman N, 2014, DIABETES CARE, V37, P2233, DOI 10.2337/dc13-2939; Sutherland JP, 2004, METAB SYNDR RELAT D, V2, P82, DOI 10.1089/met.2004.2.82; Tamashiro KL, 2011, STRESS, V14, P468, DOI 10.3109/10253890.2011.606341; Tamashiro KLK, 2011, ANN NY ACAD SCI, V1231, P46, DOI 10.1111/j.1749-6632.2011.06134.x; Tsurugano S, 2012, TOHOKU J EXP MED, V226, P101, DOI 10.1620/tjem.226.101; Van Wieren AJ, 2011, J IMMIGR MINOR HEALT, V13, P975, DOI 10.1007/s10903-011-9483-4; Whisman MA, 2010, HEALTH PSYCHOL, V29, P550, DOI 10.1037/a0020760; Zsembik BA, 2005, SOC SCI MED, V61, P53, DOI 10.1016/j.socscimed.2004.11.040	44	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124517	10.1371/journal.pone.0124517	http://dx.doi.org/10.1371/journal.pone.0124517			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KZ	25906072	Green Published, Green Submitted, gold			2022-12-27	WOS:000353332000072
J	Ribeiro, R; Wilson, AJ; Nunes, T; Ramilo, DW; Amador, R; Madeira, S; Baptista, FM; Harrup, LE; Lucientes, J; Boinas, F				Ribeiro, Rita; Wilson, Anthony J.; Nunes, Telmo; Ramilo, David W.; Amador, Rita; Madeira, Sara; Baptista, Filipa M.; Harrup, Lara E.; Lucientes, Javier; Boinas, Fernando			Spatial and Temporal Distribution of Culicoides Species in Mainland Portugal (2005-2010). Results of the Portuguese Entomological Surveillance Programme	PLOS ONE			English	Article							AFRICAN HORSE SICKNESS; BLUETONGUE-VIRUS; DIPTERA-CERATOPOGONIDAE; BITING MIDGES; IMICOLA; CLIMATE; VECTOR; EUROPE; IDENTIFICATION; TRANSMISSION	Bluetongue virus (BTV) is transmitted by Culicoides biting midges and causes an infectious, non-contagious disease of ruminants. It has been rapidly emerging in southern Europe since 1998. In mainland Portugal, strains of BTV belonging to three serotypes have been detected: BTV-10 (1956-1960), BTV-4 (2004-2006 and 2013) and BTV-1 (2007-2012). This paper describes the design, implementation and results of the Entomological Surveillance Programme covering mainland Portugal, between 2005 and 2010, including 5,650 caches. Culicoides imicola Kieffer was mostly found in central and southern regions of Portugal, although it was sporadically detected in northern latitudes. Its peak activity occurred in the autumn and it was active during the winter months in limited areas of the country. Obsoletus group was present at the highest densities in the north although they were found throughout the country in substantial numbers. Culicoides activity occurred all year round but peaked in the spring. A generalized linear mixed model was developed for the analysis of the environmental factors associated with activity of the species of Culicoides suspected vectors of BTV in the country. For C. imicola Kieffer, the most important variables were month, diurnal temperature range (DTR), the number of frost days (FRS) and median monthly temperature (TMP). For the Obsoletus group, the most important factors were month, diurnal temperature range (DTR), and linear and quadratic terms for median monthly temperature (TMP). The results reported can improve our understanding of climatic factors in Culicoides activity influencing their distribution and seasonal pattern.	[Ribeiro, Rita; Nunes, Telmo; Ramilo, David W.; Madeira, Sara; Baptista, Filipa M.; Boinas, Fernando] Univ Lisbon, Fac Vet Med, Ctr Interdisciplinary Res Anim Hlth CIISA, P-1699 Lisbon, Portugal; [Wilson, Anthony J.] Pirbright Inst, Integrat Entomol Grp, Woking, Surrey, England; [Amador, Rita] Food & Vet Cent Serv, Direcao Geral Alimentacao & Vet, Lisbon, Portugal; [Harrup, Lara E.] Pirbright Inst, Vector Borne Viral Dis Programme, Entomol Grp, Woking, Surrey, England; [Lucientes, Javier] Univ Zaragoza, Fac Vet, Dept Anim Pathol Anim Hlth, Parasitol & Parasit Dis, Zaragoza, Spain	Universidade de Lisboa; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Zaragoza	Boinas, F (corresponding author), Univ Lisbon, Fac Vet Med, Ctr Interdisciplinary Res Anim Hlth CIISA, P-1699 Lisbon, Portugal.	fboinas@fmv.ulisboa.pt	Boinas, Fernando/AAD-9779-2022	Boinas, Fernando/0000-0001-6259-4404; Ramilo, David/0000-0003-4096-2581; Nunes, Telmo/0000-0003-4388-5366; Harrup, Lara/0000-0001-8828-7349; Ribeiro, Rita/0000-0002-9976-3731; Wilson, Anthony/0000-0002-2000-2914; Madeira, Sara/0000-0001-5804-9745	Project National entomological surveillance programme of Culicoides midges, vectors of Bluetongue virus - Direcao Geral de Veterinaria [NINGA 7185573]; CIISA-Faculdade de Medicina Veterinaria; BBSRC [BBS/E/I/00001409]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001409] Funding Source: researchfish	Project National entomological surveillance programme of Culicoides midges, vectors of Bluetongue virus - Direcao Geral de Veterinaria; CIISA-Faculdade de Medicina Veterinaria; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Project National entomological surveillance programme of Culicoides midges, vectors of Bluetongue virus, reference: NINGA 7185573 Funded by Direcao Geral de Veterinaria. Author who received the funding: FB (coordinator of the programme at CIISA-Faculdade de Medicina Veterinaria). AJW and LH were funded by the BBSRC [BBS/E/I/00001409]. Funders at Direcao Geral de Veterinaria had a role in the data collection and study design, but had no role in the analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014236; Ayllon T, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-34; Backx A, 2009, VET MICROBIOL, V138, P235, DOI 10.1016/j.vetmic.2009.04.003; Barros SC, 2007, VET MICROBIOL, V124, P25, DOI 10.1016/j.vetmic.2007.04.014; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Calvete C, 2008, MED VET ENTOMOL, V22, P124, DOI 10.1111/j.1365-2915.2008.00728.x; Calvete C, 2006, VET REC, V158, P130, DOI 10.1136/vr.158.4.130; Capela R, 2003, MED VET ENTOMOL, V17, P165, DOI 10.1046/j.1365-2915.2003.00419.x; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; Conte A, 2007, VET PARASITOL, V150, P333, DOI 10.1016/j.vetpar.2007.09.021; Conte Annamaria, 2007, Vet Ital, V43, P571; Dal Pozzo F, 2009, VET MICROBIOL, V136, P352, DOI 10.1016/j.vetmic.2008.11.012; Darpel KE, 2009, EMERG INFECT DIS, V15, P2025, DOI 10.3201/eid1512.090788; Delecolle JC, 1985, NOUVELLE CONTRIBUITI, DOI [10.1016/j.crvi.2014.04.006, DOI 10.1016/J.CRVI.2014.04.006]; Direccao Geral de Alimentacao e Veterinaria (DGAV), 2012, PROGR ERR CONTR VIG; Direccao Geral de Alimentacao e Veterinaria (DGAV), 2014, BLUET SIT PORT; EFSA Panel on Animal Health and Welfare (AHAW), 2011, EFSA J; European Commission (EC), 2012, AN DIS NOT SYST; European Food Safety Authority (EFSA), 2008, EFSA J, V735, P1, DOI DOI 10.2903/J.EFSA.2008.735; Ferreira AMPJ, 2000, THESIS U AVEIRO AVEI; FFMS, 2014, PORD TEMP MED AR MED; Garcia-Lastra R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034421; Garros C, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-223; Goffredo M, 2004, VETER ITAL SER, V40, P260; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Maan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026147; Meiswinkel R, 1997, ONDERSTEPOORT J VET, V64, P81; Mellor PS, 2008, PREV VET MED, V87, P4, DOI 10.1016/j.prevetmed.2008.06.002; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Menzies FD, 2008, VET REC, V163, P203, DOI 10.1136/vr.163.7.203; Monteys VSI, 2005, VET REC, V156, P415, DOI 10.1136/vr.156.13.415; Patakakis MJ, 2009, J VECTOR ECOL, V34, P243, DOI [10.3376/038.034.0211, 10.1111/j.1948-7134.2009.00033.x]; Pena I, 2003, CONTRIBUICAO ESTUDO; Portas M, 1999, EPIDEMIOL INFECT, V123, P337, DOI 10.1017/S0950268899002897; Purse BV, 2012, MED VET ENTOMOL, V26, P168, DOI 10.1111/j.1365-2915.2011.00991.x; Purse BV, 2004, MED VET ENTOMOL, V18, P90, DOI 10.1111/j.0269-283X.2004.00492.x; Ramilo DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034896; Rawlings Peter, 1996, Graellsia, V52, P57; Scolamacchia F, 2014, MED VET ENTOMOL, V28, P143, DOI 10.1111/mve.12028; Sellers R. F., 1980, Bulletin de l'Office International des Epizooties, V92, P587; Takamatsu H, 2003, J GEN VIROL, V84, P227, DOI 10.1099/vir.0.18705-0; Tatem AJ, 2003, VET MICROBIOL, V97, P13, DOI 10.1016/j.vetmic.2003.08.009; VANARK H, 1992, ONDERSTEPOORT J VET, V59, P183; Wilson A, 2008, PLOS BIOL, V6, P1612, DOI 10.1371/journal.pbio.0060210; Wittman EJ, 2001, REV SCI TECH OIE, V20, P731, DOI 10.20506/rst.20.3.1306; Wittmann EJ, 2000, VET J, V160, P107, DOI 10.1053/tvjl.2000.0470	47	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124019	10.1371/journal.pone.0124019	http://dx.doi.org/10.1371/journal.pone.0124019			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906151	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000055
J	Kadimpati, S; Zale, EL; Hooten, MW; Ditre, JW; Warner, DO				Kadimpati, Sandeep; Zale, Emily L.; Hooten, Michael W.; Ditre, Joseph W.; Warner, David O.			Associations between Neuroticism and Depression in Relation to Catastrophizing and Pain-Related Anxiety in Chronic Pain Patients	PLOS ONE			English	Article							FEAR-AVOIDANCE MODEL; OPIOID USE STATUS; LOW-BACK-PAIN; PERSONALITY-TRAITS; TREATMENT OUTCOMES; MAJOR DEPRESSION; ANALGESIC MEDICATION; MUSCULOSKELETAL PAIN; 1ST ONSET; REHABILITATION	Several cognitive-affective constructs, including pain catastrophizing and pain-related anxiety, have been implicated in the onset and progression of chronic pain, and both constructs have been identified as key targets for multidisciplinary pain treatment. Both neuroticism and depression have been linked to these constructs (and to each other), but how each may contribute to the pain experience is unknown. This study tested associations between neuroticism, depression, and indices of catastrophizing and pain-related anxiety among persons seeking treatment for chronic non-malignant pain. We hypothesized, as a higher-order personality trait, neuroticism would remain uniquely associated with both pain catastrophizing and pain-related anxiety, even after accounting for current symptoms of depression. A retrospective study design assessed depression (as measured by the Centers for Epidemiologic Studies-Depression scale), neuroticism (measured with the Neuroticism-Extraversion-Openness Personality Inventory), the Pain Catastrophizing Scale, and the Pain Anxiety Symptom Score in a consecutive series of patients (n=595) admitted to a 3-week outpatient pain treatment program from March 2009 through January 2011. Hierarchical regression indicated that neuroticism was independently associated with greater pain catastrophizing and pain-related anxiety, above-and-beyond the contributions of sociodemographic characteristics, pain severity, and depression. A depression by neuroticism interaction was not observed, suggesting that associations between neuroticism and cognitive-affective pain constructs remained stable across varying levels of current depression. These findings represent an early but important step towards the clarification of complex associations between trait neuroticism, current depression, and tendencies toward catastrophic and anxiety-provoking appraisals of pain among persons seeking treatment for chronic pain.	[Kadimpati, Sandeep; Hooten, Michael W.; Warner, David O.] Mayo Clin, Dept Anesthesiol, Coll Med, Rochester, MN 55905 USA; [Zale, Emily L.; Ditre, Joseph W.] Syracuse Univ, Dept Psychol, Syracuse, NY USA	Mayo Clinic; Syracuse University	Warner, DO (corresponding author), Mayo Clin, Dept Anesthesiol, Coll Med, Rochester, MN 55905 USA.	warner.david@mayo.edu	Zale, Emily L./L-6585-2019					Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Castro M, 2009, ARQ NEURO-PSIQUIAT, V67, P982, DOI 10.1590/S0004-282X2009000600004; Chittka T, 2010, BEHAV RES THER, V48, P7; Costa PT, 1997, J PERS ASSESS, V68, P86, DOI 10.1207/s15327752jpa6801_7; Crisostomo RA, 2008, AM J PHYS MED REHAB, V87, P527, DOI 10.1097/PHM.0b013e31817c124f; Crombez G, 2004, PAIN, V107, P8; Currie SR, 2004, PAIN, V107, P54, DOI 10.1016/j.pain.2003.09.015; Currie SR, 2005, PSYCHOL MED, V35, P1275, DOI 10.1017/S0033291705004952; Cvijetic S, 2013, APPL RES IN QUAL LIF, P1; Evers AWM, 2001, PAIN, V93, P139, DOI 10.1016/S0304-3959(01)00303-7; Geisser ME, 1997, CLIN J PAIN, V13, P163, DOI 10.1097/00002508-199706000-00011; Goubert L, 2004, PAIN, V107, P234, DOI 10.1016/j.pain.2003.11.005; HARKINS SW, 1989, PAIN, V36, P209, DOI 10.1016/0304-3959(89)90025-0; HIRSCHFELD RMA, 1989, ARCH GEN PSYCHIAT, V46, P345; Hooten WM, 2007, PAIN MED, V8, P624, DOI 10.1111/j.1526-4637.2006.00202.x; Hooten WM, 2007, PAIN MED, V8, P8, DOI 10.1111/j.1526-4637.2007.00253.x; Hooten WM, 2009, PAIN MED, V10, P1416, DOI 10.1111/j.1526-4637.2009.00702.x; Hooten WM, 2009, ANESTH ANALG, V108, P308, DOI 10.1213/ane.0b013e31818c7b99; Kendler KS, 2006, ARCH GEN PSYCHIAT, V63, P1113, DOI 10.1001/archpsyc.63.10.1113; Kotov R, 2010, PSYCHOL BULL, V136, P768, DOI 10.1037/a0020327; Krueger RF, 1996, J ABNORM PSYCHOL, V105, P299, DOI 10.1037/0021-843X.105.3.299; Kumari V, 2007, BEHAV NEUROSCI, V121, P643, DOI 10.1037/0735-7044.121.4.643; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Lewis S, 2012, MANUAL THER, V17, P27, DOI 10.1016/j.math.2011.08.001; McCracken Lance M, 2002, Pain Res Manag, V7, P45; MCCRACKEN LM, 1992, PAIN, V50, P67, DOI 10.1016/0304-3959(92)90113-P; McCracken LM, 2000, PAIN RES MANAG, V7, P45; McCrae R.R., 2008, HDB PERSONALITY THEO, P159; McCrae RR, 1997, AM PSYCHOL, V52, P509, DOI 10.1037/0003-066X.52.5.509; MCCRAE RR, 1991, J PERS ASSESS, V57, P399, DOI 10.1207/s15327752jpa5703_2; Muris P, 2007, J ADOLESCENCE, V30, P1035, DOI 10.1016/j.adolescence.2007.03.003; Ohayon MM, 2003, ARCH GEN PSYCHIAT, V60, P39, DOI 10.1001/archpsyc.60.1.39; Osborne TL, 2007, PAIN, V127, P52, DOI 10.1016/j.pain.2006.07.017; Osman A, 1997, J BEHAV MED, V20, P589, DOI 10.1023/A:1025570508954; Ozer DJ, 2006, ANNU REV PSYCHOL, V57, P401, DOI 10.1146/annurev.psych.57.102904.190127; Martinez MP, 2011, J CLIN PSYCHOL MED S, V18, P380, DOI 10.1007/s10880-011-9263-2; Quartana PJ, 2009, EXPERT REV NEUROTHER, V9, P745, DOI 10.1586/ERN.09.34; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ramirez-Maestre C, 2004, J BEHAV MED, V27, P147, DOI 10.1023/B:JOBM.0000019849.21524.70; Richardson EJ, 2009, PAIN, V147, P147, DOI 10.1016/j.pain.2009.08.030; Rome JD, 2004, MAYO CLIN PROC, V79, P759; Rudy TE, 2009, MULTIAXIAL ASSESSMEN; Smarr KL, 2011, ARTHRIT CARE RES, V63, pS454, DOI 10.1002/acr.20556; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Swinkels-Meewisse IEJ, 2006, PAIN, V120, P36, DOI 10.1016/j.pain.2005.10.005; Tennant F, 2000, WESTERN J MED, V173, P306, DOI 10.1136/ewjm.173.5.306; Tennen H, 2006, HEALTH PSYCHOL, V25, P370, DOI 10.1037/0278-6133.25.3.370; Torelli P, 2006, NEUROL SCI, V27, pS73, DOI 10.1007/s10072-006-0574-2; Townsend CO, 2008, PAIN, V140, P177, DOI 10.1016/j.pain.2008.08.005; TURK DC, 1994, BEHAV RES THER, V32, P9, DOI 10.1016/0005-7967(94)90078-7; Turner JA, 2002, PAIN, V98, P127, DOI 10.1016/S0304-3959(02)00045-3; Van Damme S, 2002, PAIN, V96, P319, DOI 10.1016/S0304-3959(01)00463-8; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; Xu JS, 2012, NEUROIMAGE, V59, P800, DOI 10.1016/j.neuroimage.2011.07.040	55	34	38	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0126351	10.1371/journal.pone.0126351	http://dx.doi.org/10.1371/journal.pone.0126351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KV	25902153	Green Submitted, Green Published, gold			2022-12-27	WOS:000353331500122
J	Liu, YZ; Qiu, XM; Zhang, X; Yu, TX				Liu, Yuzhe; Qiu, Xinming; Zhang, Xiong; Yu, T. X.			Response of Woodpecker's Head during Pecking Process Simulated by Material Point Method	PLOS ONE			English	Article							BRAIN-INJURY; MECHANICAL-PROPERTIES; ALUMINUM FOAM; IMPACT	Prevention of brain injury in woodpeckers under high deceleration during the pecking process has been an intriguing biomechanical problem for a long time. Several studies have provided different explanations, but the function of the hyoid bone, one of the more interesting skeletal features of a woodpecker, still has not been fully explored. This paper studies the relationship between a woodpecker head's response to impact and the hyoid bone. Based on micro-CT scanning images, the material point method (MPM) is employed to simulate woodpecker's pecking process. The maximum shear stress in the brainstem (SSS) is adopted as an indicator of brain injury. The motion and deformation of the first cervical vertebra is found to be the main reason of the shear stress of the brain. Our study found that the existence of the hyoid bone reduces the SSS level, enhances the rigidity of the head, and suppresses the oscillation of the endoskeleton after impact. The mechanism is explained by a brief mechanical analysis while the influence of the material properties of the muscle is also discussed.	[Liu, Yuzhe; Qiu, Xinming; Zhang, Xiong] Tsinghua Univ, Dept Engn Mech, Beijing 100084, Peoples R China; [Yu, T. X.] Hong Kong Univ Sci & Technol, Dept Mech & Aerosp Engn, Kowloon, Hong Kong, Peoples R China; [Yu, T. X.] Ningbo Univ, Ningbo 315211, Zhejiang, Peoples R China	Tsinghua University; Hong Kong University of Science & Technology; Ningbo University	Qiu, XM (corresponding author), Tsinghua Univ, Dept Engn Mech, Beijing 100084, Peoples R China.	qxm@tsinghua.edu.cn	Zhang, Xiong/B-6733-2012	Zhang, Xiong/0000-0001-9905-281X; Qiu, Xinming/0000-0003-2187-6696	National Natural Science Foundation of China [11372163]; National Fundamental Research Program of China [2010CB832701, 2011CB610305]; NSFC [11032001]; Directorate For Geosciences [1258878] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Fundamental Research Program of China; NSFC(National Natural Science Foundation of China (NSFC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The authors gratefully acknowledge the support from the National Natural Science Foundation of China No. 11372163, the National Fundamental Research Program of China through Grant No. 2010CB832701 and 2011CB610305. The 4th author (T.X. Yu) thanks the support from the NSFC Key Project No. 11032001.	BOCK WJ, 1964, J MORPHOL, V114, P1, DOI 10.1002/jmor.1051140102; Bock WJ, 1999, OSTRICH, V70, P23, DOI 10.1080/00306525.1999.9639746; BOCK WJ, 1966, AUK, V83, P10, DOI 10.2307/4082976; Gadd C.W, 1966, USE WEIGHTED IMPULSE; Gibson LJ, 2006, J ZOOL, V270, P462, DOI 10.1111/j.1469-7998.2006.00166.x; Gong WW, 2012, CMES-COMP MODEL ENG, V83, P527; Gong WW, 2011, CMES-COMP MODEL ENG, V82, P195; HILL AV, 1953, PROC R SOC SER B-BIO, V141, P104, DOI 10.1098/rspb.1953.0027; Hirschman A., 1976, LANCET, V307, P454, DOI [10.1016/s0140-6736(76)91477-x, DOI 10.1016/S0140-6736(76)91477-X]; Hutchinson J, 1998, APPL MATH COMPUT, V96, P1, DOI 10.1016/S0096-3003(97)10106-0; Lee N, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0274; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; Ma S, 2009, CMES-COMP MODEL ENG, V39, P101; Ma ZT, 2010, CMES-COMP MODEL ENG, V55, P61; MAY PRA, 1979, ARCH NEUROL-CHICAGO, V36, P370, DOI 10.1001/archneur.1979.00500420080011; Newman JA., 2000, STAPP CAR CRASH J, V44, P215, DOI DOI 10.4271/2000-01-SC16; Oda J, 2006, JSME INT J A-SOLID M, V49, P390, DOI 10.1299/jsmea.49.390; Pan XF, 2008, COMMUN THEOR PHYS, V49, P1129, DOI 10.1088/0253-6102/49/5/09; Shang M, 2006, EXPLOSION SHOCK WAVE, V3; SULSKY D, 1994, COMPUT METHOD APPL M, V118, P179, DOI 10.1016/0045-7825(94)00033-6; SULSKY D, 1995, COMPUT PHYS COMMUN, V87, P236, DOI 10.1016/0010-4655(94)00170-7; Versace J, 1971, REV SEVERITY INDEX; Wang LZ, 2011, SCI CHINA LIFE SCI, V54, P1036, DOI 10.1007/s11427-011-4242-2; Wang LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026490; Whittaker E. T., 1952, ANAL DYNAMICS PARTIC; Wu JS, 2000, J APPL POLYM SCI, V76, P1000, DOI 10.1002/(SICI)1097-4628(20000516)76:7<1000::AID-APP3>3.0.CO;2-X; Yoon SH, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/1/016003; Yoon SH, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/3/035501; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou P, 2009, J BIONIC ENG, V6, P214, DOI 10.1016/S1672-6529(08)60126-2; Zhou S, 2013, INT J COMPUTATIONAL, V10; Zhu ZD, 2012, AIP ADV, V2, DOI 10.1063/1.4770305; Zhu ZD, 2014, J BIONIC ENG, V11, P282, DOI 10.1016/S1672-6529(14)60045-7	33	17	21	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122677	10.1371/journal.pone.0122677	http://dx.doi.org/10.1371/journal.pone.0122677			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902356	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500027
J	Mesfin, F; Berhane, Y; Worku, A				Mesfin, Firehiwot; Berhane, Yemane; Worku, Alemayehu			Anemia among Primary School Children in Eastern Ethiopia	PLOS ONE			English	Article							PARASITIC INFECTIONS; RISK-FACTORS; SCHOOLCHILDREN; MALNUTRITION; EDUCATION; HEALTH	Background Anemia during childhood impairs physical growth, cognitive development and school performance. Identifying the causes of anemia in specific contexts can help efforts to prevent negative consequences of anemia among children. The objective of this study was to assess prevalence and identify correlates of anemia among school children in Eastern Ethiopia. Methods A cross sectional study was conducted from January 2012 to February 2012 in Kersa, Eastern Ethiopia. The study included randomly selected primary school students. Hemoglobin concentration was measured using a Hemocue haemoglobinometer. A child was identified as anemic if the hemoglobin concentration was < 11.5 g/dl for children (5-11 yrs) and < 12 g/dl for child older than 12 years age. Poisson regression model with robust variance was used to calculate prevalence ratios. Result The overall prevalence of anemia was 27.1% (95% CI: 24.98, 29.14): 13.8% had mild, 10.8% moderate, and 2.3% severe anemia. Children with in the age group of 5-9 years (APR, 1.083; 95% CI, 1.044-1.124) were at higher risk for anemia. Paternal education (Illiterate, 1.109; 1.044 -1.178) was positively associated with anemia. Children who had irregular legume consumption (APR, 1.069; 95% CI, 1.022 -1.118) were at higher risk for anemia. Conclusion About a quarter of school children suffer from anemia and their educational potential is likely to be affected especially for those with moderate and severe anemia. Child age, irregular legume consumption, and low paternal schooling were associated with anemia. Intervention programmes aimed to reduce anemia among school children are crucial to ensure proper growth and development of children.	[Mesfin, Firehiwot] Haramaya Univ, Coll Hlth & Med Sci, Harar, Ethiopia; [Berhane, Yemane; Worku, Alemayehu] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia; [Worku, Alemayehu] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia	Haramaya University; Addis Continental Institute of Public Health; Addis Ababa University	Mesfin, F (corresponding author), Haramaya Univ, Coll Hlth & Med Sci, Harar, Ethiopia.	mfirehiwotm@gmail.com	Berhane, Yemane/ABB-8154-2020	Berhane, Yemane/0000-0002-2527-1339	Haramaya University	Haramaya University	This study was financially supported by grants from Haramaya University of PhD program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeredolu I. A., 2011, Food and Nutrition Sciences, V2, P1063, DOI 10.4236/fns.2011.210142; Amare B, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-108; Amare B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-752; [Anonymous], 2001, WHO TECHN REP SER; [Anonymous], 2008, WORLDW PREV AN 1993; Ashton R, 2009, SCH BASED SURVEYS MA, DOI [10.1186/1475-2875-10-25, DOI 10.1186/1475-2875-10-25]; Assefa Selomon, 2014, BMC Hematol, V14, P3, DOI 10.1186/2052-1839-14-3; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Barugahara EI, 2013, AFRICAN J FOOD AGR N, V13; Barugahara El, 2013, AFRICAN J FOOD AGR N, V13, P3; Belachew T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057643; Bobonis G, 2004, J HUM RESOURCES; Bundy Donald, 2005, Food and Nutrition Bulletin, V26, pS186; Children's Hospital & Research Center Oakland, 2012, NOV IR SOURC NEWL ID; Choi HJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-870; Coutinho LMS, 2008, REV SAUDE PUBL, V42; Djokic D, 2010, HIPPOKRATIA, V14, P252; EDHS, 2011, ETH DEM HLTH SURV 20; El Hioui M, 2008, East Afr J Public Health, V5, P62; Gari MA, 2008, MED SCI, V15, P63; Government of Federal Democratic Republic of Ethiopia, 2013, NAT NUTR PROGR; Haidar J, 2010, J HEALTH POPUL NUTR, V28, P359; Hall A, 2008, TROP MED INT HEALTH, V13, P1518, DOI 10.1111/j.1365-3156.2008.02168.x; Koukounari A, 2008, INT J PARASITOL, V38, P1663, DOI 10.1016/j.ijpara.2008.05.013; Liao X, 2013, STRUCTURE FUNCTION N, DOI [10.1080/10408398.2011.635914, DOI 10.1080/10408398.2011.635914]; Mahmud MA, 2013, PATHOG GLOB HEALTH, V107, P58, DOI 10.1179/2047773213Y.0000000074; Mekasha Amha, 2009, Ethiop Med J, V47, P129; Ministry of Education, 2012, SCH HLTH NUTR STRAT; Muhammad Ramzan, 2009, Pakistan Journal of Nutrition, V8, P259, DOI 10.3923/pjn.2009.259.263; Mulugeta A, 2010, J FEDERATION AM SOC; Onimawo I, 2010, ASSESSMENT ANAEMIA I; Prema A., 2011, INT J NUTR PHARM NEU, V1, P184, DOI [10.4103/2231-0738.84212, DOI 10.4103/2231-0738.84212]; Reji P, 2011, AFR J PRIM HEALTH CA, V3, DOI 10.4102/phcfm.v3i1.198; Semba RD, 2008, LANCET, V371, P322, DOI 10.1016/S0140-6736(08)60169-5; Tatala S R, 2008, Tanzan J Health Res, V10, P189; Tengco LW, 2008, J AM COLL NUTR, V27, P229, DOI 10.1080/07315724.2008.10719695; Theil EC, 2004, ANNU REV NUTR, V24, P327, DOI 10.1146/annurev.nutr.24.012003.132212; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Villanova PA, 1994, REFERENCE SELECTED P; VONSCHENCK H, 1986, CLIN CHEM, V32, P526; Webb P., 2003, NUTR KNOWLEDGE PAREN; WHO, 2011, WHONMHNHDMNM111; Zhao GH, 2010, BBA-GEN SUBJECTS, V1800, P815, DOI 10.1016/j.bbagen.2010.01.009	43	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123615	10.1371/journal.pone.0123615	http://dx.doi.org/10.1371/journal.pone.0123615			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902055	Green Submitted, Green Published, gold			2022-12-27	WOS:000353331500057
J	Mytnik-Ejsmont, J; Szlachetko, DL; Baranow, P; Jolliffe, K; Gorniak, M				Mytnik-Ejsmont, Joanna; Szlachetko, Dariusz L.; Baranow, Przemyslaw; Jolliffe, Kevin; Gorniak, Marcin			Phylogenetic Placement and Taxonomy of the Genus Hederorkis (Orchidaceae)	PLOS ONE			English	Article							MOLECULAR PHYLOGENETICS; SEQUENCE ALIGNMENT; DNA-SEQUENCES; TORTOISE; TOOLS	Three plastid regions, matK, rpl32-trnL and rpl16 intron and the ITS1-5.8S-ITS2 nuclear ribosomal DNA were used to demonstrate a phylogenetic placement of the genus Hederorkis (Orchidaceae) for the first time. The taxonomic position of this genus has been unclear thus far. The phylogenetic and morphological relations of Hederorkis to the most closely related genera Sirhookera, Adrorhizon, Bromheadia and Polystachya are also discussed. A hypothesis concerning an origin and evolution of Hederorkis is proposed. Hederorkis is an epiphytic two-leaved orchid genus with lateral inflorescence, non-resupinate flowers, elongate gynostemium and rudimentary column foot. It is native to the Indian Ocean Islands. Two species of Hederorkis are recognized worldwide, H. scandens endemic to Mauritius and Reunion and H. seychellensis endemic to Seychelles. For each of the species treated a full synonymy, detailed description and illustration are included. The distribution map and dichotomous keys to the species have also been provided.	[Mytnik-Ejsmont, Joanna; Szlachetko, Dariusz L.; Baranow, Przemyslaw] Univ Gdansk, Dept Plant Taxon & Nat Conservat, PL-80308 Gdansk, Poland; [Jolliffe, Kevin] Conservat Dept, Cousine Isl, Seychelles; [Gorniak, Marcin] Univ Gdansk, Dept Mol Evolut, PL-80308 Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk	Mytnik-Ejsmont, J (corresponding author), Univ Gdansk, Dept Plant Taxon & Nat Conservat, Wita Stwosza 59, PL-80308 Gdansk, Poland.	dokjom@univ.gda.pl	Górniak, Marcin/HGB-0473-2022; Baranow, Przemyslaw/G-3416-2013	Górniak, Marcin/0000-0002-7568-7818; Baranow, Przemyslaw/0000-0003-1907-7211; Mytnik, Joanna/0000-0003-4921-4950	Ministry of Science and Higher Education of Poland [N N303 343735, N N303 812440]; Seychelles Bureau of Standards [A0347]	Ministry of Science and Higher Education of Poland(Ministry of Science and Higher Education, Poland); Seychelles Bureau of Standards	1. N N303 343735, grant from the Ministry of Science and Higher Education of Poland, www.nauka.gov.pl. JME received the funding. 2. N N303 812440, grant from the Ministry of Science and Higher Education of Poland, www.nauka.gov.pl. DLS received the funding. 3. Grant from the Seychelles Bureau of Standards (A0347).	BOSSER J, 1976, Adansonia, V16, P225; Burns-Balogh P., 1986, SMITHSON CONTRIB BOT, P1, DOI [10.5479/SI.0081024X.61, DOI 10.5479/SI.0081024X.61]; Carnevali G, 2013, SYST BOT, V38, P46, DOI 10.1600/036364413X661926; Chase M.W., 2003, ORCHID CONSERV, P69; CHASE MW, 1991, TAXON, V40, P215, DOI 10.2307/1222975; Cribb PJ, 2014, GENERA ORCHIDACEAR 3, V6; Cuenoud P, 2002, AM J BOT, V89, P132, DOI 10.3732/ajb.89.1.132; Douzery EJP, 1999, AM J BOT, V86, P887, DOI 10.2307/2656709; Dressler R.L., 1990, ORCHIDS NATURAL HIST; Dressler R.L., 1981, ORCHIDS NATURAL HIST; Dressler RL, 1993, PHYLOGENY CLASSIFICA; du Petit Thouars A, 1809, NOUVEAU B SCI PUBLIE, V1, P314; du Petit Thouars A, 1822, HIST PARTICULIERE PL; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Freudenstein JV, 2004, AM J BOT, V91, P149, DOI 10.3732/ajb.91.1.149; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gerlach J, 1997, SEYCHELLES RED DATA; Gorniak M, 2010, MOL PHYLOGENET EVOL, V56, P784, DOI 10.1016/j.ympev.2010.03.003; HUNT P F, 1968, Kew Bulletin, V22, P489, DOI 10.2307/4108359; MOLVRAY M, 2000, MONOCOTS SYSTEMATICS, P441, DOI DOI 10.1002/ECE3.752; Mytnik-Ejsmont J, 2011, BIODIV RES CONSERV, V23, P17; Pridgeon Alec M., 1997, Lindleyana, V12, P89; RASMUSSEN FN, 1979, BOT NOTISER, V132, P385; Robertson SA., 1989, FLOWERING PLANTS SEY; SCHLECTER R., 1926, NOTIZBL BOT GART U MUS BERLIN DAHLEM, V9, P563, DOI 10.2307/3994326; Senghas K, 1990, ORCHIDEEN; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Szlachetko D. L., 1995, FRAGMENTA FLORISTICA, V3, P1; Thiers B., 2022, INDEX HERBARIORUM GL; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Whitten WM, 2000, AM J BOT, V87, P1842, DOI 10.2307/2656837; Wise R, 1998, FRAGILE EDEN PORTRAI	36	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122306	10.1371/journal.pone.0122306	http://dx.doi.org/10.1371/journal.pone.0122306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902058	gold, Green Published, Green Submitted			2022-12-27	WOS:000353331500017
J	He, Q; Ma, ZG; Dang, XQ; Xu, JS; Zhou, ZY				He, Qiang; Ma, Zhenggang; Dang, Xiaoqun; Xu, Jinshan; Zhou, Zeyang			Identification, Diversity and Evolution of MITEs in the Genomes of Microsporidian Nosema Parasites	PLOS ONE			English	Article							REPEAT TRANSPOSABLE ELEMENTS; DOMESTICATED SILKWORM; GENE; FAMILY; SEQUENCE; TRANSPOSITION; AMPLIFICATION; STOWAWAY; REVEAL; RICE	Miniature inverted-repeat transposable elements (MITEs) are short, non-autonomous DNA transposons, which are widespread in most eukaryotic genomes. However, genome-wide identification, origin and evolution of MITEs remain largely obscure in microsporidia. In this study, we investigated structural features for de novo identification of MITEs in genomes of silkworm microsporidia Nosema bombycis and Nosema antheraeae, as well as a honeybee microsporidia Nosema ceranae. A total of 1490, 149 and 83 MITE-related sequences from 89, 17 and five families, respectively, were found in the genomes of the above-mentioned species. Species-specific MITEs are predominant in each genome of microsporidian Nosema, with the exception of three MITE families that were shared by N. bombycis and N. antheraeae. One or multiple rounds of amplification occurred for MITEs in N. bombycis after divergence between N. bombycis and the other two species, suggesting that the more abundant families in N. bombycis could be attributed to the recent amplification of new MITEs. Significantly, some MITEs that inserted into the homologous protein-coding region of N. bombycis were recruited as introns, indicating that gene expansion occurred during the evolution of microsporidia. NbS31and NbS24had polymorphisms in different geographical strains of N. bombycis, indicating that they could still be active. In addition, several small RNAs in the MITEs in N. bombycis are mainly produced from both ends of the MITEs sequence.	[He, Qiang; Ma, Zhenggang; Dang, Xiaoqun; Xu, Jinshan; Zhou, Zeyang] Chongqing Normal Univ, Coll Life Sci, Chongqing, Peoples R China; [Zhou, Zeyang] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Chongqing Normal University; Southwest University - China	Xu, JS (corresponding author), Chongqing Normal Univ, Coll Life Sci, Chongqing, Peoples R China.	xujinshan2003@aliyun.com	He, Qiang/AAP-5896-2021		National High-tech R&D Program (863 Program) [2013AA102507]; National Natural Science Foundation of China [31001037]; Natural Science Foundation Project of Chongqing Science&technology Commission [cstc2012jjA80006, cstc2014jcyjA80039]; Key Project of Ministry of Education of China [210180]; Science and Technology Project of Chongqing Municipal Education Commission [KJ110611, KJ10627, KJ090813]	National High-tech R&D Program (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing Science&technology Commission; Key Project of Ministry of Education of China(Ministry of Education, China); Science and Technology Project of Chongqing Municipal Education Commission	This study is supported by National High-tech R&D Program (863 Program, No. 2013AA102507), National Natural Science Foundation of China (No. 31001037), Natural Science Foundation Project of Chongqing Science&technology Commission (No. cstc2012jjA80006 and No. cstc2014jcyjA80039), Key Project of Ministry of Education of China (No. 210180), Science and Technology Project of Chongqing Municipal Education Commission (No. KJ110611, KJ10627 and KJ090813). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUREAU TE, 1992, PLANT CELL, V4, P1283, DOI 10.1105/tpc.4.10.1283; Cai YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036599; Campbell SE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003676; Chen YP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-451; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Corradi N, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r106; Cuomo CA, 2012, GENOME RES, V22, P2478, DOI 10.1101/gr.142802.112; DESPORTES I, 1985, J PROTOZOOL, V32, P250; Dong HT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-135; Dufresne M, 2007, GENETICS, V175, P441, DOI 10.1534/genetics.106.064360; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; El Amrani A, 2002, MOL GENET GENOMICS, V267, P459, DOI 10.1007/s00438-002-0675-4; Fattash I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064135; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Guo XZ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05119; Han MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-520; Han YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq862; Heinz E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002979; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Jiang N, 2003, NATURE, V421, P163, DOI 10.1038/nature01214; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Kuang HH, 2009, GENOME RES, V19, P42, DOI [10.1101/gr.07816.108, 10.1101/gr.078196.108]; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liu HD, 2013, PARASITOL RES, V112, P1011, DOI 10.1007/s00436-012-3223-0; Lu C, 2012, MOL BIOL EVOL, V29, P1005, DOI 10.1093/molbev/msr282; Lyons M, 2008, MOL GENET GENOMICS, V280, P275, DOI 10.1007/s00438-008-0363-0; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Miskey C, 2007, MOL CELL BIOL, V27, P4589, DOI 10.1128/MCB.02027-06; Momose M, 2010, GENETICS, V186, P59, DOI 10.1534/genetics.110.117606; Naito K, 2006, P NATL ACAD SCI USA, V103, P17620, DOI 10.1073/pnas.0605421103; Naito K, 2009, NATURE, V461, P1130, DOI 10.1038/nature08479; Ngezahayo F, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-91; Oki N, 2008, GENES GENETIC SYSTEM, V83; Pan GQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-186; Peyretaillade E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2156; Sampath P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094499; Sampath P, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-56; Santiago N, 2002, MOL BIOL EVOL, V19, P2285, DOI 10.1093/oxfordjournals.molbev.a004052; Snowden KF, 2004, WORLD CL PARASITES, V9, P123; Sun W, 2014, MOL BIOL EVOL, V31, P3302, DOI 10.1093/molbev/msu261; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tu ZJ, 2001, P NATL ACAD SCI USA, V98, P1699, DOI 10.1073/pnas.041593198; Williams BAP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-200; Xu JS, 2006, INT J PARASITOL, V36, P1049, DOI [10.1016/j.ijpara.2006.04.010, 10.1016/j.ijpara.2006.09.010]; Xu JS, 2010, AFR J BIOTECHNOL, V9, P7900; Yaakov B, 2012, THEOR APPL GENET, V124, P1365, DOI 10.1007/s00122-012-1793-y; Yang GJ, 2005, PLANT CELL, V17, P1559, DOI 10.1105/tpc.104.030528; Yang GJ, 2009, SCIENCE, V325, P1391, DOI 10.1126/science.1175688	50	6	8	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123170	10.1371/journal.pone.0123170	http://dx.doi.org/10.1371/journal.pone.0123170			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898273	gold, Green Published, Green Submitted			2022-12-27	WOS:000353212600020
J	Henriksen, DP; Pottegard, A; Laursen, CB; Jensen, TG; Hallas, J; Pedersen, C; Lassen, AT				Henriksen, Daniel Pilsgaard; Pottegard, Anton; Laursen, Christian B.; Jensen, Thoger Gorm; Hallas, Jesper; Pedersen, Court; Lassen, Annmarie Touborg			Risk Factors for Hospitalization Due to Community-Acquired Sepsis - A Population-Based Case-Control Study	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT VISITS; UNITED-STATES; EPIDEMIOLOGY; INFECTION; HEALTH; COMORBIDITY; DISPARITIES; MORTALITY; OUTCOMES; THERAPY	Background The aim of the study was to estimate risk factors for hospitalization due to sepsis and to determine whether these risk factors vary by age and gender. Methods We performed a population-based case-control study of all adult patients admitted to a medical ED from September 2010 to August 2011. Controls were sampled within the hospital catchment-area. All potential cases were manually validated using a structured protocol. Vital signs and laboratory values measured at arrival were registered to define systemic inflammatory response syndrome and organ dysfunction. Multivariable logistic regression was used to elucidate which predefined risk factors were associated with an increased or decreased risk hospitalization due to sepsis. Results A total of 1713 patients were admitted with sepsis of any severity. The median age was 72 years (interquartile range: 57-81 years) and 793 (46.3%) were male. 621 (36.3%) patients were admitted with sepsis, 1071 (62.5%) with severe sepsis and 21 (1.2%) with septic shock. Episodes with sepsis of any severity were associated with older age (85+ years adjusted OR 6.02 [95% CI: 5.09-7.12]), immunosuppression (4.41 [3.83-5.09]), alcoholism-related conditions (2.90 [2.41-3.50]), and certain comorbidities: psychotic disorder (1.90 [1.58-2.27]), neurological (1.98 [1.73-2.26]), respiratory (3.58 [3.16-4.06]), cardiovascular (1.62 [1.41-1.85]), diabetes (1.82 [1.57-2.12]), cancer (1.44 [1.22-1.68]), gastrointestinal (1.71 [1.44-2.05]) and renal (1.46 [1.13-1.89]). The strength of the observed associations for comorbid factors was strongest among younger individuals. Conclusions Hospitalization due to sepsis of any severity was associated with several independent risk factors, including age and comorbid factors.	[Henriksen, Daniel Pilsgaard; Lassen, Annmarie Touborg] Odense Univ Hosp, Dept Emergency Med, DK-5000 Odense C, Denmark; [Pottegard, Anton; Hallas, Jesper] Univ Southern Denmark, Dept Publ Hlth, Clin Pharmacol, DK-5000 Odense C, Denmark; [Laursen, Christian B.] Odense Univ Hosp, Dept Resp Med, DK-5000 Odense C, Denmark; [Jensen, Thoger Gorm] Odense Univ Hosp, Dept Clin Microbiol, DK-5000 Odense C, Denmark; [Hallas, Jesper] Odense Univ Hosp, Dept Clin Chem & Pharmacol, DK-5000 Odense C, Denmark; [Pedersen, Court] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense C, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Henriksen, DP (corresponding author), Odense Univ Hosp, Dept Emergency Med, DK-5000 Odense C, Denmark.	dphenriksen@health.sdu.dk	Lassen, Annmarie/AAA-5816-2019	Pottegard, Anton/0000-0001-9314-5679; Jensen, Thoger Gorm/0000-0002-3889-0016; Lassen, Annmarie/0000-0003-4942-6152; Laursen, Christian Borbjerg/0000-0001-6382-9906; Henriksen, Daniel Pilsgaard/0000-0003-1303-6195	Faculty of Health Sciences, Odense University Hospital; Research Foundation of Odense University Hospital, University of Southern Denmark; private philanthropic fund TrygFonden	Faculty of Health Sciences, Odense University Hospital; Research Foundation of Odense University Hospital, University of Southern Denmark; private philanthropic fund TrygFonden	The study was supported by a stipend for PhD students from the Faculty of Health Sciences, Odense University Hospital, as well as a stipend from the Research Foundation of Odense University Hospital, University of Southern Denmark. ATL received an unrestricted grant from the private philanthropic fund TrygFonden given to the University of Southern Denmark.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P241; Esper AM, 2006, CRIT CARE MED, V34, P2576, DOI 10.1097/01.CCM.0000239114.50519.0E; Fielding JE, 1999, ANNU REV PUBL HEALTH, V20, pXIII, DOI 10.1146/annurev.publhealth.20.1.0; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Ginde AA, 2013, J CRIT CARE, V28, P606, DOI 10.1016/j.jcrc.2013.03.018; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Hallas J, 2001, PHARMACOEPIDEM DR S, V10, P619, DOI 10.1002/pds.638; Harrington R D, 2000, J Gend Specif Med, V3, P27; Henriksen DP, 2015, CRIT CARE MED, V43, P13, DOI 10.1097/CCM.0000000000000611; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mayr FB, 2010, JAMA-J AM MED ASSOC, V303, P2495, DOI 10.1001/jama.2010.851; Moss M, 2005, CLIN INFECT DIS, V41, pS490, DOI 10.1086/432003; O'Brien JM, 2007, CRIT CARE MED, V35, P345, DOI 10.1097/01.CCM.0000254340.91644.B2; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Poutsiaka DD, 2009, SCAND J INFECT DIS, V41, P469, DOI 10.1080/00365540902962756; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Seymour CW, 2010, CHEST, V137, P1289, DOI 10.1378/chest.09-2661; Soto GJ, 2013, CRIT CARE MED, V41, P2784, DOI 10.1097/CCM.0b013e3182a84a43; Storgaard M, 2013, SCAND J INFECT DIS, V45, P577, DOI 10.3109/00365548.2013.786836; Strehlow MC, 2006, ANN EMERG MED, V48, P326, DOI 10.1016/j.annemergmed.2006.05.003; Sundararajan V, 2005, CRIT CARE MED, V33, P71, DOI 10.1097/01.CCM.0000150027.98160.80; Thomsen RW, 2011, RESP MED, V105, P1063, DOI 10.1016/j.rmed.2011.01.012; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Trifiro G, 2010, ANN INTERN MED, V152, P418, DOI 10.7326/0003-4819-152-7-201004060-00006; Wang HE, 2007, CRIT CARE MED, V35, P1928, DOI 10.1097/01.CCM.0000277043.85378.C1; Wang HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048307; Wang HE, 2011, AM J NEPHROL, V34, P330, DOI 10.1159/000330673	36	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124838	10.1371/journal.pone.0124838	http://dx.doi.org/10.1371/journal.pone.0124838			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898024	Green Published, gold			2022-12-27	WOS:000353212600089
J	Sakamoto, A; Terui, Y; Yoshida, T; Yamamoto, T; Suzuki, H; Yamamoto, K; Ishihama, A; Igarashi, K; Kashiwagi, K				Sakamoto, Akihiko; Terui, Yusuke; Yoshida, Taketo; Yamamoto, Taku; Suzuki, Hideyuki; Yamamoto, Kaneyoshi; Ishihama, Akira; Igarashi, Kazuei; Kashiwagi, Keiko			Three Members of Polyamine Modulon under Oxidative Stress Conditions: Two Transcription Factors (SoxR and EmrR) and a Glutathione Synthetic Enzyme (GshA)	PLOS ONE			English	Article							SUPEROXIDE RESPONSE REGULON; ESCHERICHIA-COLI; CELL VIABILITY; MOLECULAR-MECHANISMS; PROTEIN-SYNTHESIS; RNA-POLYMERASE; GENES; STIMULATION; EXPRESSION; GROWTH	Members of polyamine modulon whose synthesis is enhanced at the level of translation were looked for under oxidative stress conditions caused by 0.6 mu M K2TeO3. When an Escherichia coli polyamine-requiring mutant MA261 was cultured in the presence of K2TeO3, the degree of polyamine stimulation of cell growth was greater than in cells cultured in the absence of K2TeO3. Under these conditions, synthesis of SoxR, a transcriptional factor for expression of the superoxide response regulon, EmrR, a negative transcriptional factor for expression of the genes for drug excretion proteins, EmrA and EmrB, and of GshA, gamma-glutamylcysteine synthetase necessary for glutathione (GSH) synthesis, were stimulated by polyamines at the level of translation. Polyamine stimulation of SoxR and EmrR synthesis was dependent on the existence of an unusually located Shine-Dalgarno (SD) sequence in soxR and emrR mRNAs. Polyamine stimulation of GshA synthesis was due to the existence of the inefficient initiation codon UUG instead of AUG. Polyamine stimulation of the synthesis of EmrR was mainly observed at the logarithmic phase of growth, while that of the synthesis of SoxR and GshA was at the stationary phase. These results strongly suggest that polyamines are involved in easing of oxidative stress through stimulation of synthesis of SoxR, EmrR and GshA together with RpoS, previously found as a member of polyamine modulon at the stationary phase.	[Sakamoto, Akihiko; Terui, Yusuke; Yoshida, Taketo; Yamamoto, Taku; Kashiwagi, Keiko] Chiba Inst Sci, Fac Pharm, Choshi, Chiba, Japan; [Suzuki, Hideyuki] Kyoto Inst Technol, Grad Sch Sci & Technol, Kyoto, Kyoto, Japan; [Yamamoto, Kaneyoshi; Ishihama, Akira] Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo 184, Japan; [Igarashi, Kazuei] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Chiba, Japan; [Igarashi, Kazuei] Chiba Univ, Amine Pharma Res Inst, Chiba, Chiba, Japan	Kyoto Institute of Technology; Hosei University; Chiba University; Chiba University	Kashiwagi, K (corresponding author), Chiba Inst Sci, Fac Pharm, Choshi, Chiba, Japan.	kkashiwagi@cis.ac.jp		Igarashi, Kazuei/0000-0003-3751-3187	Ministry of Education, Culture, Sports, Science and Technology, Japan; Futaba Electronics Memorial Foundation; Grants-in-Aid for Scientific Research [25430173] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Futaba Electronics Memorial Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. T. Yoshida was supported by the Futaba Electronics Memorial Foundation.	AMABILECUEVAS CF, 1991, NUCLEIC ACIDS RES, V19, P4479, DOI 10.1093/nar/19.16.4479; Arenas FA, 2010, BIOCHEM BIOPH RES CO, V398, P690, DOI 10.1016/j.bbrc.2010.07.002; ATKINS JF, 1975, J BIOL CHEM, V250, P5688; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chasteen TG, 2009, FEMS MICROBIOL REV, V33, P820, DOI 10.1111/j.1574-6976.2009.00177.x; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P2261, DOI 10.1073/pnas.2627990100; Chiang SM, 2012, ARCH BIOCHEM BIOPHYS, V525, P161, DOI 10.1016/j.abb.2012.02.007; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; Contreras ND, 2010, ARCH MICROBIOL, V192, P969, DOI 10.1007/s00203-010-0624-2; CUNNINGHAMRUNDLES S, 1975, J BACTERIOL, V124, P791, DOI 10.1128/JB.124.2.791-799.1975; ECHANDI G, 1975, BIOCHEM BIOPH RES CO, V67, P1185, DOI 10.1016/0006-291X(75)90798-6; EMORY SA, 1990, J BACTERIOL, V172, P4472, DOI 10.1128/jb.172.8.4472-4481.1990; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Igarashi K, 2006, J BIOCHEM, V139, P11, DOI 10.1093/jb/mvj020; IGARASHI K, 1986, J BACTERIOL, V166, P128, DOI 10.1128/jb.166.1.128-134.1986; IGARASHI K, 1979, BIOCHEM BIOPH RES CO, V91, P440, DOI 10.1016/0006-291X(79)91541-9; IGARASHI K, 1979, EUR J BIOCHEM, V93, P345, DOI 10.1111/j.1432-1033.1979.tb12829.x; IGARASHI K, 1974, EUR J BIOCHEM, V48, P495, DOI 10.1111/j.1432-1033.1974.tb03790.x; Igarashi K., 2015, POLYAMINES UNIVERSAL, P131, DOI [10.1007/978-4-431-55212-3_11, DOI 10.1007/978-4-431-55212-3_11]; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; Jishage M, 1998, P NATL ACAD SCI USA, V95, P4953, DOI 10.1073/pnas.95.9.4953; Kanai T, 2006, J BIOCHEM, V140, P703, DOI 10.1093/jb/mvj199; KASHIWAGI K, 1994, BIOCHEM BIOPH RES CO, V200, P591, DOI 10.1006/bbrc.1994.1489; LOMOVSKAYA O, 1995, J BACTERIOL, V177, P2328, DOI 10.1128/jb.177.9.2328-2334.1995; MIYAMOTO S, 1993, ARCH BIOCHEM BIOPHYS, V300, P63, DOI 10.1006/abbi.1993.1009; NIELSEN PJ, 1982, J BIOL CHEM, V257, P2316; NUNOSHIBA T, 1992, J BACTERIOL, V174, P6054, DOI 10.1128/JB.174.19.6054-6060.1992; Ogasawara H, 2010, MICROBIOL-SGM, V156, P2470, DOI 10.1099/mic.0.039131-0; Rider JE, 2007, AMINO ACIDS, V33, P231, DOI 10.1007/s00726-007-0513-4; Sakamoto A, 2012, INT J BIOCHEM CELL B, V44, P1877, DOI 10.1016/j.biocel.2012.07.010; Sambrook J., 2001, MOL CLONING LAB MANU; SCHELLHORN HE, 1988, J BACTERIOL, V170, P4286, DOI 10.1128/jb.170.9.4286-4292.1988; SHAPIRA SK, 1983, GENE, V25, P71, DOI 10.1016/0378-1119(83)90169-5; Terui Y, 2012, INT J BIOCHEM CELL B, V44, P412, DOI 10.1016/j.biocel.2011.11.017; Terui Y, 2010, J BIOL CHEM, V285, P28698, DOI 10.1074/jbc.M110.111195; WATANABE K, 1986, NUCLEIC ACIDS RES, V14, P4393, DOI 10.1093/nar/14.11.4393; WATANABE S, 1991, J BIOL CHEM, V266, P20803; Wilson K., 2001, CURR PROTOC MOL BIOL, V56, P2, DOI [10.1002/0471142727.mb0204s56, DOI 10.1002/0471142727.MB0204S56]; WU J, 1992, J BACTERIOL, V174, P3915, DOI 10.1128/jb.174.12.3915-3920.1992; WU J, 1991, J BACTERIOL, V173, P2864, DOI 10.1128/JB.173.9.2864-2871.1991; Yoshida M, 2002, J BIOL CHEM, V277, P37139, DOI 10.1074/jbc.M206668200	45	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124883	10.1371/journal.pone.0124883	http://dx.doi.org/10.1371/journal.pone.0124883			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898225	Green Submitted, gold, Green Published			2022-12-27	WOS:000353212600091
J	van Houwelingen, AH; den Elzen, WPJ; le Cessie, S; Blom, JW; Gussekloo, J				van Houwelingen, Anne H.; den Elzen, Wendy P. J.; le Cessie, Saskia; Blom, Jeanet W.; Gussekloo, Jacobijn			Consequences of Interaction of Functional, Somatic, Mental and Social Problems in Community-Dwelling Older People	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; DEPRESSIVE SYMPTOMS; ALLOSTATIC LOAD; PRIMARY-CARE; DISABILITY; LONELINESS; HEALTH; IMPACT; DECLINE; MULTIMORBIDITY	This study explores the combination of four common health problems in older people and whether problems on four domains result in an additional effect on indicators of poor health. For this purpose, a total of 2681 participants (32% male, mean age 82 years) of the Integrated Systematic Care for Older People (ISCOPE) study were screened on the presence of health problems on four domains (functional, somatic, mental, social) with the postal ISCOPE questionnaire. Extensive interview data on health indicators were obtained at baseline and at 12-months follow-up, including disability (Groningen Activities Restriction Scale, GARS), cognitive function (Mini-Mental State Examination, MMSE), depressive symptoms (Geriatric Depression Scale-15, GDS), loneliness (loneliness scale of De Jong Gierveld), and health-related quality of life (EQ-5D). General practitioner (GP) contact time (min/year) was estimated via GP electronic medical records. Of the study population, 9% had no health problems according to the screening, 8% had problems on one domain, 27% on two, 38% on three and 18% on four domains. At baseline, the number of health domains with problems was associated with poorer scores on the GARS, the MMSE, the GDS-15, the loneliness scale, the EQ-5D and with more GP contact time (p < 0.001). Problems on all four domains had an additional negative effect on these health indicators (all p(interaction) < 0.001). At follow-up, an increased number of domains with problems was associated with an increased decline in health indicators (all p < 0.001) and with an additional negative effect on GP contact time of the presence of problems on all four domains (p(interaction) < 0.001). We conclude that combinations of functional, somatic, mental and social problems are associated with poor health indicators in community-dwelling older people. Since problems on four domains have an additional effect on health, individuals with combined functional, somatic, mental and social problems could benefit from integrated care.	[van Houwelingen, Anne H.; den Elzen, Wendy P. J.; Blom, Jeanet W.; Gussekloo, Jacobijn] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands; [le Cessie, Saskia] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [le Cessie, Saskia] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	den Elzen, WPJ (corresponding author), Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands.	w.p.j.den_elzen@lumc.nl	Gussekloo, Jacobijn/ABE-3879-2021; le+Cessie, Saskia/HGC-8966-2022	Gussekloo, Jacobijn/0000-0001-7186-8278; le Cessie, Saskia/0000-0003-2154-4923; den Elzen, Wendy/0000-0002-6774-4077	ZonMw: the Netherlands Organization for Health Research and Development [311060201]	ZonMw: the Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	This study was funded by ZonMw: the Netherlands Organization for Health Research and Development: Project no. 311060201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts S., 2012, MULTIMORBIDITY GEN P, P69; Barry LC, 2009, J GERONTOL A-BIOL, V64, P1325, DOI 10.1093/gerona/glp135; Beekman ATF, 2002, ACTA PSYCHIAT SCAND, V105, P20, DOI 10.1034/j.1600-0447.2002.10078.x; Bekhet AK, 2012, ARCH PSYCHIAT NURS, V26, P214, DOI 10.1016/j.apnu.2011.09.007; Bootsma-van der Wiel A, 2002, J AM GERIATR SOC, V50, P1405; Bootsma-van der Wiel A, 2001, J AM GERIATR SOC, V49, P909; DEJONGGIERVELD J, 1985, APPL PSYCH MEAS, V9, P289, DOI 10.1177/014662168500900307; Drageset J, 2012, J CLIN NURS, V21, P965, DOI 10.1111/j.1365-2702.2011.03932.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried LP, 1999, J CLIN EPIDEMIOL, V52, P27, DOI 10.1016/S0895-4356(98)00124-3; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Glynn LG, 2011, FAM PRACT, V28, P516, DOI 10.1093/fampra/cmr013; Grau L, 1991, J Aging Health, V3, P352, DOI 10.1177/089826439100300303; Gussekloo J, 1997, BRIT MED J, V315, P1053, DOI 10.1136/bmj.315.7115.1053; Hardy SE, 2006, J GERONTOL A-BIOL, V61, P272, DOI 10.1093/gerona/61.3.272; Huyse FJ, 2006, MED CLIN N AM, V90, P703, DOI 10.1016/j.mcna.2006.05.003; Karlamangla AS, 2002, J CLIN EPIDEMIOL, V55, P696, DOI 10.1016/S0895-4356(02)00399-2; Kempen GIJM, 1996, SOC SCI MED, V43, P1601, DOI 10.1016/S0277-9536(96)00057-3; Lutomski Jennifer E, 2014, Ned Tijdschr Geneeskd, V158, pA7297; Lyness JM, 2007, AM J GERIAT PSYCHIAT, V15, P214, DOI 10.1097/01.JGP.0000235763.50230.83; Marengoni A, 2009, J INTERN MED, V265, P288, DOI 10.1111/j.1365-2796.2008.02017.x; Penninx BWJH, 1999, ARCH GEN PSYCHIAT, V56, P889, DOI 10.1001/archpsyc.56.10.889; Perissinotto CM, 2012, ARCH INTERN MED, V172, P1078, DOI 10.1001/archinternmed.2012.1993; Poot AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094326; Seeman TE, 2001, P NATL ACAD SCI USA, V98, P4770, DOI 10.1073/pnas.081072698; Tinetti ME, 2011, J AM GERIATR SOC, V59, P1686, DOI 10.1111/j.1532-5415.2011.03573.x; Unutzer J, 2000, INT PSYCHOGERIATR, V12, P15, DOI 10.1017/S1041610200006177; Van der Weele GM, 2009, INT J GERIATR PSYCH, V24, P595, DOI 10.1002/gps.2162; Vinkers DJ, 2004, INT J GERIATR PSYCH, V19, P852, DOI 10.1002/gps.1169; Weeks SK, 2003, J NURS SCHOLARSHIP, V35, P133, DOI 10.1111/j.1547-5069.2003.00133.x; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	31	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0121013	10.1371/journal.pone.0121013	http://dx.doi.org/10.1371/journal.pone.0121013			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XJ	25898203	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600007
J	Zhu, SH; Hu, XS; Yu, ZB; Peng, YZ; Zhu, JG; Liu, XH; Li, MM; Han, SP; Zhu, C				Zhu, Shasha; Hu, Xiaoshan; Yu, Zhangbin; Peng, Yuzhu; Zhu, Jingai; Liu, Xuehua; Li, Mengmeng; Han, Shuping; Zhu, Chun			Effect of miR-20b on Apoptosis, Differentiation, the BMP Signaling Pathway and Mitochondrial Function in the P19 Cell Model of Cardiac Differentiation In Vitro	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; CONGENITAL HEART-DISEASE; CARDIOMYOCYTE DIFFERENTIATION; EMBRYONIC-DEVELOPMENT; MICRORNA SPONGES; MAMMALIAN-CELLS; GENE-EXPRESSION; DEFECTS; MOUSE; OVEREXPRESSION	Objective To explore the effect of miR-20b on apoptosis, differentiation, the BMP signaling pathway and mitochondrial function in the P19 cell model of cardiac differentiation in vitro. Methods A miR-20b over-expression vector, a miR-20b silencing vector and their corresponding empty vectors were constructed and transfected into P19 cells, separately. Stably miR-20b overexpressing and silenced P19 cell lines were successfully selected by blasticidin and puromycin, separately. The cells were induced to undergo apoptosis in FBS-free-alpha-MEM. The induced cells were examined by flow cytometry and measurement of their caspase-3 activities. Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) was used to evaluate the relative expression of marker genes of cardiomyocytes during differentiation, such as cTnT, GATA4 and ANP. QRT-PCR was also used to detect the mitochondrial DNA (mtDNA) copy number. We investigated the cellular ATP production using a luciferase-based luminescence assay. The reactive oxygen species (ROS) was determined by DCFDA (2', 7'-Dichlorofluorescein diacetate) and the mitochondrial membrane potential (MMP) was elucidated by a JC-1 fluorescent probe, both using fluorescence microscopy and flow cytometer. The expression of BMP signaling pathway-related proteins were analyzed by Western blotting. Results Stably miR-20b overexpressing and silenced P19 cell lines were successfully obtained. MiR-20b overexpression increased apoptosis and promoted differentiation in P19 cells by promoting the activation of the BMP signaling pathway. In addition, miR-20b overexpression induced mitochondrial impairment in P19 cells during differentiation, which was characterized by lower MMP, raised ATP synthesis and increased ROS levels. The effects of miR-20b silencing were the exact opposite to those of overexpression. Conclusion Collectively, these results suggested that miR-20b was very important in apoptosis, differentiation and mitochondrial function of P19 cells. MiR-20b may represent a new therapeutic target for congenital heart diseases and provide new insights into the mechanisms of cardiac diseases.	[Zhu, Shasha] Soochow Univ, Dept Cardiol, Affiliated Hosp 1, Suzhou 215006, Peoples R China; [Hu, Xiaoshan; Yu, Zhangbin; Peng, Yuzhu; Zhu, Jingai; Liu, Xuehua; Li, Mengmeng; Han, Shuping; Zhu, Chun] Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, State Key Lab Reprod Med, Dept Pediat, Nanjing 210004, Jiangsu, Peoples R China	Soochow University - China; Nanjing Medical University	Han, SP (corresponding author), Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, State Key Lab Reprod Med, Dept Pediat, Nanjing 210004, Jiangsu, Peoples R China.	shupinghan@126.com; zhifangxibao@163.com			National Natural Science Foundation of China [81200126]; Key Medical Personnel Foundation of Jiangsu Province [RC2011021]; Nanjing Medical Science and Technique Development Foundation [QRX11107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Medical Personnel Foundation of Jiangsu Province; Nanjing Medical Science and Technique Development Foundation	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 81200126), the Key Medical Personnel Foundation of Jiangsu Province (Grant No. RC2011021), the Nanjing Medical Science and Technique Development Foundation (QRX11107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HW, 2010, MOL HUM REPROD, V16, P463, DOI 10.1093/molehr/gaq017; Allan L, 2000, HEART, V83, P367, DOI 10.1136/heart.83.3.367; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bajolle F, 2009, ARCH CARDIOVASC DIS, V102, P59, DOI 10.1016/j.acvd.2008.06.020; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Callis TE, 2005, CIRC RES, V97, P992, DOI 10.1161/01.RES.0000190670.92879.7d; Cascio S, 2010, J CELL PHYSIOL, V224, P242, DOI 10.1002/jcp.22126; Cataluccia D, 2008, ANN NY ACAD SCI, V1123, P20, DOI 10.1196/annals.1420.004; Chen JQ, 2007, GENESIS, V45, P482, DOI 10.1002/dvg.20320; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; de Pater E, 2012, CIRC RES, V110, P578, DOI 10.1161/CIRCRESAHA.111.261172; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Eleftheriades M, 2012, J MATERN-FETAL NEO M, V25, P2546, DOI 10.3109/14767058.2012.703716; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Gazzerro E, 2006, REV ENDOCR METAB DIS, V7, P51, DOI 10.1007/s11154-006-9000-6; Harada M, 2014, CIRC RES, V114, P689, DOI 10.1161/CIRCRESAHA.114.301798; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6; Kang D, 2002, CURR GENET, V41, P311, DOI 10.1007/s00294-002-0312-0; Kehat I, 2002, CIRC RES, V91, P659, DOI 10.1161/01.RES.0000039084.30342.9B; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Ku PM, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-57; Lesnefsky EJ, 2008, BBA-BIOENERGETICS, V1777, P1020, DOI 10.1016/j.bbabio.2008.05.444; Li JY, 2012, ASIAN PAC J CANCER P, V13, P1901, DOI 10.7314/APJCP.2012.13.5.1901; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Mack GS, 2007, NAT BIOTECHNOL, V25, P631, DOI 10.1038/nbt0607-631; MARRE M, 1994, DIABETES, V43, P384, DOI 10.2337/diabetes.43.3.384; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Matsusaka T, 1997, ANNU REV PHYSIOL, V59, P395, DOI 10.1146/annurev.physiol.59.1.395; Maxwell DP, 1999, P NATL ACAD SCI USA, V96, P8271, DOI 10.1073/pnas.96.14.8271; Meberg A, 2005, ACTA PAEDIATR, V94, P1060, DOI 10.1080/08035250410025618; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Monzen K, 1999, MOL CELL BIOL, V19, P7096; Morton SU, 2008, P NATL ACAD SCI USA, V105, P17830, DOI 10.1073/pnas.0804673105; Nabialek E, 2013, MINERVA CARDIOANGIOL, V61, P627; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Qin DN, 2013, CELL BIOCHEM BIOPHYS, V66, P709, DOI 10.1007/s12013-013-9516-9; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Shen YH, 2012, J BIOENERG BIOMEMBR, V44, P317, DOI 10.1007/s10863-012-9439-y; Shi CM, 2013, CELL BIOCHEM BIOPHYS, V66, P489, DOI 10.1007/s12013-012-9496-1; Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137; Trojnarska O, 2009, CARDIOL J, V16, P341; Ugarte-Uribe B, 2014, BIOL CHEM, V395, P297, DOI 10.1515/hsz-2013-0234; van der Heyden MAG, 2003, CARDIOVASC RES, V58, P410, DOI 10.1016/S0008-6363(03)00247-5; van der Heyden MAG, 2003, CARDIOVASC RES, V58, P292, DOI 10.1016/S0008-6363(02)00771-X; Wang J, 2011, BIRTH DEFECTS RES A, V91, P441, DOI 10.1002/bdra.20785; Wen JY, 2007, J CELL BIOCHEM, V102, P149, DOI 10.1002/jcb.21285; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Zaffran S, 2002, CIRC RES, V91, P457, DOI 10.1161/01.RES.0000034152.74523.A8; Zhang HB, 1996, DEVELOPMENT, V122, P2977; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhu JJ, 2014, HUM IMMUNOL, V75, P348, DOI 10.1016/j.humimm.2014.01.006; Zhu SS, 2013, CLIN CHIM ACTA, V424, P66, DOI 10.1016/j.cca.2013.05.010	60	16	17	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123519	10.1371/journal.pone.0123519	http://dx.doi.org/10.1371/journal.pone.0123519			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898012	Green Submitted, Green Published, gold			2022-12-27	WOS:000353212600029
J	Arighi, C; Shamovsky, V; Masci, AM; Ruttenberg, A; Smith, B; Natale, DA; Wu, C; D'Eustachio, P				Arighi, Cecilia; Shamovsky, Veronica; Masci, Anna Maria; Ruttenberg, Alan; Smith, Barry; Natale, Darren A.; Wu, Cathy; D'Eustachio, Peter			Toll-Like Receptor Signaling in Vertebrates: Testing the Integration of Protein, Complex, and Pathway Data in the Protein Ontology Framework	PLOS ONE			English	Article							RECOGNITION RECEPTORS; PATHOGEN RECOGNITION; ACTIVATION; INNATE; CD14; DROSOPHILA; GENE; TRANSDUCTION; ENDOCYTOSIS; EVOLUTION	The Protein Ontology (PRO) provides terms for and supports annotation of species-specific protein complexes in an ontology framework that relates them both to their components and to species-independent families of complexes. Comprehensive curation of experimentally known forms and annotations thereof is expected to expose discrepancies, differences, and gaps in our knowledge. We have annotated the early events of innate immune signaling mediated by Toll-Like Receptor 3 and 4 complexes in human, mouse, and chicken. The resulting ontology and annotation data set has allowed us to identify species-specific gaps in experimental data and possible functional differences between species, and to employ inferred structural and functional relationships to suggest plausible resolutions of these discrepancies and gaps.	[Arighi, Cecilia; Wu, Cathy] Univ Delaware, Ctr Bioinformat & Computat Biol, Newark, DC USA; [Shamovsky, Veronica; D'Eustachio, Peter] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10012 USA; [Masci, Anna Maria] Duke Univ, Dept Immunol, Durham, NC USA; [Ruttenberg, Alan] SUNY Buffalo, Sch Dent Med, Buffalo, NY 14260 USA; [Smith, Barry] SUNY Buffalo, Dept Philosophy, Buffalo, NY 14260 USA; [Smith, Barry] SUNY Buffalo, Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14260 USA; [Natale, Darren A.; Wu, Cathy] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Prot Informat Resource, Washington, DC 20007 USA	University of Delaware; New York University; Duke University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Georgetown University	D'Eustachio, P (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10012 USA.	deustp01@med.nyu.edu	Natale, Darren A/AAE-9303-2019; Smith, Barry/A-9525-2011; Arighi, Cecilia N/J-2381-2015	Natale, Darren A/0000-0001-5809-9523; Smith, Barry/0000-0003-1384-116X; Arighi, Cecilia N/0000-0002-0803-4817; Masci, Anna Maria/0000-0003-1940-6740; Wu, Cathy/0000-0001-6379-8601; D'Eustachio, Peter/0000-0002-5494-626X; Ruttenberg, Alan/0000-0002-1604-3078	National Institutes of Health [5R01GM080646-09]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project is supported by the National Institutes of Health grant 5R01GM080646-09 (www.nih.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsadik A, 2011, HUM IMMUNOL, V72, P1188, DOI 10.1016/j.humimm.2011.08.015; Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Arighi C., PRO ONTOLOGY MANUAL; Arighi CN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S5-S3; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Blake JA, 2014, NUCLEIC ACIDS RES, V42, pD810, DOI 10.1093/nar/gkt1225; Bult CJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-371; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Esnault E, 2011, VIRUS RES, V159, P32, DOI 10.1016/j.virusres.2011.04.022; Gillespie M, 2011, MAMM GENOME, V22, P130, DOI 10.1007/s00335-010-9296-0; Haddadi S, 2013, VET IMMUNOL IMMUNOP, V155, P270, DOI 10.1016/j.vetimm.2013.08.005; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; Hastings J, 2013, NUCLEIC ACIDS RES, V41, pD456, DOI 10.1093/nar/gks1146; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Janssens S, 2002, CURR BIOL, V12, P467, DOI 10.1016/S0960-9822(02)00712-1; Jiang QQ, 2000, J IMMUNOL, V165, P3541, DOI 10.4049/jimmunol.165.7.3541; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jupe S, 2008, DATABASE; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Keestra AM, 2008, J IMMUNOL, V181, P4354, DOI 10.4049/jimmunol.181.6.4354; Kim D, 2014, MOL IMMUNOL, V57, P210, DOI 10.1016/j.molimm.2013.09.009; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Masci AM, 2011, ICBO INT C BIOM ONT; Matsuo A, 2008, J IMMUNOL, V181, P3474, DOI 10.4049/jimmunol.181.5.3474; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Natale DA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S9-S1; Natale DA, 2014, NUCLEIC ACIDS RES, V42, pD415, DOI 10.1093/nar/gkt1173; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Qian C, 2013, ANN NY ACAD SCI, V1283, P67, DOI 10.1111/j.1749-6632.2012.06786.x; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Roach JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054156; Roy S, 2014, J BIOL CHEM, V289, P1174, DOI 10.1074/jbc.M113.523167; Sasai M, 2013, INT REV IMMUNOL, V32, P116, DOI 10.3109/08830185.2013.774391; Smith B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r46; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Teghanemt A, 2007, J BIOL CHEM, V282, P36250, DOI 10.1074/jbc.M705995200; Tsukamoto H, 2010, INT IMMUNOL, V22, P271, DOI 10.1093/intimm/dxq005; Vaure C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00316; Wu ZG, 2009, DEV COMP IMMUNOL, V33, P97, DOI 10.1016/j.dci.2008.07.008; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zhang Q, 2010, IMMUNOGENETICS, V62, P263, DOI 10.1007/s00251-010-0428-1	49	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0122978	10.1371/journal.pone.0122978	http://dx.doi.org/10.1371/journal.pone.0122978			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894391	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700020
J	Naqvi, AAT; Shahbaaz, M; Ahmad, F; Hassan, MI				Naqvi, Ahmad Abu Turab; Shahbaaz, Mohd; Ahmad, Faizan; Hassan, Md. Imtaiyaz			Identification of Functional Candidates amongst Hypothetical Proteins of Treponema pallidum ssp. pallidum	PLOS ONE			English	Article							C-DI-GMP; TARGETING VIRULENCE; CRYSTAL-STRUCTURE; GENE-EXPRESSION; GENOME SEQUENCE; PILZ DOMAIN; SYPHILIS; MEMBRANE; PATHWAY; DESIGN	Syphilis is a globally occurring venereal disease, and its infection is propagated through sexual contact. The causative agent of syphilis, Treponema pallidum ssp. pallidum, a Gram-negative sphirochaete, is an obligate human parasite. Genome of T. pallidum ssp. pallidum SS14 strain (RefSeq NC_010741.1) encodes 1,027 proteins, of which 444 proteins are known as hypothetical proteins (HPs), i.e., proteins of unknown functions. Here, we performed functional annotation of HPs of T. pallidum ssp. pallidum using various database, domain architecture predictors, protein function annotators and clustering tools. We have analyzed the sequences of 444 HPs of T. pallidum ssp. pallidum and subsequently predicted the function of 207 HPs with a high level of confidence. However, functions of 237 HPs are predicted with less accuracy. We found various enzymes, transporters, binding proteins in the annotated group of HPs that may be possible molecular targets, facilitating for the survival of pathogen. Our comprehensive analysis helps to understand the mechanism of pathogenesis to provide many novel potential therapeutic interventions.	[Naqvi, Ahmad Abu Turab; Shahbaaz, Mohd] Jamia Millia Islamia, Dept Comp Sci, New Delhi 110025, India; [Ahmad, Faizan; Hassan, Md. Imtaiyaz] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India	Jamia Millia Islamia; Jamia Millia Islamia	Hassan, MI (corresponding author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.	mihassan@jmi.ac.in	Shahbaaz, Mohd/ABG-4269-2020; Hassan, Md Imtaiyaz/G-7072-2017; Abu Turab Naqvi, Ahmad/AAX-8854-2020; Ahmad, Faizan/AGH-4493-2022; Hassan, Imtaiyaz/ABF-6485-2020; Hassan, Mohammad/GZA-7507-2022	Shahbaaz, Mohd/0000-0001-8901-7113; Hassan, Md Imtaiyaz/0000-0002-3663-4940; Abu Turab Naqvi, Ahmad/0000-0002-4991-1599; Ahmad, Faizan/0000-0001-7021-7502; Hassan, Imtaiyaz/0000-0002-3663-4940; Hassan, Mohammad/0000-0002-1712-0004	Indian Council of Medical Research [BIC/12(04)/2012]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	The authors sincerely thank the Indian Council of Medical Research for financial assistance (Project No. BIC/12(04)/2012).	ABELL E, 1975, BRIT J DERMATOL, V93, P53, DOI 10.1111/j.1365-2133.1975.tb06476.x; Ahmad F, 2013, THROMB HAEMOSTASIS, V109, P39, DOI 10.1160/TH12-07-0475; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; Anantharaman V, 2012, MOL BIOSYST, V8, P3142, DOI 10.1039/c2mb25239b; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Cerveny L, 2013, INFECT IMMUN, V81, P629, DOI 10.1128/IAI.01035-12; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; COLOMBATTI A, 1993, MATRIX, V13, P297, DOI 10.1016/S0934-8832(11)80025-9; Desler C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-289; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Franke K, 2006, MICROBIOL-SGM, V152, P3111, DOI 10.1099/mic.0.29115-0; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Galperin Michael Y., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P303; Garg A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-62; Hase CC, 1999, P NATL ACAD SCI USA, V96, P3183, DOI 10.1073/pnas.96.6.3183; Hassan MI, 2007, J PEPT SCI, V13, P849, DOI 10.1002/psc.911; Hassan MI, 2007, CHEM BIOL DRUG DES, V70, P261, DOI 10.1111/j.1747-0285.2007.00553.x; Hassan MI, 2012, BLOOD COAGUL FIBRIN, V23, P11, DOI 10.1097/MBC.0b013e32834cb35d; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; Hertel M, 2014, J ORAL MAXIL SURG, V72, P338, DOI 10.1016/j.joms.2013.07.015; Jaktaji RP, 2012, IRAN J PHARM RES, V11, P595; JORIS B, 1992, FEMS MICROBIOL LETT, V91, P257; Kishida H, 2003, ACTA CRYSTALLOGR D, V59, P23, DOI 10.1107/S0907444902017705; Kumar K, 2014, 3BIOTECH IN PRESS, V3; Kumar K, 2014, GENE, V543, P93, DOI 10.1016/j.gene.2014.03.060; Liepinsh E, 1997, NAT STRUCT BIOL, V4, P975, DOI 10.1038/nsb1297-975; Lin HT, 2009, J BIOL CHEM, V284, P1145, DOI 10.1074/jbc.M806964200; Livorsi DJ, 2011, CONTRIB MICROBIOL, V17, P31, DOI 10.1159/000324008; MACINTYRE S, 1990, BIOCHIMIE, V72, P157, DOI 10.1016/0300-9084(90)90141-3; Marra Andrea, 2006, Drugs R D, V7, P1, DOI 10.2165/00126839-200607010-00001; Matejkova P, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-76; Mazandu GK, 2012, INT J MOL SCI, V13, P7283, DOI 10.3390/ijms13067283; McGill MA, 2010, INFECT IMMUN, V78, P2631, DOI 10.1128/IAI.00173-10; McKevitt M, 2005, INFECT IMMUN, V73, P4445, DOI 10.1128/IAI.73.7.4445-4450.2005; Naismith JH, 2012, ANNU REV BIOPHYS, V41, P157, DOI 10.1146/annurev-biophys-101211-113227; Ninio S, 2001, J BIOL CHEM, V276, P48250, DOI 10.1074/jbc.M108231200; Obmolova G, 2001, J STRUCT BIOL, V136, P119, DOI 10.1006/jsbi.2001.4428; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Paster BJ, 2000, J MOL MICROB BIOTECH, V2, P341; Peeling RW, 2006, J PATHOL, V208, P224, DOI 10.1002/path.1903; Petrosova H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074319; Petrosova H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001832; Rappas M, 2004, CURR PROTEIN PEPT SC, V5, P89, DOI 10.2174/1389203043486874; RUGGERI ZM, 1993, FASEB J, V7, P308, DOI 10.1096/fasebj.7.2.8440408; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Saha Sudipto, 2006, Genomics Proteomics & Bioinformatics, V4, P42, DOI 10.1016/S1672-0229(06)60015-6; Shahbaaz M, 2015, 3 BIOTECH, V5, P317, DOI 10.1007/s13205-014-0231-z; Shahbaaz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084263; Singer HM, 2014, J BACTERIOL, V196, P1448, DOI 10.1128/JB.01438-13; Singh AE, 1999, CLIN MICROBIOL REV, V12, P187, DOI 10.1128/CMR.12.2.187; Sinha A, 2014, LETT DRUG D IN PRESS; Sinha A, 2015, LETT DRUG DES DISCOV, V12, P46; Smajs D, 2005, J BACTERIOL, V187, P1866, DOI 10.1128/JB.187.5.1866-1874.2005; STAMM LV, 1983, INFECT IMMUN, V41, P709, DOI 10.1128/IAI.41.2.709-721.1983; Stewart V, 2014, MOL MICROBIOL, V91, P853, DOI 10.1111/mmi.12516; Thakur P, 2013, J NAT SCI BIOL MED; Thakur PK, 2014, LETT DRUG DES DISCOV, V11, P363, DOI 10.2174/15701808113106660088; Thakur Prasoon Kumar, 2011, International Journal of Computational Biology and Drug Design, V4, P373, DOI 10.1504/IJCBDD.2011.044404; Titz B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002292; Vetrivel Umashankar, 2011, Hugo J, V5, P25, DOI 10.1007/s11568-011-9152-7; YANG CC, 1984, J BACTERIOL, V158, P757, DOI 10.1128/JB.158.2.757-759.1984; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3; Zheng LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042517	64	29	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124177	10.1371/journal.pone.0124177	http://dx.doi.org/10.1371/journal.pone.0124177			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894582	gold, Green Published, Green Submitted			2022-12-27	WOS:000353211700077
J	Wang, CW; Lin, YC; Tseng, HM; Xiao, FR; Chen, CM; Cheng, WL; Lu, SH; Lan, KH; Chen, WY; Liang, HK; Kuo, SH				Wang, Chun-Wei; Lin, Yin-Chun; Tseng, Ham-Min; Xiao, Furen; Chen, Chang-Mu; Cheng, Wei-Li; Lu, Szu-Huai; Lan, Keng-Hsueh; Chen, Wan-Yu; Liang, Hsiang-Kuang; Kuo, Sung-Hsin			Prolonged Treatment Time Deteriorates Positioning Accuracy for Stereotactic Radiosurgery	PLOS ONE			English	Article							INTRAFRACTION PATIENT MOTION; REPOSITIONING ACCURACY; RADIATION-THERAPY; MASK SYSTEM; HEAD; RADIOTHERAPY; MOVEMENT; FIXATION; IMRT	Introduction The accuracy of radiation delivery is increasingly important as radiotherapy technology continues to develop. The goal of this study was to evaluate intrafractional motion during intracranial radiosurgery and the relationship between motion change and treatment time. Methods and Materials A total of 50 treatment records with 5988 images, all acquired during treatments with the CyberKnife Radiosurgery System, were retrospectively analyzed in this study. We measured translation and rotation motion including superior-inferior (SI), right-left (RL), anteriorposterior (AP), roll, tilt and yaw. All of the data was obtained during the first 45 minutes of treatment. The records were divided into 3 groups based on 15-min time intervals following the beginning of treatment: group A (0-15 min), group B (16-30 min) and group C (31-45 min). The mean deviations, systematic errors, random errors and margin for planning target volume (PTV) were calculated for each group. Results The mean deviations were less than 0.1 mm in all three translation directions in the first 15 minutes. Greater motion occurred with longer treatment times, especially in the SI direction. For the 3D vector, a time-dependent change was observed, from 0.34 mm to 0.77 mm (p=0.01). There was no significant correlation between the treatment time and deviations in the AP, LR and rotation axes. Longer treatment times were associated with increases in systematic error, but not in random error. The estimated PTV margin for groups A, B and C were 0.86 / 1.14 / 1.31 mm, 0.75 / 1.12 / 1.20 mm, and 0.43 / 0.54 / 0.81 mm in the SI, RL, and AP directions, respectively. Conclusions During intracranial radiosurgery, a consistent increase in the positioning deviation over time was observed, especially in the SI direction. If treatment time is greater than 15 minutes, we recommend increasing the PTV margins to ensure treatment precision.	[Wang, Chun-Wei; Lu, Szu-Huai; Lan, Keng-Hsueh; Chen, Wan-Yu; Liang, Hsiang-Kuang; Kuo, Sung-Hsin] Natl Taiwan Univ Hosp, Dept Oncol, Div Radiat Oncol, Taipei, Taiwan; [Wang, Chun-Wei] Natl Taiwan Univ, Coll Med, Dept Radiol, Taipei 10764, Taiwan; [Lin, Yin-Chun; Cheng, Wei-Li] Natl Taiwan Univ Hosp, CyberKnife Ctr, Taipei, Taiwan; [Tseng, Ham-Min; Xiao, Furen; Chen, Chang-Mu] Natl Taiwan Univ Hosp, Div Neurosurg, Dept Surg, Taipei, Taiwan; [Kuo, Sung-Hsin] Natl Taiwan Univ, Grad Inst Oncol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Kuo, SH (corresponding author), Natl Taiwan Univ Hosp, Dept Oncol, Div Radiat Oncol, Taipei, Taiwan.	shkuo101@ntu.edu.tw		Liang, Hsiang-Kuang Tony/0000-0001-5523-6799; LAN, KENG-HSUEH/0000-0002-1575-5620; CHEN, CHANG-MU/0000-0002-7544-3856; CHEN, WAN-YU/0000-0002-2483-8292; Xiao, Furen/0000-0001-9683-3979; Kuo, Sung-Hsin/0000-0003-0054-887X	National Taiwan University Hospital [NTUH.101-001901]; Ministry of Science and Technology (MST, Taiwan) [MST 101-2314-B-002-152, 102-2314-B-002 -151 -MY3]	National Taiwan University Hospital(National Taiwan University); Ministry of Science and Technology (MST, Taiwan)	This work was supported by National Taiwan University Hospital (grants NTUH.101-001901) and Ministry of Science and Technology (MST, Taiwan, under contract of MST 101-2314-B-002-152 and 102-2314-B-002 -151 -MY3). Website: National Taiwan University Hospital: https://www.ntuh.gov.tw/en/default.aspx, Ministry of Science and Technology: http://www.most.gov.tw/mp.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumert BG, 2005, RADIOTHER ONCOL, V74, P61, DOI 10.1016/j.radonc.2004.08.002; BIJHOLD J, 1992, RADIOTHER ONCOL, V24, P261, DOI 10.1016/0167-8140(92)90233-K; Bley CR, 2003, VET RADIOL ULTRASOUN, V44, P470, DOI 10.1111/j.1740-8261.2003.tb00487.x; Engelsman M, 2005, MED PHYS, V32, P3468, DOI 10.1118/1.2089507; Feygelman V, 2008, J APPL CLIN MED PHYS, V9, P68, DOI 10.1120/jacmp.v9i4.2828; Fu DS, 2008, MED PHYS, V35, P2180, DOI 10.1118/1.2903431; Hoogeman MS, 2008, INT J RADIAT ONCOL, V70, P609, DOI 10.1016/j.ijrobp.2007.08.066; Kim S, 2004, INT J RADIAT ONCOL, V59, P1531, DOI 10.1016/j.ijrobp.2004.01.025; Kim S, 2004, MED PHYS, V31, P500, DOI 10.1118/1.1644641; Kippenes H, 2003, VET RADIOL ULTRASOUN, V44, P714, DOI 10.1111/j.1740-8261.2003.tb00536.x; Linthout N, 2006, MED PHYS, V33, P504, DOI 10.1118/1.2165417; Lopatta E, 2003, STRAHLENTHER ONKOL, V179, P571, DOI 10.1007/s00066-003-0941-3; Murphy MJ, 2003, INT J RADIAT ONCOL, V55, P1400, DOI 10.1016/S0360-3016(02)04597-2; Suzuki M, 2006, RADIOTHER ONCOL, V78, P283, DOI 10.1016/j.radonc.2006.03.006; van Herk M, 2000, INT J RADIAT ONCOL, V47, P1121, DOI 10.1016/S0360-3016(00)00518-6; van Santvoort J, 2008, INT J RADIAT ONCOL, V72, P261, DOI 10.1016/j.ijrobp.2008.05.006; Zhang QH, 2013, MED PHYS, V40, DOI 10.1118/1.4829517	17	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123359	10.1371/journal.pone.0123359	http://dx.doi.org/10.1371/journal.pone.0123359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894841	gold, Green Submitted, Green Published			2022-12-27	WOS:000353211700036
J	Robalino, J; Sandoval, C; Barton, DN; Chacon, A; Pfaff, A				Robalino, Juan; Sandoval, Catalina; Barton, David N.; Chacon, Adriana; Pfaff, Alexander			Evaluating Interactions of Forest Conservation Policies on Avoided Deforestation	PLOS ONE			English	Article							PROTECTED AREAS; ENVIRONMENTAL SERVICES; PROPENSITY SCORE; PAYMENTS; LOCATION; BIODIVERSITY; GOVERNANCE; EFFICIENCY; IMPACT	We estimate the effects on deforestation that have resulted from policy interactions between parks and payments and between park buffers and payments in Costa Rica between 2000 and 2005. We show that the characteristics of the areas where protected and unprotected lands are located differ significantly. Additionally, we find that land characteristics of each of the policies and of the places where they interact also differ significantly. To adequately estimate the effects of the policies and their interactions, we use matching methods. Matching is implemented not only to define adequate control groups, as in previous research, but also to define those groups of locations under the influence of policies that are comparable to each other. We find that it is more effective to locate parks and payments away from each other, rather than in the same location or near each other. The high levels of enforcement inside both parks and lands with payments, and the presence of conservation spillovers that reduce deforestation near parks, significantly reduce the potential impact of combining these two policies.	[Robalino, Juan; Sandoval, Catalina; Chacon, Adriana] Ctr Agron Trop Inves & Ensenanza, Turrialba, Costa Rica; [Robalino, Juan] Univ Costa Rica, San Pedro, Costa Rica; [Barton, David N.] Norwegian Inst Nat & Res, Oslo, Norway; [Pfaff, Alexander] Duke Univ, Sanford Sch Publ Policy, Durham, NC USA	Universidad Costa Rica; Norwegian Institute Nature Research; Duke University	Robalino, J (corresponding author), Ctr Agron Trop Inves & Ensenanza, Turrialba, Costa Rica.	robalino@catie.ac.cr	Chacón-Cascante, Adriana/AAH-2140-2019	Chacon-Cascante, Adriana/0000-0002-9326-4659; Robalino, Juan/0000-0003-1450-7382	POLICYMIX project; European Union [244065]; Inter-American Institute for Global Change Research; Swedish International Development Cooperation Agency through the Environment for Development Initiative; Tinker Foundation; Research Council of Norway [204058]; ICER [1128040] Funding Source: National Science Foundation	POLICYMIX project; European Union(European Commission); Inter-American Institute for Global Change Research; Swedish International Development Cooperation Agency through the Environment for Development Initiative; Tinker Foundation; Research Council of Norway(Research Council of Norway); ICER(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work is supported by POLICYMIX project (http://policymix.nina.no/) and the funding from the European Union's Seventh Programme for research, technological development, and demonstration under grant agreement No. 244065, The Inter-American Institute for Global Change Research (http://www.iai.int/) through the project Tropi-dry II CRN3, The Swedish International Development Cooperation Agency through the Environment for Development Initiative (http://www.efdinitiative.org/), Tinker Foundation, The Research Council of Norway through the PESILA-REDD Project under the grant agreement no. 204058 to the Norwegian Institute for Nature Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix-Garcia JM, 2012, LAND ECON, V88, P613, DOI 10.3368/le.88.4.613; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Arriagada RA, 2012, LAND ECON, V88, P382, DOI 10.3368/le.88.2.382; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; Duflo E., 2005, EVALUATING DEV EFFEC, V7, P205; Duflo Esther, 2007, 6059 CTR EC POL RES; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Gaveau DLA, 2007, BIOL CONSERV, V134, P495, DOI 10.1016/j.biocon.2006.08.035; Gimenez T, 2012, MASTER ENV MANAGEMEN; Glennerster Rachel, 2013, RUNNING RANDOMIZED E; Glewwe P, 2003, 9671 NBER; Haruna A, 2010, MASTER ENV MANAGEMEN; Joppa L, 2010, ANN NEW YORK ACAD SC, V1185; Joppa LN, 2010, P ROYAL SOC B; Lecuyer O, 2011, FONDAZIONE ENI E MAT; Mas JF, 2005, ENVIRON MONIT ASSESS, V105, P69, DOI 10.1007/s10661-005-3156-5; Nolte C, 2013, P NATL ACAD SCI USA, V110, P4956, DOI 10.1073/pnas.1214786110; Oliveira PJC, 2007, SCIENCE, V317, P1233, DOI 10.1126/science.1146324; Pattanayak S. K., 2010, REV ENV EC POLICY; Pfaff A, 2015, PROTECTED AREAS IMPA; Pfaff A, 2014, WORLD DEV, V55, P7, DOI 10.1016/j.worlddev.2013.01.011; Pfaff A, 2012, OXFORD REV ECON POL, V28, P164, DOI 10.1093/oxrep/grs012; Pfaff A, 2009, BE J ECON ANAL POLI, V9, DOI 10.2202/1935-1682.1990; Ring I., 2015, HDB ECOLOGICAL EC; Ring I, 2011, TECHNICAL BRIEF REC, V5; Robalino J, 2008, RESOURCE FUTURE EFD; Robalino J, 2013, LAND ECON, V89, P432, DOI 10.3368/le.89.3.432; Robalino JA, 2007, ENVIRON DEV ECON, V12, P521, DOI 10.1017/S1355770X07003671; Robalino JA, 2012, J DEV ECON, V97, P427, DOI 10.1016/j.jdeveco.2011.06.003; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Samii C, 2014, CAMPBELL SYSTEMATIC, V10; Sanchez-Azofeifa GA, 2007, CONSERV BIOL, V21, P1165, DOI 10.1111/j.1523-1739.2007.00751.x; Sierra R, 2006, ECOL ECON, V59, P131, DOI 10.1016/j.ecolecon.2005.10.010; Sims KRE, 2010, J ENVIRON ECON MANAG, V60, P94, DOI 10.1016/j.jeem.2010.05.003; Sims KRE, 2015, ITS COMPLICATED DIRE; Vuohelainen AJ, 2012, ENVIRON MANAGE, V50, P645, DOI 10.1007/s00267-012-9901-y; Wunder S, 2007, CONSERV BIOL, V21, P48, DOI 10.1111/j.1523-1739.2006.00559.x	38	40	40	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124910	10.1371/journal.pone.0124910	http://dx.doi.org/10.1371/journal.pone.0124910			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG6AH	25909323	gold, Green Published			2022-12-27	WOS:000353376800112
J	Lasecka, L; Bin-Tarif, A; Bridgen, A; Juleff, N; Waters, RA; Baron, MD				Lasecka, Lidia; Bin-Tarif, Abdelghani; Bridgen, Anne; Juleff, Nicholas; Waters, Ryan A.; Baron, Michael D.			Antibodies to the Core Proteins of Nairobi Sheep Disease Virus/Ganjam Virus Reveal Details of the Distribution of the Proteins in Infected Cells and Tissues	PLOS ONE			English	Article							CONGO-HEMORRHAGIC-FEVER; DUGBE VIRUS; UUKUNIEMI-VIRUS; GANJAM VIRUS; RNA SEGMENT; NUCLEOCAPSID PROTEIN; CYSTEINE PROTEASES; NAIROVIRUS GENUS; CYTOPLASMIC TAIL; PAPAIN-LIKE	Nairobi sheep disease virus (NSDV; also called Ganjam virus in India) is a bunyavirus of the genus Nairovirus. It causes a haemorrhagic gastroenteritis in sheep and goats with mortality up to 90%. The virus is closely related to the human pathogen Crimean-Congo haemorrhagic fever virus (CCHFV). Little is currently known about the biology of NSDV. We have generated specific antibodies against the virus nucleocapsid protein (N) and polymerase (L) and used these to characterise NSDV in infected cells and to study its distribution during infection in a natural host. Due to its large size and the presence of a papain-like protease (the OTU-like domain) it has been suggested that the L protein of nairoviruses undergoes an autoproteolytic cleavage into polymerase and one or more accessory proteins. Specific antibodies which recognise either the N-terminus or the C-terminus of the NSDV L protein showed no evidence of L protein cleavage in NSDV-infected cells. Using the specific anti-N and anti-L antibodies, it was found that these viral proteins do not fully colocalise in infected cells; the N protein accumulated near the Golgi at early stages of infection while the L protein was distributed throughout the cytoplasm, further supporting the multifunctional nature of the L protein. These antibodies also allowed us to gain information about the organs and cell types targeted by the virus in vivo. We could detect NSDV in cryosections prepared from various tissues collected post-mortem from experimentally inoculated animals; the virus was found in the mucosal lining of the small and large intestine, in the lungs, and in mesenteric lymph nodes (MLN), where NSDV appeared to target monocytes and/or macrophages.	[Lasecka, Lidia; Bin-Tarif, Abdelghani; Juleff, Nicholas; Waters, Ryan A.; Baron, Michael D.] Pirbright Inst, Woking GU24 0NF, Surrey, England; [Bridgen, Anne] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Ulster University	Lasecka, L (corresponding author), Pirbright Inst, Ash Rd, Woking GU24 0NF, Surrey, England.	lidia.lasecka@pirbright.ac.uk	Dykes, Lidia/HHM-9104-2022	Lasecka-Dykes, Lidia/0000-0003-3188-4198	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F00740X/1, BB/F006764/1]; BBSRC Institute Strategic Programme on Vector-borne Viral Diseases at The Pirbright Institute; BBSRC PhD studentship; Biotechnology and Biological Sciences Research Council [BB/F00740X/1, BB/F006764/1, BBS/E/I/00001718] Funding Source: researchfish; BBSRC [BB/F006764/1, BB/F00740X/1, BBS/E/I/00001718] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Institute Strategic Programme on Vector-borne Viral Diseases at The Pirbright Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC PhD studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants BB/F00740X/1 and BB/F006764/1 from the United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) and the BBSRC Institute Strategic Programme on Vector-borne Viral Diseases at The Pirbright Institute. LL was the recipient of a BBSRC PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu M, 2011, P NATL ACAD SCI USA, V108, P2228, DOI 10.1073/pnas.1015287108; Altamura LA, 2007, J VIROL, V81, P6632, DOI 10.1128/JVI.02730-06; Andersson I, 2004, J MED VIROL, V72, P83, DOI 10.1002/jmv.10560; Andersson I, 2008, J MED VIROL, V80, P1397, DOI 10.1002/jmv.21222; Baize S, 2002, CLIN EXP IMMUNOL, V128, P163, DOI 10.1046/j.1365-2249.2002.01800.x; Bakshi S, 2013, J GEN VIROL, V94, P298, DOI 10.1099/vir.0.048322-0; Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Beier D, 2004, J VIROL METHODS, V121, P239, DOI 10.1016/j.jviromet.2004.06.017; Bergeron E, 2010, J VIROL, V84, P216, DOI 10.1128/JVI.01859-09; Bertolotti-Ciarlet A, 2005, J VIROL, V79, P6152, DOI 10.1128/JVI.79.10.6152-6161.2005; bin Tarif A, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-71; Bjerrum O., 1986, BUFFER SYSTEMS TRANS; BOOTH TF, 1991, VIRUS RES, V21, P199, DOI 10.1016/0168-1702(91)90033-R; Bosch I, 2002, J VIROL, V76, P5588, DOI 10.1128/JVI.76.11.5588-5597.2002; BOSHELL J, 1970, INDIAN J MED RES, V58, P561; Brennan B, 2011, J GEN VIROL, V92, P2906, DOI 10.1099/vir.0.036749-0; Bridgen A, 2002, VIROLOGY, V294, P364, DOI 10.1006/viro.2001.1324; Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664; BURNEY MI, 1980, AM J TROP MED HYG, V29, P941, DOI 10.4269/ajtmh.1980.29.941; Burt FJ, 1997, ARCH PATHOL LAB MED, V121, P839; Burt FJ, 1996, EPIDEMIOL INFECT, V116, P353, DOI 10.1017/S0950268800052687; Capodagli GC, 2011, J VIROL, V85, P3621, DOI 10.1128/JVI.02496-10; Cardier JE, 2005, CYTOKINE, V30, P359, DOI 10.1016/j.cyto.2005.01.021; Carr JM, 2003, J MED VIROL, V69, P521, DOI 10.1002/jmv.10340; CASALS J, 1980, INTERVIROLOGY, V14, P144, DOI 10.1159/000149175; CASH P, 1985, J GEN VIROL, V66, P141, DOI 10.1099/0022-1317-66-1-141; Chen JL, 2013, HEPATOLOGY, V57, P470, DOI 10.1002/hep.26064; Choi J, 2003, BIOCHEM BIOPH RES CO, V305, P1049, DOI 10.1016/S0006-291X(03)00881-7; CLERX JPM, 1981, J GEN VIROL, V55, P165, DOI 10.1099/0022-1317-55-1-165; Connolly-Andersen AM, 2009, VIROLOGY, V390, P157, DOI 10.1016/j.virol.2009.06.010; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; DANDAWAT.CN, 1969, INDIAN J MED RES, V57, P799; DAVIDWES.TS, 1974, J GEN VIROL, V23, P297, DOI 10.1099/0022-1317-23-3-297; DAVIES FG, 1978, J HYG-CAMBRIDGE, V81, P259, DOI 10.1017/S0022172400025092; DAVIES FG, 1978, J COMP PATHOL, V88, P519, DOI 10.1016/0021-9975(78)90005-1; DAVIES FG, 1978, J HYG-CAMBRIDGE, V81, P251, DOI 10.1017/S0022172400025080; DEHAAN P, 1991, J GEN VIROL, V72, P2207, DOI 10.1099/0022-1317-72-9-2207; Drosten C, 2002, J CLIN MICROBIOL, V40, P1122, DOI 10.1128/JCM.40.3.1122-1123.2002; Dunster L, 2002, EMERG INFECT DIS, V8, P1005, DOI 10.3201/eid0809.010510; ElAzazy OME, 1997, T ROY SOC TROP MED H, V91, P275, DOI 10.1016/S0035-9203(97)90072-9; ELLIS DS, 1981, ARCH VIROL, V70, P189, DOI 10.1007/BF01315125; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Ergonul O, 2006, J INFECT DIS, V193, P941, DOI 10.1086/500836; Estrada DF, 2011, J BIOL CHEM, V286, P21678, DOI 10.1074/jbc.M110.216515; Estrada DF, 2009, J BIOL CHEM, V284, P8645, DOI 10.1074/jbc.M808081200; Flick R, 2001, J VIROL, V75, P1643, DOI 10.1128/JVI.75.4.1643-1655.2001; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Garrison AR, 2013, VIROLOGY, V444, P45, DOI 10.1016/j.virol.2013.05.030; Geisbert TW, 2003, J INFECT DIS, V188, P1618, DOI 10.1086/379724; Geisbert TW, 2003, AM J PATHOL, V163, P2347, DOI 10.1016/S0002-9440(10)63591-2; Geisbert TW, 2003, AM J PATHOL, V163, P2371, DOI 10.1016/S0002-9440(10)63592-4; Groseth A, 2009, VIRUS RES, V140, P8, DOI 10.1016/j.virusres.2008.10.017; HEWLETT MJ, 1977, J VIROL, V21, P1085, DOI 10.1128/JVI.21.3.1085-1093.1977; Holzer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028594; Honig JE, 2004, VIROLOGY, V321, P29, DOI 10.1016/j.virol.2003.09.042; HOWARTH JA, 1965, J COMP PATHOL THERAP, V75, P437, DOI 10.1016/0021-9975(65)90024-1; Huet S, 2010, J VIROL, V84, P1254, DOI 10.1128/JVI.01533-09; James TW, 2011, P NATL ACAD SCI USA, V108, P2222, DOI 10.1073/pnas.1013388108; Joshi MV, 2005, J MED ENTOMOL, V42, P204, DOI 10.1603/0022-2585(2005)042[0204:IOGVFT]2.0.CO;2; Katz A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-187; Kinsella E, 2004, VIROLOGY, V321, P23, DOI 10.1016/j.virol.2003.09.046; Lasecka L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094656; LAWRENCE DM, 1995, VIROLOGY, V207, P127, DOI 10.1006/viro.1995.1058; LOPEZ N, 1995, J VIROL, V69, P3972, DOI 10.1128/JVI.69.7.3972-3979.1995; Makarova KS, 2000, TRENDS BIOCHEM SCI, V25, P50, DOI 10.1016/S0968-0004(99)01530-3; Marczinke BI, 2002, VIROLOGY, V303, P146, DOI 10.1006/viro.2002.1514; Marriott A. C., 1996, The Bunyaviridae., P91; MARRIOTT AC, 1992, VIROLOGY, V190, P606, DOI 10.1016/0042-6822(92)90898-Y; Marriott AC, 1996, J GEN VIROL, V77, P1775, DOI 10.1099/0022-1317-77-8-1775; Mettam RWM, 1931, REPORT VET PATHOLOGI; Mir MA, 2006, J VIROL, V80, P11283, DOI 10.1128/JVI.00820-06; Montgomery RE, 1917, J COMP PATHOL, V30; Nabeth P, 2004, EMERG INFECT DIS, V10, P1881, DOI 10.3201/eid1010.040586; Nanda SK, 2006, J VIROL, V80, P7555, DOI 10.1128/JVI.02720-05; OLMSTED JB, 1981, J BIOL CHEM, V256, P1955; Overby AK, 2007, J VIROL, V81, P3198, DOI 10.1128/JVI.02655-06; Papa A, 2004, EMERG INFECT DIS, V10, P1465, DOI 10.3201/eid1008.040162; Papa A, 2010, CLIN MICROBIOL INFEC, V16, P843, DOI 10.1111/j.1469-0691.2009.02996.x; Papa A, 2002, EMERG INFECT DIS, V8, P50, DOI 10.3201/eid0801.010087; Papa A, 2006, J CLIN VIROL, V36, P272, DOI 10.1016/j.jcv.2006.04.007; PETTERSSON RF, 1975, J VIROL, V15, P386, DOI 10.1128/JVI.15.2.386-392.1975; Peyrefitte CN, 2010, J GEN VIROL, V91, P189, DOI 10.1099/vir.0.015701-0; Putlitz JZ, 1999, J VIROL, V73, P4188, DOI 10.1128/JVI.73.5.4188-4196.1999; Rwambo PM, 1996, ARCH VIROL, V141, P1479, DOI 10.1007/BF01718249; Sanchez AJ, 2002, J VIROL, V76, P7263, DOI 10.1128/JVI.76.14.7263-7275.2002; Schnittler HJ, 2003, THROMB HAEMOSTASIS, V89, P967; Shi XH, 2009, J GEN VIROL, V90, P297, DOI 10.1099/vir.0.007567-0; Simon M, 2009, VIROLOGY, V385, P313, DOI 10.1016/j.virol.2008.11.020; Simon M, 2009, J GEN VIROL, V90, P210, DOI 10.1099/vir.0.006387-0; SNIJDER EJ, 1995, J BIOL CHEM, V270, P16671, DOI 10.1074/jbc.270.28.16671; Sudeep AB, 2009, INDIAN J MED RES, V130, P514; Sweetman DA, 2001, VIROLOGY, V281, P193, DOI 10.1006/viro.2000.0805; Talavera D, 2004, J GEN VIROL, V85, P1801, DOI 10.1099/vir.0.19652-0; Terasaki K, 2011, P NATL ACAD SCI USA, V108, P804, DOI 10.1073/pnas.1013155108; Trunschke M, 2013, VIROLOGY, V441, P135, DOI 10.1016/j.virol.2013.03.013; Uilenberg G., 1997, Parassitologia (Rome), V39, P161; Wang H, 2010, VIRUS RES, V151, P205, DOI 10.1016/j.virusres.2010.05.008; WATRET GE, 1985, J GEN VIROL, V66, P2513, DOI 10.1099/0022-1317-66-11-2513; Weber F, 2002, J VIROL, V76, P7949, DOI 10.1128/JVI.76.16.7949-7955.2002; WEINBREN M. P., 1958, JOUR COMP PATHOL AND THERAP, V68, P174, DOI 10.1016/S0368-1742(58)80018-1; White WR, 2008, FOREIGN ANIMAL DIS, P335; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001; Williams RJ, 2000, TROP MED INT HEALTH, V5, P99, DOI 10.1046/j.1365-3156.2000.00524.x; ZELLER HG, 1989, ARCH VIROL, V108, P211, DOI 10.1007/BF01310935	104	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124966	10.1371/journal.pone.0124966	http://dx.doi.org/10.1371/journal.pone.0124966			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905707	gold, Green Submitted, Green Published			2022-12-27	WOS:000353332000096
J	Lukesova, T; Kohout, P; Vetrovsky, T; Vohnik, M				Lukesova, Tereza; Kohout, Petr; Vetrovsky, Tomas; Vohnk, Martin			The Potential of Dark Septate Endophytes to Form Root Symbioses with Ectomycorrhizal and Ericoid Mycorrhizal Middle European Forest Plants	PLOS ONE			English	Article							PHIALOCEPHALA-FORTINII S.L.; DIRECT DNA EXTRACTION; ACEPHALA-APPLANATA; HAIR ROOTS; MOLECULAR CHARACTERIZATION; HETEROCONIUM-CHAETOSPIRA; COMMUNITY STRUCTURE; FUNGAL COMMUNITIES; CO-COLONIZATION; VACCINIUM ROOTS	The unresolved ecophysiological significance of Dark Septate Endophytes (DSE) may be in part due to existence of morphologically indistinguishable cryptic species in the most common Phialocephala fortinii s. l.-Acephala applanata species complex (PAC). We inoculated three middle European forest plants (European blueberry, Norway spruce and silver birch) with 16 strains of eight PAC cryptic species and other DSE and ectomycorrhizal/ericoid mycorrhizal fungi and focused on intraradical structures possibly representing interfaces for plant-fungus nutrient transfer and on host growth response. The PAC species Acephala applanata simultaneously formed structures resembling ericoid mycorrhiza (ErM) and DSE microsclerotia in blueberry. A. macrosclerotiorum, a close relative to PAC, formed ectomycorrhizae with spruce but not with birch, and structures resembling ErM in blueberry. Phialocephala glacialis, another close relative to PAC, formed structures resembling ErM in blueberry. In blueberry, six PAC strains significantly decreased dry shoot biomass compared to ErM control. In birch, one A. macrosclerotiorum strain increased root biomass and the other shoot biomass in comparison with non-inoculated control. The dual mycorrhizal ability of A. macrosclerotiorum suggested that it may form mycorrhizal links between Ericaceae and Pinaceae. However, we were unable to detect this species in Ericaceae roots growing in a forest with presence of A. macrosclerotiorum ectomycorrhizae. Nevertheless, the diversity of Ericaceae mycobionts was high (380 OTUs) with individual sites often dominated by hitherto unreported helotialean and chaetothyrialean/verrucarialean species; in contrast, typical ErM fungi were either absent or low in abundance. Some DSE apparently have a potential to form mycorrhizae with typical middle European forest plants. However, except A. applanata, the tested representatives of all hitherto described PAC cryptic species formed typical DSE colonization without specific structures necessary for mycorrhizal nutrient transport. A. macrosclerotiorum forms ectomycorrhiza with conifers but not with broadleaves and probably does not form common mycorrhizal networks between conifers with Ericaceae.	[Lukesova, Tereza; Kohout, Petr; Vohnk, Martin] Charles Univ Prague, Fac Sci, Dept Plant Expt Biol, Prague, Czech Republic; [Lukesova, Tereza; Kohout, Petr; Vohnk, Martin] Inst Bot ASCR, Dept Mycorrhizal Symbioses, Pruhonice, Czech Republic; [Kohout, Petr] Univ Tartu, Dept Bot, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia; [Vetrovsky, Tomas] Inst Microbiol ASCR, Lab Environm Microbiol, Prague, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Vohnik, M (corresponding author), Charles Univ Prague, Fac Sci, Dept Plant Expt Biol, Prague, Czech Republic.	vohnik@ibot.cas.cz	Kohout, Petr/B-4975-2011; Vohnik, Martin/I-1736-2017; Vohník, Martin/H-1636-2014; Knoblochová, Tereza/J-3493-2017; Vetrovsky, Tomas/R-5817-2017	Kohout, Petr/0000-0002-3985-2310; Vohnik, Martin/0000-0002-8655-2708; Vohník, Martin/0000-0002-8655-2708; Knoblochová, Tereza/0000-0002-3862-9184; 	Grant Agency of Charles University [GAUK 320311]; Department of Experimental Plant Biology, Faculty of Science, Charles University in Prague [MSMT LO1417]; Institute of Botany ASCR [RVO 67985939]	Grant Agency of Charles University; Department of Experimental Plant Biology, Faculty of Science, Charles University in Prague; Institute of Botany ASCR(Czech Academy of Sciences)	This study was financed by the Grant Agency of Charles University (GAUK 320311) and constitutes a part of the long-term research projects of the Department of Experimental Plant Biology, Faculty of Science, Charles University in Prague (MSMT LO1417) and the Institute of Botany ASCR (RVO 67985939). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addy HD, 2000, MYCOL RES, V104, P1213, DOI 10.1017/S0953756200002896; Ahlich K, 1996, NEW PHYTOL, V132, P259, DOI 10.1111/j.1469-8137.1996.tb01845.x; Allen TR, 2003, NEW PHYTOL, V160, P255, DOI 10.1046/j.1469-8137.2003.00885.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beiler KJ, 2010, NEW PHYTOL, V185, P543, DOI 10.1111/j.1469-8137.2009.03069.x; Bengtsson-Palme J, 2013, METHODS ECOL EVOL, V4, P914, DOI 10.1111/2041-210X.12073; Berch SM, 2002, PLANT SOIL, V244, P55, DOI 10.1023/A:1020291516884; Bougoure DS, 2007, MOL ECOL, V16, P4624, DOI 10.1111/j.1365-294X.2007.03540.x; Bougoure DS, 2005, ENVIRON MICROBIOL, V7, P1743, DOI 10.1111/j.1462-2920.2005.00919.x; Bougoure DS, 2005, ENVIRON MICROBIOL, V7, P819, DOI 10.1111/j.1462-2920.2005.00755.x; Brundrett M, 2006, MICROBIAL ROOT ENDOP, P179; Bruzone MC, 2015, MYCORRHIZA, V25, P25, DOI 10.1007/s00572-014-0586-3; Duo A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-166; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gorzelak MA, 2012, FUNGAL ECOL, V5, P36, DOI 10.1016/j.funeco.2011.08.008; Grelet GA, 2010, NEW PHYTOL, V188, P210, DOI 10.1111/j.1469-8137.2010.03353.x; Grelet GA, 2009, NEW PHYTOL, V182, P359, DOI 10.1111/j.1469-8137.2009.02813.x; Grunig CR, 2006, FUNGAL GENET BIOL, V43, P410, DOI 10.1016/j.fgb.2006.01.007; Grunig CR, 2009, MYCOL RES, V113, P207, DOI 10.1016/j.mycres.2008.10.005; Grunig CR, 2008, BOTANY, V86, P1355, DOI 10.1139/B08-108; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hashimoto Y, 2001, ECOL RES, V16, P117, DOI 10.1046/j.1440-1703.2001.00377.x; Hazard C, 2014, FEMS MICROBIOL ECOL, V87, P586, DOI 10.1111/1574-6941.12247; Ishida TA, 2010, SOIL BIOL BIOCHEM, V42, P234, DOI 10.1016/j.soilbio.2009.10.021; Jumpponen A, 1998, NEW PHYTOL, V140, P295, DOI 10.1046/j.1469-8137.1998.00265.x; Kaldorf M, 2004, MYCORRHIZA, V14, P295, DOI 10.1007/s00572-003-0266-1; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kjoller R, 2010, FUNGAL ECOL, V3, P205, DOI 10.1016/j.funeco.2009.10.005; Klymiuk AA, 2013, MYCOLOGIA, V105, P1100, DOI 10.3852/13-025; Kohout P, 2013, FUNGAL ECOL, V6, P50, DOI 10.1016/j.funeco.2012.08.005; Kohout P, 2012, FEMS MICROBIOL ECOL, V80, P216, DOI 10.1111/j.1574-6941.2011.01291.x; Kohout P, 2011, MYCORRHIZA, V21, P403, DOI 10.1007/s00572-010-0350-2; Mayerhofer MS, 2013, MYCORRHIZA, V23, P119, DOI 10.1007/s00572-012-0456-9; Melin E, 1921, J ECOL, V9, P254; Menkis A, 2004, MYCOL RES, V108, P965, DOI 10.1017/S0953756204000668; Merrild MP, 2013, NEW PHYTOL, V200, P229, DOI 10.1111/nph.12351; Molina R., 1982, Methods and principles of mycorrhizal research., P115; Munzenberger B, 2009, MYCORRHIZA, V19, P481, DOI 10.1007/s00572-009-0239-0; Newsham KK, 2011, NEW PHYTOL, V190, P783, DOI 10.1111/j.1469-8137.2010.03611.x; Newsham KK, 1999, NEW PHYTOL, V144, P517, DOI 10.1046/j.1469-8137.1999.00537.x; Obase K, 2014, MYCORRHIZA, V24, P635, DOI 10.1007/s00572-014-0584-5; ODELL TE, 1993, NEW PHYTOL, V124, P93, DOI 10.1111/j.1469-8137.1993.tb03800.x; PEARSON V, 1973, NEW PHYTOL, V72, P371, DOI 10.1111/j.1469-8137.1973.tb02044.x; Peterson RL, 2008, BOTANY, V86, P445, DOI 10.1139/B08-016; Reininger V, 2013, ENV MICROBIOL REP, V5, P892, DOI 10.1111/1758-2229.12091; Reininger V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042865; Reininger V, 2012, ENVIRON MICROBIOL, V14, P1064, DOI 10.1111/j.1462-2920.2011.02686.x; RICHARD C, 1971, Canadian Journal of Forest Research, V1, P246, DOI 10.1139/x71-034; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Selosse MA, 2008, NEW PHYTOL, V178, P3, DOI 10.1111/j.1469-8137.2008.02390.x; Selosse MA, 2007, NEW PHYTOL, V174, P864, DOI 10.1111/j.1469-8137.2007.02064.x; Simard SW, 2004, CAN J BOT, V82, P1140, DOI [10.1139/b04-116, 10.1139/B04-116]; STOYKE G, 1993, ARCTIC ALPINE RES, V25, P189, DOI 10.2307/1551812; STOYKE G, 1991, CAN J BOT, V69, P347, DOI 10.1139/b91-047; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tellenbach C, 2012, FEMS MICROBIOL ECOL, V82, P157, DOI 10.1111/j.1574-6941.2012.01415.x; Tellenbach C, 2011, ENVIRON MICROBIOL, V13, P2508, DOI 10.1111/j.1462-2920.2011.02523.x; Usuki F, 2005, MYCORRHIZA, V15, P61, DOI 10.1007/s00572-004-0333-2; Usuki F, 2007, MYCOLOGIA, V99, P175, DOI 10.3852/mycologia.99.2.175; Vandenkoornhuyse P, 2002, SCIENCE, V295, P2051, DOI 10.1126/science.295.5562.2051; Vetrovsky T, 2013, BIOL FERT SOILS, V49, P1027, DOI 10.1007/s00374-013-0801-y; Villarreal-Ruiz L, 2012, SYMBIOSIS, V56, P67, DOI 10.1007/s13199-012-0161-7; Vohnik M, 2007, FOLIA MICROBIOL, V52, P407, DOI 10.1007/BF02932096; Vohnik M, 2005, SYMBIOSIS, V40, P87; Vohnik M, 2003, FOLIA GEOBOT, V38, P191, DOI 10.1007/BF02803151; Vohnik M, 2013, FUNGAL ECOL, V6, P281, DOI 10.1016/j.funeco.2013.03.006; Vohnik M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039524; Vohnik M, 2012, PLANT SOIL, V355, P341, DOI 10.1007/s11104-011-1106-2; Vohnik M, 2011, FOLIA GEOBOT, V46, P373, DOI 10.1007/s12224-011-9098-5; Vralstad T, 2004, NEW PHYTOL, V164, P7, DOI 10.1111/j.1469-8137.2004.01180.x; Walker JF, 2011, NEW PHYTOL, V191, P515, DOI 10.1111/j.1469-8137.2011.03703.x; WANG CJK, 1985, MYCOLOGIA, V77, P951, DOI 10.2307/3793308; Weiss M, 2004, MYCOL RES, V108, P1003, DOI 10.1017/S0953756204000772; WILCOX HE, 1987, CAN J FOREST RES, V17, P884, DOI 10.1139/x87-140; Wu LQ, 2010, MYCORRHIZA, V20, P127, DOI 10.1007/s00572-009-0268-8; Zhang C, 2009, MYCORRHIZA, V19, P417, DOI 10.1007/s00572-009-0246-1; Zimmerman E, 2007, SYMBIOSIS, V43, P45	82	58	59	2	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124752	10.1371/journal.pone.0124752	http://dx.doi.org/10.1371/journal.pone.0124752			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905493	Green Submitted, Green Published, gold			2022-12-27	WOS:000353332000085
J	Sezgin, E; Gutmann, T; Buhl, T; Dirkx, R; Grzybek, M; Coskun, U; Solimena, M; Simons, K; Levental, I; Schwille, P				Sezgin, Erdinc; Gutmann, Theresia; Buhl, Tomasz; Dirkx, Ron; Grzybek, Michal; Coskun, Uenal; Solimena, Michele; Simons, Kai; Levental, Ilya; Schwille, Petra			Adaptive Lipid Packing and Bioactivity in Membrane Domains	PLOS ONE			English	Article							GENERALIZED POLARIZATION; FLUORESCENT-PROBE; CELL-MEMBRANES; RAFTS; MODEL; PHASES; MICROSCOPY; PROTEIN; FLUCTUATIONS; RESISTANCE	Lateral compositional and physicochemical heterogeneity is a ubiquitous feature of cellular membranes on various length scales, from molecular assemblies to micrometric domains. Segregated lipid domains of increased local order, referred to as rafts, are believed to be prominent features in eukaryotic plasma membranes; however, their exact nature (i.e. size, lifetime, composition, homogeneity) in live cells remains difficult to define. Here we present evidence that both synthetic and natural plasma membranes assume a wide range of lipid packing states with varying levels of molecular order. These states may be adapted and specifically tuned by cells during active cellular processes, as we show for stimulated insulin secretion. Most importantly, these states regulate both the partitioning of molecules between coexisting domains and the bioactivity of their constituent molecules, which we demonstrate for the ligand binding activity of the glycosphingolipid receptor GM1. These results confirm the complexity and flexibility of lipid-mediated membrane organization and reveal mechanisms by which this flexibility could be functionalized by cells.	[Sezgin, Erdinc] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Sezgin, Erdinc; Buhl, Tomasz; Solimena, Michele; Simons, Kai] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Gutmann, Theresia; Dirkx, Ron; Grzybek, Michal; Coskun, Uenal; Solimena, Michele] Tech Univ Dresden, Univ Clin Carl Gustav Carus, Paul Langerhans Inst Dresden, Helmholtz Ctr Munich, Dresden, Germany; [Gutmann, Theresia; Dirkx, Ron; Grzybek, Michal; Coskun, Uenal; Solimena, Michele] German Ctr Diabet Res DZD, Neuherberg, Germany; [Levental, Ilya] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Schwille, Petra] Max Planck Inst Biochem, D-82152 Martinsried, Germany	University of Oxford; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Texas System; University of Texas Health Science Center Houston; Max Planck Society	Levental, I (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	ilya.levental@uth.tmc.edu; schwille@biochem.mpg.de	Schwille, Petra/A-4983-2010; Solimena, Michele/GVS-5990-2022; Solimena, Michele/E-1275-2011; Levental, Ilya/F-4707-2011; Coskun, Ünal/F-4683-2011; Sezgin, Erdinc/R-1980-2018; Gutmann, Theresia/R-6408-2018; Grzybek, Michal/D-3802-2017	Levental, Ilya/0000-0002-1206-9545; Coskun, Ünal/0000-0003-4375-3144; Sezgin, Erdinc/0000-0002-4915-388X; Gutmann, Theresia/0000-0003-0562-2880; Simons, Kai/0000-0002-9231-9996; Grzybek, Michal/0000-0003-2083-0506	Deutsche Forschungsgemeinschaft (DFG), German Federal Ministry of Education and Research (BMBF) [SO818/1-1, SCHW716/7-1, "Transregio 83" TRR83 TP18]; Max Planck Society; CPRIT Scholar for Cancer Research [R1215]	Deutsche Forschungsgemeinschaft (DFG), German Federal Ministry of Education and Research (BMBF); Max Planck Society(Max Planck Society); CPRIT Scholar for Cancer Research	This work was supported by grants SO818/1-1, SCHW716/7-1 and "Transregio 83" TRR83 TP18 from Deutsche Forschungsgemeinschaft (DFG), German Federal Ministry of Education and Research (BMBF) grant to the German Center for Diabetes Research (DZD e.V.) and Max Planck Society. IL is a CPRIT Scholar for Cancer Research (grant R1215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagatolli LA, 1997, BBA-BIOMEMBRANES, V1325, P80, DOI 10.1016/S0005-2736(96)00246-5; Baumgart T, 2007, BBA-BIOMEMBRANES, V1768, P2182, DOI 10.1016/j.bbamem.2007.05.012; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Delaunay JL, 2008, BBA-BIOMEMBRANES, V1778, P105, DOI 10.1016/j.bbamem.2007.09.017; Eisenberg S, 2011, MOL CELL BIOL, V31, P3938, DOI 10.1128/MCB.05570-11; Gerl MJ, 2012, J CELL BIOL, V196, P213, DOI 10.1083/jcb.201108175; Gray E, 2013, BIOPHYS J, V105, P2751, DOI 10.1016/j.bpj.2013.11.005; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Juhasz J, 2010, BIOCHEM J, V430, P415, DOI [10.1042/Bj20100516, 10.1042/BJ20100516]; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kim HM, 2007, CHEMBIOCHEM, V8, P553, DOI 10.1002/cbic.200700003; Klose C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035063; Klotzsch E, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0033; Korlach J, 1999, P NATL ACAD SCI USA, V96, P8461, DOI 10.1073/pnas.96.15.8461; Levental I, 2010, PNAS; Levental I, 2011, P NATL ACAD SCI USA, V108, P11411, DOI 10.1073/pnas.1105996108; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Levental I, 2009, BIOCHEM J, V424, P163, DOI 10.1042/BJ20091283; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Ozhan G, 2013, DEV CELL, V26, P331, DOI 10.1016/j.devcel.2013.07.020; Parasassi T, 1997, BIOPHYS J, V72, P2413, DOI 10.1016/S0006-3495(97)78887-8; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Sanchez SA, 2012, P NATL ACAD SCI USA, V109, P7314, DOI 10.1073/pnas.1118288109; Schubert S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012929; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Sezgin E, 2011, COLD SPRING HARBOR P, V3, DOI [10.1101/cshperspect.a005017, DOI 10.1101/CSHPERSPECT.A005017]; Sezgin E, 2013, CHEMBIOCHEM, V14, P695, DOI 10.1002/cbic.201300038; Sezgin E, 2012, BBA-BIOMEMBRANES, V1818, P1777, DOI 10.1016/j.bbamem.2012.03.007; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Shi DW, 2013, J BIOL CHEM, V288, P12605, DOI 10.1074/jbc.M112.399477; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Thaa B, 2011, BIOCHEM J, V437, P389, DOI 10.1042/BJ20110706; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Veatch SL, 2008, ACS CHEM BIOL, V3, P287, DOI 10.1021/cb800012x; Veatch SL, 2003, BIOPHYS J, V84, P725, DOI 10.1016/S0006-3495(03)74891-7; Veatch SL, 2003, BIOPHYS J, V85, P3074, DOI 10.1016/S0006-3495(03)74726-2; Waugh MG, 2011, J LIPID RES, V52, P582, DOI 10.1194/jlr.D012807; Yu WM, 1996, BIOPHYS J, V70, P626, DOI 10.1016/S0006-3495(96)79646-7; Zech T, 2009, EMBO J, V28, P466, DOI 10.1038/emboj.2009.6; Zidar J, 2009, J PHYS CHEM B, V113, P15795, DOI 10.1021/jp907138h	43	69	69	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123930	10.1371/journal.pone.0123930	http://dx.doi.org/10.1371/journal.pone.0123930			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905447	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000049
J	Leithner, K; Naderer, A; Hartung, D; Abrahamowicz, C; Alexopoulos, J; Walch, K; Wenzl, R; Hilger, E				Leithner, Katharina; Naderer, Andrea; Hartung, Dorothee; Abrahamowicz, Clara; Alexopoulos, Johanna; Walch, Katharina; Wenzl, Rene; Hilger, Eva			Sexual and Psychosocial Functioning in Women with MRKHS after Neovaginoplasty According to Wharton-Sheares-George: A Case Control Study	PLOS ONE			English	Article							KUSTER-HAUSER-SYNDROME; MOTHER-DAUGHTER RELATIONSHIP; VAGINAL AGENESIS; LAPAROSCOPIC DAVYDOV; BONDING INSTRUMENT; INDEX FSFI; VAGINOPLASTY; CREATION; OUTCOMES; UTILITY	Background Mayer-Rokitansky-Kuster-Hauser syndrome (MRKHS) has a major impact on a woman's psychological and sexual well-being. In most of the studies that addressed treatment techniques, postoperative sexual function was reported to be satisfactory; however, comparatively few studies have additionally provided an accurate analysis of psychosocial functions in MRKHS patients following different kinds of neovaginal treatment. This study is to evaluate sexual and psychosocial functioning after creation of a neovagina according to Wharton-Sheares-George in women with MRKHS. Methods We performed a case-control-study using multiple measures to assess sexual and psychosocial functioning. Ten MRKHS patients and 20 controls of a University hospital and tertiary center for pediatric and adolescent gynecology were assessed. The follow-up assessment comprised 6 standardized questionnaires (Female Sexuality Function Index, FSFI; Patient Health Questionnaire, PHQ; Brief Symptom Inventory, BSI; World Health Organization Quality of Life Assessment, WHOQoL-BREF; Parental Bonding Instrument, PBI; and a German questionnaire on body image). The main outcome measures were sexual function, psychological status, quality of life, body image, and parental bonding styles. Findings Sexual function, psychological status (including depressive and somatic symptoms), quality of life, and own-body experience were at least as good in operated MRKHS patients as in controls. In some measures (FSFI, PHQ-15, psychological domain of the WHOQoL-BREF, and BSI Positive Symptom Total), patients scored significantly better than controls. The results of the PBI indicated a close and sustainable mother-daughter-relationship in MRKHS patients. Conclusions We found no evidence for an impairment of sexual or psychosocial functioning in patients after neovaginoplasty according to Wharton-Sheares-George. MRKHS may not necessarily compromise sexual and psychological well-being, provided that the syndrome is properly managed by a multidisciplinary team of health professionals.	[Leithner, Katharina; Naderer, Andrea; Hartung, Dorothee; Abrahamowicz, Clara; Alexopoulos, Johanna] Med Univ Vienna, Dept Psychoanal & Psychotherapy, Vienna, Austria; [Walch, Katharina; Wenzl, Rene] Med Univ Vienna, Dept Obstet & Gynaecol, Div Gynaecol & Gynaecol Oncol, Vienna, Austria; [Hilger, Eva] Med Univ Vienna, Dept Neurol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Leithner, K (corresponding author), Med Univ Vienna, Dept Psychoanal & Psychotherapy, Vienna, Austria.	katharina.leithner@meduniwien.ac.at		Leithner-Dziubas, Katharina/0000-0002-4982-3783				ACOG, 2013, OBSTET GYNECOL, V121, P1134, DOI DOI 10.1097/01.AOG.0000429659.93470; Allen LM, 2010, FERTIL STERIL, V94, P2272, DOI 10.1016/j.fertnstert.2010.02.008; Angermeyer M, 2000, WHOQOL 100 WHOQOL BR; Bean EJ, 2009, J PEDIATR ADOL GYNEC, V22, P339, DOI 10.1016/j.jpag.2008.11.006; Berner MM, 2004, GEBURTSH FRAUENHEILK, V64, P293; Brun JL, 2002, EUR J OBSTET GYN R B, V103, P168, DOI 10.1016/S0301-2115(02)00031-3; Carrard C, 2012, FERTIL STERIL, V97, P691, DOI 10.1016/j.fertnstert.2011.12.015; Communal PH, 2003, FERTIL STERIL, V80, P600, DOI 10.1016/S0015-0282(03)00796-9; Csermely T, 2011, J PEDIATR ADOL GYNEC, V24, P147, DOI 10.1016/j.jpag.2010.12.008; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Edmonds DK, 2012, FERTIL STERIL, V97, P686, DOI 10.1016/j.fertnstert.2011.12.038; Fedele L, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.807; Fliegner M, 2014, J SEX MED, V11, P729, DOI 10.1111/jsm.12321; Fotopoulou C, 2010, FERTIL STERIL, V94, P317, DOI 10.1016/j.fertnstert.2009.01.154; Franke GH, 2000, BRIEFF S INV; Gatti C, 2010, J UROLOGY, V184, P1799, DOI 10.1016/j.juro.2010.03.078; Giannesi A, 2005, HUM REPROD, V20, P2954, DOI 10.1093/humrep/dei152; Gueniche K, 2014, B MENNINGER CLIN, V78, P57, DOI 10.1521/bumc.2014.78.1.57; HECKER BR, 1977, AM J OBSTET GYNECOL, V129, P543; Heller-Boersma JG, 2009, PSYCHOSOMATICS, V50, P277, DOI 10.1176/appi.psy.50.3.277; HERRMAN H, 1993, QUAL LIFE RES, V2, P153; Holt Re, 2003, Psychol Health Med, V8, P19, DOI 10.1080/1354850021000059232; Kimberley N, 2011, FERTIL STERIL, V95, P238, DOI 10.1016/j.fertnstert.2010.05.061; Klingele CJ, 2003, AM J OBSTET GYNECOL, V189, P1569, DOI 10.1016/S0002-9378(03)00938-4; Labus LD, 2011, SEX HEALTH, V8, P427, DOI 10.1071/SH10105; Langer M, 1990, ACTA OBSTET GYN SCAN, V69, P343, DOI 10.3109/00016349009036159; Laufer MR, 2002, CURR OPIN OBSTET GYN, V14, P441, DOI 10.1097/00001703-200210000-00001; Liao LM, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.013; Liu XS, 2009, J MINIM INVAS GYN, V16, P720, DOI 10.1016/j.jmig.2009.07.018; Loeser E, 2002, GEBURTSH FRAUENHEILK, V62, P1193, DOI 10.1055/s-2002-36371; Lowe BP, 2001, GESUNDHEITSFRAGENBOG; Mobus VJ, 1996, AM J OBSTET GYNECOL, V175, P617; Morcel K, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-13; Morgan EM, 2006, ARCH SEX BEHAV, V35, P607, DOI 10.1007/s10508-006-9054-2; PARKER G, 1990, SOC PSYCH PSYCH EPID, V25, P281, DOI 10.1007/BF00782881; Reck C, 2006, ARCH WOMEN MENT HLTH, V9, P265, DOI 10.1007/s00737-006-0144-x; Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597; Schatz T, 2005, FERTIL STERIL, V83, P437, DOI 10.1016/j.fertnstert.2004.06.079; SHEARES BH, 1960, J OBSTET GYNAECOL, V67, P24; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Strauss B, 1996, FRAGEBOGEN BEURTELLI; Walch K, 2011, FERTIL STERIL, V96, P492, DOI 10.1016/j.fertnstert.2011.06.004; Zhu L, 2013, J SEX MED, V10, P1652, DOI 10.1111/jsm.12143	44	10	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124604	10.1371/journal.pone.0124604	http://dx.doi.org/10.1371/journal.pone.0124604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KV	25901735	Green Submitted, Green Published, gold			2022-12-27	WOS:000353331500094
J	Lyberopoulou, A; Aravantinos, G; Efstathopoulos, EP; Nikiteas, N; Bouziotis, P; Isaakidou, A; Papalois, A; Marinos, E; Gazouli, M				Lyberopoulou, Anna; Aravantinos, Gerasimos; Efstathopoulos, Efstathios P.; Nikiteas, Nikolaos; Bouziotis, Penelope; Isaakidou, Athina; Papalois, Apostolos; Marinos, Evangelos; Gazouli, Maria			Mutational Analysis of Circulating Tumor Cells from Colorectal Cancer Patients and Correlation with Primary Tumor Tissue	PLOS ONE			English	Article							PERIPHERAL-BLOOD; STEM-CELLS; MESENCHYMAL TRANSITION; KRAS; CARCINOMA; THERAPY; BRAF; CHEMOTHERAPY; METASTASES; RESISTANCE	Circulating tumor cells (CTCs) provide a non-invasive accessible source of tumor material from patients with cancer. The cellular heterogeneity within CTC populations is of great clinical importance regarding the increasing number of adjuvant treatment options for patients with metastatic carcinomas, in order to eliminate residual disease. Moreover, the molecular profiling of these rare cells might lead to insight on disease progression and therapeutic strategies than simple CTCs counting. In the present study we investigated the feasibility to detect KRAS, BRAF, CD133 and Plastin3 (PLS3) mutations in an enriched CTCs cell suspension from patients with colorectal cancer, with the hypothesis that these genes mutations are of great importance regarding the generation of CTCs subpopulations. Subsequently, we compared CTCs mutational status with that of the corresponding primary tumor, in order to access the possibility of tumor cells characterization without biopsy. CTCs were detected and isolated from blood drawn from 52 colorectal cancer (CRC) patients using a quantum-dot-labelled magnetic immunoassay method. Mutations were detected by PCR-RFLP or allele-specific PCR and confirmed by direct sequencing. In 52 patients, discordance between primary tumor and CTCs was 5.77% for KRAS, 3.85% for BRAF, 11.54% for CD133 rs3130, 7.69% for CD133 rs2286455 and 11.54% for PLS3 rs6643869 mutations. Our results support that DNA mutational analysis of CTCs may enable non-invasive, specific biomarker diagnostics and expand the scope of personalized medicine for cancer patients.	[Lyberopoulou, Anna; Marinos, Evangelos; Gazouli, Maria] Univ Athens, Sch Med, Dept Basic Med Sci, Biol Lab, GR-11527 Athens, Greece; [Aravantinos, Gerasimos; Isaakidou, Athina] Agioi Anargiroi Canc Hosp, Dept Med Oncol 2, Athens, Greece; [Efstathopoulos, Efstathios P.; Gazouli, Maria] Univ Athens, Sch Med, Dept Radiol 2, GR-11527 Athens, Greece; [Nikiteas, Nikolaos] Univ Athens, Sch Med, Laiko Gen Hosp, Dept Propedeut Surg 2, GR-11527 Athens, Greece; [Bouziotis, Penelope] NCSR Demokritos, Inst Nucl & Radiol Sci & Technol, Energy & Safety, Athens, Greece; [Papalois, Apostolos] ELPEN Pharmaceut, Exprerimental Res Ctr, Attiki, Greece	Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; Laiko General Hospital; National & Kapodistrian University of Athens; National Centre of Scientific Research "Demokritos"	Gazouli, M (corresponding author), Univ Athens, Sch Med, Dept Basic Med Sci, Biol Lab, GR-11527 Athens, Greece.	mgazouli@med.uoa.gr	Gazouli, Maria/I-2572-2018; Nikiteas, Nikolaos I/A-3165-2009; Gazouli, Maria/W-6245-2019	Gazouli, Maria/0000-0002-3295-6811; Nikiteas, Nikolaos I/0000-0002-3996-1584; Gazouli, Maria/0000-0002-3295-6811; Aravantinos, Gerasimos/0000-0002-2106-1713	Experimental Research Center ELPEN Pharmaceuticals (E.R.C.E); Hellenic Society for Gastrointestinal Oncology (H.S.G.O.); non-profit organization of Greek Society of Cancer Biomarkers and Targeted Therapy	Experimental Research Center ELPEN Pharmaceuticals (E.R.C.E); Hellenic Society for Gastrointestinal Oncology (H.S.G.O.); non-profit organization of Greek Society of Cancer Biomarkers and Targeted Therapy	This study was funded by Scholarship-Grant by the Experimental Research Center ELPEN Pharmaceuticals (E.R.C.E), the Hellenic Society for Gastrointestinal Oncology (H.S.G.O.), and a non-profit organization of Greek Society of Cancer Biomarkers and Targeted Therapy. AP is employed by Experimental Research Center ELPEN Pharmaceuticals. Experimental Research Center ELPEN Pharmaceuticals provided support in the form of salary for author AP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Alamgeer M, 2013, RESPIROLOGY, V18, P757, DOI 10.1111/resp.12094; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Alunni-Fabbroni M, 2010, METHODS, V50, P289, DOI 10.1016/j.ymeth.2010.01.027; Andrea C, 2014, WORLD J GASTROENTERO, V20, P8921, DOI 10.3748/wjg.v20.i27.8921; Baas JM, 2011, ONCOLOGIST, V16, P1239, DOI 10.1634/theoncologist.2011-0024; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Barault L, 2008, INT J CANCER, V122, P2255, DOI 10.1002/ijc.23388; Bonnomet A, 2010, J MAMMARY GLAND BIOL, V15, P261, DOI 10.1007/s10911-010-9174-0; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Ciombor KK, 2014, PHARMACOGEN PERS MED, V7, P137, DOI 10.2147/PGPM.S47582; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; De Roock W, 2011, LANCET ONCOL, V12, P594, DOI 10.1016/S1470-2045(10)70209-6; Devriese LA, 2011, CANCER TREAT REV, V37, P579, DOI 10.1016/j.ctrv.2011.04.006; European Medicine Agency, COMM MED PROD HUM US; Frederick BA, 2007, MOL CANCER THER, V6, P1683, DOI 10.1158/1535-7163.MCT-07-0138; Gazouli M, 2012, WORLD J GASTROENTERO, V18, P4419, DOI 10.3748/wjg.v18.i32.4419; Goutas N, 2008, ANTICANCER RES, V28, P305; Gutierrez C, 2013, ONCOL LETT, V6, P1343, DOI 10.3892/ol.2013.1544; Hatzaki A, 2001, MOL CELL PROBE, V15, P243, DOI 10.1006/mcpr.2001.0367; Hayes DF, 2006, CLIN CANCER RES, V12, P4218, DOI 10.1158/1078-0432.CCR-05-2821; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Joosse SA, 2013, CANCER RES, V73, P8, DOI 10.1158/0008-5472.CAN-12-3422; Kaiser J, 2010, SCIENCE, V327, P1072, DOI 10.1126/science.327.5969.1074; Kalikaki A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104902; Konigsberg R, 2011, ACTA ONCOL, V50, P700, DOI 10.3109/0284186X.2010.549151; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Maheswaran S, 2010, CURR OPIN GENET DEV, V20, P96, DOI 10.1016/j.gde.2009.12.002; Melin C, 2012, ANAL CHEM, V84, P1549, DOI 10.1021/ac202797z; Meregalli M, 2010, EXPERT OPIN BIOL TH, V10, P1521, DOI 10.1517/14712598.2010.528386; Mostert B, 2013, INT J CANCER, V133, P130, DOI 10.1002/ijc.27987; Ning Y, 2014, MOL CANCER THER, V13, P528, DOI 10.1158/1535-7163.MCT-13-0646; Pawlik TM, 2007, J GASTROINTEST SURG, V11, P1057, DOI 10.1007/s11605-006-0061-3; Pinard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-216; Pohl A, 2013, PHARMACOGENOMICS J, V13, P173, DOI 10.1038/tpj.2011.61; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Ren F, 2013, WORLD J GASTROENTERO, V19, P2603, DOI 10.3748/wjg.v19.i17.2603; Sastre J, 2012, ONCOLOGIST, V17, P947, DOI 10.1634/theoncologist.2012-0048; Satelli A, 2015, CLIN CHEM, V61, P259, DOI 10.1373/clinchem.2014.228122; Shah MM, 2014, GYNECOL ONCOL, V132, P483, DOI 10.1016/j.ygyno.2013.12.001; Sinha N, 2013, ORAL ONCOL, V49, P854, DOI 10.1016/j.oraloncology.2013.06.010; Sugimachi K, 2013, ANN SURG ONCOL; Tanase CP, 2014, WORLD J GASTROENTERO, V20, P10790, DOI 10.3748/wjg.v20.i31.10790; Theodoropoulos PA, 2010, CANCER LETT, V288, P99, DOI 10.1016/j.canlet.2009.06.027; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Wicha MS, 2011, J CLIN ONCOL, V29, P1508, DOI 10.1200/JCO.2010.34.0026; Xenidis N, 2006, J CLIN ONCOL, V24, P3756, DOI 10.1200/JCO.2005.04.5948; Xia T, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/420364; Yokobori T, 2013, CANCER RES, V73, P2059, DOI 10.1158/0008-5472.CAN-12-0326	52	39	41	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123902	10.1371/journal.pone.0123902	http://dx.doi.org/10.1371/journal.pone.0123902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902072	Green Published, gold, Green Submitted			2022-12-27	WOS:000353331500065
J	Kapella, MC; Berger, BE; Vern, BA; Vispute, S; Prasad, B; Carley, DW				Kapella, Mary C.; Berger, Barbara E.; Vern, Boris A.; Vispute, Sachin; Prasad, Bharati; Carley, David W.			Health-Related Stigma as a Determinant of Functioning in Young Adults with Narcolepsy	PLOS ONE			English	Article							QUALITY-OF-LIFE; HOSPITAL ANXIETY; DAYTIME SLEEPINESS; DEPRESSION SCALE; IMPACT; PEOPLE; CATAPLEXY; EPILEPSY; VALIDITY; SELF	Symptoms of narcolepsy tend to arise during adolescence or young adulthood, a formative time in human development during which people are usually completing their education and launching a career. Little is known about the impact of narcolepsy on the social aspects of health-related quality of life in young adults. The purpose of this study was to examine relationships between health-related stigma, mood (anxiety and depression) and daytime functioning in young adults with narcolepsy compared to those without narcolepsy. Young adults (age 18-35) with narcolepsy (N = 122) and without narcolepsy (N = 93) were mailed a packet that included questionnaires and a self-addressed postage paid envelope. The questionnaire included demographic information and a composite of instruments including the SF 36, Functional Outcomes of Sleep Questionnaire (FOSQ), Fife Stigma Scale (FSS), Epworth Sleepiness Scale (ESS) and Hospital Anxiety and Depression Scale (HADS). Variable associations were assessed using descriptive statistics, ANOVA, Mann-Whitney U Test, correlations, stepwise multiple regression and path analysis. Young adults with narcolepsy perceived significantly more stigma and lower mood and health-related quality of life than young adults without narcolepsy (p<0.01). Health-related stigma was directly and indirectly associated with lower functioning through depressed mood. Fifty-two percent of the variance in functioning was explained by the final model in the young adults with narcolepsy. Health-related stigma in young adults with narcolepsy is at a level consistent with other chronic medical illnesses. Health-related stigma may be an important determinant of functioning in young adults with narcolepsy. Future work is indicated toward further characterizing stigma and developing interventions that address various domains of stigma in people with narcolepsy.	[Kapella, Mary C.; Berger, Barbara E.; Vern, Boris A.; Vispute, Sachin; Carley, David W.] Univ Illinois, Coll Nursing, Ctr Narcolepsy Sleep & Hlth Res, Dept Biobehav Hlth Sci, Chicago, IL 60612 USA; [Vern, Boris A.; Prasad, Bharati] Univ Illinois, Coll Med, Dept Pulm Crit Care Sleep & Allergy, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kapella, MC (corresponding author), Univ Illinois, Coll Nursing, Ctr Narcolepsy Sleep & Hlth Res, Dept Biobehav Hlth Sci, Chicago, IL 60612 USA.	mkapel1@uic.edu	Vispute, Sachin/ABA-4299-2021; Prasad, Bharati/AAX-4823-2020	Prasad, Bharati/0000-0003-4280-996X	NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013937] Funding Source: NIH RePORTER; NINR NIH HHS [R01 NR013937] Funding Source: Medline	NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Baker GA, 2008, EPILEPSY BEHAV, V12, P395, DOI 10.1016/j.yebeh.2007.11.001; Balfe M, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-25; Bassetti C, 2007, NARCOLEPSY HYPERSOMN; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; BROUGHTON R, 1981, CAN J NEUROL SCI, V8, P299, DOI 10.1017/S0317167100043419; BROUGHTON RJ, 1984, EPILEPSIA, V25, P423, DOI 10.1111/j.1528-1157.1984.tb03438.x; BROUGHTON WA, 1994, SLEEP, V17, pS45, DOI 10.1093/sleep/17.suppl_8.S45; Browne JL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005625; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Chama S, 2015, AIDS CARE, V27, P789, DOI 10.1080/09540121.2014.989807; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; Culbertson HBD, 2005, E J APPL PSYCHOL, V1, P14, DOI [10. 7790/ ejap. v1i1. 5, DOI 10.7790/EJAP.V1I1.5]; Daniels E, 2001, J SLEEP RES, V10, P75, DOI 10.1046/j.1365-2869.2001.00234.x; Dauvilliers Y, 2009, J NEUROL NEUROSUR PS, V80, P636, DOI 10.1136/jnnp.2008.161588; Dauvilliers Y, 2001, NEUROLOGY, V57, P2029, DOI 10.1212/WNL.57.11.2029; David A, 2012, SLEEP MED, V13, P273, DOI 10.1016/j.sleep.2011.06.021; Dodel R, 2007, SLEEP MED, V8, P733, DOI 10.1016/j.sleep.2006.10.010; Earnshaw VA, 2012, CHRONIC ILLN, V8, P79, DOI 10.1177/1742395311429393; Ervik S, 2006, ACTA NEUROL SCAND, V114, P198, DOI 10.1111/j.1600-0404.2006.00594.x; Fife BL, 2000, J HEALTH SOC BEHAV, V41, P50, DOI 10.2307/2676360; Gauffin H, 2010, EPILEPSY BEHAV, V17, P520, DOI 10.1016/j.yebeh.2010.01.167; Gerlinger G, 2013, WORLD PSYCHIATRY, V12, P155, DOI 10.1002/wps.20040; Grytten N, 2006, CHRONIC ILLN, V2, P195, DOI 10.1179/174592006X129482; Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069; Ingravallo F, 2012, SLEEP MED, V13, P1293, DOI 10.1016/j.sleep.2012.08.002; Jennum P, 2012, SLEEP MED, V13, P1086, DOI 10.1016/j.sleep.2012.06.006; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Logie C, 2009, AIDS CARE, V21, P742, DOI 10.1080/09540120802511877; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Merritt SL, 2004, SLEEP, V27, P240; Merritt SL, 1992, PSYCHOSOCIAL ASPECTS, V5, P53, DOI [10. 1300/ J132v05n03_ 06, DOI 10.1300/J132V05N03_]; Mittal D, 2012, PSYCHIAT SERV, V63, P974, DOI 10.1176/appi.ps.201100459; Morrison AP, 2013, BRIT J PSYCHIAT, V203, P140, DOI 10.1192/bjp.bp.112.123703; Ozaki A, 2012, SLEEP MED, V13, P200, DOI 10.1016/j.sleep.2011.07.014; Ozaki A, 2008, J CLIN SLEEP MED, V4, P572; Plazzi G, 2008, SLEEP MED REV, V12, P109, DOI 10.1016/j.smrv.2007.08.010; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Snead K, 2004, EPILEPSY BEHAV, V5, P547, DOI 10.1016/j.yebeh.2004.04.012; Stangl AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18734; Vignatelli L, 2011, SLEEP MED, V12, P19, DOI 10.1016/j.sleep.2010.07.008; Viteva E, 2013, SEIZURE-EUR J EPILEP, V22, P64, DOI 10.1016/j.seizure.2012.10.010; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398; Weaver TE, 2001, SLEEP MED REV, V5, P103, DOI 10.1053/smrv.2001.0152; Weaver TE, 1997, SLEEP, V20, P835; Weiss Mitchell G, 2006, Psychol Health Med, V11, P277; Whatley AD, 2010, HEALTH EDUC RES, V25, P575, DOI 10.1093/her/cyq001; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	50	37	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0122478	10.1371/journal.pone.0122478	http://dx.doi.org/10.1371/journal.pone.0122478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XJ	25898361	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600010
J	Martin-Rodriguez, AJ; Babarro, JMF; Lahoz, F; Sanson, M; Martin, VS; Norte, M; Fernandez, JJ				Martin-Rodriguez, Alberto J.; Babarro, Jose M. F.; Lahoz, Fernando; Sanson, Marta; Martin, Victor S.; Norte, Manuel; Fernandez, Jose J.			From Broad-Spectrum Biocides to Quorum Sensing Disruptors and Mussel Repellents: Antifouling Profile of Alkyl Triphenylphosphonium Salts	PLOS ONE			English	Article							QUATERNARY PHOSPHONIUM SALT; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; IN-VITRO; CHROMOBACTERIUM-VIOLACEUM; CYTOTOXIC ACTIVITY; RELEASE COATINGS; DNA RECOGNITION; IONIC LIQUIDS; AMMONIUM	'Onium' compounds, including ammonium and phosphonium salts, have been employed as antiseptics and disinfectants. These cationic biocides have been incorporated into multiple materials, principally to avoid bacterial attachment. In this work, we selected 20 alkyl-triphenylphosphonium salts, differing mainly in the length and functionalization of their alkyl chains, in fulfilment of two main objectives: 1) to provide a comprehensive evaluation of the antifouling profile of these molecules with relevant marine fouling organisms; and 2) to shed new light on their potential applications, beyond their classic use as broad-spectrum biocides. In this regard, we demonstrate for the first time that these compounds are also able to act as non-toxic quorum sensing disruptors in two different bacterial models (Chromobacterium violaceum and Vibrio harveyi) as well as repellents in the mussel Mytilus galloprovincialis. In addition, their inhibitory activity on a fouling-relevant enzymatic model (tyrosinase) is characterized. An analysis of the structure-activity relationships of these compounds for antifouling purposes is provided, which may result useful in the design of targeted antifouling solutions with these molecules. Altogether, the findings reported herein provide a different perspective on the biological activities of phosphonium compounds that is particularly focused on, but, as the reader will realize, is not limited to their use as antifouling agents.	[Martin-Rodriguez, Alberto J.; Martin, Victor S.; Norte, Manuel; Fernandez, Jose J.] Univ La Laguna, Ctr Biomed Res Canary Islands CIBICAN, Inst Bioorgan Chem Antonio Gonzalez, San Cristobal la Laguna 38206, Tenerife, Spain; [Martin-Rodriguez, Alberto J.] Ocean Platform Canary Islands PLOCAN, Telde 35214, Gran Canaria, Spain; [Babarro, Jose M. F.] CSIC, Inst Investigac Marinas, Dept Biotechnol & Aquaculture, Vigo 36208, Spain; [Lahoz, Fernando] Univ La Laguna, Fac Sci, Dept Fundamental & Expt Phys, San Cristobal la Laguna 38206, Tenerife, Spain; [Sanson, Marta] Univ La Laguna, Fac Sci, Dept Bot Ecol & Plant Physiol, San Cristobal la Laguna 38206, Tenerife, Spain	Universidad de la Laguna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); Universidad de la Laguna; Universidad de la Laguna	Fernandez, JJ (corresponding author), Univ La Laguna, Ctr Biomed Res Canary Islands CIBICAN, Inst Bioorgan Chem Antonio Gonzalez, Av Astrofis Francisco Sanchez 2, San Cristobal la Laguna 38206, Tenerife, Spain.	ajmartinr@ull.es; jjfercas@ull.es	Fernández, José Javier/AAA-3439-2019; Martín-Rodríguez, Alberto J./AAL-2520-2021; Martin, Victor/K-1760-2014; Fernandez, Jose/L-3343-2014; Sansón, Marta/F-9070-2016; Lahoz, Fernando/S-1251-2017; Babarro, Jose MF/F-1175-2016	Fernández, José Javier/0000-0002-0805-8317; Martín-Rodríguez, Alberto J./0000-0003-2422-129X; Martin, Victor/0000-0003-0300-9636; Fernandez, Jose/0000-0002-0805-8317; Lahoz, Fernando/0000-0001-8008-1696; Babarro, Jose/0000-0001-6352-1944; Norte, Manuel/0000-0003-2603-0796	Spanish Ministry of Economy and Competitiveness [SAF2011-28883-C03-01, CTQ2011-28417-C02-01/BQU, AGL2010-16464, MAT2013-40852-R]; Spanish Ministry of Education, Culture and Sport [CEI 10/00018]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Education, Culture and Sport(Spanish Government)	This study was supported by the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es/), SAF2011-28883-C03-01 (JJF), CTQ2011-28417-C02-01/BQU (VSM), AGL2010-16464 (JMFB), MAT2013-40852-R (FL); Spanish Ministry of Education, Culture and Sport (http://www.mecd.gob.es/portada-mecd/), CEI 10/00018 (MN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EB, 2010, THESIS VIRGINIA POLY; Anthierens T, 2012, INNOV FOOD SCI EMERG, V15, P81, DOI 10.1016/j.ifset.2012.02.010; Arendrup MC, 2014, EDEF92 ESCMID AFST E; ATKINSON S, 2007, BIOFILM MODE LIFE ME, P95; Bachowska B, 2012, CHEMISTRYOPEN, V1, P33, DOI 10.1002/open.201100003; Bandara N, 2013, J ADHES SCI TECHNOL, V27, P1; Bansal R, 2012, J MATER CHEM, V22, P25427, DOI 10.1039/c2jm35243e; BEAUMONT AR, 1984, MAR POLLUT BULL, V15, P402, DOI 10.1016/0025-326X(84)90256-X; Belikova NA, 2009, FEBS LETT, V583, P1945, DOI 10.1016/j.febslet.2009.04.050; Biswas S, 2012, BIOMATERIALS, V33, P4773, DOI 10.1016/j.biomaterials.2012.03.032; Bridier A, 2011, BIOFOULING, V27, P1017, DOI 10.1080/08927014.2011.626899; Brumaghim JL, 2004, EUR J ORG CHEM, V2004, P4552, DOI 10.1002/ejoc.200400428; Burgess JG, 2003, BIOFOULING, V19, P197, DOI 10.1080/0892701031000061778; Busscher HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002440; Cai X, 2013, LANGMUIR, V29, P5279, DOI 10.1021/la400824f; Callow ME, 1997, J PHYCOL, V33, P938, DOI 10.1111/j.0022-3646.1997.00938.x; Chambers LD, 2011, INT BIODETER BIODEGR, V65, P939, DOI 10.1016/j.ibiod.2011.07.002; Chang HI, 2010, REACT FUNCT POLYM, V70, P944, DOI 10.1016/j.reactfunctpolym.2010.09.005; Clinical and Laboratory Standards Institute, 2012, METH DIL ANT SUSC TE, V32; Dahms HU, 2009, WOODHEAD PUBL MATER, P275, DOI 10.1533/9781845696313.2.275; Decker JT, 2013, LANGMUIR, V29, P13023, DOI 10.1021/la402952u; Defoirdt T, 2007, TRENDS BIOTECHNOL, V25, P472, DOI 10.1016/j.tibtech.2007.08.001; Dobretsov S, 2007, FEMS MICROBIOL ECOL, V60, P177, DOI 10.1111/j.1574-6941.2007.00285.x; Dobretsov S, 2011, BIOFOULING, V27, P869, DOI 10.1080/08927014.2011.607233; FLETCHER RL, 1989, INT BIODETERIOR, V25, P407, DOI 10.1016/0265-3036(89)90067-5; Fusetani N, 2011, NAT PROD REP, V28, P400, DOI 10.1039/c0np00034e; Garcia-Arguelles S, 2013, LANGMUIR, V29, P9525, DOI 10.1021/la401353r; Garcia-Borron JC, 2002, PIGM CELL RES, V15, P162, DOI 10.1034/j.1600-0749.2002.02012.x; Gilbert P, 2005, J APPL MICROBIOL, V99, P703, DOI 10.1111/j.1365-2672.2005.02664.x; GREENBERG EP, 1979, ARCH MICROBIOL, V120, P87, DOI 10.1007/BF00409093; Hatakeyama ES, 2009, J MEMBRANE SCI, V330, P104, DOI 10.1016/j.memsci.2008.12.049; Hayashi Y., 1996, J MAR BIOTECHNOL, V4, P127; Hemp ST, 2013, MACROMOL CHEM PHYS, V214, P2099, DOI 10.1002/macp.201300322; Hertiani T, 2010, BIOORGAN MED CHEM, V18, P1297, DOI 10.1016/j.bmc.2009.12.028; Huang YL, 2007, APPL ENVIRON MICROB, V73, P6284, DOI 10.1128/AEM.00578-07; Huang YL, 2007, MICROB ECOL, V54, P384, DOI 10.1007/s00248-007-9210-9; Jellali R, 2013, PROG ORG COAT, V76, P1203, DOI 10.1016/j.porgcoat.2013.03.028; Jung K, 2011, NAT CHEM BIOL, V7, P502, DOI 10.1038/nchembio.618; KANAZAWA A, 1993, J POLYM SCI POL CHEM, V31, P335, DOI 10.1002/pola.1993.080310205; KANAZAWA A, 1994, ANTIMICROB AGENTS CH, V38, P945, DOI 10.1128/AAC.38.5.945; Kanazawa A, 2000, ANGEW CHEM INT EDIT, V39, P612, DOI 10.1002/(SICI)1521-3773(20000204)39:3<612::AID-ANIE612>3.0.CO;2-F; Kenawy ER, 2006, REACT FUNCT POLYM, V66, P419, DOI 10.1016/j.reactfunctpolym.2005.09.002; Kim D, 2006, J AGR FOOD CHEM, V54, P935, DOI 10.1021/jf0521855; Kumar V, 2009, BIOORG MED CHEM LETT, V19, P4643, DOI 10.1016/j.bmcl.2009.06.086; Lai JQ, 2011, GREEN CHEM, V13, P1860, DOI 10.1039/c1gc15140a; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd; Lejars M, 2012, CHEM REV, V112, P4347, DOI 10.1021/cr200350v; Li C, 2013, MATER LETT, V93, P145, DOI 10.1016/j.matlet.2012.11.045; Long CJ, 2010, BIOFOULING, V26, P941, DOI 10.1080/08927014.2010.531390; Maguire R.J., 1987, Applied Organometallic Chemistry, V1, P475, DOI 10.1002/aoc.590010602; Majumdar P, 2008, BIOFOULING, V24, P185, DOI 10.1080/08927010801894660; Manetta A, 1996, GYNECOL ONCOL, V60, P203, DOI 10.1006/gyno.1996.0026; Martin-Rodriguez AJ, 2014, MAR DRUGS, V12, P5503, DOI 10.3390/md12115503; Martinelli D, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-25; Millard M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013131; Moore LE, 2008, APPL ENVIRON MICROB, V74, P4825, DOI 10.1128/AEM.00573-08; Olsen SM, 2010, PROG ORG COAT, V68, P248, DOI 10.1016/j.porgcoat.2010.01.003; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Peach KC, 2011, MOL BIOSYST, V7, P1176, DOI 10.1039/c0mb00276c; Pellizzari F, 2013, BOT MAR, V56, P197, DOI 10.1515/bot-2012-0197; Pompeani AJ, 2008, MOL MICROBIOL, V70, P76, DOI 10.1111/j.1365-2958.2008.06389.x; Prasad M, 2004, J PHYS CHEM B, V108, P355, DOI 10.1021/jp036358+; Qian PY, 2007, MAR BIOTECHNOL, V9, P399, DOI 10.1007/s10126-007-9001-9; Qian P.-Y., 2012, HDB MARINE NATURAL P, P749; Qian PY, 2013, BIOFOULING, V29, P381, DOI 10.1080/08927014.2013.776546; Rambali B, 2001, J ANTIMICROB CHEMOTH, V48, P163, DOI 10.1093/jac/48.2.163; Regina VR, 2012, ACS APPL MATER INTER, V4, P5915, DOI 10.1021/am301554m; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Sanchez-Amat A, 2010, MAR DRUGS, V8, P519, DOI 10.3390/md8030519; Shrout JD, 2011, MRS BULL, V36, P367, DOI 10.1557/mrs.2011.67; Siedenbiedel F, 2012, POLYMERS-BASEL, V4, P46, DOI 10.3390/polym4010046; Silverman HG, 2007, MAR BIOTECHNOL, V9, P661, DOI 10.1007/s10126-007-9053-x; Smith RAJ, 2003, P NATL ACAD SCI USA, V100, P5407, DOI 10.1073/pnas.0931245100; Smith RAJ, 2012, TRENDS PHARMACOL SCI, V33, P341, DOI 10.1016/j.tips.2012.03.010; Solomon MA, 2013, MITOCHONDRION, V13, P464, DOI 10.1016/j.mito.2012.10.013; Soulere L, 2010, BIOORG MED CHEM LETT, V20, P4355, DOI 10.1016/j.bmcl.2010.06.081; Souza PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048589; Stauff DL, 2011, J BACTERIOL, V193, P3871, DOI 10.1128/JB.05125-11; Thalmann CR, 2002, EUR FOOD RES TECHNOL, V214, P276, DOI 10.1007/s00217-001-0455-0; Twigg MS, 2014, ENVIRON MICROBIOL, V16, P445, DOI 10.1111/1462-2920.12203; Uraguchi D, 2011, ANGEW CHEM INT EDIT, V50, P3681, DOI 10.1002/anie.201007752; VALKIRS AO, 1987, CHEMOSPHERE, V16, P201, DOI 10.1016/0045-6535(87)90124-X; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Vandeputte OM, 2010, APPL ENVIRON MICROB, V76, P243, DOI 10.1128/AEM.01059-09; Wahl M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00292; Wang K, 2012, DESALINATION, V292, P119, DOI 10.1016/j.desal.2012.02.016; Warren CR, 2008, J PLANT NUTR, V31, P1321, DOI 10.1080/01904160802135092; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Wu T, 2011, COLLOID SURFACE B, V86, P232, DOI 10.1016/j.colsurfb.2011.04.009; Yang ZC, 2012, J ORG CHEM, V77, P3191, DOI 10.1021/jo202642a; Yebra DM, 2004, PROG ORG COAT, V50, P75, DOI 10.1016/j.porgcoat.2003.06.001	91	30	31	5	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123652	10.1371/journal.pone.0123652	http://dx.doi.org/10.1371/journal.pone.0123652			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897858	Green Published, gold			2022-12-27	WOS:000353212600039
J	Tripathi, S; Chabtini, L; Dakle, PJ; Smith, B; Akiba, H; Yagita, H; Guleria, I				Tripathi, Sudipta; Chabtini, Lola; Dakle, Pranal J.; Smith, Brian; Akiba, Hisaya; Yagita, Hideo; Guleria, Indira			Effect of TIM-3 Blockade on the Immunophenotype and Cytokine Profile of Murine Uterine NK Cells	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; METRIAL GLAND-CELLS; INNATE IMMUNE CELLS; CHRONIC HEPATITIS-B; SUPPRESSOR-CELLS; RECEPTORS; PREGNANCY; DIFFERENTIATION; REPERTOIRE; MICE	NK cells are the most abundant lymphocyte population in the feto-maternal interface during gestation. The uterine NK cells (uNK) are transient, have a unique immunophenotype and produce a number of cytokines. These cytokines play an important role in establishment and maintenance of vascular remodeling and tolerance associated with successful pregnancy. The uNK cells also express TIM-3 during gestation and blockade of TIM-3 expression results in fetal loss in mice. In this study we determined the effect of TIM-3 blockade on uNK cells. Specifically we observed surface receptor phenotype and cytokine production by uNK cells following TIM-3 blockade. Our results show that TIM-3 plays a role in regulating the uNK cells and contributes to the maintenance of tolerance at the feto-maternal interface.	[Tripathi, Sudipta; Chabtini, Lola; Dakle, Pranal J.; Smith, Brian; Guleria, Indira] Harvard Univ, Sch Med, Div Renal, Childrens Hosp Boston, Boston, MA 02163 USA; [Akiba, Hisaya; Yagita, Hideo] Juntendo Univ, Dept Immunol, Tokyo, Japan	Harvard University; Boston Children's Hospital; Harvard Medical School; Juntendo University	Guleria, I (corresponding author), Harvard Univ, Sch Med, Div Renal, Childrens Hosp Boston, Boston, MA 02163 USA.	Indira.Guleria@childrens.harvard.edu			National Institutes of Health [RO1 AI84756-01A2, R21AI076794]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076794, R01AI084756] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25461503] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from the National Institutes of Health (RO1 AI84756-01A2 and R21AI076794 to I.G.).	Anderson AC, 2012, CURR OPIN IMMUNOL, V24, P213, DOI 10.1016/j.coi.2011.12.005; Ashkar AA, 2003, J IMMUNOL, V171, P2937, DOI 10.4049/jimmunol.171.6.2937; Barber EM, 2003, J IMMUNOL, V171, P37, DOI 10.4049/jimmunol.171.1.37; Carlyle JR, 2006, J IMMUNOL, V176, P7511, DOI 10.4049/jimmunol.176.12.7511; Chabtini L, 2013, J IMMUNOL, V190, P88, DOI 10.4049/jimmunol.1202176; Chazara O, 2011, J LEUKOCYTE BIOL, V90, P703, DOI 10.1189/jlb.0511227; Christiansen OB, 2013, MOL IMMUNOL, V55, P8, DOI 10.1016/j.molimm.2012.08.025; Croy BA, 2006, IMMUNOL REV, V214, P161; Croy BA, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102830; DAMJANOV A, 1992, J REPROD FERTIL, V95, P679; Dardalhon V, 2010, J IMMUNOL, V185, P1383, DOI 10.4049/jimmunol.0903275; Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x; Fu BQ, 2013, P NATL ACAD SCI USA, V110, pE231, DOI 10.1073/pnas.1206322110; Gleason MK, 2012, BLOOD, V119, P3064, DOI 10.1182/blood-2011-06-360321; Han GC, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00449; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Ju Y, 2010, J HEPATOL, V52, P322, DOI 10.1016/j.jhep.2009.12.005; Karimi K, 2012, J MOL MED, V90, P1047, DOI 10.1007/s00109-012-0872-5; Manaster I, 2010, AM J REPROD IMMUNOL, V63, P434, DOI 10.1111/j.1600-0897.2009.00794.x; Murphy SP, 2005, J IMMUNOL, V175, P4084, DOI 10.4049/jimmunol.175.6.4084; MURPHY SP, 2009, AM J OBSTET GYNECOL, V200, P308, DOI DOI 10.1016/J.AJ0G.2008.10.043; Ndhlovu LC, 2012, BLOOD, V119, P3734, DOI 10.1182/blood-2011-11-392951; Paffaro VA, 2003, PLACENTA, V24, P479, DOI 10.1053/plac.2002.0919; Park YJ, 2013, CANCER RES, V73, P5669, DOI 10.1158/0008-5472.CAN-13-0545; Patel J, 2012, IMMUNOTHERAPY-UK, V4, P1795, DOI [10.2217/IMT.12.126, 10.2217/imt.12.126]; Rahim MMA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00145; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Robertson SA, 2007, BIOL REPROD, V76, P738, DOI 10.1095/biolreprod.106.056143; Sheppard S, 2013, BLOOD, V121, P5025, DOI 10.1182/blood-2012-12-471607; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Tang ZH, 2013, J IMMUNOL, V190, P1788, DOI 10.4049/jimmunol.1202814; Varla-Leftherioti M, 2005, HUM IMMUNOL, V66, P65, DOI 10.1016/j.humimm.2004.10.005; Varla-Leftherioti M, 2003, AM J REPROD IMMUNOL, V49, P183, DOI 10.1034/j.1600-0897.2003.00018.x; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Wang CL, 2003, MICROSC RES TECHNIQ, V60, P420, DOI 10.1002/jemt.10280; Wu W, 2012, EUR J IMMUNOL, V42, P1180, DOI 10.1002/eji.201141852; Yadi H, 2008, J IMMUNOL, V181, P6140, DOI 10.4049/jimmunol.181.9.6140; Ye WG, 1996, J EXP MED, V184, P2405, DOI 10.1084/jem.184.6.2405; Yeung MY, 2011, AM J TRANSPLANT, V11, P2012, DOI 10.1111/j.1600-6143.2011.03727.x; Zhang JH, 2005, CELL MOL IMMUNOL, V2, P123; Zhao J, 2009, J IMMUNOL, V182, P6618, DOI 10.4049/jimmunol.0803876	41	10	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123439	10.1371/journal.pone.0123439	http://dx.doi.org/10.1371/journal.pone.0123439			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897749	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600025
J	Dedukh, D; Litvinchuk, S; Rosanov, J; Mazepa, G; Saifitdinova, A; Shabanov, D; Krasikova, A				Dedukh, Dmitry; Litvinchuk, Spartak; Rosanov, Juriy; Mazepa, Glib; Saifitdinova, Alsu; Shabanov, Dmitry; Krasikova, Alla			Optional Endoreplication and Selective Elimination of Parental Genomes during Oogenesis in Diploid and Triploid Hybrid European Water Frogs	PLOS ONE			English	Article							RANA-ESCULENTA; LAMPBRUSH CHROMOSOMES; GYNOGENESIS; TELEOSTEI; EXCLUSION; LOACH	Incompatibilities between parental genomes decrease viability of interspecific hybrids; however, deviations from canonical gametogenesis such as genome endoreplication and elimination can rescue hybrid organisms. To evaluate frequency and regularity of genome elimination and endoreplication during gametogenesis in hybrid animals with different ploidy, we examined genome composition in oocytes of di- and triploid hybrid frogs of the Pelophylax esculentus complex. Obtained results allowed us to suggest that during oogenesis the endoreplication involves all genomes occurring before the selective genome elimination. We accepted the hypothesis that only elimination of one copied genome occurs premeiotically in most of triploid hybrid females. At the same time, we rejected the hypothesis stating that the genome of parental species hybrid frogs co-exist with is always eliminated during oogenesis in diploid hybrids. Diploid hybrid frogs demonstrate an enlarged frequency of deviations in oogenesis comparatively to triploid hybrids. Typical for hybrid frogs deviations in gametogenesis increase variability of produced gametes and provide a mechanism for appearance of different forms of hybrids.	[Dedukh, Dmitry; Saifitdinova, Alsu; Krasikova, Alla] St Petersburg State Univ, St Petersburg 199034, Russia; [Litvinchuk, Spartak; Rosanov, Juriy] Russian Acad Sci, Inst Cytol, St Petersburg 196140, Russia; [Mazepa, Glib] Uppsala Univ, Evolutionary Biol Ctr, Dept Ecol & Genet, Uppsala, Sweden; [Mazepa, Glib; Shabanov, Dmitry] Kharkov Natl Univ, Kharkiv, Ukraine	Saint Petersburg State University; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Uppsala University; Ministry of Education & Science of Ukraine; VN Karazin Kharkiv National University	Krasikova, A (corresponding author), St Petersburg State Univ, St Petersburg 199034, Russia.	alla.krasikova@gmail.com	Dedukh, Dmitrij/H-8403-2013; Shabanov, Dmitry/N-3128-2019; Krasikova, Alla/E-4767-2011; Rozanov, Yuriy M./K-2158-2018; Dedukh, Dmitrij/AAE-8994-2022; Litvinchuk, Spartak N/F-1929-2017; Saifitdinova, Alsu F/C-1104-2011; Shabanov, Dmitry A./J-5370-2014	Dedukh, Dmitrij/0000-0002-1152-813X; Shabanov, Dmitry/0000-0003-3247-6882; Krasikova, Alla/0000-0002-6571-5328; Dedukh, Dmitrij/0000-0002-1152-813X; Saifitdinova, Alsu F/0000-0002-1221-479X; Shabanov, Dmitry A./0000-0003-3247-6882; Litvinchuk, Spartak/0000-0001-7447-6691; Mazepa, Glib/0000-0001-6555-1434	Russian Foundation for Basic Research [12-04-01277]; President of Russia [NS-3553.2014.4, JC-3609.2014.4]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); President of Russia	This work was funded in part by the Russian Foundation for Basic Research (http://www.rfbr.ru/rffi/eng) grant 12-04-01277 to SL and JR and by the grants of the President of Russia (https://grants.extech.ru/) NS-3553.2014.4 to AK, DD and AS and JC-3609.2014.4 to AK and DD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves MJ, 1998, MOL BIOL EVOL, V15, P1233, DOI 10.1093/oxfordjournals.molbev.a025852; ARNOLD ML, 1995, TRENDS ECOL EVOL, V10, P67, DOI 10.1016/S0169-5347(00)88979-X; Berger L, 1970, ANN ZOOL FENN, V27, P374; Bogart JP, 2007, GENOME, V50, P119, DOI 10.1139/G06-152; Borkin LJ, 2004, RUSS J HERPETOL, V11, P194; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brown JD, 2010, ANNU REV GENOM HUM G, V11, P291, DOI 10.1146/annurev-genom-082509-141554; BUCCI S, 1990, J EXP ZOOL, V255, P37, DOI 10.1002/jez.1402550107; Callan H G, 1986, Mol Biol Biochem Biophys, V36, P1; Chapman MA, 2007, EVOLUTION, V61, P1773, DOI 10.1111/j.1558-5646.2007.00134.x; Christiansen DG, 2009, EVOLUTION, V63, P1754, DOI 10.1111/j.1558-5646.2009.00673.x; CIMINO MC, 1972, EVOLUTION, V26, P294, DOI 10.1111/j.1558-5646.1972.tb00195.x; Dedukh D, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-26; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; GALL JG, 1991, METHOD CELL BIOL, V36, P149; Gernand D, 2005, PLANT CELL, V17, P2431, DOI 10.1105/tpc.105.034249; GIORGI F, 1972, CARYOLOGIA, V25, P107, DOI 10.1080/00087114.1972.10796470; GRAF JD, 1979, EXPERIENTIA, V35, P1574, DOI 10.1007/BF01953200; Graf Jean-Daniel, 1989, New York State Museum Bulletin, V466, P289; Herrick Glenn, 1999, Results and Problems in Cell Differentiation, V25, P41; Itono M, 2006, J EXP ZOOL PART A, V305A, P513, DOI 10.1002/jez.a.283; Kearney M, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P447, DOI 10.1007/978-90-481-2770-2_21; Korshunov AV, 2009, KHARKOV NAT U J, V8, P48; Krasikova A, 2004, CHROMOSOMA, V113, P316, DOI 10.1007/s00412-004-0321-5; Krasikova A, 2012, CHROMOSOME RES, V20, P979, DOI 10.1007/s10577-012-9327-7; Lamatsch DK, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P399, DOI 10.1007/978-90-481-2770-2_19; Litvinchuk Spartak N., 2004, Asiatic Herpetological Research, V10, P282; Lutes AA, 2010, NATURE, V464, P283, DOI 10.1038/nature08818; MACGREGOR HC, 1990, J EVOLUTION BIOL, V3, P329, DOI 10.1046/j.1420-9101.1990.3050329.x; MACGREGOR HC, 1964, SCIENCE, V143, P1043, DOI 10.1126/science.143.3610.1043; Neaves WB, 2011, TRENDS GENET, V27, P81, DOI 10.1016/j.tig.2010.12.002; Ogielska M., 1994, ZOOL POLONIAE, V39, P461; Plotner J., 2005, W PALEARCTIC WATER F, P1; Pruvost NBM, 2013, ECOL EVOL, V3, P2933, DOI 10.1002/ece3.687; Shabanov DA, 2006, KHARKOV NAT U J, V3, P208; Stenberg P, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P63, DOI 10.1007/978-90-481-2770-2_4; Stock M, 2012, P ROY SOC B-BIOL SCI, V279, P1293, DOI 10.1098/rspb.2011.1738; TUNNER HG, 1981, NATURWISSENSCHAFTEN, V68, P207, DOI 10.1007/BF01047207; TUNNER HG, 1991, NATURWISSENSCHAFTEN, V78, P32, DOI 10.1007/BF01134041; TUNNER HG, 1973, NATURWISSENSCHAFTEN, V60, P481; Uzzell T., 1979, Mitteilungen aus dem Zoologischen Museum in Berlin, V55, P13; VINOGRADOV AE, 1990, GENOME, V33, P619, DOI 10.1139/g90-092; VINOGRADOV AE, 1991, HEREDITAS, V114, P245, DOI 10.1111/j.1601-5223.1991.tb00331.x; YAMASHITA M, 1993, DEV GROWTH DIFFER, V35, P631; Zalesna A, 2011, CYTOGENET GENOME RES, V134, P206, DOI 10.1159/000327716; Zhang QQ, 1998, J EXP ZOOL, V281, P608, DOI 10.1002/(SICI)1097-010X(19980815)281:6&lt;608::AID-JEZ9&gt;3.0.CO;2-R	46	23	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123304	10.1371/journal.pone.0123304	http://dx.doi.org/10.1371/journal.pone.0123304			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894314	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700033
J	Dutta, DK; Potnis, PA; Rhodes, K; Wood, SC				Dutta, Debargh K.; Potnis, Pushya A.; Rhodes, Kelly; Wood, Steven C.			Wear Particles Derived from Metal Hip Implants Induce the Generation of Multinucleated Giant Cells in a 3-Dimensional Peripheral Tissue-Equivalent Model	PLOS ONE			English	Article							TOTAL JOINT ARTHROPLASTIES; COBALT-ALLOY PARTICLES; ACID-PHOSPHATASE TRAP; IN-VITRO; OSTEOCLAST DIFFERENTIATION; ORTHOPEDIC IMPLANTS; ENDOTHELIAL-CELLS; BONE; MACROPHAGES; EXPRESSION	Multinucleate giant cells (MGCs) are formed by the fusion of 5 to 15 monocytes or macrophages. MGCs can be generated by hip implants at the site where the metal surface of the device is in close contact with tissue. MGCs play a critical role in the inflammatory processes associated with adverse events such as aseptic loosening of the prosthetic joints and bone degeneration process called osteolysis. Upon interaction with metal wear particles, endothelial cells upregulate pro-inflammatory cytokines and other factors that enhance a localized immune response. However, the role of endothelial cells in the generation of MGCs has not been completely investigated. We developed a three-dimensional peripheral tissue-equivalent model (PTE) consisting of collagen gel, supporting a monolayer of endothelial cells and human peripheral blood mononuclear cells (PBMCs) on top, which mimics peripheral tissue under normal physiological conditions. The cultures were incubated for 14 days with Cobalt chromium alloy (CoCr ASTM F75, 1-5 micron) wear particles. PBMC were allowed to transit the endothelium and harvested cells were analyzed for MGC generation via flow cytometry. An increase in forward scatter (cell size) and in the propidium iodide (PI) uptake (DNA intercalating dye) was used to identify MGCs. Our results show that endothelial cells induce the generation of MGCs to a level 4 fold higher in 3-dimentional PTE system as compared to traditional 2-dimensional culture plates. Further characterization of MGCs showed upregulated expression of tartrate resistant alkaline phosphatase (TRAP) and dendritic cell specific transmembrane protein, (DC-STAMP), which are markers of bone degrading cells called osteoclasts. In sum, we have established a robust and relevant model to examine MGC and osteoclast formation in a tissue like environment using flow cytometry and RT-PCR. With endothelial cells help, we observed a consistent generation of metal wear particle-induced MGCs, which heralds metal on metal hip failures.	[Dutta, Debargh K.; Potnis, Pushya A.; Rhodes, Kelly; Wood, Steven C.] FDA, CDRH, Dept Biol Chem & Mat Sci, Off Sci & Engn Labs, Silver Spring, MD 20993 USA; [Dutta, Debargh K.] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA; [Rhodes, Kelly] Univ Maryland, College Pk, MD 20742 USA	US Food & Drug Administration (FDA); Uniformed Services University of the Health Sciences - USA; University System of Maryland; University of Maryland College Park	Dutta, DK (corresponding author), FDA, CDRH, Dept Biol Chem & Mat Sci, Off Sci & Engn Labs, Silver Spring, MD 20993 USA.	debargh.dutta@gmail.com	Dutta, Debargh/J-6086-2015	Dutta, Debargh/0000-0003-1517-0670	Office of Women's Health [14-01-0009-SW]; Food and Drug Administration	Office of Women's Health; Food and Drug Administration(United States Department of Health & Human Services)	This work was supported by Office of Women's Health, grant number#14-01-0009-SW; intramural funding from the Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSAFFAR N, 1994, J MATER SCI-MATER M, V5, P813, DOI 10.1007/BF00213140; Archibeck M J, 2001, Instr Course Lect, V50, P185; Campbell P, 2010, CLIN ORTHOP RELAT R, V468, P2321, DOI 10.1007/s11999-010-1372-y; Carli A, 2011, BULL HOSP JT DIS, V69, pS47; Choi J, 2013, CELL SIGNAL, V25, P1222, DOI 10.1016/j.cellsig.2013.02.015; Clarke SA, 2001, J BIOMED MATER RES, V57, P84, DOI 10.1002/1097-4636(200110)57:1<84::AID-JBM1145>3.0.CO;2-5; Cuckler JM, 2005, CLIN ORTHOP RELAT R, P132, DOI 10.1097/01.blo.0000193809.85587.f8; Dalal A, 2012, J BIOMED MATER RES A, V100A, P2147, DOI 10.1002/jbm.a.34122; Graves Stephen E, 2011, J Bone Joint Surg Am, V93 Suppl 3, P43, DOI 10.2106/JBJS.K.01220; Hayman AR, 2008, AUTOIMMUNITY, V41, P218, DOI 10.1080/08916930701694667; Jacobs JJ, 2001, CLIN ORTHOP RELAT R, P71; Kadoya Y, 1997, CLIN ORTHOP RELAT R, P118, DOI 10.1097/00003086-199707000-00016; Kadoya Y, 1996, J ORTHOP RES, V14, P473, DOI 10.1002/jor.1100140318; Knight Stephen Richard, 2011, Orthop Rev (Pavia), V3, pe16, DOI 10.4081/or.2011.e16; Kohara H, 2011, IMMUNOL LETT, V137, P53, DOI 10.1016/j.imlet.2011.02.017; Kondo Y, 2009, CLIN EXP IMMUNOL, V158, P84, DOI 10.1111/j.1365-2249.2009.03990.x; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; LINDUNGER A, 1990, BONE MINER, V10, P109, DOI 10.1016/0169-6009(90)90086-U; McFarlane T, 2004, J MATER SCI-MATER M, V15, P315, DOI 10.1023/B:JMSM.0000021094.50889.5c; Mensah KA, 2010, J CELL PHYSIOL, V223, P76, DOI 10.1002/jcp.22012; Miyamoto Takeshi, 2006, Mod Rheumatol, V16, P341; Miyamoto Takeshi, 2011, Keio Journal of Medicine, V60, P101; Miyazaki T, 2011, ANAL BIOCHEM, V410, P7, DOI 10.1016/j.ab.2010.11.014; Morita Y, 2010, CALCIFIED TISSUE INT, V86, P242, DOI 10.1007/s00223-010-9335-6; Nakano K, 2007, RHEUMATOLOGY, V46, P597, DOI 10.1093/rheumatology/kel356; Ninomiya JT, 2013, J ORTHOP RES, V31, P1484, DOI 10.1002/jor.22377; Ohtsuji M, 2014, MOD RHEUMATOL, P1; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Potnis PA, 2013, CELL IMMUNOL, V282, P53, DOI 10.1016/j.cellimm.2013.04.003; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Revell PA, 2008, J R SOC INTERFACE, V5, P1263, DOI 10.1098/rsif.2008.0142; Robinson E, 2014, ACTA ORTHOP, P1; Suuronen EJ, 2005, INT REV CYTOL, V244, P137, DOI 10.1016/S0074-7696(05)44004-8; Taylor RM, 2012, LAB INVEST, V92, P1398, DOI 10.1038/labinvest.2012.108; Wunschmann S, 2000, J CLIN MICROBIOL, V38, P3055; Yadav Jessica, 2013, Open Orthop J, V7, P605, DOI 10.2174/1874325001307010605; Yoshimatsu M, 2009, BONE, V45, P1010, DOI 10.1016/j.bone.2009.07.079	38	5	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124389	10.1371/journal.pone.0124389	http://dx.doi.org/10.1371/journal.pone.0124389			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894745	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700090
J	Ohta, K; Ichinose, M; Tohda, Y; Engel, M; Moroni-Zentgraf, P; Kunimitsu, S; Sakamoto, W; Adachi, M				Ohta, Ken; Ichinose, Masakazu; Tohda, Yuji; Engel, Michael; Moroni-Zentgraf, Petra; Kunimitsu, Satoko; Sakamoto, Wataru; Adachi, Mitsuru			Long-Term Once-Daily Tiotropium Respimat (R) Is Well Tolerated and Maintains Efficacy over 52 Weeks in Patients with Symptomatic Asthma in Japan: A Randomised, Placebo-Controlled Study	PLOS ONE			English	Article							LUNG-FUNCTION; RISK; INFECTION; GUIDELINE; ADULTS	Background This study assessed the long-term safety and efficacy of tiotropium Respimat, a long-acting inhaled anticholinergic bronchodilator, in asthma, added on to inhaled corticosteroids (ICS) with or without long-acting beta(2)-agonist (LABA). Methods 285 patients with symptomatic asthma, despite treatment with ICS +/- LABA, were randomised 2: 2: 1 to once-daily tiotropium 5 mu g, tiotropium 2.5 mu g or placebo for 52 weeks (via the Respimat SoftMist inhaler) added on to ICS +/- LABA, in a double-blind, placebo-controlled, parallel-group study (NCT01340209). Primary objective: to describe the long-term safety profile of tiotropium. Secondary end points included: trough forced expiratory volume in 1 second (FEV1) response; peak expiratory flow rate (PEFR) response; seven-question Asthma Control Questionnaire (ACQ-7) score. Results At Week 52, adverse-event (AE) rates with tiotropium 5 mu g, 2.5 mu g and placebo were 88.6%, 86.8% and 89.5%, respectively. Commonly reported AEs with tiotropium 5 mu g, 2.5 mu g and placebo were nasopharyngitis (48.2%, 44.7%, 42.1%), asthma (28.9%, 29.8%, 38.6%), decreased PEFR (15.8%, 7.9%, 21.1%), bronchitis (9.6%, 13.2%, 7.0%), pharyngitis (7.9%, 13.2%, 3.5%) and gastroenteritis (10.5%, 3.5%, 5.3%). In the tiotropium 5 mu g, 2.5 mu g and placebo groups, 8.8%, 5.3% and 5.3% of patients reported drug-related AEs; 3.5%, 3.5% and 15.8% reported serious AEs. Asthma worsening was the only serious AE reported in more than one patient. At Week 52, adjusted mean trough FEV1 and trough PEFR responses were significantly higher with tiotropium 5 mu g (but not 2.5 mu g) versus placebo. ACQ-7 responder rates were higher with tiotropium 5 mu g and 2.5 mu g versus placebo at Week 24. Conclusions The long-term tiotropium Respimat safety profile was comparable with that of placebo Respimat, and associated with mild to moderate, non-serious AEs in patients with symptomatic asthma despite ICS +/- LABA therapy. Compared with placebo, tiotropium 5 mu g, but not 2.5 mu g, significantly improved lung function and symptoms, supporting the long-term efficacy of the 5 mu g dose.	[Ohta, Ken] Tokyo Natl Hosp, Natl Hosp Org, Tokyo, Japan; [Ichinose, Masakazu] Tohoku Univ, Grad Sch Med, Dept Resp Med, Sendai, Miyagi 980, Japan; [Tohda, Yuji] Kinki Univ, Fac Med, Dept Resp Med & Allergol, Osakasayama City, Japan; [Engel, Michael; Moroni-Zentgraf, Petra] Boehringer Ingelheim Pharma GmbH & Co KG, TA Resp Dis, Ingelheim, Germany; [Kunimitsu, Satoko] Nippon Boehringer Ingelheim Co Ltd, Clin Trial Management Dept, Tokyo, Japan; [Sakamoto, Wataru] Nippon Boehringer Ingelheim Co Ltd, Med Data Serv Dept, Tokyo, Japan; [Adachi, Mitsuru] Int Univ Hlth & Welf, Sanno Hosp, Dept Clin Res Ctr, Tokyo, Japan	Tohoku University; Kindai University (Kinki University); Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; International University of Health & Welfare	Ohta, K (corresponding author), Tokyo Natl Hosp, Natl Hosp Org, Tokyo, Japan.	kenohta@tokyo-hosp.jp			Boehringer Ingelheim	Boehringer Ingelheim(Boehringer Ingelheim)	This work was supported by Boehringer Ingelheim who provided support in the form of salaries for authors ME, PMZ, SK and WS but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Bateman ED, 2013, EUR RESP SOC ANN C B; Bateman ED, 2014, THORAX, V69, P312, DOI 10.1136/thoraxjnl-2013-203600; Bateman ED, 2011, J ALLERGY CLIN IMMUN, V128, P315, DOI 10.1016/j.jaci.2011.06.004; Demoly P, 2009, EUR RESPIR REV, V18, P105, DOI 10.1183/09059180.00001209; Ducharme FM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005535.pub2; Fukuchi Y, 2011, RESPIROLOGY, V16, P825, DOI 10.1111/j.1440-1843.2011.01982.x; Global Initiative for Asthma, GLOB STRAT ASTHM MAN; Kerstjens HAM, 2013, EUR RESP J S57, V42, p876s; Kerstjens HAM, 2012, NEW ENGL J MED, V367, P1198, DOI 10.1056/NEJMoa1208606; Kerstjens HAM, 2011, J ALLERGY CLIN IMMUN, V128, P308, DOI 10.1016/j.jaci.2011.04.039; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Monto AS, 2001, CLIN THER, V23, P1615, DOI 10.1016/S0149-2918(01)80133-8; Ohta Ken, 2011, Allergology International, V60, P115, DOI 10.2332/allergolint.11-RAI-0327; Partridge MR, 2011, PRIM CARE RESP J, V20, P315, DOI 10.4104/pcrj.2011.00056; Peters SP, 2010, NEW ENGL J MED, V363, P1715, DOI 10.1056/NEJMoa1008770; Roche Hoffmann-La, 2013, PEGASYS HIGHLIGHTS O; Singh S, 2008, JAMA-J AM MED ASSOC, V300, P1439, DOI 10.1001/jama.300.12.1439; Spannhake EW, 2002, ENVIRON HEALTH PERSP, V110, P665, DOI 10.1289/ehp.02110665; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Wise RA, 2013, NEW ENGL J MED, V369, P1491, DOI 10.1056/NEJMoa1303342	21	67	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124109	10.1371/journal.pone.0124109	http://dx.doi.org/10.1371/journal.pone.0124109			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894430	Green Submitted, gold, Green Published			2022-12-27	WOS:000353211700073
J	Chung, DY; Cho, KS; Lee, DH; Han, JH; Kang, DH; Do Jung, H; Kown, JK; Ham, WS; Choi, YD; Lee, JY				Chung, Doo Yong; Cho, Kang Su; Lee, Dae Hun; Han, Jang Hee; Kang, Dong Hyuk; Do Jung, Hae; Kown, Jong Kyou; Ham, Won Sik; Choi, Young Deuk; Lee, Joo Yong			Impact of Colic Pain as a Significant Factor for Predicting the Stone Free Rate of One-Session Shock Wave Lithotripsy for Treating Ureter Stones: A Bayesian Logistic Regression Model Analysis	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; PROPENSITY SCORES; CLINICAL-EXPERIENCE; HOUNSFIELD UNITS; MEDICAL-RESEARCH; SUCCESS; CALCULI; PRINCIPLES; PATIENT	Purpose This study was conducted to evaluate colic pain as a prognostic pretreatment factor that can influence ureter stone clearance and to estimate the probability of stone-free status in shock wave lithotripsy (SWL) patients with a ureter stone. Materials and Methods We retrospectively reviewed the medical records of 1,418 patients who underwent their first SWL between 2005 and 2013. Among these patients, 551 had a ureter stone measuring 4-20 mm and were thus eligible for our analyses. The colic pain as the chief complaint was defined as either subjective flank pain during history taking and physical examination. Propensity-scores for established for colic pain was calculated for each patient using multivariate logistic regression based upon the following covariates: age, maximal stone length (MSL), and mean stone density (MSD). Each factor was evaluated as predictor for stone-free status by Bayesian and non-Bayesian logistic regression model. Results After propensity-score matching, 217 patients were extracted in each group from the total patient cohort. There were no statistical differences in variables used in propensity-score matching. One-session success and stone-free rate were also higher in the painful group (73.7% and 71.0%, respectively) than in the painless group (63.6% and 60.4%, respectively). In multivariate non-Bayesian and Bayesian logistic regression models, a painful stone, shorter MSL, and lower MSD were significant factors for one-session stone-free status in patients who underwent SWL. Conclusions Colic pain in patients with ureter calculi was one of the significant predicting factors including MSL and MSD for one-session stone-free status of SWL.	[Chung, Doo Yong; Han, Jang Hee; Do Jung, Hae; Ham, Won Sik; Choi, Young Deuk; Lee, Joo Yong] Yonsei Univ, Coll Med, Severance Hosp, Urol Sci Inst,Dept Urol, Seoul, South Korea; [Cho, Kang Su] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Urol Sci Inst,Dept Urol, Seoul, South Korea; [Lee, Dae Hun] Yonsei Univ Hlth Syst, Severance Check Up, Dept Urol, Seoul, South Korea; [Kang, Dong Hyuk] Yangpyeong Hlth Ctr, Dept Urol, Yangpyeong, South Korea; [Kown, Jong Kyou] Inje Univ, Haeundae Paik Hosp, Coll Med, Dept Urol, Busan, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Inje University	Lee, JY (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Urol Sci Inst,Dept Urol, Seoul, South Korea.	joouro@yuhs.ac	; Lee, Joo Yong/C-3851-2013	Choi, Young Deuk/0000-0002-8545-5797; Lee, Joo Yong/0000-0002-3470-1767; Cho, Kang Su/0000-0002-3500-8833; Ham, Won Sik/0000-0003-2246-8838				Bandi G, 2009, BJU INT, V103, P524, DOI 10.1111/j.1464-410X.2008.08069.x; Berry DA, 2006, NAT REV DRUG DISCOV, V5, P27, DOI 10.1038/nrd1927; BORGHI L, 1994, J UROLOGY, V152, P1095, DOI 10.1016/S0022-5347(17)32511-9; Cakiroglu B, 2014, INT J CLIN EXP MED, V7, P1276; CHAUSSY C, 1982, J UROLOGY, V127, P417, DOI 10.1016/S0022-5347(17)53841-0; Choi JW, 2012, KOREAN J UROL, V53, P424, DOI 10.4111/kju.2012.53.6.424; Cooper JT, 2000, UROLOGY, V56, P575, DOI 10.1016/S0090-4295(00)00658-0; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; El-Nahas AR, 2007, EUR UROL, V51, P1688, DOI 10.1016/j.eururo.2006.11.048; Elganainy Ehab, 2009, Int Arch Med, V2, P13, DOI 10.1186/1755-7682-2-13; ERTURK E, 1993, J UROLOGY, V149, P1425, DOI 10.1016/S0022-5347(17)36405-4; Hay KE, 2014, PREV VET MED; Jacobs BL, 2008, J ENDOUROL, V22, P1623, DOI 10.1089/end.2008.0169; Jee JY, 2013, KOREAN J UROL, V54, P865, DOI 10.4111/kju.2013.54.12.865; Lee JY, 2013, INT J UROL, V20, P1169, DOI 10.1111/iju.12144; Matlaga BR, 2009, J UROLOGY, V181, P2152, DOI 10.1016/j.juro.2009.01.023; MUELLER SC, 1986, J UROLOGY, V135, P831, DOI 10.1016/S0022-5347(17)45870-8; Musa AAK, 2008, INT UROL NEPHROL, V40, P19, DOI 10.1007/s11255-006-9030-8; Pareek G, 2005, UROLOGY, V65, P33, DOI 10.1016/j.urology.2004.08.004; Pareek G, 2003, J UROLOGY, V169, P1679, DOI 10.1097/01.ju.0000055608.92069.3a; Park J, 2013, WORLD J UROL, V31, P1569, DOI 10.1007/s00345-012-0966-2; Ringden I, 2007, SCAND J UROL NEPHROL, V41, P316, DOI 10.1080/00365590601154551; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Rubin DB, 2004, PHARMACOEPIDEM DR S, V13, P855, DOI 10.1002/pds.968; Sackett D.L., 1985, CLIN EPIDEMIOLOGY BA; Sarica K, 2014, UROLITHIASIS; Seitz C, 2007, EUR UROL, V52, P1223, DOI 10.1016/j.eururo.2007.02.001; Seitz C, 2006, EUR UROL, V49, P1099, DOI 10.1016/j.eururo.2005.12.003; Tanaka M, 2013, KOREAN J UROL, V54, P454, DOI 10.4111/kju.2013.54.7.454; Tombal B, 2005, EUR UROL, V47, P855, DOI 10.1016/j.eururo.2005.03.006; Weitzen S, 2004, PHARMACOEPIDEM DR S, V13, P841, DOI 10.1002/pds.969; Weld KJ, 2007, UROLOGY, V70, P1043, DOI 10.1016/j.urology.2007.07.074	32	51	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0123800	10.1371/journal.pone.0123800	http://dx.doi.org/10.1371/journal.pone.0123800			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902059	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500064
J	E, ZG; Zhang, YP; Li, TT; Wang, L; Zhao, HM				E, Zhiguo; Zhang, Yuping; Li, Tingting; Wang, Lei; Zhao, Heming			Characterization of the Ubiquitin-Conjugating Enzyme Gene Family in Rice and Evaluation of Expression Profiles under Abiotic Stresses and Hormone Treatments	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; PROTEASOME SYSTEM; E2; PROTEIN; MECHANISMS; PHOSPHATE; CLASSIFICATION; EXTENSION; SOFTWARE; LIGASE	Ubiquitin-conjugating enzyme E2s (UBCs), which catalyze the transfer of ubiquitin to substrate or E3 ligases, are key enzymes in ubiquitination modifications of target proteins. However, little is known about the knowledge of UBC gene family in rice. In this study, a total of 39 UBC encoding genes, which all contained an UBC domain with a cysteine active site, were identified in the rice genome. These were classified into fifteen distinct subfamilies based upon their sequence similarity and phylogenetic relationships. A subset of 19 OsUBC genes exhibited chromosomal duplication; 4 and 15 OsUBC genes were tandemly and segmentally duplicated, respectively. Comprehensive analyses were performed to investigate the expression profiles of OsUBC genes in various stages of vegetative and reproductive development using data from EST, Microarrays, MPSS, and real-time PCR. Many OsUBC genes exhibited abundant and tissue-specific expression patterns. Moreover, 14 OsUBCs were found to be differentially expressed under treatments with drought, or salt stresses. The expression analysis after treatments with IAA, 6-BA, GA and ABA indicated that almost all OsUBC genes were responsive to at least two of the four hormones. Several genes were significantly down-regulated under all of the hormone treatments, and most of the genes reduced by 6-BA were also reduced by GA. This study will facilitate further studies of the OsUBC gene family and provide useful clues for functional validation of OsUBCs in rice.	[E, Zhiguo; Zhang, Yuping; Li, Tingting; Wang, Lei] China Natl Rice Res Inst, Hangzhou 310006, Zhejiang, Peoples R China; [Zhao, Heming] Fujian Agr & Forestry Univ, Ctr Genom & Biotechnol, Fuzhou 350002, Fujian Province, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Fujian Agriculture & Forestry University	Wang, L (corresponding author), China Natl Rice Res Inst, 359 Tiyuchang Rd, Hangzhou 310006, Zhejiang, Peoples R China.	wanglei05@caas.cn; zhaoheming@whu.edu.cn			special fund for Agro-Scientific Research in the Public Interest [201203031, 201203029, 201003016]; Special Foundation for Basic Research and the Development of Central Level Scientific Research Institutes in China [2012RG006]; Life Science and Technology Center, China National Seed Group Co., Ltd.	special fund for Agro-Scientific Research in the Public Interest; Special Foundation for Basic Research and the Development of Central Level Scientific Research Institutes in China; Life Science and Technology Center, China National Seed Group Co., Ltd.	This research was supported by the special fund for Agro-Scientific Research in the Public Interest (201203031, 201203029, 201003016) and the Special Foundation for Basic Research and the Development of Central Level Scientific Research Institutes in China (2012RG006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Heming Zhao is employed by Life Science and Technology Center, China National Seed Group Co., Ltd. Life Science and Technology Center, China National Seed Group Co., Ltd. provided support in the form of salary for author HZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arrigoni A, 2012, J STRUCT BIOL, V178, P245, DOI 10.1016/j.jsb.2012.04.003; Aung K, 2006, PLANT PHYSIOL, V141, P1000, DOI 10.1104/pp.106.078063; Bae H, 2014, BIOCHEM BIOPH RES CO, V444, P575, DOI 10.1016/j.bbrc.2014.01.098; Bae H, 2013, BIOCHEM BIOPH RES CO, V433, P266, DOI 10.1016/j.bbrc.2013.03.005; Baloglu MC, 2014, BIOCHEM GENET, V52, P90, DOI 10.1007/s10528-013-9630-9; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Chung E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066056; Cooper B, 2003, P NATL ACAD SCI USA, V100, P4945, DOI 10.1073/pnas.0737574100; Criqui MC, 2002, PLANT PHYSIOL, V130, P1230, DOI 10.1104/pp.011353; Cui F, 2012, PLANT CELL, V24, P233, DOI 10.1105/tpc.111.093062; Dong B, 1998, PLANTA, V205, P251, DOI 10.1007/s004250050318; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jeon EH, 2012, BIOCHEM BIOPH RES CO, V427, P309, DOI 10.1016/j.bbrc.2012.09.048; Jones S, 2001, GENOME BIOL, V2; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; Li WF, 2010, PLANT J, V62, P330, DOI 10.1111/j.1365-313X.2010.04150.x; Lin WY, 2009, J EXP BOT, V60, P1427, DOI 10.1093/jxb/ern303; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Ma HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025184; Ma HL, 2010, J EXP BOT, V61, P2647, DOI 10.1093/jxb/erq104; Michelle C, 2009, J MOL EVOL, V68, P616, DOI 10.1007/s00239-009-9225-6; Papaleo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040786; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Sadanandom A, 2012, NEW PHYTOL, V196, P13, DOI 10.1111/j.1469-8137.2012.04266.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schumacher FR, 2013, J MOL BIOL, V425, P4099, DOI 10.1016/j.jmb.2013.06.039; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Takai R, 2002, PLANT J, V30, P447, DOI 10.1046/j.1365-313X.2002.01299.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Vierstra RD, 1996, PLANT MOL BIOL, V32, P275, DOI 10.1007/BF00039386; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wan XR, 2011, J BIOSCI BIOENG, V111, P478, DOI 10.1016/j.jbiosc.2010.11.021; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wen R, 2006, PLANT MOL BIOL, V61, P241, DOI 10.1007/s11103-006-0007-x; Xu L, 2009, PLANT J, V57, P279, DOI 10.1111/j.1365-313X.2008.03684.x; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zhang XW, 2013, GENE, V530, P185, DOI 10.1016/j.gene.2013.08.048; Zhao HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049210; Zhou GA, 2010, PLANT MOL BIOL, V72, P357, DOI 10.1007/s11103-009-9575-x	47	35	39	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122621	10.1371/journal.pone.0122621	http://dx.doi.org/10.1371/journal.pone.0122621			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902049	Green Published, gold, Green Submitted			2022-12-27	WOS:000353331500024
J	Kierny, MR; Cunningham, TD; Bouhenni, RA; Edward, DP; Kay, BK				Kierny, Michael R.; Cunningham, Thomas D.; Bouhenni, Rachida A.; Edward, Deepak P.; Kay, Brian K.			Generating Recombinant Antibodies against Putative Biomarkers of Retinal Injury	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; HUMAN PLASMA; LASER; ANTIGENS; CANCER; PHAGE; SERUM; EXPRESSION; PEPTIDES; PROTEINS	Candidate biomarkers, indicative of disease or injury, are beginning to overwhelm the process of validation through immunological means. Recombinant antibodies developed through phage-display offer an alternative means of generating monoclonal antibodies faster than traditional immunization of animals. Peptide segments of putative biomarkers of laser induced injury in the rabbit, discovered through mass spectrometry, were used as targets for a selection against a library of phage-displayed human single-chain variable fragment (scFv) antibodies. Highly specific antibodies were isolated to four of these unique peptide sequences. One antibody against the retinal protein, Guanine Nucleotide-Binding Protein Beta 5 (GBB5), had a dissociation constant similar to 300 nM and recognized the full-length endogenous protein in retinal homogenates of three different animal species by western blot. Alanine scanning of the peptide target identified three charged and one hydrophobic amino acid as the critical binding residues for two different scFvs. To enhance the utility of the reagent, one scFv was dimerized through a Fragment-crystallizable hinge region (i.e., Fc) and expressed in HEK-293 cells. This dimeric reagent yielded a 25-fold lower detection limit in western blots.	[Kierny, Michael R.; Cunningham, Thomas D.; Bouhenni, Rachida A.; Edward, Deepak P.; Kay, Brian K.] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kay, BK (corresponding author), Univ Illinois, Dept Biol Sci, 845 W Taylor St,3240 SES-MC 066, Chicago, IL 60607 USA.	bkay@uic.edu		Kierny, Michael/0000-0002-5409-0991	US Air Force Grant [FA014-07-C-0047]; Common Fund at the National Institutes of Health [U54 DK093444]	US Air Force Grant; Common Fund at the National Institutes of Health	This work was funded by grants from the US Air Force Grant (FA014-07-C-0047) and the Common Fund at the National Institutes of Health (U54 DK093444). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2004, J PROTEOME RES, V3, P235, DOI 10.1021/pr034086h; [Anonymous], 2004, DOTFAAAM049; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Corzo J, 2006, BIOCHEM MOL BIOL EDU, V34, P413, DOI 10.1002/bmb.2006.494034062678; Cunningham BT, 2004, J BIOMOL SCREEN, V9, P481, DOI 10.1177/1087057104267604; de Andrade EV, 2000, J BIOCHEM-TOKYO, V128, P891, DOI 10.1093/oxfordjournals.jbchem.a022838; Devarajan P, 2010, NEPHROLOGY, V15, P419, DOI 10.1111/j.1440-1797.2010.01317.x; Dyson MR, 2011, ANAL BIOCHEM, V417, P25, DOI 10.1016/j.ab.2011.05.005; EINHORN N, 1992, OBSTET GYNECOL, V80, P14; Falk R, 2012, METHODS, V58, P69, DOI 10.1016/j.ymeth.2012.07.008; GOLD P, 1965, J EXP MED, V121, P439, DOI 10.1084/jem.121.3.439; Gould LH, 2005, J VIROL, V79, P14606, DOI 10.1128/JVI.79.23.14606-14613.2005; Gutman S, 2006, NAT REV CANCER, V6, P565, DOI 10.1038/nrc1911; Haidaris CG, 2001, J IMMUNOL METHODS, V257, P185, DOI 10.1016/S0022-1759(01)00463-X; Kehoe JW, 2005, CHEM REV, V105, P4056; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lam TT, 1996, RETINA-J RET VIT DIS, V16, P42, DOI 10.1097/00006982-199616010-00008; Mainster MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P1210, DOI 10.1001/archopht.122.8.1210; MARSHALL J, 1970, INVEST OPHTH VISUAL, V9, P97; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Nakagawara RWM V.B., 2003, DOTFAAAM0312; Nakagawara Van B, 2008, Optometry, V79, P518, DOI 10.1016/j.optm.2007.08.022; Pershad K, 2011, ANAL BIOCHEM, V412, P210, DOI 10.1016/j.ab.2011.02.006; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Prensner JR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003180; Rusling JF, 2010, ANALYST, V135, P2496, DOI 10.1039/c0an00204f; Schmitz U, 2000, PLACENTA, V21, pS106, DOI 10.1053/plac.1999.0511; Scott SE, 2012, INVEST OPHTH VIS SCI, V53, P1764, DOI 10.1167/iovs.11-7685; Simmons LC, 2002, J IMMUNOL METHODS, V263, P133, DOI 10.1016/S0022-1759(02)00036-4; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Smith RA, 2014, CA-CANCER J CLIN, V64, P31, DOI 10.3322/caac.21212; STAMEY TA, 1987, NEW ENGL J MED, V317, P909, DOI 10.1056/NEJM198710083171501; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Veenstra TD, 2005, MOL CELL PROTEOMICS, V4, P409, DOI 10.1074/mcp.M500006-MCP200; Whiteaker JR, 2014, J PROTEOME RES, V13, P2187, DOI 10.1021/pr4009404; Yi JZ, 2007, J PROTEOME RES, V6, P1768, DOI 10.1021/pr060550h; Yi JZ, 2008, J PROTEOME RES, V7, P5112, DOI 10.1021/pr800396c	40	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124492	10.1371/journal.pone.0124492	http://dx.doi.org/10.1371/journal.pone.0124492			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902199	Green Published, gold, Green Submitted			2022-12-27	WOS:000353331500090
J	Liao, YJ; Zeng, ZW; Lu, F; Dong, ZQ; Chang, Q; Gao, JH				Liao, Yunjun; Zeng, Zhaowei; Lu, Feng; Dong, Ziqing; Chang, Qiang; Gao, Jianhua			In Vivo Dedifferentiation of Adult Adipose Cells	PLOS ONE			English	Article							DFAT CELLS; FAT-CELLS; STEM-CELL; TISSUE; ADIPOCYTES; TRANSDIFFERENTIATION; DIFFERENTIATION; TRANSPLANTATION; ADIPOGENESIS; REPAIR	Introduction Adipocytes can dedifferentiate into fibroblast-like cells in vitro and thereby acquire proliferation and multipotent capacities to participate in the repair of various organs and tissues. Whether dedifferentiation occurs under physiological or pathological conditions in vivo is unknown. Methods A tissue expander was placed under the inguinal fat pads of rats and gradually expanded by injection of water. Samples were collected at various time points, and morphological, histological, cytological, ultrastructural, and gene expression analyses were conducted. In a separate experiment, purified green fluorescent protein+ adipocytes were transplanted into C57 mice and collected at various time points. The transplanted adipocytes were assessed by bioluminescence imaging and whole-mount staining. Results The expanded fat pad was obviously thinner than the untreated fat pad on the opposite side. It was also tougher in texture and with more blood vessels attached. Hematoxylin and eosin staining and transmission electron microscopy indicated there were fewer monolocular adipocytes in the expanded fat pad and the morphology of these cells was altered, most notably their lipid content was discarded. Immunohistochemistry showed that the expanded fat pad contained an increased number of proliferative cells, which may have been derived from adipocytes. Following removal of the tissue expander, many small adipocytes were observed. Bioluminescence imaging suggested that some adipocytes survived when transplanted into an ischemic-hypoxic environment. Whole-mount staining revealed that surviving adipocytes underwent a process similar to adipocyte dedifferentiation in vitro. Monolocular adipocytes became multilocular adipocytes and then fibroblast-like cells. Conclusions Mature adipocytes may be able to dedifferentiate in vivo, and this may be an adipose tissue self-repair mechanism. The capacity of adipocytes to dedifferentiate into stem cell-like cells may also have a more general role in the regeneration of many tissues, notably in fat grafting.	[Liao, Yunjun; Zeng, Zhaowei; Lu, Feng; Dong, Ziqing; Chang, Qiang; Gao, Jianhua] Southern Med Univ, Dept Plast & Cosmet Surg, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Liao, YJ (corresponding author), Southern Med Univ, Dept Plast & Cosmet Surg, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China.	573233820@qq.com; gaopsnf@163.com			National Nature Science Foundation of China [81471881, 81372083, 81171834, 81201482]; Key Clinical Specialty Discipline Construction Program; Health Collaborative Innovation major projects of Guangzhou [7414275040815]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Clinical Specialty Discipline Construction Program; Health Collaborative Innovation major projects of Guangzhou	This work was supported by National Nature Science Foundation of China (81471881, 81372083, 81171834 and 81201482), Key Clinical Specialty Discipline Construction Program, Health Collaborative Innovation major projects of Guangzhou (7414275040815). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avram MM, 2007, J AM ACAD DERMATOL, V56, P472, DOI 10.1016/j.jaad.2006.06.022; Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Choi M, 2013, PLAST RECONSTR SURG, V131, P185, DOI 10.1097/PRS.0b013e3182789b13; Cinti S, 2000, METH MOL B, V155, P21; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; De Matteis R, 2009, STEM CELLS, V27, P2761, DOI 10.1002/stem.197; Dodson Michael V, 2011, Int J Stem Cells, V4, P76; Eguizabal C, 2013, SEMIN REPROD MED, V31, P82, DOI 10.1055/s-0032-1331802; Eto H, 2012, PLAST RECONSTR SURG, V129, P1081, DOI 10.1097/PRS.0b013e31824a2b19; Eto H, 2009, PLAST RECONSTR SURG, V124, P1087, DOI 10.1097/PRS.0b013e3181b5a3f1; Fan Y, 2008, TRENDS CELL BIOL, V18, P467, DOI 10.1016/j.tcb.2008.08.001; Gao Q, 2012, MOL BIOL REP, V39, P5791, DOI 10.1007/s11033-011-1371-4; Hausman Gary J, 2013, J Genomics, V1, P56, DOI 10.7150/jgen.3813; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Jumabay M, 2012, J MOL CELL CARDIOL, V53, P790, DOI 10.1016/j.yjmcc.2012.09.005; Jumabay M, 2009, J MOL CELL CARDIOL, V47, P565, DOI 10.1016/j.yjmcc.2009.08.004; Knopf F, 2011, DEV CELL, V20, P713, DOI 10.1016/j.devcel.2011.04.014; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McGown C, 2014, CLIN LIVER DIS, V18, P41, DOI 10.1016/j.cld.2013.09.012; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Obinata D, 2011, INT J UROL, V18, P827, DOI 10.1111/j.1442-2042.2011.02865.x; Ohta Y, 2008, CELL TRANSPLANT, V17, P877, DOI 10.3727/096368908786576516; Ono H, 2011, BIOCHEM BIOPH RES CO, V407, P562, DOI 10.1016/j.bbrc.2011.03.063; Piccolo S, 2013, DIFFERENTIATION, V86, P75, DOI 10.1016/j.diff.2013.08.001; Poloni A, 2012, STEM CELLS, V30, P965, DOI 10.1002/stem.1067; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Shoshani O, 2011, STEM CELL REV REP, V7, P488, DOI 10.1007/s12015-011-9231-0; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Suga H, 2010, PLAST RECONSTR SURG, V126, P1911, DOI 10.1097/PRS.0b013e3181f4468b; Suga H, 2009, STEM CELLS, V27, P238, DOI 10.1634/stemcells.2008-0261; SUGIHARA H, 1986, DIFFERENTIATION, V31, P42, DOI 10.1111/j.1432-0436.1986.tb00381.x; Ullah M, 2013, DIFFERENTIATION, V85, P78, DOI 10.1016/j.diff.2013.02.001; von Heimburg D, 2005, RESP PHYSIOL NEUROBI, V146, P107, DOI 10.1016/j.resp.2004.12.013; VONHEIMBURG D, 1994, BRIT J PLAST SURG, V47, P470, DOI 10.1016/0007-1226(94)90029-9; Yoshimura Kotaro, 2011, Regen Med, V6, P33, DOI 10.2217/rme.11.62	39	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0125254	10.1371/journal.pone.0125254	http://dx.doi.org/10.1371/journal.pone.0125254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901360	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500116
J	Mowls, DS; McCaffree, DR; Beebe, LA				Mowls, Dana S.; McCaffree, D. Robert; Beebe, Laura A.			Trends in Lung Cancer Incidence Rates, Oklahoma 2005-2010	PLOS ONE			English	Article							TOBACCO CONTROL PROGRAMS; UNITED-STATES; SMOKING; EPIDEMIOLOGY; ADULTS; IMPACT	Purpose Lung cancer is the second most frequently diagnosed cancer among men and women in the United States. With cigarette smoking causing the majority of cases, patterns in lung cancer are often monitored to understand the impact of anti-tobacco efforts. The purpose of this research was to investigate trends in lung cancer incidence rates for the period 2005-2010 in Oklahoma. Methods Data on Oklahoma's incident cases of lung cancer (2005-2010) were obtained from the Centers for Disease Control and Prevention WONDER system. Annual percent change (APC) was calculated by linear regression to characterize trends in lung cancer incidence rates over time for the overall population, by gender, by age group, and by age group within gender. Rates were considered to increase or decrease if the p-value for trend was <0.05. Results From 2005 through 2010, lung cancer incidence rates declined from 81.96 to 68.19 per 100,000 population, with an APC of -3.58% (p-value: 0.0220). When subgroups were examined, declines were observed among all males (APC: -4.25%; p-value: 0.0270), males <65 years (APC: -5.32%; p-value: 0.0008), females <65 years (APC: -4.85%; p-value: 0.0044), and persons aged 55-64 years (APC: -6.38%; p-value: 0.0017). Conclusions Declines in lung cancer incidence rates occurred during 2005-2010 among the overall population and within select demographic groups in Oklahoma. Although trends were stable for several demographic groups, rates of lung cancer incidence were lower in 2010 compared to 2005. Continued evidence-based tobacco control efforts are needed to ensure further reductions in lung cancer incidence rates in the state of Oklahoma.	[Mowls, Dana S.; Beebe, Laura A.] Univ Oklahoma, Coll Publ Hlth, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK 73104 USA; [McCaffree, D. Robert; Beebe, Laura A.] Oklahoma Tobacco Res Ctr, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Beebe, LA (corresponding author), Univ Oklahoma, Coll Publ Hlth, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK 73104 USA.	Laura-Beebe@ouhsc.edu		Beebe, Laura/0000-0002-5784-9203	Oklahoma Tobacco Settlement Endowment Trust	Oklahoma Tobacco Settlement Endowment Trust	This study was funded by the Oklahoma Tobacco Settlement Endowment Trust. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2003, CHEST, V123, p21S, DOI 10.1378/chest.123.1_suppl.21S; Beebe LA, 2011, TRENDS CIGARETTE SMO; Clegg LX, 2009, STAT MED, V28, P3670, DOI 10.1002/sim.3733; Durkin S, 2012, TOB CONTROL, V21, P127, DOI 10.1136/tobaccocontrol-2011-050345; Farrelly MC, 2008, AM J PUBLIC HEALTH, V98, P304, DOI 10.2105/AJPH.2006.106377; Farrelly MC, 2003, J HEALTH ECON, V22, P843, DOI 10.1016/S0167-6296(03)00057-2; Fichtenberg CM, 2000, NEW ENGL J MED, V343, P1772, DOI 10.1056/NEJM200012143432406; Henley SJ, 2014, MMWR-MORBID MORTAL W, V63, P1; Jemal A, 2003, CANCER CAUSE CONTROL, V14, P579, DOI 10.1023/A:1024891201329; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Orzechowski B, 2012, TAX BURDEN TOBACCO H; Rhoades RR, 2015, AM J PREV MED, V48, pS21, DOI 10.1016/j.amepre.2014.10.002; Toh Chee-Keong, 2009, V472, P397, DOI 10.1007/978-1-60327-492-0_19; US Cancer Statistics Working Group, 2014, US CANC STAT 1999 20; US Department of Health Human Services, 2014, HLTH CONSMOK 50 YE, P17, DOI DOI 10.1037/E510072014-001; Wakefield M, 2000, TOB CONTROL, V9, P177, DOI 10.1136/tc.9.2.177	17	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0119251	10.1371/journal.pone.0119251	http://dx.doi.org/10.1371/journal.pone.0119251			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KV	25901351	gold, Green Submitted, Green Published			2022-12-27	WOS:000353331500004
J	Haraka, F; Glass, TR; Sikalengo, G; Gamell, A; Ntamatungiro, A; Hatz, C; Tanner, M; Furrer, H; Battegay, M; Letang, E				Haraka, Frederick; Glass, Tracy R.; Sikalengo, George; Gamell, Anna; Ntamatungiro, Alex; Hatz, Christoph; Tanner, Marcel; Furrer, Hansjakob; Battegay, Manuel; Letang, Emilio			A Bundle of Services Increased Ascertainment of Tuberculosis among HIV-Infected Individuals Enrolled in a HIV Cohort in Rural Sub-Saharan Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; CARE; PREVALENCE; FEASIBILITY; MULTICENTER; INTEGRATION; PREDICTORS; RESISTANCE; ACCURACY; LESSONS	Objectives To report on trends of tuberculosis ascertainment among HIV patients in a rural HIV cohort in Tanzania, and assessing the impact of a bundle of services implemented in December 2012, consisting of three components:(i) integration of HIV and tuberculosis services; (ii) GeneXpert for tuberculosis diagnosis; and (iii) electronic data collection. Design Retrospective cohort study of patients enrolled in the Kilombero Ulanga Antiretroviral Cohort (KIULARCO), Tanzania.) Methods HIV patients without prior history of tuberculosis enrolled in the KIULARCO cohort between 2005 and 2013 were included. Cox proportional hazard models were used to estimate rates and predictors of tuberculosis ascertainment Results Of 7114 HIV positive patients enrolled, 5123(72%) had no history of tuberculosis. Of these, 66% were female, median age was 38 years, median baseline CD4+ cell count was 243 cells/mu l, and 43% had WHO clinical stage 3 or 4. During follow-up, 421 incident tuberculosis cases were notified with an estimated incidence of 3.6 per 100 person-years(p-y)[95% confidence interval(CI) 3.26-3.97]. The incidence rate varied over time and increased significantly from 2.96 to 43.98 cases per 100 p-y after the introduction of the bundle of services in December 2012. Four independent predictors of tuberculosis ascertainment were identified: poor clinical condition at baseline (Hazard Ratio (HR) 3.89, 95% CI 2.87-5.28), WHO clinical stage 3 or 4 (HR 2.48, 95% CI 1.88-3.26), being antiretroviralnaive (HR 2.97, 95% CI 2.25-3.94), and registration in 2013(HR 6.07, 95% CI 4.39-8.38). Conclusion The integration of tuberculosis and HIV services together with comprehensive electronic data collection and use of GeneXpert increased dramatically the ascertainment of tuberculosis in this rural African HIV cohort.	[Haraka, Frederick] Bagamoyo Res & Training Ctr, Ifakara Hlth Inst, Bagamoyo, Tanzania; [Glass, Tracy R.; Gamell, Anna; Hatz, Christoph; Tanner, Marcel; Letang, Emilio] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Glass, Tracy R.; Battegay, Manuel] Univ Basel, Basel, Switzerland; [Sikalengo, George; Gamell, Anna; Ntamatungiro, Alex; Letang, Emilio] Ifakara Hlth Inst, Ifakara, Tanzania; [Furrer, Hansjakob] Univ Hosp Bern, Dept Infect Dis, CH-3010 Bern, Switzerland; [Furrer, Hansjakob] Univ Bern, CH-3010 Bern, Switzerland; [Battegay, Manuel] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, Dept Med & Clin Res, CH-4031 Basel, Switzerland; [Letang, Emilio] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain	Ifakara Health Institute; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Ifakara Health Institute; University of Bern; University Hospital of Bern; University of Bern; University of Basel; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona	Letang, E (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	emili.letang@unibas.ch	Furrer, Hansjakob/G-6768-2013; Glass, Tracy R/D-5046-2017	Furrer, Hansjakob/0000-0002-1375-3146; Glass, Tracy R/0000-0001-7075-9803; Ntamatungiro, Alex/0000-0002-3134-3992; Sikalengo, George/0000-0002-6749-7109	Government of the Canton of Basel	Government of the Canton of Basel	KIULARCO receives funds from the Government of the Canton of Basel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WG, 2003, PEDIATRICS, V111, P626, DOI 10.1542/peds.111.3.626; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; del Amo J, 2012, CLIN INFECT DIS, V54, P1364, DOI 10.1093/cid/cis203; Elzi L, 2007, CLIN INFECT DIS, V44, P94, DOI 10.1086/510080; Gasana M, 2008, INT J TUBERC LUNG D, V12, pS39; Harris JB, 2008, INT J TUBERC LUNG D, V12, P773; Hillestad R, 2005, HEALTH AFFAIR, V24, P1103, DOI 10.1377/hlthaff.24.5.1103; Hoog van't A, 2013, SYSTEMATIC REV SENSI; Howard AA, 2010, CLIN INFECT DIS, V50, pS238, DOI 10.1086/651497; Iliyasu Z, 2009, J EPIDEMIOL, V19, P81, DOI 10.2188/jea.JE20080026; Kapata N, 2011, TROP MED INT HEALTH, V16, P1404, DOI 10.1111/j.1365-3156.2011.02849.x; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lawn SD, 2010, AIDS, V24, P1323, DOI 10.1097/QAD.0b013e3283390dd1; Legido-Quigley H, 2013, TROP MED INT HEALTH, V18, P199, DOI 10.1111/tmi.12029; Li N, 2013, AIDS, V27, P1273, DOI 10.1097/QAD.0b013e32835ecb24; Lodi S, 2013, THORAX, V68, P207, DOI 10.1136/thoraxjnl-2012-201740; Marlowe EM, 2011, J CLIN MICROBIOL, V49, P1621, DOI 10.1128/JCM.02214-10; Masimba P, 2013, AIDS RES HUM RETROV, V29, P1229, DOI [10.1089/AID.2011.0367, 10.1089/aid.2011.0367]; Meyer-Rath G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036966; Middelkoop K, 2011, JAIDS-J ACQ IMM DEF, V56, P263, DOI 10.1097/QAI.0b013e31820413b3; Miranda A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000826; Mossdorf E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-98; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Ngowi BJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-341; Pape Jean William, 2004, Top HIV Med, V12, P144; Scott LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001061; Siika AM, 2005, INT J MED INFORM, V74, P345, DOI 10.1016/j.ijmedinf.2005.03.002; Tanzania Ministry of Health and Social Welfare, 2008, NAT POL GUID COLL TB; Tanzania Ministry of Health and Social Welfare, 2013, 1 TUB PREV SURV UN R; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; Venkatesh PA, 2005, INT J TUBERC LUNG D, V9, P1105; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2012, INC TUB PER 100000 P; Williams Faustine, 2008, Inform Prim Care, V16, P139; World Health Organization, 2013, SYST SCREEN ACT TUB	37	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123275	10.1371/journal.pone.0123275	http://dx.doi.org/10.1371/journal.pone.0123275			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897491	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000353212600023
J	Liu, PJ; Hsin, MC; Huang, YH; Fan, TY; Meng, PJ; Lu, CC; Lin, HJ				Liu, Pi-Jen; Hsin, Min-Chieh; Huang, Yen-Hsun; Fan, Tung-Yung; Meng, Pei-Jie; Lu, Chung-Cheng; Lin, Hsing-Juh			Nutrient Enrichment Coupled with Sedimentation Favors Sea Anemones over Corals	PLOS ONE			English	Article							REEF-BUILDING CORAL; GREAT-BARRIER-REEF; SOUTHERN TAIWAN; SCLERACTINIAN CORALS; NATURAL-WATERS; LONG-TERM; PHOSPHORUS; AVAILABILITY; TEMPERATURE; MACROALGAE	Fine sediments, which account for the majority of total fluvial sediment flux, have been suggested to degrade coral reefs on a global scale. Furthermore, sediment impacts can be exacerbated by extreme rainfall events associated with global climate change and anthropogenic nutrient enrichment. We report the findings from a series of mesocosm experiments exploring the effects of short-term sedimentation and nutrient enrichment on the interactions between the hard coral Acropora muricata, the sea anemone Mesactinia ganesis, and the green macroalga Codium edule. Mesocosms were manipulated to simulate either unimpacted reefs or reefs exposed to elevated levels of fine sediments for 10 or 14 days to simulate the effects of heavy rainfall. The first and second experiments were aimed to examine the effects of inorganic and organic sediments, respectively. The third experiment was designed to examine the interactive effects of nutrient enrichment and elevated sediment loads. Neither inorganic nor organic sediment loadings significantly affected the physiological performance of the coral, but, importantly, did reduce its ability to compete with other organisms. Photosynthetic efficiencies of both the green macroalga and the sea anemone increased in response to both sediment loadings when they were simultaneously exposed to nutrient enrichment. While organic sediment loading increased the nitrogen content of the green macroalga in the first experiment, inorganic sediment loading increased its phosphorus content in the second experiment. The coral mortality due to sea anemones attack was significantly greater upon exposure to enriched levels of organic sediments and nutrients. Our findings suggest that the combined effects of short-term sedimentation and nutrient enrichment could cause replacement of corals by sea anemones on certain coral reefs.	[Liu, Pi-Jen; Fan, Tung-Yung; Meng, Pei-Jie] Natl Dong Hwa Univ, Grad Inst Marine Biol, Pingtung 944, Taiwan; [Liu, Pi-Jen; Fan, Tung-Yung; Meng, Pei-Jie] Natl Museum Marine Biol & Aquarium, Pingtung 944, Taiwan; [Hsin, Min-Chieh; Huang, Yen-Hsun; Lu, Chung-Cheng; Lin, Hsing-Juh] Natl Chung Hsing Univ, Dept Life Sci, Taichung 402, Taiwan; [Hsin, Min-Chieh; Huang, Yen-Hsun; Lu, Chung-Cheng; Lin, Hsing-Juh] Natl Chung Hsing Univ, Res Ctr Global Change Biol, Taichung 402, Taiwan; [Lin, Hsing-Juh] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan	National Dong Hwa University; National Museum of Marine Biology & Aquarium; National Chung Hsing University; National Chung Hsing University; Academia Sinica - Taiwan	Liu, PJ (corresponding author), Natl Dong Hwa Univ, Grad Inst Marine Biol, Pingtung 944, Taiwan.	pijenliu@hotmail.com; hjlin@dragon.nchu.edu.tw	Meng, PJ/AAC-3677-2021; Liu, Pi-Jen/ABC-6596-2021		National Science Council [NSC 97-2621-B-005-001]	National Science Council(Ministry of Science and Technology, Taiwan)	The funding for this study was provided by the National Science Council under grant number NSC 97-2621-B-005-001.	Anthony KRN, 2004, LIMNOL OCEANOGR, V49, P2201, DOI 10.4319/lo.2004.49.6.2201; BAK RPM, 1976, MAR BIOL, V37, P105, DOI 10.1007/BF00389121; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brodie J, 2001, WATER SCI TECHNOL, V43, P203, DOI 10.2166/wst.2001.0540; Chadwick-Furman NE, 2000, INVERTEBR BIOL, V119, P351; Chen CA, 2004, CORAL REEFS, V23, P508, DOI 10.1007/s00338-004-0423-9; Chen CC, 2005, MAR ECOL PROG SER, V304, P91, DOI 10.3354/meps304091; Cooke WJ, 1976, COELENTERATE ECOLOGY, P281; D'Angelo C, 2014, CURR OPIN ENV SUST, V7, P82, DOI 10.1016/j.cosust.2013.11.029; Dai C-F, 1998, J NATL PARK, V8, P79; Dai CF, 1999, J NATL PARK, V9, P111; Dai CF, 1993, MAR ECOL, V42, P185; Dai CF, 1997, STATUS CORAL REEFS P, P123; Devlin MJ, 2005, MAR POLLUT BULL, V51, P9, DOI 10.1016/j.marpolbul.2004.10.037; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Gilmour JP, 2002, MAR FRESHWATER RES, V53, P805, DOI 10.1071/MF01219; Golbuu Y, 2003, ESTUAR COAST SHELF S, V57, P941, DOI 10.1016/S0272-7714(02)00424-9; Jeffery SW, 1975, BIOCH PHYSL PFLANZEN, V167, P191; Ketterings QM, 2002, AGR ECOSYST ENVIRON, V92, P37, DOI 10.1016/S0167-8809(01)00287-0; Lin HJ, 1998, BOT BULL ACAD SINICA, V39, P191; Lin HJ, 2004, MAR BIOL, V144, P653, DOI 10.1007/s00227-003-1231-4; Lin HJ, 2007, MAR ECOL PROG SER, V335, P95, DOI 10.3354/meps335095; Linton D, 2002, STATUS CORAL REEFS W, P277; Liu PJ, 2012, MAR POLLUT BULL, V64, P1129, DOI 10.1016/j.marpolbul.2012.03.031; Liu PJ, 2009, LIMNOL OCEANOGR, V54, P1167, DOI 10.4319/lo.2009.54.4.1167; Mayfield AB, 2013, CORAL REEFS, V32, P909, DOI 10.1007/s00338-013-1067-4; Mayfield AB, 2012, J EXP BIOL, V215, P4183, DOI 10.1242/jeb.071688; McGlathery KJ, 1997, AQUAT BOT, V59, P99, DOI 10.1016/S0304-3770(97)00026-0; Meng PJ, 2004, J NATL PARK, V14, P43; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; PAI SC, 1990, ANAL CHIM ACTA, V232, P345, DOI 10.1016/S0003-2670(00)81252-0; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Philipp E, 2003, J EXP MAR BIOL ECOL, V287, P57, DOI 10.1016/S0022-0981(02)00495-1; RICHARDSON CJ, 1986, ECOL MONOGR, V56, P279, DOI 10.2307/1942548; Ridzwan AR, 1993, THESIS; RIEGL B, 1995, J EXP MAR BIOL ECOL, V186, P259, DOI 10.1016/0022-0981(94)00164-9; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; SOLORZANO L, 1980, LIMNOL OCEANOGR, V25, P754, DOI 10.4319/lo.1980.25.4.0754; STAFFORDSMITH MG, 1993, MAR BIOL, V115, P229, DOI 10.1007/BF00346340; Stimson J, 1991, J EXP MAR BIOL ECOL, V153, P3; Strickland JDH, 1972, B FISH RES BD CAN, V167; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Tkachenko KS, 2007, MAR BIOL, V151, P185, DOI 10.1007/s00227-006-0467-1; Wiedenmann J, 2007, J MAR BIOL ASSOC UK, V87, P851, DOI 10.1017/S0025315407057050; Wiedenmann J, 2013, NAT CLIM CHANGE, V3, P160, DOI 10.1038/NCLIMATE1661	48	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0125175	10.1371/journal.pone.0125175	http://dx.doi.org/10.1371/journal.pone.0125175			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897844	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600099
J	Lv, J; Chen, W; Sun, DJY; Li, SX; Millwood, IY; Smith, M; Guo, Y; Bian, Z; Yu, CQ; Zhou, HY; Tan, YL; Chen, JS; Chen, ZM; Li, LM				Lv, Jun; Chen, Wei; Sun, Dianjianyi; Li, Shengxu; Millwood, Iona Y.; Smith, Margaret; Guo, Yu; Bian, Zheng; Yu, Canqing; Zhou, Huiyan; Tan, Yunlong; Chen, Junshi; Chen, Zhengming; Li, Liming		China Kadoorie Biobank Collaborati	Gender-Specific Association between Tobacco Smoking and Central Obesity among 0.5 Million Chinese People: The China Kadoorie Biobank Study	PLOS ONE			English	Article							BODY-MASS INDEX; METABOLIC SYNDROME; RISK-FACTORS; CIGARETTE-SMOKING; FAT DISTRIBUTION; BIRTH-WEIGHT; HIP RATIO; ADULTS; MEN; OVERWEIGHT	Objectives Lifestyle factors are well-known important modifiable risk factors for obesity; the association between tobacco smoking and central obesity, however, is largely unknown in the Chinese population. This study examined the relationship between smoking and central obesity in 0.5 million Chinese adults, a population with a low prevalence of general obesity, but a high prevalence of central obesity. Subjects A total of 487,527 adults (200,564 males and 286,963 females), aged 30-79 years, were enrolled in the baseline survey of the China Kadoorie Biobank (CKB) Study conducted during 2004-2008. Waist circumference (WC) and WC/height ratio (WHtR) were used as measures of central obesity. Results The prevalence of regular smokers was significantly higher among males (60.6%) than among females (2.2%). The prevalence of central obesity increased with age and BMI levels, with a significant gender difference (females>males). Of note, almost all obese adults (99.4%) were centrally obese regardless of gender. In multivariable regression analyses, adjusting for age, education, physical activity, alcohol use and survey site, regular smoking was inversely associated with BMI in males (standardized regression coefficients, beta= -0.093, p<0.001) and females (beta= -0.025, p<0.001). Of interest, in the BMI stratification analyses in 18 groups, all beta s of regular smoking for WHtR were positive in both genders; the beta s showed a significantly greater increasing trend with increasing BMI in males than in females. In the analyses with model adjustment for BMI, the positive associations between regular smoking and WHtR were stronger in males (beta= 0.021, p<0.001) than in females (beta= 0.008, p<0.001) (p<0.001 for gender difference). WC showed considerably consistent results. Conclusions The data indicate that tobacco smoking is an important risk factor for central obesity, but the association is gender-specific and depends on the adjustment for general obesity.	[Lv, Jun; Chen, Wei; Sun, Dianjianyi; Li, Shengxu; Yu, Canqing; Li, Liming] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China; [Chen, Wei; Sun, Dianjianyi; Li, Shengxu] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA; [Millwood, Iona Y.; Smith, Margaret; Chen, Zhengming] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford OX1 2JD, England; [Millwood, Iona Y.; Smith, Margaret; Chen, Zhengming] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit CTSU, Oxford OX1 2JD, England; [Guo, Yu; Bian, Zheng; Zhou, Huiyan; Tan, Yunlong; Li, Liming] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Chen, Junshi] China Natl Ctr Food Safety Risk Assessment, Beijing, Peoples R China	Peking University; Tulane University; University of Oxford; University of Oxford; Chinese Academy of Medical Sciences - Peking Union Medical College	Chen, ZM (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford OX1 2JD, England.	zhengming.chen@ctsu.ox.ac.uk; lmlee@vip.163.com	Lv, Jun/O-4746-2019	Lv, Jun/0000-0001-7916-3870; Sun, Dianjianyi/0000-0003-3651-6693; Chen, Zhengming/0000-0001-6423-105X	CKB baseline survey; Kadoorie Charitable Foundation in Hong Kong; Wellcome Trust in the UK [088158/Z/09/Z]; National Key Technologies Research and Development Program, Chinese Ministry of Science and Technology [2011BAI09B01]; National Natural Science Foundation of China [81390541]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043451] Funding Source: NIH RePORTER; Medical Research Council [MC_U137686851] Funding Source: researchfish; MRC [MC_U137686851] Funding Source: UKRI	CKB baseline survey; Kadoorie Charitable Foundation in Hong Kong; Wellcome Trust in the UK(Instituto de Salud Carlos IIIWellcome Trust); National Key Technologies Research and Development Program, Chinese Ministry of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the CKB baseline survey and the first re-survey were supported by the Kadoorie Charitable Foundation in Hong Kong. The long-term follow-up of the project during 2009-14 is supported by the Wellcome Trust in the UK [088158/Z/09/Z] and the National Key Technologies Research and Development Program in the 12th Five-year Plan, Chinese Ministry of Science and Technology [2011BAI09B01, 2012-14]. Support for this analysis is provided by the National Natural Science Foundation of China [No. 81390541]. The sponsors had no role in the design, analysis, interpretation or drafting of this manuscript.	Audrain-McGovern J, 2011, CLIN PHARMACOL THER, V90, P164, DOI 10.1038/clpt.2011.105; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Benowitz NL, 2010, NEW ENGL J MED, V362, P2295, DOI 10.1056/NEJMra0809890; Bjorntorp P, 1993, Obes Res, V1, P206; Cameron AJ, 2008, OBESITY, V16, P2707, DOI 10.1038/oby.2008.412; Canoy D, 2005, OBES RES, V13, P1466, DOI 10.1038/oby.2005.177; Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120; Cheng TO, 2004, INT J CARDIOL, V96, P425, DOI 10.1016/j.ijcard.2003.10.011; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Du H, 2013, AM J CLIN NUTR, V97, P487, DOI DOI 10.3945/AJCN.112.046854; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Hebden L, 2012, OBES REV, V13, P692, DOI 10.1111/j.1467-789X.2012.00990.x; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hernandez-Diaz S, 2006, AM J EPIDEMIOL, V164, P1115, DOI 10.1093/aje/kwj275; Hsieh SD, 2006, PREV MED, V42, P135, DOI 10.1016/j.ypmed.2005.08.007; Hsieh SD, 2005, PREV MED, V40, P216, DOI 10.1016/j.ypmed.2004.05.025; Jee SH, 2002, OBES RES, V10, P891, DOI 10.1038/oby.2002.122; Kanter R, 2012, ADV NUTR, V3, P491, DOI 10.3945/an.112.002063; Kim JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045815; Li Li-ming, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P249; Liu CT, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003681; Lizcano F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/757461; Low S, 2009, ANN ACAD MED SINGAP, V38, P66; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Misra A, 2013, NUTRIENTS, V5, P2708, DOI 10.3390/nu5072708; Molarius A, 1997, J EPIDEMIOL COMMUN H, V51, P252, DOI 10.1136/jech.51.3.252; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ramachandran A, 2012, DIABETES-METAB RES, V28, P47, DOI 10.1002/dmrr.2353; Reynolds K, 2007, OBESITY, V15, P10, DOI 10.1038/oby.2007.527; SHIMOKATA H, 1989, JAMA-J AM MED ASSOC, V261, P1169, DOI 10.1001/jama.261.8.1169; Srinivasan SR, 2009, AM J CARDIOL, V104, P721, DOI 10.1016/j.amjcard.2009.04.037; Tu YK, 2005, AM J EPIDEMIOL, V161, P27, DOI 10.1093/aje/kwi002; Wadden TA, 2012, CIRCULATION, V125, P1157, DOI 10.1161/CIRCULATIONAHA.111.039453; Wakabayashi I, 2014, METAB SYNDR RELAT D, V12, P70, DOI 10.1089/met.2013.0110; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wietlisbach V, 2013, NUTR METAB CARDIOVAS, V23, P432, DOI 10.1016/j.numecd.2011.09.002; Wildman RP, 2008, OBESITY, V16, P1448, DOI 10.1038/oby.2008.208; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	43	27	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124586	10.1371/journal.pone.0124586	http://dx.doi.org/10.1371/journal.pone.0124586			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897789	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600074
J	Sato, T; Mori, S; Sakamoto, M; Arai, Y; Kodama, T				Sato, Takuma; Mori, Shiro; Sakamoto, Maya; Arai, Yoichi; Kodama, Tetsuya			Direct Delivery of a Cytotoxic Anticancer Agent into the Metastatic Lymph Node Using Nano/Microbubbles and Ultrasound	PLOS ONE			English	Article							DRUG-DELIVERY; APOPTOSIS; CHEMOTHERAPY	Direct injection of an anticancer agent into a metastatic lymph node (LN) has not been used as a standard treatment because evidence concerning the efficacy of local administration of a drug into a metastatic LN has not been established. Here we show that the combination of intralymphatic drug delivery with nano/microbubbles (NMBs) and ultrasound has the potential to improve the chemotherapeutic effect. We delivered cis-diamminedichloroplatinum (II) (CDDP) into breast carcinoma cells in vitro and found that apoptotic processes were involved in the antitumor action. Next, we investigated the antitumor effect of intralymphatic chemotherapy with NMBs and ultrasound in an experimental model of LN metastasis using MXH10/Mo-lpr/lpr mice exhibiting lymphadenopathy. The combination of intralymphatic chemotherapy with NMBs and ultrasound has the potential to improve the delivery of CDDP into target LNs without damage to the surrounding normal tissues. The present study indicates that intralymphatic drug delivery with NMBs and ultrasound will potentially be of great benefit in the clinical setting.	[Sato, Takuma; Mori, Shiro; Kodama, Tetsuya] Tohoku Univ, Grad Sch Biomed Engn, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Mori, Shiro] Tohoku Univ Hosp, Dept Oral & Maxillofacial Surg, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Sakamoto, Maya] Tohoku Univ Hosp, Dept Oral Diag, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Sato, Takuma; Arai, Yoichi] Tohoku Univ, Grad Sch Med, Dept Urol, Aoba Ku, Sendai, Miyagi 9808575, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Kodama, T (corresponding author), Tohoku Univ, Grad Sch Biomed Engn, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	kodama@bme.tohoku.ac.jp	Kodama, Tetsuya/T-2246-2019	Kodama, Tetsuya/0000-0003-4727-9558	JSPS KAKENHI [26293425, 26670856, 25293382, 24659834, 26242051, 24650286]; Grants-in-Aid for Scientific Research [26293425] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by JSPS KAKENHI grant numbers 26293425 (SM), 26670856 (SM), 25293382 (MS), 24659834 (MS), 26242051 (TK) and 24650286 (TK). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; de Jong JS, 2000, HISTOPATHOLOGY, V36, P306; DORR RT, 1990, BLOOD REV, V4, P41, DOI 10.1016/0268-960X(90)90015-K; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Furusawa Y, 2010, CANCER LETT, V288, P107, DOI 10.1016/j.canlet.2009.06.029; Gonzalez VM, 2001, MOL PHARMACOL, V59, P657, DOI 10.1124/mol.59.4.657; Johansen P, 2005, EUR J IMMUNOL, V35, P568, DOI 10.1002/eji.200425599; Klerk CPW, 2007, BIOTECHNIQUES, V43, P7, DOI 10.2144/000112515; Kodama T, 2010, ULTRASOUND MED BIOL, V36, P1196, DOI 10.1016/j.ultrasmedbio.2010.04.016; Kodama T, 2010, J ELECTRON MICROSC, V59, P187, DOI 10.1093/jmicro/dfp056; Li L, 2013, CANCER RES, V73, P2082, DOI 10.1158/0008-5472.CAN-12-4200; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055797; Margaris KN, 2012, J R SOC INTERFACE, V9, P601, DOI 10.1098/rsif.2011.0751; Martinez-Gomez JM, 2009, INT ARCH ALLERGY IMM, V150, P59, DOI 10.1159/000210381; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Okamura M, 2004, ANTICANCER RES, V24, P655; Osaki T, 1997, Oral Dis, V3, P247; Ross MH, 2003, HISTOLOGY TEXT ALTAS; Sato T, 2014, ULTRASOUND MED BIOL, V40, P1237, DOI 10.1016/j.ultrasmedbio.2013.12.012; Shao L, 2013, J IMMUNOL METHODS, V389, P69, DOI 10.1016/j.jim.2013.01.004; TIMMERBOSSCHA H, 1992, BRIT J CANCER, V66, P227, DOI 10.1038/bjc.1992.249; Toriyabe Y, 1997, CLIN RADIOL, V52, P927, DOI 10.1016/S0009-9260(97)80226-7; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Watanabe Y, 2008, CANCER SCI, V99, P2525, DOI 10.1111/j.1349-7006.2008.00989.x; Xie YM, 2009, EXPERT OPIN DRUG DEL, V6, P785, DOI 10.1517/17425240903085128; Zhong WJ, 2011, ULTRASOUND MED BIOL, V37, P2149, DOI 10.1016/j.ultrasmedbio.2011.09.012	26	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123619	10.1371/journal.pone.0123619	http://dx.doi.org/10.1371/journal.pone.0123619			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897663	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600036
J	Steichen, AL; Simonson, TJ; Salmon, SL; Metzger, DW; Mishra, BB; Sharma, J				Steichen, Anthony L.; Simonson, Tanner J.; Salmon, Sharon L.; Metzger, Dennis W.; Mishra, Bibhuti B.; Sharma, Jyotika			Alarmin Function of Galectin-9 in Murine Respiratory Tularemia	PLOS ONE			English	Article							FRANCISELLA-TULARENSIS; MOLECULAR-MECHANISMS; NEUTROPHIL MIGRATION; PULMONARY INFECTION; INNATE IMMUNITY; MACROPHAGES; ACTIVATION; CELLS; TIM-3; HMGB1	Sepsis is a complex immune disorder that is characterized by systemic hyperinflammation. Alarmins, which are multifunctional endogenous factors, have been implicated in exacerbation of inflammation in many immune disorders including sepsis. Here we show that Galectin-9, a host endogenous beta-galactoside binding lectin, functions as an alarmin capable of mediating inflammatory response during sepsis resulting from pulmonary infection with Francisella novicida, a Gram negative bacterial pathogen. Our results show that this galectin is upregulated and is likely released during tissue damage in the lungs of F. novicida infected septic mice. In vitro, purified recombinant galectin-9 exacerbated F. novicida-induced production of the inflammatory mediators by macrophages and neutrophils. Concomitantly, Galectin-9 deficient (Gal-9(-/-)) mice exhibited improved lung pathology, reduced cell death and reduced leukocyte infiltration, particularly neutrophils, in their lungs. This positively correlated with overall improved survival of F. novicida infected Gal-9(-/-) mice as compared to their wild-type counterparts. Collectively, these findings suggest that galectin-9 functions as a novel alarmin by augmenting the inflammatory response in sepsis development during pulmonary F. novicida infection.	[Steichen, Anthony L.; Simonson, Tanner J.; Mishra, Bibhuti B.; Sharma, Jyotika] Univ N Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58201 USA; [Salmon, Sharon L.; Metzger, Dennis W.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	University of North Dakota Grand Forks; Albany Medical College	Sharma, J (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58201 USA.	jyotika.sharma@med.und.edu	Metzger, Dennis W/I-2771-2019	Metzger, Dennis W/0000-0002-8000-9907	American Heart Association [10BGIA4300041]; NIH [1R21AI101644-01, P01AI56320]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101644, P01AI056320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103329] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association grant (10BGIA4300041) and NIH 1R21AI101644-01 to JS and P01AI56320 to DWM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Balamayooran G, 2012, J IMMUNOL, V189, P5849, DOI 10.4049/jimmunol.1200585; Berthelot F, 2012, J INNATE IMMUN, V4, P41, DOI 10.1159/000328798; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Brett ME, 2014, CLIN INFECT DIS, V59, P826, DOI 10.1093/cid/ciu430; Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x; Cerliani JP, 2011, J CLIN IMMUNOL, V31, P10, DOI 10.1007/s10875-010-9494-2; Fink MP, 2014, CRIT CARE, V18, DOI 10.1186/cc13810; Foell D, 2008, J PATHOL, V216, P183, DOI 10.1002/path.2394; Gieseke F, 2013, EUR J IMMUNOL, V43, P2741, DOI 10.1002/eji.201343335; Gundra UM, 2011, INFECT IMMUN, V79, P2586, DOI 10.1128/IAI.00920-10; Hall JD, 2009, CLIN EXP IMMUNOL, V156, P278, DOI 10.1111/j.1365-2249.2009.03882.x; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hreggvidsdottir HS, 2009, J LEUKOCYTE BIOL, V86, P655, DOI 10.1189/jlb.0908548; Jayaraman P, 2013, J IMMUNOL, V190, P4196, DOI 10.4049/jimmunol.1202688; Jayaraman P, 2010, J EXP MED, V207, P2343, DOI 10.1084/jem.20100687; Katoh S, 2010, INT ARCH ALLERGY IMM, V153, P294, DOI 10.1159/000314371; Li X, 2012, EXPERT OPIN THER TAR, V16, P1145, DOI 10.1517/14728222.2012.726616; Liu FT, 2002, BBA-GEN SUBJECTS, V1572, P263, DOI 10.1016/S0304-4165(02)00313-6; Liu FT, 2010, ANN NY ACAD SCI, V1183, P158, DOI 10.1111/j.1749-6632.2009.05131.x; Mares CA, 2011, IMMUNOL CELL BIOL, V89, P167, DOI 10.1038/icb.2010.81; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Mengshol JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009504; Milovanovic M, 2012, IMMUNOL RES, V52, P89, DOI 10.1007/s12026-012-8283-9; Mishra BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059616; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Parmely MJ, 2009, FEMS MICROBIOL LETT, V301, P1, DOI 10.1111/j.1574-6968.2009.01791.x; Rabinovich GA, 2002, CELL DEATH DIFFER, V9, P661, DOI 10.1038/sj.cdd.4401009; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Rabinovich GA, 2012, ANN NY ACAD SCI, V1253, P1, DOI 10.1111/j.1749-6632.2012.06492.x; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Sada-Ovalle I, 2012, J IMMUNOL, V189, P5896, DOI 10.4049/jimmunol.1200990; Sakai K, 2011, EUR J IMMUNOL, V41, P67, DOI 10.1002/eji.200939931; Sangiuliano B, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/821043; Sato S, 2002, GLYCOCONJUGATE J, V19, P583, DOI 10.1023/B:GLYC.0000014089.17121.cc; Sato S, 2002, J IMMUNOL, V168, P1813, DOI 10.4049/jimmunol.168.4.1813; Sato S, 2009, IMMUNOL REV, V230, P172, DOI 10.1111/j.1600-065X.2009.00790.x; Sharma J, 2011, MICROB PATHOGENESIS, V51, P39, DOI 10.1016/j.micpath.2011.03.007; Sharma J, 2009, INFECT IMMUN, V77, P4314, DOI 10.1128/IAI.00654-09; Sharma J, 2009, J LEUKOCYTE BIOL, V86, P491, DOI 10.1189/jlb.1208728; Sharma J, 2009, CELL IMMUNOL, V257, P1, DOI 10.1016/j.cellimm.2009.03.011; Steelman AJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0144-0; Tsai SY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003848; Vandal K, 2003, J IMMUNOL, V171, P2602, DOI 10.4049/jimmunol.171.5.2602; Vega-Carrascal I, 2014, J IMMUNOL, V192, P2418, DOI 10.4049/jimmunol.1300711; Vega-Carrascal I, 2011, J IMMUNOL, V186, P2897, DOI 10.4049/jimmunol.1003187; Wheeler DS, 2007, INFLAMM RES, V56, P216, DOI 10.1007/s00011-007-6108-4; Wickstrum JR, 2009, INFECT IMMUN, V77, P4827, DOI 10.1128/IAI.00246-09; Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	53	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0123573	10.1371/journal.pone.0123573	http://dx.doi.org/10.1371/journal.pone.0123573			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898318	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600033
J	Jang, JW; Kim, YW; Lee, SW; Kwon, JH; Nam, SW; Bae, SH; Choi, JY; Yoon, SK; Chung, KW				Jang, Jeong Won; Kim, Young Woon; Lee, Sung Won; Kwon, Jung Hyun; Nam, Soon Woo; Bae, Si Hyun; Choi, Jong Young; Yoon, Seung Kew; Chung, Kyu Won			Reactivation of Hepatitis B Virus in HBsAg-Negative Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							HBV REACTIVATION; RISK; CHEMOEMBOLIZATION; CHEMOTHERAPY; MANAGEMENT; LYMPHOMA	Background & Aims Despite increasing attention to hepatitis B virus (HBV) reactivation in hematologic settings, information on reactivation in hepatitis B surface (HBsAg)-negative patients with hepatocellular carcinoma (HCC) remains unknown. This study aimed to determine the incidence and risk factors of HBV reactivation in HBsAg-negative patients undergoing transarterial chemoembolization (TACE). Methods A total of 109 HBsAg-negative patients with HCC were consecutively recruited for this study and treated with either mono-(n = 75), combination-drug TACE (n = 20), or combination-drug TACE plus radiotherapy (n = 14). With serial monitoring of virological markers every 2-3 months, patients were observed for HBV reactivation (defined as the reappearance of HBV DNA or sero-reversion of HBsAg) in comparison with control subjects with HBsAg-negative cirrhosis (n = 16) or HBsAg loss (n = 46). Results During the study period, HBV reactivation occurred in 12 (11.0%) and 1 (1.6%) patients in the TACE and control groups, respectively. The median level of HBV DNA at reactivation was 5,174 copies/ml (range: 216-116,058). Of the 12 patients with HBV reactivation, four (33.3%) developed clinical hepatitis, including one patient who suffered from decompensation. All antiviral-treated patients achieved undetectable HBV DNA or HBsAg loss after commencement of antiviral drugs. TACE was significantly correlated with a high incidence of HBV reactivation, with increasing risk of reactivation with intensive treatment. On multivariate analysis, treatment intensity and a prior history of chronic hepatitis B remained independently predictive of reactivation. Conclusions TACE can reactivate HBV replication in HBsAg-negative patients, with a dose-risk relationship between treatment intensity and reactivation. Patients with prior chronic HBV infection who are to undergo intensive TACE should be closely monitored, with an alternative approach of antiviral prophylaxis against HBV reactivation.	[Jang, Jeong Won; Bae, Si Hyun; Choi, Jong Young; Yoon, Seung Kew] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Internal Med, Seoul, South Korea; [Kim, Young Woon; Lee, Sung Won; Kwon, Jung Hyun; Nam, Soon Woo; Chung, Kyu Won] Catholic Univ Korea, Incheon St Marys Hosp, Dept Internal Med, Incheon, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Nam, SW (corresponding author), Catholic Univ Korea, Incheon St Marys Hosp, Dept Internal Med, Incheon, South Korea.	drswnam@hanmail.net			College of Medicine, the Catholic University of Korea	College of Medicine, the Catholic University of Korea	This work was supported by a Sabbatical researcher fund from College of Medicine, the Catholic University of Korea (2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dong HJ, 2013, J CLIN VIROL, V57, P209, DOI 10.1016/j.jcv.2013.03.010; Hoofnagle JH, 2009, HEPATOLOGY, V49, pS156, DOI 10.1002/hep.22945; Huang G, 2013, ANN SURG, V257, P490, DOI 10.1097/SLA.0b013e318262b218; Huang YH, 2013, J CLIN ONCOL, V31, P2765, DOI 10.1200/JCO.2012.48.5938; Hui CK, 2006, GASTROENTEROLOGY, V131, P59, DOI 10.1053/j.gastro.2006.04.015; Hung HH, 2010, J HEPATOL, V52, P463, DOI 10.1016/j.jhep.2009.11.023; Jang JW, 2014, WORLD J GASTROENTERO, V20, P7675, DOI 10.3748/wjg.v20.i24.7675; Jang JW, 2011, ANTIVIR THER, V16, P969, DOI 10.3851/IMP1840; Jang JW, 2006, HEPATOLOGY, V43, P233, DOI 10.1002/hep.21024; Kusumoto S, 2009, INT J HEMATOL, V90, P13, DOI 10.1007/s12185-009-0359-5; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Peng JW, 2012, ASIA-PAC J CLIN ONCO, V8, P356, DOI 10.1111/j.1743-7563.2012.01534.x; Yeo W, 2006, HEPATOLOGY, V43, P209, DOI 10.1002/hep.21051; Yeo WN, 2009, J CLIN ONCOL, V27, P605, DOI 10.1200/JCO.2008.18.0182; Yu SJ, 2013, RADIOLOGY, V267, P638, DOI 10.1148/radiol.13121498	17	21	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0122041	10.1371/journal.pone.0122041	http://dx.doi.org/10.1371/journal.pone.0122041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894607	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700011
J	Wagner, M; Ashby, DR; Kurtz, C; Alam, A; Busbridge, M; Raff, U; Zimmermann, J; Heuschmann, PU; Wanner, C; Schramm, L				Wagner, Martin; Ashby, Damien R.; Kurtz, Caroline; Alam, Ahsan; Busbridge, Mark; Raff, Ulrike; Zimmermann, Josef; Heuschmann, Peter U.; Wanner, Christoph; Schramm, Lothar			Hepcidin-25 in Diabetic Chronic Kidney Disease Is Predictive for Mortality and Progression to End Stage Renal Disease	PLOS ONE			English	Article							INTRAINDIVIDUAL VARIABILITY; CARDIOVASCULAR EVENTS; SERUM HEPCIDIN-25; ANEMIA; ERYTHROPOIETIN; INFLAMMATION; IMMUNOASSAY; HYPOXIA; PROTEIN	Background Anemia is common and is associated with impaired clinical outcomes in diabetic chronic kidney disease (CKD). It may be explained by reduced erythropoietin (EPO) synthesis, but recent data suggest that EPO-resistance and diminished iron availability due to inflammation contribute significantly. In this cohort study, we evaluated the impact of hepcidin-25-the key hormone of iron-metabolism-on clinical outcomes in diabetic patients with CKD along with endogenous EPO levels. Methods 249 diabetic patients with CKD of any stage, excluding end-stage renal disease (ESRD), were enrolled (2003-2005), if they were not on EPO-stimulating agent and iron therapy. Hepcidin-25 levels were measured by radioimmunoassay. The association of hepcidin-25 at baseline with clinical variables was investigated using linear regression models. All-cause mortality and a composite endpoint of CKD progression (ESRD or doubling of serum creatinine) were analyzed by Cox proportional hazards models. Results Patients (age 67 yrs, 53% male, GFR 51 ml/min, hemoglobin 131 g/L, EPO 13.5 U/L, hepcidin-25 62.0 ng/ml) were followed for a median time of 4.2 yrs. Forty-nine patients died (19.7%) and forty (16.1%) patients reached the composite endpoint. Elevated hepcidin levels were independently associated with higher ferritin-levels, lower EPO-levels and impaired kidney function (all p<0.05). Hepcidin was related to mortality, along with its interaction with EPO, older age, greater proteinuria and elevated CRP (all p<0.05). Hepcidin was also predictive for progression of CKD, aside from baseline GFR, proteinuria, low albumin-and hemoglobin-levels and a history of CVD (all p<0.05). Conclusions We found hepcidin-25 to be associated with EPO and impaired kidney function in diabetic CKD. Elevated hepcidin-25 and EPO-levels were independent predictors of mortality, while hepcidin-25 was also predictive for progression of CKD. Both hepcidin-25 and EPO may represent important prognostic factors of clinical outcome and have the potential to further define "high risk" populations in CKD.	[Wagner, Martin; Kurtz, Caroline; Zimmermann, Josef; Wanner, Christoph; Schramm, Lothar] Univ Hosp Wurzburg, Dept Med 1, Div Nephrol, Wurzburg, Germany; [Wagner, Martin; Heuschmann, Peter U.] Unin Wurzburg, Inst Clin Epidemiol & Biometry, Wurzburg, Germany; [Wagner, Martin; Heuschmann, Peter U.] Unin Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany; [Ashby, Damien R.] Univ London Imperial Coll Sci Technol & Med, Kidney & Transplant Inst, London, England; [Alam, Ahsan] McGill Univ, Div Nephrol, Montreal, PQ, Canada; [Busbridge, Mark] Univ London Imperial Coll Sci Technol & Med, Dept Clin Chem, London, England; [Raff, Ulrike] Univ Erlangen Nurnberg, Dept Internal Med 4, Div Nephrol & Hypertens, Erlangen, Germany; [Heuschmann, Peter U.] Univ Hosp Wurzburg, Clin Trial Unit, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; Imperial College London; McGill University; Imperial College London; University of Erlangen Nuremberg; University of Wurzburg	Wagner, M (corresponding author), Univ Hosp Wurzburg, Dept Med 1, Div Nephrol, Wurzburg, Germany.	wagner_m@ukw.de			Roche, Germany	Roche, Germany(Roche Holding)	The study was funded by the participating institutions. Furthermore, data collection, measurement of EPO and hepcidin levels were supported by Roche, Germany. Roche, Germany, had no influence on the conduct of the study, data analysis, and interpretation. The data are owned by the authors.	Abdel-Khalek MA, 2011, J RHEUMATOL, V38, P2153, DOI 10.3899/jrheum.110339; Ashby DR, 2010, HAEMATOL-HEMATOL J, V95, P505, DOI 10.3324/haematol.2009.013136; Ashby DR, 2009, KIDNEY INT, V75, P976, DOI 10.1038/ki.2009.21; Bassi R, 2012, EXP DIABETES RES, DOI 10.1155/2012/916560; Belesley D. A., 1980, REGRESSION DIAGNOSTI; Busbridge M, 2009, BRIT J BIOMED SCI, V66, P150, DOI 10.1080/09674845.2009.11730263; Cullis J, 2013, CLIN MED, V13, P193, DOI 10.7861/clinmedicine.13-2-193; Doria A, 2012, SEMIN NEPHROL, V32, P437, DOI 10.1016/j.semnephrol.2012.07.006; El-Achkar TM, 2005, KIDNEY INT, V67, P1483, DOI 10.1111/j.1523-1755.2005.00226.x; Ferrucci L, 2007, BRIT J HAEMATOL, V136, P849, DOI 10.1111/j.1365-2141.2007.06502.x; Fiorina P, 2014, J AM SOC NEPHROL, V25, P1415, DOI 10.1681/ASN.2013050518; Ford BA, 2010, KIDNEY INT, V78, P769, DOI 10.1038/ki.2010.254; Freund R.J., 2000, SAS SYSTEM REGRESSIO, DOI 10.1002/9780470057339.vas007; Ganz T, 2008, BLOOD, V112, P4292, DOI 10.1182/blood-2008-02-139915; Ganz T, 2007, J AM SOC NEPHROL, V18, P394, DOI 10.1681/ASN.2006070802; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Ganz T, 2011, ANNU REV MED, V62, P347, DOI 10.1146/annurev-med-050109-142444; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mast AE, 1998, CLIN CHEM, V44, P45; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; McGill JB, 2006, J DIABETES COMPLICAT, V20, P262, DOI 10.1016/j.jdiacomp.2005.08.001; McMurray J., 2012, KIDNEY INT SUPPL, V2, P279, DOI [10.1038/kisup.2012.37, DOI 10.1038/KISUP.2012.37]; MEANS RT, 1992, BLOOD, V80, P1639; Mohanram A, 2004, KIDNEY INT, V66, P1131, DOI 10.1111/j.1523-1755.2004.00863.x; Mostovaya IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084587; Nakanishi T, 2011, NEPHROL DIAL TRANSPL, V26, P3092, DOI 10.1093/ndt/gfr410; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nemeth E, 2009, ACTA HAEMATOL-BASEL, V122, P78, DOI 10.1159/000243791; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Niihata K, 2012, NEPHROL DIAL TRANSPL, V27, P4378, DOI 10.1093/ndt/gfs322; Peters HPE, 2012, NEPHROL DIAL TRANSPL, V27, P3923, DOI 10.1093/ndt/gfs164; Ritz E, 2005, EUR J CLIN INVEST, V35, P66, DOI 10.1111/j.1365-2362.2005.01544.x; Roy CN, 2007, BLOOD, V109, P4038, DOI 10.1182/blood-2006-10-051755; Smith TG, 2010, ANTIOXID REDOX SIGN, V12, P431, DOI 10.1089/ars.2009.2901; Solomon SD, 2010, NEW ENGL J MED, V363, P1146, DOI 10.1056/NEJMoa1005109; Soriano S, 2007, CLIN NEPHROL, V67, P352; Stockmann C, 2006, CLIN EXP PHARMACOL P, V33, P968, DOI 10.1111/j.1440-1681.2006.04474.x; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Thomas MC, 2006, DIABETIC MED, V23, P502, DOI 10.1111/j.1464-5491.2006.01829.x; van der Weerd NC, 2013, NEPHROL DIAL TRANSPL, V28, P3062, DOI 10.1093/ndt/gfs488; Vlagopoulos PT, 2005, J AM SOC NEPHROL, V16, P3403, DOI 10.1681/ASN.2005030226; Wagner M, 2013, NEPHROL DIAL TRANSPL, V28, P2936, DOI 10.1093/ndt/gft330; Wagner M, 2011, CLIN J AM SOC NEPHRO, V6, P1573, DOI 10.2215/CJN.00380111; Wang LJ, 2012, INFLAMM BOWEL DIS, V18, P112, DOI 10.1002/ibd.21675; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Zhao NN, 2013, J CLIN INVEST, V123, P2337, DOI 10.1172/JCI67225	49	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123072	10.1371/journal.pone.0123072	http://dx.doi.org/10.1371/journal.pone.0123072			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894587	gold, Green Published, Green Submitted			2022-12-27	WOS:000353211700022
J	Doroftei, B; Mambet, C; Zlei, M				Doroftei, Bogdan; Mambet, Cristina; Zlei, Mihaela			It's Never over until It's over: How Can Age and Ovarian Reserve Be Mathematically Bound through the Measurement of Serum AMH-A Study of 5069 Romanian Women	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; EXTERNAL VALIDATION; POPULATION; MENOPAUSE; DECLINE	Wide regional differences in the age-related Anti Mullerian hormone (AMH) regression patterns or age at onset of natural menopause have been reported, possibly reflecting genetic, socioeconomic, environmental, racial or ethnic peculiarities. Moreover, adaptation of AMH levels from different assays using regression functions may lack accuracy and externally defined references for AMH levels may not fully comply with a specific geographical area. The current study aimed to establish an accurate mathematical relationship between AMH serum values and age in a large group of women from Romania, as any consistent difference from previously reported regression models may aid in building specific profiles for the AMH decline with age in this geographical region. Our study pointed out to the quadratic regression as the most fitted pattern of correlation for all the age groups between 24 and 45. To our knowledge the current manuscript is based on the singular study carried out in this geographical region, generating a particular age-related pattern of association between age and serum AMH levels in women, regardless of their subjacent pathologies.	[Doroftei, Bogdan] Gr T Popa Univ Med & Pharm, Dept Obstet & Gynecol, Iasi, Romania; [Doroftei, Bogdan; Zlei, Mihaela] Origyn Fertil Ctr, Iasi, Romania; [Mambet, Cristina] Synevo Cent Lab Medicover Grp, Bucharest, Romania; [Zlei, Mihaela] Reg Inst Oncol, Mol Biol Lab, Iasi, Romania	Grigore T Popa University of Medicine & Pharmacy; Regional Institute of Oncology IASI	Zlei, M (corresponding author), Origyn Fertil Ctr, Iasi, Romania.	mihaelazlei@gmail.com	Doroftei, Bogdan/AAX-2358-2020; MAMBET, CRISTINA D/I-5116-2018; MAMBET, CRISTINA/K-8562-2019	Doroftei, Bogdan/0000-0002-6618-141X; MAMBET, CRISTINA D/0000-0001-8495-7704; MAMBET, CRISTINA/0000-0001-8495-7704	National Authority of Scientific Research of Romania (POSCCE Grant "Infertility a tree pieces puzzle: couple investigation, infertility diagnostic, possible therapy") [1357]; Medicover Group	National Authority of Scientific Research of Romania (POSCCE Grant "Infertility a tree pieces puzzle: couple investigation, infertility diagnostic, possible therapy"); Medicover Group	The current survey was supported by National Authority of Scientific Research of Romania (POSCCE Grant 1357 "Infertility a tree pieces puzzle: couple investigation, infertility diagnostic, possible therapy"). Medicover Group provided support in the form of salaries for author [CM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almog B, 2011, FERTIL STERIL, V95, P2359, DOI 10.1016/j.fertnstert.2011.02.057; Broer SL, 2011, J CLIN ENDOCR METAB, V96, P2532, DOI 10.1210/jc.2010-2776; Cassar S, 2014, CLIN ENDOCRINOL, V81, P899, DOI 10.1111/cen.12557; Cengiz H, 2014, EUR J OBSTET GYN R B, V180, P46, DOI 10.1016/j.ejogrb.2014.06.018; Chun Sungwook, 2014, Clin Exp Reprod Med, V41, P86, DOI 10.5653/cerm.2014.41.2.86; Fong SL, 2012, J CLIN ENDOCR METAB, V97, P4650, DOI 10.1210/jc.2012-1440; Gold EB, 2011, OBSTET GYN CLIN N AM, V38, P425, DOI 10.1016/j.ogc.2011.05.002; Khader A, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-3; La Marca A, 2010, REPROD BIOMED ONLINE, V21, P463, DOI 10.1016/j.rbmo.2010.05.009; McKnight KK, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.05.014; Naasan MN, 2015, IRISH J MED SCI, V184, P213, DOI 10.1007/s11845-014-1089-0; Nelson SM, 2011, REPROD BIOMED ONLINE, V23, P204, DOI 10.1016/j.rbmo.2011.05.006; Nelson SM, 2011, FERTIL STERIL, V95, P736, DOI 10.1016/j.fertnstert.2010.08.022; Palacios S, 2010, CLIMACTERIC, V13, P419, DOI 10.3109/13697137.2010.507886; Pinola P, 2014, HUM REPROD, V29, P2317, DOI 10.1093/humrep/deu182; Seifer DB, 2011, FERTIL STERIL, V95, P747, DOI 10.1016/j.fertnstert.2010.10.011; Su HI, 2014, FERTIL STERIL, V101, P1766, DOI 10.1016/j.fertnstert.2014.02.046; Tian X, 2014, GYNECOLENDOCRINOL, V21, P1; van Rooij IAJ, 2002, HUM REPROD, V17, P3065, DOI 10.1093/humrep/17.12.3065; van Rooij IAJ, 2005, FERTIL STERIL, V83, P979, DOI 10.1016/j.fertnstert.2004.11.029; Welsh P, 2014, HUM REPROD, V29, P1035, DOI 10.1093/humrep/deu036	21	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125216	10.1371/journal.pone.0125216	http://dx.doi.org/10.1371/journal.pone.0125216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909458	Green Published, Green Submitted, gold			2022-12-27	WOS:000353376800134
J	Harpenslager, SF; Smolders, AJP; Kieskamp, AAM; Roelofs, JGM; Lamers, LPM				Harpenslager, Sarah F.; Smolders, Alfons J. P.; Kieskamp, Ariet A. M.; Roelofs, Jan G. M.; Lamers, Leon P. M.			To Float or Not to Float: How Interactions between Light and Dissolved Inorganic Carbon Species Determine the Buoyancy of Stratiotes aloides	PLOS ONE			English	Article							DIFFERENTIAL ABILITY; AQUATIC PLANTS; WATER; MACROPHYTE; NETHERLANDS; HYDROCHARITACEAE; ASSIMILATION; BICARBONATE; LIMITATION; DYNAMICS	Structural diversity formed by dense, floating Stratiotes aloides stands, generates hotspots of biodiversity of flora and fauna in wetlands. However, only part of the populations become emergent and provide this important facilitation. Since it has been hypothesised that its buoyancy depends on the rates of underwater photosynthesis, we investigated the role of dissolved CO2 availability and PAR on photosynthesis, biomass production and buoyancy in a controlled greenhouse experiment. Photosynthesis and growth were strongly influenced by both PAR and CO2 availability. At low PAR, plants formed less biomass and produced no emergent leaves, even when CO2 was abundant. At low CO2 levels, S. aloides switched to HCO3- use, resulting in a lower photosynthetic O-2 production, decreased emergent leaf formation and increased CaCO3 precipitation on its leaves, all of which impaired buoyancy. At high PAR, low CO2 availability resulted in slower colonisation of the water layer, whereas CO2 availability did not influence PAR-limited plants. Our study shows that site conditions, rather than the sole abundance of potentially facilitating species, may strongly determine whether or not they form the structure necessary to act as a facilitator for biodiversity in aquatic environments.	[Harpenslager, Sarah F.; Smolders, Alfons J. P.; Kieskamp, Ariet A. M.; Roelofs, Jan G. M.; Lamers, Leon P. M.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Aquat Ecol & Environm Biol, NL-6525 ED Nijmegen, Netherlands; [Smolders, Alfons J. P.] B Ware Res Ctr, Nijmegen, Netherlands	Radboud University Nijmegen	Harpenslager, SF (corresponding author), Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Aquat Ecol & Environm Biol, NL-6525 ED Nijmegen, Netherlands.	S.Harpenslager@science.ru.nl	Harpenslager, Sarah Faye/Q-7274-2017; Smolders, Alfons J.P./H-2583-2012; Roelofs, Jan GM/C-1243-2011; Lamers, Leon P.M./A-8718-2012	Harpenslager, Sarah Faye/0000-0002-0338-3372; Lamers, Leon P.M./0000-0003-3769-2154	PeatCap: Natural capping in the polluted Volgermeer Polder (the Netherlands) provides new chances for peat growth counteracting land subsidence [11264]; Technology Foundation STW	PeatCap: Natural capping in the polluted Volgermeer Polder (the Netherlands) provides new chances for peat growth counteracting land subsidence; Technology Foundation STW(Technologiestichting STW)	Research performed as part of Project: 11264; PeatCap: Natural capping in the polluted Volgermeer Polder (the Netherlands) provides new chances for peat growth counteracting land subsidence. Subsidised by Technology Foundation STW, giving grants to applied research.	ALLEN ED, 1981, NEW PHYTOL, V87, P269, DOI 10.1111/j.1469-8137.1981.tb03198.x; Bloemendaal FHJL, 1988, WATERPLANTEN WATERKW; BOROWITZKA MA, 1984, PLANT CELL ENVIRON, V7, P457, DOI 10.1111/j.1365-3040.1984.tb01436.x; COOK CDK, 1983, AQUAT BOT, V16, P213, DOI 10.1016/0304-3770(83)90035-9; Efremov Andrey N., 2012, Botanica Serbica, V36, P59; ERIXON G, 1979, HYDROBIOLOGIA, V67, P215, DOI 10.1007/BF00023178; GRASSHOFF K, 1972, J CONSEIL, V34, P516; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Higler L. W. G., 1977, MACROFAUNA CENOSES S; KAMPHAKE LJ, 1967, WATER RES, V1, P205, DOI 10.1016/0043-1354(67)90011-5; Lamers LPM, 2002, HYDROBIOLOGIA, V478, P107, DOI 10.1023/A:1021022529475; Lichtenthaler HK, 1983, BIOCHEM SOC T, V11, P519; Madsen JD, 2001, HYDROBIOLOGIA, V444, P71, DOI 10.1023/A:1017520800568; MADSEN TV, 1991, FRESHWATER BIOL, V26, P175, DOI 10.1111/j.1365-2427.1991.tb01727.x; MADSEN TV, 1991, AQUAT BOT, V41, P5, DOI 10.1016/0304-3770(91)90037-6; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Milla R, 2007, P ROY SOC B-BIOL SCI, V274, P2109, DOI 10.1098/rspb.2007.0417; MNR, 2013, ONT INV AQ PLANT LIS; Montesantos N, 1913, FLORA, V105, P1; Mulderij G, 2006, FRESHWATER BIOL, V51, P554, DOI 10.1111/j.1365-2427.2006.01510.x; Nielsen LT, 2008, AQUAT BOT, V89, P379, DOI 10.1016/j.aquabot.2008.04.008; NRCS, 2014, STAT NOX WEED LISTS; NRM-SA, 2011, STAT AL WEED STR AL; PRINS HBA, 1986, AQUAT BOT, V26, P225, DOI 10.1016/0304-3770(86)90023-9; PRINS HBA, 1982, PLANT CELL ENVIRON, V5, P207, DOI 10.1111/1365-3040.ep11571916; Rantala MJ, 2004, AQUAT ECOL, V38, P77; RENMAN G, 1989, HYDROBIOLOGIA, V185, P211, DOI 10.1007/BF00036609; ROELOFS JGM, 1991, AQUAT BOT, V39, P267, DOI 10.1016/0304-3770(91)90004-O; Sculthorpe CD., 1967, BIOL AQUATIC VASCULA; SMOLDERS A, 1993, AQUAT BOT, V46, P247, DOI 10.1016/0304-3770(93)90005-H; Smolders AJP, 2003, HYDROBIOLOGIA, V506, P603, DOI 10.1023/B:HYDR.0000008551.56661.8e; Smolders AJP, 1996, NEW PHYTOL, V133, P253, DOI 10.1111/j.1469-8137.1996.tb01892.x; Strzalek M, 2009, AQUAT BOT, V90, P1, DOI 10.1016/j.aquabot.2008.04.010; Stumm W, 1996, CURRENT CONTENTS AGR, P157, DOI [10.7717/peerj.328PMID:24749007, DOI 10.7717/PEERJ.328PMID:24749007]; Sugier P, 2010, HYDROBIOLOGIA, V656, P43, DOI 10.1007/s10750-010-0433-2; Suhonen J, 2013, J INSECT CONSERV, V17, P393, DOI 10.1007/s10841-012-9521-0; Toma C., 2006, BIODIVERSITY RES CON, V3-4, P251; Van der Winden J, 2004, ARDEA, V92, P53; Verhoeven JTA, 2001, BIODIVERSITY IN WETLANDS: ASSESSMENT, FUNCTION AND CONSERVATION, VOL 2, P65	39	3	3	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124026	10.1371/journal.pone.0124026	http://dx.doi.org/10.1371/journal.pone.0124026			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909504	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800056
J	Xu, XX; Li, JY; Zhang, W; Huang, HQ; Shi, PJ; Luo, HY; Liu, B; Zhang, YH; Zhang, ZF; Fan, YL; Yao, B				Xu, Xinxin; Li, Jinyang; Zhang, Wei; Huang, Huoqing; Shi, Pengjun; Luo, Huiying; Liu, Bo; Zhang, Yuhong; Zhang, Zhifang; Fan, Yunliu; Yao, Bin			A Neutral Thermostable beta-1,4-Glucanase from Humicola insolens Y1 with Potential for Applications in Various Industries	PLOS ONE			English	Article							PHIALOPHORA SP G5; ENZYMATIC-PROPERTIES; CELLULASES; ENDOGLUCANASE; CELLULOSE; DEGRADATION; PURIFICATION; SYNERGY; CLONING; MODE	We cloned a new glycoside hydrolase family 6 gene, Hicel6C, from the thermophilic fungus Humicola insolens Y1 and expressed it in Pichia pastoris. Using barley beta-glucan as a substrate, recombinant HiCel6C protein exhibited neutral pH (6.5) and high temperature (70 degrees C) optima. Distinct from most reported acidic fungal endo-beta-1,4-glucanases, HiCel6C was alkali- tolerant, retaining greater than 98.0, 61.2, and 27.6% of peak activity at pH 8.0, 9.0, and 10.0, respectively, and exhibited good stability over a wide pH range (pH 5.0-11.0) and at temperatures up to 60 degrees C. The Km and V-max values of HiCel6C for barley beta-glucan were 1.29 mg/mL and 752 mu mol/min.mg, respectively. HiCel6C was strictly specific for the beta-1,4-glucoside linkage exhibiting activity toward barley beta-glucan, lichenan, and carboxy methylcellulose sodium salt (CMC-Na), but not toward laminarin (1,3-beta-glucan). HiCel6C cleaved the internal glycosidic linkages of cellooligosaccharides randomly and thus represents an endo-cleaving enzyme. The predominant product of polysaccharide hydrolysis by HiCel6C was cellobiose, suggesting that it functions by an endo-processive mechanism. The favorable properties of HiCel6C make it a good candidate for basic research and for applications in the textile and brewing industries.	[Xu, Xinxin; Li, Jinyang; Zhang, Wei; Liu, Bo; Zhang, Yuhong; Zhang, Zhifang; Fan, Yunliu] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100081, Peoples R China; [Huang, Huoqing; Shi, Pengjun; Luo, Huiying; Yao, Bin] Chinese Acad Agr Sci, Feed Res Inst, Key Lab Feed Biotechnol, Minist Agr, Beijing 100081, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Zhang, W (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100081, Peoples R China.	zhangwei02@caas.cn; binyao@caas.cn			National High Technology Research and Development Program of China [2012AA022105, 2012AA022207]; National Science Foundation for Distinguished Young Scholars of China [31225026]; China Modern Agriculture Research System [CARS-42]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); China Modern Agriculture Research System	This research was supported by the National High Technology Research and Development Program of China (2012AA022105, 2012AA022207) and the National Science Foundation for Distinguished Young Scholars of China (31225026) and the China Modern Agriculture Research System (CARS-42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anish R, 2007, BIOTECHNOL BIOENG, V96, P48, DOI 10.1002/bit.21175; Bayer EA, 1998, CURR OPIN STRUC BIOL, V8, P548, DOI 10.1016/S0959-440X(98)80143-7; Bhat MK, 2000, BIOTECHNOL ADV, V18, P355, DOI 10.1016/S0734-9750(00)00041-0; Busk PK, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-47; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cavaco-Paulo A, 1998, TEXT RES J, V68, P398, DOI 10.1177/004051759806800602; Conde R, 2004, J BIOL CHEM, V279, P43789, DOI 10.1074/jbc.M406678200; Davies GJ, 2000, BIOCHEM J, V348, P201, DOI 10.1042/0264-6021:3480201; Du YL, 2013, BIORESOURCE TECHNOL, V130, P161, DOI 10.1016/j.biortech.2012.12.067; Ghatge SS, 2014, APPL MICROBIOL BIOT, V98, P4421, DOI 10.1007/s00253-013-5446-0; Jeya M, 2010, APPL MICROBIOL BIOT, V85, P1005, DOI 10.1007/s00253-009-2070-0; Karlsson J, 2002, BIOPOLYMERS, V63, P32, DOI 10.1002/bip.1060; Li D.C., 2011, ENZYME RES, V2011; Luo HY, 2012, J IND MICROBIOL BIOT, V39, P547, DOI 10.1007/s10295-011-1067-8; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Maheshwari R, 2000, MICROBIOL MOL BIOL R, V64, P461, DOI 10.1128/MMBR.64.3.461-488.2000; MEINKE A, 1995, J BIOL CHEM, V270, P4383, DOI 10.1074/jbc.270.9.4383; Miettinen-Oinonen A, 2004, ENZYME MICROB TECH, V34, P332, DOI 10.1016/j.enzmictec.2003.11.011; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Souza FHM, 2013, J MOL CATAL B-ENZYM, V94, P119, DOI 10.1016/j.molcatb.2013.05.012; Oliveira GS, 2013, WORLD J MICROB BIOT, V29, P19, DOI 10.1007/s11274-012-1153-8; Pham TH, 2011, J MICROBIOL BIOTECHN, V21, P1012, DOI 10.4014/jmb.1104.04030; Samanta S, 2012, J MICROBIOL, V50, P518, DOI 10.1007/s12275-012-1207-5; Schulein M, 1997, J BIOTECHNOL, V57, P71, DOI 10.1016/S0168-1656(97)00090-4; Sorensen HR, 2006, APPL MICROBIOL BIOT, V73, P850, DOI 10.1007/s00253-006-0543-y; Takashima S, 1999, J BIOTECHNOL, V67, P85, DOI 10.1016/S0168-1656(98)00168-0; Tiwari P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/203735; Wang K, 2014, APPL MICROBIOL BIOTE; Watson BJ, 2009, J BACTERIOL, V191, P5697, DOI 10.1128/JB.00481-09; Wilson DB, 2011, CURR OPIN MICROBIOL, V14, P259, DOI 10.1016/j.mib.2011.04.004; Yang XZ, 2014, FOOD CHEM, V148, P381, DOI 10.1016/j.foodchem.2013.10.062; Zhao JQ, 2012, J BIOSCI BIOENG, V114, P379, DOI 10.1016/j.jbiosc.2012.04.021; Zhao JQ, 2012, BIORESOURCE TECHNOL, V121, P404, DOI 10.1016/j.biortech.2012.07.027; Zheng F, 2013, APPL ENVIRON MICROB, V79, P989, DOI 10.1128/AEM.02725-12	34	69	74	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124925	10.1371/journal.pone.0124925	http://dx.doi.org/10.1371/journal.pone.0124925			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909505	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800116
J	Auldridge, ME; Cao, HN; Sen, S; Franz, LP; Bingman, CA; Yennamalli, RM; Phillips, GN; Mead, D; Steinmetz, EJ				Auldridge, Michele E.; Cao, Hongnan; Sen, Saurabh; Franz, Laura P.; Bingman, Craig A.; Yennamalli, Ragothaman M.; Phillips, George N., Jr.; Mead, David; Steinmetz, Eric J.			LucY: A Versatile New Fluorescent Reporter Protein	PLOS ONE			English	Article							PHOTOINDUCED ELECTRON-TRANSFER; ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE MURB; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; VIBRIO-FISCHERI; DYNAMICS; COMPLEMENTATION; PURIFICATION; FEMTOSECOND; ALIGNMENT	We report on the discovery, isolation, and use of a novel yellow fluorescent protein. Lucigen Yellow (LucY) binds one FAD molecule within its core, thus shielding it from water and maintaining its structure so that fluorescence is 10-fold higher than freely soluble FAD. LucY displays excitation and emission spectra characteristic of FAD, with 3 excitation peaks at 276nm, 377nm, and 460nm and a single emission peak at 530nm. These excitation and emission maxima provide the large Stokes shift beneficial to fluorescence experimentation. LucY belongs to the MurB family of UDP-N-acetylenolpyruvylglucosamine reductases. The high resolution crystal structure shows that in contrast to other structurally resolved MurB enzymes, LucY does not contain a potentially quenching aromatic residue near the FAD isoalloxazine ring, which may explain its increased fluorescence over related proteins. Using E. coli as a system in which to develop LucY as a reporter, we show that it is amenable to circular permutation and use as a reporter of protein-protein interaction. Fragmentation between its distinct domains renders LucY non-fluorescent, but fluorescence can be partially restored by fusion of the fragments to interacting protein domains. Thus, LucY may find application in Protein-fragment Complementation Assays for evaluating proteinprotein interactions.	[Auldridge, Michele E.; Sen, Saurabh; Franz, Laura P.; Mead, David; Steinmetz, Eric J.] Lucigen Corp, Middleton, WI 53562 USA; [Cao, Hongnan; Yennamalli, Ragothaman M.; Phillips, George N., Jr.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Bingman, Craig A.; Phillips, George N., Jr.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA	Rice University; University of Wisconsin System; University of Wisconsin Madison	Steinmetz, EJ (corresponding author), Lucigen Corp, Middleton, WI 53562 USA.	esteinmetz@lucigen.com	Yennamalli, Ragothaman/M-7870-2017	Yennamalli, Ragothaman/0000-0002-3327-1582; Cao, Hongnan/0000-0003-2496-1298; MEAD, David/0000-0003-1982-9356	U.S. DOE [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]	U.S. DOE(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor	Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], PYM MOL GRAPH SYST V; Avila-Perez M, 2006, J BACTERIOL, V188, P6411, DOI 10.1128/JB.00716-06; Avila-Perez M, 2009, J BIOL CHEM, V284, P24958, DOI 10.1074/jbc.M109.033316; Axley MJ, 1997, BIOCHEMISTRY-US, V36, P812, DOI 10.1021/bi962260s; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; BENSON TE, 1995, NAT STRUCT BIOL, V2, P644, DOI 10.1038/nsb0895-644; Benson TE, 1996, STRUCTURE, V4, P47, DOI 10.1016/S0969-2126(96)00008-1; BENSON TE, 1993, BIOCHEMISTRY-US, V32, P2024, DOI 10.1021/bi00059a019; Benson TE, 2001, BIOCHEMISTRY-US, V40, P2340, DOI 10.1021/bi002162d; Benson TE, 1997, BIOCHEMISTRY-US, V36, P796, DOI 10.1021/bi962220o; Chapman S, 2008, P NATL ACAD SCI USA, V105, P20038, DOI 10.1073/pnas.0807551105; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; DAUBNER SC, 1987, P NATL ACAD SCI USA, V84, P8912, DOI 10.1073/pnas.84.24.8912; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; Doose S, 2009, CHEMPHYSCHEM, V10, P1389, DOI 10.1002/cphc.200900238; Drepper T, 2007, NAT BIOTECHNOL, V25, P443, DOI 10.1038/nbt1293; El Zoeiby A, 2003, MOL MICROBIOL, V47, P1, DOI 10.1046/j.1365-2958.2003.03289.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filippova E, XRAY CRYSTAL S UNPUB; Filonov GS, 2013, CHEM BIOL, V20, P1078, DOI 10.1016/j.chembiol.2013.06.009; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Hof M, 2005, FLUORECENCE SPECTROS; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Kim MK, 2007, PROTEINS, V66, P751, DOI 10.1002/prot.21174; Kodama Y, 2012, BIOTECHNIQUES, V53, P285, DOI [10.2144/0000113943, 10.2144/000113943]; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lugsanangarm K, 2012, PROTEIN STRUCTURE; Lukacs A, 2012, J PHYS CHEM B, V116, P5810, DOI 10.1021/jp2116559; MACHEROUX P, 1987, BIOCHEM BIOPH RES CO, V146, P101, DOI 10.1016/0006-291X(87)90696-6; Mataga N, 2002, J PHYS CHEM B, V106, P8917, DOI 10.1021/jp0205741; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McFall-Ngai M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001783; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Mukherjee A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064753; Mukherjee A, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-20; Munro AW, 1999, METH MOL B, V131, P25; Nakabayashi T, 2010, J PHYS CHEM B, V114, P15254, DOI 10.1021/jp1063066; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paulmurugan R, 2003, ANAL CHEM, V75, P1584, DOI 10.1021/ac020731c; Saff EB, 1997, MATH INTELL, V19, P5, DOI 10.1007/BF03024331; Sarver RW, 2002, J BIOMOL SCREEN, V7, P21, DOI 10.1177/108705710200700104; Sen S, 2012, NAT METHODS, V9, pIII, DOI 10.1038/nmeth.f.356; Shyu YJ, 2008, TRENDS BIOTECHNOL, V26, P622, DOI 10.1016/j.tibtech.2008.07.006; Steinmetz E, 2010, GENETIC ENG BIOTECHN; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tanaka F, 2007, J PHYS CHEM B, V111, P5694, DOI 10.1021/jp066450g; Tchekanda E, 2014, NAT METHODS, V11, P641, DOI [10.1038/nmeth.2934, 10.1038/NMETH.2934]; Theorell H, 1955, NOBLE PRIZE LECT; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; van den Berg PAW, 1998, BIOPHYS J, V74, P2046, DOI 10.1016/S0006-3495(98)77911-1; WILLIAMS ATR, 1983, ANALYST, V108, P1067, DOI 10.1039/an9830801067; Yang YJ, 2006, ANTIMICROB AGENTS CH, V50, P556, DOI 10.1128/AAC.50.2.556-564.2006; Yu Y, 2011, TRENDS BIOTECHNOL, V29, P18, DOI 10.1016/j.tibtech.2010.10.004; Zhang R, XRAY CRYSTAL S UNPUB	63	2	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124272	10.1371/journal.pone.0124272	http://dx.doi.org/10.1371/journal.pone.0124272			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906065	gold, Green Submitted, Green Published			2022-12-27	WOS:000353332000063
J	Keith, MCL; Tang, XL; Tokita, Y; Li, QH; Ghafghazi, S; Moore, J; Hong, KU; Elmore, B; Amraotkar, A; Ganzel, BL; Grubb, KJ; Flaherty, MP; Hunt, G; Vajravelu, B; Wysoczynski, M; Bolli, R				Keith, Matthew C. L.; Tang, Xian-Liang; Tokita, Yukichi; Li, Qian-hong; Ghafghazi, Shahab; Moore, Joseph; Hong, Kyung U.; Elmore, Brandon; Amraotkar, Alok; Ganzel, Brian L.; Grubb, Kendra J.; Flaherty, Michael P.; Hunt, Gregory; Vajravelu, Bathri; Wysoczynski, Marcin; Bolli, Roberto			Safety of Intracoronary Infusion of 20 Million C-Kit Positive Human Cardiac Stem Cells in Pigs	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; ACUTE MYOCARDIAL-INFARCTION; PROGENITOR CELLS; PORCINE MODEL; DELIVERY; TRANSPLANTATION; REGENERATION; INJECTION; EFFICACY	Background There is mounting interest in using c-kit positive human cardiac stem cells (c-kit(pos) hCSCs) to repair infarcted myocardium in patients with ischemic cardiomyopathy. A recent phase I clinical trial (SCIPIO) has shown that intracoronary infusion of 1 million hCSCs is safe. Higher doses of CSCs may provide superior reparative ability; however, it is unknown if doses >1 million cells are safe. To address this issue, we examined the effects of 20 million hCSCs in pigs. Methods Right atrial appendage samples were obtained from patients undergoing cardiac surgery. The tissue was processed by an established protocol with eventual immunomagnetic sorting to obtain in vitro expanded hCSCs. A cumulative dose of 20 million cells was given intracoronarily to pigs without stop flow. Safety was assessed by measurement of serial biomarkers (cardiac: troponin I and CK-MB, renal: creatinine and BUN, and hepatic: AST, ALT, and alkaline phosphatase) and echocardiography pre- and post-infusion. hCSC retention 30 days after infusion was quantified by PCR for human genomic DNA. All personnel were blinded as to group assignment. Results Compared with vehicle-treated controls (n=5), pigs that received 20 million hCSCs (n=9) showed no significant change in cardiac function or end organ damage (assessed by organ specific biomarkers) that could be attributed to hCSCs (P>0.05 in all cases). No hCSCs could be detected in left ventricular samples 30 days after infusion. Conclusions Intracoronary infusion of 20 million c-kit positive hCSCs in pigs (equivalent to similar to 40 million hCSCs in humans) does not cause acute cardiac injury, impairment of cardiac function, or liver and renal injury. These results have immediate translational value and lay the groundwork for using doses of CSCs >1 million in future clinical trials. Further studies are needed to ascertain whether administration of >1 million hCSCs is associated with greater efficacy in patients with ischemic cardiomyopathy.	[Keith, Matthew C. L.; Tang, Xian-Liang; Tokita, Yukichi; Li, Qian-hong; Ghafghazi, Shahab; Moore, Joseph; Hong, Kyung U.; Elmore, Brandon; Amraotkar, Alok; Flaherty, Michael P.; Hunt, Gregory; Vajravelu, Bathri; Wysoczynski, Marcin; Bolli, Roberto] Univ Louisville, Inst Mol Cardiol, Louisville, KY 40292 USA; [Ganzel, Brian L.; Grubb, Kendra J.] Univ Louisville, Dept Cardiothorac Surg, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Bolli, R (corresponding author), Univ Louisville, Inst Mol Cardiol, Louisville, KY 40292 USA.	Roberto.Bolli@louisville.edu	Moore, Joseph B/I-4161-2013; Wysoczynski, Marcin/I-4334-2013; Vajravelu, Bathri/K-5504-2019; Hong, Kyung Uk/G-7145-2011; Li, Qianhong/AAJ-7643-2020; Amraotkar, Alok/B-6429-2016	Hong, Kyung Uk/0000-0001-6700-9470; Amraotkar, Alok/0000-0001-7506-8673; Grubb, Kendra/0000-0002-1369-5521; Ghafghazi, Shahab/0000-0001-5061-6119	NIH [P01-HL78825, 1 UM1 HL-113530]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UM1HL113530, P01HL078825] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by NIH grants P01-HL78825 and 1 UM1 HL-113530. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bolli R, 2013, CIRCULATION, V128, P122, DOI 10.1161/CIRCULATIONAHA.112.001075; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Chen Shaoliang, 2006, J Invasive Cardiol, V18, P552; Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034; Diris JHC, 2004, CIRCULATION, V109, P23, DOI 10.1161/01.CIR.0000109483.45211.8F; ENGLISH J, 1987, TRANSPLANTATION, V44, P135, DOI 10.1097/00007890-198707000-00027; Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818; Gao LR, 2013, INT J CARDIOL, V168, P3191, DOI 10.1016/j.ijcard.2013.04.112; Gleeson TG, 2004, AM J ROENTGENOL, V183, P1673, DOI 10.2214/ajr.183.6.01831673; Grieve SM, 2010, CIRC-HEART FAIL, V3, pE5, DOI 10.1161/CIRCHEARTFAILURE.109.931360; Hong KU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096725; Hong KU, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0346-0; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; KASSAB GS, 1994, AM J PHYSIOL, V267, pH319, DOI 10.1152/ajpheart.1994.267.1.H319; Katritsis DG, 2005, CATHETER CARDIO INTE, V65, P321, DOI 10.1002/ccd.20406; Keith MC, 2014, CIRCULATION, V130; Lakota J, 2014, INT J CARDIOL, V176, P547, DOI 10.1016/j.ijcard.2014.07.024; Lee JW, 2014, J KOREAN MED SCI, V29, P23, DOI 10.3346/jkms.2014.29.1.23; Li QH, 2011, BASIC RES CARDIOL, V106, P849, DOI 10.1007/s00395-011-0180-1; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Meluzin J, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.08.004; Nathwani RA, 2005, HEPATOLOGY, V41, P380, DOI 10.1002/hep.20548; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Suzuki G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113009; Suzuki G, 2011, CIRC RES, V109, P1044, DOI 10.1161/CIRCRESAHA.111.245969; Taghavi S, 2013, AM J TRANSL RES, V5, P404; Traverse JH, 2012, JAMA-J AM MED ASSOC, V308, P2380, DOI 10.1001/jama.2012.28726; Traverse JH, 2011, JAMA-J AM MED ASSOC, V306, P2110, DOI 10.1001/jama.2011.1670; Vulliet PR, 2004, LANCET, V363, P783, DOI 10.1016/S0140-6736(04)15695-X; Weibrecht K, 2010, J MED TOXICOL, V6, P294, DOI 10.1007/s13181-010-0075-9	34	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124227	10.1371/journal.pone.0124227	http://dx.doi.org/10.1371/journal.pone.0124227			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905721	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000060
J	Lopez-Campos, JL; Hartl, S; Pozo-Rodriguez, F; Roberts, M				Luis Lopez-Campos, Jose; Hartl, Sylvia; Pozo-Rodriguez, Francisco; Roberts, Michael		European COPD Audit Team	Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; C-REACTIVE PROTEIN; PROCALCITONIN; MOXIFLOXACIN; MANAGEMENT; OUTCOMES; SPUTUM; SEX	Objective Appropriate use of antibiotics in the management of hospitalised patients with COPD exacerbations is defined within the GOLD strategy. This paper analyses the factors associated with antibiotic prescribing in patients to better understand how prescribing may be improved. Methods The European COPD audit was a study of clinical care in 384 hospitals from 13 European countries between 2010 and 2011 enrolling 16018 patients. Those admitted to hospital due to a clinician-made diagnosis of exacerbation of COPD at the time of discharge were audited. We defined antibiotic prescribing compliance as consistent with the GOLD 2010 recommendations. Two different multivariate models were used to evaluate factors associated with the prescription of antibiotics and the guideline-compliant prescriptions. Results Overall 86% of admissions were given antibiotics but only 61.4% cases met the GOLD recommendations. Antibiotics were more likely to be given in hospital and at discharge if received prior to admission. Antibiotic prescription was more likely in patients who met the GOLD recommendations and in those with radiological consolidation but there was also a significant use of antibiotics in patients who did not meet either criterion. Patients cared for on a Respiratory Ward were more likely to receive GOLD compliant antibiotic management. Conclusions The present study describes the audited in-hospital antibiotic prescription for COPD exacerbation across different European countries. In general, there is an apparent overuse of antibiotics likely to be associated with both patient and practice-related variables.	[Luis Lopez-Campos, Jose] Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS, Seville, Spain; [Luis Lopez-Campos, Jose; Pozo-Rodriguez, Francisco] Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid, Spain; [Hartl, Sylvia] Ludwig Boltzmann Inst COPD & Resp Epidemiol, Vienna, Austria; [Pozo-Rodriguez, Francisco] Hosp 12 Octubre, Inst Invest I 12, E-28041 Madrid, Spain; [Roberts, Michael] Univ London, Barts & London Sch Med & Dent, London WC1E 7HU, England	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Ludwig Boltzmann Institute; Hospital Universitario 12 de Octubre; University of London; Queen Mary University London	Lopez-Campos, JL (corresponding author), Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS, Seville, Spain.	lcampos@separ.es	López-Quílez, Antonio/H-5945-2011; Özgür, Eylem Sercan/I-1921-2015; Bodineau, José Luis López-Campos/AAG-5203-2019; Arghir, Oana C/F-8515-2015; Guardia, Sergi Pascual/L-7652-2014	López-Quílez, Antonio/0000-0002-7022-9260; Özgür, Eylem Sercan/0000-0003-4459-232X; Bodineau, José Luis López-Campos/0000-0003-1703-1367; Arghir, Oana C/0000-0001-9844-8521; Guardia, Sergi Pascual/0000-0002-6567-0916; CORBACHO, DOLORES/0000-0003-1239-5276; roberts, christopher/0000-0001-8212-1460	Almirall; Takeda; Bohringer; Novartis; GlaxoSmithKline; Torrex Chiesi; AstraZeneca; MeckSharpDome	Almirall(Almirall); Takeda(Takeda Pharmaceutical Company Ltd); Bohringer; Novartis(Novartis); GlaxoSmithKline(GlaxoSmithKline); Torrex Chiesi(Chiesi Pharmaceuticals Inc); AstraZeneca(AstraZeneca); MeckSharpDome	Almirall, Takeda, Bohringer, Novartis, GlaxoSmithKline, Torrex Chiesi, AstraZeneca, and MeckSharpDome provided support in the form of salaries for authors SH and CMR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aryal S, 2014, INT J CHRONIC OBSTR, V9, P1145, DOI 10.2147/COPD.S54476; Brusse-Keizer M, 2013, BMJ OPEN RESPIR RES, V1, DOI 10.1136/bmjresp-2014-000052; Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-8; Daniels JMA, 2010, CHEST, V138, P1108, DOI 10.1378/chest.09-2927; DiSantostefano RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097149; Huerta A, 2013, CHEST, V144, P1134, DOI 10.1378/chest.13-0488; Liu KX, 2014, J THORAC DIS, V6, P221, DOI 10.3978/j.issn.2072-1439.2013.11.12; Llor C, 2013, THER ADV RESPIR DIS, V7, P131, DOI 10.1177/1753465812472387; Lopez-Campos JL, 2013, EUR RESPIR J, V41, P270, DOI 10.1183/09031936.00021812; Myint PK, 2011, RESPIRATION, V82, P320, DOI 10.1159/000327203; Papaioannou AI, 2014, INT J CHRONIC OBSTR, V9, P203, DOI 10.2147/COPD.S52500; Pozo-Rodriguez F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042156; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Roberts CM, 2013, THORAX, V68, P1169, DOI 10.1136/thoraxjnl-2013-203465; Roche N, 2007, RESPIRATION, V74, P19, DOI 10.1159/000093158; Roche N, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-20; Schwarzmann S W, 2000, Postgrad Med, V108, P25, DOI 10.3810/pgm.12.2000.suppl10.53; Stefan MS, 2013, CHEST, V143, P82, DOI 10.1378/chest.12-0649; Stockley RA, 2000, CHEST, V117, P1638, DOI 10.1378/chest.117.6.1638; Stolz D, 2009, CURR OPIN PULM MED, V15, P126, DOI 10.1097/MCP.0b013e328324e6d7; Vollenweider Daniela J, 2012, Cochrane Database Syst Rev, V12, pCD010257, DOI 10.1002/14651858.CD010257; Weis N, 2006, EUR J INTERN MED, V17, P88, DOI 10.1016/j.ejim.2005.09.020; Wilson R, 2012, EUR RESPIR J, V40, P17, DOI 10.1183/09031936.00090311; Woodhead M, 2005, EUR RESPIR J, V26, P1138, DOI 10.1183/09031936.05.00055705	24	32	32	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124374	10.1371/journal.pone.0124374	http://dx.doi.org/10.1371/journal.pone.0124374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905726	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000069
J	Meulenbroeks, C; van der Lugt, JJ; van der Meide, NMA; Willemse, T; Rutten, VPMG; Zaiss, DMW				Meulenbroeks, Chantal; van der Lugt, Jaco J.; van der Meide, Nathalie M. A.; Willemse, Ton; Rutten, Victor P. M. G.; Zaiss, Dietmar M. W.			Allergen-Specific Cytokine Polarization Protects Shetland Ponies against Culicoides obsoletus-Induced Insect Bite Hypersensitivity	PLOS ONE			English	Article							E-BEARING CELLS; MAST-CELLS; BRITISH-COLUMBIA; FRIESIAN HORSES; SKIN BIOPSIES; SWEET ITCH; IGE; ANTIBODIES; TOLERANCE; IMMUNOTHERAPY	The immunological mechanisms explaining development of an allergy in some individuals and not in others remain incompletely understood. Insect bite hypersensitivity (IBH) is a common, seasonal, IgE-mediated, pruritic skin disorder that affects considerable proportions of horses of different breeds, which is caused by bites of the insect Culicoides obsoletus (C. obsoletus). We investigated the allergen-specific immune status of individual horses that had either been diagnosed to be healthy or to suffer of IBH. Following intradermal allergen injection, skin biopsies were taken of IBH-affected and healthy ponies and cytokine expression was determined by RT-PCR. In addition, allergen-specific antibody titers were measured and cytokine expression of in vitro stimulated, allergen-specific CD4 T-cells was determined. 24 hrs after allergen injection, a significant increase in mRNA expression of the type-2 cytokine IL-4 was observed in the skin of IBH-affected Shetland ponies. In the skin of healthy ponies, however, an increase in IFN gamma mRNA expression was found. Analysis of allergen-specific antibody titers revealed that all animals produced allergen-specific antibodies, and allergen-specific stimulation of CD4 T-cells revealed a significant higher percentage of IFN gamma-expressing CD4 T-cells in healthy ponies compared to IBH-affected ponies. These data indicate that horses not affected by IBH, in contrast to the so far established dogma, are not immunologically ignorant but have a Th1-skewed allergen-specific immune response that appears to protect against IBH-associated symptoms. To our knowledge this is the first demonstration of a natural situation, in which an allergen-specific immune skewing is protective in an allergic disorder.	[Meulenbroeks, Chantal; Willemse, Ton; Rutten, Victor P. M. G.; Zaiss, Dietmar M. W.] Univ Utrecht, Dept Infect Dis & Immunol, Fac Vet Med, Utrecht, Netherlands; [van der Lugt, Jaco J.] IDEXX Labs, Hoofddorp, Netherlands; [van der Meide, Nathalie M. A.] Wageningen Univ, Dept Cell Biol & Immunol, NL-6700 AP Wageningen, Netherlands; [Willemse, Ton] Univ Utrecht, Dept Clin Sci Compan Anim, Fac Vet Med, Utrecht, Netherlands; [Rutten, Victor P. M. G.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0110 Onderstepoort, South Africa; [Zaiss, Dietmar M. W.] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland	Utrecht University; Wageningen University & Research; Utrecht University; University of Pretoria; University of Edinburgh	Zaiss, DMW (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Fac Vet Med, Utrecht, Netherlands.	Dietmar.Zaiss@ed.ac.uk	Rutten, Victor PMG/AAB-6833-2022	Rutten, Victor PMG/0000-0002-6171-1805; Zaiss, Dietmar M.W./0000-0003-3596-7062	Dutch Technology Foundation (STW-NOW); Dutch Federation of horse breeding and ALK-Abello/Artu Biologicals	Dutch Technology Foundation (STW-NOW); Dutch Federation of horse breeding and ALK-Abello/Artu Biologicals	This work was financially supported by the Dutch Technology Foundation (STW-NOW), the Dutch Federation of horse breeding and ALK-Abello/Artu Biologicals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Jaco J. van der Lugt is employed by IDEXX Laboratories. IDEXX Laboratories provided support in the form of salary for author JJvdL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section.	ANDERSON GS, 1988, CAN VET J, V29, P718; ANDERSON GS, 1991, J MED ENTOMOL, V28, P685, DOI 10.1093/jmedent/28.5.685; Burton OT, 2014, IMMUNITY, V41, P141, DOI 10.1016/j.immuni.2014.05.017; Byrne SN, 2008, J IMMUNOL, V180, P4648, DOI 10.4049/jimmunol.180.7.4648; Campbell JD, 2014, THORAX, V69, P565, DOI 10.1136/thoraxjnl-2013-204605; Creticos PS, 2006, NEW ENGL J MED, V355, P1445, DOI 10.1056/NEJMoa052916; de Vries VC, 2009, AM J TRANSPLANT, V9, P2270, DOI 10.1111/j.1600-6143.2009.02755.x; Forward NA, 2009, J IMMUNOL, V183, P3014, DOI 10.4049/jimmunol.0802509; Geroldinger-Simic M, 2011, J ALLERGY CLIN IMMUN, V127, P616, DOI 10.1016/j.jaci.2010.10.027; Hamza E, 2012, VET IMMUNOL IMMUNOP, V148, P139, DOI 10.1016/j.vetimm.2011.05.033; Heimann M, 2011, VET IMMUNOL IMMUNOP, V140, P63, DOI 10.1016/j.vetimm.2010.11.016; Hellberg W, 2006, VET IMMUNOL IMMUNOP, V113, P99, DOI 10.1016/j.vetimm.2006.04.009; Kline JN, 2002, AM J PHYSIOL-LUNG C, V283, pL170, DOI 10.1152/ajplung.00402.2001; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Matsuoka T, 2013, ALLERGOL INT, V62, P403, DOI 10.2332/allergolint.13-RAI-0650; Meulenbroeks C, 2013, VET IMMUNOL IMMUNOP, V151, P147, DOI 10.1016/j.vetimm.2012.11.007; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Romagnani S, 2004, J ALLERGY CLIN IMMUN, V113, P395, DOI 10.1016/j.jaci.2003.11.025; Rufenacht S, 2005, VET DERMATOL, V16, P94, DOI 10.1111/j.1365-3164.2005.00440.x; Savilahti EM, 2010, J ALLERGY CLIN IMMUN, V125, P1315, DOI 10.1016/j.jaci.2010.03.025; Schaffartzik A, 2012, VET IMMUNOL IMMUNOP, V147, P113, DOI 10.1016/j.vetimm.2012.03.017; Schurink A, 2013, VET J, V195, P382, DOI 10.1016/j.tvjl.2012.06.037; van der Haegen A, 2001, EQUINE VET J, V33, P699, DOI 10.2746/042516401776249444; van der Meide NMA, 2012, VET IMMUNOL IMMUNOP, V149, P245, DOI 10.1016/j.vetimm.2012.07.007; van der Rijt R, 2008, VET J, V178, P91, DOI 10.1016/j.tvjl.2007.07.005; Van Grevenhof EM, 2007, EQUINE VET J, V39, P69, DOI 10.2746/042516407X153020; Varga EM, 2013, J ALLERGY CLIN IMMUN, V131, P1419, DOI 10.1016/j.jaci.2012.08.037; Wagner B, 2006, DEV COMP IMMUNOL, V30, P155, DOI 10.1016/j.dci.2005.06.008; Wagner B, 2006, VET RES, V37, P813, DOI 10.1051/vetres:2006039; Wilson AD, 2001, EQUINE VET J, V33, P707, DOI 10.2746/042516401776249363; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023	32	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0122090	10.1371/journal.pone.0122090	http://dx.doi.org/10.1371/journal.pone.0122090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901733	Green Published, gold, Green Submitted			2022-12-27	WOS:000353331500014
J	Gilad, R; Meir, K; Stein, I; German, L; Pikarsky, E; Mabjeesh, NJ				Gilad, Roni; Meir, Karen; Stein, Ilan; German, Larissa; Pikarsky, Eli; Mabjeesh, Nicola J.			High SEPT9_i1 Protein Expression Is Associated with High-Grade Prostate Cancers	PLOS ONE			English	Article							ACTIVE SURVEILLANCE; VIRAL VACCINE; HYPOXIA; TUMORIGENESIS; ANGIOGENESIS; THERAPY; ANTIGEN; BREAST; CELLS; HIF-1	Septins are a family of GTP-binding cytoskeleton proteins expressed in many solid tumors. Septin 9 (SEPT9) in particular was found overexpressed in diverse carcinomas. Herein, we studied the expression of SEPT9 isoform 1 protein (SEPT9_i1) in human prostate cancer specimens. We utilized immunohistochemical staining to study the expression of SEPT9_i1 protein. Staining level was analyzed in association with clinical characteristics and the pathological Gleason grade and score. Fifty human prostate cancer specimens (42 primary tumors and 8 metastatic lesions) were stained by SEPT9_i1 antibody and analyzed. SEPT9_i1 protein was expressed in prostate cancer cells but absent in normal epithelial cells. The intensity of staining was correlated proportionally to pretreatment prostate-specific antigen (PSA) blood levels and Gleason score (P < 0.05). SEPT9_i1 was highly expressed in all metastatic lesions. A significant assocation between SEPT9_i1 expression and high Gleason score on multivariate linear regression analysis was found. We conclude that SEPT9_i1 is expressed in high-grade prostate tumors suggesting it has a significant role in prostate tumorigenesis and that it could serve as a molecular marker for prostate tumor progression.	[Gilad, Roni; German, Larissa; Mabjeesh, Nicola J.] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Dept Urol, IL-69978 Tel Aviv, Israel; [Meir, Karen; Stein, Ilan; Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Pathol, IL-91010 Jerusalem, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Hebrew University of Jerusalem	Mabjeesh, NJ (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Dept Urol, IL-69978 Tel Aviv, Israel.	nicolam@tlvmc.gov.il	pikarsky, eli/GXV-7099-2022	German, Larissa/0000-0003-3456-3509; pikarsky, eli/0000-0003-4186-7105	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF)	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF)	This work was supported by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir S, 2006, CANCER RES, V66, P856, DOI 10.1158/0008-5472.CAN-05-2738; Amir S, 2010, MOL CANCER RES, V8, P643, DOI 10.1158/1541-7786.MCR-09-0497; Arnir S, 2007, CANCER BIOL THER, V6, P1926, DOI 10.4161/cbt.6.12.4971; Chacko AD, 2005, J PATHOL, V206, P458, DOI 10.1002/path.1794; Chacko AD, 2012, CELL ONCOL, V35, P85, DOI 10.1007/s13402-011-0066-0; Connolly D, 2011, BIOL CHEM, V392, P725, DOI 10.1515/BC.2011.073; Culig Z, 2009, J UROLOGY, V182, P1255, DOI 10.1016/j.juro.2009.07.073; Epstein JI, 2010, J UROLOGY, V183, P433, DOI 10.1016/j.juro.2009.10.046; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gonzalez ME, 2007, CANCER RES, V67, P8554, DOI 10.1158/0008-5472.CAN-07-1474; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Kinoshita M, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-236; Lechleider RJ, 2008, CLIN CANCER RES, V14, P5284, DOI 10.1158/1078-0432.CCR-07-5162; Lindstrom S, 2012, CANCER EPIDEM BIOMAR, V21, P437, DOI 10.1158/1055-9965.EPI-11-1038; Mabjeesh NJ, 2007, HISTOL HISTOPATHOL, V22, P559, DOI 10.14670/HH-22.559; Mostowy S, 2014, BIOL CHEM, V395, P119, DOI 10.1515/hsz-2013-0291; Mullins JK, 2013, BJU INT, V111, P1037, DOI 10.1111/j.1464-410X.2012.11641.x; Nesslinger NJ, 2010, CLIN CANCER RES, V16, P4046, DOI 10.1158/1078-0432.CCR-10-0948; Oh Y, 2011, TRENDS CELL BIOL, V21, P141, DOI 10.1016/j.tcb.2010.11.006; Quintero M, 2004, EJSO-EUR J SURG ONC, V30, P465, DOI 10.1016/j.ejso.2004.03.008; Sandrock K, 2011, BIOL CHEM, V392, P751, DOI 10.1515/BC.2011.081; Santos J, 2010, LEUKEMIA RES, V34, P615, DOI 10.1016/j.leukres.2009.08.018; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Stanbery L, 2010, TRANSL ONCOL, V3, P239, DOI 10.1593/tlo.10109; van den Bergh RCN, 2014, EUR UROL, V65, P1023, DOI 10.1016/j.eururo.2014.01.027; Welty CJ, 2014, EUR UROL, V65, P1032, DOI 10.1016/j.eururo.2014.02.044; Yutkin V, 2007, J UROLOGY, V178, P2660, DOI 10.1016/j.juro.2007.07.118	28	15	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124251	10.1371/journal.pone.0124251	http://dx.doi.org/10.1371/journal.pone.0124251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898316	gold, Green Published, Green Submitted			2022-12-27	WOS:000353212600057
J	Hidron, AI; Hill, B; Guest, JL; Rimland, D				Hidron, Alicia I.; Hill, Brittany; Guest, Jodie L.; Rimland, David			Risk Factors for Vitamin D Deficiency among Veterans with and without HIV Infection	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; D INSUFFICIENCY; COHORT; PREVALENCE; HEALTH; TRIAL	Objectives We aimed to describe and compare the prevalence of vitamin D deficiency between HIV-negative and HIV-infected veterans in the southern United States, and to determine risk factors for vitamin D deficiency for HIV-infected patients. Methods Cross-sectional, retrospective study including all patients followed at the Atlanta VA Medical Center with the first 25-hydroxyvitamin D [25(OH) D] level determined between January 2007 and August 2010. Multivariate logistic regression analysis was used to determine risk factors associated with vitamin D deficiency (< 20 ng/ml). Results There was higher prevalence of 25(OH) D deficiency among HIV-positive compared to HIV-negative patients (53.2 vs. 38.5%, p < 0.001). Independent risk factors for vitamin D deficiency in HIV + patients included black race (OR 3.24, 95% CI 2.28-4.60), winter season (OR 1.39, 95% CI 1.05-1.84) and higher GFR (OR 1.01, CI 1.00-1.01); increasing age (OR 0.98, 95% CI 0.95-0.98), and tenofovir use (OR 0.72, 95% CI 0.54-0.96) were associated with less vitamin D deficiency. Conclusions Vitamin D deficiency is a prevalent problem that varies inversely with age and affects HIV-infected patients more than other veterans in care. In addition to age, tenofovir and kidney disease seem to confer a protective effect from vitamin D deficiency in HIV-positive patients.	[Hidron, Alicia I.; Hill, Brittany; Guest, Jodie L.; Rimland, David] Atlanta Vet Affairs Med Ctr, Decatur, GA 30033 USA; [Hidron, Alicia I.; Guest, Jodie L.; Rimland, David] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Hidron, Alicia I.] Univ Pontificia Bolivariana, Medellin, Colombia; [Hidron, Alicia I.] Hosp Pablo Tobon Uribe, Medellin, Colombia; [Hill, Brittany] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Guest, Jodie L.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University; Universidad Pontificia Bolivariana; Emory University; Emory University; Rollins School Public Health	Hidron, AI (corresponding author), Atlanta Vet Affairs Med Ctr, Decatur, GA 30033 USA.	ahidron@emory.edu		Guest, Jodie/0000-0002-3650-3975	Center for AIDS Research at Emory University [P30 AI050409]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER	Center for AIDS Research at Emory University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was facilitated by the Center for AIDS Research at Emory University (P30 AI050409). The sponsors had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemi OM, 2011, JAIDS-J ACQ IMM DEF, V57, P197, DOI 10.1097/QAI.0b013e31821ae418; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Childs KE, 2010, AIDS RES HUM RETROV, V26, P855, DOI 10.1089/aid.2009.0308; Crutchley RD, 2011, AIDS RES HUM RETROVI; Dao CN, 2011, CLIN INFECT DIS, V52, P396, DOI 10.1093/cid/ciq158; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; Fox J, 2011, AIDS RES HUM RETROV, V27, P29, DOI 10.1089/aid.2010.0081; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Aparicio AMG, 2006, CLIN RHEUMATOL, V25, P537, DOI 10.1007/s10067-005-0028-x; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI DOI 10.1001/ARCHINTERNMED; Havers F, 2014, J INFECT DIS, V210, P244, DOI 10.1093/infdis/jiu259; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hossein-nezhad A, 2013, MAYO CLIN PROC, V88, P720, DOI 10.1016/j.mayocp.2013.05.011; Institute of Medicine, 2011, DIETARY REFERENCE IN; Kim JH, 2011, AIDS RES HUMAN RETRO; Ormesher B, 2011, AIDS, V25, P1237, DOI 10.1097/QAD.0b013e3283474ef9; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Rosenvinge MM, 2010, JAIDS-J ACQ IMM DEF, V54, P496, DOI 10.1097/QAI.0b013e3181caebaa; Schwalfenberg GK, 2010, CAN MED ASSOC J, V182, P1763, DOI 10.1503/cmaj.110-2118; Shepherd L, 2014, J INFECT DIS, V210, P234, DOI 10.1093/infdis/jiu074; Van Den Bout-Van Den Beukel CJP, 2008, AIDS RES HUM RETROV, V24, P1375, DOI 10.1089/aid.2008.0058; Vescini F, 2011, JAIDS-J ACQ IMM DEF, V58, P163, DOI 10.1097/QAI.0b013e31822e57e9; Viard JP, 2011, AIDS, V25, P1305, DOI 10.1097/QAD.0b013e328347f6f7; Welz T, 2010, AIDS, V24, P1923, DOI 10.1097/QAD.0b013e32833c3281; Woodward CLN, 2009, HIV MED, V10, P482, DOI 10.1111/j.1468-1293.2009.00716.x; Zadshir Ashraf, 2005, Ethn Dis, V15, pS5	27	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124168	10.1371/journal.pone.0124168	http://dx.doi.org/10.1371/journal.pone.0124168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898185	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600055
J	Kim, Y; Liesack, W				Kim, Yongkyu; Liesack, Werner			Differential Assemblage of Functional Units in Paddy Soil Microbiomes	PLOS ONE			English	Article							CLOSTRIDIUM-ACETOBUTYLICUM ATCC-824; RICE FIELD SOIL; BACTERIAL COMMUNITIES; RIBOSOMAL-RNA; NITRATE ASSIMILATION; METATRANSCRIPTOMICS; IDENTIFICATION; BIOGEOGRAPHY; GENES; MICROORGANISMS	Flooded rice fields are not only a global food source but also a major biogenic source of atmospheric methane. Using metatranscriptomics, we comparatively explored structural and functional succession of paddy soil microbiomes in the oxic surface layer and anoxic bulk soil. Cyanobacteria, Fungi, Xanthomonadales, Myxococcales, and Methylococcales were the most abundant and metabolically active groups in the oxic zone, while Clostridia, Actinobacteria, Geobacter, Anaeromyxobacter, Anaerolineae, and methanogenic archaea dominated the anoxic zone. The protein synthesis potential of these groups was about 75% and 50% of the entire community capacity, respectively. Their structure-function relationships in microbiome succession were revealed by classifying the protein-coding transcripts into core, non-core, and taxon-specific transcripts based on homologous gene distribution. The differential expression of core transcripts between the two microbiomes indicated that structural succession is primarily governed by the cellular ability to adapt to the given oxygen condition, involving oxidative stress, nitrogen/phosphorus metabolism, and fermentation. By contrast, the non-core transcripts were expressed from genes involved in the metabolism of various carbon sources. Among those, taxon-specific transcripts revealed highly specialized roles of the dominant groups in community-wide functioning. For instance, taxon-specific transcripts involved in photosynthesis and methane oxidation were a characteristic of the oxic zone, while those related to methane production and aromatic compound degradation were specific to the anoxic zone. Degradation of organic matters, antibiotics resistance, and secondary metabolite production were detected to be expressed in both the oxic and anoxic zones, but by different taxonomic groups. Cross-feeding of methanol between members of the Methylococcales and Xanthomonadales was suggested by the observation that in the oxic zone, they both exclusively expressed homologous genes encoding methanol dehydrogenase. Our metatranscriptomic analysis suggests that paddy soil microbiomes act as complex, functionally coordinated assemblages whose taxonomic composition is governed by the prevailing habitat factors and their hierarchical importance for community succession.	[Kim, Yongkyu; Liesack, Werner] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany	Max Planck Society	Liesack, W (corresponding author), Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany.	liesack@mpi-marburg.mpg.de		Liesack, Werner/0000-0002-9533-1552; Kim, Yongkyu/0000-0002-6781-7168	Deutsche Forschungsgemeinschaft (collaborative research center) [SFB 987]	Deutsche Forschungsgemeinschaft (collaborative research center)(German Research Foundation (DFG))	This research was funded by the Deutsche Forschungsgemeinschaft (collaborative research center SFB 987). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blazewicz SJ, 2013, ISME J, V7, P2061, DOI 10.1038/ismej.2013.102; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Burow LC, 2013, ISME J, V7, P817, DOI 10.1038/ismej.2012.150; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carvalhais LC, 2012, J MICROBIOL METH, V91, P246, DOI 10.1016/j.mimet.2012.08.011; Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109; Chidthaisong A, 1999, APPL ENVIRON MICROB, V65, P2350; Chin KJ, 1999, APPL ENVIRON MICROB, V65, P5042; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Conrad R, 1999, FEMS MICROBIOL ECOL, V28, P193, DOI 10.1016/S0168-6496(98)00086-5; Cordero OX, 2012, SCIENCE, V337, P1228, DOI 10.1126/science.1219385; Crump BC, 2004, APPL ENVIRON MICROB, V70, P1494, DOI 10.1128/AEM.70.3.1494-1505.2004; Damon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028967; de Menezes A, 2012, ENVIRON MICROBIOL, V14, P2577, DOI 10.1111/j.1462-2920.2012.02781.x; DeAngelis KM, 2012, APPL ENVIRON MICROB, V78, P2459, DOI 10.1128/AEM.07547-11; Du XJ, 2013, GENOME BIOL EVOL, V5, P494, DOI 10.1093/gbe/evt024; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Finucane MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084689; Flores E, 2005, PHOTOSYNTH RES, V83, P117, DOI 10.1007/s11120-004-5830-9; FRENZEL P, 1992, BIOL FERT SOILS, V14, P84, DOI 10.1007/BF00336255; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Garcia-Martinez J, 2000, MOL ECOL, V9, P935, DOI 10.1046/j.1365-294x.2000.00953.x; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Gottig N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004358; Gregory T. Ryan, 2005, P585; Han B, 2009, FEMS MICROBIOL ECOL, V70, P196, DOI 10.1111/j.1574-6941.2009.00707.x; Helbling DE, 2012, ISME J, V6, P902, DOI [10.1038/ISMEJ.2011.158, 10.1038/ismej.2011.158]; Hori T, 2007, APPL ENVIRON MICROB, V73, P101, DOI 10.1128/AEM.01676-06; Hori T, 2010, ISME J, V4, P267, DOI 10.1038/ismej.2009.100; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Hutchens E, 2004, ENVIRON MICROBIOL, V6, P111, DOI 10.1046/j.1462-2920.2003.00543.x; Khalil MAK, 1998, J GEOPHYS RES-ATMOS, V103, P25233, DOI 10.1029/98JD01116; Kim Y., 2014, OMICS SOIL SCI, P63; Liesack W, 2000, FEMS MICROBIOL REV, V24, P625, DOI 10.1111/j.1574-6976.2000.tb00563.x; Makarova KS, 1999, GENOME RES, V9, P608; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; Mettel C, 2010, APPL ENVIRON MICROB, V76, P5995, DOI 10.1128/AEM.03047-09; Mills CT, 2013, FEMS MICROBIOL ECOL, V84, P474, DOI 10.1111/1574-6941.12079; Moran MA, 2009, MICROBE, V7, P329; Moran MA, 2013, ISME J, V7, P237, DOI 10.1038/ismej.2012.94; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Mou XZ, 2011, ENV MICROBIOL REP, V3, P798, DOI 10.1111/j.1758-2229.2011.00289.x; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Noll M, 2005, ENVIRON MICROBIOL, V7, P382, DOI 10.1111/j.1462-2920.2005.00700.x; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Phelan VV, 2012, NAT CHEM BIOL, V8, P26, DOI 10.1038/nchembio.739; Pradella S, 2002, ARCH MICROBIOL, V178, P484, DOI 10.1007/s00203-002-0479-2; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Serkebaeva YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063994; Shi YM, 2011, ISME J, V5, P999, DOI 10.1038/ismej.2010.189; Shrestha M, 2008, ENVIRON MICROBIOL, V10, P400, DOI 10.1111/j.1462-2920.2007.01462.x; Shrestha PM, 2009, ENVIRON MICROBIOL, V11, P960, DOI 10.1111/j.1462-2920.2008.01821.x; Sims GK, 2002, APPL SOIL ECOL, V19, P217, DOI 10.1016/S0929-1393(01)00192-5; Stewart FJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r26; Tangney M, 2007, APPL MICROBIOL BIOT, V74, P398, DOI 10.1007/s00253-006-0679-9; Tremblay PL, 2012, ENV MICROBIOL REP, V4, P82, DOI 10.1111/j.1758-2229.2011.00305.x; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Urich T, 2011, HDB MOL MICROBIAL EC, P587; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Valles Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004406; Vila-Costa M, 2010, ISME J, V4, P1410, DOI 10.1038/ismej.2010.62; Wang QF, 2000, J BACTERIOL, V182, P1764, DOI 10.1128/JB.182.6.1764-1767.2000; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wawrik B, 2005, APPL ENVIRON MICROB, V71, P2232, DOI 10.1128/AEM.71.5.2232-2238.2005; Yu Y, 2007, APPL ENVIRON MICROB, V73, P1842, DOI 10.1128/AEM.02082-06; Zhang JH, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-60	75	32	34	6	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0122221	10.1371/journal.pone.0122221	http://dx.doi.org/10.1371/journal.pone.0122221			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898319	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600009
J	Nagasawa, K; Meguro, M; Sato, K; Tanizaki, Y; Nogawa-Kosaka, N; Kato, T				Nagasawa, Kazumichi; Meguro, Mizue; Sato, Kei; Tanizaki, Yuta; Nogawa-Kosaka, Nami; Kato, Takashi			The Influence of Artificially Introduced N-Glycosylation Sites on the In Vitro Activity of Xenopus laevis Erythropoietin	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; BIOLOGICAL-ACTIVITY; VIVO POTENCY; EXPRESSION; CLONING; CDNA; SEQUENCE; GENE; IDENTIFICATION; CARBOHYDRATE	Erythropoietin (EPO), the primary regulator of erythropoiesis, is a heavily glycosylated protein found in humans and several other mammals. Intriguingly, we have previously found that EPO in Xenopus laevis (xlEPO) has no N-glycosylation sites, and cross-reacts with the human EPO (huEPO) receptor despite low homology with huEPO. In this study, we introduced N-glycosylation sites into wild-type xlEPO at the positions homologous to those in huEPO, and tested whether the glycosylated mutein retained its biological activity. Seven xlEPO muteins, containing 1-3 additional N-linked carbohydrates at positions 24, 38, and/or 83, were expressed in COS-1 cells. The muteins exhibited lower secretion efficiency, higher hydrophilicity, and stronger acidic properties than the wild type. All muteins stimulated the proliferation of both cell lines, xlEPO receptor-expressing xlEPOR-FDC/P2 cells and huEPO receptor-expressing UT-7/EPO cells, in a dose-dependent manner. Thus, the muteins retained their in vitro biological activities. The maximum effect on xlEPOR-FDC/P2 proliferation was decreased by the addition of N-linked carbohydrates, but that on UT-7/EPO proliferation was not changed, indicating that the muteins act as partial agonists to the xlEPO receptor, and near-full agonists to the huEPO receptor. Hence, the EPO-EPOR binding site in X. laevis locates the distal region of artificially introduced three N-glycosylation sites, demonstrating that the vital conformation to exert biological activity is conserved between humans and X. laevis, despite the low similarity in primary structures of EPO and EPOR.	[Nagasawa, Kazumichi; Meguro, Mizue; Sato, Kei; Tanizaki, Yuta; Nogawa-Kosaka, Nami; Kato, Takashi] Waseda Univ, Integrat Bioscience & Biomed Engn, Grad Sch Adv Sci & Engn, Ctr Adv Biomed Sci,Shinjuku Ku, Tokyo 1628480, Japan; [Tanizaki, Yuta; Kato, Takashi] Waseda Univ, Dept Biol, Sch Educ, Ctr Adv Biomed Sci,Shinjuku Ku, Tokyo 1628480, Japan	Waseda University; Waseda University	Kato, T (corresponding author), Waseda Univ, Integrat Bioscience & Biomed Engn, Grad Sch Adv Sci & Engn, Ctr Adv Biomed Sci,Shinjuku Ku, TWIns Bldg 2-2 Wakamatsu Cho, Tokyo 1628480, Japan.	tkato@waseda.jp	Kato, Takashi/AFO-2557-2022	Kato, Takashi/0000-0003-0384-7971; Sato, Kei/0000-0001-6923-5594	Japan Society for the Promotion of Science [20570063, 26440171]; Waseda University [2007B-061, 2011B-047, 2012B-045, 2013B-056]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [07H016]; MEXT	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Waseda University; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research (KAKENHI) from Japan Society for the Promotion of Science (No. 20570063 and 26440171), Grants for Special Research Project from Waseda University (No. 2007B-061, 2011B-047, 2012B-045 and 2013B-056) and by "High-Tech Research Center" Project for Private Universities: matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (No. 07H016). A part of this study was performed as MEXT-Supported Program for the Strategic Research Foundation at Private Universities.	Aizawa Y, 2005, J BIOCHEM, V138, P167, DOI 10.1093/jb/mvi113; Barrio Rendo Maria E., 1997, Acta Physiologica Pharmacologica et Therapeutica Latinoamericana, V47, P225; Bunn HF, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011619; Chou CF, 2004, BLOOD, V104, P1498, DOI 10.1182/blood-2003-10-3404; Chu CY, 2007, FEBS LETT, V581, P4265, DOI 10.1016/j.febslet.2007.07.073; Cowgill LD, 1998, J AM VET MED ASSOC, V212, P521; Darling RJ, 2002, BIOCHEMISTRY-US, V41, P14524, DOI 10.1021/bi0265022; David RB, 2001, DOMEST ANIM ENDOCRIN, V20, P137, DOI 10.1016/S0739-7240(01)00089-3; DELORME E, 1992, BIOCHEMISTRY-US, V31, P9871, DOI 10.1021/bi00156a003; Egrie JC, 2003, EXP HEMATOL, V31, P290, DOI 10.1016/S0301-472X(03)00006-7; Elliott S, 1997, BLOOD, V89, P493, DOI 10.1182/blood.V89.2.493; Elliott S, 2004, J BIOL CHEM, V279, P16854, DOI 10.1074/jbc.M311095200; Elliott S, 2003, NAT BIOTECHNOL, V21, P414, DOI 10.1038/nbt799; Elliott S, 2004, EXP HEMATOL, V32, P1146, DOI 10.1016/j.exphem.2004.08.004; FU P, 1993, MOL CELL ENDOCRINOL, V93, P107, DOI 10.1016/0303-7207(93)90113-X; FUKUDA MN, 1989, BLOOD, V73, P84; Gimenez E, 2007, ANAL BIOANAL CHEM, V388, P1531, DOI 10.1007/s00216-007-1334-8; GRODBERG J, 1993, EUR J BIOCHEM, V218, P597, DOI 10.1111/j.1432-1033.1993.tb18413.x; IMAI N, 1990, EUR J BIOCHEM, V194, P457, DOI 10.1111/j.1432-1033.1990.tb15639.x; JACOBS K, 1985, NATURE, V313, P806, DOI 10.1038/313806a0; Jelkmann W, 2013, TRANSFUS MED HEMOTH, V40, P302, DOI 10.1159/000356193; Katakura F, 2013, DEV COMP IMMUNOL, V40, P148, DOI 10.1016/j.dci.2013.02.007; KOMATSU N, 1993, BLOOD, V82, P456; Lasne F, 2000, NATURE, V405, P635, DOI 10.1038/35015164; LIN FK, 1985, P NATL ACAD SCI USA, V82, P7580, DOI 10.1073/pnas.82.22.7580; MacLeod JN, 1998, AM J VET RES, V59, P1144; Matthews DJ, 1996, P NATL ACAD SCI USA, V93, P9471, DOI 10.1073/pnas.93.18.9471; MCDONALD JD, 1986, MOL CELL BIOL, V6, P842, DOI 10.1128/MCB.6.3.842; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nogawa-Kosaka N, 2011, J EXP BIOL, V214, P921, DOI 10.1242/jeb.050286; Nogawa-Kosaka N, 2010, EXP HEMATOL, V38, P363, DOI 10.1016/j.exphem.2010.02.009; Paffett-Lugassy N, 2007, BLOOD, V110, P2718, DOI 10.1182/blood-2006-04-016535; Pisal DS, 2010, J PHARM SCI-US, V99, P2557, DOI 10.1002/jps.22054; Randolph JF, 2004, AM J VET RES, V65, P1355, DOI 10.2460/ajvr.2004.65.1355; Sato F, 2004, AM J VET RES, V65, P15, DOI 10.2460/ajvr.2004.65.15; Sebaugh JL, 2011, PHARM STAT, V10, P128, DOI 10.1002/pst.426; Seyfang A, 2004, ANAL BIOCHEM, V324, P285, DOI 10.1016/j.ab.2003.10.012; SPIVAK JL, 1989, BLOOD, V73, P90; Suliman HB, 1996, GENE, V171, P275, DOI 10.1016/0378-1119(95)00895-0; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; TSUDA E, 1990, EUR J BIOCHEM, V188, P405, DOI 10.1111/j.1432-1033.1990.tb15417.x; Vilalta A, 2001, BIOCHEM BIOPH RES CO, V284, P823, DOI 10.1006/bbrc.2001.5028; Wang YJ, 2010, J CONTROL RELEASE, V145, P306, DOI 10.1016/j.jconrel.2010.04.021; Wang ZL, 2012, CHINESE SCI BULL, V57, P997, DOI 10.1007/s11434-011-4911-3; WASLEY LC, 1991, BLOOD, V77, P2624; WEN D, 1993, BLOOD, V82, P1507; WEN DY, 1994, J BIOL CHEM, V269, P22839; Wilson S, 2011, J AM ASSOC LAB ANIM, V50, P635; YAMAGUCHI K, 1991, J BIOL CHEM, V266, P20434	49	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124676	10.1371/journal.pone.0124676	http://dx.doi.org/10.1371/journal.pone.0124676			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25898205	Green Published, gold, Green Submitted			2022-12-27	WOS:000353212600079
J	Pak, HK; Gil, M; Lee, Y; Lee, H; Lee, AN; Roh, J; Park, CS				Pak, Hyo-Kyung; Gil, Minchan; Lee, Yoonkyung; Lee, Hyunji; Lee, A-Neum; Roh, Jin; Park, Chan-Sik			Regulator of G Protein Signaling 1 Suppresses CXCL12-Mediated Migration and AKT Activation in RPMI 8226 Human Plasmacytoma Cells and Plasmablasts	PLOS ONE			English	Article							EXPRESSION; RESPONSES; CXCR4; RESPONSIVENESS; PROLIFERATION; CHEMOKINES; SURVIVAL; LINE; RGS1	Migration of plasma cells to the bone marrow is critical factor to humoral immunity and controlled by chemokines. Regulator of G protein signaling 1 (RGS1) is a GTPase-activating protein that controls various crucial functions such as migration. Here, we show that RGS1 controls the chemotactic migration of RPMI 8226 human plasmacytoma cells and human plasmablasts. LPS strongly increased RGS1 expression and retarded the migration of RPMI 8226 cells by suppressing CXCL12-mediated AKT activation. RGS1 knockdown by siRNA abolished the retardation of migration and AKT suppression by LPS. RGS1-dependent regulation of migration via AKT is also observed in cultured plasmablasts. We propose novel functions of RGS1 that suppress AKT activation and the migration of RPMI 8226 cells and plasmablasts in CXCL12-mediated chemotaxis.	[Pak, Hyo-Kyung; Gil, Minchan; Lee, Yoonkyung; Lee, Hyunji; Lee, A-Neum; Park, Chan-Sik] Univ Ulsan, Coll Med, Cell Dysfunct Res Ctr, Seoul, South Korea; [Park, Chan-Sik] Univ Ulsan, Coll Med, Asan Med Ctr, Inst Life Sci, Seoul, South Korea; [Pak, Hyo-Kyung; Roh, Jin; Park, Chan-Sik] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea	University of Ulsan; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Park, CS (corresponding author), Univ Ulsan, Coll Med, Cell Dysfunct Res Ctr, Seoul, South Korea.	csikpark@amc.seoul.kr	Pak, Hyo-Kyung/A-1136-2014; Gil, Minchan/R-1280-2019	Pak, Hyo-Kyung/0000-0001-5897-4703	National Research Foundation of Korea [2008-0062286]; Asan Institute for Life Sciences [2011-0794]	National Research Foundation of Korea(National Research Foundation of Korea); Asan Institute for Life Sciences	This work was supported by the National Research Foundation of Korea, Grant No 2008-0062286, to C-SP (http://www.nrf.re.kr/) and the Asan Institute for Life Sciences, grant no. 2011-0794 to C-SP (http://en.ails.amc.seoul.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Anger T, 2007, J BIOCHEM MOL BIOL, V40, P899; Azab AK, 2009, BLOOD, V113, P4341, DOI 10.1182/blood-2008-10-186668; Bansal G, 2008, J IMMUNOL, V181, P7882, DOI 10.4049/jimmunol.181.11.7882; Berthebaud M, 2005, BLOOD, V106, P2962, DOI 10.1182/blood-2005-02-0526; Fernandes JR, 2010, INT IMMUNOL, V22, P527, DOI 10.1093/intimm/dxq037; Fooksman DR, 2010, IMMUNITY, V33, P118, DOI 10.1016/j.immuni.2010.06.015; Gil M, 2010, IMMUNOLOGY, V130, P536, DOI 10.1111/j.1365-2567.2010.03252.x; Han JI, 2006, J LEUKOCYTE BIOL, V79, P1357, DOI 10.1189/jlb.1105693; Han SB, 2005, IMMUNITY, V22, P343, DOI 10.1016/j.immuni.2005.01.017; Hauser AE, 2002, J IMMUNOL, V169, P1277, DOI 10.4049/jimmunol.169.3.1277; Hideshima T, 2002, MOL CANCER THER, V1, P539; Kehrl JH, 1998, IMMUNITY, V8, P1, DOI 10.1016/S1074-7613(00)80453-7; KIM HS, 1995, J IMMUNOL, V155, P1101; Leleu X, 2007, BLOOD, V110, P4417, DOI 10.1182/blood-2007-05-092098; Lione AM, 2000, J NEUROCHEM, V75, P934, DOI 10.1046/j.1471-4159.2000.0750934.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mariani M, 2014, BLOOD TRANSFUS-ITALY, V12, P416, DOI 10.2450/2014.0198-13; Mellado M, 2001, ANNU REV IMMUNOL, V19, P397, DOI 10.1146/annurev.immunol.19.1.397; Moratz C, 2004, MOL CELL BIOL, V24, P5767, DOI 10.1128/MCB.24.13.5767-5775.2004; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Muehlinghaus G, 2005, BLOOD, V105, P3965, DOI 10.1182/blood-2004-08-2992; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Ryu CH, 2010, BIOCHEM BIOPH RES CO, V398, P105, DOI 10.1016/j.bbrc.2010.06.043; Shi CS, 2001, J BIOL CHEM, V276, P24293, DOI 10.1074/jbc.M100089200; Shi GX, 2004, J IMMUNOL, V172, P5175, DOI 10.4049/jimmunol.172.9.5175; Tangye SG, 2011, TRENDS IMMUNOL, V32, P595, DOI 10.1016/j.it.2011.09.001; Wieland T, 2003, PHARMACOL THERAPEUT, V97, P95, DOI 10.1016/S0163-7258(02)00326-1; Willimott S, 2007, BRIT J HAEMATOL, V138, P721, DOI 10.1111/j.1365-2141.2007.06717.x; Xue GD, 2013, JNCI-J NATL CANCER I, V105, P393, DOI 10.1093/jnci/djs648; Yoon SO, 2009, J LEUKOCYTE BIOL, V86, P1311, DOI 10.1189/jlb.0409268; Zamponi GW, 2001, CELL BIOCHEM BIOPHYS, V34, P79, DOI 10.1385/CBB:34:1:79	32	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124793	10.1371/journal.pone.0124793	http://dx.doi.org/10.1371/journal.pone.0124793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897806	Green Submitted, Green Published, gold			2022-12-27	WOS:000353212600086
J	Euba, B; Moleres, J; Viadas, C; Mozos, IRD; Valle, J; Bengoechea, JA; Garmendia, J				Euba, Begona; Moleres, Javier; Viadas, Cristina; de Los Mozos, Igor Ruiz; Valle, Jaione; Antonio Bengoechea, Jose; Garmendia, Junkal			Relative Contribution of P5 and Hap Surface Proteins to Nontypable Haemophilus influenzae Interplay with the Host Upper and Lower Airways	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; RESPIRATORY EPITHELIAL-CELLS; MICROCOLONY FORMATION; SIALIC-ACID; CARCINOEMBRYONIC ANTIGENS; ICAM-1 EXPRESSION; SERINE-PROTEASE; N-GLYCOSYLATION; OTITIS-MEDIA; AUTOTRANSPORTER	Nontypable Haemophilus influenzae (NTHi) is a major cause of opportunistic respiratory tract disease, and initiates infection by colonizing the nasopharynx. Bacterial surface proteins play determining roles in the NTHi-airways interplay, but their specific and relative contribution to colonization and infection of the respiratory tract has not been addressed comprehensively. In this study, we focused on the ompP5 and hap genes, present in all H. influenzae genome sequenced isolates, and encoding the P5 and Hap surface proteins, respectively. We employed isogenic single and double mutants of the ompP5 and hap genes generated in the pathogenic strain NTHi375 to evaluate P5 and Hap contribution to biofilm growth under continuous flow, to NTHi adhesion, and invasion/phagocytosis on nasal, pharyngeal, bronchial, alveolar cultured epithelial cells and alveolar macrophages, and to NTHi murine pulmonary infection. We show that P5 is not required for bacterial biofilm growth, but it is involved in NTHi interplay with respiratory cells and in mouse lung infection. Mechanistically, P5(NTHi375) is not a ligand for CEACAM1 or alpha 5 integrin receptors. Hap involvement in NTHi375-host interaction was shown to be limited, despite promoting bacterial cell adhesion when expressed in H. influenzae RdKW20. We also show that Hap does not contribute to bacterial biofilm growth, and that its absence partially restores the deficiency in lung infection observed for the Delta ompP5 mutant. Altogether, this work frames the relative importance of the P5 and Hap surface proteins in NTHi virulence.	[Euba, Begona; Moleres, Javier; Viadas, Cristina; Antonio Bengoechea, Jose; Garmendia, Junkal] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain; [Euba, Begona; Moleres, Javier; Viadas, Cristina; de Los Mozos, Igor Ruiz; Valle, Jaione; Garmendia, Junkal] Univ Publ Navarra Gobierno Navarra, CSIC, Inst Agrobiotecnol, Mutilva, Spain; [Viadas, Cristina; Antonio Bengoechea, Jose; Garmendia, Junkal] Govern Illes Balears, CSIC, FISIB, Lab Microbial Pathogenesis, Bunyola, Spain; [Antonio Bengoechea, Jose] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; Consejo Superior de Investigaciones Cientificas (CSIC); Queens University Belfast	Garmendia, J (corresponding author), Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain.	juncal.garmendia@unavarra.es	jaione, valle/N-8005-2019; Moleres, Javier/AAR-4222-2020; Ruiz de los Mozos, Igor/C-3313-2013; Garmendia, Juncal/G-4360-2011; jaione, valle/G-6213-2011; de los Mozos, Igor Ruiz/Q-6269-2019	jaione, valle/0000-0003-3115-0207; Ruiz de los Mozos, Igor/0000-0003-4097-6422; Garmendia, Juncal/0000-0002-7440-2737; jaione, valle/0000-0003-3115-0207; de los Mozos, Igor Ruiz/0000-0003-4097-6422; Bengoechea, Jose/0000-0002-9677-8751; Moleres Apilluelo, Javier/0000-0002-2749-6988	ISCIII [PS09/00130]; Ministerio Economia y Competitividad-MINECO [SAF2012-31166]; Dpto. Salud Gobierno Navarra [359/2012]; CIBERES	ISCIII(Instituto de Salud Carlos III); Ministerio Economia y Competitividad-MINECO; Dpto. Salud Gobierno Navarra; CIBERES	This study was supported by ISCIII PS09/00130, Ministerio Economia y Competitividad-MINECO SAF2012-31166, Dpto. Salud Gobierno Navarra 359/2012, CIBERES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2011, J CLIN MICROBIOL, V49, P3728, DOI 10.1128/JCM.05476-11; Allen S, 2005, INFECT IMMUN, V73, P5291, DOI 10.1128/IAI.73.9.5291-5300.2005; Avadhanula V, 2006, INFECT IMMUN, V74, P830, DOI 10.1128/IAI.74.2.830-838.2006; Bookwalter JE, 2008, INFECT IMMUN, V76, P48, DOI 10.1128/IAI.00980-07; Bouchet V, 2003, P NATL ACAD SCI USA, V100, P8898, DOI 10.1073/pnas.1432026100; De Chiara M, 2014, P NATL ACAD SCI USA, V111, P5439, DOI 10.1073/pnas.1403353111; Duim B, 1997, INFECT IMMUN, V65, P1351, DOI 10.1128/IAI.65.4.1351-1356.1997; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faustoferri RC, 1998, PLASMID, V40, P247, DOI 10.1006/plas.1998.1371; Fink DL, 2003, J BACTERIOL, V185, P1608, DOI 10.1128/JB.185.5.1608-1615.2003; Fink DL, 2001, J BIOL CHEM, V276, P39492, DOI 10.1074/jbc.M106913200; Fink DL, 2003, CELL MICROBIOL, V5, P175, DOI 10.1046/j.1462-5822.2003.00266.x; Fink DL, 2002, INFECT IMMUN, V70, P4902, DOI 10.1128/IAI.70.9.4902-4907.2002; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Frick AG, 2000, J IMMUNOL, V164, P4185, DOI 10.4049/jimmunol.164.8.4185; Garmendia J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097020; Garmendia J, 2012, INT MICROBIOL, V15, P158, DOI 10.2436/20.1501.01.169; GAUTHIER F, 1982, BIOCHIM BIOPHYS ACTA, V700, P178, DOI 10.1016/0167-4838(82)90095-4; GrayOwen SD, 1997, EMBO J, V16, P3435, DOI 10.1093/emboj/16.12.3435; Hendrixson DR, 1998, MOL CELL, V2, P841, DOI 10.1016/S1097-2765(00)80298-1; HERRIOTT RM, 1970, J BACTERIOL, V101, P513, DOI 10.1128/JB.101.2.513-516.1970; Hill DJ, 2001, MOL MICROBIOL, V39, P850, DOI 10.1046/j.1365-2958.2001.02233.x; Hood DW, 1999, MOL MICROBIOL, V33, P679, DOI 10.1046/j.1365-2958.1999.01509.x; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Jiang ZL, 1999, INFECT IMMUN, V67, P187, DOI 10.1128/IAI.67.1.187-192.1999; Kilian M, 2002, MOL MICROBIOL, V46, P1367, DOI 10.1046/j.1365-2958.2002.03254.x; Lopez-Gomez A, 2012, MICROBIOL-SGM, V158, P2384, DOI 10.1099/mic.0.059972-0; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Marti-Lliteras P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021133; Marti-Lliteras P, 2009, INFECT IMMUN, V77, P4232, DOI 10.1128/IAI.00305-09; Mell JC, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01245-14; Miyamoto N, 1996, MICROB PATHOGENESIS, V21, P343, DOI 10.1006/mpat.1996.0067; Morey P, 2013, INFECT IMMUN, V81, P4100, DOI 10.1128/IAI.00492-13; Morey P, 2011, MICROBIOL-SGM, V157, P234, DOI 10.1099/mic.0.040451-0; Mullins MA, 2009, J BACTERIOL, V191, P5988, DOI 10.1128/JB.00469-09; Murphy TF, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-7; Novotny LA, 2008, INFECT IMMUN, V76, P967, DOI 10.1128/IAI.01395-07; Otto VI, 2006, GLYCOBIOLOGY, V16, P1033, DOI 10.1093/glycob/cwl032; Reddy MS, 1996, INFECT IMMUN, V64, P1477, DOI 10.1128/IAI.64.4.1477-1479.1996; Rosadini CV, 2014, INFECT IMMUN, V82, P640, DOI 10.1128/IAI.01224-13; Rougeaux C, 2008, CELL MICROBIOL, V10, P632, DOI 10.1111/j.1462-5822.2007.01072.x; SIRAKOVA T, 1994, INFECT IMMUN, V62, P2002, DOI 10.1128/IAI.62.5.2002-2020.1994; Spahich NA, 2014, MICROBIOLOGY; Spahich NA, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00005; Spahich NA, 2012, J BACTERIOL, V194, P1815, DOI 10.1128/JB.06316-11; STGEME JW, 1994, MOL MICROBIOL, V14, P217, DOI 10.1111/j.1365-2958.1994.tb01283.x; STGEME JW, 1994, INFECT IMMUN, V62, P3881, DOI 10.1128/IAI.62.9.3881-3889.1994; Virji M, 2000, MOL MICROBIOL, V36, P784, DOI 10.1046/j.1365-2958.2000.01885.x; Webb DC, 1998, J MED MICROBIOL, V47, P1059, DOI 10.1099/00222615-47-12-1059; Webster P, 2006, J HISTOCHEM CYTOCHEM, V54, P829, DOI 10.1369/jhc.6A6922.2006; Wong SM, 2013, P NATL ACAD SCI USA, V110, P15413, DOI 10.1073/pnas.1311217110; ZHENG MZ, 1994, J BIOL CHEM, V269, P12325	52	17	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123154	10.1371/journal.pone.0123154	http://dx.doi.org/10.1371/journal.pone.0123154			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894755	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700024
J	Mi, WD; Zhang, CS; Wang, H; Cao, JB; Li, CT; Yang, L; Guo, F; Wang, XW; Yang, T				Mi, Weidong; Zhang, Changsheng; Wang, Hong; Cao, Jiangbei; Li, Changtian; Yang, Li; Guo, Fang; Wang, Xianwang; Yang, Tie			Measurement and Analysis of the Tracheobronchial Tree in Chinese Population Using Computed Tomography	PLOS ONE			English	Article							DOUBLE-LUMEN TUBE; LEFT MAIN BRONCHUS; TRACHEAL WIDTH; SIZE; DIMENSIONS; SELECTION; DIAMETERS; PRESSURE; LENGTH; VOLUME	Objective To ascertain accurate measurements of, and the relationships between, the normative parameters of the tracheobronchial trees in the Chinese population using multi-slice spiral computed tomography (CT) and multi-planar reconstruction (MPR). Materials and Methods Measurements were performed on 2107 patients who underwent thoracic CT scans in the PLA General Hospital. The lengths of the trachea and the main stem bronchi, and the sizes of the subcarinal angle were obtained through CT or MPR imaging. Multi-variance analyses were performed to detect potential correlations between obtained parameters. Results The mean length of the trachea was 104.9 +/- 13.4 mm (107.8 +/- 13.2 mm for men and 101.4 +/- 12.8 mm for women). The mean lengths of the right and left main stem bronchi were 13.6 +/- 4.3 and 48.3 +/- 6.5 mm, respectively. The right bronchus angle and the left bronchus angle were 34.9 and 42.5 degrees, respectively. Significant gender differences were found in all the parameters measured except for the angle of the right upper lobe bronchus. There are no statistically significant correlations among these parameters. Conclusions The normal reference values and the likely ranges of distribution of the tracheobronchial trees in the Chinese population have been established. Significant gender differences exist in the dimensions of the trachea, with the exception of the Right upper bronchial angle (RUA).	[Mi, Weidong; Zhang, Changsheng; Wang, Hong; Cao, Jiangbei; Guo, Fang] Chinese Peoples Liberat Army Gen Hosp, Anesthesia & Operat Ctr, Beijing 100853, Peoples R China; [Li, Changtian] Chinese Peoples Liberat Army Gen Hosp, Southern Bldg, Dept Ultrasound, Beijing 100853, Peoples R China; [Yang, Li; Yang, Tie] Chinese Peoples Liberat Army Gen Hosp, Dept Radiol, Beijing 100853, Peoples R China; [Wang, Xianwang] Th Hosp Chinese PLA, Dept Anesthesia, Beijing 100096, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Mi, WD (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Anesthesia & Operat Ctr, Beijing 100853, Peoples R China.	plamzk@126.com	Cao, jiangbei/AFS-3772-2022; Cao, Jiangbei/ADE-0079-2022	Cao, Jiangbei/0000-0003-1218-4639				Munguia-Canales DA, 2011, CIR CIR, V79, P465; ATWELL SW, 1967, DIS CHEST, V52, P611, DOI 10.1378/chest.52.5.611; BENUMOF JL, 1987, ANESTHESIOLOGY, V67, P729, DOI 10.1097/00000542-198711000-00018; BREATNACH E, 1984, AM J ROENTGENOL, V142, P903, DOI 10.2214/ajr.142.5.903; Brodsky JB, 1996, ANESTH ANALG, V82, P861, DOI 10.1097/00000539-199604000-00032; Brodsky JB, 2005, J CLIN ANESTH, V17, P267, DOI 10.1016/j.jclinane.2004.07.008; Brodsky JB, 2001, J CARDIOTHOR VASC AN, V15, P216, DOI 10.1053/jcan.2001.21970; Cai BQ, 2011, PUMC RESPIROLOGY, P3; Chow MYH, 1999, ANESTH ANALG, V88, P302, DOI 10.1097/00000539-199902000-00014; Chunder R, 2010, Nepal Med Coll J, V12, P207; CROTEAU JR, 1961, J APPL PHYSIOL, V16, P170, DOI 10.1152/jappl.1961.16.1.170; Eberle B, 1999, J CARDIOTHOR VASC AN, V13, P532, DOI 10.1016/S1053-0770(99)90003-4; Ellis H, 2013, ANATOMY ANAESTHETIST, P42; FEARON B, 1967, ANN OTO RHINOL LARYN, V76, P964, DOI 10.1177/000348946707600507; GAMSU G, 1983, SEMIN ROENTGENOL, V18, P51, DOI 10.1016/S0037-198X(83)80009-1; Gatzoulis MA, 2008, GRAYS ANATOMY ANATOM, P989; GILES E, 1988, J FORENSIC SCI, V33, P1218; Grillo HC, 2004, SURG TRACHEA BRONCHI, P43; GRISCOM NT, 1982, RADIOLOGY, V145, P361, DOI 10.1148/radiology.145.2.7134436; GRISCOM NT, 1986, AM J ROENTGENOL, V146, P233, DOI 10.2214/ajr.146.2.233; GRISCOM NT, 1983, RADIOLOGY, V149, P27, DOI 10.1148/radiology.149.1.6611936; GRISCOM NT, 1985, AM REV RESPIR DIS, V131, P840; Hampton T, 2000, ANAESTH INTENS CARE, V28, P540, DOI 10.1177/0310057X0002800510; Hautmann H, 2000, ANESTH ANALG, V90, P1436, DOI 10.1097/00000539-200006000-00034; JESSEPH JE, 1957, SURG GYNECOL OBSTET, V105, P210; Kim D, 2014, J CARDIOTHOR VASC AN, V28, P890, DOI 10.1053/j.jvca.2013.05.029; Liu ZY, 2009, ENGLISH CHINESE TXB, P143; Olivier P, 2006, CHEST, V130, P101, DOI 10.1378/chest.130.1.101; S-R N, 2013, 5 MINUTE ANESTHESIA, P500; Seymour AH, 2003, J CARDIOTHOR VASC AN, V17, P299, DOI 10.1016/S1053-0770(03)00057-0; WITTENBORG MH, 1967, RADIOLOGY, V88, P653, DOI 10.1148/88.4.653; Yuceyar L, 2003, ACTA ANAESTH SCAND, V47, P622, DOI 10.1034/j.1399-6576.2003.00102.x; Zhevnov V N, 1969, Vestn Khir Im I I Grek, V103, P116	33	38	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123177	10.1371/journal.pone.0123177	http://dx.doi.org/10.1371/journal.pone.0123177			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894917	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700025
J	Rong, Y; Evans, J; Xu-Welliver, M; Pickett, C; Jia, G; Chen, Q; Zuo, L				Rong, Yi; Evans, Josh; Xu-Welliver, Meng; Pickett, Cadron; Jia, Guang; Chen, Quan; Zuo, Li			Dosimetric Evaluation of Intensity-Modulated Radiotherapy, Volumetric Modulated Arc Therapy, and Helical Tomotherapy for Hippocampal-Avoidance Whole Brain Radiotherapy	PLOS ONE			English	Article							ADULT NEUROGENESIS; RADIATION-THERAPY; IRRADIATION; METASTASES; IMRT; PROLIFERATION	Background Whole brain radiotherapy (WBRT) is a vital tool in radiation oncology and beyond, but it can result in adverse health effects such as neurocognitive decline. Hippocampal Avoidance WBRT (HA-WBRT) is a strategy that aims to mitigate the neuro-cognitive side effects of whole brain radiotherapy treatment by sparing the hippocampi while delivering the prescribed dose to the rest of the brain. Several competing modalities capable of delivering HA-WBRT, include: Philips Pinnacle step-and-shoot intensity modulated radiotherapy (IMRT), Varian RapidArc volumetric modulated arc therapy (RapidArc), and helical TomoTherapy (TomoTherapy). Methods In this study we compared these methods using 10 patient datasets. Anonymized planning CT (computerized tomography) scans and contour data based on fused MRI images were collected. Three independent planners generated treatment plans for the patients using three modalities, respectively. All treatment plans met the RTOG 0933 criteria for HA-WBRT treatment. Results In dosimetric comparisons between the three modalities, TomoTherapy has a significantly superior homogeneity index of 0.15 +/- 0.03 compared to the other two modalities (0.28 +/- .04, p < .005 for IMRT and 0.22 +/- 0.03, p < .005 for RapidArc). RapidArc has the fastest average delivery time of 2.5 min compared to the other modalities (15 min for IMRT and 18 min for TomoTherapy). Conclusion TomoTherapy is considered to be the preferred modality for HA-WBRT due to its superior dose distribution. When TomoTherapy is not available or treatment time is a concern, RapidArc can provide sufficient dose distribution meeting RTOG criteria and efficient treatment delivery.	[Rong, Yi; Xu-Welliver, Meng] Ohio State Univ, James Canc Hosp, Wexner Med Ctr, Dept Radiat Oncol, Columbus, OH 43210 USA; [Zuo, Li] Ohio State Univ, Wexner Med Ctr, Coll Med,Biophys Grad Program, Sch Hlth & Rehabil Sci,Radiol Sci & Resp Therapy, Columbus, OH 43210 USA; [Evans, Josh; Chen, Quan] Univ Virginia Hlth Syst, Dept Radiat Oncol, Charlottesville, VA 22903 USA; [Pickett, Cadron; Jia, Guang] Louisiana State Univ, Dept Phys & Astron, Baton Rouge, LA 70803 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Virginia; Louisiana State University System; Louisiana State University	Chen, Q (corresponding author), Univ Virginia Hlth Syst, Dept Radiat Oncol, Charlottesville, VA 22903 USA.	QC3K@hscmail.mcc.virginia.edu; zuo.4@osu.edu	Jia, Guang/A-1275-2016; Chen, Quan/E-5943-2012; Jia, Guang/E-3312-2011	Chen, Quan/0000-0001-5570-2462; Jia, Guang/0000-0001-5306-5607				Abayomi OK, 1996, ACTA ONCOL, V35, P659, DOI 10.3109/02841869609083995; Awad R, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-62; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; Chen Q, 2012, MED PHYS, V39, P1877, DOI 10.1118/1.3693057; Chen QA, 2011, MED PHYS, V38, P1150, DOI 10.1118/1.3551996; DEANGELIS LM, 1989, NEUROLOGY, V39, P789, DOI 10.1212/WNL.39.6.789; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FERRER I, 1993, J NEUROPATH EXP NEUR, V52, P370, DOI 10.1097/00005072-199307000-00004; Gondi V, 2010, RADIOTHER ONCOL, V97, P370, DOI 10.1016/j.radonc.2010.09.013; Gondi V, 2010, INT J RADIAT ONCOL, V78, P1244, DOI 10.1016/j.ijrobp.2010.01.039; Gondi V, 2010, RADIOTHER ONCOL, V95, P327, DOI 10.1016/j.radonc.2010.02.030; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Li J, 2007, J CLIN ONCOL, V25, P1260, DOI 10.1200/JCO.2006.09.2536; Lu WG, 2010, PHYS MED BIOL, V55, P7175, DOI 10.1088/0031-9155/55/23/002; Lu WG, 2010, PHYS MED BIOL, V55, P7211, DOI 10.1088/0031-9155/55/23/003; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Marsh JC, 2013, J MED IMAG RADIAT ON, V57, P378, DOI 10.1111/1754-9485.12048; Meyers CA, 2006, J CLIN ONCOL, V24, P1305, DOI 10.1200/JCO.2005.04.6086; Meyers CA, 2004, J CLIN ONCOL, V22, P157, DOI 10.1200/JCO.2004.05.128; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Nagai R, 2000, SURG NEUROL, V53, P503, DOI 10.1016/S0090-3019(00)00214-7; Nussbaum ES, 1996, CANCER-AM CANCER SOC, V78, P1781, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1781::AID-CNCR19>3.3.CO;2-Z; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Regine WF, 2004, INT J RADIAT ONCOL, V58, P1346, DOI 10.1016/j.ijrobp.2003.09.023; ROMAN DD, 1995, INT J RADIAT ONCOL, V31, P983, DOI 10.1016/0360-3016(94)00550-8; Rong Y, 2014, MED PHYS, V41, DOI 10.1118/1.4870987; Siglin J, 2014, PRACT RADIAT ONCOL, V4, P378, DOI 10.1016/j.prro.2013.11.008; Tada E, 2000, NEUROSCIENCE, V99, P33, DOI 10.1016/S0306-4522(00)00151-2; Van Vulpen M, 2005, INT J RADIAT ONCOL, V62, P1535, DOI 10.1016/j.ijrobp.2005.04.011; Welzel G, 2008, INT J RADIAT ONCOL, V72, P1311, DOI 10.1016/j.ijrobp.2008.03.009	32	31	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0126222	10.1371/journal.pone.0126222	http://dx.doi.org/10.1371/journal.pone.0126222			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894615	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700141
J	Seo, K; Kitazawa, T; Yoshino, Y; Koga, I; Ota, Y				Seo, Kazunori; Kitazawa, Takatoshi; Yoshino, Yusuke; Koga, Ichiro; Ota, Yasuo			Characteristics of Serum Endocan Levels in Infection	PLOS ONE			English	Article							CELL-SPECIFIC MOLECULE-1; C-REACTIVE PROTEIN; PROCALCITONIN; BACTEREMIA; EXPRESSION; ESM-1; MARKER; IMPACT; LUNG	Objectives Endocan is a newly recognized biomarker of sepsis. However, there have been no studies of the trends in endocan levels during infection and their associations with other clinical factors. The aim of this study was to assess the time course of endocan levels and the associations of endocan with clinical factors during infection by comparison with other biomarkers. Methods Serum samples and blood cultures were obtained from patients who were diagnosed with infection from June 2013 to March 2014. Serum endocan, C-reactive protein (CRP), and procalcitonin (PCT) levels during four periods during infection were measured (day 0, day 12, day 3-5, and day 6-10). Results A total of 78 patients were enrolled in this study. The median endocan level decreased by only 23% during infection, whereas both serum CRP and PCT levels decreased by more than 80%. Endocan levels were correlated to neither CRP levels nor PCT levels in each period. Endocan levels at day 0 in patients with bacteremia were higher than those without bacteremia (1.09 ng/mL vs 0.82 ng/mL, P=0.002), but neither CRP levels nor PCT levels at day 0 were different between the two groups. Areas under the receiver operator characteristic (ROC) curves of endocan, CRP, and PCT at day 0 were 0.662, 0.343, and 0.563, respectively. Positive blood cultures tended to be related to high endocan levels, but not significantly (odds ratio: 4.24, 95% CI: 0.99-10.34, P=0.05). Conclusions In bacteremic cases, serum endocan levels in bacteremia tended to be higher than in non-bacteremic cases. Although endocan level was not identified as a prognostic factor of bacteremia, further prospective study concerning the relationship between serum endocan level and bacteremia would be needed.	[Seo, Kazunori; Kitazawa, Takatoshi; Yoshino, Yusuke; Koga, Ichiro; Ota, Yasuo] Teikyo Univ, Dept Internal Med, Tokyo 173, Japan	Teikyo University	Kitazawa, T (corresponding author), Teikyo Univ, Dept Internal Med, Tokyo 173, Japan.	tkitazaw@med.teikyo-u.ac.jp	Yoshino, Yusuke/V-9649-2019		Japan Society for the Promotion of Science KAKENHI [25462833]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 25462833, http://www.jsps.go.jp/j-grantsinaid/, preparation of the manuscript.	Bates DW, 1997, J INFECT DIS, V176, P1538, DOI 10.1086/514153; Bechard D, 2000, J VASC RES, V37, P417, DOI 10.1159/000025758; Bechard D, 2001, J BIOL CHEM, V276, P48341, DOI 10.1074/jbc.M108395200; Chen LY, 2010, J INT MED RES, V38, P498, DOI 10.1177/147323001003800213; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; El Behery MM, 2013, ARCH GYNECOL OBSTET, V288, P1371, DOI 10.1007/s00404-013-2863-3; Grigoriu BD, 2006, CLIN CANCER RES, V12, P4575, DOI 10.1158/1078-0432.CCR-06-0185; Hatfield KJ, 2011, HEMATOLOGY, V16, P351, DOI 10.1179/102453311X13127324303434; Hoenigl M, 2014, INT J CLIN PRACT, V68, P1278, DOI 10.1111/ijcp.12474; Hohn A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-158; HURLIMANN J, 1966, J EXP MED, V123, P365, DOI 10.1084/jem.123.2.365; Kim JH, 2012, ONCOL REP, V28, P1701, DOI 10.3892/or.2012.2012; Lassalle P, 1996, J BIOL CHEM, V271, P20458, DOI 10.1074/jbc.271.34.20458; Lee W, 2014, J CELL PHYSIOL, V229, P620, DOI 10.1002/jcp.24485; Leroy X, 2010, HISTOPATHOLOGY, V56, P180, DOI 10.1111/j.1365-2559.2009.03458.x; Liaudat S, 2001, EUR J CLIN MICROBIOL, V20, P524, DOI 10.1007/s100960100548; Luzzani A, 2003, CRIT CARE MED, V31, P1737, DOI 10.1097/01.CCM.0000063440.19188.ED; Mathevon T, 2002, SCAND J INFECT DIS, V34, P831, DOI 10.1080/0036554021000026934; Maurage CA, 2009, J NEUROPATH EXP NEUR, V68, P633, DOI 10.1097/NEN.0b013e3181a52a7f; Meisner M, 2002, CLIN CHIM ACTA, V323, P17, DOI 10.1016/S0009-8981(02)00101-8; Mikkelsen ME, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.07.077; Roudnicky F, 2013, CANCER RES, V73, P1097, DOI 10.1158/0008-5472.CAN-12-1855; Sarrazin S, 2006, BBA-REV CANCER, V1765, P25, DOI 10.1016/j.bbcan.2005.08.004; Scherpereel A, 2006, CRIT CARE MED, V34, P532, DOI 10.1097/01.CCM.0000198525.82124.74; Su YH, 2014, TRANSPL P, V46, P323, DOI 10.1016/j.transproceed.2013.10.057; Tang L, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/625180; TRINCHET JC, 1983, GASTROEN CLIN BIOL, V7, P518; Voiosu T, 2014, CLIN LAB, V60, P505, DOI 10.7754/Clin.Lab.2013.130333	28	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123358	10.1371/journal.pone.0123358	http://dx.doi.org/10.1371/journal.pone.0123358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894539	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700035
J	Yang, X; Yang, Y; Li, ZL; Cheng, C; Yang, T; Wang, C; Liu, L; Liu, SC				Yang, Xin; Yang, Yuan; Li, Zhilu; Cheng, Chen; Yang, Ting; Wang, Cheng; Liu, Lin; Liu, Shengchun			Diagnostic Value of Circulating Chromogranin A for Neuroendocrine Tumors: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							NEURON-SPECIFIC ENOLASE; MEDULLARY-THYROID CARCINOMA; 5-HYDROXYINDOLEACETIC ACID; GLYCOPROTEIN HORMONES; CONSENSUS GUIDELINES; ENDOCRINE TUMORS; PUBLICATION BIAS; ALPHA-SUBUNIT; PLASMA; MARKER	Background In previous decades, chromogranin A (CgA) has been demonstrated to be the most promising biomarker for the diagnosis of neuroendocrine tumors (NETs), but its diagnostic value is still controversial. This meta-analysis aimed to estimate the potential diagnostic value of circulating CgA for NETs. Methods We collected relevant studies from several electronic databases as well as from reference lists. Diagnostic indices of CgA were pooled with random effects models. Pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR) and summary receiver operating characteristic (SROC) curves for the diagnosis of NETs were used to estimate the overall diagnostic efficiency. Results Through a search strategy, 13 studies met the inclusion criteria and were included. These studies contained 1260 patients with NETs and 967 healthy controls in the total sample. As a result, the overall sensitivity, specificity and diagnostic odds ratio (DOR) were 0.73 (95% CI: 0.71 to 0.76), 0.95 (95% CI: 0.93 to 0.96) and 56.29 (95% CI: 25.27 to 125.38), respectively, while the summary positive likelihood ratio (PLR) and negative likelihood ratio (NLR) were 14.56 (95% CI: 6.62 to 32.02) and 0.26 (95% CI: 0.18 to 0.38), respectively. In addition, the area under the curve (AUC) of the circulating CgA in the diagnosis of NETs was 0.8962. Conclusions These data demonstrate that circulating CgA is an efficient biomarker for the diagnosis of NETs with high sensitivity and specificity, which indicates that it may be helpful for the clinical management of NETs. However, further studies are needed to clarify this issue.	[Yang, Xin; Li, Zhilu; Cheng, Chen; Yang, Ting; Wang, Cheng; Liu, Lin; Liu, Shengchun] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing, Peoples R China; [Yang, Yuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Liu, SC (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing, Peoples R China.	liushengchun1968@163.com	liu, li/HGC-0900-2022; liu, liu/GXF-0906-2022		National Natural Science Foundation of China (NSFC) [81272265, 81472658]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	LS was supported by grants from the National Natural Science Foundation of China (NSFC, 81272265 and 81472658, URL: http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameri P, 2012, NEUROENDOCRINOLOGY, V95, P267, DOI 10.1159/000334612; Bajetta E, 1999, CANCER, V86, P858, DOI 10.1002/(SICI)1097-0142(19990901)86:5<858::AID-CNCR23>3.0.CO;2-8; Baudin E, 1998, BRIT J CANCER, V78, P1102, DOI 10.1038/bjc.1998.635; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Belli Susana Haydee, 2009, Acta Gastroenterol Latinoam, V39, P184; Bernini GP, 2001, BRIT J CANCER, V84, P636, DOI 10.1054/bjoc.2000.1659; BLIND E, 1992, THYROID, V2, P5, DOI 10.1089/thy.1992.2.5; Campana D, 2007, J CLIN ONCOL, V25, P1967, DOI 10.1200/JCO.2006.10.1535; Colombo B, 2002, CANCER RES, V62, P941; Colombo B, 2002, J BIOL CHEM, V277, P45911, DOI 10.1074/jbc.M202637200; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Degg TJ, 2000, ANN CLIN BIOCHEM, V37, P724, DOI 10.1258/0004563001899780; Donica H, 2010, FOLIA HISTOCHEM CYTO, V48, P603, DOI 10.2478/v10042-010-0088-x; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Guignat L, 2001, BRIT J CANCER, V84, P808, DOI 10.1054/bjoc.2000.1677; Hauser H, 1995, Eur J Surg Oncol, V21, P297, DOI 10.1016/S0748-7983(95)91624-5; Helle KB, 2007, CELL MOL LIFE SCI, V64, P2863, DOI 10.1007/s00018-007-7254-0; HSIAO RJ, 1990, J CLIN INVEST, V85, P1555, DOI 10.1172/JCI114604; Jones CM, 2005, ANN THORAC SURG, V79, P16, DOI 10.1016/j.athoracsur.2004.09.040; Kaltsas GA, 2004, ENDOCR REV, V25, P458, DOI 10.1210/er.2003-0014; KEMA IP, 1992, CLIN CHEM, V38, P1730; Korse CM, 2012, EUR J CANCER, V48, P662, DOI 10.1016/j.ejca.2011.08.012; Kulke MH, 2012, J NATL COMPR CANC NE, V10, P724, DOI 10.6004/jnccn.2012.0075; LANGLEY K, 1994, ANN NY ACAD SCI, V733, P1, DOI 10.1111/j.1749-6632.1994.tb17251.x; Lijmer JG, 2002, STAT MED, V21, P1525, DOI 10.1002/sim.1185; Lindblom A, 2000, BMJ-BRIT MED J, V320, P424, DOI 10.1136/bmj.320.7232.424; Modlin IM, 2005, GASTROENTEROLOGY, V128, P1717, DOI 10.1053/j.gastro.2005.03.038; Modlin IM, 2008, LANCET ONCOL, V9, P61, DOI 10.1016/S1470-2045(07)70410-2; Modlin IM, 2006, NEUROENDOCRINOLOGY, V84, P69, DOI 10.1159/000096997; Modlin IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063364; Molina R, 2011, TUMOR BIOL, V32, P13, DOI 10.1007/s13277-010-0085-x; Neary PC, 1997, DIS COLON RECTUM, V40, P349, DOI 10.1007/BF02050428; Nehar D, 2004, CLIN ENDOCRINOL, V60, P644, DOI 10.1111/j.1365-2265.2004.02030.x; Nobels FRE, 1997, J CLIN ENDOCR METAB, V82, P2622, DOI 10.1210/jc.82.8.2622; Nobels FRE, 1998, EUR J CLIN INVEST, V28, P431; O'Toole D, 2009, NEUROENDOCRINOLOGY, V90, P194, DOI 10.1159/000225948; OCONNOR DT, 1986, NEW ENGL J MED, V314, P1145, DOI 10.1056/NEJM198605013141803; OCONNOR DT, 1983, J CLIN ENDOCR METAB, V57, P1084, DOI 10.1210/jcem-57-5-1084; OCONNOR DT, 1983, REGUL PEPTIDES, V6, P263, DOI 10.1016/0167-0115(83)90145-3; OCONNOR DT, 1984, NEW ENGL J MED, V311, P764, DOI 10.1056/NEJM198409203111204; Panzuto F, 2004, J ENDOCRINOL INVEST, V27, P6, DOI 10.1007/BF03350903; PEARSE AGE, 1968, PROC R SOC SER B-BIO, V170, P71, DOI 10.1098/rspb.1968.0025; PEARSE AGE, 1976, CLIN ENDOCRINOL, V5, pS229, DOI 10.1111/j.1365-2265.1976.tb03832.x; Peracchi M, 2003, EUR J ENDOCRINOL, V148, P39, DOI 10.1530/eje.0.1480039; SOBOL RE, 1986, ANN INTERN MED, V105, P698, DOI 10.7326/0003-4819-105-5-698; Solcia E., 2000, CLIN ENDOCRINOL, V53, P259, DOI DOI 10.1046/J.1365-2265.2000.01073.X; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; STRIDSBERG M, 1995, J ENDOCRINOL, V144, P49, DOI 10.1677/joe.0.1440049; TAPIA FJ, 1981, LANCET, V1, P808; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Tohmola N, 2014, CLIN CHIM ACTA, V428, P38, DOI 10.1016/j.cca.2013.10.025; Tomassetti P, 2001, EUR J GASTROEN HEPAT, V13, P55, DOI 10.1097/00042737-200101000-00010; Vinik AI, 2010, PANCREAS, V39, P713, DOI 10.1097/MPA.0b013e3181ebaffd; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zatelli MC, 2007, ENDOCR-RELAT CANCER, V14, P473, DOI 10.1677/ERC-07-0001	57	51	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124884	10.1371/journal.pone.0124884	http://dx.doi.org/10.1371/journal.pone.0124884			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894842	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700126
J	Liu, X; Lai, CC; Wang, KY; Xing, L; Yang, PH; Duan, Q; Wang, XL				Liu, Xin; Lai, Chengcai; Wang, Keyu; Xing, Li; Yang, Penghui; Duan, Qing; Wang, Xiliang			A Functional Role of Fibroblast Growth Factor Receptor 1 (FGFR1) in the Suppression of Influenza A Virus Replication	PLOS ONE			English	Article							CELL ENTRY; H1N1 VIRUS; ANGIOGENESIS; MECHANISM; INFECTION; PROTEIN	Influenza A virus causes annual epidemics and occasional pandemics in humans. Here, we investigated four members of the fibroblast growth factor receptor (FGFR) family; FGFR1 to 4, and examined their expression patterns in human lung epithelial cells A549 with influenza A virus infection. We identified a functional role of FGFR1 in influenza A/Puerto Rico/8/1934 (PR8) and A/Anhui/01/2005 (H5N1) virus replication. Our results showed that FGFR1 silencing by siRNA interference promoted influenza A/PR8 and H5N1 virus replication in A549 cells, while lentivirus-mediated exogenous FGFR1 expression significantly suppressed influenza A virus replication; however, FGFR4 did not have the same effects. Moreover, FGFR1 phosphorylation levels were downregulated in A549 cells by influenza A virus infection, while the repression of FGFR1 kinase using PD173074, a potent and selective FGFR1 inhibitor, could enhance virus replication. Furthermore, we found that FGFR1 inhibits influenza virus internalization, but not binding, during viral entry. These results suggested that FGFR1 specifically antagonizes influenza A virus replication, probably by blocking viral entry.	[Liu, Xin; Lai, Chengcai; Wang, Keyu; Xing, Li; Yang, Penghui; Duan, Qing; Wang, Xiliang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Yang, Penghui] 302 Mil Hosp, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Fifth Medical Center of Chinese PLA General Hospital	Wang, XL (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	xiliangw@126.com		Wang, Keyu/0000-0002-1973-9927	Ministry of Science and Technology of China; National Basic Research Program [2012CB518905]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Basic Research Program(National Basic Research Program of China)	This work is supported by the Ministry of Science and Technology of China, the National Basic Research Program (973, 2012CB518905, http://www.most.gov.cn/eng/). XW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; BYERS S, 1992, DEV BIOL, V152, P411, DOI 10.1016/0012-1606(92)90149-B; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Chu VC, 2004, P NATL ACAD SCI USA, V101, P18153, DOI 10.1073/pnas.0405172102; Eierhoff T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001099; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; GIVOL D, 1992, FASEB J, V6, P3362, DOI 10.1096/fasebj.6.15.1464370; Hughes SE, 1997, J HISTOCHEM CYTOCHEM, V45, P1005, DOI 10.1177/002215549704500710; Kumar N, 2011, J VIROL, V85, P2818, DOI 10.1128/JVI.01969-10; Lakadamyali M, 2004, MICROBES INFECT, V6, P929, DOI 10.1016/j.micinf.2004.05.002; Liu X, 2014, VIRUS RES, V185, P64, DOI 10.1016/j.virusres.2014.03.010; MATLIN KS, 1981, J CELL BIOL, V91, P601, DOI 10.1083/jcb.91.3.601; MIMA T, 1995, P NATL ACAD SCI USA, V92, P467, DOI 10.1073/pnas.92.2.467; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; PATTERSON S, 1979, J GEN VIROL, V43, P223, DOI 10.1099/0022-1317-43-1-223; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Qing K, 1999, NAT MED, V5, P71, DOI 10.1038/4758; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roy AMM, 2000, VIROLOGY, V267, P17, DOI 10.1006/viro.1999.0109; Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sun XJ, 2013, ADV EXP MED BIOL, V790, P72, DOI 10.1007/978-1-4614-7651-1_4; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Yang N, 2012, J BIOL CHEM, V287, P8457, DOI 10.1074/jbc.M111.312561; Yang N, 2011, J MOL CELL BIOL, V3, P221, DOI 10.1093/jmcb/mjr017; YOSHIMURA A, 1982, J VIROL, V43, P284, DOI 10.1128/JVI.43.1.284-293.1982; Zhu LQ, 2014, J VIROL, V88, P417, DOI 10.1128/JVI.02591-13	29	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124651	10.1371/journal.pone.0124651	http://dx.doi.org/10.1371/journal.pone.0124651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909503	gold, Green Submitted, Green Published			2022-12-27	WOS:000353376800096
J	Semaan, M; Ivanusic, D; Denner, J				Semaan, Marwan; Ivanusic, Daniel; Denner, Joachim			Cytotoxic Effects during Knock Out of Multiple Porcine Endogenous Retrovirus (PERV) Sequences in the Pig Genome by Zinc Finger Nucleases (ZFN)	PLOS ONE			English	Article							HUMAN-CELLS; TRANSGENIC PIGS; BIALLELIC KNOCKOUT; NEUTRALIZING ANTIBODIES; RESTRICTION ENZYMES; PROXIMITY LIGATION; RNA INTERFERENCE; IN-SITU; XENOTRANSPLANTATION; PROTEINS	Xenotransplantation has been proposed as a solution to the shortage of suitable human donors for transplantation and pigs are currently favoured as donor animals. However, xenotransplantation may be associated with the transmission of zoonotic microorganisms. Whereas most porcine microorganisms representing a risk for the human recipient may be eliminated by designated pathogen free breeding, multiple copies of porcine endogenous retroviruses (PERVs) are integrated in the genome of all pigs and cannot be eliminated this way. PERVs are released as infectious particles and infect human cells. The zinc finger nuclease (ZFN) technology allows knocking out specifically cellular genes, however it was not yet used to eliminate multiple integrated proviral sequences with a strong conservation in the target sequence. To reduce the risk of horizontal PERV transmission and to knock out as many as possible proviruses, for the first time the powerful tool of the ZFN technology was used. ZFN were designed to bind specifically to sequences conserved in all known replication-competent proviruses. Expression and transport of the ZFN into the nucleus was shown by Western blot analysis, co-localisation analysis, PLA and FRET. Survival of transfected cells was analysed using fluorescent ZFN and cell counting. After transfection a strong expression of the ZFN proteins and a co-localisation of the expressed ZFN proteins were shown. However, expression of the ZFN was found to be extremely toxic for the transfected cells. The induced cytotoxicity was likely due to the specific cutting of the high copy number of the PERV proviruses, which is also commonly observed when ZFN with low specificity cleave numerous off-target sites in a genome. This is the first attempt to knock out multiple, nearly identical, genes in a cellular genome using ZFN. The attempt failed, and other strategies should be used to prevent PERV transmission.	[Semaan, Marwan; Ivanusic, Daniel; Denner, Joachim] Robert Koch Inst, Berlin, Germany; [Ivanusic, Daniel] Free Univ Berlin, Berlin, Germany	Robert Koch Institute; Free University of Berlin	Denner, J (corresponding author), Robert Koch Inst, Nordufer 20, Berlin, Germany.	DennerJ@rki.de			Deutsche Forschungsgemeinschaft (DFG) [SFB 127]; Peter and Traudl Engelhorn Foundation; Jung-Stiftung fur Wissenschaft und Forschung, Hamburg, Germany	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Peter and Traudl Engelhorn Foundation; Jung-Stiftung fur Wissenschaft und Forschung, Hamburg, Germany	Funding was provided by Deutsche Forschungsgemeinschaft (DFG) (TR SFB 127), the Peter and Traudl Engelhorn Foundation and the Jung-Stiftung fur Wissenschaft und Forschung, Hamburg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwin S, 2005, MOL THER, V12, P610, DOI 10.1016/j.ymthe.2005.06.094; Bao L, 2014, SCI CHINA LIFE SCI, V57, P263, DOI 10.1007/s11427-013-4601-2; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Chao CH, 2006, CANCER RES, V66, P6579, DOI 10.1158/0008-5472.CAN-05-2415; Denner J, 2008, ARCH VIROL, V153, P1421, DOI 10.1007/s00705-008-0141-7; Denner J, 2012, CLIN MICROBIOL REV, V25, P318, DOI 10.1128/CMR.05011-11; Denner J, 2009, XENOTRANSPLANTATION, V16, P239, DOI 10.1111/j.1399-3089.2009.00544.x; Dieckhoff B, 2008, XENOTRANSPLANTATION, V15, P36, DOI 10.1111/j.1399-3089.2008.00442.x; Fiebig U, 2003, VIROLOGY, V307, P406, DOI 10.1016/S0042-6822(02)00140-X; Fishman JA, 1998, ANN NY ACAD SCI, V862, P52, DOI 10.1111/j.1749-6632.1998.tb09117.x; Flisikowska T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021045; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Hauschild-Quintern J, 2013, TRANSGENIC RES, V22, P1, DOI 10.1007/s11248-012-9647-6; Hurt JA, 2003, P NATL ACAD SCI USA, V100, P12271, DOI 10.1073/pnas.2135381100; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; Karlas A, 2004, VIROLOGY, V325, P18, DOI 10.1016/j.virol.2004.04.022; Kaulitz D, 2011, VIROLOGY, V411, P78, DOI 10.1016/j.virol.2010.12.032; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Kues WA, 2006, FASEB J, V20, P1200, DOI 10.1096/fj.05-5415fje; LeTissier P, 1997, NATURE, V389, P681, DOI 10.1038/39489; Li P, 2013, J SURG RES, V181, pE39, DOI 10.1016/j.jss.2012.06.035; Lillico SG, 2013, SCI REP-UK, V3, DOI 10.1038/srep02847; Lutz AJ, 2013, XENOTRANSPLANTATION, V20, P27, DOI 10.1111/xen.12019; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Owsianka AM, 1999, VIROLOGY, V257, P330, DOI 10.1006/viro.1999.9659; Patience C, 1997, NAT MED, V3, P282, DOI 10.1038/nm0397-282; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Pederson T, 2002, J STRUCT BIOL, V140, P3, DOI 10.1016/S1047-8477(02)00528-2; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Pruett-Miller SM, 2008, MOL THER, V16, P707, DOI 10.1038/mt.2008.20; Ramsoondar J, 2009, XENOTRANSPLANTATION, V16, P164, DOI 10.1111/j.1399-3089.2009.00525.x; Sachs DH, 2001, ADV IMMUNOL, V79, P129, DOI 10.1016/S0065-2776(01)79004-9; Semaan M, 2012, XENOTRANSPLANTATION, V19, P112, DOI 10.1111/j.1399-3089.2012.00683.x; Shaikh Shamim, 2006, J Biomol Tech, V17, P283; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Takeuchi Y, 1998, J VIROL, V72, P9986, DOI 10.1128/JVI.72.12.9986-9991.1998; Waechter A, 2014, IMMUNOL RES, V58, P9, DOI 10.1007/s12026-013-8430-y; Watanabe M, 2010, BIOCHEM BIOPH RES CO, V402, P14, DOI 10.1016/j.bbrc.2010.09.092; Whyte JJ, 2012, J ANIM SCI, V90, P1111, DOI 10.2527/jas.2011-4546; Wilson CA, 1998, J VIROL, V72, P3082, DOI 10.1128/JVI.72.4.3082-3087.1998; Yang DS, 2011, CELL RES, V21, P979, DOI 10.1038/cr.2011.70	46	26	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0122059	10.1371/journal.pone.0122059	http://dx.doi.org/10.1371/journal.pone.0122059			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909512	gold, Green Published, Green Submitted			2022-12-27	WOS:000353376800016
J	Veerappa, AM; Vishweswaraiah, S; Lingaiah, K; Murthy, M; Suresh, RV; Manjegowda, DS; Ramachandra, NB				Veerappa, Avinash M.; Vishweswaraiah, Sangeetha; Lingaiah, Kusuma; Murthy, Megha; Suresh, Raviraj V.; Manjegowda, Dinesh S.; Ramachandra, Nallur B.			Global Spectrum of Copy Number Variations Reveals Genome Organizational Plasticity and Proposes New Migration Routes	PLOS ONE			English	Article							SUSCEPTIBILITY; INSIGHTS; MUTATION; HUMANS; MOUSE	Global spectrum of CNVs is required to catalog variations to provide a high-resolution on the dynamics of genome-organization and human migration. In this study, we performed genome-wide genotyping using high-resolution arrays and identified 44,109 CNVs from 1,715 genomes across 12 populations. The study unraveled the force of independent evolutionary dynamics on genome-organizational plasticity across populations. We demonstrated the use of CNV tool to study human migration and identified a second major settlement establishing new migration routes in addition to existing ones.	[Veerappa, Avinash M.; Vishweswaraiah, Sangeetha; Lingaiah, Kusuma; Murthy, Megha; Suresh, Raviraj V.; Ramachandra, Nallur B.] Univ Mysore, Dept Studies Zool, Genet & Genom Lab, Mysore 06, Karnataka, India; [Manjegowda, Dinesh S.] Nitte Univ, KS Hegde Med Acad, NUCSER, Mangalore 18, Karnataka, India	University of Mysore; NITTE (Deemed to be University); K.S. Hegde Medical Academy; Nitte University Center for Science Education & Research (NUCSER)	Ramachandra, NB (corresponding author), Univ Mysore, Dept Studies Zool, Genet & Genom Lab, Mysore 06, Karnataka, India.	nallurbr@gmail.com		Vishweswaraiah, Sangeetha/0000-0001-5681-5143	Department of Science and Technology-Health Science [SR/SO/HS-103/2007]	Department of Science and Technology-Health Science	The work was supported by Department of Science and Technology-Health Science, grant number SR/SO/HS-103/2007, funding website http://www.dst.gov.in/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Adams SM, 2006, FORENSIC SCI INT, V159, P14, DOI 10.1016/j.forsciint.2005.06.003; Affymetrix Inc, 2008, US MAN GEN CONS SOFT; Affymetrix Inc, 2005, TECHN NOT GUID PROB; Affymetrix Inc, 2009, DAT SHEET GEN WID HU; Affymetrix Inc, 2007, WHIT PAP BRLMM P GEN; [Anonymous], 2008, ANN ICRP, V38, P1; Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Bernardi G, 1995, ANNU REV GENET, V29, P445, DOI 10.1146/annurev.ge.29.120195.002305; Bourque G, 2004, GENOME RES, V14, P507, DOI 10.1101/gr.1975204; Bozeman MT, SNP VAR SUIT VERS 7; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Chen W, 2011, PLOS ONE, V6; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Duggan AT, 2013, AM J HUM GENET, V92, P279, DOI 10.1016/j.ajhg.2012.12.004; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gautam P, 2012, HUM GENET, V131, P131, DOI 10.1007/s00439-011-1050-5; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Haraksingh RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027859; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kanduri C, 2013, EUR J HUM GENET, V21, P1411, DOI 10.1038/ejhg.2013.60; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lacaria M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002713; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Lin CH, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-92; Liu X, 2013, AEROSP MANUF TECHNOL, V1, P1, DOI DOI 10.1109/TNNLS.2013.2287275; Lou HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025825; McElroy JP, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-15; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Oppenheimer S, 2012, PHILOS T R SOC B, V367, P770, DOI 10.1098/rstb.2011.0306; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987; Thangaraj K, 2008, HUM HERED, V66, P1, DOI 10.1159/000114160; Veerappa AM, 2014, GENET RES, V96, DOI 10.1017/S0016672314000202; Veerappa AM, 2013, AM J MED GENET B, V162, P889, DOI 10.1002/ajmg.b.32199; Veerappa AM, 2013, J HUM GENET, V58, P539, DOI 10.1038/jhg.2013.47; Wang J, 2009, OPEN BIOL J, V2, P54; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Zhang Y., 2012, PLOS ONE, V7; Zhao SY, 2004, GENOME RES, V14, P1851, DOI 10.1101/gr.2663304	53	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0121846	10.1371/journal.pone.0121846	http://dx.doi.org/10.1371/journal.pone.0121846			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909454	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000353376800014
J	Devay, RM; Yamamoto, L; Shelton, DL; Liang, H				Devay, Rachel M.; Yamamoto, Lynn; Shelton, David L.; Liang, Hong			Common Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Epitopes Mediate Multiple Routes for Internalization and Function	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTORS; SECRETED PCSK9; LDL RECEPTORS; ANTIBODY; CHOLESTEROL; DOMAIN; TRAFFICKING; DEGRADATION; PLASMA; BINDS	Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a soluble protein that directs membrane-bound receptors to lysosomes for degradation. In the most studied example of this, PCSK9 binding leads to the degradation of low density lipoprotein receptor (LDLR), significantly affecting circulating LDL-C levels. The mechanism mediating this degradation, however, is not completely understood. We show here that LDLR facilitates PCSK9 interactions with amyloid precursor like protein 2 (APLP2) at neutral pH leading to PCSK9 internalization, although direct binding between PCSK9 and LDLR is not required. Moreover, binding to APLP2 or LDLR is independently sufficient for PCSK9 endocytosis in hepatocytes, while LDL can compete with APLP2 for PCSK9 binding to indirectly mediate PCSK9 endocytosis. Finally, we show that APLP2 and LDLR are also required for the degradation of another PCSK9 target, APOER2, necessitating a general role for LDLR and APLP2 in PCSK9 function. Together, these findings provide evidence that PCSK9 has at least two endocytic epitopes that are utilized by a variety of internalization mechanisms and clarifies how PCSK9 may direct proteins to lysosomes.	[Devay, Rachel M.; Yamamoto, Lynn; Shelton, David L.; Liang, Hong] Rinat Pfizer Inc, San Francisco, CA 94080 USA	Pfizer	Liang, H (corresponding author), Rinat Pfizer Inc, San Francisco, CA 94080 USA.	hong.liang@pfizer.com			Pfizer	Pfizer(Pfizer)	This study was sponsored by Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Canuel M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064145, DOI 10.1371/J0URNAL.P0NE.0064145]; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Chaparro-Riggers J, 2012, J BIOL CHEM, V287, P11090, DOI 10.1074/jbc.M111.319764; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; DeVay RM, 2013, J BIOL CHEM, V288, P10805, DOI 10.1074/jbc.M113.453373; Fan D, 2008, BIOCHEMISTRY-US, V47, P1631, DOI 10.1021/bi7016359; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Grefhorst A, 2008, J LIPID RES, V49, P1303, DOI 10.1194/jlr.M800027-JLR200; Holla OL, 2011, J LIPID RES, V52, P1787, DOI 10.1194/jlr.M018093; Jeon H, 2005, ANNU REV BIOCHEM, V74, P535, DOI 10.1146/annurev.biochem.74.082803.133354; Jonas MC, 2008, EMBO REP, V9, P916, DOI 10.1038/embor.2008.132; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kosenko T, 2013, J BIOL CHEM, V288, P8279, DOI 10.1074/jbc.M112.421370; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Liang H, 2012, J PHARM EXPT THERAPE; Luna Saavedra YG, 2012, J BIOL CHEM; Maxwell KN, 2005, CURR OPIN LIPIDOL, V16, P167, DOI 10.1097/01.mol.0000162321.31925.a3; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Ni YG, 2011, J LIPID RES, V52, P78, DOI 10.1194/jlr.M011445; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Roth EM, 2012, NEW ENGL J MED, V367, P1891, DOI 10.1056/NEJMoa1201832; Schmidt RJ, 2008, BIOCHEM BIOPH RES CO, V370, P634, DOI 10.1016/j.bbrc.2008.04.004; Shan LX, 2008, BIOCHEM BIOPH RES CO, V375, P69, DOI 10.1016/j.bbrc.2008.07.106; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5; Strom TB, 2011, BIOCHEM BIOPH RES CO, V408, P642, DOI 10.1016/j.bbrc.2011.04.077; Surdo PL, 2011, EMBO REPORTS; Tavori H, 2013, CIRCULATION, V127, P2403, DOI 10.1161/CIRCULATIONAHA.113.001592	33	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125127	10.1371/journal.pone.0125127	http://dx.doi.org/10.1371/journal.pone.0125127			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905719	gold, Green Published, Green Submitted			2022-12-27	WOS:000353332000105
J	Kozak, A; Goldyn, R; Dondajewska, R				Kozak, Anna; Goldyn, Ryszard; Dondajewska, Renata			Phytoplankton Composition and Abundance in Restored Maltanski Reservoir under the Influence of Physico-Chemical Variables and Zooplankton Grazing Pressure	PLOS ONE			English	Article							FRESH-WATER; RESTORATION MEASURES; RECREATIONAL LAKES; HYPERTROPHIC LAKE; FILTERING RATE; SHALLOW LAKE; PHOSPHORUS; CYANOBACTERIA; DAPHNIA; POZNAN	In this paper we present the effects of environmental factors and zooplankton food pressure on phytoplankton in the restored man-made Maltanski Reservoir (MR). Two methods of restoration: biomanipulation and phosphorus inactivation have been applied in the reservoir. Nine taxonomical groups of phytoplankton represented in total by 183 taxa were stated there. The richest groups in respect of taxa number were green algae, cyanobacteria and diatoms. The diatoms, cryptophytes, chrysophytes, cyanobacteria, green algae and euglenophytes dominated in terms of abundance and/or biomass. There were significant changes among environmental parameters resulting from restoration measures which influenced the phytoplankton populations in the reservoir. These measures led to a decrease of phosphorus concentration due to its chemical inactivation and enhanced zooplankton grazing as a result of planktivorous fish stocking. The aim of the study is to analyse the reaction of phytoplankton to the restoration measures and, most importantly, to determine the extent to which the qualitative and quantitative composition of phytoplankton depends on variables changing under the influence of restoration in comparison with other environmental variables. We stated that application of restoration methods did cause significant changes in phytoplankton community structure. The abundance of most phytoplankton taxa was negatively correlated with large zooplankton filter feeders, and positively with zooplankton predators and concentrations of ammonium nitrogen and partly of phosphates. However, restoration was insufficient in the case of decreasing phytoplankton abundance. The effects of restoration treatments were of less importance for the abundance of phytoplankton than parameters that were independent of the restoration. This was due to the continuous inflow of large loads of nutrients from the area of the river catchment.	[Kozak, Anna; Goldyn, Ryszard; Dondajewska, Renata] Adam Mickiewicz Univ, Fac Biol, Dept Water Protect, Poznan, Poland	Adam Mickiewicz University	Kozak, A (corresponding author), Adam Mickiewicz Univ, Fac Biol, Dept Water Protect, Poznan, Poland.	akozak@amu.edu.pl	Gołdyn, Ryszard Jan/J-1093-2018	Gołdyn, Ryszard Jan/0000-0001-8325-5161; Dondajewska-Pielka, Renata/0000-0002-6761-0669; Kozak, Anna/0000-0001-7448-0498	Ministry of Science and Higher Education (Poland) [NN305 372838]	Ministry of Science and Higher Education (Poland)(Ministry of Science and Higher Education, Poland)	This research was financed by the grant No NN305 372838 from the Ministry of Science and Higher Education (Poland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballot A, 2010, TOXICON, V56, P964, DOI 10.1016/j.toxicon.2010.06.021; Bednarska A, 2007, LIMNOL OCEANOGR, V52, P2358, DOI 10.4319/lo.2007.52.6.2358; BENNDORF J, 1990, HYDROBIOLOGIA, V200, P187, DOI 10.1007/BF02530339; Bishop WM, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-2018-6; BOTTRELL HH, 1976, NORW J ZOOL, V24, P419; Budzynska A, 2010, THESIS A MICKIEWICZ; Chen FZ, 2013, HYDROBIOLOGIA, V718, P59, DOI 10.1007/s10750-013-1603-9; Cooke GD, 2003, RESTORATION MANAGEME, P1; CRONBERG G, 1982, HYDROBIOLOGIA, V86, P185, DOI 10.1007/BF00005809; Ejsmont-Karabin Jolanta, 1998, Polskie Archiwum Hydrobiologii, V45, P513; Elbanowska H., 1999, PHYSICOCHEMICAL WATE; Elliott JA, 2012, WATER RES, V46, P1364, DOI 10.1016/j.watres.2011.12.018; FORSYTH DJ, 1990, ARCH HYDROBIOL, V117, P385; Gawroska H., 2007, LIMNOL REV, V7, P27; Goldyn R, 1997, HYDROBIOLOGIA, V342, P327, DOI 10.1023/A:1017036717550; Goldyn R, 2008, J PLANKTON RES, V30, P33, DOI 10.1093/plankt/fbm086; Goldyn Ryszard, 2014, Ecohydrology & Hydrobiology, V14, P68, DOI 10.1016/j.ecohyd.2013.12.001; Goldyn R, 2013, CARPATH J EARTH ENV, V8, P43; Goldyn R, 2010, OCEANOL HYDROBIOL ST, V39, P65, DOI 10.2478/v10009-010-0040-6; Grochowska JK, 2013, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2013056; Hammer A, 2002, AQUAT MICROB ECOL, V29, P287, DOI 10.3354/ame029287; HAWKINS P, 1989, LIMNOL OCEANOGR, V34, P1084; Hodoki Y, 2012, HARMFUL ALGAE, V16, P49, DOI 10.1016/j.hal.2012.01.003; Jaworska Bozena, 2014, Archives of Polish Fisheries, V22, P7; Jeppesen E, 1997, HYDROBIOLOGIA, V342, P151, DOI 10.1023/A:1017046130329; Jeppesen E, 2007, HYDROBIOLOGIA, V584, P239, DOI 10.1007/s10750-007-0596-7; Kangro K, 2005, HYDROBIOLOGIA, V547, P91, DOI 10.1007/s10750-005-4151-0; KNOECHEL R, 1986, LIMNOL OCEANOGR, V31, P195, DOI 10.4319/lo.1986.31.1.0195; Kobos J, 2013, OCEANOL HYDROBIOL ST, V42, P358, DOI 10.2478/s13545-013-0093-8; Kokocinski M, 2013, ENVIRON SCI POLLUT R, V20, P5243, DOI 10.1007/s11356-012-1426-7; Kopp R, 2009, AQUAC RES, V40, P1683, DOI 10.1111/j.1365-2109.2009.02285.x; Kowalczewska-Madura K, 2010, OCEANOL HYDROBIOL ST, V39, P135, DOI 10.2478/v10009-010-0046-0; Kowalczewska-Madura K, 2010, OCEANOL HYDROBIOL ST, V39, P21, DOI 10.2478/v10009-010-0041-5; Kozak A, 2005, POL J ENVIRON STUD, V14, P451; Kozak A, 2004, J PLANKTON RES, V26, P37, DOI 10.1093/plankt/fbh006; Kozak A, 2007, TEKA KOM OCHR KSZT S, V4, P7; Kozak A, 2014, POL J ENVIRON STUD, V23, P1201; Kozak Anna, 2014, Archives of Polish Fisheries, V22, P17; Kozak Anna, 2013, Polish Journal of Natural Sciences, V28, P217; Kurmayer R, 2001, HYDROBIOLOGIA, V442, P279, DOI 10.1023/A:1017598518952; LAMPERT W, 1988, Limnologica, V19, P11; Lopata M, 2013, WATER SCI TECHNOL, V68, P2127, DOI 10.2166/wst.2013.461; Lopata M, 2008, OCEANOL HYDROBIOL ST, V37, P99, DOI 10.2478/v10009-007-0046-x; Lurling M, 2013, WATER RES, V47, P6527, DOI 10.1016/j.watres.2013.08.019; Lurling M, 2013, FRESHWATER BIOL, V58, P552, DOI 10.1111/j.1365-2427.2012.02866.x; Mehnert G, 2010, J PLANKTON RES, V32, P1009, DOI 10.1093/plankt/fbq033; Mischke U, 2003, ACTA OECOL, V24, pS11, DOI 10.1016/S1146-609X(03)00003-1; Moos MT, 2014, J ENVIRON MANAGE, V141, P77, DOI 10.1016/j.jenvman.2014.02.038; Padisak J, 1998, HYDROBIOLOGIA, V384, P41, DOI 10.1023/A:1003255529403; Pawlik-Skowronska B, 2011, OCEANOL HYDROBIOL ST, V40, P30, DOI 10.2478/s13545-011-0038-z; Pelechata Aleksandra, 2006, Oceanological and Hydrobiological Studies, V35, P3; Radwan S, 2004, FAUNA SLODKOWODNA PO; Reynolds CS, 2002, J PLANKTON RES, V24, P417, DOI 10.1093/plankt/24.5.417; ROJO C, 1994, HYDROBIOLOGIA, V275, P165, DOI 10.1007/BF00026708; Sarnelle O, 2007, LIMNOL OCEANOGR, V52, P2120, DOI 10.4319/lo.2007.52.5.2120; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; Shapiro J, 1991, P S WAT QUAL MAN BIO, P85; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; STEFANIAK K, 2005, OCEANOL HYDROBIOL ST, V34, P137; STEFKO B, 1976, Poznanskie Towarzystwo Przyjaciol Nauk Wydzial Matematyczno-Przyrodniczy Prace Komisji Biologicznej, V42, P55; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Walsby AE, 2006, NEW PHYTOL, V169, P109, DOI 10.1111/j.1469-8137.2005.01567.x; Wetzel R. G., 1991, LIMNOLOGICAL ANAL; Wilk-Wozniak E, 2003, BIOLOGIA, V58, P17; Wilk-Wozniak E, 2013, BIOLOGIA, V68, P838, DOI 10.2478/s11756-013-0221-3; Zagajewski P, 2009, OCEANOL HYDROBIOL ST, V38, P113; Zagajewski Pawel, 2007, Oceanological and Hydrobiological Studies, V36, P181; Zamparas M, 2014, SCI TOTAL ENVIRON, V496, P551, DOI 10.1016/j.scitotenv.2014.07.076	68	28	32	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124738	10.1371/journal.pone.0124738	http://dx.doi.org/10.1371/journal.pone.0124738			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906352	Green Submitted, gold, Green Published			2022-12-27	WOS:000353332000084
J	Lowther, AD; Lydersen, C; Fedak, MA; Lovell, P; Kovacs, KM				Lowther, Andrew D.; Lydersen, Christian; Fedak, Mike A.; Lovell, Phil; Kovacs, Kit M.			The Argos-CLS Kalman Filter: Error Structures and State-Space Modelling Relative to Fastloc GPS Data	PLOS ONE			English	Article							ANIMAL MOVEMENT; LOCATION ACCURACY; SATELLITE; TIME; TACTICS; WHALES; SEALS	Understanding how an animal utilises its surroundings requires its movements through space to be described accurately. Satellite telemetry is the only means of acquiring movement data for many species however data are prone to varying amounts of spatial error; the recent application of state-space models (SSMs) to the location estimation problem have provided a means to incorporate spatial errors when characterising animal movements. The predominant platform for collecting satellite telemetry data on free-ranging animals, Service Argos, recently provided an alternative Doppler location estimation algorithm that is purported to be more accurate and generate a greater number of locations that its predecessor. We provide a comprehensive assessment of this new estimation process performance on data from free-ranging animals relative to concurrently collected Fastloc GPS data. Additionally, we test the efficacy of three readily-available SSM in predicting the movement of two focal animals. Raw Argos location estimates generated by the new algorithm were greatly improved compared to the old system. Approximately twice as many Argos locations were derived compared to GPS on the devices used. Root Mean Square Errors (RMSE) for each optimal SSM were less than 4.25km with some producing RMSE of less than 2.50km. Differences in the biological plausibility of the tracks between the two focal animals used to investigate the utility of SSM highlights the importance of considering animal behaviour in movement studies. The ability to reprocess Argos data collected since 2008 with the new algorithm should permit questions of animal movement to be revisited at a finer resolution.	[Lowther, Andrew D.; Lydersen, Christian; Kovacs, Kit M.] Norwegian Polar Res Inst, Fram Ctr, N-9296 Tromso, Norway; [Fedak, Mike A.; Lovell, Phil] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews KY16 9AJ, Fife, Scotland	Norwegian Polar Institute; University of St Andrews	Lowther, AD (corresponding author), Norwegian Polar Res Inst, Fram Ctr, N-9296 Tromso, Norway.	andrew.lowther@npolar.no	Lowther, Andrew/T-2511-2019; Fedak, Michael A/B-3987-2009; Patterson, Ruth/A-7540-2018	Lowther, Andrew/0000-0003-4294-3157; Fedak, Michael A/0000-0002-9569-1128; 	Norwegian Polar Institute centre for Ice, Climate and Ecosystems (ICE); Natural Environment Research Council [smru10001] Funding Source: researchfish	Norwegian Polar Institute centre for Ice, Climate and Ecosystems (ICE); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided by the Norwegian Polar Institute centre for Ice, Climate and Ecosystems (ICE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts G, 2008, ECOGRAPHY, V31, P140, DOI 10.1111/j.2007.0906-7590.05236.x; Andrews RD, 2008, POLAR BIOL, V31, P1461, DOI 10.1007/s00300-008-0487-z; Argos, 1989, US MAN ARGOS SYST; Benoit-Bird KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053348; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Boehme L, 2009, OCEAN SCI, V5, P685, DOI 10.5194/os-5-685-2009; Bograd Steven J., 2010, Endangered Species Research, V10, P1, DOI 10.3354/esr00269; Bradshaw CJA, 2007, ECOL APPL, V17, P628, DOI 10.1890/06-0964; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; Bryant E, 2007, TR01 WILDTR TEL SYST; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; DIACONIS P, 1985, ANN STAT, V13, P845, DOI 10.1214/aos/1176349634; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Dragon AC, 2012, MAR ECOL PROG SER, V452, P253, DOI 10.3354/meps09618; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Filzmoser P, 2005, COMPUT GEOSCI-UK, V31, P579, DOI 10.1016/j.cageo.2004.11.013; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Freitas C, 2008, OECOLOGIA, V155, P193, DOI 10.1007/s00442-007-0894-9; Hammerschlag N, 2011, J EXP MAR BIOL ECOL, V398, P1, DOI 10.1016/j.jembe.2010.12.012; Hays GC, 2001, ANIM BEHAV, V61, P1035, DOI 10.1006/anbe.2001.1685; Hindell MA, 2011, KERGUELEN PLATEAU MA, P203, DOI DOI 10.1007/S003960050133; Hoenner X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040713; Jakobsson M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052219; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Jonsen ID, 2013, DEEP-SEA RES PT II, V88-89, P34, DOI 10.1016/j.dsr2.2012.07.008; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Kennedy AS, 2014, ENDANGER SPECIES RES, V23, P187, DOI 10.3354/esr00570; Kuhn CE, 2009, MAR ECOL PROG SER, V393, P97, DOI 10.3354/meps08229; LEVANON N, 1985, IEEE T AERO ELEC SYS, V21, P783, DOI 10.1109/TAES.1985.310663; Lopez R, 2014, IEEE T GEOSCI REMOTE, V52, P4744, DOI 10.1109/TGRS.2013.2284293; Lowther AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074348; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Maxwell SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019905; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Patterson TA, 2010, ECOLOGY, V91, P273, DOI 10.1890/08-1480.1; R Core Team, 2021, R LANGUAGE ENV STAT; Silva MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092277; Sumner MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007324; Thums M, 2011, ECOLOGY, V92, P1258, DOI 10.1890/09-1299.1; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Witt MJ, 2010, ANIM BEHAV, V80, P571, DOI 10.1016/j.anbehav.2010.05.022	42	26	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124754	10.1371/journal.pone.0124754	http://dx.doi.org/10.1371/journal.pone.0124754			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905640	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000086
J	Sandoval, C; Ortega, A; Sanchez, SA; Morales, J; Gunther, G				Sandoval, Catalina; Ortega, Anakenna; Sanchez, Susana A.; Morales, Javier; Gunther, German			Structuration in the Interface of Direct and Reversed Micelles of Sucrose Esters, Studied by Fluorescent Techniques	PLOS ONE			English	Article							BETA-D-THIOGLUCOSIDE; MIXED MICELLES; EXCITED-STATE; SOLVATION DYNAMICS; SURFACTANT; SOLVENT; PYRANINE; SOLUBILIZATION; PROBE; DEACTIVATION	Background Reactors found in nature can be described as micro-heterogeneous systems, where media involved in each micro-environment can behave in a markedly different way compared with the properties of the bulk solution. The presence of water molecules in micro-organized assemblies is of paramount importance for many chemical processes, ranging from biology to environmental science. Self-organized molecular assembled systems are frequently used to study dynamics of water molecules because are the simplest models mimicking biological membranes. The hydrogen bonds between sucrose and water molecules are described to be stronger (or more extensive) than the ones between water molecules themselves. In this work, we studied the capability of sucrose moiety, attached to alkyl chains of different length, as a surface blocking agent at the water-interface and we compared its properties with those of polyethylenglycol, a well-known agent used for this purposes. Published studies in this topic mainly refer to the micellization process and the stability of mixed surfactant systems using glycosides. We are interested in the effect induced by the presence of sucrose monoesters at the interface (direct and reverse micelles) and at the palisade (mixtures with Triton X-100). We believe that the different functional group (ester), the position of alkyl chain (6-O) and the huge capability of sucrose to interact with water will dramatically change the water structuration at the interface and at the palisade, generating new possibilities for technological applications of these systems. Results Our time resolved and steady state fluorescence experiments in pure SEs micelles show that sucrose moieties are able to interact with a high number of water molecules promoting water structuration and increased viscosity. These results also indicate that the barrier formed by sucrose moieties on the surface of pure micelles is more effective than the polyoxyethylene palisade of Triton X-100. The fluorescence quenching experiments of SEs at the palisade of Triton X-100 micelles indicate a blocking effect dependent on the number of methylene units present in the hydrophobic tail of the surfactant. A remarkable blocking effect is observed when there is a match in size between the hydrophobic regions forming the apolar core (lauryl SE/Triton X-100). This blocking effect disappears when a mismatch in size between hydrophobic tails, exists due to the disturbing effect on the micelle core.	[Sandoval, Catalina; Ortega, Anakenna; Gunther, German] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Quim Organ & Fisicoquim, Santiago, Chile; [Sanchez, Susana A.] Univ Concepcion, Fac Quim, Dept Polimeros, Concepcion, Chile; [Morales, Javier] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Ciencias Tecnol & Farmaceut, Santiago, Chile	Universidad de Chile; Universidad de Concepcion; Universidad de Chile	Gunther, G (corresponding author), Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Quim Organ & Fisicoquim, Santiago, Chile.	ggunther@ciq.uchile.cl	Sánchez, Susana/HII-3113-2022; Gunther, German/I-1028-2013	Gunther, German/0000-0002-4733-8426; Morales Valenzuela, Javier Eduardo/0000-0002-9880-2567; Sandoval-Altamirano, Catalina/0000-0002-8550-3218	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1120196, 1140454]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Funding was received from the Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) 1120196, http://www.conicyt.cl/fondecyt/, GG; and the Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) 1140454, http://www.conicyt.cl/fondecyt/, SAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMGREN M, 1992, ADV COLLOID INTERFAC, V41, P9, DOI 10.1016/0001-8686(92)80004-H; Avnir Y, 2005, ANAL BIOCHEM, V347, P34, DOI 10.1016/j.ab.2005.09.026; Bales BL, 2000, J PHYS CHEM B, V104, P264, DOI 10.1021/jp993290i; Barnadas-Rodriguez R, 2008, J PHOTOCH PHOTOBIO A, V198, P262, DOI 10.1016/j.jphotochem.2008.04.003; Becerra N, 2008, COLLOID SURFACE A, V327, P134, DOI 10.1016/j.colsurfa.2008.06.012; Becerra N, 2006, COLLOID SURFACE A, V272, P2, DOI 10.1016/j.colsurfa.2005.04.024; Berrios E, 2008, J CHIL CHEM SOC, V53, P1728, DOI 10.4067/S0717-97072008000400021; Borsarelli CD, 1997, J PHYS CHEM B, V101, P6036, DOI 10.1021/jp971184f; Ruiz CC, 2012, PHOTOCH PHOTOBIO SCI, V11, P1331, DOI 10.1039/c2pp25049g; Ruiz CC, 2011, J COLLOID INTERF SCI, V361, P178, DOI 10.1016/j.jcis.2011.05.019; Chaudhuri A, 2009, BIOCHEM BIOPH RES CO, V390, P728, DOI 10.1016/j.bbrc.2009.10.037; DONG DC, 1984, CAN J CHEM, V62, P2560, DOI 10.1139/v84-437; DRUMMOND CJ, 1985, J PHYS CHEM-US, V89, P2103, DOI 10.1021/j100256a060; Garcia MT, 1997, CHEMOSPHERE, V35, P545; Garofalakis G, 2000, J COLLOID INTERF SCI, V229, P391, DOI 10.1006/jcis.2000.7035; GEHLEN MH, 1993, CHEM REV, V93, P199, DOI 10.1021/cr00017a010; Granizo N, 2004, J COLLOID INTERF SCI, V273, P638, DOI 10.1016/j.jcis.2004.02.004; Grasjo J, 2009, J PHYS CHEM B, V113, P8201, DOI 10.1021/jp902058w; Hara K, 2001, J PHYS CHEM A, V105, P7174, DOI 10.1021/jp0109776; Hierrezuelo JM, 2006, J COLLOID INTERF SCI, V294, P449, DOI 10.1016/j.jcis.2005.07.024; JENNY TA, 1982, TETRAHEDRON LETT, V23, P2923, DOI 10.1016/S0040-4039(00)87495-X; Jimenez-Banzo A, 2008, PHOTOCH PHOTOBIO SCI, V7, P1003, DOI 10.1039/b804333g; KONDO H, 1982, J PHYS CHEM-US, V86, P4826, DOI 10.1021/j100221a035; Kumbhakar M, 2004, J CHEM PHYS, V121, P6026, DOI 10.1063/1.1784774; Mondal SK, 2005, CHEM PHYS LETT, V412, P228, DOI 10.1016/j.cplett.2005.07.001; Montenegro MA, 2002, PHOTOCHEM PHOTOBIOL, V75, P353, DOI 10.1562/0031-8655(2002)075<0353:SMOQAO>2.0.CO;2; Nonell S, 2000, METHOD ENZYMOL, V319, P37; Noritomi H, 2006, COLLOID POLYM SCI, V284, P677, DOI 10.1007/s00396-005-1419-x; Parasassi T, 1998, J FLUORESC, V8, P365, DOI 10.1023/A:1020528716621; PARASASSI T, 1994, BIOPHYS J, V66, P120, DOI 10.1016/S0006-3495(94)80763-5; Rameez S, 2011, LANGMUIR, V27, P8829, DOI 10.1021/la201246m; Regev O, 1999, J COLLOID INTERF SCI, V210, P8, DOI 10.1006/jcis.1998.5776; Rodriguez HB, 2012, PHOTOCHEM PHOTOBIOL, V88, P831, DOI 10.1111/j.1751-1097.2012.01152.x; Ruiz CC, 2003, COLLOID POLYM SCI, V281, P531, DOI 10.1007/s00396-002-0801-1; Ruiz CC, 2000, LANGMUIR, V16, P7946, DOI 10.1021/la000154s; Salokhiddinov K. I., 1981, Journal of Applied Spectroscopy, V34, P561, DOI 10.1007/BF00613067; Sanchez SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029278; SCHMIDT R, 1987, J AM CHEM SOC, V109, P6976, DOI 10.1021/ja00257a012; Sierra ML, 1999, LANGMUIR, V15, P2301, DOI 10.1021/la9804177; Szuts A, 2012, INT J PHARMACEUT, V433, P1, DOI 10.1016/j.ijpharm.2012.04.076; Thevenet S, 1999, CARBOHYD RES, V318, P52, DOI 10.1016/S0008-6215(99)00079-8; Tong S, 2011, NANO LETT, V11, P3720, DOI 10.1021/nl201978c; Toro C, 2009, CHEM PHYS LIPIDS, V157, P104, DOI 10.1016/j.chemphyslip.2008.11.004; Ullrich S, 2008, EUR J PHARM BIOPHARM, V70, P550, DOI 10.1016/j.ejpb.2008.05.014; Valdes K, 2014, COLLOID SURFACE B, V117, P1, DOI 10.1016/j.colsurfb.2014.01.029; Verma PK, 2009, PHYS CHEM CHEM PHYS, V11, P8467, DOI 10.1039/b905573h; Vlahov IR, 1997, J CARBOHYD CHEM, V16, P1, DOI 10.1080/07328309708006506; WEBER G, 1979, BIOCHEMISTRY-US, V18, P3075, DOI 10.1021/bi00581a025; Wolszczak M, 2002, J PHOTOCH PHOTOBIO A, V147, P45, DOI 10.1016/S1010-6030(01)00611-6; Youan BBC, 2003, AAPS PHARMSCI, V5; Zhao SN, 2014, LANGMUIR, V30, P6920, DOI 10.1021/la501141m; ZULAUF M, 1979, J PHYS CHEM-US, V83, P480, DOI 10.1021/j100467a011	52	5	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123669	10.1371/journal.pone.0123669	http://dx.doi.org/10.1371/journal.pone.0123669			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905632	Green Published, gold, Green Submitted			2022-12-27	WOS:000353332000041
J	Yi, JZ; Mao, X; Chen, LJ; Xue, YL; Rovetta, A; Caleanu, CD				Yi, Jizheng; Mao, Xia; Chen, Lijiang; Xue, Yuli; Rovetta, Alberto; Caleanu, Catalin-Daniel			Illumination Normalization of Face Image Based on Illuminant Direction Estimation and Improved Retinex	PLOS ONE			English	Article							HISTOGRAM EQUALIZATION; RECOGNITION; COMPENSATION	Illumination normalization of face image for face recognition and facial expression recognition is one of the most frequent and difficult problems in image processing. In order to obtain a face image with normal illumination, our method firstly divides the input face image into sixteen local regions and calculates the edge level percentage in each of them. Secondly, three local regions, which meet the requirements of lower complexity and larger average gray value, are selected to calculate the final illuminant direction according to the error function between the measured intensity and the calculated intensity, and the constraint function for an infinite light source model. After knowing the final illuminant direction of the input face image, the Retinex algorithm is improved from two aspects: (1) we optimize the surround function; (2) we intercept the values in both ends of histogram of face image, determine the range of gray levels, and stretch the range of gray levels into the dynamic range of display device. Finally, we achieve illumination normalization and get the final face image. Unlike previous illumination normalization approaches, the method proposed in this paper does not require any training step or any knowledge of 3D face and reflective surface model. The experimental results using extended Yale face database B and CMU-PIE show that our method achieves better normalization effect comparing with the existing techniques.	[Yi, Jizheng; Mao, Xia; Chen, Lijiang; Xue, Yuli] Beihang Univ, Sch Elect & Informat Engn, Beijing 100191, Peoples R China; [Rovetta, Alberto] Polytech Univ Milan, Dept Mech, I-20156 Milan, Italy; [Caleanu, Catalin-Daniel] Univ POLITEHN Timisoara, Dept Appl Elect, Timisoara 300223, Romania	Beihang University; Polytechnic University of Milan; Polytechnic University of Timisoara	Chen, LJ (corresponding author), Beihang Univ, Sch Elect & Informat Engn, Beijing 100191, Peoples R China.	clj@ee.buaa.edu.cn	Caleanu, Catalin Daniel/AAE-2995-2019	Caleanu, Catalin Daniel/0000-0002-0252-7047	Specialized Research Fund for the Doctoral Program of Higher Education [20121102130001]; China Postdoctoral Science Foundation [2013M540837]; Innovation Foundation of BUAA for PhD Graduates; National Natural Science Foundation of China [61103097]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Innovation Foundation of BUAA for PhD Graduates; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 20121102130001), the China Postdoctoral Science Foundation (Grant No. 2013M540837), the Innovation Foundation of BUAA for PhD Graduates, and the National Natural Science Foundation of China (Grant No. 61103097). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini Y, 1997, IEEE T PATTERN ANAL, V19, P721, DOI 10.1109/34.598229; Bayu BSD, 2013, P 2013 IEEE WORKSH A, P131; Chacon M, P 10 IEEE INT C FUZZ, P675; Chacon M, P IEEE ANN M N AM FU, P241; Chen WL, 2006, IEEE T SYST MAN CY B, V36, P458, DOI 10.1109/TSMCB.2005.857353; Cheng Y, 2012, P 4 INT C INT HUM MA, V1, P94; Diaz-Ramirez VH, 2009, APPL OPTICS, V48, P1408, DOI 10.1364/AO.48.001408; Emadi M, 2012, PROCEDIA ENGINEER, V41, P854, DOI 10.1016/j.proeng.2012.07.254; Filippi AM, 2013, OPT LETT, V38, P1676, DOI 10.1364/OL.38.001676; Ge Wei, 2010, Optics and Precision Engineering, V18, P1011; Georghiades AS, 2001, IEEE T PATTERN ANAL, V23, P643, DOI 10.1109/34.927464; Jobson DJ, 1997, IEEE T IMAGE PROCESS, V6, P965, DOI 10.1109/83.597272; Jobson DJ, 1997, IEEE T IMAGE PROCESS, V6, P451, DOI 10.1109/83.557356; Jung C, 2013, NEUROCOMPUTING, V113, P130, DOI 10.1016/j.neucom.2013.01.038; LAND EH, 1971, J OPT SOC AM, V61, P1, DOI 10.1364/JOSA.61.000001; Lee KC, 2005, IEEE T PATTERN ANAL, V27, P684, DOI 10.1109/TPAMI.2005.92; Lee PH, 2012, IEEE T IMAGE PROCESS, V21, P4280, DOI 10.1109/TIP.2012.2202670; Luo Y., 2013, INT J ADV MANUF TECH, P1; Mian A, 2011, OPT EXPRESS, V19, P7491, DOI 10.1364/OE.19.007491; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Park S, P 19 INT C PATT REC, P1; Patil NK, 2013, P 2013 INT S EL SYST, P148; PIZER SM, 1987, COMPUT VISION GRAPH, V39, P355, DOI 10.1016/S0734-189X(87)80186-X; Qin J, 2013, APPL OPTICS, V52, P6512, DOI 10.1364/AO.52.006512; Rahman ZU, 2004, J ELECTRON IMAGING, V13, P100, DOI 10.1117/1.1636183; Rahman ZU, 2002, PROC SPIE, V4662, P390, DOI 10.1117/12.469537; Restrepo R, 2012, OPT COMMUN, V285, P546, DOI 10.1016/j.optcom.2011.10.077; Ruiz-Del-Solar J, 2008, PATTERN RECOGN LETT, V29, P1966, DOI 10.1016/j.patrec.2008.06.015; Shashua A, 2001, IEEE T PATTERN ANAL, V23, P129, DOI 10.1109/34.908964; Sim T, 2003, IEEE T PATTERN ANAL, V25, P1615, DOI 10.1109/TPAMI.2003.1251154; Vishwakarma Virendra P., 2009, International Journal of Recent Trends in Engineering, V1, P318; Wang HT, 2004, SIXTH IEEE INTERNATIONAL CONFERENCE ON AUTOMATIC FACE AND GESTURE RECOGNITION, PROCEEDINGS, P819; Wang HT, 2004, PROC CVPR IEEE, P498; Wang YH, 2008, INFORM SCIENCES, V178, P2705, DOI 10.1016/j.ins.2007.12.017; Xie XD, 2006, PATTERN RECOGN LETT, V27, P609, DOI 10.1016/j.patrec.2005.09.026; Xie XD, 2005, IEEE INT SYMP CIRC S, P3841; Xie XD, 2005, PATTERN RECOGN, V38, P221, DOI 10.1016/j.patcog.2004.07.002; Yang Jie, 2013, Journal of Multimedia, V8, P541, DOI 10.4304/jmm.8.5.541-547; Yang Jie, 2002, Journal of Shanghai Jiaotong University, V36, P894; Yi JZ, 2014, APPL OPTICS, V53, P226, DOI 10.1364/AO.53.000226; Zhao XX, 2011, THESIS CHINA U MININ; Zhou Y, 2013, OPT EXPRESS, V21, P11294, DOI 10.1364/OE.21.011294	42	12	12	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0122200	10.1371/journal.pone.0122200	http://dx.doi.org/10.1371/journal.pone.0122200			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906370	Green Published, Green Submitted, gold			2022-12-27	WOS:000353332000012
J	Suo, YJ; Dong, C; Kang, XY				Suo, Yujing; Dong, Chunbo; Kang, Xiangyang			Inheritance and Variation of Cytosine Methylation in Three Populus Allotriploid Populations with Different Heterozygosity	PLOS ONE			English	Article							DNA-METHYLATION; WIDE HYBRIDIZATION; GENOME; POLYPLOIDY; ALLOPOLYPLOIDY; BRASSICA; PATTERNS; RICE	DNA methylation is an epigenetic mechanism with the potential to regulate gene expression and affect plant phenotypes. Both hybridization and genome doubling may affect the DNA methylation status of newly formed allopolyploid plants. Previous studies demonstrated that changes in cytosine methylation levels and patterns were different among individual hybrid plant, therefore, studies investigating the characteristics of variation in cytosine methylation status must be conducted at the population level to avoid sampling error. In the present study, an F1 hybrid diploid population and three allotriploid populations with different heterozygosity [originating from first-division restitution (FDR), second-division restitution (SDR), and post-meiotic restitution (PMR) 2n eggs of the same female parent] were used to investigate cytosine methylation inheritance and variation relative to their common parents using methylation-sensitive amplification polymorphism (MSAP). The variation in cytosine methylation in individuals in each population exhibited substantial differences, confirming the necessity of population epigenetics. The total methylation levels of the diploid population were significantly higher than in the parents, but those of the three allotriploid populations were significantly lower than in the parents, indicating that both hybridization and polyploidization contributed to cytosine methylation variation. The vast majority of methylated status could be inherited from the parents, and the average percentages of non-additive variation were 6.29, 3.27, 5.49 and 5.07% in the diploid, FDR, SDR and PMR progeny populations, respectively. This study lays a foundation for further research on population epigenetics in allopolyploids.	[Suo, Yujing; Dong, Chunbo; Kang, Xiangyang] Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Tree Breeding, Beijing, Peoples R China; [Kang, Xiangyang] Beijing Forestry Univ, Coll Biol Sci & Technol, Key Lab Genet & Breeding Forest Trees & Ornamenta, Minist Educ, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Kang, XY (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Tree Breeding, Beijing, Peoples R China.	kangxy@bjfu.edu.cn		Kang, Xiangyang/0000-0002-2557-4356	Special Fund for Forest Scientific Research in the Public Welfare [201404113]; 111 Project [B13007]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13047]	Special Fund for Forest Scientific Research in the Public Welfare; 111 Project(Ministry of Education, China - 111 Project); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the Special Fund for Forest Scientific Research in the Public Welfare (201404113), the 111 Project (B13007) and the Program for Changjiang Scholars and Innovative Research Team in University (IRT13047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2004, BIOL J LINN SOC, V82, P467, DOI 10.1111/j.1095-8312.2004.00333.x; Baumel A, 2002, MOL PHYLOGENET EVOL, V22, P303, DOI 10.1006/mpev.2001.1064; Chen CB, 2013, FOREST RES, P69; Chen LZ, 2008, GENOME, V51, P789, DOI 10.1139/G08-063; Dong CB, 2014, PLANT J, V80, P282, DOI 10.1111/tpj.12631; Dong CB, 2014, CAN J FOREST RES, V44, P692, DOI 10.1139/cjfr-2013-0360; Fulnecek J, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-2; Hegarty MJ, 2011, MOL ECOL, V20, P105, DOI 10.1111/j.1365-294X.2010.04926.x; Kang XiangYang, 1997, Acta Botanica Yunnanica, V19, P402; Kang XiangYang, 2010, Journal of Beijing Forestry University, V32, P149; Kashkush K, 2002, GENETICS, V160, P1651; KURATA N, 1978, JPN J GENET, V53, P251, DOI 10.1266/jjg.53.251; Leitch IJ, 1997, TRENDS PLANT SCI, V2, P470, DOI 10.1016/S1360-1385(97)01154-0; LEVIN DA, 1983, AM NAT, V122, P1, DOI 10.1086/284115; Li A, 2011, PLANT MOL BIOL REP, V29, P784, DOI 10.1007/s11105-010-0280-3; Li XL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-207; Lu YL, 2008, J GENET GENOMICS, V35, P41, DOI 10.1016/S1673-8527(08)60006-5; Lukens LN, 2006, PLANT PHYSIOL, V140, P336, DOI 10.1104/pp.105.066308; Madlung A, 2002, PLANT PHYSIOL, V129, P733, DOI 10.1104/pp.003095; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; MENDIBURU AO, 1977, THEOR APPL GENET, V49, P53, DOI 10.1007/BF00275164; Parisod C, 2009, NEW PHYTOL, V184, P1003, DOI 10.1111/j.1469-8137.2009.03029.x; Peredo EL, 2006, J PLANT PHYSIOL, V163, P1071, DOI 10.1016/j.jplph.2005.09.010; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Sha AH, 2005, MOL GENET GENOMICS, V273, P484, DOI 10.1007/s00438-005-1148-3; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Verhoeven KJF, 2010, MOL ECOL, V19, P315, DOI 10.1111/j.1365-294X.2009.04460.x; Wang CG, 2009, BOT STUD, V50, P389; Wang J, 2012, SILVAE GENET, V61, P85, DOI 10.1515/sg-2012-0011; Wang J, 2012, ANN FOREST SCI, V69, P59, DOI 10.1007/s13595-011-0152-5; Xu ML, 2000, PLANT MOL BIOL REP, V18, P361, DOI 10.1007/BF02825064; Zhao XX, 2007, PLANT SCI, V172, P930, DOI 10.1016/j.plantsci.2007.01.002	33	6	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0126491	10.1371/journal.pone.0126491	http://dx.doi.org/10.1371/journal.pone.0126491			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901359	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500124
J	Tang, XL; Wang, HY; Shao, CY; Shao, HB				Tang, Xiaoli; Wang, Hongyan; Shao, Chuyang; Shao, Hongbo			Global Gene Expression of Kosteletzkya virginica Seedlings Responding to Salt Stress	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; BETULA-PLATYPHYLLA; SEASHORE MALLOW; SALINITY; DROUGHT; COLD; ACID; TOLERANCE; BIODIESEL; PROFILE	Soil salinization is becoming a serious threat to crop yield all over the world. Nowadays, acquainting the specific molecular mechanisms underlying various abiotic stresses especially to salt stress should be of great importance. While the development of the high-throughout sequencing technology promoted the progress powerfully. The intricate perception, transduction and regulation mechanisms underlying salt stress are being illustrated more and more clearly. As a perennial halophytic plant, Kosteletzkya virginica is able to help us to understand the mechanisms more directly and effectively. We carried out the whole transcriptome analysis on young seedlings with or without salt treatment through high-throughout sequencing technology. The results revealed that the numbers of different expressed transcripts between control and different treatments are 4145 and 9134, respectively. The ORF prediction suggested that there were 94308 ORF out of the 103489 (91.10%) total transcripts. We also carried out further differential expression analysis through gene ontology (GO) classification, cluster of orthologous groups (COG) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. In a word, our transcriptome study on Kosteletzkya virginica would provide direct and effective references for researches on molecular mechanisms of salt-tolerance, extending our view of salt tolerance in plant further. Above all, the related report in this paper is the first about Kosteletzkya virginica.	[Tang, Xiaoli; Wang, Hongyan; Shao, Hongbo] Chinese Acad Sci, Yantai Inst Coastal Zone Res YIC, Key Lab Coastal Biol & Bioresources Utilizat, Yantai 264003, Peoples R China; [Shao, Hongbo] Jiangsu Acad Agr Sci, Inst Biotechnol, Nanjing 210014, Peoples R China; [Wang, Hongyan] China Agr Univ, Yantai Acad, Yantai 264670, Peoples R China; [Shao, Chuyang] Shandong Agr Univ, Tai An 271018, Shandong, Peoples R China; [Tang, Xiaoli; Wang, Hongyan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; Jiangsu Academy of Agricultural Sciences; China Agricultural University; Shandong Agricultural University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shao, HB (corresponding author), Chinese Acad Sci, Yantai Inst Coastal Zone Res YIC, Key Lab Coastal Biol & Bioresources Utilizat, Yantai 264003, Peoples R China.	shaohongbochu@126.com			National Natural Science Foundation of China [41171216]; National Basic Research Program of China [2013CB430403]; CAS/SAFEA International Partnership Program for Creative Research Teams, Yantai Science & Technology Development Project [2011016]; Yantai Double-hundred Talent Plan [XY-003-02]; 135 Development Plan of YIC-CAS; Science & Technology Development Plan of Shandong Province [010GSF10208]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); CAS/SAFEA International Partnership Program for Creative Research Teams, Yantai Science & Technology Development Project; Yantai Double-hundred Talent Plan; 135 Development Plan of YIC-CAS(Chinese Academy of Sciences); Science & Technology Development Plan of Shandong Province	This research was partially supported by the National Natural Science Foundation of China (41171216), the National Basic Research Program of China (2013CB430403), the CAS/SAFEA International Partnership Program for Creative Research Teams, Yantai Science & Technology Development Project (No. 2011016), Yantai Double-hundred Talent Plan (XY-003-02), 135 Development Plan of YIC-CAS and the Science & Technology Development Plan of Shandong Province (010GSF10208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashraf M, 2009, BIOTECHNOL ADV, V27, P744, DOI 10.1016/j.biotechadv.2009.05.026; Bedell JA, 2005, PLOS BIOL, V3, P103, DOI 10.1371/journal.pbio.0030013; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Comai L, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001876; Cui MH, 2013, FEBS LETT, V587, P1773, DOI 10.1016/j.febslet.2013.04.028; deBruxelles GL, 1996, PLANT PHYSIOL, V111, P381, DOI 10.1104/pp.111.2.381; FAO, 2008, LAND PLANT NUTR MAN; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; GALLAGHER JL, 1985, PLANT SOIL, V89, P323, DOI 10.1007/BF02182251; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Guo YQ, 2009, GENETICA, V137, P189, DOI 10.1007/s10709-009-9384-9; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Ibrahim MH, 2013, MOLECULES, V18, P7957, DOI 10.3390/molecules18077957; Jiang YQ, 2009, MOL GENET GENOMICS, V282, P503, DOI 10.1007/s00438-009-0481-3; Jiang YQ, 2009, PLANT MOL BIOL, V69, P91, DOI 10.1007/s11103-008-9408-3; Kalra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083336; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li HZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083530; Lv JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082155; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; Menzel U, 1999, PROG BIOMET, V14, P127; Moser BR, 2013, RENEW ENERG, V50, P833, DOI 10.1016/j.renene.2012.08.016; Mu HZ, 2012, INT J MOL SCI, V13, P13012, DOI 10.3390/ijms131013012; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Pfeifer-Sancar K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-888; Pinto AC, 2011, GENET MOL RES, V10, P1707, DOI 10.4238/vol10-3gmr1554; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruan CJ, 2008, ECOL ENG, V32, P320, DOI 10.1016/j.ecoleng.2007.12.010; Schroeder JI, 2013, NATURE, V497, P60, DOI 10.1038/nature11909; Tang X., 2014, CRIT REVI BIOTECH, P1; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Varshney RK, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001883; Villarino GH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094651; Voytas DF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001877; Wang H, 2014, SCI WORLD J, V2014, P7; Wang YC, 2012, TREE GENET GENOMES, V8, P1031, DOI 10.1007/s11295-012-0483-x; Wang Zhangying FB, 2010, BMC GENOM, V11; Yan K, 2013, ACTA PHYSIOL PLANT, V35, P2867, DOI 10.1007/s11738-013-1325-7; Yang A, 2012, J EXP BOT, V63, P2541, DOI 10.1093/jxb/err431; Yang O, 2009, GENE, V436, P45, DOI 10.1016/j.gene.2009.02.010; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Ye NH, 2011, PLANT CELL PHYSIOL, V52, P689, DOI 10.1093/pcp/pcr028; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou GS, 2010, AGRON J, V102, P395, DOI 10.2134/agronj2009.0274	49	18	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0124421	10.1371/journal.pone.0124421	http://dx.doi.org/10.1371/journal.pone.0124421			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25901608	Green Published, gold, Green Submitted			2022-12-27	WOS:000353331500085
J	Taylor, KL; Weston, M; Batterham, AM				Taylor, Kathryn L.; Weston, Matthew; Batterham, Alan M.			Evaluating Intervention Fidelity: An Example from a High-Intensity Interval Training Study	PLOS ONE			English	Article							LOW-VOLUME; HEALTH; OUTCOMES; FITNESS; IMPACT; RPE	Aim Intervention fidelity refers to the degree to which an experimental manipulation has been implemented as intended, but simple, robust methods for quantifying fidelity have not been well documented. Therefore, we aim to illustrate a rigorous quantitative evaluation of intervention fidelity, using data collected during a high-intensity interval training intervention. Design Single-group measurement study. Methods Seventeen adolescents (mean age +/- standard deviation [SD] 14.0 +/- 0.3 years) attended a 10-week high-intensity interval training intervention, comprising two exercise sessions per week. Sessions consisted of 4-7 45-s maximal effort repetitions, interspersed with 90-s rest. We collected heart rate data at 5-s intervals and recorded the peak heart rate for each repetition. The high-intensity exercise criterion was >= 90% of individual maximal heart rate. For each participant, we calculated the proportion of total exercise repetitions exceeding this threshold. A linear mixed model was applied to properly separate the variability in peak heart rate between-and within-subjects. Results are presented both as intention to treat (including missed sessions) and per protocol (only participants with 100% attendance; n=8). Results For intention to treat, the median (interquartile range) proportion of repetitions meeting the high-intensity criterion was 58% (42% to 68%). The mean peak heart rate was 85% of maximal, with a between-subject SD of 7.8 (95% confidence interval 5.4 to 11.3) percentage points and a within-subject SD of 15.1 (14.6 to 15.6) percentage points. For the per protocol analysis, the median proportion of high-intensity repetitions was 68% (47% to 86%). The mean peak heart rate was 91% of maximal, with between-and within-subject SDs of 3.1 (-1.3 to 4.6) and 3.4 (3.2 to 3.6) percentage points, respectively. Conclusions Synthesising information on exercise session attendance and compliance (exercise intensity) quantifies the intervention dose and informs evaluations of treatment fidelity.	[Taylor, Kathryn L.; Batterham, Alan M.] Univ Teesside, Hlth & Social Care Inst, Middlesbrough, Cleveland, England; [Weston, Matthew] Univ Teesside, Dept Sport & Exercise Sci, Sch Social Sci Business & Law, Middlesbrough, Cleveland, England	University of Teesside; University of Teesside	Taylor, KL (corresponding author), Univ Teesside, Hlth & Social Care Inst, Middlesbrough, Cleveland, England.	k.taylor@tees.ac.uk	Weston, Kathryn/AAB-3155-2020	Weston, Kathryn/0000-0001-5918-6389; Weston, Matthew/0000-0002-9531-3004; BATTERHAM, ALAN/0000-0002-7865-7227	Medical Research Council [MR/K02325X/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Achten J, 2003, SPORTS MED, V33, P517, DOI 10.2165/00007256-200333070-00004; Bellg AJ, 2004, HEALTH PSYCHOL, V23, P443, DOI 10.1037/0278-6133.23.5.443; Buchheit M, 2013, SPORTS MED, V43, P313, DOI 10.1007/s40279-013-0029-x; CERRETELLI P, 1971, Scandinavian Journal of Respiratory Diseases Supplementum, V77, p35A; Dumas JE, 2001, AM J PREV MED, V20, P38, DOI 10.1016/S0749-3797(00)00272-5; Fortington LV, 2014, J SCI MED SPORT, V10, DOI 1016/j.jsams.2014.05.001; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; Horner S, 2006, J SPEC PEDIATR NURS, V11, P80, DOI 10.1111/j.1744-6155.2006.00050.x; Impellizzeri FM, 2004, MED SCI SPORT EXER, V36, P1042, DOI 10.1249/01.MSS.0000128199.23901.2F; Little JP, 2011, J APPL PHYSIOL, V111, P1554, DOI 10.1152/japplphysiol.00921.2011; Lunt H, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0083256, 10.1371/journal.pone.0105360]; Midgley AW, 2007, INT J SPORTS MED, V28, P40, DOI 10.1055/s-2006-923856; Miller FL, 2014, MED SCI SPORT EXER, V46, P69, DOI 10.1249/MSS.0b013e3182a038b9; Mujika I, 2013, INT J SPORT PHYSIOL, V8, P465, DOI 10.1123/ijspp.8.5.465; Porta N, 2007, J CLIN EPIDEMIOL, V60, P663, DOI 10.1016/j.jclinepi.2006.09.013; Ramsbottom R, 1988, Br J Sports Med, V22, P141; Resnick B, 2011, TOP STROKE REHABIL, V18, P611, DOI 10.1310/tsr18s01-611; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Seiler S, 2005, MED SCI SPORT EXER, V37, P1601, DOI 10.1249/01.mss.0000177560.18014.d8; Senn SS, 2008, STATISTICAL ISSUES I, P166; Soldano C, 1997, J SCHOOL HEALTH, V67, P292, DOI 10.1111/j.1746-1561.1997.tb03455.x; Stegle O, 2008, IEEE T BIO-MED ENG, V55, P2143, DOI 10.1109/TBME.2008.923118; Taylor K.L., 2014, THESIS; Weston M, 2004, AM J SPORT MED, V32, p54S, DOI 10.1177/0363546503261421; Weston M, 2014, SPORTS MED, V44, P1005, DOI 10.1007/s40279-014-0180-z	25	46	48	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2015	10	4							e0125166	10.1371/journal.pone.0125166	http://dx.doi.org/10.1371/journal.pone.0125166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KV	25902066	Green Published, Green Submitted, gold			2022-12-27	WOS:000353331500113
J	Tran, MP; Phuong, NT; Scippo, ML; Dalsgaard, A				Tran Minh Phu; Phuong, Nguyen Thanh; Scippo, Marie-Louise; Dalsgaard, Anders			Quality of Antimicrobial Products Used in Striped Catfish (Pangasianodon hypophthalmus) Aquaculture in Vietnam	PLOS ONE			English	Article							EDWARDSIELLA-ICTALURI; ANTIBIOTICS; FEED	Antimicrobial usage is common in Asian aquaculture. This study aimed to determine the quality of antimicrobial products used by Vietnamese striped catfish (Pangasianodon hypophthalmus) farmers. Twenty one antimicrobial products (11 products contained a single antimicrobial and 10 products contained a mixture of two different antimicrobials) commonly used by catfish farmers were obtained from so-called chemical shops located in the Mekong Delta, Vietnam. Ultra High Performance Liquid Chromatography Mass Spectrometry was used to analyze concentration of sulfonamides, trimethoprim, amoxicillin, cefalexin and ciprofloxacin whereas concentrations of florfenicol and doxycycline were analyzed by High Performance Liquid Chromatography with UV detection. Results revealed that only 4/11 products with a single antimicrobial and 2/10 products with a mixture of antimicrobials contained active substances within +/- 10% of the concentration declared on the product label. Two products with antimicrobial mixtures did not contain any of the declared antimicrobials. Comparing two batches, analysis of 11 products revealed that only one product contained a concentration of active compound that varied with less than 10% in both batches. Several product labels provided inadequate information on how to calculate therapeutic dosage and further stated withdrawal time despite lack of pharmacokinetic data on the antimicrobials in catfish. There is an urgent need to strengthen approval procedures and in particular regularly to monitor the quality of antimicrobials used in Vietnamese aquaculture.	[Tran Minh Phu; Phuong, Nguyen Thanh] Can Tho Univ, Coll Aquaculture & Fisheries, Dept Aquat Nutr & Prod Proc, Can Tho, Vietnam; [Tran Minh Phu; Dalsgaard, Anders] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Microbiol, Copenhagen, Denmark; [Scippo, Marie-Louise] Univ Liege, Fac Vet Med, Dept Food Sci, Liege, Belgium	Can Tho University; University of Copenhagen; University of Liege	Tran, MP (corresponding author), Can Tho Univ, Coll Aquaculture & Fisheries, Dept Aquat Nutr & Prod Proc, Can Tho, Vietnam.	tmphu@ctu.edu.vn		Tran, Minh Phu/0000-0002-2521-0667	EU-funded FP7 project "Sustaining Ethical Aquaculture Trade" (SEAT) [222889]	EU-funded FP7 project "Sustaining Ethical Aquaculture Trade" (SEAT)	The work presented received financial and other support from the EU-funded FP7 project "Sustaining Ethical Aquaculture Trade" (SEAT project number 222889; www.seatglobal.eu). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulah R., 2012, PHARM REGUL AFF, V1, P2, DOI [10.4172/2167-7689.1000e106, DOI 10.4172/2167-7689.1000E106]; [Anonymous], 2017, 17025 ISOIEC; Bekoe SO, 2014, ANAL METHODS-UK, V6, P5847, DOI 10.1039/c4ay00748d; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Depaola Angelo, 1995, Journal of Aquatic Animal Health, V7, P155, DOI 10.1577/1548-8667(1995)007&lt;0155:TRBBIR&gt;2.3.CO;2; Dung TT, 2008, MICROB DRUG RESIST, V14, P311, DOI 10.1089/mdr.2008.0848; Gaunt PS, 2004, J WORLD AQUACULT SOC, V35, P257, DOI 10.1111/j.1749-7345.2004.tb01083.x; KAMAKURA K, 1994, J FOOD HYG SOC JPN, V35, P310; Mai Van Tai, 2012, FAO Fisheries and Aquaculture Technical Paper, V547, P91; Pearce JN, 2009, FOOD ADDIT CONTAM A, V26, P39, DOI 10.1080/02652030802189757; Phan LT, 2009, AQUACULTURE, V296, P227, DOI 10.1016/j.aquaculture.2009.08.017; Phuc NT, 2012, INT FISH S SHAR KNOW, P98; Prazuck T, 2002, SEX TRANSM DIS, V29, P624, DOI 10.1097/00007435-200211000-00002; Rico A, 2013, AQUACULTURE, V412, P231, DOI 10.1016/j.aquaculture.2013.07.028; Phu TM, 2015, AQUACULTURE, V438, P1, DOI 10.1016/j.aquaculture.2014.12.032; United States Department of Agriculture, 2010, CLG FLOR, V1. 04, P1; US Food and Drug Administration, 2011, US FISH WILDL SERV A; USDA, 2021, OILS WORLD MARK TRAD; Vietnamese Ministry of Agriculture and Rural Development, 2003, GUID 788 TY QLT REG; Zhao L, 2012, 201259905086EN AG, P5990	20	24	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2015	10	4							e0124267	10.1371/journal.pone.0124267	http://dx.doi.org/10.1371/journal.pone.0124267			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XJ	25897517	Green Published, Green Submitted, gold			2022-12-27	WOS:000353212600059
J	Saeidi, A; Tien, VLT; Al-Batran, R; Al-Darraji, HA; Tan, HY; Yong, YK; Ponnampalavanar, S; Barathan, M; Rukumani, DV; Ansari, AW; Velu, V; Kamarulzaman, A; Larsson, M; Shankar, EM				Saeidi, Alireza; Tien, Vicky L. Tien; Al-Batran, Rami; Al-Darraji, Haider A.; Tan, Hong Y.; Yong, Yean K.; Ponnampalavanar, Sasheela; Barathan, Muttiah; Rukumani, Devi V.; Ansari, Abdul W.; Velu, Vijayakumar; Kamarulzaman, Adeeba; Larsson, Marie; Shankar, Esaki M.			Attrition of TCR Va7.2+CD161++ MAIT Cells in HIV-Tuberculosis Co-Infection Is Associated with Elevated Levels of PD-1 Expression	PLOS ONE			English	Article							INVARIANT T-CELLS; DISEASE PROGRESSION; INFECTION; LYMPHOCYTES; EXHAUSTION; RECEPTORS; SUBSETS; CD161	Mucosal-associated invariant T (MAIT) cells are evolutionarily conserved antimicrobial MR1-restricted CD8+ T cells co-expressing the semi-invariant TCR V alpha 7.2, and are numerous in the blood and mucosal tissues of humans. MAIT cells appear to undergo exhaustion in chronic viral infections. However, their role in human immunodeficiency virus type 1 (HIV1) mono-infection and HIV/tuberculosis (TB) co-infection have seldom been elaborately investigated. We conducted a cross-sectional study to investigate the frequencies and phenotypes of CD161++ CD8+ T cells among anti-retroviral therapy (ART)/anti-TB therapy (ATT) treatment-naive HIV/TB co-infected, ART/TB treated HIV/TB co-infected, ART naive HIV-infected, ART-treated HIV-infected patients, and HIV negative healthy controls (HCs) by flow cytometry. Our data revealed that the frequency of MAIT cells was severely depleted in HIV mono-and HIV/TB co-infections. Further, PD-1 expression on MAIT cells was significantly increased in HIV mono-and HIV-TB co-infected patients. The frequency of MAIT cells did not show any significant increase despite the initiation of ART and/or ATT. Majority of the MAIT cells in HCs showed a significant increase in CCR6 expression as compared to HIV/TB co-infections. No marked difference was seen with expressions of chemokine co-receptor CCR5 and CD103 among the study groups. Decrease of CCR6 expression appears to explain why HIV-infected patients display weakened mucosal immune responses.	[Saeidi, Alireza; Barathan, Muttiah; Rukumani, Devi V.; Shankar, Esaki M.] Univ Malaya, Fac Med, TIDREC, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia; [Saeidi, Alireza; Al-Darraji, Haider A.; Tan, Hong Y.; Yong, Yean K.; Ponnampalavanar, Sasheela; Ansari, Abdul W.; Kamarulzaman, Adeeba; Shankar, Esaki M.] Univ Malaya, CERiA, Kuala Lumpur 50603, Malaysia; [Tien, Vicky L. Tien] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur 50603, Malaysia; [Al-Batran, Rami] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Malaysia; [Velu, Vijayakumar] Emory Vaccine Ctr, Dept Microbiol & Immunol, Atlanta, GA 30329 USA; [Larsson, Marie] Linkoping Univ, Inst Klin Expt Med, Mol Virol, S-58185 Linkoping, Sweden	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Emory University; Linkoping University	Shankar, EM (corresponding author), Univ Malaya, Fac Med, TIDREC, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia.	shankarem@um.edu.my	Muthu, Shankar Esaki/B-3132-2019; LA SRI PONNAMPALAVANAR, SASHEELA SRI/B-9703-2010; Al-Darraji, Haider Abdulrazzaq Abed/B-7978-2012; Yong, Yean Kong/Q-5318-2016; Velu, Vijayakumar/I-7585-2019; Yong, Yean/B-9202-2017; KAMARULZAMAN, ADEEBA/B-5216-2010; Muttiah, Barathan/M-8963-2016	Muthu, Shankar Esaki/0000-0002-7866-9818; Al-Darraji, Haider Abdulrazzaq Abed/0000-0003-2576-3218; Velu, Vijayakumar/0000-0003-4238-1924; Yong, Yean/0000-0002-8409-6251; sri la sri ponnampalavanar, sasheela/0000-0002-4506-1304; Larsson, Marie/0000-0002-4524-0177	High Impact Research [UM.C/625/1/HIR/MOHE/MED/014]; University of Malaya Research of the Health and Translational Medicine Research Cluster [RP021A-13HTM, RG448-12HTM]; Swedish Research Council [AI52731]; Swedish Physicians against AIDS Research Foundation; Swedish International Development Cooperation Agency; SIDA SARC; VINNMER for Vinnova; Linkoping University Hospital Research Fund; CALF; Swedish Society of Medicine	High Impact Research; University of Malaya Research of the Health and Translational Medicine Research Cluster; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Physicians against AIDS Research Foundation; Swedish International Development Cooperation Agency; SIDA SARC; VINNMER for Vinnova(Vinnova); Linkoping University Hospital Research Fund; CALF; Swedish Society of Medicine	The authors gratefully acknowledge funding support from High Impact Research project titled "Development of diagnostics to detect active and latent tuberculosis in humans using a novel peptide antigen derived from peptidoglycan layer of Mycobacterium tuberculosis" (UM.C/625/1/HIR/MOHE/MED/014) to Adeeba Kamarulzaman. The authors also acknowledge the funding support received from the University of Malaya Research Grants (UMRG) RP021A-13HTM and RG448-12HTM of the Health and Translational Medicine Research Cluster. Marie Larsson is supported by Grant No. AI52731 from the Swedish Research Council, the Swedish Physicians against AIDS Research Foundation, the Swedish International Development Cooperation Agency; SIDA SARC, VINNMER for Vinnova, Linkoping University Hospital Research Fund, CALF and the Swedish Society of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; Chung DR, 2003, J IMMUNOL, V170, P1958, DOI 10.4049/jimmunol.170.4.1958; Cosgrove C, 2013, BLOOD, V121, P951, DOI 10.1182/blood-2012-06-436436; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Fergusson JR, 2014, CELL REP, V9, P1075, DOI 10.1016/j.celrep.2014.09.045; Fergusson JR, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00036; Fernandez CS, 2015, IMMUNOL CELL BIOL, V93, P177, DOI 10.1038/icb.2014.91; Geldmacher C, 2008, J INFECT DIS, V198, P1590, DOI 10.1086/593017; Gold MC, 2011, MICROBES INFECT, V13, P742, DOI 10.1016/j.micinf.2011.03.007; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Greenspan D, 1996, LANCET, V348, P729, DOI 10.1016/S0140-6736(96)02308-2; Huang SX, 2009, P NATL ACAD SCI USA, V106, P8290, DOI 10.1073/pnas.0903196106; Jiang J, 2014, AM J RESP CRIT CARE, V190, P329, DOI 10.1164/rccm.201401-0106OC; Kurioka A, 2015, MUCOSAL IMMUNOL, V8, P429, DOI 10.1038/mi.2014.81; LANIER LL, 1994, J IMMUNOL, V153, P2417; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Lecureuil C, 2007, BLOOD, V109, P3649, DOI 10.1182/blood-2006-01-035717; Leeansyah E, 2013, BLOOD, V121, P1124, DOI 10.1182/blood-2012-07-445429; Maggi L, 2010, EUR J IMMUNOL, V40, P2174, DOI 10.1002/eji.200940257; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Shankar EM, 2014, PATHOG DIS, V70, P110, DOI 10.1111/2049-632X.12108; Siawaya JFD, 2007, INT J INFECT DIS, V11, P289, DOI 10.1016/j.ijid.2007.02.001; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Sutherland R, 2006, AIDS, V20, P821, DOI 10.1097/01.aids.0000218545.31716.a4; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Ussher JE, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00450; Walker LJ, 2012, BLOOD, V119, P422, DOI 10.1182/blood-2011-05-353789; Wong EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083474	35	58	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124659	10.1371/journal.pone.0124659	http://dx.doi.org/10.1371/journal.pone.0124659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894562	Green Submitted, Green Published, gold			2022-12-27	WOS:000353211700114
J	Wu, ZZ; Che, ZW; Wang, YS; Dong, JD; Wu, ML				Wu, Zhen-Zhen; Che, Zhi-Wei; Wang, You-Shao; Dong, Jun-De; Wu, Mei-Lin			Identification of Surface Water Quality along the Coast of Sanya, South China Sea	PLOS ONE			English	Article							SELF-ORGANIZING MAP; DAYA BAY; PHYTOPLANKTON; RIVER; DYNAMICS; LIMITATION; ECOSYSTEMS; BASIN	Principal component analysis (PCA) and cluster analysis (CA) are utilized to identify the effects caused by human activities on water quality along the coast of Sanya, South China Sea. PCA and CA identify the seasonality of water quality (dry and wet seasons) and polluted status (polluted area). The seasonality of water quality is related to climate change and Southeast monsoons. Spatial pattern is mainly related to anthropogenic activities (especially land input of pollutions). PCA reveals the characteristics underlying the generation of coastal water quality. The temporal and spatial variation of the trophic status along the coast of Sanya is governed by hydrodynamics and human activities. The results provide a novel typological understanding of seasonal trophic status in a shallow, tropical, open marine bay.	[Wu, Zhen-Zhen; Wang, You-Shao; Dong, Jun-De; Wu, Mei-Lin] Chinese Acad Sci, State Key Lab Trop Oceanog, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China; [Wu, Zhen-Zhen; Wang, You-Shao; Dong, Jun-De] Chinese Acad Sci, Key Lab Marine Bioresources Sustainable Utilizat, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China; [Wu, Zhen-Zhen; Che, Zhi-Wei] State Ocean Adm, Haikou Marine Environm Monitoring Cent Stn, Haikou, Peoples R China; [Dong, Jun-De] Chinese Acad Sci, Trop Marine Biol Res Stn Hainan, Sanya, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; State Oceanic Administration; Chinese Academy of Sciences	Wu, ML (corresponding author), Chinese Acad Sci, State Key Lab Trop Oceanog, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China.	mlwu@scsio.ac.cn	Wu, Mei-Lin/G-4776-2011		Foundation of Key Laboratory of Yangtze River Water Environment, Ministry of Education (Tongji University), China [YRWEF201304]; State Key Laboratory of Tropical Oceanography (South China Sea Institute of Oceanology, Chinese Academy of Sciences) [LTO1304]; key laboratory for ecological environment in coastal areas, State Oceanic Administration [201211]; key laboratory of marine ecology and environmental science and engineering, State Oceanic Administration [MESE-2013-02]; National Natural Science Foundation of China [41206082]; Project of Key Laboratory of Sanya [L1301]; Special research fund of Sanya [2014KS20]	Foundation of Key Laboratory of Yangtze River Water Environment, Ministry of Education (Tongji University), China; State Key Laboratory of Tropical Oceanography (South China Sea Institute of Oceanology, Chinese Academy of Sciences); key laboratory for ecological environment in coastal areas, State Oceanic Administration; key laboratory of marine ecology and environmental science and engineering, State Oceanic Administration; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Key Laboratory of Sanya; Special research fund of Sanya	This research was supported by: 1. The Foundation of Key Laboratory of Yangtze River Water Environment, Ministry of Education (Tongji University), China (No. YRWEF201304), State Key Laboratory of Tropical Oceanography (South China Sea Institute of Oceanology, Chinese Academy of Sciences (No. LTO1304). These two foundations supported sampling and data collection and analysis. 2. The key laboratory for ecological environment in coastal areas, State Oceanic Administration (No. 201211), key laboratory of marine ecology and environmental science and engineering, State Oceanic Administration (MESE-2013-02), the National Natural Science Foundation of China (No. 41206082). These three foundations supported ecological environment research in tropical marine area. 3. Project of Key Laboratory of Sanya (L1301) and Special research fund of Sanya (2014KS20). These two foundations come from Sanya and had acquired some results about coastal area along Sanya City. The authors used previous results to design research programs, such as setting sampling stations.	[Anonymous], 2006, SAN STAT YB, P491; Boyacioglu H, 2008, ENVIRON GEOL, V54, P275, DOI 10.1007/s00254-007-0815-6; Cloern JE, 1996, REV GEOPHYS, V34, P127, DOI 10.1029/96RG00986; Dong JD, 2010, BRAZ J OCEANOGR, V58, P339, DOI 10.1590/S1679-87592010000400008; Dong JD, 2010, ENVIRON EARTH SCI, V60, P1673, DOI 10.1007/s12665-009-0301-4; Huang LM, 2003, MAR POLLUT BULL, V47, P180, DOI 10.1016/S0025-326X(03)00070-5; Jeong KS, 2008, LIMNOLOGY, V9, P231, DOI 10.1007/s10201-008-0243-7; Jickells TD, 1998, SCIENCE, V281, P217, DOI 10.1126/science.281.5374.217; Mendiguchia C, 2007, CHEMOSPHERE, V69, P1509, DOI 10.1016/j.chemosphere.2007.05.082; Nixon SW, 1993, INT S NUTR DYN COAST, P199; Paerl HW, 2002, ANTON LEEUW INT J G, V81, P487, DOI 10.1023/A:1020561422706; PENNOCK JR, 1985, ESTUAR COAST SHELF S, V21, P711, DOI 10.1016/0272-7714(85)90068-X; Shrestha S, 2007, ENVIRON MODELL SOFTW, V22, P464, DOI 10.1016/j.envsoft.2006.02.001; Simeonov V, 2003, WATER RES, V37, P4119, DOI 10.1016/S0043-1354(03)00398-1; Webster IT, 2005, MAR FRESHWATER RES, V56, P303, DOI 10.1071/MF04083; Wu ML, 2007, ESTUAR COAST SHELF S, V72, P732, DOI 10.1016/j.ecss.2006.11.032; Wu ML, 2012, OCEANOL HYDROBIOL ST, V41, P57, DOI 10.2478/s13545-012-0007-1; Wu ML, 2011, AQUAT ECOSYST HEALTH, V14, P291, DOI 10.1080/14634988.2011.604273; Wu ML, 2010, MAR POLLUT BULL, V60, P852, DOI 10.1016/j.marpolbul.2010.01.007; Wu ML, 2009, J ENVIRON MANAGE, V90, P3082, DOI 10.1016/j.jenvman.2009.04.017; Yin KD, 2001, MAR ECOL PROG SER, V221, P17, DOI 10.3354/meps221017; Zhou WH, 2009, J ENVIRON SCI-CHINA, V21, P595, DOI 10.1016/S1001-0742(08)62313-X	22	6	6	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123515	10.1371/journal.pone.0123515	http://dx.doi.org/10.1371/journal.pone.0123515			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894980	gold, Green Published, Green Submitted			2022-12-27	WOS:000353211700038
